PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhang, X; Nemeria, NS; Leandro, J; Houten, S; Lazarus, M; Gerfen, G; Ozohanics, O; Ambrus, A; Nagy, B; Brukh, R; Jordan, F				Zhang, Xu; Nemeria, Natalia S.; Leandro, Joao; Houten, Sander; Lazarus, Michael; Gerfen, Gary; Ozohanics, Oliver; Ambrus, Attila; Nagy, Balint; Brukh, Roman; Jordan, Frank			Structure?function analyses of the G729R 2-oxoadipate dehydrogenase genetic variant associated with a disorder of l-lysine metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); protein conformation; DNA damage; neurodegenerative disease; cell metabolism; 2-oxoadipate dehydrogenase; 2-oxoadipate dehydrogenase complex; H; D exchange mass spectrometry; multiple 2-oxoadipate dehydrogenase conformations; substrate channeling	EXCHANGE MASS-SPECTROMETRY; ESCHERICHIA-COLI; STRUCTURAL-ANALYSIS; PROTEIN-STRUCTURE; CRYSTAL-STRUCTURE; DHTKD1 MUTATIONS; CATALYTIC DOMAIN; E1 COMPONENT; CUBIC CORE; PYRUVATE	2-Oxoadipate dehydrogenase (E1a, also known as DHTKD1, dehydrogenase E1, and transketolase domain-containing protein 1) is a thiamin diphosphate-dependent enzyme and part of the 2-oxoadipate dehydrogenase complex (OADHc) in l-lysine catabolism. Genetic findings have linked mutations in the DHTKD1 gene to several metabolic disorders. These include ?-aminoadipic and ?-ketoadipic aciduria (AMOXAD), a rare disorder of l-lysine, l-hydroxylysine, and l-tryptophan catabolism, associated with clinical presentations such as developmental delay, mild-to-severe intellectual disability, ataxia, epilepsy, and behavioral disorders that cannot currently be managed by available treatments. A heterozygous missense mutation, c.2185G?A (p.G729R), in DHTKD1 has been identified in most AMOXAD cases. Here, we report that the G729R E1a variant when assembled into OADHc in vitro displays a 50-fold decrease in catalytic efficiency for NADH production and a significantly reduced rate of glutaryl-CoA production by dihydrolipoamide succinyl-transferase (E2o). However, the G729R E1a substitution did not affect any of the three side-reactions associated solely with G729R E1a, prompting us to determine the structure?function effects of this mutation. A multipronged systematic analysis of the reaction rates in the OADHc pathway, supplemented with results from chemical cross-linking and hydrogen?deuterium exchange MS, revealed that the c.2185G?A DHTKD1 mutation affects E1a?E2o assembly, leading to impaired channeling of OADHc intermediates. Cross-linking between the C-terminal region of both E1a and G729R E1a with the E2o lipoyl and core domains suggested that correct positioning of the C-terminal E1a region is essential for the intermediate channeling. These findings may inform the development of interventions to counter the effects of pathogenic DHTKD1 mutations.	[Zhang, Xu; Nemeria, Natalia S.; Brukh, Roman; Jordan, Frank] Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA; [Leandro, Joao; Houten, Sander; Lazarus, Michael] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Gerfen, Gary] Albert Einstein Coll Med, Dept Physiol & Biophys, Bronx, NY 10641 USA; [Ozohanics, Oliver; Ambrus, Attila; Nagy, Balint] Semmelweis Univ, Dept Med Biochem, MTA SE Lab Neurobiochem, H-1094 Budapest, Hungary	Rutgers State University Newark; Rutgers State University New Brunswick; Icahn School of Medicine at Mount Sinai; Yeshiva University; Albert Einstein College of Medicine; Semmelweis University	Nemeria, NS; Jordan, F (corresponding author), Rutgers State Univ, Dept Chem, Newark, NJ 07102 USA.; Houten, S (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.	nemerianatalia@gmail.com; sander.houten@mssm.edu; frjordan@rutgers.edu	Leandro, João T/A-8555-2014; ZHANG, XU/AAL-6729-2020; Ambrus, Attila/O-4301-2017; Ozohanics, Oliver/AAH-4449-2019; Nagy, Balint/E-6960-2017	Leandro, João T/0000-0002-0163-3235; Ambrus, Attila/0000-0001-6014-3175; Ozohanics, Oliver/0000-0002-2705-9921; Houten, Sander/0000-0002-6167-9147; Nagy, Balint/0000-0003-3669-7041	National Institutes of Health [9R15GM116077-01, R03HD092878, R21HD088775]; National Science Foundation [CHE-1402675, CHE1213550]; Hungarian Higher Education Institution Excellence Program [FIKP61826 690289 EATV]; Erasmus grant from the European Union; Rutgers-Newark Chancellor's SEED grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Hungarian Higher Education Institution Excellence Program; Erasmus grant from the European Union; Rutgers-Newark Chancellor's SEED grant	This work was supported by National Institutes of Health Grants 9R15GM116077-01 (to F. J.), R03HD092878 (to S. H.), and R21HD088775 (to S. H.); National Science Foundation Grants CHE-1402675 (to F. J.) and CHE1213550 (to G. G.); the Rutgers-Newark Chancellor's SEED grant (to F. J.); Hungarian Higher Education Institution Excellence Program FIKP61826 690289 EATV (to A. A); and an Erasmus grant from the European Union (to A. A. and F. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrus A, 2016, BBA-MOL BASIS DIS, V1862, P2098, DOI 10.1016/j.bbadis.2016.08.013; Arjunan P, 2014, J BIOL CHEM, V289, P30161, DOI 10.1074/jbc.M114.592915; Balakrishnan A, 2013, J BIOL CHEM, V288, P21688, DOI 10.1074/jbc.M113.465419; Balakrishnan A, 2012, J AM CHEM SOC, V134, P18644, DOI 10.1021/ja3062375; Barsnes H, 2018, J PROTEOME RES, V17, P2552, DOI 10.1021/acs.jproteome.8b00175; Bezerra G. A., 2020, CRYSTAL STRUCTURE IN, DOI [10.1101/2020.01.20.912931, DOI 10.1101/2020.01.20.912931]; Biagosch C, 2017, BBA-MOL BASIS DIS, V1863, P2220, DOI 10.1016/j.bbadis.2017.05.018; Byron O, 2017, SUBCELL BIOCHEM, V83, P523, DOI 10.1007/978-3-319-46503-6_19; Chakraborty J, 2020, AICHE J, V66, DOI 10.1002/aic.16769; Chakraborty J, 2018, FEBS OPEN BIO, V8, P880, DOI 10.1002/2211-5463.12431; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; Danhauser K, 2012, AM J HUM GENET, V91, P1082, DOI 10.1016/j.ajhg.2012.10.006; DeColli AA, 2019, BIOCHEMISTRY-US, V58, P4970, DOI 10.1021/acs.biochem.9b00878; DEROSIER DJ, 1971, P NATL ACAD SCI USA, V68, P1135, DOI 10.1073/pnas.68.6.1135; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Frank RAW, 2007, J MOL BIOL, V368, P639, DOI 10.1016/j.jmb.2007.01.080; Gotze M, 2015, J AM SOC MASS SPECTR, V26, P83, DOI 10.1007/s13361-014-1001-1; Grimm M, 2015, NUCLEIC ACIDS RES, V43, pW362, DOI 10.1093/nar/gkv463; Hage C, 2017, ANGEW CHEM INT EDIT, V56, P14551, DOI 10.1002/anie.201708273; Hagen J, 2015, J INHERIT METAB DIS, V38, P873, DOI 10.1007/s10545-015-9841-9; Hamuro Y, 2008, RAPID COMMUN MASS SP, V22, P1041, DOI 10.1002/rcm.3467; Jordan F, 2019, NEUROCHEM RES, V44, P2325, DOI 10.1007/s11064-019-02765-w; Knapp JE, 1998, J MOL BIOL, V280, P655, DOI 10.1006/jmbi.1998.1924; Knapp JE, 2000, PROTEIN SCI, V9, P37; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Leandro J., 2020, INHIBITION CRYSTAL S, DOI [10.1101/2020.01.20.913012, DOI 10.1101/2020.01.20.913012]; Leandro J, 2020, HUM MOL GENET, V29, P1168, DOI 10.1093/hmg/ddaa037; Murphy GE, 2005, STRUCTURE, V13, P1765, DOI 10.1016/j.str.2005.08.016; Nemeria NS, 2018, BBA-BIOENERGETICS, V1859, P932, DOI 10.1016/j.bbabio.2018.05.001; Nemeria NS, 2018, FREE RADICAL BIO MED, V115, P136, DOI 10.1016/j.freeradbiomed.2017.11.018; Nemeria NS, 2017, FREE RADICAL BIO MED, V108, P644, DOI 10.1016/j.freeradbiomed.2017.04.017; Nemeria NS, 2014, J BIOL CHEM, V289, P29859, DOI 10.1074/jbc.M114.591073; Parthasarathy A, 2011, BIOCHEMISTRY-US, V50, P3540, DOI 10.1021/bi1020056; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rappsilber J, 2011, J STRUCT BIOL, V173, P530, DOI 10.1016/j.jsb.2010.10.014; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Salisbury JP, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0403-1; Sherrill JD, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99922; Song JY, 2012, BIOCHEMISTRY-US, V51, P2795, DOI 10.1021/bi201614n; Stiles AR, 2016, JIMD REP, V25, P15, DOI 10.1007/8904_2015_462; Suzuki K, 2002, ACTA CRYSTALLOGR D, V58, P833, DOI 10.1107/S0907444902005048; Vaudel M, 2015, NAT BIOTECHNOL, V33, P22, DOI 10.1038/nbt.3109; WAGENKNECHT T, 1992, J STRUCT BIOL, V109, P70, DOI 10.1016/1047-8477(92)90069-M; WAGENKNECHT T, 1990, J BIOL CHEM, V265, P22402; Wagner T, 2014, BIOCHEM J, V457, P425, DOI 10.1042/BJ20131142; Wagner T, 2011, CHEM BIOL, V18, P1011, DOI 10.1016/j.chembiol.2011.06.004; Wang JJ, 2015, BIOCHEMISTRY-US, V54, P69, DOI 10.1021/bi5013113; Wang JJ, 2014, J BIOL CHEM, V289, P15215, DOI 10.1074/jbc.M113.544080; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Xu WY, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00085-18; Xu WY, 2012, AM J HUM GENET, V91, P1088, DOI 10.1016/j.ajhg.2012.09.018; Xu WY, 2013, FEBS LETT, V587, P3587, DOI 10.1016/j.febslet.2013.08.047; Zhou JY, 2018, J BIOL CHEM, V293, P19213, DOI 10.1074/jbc.RA118.005432; Zhou JY, 2017, P NATL ACAD SCI USA, V114, P9355, DOI 10.1073/pnas.1619981114	54	5	5	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8078	8095		10.1074/jbc.RA120.012761	http://dx.doi.org/10.1074/jbc.RA120.012761			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32303640	hybrid, Green Published			2022-12-26	WOS:000540935400020
J	Fouani, FZ; Fadaei, R; Moradi, N; Zandieh, Z; Ansaripour, S; Yekaninejad, MS; Vatannejad, A; Mahmoudi, M				Fouani, Fatima Zahraa; Fadaei, Reza; Moradi, Nariman; Zandieh, Zahra; Ansaripour, Soheila; Yekaninejad, Mir Saeed; Vatannejad, Akram; Mahmoudi, Maryam			Circulating levels of Meteorin-like protein in polycystic ovary syndrome: A case-control study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ADIPOSE-TISSUE; INSULIN-RESISTANCE; LEAN WOMEN; ADIPONECTIN; METRNL; FAT; INFLAMMATION; CYTOKINES; OBESITY	Patients diagnosed with polycystic ovary syndrome (PCOS) are at high risk of developing a myriad of endocrinologic and metabolic derailments. Moreover, PCOS is a leading cause of habitual abortion, also known as recurrent pregnancy loss (RPL). Meteorin-like protein (Metrnl) is a newly discovered adipokine with the potential to counteract the metaflammation. This study aimed at determining the associations of serum Metrnl levels with homocysteine, hs-CRP, and some components of metabolic syndrome in PCOS-RPL and infertile PCOS patients.This case-control study was conducted in 120 PCOS patients (60 PCOS-RPL and 60 infertile) and 60 control. Serum hs-CRP and homocysteine were assessed using commercial kits, while adiponectin, Metrnl, FSH, LH, free testosterone and insulin levels were analyzed using ELISA technique. Serum Metrnl levels were found to be lower in PCOS patients when compared to controls (67.98 +/- 26.66 vs. 96.47 +/- 28.72 pg/mL, P <0.001)). Furthermore, serum adiponectin levels were lower, while free testosterone, fasting insulin, HOMA-IR, homocysteine, and hs-CRP were significantly higher in PCOS group compared to controls. Moreover, serum Metrnl correlated with BMI, adiponectin, and homocysteine in controls, and inversely correlated with FBG, fasting insulin, and HOMA-IR in PCOS group and subgroups. Besides, it inversely correlated with hs-CRP in control, and PCOS group and subgroups. These findings revealed a possible role of Metrnl in the pathogenesis of PCOS and RPL. Nevertheless, there is a necessity for future studies to prove this concept.	[Fouani, Fatima Zahraa; Mahmoudi, Maryam] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran; [Fadaei, Reza] Kermanshah Univ Med Sci, Sleep Disorders Res Ctr, Kermanshah, Iran; [Moradi, Nariman] Kurdistan Univ Med Sci, Res Inst Hlth Dev, Cellular & Mol Res Ctr, Sanandaj, Iran; [Moradi, Nariman] Iran Univ Med Sci, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran; [Zandieh, Zahra] Iran Univ Med Sci, Sch Med, Cellular & Mol Res Ctr, Tehran, Iran; [Zandieh, Zahra] Iran Univ Med Sci, Shahid Akbar Abadi Clin Res Dev Unit ShACRDU, Tehran, Iran; [Ansaripour, Soheila] ACECR, Avicenna Res Inst, Reprod Biotechnol Res Ctr, Tehran, Iran; [Yekaninejad, Mir Saeed] Univ Tehran Med Sci, Sch Publ Hlth, Dept Stat, Tehran, Iran; [Vatannejad, Akram] Univ Tehran, Dept Comparat Biosci, Fac Vet Med, Tehran, Iran; [Vatannejad, Akram] Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Kermanshah University of Medical Sciences; Kurdistan University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Academic Center for Education, Culture & Research (ACECR); Tehran University of Medical Sciences; University of Tehran; Tehran University of Medical Sciences	Mahmoudi, M (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Cellular & Mol Nutr, Tehran, Iran.; Vatannejad, A (corresponding author), Univ Tehran, Dept Comparat Biosci, Fac Vet Med, Tehran, Iran.; Vatannejad, A (corresponding author), Univ Tehran Med Sci, Students Sci Res Ctr, Tehran, Iran.	vatannejad@ut.ac.ir; mahmoodi_maryam@yahoo.com	Zandieh, Zahra/AAY-5143-2020	fouani, Fatema/0000-0001-7673-9731; Zandieh, Zahra/0000-0002-7720-9465	Tehran University of Medial Sciences (TUMS), Tehran, Iran [97-03-161-40490, 97-03-103-40-129]	Tehran University of Medial Sciences (TUMS), Tehran, Iran	This project was supported by Tehran University of Medial Sciences (TUMS), Tehran, Iran, grant number 97-03-161-40490 and 97-03-103-40-129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This project was supported by Tehran University of Medial Sciences (TUMS), Tehran, Iran, grant number 97-03-161-40490 and 97-03-103-40-129. The authors would like to thank all patients, without whom, this study would not have been possible.	Abbasi-Ranjbar Zahra, 2018, J Family Reprod Health, V12, P1; Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; AlKhairi I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101283; Arpaci H, 2019, J OBSTET GYNAECOL, V39, P504, DOI 10.1080/01443615.2018.1519530; Bae JY, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0751-3; Bik W, 2007, GYNECOL ENDOCRINOL, V23, P325, DOI 10.1080/09513590701260169; Blagojevic IP, 2018, J MED BIOCHEM, V37, P476, DOI 10.2478/jomb-2018-0008; Brochu-Gaudreau K, 2010, ENDOCRINE, V37, P11, DOI 10.1007/s12020-009-9278-8; Cao HM, 2014, J ENDOCRINOL, V220, pT47, DOI 10.1530/JOE-13-0339; Cardoso RC, 2015, NEUROENDOCRINOLOGY, V102, P226, DOI 10.1159/000381830; Catalan V, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00275; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064446; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen CI, 2015, GYNECOL ENDOCRINOL, V31, P264, DOI 10.3109/09513590.2014.984676; Chung HS, 2018, DIABETES RES CLIN PR, V136, P100, DOI 10.1016/j.diabres.2017.11.031; Crewe C, 2017, J CLIN INVEST, V127, P74, DOI 10.1172/JCI88883; Cupisti S, 2010, FERTIL STERIL, V94, P673, DOI 10.1016/j.fertnstert.2009.03.062; Dadmanesh M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204180; Dadson Keith, 2011, Front Endocrinol (Lausanne), V2, P62, DOI 10.3389/fendo.2011.00062; Delitala AP, 2017, ARCH GYNECOL OBSTET, V296, P405, DOI 10.1007/s00404-017-4429-2; Diamanti-Kandarakis E, 2007, TRENDS ENDOCRIN MET, V18, P280, DOI 10.1016/j.tem.2007.07.004; Diamanti-Kandarakis E, 2006, TRENDS MOL MED, V12, P324, DOI 10.1016/j.molmed.2006.05.006; Ding XJ, 2014, INT J FUTUR GENER CO, V7, P9, DOI 10.14257/ijfgcn.2014.7.2.02; Du YF, 2020, DIABETES RES CLIN PR, V161, DOI 10.1016/j.diabres.2020.108068; El-Ashmawy HM, 2019, DIABETES RES CLIN PR, V150, P57, DOI 10.1016/j.diabres.2019.02.026; Escobar-Morreale HF, 2011, FERTIL STERIL, V95, P1048, DOI 10.1016/j.fertnstert.2010.11.036; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Ilich JZ, 2014, AGEING RES REV, V15, P51, DOI 10.1016/j.arr.2014.02.007; Inhorn MC, 2015, HUM REPROD UPDATE, V21, P411, DOI 10.1093/humupd/dmv016; JafariNasabian P, 2017, INT J WOMENS HEALTH, V9, P33, DOI 10.2147/IJWH.S106107; Jiang YD, 2008, DNA CELL BIOL, V27, P143, DOI 10.1089/dna.2007.0658; Jung TW, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0147-5; Kim JJ, 2014, FERTIL STERIL, V101, P1424, DOI 10.1016/j.fertnstert.2014.01.049; KIM YR, 2018, MATH PROBL ENG, V2018, DOI DOI 10.1155/2018/6283932; Kuoppamaki M, 2015, ARCH GERONTOL GERIAT, V60, P112, DOI 10.1016/j.archger.2014.10.002; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; Lee JH, 2018, DIABETES RES CLIN PR, V135, P7, DOI 10.1016/j.diabres.2017.10.005; Lee RM, 2000, SEMIN REPROD MED, V18, P433, DOI 10.1055/s-2000-13733; Leeners B, 2017, HUM REPROD UPDATE, V23, P300, DOI 10.1093/humupd/dmw045; Li J, 2018, HUM REPROD, V33, P617, DOI 10.1093/humrep/dey027; Li ZY, 2015, DIABETES, V64, P4011, DOI 10.2337/db15-0274; Li ZY, 2014, CNS NEUROSCI THER, V20, P344, DOI 10.1111/cns.12219; Liu ZX, 2019, J CELL MOL MED, V23, P271, DOI 10.1111/jcmm.13915; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mazloomi Sahar, 2012, ISRN Endocrinol, V2012, P949427, DOI 10.5402/2012/949427; MOSHAGE HJ, 1988, BIOCHEM BIOPH RES CO, V155, P112, DOI 10.1016/S0006-291X(88)81056-8; Muller MJ, 2016, OBESITY FACTS, V9, P193, DOI 10.1159/000445380; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Norman RJ, 2002, TRENDS ENDOCRIN MET, V13, P251, DOI 10.1016/S1043-2760(02)00612-4; Ombelet W, 2013, FACTS VIEWS VIS OBGY, V5, P161; Patgiri D, 2014, J CLIN DIAGN RES, V8, pCC8, DOI 10.7860/JCDR/2014/10386.5302; Rachdaoui N, 2013, ENDOCRIN METAB CLIN, V42, P593, DOI 10.1016/j.ecl.2013.05.008; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; Ridker PM, 2016, CIRC RES, V118, P145, DOI 10.1161/CIRCRESAHA.115.306656; Sadeghi A, 2020, IUBMB LIFE, V72, P1449, DOI 10.1002/iub.2272; Saeidi A, 2019, HEALTH PROMOT PERSPE, V9, P89, DOI 10.15171/hpp.2019.12; Saghebjoo M, 2018, HORM MOL BIOL CLIN I, V36, DOI 10.1515/hmbci-2018-0027; Serazin V, 2018, J OBSTET GYNAECOL RE, V44, P1015, DOI 10.1111/jog.13623; Shanaki M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208059; Song ZY, 2008, HEPATOLOGY, V47, P867, DOI 10.1002/hep.22074; Spritzer PM, 2015, REPRODUCTION, V149, pR219, DOI 10.1530/REP-14-0435; Stefanaki C, 2019, NUTRIENTS, V11, DOI 10.3390/nu11092055; Sun K, 2013, CELL METAB, V18, P470, DOI 10.1016/j.cmet.2013.06.016; Tam CS, 2013, HORM MOL BIOL CLIN I, V15, P19, DOI 10.1515/hmbci-2013-0032; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Ushach I, 2015, CLIN IMMUNOL, V156, P119, DOI 10.1016/j.clim.2014.11.006; Villa J, 2011, CURR DIABETES REP, V11, P179, DOI 10.1007/s11892-011-0189-8; Wagner MM, 2018, PREGNANCY HYPERTENS, V11, P129, DOI 10.1016/j.preghy.2017.10.012; Wang KX, 2019, MED SCI MONITOR, V25, P2337, DOI 10.12659/MSM.915331; Wolf AM, 2004, BIOCHEM BIOPH RES CO, V323, P630, DOI 10.1016/j.bbrc.2004.08.145; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhang Yuehui, 2018, Oncotarget, V9, P18180, DOI 10.18632/oncotarget.24477	73	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231943	10.1371/journal.pone.0231943	http://dx.doi.org/10.1371/journal.pone.0231943			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330176	Green Published, gold			2022-12-26	WOS:000536647300031
J	Kim, K; Ratri, MC; Choe, G; Nam, M; Cho, D; Shin, K				Kim, Kihoon; Ratri, Monica Cahyaning; Choe, Giho; Nam, Myeongyun; Cho, Daehyoung; Shin, Kwanwoo			Three-dimensional, printed water-filtration system for economical, on-site arsenic removal	PLOS ONE			English	Article							POLYLACTIC ACID PLA; AQUEOUS-SOLUTIONS; ADSORPTION; AS(III); AS(V); BIOSORBENT; CHEMISTRY; ADSORBENT; TOXICITY; SORPTION	The threat of arsenic contamination to public health, particularly in developing countries, has become a serious problem. Millions of people in their daily lives are still highly dependent on groundwater containing high levels of arsenic, which causes excessive exposure to this toxic element, due to the high cost and lack of water-treatment infrastructures. Therefore, a technique for large-scale treatment of water in rural areas to remove arsenic is needed and should be low-cost, be easily customized, and not rely on electrical power. In this study, in an effort to fulfill those requirements, we introduce a three-dimensional (3D), printed water-filtration system for arsenic removal. Three-dimensional printing can provide a compact, customized filtration system that can fulfill the above-mentioned requirements and that can be made from plastic materials, which are abundant. Armed with the versatility of 3D printing, we were able to design the internal surface areas of filters, after which we modified the surfaces of the 3D, printed filters by using iron (III) oxide as an adsorbent for arsenite. We investigated the effects of the controlled surface area on the flow rate and the deposition of the adsorbent, which are directly related to the adsorption of arsenic. We conducted isotherm studies to quantify the adsorption of arsenic on our 3D, printed filtration system.	[Kim, Kihoon; Ratri, Monica Cahyaning; Choe, Giho; Nam, Myeongyun; Cho, Daehyoung; Shin, Kwanwoo] Sogang Univ, Dept Chem, Seoul, South Korea; [Kim, Kihoon; Ratri, Monica Cahyaning; Choe, Giho; Nam, Myeongyun; Cho, Daehyoung; Shin, Kwanwoo] Sogang Univ, Inst Biol Interfaces, Seoul, South Korea; [Ratri, Monica Cahyaning] Sanata Dharma Univ, Dept Chem Educ, Yogyakarta, Indonesia	Sogang University; Sogang University	Shin, K (corresponding author), Sogang Univ, Dept Chem, Seoul, South Korea.; Shin, K (corresponding author), Sogang Univ, Inst Biol Interfaces, Seoul, South Korea.	kwshin@sogang.ac.kr		Ratri, Monica Cahyaning/0000-0002-6702-4096	Basic Science Research Program through the National Research Foundation (NRF) - Ministry of Science and ICT (MSIT), Korea [2018R1A6A1A03024940]	Basic Science Research Program through the National Research Foundation (NRF) - Ministry of Science and ICT (MSIT), Korea	This research gets support from the Basic Science Research Program (2018R1A6A1A03024940) through the National Research Foundation (NRF) funded by the Ministry of Science and ICT (MSIT), Korea. http://www.nrf.re.kr The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akowanou AVO, 2019, PROG ADDIT MANUF, V4, P315, DOI [10.1007/s40964-019-00091-9, DOI 10.1007/S40964-019-00091-9]; Amin MN, 2006, IND ENG CHEM RES, V45, P8105, DOI 10.1021/ie060344j; Anetor JI, 2007, ASIAN PAC J CANCER P, V8, P13; [Anonymous], 2014, INT J COMPUTER APPL, DOI DOI 10.5120/18249-9329; Asere TG, 2019, SCI TOTAL ENVIRON, V676, P706, DOI 10.1016/j.scitotenv.2019.04.237; Benjamin MM, 1996, WATER RES, V30, P2609, DOI 10.1016/S0043-1354(96)00161-3; Casalini T, 2017, WOODH PUBL SER BIOM, V120, P65, DOI 10.1016/B978-0-08-100262-9.00003-3; Casalini T, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00259; Chen WF, 2007, WATER RES, V41, P1851, DOI 10.1016/j.watres.2007.01.052; Deng S, 2016, J MATER CHEM A, V4, P15851, DOI 10.1039/c6ta06051j; Din SU, 2019, ENVIRON TECHNOL, V40, P261, DOI 10.1080/09593330.2017.1385649; Dotz AD, 2015, PILOT 3D PRINTING ME; Elsawy MA, 2017, RENEW SUST ENERG REV, V79, P1346, DOI 10.1016/j.rser.2017.05.143; Goswami A, 2012, CHEM ENG RES DES, V90, P1387, DOI 10.1016/j.cherd.2011.12.006; Gupta A, 2009, WATER RES, V43, P3862, DOI 10.1016/j.watres.2009.05.040; Gupta A, 2015, J ENVIRON CHEM ENG, V3, P113, DOI 10.1016/j.jece.2014.11.023; Gupta VK, 2005, J COLLOID INTERF SCI, V288, P55, DOI 10.1016/j.jcis.2005.02.054; Ho YS, 2000, WATER RES, V34, P735, DOI 10.1016/S0043-1354(99)00232-8; Huang ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159802; Janjaroen D, 2018, ENG J-THAIL, V22, P13, DOI 10.4186/ej.2018.22.2.13; Jeon CS, 2009, J HAZARD MATER, V163, P804, DOI 10.1016/j.jhazmat.2008.07.052; John Y, 2018, INT J CHEM ENG, V2018, DOI 10.1155/2018/3975948; Jolivet JP, 2004, CHEM COMMUN, P481, DOI 10.1039/b304532n; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Joshi S, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183732; Katsoyiannis IA, 2002, WATER RES, V36, P5141, DOI 10.1016/S0043-1354(02)00236-1; Kolesky DB, 2014, ADV MATER, V26, P3124, DOI 10.1002/adma.201305506; Kundu S, 2006, CHEM ENG J, V122, P93, DOI 10.1016/j.cej.2006.06.002; Kuriakose S, 2004, WATER QUAL RES J CAN, V39, P258, DOI 10.2166/wqrj.2004.036; Leigh SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049365; Liao C, 2020, MICROCHEM J, V152, DOI 10.1016/j.microc.2019.104288; Lyu W, 2019, CHEM ENG J, V363, P107, DOI 10.1016/j.cej.2019.01.109; Medpelli D., 2015, REFFIT, V1, P19, DOI [10.1016/j.reffit.2015.06.007, DOI 10.1016/J.REFFIT.2015.06.007]; Morgan AJL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152023; Ntim SA, 2011, J CHEM ENG DATA, V56, P2077, DOI 10.1021/je1010664; Patrick WG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143636; Pohl C, 2017, CHEMISTRY AND WATER: THE SCIENCE BEHIND SUSTAINING THE WORLD'S MOST CRUCIAL RESOURCE, P353, DOI 10.1016/B978-0-12-809330-6.00010-6; Pokhrel D, 2006, WATER RES, V40, P549, DOI 10.1016/j.watres.2005.11.040; Rahman MM, 2001, J TOXICOL-CLIN TOXIC, V39, P683, DOI 10.1081/CLT-100108509; Revanasiddappa HD, 2007, ENVIRON CHEM LETT, V5, P151, DOI 10.1007/s10311-007-0097-y; Rodriguez-Lado L, 2013, SCIENCE, V341, P866, DOI 10.1126/science.1237484; Siparsky GL, 1998, J ENVIRON POLYM DEGR, V6, P31, DOI 10.1023/A:1022826528673; Sthiannopkao S, 2010, APPL GEOCHEM, V25, P81, DOI 10.1016/j.apgeochem.2009.10.003; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Tham CY, 2014, KEY ENG MATER, V594-595, P214, DOI 10.4028/www.scientific.net/KEM.594-595.214; Wang JW, 2010, SEP SCI TECHNOL, V45, P1058, DOI 10.1080/01496391003684356; Washington Uo Agency USEP, 1992, MET TREATM SUP SIT A; Wehner M, 2016, NATURE, V536, P451, DOI 10.1038/nature19100; Weller C, 2015, INT J PROD ECON, V164, P43, DOI 10.1016/j.ijpe.2015.02.020; Yamamura S., 2003, ARSENIC WATER HLTH S; Yao SH, 2014, J ENVIRON HEALTH SCI, V12, DOI 10.1186/2052-336X-12-58; Zeng TQ, 2019, MATER CHEM PHYS, V231, P105, DOI 10.1016/j.matchemphys.2019.04.019; Zuniga Jorge, 2015, BMC Res Notes, V8, P10, DOI 10.1186/s13104-015-0971-9	53	7	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231475	10.1371/journal.pone.0231475	http://dx.doi.org/10.1371/journal.pone.0231475			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LL8ZA	32330139	Green Published, Green Accepted, gold			2022-12-26	WOS:000531841300001
J	Agarwal, A; Park, S; Ha, S; Kwon, JS; Khan, MR; Kang, BG; Dawson, TM; Dawson, VL; Andrabi, SA; Kang, SU				Agarwal, Ank; Park, Seongje; Ha, Shinwon; Kwon, Ji-Sun; Khan, Mohammed Repon; Kang, Bong Gu; Dawson, Ted M.; Dawson, Valina L.; Andrabi, Shaida A.; Kang, Sung-Ung			Quantitative mass spectrometric analysis of the mouse cerebral cortex after ischemic stroke	PLOS ONE			English	Article							BRAIN; DOMAIN; PROTEINS; PROTEOME; OXIDE	Ischemic strokes result in the death of brain tissue and a wave of downstream effects, often leading to lifelong disabilities or death. However, the underlying mechanisms of ischemic damage and repair systems remain largely unknown. In order to better understand these mechanisms, TMT-isobaric mass tagging and mass spectrometry were conducted on brain cortex extracts from mice subjected to one hour of middle cerebral artery occlusion (MCAO) and after one hour of reperfusion. In total, 2,690 proteins were identified and quantified, out of which 65% of the top 5% of up- and down-regulated proteins were found to be significant (p < 0.05). Network-based gene ontology analysis was then utilized to cluster all identified proteins by protein functional groups and cellular roles. Although three different cellular functions were identified-organelle outer membrane proteins, cytosolic ribosome proteins, and spliceosome complex proteins-several functional domains were found to be common. Of these, organelle outer membrane proteins were downregulated whereas cytosolic ribosome and spliceosome complex proteins were upregulated, indicating that major molecular events post-stroke were translation-associated and subsequent signaling pathways (e.g., poly (ADP-ribose) (PAR) dependent cell death). By approaching stroke analyses via TMT-isobaric mass tagging, the work herein presents a grand scope of protein-based molecular mechanisms involved with ischemic stroke recovery.	[Agarwal, Ank; Ha, Shinwon; Kwon, Ji-Sun; Khan, Mohammed Repon; Kang, Bong Gu; Dawson, Ted M.; Dawson, Valina L.; Kang, Sung-Ung] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA; [Park, Seongje] Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA; [Dawson, Ted M.; Kang, Sung-Ung] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Dawson, Ted M.; Dawson, Valina L.] Adrienne Helis Malvin Med Res Fdn, New Orleans, LA USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Andrabi, Shaida A.] Univ Alabama Birmingham, Dept Pharmacol & Toxicol, Birmingham, AL USA; [Andrabi, Shaida A.] Univ Alabama Birmingham, Dept Neurol, UAB Stn, Birmingham, AL 35294 USA	Johns Hopkins University; University of Southern California; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Kang, SU (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Neuroregenerat & Stem Cell Programs, Baltimore, MD 21218 USA.; Kang, SU (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21218 USA.	skang34@jhmi.edu		Agarwal, Ank/0000-0002-8307-4931	Johns Hopkins University (Woodrow Wilson Scholarship for Undergraduate Researchers)	Johns Hopkins University (Woodrow Wilson Scholarship for Undergraduate Researchers)	A.A. is supported by Johns Hopkins University (Woodrow Wilson Scholarship for Undergraduate Researchers).	Benjamin EJ, 2017, CIRCULATION, V135, pE146, DOI 10.1161/CIR.0000000000000485; Cuadrado E, 2010, J NEUROPATH EXP NEUR, V69, P1105, DOI 10.1097/NEN.0b013e3181f8c539; Dawson TM, 2017, ANNU REV PHARMACOL, V57, P437, DOI 10.1146/annurev-pharmtox-010716-105001; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Focking M, 2006, ACTA NEUROBIOL EXP, V66, P273; Forstermann U, 2012, EUR HEART J, V33, P829, DOI 10.1093/eurheartj/ehr304; Gagne JP, 2008, NUCLEIC ACIDS RES, V36, P6959, DOI 10.1093/nar/gkn771; Hata R, 2000, J CEREBR BLOOD F MET, V20, P937, DOI 10.1097/00004647-200006000-00006; Herring BE, 2016, P NATL ACAD SCI USA, V113, P2264, DOI 10.1073/pnas.1600179113; Hori M, 2012, DIS MODEL MECH, V5, P270, DOI 10.1242/dmm.008276; Lee MW, 2015, NUCLEIC ACIDS RES, V43, P3826, DOI 10.1093/nar/gkv156; Lind L, 2015, STROKE, V46, P3340, DOI 10.1161/STROKEAHA.115.010829; Liu DZ, 2010, J CEREBR BLOOD F MET, V30, P92, DOI 10.1038/jcbfm.2009.186; Pengelly RJ, 2016, J MED GENET, V53, P735, DOI 10.1136/jmedgenet-2016-103942; Rishi AK, 2003, J BIOL CHEM, V278, P33422, DOI 10.1074/jbc.M303173200; Saver JL, 2010, STROKE, V41, P1431, DOI 10.1161/STROKEAHA.110.583815; Seipel K, 1999, J CELL SCI, V112, P1825; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Woodruff TM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-11; Zhang ZW, 2017, MED GAS RES, V7, P273, DOI 10.4103/2045-9912.222452	21	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231978	10.1371/journal.pone.0231978	http://dx.doi.org/10.1371/journal.pone.0231978			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315348	Green Published, gold			2022-12-26	WOS:000536024800067
J	Chirenda, J; Gwitira, I; Warren, RM; Sampson, SL; Murwira, A; Masimirembwa, C; Mateveke, KM; Duri, C; Chonzi, P; Rusakaniko, S; Streicher, EM				Chirenda, Joconiah; Gwitira, Isaiah; Warren, Robin M.; Sampson, Samantha L.; Murwira, Amon; Masimirembwa, Collen; Mateveke, Kudzanai M.; Duri, Cremence; Chonzi, Prosper; Rusakaniko, Simbarashe; Streicher, Elizabeth M.			Spatial distribution of Mycobacterium Tuberculosis in metropolitan Harare, Zimbabwe	PLOS ONE			English	Article							TRANSMISSION; AUTOCORRELATION; ASSOCIATION; PATTERNS	Introduction The contribution of high tuberculosis (TB) transmission pockets in propagating area-wide transmission has not been adequately described in Zimbabwe. This study aimed to describe the presence of hotspot transmission of TB cases in Harare city from 2011 to 2012 using geospatial techniques. Methods Anonymised TB patient data stored in an electronic database at Harare City Health department was analysed using geospatial methods. Confirmed TB cases were mapped using geographic information system (GIS). Global Moran's I and Anselin Local Moran's I (LISA) were used to assess clustering and the local Getis-Ord G(i)* was used to estimate hotspot phenomenon of TB cases in Harare City for the period between 2011 and 2012. Results A total of 12,702 TB cases were accessed and mapped on the Harare City map. In both 2011 and 2012, ninety (90%) of cases were new and had a high human immunodeficiency virus (HIV)/TB co-infection rate of 72% across all suburbs. Tuberculosis prevalence was highest in the Southern district in both 2011 and 2012. There were pockets of spatial distribution of TB prevalence across West South West, Southern, Western, South Western and Eastern health districts. TB hot spot occurrence was restricted to the West South West, parts of South Western, Western health districts. West South West district had an increased peri-urban population with inadequate social services including health facilities. These conditions were conducive for increased intensity of TB occurrence, a probable indication of high transmission especially in the presence of high HIV co-infection. Conclusions and recommendations Increased TB transmission was limited to a health district with high informal internal migrants with limited health services in Harare City. To minimise spread of TB into greater Harare, there is need to improve access to TB services in the peri-urban areas.	[Chirenda, Joconiah; Masimirembwa, Collen; Mateveke, Kudzanai M.; Rusakaniko, Simbarashe] Univ Zimbabwe, Dept Community Med, Coll Hlth Sci, Harare, Zimbabwe; [Chirenda, Joconiah; Warren, Robin M.; Sampson, Samantha L.; Streicher, Elizabeth M.] Stellenbosch Univ, South African Med Res Council, NRF DST Ctr Excellence Biomed TB Res,Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa; [Gwitira, Isaiah; Murwira, Amon] Univ Zimbabwe, Dept Geog & Environm Sci, Harare, Zimbabwe; [Masimirembwa, Collen] Wilkins Hosp, African Inst Biomed Sci & Technol, Cnr J Tongogara & R Tangwena, Harare, Zimbabwe; [Duri, Cremence; Chonzi, Prosper] Harare City Council, Dept Hlth, Harare, Zimbabwe	University of Zimbabwe; South African Medical Research Council; Stellenbosch University; University of Zimbabwe	Chirenda, J (corresponding author), Univ Zimbabwe, Dept Community Med, Coll Hlth Sci, Harare, Zimbabwe.; Chirenda, J (corresponding author), Stellenbosch Univ, South African Med Res Council, NRF DST Ctr Excellence Biomed TB Res,Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Cape Town, South Africa.	joconiahc@gmail.com		Chirenda, Joconiah/0000-0003-2441-3304; Masimirembwa, Collen/0000-0002-4053-212X; Warren, Robin/0000-0001-5741-7358	Letten Foundation; SACORE grant, from the Welcome Trust [WT087537MA]; National Research Foundation (NRF) Research Career Advancement Award [91439]; South African Research Chairs Initiative of the Department of Science and Technology; South African Medical Research Council (SAMRC), Centre for Tuberculosis Research; National Research Foundation (NRF) of South Africa [UID 86539]	Letten Foundation; SACORE grant, from the Welcome Trust; National Research Foundation (NRF) Research Career Advancement Award; South African Research Chairs Initiative of the Department of Science and Technology; South African Medical Research Council (SAMRC), Centre for Tuberculosis Research(South African Medical Research Council); National Research Foundation (NRF) of South Africa(National Research Foundation - South Africa)	This research was funded through support from the Letten Foundation and SACORE grant, award number, WT087537MA, from the Welcome Trust for Dr. Joconiah Chirenda. Dr. EM Streicher was supported by the National Research Foundation (NRF) Research Career Advancement Award, award number, 91439. Professor Samantha L. Sampson was funded by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation (NRF) of South Africa, award number UID 86539. Prof. Robin M Warren was funded by South African Medical Research Council (SAMRC), Centre for Tuberculosis Research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the sponsors. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alene KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226127; Alvarez-Hernandez G, 2010, INT J TUBERC LUNG D, V14, P708; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Buzdugan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134571; Chan K.-W., 2009, SPATIAL EPIDEMIOLOGI; Churchyard G, 2017, J INFECT DIS, V216, pS629, DOI 10.1093/infdis/jix362; Coffee MP, 2005, J INFECT DIS, V191, pS159, DOI 10.1086/425270; Dowdy DW, 2012, P NATL ACAD SCI USA, V109, P9557, DOI 10.1073/pnas.1203517109; Erazo C, 2014, REV PANAM SALUD PUBL, V36, P24; Feenstra SG, 2013, J HEALTH POPUL NUTR, V31, P424; Fernandez MAL, 2011, T ROY SOC TROP MED H, V105, P38, DOI 10.1016/j.trstmh.2010.10.001; Getis A, 2010, ADV SPAT SCI, P127, DOI 10.1007/978-3-642-01976-0_10; Government of Zimbabwe, 2015, REP 2015; Izumi K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138831; Kirenga BJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1376-3; Kompala T, 2013, CURR HIV-AIDS REP, V10, P264, DOI 10.1007/s11904-013-0164-x; Mahara Gehendra, 2018, Med Sci (Basel), V6, DOI 10.3390/medsci6020026; Marsha L, 2011, TUBERCULOSIS S1, V91, pS61; Mathema B, 2017, J INFECT DIS, V216, pS644, DOI 10.1093/infdis/jix354; McCreesh N, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1406-5; McMichael AJ, 2000, B WHO, V10; Moonan Patrick K, 2004, Int J Health Geogr, V3, P23, DOI 10.1186/1476-072X-3-23; Noppert Grace, 2015, BMC Res Notes, V8, P575, DOI 10.1186/s13104-015-1568-z; ORD JK, 1995, GEOGR ANAL, V27, P286, DOI 10.1111/j.1538-4632.1995.tb00912.x; Ord JK, 2001, J REGIONAL SCI, V41, P411, DOI 10.1111/0022-4146.00224; Porter JDH, 1999, TROP MED INT HEALTH, V4, P631, DOI 10.1046/j.1365-3156.1999.00475.x; Shaweno D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1178-4; Wang Q, 2019, TROP MED INT HEALTH, V24, P1104, DOI 10.1111/tmi.13289; Wang T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-885; Wei W, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone, DOI 10.1371/JOURNAL.PONE]; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; WHO, 2014, GLOB TUB REP 2014; WHO, 2017, GLOB TUB REP 2017; Wright CM, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0945-5; Yang CG, 2018, LANCET INFECT DIS, V18, P788, DOI 10.1016/S1473-3099(18)30218-4; Yates TA, 2016, LANCET INFECT DIS, V16, P227, DOI 10.1016/S1473-3099(15)00499-5; Zimbabwe National Statistical Agency, 2012, ZIMB POP CENS 2012, P152	37	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231637	10.1371/journal.pone.0231637	http://dx.doi.org/10.1371/journal.pone.0231637			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315335	Green Published, gold			2022-12-26	WOS:000536024800037
J	Lee, HS; Park, YM; Han, K; Yang, JH; Lee, S; Lee, SS; Yoo, S; Kim, SR				Lee, Hong Seok; Park, Yong-Moon; Han, Kyungdo; Yang, Jin-Hong; Lee, Seungwon; Lee, Seong-Su; Yoo, Soonjib; Kim, Sung Rae			Obesity-related hypertension: Findings from The Korea National Health and Nutrition Examination Survey 2008-2010	PLOS ONE			English	Article							BODY-MASS INDEX; NORMAL-WEIGHT OBESITY; METABOLIC SYNDROME; BLOOD-PRESSURE; RISK-FACTORS; WAIST CIRCUMFERENCE; ABDOMINAL OBESITY; US ADULTS; FAT; PREVALENCE	We aimed to investigate the association of various obesity parameters and phenotypes with hypertension in nationally representative Korean adults. Among adults aged 19 years and older who participated in the Korea National Health and Nutrition Examination Survey in 2008-2010, a total of 16,363 subjects (8,184 men and 8,179 women) were analyzed. Hypertension was defined as blood pressure of 140/90 mm Hg or higher or taking antihypertensive medication. Multiple logistic regression analysis was used to estimate multivariable-adjusted odds ratios (ORs) and 95% confidence intervals (CIs). Higher obesity parameters [body mass index (BMI) representing general obesity, waist circumference (WC) representing central obesity, and percentage body fat (PBF) representing elevated body fat] were consistently associated with increased odds of prevalent hypertension (OR, 7.54; 95% CI, 5.89-9.65 for BMI >= 30 vs. 18.5-23; OR, 3.97; 95% CI, 3.41-4.63 for WC >= 95 cm in males and >= 90 cm in females vs. < 85 cm in males and < 80 cm in females; OR, 3.56; 95% CI, 3.05-4.15 for PBF, highest vs. lowest quartile; all p trends< 0.0001). These associations were stronger in the younger age group (< 40 years), and were observed in both sexes. Furthermore, even in individuals with normal BMI (18.5-23), the odds of prevalent hypertension were consistently increased in those with central obesity (WC >= 90 cm in males, WC >= 80 cm in females; normal weight central obesity phenotype) (OR, 1.89; 95% CI, 1.63-2.19) and those with high PBF (highest quartile of PBF; normal weight obesity phenotype) (OR, 1.49; 95% CI, 1.25-1.77). These associations were consistent with updated hypertension guidelines in 2017. Obesity may be positively associated with hypertension, regardless of obesity parameters. Even within normal BMI range, high WC and high PBF may be associated with hypertension.	[Lee, Hong Seok] Mayo Clin, Div Cardiol, Dept Med, Scottsdale, AZ USA; [Lee, Hong Seok] Univ Calif Riverside, Div Cardiol, Dept Med, Riverside, CA 92521 USA; [Lee, Hong Seok] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Park, Yong-Moon] NIEHS, Epidemiol Branch, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Han, Kyungdo] Soongsil Univ, Dept Stat & Actuarial Sci, Seoul, South Korea; [Yang, Jin-Hong] Catholic Univ Korea, Dept Emergency Med, Coll Med, Seoul, South Korea; [Lee, Seungwon] Sungkyunkwan Univ, Dept Anesthesiol & Pain Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Lee, Seong-Su; Yoo, Soonjib; Kim, Sung Rae] Catholic Univ Korea, Bucheon St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea	Mayo Clinic; Mayo Clinic Phoenix; University of California System; University of California Riverside; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Soongsil University; Catholic University of Korea; Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Kim, SR (corresponding author), Catholic Univ Korea, Bucheon St Marys Hosp, Div Endocrinol & Metab, Dept Internal Med, Seoul, South Korea.	kimsungrae@catholic.ac.kr	PARK, YONG-MOON ("MARK")/ABA-2765-2021	PARK, YONG-MOON ("MARK")/0000-0002-5879-6879	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences	Intramural Research Program of the NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Hong Seok Lee, Yong-Moon Park, and Sung Rae Kim conceived the project and developed the overall research plan; Kyungdo Han performed statistical analyses; Hong Seok Lee and YongMoon Park wrote the manuscript; all authors interpreted the data and critically revised the manuscript for important intellectual content. Hong Seok Lee, Yong-Moon Park, and Sung Rae Kim had primary responsibility for final contents. All authors read and approved the final manuscript. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences.	Aekplakorn W, 2011, ASIA-PAC J PUBLIC HE, V23, P298, DOI 10.1177/1010539509340690; [Anonymous], 2017, ANN TRANSLATIONAL ME, V5; Anuurad E, 2003, J OCCUP HEALTH, V45, P335, DOI 10.1539/joh.45.335; Cohen JB, 2018, ANN INTERN MED, V168, P287, DOI 10.7326/M17-3103; Delvecchio L, 2016, J EXERC REHABIL, V12, P442, DOI 10.12965/jer.1632672.336; Fazliana M, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0592-2; Feldman H, 2014, JAAPA-J AM ACAD PHYS, V27, P44, DOI 10.1097/01.JAA.0000451865.17954.9b; George C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154894; Gillespie CD, 2013, MMWR-MORBID MORTAL W, V62, P144; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Humphreys BR, 2014, HEALTH ECON, V23, P33, DOI 10.1002/hec.2900; Imboden MT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176161; Jean N, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0464-7; Jiang JC, 2016, INT J CARDIOL, V219, P204, DOI 10.1016/j.ijcard.2016.06.032; Kim MK, 2014, CLIN ENDOCRINOL, V80, P214, DOI 10.1111/cen.12162; Landecho MF, 2016, CURR PHARM DESIGN, V22, P5687, DOI 10.2174/1381612822666160822125834; Lavie CJ, 2009, J AM COLL CARDIOL, V53, P1925, DOI 10.1016/j.jacc.2008.12.068; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lee HS, 2013, J HUM HYPERTENS, V27, P381, DOI 10.1038/jhh.2012.56; Lee HS, 2010, CLIN EXP HYPERTENS, V32, P166, DOI 10.3109/10641960903254497; Litwin SE, 2012, CIRC-CARDIOVASC IMAG, V5, P286, DOI 10.1161/CIRCIMAGING.112.974840; Masters RK, 2013, AM J PUBLIC HEALTH, V103, P1895, DOI 10.2105/AJPH.2013.301379; Matsuzawa Y, 2011, J ATHEROSCLER THROMB, V18, P629, DOI 10.5551/jat.7922; Oliveros E, 2014, PROG CARDIOVASC DIS, V56, P426, DOI 10.1016/j.pcad.2013.10.003; Ostchega Y, 2012, AM J HYPERTENS, V25, P1271, DOI 10.1038/ajh.2012.120; Park YM, 2010, YONSEI MED J, V51, P511, DOI 10.3349/ymj.2010.51.4.511; Park YMM, 2016, MAYO CLIN PROC, V91, P1372, DOI 10.1016/j.mayocp.2016.06.022; Poirier Paul, 2001, Cardiology Clinics, V19, P459, DOI 10.1016/S0733-8651(05)70229-0; Roka R, 2015, HIGH BLOOD PRESS CAR, V22, P265, DOI 10.1007/s40292-015-0106-3; Ruiz-Hurtado G, 2014, J CLIN HYPERTENS, V16, P559, DOI 10.1111/jch.12356; Sahakyan KR, 2015, ANN INTERN MED, V163, P827, DOI 10.7326/M14-2525; Sato F, 2018, CIRC J, V82, P502, DOI 10.1253/circj.CJ-17-0820; Senthil S, 2016, J CLIN DIAGN RES, V10, pCC5, DOI 10.7860/JCDR/2016/20626.8447; Shah AD, 2016, INT J OBESITY, V40, P639, DOI 10.1038/ijo.2015.219; Shea JL, 2012, NUTR METAB CARDIOVAS, V22, P741, DOI 10.1016/j.numecd.2010.11.009; Shen Y, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0634-7; Shrivastava U MA, 2016, CURRENT DIABETES REV; Simonds SE, 2014, CELL, V159, P1404, DOI 10.1016/j.cell.2014.10.058; Song HJ, 2017, ASIA PAC J CLIN NUTR, V26, P698, DOI 10.6133/apjcn.042016.13; Unsal S, 2016, CLIN EXP HYPERTENS, V38, P218, DOI 10.3109/10641963.2015.1047951; Uretsky S, 2007, AM J MED, V120, P863, DOI 10.1016/j.amjmed.2007.05.011; Whelton PK, 2018, J AM COLL CARDIOL, V71, pE127, DOI 10.1016/j.jacc.2017.11.006; Yano Y, 2016, HYPERTENSION, V68, P576, DOI 10.1161/HYPERTENSIONAHA.116.07876; Zhang M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31935	44	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230616	10.1371/journal.pone.0230616	http://dx.doi.org/10.1371/journal.pone.0230616			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315310	gold, Green Published			2022-12-26	WOS:000536024800008
J	de Bortoli, MM; Fell, AKM; Svendsen, MV; Henneberger, PK; Kongerud, J; Oellingrath, IM				de Bortoli, Marit Muller; Fell, Anne Kristin Moller; Svendsen, Martin Veel; Henneberger, Paul K.; Kongerud, Johny; Oellingrath, Inger M.			Lifestyle, sick leave and work ability among Norwegian employees with asthma-A population-based cross-sectional survey conducted in Telemark County, Norway	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SYMPTOMS; WEIGHT; HEALTH; HUNT; PREVALENCE; EMPLOYMENT; OBESITY; ABSENCE; INDEX	Objective To investigate whether physician-diagnosed asthma modifies the associations between multiple lifestyle factors, sick leave and work ability in a general working population. Methods A cross-sectional study was conducted in Telemark County, Norway, in 2013. A sample of 16 099 respondents completed a self-administered questionnaire. We obtained complete data on lifestyle, work ability and sick leave for 10 355 employed persons aged 18-50 years. We modelled sick leave and work ability using multiple logistic regression, and introduced interaction terms to investigate whether associations with lifestyle factors were modified by asthma status. Results Several lifestyle risk factors and a multiple lifestyle risk index were associated with sick leave and reduced work ability score among persons both with and without physician-diagnosed asthma. A stronger association between lifestyle and sick leave among persons with asthma was confirmed by including interaction terms in the analysis: moderate lifestyle risk score * asthma OR = 1.4 (95% CI 1.02-2.1); high lifestyle risk score * asthma OR = 1.6 (95% CI 1.1-2.3); very high lifestyle risk score * asthma OR = 1.6 (95% CI 0.97-2.7); obesity * asthma OR = 1.5 (95% CI 1.02-2.1); past smoking * asthma OR = 1.4 (95% CI 1.01-1.9); and current smoking * asthma OR = 1.4 (95% CI 1.03-2.0). There was no significant difference in the association between lifestyle and work ability score among respondents with and without asthma. Conclusions In the present study, we found that physician-diagnosed asthma modified the association between lifestyle risk factors and sick leave. Asthma status did not significantly modify these associations with reduced work ability score. The results indicate that lifestyle changes could be of particular importance for employees with asthma.	[de Bortoli, Marit Muller; Oellingrath, Inger M.] Univ South Eastern, Fac Hlth & Social Sci, Dept Nursing & Hlth Sci, Porsgrunn, Vestfold & Tele, Norway; [de Bortoli, Marit Muller; Fell, Anne Kristin Moller; Svendsen, Martin Veel] Telemark Hosp, Dept Occupat & Environm Med, Skien, Vestfold & Tele, Norway; [Henneberger, Paul K.] NIOSH, Ctr Dis Control & Prevent, Morgantown, WV USA; [Kongerud, Johny] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Kongerud, Johny] Oslo Univ Hosp, Dept Resp Med, Oslo, Norway; [de Bortoli, Marit Muller] Univ South Eastern Norway, Fac Hlth & Social Sci, Dept Nursing & Hlth Sci, Porsgrunn, Norway	Telemark Hospital Trust; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); University of Oslo; University of Oslo	de Bortoli, MM (corresponding author), Univ South Eastern, Fac Hlth & Social Sci, Dept Nursing & Hlth Sci, Porsgrunn, Vestfold & Tele, Norway.; de Bortoli, MM (corresponding author), Telemark Hosp, Dept Occupat & Environm Med, Skien, Vestfold & Tele, Norway.	marit.muller@usn.no			University of South-Eastern Norway; Telemark Hospital	University of South-Eastern Norway; Telemark Hospital	The work was supported by the University of South-Eastern Norway and Telemark Hospital.	Abrahamsen R, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014018; Abrahamsen R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009912; Accordini S, 2008, ALLERGY, V63, P116, DOI 10.1111/j.1398-9995.2007.01523.x; Ahlstrom L, 2010, SCAND J WORK ENV HEA, V36, P404, DOI 10.5271/sjweh.2917; Alexopoulos EC, 2001, OCCUP ENVIRON MED, V58, P246, DOI 10.1136/oem.58.4.246; Balder B, 1998, RESP MED, V92, P729, DOI 10.1016/S0954-6111(98)90003-8; Belsky DW, 2014, EXPERT REV RESP MED, V8, P137, DOI 10.1586/17476348.2014.879826; Boot CRL, 2005, RESP MED, V99, P1022, DOI 10.1016/j.rmed.2005.02.002; Burke MA, 2017, ECON HUM BIOL, V27, P198, DOI 10.1016/j.ehb.2017.06.002; DEMARCO R, 1994, EUR RESPIR J, V7, P2139, DOI 10.1183/09031936.94.07122139; El Fassi M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-305; Ernstsen L, 2016, AM J MED, V129, P82, DOI 10.1016/j.amjmed.2015.08.012; Barcala FJG, 2011, J ASTHMA, V48, P194, DOI 10.3109/02770903.2010.539294; Gould R., 2008, DIMENSIONS WORK ABIL; Hakala K, 2000, CHEST, V118, P1315, DOI 10.1378/chest.118.5.1315; Handeland K, 2016, NUTRIENTS, V8, DOI 10.3390/nu8080467; Hansen CL, 2012, SCAND J PUBLIC HEALT, V40, P377, DOI 10.1177/1403494812449079; Jaakkola JJK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48484-8; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Kurtze N, 2008, SCAND J PUBLIC HEALT, V36, P52, DOI 10.1177/1403494807085373; Lindstrom I, 2011, RESP MED, V105, P950, DOI 10.1016/j.rmed.2011.01.011; Mancuso CA, 2003, AM J IND MED, V44, P236, DOI 10.1002/ajim.10257; Meader N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3373-6; Mostad IL, 2014, APPL PHYSIOL NUTR ME, V39, P819, DOI 10.1139/apnm-2013-0356; Nathell L, 2002, RESP MED, V96, P642, DOI 10.1053/rmed.2002.1317; Norwegian Institute of Public Health, 2009, ASTHM ALL NORW PUBL; Oellingrath IM, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026215; Ronmark E, 1999, EUR J EPIDEMIOL, V15, P293, DOI 10.1023/A:1007582518922; Sauni R, 2001, OCCUP MED-OXFORD, V51, P163, DOI 10.1093/occmed/51.3.163; Schulte PA, 2018, J OCCUP ENVIRON MED, V60, P440, DOI 10.1097/JOM.0000000000001295; Sehgal S, 2019, RESP MED, V151, P81, DOI 10.1016/j.rmed.2019.03.019; Stenius-Aarniala B, 2000, BRIT MED J, V320, P827, DOI 10.1136/bmj.320.7238.827; Taponen S, 2017, J OCCUP MED TOXICOL, V12, P1, DOI 10.1186/s12995-017-0165-6; Taylor B, 2008, THORAX, V63, P14, DOI 10.1136/thx.2007.082784; The Norwegian Directorate of Health, 2014, NORW GUID DIET NUTR; To T, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-204; Tonnon SC, 2019, INT ARCH OCC ENV HEA, V92, P855, DOI 10.1007/s00420-019-01422-7; TOREN K, 1993, CHEST, V104, P600, DOI 10.1378/chest.104.2.600; van den Berg TIJ, 2009, OCCUP ENVIRON MED, V66, P211, DOI 10.1136/oem.2008.039883; Vandevijvere S., 2017, INFORM PROTOCOL LABE, P1; Virtanen M, 2018, LANCET PUBLIC HEALTH, V3, pE545, DOI 10.1016/S2468-2667(18)30201-9; World Health Organization, BOD MASS IND BMI	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231710	10.1371/journal.pone.0231710	http://dx.doi.org/10.1371/journal.pone.0231710			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302337	Green Published, gold, Green Submitted			2022-12-26	WOS:000536016100045
J	Becker, L; Schade, U; Rohleder, N				Becker, Linda; Schade, Ursula; Rohleder, Nicolas			Activation of the hypothalamic-pituitary adrenal axis in response to a verbal fluency task and associations with task performance	PLOS ONE			English	Article							ACUTE PSYCHOSOCIAL STRESS; SALIVARY ALPHA-AMYLASE; WORKING-MEMORY; NEGATIVE AFFECT; SEX-DIFFERENCES; LABORATORY STRESSORS; DECLARATIVE MEMORY; CORTISOL-LEVELS; DETERMINANTS; METAANALYSIS	Speech fluency can be impaired in stressful situations. In this study, it was investigated whether a verbal fluency task by itself, i.e. without the presence of any further stressors, induces responses of the hypothalamic-pituitary adrenal (HPA) axis and of the sympathetic nervous system (SNS). The sample consisted of n = 85 participants (68.2% female; 33.3 +/- 15.2 years) who performed two consecutive verbal fluency tasks for two minutes each. The categories were either 'stress' or 'disease' and 'animals' or 'foods' which were presented in a randomized order. Three saliva samples were collected, prior to the task (t(0)), immediately after (t(1)), and ten minutes after it (t(2)). Salivary alpha-amylase and cortisol were assessed. Furthermore, blood pressure, heart rate, and ratings of actual stress perception, level of effort, and tiredness were measured. The verbal fluency task induced a HPA axis response with a maximum cortisol level at t(2) which was independent of task performance. Furthermore, perceived stress and effort, as well as tiredness increased after the task. Moreover, tiredness immediately after the task was negatively correlated with task performance. No alpha-amylase, blood pressure, or heart rate, and therefore SNS, responses were found. Implications for the integrated specificity model are discussed. We conclude that a verbal fluency task acts like an acute stressor that induces a cortisol and a perceived stress response without the need for further (e.g., social-evaluative) stress components. Therefore, it is a less time-consuming alternative to other stress tasks that can be used in field studies with little effort.	[Becker, Linda; Schade, Ursula; Rohleder, Nicolas] Friedrich Alexander Univ Erlangen Nurnberg, Dept Psychol, Erlangen, Germany	University of Erlangen Nuremberg	Becker, L (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg, Dept Psychol, Erlangen, Germany.	linda.becker@fau.de	Rohleder, Nicolas/N-7598-2013	Rohleder, Nicolas/0000-0003-2602-517X; Becker, Linda/0000-0002-9950-6882	Bavarian Ministry of Science and Arts; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Bavarian Ministry of Science and Arts; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	During this work, LB was postdoctoral research associate in the research project "Psychological and biological stress response patterns to digital stress" which is led by NR from the Institute of Psychology of the FriedrichAlexander University Erlangen-Nurnberg. The project is part of the Bavarian Research Association on Healthy Use of Digital Technologies and Media (ForDigitHealth), funded by the Bavarian Ministry of Science and Arts. We acknowledge support by Deutsche Forschungsgemeinschaft and FriedrichAlexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Baddeley A, 1996, Q J EXP PSYCHOL-A, V49, P5, DOI 10.1080/713755608; Becker L, 2019, PEERJ, V7, DOI 10.7717/peerj.7521; Becker L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213883; Bergman I, 2015, SCAND J PSYCHOL, V56, P140, DOI 10.1111/sjop.12170; Bosch JA, 2003, PSYCHOSOM MED, V65, P245, DOI 10.1097/01.PSY.0000058376.50240.2D; Buchanan TW, 2014, BIOL PSYCHOL, V97, P60, DOI 10.1016/j.biopsycho.2014.02.005; Campbell J, 2012, PSYCHONEUROENDOCRINO, V37, P1111, DOI 10.1016/j.psyneuen.2011.12.010; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; CHROUSOS GP, 1992, JAMA-J AM MED ASSOC, V267, P1244, DOI 10.1001/jama.267.9.1244; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Da Silva JAP, 1999, ANN NY ACAD SCI, V876, P102; Dedovic K, 2005, J PSYCHIATR NEUROSCI, V30, P319; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Fiocco AJ, 2007, PSYCHONEUROENDOCRINO, V32, P1158, DOI 10.1016/j.psyneuen.2007.08.008; Fulford A.J., 2005, TEC BEHAV N 1, V15, P43; Gillespie CF, 2009, DEPRESS ANXIETY, V26, P984, DOI 10.1002/da.20605; Gold PW, 2015, MOL PSYCHIATR, V20, P32, DOI 10.1038/mp.2014.163; Greendale GA, 2000, J AM GERIATR SOC, V48, P1655, DOI 10.1111/j.1532-5415.2000.tb03878.x; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Gruenewald TL, 2004, PSYCHOSOM MED, V66, P915, DOI 10.1097/01.psy.0000143639.61693.ef; Hautzinger M., 2012, ADS ALLGEMEINE DEPRE; Hautzinger M., 2012, PSYCHIAT PRAX, V2nd, DOI DOI 10.1055/S-0032-1326702; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Het S, 2005, PSYCHONEUROENDOCRINO, V30, P771, DOI 10.1016/j.psyneuen.2005.03.005; Jones A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039143; Juster RP, 2010, NEUROSCI BIOBEHAV R, V35, P2, DOI 10.1016/j.neubiorev.2009.10.002; Kemeny ME, 2003, CURR DIR PSYCHOL SCI, V12, P124, DOI 10.1111/1467-8721.01246; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klein EM, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0875-9; Krohne HW, 1996, DIAGNOSTICA, V42, P139; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Lazarus R. S., 1990, PSYCHOL INQ, V1, P3, DOI DOI 10.1207/S15327965PLI0101_1; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Lupien SJ, 1997, J CLIN ENDOCR METAB, V82, P2070, DOI 10.1210/jc.82.7.2070; Mattarella-Micke A, 2011, EMOTION, V11, P1000, DOI 10.1037/a0023224; Mauchly JW, 1940, ANN MATH STAT, V11, P204, DOI 10.1214/aoms/1177731915; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McHugh RK, 2010, ANXIETY STRESS COPIN, V23, P529, DOI 10.1080/10615801003596969; McInnis CM, 2014, BRAIN BEHAV IMMUN, V42, P33, DOI 10.1016/j.bbi.2014.07.018; Meaney E, 2000, HEART, V84, P64, DOI 10.1136/heart.84.1.64; Miller G. E., 2007, IT GOES MUST IT COME; Minkley N, 2014, PSYCHONEUROENDOCRINO, V45, P119, DOI 10.1016/j.psyneuen.2014.03.022; Morris SB, 2008, ORGAN RES METHODS, V11, P364, DOI 10.1177/1094428106291059; Nater UM, 2005, INT J PSYCHOPHYSIOL, V55, P333, DOI 10.1016/j.ijpsycho.2004.09.009; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P392, DOI 10.1016/j.psyneuen.2007.02.007; Oei NYL, 2006, STRESS, V9, P133, DOI 10.1080/10253890600965773; Oyola MG, 2017, STRESS, V20, P476, DOI 10.1080/10253890.2017.1369523; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rohleder N, 2009, PSYCHONEUROENDOCRINO, V34, P469, DOI 10.1016/j.psyneuen.2008.12.004; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Sapolsky RM, 1996, SCIENCE, V273, P749, DOI 10.1126/science.273.5276.749; Schoofs D, 2008, PSYCHONEUROENDOCRINO, V33, P643, DOI 10.1016/j.psyneuen.2008.02.004; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Schwabe L, 2013, TRENDS COGN SCI, V17, P60, DOI 10.1016/j.tics.2012.12.001; SELYE H, 1950, BRIT MED J, V1, P1383, DOI 10.1136/bmj.1.4667.1383; Shields GS, 2017, PSYCHOL BULL, V143, P636, DOI 10.1037/bul0000100; Shields GS, 2015, PSYCHONEUROENDOCRINO, V58, P91, DOI 10.1016/j.psyneuen.2015.04.017; Sinclair J, 2013, INT J SPORTS SCI ENG, V7, P17; Skoluda N, 2015, PSYCHONEUROENDOCRINO, V51, P227, DOI 10.1016/j.psyneuen.2014.10.002; Stephens MAC, 2016, PSYCHONEUROENDOCRINO, V66, P47, DOI 10.1016/j.psyneuen.2015.12.021; STONEY CM, 1988, PSYCHOPHYSIOLOGY, V25, P645, DOI 10.1111/j.1469-8986.1988.tb01902.x; Stratakis CA, 1995, ANN NY ACAD SCI, V771, P1, DOI 10.1111/j.1749-6632.1995.tb44666.x; Thompson ER, 2007, J CROSS CULT PSYCHOL, V38, P227, DOI 10.1177/0022022106297301; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Vedhara K, 2000, PSYCHONEUROENDOCRINO, V25, P535, DOI 10.1016/S0306-4530(00)00008-1; von Dawans B, 2011, PSYCHONEUROENDOCRINO, V36, P514, DOI 10.1016/j.psyneuen.2010.08.004; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Wolf OT, 2009, BRAIN RES, V1293, P142, DOI 10.1016/j.brainres.2009.04.013	71	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0227721	10.1371/journal.pone.0227721	http://dx.doi.org/10.1371/journal.pone.0227721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298298	Green Published, Green Submitted, gold			2022-12-26	WOS:000536011400005
J	Tchankoni, MK; Gbeasor-Komlanvi, FA; Bitty-Anderson, AM; Sewu, EK; Zida-Compaore, WIC; Alioum, A; Salou, M; Dagnra, CA; Ekouevi, DK				Tchankoni, Martin Kouame; Gbeasor-Komlanvi, Fifonsi Adjidossi; Bitty-Anderson, Alexandra Marie; Sewu, Esseboe Koffitse; Zida-Compaore, Wendpouire Ida Carine; Alioum, Ahmadou; Salou, Mounerou; Dagnra, Claver Anoumou; Ekouevi, Didier Koumavi			Prevalence and factors associated with psychological distress among key populations in Togo, 2017	PLOS ONE			English	Article							DISORDERS IDENTIFICATION TEST; MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; PROPORTIONAL ODDS; HIV PREVALENCE; PRIMARY-CARE; GAY MALE; RISK; SEX; ALCOHOL	Objectives Mental health is a largely neglected issue among in Sub-Saharan Africa, especially among key populations at risk for HIV. The aim of this study was to estimate the prevalence of psychological distress (PD) and to assess the factors associated among males who have sex with males (MSM), female sex workers (FSW) and drug users (DU) in Togo in 2017. Study design A cross-sectional bio-behavioral study was conducted in August and September 2017 using a respondent-driven sampling (RDS) method, in eight cities in Togo. Methods A standardized questionnaire was used to record sociodemographic characteristics and sexual behaviors. The Alcohol Use Disorders Identification Test (AUDIT) and a subset of questions from the Tobacco Questions for Survey were used to assess alcohol and tobacco consumption respectively. PD was assessed with the Kessler Psychological Distress Scale. A blood sample was taken to test for HIV. Descriptive statistics, univariable and multivariable ordinal regression models were used for analysis. Results A total of 2044 key populations including 449 DU, 952 FSW and 643 MSM with a median age of 25 years, interquartile range (IQR) [21-32] were recruited. The overall prevalence of mild PD among the three populations was 19.9% (95%CI = [18.3-21.8]) and was 19.2% (95%CI = [17.5-20.9]) for severe/moderate PD. HIV prevalence was 13.7% (95%CI = [12.2-15.2]). High age (>= 25 years) [aOR = 1.24 (95% CI: 1.02-1.50)], being HIV positive [aOR = 1.80 (95% CI: 1.31-2.48)] and hazardous alcohol consumption [aOR = 1.52 (95% CI: 1.22-1.87)] were risk factors for PD. Secondary [aOR = 0.52 (95% CI: 0.42-0.64)] or higher [aOR = 0.46 (95% CI: 0.32-0.64)] education levels were protective factors associated with PD. FSW [OR = 0.55 (95% CI: 0.43-0.68)] and MSM [OR = 0.33 (95% CI: 0.240.44)] were less likely to report PD compared with DU. Conclusion and recommendations This is the first study conducted among a large, nationally representative sample of key populations in Togo. The prevalence of PD is high among these populations in Togo and was associated to HIV infection. The present study indicates that mental health care must be integrated within health programs in Togo with a special focus to key populations through interventions such as social support groups.	[Tchankoni, Martin Kouame; Gbeasor-Komlanvi, Fifonsi Adjidossi; Sewu, Esseboe Koffitse; Zida-Compaore, Wendpouire Ida Carine; Ekouevi, Didier Koumavi] African Ctr Epidemiol & Publ Hlth Res CARESP, Lome, Togo; [Gbeasor-Komlanvi, Fifonsi Adjidossi; Ekouevi, Didier Koumavi] Univ Lome, Fac Hlth Sci, Dept Publ Hlth, Lome, Togo; [Bitty-Anderson, Alexandra Marie; Ekouevi, Didier Koumavi] Treichville Univ Hosp, ANRS Ivory Coast Site, PACCI Program, Abidjan, Cote Ivoire; [Alioum, Ahmadou; Ekouevi, Didier Koumavi] Univ Bordeaux, Inserm Ctr, Bordeaux, France; [Alioum, Ahmadou; Ekouevi, Didier Koumavi] Univ Bordeaux, Inst Publ Hlth Epidemiol Dev ISPED, Bordeaux, France; [Salou, Mounerou; Dagnra, Claver Anoumou] Univ Lome, Dept Basic Sci, Ctr Mol Biol & Immunol, Lome, Togo	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Tchankoni, MK (corresponding author), African Ctr Epidemiol & Publ Hlth Res CARESP, Lome, Togo.	tchankonimartin@yahoo.fr		ZIDA - COMPAORE, Wendpouire Ida Carine/0000-0001-5584-8111; GBEASOR-KOMLANVI, Fifonsi Adjidossi/0000-0002-1744-0454; TCHANKONI, Martin Kouame/0000-0001-9873-3293	"Centre Africain de Recherche en Epidemiologie et en Sante Publique (CARESP)" (African Center for Epidemiology and Public Health Research); Togo National HIV/AIDS and STI Control Program	"Centre Africain de Recherche en Epidemiologie et en Sante Publique (CARESP)" (African Center for Epidemiology and Public Health Research); Togo National HIV/AIDS and STI Control Program	This work was supported by the "Centre Africain de Recherche en Epidemiologie et en Sante ' Publique (CARESP)" (African Center for Epidemiology and Public Health Research) and the Togo National HIV/AIDS and STI Control Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amon J., 2000, BEHAV SURVEILLANCE S; Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; [Anonymous], WHO SURV MON; [Anonymous], NO HLTH MENT HLTH; Banque Mondiale, 2018, MENTAL HLTH; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Foxcroft DR, 2015, ALCOHOL ALCOHOLISM, V50, P244, DOI 10.1093/alcalc/agu095; Fredriksen-Goldsen KI, 2013, GERONTOLOGIST, V53, P664, DOI 10.1093/geront/gns123; Fullerton AS, 2012, SOC SCI RES, V41, P182, DOI 10.1016/j.ssresearch.2011.09.003; Gache P, 2005, ALCOHOL CLIN EXP RES, V29, P2001, DOI 10.1097/01.alc.0000187034.58955.64; Gyawali B, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-1003-6; Hassanzadeh J, 2018, AM J MENS HEALTH, V12, P96, DOI 10.1177/1557988316630720; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hutton HE, 2004, AM J PSYCHIAT, V161, P912, DOI 10.1176/appi.ajp.161.5.912; Igwe MN, 2016, MENT HEALTH RELIG CU, V19, P961, DOI 10.1080/13674676.2017.1287166; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Klein H, 2014, J GAY LESBIAN MENT H, V18, P164, DOI 10.1080/19359705.2013.834858; Luo ZZ, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1575-9; Mthembu JC, 2017, SSM-POPUL HLTH, V3, P658, DOI 10.1016/j.ssmph.2017.07.009; Myer L, 2008, SOC SCI MED, V66, P1828, DOI 10.1016/j.socscimed.2008.01.025; Organisation Mondiale de la Sante, 2018, MENT HLTH STRENGTH R; Patel S. K., 2015, Health, V7, P1114, DOI 10.4236/health.2015.79127; Peltzer K, 2012, SAJP-S AFR J PSYCHI, V18, P10; PETERSON B, 1990, J R STAT SOC C-APPL, V39, P205; Prajapati AC, 2014, INDIAN J PSYCHIAT, V56, P161, DOI 10.4103/0019-5545.130498; Prince M, NO HLTH MENT HLTH; Rael Christine T, 2017, DEPRESSION KEY ASS F, DOI [10.1177/0956462416651374, DOI 10.1177/0956462416651374]; Reisner SL, 2009, AIDS BEHAV, V13, P798, DOI 10.1007/s10461-009-9571-9; Safren SA, 2009, PSYCHOL HEALTH MED, V14, P705, DOI 10.1080/13548500903334754; Sandfort TGM, 2001, ARCH GEN PSYCHIAT, V58, P85, DOI 10.1001/archpsyc.58.1.85; SAVINWILLIAMS RC, 1994, J CONSULT CLIN PSYCH, V62, P261, DOI 10.1037/0022-006X.62.2.261; Sipsma Heather, 2019, POOR MENTAL HLTH GHA; Soboka Matiwos, 2014, BMC Res Notes, V7, P828, DOI 10.1186/1756-0500-7-828; Teclessou J N, 2017, Bull Soc Pathol Exot, V110, P270, DOI 10.1007/s13149-017-0565-y; Teclessou JN, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.191.11285; UNAIDS, 2015, UNAIDS TERM GUID; van Griensven F, 2010, AIDS, V24, pS30, DOI 10.1097/01.aids.0000390087.22565.b4; Whiteford HA, GLOBAL BURDEN DIS AT; Zaller N, 2017, J SUBST ABUSE TREAT, V80, P26, DOI 10.1016/j.jsat.2017.06.003	40	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231726	10.1371/journal.pone.0231726	http://dx.doi.org/10.1371/journal.pone.0231726			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298337	Green Published, gold			2022-12-26	WOS:000536011400096
J	Kim, HS; Park, KN; Kim, SH; Lee, BK; Oh, SH; Jeung, KW; Choi, SP; Youn, CS				Kim, Hyun Soo; Park, Kyu Nam; Kim, Soo Hyun; Lee, Byung Kook; Oh, Sang Hoon; Jeung, Kyung Woon; Choi, Seung Pill; Youn, Chun Song			Prognostic value of OHCA, C-GRApH and CAHP scores with initial neurologic examinations to predict neurologic outcomes in cardiac arrest patients treated with targeted temperature management	PLOS ONE			English	Article							CARDIOVASCULAR CARE SCIENCE; CARDIOPULMONARY-RESUSCITATION; INTERNATIONAL CONSENSUS; LIFE-SUPPORT; ASSOCIATION; GUIDELINES; MORTALITY; SURVIVAL; COMBINATION; WITHDRAWAL	Objective The aim of this study in out-of-hospital cardiac arrest (OHCA) patients treated with targeted temperature management (TTM) was to evaluate the prognostic value of OHCA, CGRApH, and CAHP scores with initial neurologic examinations for predicting neurologic outcomes. Methods This retrospective study included OHCA patients treated with TTM from 2009 to 2017. We calculated three cardiac arrest (CA)-specific risk scores (OHCA, C-GRApH, and CAHP) at the time of admission. The initial neurologic examination included an evaluation of the Full Outline of UnResponsiveness brainstem reflexes (FOUR_B) and Glasgow Coma Scale motor (GCS_M) scores. The primary outcome was the neurologic outcome at hospital discharge. Results Of 311 subjects, 99 (31.8%) had a good neurologic outcome at hospital discharge. The OHCA score had an area under the receiver operating characteristic curve (AUROC) of 0.844 (95% confidence interval (CI): 0.798-0.884), the C-GRApH score had an AUROC of 0.779 (95% CI: 0.728-0.824), and the CAHP score had an AUROC of 0.872 (95% CI: 0.830-0.907). The addition of the FOUR_B or GCS_M score to the OHCA score improved the prediction of poor neurologic outcome (with FOUR_B: AUROC = 0.899, p = 0.001; with GCS_M: AUROC = 0.880, p = 0.004). The results were similar with the C-GRApH and CAHP scores in predicting poor neurologic outcome. Conclusions This study confirms the good prognostic performance of CA-specific scores to predict neurologic outcomes in OHCA patients treated with TTM. By adding new variables associated with the initial neurologic examinations, the prognoses of neurologic outcomes improved compared to the existing scoring models.	[Kim, Hyun Soo; Park, Kyu Nam; Oh, Sang Hoon; Youn, Chun Song] Catholic Univ Korea, Seoul St Mary Hosp, Dept Emergency Med, Coll Med, Seoul, South Korea; [Kim, Soo Hyun; Choi, Seung Pill] Catholic Univ Korea, Eunpyeong St Mary Hosp, Dept Emergency Med, Coll Med, Seoul, South Korea; [Lee, Byung Kook; Jeung, Kyung Woon] Chonnam Natl Univ, Med Sch, Dept Emergency Med, Gwangju, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Chonnam National University	Youn, CS (corresponding author), Catholic Univ Korea, Seoul St Mary Hosp, Dept Emergency Med, Coll Med, Seoul, South Korea.	ycs1005@catholic.ac.kr	Oh, Sang Hoon/Y-4177-2018; Lee, Byung Kook/M-2236-2018	Oh, Sang Hoon/0000-0002-5549-1148; Lee, Byung Kook/0000-0003-3571-9448; Youn, Chun Song/0000-0002-6709-7703	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2018R1D1A1B07047594]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2018R1D1A1B07047594), awarded to CSY.	Adrie C, 2006, EUR HEART J, V27, P2840, DOI 10.1093/eurheartj/ehl335; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Chang YJ, 2017, J NEUROL SCI, V381, P752, DOI 10.1016/j.jns.2017.08.2124; Choi JY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196197; Choi SP, 2008, EMERG MED J, V25, P666, DOI 10.1136/emj.2007.053306; Donnino MW, 2015, CIRCULATION, V132, P2448, DOI 10.1161/CIR.0000000000000313; Elmer J, 2016, RESUSCITATION, V102, P127, DOI 10.1016/j.resuscitation.2016.01.016; Hazinski MF, 2010, CIRCULATION, V122, P8250, DOI 10.1161/CIRCULATIONAHA.110.970897; Kiehl EL, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.003821; Larsson M, 2005, RESUSCITATION, V66, P303, DOI 10.1016/j.resuscitation.2005.03.012; Lee BK, 2017, RESUSCITATION, V115, P75, DOI 10.1016/j.resuscitation.2017.04.009; Lemiale V, 2013, INTENS CARE MED, V39, P1972, DOI 10.1007/s00134-013-3043-4; Martinell L, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1677-2; Maupain C, 2016, EUR HEART J, V37, P3222, DOI 10.1093/eurheartj/ehv556; Nolan JP, 2015, INTENS CARE MED, V41, P2204, DOI 10.1007/s00134-015-4094-5; Nolan JP, 2015, RESUSCITATION, V95, pE1, DOI 10.1016/j.resuscitation.2015.07.039; Perkins GD, 2015, RESUSCITATION, V95, P81, DOI 10.1016/j.resuscitation.2015.07.015; Ro YS, 2016, RESUSCITATION, V102, P17, DOI 10.1016/j.resuscitation.2016.02.004; Samaniego EA, 2011, NEUROCRIT CARE, V15, P113, DOI 10.1007/s12028-010-9412-8; Sauneuf B, 2020, RESUSCITATION, V148, P200, DOI 10.1016/j.resuscitation.2020.01.011; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Torbey MT, 2004, RESUSCITATION, V63, P55, DOI 10.1016/j.resuscitation.2004.03.021; Wijdicks EFM, 2005, ANN NEUROL, V58, P585, DOI 10.1002/ana.20611; Yanagawa Y, 2005, RESUSCITATION, V64, P97, DOI 10.1016/j.resuscitation.2004.06.015; Youn CS, 2017, RESUSCITATION, V110, P120, DOI 10.1016/j.resuscitation.2016.10.024; Youn CS, 2015, RESUSCITATION, V94, P73, DOI 10.1016/j.resuscitation.2015.06.016	28	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232227	10.1371/journal.pone.0232227	http://dx.doi.org/10.1371/journal.pone.0232227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330180	Green Published, gold			2022-12-26	WOS:000536647300066
J	Lahuerta, M; Syowai, M; Vakil, S; Odhiambo, J; Gitonga, M; Sugandhi, N; Odhiambo, S; Kimani, M; Wamicwe, J; Batuka, J; Imbuki, E; Bartilol, K; Abrams, EJ				Lahuerta, Maria; Syowai, Maureen; Vakil, Shobha; Odhiambo, Jacob; Gitonga, Mwenda; Sugandhi, Nandita; Odhiambo, Stanslaus; Kimani, Maureen; Wamicwe, Joyce; Batuka, James; Imbuki, Evans; Bartilol, Kigen; Abrams, Elaine J.			Monitoring the transition to new antiretroviral treatment regimens through an enhanced data system in Kenya	PLOS ONE			English	Article							DOLUTEGRAVIR	Background While the scale-up of HIV services has improved national health management information systems (HMIS), there remain challenges in using routine data to guide the introduction of optimized antiretroviral (ARV) drugs. Methods Building on the recent enhancements to the HMIS in Kenya and coinciding with the introduction of a new ARV regimen, tenofovir+lamivudine+dolutegravir (TLD), we developed and implemented an enhanced data system (EDS) to improve availability of safety and efficacy data among people living with HIV (PLHIV) in Kenya. Using data from one health facility, we showcase how the EDS can be used to monitor ARV transition and identify missed opportunities to transition eligible patients to optimized regimes. Results The EDS was designed to create a comprehensive PLHIV database by triangulating patient-level data from the EMR, the pharmacy ARV dispensing tool (ADT) and HIV viral load (VL) databases. On a monthly basis, the database is de-identified and uploaded into a national data warehouse, with interactive dashboards. Using the EDS, we determined that of the 5,500 PLHIV.15 years on first-line ART at one facility, 4,233 (77%) had transitioned to optimized ARVs. Of the 1,267 still on legacy regimens, 459 (36%) were determined to be eligible and prioritized to switch. Conclusions This project illustrates how enhancements to the national HMIS can facilitate the use of routine patient-level data to monitor the transition to new ARVs and inform the national HIV response.	[Lahuerta, Maria; Syowai, Maureen; Vakil, Shobha; Sugandhi, Nandita; Odhiambo, Stanslaus; Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10032 USA; [Lahuerta, Maria; Abrams, Elaine J.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Odhiambo, Jacob; Gitonga, Mwenda] Palladium, Nairobi, Kenya; [Kimani, Maureen; Wamicwe, Joyce; Imbuki, Evans; Bartilol, Kigen] Natl AIDS & STI Control Programme NASCOP, Nairobi, Kenya; [Batuka, James] US Agcy Int Dev USAID, Nairobi, Kenya; [Abrams, Elaine J.] Columbia Univ, Vagelos Coll Phys & Surg, Dept Pediat, New York, NY USA	Columbia University; Columbia University; United States Agency for International Development (USAID); Columbia University	Lahuerta, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10032 USA.; Lahuerta, M (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA.	ml2842@cumc.columbia.edu			U.S. Agency for International Development (USAID) through OPTIMIZE [AID-OAA-A-15-00069]	U.S. Agency for International Development (USAID) through OPTIMIZE(United States Agency for International Development (USAID))	This project was funded by the U.S. Agency for International Development (USAID) through OPTIMIZE (Cooperative Agreement No. AID-OAA-A-15-00069), a global consortium dedicated to rapidly improving treatment outcomes for people living with HIV (PLHIV) by optimizing antiretroviral drugs and regimens and accelerating their introduction in low-and middle-income countries. USAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Palladium provided support in the form of salaries for authors JO and MG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Brandt AM, 2013, NEW ENGL J MED, V368, P2149, DOI 10.1056/NEJMp1305297; Clotet B, 2014, LANCET, V383, P2222, DOI 10.1016/S0140-6736(14)60084-2; El-Sadr WM, 2012, JAIDS-J ACQ IMM DEF, V60, pS96, DOI 10.1097/QAI.0b013e31825eb27b; EMR Technical Working Group Ministry of Public Health and Sanitation, STAND GUID EL MED SY; Heeks R, 2002, INFORM SOC, V18, P101, DOI 10.1080/01972240290075039; Ministry of Health National AIDS STI Control Program., 2018, GUIDELINES USE ANTIR; Ministry of Health National AIDS & STI Control Programme, 2016, GUIDELINES USE ANTIR; Mwau M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190659; Walmsley SL, 2013, NEW ENGL J MED, V369, P1807, DOI 10.1056/NEJMoa1215541	9	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232104	10.1371/journal.pone.0232104	http://dx.doi.org/10.1371/journal.pone.0232104			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324800	gold, Green Published, Green Submitted			2022-12-26	WOS:000536033700075
J	Liang, PD; Fang, X; Hu, YY; Yuan, M; Raba, DA; Ding, J; Bunn, DC; Sanjana, K; Yang, J; Rosas-Lemus, M; Hase, CC; Tuz, K; Juarez, O				Liang, Pingdong; Fang, Xuan; Hu, Yuyao; Yuan, Ming; Raba, Daniel A.; Ding, Jie; Bunn, Dakota C.; Sanjana, Krithica; Yang, Jun; Rosas-Lemus, Monica; Hase, Claudia C.; Tuz, Karina; Juarez, Oscar			The aerobic respiratory chain of Pseudomonas aeruginosa cultured in artificial urine media: Role of NQR and terminal oxidases	PLOS ONE			English	Article							NA+-TRANSLOCATING NADH; CYTOCHROME-C-OXIDASE; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; QUINONE OXIDOREDUCTASE; COMPLEX-I; UBIQUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; BINDING-SITE; CYANIDE	Pseudomonas aeruginosa is a Gram-negative gamma-proteobacterium that forms part of the normal human microbiota and it is also an opportunistic pathogen, responsible for 30% of all nosocomial urinary tract infections. P. aeruginosa carries a highly branched respiratory chain that allows the colonization of many environments, such as the urinary tract, catheters and other medical devices. P. aeruginosa respiratory chain contains three different NADH dehydrogenases (complex I, NQR and NDH-2), whose physiologic roles have not been elucidated, and up to five terminal oxidases: three cytochrome c oxidases (COx), a cytochrome bo(3) oxidase (CYO) and a cyanide-insensitive cytochrome bd-like oxidase (CIO). In this work, we studied the composition of the respiratory chain of P. aeruginosa cells cultured in Luria Broth (LB) and modified artificial urine media (mAUM), to understand the metabolic adaptations of this microorganism to the growth in urine. Our results show that the COx oxidases play major roles in mAUM, while P. aeruginosa relies on CYO when growing in LB medium. Moreover, our data demonstrate that the proton-pumping NQR complex is the main NADH dehydrogenase in both LB and mAUM. This enzyme is resistant to HQNO, an inhibitory molecule produced by P. aeruginosa, and may provide an advantage against the natural antibacterial agents produced by this organism. This work offers a clear picture of the composition of this pathogen's aerobic respiratory chain and the main roles that NQR and terminal oxidases play in urine, which is essential to understand its physiology and could be used to develop new antibiotics against this notorious multidrug-resistant microorganism.	[Liang, Pingdong; Fang, Xuan; Hu, Yuyao; Yuan, Ming; Raba, Daniel A.; Ding, Jie; Bunn, Dakota C.; Sanjana, Krithica; Yang, Jun; Rosas-Lemus, Monica; Tuz, Karina; Juarez, Oscar] IIT, Dept Biol Sci, Chicago, IL 60616 USA; [Hase, Claudia C.] Oregon State Univ, Carlson Coll Vet Med, Corvallis, OR 97331 USA	Illinois Institute of Technology; Oregon State University	Juarez, O (corresponding author), IIT, Dept Biol Sci, Chicago, IL 60616 USA.	ojuarez@iit.edu	Fang, Xuan/CAG-5381-2022	Fang, Xuan/0000-0001-6394-4015; Bunn, Dakota/0000-0002-4912-9839; Tuz, Karina/0000-0002-1669-4612; Raba, Daniel/0000-0003-4334-0008; Juarez, Oscar/0000-0002-2915-8413	Illinois Institute of Technology startup funds; National Institutes of Health [R15GM131292]; "Programa de Estancias Postdoctorales al Extranjero", CONACYT, Mexico	Illinois Institute of Technology startup funds; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Programa de Estancias Postdoctorales al Extranjero", CONACYT, Mexico	This work was supported by Illinois Institute of Technology startup funds to OJ and by the National Institutes of Health (R15GM131292; OJ). MRL postdoctoral research was partially supported by "Programa de Estancias Postdoctorales al Extranjero", CONACYT, Mexico.	Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; [Anonymous], 2009, LANCET INFECT DIS, DOI DOI 10.1016/S1473-3099(09)70222-1; Arai H, 2014, J BACTERIOL, V196, P4206, DOI 10.1128/JB.02176-14; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Banin E, 2006, APPL ENVIRON MICROB, V72, P2064, DOI 10.1128/AEM.72.3.2064-2069.2006; Barquera B, 2001, FEBS LETT, V492, P45, DOI 10.1016/S0014-5793(01)02224-4; Barquera B, 2002, P NATL ACAD SCI USA, V99, P10322, DOI 10.1073/pnas.162361299; Barquera B, 2004, BIOCHEMISTRY-US, V43, P12322, DOI 10.1021/bi048689y; BARR JG, 1985, BRIT J OBSTET GYNAEC, V92, P506, DOI 10.1111/j.1471-0528.1985.tb01356.x; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088368; Bjorklof K, 2000, FEBS LETT, V467, P105, DOI 10.1016/S0014-5793(00)01130-3; Blaza JN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40165; Bogachev AV, 2009, BIOCHEMISTRY-US, V48, P6291, DOI 10.1021/bi900524m; BOGACHEV AV, 1993, BIOCHIM BIOPHYS ACTA, V1142, P321, DOI 10.1016/0005-2728(93)90160-H; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brooks T, 1997, LETT APPL MICROBIOL, V24, P203, DOI 10.1046/j.1472-765X.1997.00378.x; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; Comolli JC, 2004, MOL MICROBIOL, V51, P1193, DOI 10.1046/j.1365-2958.2003.03904.x; CUNNINGHAM L, 1995, J BACTERIOL, V177, P432, DOI 10.1128/jb.177.2.432-438.1995; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Di Tomaso G, 2002, MICROBIOL-SGM, V148, P1699, DOI 10.1099/00221287-148-6-1699; Dietrich LEP, 2013, J BACTERIOL, V195, P1371, DOI 10.1128/JB.02273-12; ERNSTER L, 1963, J BIOL CHEM, V238, P1124; Esposti MD, 1998, BBA-BIOENERGETICS, V1364, P222, DOI 10.1016/S0005-2728(98)00029-2; Fadeeva MS, 2008, FEMS MICROBIOL LETT, V279, P116, DOI 10.1111/j.1574-6968.2007.01015.x; FRIEDRICH T, 1995, FEBS LETT, V367, P107, DOI 10.1016/0014-5793(95)00548-N; Furt F, 2010, PLANT J, V64, P38, DOI 10.1111/j.1365-313X.2010.04305.x; Giannakopoulos X., 1997, International Urology and Nephrology, V29, P393, DOI 10.1007/BF02551103; Giuffre A, 2014, BBA-BIOENERGETICS, V1837, P1178, DOI 10.1016/j.bbabio.2014.01.016; Gong HR, 2018, SCIENCE, V362, P1020, DOI 10.1126/science.aat8923; Hardalo C, 1997, CRIT REV MICROBIOL, V23, P47, DOI 10.3109/10408419709115130; Hase CC, 2001, BBA-BIOENERGETICS, V1505, P169, DOI 10.1016/S0005-2728(00)00286-3; Hazan R, 2016, CURR BIOL, V26, P195, DOI 10.1016/j.cub.2015.11.056; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Jo J, 2017, ELIFE, V6, DOI [10.7554/eLife.30205, 10.7554/elife.30205]; Juarez O, 2004, BBA-BIOENERGETICS, V1658, P244, DOI 10.1016/j.bbabio.2004.06.005; Juarez O, 2008, J BIOL CHEM, V283, P33162, DOI 10.1074/jbc.M806913200; Juarez O, 2012, BBA-BIOENERGETICS, V1817, P1823, DOI 10.1016/j.bbabio.2012.03.017; Juarez O, 2009, J BIOL CHEM, V284, P8963, DOI 10.1074/jbc.M809395200; Kahm M, 2010, J STAT SOFTW, V33, P1; Kang JW, 2007, J BIOCHEM MOL BIOL, V40, P53; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; KEMP MB, 1972, BIOCHEM J, V130, P307, DOI 10.1042/bj1300307; Kerscher Stefan, 2008, V45, P185, DOI 10.1007/400_2007_028; Kim YJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-161; KITA K, 1984, J BIOL CHEM, V259, P3368; Kretzschmar U, 2002, MICROBIOL-SGM, V148, P3839, DOI 10.1099/00221287-148-12-3839; Leavesley HB, 2008, TOXICOL SCI, V101, P101, DOI 10.1093/toxsci/kfm254; Liang PD, 2018, J BIOL CHEM, V293, P510, DOI 10.1074/jbc.M117.797209; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Liu J, 2008, BBA-BIOENERGETICS, V1777, P453, DOI 10.1016/j.bbabio.2008.02.004; Lummen P, 1998, BBA-BIOENERGETICS, V1364, P287, DOI 10.1016/S0005-2728(98)00034-6; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Maiuolo J, 2016, INT J CARDIOL, V213, P8, DOI 10.1016/j.ijcard.2015.08.109; Matsunaga K, 2017, VITAMIN K2 VITAL HLT, DOI [10.5772/63343, DOI 10.5772/63343]; MATSUSHITA K, 1984, BIOCHEMISTRY-US, V23, P4703, DOI 10.1021/bi00315a028; Merrell DS, 2002, MOL MICROBIOL, V43, P1471, DOI 10.1046/j.1365-2958.2002.02857.x; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Mogi T, 2009, J BIOCHEM, V146, P263, DOI 10.1093/jb/mvp067; Nakayama Y, 1999, BIOL PHARM BULL, V22, P1064; Neehaubl Y, 2013, BIOCHEMISTRY-US, V52, P3085, DOI 10.1021/bi4000386; Orazi G, 2017, MBIO, V8, DOI 10.1128/mBio.00873-17; Osamura T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177957; PETERSEN LC, 1977, BIOCHIM BIOPHYS ACTA, V460, P299, DOI 10.1016/0005-2728(77)90216-X; Petri J, 2018, BBA-BIOENERGETICS, V1859, P482, DOI 10.1016/j.bbabio.2018.03.014; Poole RK, 2000, ADV MICROB PHYSIOL, V43, P165, DOI 10.1016/S0065-2911(00)43005-5; PUUSTINEN A, 1991, BIOCHEMISTRY-US, V30, P3936, DOI 10.1021/bi00230a019; Raba DA, 2018, J BIOL CHEM, V293, P15664, DOI 10.1074/jbc.RA118.003194; Ray A, 1996, FEMS MICROBIOL LETT, V135, P123; Reyes-Prieto A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096696; Richhardt J, 2013, J BACTERIOL, V195, P4210, DOI 10.1128/JB.00470-13; Rossi E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05944-5; Scheijen JLJM, 2012, EXP DIABETES RES, DOI 10.1155/2012/234812; Schoenmakers TJ, 1992, BIOTECHNIQUES, V12, p[870, 876]; Silver S., 2003, TRENDS MICROBIOL, V2, P33, DOI [10.1016/0966-842x(94)90345-x, DOI 10.1016/0966-842X(94)90345-X]; STANNARD JN, 1948, J BIOL CHEM, V172, P599; Steuber J, 2015, BIOL CHEM, V396, P1015, DOI 10.1515/hsz-2015-0128; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Torres A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00075; Toyofuku M, 2008, J BACTERIOL, V190, P7947, DOI 10.1128/JB.00968-08; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Tuz K, 2017, J BIOL CHEM, V292, P3039, DOI [10.1074/jbc.M116.770982, 10.1074/jbc.m116.770982]; Tuz K, 2015, J BIOL CHEM, V290, P20009, DOI 10.1074/jbc.M115.658773; Ugidos A, 2008, ENVIRON MICROBIOL, V10, P1690, DOI 10.1111/j.1462-2920.2008.01586.x; VANARK G, 1977, BIOCHIM BIOPHYS ACTA, V459, P119, DOI 10.1016/0005-2728(77)90014-7; Warren JW, 2001, INT J ANTIMICROB AG, V17, P299, DOI 10.1016/S0924-8579(00)00359-9; Weiss SA, 2010, BBA-BIOENERGETICS, V1797, P1917, DOI 10.1016/j.bbabio.2010.01.012; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Williams HD, 2007, ADV MICROB PHYSIOL, V52, P1, DOI 10.1016/S0065-2911(06)52001-6; Wilson ML, 2004, CLIN INFECT DIS, V38, P1150, DOI 10.1086/383029; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; WORTH PHL, 1980, BRIT MED J, V281, P1285, DOI 10.1136/bmj.281.6250.1285-b; Xie H, 2014, J BACTERIOL, V196, P472, DOI 10.1128/JB.01072-13; YAGI T, 1991, J BIOENERG BIOMEMBR, V23, P211, DOI 10.1007/BF00762218; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Zhou WD, 1999, BIOCHEMISTRY-US, V38, P16246, DOI 10.1021/bi991664s; Zlosnik JEA, 2006, MICROBIOL-SGM, V152, P1407, DOI 10.1099/mic.0.28396-0	97	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231965	10.1371/journal.pone.0231965	http://dx.doi.org/10.1371/journal.pone.0231965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324772	gold, Green Published			2022-12-26	WOS:000536033700052
J	Valdes-Donoso, P; Sumner, DA; Goldstein, R				Valdes-Donoso, Pablo; Sumner, Daniel A.; Goldstein, Robin			Costs of cannabis testing compliance: Assessing mandatory testing in the California cannabis market	PLOS ONE			English	Article								Most U.S. states that have regulated and taxed cannabis have imposed some form of mandatory safety testing requirements. In California, the country's largest and oldest legal cannabis market, mandatory testing was first enforced by state regulators in July 2018, and additional mandatory tests were introduced at the end of 2018. All cannabis must be tested and labeled as certified by a state-licensed cannabis testing laboratory before it can be legally marketed in California. Every batch that is sold by licensed retailers must be tested for more than 100 contaminants, including 66 pesticides with tolerance levels lower than the levels allowable for any other agricultural product in California. This paper estimates the costs of compliance with mandatory cannabis testing laws and regulations, using California's testing regime as a case study. We use state government data, data collected from testing laboratories, and data collected from lab equipment suppliers to run a set of Monte Carlo simulations and estimate the cost per pound of compliance with California's new cannabis testing regulations. We find that cost per pound is highly sensitive to average batch size and testing failure rates. We present results under a variety of different assumptions about batch size and failure rates. We also find that under realistic assumptions, the loss of cannabis that must be destroyed if a batch fails testing accounts for a larger share of total testing costs than does the cost of the lab tests. Using our best estimates of average batch size (8 pounds) and failure rate (4%) in the 2019 California market, we estimate testing cost at $136 per pound of dried cannabis flower, or about 10 percent of the reported average wholesale price of legal cannabis in the state. Our findings explain effects of the testing standards on the cost of supplying legal licensed cannabis, in California, other U.S. states, and foreign jurisdictions with similar testing regimes.	[Valdes-Donoso, Pablo; Sumner, Daniel A.; Goldstein, Robin] Univ Calif Davis, Agr Issues Ctr, Davis, CA 95616 USA; [Sumner, Daniel A.] Univ Calif Davis, Dept Agr & Resource Econ, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Valdes-Donoso, P (corresponding author), Univ Calif Davis, Agr Issues Ctr, Davis, CA 95616 USA.	pvaldesdonoso@ucdavis.edu	donoso, pablo valdes/U-3208-2017					Auguie B, 2017, GRIDEXTRA MISCELLANE; Bureau of Cannabis Control, 2019, WEEKL REP; Bureau of Cannabis Control, 2019, CANN LIC SEARCH; California Department of Pesticide Regulation, 2019, PEST REG PEST RES MO; Colorado Department of Revenue, 2018, ANN UPD; Drug Enforcement Administration, 2018, CANN ER DOM; Drug Enforcement Administration, 2016, SCHED CONTR SUBST MA; Government of the People's Republic of Bangladesh, 2018, SB 94, P1; Gray RS, 2005, GIANNINI FDN MONOGR, V46, P1; Grover J, 2017, NBC4; Lindsey TD, 2012, MED MARIJUANA CULTIV, P1; MacEwan D, 2017, STANDARDIZED REGULAT; Schroyer J., 2018, MARIJUANA BUSINESS D; Stone D, 2014, REGUL TOXICOL PHARM, V69, P284, DOI 10.1016/j.yrtph.2014.05.015; Sumner DA, 2018, STANDARDIZED REGULAT; Valdes-Donoso P, 2019, CALIF AGR, V73, P154, DOI 10.3733/ca.2019a0014; Washington Administrative Code, 2018, MAR LIC APPL PROC RE; WSLCB, 2018, RESP PUBL REC REQ DA	18	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232041	10.1371/journal.pone.0232041	http://dx.doi.org/10.1371/journal.pone.0232041			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324781	Green Published, gold			2022-12-26	WOS:000536033700065
J	VanDerslice, J; Taddie, MC; Curtin, K; Miller, C; Yu, Z; Hemmert, R; Cannon-Albright, LA; Neklason, DW				VanDerslice, James; Taddie, Marissa C.; Curtin, Karen; Miller, Caroline; Yu, Zhe; Hemmert, Rachael; Cannon-Albright, Lisa A.; Neklason, Deborah W.			Early life exposures associated with risk of small intestinal neuroendocrine tumors	PLOS ONE			English	Article							POPULATION-BASED ANALYSIS; CANCER INCIDENCE; EPIDEMIOLOGY	Small intestinal neuroendocrine tumors (SINT) are rare with incidence increasing over the past 40 years. The purpose of this work is to examine the role of environmental exposures in the rise of SINT incidence using the Utah Population Database, a resource of linked records including life events, cancer diagnoses and residential histories. SINT cases born in Utah were identified through the Utah Cancer Registry with: diagnosis years of 1948 to 2014 and age at diagnosis of 23 to 88 years. Controls were matched to cases 10:1 based on sex, birth year and residence time in Utah. Cases and controls were geocoded to their birth locale. An isotonic spatial scan statistic was used to test for the occurrence and location(s) of SINT clusters. Potential environmental exposures and economic conditions in the birth locales at the time of the birth (1883-1982) were generated using historical references. Conditional logistic regression was used to estimate odd ratios. We report a spatial cluster central to historic coal mining communities, associated with a 2.86 relative risk (p = 0.016) of SINT. Aspatial analyses of industry and mining exposures further suggest elevated risk for early life exposure near areas involved in the construction industry (OR 1.98 p = 0.024). Other exposures approached significance including coal, uranium and hard rock mining during the earliest period (1883-1929) when safety from exposures was not considered. We do observe a lower risk (OR 0.58 p = 0.033) associated with individuals born in rural areas in the most recent period (1945-1982). Environmental exposures early in life, especially those from industries such as mining, may confer an elevated risk of SINT.	[VanDerslice, James; Taddie, Marissa C.; Miller, Caroline; Hemmert, Rachael] Univ Utah, Dept Family & Preventat Med, Div Publ Hlth, Salt Lake City, UT USA; [Curtin, Karen; Cannon-Albright, Lisa A.; Neklason, Deborah W.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA; [Curtin, Karen; Yu, Zhe; Cannon-Albright, Lisa A.; Neklason, Deborah W.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA; [Cannon-Albright, Lisa A.] Vet Affairs Med Ctr, George E Wahlen Dept, Salt Lake City, UT 84148 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Neklason, DW (corresponding author), Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA.; Neklason, DW (corresponding author), Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.	deb.neklason@hci.utah.edu			National Cancer Institute at the National Institutes of Health [R21CA205796, P30CA042014]; Huntsman Cancer Foundation; National Cancer Institute's SEER Program [HHSN261201800016I]; US Center for Disease Control and Prevention's National Program of Cancer Registries [NU58DP0063200]; University of Utah; NCRR grant, "Sharing Statewide Health Data for Genetic Research" [R01 RR021746]; Utah State Department of Health	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Huntsman Cancer Foundation; National Cancer Institute's SEER Program; US Center for Disease Control and Prevention's National Program of Cancer Registries; University of Utah; NCRR grant, "Sharing Statewide Health Data for Genetic Research"; Utah State Department of Health	This work was supported by grants from the National Cancer Institute at the National Institutes of Health, R21CA205796 and P30CA042014 and Huntsman Cancer Foundation. Support for the Utah Cancer Registry is provided by the National Cancer Institute's SEER Program, Contract No. HHSN261201800016I, the US Center for Disease Control and Prevention's National Program of Cancer Registries, Cooperative Agreement No. NU58DP0063200, with additional support from the University of Utah and Huntsman Cancer Foundation. Research was supported by the NCRR grant, "Sharing Statewide Health Data for Genetic Research" (R01 RR021746) with additional support from the Utah State Department of Health and the University of Utah.	Affolter K, 2017, DIGEST DIS SCI, V62, P1455, DOI 10.1007/s10620-017-4543-9; [Anonymous], 2018, SALT LAKE CITY PLANN; [Anonymous], 2018, SALT LAKE CITY GIS O; Bradley MS, 1995, UTAH CENTENNIAL COUN; Christian WJ, 2011, PUBLIC HEALTH REP, V126, P789, DOI 10.1177/003335491112600604; Cives M, 2016, CURR OPIN ONCOL, V28, P359, DOI 10.1097/CCO.0000000000000299; Clarke MA, 2017, EPIDEMIOL REV, V39, P11, DOI 10.1093/epirev/mxx004; Curtin K, 2019, CANCER EPIDEM BIOMAR, V28, P1998, DOI 10.1158/1055-9965.EPI-19-0465; Dasari A, 2017, JAMA ONCOL, V3, P1335, DOI 10.1001/jamaoncol.2017.0589; DISARIO JA, 1994, AM J GASTROENTEROL, V89, P699; DWASS M, 1957, ANN MATH STAT, V28, P181, DOI 10.1214/aoms/1177707045; EPA, 2018, SUP SIT REG 8, P8; Giovino Gary A., 1994, Morbidity and Mortality Weekly Report, V43, P1; GNIS, 2016, US GEOGR NAM INF SYS; Hallet J, 2015, CANCER-AM CANCER SOC, V121, P2214, DOI 10.1002/cncr.29338; Hallet J, 2015, CANCER-AM CANCER SOC, V121, P589, DOI 10.1002/cncr.29099; Haugvik SP, 2017, SCAND J GASTROENTERO, V52, P797, DOI 10.1080/00365521.2017.1310290; Hiripi E, 2009, ANN ONCOL, V20, P950, DOI 10.1093/annonc/mdn706; Kharazmi E, 2013, CLIN GASTROENTEROL H, V11, P944, DOI 10.1016/j.cgh.2013.02.025; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M., 2018, SOFTWARE SPATIAL SPA; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Merrill RM, 2005, PREV MED, V40, P535, DOI 10.1016/j.ypmed.2004.10.011; Modlin IM, 2003, CANCER-AM CANCER SOC, V97, P934, DOI 10.1002/cncr.11105; Mueller GS, 2015, ECOTOX ENVIRON SAFE, V120, P155, DOI 10.1016/j.ecoenv.2015.05.037; Murphy CC, 2018, GASTROENTEROLOGY, V155, P1716, DOI 10.1053/j.gastro.2018.07.045; Neklason DW, 2016, ENDOCR-RELAT CANCER, V23, P93, DOI 10.1530/ERC-15-0442; Neugut AI, 1998, CANCER EPIDEM BIOMAR, V7, P243; Nguyen QC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16573-1; Norton MC, 2017, BIODEMOGR SOC BIOL, V63, P104, DOI 10.1080/19485565.2017.1281099; Ou JY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061081; Powell Allan Kent, 1994, UTAH HIST ENCY; Prahalad S, 2004, ARTHRITIS RHEUM, V50, P4022, DOI 10.1002/art.20677; Preston DL, 2008, JNCI-J NATL CANCER I, V100, P428, DOI 10.1093/jnci/djn045; Skolnick M, 1979, SOC RES, P506; Smith KR, 2009, SOC SCI MED, V68, P1649, DOI 10.1016/j.socscimed.2009.02.010; Strack D., 2000, UTAHRAILS NET UTAH F; Stroup AM, 2017, CANCER EPIDEM BIOMAR, V26, P75, DOI 10.1158/1055-9965.EPI-16-0371; UDSH, 2015, GHOST TOWNS UT; VanCott JW, 1990, UTAH PLACE NAMES; Wang Q, 2016, MOL ENDOCRINOL, V30, P856, DOI 10.1210/me.2015-1310; Whitley C, 2006, FROM THE GROUND UP: THE HISTORY OF MINING IN UTAH, pXIII; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377	43	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231991	10.1371/journal.pone.0231991	http://dx.doi.org/10.1371/journal.pone.0231991			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324813	Green Published, gold			2022-12-26	WOS:000536033700056
J	Huang, L; Yin, YF; Fu, Z; Zhang, SF; Deng, H; Liu, DB				Huang, Li; Yin, Yifeng; Fu, Zeng; Zhang, Shifa; Deng, Hao; Liu, Dianbo			LoAdaBoost: Loss-based AdaBoost federated machine learning with reduced computational complexity on IID and non-IID intensive care data	PLOS ONE			English	Article								Intensive care data are valuable for improvement of health care, policy making and many other purposes. Vast amount of such data are stored in different locations, on many different devices and in different data silos. Sharing data among different sources is a big challenge due to regulatory, operational and security reasons. One potential solution is federated machine learning, which is a method that sends machine learning algorithms simultaneously to all data sources, trains models in each source and aggregates the learned models. This strategy allows utilization of valuable data without moving them. One challenge in applying federated machine learning is the possibly different distributions of data from diverse sources. To tackle this problem, we proposed an adaptive boosting method named LoAdaBoost that increases the efficiency of federated machine learning. Using intensive care unit data from hospitals, we investigated the performance of learning in IID and non-IID data distribution scenarios, and showed that the proposed LoAdaBoost method achieved higher predictive accuracy with lower computational complexity than the baseline method.	[Huang, Li] Tsinghua Univ, Acad Arts & Design, Beijing, Peoples R China; [Huang, Li] Tsinghua Univ, Future Lab, Beijing, Peoples R China; [Yin, Yifeng] Univ Huddersfield, Huddersfield, W Yorkshire, England; [Fu, Zeng] Univ Calif San Diego, La Jolla, CA 92093 USA; [Zhang, Shifa] Northeastern Univ, Boston, MA 02115 USA; [Zhang, Shifa; Liu, Dianbo] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Deng, Hao] Massachusetts Gen Hosp, Dept Anesthesia, Boston, MA 02114 USA; [Liu, Dianbo] Harvard Med Sch, Boston, MA 02115 USA; [Liu, Dianbo] Boston Childrens Hosp, Boston, MA 02115 USA	Tsinghua University; Tsinghua University; University of Huddersfield; University of California System; University of California San Diego; Northeastern University; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Liu, DB (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Liu, DB (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Liu, DB (corresponding author), Boston Childrens Hosp, Boston, MA 02115 USA.	dianbo@mit.edu						[Anonymous], 2012, PROC INT C MACH LEAR; Bagdasaryan E., 2018, ARXIV180700459; Balcan M.F., 2012, P C LEARN THEOR, P26; Barcelos Carla Fillmann, 2011, Interdisciplinary Journal of e-Learning and Learning Objects, V7, P37; Bonawitz K. A., 2016, P NIPS WORKSH PRIV M; Bottou L, 2010, COMPSTAT'2010: 19TH INTERNATIONAL CONFERENCE ON COMPUTATIONAL STATISTICS, P177, DOI 10.1007/978-3-7908-2604-3_16; FERCOQ O., 2014, IEEE INT WORKSHOP MA, P1, DOI DOI 10.1109/MLSP.2014.6958862; Ghadimi S, 2013, SIAM J OPTIMIZ, V23, P2341, DOI 10.1137/120880811; Huang L, 2019, ARXIV190309296; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Konecny J., 2016, ARXIV161005492; Liu D., 2018, ARXIV181209659; Liu D., 2018, MACHINE LEARNING HLT; Liu DB, 2019, SIGBIOMED WORKSHOP ON BIOMEDICAL NATURAL LANGUAGE PROCESSING (BIONLP 2019), P283, DOI 10.18653/v1/W19-5030; McMahan H. Brendan, 2016, ARXIV160205629; Pollard TJ, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.178; Rehak D., 2005, INT WEB BAS ED SYST, P143; Richtarik P., 2013, ARXIV13102059; Smith V., 2017, ADV NEURAL INFORM PR, P4424; Zhao Y., 2018, ARXIV180600582	21	30	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0230706	10.1371/journal.pone.0230706	http://dx.doi.org/10.1371/journal.pone.0230706			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302316	Green Submitted, gold, Green Published			2022-12-26	WOS:000536016100009
J	Jankowska-Polanska, B; Swiatoniowska-Lonc, N; Slawuta, A; Krowczynska, D; Dudek, K; Mazur, G				Jankowska-Polanska, Beata; Swiatoniowska-Lonc, Natalia; Slawuta, Agnieszka; Krowczynska, Dorota; Dudek, Krzysztof; Mazur, Grzegorz			Patient-Reported Compliance in older age patients with chronic heart failure	PLOS ONE			English	Article							MEDICATION ADHERENCE; DEPRESSION; ASSOCIATION; VARIABLES; BARRIERS; BELIEFS	The purpose of the study was to evaluate compliance with medical treatment in elderly patients with heart failure (HF), and to identify factors that associated with patients' compliance levels. Methods and results 475 patients (including 222 women), mean age 69.7 +/- 7.7, with HF, hospitalized at University Hospital between January and December 2018 were included in the study. The patients were selected by a physician specializing in cardiology. A cardiac nurse assessed the non-pharmacological level of compliance using the Revised Heart Failure Compliance Questionnaire (RHFCQ). The socio-clinical data were obtained from medical records. The majority of the study group were patients in NYHA II (62.4%) and NYHA III (28.3%), the mean duration of the disease was 6.2 +/- 4.9 years, and the mean ejection fraction of the left ventricle (EF) was 48.6 +/- 12.6. The average level of compliance in the study group measured on a scale from 0 to 4 points was: median = 2.7, IQR [2.32; 3.25]. Only 6.9% of the respondents adhere to recommendations totally (all dimensions of RHFCQ). In univariate analysis, predictors negatively affecting compliance were: female gender (rho = -0.325), age below 65 years (rho = -0.014)), loneliness (rho = -0.559), number of hospitalizations (rho = -0.242), higher stage of NYHA (rho = -1.612), co-morbidities (rho = -0.729), re-hospitalizations (rho = -0.729), beta-blockers treatment (rho = -1.612) and diuretics treatment (rho = -0.276). Factors positively affecting compliance were: EF >= 45% (rho = 0.020) and treatment with ACEI/ARB (rho = 0.34), whereas compliance was negatively affected by-EF<45% (beta = 0.009). Independent predictors influencing the level of compliance were: loneliness (beta = -1.816), number of hospitalizations (beta = -0.117), NYHA III and IV and number of co-morbidities (beta = -0.676). Conclusions Patients with HF do not adhere to therapeutic recommendations. The lowest compliance levels were found for exercise and daily weighing, and the highest for follow-up appointment-keeping and medication. Loneliness and age are the strongest predictors which influence the level of compliance.	[Jankowska-Polanska, Beata; Swiatoniowska-Lonc, Natalia] Wroclaw Med Univ, Dept Clin Nursing, Fac Hlth Sci, Wroclaw, Poland; [Slawuta, Agnieszka; Mazur, Grzegorz] Wroclaw Med Univ, Dept Internal Dis Occupat Med Hypertens & Clin On, Wroclaw, Poland; [Krowczynska, Dorota] Med Univ Warsaw, Dept Clin Nursing, Warsaw, Poland; [Dudek, Krzysztof] Tech Univ Wroclaw, Fac Mech Engn, Wroclaw, Poland	Wroclaw Medical University; Wroclaw Medical University; Medical University of Warsaw; Wroclaw University of Science & Technology	Jankowska-Polanska, B (corresponding author), Wroclaw Med Univ, Dept Clin Nursing, Fac Hlth Sci, Wroclaw, Poland.	beata.jankowska-polanska@umed.wroc.pl	Świątoniowska-Lonc, Natalia/AAM-7360-2021; Jankowska-Polanska, Beata Katarzyna/AAC-8354-2022	Świątoniowska-Lonc, Natalia/0000-0003-4211-9205; Jankowska-Polanska, Beata/0000-0003-1120-3535; Mazur, Grzegorz/0000-0001-6610-2008; Slawuta, Agnieszka/0000-0001-5671-9864	Wroclaw Medical University [ST.A210.I6.040]; Ministry of Science and Higher Education [016/RID/2018/19]	Wroclaw Medical University; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by Wroclaw Medical University [ST.A210.I6.040]. The publication was also prepared under the project of NS and BJP financed from the funds granted by the Ministry of Science and Higher Education in the "Regional Initiative of Excellence" programme for the years 2019-2022, project number 016/RID/2018/19. http://www.rid.umed.wroc.pl/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berliner D, 2018, HERZ, V43, P207, DOI 10.1007/s00059-017-4668-9; Colin-Ramirez E, 2015, J CARDIOVASC NURS, V30, P58, DOI 10.1097/JCN.0000000000000124; Conraads VM, 2012, EUR J HEART FAIL, V14, P451, DOI 10.1093/eurjhf/hfs048; Cottrell WN, 2013, PATIENT PREFER ADHER, V7, P141, DOI 10.2147/PPA.S40725; Leiro MGC, 2006, REV ESP CARDIOL, V59, P725, DOI 10.1016/S1885-5857(07)60031-0; Dentino AN, 1999, J AM GERIATR SOC, V47, P6, DOI 10.1111/j.1532-5415.1999.tb01894.x; Dharmarajan K, 2017, HEART FAIL CLIN, V13, P417, DOI 10.1016/j.hfc.2017.02.001; Dontje ML, 2014, J CARDIOVASC NURS, V29, P218, DOI 10.1097/JCN.0b013e318283ba14; Ekman I, 2006, PATIENT EDUC COUNS, V61, P348, DOI 10.1016/j.pec.2005.04.005; Evangelista LS, 2001, HEART LUNG, V30, P294, DOI 10.1067/mhl.2001.116011; Favaro A, 2011, GEN HOSP PSYCHIAT, V33, P1, DOI 10.1016/j.genhosppsych.2010.10.001; Francis JL, 2009, PSYCHOSOM MED, V71, P821, DOI 10.1097/PSY.0b013e3181b39aa1; Gardner B, 2012, BRIT J GEN PRACT, V62, P664, DOI 10.3399/bjgp12X659466; Granger BB, 2009, EUR J HEART FAIL, V11, P1092, DOI 10.1093/eurjhf/hfp142; Haynes RB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000011.pub3; Haynes R. Brian, 1979, COMPLIANCE HLTH CARE, P516; Jankowska-Polanska B, 2017, J ED HLTH SPORT, V7, P392; Jankowska-Polanska B, 2018, J GERIATR CARDIOL, V15, P153, DOI 10.11909/j.issn.1671-5411.2018.02.002; Jankowska-Polanska B, 2017, PATIENT PREFER ADHER, V11, P363, DOI 10.2147/PPA.S127407; Jankowska-Polanska B, 2016, PATIENT PREFER ADHER, V10, P1759, DOI 10.2147/PPA.S101904; Kim MT, 2003, ANN BEHAV MED, V26, P24, DOI 10.1207/S15324796ABM2601_04; Klompstra L, 2015, PATIENT PREFER ADHER, V9, P1603, DOI 10.2147/PPA.S90942; Krueger K, 2015, INT J CARDIOL, V184, P728, DOI 10.1016/j.ijcard.2015.03.042; Marti Catherine N, 2013, Congest Heart Fail, V19, P16, DOI 10.1111/j.1751-7133.2012.00308.x; Nieuwenhuis MMW, 2012, NETH HEART J, V20, P313, DOI 10.1007/s12471-012-0283-9; Nieuwenhuis M.M.W., SELF CARE BEHAV TERM; Nieuwenhuis MMW, 2012, AM J CARDIOL, V110, P392, DOI 10.1016/j.amjcard.2012.03.039; Nwosu C, 2016, CURR CARDIOL REV, V12, P311, DOI 10.2174/1573403X12666160301120030; Oosterom-Calo R, 2013, HEART FAIL REV, V18, P409, DOI 10.1007/s10741-012-9321-3; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Riegel B, 2019, HEART LUNG, V48, P179, DOI 10.1016/j.hrtlng.2018.12.008; Rockwell JM, 2001, HEART LUNG, V30, P18, DOI 10.1067/mhl.2001.112503; Seid MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211768; Simpson SH, 2002, PHARMACOTHERAPY, V22, P1163, DOI 10.1592/phco.22.13.1163.33512; Stromberg A, 1999, HEART LUNG, V28, P334, DOI 10.1053/hl.1999.v28.a99538; Sullivan MD, 2004, AM J CARDIOL, V94, P1577, DOI 10.1016/j.amjcard.2004.08.046; Uchmanowicz Izabella, 2014, Curr Heart Fail Rep, V11, P266, DOI 10.1007/s11897-014-0198-4; van der Wal MHL, 2008, INT J CARDIOL, V125, P203, DOI 10.1016/j.ijcard.2007.10.011; van der Wal MHL, 2007, HEART LUNG, V36, P253, DOI 10.1016/j.hrtlng.2006.10.007; van der Wal MHL, 2006, EUR HEART J, V27, P434, DOI 10.1093/eurheartj/ehi603; Viana M, 2014, J MANAG CARE SPEC PH, V20, P1018, DOI 10.18553/jmcp.2014.20.10.1018; Wu JR, 2008, HEART LUNG, V37, P8, DOI 10.1016/j.hrtlng.2007.02.003	42	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231076	10.1371/journal.pone.0231076	http://dx.doi.org/10.1371/journal.pone.0231076			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298283	gold, Green Published			2022-12-26	WOS:000536011400026
J	Mao, WL; Shu, YM; Gu, K; Zhang, XL; Zhang, Z				Mao, Wen-Long; Shu, Yi-Ming; Gu, Ke; Zhang, Xian-Lei; Zhang, Zhen			Horizontal seepage failure model and experimental study of damaged sidewalls of seams between geotube dam tubes	PLOS ONE			English	Article							GEOTEXTILE FILTERS; FACE STABILITY; FILTRATION; BEHAVIOR; EROSION; DESIGN	The impact of damaged sidewalls at the joints between tubes on dam structures subjected to horizontal seepage is investigated. First, an experimental scheme is designed to test the mode and critical gradient of seepage failure of the soil in the damaged tubes. The effects of various overburden pressures (0, 5, 10, 20, and 30 kPa), hole radii(0.5, 1.0, 1.5, and 2 cm) and soil specimen properties were studied. The test phenomena and the changes in the pore water pressure were used to determine the seepage failure modes and the critical gradients under different conditions. Combined with the modified Terzaghi soil arching theory, a mathematical model was developed for the critical gradient for soil seepage failure. The model fitting curve was in good agreement with the laboratory test results. The critical gradient is independent of the overburden pressure and weakly dependent on the internal friction angle of the soil. The critical gradient increases with the cohesion. For fixed characteristic soil parameters, the critical gradient decreases at a gradually decreasing rate as the radius of the damaged hole increases.	[Mao, Wen-Long; Shu, Yi-Ming; Zhang, Xian-Lei; Zhang, Zhen] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Peoples R China; [Gu, Ke] Hohai Univ, Coll Civil & Transportat Engn, Nanjing, Peoples R China; [Zhang, Xian-Lei] North China Univ Water Resources & Elect Power, Sch Water Conservancy, Zhengzhou, Peoples R China	Hohai University; Hohai University; North China University of Water Resources & Electric Power	Mao, WL (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Peoples R China.	1033901878@qq.com		mao, wen long/0000-0003-0532-7101	National Natural Science Foundation of China [51179065, 51307611]; Fundamental Research Funds for the Central Universities [2016B40814]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (51179065 and 51307611) to YMS and the Fundamental Research Funds for the Central Universities (2016B40814) to WLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostou G, 1996, TUNN UNDERGR SP TECH, V11, P165, DOI 10.1016/0886-7798(96)00017-X; ANAGNOSTOU G, 1994, TUNN UNDERGR SP TECH, V9, P165, DOI 10.1016/0886-7798(94)90028-0; Bolt A.F., 2004, INT C GEOS GEOENV EN, V8-10, P12; Cao M-j, 2013, EXPT STUDY SEEPAGE F; Cha JY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-016-0014-9; Chang Y, 2018, LANDSCAPE URBAN PLAN, V174, P24, DOI 10.1016/j.landurbplan.2018.02.012; Cheah C, 2017, GEOTEXT GEOMEMBRANES, V45, P462, DOI 10.1016/j.geotexmem.2017.07.002; Chew SH, 2003, GEOTEXT GEOMEMBRANES, V21, P221, DOI 10.1016/S0266-1144(03)00027-X; Finno RJ, 2017, J GEOTECH GEOENVIRON, V143, DOI [10.1061/(asce)gt.1943-5606.0001797, 10.1061/(ASCE)GT.1943-5606.0001797]; Gao J, 2009, CHINESE J GEOTECHNIC, P73; Guo W, 2014, GEOTEXT GEOMEMBRANES, V42, P277, DOI 10.1016/j.geotexmem.2014.05.001; Indraratna B, 2015, J GEOTECH GEOENVIRON, V141, DOI 10.1061/(ASCE)GT.1943-5606.0001343; Israr J, 2019, J GEOTECH GEOENVIRON, V145, DOI 10.1061/(ASCE)GT.1943-5606.0002062; Khachan MM, 2017, GEOTEXT GEOMEMBRANES, V45, P280, DOI 10.1016/j.geotexmem.2017.04.001; Kim HJ, 2018, GEOSYNTH INT, V25, P507, DOI 10.1680/jgein.18.00015; Kim HJ, 2016, INT J GEOMECH, V16, DOI 10.1061/(ASCE)GM.1943-5622.0000532; Kim HJ, 2015, INT J GEOMECH, V15, DOI 10.1061/(ASCE)GM.1943-5622.0000420; Lee SC, 2014, SCI WORLD J, DOI 10.1155/2014/494020; Man X-l, 2017, EXPT RES SCOUR SEAMS; Man X-l, 2016, CHINESE J GEOTECHNIC, V38, P238, DOI [10.11779/CJGE2016S1044, DOI 10.11779/CJGE2016S1044]; Man XL, 2018, OCEAN ENG, V152, P1, DOI 10.1016/j.oceaneng.2018.01.040; [满晓磊 Man Xiaolei], 2018, [水利水电科技进展, Advances in Science and Technology of Water Resources], V38, P36; Moffat R, 2011, CAN GEOTECH J, V48, P399, DOI 10.1139/T10-071; Palmeira EM, 2017, GEOSYNTH INT, V24, P125, DOI 10.1680/jgein.16.00021; Palmeira EM, 2019, GEOTEXT GEOMEMBRANES, V47, P566, DOI 10.1016/j.geotexmem.2019.02.004; Palmeira EM, 2015, GEOTEXT GEOMEMBRANES, V43, P46, DOI 10.1016/j.geotexmem.2014.11.003; Pinho-Lopes M, 2018, GEOSYNTH INT, V25, P98, DOI 10.1680/jgein.17.00036; Pinho-Lopes M, 2018, CONSTR BUILD MATER, V185, P468, DOI 10.1016/j.conbuildmat.2018.07.094; Ratnayesuraj CR, 2018, GEOSYNTH INT, V25, P132, DOI 10.1680/jgein.17.00038; Rupakheti P, 2017, GEOSYNTH INT, V24, P321, DOI 10.1680/jgein.17.00004; Sawada Y, 2019, GEOTEXT GEOMEMBRANES, V47, P502, DOI 10.1016/j.geotexmem.2019.03.001; [束一鸣 Shu Yiming], 2018, [水利水电科技进展, Advances in Science and Technology of Water Resources], V38, P1; Stoltz G, 2019, GEOTEXT GEOMEMBRANES, V47, P230, DOI 10.1016/j.geotexmem.2018.12.008; Tano BFG, 2018, GEOSYNTH INT, V25, P242, DOI 10.1680/jgein.18.00005; Yang YH, 2019, GEOTEXT GEOMEMBRANES, V47, P187, DOI 10.1016/j.geotexmem.2018.12.007; Yoo C, 2016, GEOSYNTH INT, V23, P463, DOI 10.1680/jgein.16.00010	36	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231624	10.1371/journal.pone.0231624	http://dx.doi.org/10.1371/journal.pone.0231624			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298353	Green Published, gold			2022-12-26	WOS:000536011400075
J	Szulc, P; Mravcakova, D; Szumacher-Strabel, M; Varadyova, Z; Varady, M; Cobanova, K; Syahrulawal, L; Patra, AK; Cieslak, A				Szulc, Paulina; Mravcakova, Dominika; Szumacher-Strabel, Malgorzata; Varadyova, Zora; Varady, Marian; Cobanova, Klaudia; Syahrulawal, Linggawastu; Patra, Amlan Kumar; Cieslak, Adam			Ruminal fermentation, microbial population and lipid metabolism in gastrointestinal nematode-infected lambs fed a diet supplemented with herbal mixtures	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; RUMEN FERMENTATION; HAEMONCHUS-CONTORTUS; METHANE PRODUCTION; MEAT QUALITY; MUSCLE; GREEN; BEEF; BIOHYDROGENATION; POLYPHENOLS	The aim of this study was to evaluate the effects of medicinal herbal mixtures rich in phenolic, flavonoid and alkaloid compounds on ruminal fermentation and microbial populations, and fatty acid (FA) concentrations and lipid oxidation in tissues of lambs infected with the gastrointestinal nematode (GIN) parasite (Haemonchus contortus). Parallel in vitro and in vivo studies were performed using two different herbal mixtures (Mix1 and Mix2). The in vitro study was conducted in a 2 (infection status; non-infected versus infected) x 3 (diets; control, Mix1 and Mix2) factorial design. In the in vivo study, 24 lambs were equally divided into four treatments: non-infected lambs fed a control diet, infected lambs fed the control diet, infected lambs fed a diet with Mix1 and infected lambs fed a diet with Mix2. Herbal mixtures (100 g dry matter (DM)/d) were added to the basal diets of meadow hay (ad libitum) and a commercial concentrate (500 g DM/d). The experimental period lasted for 70 days. Ruminal fermentation characteristics and methane production were not affected by infection in vivo or in vitro. Both herbal mixture supplementation increased total volatile fatty acid (VFA) concentrations (P < 0.01) and DM digestibility (P < 0.01) in vitro. Archaea population was slightly diminished by both herbal mixtures (P < 0.05), but they did not lower methane production in vitro or in vivo (P > 0.05). Infection of H. contortus or herbal mixtures modulated FA proportion mainly in the liver, especially the long chain FA proportion. Concentrations of thiobarbituric acid reactive substances (TBARS) in serum were significantly higher after 70 days post-infection in the infected lambs. Herbal Mix1 supplementation reduced TBARS concentrations in meat after seven days of storage. In conclusion, supplementing of herbal mixtures to the diets of GIN parasite infected lambs did not affect the basic ruminal fermentation parameters. Herbal mixtures may improve few FA proportions mainly in liver as well as decrease lipid oxidation in meat.	[Szulc, Paulina; Szumacher-Strabel, Malgorzata; Syahrulawal, Linggawastu; Cieslak, Adam] Poznan Univ Life Sci, Dept Anim Nutr, Poznan, Poland; [Mravcakova, Dominika; Varadyova, Zora; Cobanova, Klaudia] Slovak Acad Sci, Ctr Biosci, Inst Anim Physiol, Kosice, Slovakia; [Varady, Marian] Slovak Acad Sci, Inst Parasitol, Kosice, Slovakia; [Patra, Amlan Kumar] West Bengal Univ Anim & Fishery Sci, Dept Anim Nutr, Kolkata, India	Poznan University of Life Sciences; Slovak Academy of Sciences; Slovak Academy of Sciences; West Bengal University of Animal & Fishery Sciences	Cieslak, A (corresponding author), Poznan Univ Life Sci, Dept Anim Nutr, Poznan, Poland.	adam.cieslak@up.poznan.pl	Varadyova, Zora/P-2806-2016; Cobanova Boldizarova, Klaudia/GZG-8733-2022; Várady, Marián/AAN-6094-2020; Batťányi, Dominika/AFV-4822-2022	Varadyova, Zora/0000-0003-3675-8641; Cobanova Boldizarova, Klaudia/0000-0001-5842-1965; Várady, Marián/0000-0001-6589-8219; Batťányi, Dominika/0000-0002-9070-0558; Cieslak, Adam/0000-0001-7518-579X; Patra, Amlan/0000-0003-1410-0902; Szumacher-Strabel, Malgorzata/0000-0003-0086-5744	Slovak Research and Development Agency [APVV 18-0131, APVV 17-0297]; Ministry of Science and Higher Education, Poland [005/RID/2018/19]; National Science Center, Poland [2016/23/B/NZ9/03427]; Polish National Agency for Academic Exchange (NAWA); SAIA, n. o. (Slovak Academy Information Agency)	Slovak Research and Development Agency(Slovak Research and Development Agency); Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); National Science Center, Poland(National Science Centre, Poland); Polish National Agency for Academic Exchange (NAWA)(Polish National Agency for Academic Exchange (NAWA)); SAIA, n. o. (Slovak Academy Information Agency)	This study was supported by funds from the Slovak Research and Development Agency (APVV 18-0131, APVV 17-0297) and by the framework of the Ministry of Science and Higher Education, Poland, programme "Regional Initiative Excellence" in years 2019-2022, Project No. 005/RID/2018/19. PSz is a PhD scholarship holder of the grant 2016/23/B/NZ9/03427 funded by National Science Center, Poland. LS has been awarded a full master degree by Ignacy Lukasiewicz scholarship from the Polish National Agency for Academic Exchange (NAWA). AC acknowledges the SAIA, n. o. (Slovak Academy Information Agency) for Academy Mobility Scholarship.	Anand David Alexander Victor, 2016, Pharmacogn Rev, V10, P84, DOI 10.4103/0973-7847.194044; [Anonymous], 2016, ADV PARASIT, DOI DOI 10.1016/bs.apar.2016.02.025; Berthelot V, 2012, MEAT SCI, V90, P548, DOI 10.1016/j.meatsci.2011.09.014; Bodas R, 2012, ANIM FEED SCI TECH, V176, P78, DOI 10.1016/j.anifeedsci.2012.07.010; Bressan MC, 2011, J ANIM SCI, V89, P221, DOI 10.2527/jas.2009-2672; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Brogna DMR, 2011, ANIMAL, V5, P1124, DOI 10.1017/S1751731111000048; Bryszak M, 2019, J DAIRY SCI, V102, P1257, DOI 10.3168/jds.2018-15322; Chilliard Y, 2003, J DAIRY SCI, V86, P1751, DOI 10.3168/jds.S0022-0302(03)73761-8; Cieslak A, 2014, J AGR SCI-CAMBRIDGE, V152, P981, DOI 10.1017/S0021859614000239; Cieslak A, 2013, EUR J LIPID SCI TECH, V115, P1258, DOI 10.1002/ejlt.201200119; Denman SE, 2006, FEMS MICROBIOL ECOL, V58, P572, DOI 10.1111/j.1574-6941.2006.00190.x; DOREAU M, 1994, ANIM FEED SCI TECH, V45, P379, DOI 10.1016/0377-8401(94)90039-6; El-Ashram S, 2017, VET RES COMMUN, V41, P263, DOI 10.1007/s11259-017-9698-5; EMMANUEL B, 1978, BIOCHIM BIOPHYS ACTA, V528, P239, DOI 10.1016/0005-2760(78)90198-4; ENOCH HG, 1976, J BIOL CHEM, V251, P5095; Fox NJ, 2018, INT J PARASITOL, V48, P1017, DOI 10.1016/j.ijpara.2018.06.001; Garcia-Gonzalez R, 2008, ANIM FEED SCI TECH, V147, P36, DOI 10.1016/j.anifeedsci.2007.09.008; Glogowski R, 2010, MEAT SCI, V85, P577, DOI 10.1016/j.meatsci.2010.03.008; Horwitz, 2007, OFFICIAL METHODS ANA; Hoste H, 2015, VET PARASITOL, V212, P5, DOI 10.1016/j.vetpar.2015.06.026; Houdijk JGM, 2017, INT J PARASITOL, V47, P633, DOI 10.1016/j.ijpara.2017.03.006; Jenkins TC, 2008, J ANIM SCI, V86, P397, DOI 10.2527/jas.2007-0588; Jo C, 1998, POULTRY SCI, V77, P475, DOI 10.1093/ps/77.3.475; Jozefiak D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085347; Kumar P, 2018, J ANIM PHYSIOL AN N, V102, P769, DOI 10.1111/jpn.12880; Lanier JS, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0025-0; LANS C, 2007, J ETHNOBIOL ETHNOMED, V3, P1916, DOI DOI 10.1186/1746-4269-3-1; Li M, 2009, J APPL MICROBIOL, V107, P1924, DOI 10.1111/j.1365-2672.2009.04376.x; Lightbody JH, 2001, J COMP PATHOL, V124, P192, DOI 10.1053/jcpa.2000.0453; Machado V, 2014, PATHOL RES PRACT, V210, P812, DOI 10.1016/j.prp.2014.09.006; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Malau-Aduli AEO, 1998, J ANIM SCI, V76, P766; McRae KM, 2015, PARASITE IMMUNOL, V37, P605, DOI 10.1111/pim.12290; MICHALOWSKI T, 1986, BRIT J NUTR, V56, P625, DOI 10.1079/BJN19860143; Mravcakova D, 2019, BMC VET RES, V15, DOI 10.1186/s12917-019-2050-2; Oskoueian E, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/349129; Park WJ, 2009, J LIPID RES, V50, P1195, DOI 10.1194/jlr.M800630-JLR200; Patra A.K., 2015, FRONT MICROBIOL, V6, P1, DOI DOI 10.3389/FMICB.2015.00001; Patra A, 2017, J ANIM SCI BIOTECHNO, V8, DOI 10.1186/s40104-017-0145-9; Patra AK, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02038; Patra AK, 2016, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00039; Patra AK, 2011, J SCI FOOD AGR, V91, P24, DOI 10.1002/jsfa.4152; Patra AK, 2010, PHYTOCHEMISTRY, V71, P1198, DOI 10.1016/j.phytochem.2010.05.010; Pietta P, 2003, STUD NAT PROD CHEM, V28, P257; Potu RB, 2011, J MICROBIOL, V49, P216, DOI 10.1007/s12275-011-0365-1; Qwele K, 2013, MEAT SCI, V93, P455, DOI 10.1016/j.meatsci.2012.11.009; Raes K, 2004, ANIM FEED SCI TECH, V113, P199, DOI 10.1016/j.anifeedsci.2003.09.001; SAS Institute Inc, 2014, SASONLINEDOC VERS 9; Selemon M., 2018, J VET MED RES, V5, P1139; Sinclair LA, 2005, ANIM SCI, V81, P239, DOI 10.1079/ASC50040239; Sinnathamby G, 2018, PLOS ONE, V13, P1, DOI [10.1371/journal.pone.0192164, DOI 10.1371/J0URNAL.P0NE.0192164]; Smith SB, 2006, ANIM SCI J, V77, P478, DOI 10.1111/j.1740-0929.2006.00375.x; Soliva CR, 2004, BRIT J NUTR, V92, P689, DOI 10.1079/BJN20041250; Spiegler V, 2017, NAT PROD REP, V34, P627, DOI 10.1039/c6np00126b; SYKES AR, 1976, J AGR SCI-CAMBRIDGE, V86, P507, DOI 10.1017/S0021859600061049; Szczechowiak J, 2016, ANIM FEED SCI TECH, V216, P93, DOI 10.1016/j.anifeedsci.2016.03.014; Szczechowiak J, 2018, ANN ANIM SCI, V18, P155, DOI 10.1515/aoas-2017-0039; Vahmani R, 2014, J DAIRY SCI, V97, P4174, DOI 10.3168/jds.2013-7290; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; Varadyova Z, 2017, SMALL RUMINANT RES, V151, P124, DOI 10.1016/j.smallrumres.2017.04.023; Varadyova Z, 2018, J ANIM PHYSIOL AN N, V102, P1131, DOI 10.1111/jpn.12940; Varadyova Z, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1405-4; Wang RF, 2004, MOL CELL PROBE, V18, P223, DOI 10.1016/j.mcp.2004.03.002; Warren HE, 2008, MEAT SCI, V78, P256, DOI 10.1016/j.meatsci.2007.06.008; Wencelova M, 2015, SMALL RUMINANT RES, V125, P64, DOI 10.1016/j.smallrumres.2015.01.028; WOLIN MJ, 1960, J DAIRY SCI, V43, P1452, DOI 10.3168/jds.S0022-0302(60)90348-9; Wolstenholme AJ, 2004, TRENDS PARASITOL, V20, P469, DOI 10.1016/j.pt.2004.07.010; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Zhong RZ, 2015, MEAT SCI, V105, P1, DOI 10.1016/j.meatsci.2015.02.003	70	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231516	10.1371/journal.pone.0231516	http://dx.doi.org/10.1371/journal.pone.0231516			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298315	Green Published, gold			2022-12-26	WOS:000536011400057
J	Breindel, L; Yu, JC; Burz, DS; Shekhtman, A				Breindel, Leonard; Yu, Jianchao; Burz, David S.; Shekhtman, Alexander			Intact ribosomes drive the formation of protein quinary structure	PLOS ONE			English	Article							ROTATIONAL MOBILITY; CELL; RNA; THERMODYNAMICS; STABILITY; GROWTH	Transient, site-specific, or so-called quinary, interactions are omnipresent in live cells and modulate protein stability and activity. Quinary intreactions are readily detected by in-cell NMR spectroscopy as severe broadening of the NMR signals. Intact ribosome particles were shown to be necessary for the interactions that give rise to the NMR protein signal broadening observed in cell lysates and sufficient to mimic quinary interactions present in the crowded cytosol. Recovery of target protein NMR spectra that were broadened in lysates, in vitro and in the presence of purified ribosomes was achieved by RNase A digestion only after the structure of the ribosome was destabilized by removing magnesium ions from the system. Identifying intact ribosomal particles as the major protein-binding component of quinary interactions and consequent spectral peak broadening will facilitate quantitative characterization of macromolecular crowding effects in live cells and streamline models of metabolic activity.	[Breindel, Leonard; Yu, Jianchao; Burz, David S.; Shekhtman, Alexander] SUNY Albany, Dept Chem, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany	Shekhtman, A (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	ashekhtman@albany.edu			United States National Institute of Health [R01GM085006]	United States National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded studies. A.S.; United States National Institute of Health grant R01GM085006 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barbieri L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14456; Basak A, 2003, J MOL BIOL, V328, P1137, DOI 10.1016/S0022-2836(03)00375-9; Breindel L, 2018, BIOCHEMISTRY-US, V57, P540, DOI 10.1021/acs.biochem.7b00938; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Cohen RD, 2017, PROTEIN SCI, V26, P403, DOI 10.1002/pro.3092; Crowley PB, 2011, CHEMBIOCHEM, V12, P1043, DOI 10.1002/cbic.201100063; Culver GM, 2000, METHOD ENZYMOL, V318, P446; Danielsson J, 2015, P NATL ACAD SCI USA, V112, P12402, DOI 10.1073/pnas.1511308112; Davidi D, 2016, P NATL ACAD SCI USA, V113, P3401, DOI 10.1073/pnas.1514240113; DeMott CM, 2018, ACS CHEM BIOL, V13, P733, DOI 10.1021/acschembio.7b00879; DeMott CM, 2017, BIOCHEMISTRY-US, V56, P4117, DOI 10.1021/acs.biochem.7b00613; Ghaemmaghami S, 2001, NAT STRUCT BIOL, V8, P879, DOI 10.1038/nsb1001-879; Gnutt D, 2019, J AM CHEM SOC, V141, P4660, DOI 10.1021/jacs.8b13025; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guin D, 2019, CHEM REV, V119, P10691, DOI 10.1021/acs.chemrev.8b00753; Guo MH, 2012, P NATL ACAD SCI USA, V109, P17863, DOI 10.1073/pnas.1201797109; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Kiel MC, 1999, BIOCHIMIE, V81, P1097, DOI 10.1016/S0300-9084(99)00352-1; Kyne C, 2017, BIOCHEMISTRY-US, V56, P5026, DOI 10.1021/acs.biochem.7b00731; Kyne C, 2016, FEBS J, V283, P3016, DOI 10.1111/febs.13744; Majumder S, 2016, BIOCHEMISTRY-US, V55, P4568, DOI 10.1021/acs.biochem.6b00330; Majumder S, 2015, BIOCHEMISTRY-US, V54, P2727, DOI 10.1021/acs.biochem.5b00036; Maldonado AY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074576; MCCONKEY EH, 1982, P NATL ACAD SCI-BIOL, V79, P3236, DOI 10.1073/pnas.79.10.3236; Milo R., 2015, CELL BIOL NUMBERS; MOLLER W, 1969, BIOCHIM BIOPHYS ACTA, V190, P381, DOI 10.1016/0005-2787(69)90088-4; Monteith WB, 2015, P NATL ACAD SCI USA, V112, P1739, DOI 10.1073/pnas.1417415112; Noeske J, 2015, NAT STRUCT MOL BIOL, V22, P336, DOI 10.1038/nsmb.2994; Rivas German, 2018, Biophys Rev, V10, P241, DOI 10.1007/s12551-017-0347-6; SANTER M, 1963, SCIENCE, V141, P1049, DOI 10.1126/science.141.3585.1049; Schavemaker PE, 2017, ELIFE, V6, DOI [10.7554/elife.30084, 10.7554/eLife.30084]; Scott M, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145379; Scott M, 2010, SCIENCE, V330, P1099, DOI 10.1126/science.1192588; Serber Z, 2001, BIOCHEMISTRY-US, V40, P14317, DOI 10.1021/bi011751w; Simsek D, 2017, CELL, V169, P1051, DOI 10.1016/j.cell.2017.05.022; Smith AE, 2016, P NATL ACAD SCI USA, V113, P1725, DOI 10.1073/pnas.1518620113; TISSIERES A, 1959, J MOL BIOL, V1, P221, DOI 10.1016/S0022-2836(59)80029-2; Vainshtein B. K., 1973, SOV PHYS USP, V16, P185; Williams SP, 1997, BIOPHYS J, V72, P490, DOI 10.1016/S0006-3495(97)78690-9; Ye YS, 2019, J PHYS CHEM B, V123, P4527, DOI 10.1021/acs.jpcb.9b02162; Ye YS, 2018, ANAL BIOANAL CHEM, V410, P869, DOI 10.1007/s00216-017-0745-4; Ye YS, 2013, CHEM-EUR J, V19, P12705, DOI 10.1002/chem.201301657	43	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232015	10.1371/journal.pone.0232015	http://dx.doi.org/10.1371/journal.pone.0232015			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330166	gold, Green Published, Green Submitted			2022-12-26	WOS:000536647300040
J	Forehead, H; Barthelemy, J; Arshad, B; Verstaevel, N; Price, O; Perez, P				Forehead, Hugh; Barthelemy, Johan; Arshad, Bilal; Verstaevel, Nicolas; Price, Owen; Perez, Pascal			Traffic exhaust to wildfires: PM2.5 measurements with fixed and portable, low-cost LoRaWAN-connected sensors	PLOS ONE			English	Article							FINE PARTICULATE MATTER; AIR-POLLUTION; EXPOSURE; VARIABILITY	Air pollution with PM2.5 (particulate matter smaller than 2.5 micro-metres in diameter) is a major health hazard in many cities worldwide, but since measuring instruments have traditionally been expensive, monitoring sites are rare and generally show only background concentrations. With the advent of low-cost, wirelessly connected sensors, air quality measurements are increasingly being made in places where many people spend time and pollution is much worse: on streets near traffic. In the interests of enabling members of the public to measure the air that they breathe, we took an open-source approach to designing a device for measuring PM2.5. Parts are relatively cheap, but of good quality and can be easily found in electronics or hardware stores, or on-line. Software is open source and the free LoRaWAN-based "The Things Network" the platform. A number of low-cost sensors we tested had problems, but those selected performed well when co-located with reference-quality instruments. A network of the devices was deployed in an urban centre, yielding valuable data for an extended time. Concentrations of PM2.5 at street level were often ten times worse than at air quality stations. The devices and network offer the opportunity for measurements in locations that concern the public.	[Forehead, Hugh; Barthelemy, Johan; Arshad, Bilal; Verstaevel, Nicolas; Perez, Pascal] Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW, Australia; [Forehead, Hugh; Perez, Pascal] Clean Air & Urban Landscapes CAUL Hub, Melbourne, Vic, Australia; [Verstaevel, Nicolas] Univ Toulouse 1 Capitole, Inst Rech Informat Toulouse IRIT, Toulouse, France; [Price, Owen] Univ Wollongong, Ctr Sustainable Ecosyst Solut, Wollongong, NSW, Australia	University of Wollongong; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Universite Toulouse 1 Capitole; Universite de Toulouse - Jean Jaures; Centre National de la Recherche Scientifique (CNRS); University of Wollongong	Forehead, H (corresponding author), Univ Wollongong, SMART Infrastruct Facil, Wollongong, NSW, Australia.; Forehead, H (corresponding author), Clean Air & Urban Landscapes CAUL Hub, Melbourne, Vic, Australia.	hughf@uow.edu.au	Verstaevel, Nicolas/AAA-3044-2019; Arshad, Bilal/AAR-9585-2020; Forehead, Hugh/O-4713-2018; Barthelemy, Johan/M-1704-2017	Verstaevel, Nicolas/0000-0002-7879-6681; Arshad, Bilal/0000-0002-6078-0235; Forehead, Hugh/0000-0001-7035-2894; Barthelemy, Johan/0000-0002-7800-5309; perez, pascal/0000-0001-6151-6228	Australian Government's Smart Cities and Suburbs scheme [SCS59378]; Australian Government's National Environmental Science Programme, Clean Air and Urban Landscapes hub, under Project 7 'Air Quality in Australia'	Australian Government's Smart Cities and Suburbs scheme(Australian Government); Australian Government's National Environmental Science Programme, Clean Air and Urban Landscapes hub, under Project 7 'Air Quality in Australia'	HF, JB, BA, NV, and PP received funding from Australian Government's Smart Cities and Suburbs scheme: https://infrastructure.gov.au/cities/smart-cities/. GRANT_NUMBER: SCS59378. HF also received funding from the Australian Government's National Environmental Science Programme, Clean Air and Urban Landscapes hub, under Project 7 'Air Quality in Australia', https://nespurban.edu.au/research-projects/air-quality/. BlueScope Steel Ltd. (https://www.bluescope.com/) provided material support by providing infrastructure and installing devices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2019, WOLL REG SUMM; [Anonymous], 2019, R LANG ENV STAT COMP; Asbach C, 2017, SCI TOTAL ENVIRON, V603, P793, DOI 10.1016/j.scitotenv.2017.03.049; Balmes JR, 2018, NEW ENGL J MED, V378, P881, DOI 10.1056/NEJMp1716846; Barthelemy J, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19092048; Broday DM, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102263; Brook B, 2019, HAZARD REDUCTION BUR; Carslaw DC, 2012, ENVIRON MODELL SOFTW, V27-28, P52, DOI 10.1016/j.envsoft.2011.09.008; Clun Rachel, 2019, SYDNEY MORNING HERAL; Coker E, 2015, ENVIRON RES, V142, P354, DOI 10.1016/j.envres.2015.06.044; Cox L., 2019, GUARDIAN; Ewald B, 2019, CLEAN AIR NEW S WALE, P4; Feinberg SN, 2019, ATMOS ENVIRON, V213, P579, DOI 10.1016/j.atmosenv.2019.06.026; Genikomsakis KN, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041056; George DP, 2019, MICROPYTHON LANGUAGE; Gov Australia, 2016, NAT ENV PROT AMB AIR; He C, 2020, INT J PHYTOREMEDIAT, V22, P184, DOI 10.1080/15226514.2019.1652565; He T, 2018, 18 COTA INT C TRANSP; Holguin F, 2014, AM J RESP CRIT CARE, V189, P1018, DOI 10.1164/rccm.201404-0613ED; Kim S, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9091947; Kumar P, 2015, ENVIRON INT, V75, P199, DOI 10.1016/j.envint.2014.11.019; Kunde V, 2017, GEFAHRST REINHALT L, V77, P421; Liu HY, 2019, ATMOSPHERE-BASEL, V10, DOI 10.3390/atmos10020041; Liu JC, 2019, J EXPO SCI ENV EPID, V29, P765, DOI 10.1038/s41370-018-0064-7; Liverpool CC, 2019, PLANN FUT LIV; Lung SCC, 2018, LOW COST SENSORS MEA, P18; Mugica I, 2017, SCI TOTAL ENVIRON, V609, P348, DOI 10.1016/j.scitotenv.2017.06.184; Ottosen TB, 2020, SUSTAIN CITIES SOC, V53, DOI 10.1016/j.scs.2019.101919; Prosser Scully R, 2019, NEW SCI DAILY NEWSLE; Rice MB, 2015, AM J RESP CRIT CARE, V191, P656, DOI 10.1164/rccm.201410-1875OC; Ruckerl R, 2011, INHAL TOXICOL, V23, P555, DOI 10.3109/08958378.2011.593587; Shoebridge N, 2019, DAILY TELEGRAPH; Sun CX, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19010189; Thammasaroj P., 2019, ENVIRONMENTASIA, V12, P28, DOI DOI 10.14456/ea.2019.60; Van Rossum G., 1995, PYTHON TUTORIAL, V620; Vardoulakis S, 2011, ATMOS ENVIRON, V45, P5069, DOI 10.1016/j.atmosenv.2011.06.038; WADLOW I, 2019, ATMOSPHERE, V10, DOI DOI 10.3390/ATMOS10040176; Wadlow I, 2019, ATMOSPHERE-BASEL, V10, DOI 10.3390/atmos10040217; Wang SB, 2020, TRANSPORT RES D-TR E, V78, DOI 10.1016/j.trd.2019.11.005; Wang ZY, 2017, FRONT EARTH SCI-PRC, V11, P63, DOI 10.1007/s11707-016-0564-5; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Xia M, 2018, J ENVIRON SCI-CHINA, V72, P75, DOI 10.1016/j.jes.2017.12.013	42	7	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231778	10.1371/journal.pone.0231778	http://dx.doi.org/10.1371/journal.pone.0231778			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330173	Green Published, gold, Green Submitted			2022-12-26	WOS:000536647300023
J	Quijano-Scheggia, SI; Olivos-Ortiz, A; Garcia-Mendoza, E; Sanchez-Bravo, Y; Sosa-Avalos, R; Marias, NS; Lim, HC				Isabel Quijano-Scheggia, Sonia; Olivos-Ortiz, Aramis; Garcia-Mendoza, Ernesto; Sanchez-Bravo, Yaireb; Sosa-Avalos, Ramon; Salas Marias, Nathalli; Lim, Hong Chang			Phylogenetic relationships of Pseudo-nitzschia subpacifica (Bacillariophyceae) from the Mexican Pacific, and its production of domoic acid in culture	PLOS ONE			English	Article							SP-NOV BACILLARIOPHYCEAE; COASTAL WATERS; MOLECULAR CHARACTERIZATION; COMPLEX BACILLARIOPHYCEAE; DIVERSITY; ITS2; DIATOM; RNA; MORPHOLOGY; PERAGALLO	Pseudo-nitzschia is a cosmopolitan genus, some species of which can produce domoic acid (DA), a neurotoxin responsible for the Amnesic Shellfish Poisoning (ASP). In this study, we identified P. subpacifica for the first time in Todos Santos Bay and Manzanillo Bay, in the Mexican Pacific using SEM and molecular methods. Isolates from Todos Santos Bay were cultivated under conditions of phosphate sufficiency and deficiency at 16 degrees C and 22 degrees C to evaluate the production of DA. This toxin was detected in the particulate (DAp) and dissolved (DAd) fractions of the cultures during the exponential and stationary phases of growth of the cultures. The highest DA concentration was detected during the exponential phase grown in cells maintained in P-deficient medium at 16 degrees C (1.14 +/- 0.08 ng mL(-1) DAd and 4.71 +/- 1.11 x 10(-5) ng cell(-1) of DAp). In P-sufficient cultures DA was higher in cells maintained at 16 degrees C (0.25 +/- 0.05 ng mL(-1) DAd and 9.41 +/- 1.23 x 10(-7) ng cell(-1) of DAp) than in cells cultured at 22 degrees C. Therefore, we confirm that P. subpacifica can produce DA, especially under P-limited conditions that could be associated with extraordinary oceanographic events such as the 2013-2016 "Blob" in the northeastern Pacific Ocean. This event altered local oceanographic conditions and possibly generated the presence of potential harmful species in areas with economic importance on the Mexican Pacific coast.	[Isabel Quijano-Scheggia, Sonia; Olivos-Ortiz, Aramis; Sosa-Avalos, Ramon; Salas Marias, Nathalli] Univ Colima, Ctr Univ Invest Oceanol, Manzanillo, Mexico; [Garcia-Mendoza, Ernesto; Sanchez-Bravo, Yaireb] Ctr Invest Cient & Super Ensenada, Dept Oceanog Biol, Ensenada, Baja California, Mexico; [Lim, Hong Chang] Regal City Coll, Sarawak, Malaysia	Universidad de Colima	Quijano-Scheggia, SI (corresponding author), Univ Colima, Ctr Univ Invest Oceanol, Manzanillo, Mexico.	quijano@ucol.mx	Sosa-Avalos, Ramón/GMW-4315-2022; Lim, Hong Chang/J-8761-2012	Sosa-Avalos, Ramón/0000-0002-5768-8737; Lim, Hong Chang/0000-0003-0013-7819; Garcia-Mendoza, Ernesto/0000-0003-1738-7419; Olivos-Ortiz, Aramis/0000-0002-9886-9817; Quijano, Sonia/0000-0003-1499-8337				Ajani PA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195622; Amato A, 2019, CRYPTIC DIVERSITY LO; Amato A, 2008, PHYCOLOGIA, V47, P487, DOI 10.2216/07-92.1; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Amato A, 2010, TOXICON, V55, P157, DOI 10.1016/j.toxicon.2009.07.005; Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; [Anonymous], 2018, ALGAEBASE WORLD WIDE; Bates SS, 2018, HARMFUL ALGAE, V79, P3, DOI 10.1016/j.hal.2018.06.001; Bond NA, 2015, GEOPHYS RES LETT, V42, P3414, DOI 10.1002/2015GL063306; Bresnan E., 2010, IOC MANUALS GUIDES N; Bresnan E, 2015, HELGOLAND MAR RES, V69, P193, DOI 10.1007/s10152-015-0428-5; Brunson JK, 2018, SCIENCE, V361, P1356, DOI 10.1126/science.aau0382; Cabrales-Talavera G, 2010, THESIS; Cavole LM, 2016, OCEANOGRAPHY, V29, P273, DOI 10.5670/oceanog.2016.32; Cho ES, 2002, BOT MAR, V45, P364, DOI 10.1515/BOT.2002.037; Churro CI, 2009, DIATOM RES, V24, P35; Coleman AW, 2007, NUCLEIC ACIDS RES, V35, P3322, DOI 10.1093/nar/gkm233; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Coleman AW, 2000, PROTIST, V151, P1, DOI 10.1078/1434-4610-00002; Cusack Caroline, 2004, Biology and Environment, V104B, P55, DOI 10.3318/BIOE.2004.104.1.55; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Doyle JJ, 1990, ISOLATION PLANT DNA; Fernandes LF, 2014, DEEP-SEA RES PT II, V103, P139, DOI 10.1016/j.dsr2.2013.06.022; Gai FF, 2018, HARMFUL ALGAE, V76, P80, DOI 10.1016/j.hal.2018.05.003; Garcia-Mendoza E, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00454; Godinho L, 2018, TOXICON, V155, P27, DOI 10.1016/j.toxicon.2018.10.003; Grasshoff K., 1983, METHODS SEA WATER AN, V2nd; Grebner W, 2019, LIMNOL OCEANOGR, V64, P820, DOI 10.1002/lno.11077; GUILLARD RRL, 1993, PHYCOLOGIA, V32, P234, DOI 10.2216/i0031-8884-32-3-234.1; HALLEGRAEFF GM, 1994, BOT MAR, V37, P397, DOI 10.1515/botm.1994.37.5.397; Hasle G.R., 1965, SKR NOR VIDENSK AKAD, V18, P1; Hasle GR, 1996, HELGOLANDER MEERESUN, V50, P131, DOI 10.1007/BF02367149; Hasle Grethe R., 2002, Harmful Algae, V1, P137, DOI 10.1016/S1568-9883(02)00014-8; Hernandez-Becerril DU, 1998, HYDROBIOLOGIA, V379, P77, DOI 10.1023/A:1003471828302; JUSTIC D, 1995, ESTUAR COAST SHELF S, V40, P339, DOI 10.1016/S0272-7714(05)80014-9; Kaczmarska I, 2005, HARMFUL ALGAE, V4, P1, DOI 10.1016/j.hal.2003.07.001; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Lema KA, 2017, HARMFUL ALGAE, V64, P11, DOI 10.1016/j.hal.2017.03.001; Li Y, 2018, J PHYCOL, V54, P918, DOI 10.1111/jpy.12791; Licea S, 2000, P 16 INT DIAT S ATH; Lim HC, 2018, J PHYCOL, V54, P234, DOI 10.1111/jpy.12620; Lim HC, 2013, J PHYCOL, V49, P902, DOI 10.1111/jpy.12101; Lim HC, 2012, J APPL PHYCOL, V24, P1465, DOI 10.1007/s10811-012-9803-7; Lim HC, 2012, J PHYCOL, V48, P1232, DOI 10.1111/j.1529-8817.2012.01213.x; Lu SH, 2012, NOVA HEDWIGIA, V95, P123, DOI 10.1127/0029-5035/2012/0046; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; Lundholm N, 2002, PHYCOLOGIA, V41, P480, DOI 10.2216/i0031-8884-41-5-480.1; Lundholm N, 2018, HARMFUL ALGAE, V79, P64, DOI 10.1016/j.hal.2018.06.005; Mafra LL, 2009, J CHROMATOGR A, V1216, P6003, DOI 10.1016/j.chroma.2009.06.050; Mai JC, 1997, J MOL EVOL, V44, P258, DOI 10.1007/PL00006143; Marchetti A, 2008, J PHYCOL, V44, P650, DOI 10.1111/j.1529-8817.2008.00526.x; McCabe RM, 2016, GEOPHYS RES LETT, V43, P10366, DOI 10.1002/2016GL070023; Medina-Elizalde J, 2016, FLORECIMIENTOS ALGAL, P26; Moschandreou K, 12 INT C HARMF ALG C; Moschandreou KK, 2012, EUR J PHYCOL, V47, P321, DOI 10.1080/09670262.2012.713998; Nezan E., 2007, HARMFUL ALGAE NEWS, V35, P5; Orive E, 2013, J PHYCOL, V49, P1192, DOI 10.1111/jpy.12130; Ortiz A., 2016, FLORECIMIENTOS ALGAL, VI, P26; Pan YL, 2001, MAR ECOL PROG SER, V220, P83, DOI 10.3354/meps220083; Quijano-Scheggia S, 2010, 14 INT C HARMF ALG H; Quijano-Scheggia S, 2011, REV BIOL MAR OCEANOG, V46, P189, DOI 10.4067/S0718-19572011000200008; Rivera-Vilarelle M, 2018, DIATOM RES, V33, P55, DOI 10.1080/0269249X.2018.1426633; Rivera-Vilarelle M, 2013, BOT MAR, V56, P357, DOI 10.1515/bot-2012-0176; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santiago-Morales IS, 2011, HARMFUL ALGAE, V12, P82, DOI 10.1016/j.hal.2011.09.004; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schultz J, 2006, NUCLEIC ACIDS RES, V34, pW704, DOI 10.1093/nar/gkl129; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Selander E, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat5096; Selig C, 2008, NUCLEIC ACIDS RES, V36, pD377, DOI 10.1093/nar/gkm827; *STATSOFT I, 2003, STATISTICA DAT AN SO; Stehr CM, 2002, J PHYCOL, V38, P55, DOI 10.1046/j.1529-8817.2002.01106.x; Strickland JDH, 1972, PRACTICAL HDB SEA WA; Swain DL, 2015, GEOPHYS RES LETT, V42, P9999, DOI 10.1002/2015GL066628; Teng ST, 2015, J PHYCOL, V51, P706, DOI 10.1111/jpy.12313; Tenorio C, 2016, DIATOM RES, V31, P331, DOI 10.1080/0269249X.2016.1247018; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Van Meerssche E, 2018, ESTUAR COAST SHELF S, V209, P70, DOI 10.1016/j.ecss.2018.05.013; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Wolf M, 2005, RNA, V11, P1616, DOI 10.1261/rna.2144205; Wolf M, 2014, GENE, V546, P145, DOI 10.1016/j.gene.2014.05.065; Wolf M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066726; Zhu Z, 2017, HARMFUL ALGAE, V67, P36, DOI 10.1016/j.hal.2017.06.004	85	4	4	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231902	10.1371/journal.pone.0231902	http://dx.doi.org/10.1371/journal.pone.0231902			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330168	Green Published, gold			2022-12-26	WOS:000536647300029
J	Schmidt, CA; Goldberg, EJ; Green, TD; Karnekar, RR; Brault, JJ; Miller, SG; Amorese, AJ; Yamaguchi, DJ; Spangenburg, EE; McClung, JM				Schmidt, Cameron A.; Goldberg, Emma J.; Green, Tom D.; Karnekar, Reema R.; Brault, Jeffrey J.; Miller, Spencer G.; Amorese, Adam J.; Yamaguchi, Dean J.; Spangenburg, Espen E.; McClung, Joseph M.			Effects of fasting on isolated murine skeletal muscle contractile function during acute hypoxia	PLOS ONE			English	Article							GLYCOGEN-METABOLISM; REPERFUSION INJURY; FIBER-TYPE; IN-VIVO; ARTERIAL; ISCHEMIA; EXERCISE; RELEASE; GLUCOSE; ENERGETICS	Stored muscle carbohydrate supply and energetic efficiency constrain muscle functional capacity during exercise and are influenced by common physiological variables (e.g. age, diet, and physical activity level). Whether these constraints affect overall functional capacity or the timing of muscle energetic failure during acute hypoxia is not known. We interrogated skeletal muscle contractile properties in two anatomically distinct rodent hindlimb muscles that have well characterized differences in energetic efficiency (locomotory- extensor digitorum longus (EDL) and postural- soleus muscles) following a 24 hour fasting period that resulted in substantially reduced muscle carbohydrate supply. 180 mins of acute hypoxia resulted in complete energetic failure in all muscles tested, indicated by: loss of force production, substantial reductions in total adenosine nucleotide pool intermediates, and increased adenosine nucleotide degradation product-inosine monophosphate (IMP). These changes occurred in the absence of apparent myofiber structural damage assessed histologically by both transverse section and whole mount. Fasting and the associated reduction of the available intracellular carbohydrate pool (similar to 50% decrease in skeletal muscle) did not significantly alter the timing to muscle functional impairment or affect the overall force/work capacities of either muscle type. Fasting resulted in greater passive tension development in both muscle types, which may have implications for the design of pre-clinical studies involving optimal timing of reperfusion or administration of precision therapeutics.	[Schmidt, Cameron A.; Goldberg, Emma J.; Green, Tom D.; Karnekar, Reema R.; Brault, Jeffrey J.; Amorese, Adam J.; Spangenburg, Espen E.; McClung, Joseph M.] East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA; [Schmidt, Cameron A.; Goldberg, Emma J.; Green, Tom D.; Karnekar, Reema R.; Amorese, Adam J.; Spangenburg, Espen E.; McClung, Joseph M.] East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA; [Brault, Jeffrey J.; Miller, Spencer G.] Indiana Univ Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Yamaguchi, Dean J.; McClung, Joseph M.] East Carolina Univ, Dept Cardiovasc Sci, Greenville, NC 27858 USA; [Yamaguchi, Dean J.] East Carolina Univ, Brody Sch Med, Div Surg, Greenville, NC 27858 USA	University of North Carolina; East Carolina University; University of North Carolina; East Carolina University; Indiana University System; Indiana University Bloomington; University of North Carolina; East Carolina University; University of North Carolina; East Carolina University	McClung, JM (corresponding author), East Carolina Univ, Brody Sch Med, Dept Physiol, Greenville, NC 27858 USA.; McClung, JM (corresponding author), East Carolina Univ, East Carolina Diabet & Obes Inst, Greenville, NC 27858 USA.; McClung, JM (corresponding author), East Carolina Univ, Dept Cardiovasc Sci, Greenville, NC 27858 USA.	mcclungj@ecu.edu	Brault, Jeffrey/AAH-3293-2021	Brault, Jeffrey/0000-0003-3503-0528; Schmidt, Cameron/0000-0001-6628-6329	National Institutes of Health (NIH. gov) [R01HL125695, R01AR066660, R01AR070200]	National Institutes of Health (NIH. gov)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was made possible by grants awarded by the National Institutes of Health (NIH. gov) to JMM (R01HL125695), EES (R01AR066660) and JJB (R01AR070200).	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Armstrong SC, 2001, J MOL CELL CARDIOL, V33, P1165, DOI 10.1006/jmcc.2001.1380; Askew CD, 2005, J VASC SURG, V41, P802, DOI 10.1016/j.jvs.2005.01.037; Augusto V, 2004, BRAZ J MORPHOL SCIS, V21, P89; Barclay CJ, 2015, COMPR PHYSIOL, V5, P961, DOI 10.1002/cphy.c140038; Barclay CJ, 2017, CLIN EXP PHARMACOL P, V44, P1279, DOI 10.1111/1440-1681.12850; BARCLAY CJ, 1993, J PHYSIOL-LONDON, V472, P61, DOI 10.1113/jphysiol.1993.sp019937; Barton E.R., 2008, EXP PROTOC DMD ANIM, V1, P14; Berglund ED, 2008, DIABETES, V57, P1790, DOI 10.2337/db07-1615; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; BONEN A, 1990, AM J PHYSIOL, V258, pC693; BONEN A, 1994, J APPL PHYSIOL, V76, P1753, DOI 10.1152/jappl.1994.76.4.1753; Brault JJ, 2013, J CELL BIOCHEM, V114, P1445, DOI 10.1002/jcb.24486; Callum K, 2000, BRIT MED J, V320, P764, DOI 10.1136/bmj.320.7237.764; Chan RK, 2004, J SURG RES, V122, P54, DOI 10.1016/j.jss.2004.05.003; Chin ER, 1997, J PHYSIOL-LONDON, V498, P17, DOI 10.1113/jphysiol.1997.sp021838; COHEN N, 1995, DIABETES, V44, P423, DOI 10.2337/diabetes.44.4.423; CONLEE RK, 1976, AM J PHYSIOL, V231, P614, DOI 10.1152/ajplegacy.1976.231.2.614; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; Dolan NC, 2002, DIABETES CARE, V25, P113, DOI 10.2337/diacare.25.1.113; FIELDING RA, 1993, AM J PHYSIOL, V265, pR166, DOI 10.1152/ajpregu.1993.265.1.R166; FUNABIKI R, 1975, AGR BIOL CHEM TOKYO, V39, P791, DOI 10.1080/00021369.1975.10861692; GARBER AJ, 1976, J BIOL CHEM, V251, P836; Hamada T, 2006, J APPL PHYSIOL, V101, P1368, DOI 10.1152/japplphysiol.00416.2006; Helander I, 2002, AM J PHYSIOL-CELL PH, V282, pC1306, DOI 10.1152/ajpcell.00490.2001; Howlett RA, 2007, EXP PHYSIOL, V92, P887, DOI 10.1113/expphysiol.2007.037291; Hunter RW, 2011, DIABETES, V60, P766, DOI 10.2337/db10-1148; IDSTROM JP, 1990, AM J PHYSIOL, V258, pH1668, DOI 10.1152/ajpheart.1990.258.6.H1668; JANSSON E, 1988, CLIN PHYSIOL, V8, P17, DOI 10.1111/j.1475-097X.1988.tb00258.x; JENNISCHE E, 1985, ACTA PHYSIOL SCAND, V125, P727, DOI 10.1111/j.1748-1716.1985.tb07776.x; Jorgensen SB, 2004, J BIOL CHEM, V279, P1070, DOI 10.1074/jbc.M306205200; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; LEIGHTON B, 1987, BIOCHEM J, V246, P551, DOI 10.1042/bj2460551; LIU Jiahui, 2018, CHINA MECH ENG, V2018, P1, DOI DOI 10.1155/2018/3491960; MAGID A, 1985, SCIENCE, V230, P1280, DOI 10.1126/science.4071053; McGuigan MRM, 2001, MED SCI SPORT EXER, V33, P2016, DOI 10.1097/00005768-200112000-00007; Ortenblad N, 2013, J PHYSIOL-LONDON, V591, P4405, DOI 10.1113/jphysiol.2013.251629; Paradis S, 2016, AM J PHYSIOL-CELL PH, V310, pC968, DOI 10.1152/ajpcell.00356.2015; PASSONNEAU JV, 1974, ANAL BIOCHEM, V60, P405, DOI 10.1016/0003-2697(74)90248-6; PESSACQ MT, 1975, METABOLISM, V24, P737, DOI 10.1016/0026-0495(75)90041-4; PETRASEK PF, 1994, J VASC SURG, V19, P623, DOI 10.1016/S0741-5214(94)70035-4; Saltin B, 2010, COMPR PHYSIOL, P555; Sandstrom ME, 2004, PFLUG ARCH EUR J PHY, V448, P533, DOI 10.1007/s00424-004-1280-7; Schmidt CA, 2018, AM J PATHOL, V188, P1246, DOI 10.1016/j.ajpath.2018.01.008; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Smith IC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068924; SPRIET LL, 1987, J APPL PHYSIOL, V62, P611, DOI 10.1152/jappl.1987.62.2.611; Tarpey MD, 2018, SKELET MUSCLE, V8, DOI 10.1186/s13395-018-0160-3; Vignaud A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/724914; VOLLESTAD NK, 1985, ACTA PHYSIOL SCAND, V125, P395, DOI 10.1111/j.1748-1716.1985.tb07735.x; Walker P M, 1991, Ann Vasc Surg, V5, P399, DOI 10.1007/BF02015307; Weibel ER, 2005, J EXP BIOL, V208, P1635, DOI 10.1242/jeb.01548; Westerblad H, 1998, ACTA PHYSIOL SCAND, V162, P253, DOI 10.1046/j.1365-201X.1998.0301f.x; Woitaske MD, 1998, PLAST RECONSTR SURG, V102, P2052, DOI 10.1097/00006534-199811000-00037	56	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0225922	10.1371/journal.pone.0225922	http://dx.doi.org/10.1371/journal.pone.0225922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324778	Green Published, gold			2022-12-26	WOS:000536033700004
J	Shingu, Y; Takada, S; Yokota, T; Shirakawa, R; Yamada, A; Ooka, T; Katoh, H; Kubota, S; Matsui, Y				Shingu, Yasushige; Takada, Shingo; Yokota, Takashi; Shirakawa, Ryosuke; Yamada, Akira; Ooka, Tomonori; Katoh, Hiroki; Kubota, Suguru; Matsui, Yoshiro			Correlation between increased atrial expression of genes related to fatty acid metabolism and autophagy in patients with chronic atrial fibrillation	PLOS ONE			English	Article							HEART-FAILURE; RISK; STROKE; IMPACT; DELAY	Atrial metabolic disturbance contributes to the onset and development of atrial fibrillation (AF). Autophagy plays a role in maintaining the cellular energy balance. We examined whether atrial gene expressions related to fatty acid metabolism and autophagy are altered in chronic AF and whether they are related to each other. Right atrial tissue was obtained during heart surgery from 51 patients with sinus rhythm (SR, n = 38) or chronic AF (n = 13). Preoperative fasting serum free-fatty-acid levels were significantly higher in the AF patients. The atrial gene expression of fatty acid binding protein 3 (FABP3), which is involved in the cells' fatty acid uptake and intracellular fatty acid transport, was significantly increased in AF patients compared to SR patients; in the SR patients it was positively correlated with the right atrial diameter and intra-atrial electromechanical delay (EMD), parameters of structural and electrical atrial remodeling that were evaluated by an echocardiography. In contrast, the two groups' atrial contents of diacylglycerol (DAG), a toxic fatty acid metabolite, were comparable. Importantly, the atrial gene expression of microtubule-associated protein light chain 3 (LC3) was significantly increased in AF patients, and autophagy-related genes including LC3 were positively correlated with the atrial expression of FABP3. In conclusion, in chronic AF patients, the atrial expression of FABP3 was upregulated in association with autophagy-related genes without altered atrial DAG content. Our findings may support the hypothesis that dysregulated cardiac fatty acid metabolism contributes to the progression of AF and induction of autophagy has a cardioprotective effect against cardiac lipotoxicity in chronic AF.	[Shingu, Yasushige; Ooka, Tomonori; Kubota, Suguru; Matsui, Yoshiro] Hokkaido Univ, Fac Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan; [Shingu, Yasushige; Takada, Shingo; Yokota, Takashi; Shirakawa, Ryosuke; Ooka, Tomonori; Kubota, Suguru; Matsui, Yoshiro] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Takada, Shingo; Yokota, Takashi; Shirakawa, Ryosuke] Hokkaido Univ, Dept Cardiovasc Med, Fac Med, Sapporo, Hokkaido, Japan; [Yamada, Akira] Teine Keijinkai Hosp, Dept Cardiovasc Surg, Sapporo, Hokkaido, Japan; [Katoh, Hiroki] Hokkaido Univ Hosp, Emergency & Crit Care Ctr, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Teine Keijinkai Hospital; Hokkaido University	Yokota, T (corresponding author), Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan.; Yokota, T (corresponding author), Hokkaido Univ, Dept Cardiovasc Med, Fac Med, Sapporo, Hokkaido, Japan.	t-yokota@med.hokudai.ac.jp	Yokota, Takashi/ABA-6930-2020; Shingu, Yasushige/E-1939-2012	Shingu, Yasushige/0000-0001-8471-5166; Takada, Shingo/0000-0002-7781-9482	KAKENHI [18K08022, JP24791453]; Cardiovascular Research Fund; Center of Innovation Program from the Japan Science and Technology Agency [JPMJCE1301]	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cardiovascular Research Fund; Center of Innovation Program from the Japan Science and Technology Agency	This study was supported by KAKENHI Grant-in-Aid for Young Scientists (B) (#JP24791453 to Y.S.), KAKENHI Grant-in-Aid for Scientific Research (18K08022 to T.Y.), the Cardiovascular Research Fund (to Y.S.), and the Center of Innovation Program from the Japan Science and Technology Agency (#JPMJCE1301 to T.Y.).	Ari H, 2013, CARDIOL J, V20, P639, DOI 10.5603/CJ.2013.0164; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Casaclang-Verzosa G, 2008, J AM COLL CARDIOL, V51, P1, DOI 10.1016/j.jacc.2007.09.026; Choi JY, 2016, ANN NEUROL, V79, P317, DOI 10.1002/ana.24568; Czegledi A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071628; D'Souza K, 2016, BBA-MOL CELL BIOL L, V1861, P1513, DOI 10.1016/j.bbalip.2016.02.016; Garcia L, 2012, J THORAC CARDIOV SUR, V143, P451, DOI 10.1016/j.jtcvs.2011.07.056; Gizurarson S, 2015, J ELECTROCARDIOL, V48, P853, DOI 10.1016/j.jelectrocard.2014.12.010; Goette A, 1996, CIRCULATION, V94, P2968, DOI 10.1161/01.CIR.94.11.2968; Golaszewska K, 2019, J PHYSIOL PHARMACOL, V70, P25, DOI 10.26402/jpp.2019.1.11; Gyongyosi A, 2019, CURR PHARM DESIGN, V25, P2192, DOI 10.2174/1381612825666190619145025; Karam BS, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0604-9; Khawaja O, 2012, AM J CARDIOL, V110, P212, DOI 10.1016/j.amjcard.2012.03.010; Lau DH, 2017, CIRCULATION, V136, P583, DOI 10.1161/CIRCULATIONAHA.116.023163; Meyer G, 2013, CURR PHARM DESIGN, V19, P6912, DOI 10.2174/138161281939131127122510; Montaigne D, 2013, J AM COLL CARDIOL, V62, P1466, DOI 10.1016/j.jacc.2013.03.061; Schnabel RB, 2013, EUR J HEART FAIL, V15, P843, DOI 10.1093/eurjhf/hft041; Shingu Y, 2018, J CARDIOL, V71, P65, DOI 10.1016/j.jjcc.2017.07.003; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slagsvold KH, 2014, PHYSIOL GENOMICS, V46, P505, DOI 10.1152/physiolgenomics.00042.2014; Takada S, 2016, CARDIOVASC RES, V111, P338, DOI 10.1093/cvr/cvw182; Wiersma M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006458; Wolf PA, 1998, ARCH INTERN MED, V158, P229, DOI 10.1001/archinte.158.3.229; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Xu ZX, 2014, ULTRASOUND MED BIOL, V40, P1133, DOI 10.1016/j.ultrasmedbio.2014.01.006; Yamamoto T, 2009, BIOTECHNOL LETT, V31, P1695, DOI 10.1007/s10529-009-0065-7; Yuan Y, 2014, INT J CARDIOL, V172, P492, DOI 10.1016/j.ijcard.2014.01.027; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	29	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0224713	10.1371/journal.pone.0224713	http://dx.doi.org/10.1371/journal.pone.0224713			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315296	Green Published, Green Submitted, gold			2022-12-26	WOS:000536024800001
J	Arefaine, ZG; Abebe, S; Bekele, E; Adem, A; Adama, Y; Brockmeyer, NH; Coenenberg, J; Potthoff, A; Gebremeskel, TG				Arefaine, Zekarias Gessesse; Abebe, Sintayehu; Bekele, Ephrem; Adem, Amir; Adama, Yohannes; Brockmeyer, Norbert H.; Coenenberg, Judith; Potthoff, Anja; Gebremeskel, Teferi Gebru			Incidence and predictors of HIV related opportunistic infections after initiation of highly active antiretroviral therapy at Ayder Referral Hospital, Mekelle, Ethiopia: A retrospective single centered cohort study	PLOS ONE			English	Article							VIRAL LOAD; ADHERENCE; ILLNESSES; MORTALITY	Introduction Even though use of antiretroviral therapy (HAART) decreases the incidence of opportunistic infections (OIs) they are continuing to be a major cause of morbidity and mortality. Studies concerning this problem are scarce in Eastern Africa. The aim of this study was to determine the incidence and predictors of OIs after initiation of HAART in Ethiopia. Methods A health facility based single centered cohort study using structured data extraction sheet was conducted. The study population was all HIV positive ART naive adolescents and adults who started HAART between January 2009 and May 2012. Simple random sampling technique was used to select 317 patients from the record. Multivariate binary logistic regression model was used to determine factors for the occurrence of OIs after initiation of HAART. Results The incidence of OIs after HAART was 7.5 cases/100person years. Tuberculosis, oral candidiasis, pneumonia and toxoplasmosis were the leading OIs after HAART. A bed ridden functional status at initiation of HAART, presence of OIs before HAART, non-adherence and low hemoglobin level were predictors for the occurrence of OIs after HAART. Conclusion The incidence of OIs after HAART was higher than in previous studies. Patients with the identified risk factors need strict follow up to reduce the morbidity and mortality attributed to OIs. Earlier initiation of HAART before advanced immune suppression, better management of TB and extended baseline assessment could help to reduce opportunistic infections and mortality after the initiation of HAART in Ethiopian patients.	[Arefaine, Zekarias Gessesse; Abebe, Sintayehu; Bekele, Ephrem; Adem, Amir] Mekelle Univ, Coll Hlth Sci, Dept Internal Med, Mekelle, Ethiopia; [Adama, Yohannes] Mekelle Univ, Coll Hlth Sci, Dept Publ Hlth, Mekelle, Ethiopia; [Brockmeyer, Norbert H.; Coenenberg, Judith; Potthoff, Anja] Ruhr Univ Bochum, Clin Dermatol Venerol & Allergol, Bochum, Germany; [Gebremeskel, Teferi Gebru] Aksum Univ, Coll Hlth Sci, Dept Reprod Hlth, Aksum, Ethiopia	Mekelle University; Mekelle University; Ruhr University Bochum	Arefaine, ZG (corresponding author), Mekelle Univ, Coll Hlth Sci, Dept Internal Med, Mekelle, Ethiopia.	gessesse359@yahoo.com	Gebremeskel, Teferi Gebru/AAV-8340-2020	Gebremeskel, Teferi Gebru/0000-0002-8276-5685				Bangsberg DR, 2000, AIDS, V14, P357, DOI 10.1097/00002030-200003100-00008; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Buchacz K, 2010, AIDS, V24, P1549, DOI 10.1097/QAD.0b013e32833a3967; Central Statistical Authority, 2000, DEM HLTH SURV; De Beaudrap P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-179; Eldred LJ, 1998, J ACQ IMMUN DEF SYND, V18, P117, DOI 10.1097/00042560-199806010-00003; Federal Democratic Republic of Ethiopia, 2012, COUNTR PROGR REP HIV; FMOH, 2007, SINGL POINT PREV EST; FMOH, 2007, GUID MAN OPP INF ANT; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Huruy K, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-46; Kaplan JE, 2001, EMERG INFECT DIS, V7, P541; Kassa A, 2012, T ROY SOC TROP MED H, V106, P363, DOI 10.1016/j.trstmh.2012.03.002; Ledergerber B, 1999, JAMA-J AM MED ASSOC, V282, P2220, DOI 10.1001/jama.282.23.2220; Podlasin RB, 2006, INFECTION, V34, P196, DOI 10.1007/s15010-006-5030-y; Salami A K, 2006, West Afr J Med, V25, P52; Srirangaraj S, 2011, INDIAN J MED MICROBI, V29, P395, DOI 10.4103/0255-0857.90175; Torti C, 2007, HIV CLIN TRIALS, V8, P112, DOI 10.1310/hct0803-112; Vanhove GF, 1996, JAMA-J AM MED ASSOC, V276, P1955, DOI 10.1001/jama.276.24.1955; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed	21	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0229757	10.1371/journal.pone.0229757	http://dx.doi.org/10.1371/journal.pone.0229757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310961	gold, Green Published			2022-12-26	WOS:000536019800003
J	Brannstrom, L; Forsman, H; Vinnerljung, B; Almquist, YB				Brannstrom, Lars; Forsman, Hilma; Vinnerljung, Bo; Almquist, Ylva B.			Inequalities in educational outcomes in individuals with childhood experience of out-of-home care: What are driving the differences?	PLOS ONE			English	Article							STOCKHOLM BIRTH COHORT; FOSTER-CARE; PSYCHOSOCIAL PROBLEMS; SCHOOL ACHIEVEMENTS; YOUNG-PEOPLE; CHILDREN; YOUTH; INTERVENTIONS; MALTREATMENT; PERFORMANCE	Background Prior research has shown that individuals with experience of out-of-home care (foster family care or residential care) in childhood are educationally disadvantaged compared to their peers. In order to be better equipped to design interventions aimed at improving the educational outcomes of children for whom society has assumed responsibility, this study seeks to further our understanding about which factors that contribute to the educational disparities throughout the life course. Methods Using longitudinal data from a cohort of more than 13,000 Swedes, of which around 7% have childhood experience of out-of-home care, Peters-Belson decomposition is utilized to quantify the extent to which the gap in educational achievement in school (age 16) and midlife educational attainment (age 50) captures differences in the prevalence of factors influencing educational outcomes, and differences in the impacts between these factors. Results We find that the achievement and the attainment gap was around 13% and 9% respectively. These gaps were to a large extent explained by differences in the distribution of predictors. The major explanatory factor for placed children's lower achievement was a lower average cognitive ability. Yet there were some evidence that the rewards of cognitive ability in these children differed across the life course. While the lower returns of cognitive ability suggest that they were underperforming in compulsory school, the higher returns of cognitive ability on midlife attainment indicate that-given previous underperformance-their attainment at age 50 reflects their cognitive capacity more accurately than their achievement at age 16 do. Conclusion The large influence of the unequal distribution of predictors suggests that policy efforts are needed to promote equity in the distribution of factors contributing to educational achievement and attainment. Since cognitive ability was found to be an important contributory factor, such efforts may include promoting cognitive and intellectual development among children in out-of-home care, preferably starting at a young age.	[Brannstrom, Lars; Forsman, Hilma; Vinnerljung, Bo] Stockholm Univ, Dept Social Work, Stockholm, Sweden; [Almquist, Ylva B.] Stockholm Univ, Dept Publ Hlth Sci, Stockholm, Sweden	Stockholm University; Stockholm University	Brannstrom, L (corresponding author), Stockholm Univ, Dept Social Work, Stockholm, Sweden.	lars.brannstrom@socarb.su.se		Brannstrom, Lars/0000-0002-8526-9396	Swedish Research Council [2017-01746]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was financially supported by the Swedish Research Council (grant no 2017-01746). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist YB, 2018, J EPIDEMIOL COMMUN H, V72, P997, DOI 10.1136/jech-2018-210487; BELSON WA, 1956, ROY STAT SOC C-APP, V5, P195; Berlin M, 2011, CHILD YOUTH SERV REV, V33, P2489, DOI 10.1016/j.childyouth.2011.08.024; BLINDER AS, 1973, J HUM RESOUR, V8, P436, DOI 10.2307/144855; Daehlen M., 2014, NORDIC SOCIAL WORK R, V4, P22, DOI [10.1080/2156857X.2013.779933, DOI 10.1080/2156857X.2013.779933]; Dill K, 2012, CHILD YOUTH SERV REV, V34, P1081, DOI 10.1016/j.childyouth.2012.01.031; Duyme M, 1999, P NATL ACAD SCI USA, V96, P8790, DOI 10.1073/pnas.96.15.8790; Evans R, 2017, BRIT EDUC RES J, V43, P68, DOI 10.1002/berj.3252; Forsman H, 2016, CHILD ABUSE NEGLECT, V57, P61, DOI 10.1016/j.chiabu.2016.06.006; Forsman H, 2012, CHILD YOUTH SERV REV, V34, P1084, DOI 10.1016/j.childyouth.2012.01.037; Foster EM, 2011, CHILD YOUTH SERV REV, V33, P118, DOI 10.1016/j.childyouth.2010.08.021; Frones I, 2016, CHILD INDIC RES, V9, P247, DOI 10.1007/s12187-015-9309-3; Jann B, 2008, STATA J, V8, P453, DOI 10.1177/1536867X0800800401; Janson C.-G., 1980, REGISTER DATA 2 CODE; Kaariala A, 2017, CHILD YOUTH SERV REV, V79, P107, DOI 10.1016/j.childyouth.2017.05.030; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Naccarato T, 2010, CHILD YOUTH SERV REV, V32, P551, DOI 10.1016/j.childyouth.2009.11.009; O'Higgins A, 2017, CHILD YOUTH SERV REV, V79, P198, DOI 10.1016/j.childyouth.2017.06.004; Oaxaca R., 1973, INT ECON REV, V14, P693, DOI DOI 10.2307/2525981; Pears KC, 2013, EARLY EDUC DEV, V24, P771, DOI 10.1080/10409289.2013.736037; Pecora PJ, 2012, CHILD YOUTH SERV REV, V34, P1121, DOI 10.1016/j.childyouth.2012.01.044; Peters CC, 1941, J EDUC RES, V34, P606, DOI 10.1080/00220671.1941.10881036; Romano E, 2015, TRAUMA VIOLENCE ABUS, V16, P418, DOI 10.1177/1524838014537908; Scherr TG, 2007, SCHOOL PSYCHOL INT, V28, P419, DOI 10.1177/0143034307084133; SCHIFF M, 1982, COGNITION, V12, P165, DOI 10.1016/0010-0277(82)90011-7; Sebba J., 2015, ED PROGR LOOKED CHIL; StataCorp, 2017, STATA 15 BAS REF MAN; Stenberg S.-A., 2018, BORN 1953; Stenberg SA, 2006, INT J EPIDEMIOL, V35, P546, DOI 10.1093/ije/dyi310; Stenberg SA, 2007, SCAND J PUBLIC HEALT, V35, P104, DOI 10.1080/14034940600777385; Stone S, 2007, CHILD YOUTH SERV REV, V29, P139, DOI 10.1016/j.childyouth.2006.05.001; Tideman E, 2011, ADOPT FOSTER, V35, P44, DOI 10.1177/030857591103500106; Trout AL, 2008, CHILD YOUTH SERV REV, V30, P979, DOI 10.1016/j.childyouth.2007.11.019; Vinnerljung B, 2014, ADOPT FOSTER, V38, P361, DOI 10.1177/0308575914553543	34	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0232061	10.1371/journal.pone.0232061	http://dx.doi.org/10.1371/journal.pone.0232061			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9MR	32311003	gold, Green Published			2022-12-26	WOS:000536019800046
J	Safra, L; Baumard, N; Wyart, V; Chevallier, C				Safra, Lou; Baumard, Nicolas; Wyart, Valentin; Chevallier, Coralie			Social motivation is associated with increased weight granted to cooperation-related impressions in face evaluation tasks	PLOS ONE			English	Article							FACIAL WIDTH; MODELS; CHOICE; TRUST	It is a trope in psychological science to define the human species as inherently social. Yet, despite its key role in human behaviour, the mechanisms by which social bonding actually shapes social behaviour have not been fully characterized. Across six studies, we show that the motivation for social bonding does not indiscriminately increase individuals' willingness to approach others but that it is instead associated with specific variations in social evaluations. Studies 1-4 demonstrate that social motivation is associated with a larger importance granted to cooperation-related impressions, i.e. perceived trustworthiness, during social evaluations. Studies 5 and 6 further reveal that this weighting difference leads strongly socially motivated participants to approach more partners that are perceived as both dominant and trustworthy. Taken together, our results provide support for the idea that humans' social motivation is associated with specific social preferences that could favour successful cooperative interactions and a widening of people's cooperative circle.	[Safra, Lou] Sciences Po, CEVIPOF, CNRS, UMR7048, Paris, France; [Safra, Lou; Wyart, Valentin; Chevallier, Coralie] PSL Res Univ, Ecole Normale Super, Lab Neurosci Cognit & Computat LNC2, Dept Etud Cognit,Inserm,U960, Paris, France; [Baumard, Nicolas] PSL Res Univ, Ecole Normale Super, Inst Jean Nicod, Dept Etud Cognit,CNRS,UMR8129, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Safra, L (corresponding author), Sciences Po, CEVIPOF, CNRS, UMR7048, Paris, France.; Safra, L; Chevallier, C (corresponding author), PSL Res Univ, Ecole Normale Super, Lab Neurosci Cognit & Computat LNC2, Dept Etud Cognit,Inserm,U960, Paris, France.	lou.safra@sciencespo.fr; coralie.chevallier@ens.fr			Institut d'Etudes Cognitives (FrontCog) [ANR-17-EURE-0017, ANR-10-LABX-0087 IEC, ANR-10-IDEX-0001-02 PSL]	Institut d'Etudes Cognitives (FrontCog)	All authors are supported by the Institut d'E ' tudes Cognitives (FrontCog, ANR-17-EURE-0017, ANR-10-LABX-0087 IEC and ANR-10-IDEX-0001-02 PSL) https://anr.fr/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts AA, 2015, SCIENCE, V349, DOI 10.1126/science.aac4716; Assouly-Besse F., 1995, LENCEPHALE, V21, P273; BERKEY CS, 1995, STAT MED, V14, P395, DOI 10.1002/sim.4780140406; Boksem MAS, 2013, PSYCHOL SCI, V24, P2306, DOI 10.1177/0956797613495063; Bone JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117183; Bonnefon JF, 2017, CURR DIR PSYCHOL SCI, V26, P276, DOI 10.1177/0963721417693352; Braver SL, 2014, PERSPECT PSYCHOL SCI, V9, P333, DOI 10.1177/1745691614529796; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; BUSS DM, 1995, PSYCHOL INQ, V6, P1, DOI 10.1207/s15327965pli0601_1; Carre JM, 2009, PSYCHOL SCI, V20, P1194, DOI 10.1111/j.1467-9280.2009.02423.x; CHAPMAN LJ, 1976, J ABNORM PSYCHOL, V85, P374, DOI 10.1037/0021-843X.85.4.374; Chevallier C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167024; Chevallier Coralie, 2012, J Autism Dev Disord, V42, P1504, DOI 10.1007/s10803-011-1364-0; Chevallier C, 2012, TRENDS COGN SCI, V16, P231, DOI 10.1016/j.tics.2012.02.007; Eisenbruch AB, 2016, EVOL HUM BEHAV, V37, P429, DOI 10.1016/j.evolhumbehav.2016.04.002; Eisenegger C, 2010, NATURE, V463, P356, DOI 10.1038/nature08711; Hughes BL, 2017, SOC COGN AFFECT NEUR, V12, P49, DOI 10.1093/scan/nsw147; Hughes BL, 2015, TRENDS COGN SCI, V19, P62, DOI 10.1016/j.tics.2014.12.006; KAUFMANN JH, 1983, BIOL REV, V58, P1, DOI 10.1111/j.1469-185X.1983.tb00379.x; Lefevre CE, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0729; Lefevre CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093369; Lewis GJ, 2012, PERS INDIV DIFFER, V52, P855, DOI 10.1016/j.paid.2011.12.030; Lin N, 1999, ANNU REV SOCIOL, V25, P467, DOI 10.1146/annurev.soc.25.1.467; Little AC, 2007, EVOL HUM BEHAV, V28, P18, DOI 10.1016/j.evolhumbehav.2006.09.002; Long J. S., 2009, GROUP COMP LOGIT PRO, V1; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; McAleer P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090779; McCullough ME, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2104; MCFADDEN D, 1980, J BUS, V53, pS13, DOI 10.1086/296093; Medin D, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-017-0088; Nettle D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026922; Petersen MB, 2015, PSYCHOL SCI, V26, P1681, DOI 10.1177/0956797615595622; Platt ML, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0096; Safra L, 2017, EVOL HUM BEHAV, V38, P645, DOI 10.1016/j.evolhumbehav.2017.05.001; Schonbrodt FD, 2013, J RES PERS, V47, P609, DOI 10.1016/j.jrp.2013.05.009; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Snyder JK, 2011, EVOL HUM BEHAV, V32, P127, DOI 10.1016/j.evolhumbehav.2010.08.007; Spisak BR, 2012, LEADERSHIP QUART, V23, P273, DOI 10.1016/j.leaqua.2011.08.006; Stewart LH, 2012, J EXP PSYCHOL GEN, V141, P715, DOI 10.1037/a0027950; Stirrat M, 2010, PSYCHOL SCI, V21, P349, DOI 10.1177/0956797610362647; Stockley P, 2011, BIOL REV, V86, P341, DOI 10.1111/j.1469-185X.2010.00149.x; Sutherland CAM, 2013, COGNITION, V127, P105, DOI 10.1016/j.cognition.2012.12.001; Todorov A, 2013, EMOTION, V13, P724, DOI 10.1037/a0032335; Todorov A, 2011, J COGNITIVE NEUROSCI, V23, P2766, DOI 10.1162/jocn.2011.21616; Todorov A, 2008, TRENDS COGN SCI, V12, P455, DOI 10.1016/j.tics.2008.10.001; Tomasello M, 2005, BEHAV BRAIN SCI, V28, P675, DOI 10.1017/S0140525X05000129; van Honk J., 2012, NEW EVIDENCE TESTOST, V485; Von Rueden C., 2014, PSYCHOL SOCIAL STATU, P179; von Rueden C, 2011, P ROY SOC B-BIOL SCI, V278, P2223, DOI 10.1098/rspb.2010.2145; Wibral M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046774; Wilson V, 2014, PERS INDIV DIFFER, V58, P89, DOI 10.1016/j.paid.2013.10.008	51	2	2	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0230011	10.1371/journal.pone.0230011	http://dx.doi.org/10.1371/journal.pone.0230011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9MR	32310985	Green Published, gold			2022-12-26	WOS:000536019800004
J	Pancholi, S; Ribas, R; Simigdala, N; Schuster, E; Nikitorowicz-Buniak, J; Ressa, A; Gao, Q; Leal, MF; Bhamra, A; Thornhill, A; Morisset, L; Montaudon, E; Sourd, L; Fitzpatrick, M; Altelaar, M; Johnston, SR; Marangoni, E; Dowsett, M; Martin, LA				Pancholi, Sunil; Ribas, Ricardo; Simigdala, Nikiana; Schuster, Eugene; Nikitorowicz-Buniak, Joanna; Ressa, Anna; Gao, Qiong; Leal, Mariana Ferreira; Bhamra, Amandeep; Thornhill, Allan; Morisset, Ludivine; Montaudon, Elodie; Sourd, Laura; Fitzpatrick, Martin; Altelaar, Maarten; Johnston, Stephen R.; Marangoni, Elisabetta; Dowsett, Mitch; Martin, Lesley-Ann			Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities	ONCOGENE			English	Article							DEPENDENT KINASE 4/6; CELL-CYCLE; ADJUVANT TAMOXIFEN; TRANSCRIPTION; DEPRIVATION; INHIBITION; CYCLIN-D1; CDK7; AMPLIFICATION; TARGET	Combination of CDK4/6 inhibitors and endocrine therapy improves clinical outcome in advanced oestrogen receptor (ER)-positive breast cancer, however relapse is inevitable. Here, we show in model systems that other than loss of RB1 few gene-copy number (CN) alterations are associated with irreversible-resistance to endocrine therapy and subsequent secondary resistance to palbociclib. Resistance to palbociclib occurred as a result of tumour cell re-wiring leading to increased expression of EGFR, MAPK, CDK4, CDK2, CDK7, CCNE1 and CCNE2. Resistance altered the ER genome wide-binding pattern, leading to decreased expression of 'classical' oestrogen-regulated genes and was accompanied by reduced sensitivity to fulvestrant and tamoxifen. Persistent CDK4 blockade decreased phosphorylation of tuberous sclerosis complex 2 (TSC2) enhancing EGFR signalling, leading to the re-wiring of ER. Kinome-knockdown confirmed dependency on ERBB-signalling and G2/M-checkpoint proteins such as WEE1, together with the cell cycle master regulator, CDK7. Noteworthy, sensitivity to CDK7 inhibition was associated with loss of ER and RB1 CN. Overall, we show that resistance to CDK4/6 inhibitors is dependent on kinase re-wiring and the redeployment of signalling cascades previously associated with endocrine resistance and highlights new therapeutic networks that can be exploited upon relapse after CDK4/6 inhibition.	[Pancholi, Sunil; Ribas, Ricardo; Simigdala, Nikiana; Schuster, Eugene; Nikitorowicz-Buniak, Joanna; Leal, Mariana Ferreira; Dowsett, Mitch; Martin, Lesley-Ann] Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London SW7 3RP, England; [Ressa, Anna; Fitzpatrick, Martin; Altelaar, Maarten] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote, NL-3584 CH Utrecht, Netherlands; [Ressa, Anna; Fitzpatrick, Martin; Altelaar, Maarten] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Gao, Qiong] Inst Canc Res, Bioinformat Cofacil, CRUK, Sutton SM2 5NG, Surrey, England; [Bhamra, Amandeep] Inst Canc Res, Prote Unit, Sutton SW7 3RP, Surrey, England; [Thornhill, Allan] Inst Canc Res, Ctr Canc Imaging, Sutton SM2 5NG, Surrey, England; [Morisset, Ludivine; Montaudon, Elodie; Sourd, Laura; Marangoni, Elisabetta] Inst Curie, Dept Translat Res, Paris, France; [Johnston, Stephen R.] Royal Marsden Hosp, Breast Unit, London SW3 6JJ, England; [Dowsett, Mitch] Royal Marsden Hosp, Ralph Lauren Ctr Breast Canc Res, London SW3 6JJ, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Utrecht University; Utrecht University; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; University of London; Institute of Cancer Research - UK; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust	Martin, LA (corresponding author), Inst Canc Res, Breast Canc Now Toby Robins Res Ctr, London SW7 3RP, England.	lesley-ann.martin@icr.ac.uk	Marangoni, Elisabetta/GSO-3945-2022	Marangoni, Elisabetta/0000-0002-3337-6448; Ribas, Ricardo/0000-0002-8134-0036; Schuster, Eugene/0000-0001-5076-2810; Gao, Qiong/0000-0002-0406-1594; Pancholi, Sunil/0000-0002-0880-1588	Pfizer; NHS; Breast Cancer Now; Walk the Walk; Proteins@Work - Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands [184.032.201]; HighThroughput Genomics Group at the Wellcome Trust Centre for Human Genetics (Wellcome Trust) [090532/Z/09/Z]; Arthur Foundation	Pfizer(Pfizer); NHS; Breast Cancer Now; Walk the Walk; Proteins@Work - Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands(Netherlands Organization for Scientific Research (NWO)); HighThroughput Genomics Group at the Wellcome Trust Centre for Human Genetics (Wellcome Trust); Arthur Foundation	We also would like to thank Pfizer, for academic funding and NHS funding to the Royal Marsden Hospital's NIHR Biomedical Research Centre. This work was also supported by Breast Cancer Now, working in partnership with Walk the Walk; Proteins@Work, financed by the Netherlands Organisation for Scientific Research (NWO) as part of the National Roadmap Large-scale Research Facilities of the Netherlands (project number 184.032.201); HighThroughput Genomics Group at the Wellcome Trust Centre for Human Genetics (funded by Wellcome Trust grant reference 090532/Z/09/Z) for the generation of the Sequencing data and The Arthur Foundation.	Asghar U, 2015, NAT REV DRUG DISCOV, V14, P130, DOI 10.1038/nrd4504; Bhat-Nakshatri P, 2008, MOL CELL BIOL, V28, P7487, DOI 10.1128/MCB.00799-08; Bhinge K, 2017, ONCOTARGET, V8, P27155, DOI 10.18632/oncotarget.15676; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Brough R, 2011, CANCER DISCOV, V1, P260, DOI 10.1158/2159-8290.CD-11-0107; Chandarlapaty S, 2011, CANCER CELL, V19, P58, DOI 10.1016/j.ccr.2010.10.031; De Falco G, 2000, ONCOGENE, V19, P373, DOI 10.1038/sj.onc.1203305; de Leeuw R, 2018, CLIN CANCER RES, V24, P4201, DOI 10.1158/1078-0432.CCR-18-0410; DICKSON C, 1995, CANCER LETT, V90, P43, DOI 10.1016/0304-3835(94)03676-A; Finn RS, 2016, NEW ENGL J MED, V375, P1925, DOI 10.1056/NEJMoa1607303; Fisher RP, 2005, J CELL SCI, V118, P5171, DOI 10.1242/jcs.02718; Fry DW, 2004, MOL CANCER THER, V3, P1427; Gao Q, 2014, CLIN CANCER RES, V20, P2485, DOI 10.1158/1078-0432.CCR-13-2602; GILLETT C, 1994, CANCER RES, V54, P1812; Goel S, 2016, CANCER CELL, V29, P255, DOI 10.1016/j.ccell.2016.02.006; Goetz MP, 2017, J CLIN ONCOL, V35, P3638, DOI 10.1200/JCO.2017.75.6155; Grinstein E, 2002, ONCOGENE, V21, P1485, DOI 10.1038/sj.onc.1205211; Halaban R, 1998, INT J MOL MED, V1, P419; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Jansen VM, 2017, CANCER RES, V77, P2488, DOI 10.1158/0008-5472.CAN-16-2653; Jirstrom K, 2005, CANCER RES, V65, P8009, DOI 10.1158/0008-5472.CAN-05-0746; Kettner NM, 2019, CLIN CANCER RES, V25, P3996, DOI 10.1158/1078-0432.CCR-18-3274; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Li B, 2017, CANCER RES, V77, P3834, DOI 10.1158/0008-5472.CAN-16-2546; Lundgren K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3161; Lupien M, 2010, GENE DEV, V24, P2219, DOI 10.1101/gad.1944810; Ma CX, 2017, CLIN CANCER RES, V23, P4055, DOI 10.1158/1078-0432.CCR-16-3206; Martin M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15127, 10.1038/s41467-017-01864-y]; Matheson CJ, 2016, TRENDS PHARMACOL SCI, V37, P872, DOI 10.1016/j.tips.2016.06.006; Michaloglou C, 2018, MOL CANCER THER, V17, P908, DOI 10.1158/1535-7163.MCT-17-0537; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Morandi A, 2013, CANCER RES, V73, P3783, DOI 10.1158/0008-5472.CAN-12-4265; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Narasimha AM, 2014, ELIFE, V3, DOI 10.7554/eLife.02872; O'Leary B, 2018, CANCER DISCOV, V8, P1390, DOI 10.1158/2159-8290.CD-18-0264; Patani N, 2014, MOL CELL ENDOCRINOL, V382, P683, DOI 10.1016/j.mce.2013.09.038; Patel H, 2018, MOL CANCER THER, V17, P1156, DOI 10.1158/1535-7163.MCT-16-0847; Paternot S, 2010, CELL CYCLE, V9, P689, DOI 10.4161/cc.9.4.10611; Raaijmakers LM, 2015, J PROTEOME RES, V14, P4332, DOI 10.1021/acs.jproteome.5b00529; Ressa A, 2019, J PROTEOME RES, V18, P576, DOI 10.1021/acs.jproteome.8b00576; Ribas R, 2015, MOL CANCER THER, V14, P2035, DOI 10.1158/1535-7163.MCT-15-0143; Rondon-Lagos M, 2014, MOL CYTOGENET, V7, DOI 10.1186/1755-8166-7-8; Rudas M, 2008, CLIN CANCER RES, V14, P1767, DOI 10.1158/1078-0432.CCR-07-4122; Rudolph JD, 2016, CELL SYST, V3, P585, DOI 10.1016/j.cels.2016.11.005; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Shaw AS, 2014, MOL CELL BIOL, V34, P1538, DOI 10.1128/MCB.00057-14; Simigdala N, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0713-5; Smith EJ, 1998, CELL GROWTH DIFFER, V9, P297; Stark R., 2011, R PACKAGE VERSION, V100, P1; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Yang C, 2017, ONCOGENE, V36, P2255, DOI 10.1038/onc.2016.379; Zacharek SJ, 2005, CANCER RES, V65, P11354, DOI 10.1158/0008-5472.CAN-05-2236; Zhou HJ, 2013, NAT PROTOC, V8, P461, DOI 10.1038/nprot.2013.010	56	30	30	2	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 18	2020	39	25					4781	4797		10.1038/s41388-020-1284-6	http://dx.doi.org/10.1038/s41388-020-1284-6		APR 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LZ3HT	32307447	Green Published, hybrid			2022-12-26	WOS:000527477100001
J	Wang, D; Zeng, ZY; Zhang, SS; Xiong, F; He, BY; Wu, YF; Li, WM; Tang, L; Wei, F; Xiang, B; Li, Z; Zhou, YH; Zhou, M; Li, XL; Li, Y; Li, GY; Xiong, W; Guo, C				Wang, Dan; Zeng, Zhaoyang; Zhang, Shanshan; Xiong, Fang; He, Baoyu; Wu, Yingfen; Li, Weimin; Tang, Le; Wei, Fang; Xiang, Bo; Li, Zheng; Zhou, Yanhong; Zhou, Ming; Li, Xiaoling; Li, Yong; Li, Guiyuan; Xiong, Wei; Guo, Can			Epstein-Barr virus-encoded miR-BART6-3p inhibits cancer cell proliferation through the LOC553103-STMN1 axis	FASEB JOURNAL			English	Article						BART6-3p; Epstein-Barr virus; gastric cancer; nasopharyngeal carcinoma; Stathmin 1; tumor suppressor	NASOPHARYNGEAL CARCINOMA; EXPRESSION PROFILES; MICRORNA TARGETS; EMERGING ROLE; PROMOTES; STATHMIN; ROLES; METASTASIS; APOPTOSIS; RNA	Epstein-Barr virus (EBV) is a tumorigenic virus that can cause various human malignancies such as nasopharyngeal carcinoma (NPC) and gastric cancer (GC). EBV encodes 44 mature micro (mi)RNAs, mostly exhibiting oncogenic properties and promoting cancer progression. However, we have previously found that one EBV-encoded miRNA, namely EBV-miR-BART6-3p, acts as a tumor suppressor by inhibiting metastasis and invasion. Here, we report that EBV-miR-BART6-3p inhibits the proliferation of EBV-associated cancers, NPC, and GC, by targeting and downregulating a long non-coding RNA (lncRNA), LOC553103. Through proteomics analysis, we determined that stathmin (STMN1) is affected by EBV-miR-BART6-3p and LOC553103. Further, via RNA immunoprecipitation and luciferase reporter assay, we confirmed that LOC553103 directly binds and stabilizes the 3 ' UTR region of STMN1 mRNA. These results indicate that the EBV-miR-BART6-3p/LOC553103/STMN1 axis regulates the expression of cell cycle-associated proteins, which then inhibit EBV-associated tumor cell proliferation. These findings provide potential targets or strategies for novel EBV-related cancer treatments, as well as contributes new insights into the understanding of EBV infection-related carcinogenesis.	[Wang, Dan; Zeng, Zhaoyang; Xiong, Wei; Guo, Can] Cent South Univ, Xiangya Sch Med, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Wang, Dan; Zeng, Zhaoyang; Xiong, Wei; Guo, Can] Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Wang, Dan; Zeng, Zhaoyang; He, Baoyu; Wu, Yingfen; Li, Weimin; Tang, Le; Wei, Fang; Xiang, Bo; Li, Zheng; Zhou, Yanhong; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Xiong, Wei; Guo, Can] Cent South Univ, Canc Res Inst, Chinese Minist Educ, Key Lab Carcinogenesis & Canc Invas, Changsha, Peoples R China; [Wang, Dan; Zeng, Zhaoyang; He, Baoyu; Wu, Yingfen; Li, Weimin; Tang, Le; Wei, Fang; Xiang, Bo; Li, Zheng; Zhou, Yanhong; Zhou, Ming; Li, Xiaoling; Li, Guiyuan; Xiong, Wei; Guo, Can] Cent South Univ, Sch Basic Med Sci, Changsha, Peoples R China; [Zhang, Shanshan; Xiong, Fang] Cent South Univ, Xiangya Hosp, Dept Stomatol, Changsha, Peoples R China; [Xiang, Bo; Li, Zheng; Zhou, Yanhong; Xiong, Wei] Cent South Univ, Xiangya Hosp 3, Dis Genome Res Ctr, Hunan Key Lab Nonresolving Inflammat & Canc, Changsha, Peoples R China; [Li, Yong] Baylor Coll Med, Dept Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA	Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Baylor College of Medicine	Guo, C (corresponding author), Cent South Univ, Xiangya Sch Med, Hunan Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.; Guo, C (corresponding author), Cent South Univ, Xiangya Sch Med, Affiliated Canc Hosp, NHC Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China.	guocde@csu.edu.cn	li, xiao/GSN-6181-2022; li, xiaofeng/GXF-9442-2022	Li, Yong/0000-0001-8838-1714	National Natural Science Foundation of China [81972776, 81803025, 81903138, 81772928, 81872278, 81672993, 81702907, 81672683]; Overseas Expertise Introduction Project for Discipline Innovation [111-2-12]; Natural Science Foundation of Hunan Province [2017SK2105, 2018JJ3704, 2018JJ3815, 2018SK21210, 2018SK21211, 2019JJ50778]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Overseas Expertise Introduction Project for Discipline Innovation; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province)	the National Natural Science Foundation of China, Grant/Award Number: 81972776, 81803025, 81903138, 81772928, 81872278, 81672993, 81803025, 81702907 and 81672683; the Overseas Expertise Introduction Project for Discipline Innovation, Grant/Award Number: 111 Project,No. 111-2-12; the Natural Science Foundation of Hunan Province, Grant/Award Number: 2017SK2105, 2018JJ3704, 2018JJ3815, 2018SK21210, 2018SK21211 and 2019JJ50778	Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bellot G, 2007, CELL DEATH DIFFER, V14, P785, DOI 10.1038/sj.cdd.4402055; Bo H, 2018, J CANCER, V9, P4677, DOI 10.7150/jca.26461; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Choi H, 2013, J VIROL, V87, P8135, DOI 10.1128/JVI.03159-12; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Coqueret O, 2003, TRENDS CELL BIOL, V13, P65, DOI 10.1016/S0962-8924(02)00043-0; Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008; Duan SX, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0956-8; Fan CM, 2019, J CANCER, V10, P3926, DOI 10.7150/jca.31345; Fan CM, 2019, CARCINOGENESIS, V40, P380, DOI 10.1093/carcin/bgy143; Fan CM, 2018, J CANCER, V9, P2852, DOI 10.7150/jca.25460; Ge JS, 2020, J CANCER, V11, P932, DOI 10.7150/jca.33105; Guo QW, 2010, MOL IMMUNOL, V47, P1783, DOI 10.1016/j.molimm.2010.02.017; He BY, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.253; He RF, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0614-1; He Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0265-y; Hsu CY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003974; Jeon TY, 2010, BRIT J CANCER, V102, P710, DOI 10.1038/sj.bjc.6605537; Jiang XJ, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0928-4; Jin K, 2019, CELL MOL LIFE SCI, V76, P4275, DOI 10.1007/s00018-019-03222-1; Johnston CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040009; Kang D, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004979; Kim H, 2016, J VIROL, V90, P1359, DOI 10.1128/JVI.02794-15; Lian Y, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0918-9; Lu YJ, 2017, J INNATE IMMUN, V9, P574, DOI 10.1159/000479749; Lung RWM, 2013, INT J MOL SCI, V14, P17378, DOI 10.3390/ijms140917378; Maes E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061933; Mistry SJ, 2002, MT SINAI J MED, V69, P299; Mo YZ, 2019, J CANCER, V10, P3789, DOI 10.7150/jca.31166; Mo YZ, 2019, J CANCER, V10, P2342, DOI 10.7150/jca.30454; Ott M, 2009, CELL DEATH DIFFER, V16, P1075, DOI 10.1038/cdd.2009.61; Pandya D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136058; Peng M, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1055-6; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Ren DX, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1144-6; Rodriguez A, 2001, J VIROL, V75, P4482, DOI 10.1128/JVI.75.10.4482-4489.2001; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Shinozaki-Ushiku A, 2015, J VIROL, V89, P5581, DOI 10.1128/JVI.03639-14; Song YL, 2016, ONCOTARGET, V7, P36783, DOI 10.18632/oncotarget.9170; Su D, 2009, CANCER-AM CANCER SOC, V115, P2453, DOI 10.1002/cncr.24282; Tu CF, 2018, CARCINOGENESIS, V39, P1517, DOI 10.1093/carcin/bgy108; Tu CF, 2017, J VIROL, V91, DOI 10.1128/JVI.00301-17; Vereide DT, 2014, ONCOGENE, V33, P1258, DOI 10.1038/onc.2013.71; Vetter NS, 2017, MOL CANCER RES, V15, P953, DOI 10.1158/1541-7786.MCR-16-0372; Wan XX, 2015, ONCOL REP, V34, P2585, DOI 10.3892/or.2015.4237; Wang D, 2020, CELL MOL LIFE SCI, V77, P2949, DOI 10.1007/s00018-020-03469-z; Wang FW, 2019, J CLIN INVEST, V129, P727, DOI 10.1172/JCI122478; Wang J, 2019, J BIOL CHEM, V294, P4854, DOI 10.1074/jbc.RA118.006853; Wang WX, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00609; Wang YA, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0913-y; Wei F, 2019, J CANCER, V10, P1145, DOI 10.7150/jca.29049; Wei F, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0409-0; Wu P, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1147-3; Wu YF, 2019, J CANCER, V10, P2185, DOI 10.7150/jca.30222; Wu Y, 2014, CELL ONCOL, V37, P53, DOI 10.1007/s13402-013-0163-3; Xiao K, 2016, J CANCER, V7, P214, DOI 10.7150/jca.13150; Xiao L, 2019, CARCINOGENESIS, V40, P819, DOI 10.1093/carcin/bgz095; Xiong F, 2019, CHINESE MED J-PEKING, V132, P749, DOI 10.1097/CM9.0000000000000132; Yan QJ, 2015, ONCOTARGET, V6, P41766, DOI 10.18632/oncotarget.6155; Yang J, 2014, J PROTEOMICS, V109, P162, DOI 10.1016/j.jprot.2014.06.025; Zeng Z, 2016, CLIN TRANSL ONCOL, V18, P206, DOI 10.1007/s12094-015-1354-3; Zeng ZY, 2007, J CANCER RES CLIN, V133, P71, DOI 10.1007/s00432-006-0136-2; Zeng ZY, 2014, SCI CHINA LIFE SCI, V57, P315, DOI 10.1007/s11427-013-4577-y; Zhang YZ, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0796-y; Zhao J, 2020, CANCER LETT, V477, P131, DOI 10.1016/j.canlet.2020.02.010; Zheng X, 2018, J VIROL, V92, DOI 10.1128/JVI.01022-18; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8; Zhou BL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00575	70	31	34	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8012	8027		10.1096/fj.202000039RR	http://dx.doi.org/10.1096/fj.202000039RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32306460	Bronze			2022-12-26	WOS:000526960200001
J	Bever, CS; Adams, CA; Hnasko, RM; Cheng, LW; Stanker, LH				Bever, Candace S.; Adams, Catharine A.; Hnasko, Robert M.; Cheng, Luisa W.; Stanker, Larry H.			Lateral flow immunoassay (LFIA) for the detection of lethal amatoxins from mushrooms	PLOS ONE			English	Article							ALPHA-AMANITIN; PHALLOTOXIN CONCENTRATION; AMERICAN ASSOCIATION; BETA-AMANITIN; SPECIFICITY; ANTIBODY; TOXINS; ASSAY	The mushroom poison that causes the most deaths is the class of toxins known as amatoxins. Current methods to sensitively and selectively detect these toxins are limited by the need for expensive equipment, or they lack accuracy due to cross-reactivity with other chemicals found in mushrooms. In this work, we report the development of a competition-based lateral flow immunoassay (LFIA) for the rapid, portable, selective, and sensitive detection of amatoxins. Our assay clearly indicates the presence of 10 ng/mL of alpha-AMA or gamma-AMA and the method including extraction and detection can be completed in approximately 10 minutes. The test can be easily read by eye and has a presumed shelf-life of at least 1 year. From testing 110 wild mushrooms, the LFIA identified 6 out of 6 species that were known to contain amatoxins. Other poisonous mushrooms known not to contain amatoxins tested negative by LFIA. This LFIA can be used to quickly identify amatoxin-containing mushrooms.	[Bever, Candace S.; Cheng, Luisa W.; Stanker, Larry H.] USDA ARS, Foodborne Toxin Detect & Prevent Res Unit, Western Reg Res Ctr, Albany, CA 94710 USA; [Adams, Catharine A.] Univ Calif Berkeley, Plant & Microbial Biol Dept, Berkeley, CA 94720 USA; [Hnasko, Robert M.] ARS, Produce Safety & Microbiol Res Unit, Western Reg Res Ctr, USDA, Albany, CA USA	United States Department of Agriculture (USDA); University of California System; University of California Berkeley; United States Department of Agriculture (USDA)	Cheng, LW (corresponding author), USDA ARS, Foodborne Toxin Detect & Prevent Res Unit, Western Reg Res Ctr, Albany, CA 94710 USA.	luisa.cheng@usda.gov		Bever, Candace/0000-0001-6564-5924	United States Department of Agriculture, Agricultural Research Service [NP108, CRIS 2030-42000-049-00D]; USDA; University of California-Berkeley Chancellor's Fellowship	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); USDA(United States Department of Agriculture (USDA)); University of California-Berkeley Chancellor's Fellowship	This research was funded by the United States Department of Agriculture, Agricultural Research Service, National Program project NP108, CRIS 2030-42000-049-00D and the USDA's Innovation Fund Award. C.A.A was funded by the University of California-Berkeley Chancellor's Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuknesha RA, 2004, ANAL BIOANAL CHEM, V379, P853, DOI 10.1007/s00216-004-2663-5; ALAGOZLU H, 2002, TURK J MED SCI, V32, P39; ANDERSON G, 1991, CLIN CHEM, V37, P398; Bass David, 2011, Fungal Biology Reviews, V25, P159, DOI 10.1016/j.fbr.2011.10.003; Beuhler M, 2004, ANN EMERG MED, V44, P114, DOI 10.1016/j.annemergmed.2004.03.017; Bever CS, 2019, TOXINS, V11, DOI 10.3390/toxins11120724; Bever CS, 2018, TOXINS, V10, DOI 10.3390/toxins10070265; Brandenburg WE, 2018, MYCOLOGIA, V110, P637, DOI 10.1080/00275514.2018.1479561; Bruggemann O, 1996, J CHROMATOGR A, V744, P167, DOI 10.1016/0021-9673(96)00173-2; Buhlmann Laboratories A.G, 2013, AM ELISA PROD INS CA; Bunyard BA, 2015, FUNGI MAGAZINE, V8, P6; Cervellin G, 2018, HUM EXP TOXICOL, V37, P697, DOI 10.1177/0960327117730882; COSTANTINO D, 1978, INT J ARTIF ORGANS, V1, P257; Duffy T., 2008, TOXIC FUNGI W N AM; Enjalbert F, 2004, MYCOLOGIA, V96, P720, DOI 10.2307/3762106; ENJALBERT F, 1993, TOXICON, V31, P803, DOI 10.1016/0041-0101(93)90386-W; ENJALBERT F, 1992, J CHROMATOGR, V598, P227, DOI 10.1016/0021-9673(92)85052-U; Eren SH, 2010, CLINICS, V65, P491, DOI 10.1590/S1807-59322010000500006; FAULSTICH H, 1975, FEBS LETT, V56, P312, DOI 10.1016/0014-5793(75)81116-1; Filigenzi MS, 2007, J AGR FOOD CHEM, V55, P2784, DOI 10.1021/jf063194w; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Graeme KA, 2014, J MED TOXICOL, V10, P173, DOI 10.1007/s13181-013-0355-2; Gummin DD, 2018, CLIN TOXICOL, V56, P1213, DOI 10.1080/15563650.2018.1533727; Gummin DD, 2017, CLIN TOXICOL, V55, P1072, DOI 10.1080/15563650.2017.1388087; Hall A H, 1987, Pediatr Rev, V8, P291, DOI 10.1542/pir.8-10-291; Hallen HE, 2003, MYCOL RES, V107, P969, DOI 10.1017/S0953756203008190; Hallen HE, 2002, S AFR J BOT, V68, P322, DOI 10.1016/S0254-6299(15)30393-8; Hallen HE, 2007, P NATL ACAD SCI USA, V104, P19097, DOI 10.1073/pnas.0707340104; Harper KA, 2011, J FORENSIC SCI, V56, P1003, DOI 10.1111/j.1556-4029.2011.01739.x; He K, 2017, BIOLOGICALS, V49, P57, DOI 10.1016/j.biologicals.2017.06.008; He K, 2016, MICROCHIM ACTA, V183, P2211, DOI 10.1007/s00604-016-1856-x; Horowitz BZ, 2019, STATPEARLS; Jiang L, 2018, SE ASIAN J TROP MED, V49, P509; Kaya E, 2015, TOXICOL IND HEALTH, V31, P1172, DOI 10.1177/0748233713491809; Kaya E, 2013, TOXICON, V76, P225, DOI 10.1016/j.toxicon.2013.10.008; McKnight TA, 2010, MYCOLOGIA, V102, P763, DOI 10.3852/09-131; MEIXNER A, 1979, Zeitschrift fuer Mykologie, V45, P137; Morel S, 2016, CRYPTOGAMIE MYCOL, V37, P217, DOI 10.7872/crym/v37.iss2.2016.217; Mowry JB, 2016, CLIN TOXICOL, V54, P924, DOI 10.1080/15563650.2016.1245421; Pulman JA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3378-7; SEEGER R, 1984, Zeitschrift fuer Mykologie, V50, P353; Sgambelluri RM, 2014, TOXINS, V6, P2336, DOI 10.3390/toxins6082336; Walton J., 2018, CYCLIC PEPTIDE TOXIN; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WIELAND T, 1978, CRC CR REV BIOCH MOL, V5, P185, DOI 10.3109/10409237809149870; WIELAND T, 1959, PHARMACOL REV, V11, P87; Yilmaz I, 2014, TOXICON, V87, P68, DOI 10.1016/j.toxicon.2014.05.019; Zhang XY, 2016, FOOD ANAL METHOD, V9, P3278, DOI 10.1007/s12161-016-0509-3	48	21	22	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231781	10.1371/journal.pone.0231781	http://dx.doi.org/10.1371/journal.pone.0231781			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302363	Green Published, gold			2022-12-26	WOS:000536016100049
J	Nguyen, DM; Chen, LS; Jeng, G; Yu, WP; Chen, TY				Nguyen, Dung M.; Chen, Louisa S.; Jeng, Grace; Yu, Wei-Ping; Chen, Tsung-Yu			Cobalt ion interaction with TMEM16A calcium-activated chloride channel: Inhibition and potentiation	PLOS ONE			English	Article							INDEPENDENT ACTIVATION; DIVALENT-CATIONS; CRYO-EM; PROTEIN; EXPRESSION; MECHANISMS; ADSORPTION; PORES; CELLS; CLC-0	TMEM16A, a Ca2+-sensitive Cl- channel, plays key roles in many physiological functions related to Cl- transport across lipid membranes. Activation of this channel is mediated via binding intracellular Ca2+ to the channel with a relatively high apparent affinity, roughly in the sub-mu M to low mu M concentration range. Recently available high-resolution structures of TMEM16 molecules reveal that the high-affinity Ca2+ activation sites are formed by several acidic amino acids, using their negatively charged sidechain carboxylates to coordinate the bound Ca2+. In this study, we examine the interaction of TMEM16A with a divalent cation, Co2+, which by itself cannot activate current in TMEM16A. This divalent cation, however, has two effects when applied intracellularly. It inhibits the Ca2+-induced TMEM16A current by competing with Ca2+ for the aforementioned high-affinity activation sites. In addition, Co-2(+) also potentiates the Ca2+-induced current with a low affinity. This potentiation effect requires high concentration (mM) of Co2+, similar to our previous findings that high concentrations (mM) of intracellular Ca2+ ([Ca2+](i)) can induce more TMEM16A current after the Ca2+-activation sites are saturated by tens of mu M [Ca2+](i). The degrees of potentiation by Co2+ and Ca2+ also roughly correlate with each other. Interestingly, mutating a pore residue of TMEM16A, Y589, alters the degree of potentiation in that the smaller the sidechain of the replaced residue, the larger the potentiation induced by divalent cations. We suggest that the Co2+ potentiation and the Ca2+ potentiation share a similar mechanism by increasing Cl(-)flux through the channel pore, perhaps due to an increase of positive pore potential after the binding of divalent cations to phospholipids in the pore. A smaller sidechain of a pore residue may allow the pore to accommodate more phospholipids, thus enhancing the current potentiation caused by high concentrations of divalent cations.	[Nguyen, Dung M.; Chen, Louisa S.; Jeng, Grace; Yu, Wei-Ping; Chen, Tsung-Yu] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Chen, Tsung-Yu] Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Chen, TY (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.; Chen, TY (corresponding author), Univ Calif Davis, Dept Neurol, Davis, CA 95616 USA.	tycchen@ucdavis.edu			NIH [R01GM065447]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by an NIH grant R01GM065447. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvadia C, 2019, ELIFE, V8, DOI 10.7554/eLife.44365; Bethel NP, 2016, P NATL ACAD SCI USA, V113, P14049, DOI 10.1073/pnas.1607574113; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Castoldi E, 2011, BLOOD, V117, P4399, DOI 10.1182/blood-2011-01-332502; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; De Jesus-Perez JJ, 2018, BBA-MOL CELL BIOL L, V1863, P299, DOI 10.1016/j.bbalip.2017.12.009; Fallah G, 2010, MOL CELL PROTEOMICS, V10, pM110; Falzone ME, 2019, ELIFE, V8, DOI 10.7554/eLife.43229; Falzone ME, 2018, J GEN PHYSIOL, V150, P933, DOI 10.1085/jgp.201711957; Feng SJ, 2019, CELL REP, V28, P567, DOI 10.1016/j.celrep.2019.06.023; Ferrera L, 2009, J BIOL CHEM, V284, P33360, DOI 10.1074/jbc.M109.046607; Fischer H, 2010, AM J PHYSIOL-LUNG C, V299, pL585, DOI 10.1152/ajplung.00421.2009; Hahn AK, 2017, FASEB J, V31; Han YF, 2016, J BIOL CHEM, V291, P20345, DOI 10.1074/jbc.M116.750224; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Hwang SJ, 2009, J PHYSIOL-LONDON, V587, P4887, DOI 10.1113/jphysiol.2009.176198; Jeng G, 2016, J GEN PHYSIOL, V148, P393, DOI 10.1085/jgp.201611651; Jiang Tao, 2017, Elife, V6, DOI 10.7554/eLife.28671; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lam AKM, 2018, ELIFE, V7, DOI 10.7554/eLife.39122; LAU A, 1981, BIOCHIM BIOPHYS ACTA, V645, P279, DOI 10.1016/0005-2736(81)90199-1; Lim NK, 2016, J GEN PHYSIOL, V148, P375, DOI 10.1085/jgp.201611650; MCLAUGHLIN S, 1981, J GEN PHYSIOL, V77, P445, DOI 10.1085/jgp.77.4.445; Nguyen DM, 2019, J GEN PHYSIOL, V151, P518, DOI 10.1085/jgp.201812270; Ni Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086734p, DOI 10.1371/JOURNAL.PONE.0086734P]; OHKI S, 1981, BIOCHIM BIOPHYS ACTA, V645, P170, DOI 10.1016/0005-2736(81)90187-5; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Paulino C, 2017, ELIFE, V6, DOI 10.7554/eLife.26232; Pomorski TG, 2016, PROG LIPID RES, V64, P69, DOI 10.1016/j.plipres.2016.08.003; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Stephan AB, 2009, P NATL ACAD SCI USA, V106, P11776, DOI 10.1073/pnas.0903304106; Stohr H, 2009, J NEUROSCI, V29, P6809, DOI 10.1523/JNEUROSCI.5546-08.2009; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Tien J, 2014, ELIFE, V3, DOI 10.7554/eLife.02772; Whitlock JM, 2017, ANNU REV PHYSIOL, V79, P119, DOI 10.1146/annurev-physiol-022516-034031; Whitlock JM, 2016, PFLUG ARCH EUR J PHY, V468, P455, DOI 10.1007/s00424-015-1777-2; Xiao QH, 2011, P NATL ACAD SCI USA, V108, P8891, DOI 10.1073/pnas.1102147108; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Ye WL, 2018, P NATL ACAD SCI USA, V115, pE1667, DOI 10.1073/pnas.1718728115; Yu K, 2015, ELIFE, V4, DOI 10.7554/eLife.06901; Yu K, 2012, CIRC RES, V110, P990, DOI 10.1161/CIRCRESAHA.112.264440; Yu YW, 2014, J GEN PHYSIOL, V144, P113, DOI 10.1085/jgp.201411179; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3; Zhang XD, 2009, J GEN PHYSIOL, V133, P59, DOI 10.1085/jgp.200810005; Zhang XD, 2009, J GEN PHYSIOL, V133, P43, DOI 10.1085/jgp.200810004	49	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231812	10.1371/journal.pone.0231812	http://dx.doi.org/10.1371/journal.pone.0231812			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302365	gold, Green Published			2022-12-26	WOS:000536016100055
J	Abbas, HA; Hegazy, WAH				Abbas, Hisham A.; Hegazy, Wael A. H.			Repurposing anti-diabetic drug "Sitagliptin" as a novel virulence attenuating agent in Serratia marcescens	PLOS ONE			English	Article							QUORUM-SENSING SYSTEM; PSEUDOMONAS-AERUGINOSA; SWARMING MOTILITY; BIOSYNTHESIS; INHIBITION; PRODIGIOSIN; PLYMUTHICA; CARBAPENEM; FAMILY; RSMA	Background Serratia marcescens is an emerging pathogen that causes a variety of health care associated infections. S. marcescens is equipped with an arsenal of virulence factors such as biofilm formation, swimming and swarming motilities, prodigiosin, protease and others which enable it to initiate and cause the infection. These virulence factors are orchestrated under the umbrella of an intercellular communication system named Quorum sensing (QS). QS allows bacterial population to synchronize the expression of virulence genes upon detection of a chemical signaling molecule. Targeting bacterial virulence is a promising approach to attenuate bacteria and enhances the ability of immune system to eradicate the bacterial infection. Drug repurposing is an advantageous strategy that confers new applications for drugs outside the scope of their original medical use. This promising strategy offers the use of safe approved compounds, which potentially lowers the costs and shortens the time than that needed for development of new drugs. Sitagliptin is dipeptidyl peptidase-4 (DPP-4) inhibitor, is used to treat diabetes mellitus type II as it increases the production of insulin and decreasing the production of glucagon by the pancreas. We aimed in this study to repurpose sitagliptin, investigating the anti-virulence activities of sitagliptin on S. marcescens. Methods The effect of sub-inhibitory concentrations of sitagliptin on virulence factors; protease, prodigiosin, biofilm formation, swimming and swarming motilities was estimated phenotypically. The qRT-PCR was used to show the effect of sitagliptin on the expression of QS-regulated virulence genes. The in-vivo protective activity of sitagliptin on S. marcescens pathogenesis was evaluated on mice. Results Sitagliptin (1 mg/ml) significantly reduced the biofilm formation, swimming and swarming motilities, prodigiosin and protease. The qRT-PCR confirmed the effect on virulence as shown by down regulating the expression of fimA, fimC, flhC, flhD, bsmB, rssB, rsmA, pigP, and shlA genes. Moreover, the in-vivo findings showed the efficient ability of sitagliptin to weaken S. marcescens pathogenesis. Conclusion Sitagliptin is a promising anti-virulence agent against S. marcescens that may be beneficial in the control of healthcare associated infections caused by S. marcescens.	[Abbas, Hisham A.; Hegazy, Wael A. H.] Zagazig Univ, Dept Microbiol & Immunol, Fac Pharm, Zagazig, Egypt	Egyptian Knowledge Bank (EKB); Zagazig University	Hegazy, WAH (corresponding author), Zagazig Univ, Dept Microbiol & Immunol, Fac Pharm, Zagazig, Egypt.	waelmhegazy@daad-alumni.de	Hegazy, Wael/ABC-2263-2021; Hegazy, Wael/ABF-3684-2021	Hegazy, Wael/0000-0001-5683-4803				Abbas H.A., 2017, ROUM ARCH MICROBIOL, V76, P27; Abbas HA, 2020, CURR MICROBIOL, V77, P1051, DOI 10.1007/s00284-020-01909-4; Abraham SVPI, 2011, ARCH MED RES, V42, P658, DOI 10.1016/j.arcmed.2011.12.002; Adonizio A, 2008, ANTIMICROB AGENTS CH, V52, P198, DOI 10.1128/AAC.00612-07; Ahren B, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00376; Ang S, 2001, J BIOMED SCI, V8, P160, DOI 10.1159/000054028; Ball AS, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00105-17; Brothers KM, 2015, INFECT IMMUN, V83, P4373, DOI 10.1128/IAI.00466-15; Choo JH, 2006, LETT APPL MICROBIOL, V42, P637, DOI 10.1111/j.1472-765X.2006.01928.x; Coulthurst SJ, 2006, MICROBIOL-SGM, V152, P1899, DOI 10.1099/mic.0.28803-0; Cristina ML, 2019, INT J ENV RES PUBLIC, V16; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; ENGEBRECHT J, 1984, P NATL ACAD SCI-BIOL, V81, P4154, DOI 10.1073/pnas.81.13.4154; Feng LH, 2015, CELL, V160, P228, DOI 10.1016/j.cell.2014.11.051; Fu O, 2015, CHEMISTRYOPEN, V4, P463, DOI 10.1002/open.201402171; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gebreyohannes G, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02192; Hansen MR, 2015, BIOORGAN MED CHEM, V23, P1638, DOI 10.1016/j.bmc.2015.01.038; Hema M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00441; Horng YT, 2002, MOL MICROBIOL, V45, P1655, DOI 10.1046/j.1365-2958.2002.03117.x; Iguchi A, 2014, GENOME BIOL EVOL, V6, P2096, DOI 10.1093/gbe/evu160; Jones RN, 2010, CLIN INFECT DIS, V51, pS81, DOI 10.1086/653053; Kalia VC, 2011, CRIT REV MICROBIOL, V37, P121, DOI 10.3109/1040841X.2010.532479; Kim HS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08656; Lazzaro M, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13045; Liaw SJ, 2003, J MED MICROBIOL, V52, P19, DOI 10.1099/jmm.0.05024-0; Lin CS, 2016, SCI REP-UK, V6, DOI 10.1038/srep36747; MATSUYAMA T, 1992, J BACTERIOL, V174, P1769, DOI 10.1128/jb.174.6.1769-1776.1992; Memariani H, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2719-5; Mion S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02049; Nalca Y, 2006, ANTIMICROB AGENTS CH, V50, P1680, DOI 10.1128/AAC.50.5.1680-1688.2006; Nicholson WL, 2013, GENOME ANNOUNC, V1; Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168; Ramanathan S, 2018, ANTON LEEUW INT J G, V111, P501, DOI 10.1007/s10482-017-0971-y; Reboud E, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006579; Sakai-Kawada FE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01715; Salini R, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv038; Sarkar R, 2014, J ETHNOPHARMACOL, V154, P170, DOI 10.1016/j.jep.2014.03.067; Senwar KR, 2015, EUR J MED CHEM, V102, P413, DOI 10.1016/j.ejmech.2015.08.017; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shanks RMQ, 2016, CAN J MICROBIOL, V62, P83, DOI 10.1139/cjm-2015-0566; Slater H, 2003, MOL MICROBIOL, V47, P303, DOI 10.1046/j.1365-2958.2003.03295.x; Srinivasan R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00498; Stella NA, 2012, ADV MICROBIOL, V2; Stock I, 2003, J ANTIMICROB CHEMOTH, V51, P865, DOI 10.1093/jac/dkg156; Su LH, 2003, J CLIN MICROBIOL, V41, P4726, DOI 10.1128/JCM.41.10.4726-4732.2003; SWIFT S, 1993, MOL MICROBIOL, V10, P511, DOI 10.1111/j.1365-2958.1993.tb00923.x; Takayama Y, 2016, BIOTECHNOL BIOENG, V113, P2513, DOI 10.1002/bit.26013; Thomson NR, 2000, MOL MICROBIOL, V36, P539, DOI 10.1046/j.1365-2958.2000.01872.x; Traub WH, 2000, CHEMOTHERAPY, V46, P315, DOI 10.1159/000007304; Tsai YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024154; Tu KC, 2007, GENE DEV, V21, P221, DOI 10.1101/gad.1502407; Van Houdt R, 2007, FEMS MICROBIOL REV, V31, P407, DOI 10.1111/j.1574-6976.2007.00071.x; Van Houdt R, 2007, RES MICROBIOL, V158, P150, DOI 10.1016/j.resmic.2006.11.008; Wang WZ, 2008, ACTA BIOCH BIOPH SIN, V40, P1023, DOI 10.1111/j.1745-7270.2008.00490.x; Wei CF, 2017, BIOCHEM BIOPH RES CO, V489, P70, DOI 10.1016/j.bbrc.2017.05.077; Zhang B., 2018, MOLECULES, V23; Zhang DW, 2017, ULTRASON SONOCHEM, V36, P343, DOI 10.1016/j.ultsonch.2016.12.011	58	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231625	10.1371/journal.pone.0231625	http://dx.doi.org/10.1371/journal.pone.0231625			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298346	gold, Green Published			2022-12-26	WOS:000536011400076
J	Karstens, KF; Kempski, J; Giannou, AD; Freiwald, E; Reeh, M; Tachezy, M; Izbicki, JR; Lohse, AW; Gagliani, N; Huber, S; Pelczar, P				Karstens, Karl-Frederick; Kempski, Jan; Giannou, Anastasios D.; Freiwald, Erik; Reeh, Matthias; Tachezy, Michael; Izbicki, Jakob R.; Lohse, Ansgar W.; Gagliani, Nicola; Huber, Samuel; Pelczar, Penelope			Systemic interleukin 10 levels indicate advanced stages while interleukin 17A levels correlate with reduced survival in esophageal adenocarcinomas	PLOS ONE			English	Article							SQUAMOUS-CELL CANCER; REGULATORY T-CELLS; TUMOR PROGRESSION; GASTRIC-CANCER; SERUM LEVELS; TH17 CELLS; INFLAMMATION; IMMUNITY; MARKERS; IL-2	Introduction Reflux promotes esophageal adenocarcinomas (EAC) creating a chronic inflammatory environment. EAC show an increasing incidence in the Western World and median survival rates are still low. The main reasons for poor prognosis despite new multimodal therapies are diagnosis of EACs at an already advanced stage and distant metastases. Hence, we wanted to investigate the presence of systemic inflammatory interleukins (IL) and their impact on patient prognosis. Material and methods Systemic expression levels of pro- and anti-inflammatory markers (IL-2, IL-4, IL-6, IL-10, IL-17A and IL-22) in the sera of 43 EAC patients without neoadjuvant radiochemotherapy were measured by flow cytometric analysis. A correlation to clinicopathological data was performed. Log-rank and Cox regression analysis were used to investigate the impact on patient survival. 43 sera of age and gender matched healthy volunteers were used as controls. Results Increased systemic IL-6 (p = 0.044) and lower IL-17A (p = 0.002) levels were found in EAC patients as opposed to controls. A correlation of IL-10 levels with an increased T stage was found (p = 0.020). Also, systemic IL-10 levels were highly elevated in patients with distant metastasis (p<0.001). However, only systemic IL-17A levels had an influence on patient survival in multivariate analysis. Conclusion Systemic IL-6 levels are increased, while IL-17A levels are reduced in EAC patients compared to healthy controls. In addition, circulating IL-10 might help to identify patients with advanced disease and high IL-17A might indicate a limited prognosis.	[Karstens, Karl-Frederick; Reeh, Matthias; Tachezy, Michael; Izbicki, Jakob R.; Gagliani, Nicola] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Kempski, Jan; Giannou, Anastasios D.; Lohse, Ansgar W.; Gagliani, Nicola; Huber, Samuel; Pelczar, Penelope] Univ Med Ctr Hamburg Eppendorf, Sect Mol Immunol & Gastroenterol, Dept Med 1, Hamburg, Germany; [Freiwald, Erik] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany; [Gagliani, Nicola] Karolinska Inst, Immunol & Allergy Unit, Dept Med, Stockholm, Sweden; [Gagliani, Nicola] Univ Hosp, Stockholm, Sweden	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Karolinska Institutet	Huber, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Sect Mol Immunol & Gastroenterol, Dept Med 1, Hamburg, Germany.	shuber@uke.de	Tachezy, Michael/AAD-6759-2022; Reeh, Matthias/AAB-6917-2022	Gagliani, Nicola/0000-0001-8514-1395; Huber, Samuel/0000-0001-9325-8227; Karstens, Karl-Frederick/0000-0002-5070-874X				Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276; Blank S, 2013, LANGENBECK ARCH SURG, V398, P211, DOI 10.1007/s00423-012-1034-5; Blank S, 2017, ONCOTARGET, V8, P47518, DOI 10.18632/oncotarget.17671; Chen DY, 2012, CELL IMMUNOL, V272, P166, DOI 10.1016/j.cellimm.2011.10.015; Chen MF, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-26; Coleman HG, 2018, GASTROENTEROLOGY, V154, P390, DOI 10.1053/j.gastro.2017.07.046; Cook MB, 2019, GUT, V68, P960, DOI 10.1136/gutjnl-2018-316678; De Vita F, 2001, J INTERF CYTOK RES, V21, P45, DOI 10.1089/107999001459150; De Vita F, 1999, CANCER, V86, P1936, DOI 10.1002/(SICI)1097-0142(19991115)86:10<1936::AID-CNCR9>3.0.CO;2-9; Dvorakova K, 2004, CLIN CANCER RES, V10, P2020, DOI 10.1158/1078-0432.CCR-0437-03; Epplein M, 2013, CANCER CAUSE CONTROL, V24, P2245, DOI 10.1007/s10552-013-0284-z; Forones NM, 2001, HEPATO-GASTROENTEROL, V48, P1199; Gabitass RF, 2011, CANCER IMMUNOL IMMUN, V60, P1419, DOI 10.1007/s00262-011-1028-0; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hardikar S, 2014, CANCER EPIDEM BIOMAR, V23, P2393, DOI 10.1158/1055-9965.EPI-14-0384; Hattori Y, 2017, J GASTROINTEST DIG S, V7, P1, DOI [https:// doi. org/ 10.4172/ 2161- 069X. 1000531, DOI 10.4172/2161-069X.1000531]; Hodi FS, 2008, P NATL ACAD SCI USA, V105, P3005, DOI 10.1073/pnas.0712237105; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Hvid-Jensen F, 2011, NEW ENGL J MED, V365, P1375, DOI 10.1056/NEJMoa1103042; Ikeguchi M, 2009, GASTRIC CANCER, V12, P95, DOI 10.1007/s10120-009-0509-8; Jiang RQ, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-59; Karstens KF, 2020, CANCER IMMUNOL IMMUN, V69, P1043, DOI 10.1007/s00262-020-02517-8; Kono K, 2006, CANCER IMMUNOL IMMUN, V55, P1064, DOI 10.1007/s00262-005-0092-8; Kumari N, 2016, TUMOR BIOL, V37, P11553, DOI 10.1007/s13277-016-5098-7; Kurose K, 2015, CLIN CANCER RES, V21, P4327, DOI 10.1158/1078-0432.CCR-15-0357; Lippitz BE, 2013, LANCET ONCOL, V14, pE218, DOI 10.1016/S1470-2045(12)70582-X; Liu T, 2012, J CLIN IMMUNOL, V32, P1332, DOI 10.1007/s10875-012-9718-8; Long E, 2014, THER ADV GASTROENTER, V7, P247, DOI 10.1177/1756283X14538689; Lu L, 2016, ONCOTARGET, V7, P21853, DOI 10.18632/oncotarget.7869; Lukaszewicz-Zajac M, 2012, DIS ESOPHAGUS, V25, P242, DOI 10.1111/j.1442-2050.2011.01242.x; Mahmoodi M, 2008, EUR CYTOKINE NETW, V19, P92, DOI 10.1684/ecn.2008.0126; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Nelson BH, 2004, J IMMUNOL, V172, P3983, DOI 10.4049/jimmunol.172.7.3983; Orditura M, 2000, CANCER IMMUNOL IMMUN, V49, P530, DOI 10.1007/s002620000150; Park HS, 2005, DIABETES RES CLIN PR, V69, P29, DOI 10.1016/j.diabres.2004.11.007; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Ren ZG, 2001, J GASTROEN HEPATOL, V16, P142, DOI 10.1046/j.1440-1746.2001.02385.x; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Roviello G, 2017, IMMUNOTHERAPY-UK, V9, P25, DOI 10.2217/imt-2016-0107; Sanchez-Zauco N, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3310-9; Scheller J, 2006, SCAND J IMMUNOL, V63, P321, DOI 10.1111/j.1365-3083.2006.01750.x; Sindhu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133494; Song M, 2019, J GASTROEN HEPATOL, V34, P852, DOI 10.1111/jgh.14518; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Tong Q, 2018, ONCOTARGETS THER, V11, P5777, DOI 10.2147/OTT.S171242; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Vainer Noomi, 2018, Oncotarget, V9, P29820, DOI 10.18632/oncotarget.25661; Yan GQ, 2018, CELL MOL BIOL, V64, P94, DOI 10.14715/cmb/2018.64.6.16; Zhang HY, 2011, AM J PHYSIOL-GASTR L, V300, pG454, DOI 10.1152/ajpgi.00458.2010; Zhao S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139598; Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742	52	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231833	10.1371/journal.pone.0231833	http://dx.doi.org/10.1371/journal.pone.0231833			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298379	Green Published, gold			2022-12-26	WOS:000536011400116
J	Rimoldi, S; Torrecillas, S; Montero, D; Gini, E; Makol, A; Valdenegro, VV; Izquierdo, M; Terova, G				Rimoldi, Simona; Torrecillas, Silvia; Montero, Daniel; Gini, Elisabetta; Makol, Alex; Valdenegro, Victoria V.; Izquierdo, Marisol; Terova, Genciana			Assessment of dietary supplementation with galactomannan oligosaccharides and phytogenics on gut microbiota of European sea bass (Dicentrarchus Labrax) fed low fishmeal and fish oil based diet	PLOS ONE			English	Article							PLANT ESSENTIAL OILS; GROWTH-PERFORMANCE; MANNAN-OLIGOSACCHARIDES; FEED-UTILIZATION; INTESTINAL MICROBIOTA; IMMUNE-SYSTEM; HEALTH; PREBIOTICS; L.; AQUACULTURE	There is an increasing interest from the aquafeed industry in functional feeds containing selected additives that improve fish growth performance and health status. Functional feed additives include probiotics, prebiotics, organic acids, and phytogenics (substances derived from plants and their extracts). This study evaluated the effects of dietary inclusion of a mucilage extract rich in galactomannan oligosaccharides (GMOS), a mixture of garlic and labiatae-plants oils (PHYTO), and a combination of them (GMOSPHYTO), on gut microbiota composition of European sea bass (Dicentrarchus labrax) fed with a low fishmeal (FM) and fish oil (FO) diet. Three experimental diets and a control diet (plant-based formulation with 10% FM and 6% FO) were tested in a 63-days feeding trial. To analyze the microbiota associated to feeds and the intestinal autochthonous (mucosa-adhered) and allochthonous (transient) microbial communities, the Illumina MiSeq platform for sequencing of 16S rRNA gene and QIIME2 pipeline were used. Metabarcoding analysis of feed-associated bacteria showed that the microbial communities of control (CTRL) feed deeply differed from those of experimental diets. The number of reads was significantly lower in CTRL feed than in other feeds. The OTU (operational taxonomic unit) number was instead similar between the feeds, ranging from 42 to 50 OTUs. The variation of resident gut microbiota induced by diet was lower than the variation of transient intestinal microbiota, because feedstuffs are a major source of allochthonous bacteria, which can temporarily integrate into the gut transient microbiome. However, the composition of transient bacterial communities was not simply a mirror of feed-borne bacteria. Indeed, the microbial profile of feeds was different from both faecal and mucosa profiles. Our findings suggest that the dietary inclusion of GMOS (0.5%) and PHYTO (0.02%) in a low FM and FO diet induces changes in gut microbiota composition of European sea bass. However, if on allochthonous microbiota the combined inclusion of GMOS and PHYTO showed an antagonistic effect on bactericidal activity against Vibrionales, at mucosa level, only GMOSPHYTO diet increased the relative abundance of Bacteroidales, Lactobacillales, and Clostridiales resident bacterial orders. The main beneficial effects of GMOS and PHYTO on gut microbiota are the reduction of coliforms and Vibrionales bacteria, which include several potentially pathogenic species for fish, and the enrichment of gut microbiota composition with butyrate producer taxa. Therefore, these functional ingredients have a great potential to be used as health-promoting agents in the farming of European sea bass and other marine fish.	[Rimoldi, Simona; Gini, Elisabetta; Terova, Genciana] Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy; [Torrecillas, Silvia; Montero, Daniel; Izquierdo, Marisol] Univ Las Palmas Gran Canaria, IU ECOAQUA, GIA, Las Palmas Gran Canaria, Canary Islands, Spain; [Makol, Alex] Delacon Biotech GmbH, Steyregg, Austria; [Valdenegro, Victoria V.] BioMar AS, Trondheim, Norway	University of Insubria; Universidad de Las Palmas de Gran Canaria	Terova, G (corresponding author), Univ Insubria, Dept Biotechnol & Life Sci, Varese, Italy.	genciana.terova@uninsubria.it	montero, daniel/O-7108-2015; Terova, Genciana/AAL-6412-2021; montero, daniel/ABE-3894-2020; Torrecillas, Silvia/F-5378-2016	montero, daniel/0000-0002-4358-2157; Terova, Genciana/0000-0002-7532-7951; Izquierdo, Marisol/0000-0003-3583-6660; Rimoldi, Simona/0000-0002-1995-263X; Marisol, Izquierdo/0000-0003-4297-210X; Torrecillas, Silvia/0000-0003-2823-9999	Italian AGER project Fine Feed for Fish (4F) [2016-01-01]; Spanish Government [AGL2016-79725-P]; Spanish Ministry of Economy, Industry and Competitiveness [IJCI-2015-25748]	Italian AGER project Fine Feed for Fish (4F); Spanish Government(Spanish GovernmentEuropean Commission); Spanish Ministry of Economy, Industry and Competitiveness	GT received an award from the Italian AGER project Fine Feed for Fish (4F), Rif. No. 2016-01-01 (https://acquacoltura.progettoager.it) DM, and ST received an award by Spanish Government through the specific program "Subprograma Estatal de Generacion de Conocimiento, en el marco del Plan Estatal de Investigacion Cientifica y Tecnica y de Innovacion 2013-2016" by the PROINMUNOIL PLUS (AGL2016-79725-P) project: "Functional diets for marine raw materials replacement: boosting the fish disease resistance through epithelial barriers reinforcement and immunization tools". ST received complementary funding from the Spanish Ministry of Economy, Industry and Competitiveness, though the "Subprogama Juan de la Cierva-Incoproracion. Convocatoria 2015. IJCI-2015-25748. The funders had no role in study design, data collection and analysis, decision to publish, and preparation of the the manuscript. Special thanks to Delacon Biotechnik GmbH and to BioMar A/S, which provided the functional products and diets, and support in the form of salaries for authors Alex Makol and Victoria Valdenegro, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Sagheer AA, 2018, AQUACULT NUTR, V24, P1006, DOI 10.1111/anu.12637; Ankri S, 1999, MICROBES INFECT, V1, P125, DOI 10.1016/S1286-4579(99)80003-3; Apper E, 2016, AQUACULTURE, V453, P40, DOI 10.1016/j.aquaculture.2015.11.018; Awad E, 2015, FISH SHELLFISH IMMUN, V45, P454, DOI 10.1016/j.fsi.2015.04.035; Benedito-Palos L, 2008, BRIT J NUTR, V100, P992, DOI 10.1017/S0007114508966071; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bonder MJ, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0295-y; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Butt RL, 2019, FRONT ENDOCRINOL, P10, DOI [10.3389/fendo.2019.0000930733706, DOI 10.3389/FEND0.2019.00009]; Buyukdeveci ME, 2018, AQUACULTURE, V486, P170, DOI 10.1016/j.aquaculture.2017.12.022; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Carda-Dieguez M, 2014, FEMS MICROBIOL ECOL, V87, P451, DOI 10.1111/1574-6941.12236; Chakraborty SB, 2014, REV AQUACULT, V6, P1, DOI 10.1111/raq.12021; Cho JH, 2014, LIVEST SCI, V160, P82, DOI 10.1016/j.livsci.2013.11.006; da Cunha JA, 2018, J APPL MICROBIOL, V125, P328, DOI 10.1111/jam.13911; Dawood MAO, 2018, REV AQUACULT, V10, P950, DOI 10.1111/raq.12209; Dimitroglou A, 2009, J ANIM SCI, V87, P3226, DOI 10.2527/jas.2008-1428; Dimitroglou A, 2011, FISH SHELLFISH IMMUN, V30, P1, DOI 10.1016/j.fsi.2010.08.009; Dimitroglou A, 2010, AQUACULTURE, V300, P182, DOI 10.1016/j.aquaculture.2010.01.015; Encarnacao P, 2016, AQUAFEED FORMULATION, P217, DOI 10.1016/B978-0-12-800873-7.00005-1; Esquivel-Elizondo S, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00051-17; FAO, 2018, WORLD FISH AQ; Ferreira-Halder CV, 2017, BEST PRACT RES CL GA, V31, P643, DOI 10.1016/j.bpg.2017.09.011; Franciosini MP, 2016, J APPL ANIM RES, V44, P474, DOI 10.1080/09712119.2015.1091322; Francis G, 2001, AQUACULTURE, V199, P197, DOI 10.1016/S0044-8486(01)00526-9; Gatesoupe FJ, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0885-2; Giannenas I, 2012, AQUACULTURE, V350, P26, DOI 10.1016/j.aquaculture.2012.04.027; Giannenas I., 2013, MED AROMAT PLANTS, V2, P2167, DOI DOI 10.4172/2167-0412.1000140; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Goncalves AT, 2017, J APPL MICROBIOL, V122, P1333, DOI 10.1111/jam.13437; Grisdale-Helland B, 2008, AQUACULTURE, V283, P163, DOI 10.1016/j.aquaculture.2008.07.012; Guardiola FA, 2017, FISH SHELLFISH IMMUN, V65, P169, DOI 10.1016/j.fsi.2017.04.014; Guerreiro I, 2018, AQUACULT NUTR, V24, P153, DOI 10.1111/anu.12543; Guerreiro I, 2018, REV AQUACULT, V10, P800, DOI 10.1111/raq.12201; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harikrishnan R, 2011, AQUACULTURE, V317, P1, DOI 10.1016/j.aquaculture.2011.03.039; Helander IM, 1998, J AGR FOOD CHEM, V46, P3590, DOI 10.1021/jf980154m; Husnu K., 2007, FLAVOURS FRAGRANCES, P43, DOI [10.1007/978-3-540-49339-6_4, DOI 10.1007/9783-54049339-6_, 10.1007/978-3-540-49339-6_4/COVER, DOI 10.1007/978-3-540-49339-6_4/COVER]; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Kim SK, 2012, ADV FOOD NUTR RES, V65, P353, DOI 10.1016/B978-0-12-416003-3.00023-8; Krogdahl A, 2010, AQUAC RES, V41, P333, DOI 10.1111/j.1365-2109.2009.02426.x; Kyu-Song S, 2014, FISH SHELLFISH IMMUN, V40, P40, DOI 10.1016/j.fsi.2014.06.016; Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760; Levy-Pereira N, 2018, REV BRAS ZOOTECN, V47, DOI [10.1590/rbz472010006, 10.1590/rbz4720170006]; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Mountzouris KC, 2011, ANIM FEED SCI TECH, V168, P223, DOI 10.1016/j.anifeedsci.2011.03.020; Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451; Overland M, 2009, AQUACULTURE, V288, P305, DOI 10.1016/j.aquaculture.2008.12.012; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Ran C, 2016, J NUTR, V146, P1132, DOI 10.3945/jn.115.229377; Reverter M, 2014, AQUACULTURE, V433, P50, DOI 10.1016/j.aquaculture.2014.05.048; Rimoldi S, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9040143; Rimoldi S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193652; Rimoldi Simona, 2016, Fisheries and Aquatic Sciences, V19, P40, DOI 10.1186/s41240-016-0041-9; Ringo E, 1998, AQUACULTURE, V160, P177, DOI 10.1016/S0044-8486(97)00299-8; Ringo E., 1995, Aquaculture Research, V26, P773, DOI 10.1111/j.1365-2109.1995.tb00870.x; Ringo E, 2010, AQUACULT NUTR, V16, P117, DOI 10.1111/j.1365-2095.2009.00731.x; Ringo E, 2007, AQUACULTURE, V268, P251, DOI 10.1016/j.aquaculture.2007.04.047; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shepherd CJ, 2013, J FISH BIOL, V83, P1046, DOI 10.1111/jfb.12224; Shtriker MG, 2018, NUTRITION, V46, P134, DOI 10.1016/j.nut.2017.07.012; Spring P, 2000, POULTRY SCI, V79, P205, DOI 10.1093/ps/79.2.205; Stevanovic ZD, 2018, MOLECULES, V23, DOI 10.3390/molecules23071717; Sutili FJ, 2015, J APPL MICROBIOL, V119, P47, DOI 10.1111/jam.12812; Sutili FJ, 2018, REV AQUACULT, V10, P716, DOI 10.1111/raq.12197; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Terova G, 2019, REV FISH BIOL FISHER, V29, P465, DOI 10.1007/s11160-019-09558-y; Terova G, 2009, COMP BIOCHEM PHYS B, V153, P372, DOI 10.1016/j.cbpb.2009.04.008; Torrecillas S, 2007, FISH SHELLFISH IMMUN, V23, P969, DOI 10.1016/j.fsi.2007.03.007; Torrecillas S, 2018, FISH SHELLFISH IMMUN, V81, P10, DOI 10.1016/j.fsi.2018.07.007; Torrecillas S, 2017, AQUACULTURE, V468, P386, DOI 10.1016/j.aquaculture.2016.11.005; Torrecillas S, 2016, AQUACULT NUTR, V22, P1079, DOI 10.1111/anu.12322; Torrecillas S, 2012, J FISH DIS, V35, P591, DOI 10.1111/j.1365-2761.2012.01384.x; Torrecillas S, 2011, AQUACULT NUTR, V17, P223, DOI 10.1111/j.1365-2095.2009.00730.x; Torrecillas S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222063; Torrecillas S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00397; Torrecillas S, 2015, FISH SHELLFISH IMMUN, V42, P508, DOI 10.1016/j.fsi.2014.11.033; Torrecillas S, 2014, FISH SHELLFISH IMMUN, V36, P525, DOI 10.1016/j.fsi.2013.12.029; Torrecillas S, 2013, FISH SHELLFISH IMMUN, V34, P1485, DOI 10.1016/j.fsi.2013.03.351; Walker AW, 2011, ISME J, V5, P220, DOI 10.1038/ISMEJ.2010.118; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu SG, 2010, AQUACULTURE, V303, P1, DOI 10.1016/j.aquaculture.2009.12.025; Zaki MA, 2012, APCBEE PROC, V4, P220, DOI 10.1016/j.apcbee.2012.11.037; Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4; Zeng ZK, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0004-5; Zhou QC, 2010, AQUACULTURE, V309, P253, DOI 10.1016/j.aquaculture.2010.09.003	88	36	37	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231494	10.1371/journal.pone.0231494	http://dx.doi.org/10.1371/journal.pone.0231494			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298317	Green Published, gold			2022-12-26	WOS:000536011400053
J	Faulk, KE; Anderson-Mellies, A; Cockburn, M; Green, AL				Faulk, Kelly E.; Anderson-Mellies, Amy; Cockburn, Myles; Green, Adam L.			Assessment of enrollment characteristics for Children's Oncology Group (COG) upfront therapeutic clinical trials 2004-2015	PLOS ONE			English	Article							ACUTE-LYMPHOBLASTIC-LEUKEMIA; YOUNG-ADULTS; CHILDHOOD-CANCER; ADOLESCENTS; SURVIVAL; PARTICIPATION; AGE; BARRIERS; PROTOCOLS; PATTERNS	Background Improvements in pediatric cancer survival are attributed to cooperative clinical trials. Under-representation of specific demographic groups has been described in adult and pediatric cancer trials and poses a threat to the generalizability of results. An evaluation of data provided by the Children's Oncology Group (COG) of upfront trial enrollment for US patients 0 to 29 years old between 2004 and 2015 was performed. Methods US cancer cases were estimated using incidence data and US population estimates from the Surveillance, Epidemiology, and End Results Program and compared to observed COG cases. Percent enrollment and standardized ratios of enrollment were calculated across demographic, disease, and socioeconomic groups. The COG website was utilized to quantify available trials and assess age eligibility. Results 19.9% of estimated US cancer patients age 0 to 19 years enrolled on COG trials. Younger patients were more represented across diseases and races/ethnicities. Patients with hematologic malignancies were more represented compared to solid and central nervous system (CNS) tumors. Conclusion COG trial enrollment rates are declining when compared to previously published data, potentially from challenges in pediatric drug development, difficulty designing feasible trials for highly curable diagnoses, and issues ensuring trial availability for the heterogeneous group of solid and CNS tumors. Though racial/ethnic groups and county-level socioeconomic factors were proportionally represented, under representation of the adolescent/ young adult (AYA) population and younger patients with solid and CNS tumors remains a concern. Targeted efforts should focus on these subgroups and further research should evaluate AYA enrollment rates across all available trials.	[Faulk, Kelly E.; Green, Adam L.] Univ Colorado, Sch Med, Dept Pediat, Ctr Canc & Blood Disorders, Aurora, CO 80045 USA; [Faulk, Kelly E.; Green, Adam L.] Univ Colorado, Childrens Hosp Colorado, Aurora, CO 80045 USA; [Anderson-Mellies, Amy; Cockburn, Myles; Green, Adam L.] Univ Colorado, Comprehens Canc Ctr, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Faulk, KE (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Ctr Canc & Blood Disorders, Aurora, CO 80045 USA.; Faulk, KE (corresponding author), Univ Colorado, Childrens Hosp Colorado, Aurora, CO 80045 USA.	Kelly.Faulk@childrenscolorado.org			Population Health Shared Resource of the University of Colorado Cancer Center - National Cancer Institute at the National Institutes of Health [P30CA046934]	Population Health Shared Resource of the University of Colorado Cancer Center - National Cancer Institute at the National Institutes of Health	This work was supported in part by the Population Health Shared Resource of the University of Colorado Cancer Center funded by the National Cancer Institute at the National Institutes of Health (P30CA046934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aristizabal P, 2015, PEDIATR BLOOD CANCER, V62, P1337, DOI 10.1002/pbc.25472; Bhatia S, 2002, BLOOD, V100, P1957, DOI 10.1182/blood-2002-02-0395; Bleyer A, 2005, CANCER-AM CANCER SOC, V103, P1891, DOI 10.1002/cncr.20995; Bleyer A, 2006, CANCER-AM CANCER SOC, V107, P1645, DOI 10.1002/cncr.22102; Bleyer WA, 1997, J PEDIAT HEMATOL ONC, V19, P423, DOI 10.1097/00043426-199709000-00003; Boissel N, 2003, J CLIN ONCOL, V21, P774, DOI 10.1200/JCO.2003.02.053; Buchanan ND, 2014, PEDIATRICS, V133, pS123, DOI 10.1542/peds.2014-0122I; Burke ME, 2007, CANCER-AM CANCER SOC, V110, P2385, DOI 10.1002/cncr.23060; Chuk MK, 2017, CLIN CANCER RES, V23, P9, DOI 10.1158/1078-0432.CCR-16-1367; Collins CL, 2015, CANCER-AM CANCER SOC, V121, P4398, DOI 10.1002/cncr.29669; Delavar A, 2018, CANCER; Downs-Canner S, 2009, J PEDIAT HEMATOL ONC, V31, P927, DOI 10.1097/MPH.0b013e3181b91180; Felgenhauer J, 2014, PEDIATRICS, V133, pS119, DOI 10.1542/peds.2014-0122H; Ford JG, 2008, CANCER, V112, P228, DOI 10.1002/cncr.23157; Hallbook H, 2006, CANCER-AM CANCER SOC, V107, P1551, DOI 10.1002/cncr.22189; Hunger SP, 2012, J CLIN ONCOL, V30, P1663, DOI 10.1200/JCO.2011.37.8018; Jacob SA, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26638; Linabery AM, 2008, CANCER-AM CANCER SOC, V113, P2575, DOI 10.1002/cncr.23866; Lund MJ, 2009, CANCER-AM CANCER SOC, V115, P3808, DOI 10.1002/cncr.24437; Moke DJ, 2018, PEDIATR BLOOD CANCER, V65, DOI 10.1002/pbc.26788; Murthy VH, 2004, JAMA-J AM MED ASSOC, V291, P2720, DOI 10.1001/jama.291.22.2720; National Cancer Institute LYAA, 2006, CLOS GAP RES CAR IMP; Nooka AK, 2016, CANCER-AM CANCER SOC, V122, P3207, DOI 10.1002/cncr.30090; Parsons HM, 2015, J ADOLESC YOUNG ADUL, V4, P141, DOI 10.1089/jayao.2014.0041; Parsons HM, 2011, J CLIN ONCOL, V29, P4045, DOI 10.1200/JCO.2011.36.2954; Ramanujachar R, 2007, PEDIATR BLOOD CANCER, V48, P254, DOI 10.1002/PBC.20749; Shaw PH, 2007, J PEDIAT HEMATOL ONC, V29, P811, DOI 10.1097/MPH.0b013e31815814f3; Shaw PH, 2012, CANCER-AM CANCER SOC, V118, P3614, DOI 10.1002/cncr.26634; Shochat SJ, 2001, CA-CANCER J CLIN, V51, P119, DOI 10.3322/canjclin.51.2.119; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; STILLER CA, 1994, ARCH DIS CHILD, V70, P219, DOI 10.1136/adc.70.3.219; STILLER CA, 1989, ARCH DIS CHILD, V64, P657, DOI 10.1136/adc.64.5.657; Stiller CA, 1999, ARCH DIS CHILD, V81, P202, DOI 10.1136/adc.81.3.202; Stock W, 2008, BLOOD, V112, P1646, DOI 10.1182/blood-2008-01-130237; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT POP TO; Surveillance Epidemiology and End Results (SEER) Program, 2017, SEER STAT DAT INC SE; Tejeda HA, 1996, J NATL CANCER I, V88, P812, DOI 10.1093/jnci/88.12.812; Tercyak KP, 2006, J PEDIATR PSYCHOL, V31, P252, DOI 10.1093/jpepsy/jsj013; Ward E, 2014, CA-CANCER J CLIN, V64, P83, DOI 10.3322/caac.21219	39	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0230824	10.1371/journal.pone.0230824	http://dx.doi.org/10.1371/journal.pone.0230824			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324751	Green Published, gold			2022-12-26	WOS:000536033700007
J	Laschinger, M; Wang, Y; Holzmann, G; Wang, BC; Stoss, C; Lu, M; Brugger, M; Schneider, A; Knolle, P; Wohlleber, D; Schulze, S; Steiger, K; Tsujikawa, K; Altmayr, F; Friess, H; Hartmann, D; Huser, N; Holzmann, B				Laschinger, Melanie; Wang, Yang; Holzmann, Gabriela; Wang, Baocai; Stoess, Christian; Lu, Miao; Brugger, Marcus; Schneider, Annika; Knolle, Percy; Wohlleber, Dirk; Schulze, Sarah; Steiger, Katja; Tsujikawa, Kazutake; Altmayr, Felicitas; Friess, Helmut; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard			The CGRP receptor component RAMP1 links sensory innervation with YAP activity in the regenerating liver	FASEB JOURNAL			English	Article						CGRP; liver regeneration; RAMP1; sensory innervation; YAP; TAZ	GENE-RELATED PEPTIDE; HIPPO PATHWAY; HEPATOCYTE PROLIFERATION; IMMUNE-RESPONSES; PHOSPHORYLATION; ADRENOMEDULLIN; SURGERY; SIZE; TAZ	The effectiveness of liver regeneration limits surgical therapies of hepatic disorders and determines patient outcome. Here, we investigated the role of the neuropeptide calcitonin gene-related peptide (CGRP) for liver regeneration after acute or chronic injury. Mice deficient for the CGRP receptor component receptor activity-modifying protein 1 (RAMP1) were subjected to a 70% partial hepatectomy or repeated intraperitoneal injections of carbon tetrachloride. RAMP1 deficiency severely impaired recovery of organ mass and hepatocyte proliferation after both acute and chronic liver injury. Mechanistically, protein expression of the transcriptional coactivators Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) was decreased in regenerating livers of RAMP1-deficient mice. Lack of RAMP1 was associated with hyperphosphorylation of YAP on Ser127 and Ser397, which regulates YAP functional activity and protein levels. Consequently, expression of various YAP-controlled cell cycle regulators and hepatocyte proliferation were severely reduced in the absence of RAMP1. In vitro, CGRP treatment caused increased YAP protein expression and a concomitant decline of YAP phosphorylation in liver tissue slice cultures of mouse and human origin and in primary human hepatocytes. Thus, our results indicate that sensory nerves represent a crucial control element of liver regeneration after acute and chronic injury acting through the CGRP-RAMP1 pathway, which stimulates YAP/TAZ expression and activity.	[Laschinger, Melanie; Wang, Yang; Holzmann, Gabriela; Wang, Baocai; Stoess, Christian; Lu, Miao; Schulze, Sarah; Altmayr, Felicitas; Friess, Helmut; Hartmann, Daniel; Hueser, Norbert; Holzmann, Bernhard] Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany; [Brugger, Marcus; Schneider, Annika; Knolle, Percy; Wohlleber, Dirk] Tech Univ Munich, Sch Med, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Steiger, Katja] Tech Univ Munich, Sch Med, Inst Pathol, Munich, Germany; [Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Osaka, Japan	Technical University of Munich; Technical University of Munich; Technical University of Munich; Osaka University	Holzmann, B (corresponding author), Tech Univ Munich, Sch Med, Dept Surg, Ismaninger Str 22, D-81675 Munich, Germany.	bernhard.holzmann@tum.de	Wohlleber, Dirk/J-2549-2017	Wohlleber, Dirk/0000-0003-3861-5150; Stoess, Christian/0000-0002-0682-8808	China Scholarship Council; PhD program "Translational Medicine" of the School of Medicine, Technical University of Munich	China Scholarship Council(China Scholarship Council); PhD program "Translational Medicine" of the School of Medicine, Technical University of Munich	The authors would like to thank Silke Hegenbarth (Technical University of Munich, School of Medicine, Institute of Molecular Immunology & Experimental Oncology) for excellent technical support during the isolation of primary human hepatocytes. Y. W., BW, and ML were supported by the China Scholarship Council. This work was supported in part by a grant from the PhD program "Translational Medicine" of the School of Medicine, Technical University of Munich, to CS	Alison MR, 2016, J PATHOL, V238, P371, DOI 10.1002/path.4667; Apte U, 2009, HEPATOLOGY, V50, P844, DOI 10.1002/hep.23059; Berthoud HR, 2004, ANAT REC PART A, V280A, P827, DOI 10.1002/ar.a.20088; Booe JM, 2015, MOL CELL, V58, P1040, DOI 10.1016/j.molcel.2015.04.018; BRACQ S, 1994, FEBS LETT, V351, P63, DOI 10.1016/0014-5793(94)00823-X; Clavien P, 2007, NEW ENGL J MED, V356, P1545, DOI 10.1056/NEJMra065156; Clavien PA, 2010, HEPATOLOGY, V52, P715, DOI 10.1002/hep.23713; de Graaf IAM, 2010, NAT PROTOC, V5, P1540, DOI 10.1038/nprot.2010.111; Di Agostino S, 2016, EMBO REP, V17, P188, DOI 10.15252/embr.201540488; Ehmer U, 2014, CELL REP, V8, P370, DOI 10.1016/j.celrep.2014.06.025; Evans BN, 2000, J BIOL CHEM, V275, P31438, DOI 10.1074/jbc.M005604200; Fausto N, 2012, J HEPATOL, V57, P692, DOI 10.1016/j.jhep.2012.04.016; Gingell JJ, 2019, TRENDS PHARMACOL SCI, V40, P71, DOI 10.1016/j.tips.2018.11.005; Glaser SS, 2007, LAB INVEST, V87, P914, DOI 10.1038/labinvest.3700602; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Holzmann B, 2013, CURR PROTEIN PEPT SC, V14, P268, DOI 10.2174/13892037113149990046; Holzmann B, 2013, AMINO ACIDS, V45, P1, DOI 10.1007/s00726-011-1161-2; Hwang ISS, 2006, REGUL PEPTIDES, V135, P69, DOI 10.1016/j.regpep.2006.04.006; Kawanami Y, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-8; Kim AR, 2019, FASEB J, V33, P5914, DOI 10.1096/fj.201801256RR; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; Li JW, 2011, J GENET, V90, P435; Liu B, 2010, HEPATOLOGY, V52, P1060, DOI 10.1002/hep.23794; Loforese G, 2017, EMBO MOL MED, V9, P46, DOI 10.15252/emmm.201506089; Lu L, 2018, EXP MOL MED, V50, DOI 10.1038/emm.2017.205; Michalopoulos GK, 2017, HEPATOLOGY, V65, P1384, DOI 10.1002/hep.28988; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mitchell C, 2008, NAT PROTOC, V3, P1167, DOI 10.1038/nprot.2008.80; Mizutani T, 2013, J SURG RES, V183, P138, DOI 10.1016/j.jss.2012.11.028; Ouwens DM, 2002, EMBO J, V21, P3782, DOI 10.1093/emboj/cdf361; Patel SH, 2017, GASTROENTEROLOGY, V152, P533, DOI 10.1053/j.gastro.2016.10.047; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Riehle KJ, 2008, J EXP MED, V205, P91, DOI 10.1084/jem.20070820; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Russell FA, 2014, PHYSIOL REV, V94, P1099, DOI 10.1152/physrev.00034.2013; Scholten D, 2015, LAB ANIM-UK, V49, P4, DOI 10.1177/0023677215571192; Swiderska-Syn M, 2016, HEPATOLOGY, V64, P232, DOI 10.1002/hep.28542; Tsujikawa K, 2007, P NATL ACAD SCI USA, V104, P16702, DOI 10.1073/pnas.0705974104; Walker CS, 2010, TRENDS PHARMACOL SCI, V31, P476, DOI 10.1016/j.tips.2010.06.006; Wan Y, 2019, LAB INVEST, V99, P764, DOI 10.1038/s41374-018-0178-5; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	45	5	5	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8125	8138		10.1096/fj.201903200R	http://dx.doi.org/10.1096/fj.201903200R		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329113	hybrid, Green Published			2022-12-26	WOS:000529446600001
J	Norenberg, D; Schmidt, F; Schinke, K; Frenzel, T; Pietsch, H; Giese, A; Ertl-Wagner, B; Levin, J				Noerenberg, Dominik; Schmidt, Felix; Schinke, Karin; Frenzel, Thomas; Pietsch, Hubertus; Giese, Armin; Ertl-Wagner, Birgit; Levin, Johannes			Investigation of potential adverse central nervous system effects after long term oral administration of gadolinium in mice	PLOS ONE			English	Article							T1-WEIGHTED MR-IMAGES; HIGH SIGNAL INTENSITY; DENTATE NUCLEUS; CONTRAST AGENTS; GLOBUS-PALLIDUS; ANTHROPOGENIC GADOLINIUM; PROGRESSIVE INCREASE; OLIGOMER MODULATOR; CHLORIDE TOXICITY; RENAL-FUNCTION	Objectives To examine potential gadolinium (Gd) accumulation in the brain of healthy mice after long-term oral administration of Gd-containing food pellets and to investigate whether Gd leads to adverse central nervous system (CNS) effects, specifically focussing on locomotor impairment in Gd exposed compared to control animals. Materials and methods The local Animal Experimental Ethics Committee approved all procedures and applications. Fifteen female C57Bl/6 mice were orally exposed to a daily intake of 0.57 mmol Gd chloride/kg body weight over a period of 90 weeks from the age of 4 weeks on. Gd-free, but otherwise equivalent experimental diets were given to the control group (N = 13). The animals were monitored daily by animal caretakers regarding any visible signs of distress and evaluated clinically every four weeks for the first 60 weeks and afterwards every two weeks for a better temporal resolution of potential long-term effects regarding impairment of motor performance and loss of body weight. The individual Gd content was measured using mass spectrometry in a sub-cohort of N = 6 mice. Results The absolute brain Gd levels of the Gd-exposed mice were significantly increased compared to control mice (0.033 +/- 0.009 vs. 0.006 +/- 0.002 nmol Gd/g brain tissue). Long-term oral Gd exposure over almost the entire life-span did not lead to adverse CNS effects including locomotor changes (rotarod performance, p = 0.1467) in healthy mice throughout the study period. Gd-exposed mice showed less increased body weight compared to control mice during the study period (p = 0.0423). Histopathological alterations, such as hepatocellular vacuolization due to fatty change in the liver and a loss of nucleated cells in the red pulp of the spleen, were found in peripheral organs of both groups. Conclusions Low levels of intracerebral Gd caused by chronic oral exposure over almost the entire life span of mice did not lead to alterations in locomotor abilities in healthy mice throughout the normal aging process.	[Noerenberg, Dominik] Univ Med Ctr Mannheim, Dept Clin Radiol & Nucl Med, Mannheim, Germany; [Noerenberg, Dominik; Ertl-Wagner, Birgit] LMU, Munich Univ Hosp, Dept Radiol, Munich, Germany; [Schmidt, Felix; Schinke, Karin; Giese, Armin] Ludwig Maximilians Univ Munchen, Munich Ctr Neuropathol, Munich, Germany; [Schmidt, Felix; Levin, Johannes] LMU, Munich Univ Hosp, Dept Neurol, Munich, Germany; [Frenzel, Thomas; Pietsch, Hubertus] Bayer AG, MR & CT Contrast Media Res, Berlin, Germany; [Ertl-Wagner, Birgit] Univ Toronto, Hosp Sick Children, Dept Med Imaging, Toronto, ON, Canada; [Levin, Johannes] German Ctr Neurodegenerat Dis DZNE, Munich, Germany	Ruprecht Karls University Heidelberg; University of Munich; University of Munich; University of Munich; Bayer AG; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Norenberg, D (corresponding author), Univ Med Ctr Mannheim, Dept Clin Radiol & Nucl Med, Mannheim, Germany.; Norenberg, D (corresponding author), LMU, Munich Univ Hosp, Dept Radiol, Munich, Germany.	Dominik.Noerenberg@medma.uni-heidelberg.de	Giese, Armin/F-3271-2010; Levin, Johannes/W-8686-2019	Giese, Armin/0000-0002-8238-4102; Levin, Johannes/0000-0001-5092-4306; Ertl-Wagner, Birgit/0000-0002-7896-7049; /0000-0001-7726-9006	"Deutsche Forschungsgemeinschaft" (DFG, German Research Foundation) [390857198]; Luneburg foundation for Parkinson research; "Deutsche Gesellschaft fur Parkinson und Bewegungsstorungen" (DPG)	"Deutsche Forschungsgemeinschaft" (DFG, German Research Foundation)(German Research Foundation (DFG)); Luneburg foundation for Parkinson research; "Deutsche Gesellschaft fur Parkinson und Bewegungsstorungen" (DPG)	T.F. and H.P. are employees of Bayer AG and contributed substantially to the methodology of intracerebral Gd measurements by ICP-MS. However, no commercial product or productrelated applications have been tested in the study. The research is not financially supported by industry. Academic researchers [F.S., D.N., B.E.W., J.L., K.S., A.G.] had full control over the data and contributed substantially on conceptualization, data curation and all the analyses performed. J.L. and A. G. were responsible for supervision and funding acquisition of this research project. Conceptualization and funding were not related to industry. Funding was provided by academic grants in the form of research materials for authors [F.S. and J.L.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. This study was funded by the "Deutsche Forschungsgemeinschaft" (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy, ID 390857198, grant recipient J.L.), by the Luneburg foundation for Parkinson research [grant recipients A.G. and F.S.] and the "Deutsche Gesellschaft fur Parkinson und Bewegungsstorungen" (DPG) (grant recipient J.L.). There are no financial or other relations that could lead to a conflict of interest.	Adding LC, 2001, CARDIOVASC DRUG REV, V19, P41; Adin ME, 2015, AM J NEURORADIOL, V36, P1859, DOI 10.3174/ajnr.A4378; BARNHART JL, 1987, MAGN RESON IMAGING, V5, P221, DOI 10.1016/0730-725X(87)90023-3; Birka M, 2015, ANAL CHEM, V87, P3321, DOI 10.1021/ac504488k; Bussi S, 2007, EXP TOXICOL PATHOL, V58, P323, DOI 10.1016/j.etp.2006.09.003; Cao Y, 2016, AM J ROENTGENOL, V206, P414, DOI 10.2214/AJR.15.15327; CHVEDOFF M, 1980, FOOD COSMET TOXICOL, V18, P517, DOI 10.1016/0015-6264(80)90167-4; Cowper SE, 2000, LANCET, V356, P1000, DOI 10.1016/S0140-6736(00)02694-5; El-Khatib AH, 2019, NEUROL-NEUROIMMUNOL, V6, DOI 10.1212/NXI.0000000000000515; Errante Y, 2014, INVEST RADIOL, V49, P685, DOI 10.1097/RLI.0000000000000072; Ersoy H, 2007, J MAGN RESON IMAGING, V26, P1190, DOI 10.1002/jmri.21135; Fingerhut S, 2018, ACTA NEUROPATHOL, V136, P127, DOI 10.1007/s00401-018-1857-4; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; HALEY TJ, 1961, BRIT J PHARM CHEMOTH, V17, P526, DOI 10.1111/j.1476-5381.1961.tb01139.x; Hao DP, 2012, J MAGN RESON IMAGING, V36, P1060, DOI 10.1002/jmri.23725; Hatje V, 2016, ENVIRON SCI TECHNOL, V50, P4159, DOI 10.1021/acs.est.5b04322; Idee JM, 2014, CRIT REV TOXICOL, V44, P895, DOI 10.3109/10408444.2014.955568; Jost G, 2016, INVEST RADIOL, V51, P83, DOI 10.1097/RLI.0000000000000242; Kanda T, 2016, JPN J RADIOL, V34, P3, DOI 10.1007/s11604-015-0503-5; Kanda T, 2015, RADIOLOGY, V276, P228, DOI 10.1148/radiol.2015142690; Kanda T, 2015, RADIOLOGY, V275, P803, DOI 10.1148/radiol.14140364; Kanda T, 2014, RADIOLOGY, V270, P834, DOI 10.1148/radiol.13131669; Kartamihardja AAP, 2016, INVEST RADIOL, V51, P655, DOI 10.1097/RLI.0000000000000295; Khairinisa MA, 2018, INVEST RADIOL, V53, P110, DOI 10.1097/RLI.0000000000000417; Lawrence MG, 2010, MAR POLLUT BULL, V60, P1113, DOI 10.1016/j.marpolbul.2010.03.027; Leggett R, 2014, INT J RADIAT BIOL, V90, P996, DOI 10.3109/09553002.2014.887868; Levin J, 2014, ACTA NEUROPATHOL, V127, P779, DOI 10.1007/s00401-014-1265-3; Liu HF, 2017, ACS APPL MATER INTER, V9, P5784, DOI 10.1021/acsami.6b14682; Lohrke J, 2017, INVEST RADIOL, V52, P324, DOI 10.1097/RLI.0000000000000344; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Miller JH, 2015, PEDIATRICS, V136, pE1637, DOI 10.1542/peds.2015-2222; Murata N, 2016, INVEST RADIOL, V51, P447, DOI 10.1097/RLI.0000000000000252; Ogawa Yukio, 1995, Journal of Environmental Pathology Toxicology and Oncology, V14, P1; Ogawa Yukio, 1992, Journal of Toxicological Sciences, V17, P331; Pietsch H, 2009, EUR RADIOL, V19, P1417, DOI 10.1007/s00330-008-1259-4; Quattrocchi CC, 2015, INVEST RADIOL, V50, P470, DOI 10.1097/RLI.0000000000000154; Radbruch A, 2015, RADIOLOGY, V275, P783, DOI 10.1148/radiol.2015150337; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Ramalho M, 2017, ADV CHRONIC KIDNEY D, V24, P138, DOI 10.1053/j.ackd.2017.03.004; Robert P, 2016, INVEST RADIOL, V51, P73, DOI 10.1097/RLI.0000000000000241; Robert P, 2015, INVEST RADIOL, V50, P473, DOI 10.1097/RLI.0000000000000181; Roberts DR, 2016, BRAIN DEV-JPN, V38, P331, DOI 10.1016/j.braindev.2015.08.009; Sadowski EA, 2007, RADIOLOGY, V243, P148, DOI 10.1148/radiol.2431062144; Shellock FG, 1999, J MAGN RESON IMAGING, V10, P477, DOI 10.1002/(SICI)1522-2586(199909)10:3<477::AID-JMRI33>3.0.CO;2-E; Smith AP, 2016, RADIOLOGY; Spencer A, 1998, HUM EXP TOXICOL, V17, P633, DOI 10.1191/096032798678908035; Spencer AJ, 1997, TOXICOL PATHOL, V25, P245, DOI 10.1177/019262339702500301; Stojanov DA, 2016, EUR RADIOL, V26, P807, DOI 10.1007/s00330-015-3879-9; Wagner J, 2013, ACTA NEUROPATHOL, V125, P795, DOI 10.1007/s00401-013-1114-9; Weberling LD, 2015, INVEST RADIOL, V50, P743, DOI 10.1097/RLI.0000000000000206	51	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231495	10.1371/journal.pone.0231495	http://dx.doi.org/10.1371/journal.pone.0231495			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324769	Green Published, gold			2022-12-26	WOS:000536033700016
J	Rooney, D; Wittkowski, M; Bartels, S; Weidenfeld, S; Aeschbach, D				Rooney, Daniel; Wittkowski, Martin; Bartels, Susanne; Weidenfeld, Sarah; Aeschbach, Daniel			Influence of transient pressure changes on speech intelligibility: Implications for nextgeneration train travel	PLOS ONE			English	Article							MIDDLE-EAR PRESSURE; RAILWAY NOISE; HEARING-LOSS; SAMPLE-SIZE; ANNOYANCE; PILOT	High-speed trains are operated in increasingly complex railway networks and continual improvement of driver assistance systems is necessary to maintain safety. Speech offers the opportunity to provide information to the driver without disrupting visual attention. However, it is not known whether the transient pressure changes inside trains passing through tunnels interfere with speech intelligibility. Our primary goal was to test whether the most severe pressure variations occurring in high-speed trains (25 hPa in 2 s) affect speech intelligibility in individuals with normal hearing ability and secondly whether a potential effect would depend on the direction of the pressure change. A cross-over design was used to compare speech intelligibility, measured with the monosyllable word test by Wallenberg and Kollmeier, in steady ambient pressure versus subsequent to pressure events, both realised in a pressure chamber. Since data for a power calculation did not exist, we conducted a pilot study with 20 participants to estimate variance of intra-individual differences. The upper 80% confidence limit guided sample size of the main campaign, which was performed with 72 participants to identify a 10% difference while limiting alpha (5%) and beta error (10%). On average, a participant understood 0.7 fewer words following a pressure change event compared to listening in steady ambient pressure. However, this intra-individual differences varied strongly between participants, standard deviation (SD) +/- 4.5 words, resulting in a negligible effect size of 0.1 and the Wilcoxon signed rank test (Z = -1.26; p = 0.21) did not distinguish it from chance. When comparing decreasing and increasing pressure events an average of 0.2 fewer words were understood (+/- 3.9 SD). The most severe pressure changes expected to occur in high-speed trains passing through tunnels do not interfere with speech intelligibility and are in itself not a risk factor for loss of verbal information transmission.	[Rooney, Daniel; Wittkowski, Martin; Bartels, Susanne; Weidenfeld, Sarah; Aeschbach, Daniel] German Aerosp Ctr DLR, Inst Aerosp Med, Dept Sleep & Human Factors Res, Cologne, Germany; [Aeschbach, Daniel] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Aeschbach, Daniel] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA	Helmholtz Association; German Aerospace Centre (DLR); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Rooney, D (corresponding author), German Aerosp Ctr DLR, Inst Aerosp Med, Dept Sleep & Human Factors Res, Cologne, Germany.	daniel.rooney@dlr.de		Rooney, Daniel/0000-0002-2966-9483	Program Directorate Transport of the German Aerospace Center	Program Directorate Transport of the German Aerospace Center	This study was part of the Next Generation Train project and funded by the Program Directorate Transport of the German Aerospace Center (www.dlr.de).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acoustical Society of America, 1997, S351997 ANSI; Aibara R, 2001, HEARING RES, V152, P100, DOI 10.1016/S0378-5955(00)00240-9; Basner M, 2014, LANCET, V383, P1325, DOI 10.1016/S0140-6736(13)61613-X; Bergevin C, 2014, J ACOUST SOC AM, V135, P1294, DOI 10.1121/1.4864475; Bizley JK, 2016, TRENDS NEUROSCI, V39, P74, DOI 10.1016/j.tins.2015.12.007; Bostron JH, 2011, J ACOUST SOC AM, V129, P2237, DOI 10.1121/1.3559710; BROWNE RH, 1995, STAT MED, V14, P1933, DOI 10.1002/sim.4780141709; FRENCH NR, 1947, J ACOUST SOC AM, V19, P90, DOI 10.1121/1.1916407; FURUKAWA CT, 1988, J ALLERGY CLIN IMMUN, V81, P1015, DOI 10.1016/0091-6749(88)90171-6; KRYTER KD, 1962, J ACOUST SOC AM, V34, P1689, DOI 10.1121/1.1909094; Licitra G, 2016, SCI TOTAL ENVIRON, V568, P1315, DOI 10.1016/j.scitotenv.2015.11.071; Liu TH, 2017, J WIND ENG IND AEROD, V169, P54, DOI 10.1016/j.jweia.2017.07.004; Mapp P., 2008, HDB SOUND ENG, P1385; MOORE DR, 1995, HEARING RES, V89, P93, DOI 10.1016/0378-5955(95)00125-0; Peng Y, 2019, OCCUP ENVIRON MED, V76, P97, DOI 10.1136/oemed-2018-105269; Pennig S, 2012, J ACOUST SOC AM, V132, P3109, DOI 10.1121/1.4757732; PRATT JW, 1959, J AM STAT ASSOC, V54, P655, DOI 10.2307/2282543; Proudfoot JA, 2018, GEN PSYCHIAT, V31, P46, DOI 10.1136/gpsych-2018-100004; Roets B, 2019, J TRANSP SAF SECUR, V11, P207, DOI 10.1080/19439962.2017.1376022; Sanok S, 2015, ERGONOMICS, V58, P1022, DOI 10.1080/00140139.2014.997805; Schwanitz S, 2013, APPL ERGON, V44, P200, DOI 10.1016/j.apergo.2012.07.003; Smith RA, 2018, ADV HIGH-SPEED RAIL, P47, DOI 10.1007/978-981-10-5610-9_3; STEENEKEN HJM, 1980, J ACOUST SOC AM, V67, P318, DOI 10.1121/1.384464; Sun XM, 2012, EAR HEARING, V33, P69, DOI 10.1097/AUD.0b013e3182280326; TRUSWELL WH, 1979, LARYNGOSCOPE, V89, P306; von Wallenberg E. L., 1989, AUDIOL AKUSTIK, V28, P50; Wagstaff AS, 1999, AVIAT SPACE ENVIR MD, V70, P1064; Whitehead AL, 2016, STAT METHODS MED RES, V25, P1057, DOI 10.1177/0962280215588241; Xun J, 2019, TRANSPORT RES C-EMER, V102, P106, DOI 10.1016/j.trc.2019.02.023	29	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232024	10.1371/journal.pone.0232024	http://dx.doi.org/10.1371/journal.pone.0232024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324825	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000536033700062
J	Fukuda, S; Tacharoenmuang, R; Guntapong, R; Upachai, S; Singchai, P; Ide, T; Hatazawa, R; Sutthiwarakom, K; Kongjorn, S; Onvimala, N; Ruchusatsawast, K; Rungnopakun, P; Mekmallika, J; Kawamura, Y; Motomura, K; Tatsumi, M; Takeda, N; Murata, T; Yoshikawa, T; Uppapong, B; Taniguchi, K; Komoto, S				Fukuda, Saori; Tacharoenmuang, Ratana; Guntapong, Ratigorn; Upachai, Sompong; Singchai, Phakapun; Ide, Tomihiko; Hatazawa, Riona; Sutthiwarakom, Karun; Kongjorn, Santip; Onvimala, Napa; Ruchusatsawast, Kriangsak; Rungnopakun, Pimpa; Mekmallika, Jutarat; Kawamura, Yoshiki; Motomura, Kazushi; Tatsumi, Masashi; Takeda, Naokazu; Murata, Takayuki; Yoshikawa, Tetsushi; Uppapong, Ballang; Taniguchi, Koki; Komoto, Satoshi			Full genome characterization of novel DS-1-like G9P[8] rotavirus strains that have emerged in Thailand	PLOS ONE			English	Article							EQUINE-LIKE; REASSORTANT ROTAVIRUS; G3 ROTAVIRUS; MOLECULAR CHARACTERIZATION; GENOTYPE CONSTELLATION; 1ST DETECTION; GASTROENTERITIS; CHILDREN; JAPAN; BOVINE	The emergence and rapid spread of unusual DS-1-like intergenogroup reassortant rotaviruses having G1/3/8 genotypes have been recently reported from major parts of the world (Africa, Asia, Australia, Europe, and the Americas). During rotavirus surveillance in Thailand, three novel intergenogroup reassortant strains possessing the G9P[8] genotype (DBM2017-016, DBM2017-203, and DBM2018-291) were identified in three stool specimens from diarrheic children. In the present study, we determined and analyzed the full genomes of these three strains. On full-genomic analysis, all three strains were found to share a unique genotype constellation comprising both genogroup 1 and 2 genes: G9-P[8]-I2-R2-C2-M2-A2-N2-T2-E2-H2. Phylogenetic analysis demonstrated that each of the 11 genes of the three strains was closely related to that of emerging DS-1-like intergenogroup reassortant, human, and/or locally circulating human strains. Thus, the three strains were suggested to be multiple reassortants that had acquired the G9-VP7 genes from co-circulating Wa-like G9P[8] rotaviruses in the genetic background of DS-1-like intergenogroup reassortant (likely equine-like G3P[8]) strains. To our knowledge, this is the first description of emerging DS-1-like intergenogroup reassortant strains having the G9P[8] genotype. Our observations will add to the growing insights into the dynamic evolution of emerging DS-1like intergenogroup reassortant rotaviruses through reassortment.	[Fukuda, Saori; Tacharoenmuang, Ratana; Ide, Tomihiko; Hatazawa, Riona; Murata, Takayuki; Taniguchi, Koki; Komoto, Satoshi] Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan; [Tacharoenmuang, Ratana; Guntapong, Ratigorn; Upachai, Sompong; Singchai, Phakapun; Sutthiwarakom, Karun; Kongjorn, Santip; Onvimala, Napa; Ruchusatsawast, Kriangsak; Uppapong, Ballang] Natl Inst Hlth, Dept Med Sci, Nonthaburi, Thailand; [Tacharoenmuang, Ratana; Kawamura, Yoshiki; Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Sch Med, Toyoake, Aichi, Japan; [Ide, Tomihiko] Fujita Hlth Univ, Ctr Res Promot & Support, Joint Res Support Promot Facil, Toyoake, Aichi, Japan; [Rungnopakun, Pimpa; Mekmallika, Jutarat] Bhumibol Adulyadej Hosp, Bangkok, Thailand; [Motomura, Kazushi; Tatsumi, Masashi; Takeda, Naokazu] Thailand Japan Res Collaborat Ctr Emerging & Re E, Nonthaburi, Thailand; [Motomura, Kazushi] Osaka Inst Publ Hlth, Osaka, Japan	Fujita Health University; Ministry of Public Health - Thailand; Fujita Health University; Fujita Health University; Osaka Prefectural Institute of Public Health	Komoto, S (corresponding author), Fujita Hlth Univ, Dept Virol & Parasitol, Sch Med, Toyoake, Aichi, Japan.	satoshik@fujita-hu.ac.jp	Murata, Takayuki/I-2621-2013	Murata, Takayuki/0000-0001-7228-0839	Thailand-Japan Research Collaboration Center on Emerging and Re-emerging Infections, RCC-ERI; RONPAKU (Dissertation PhD) Program, Japan Society for the Promotion of Science (JSPS)	Thailand-Japan Research Collaboration Center on Emerging and Re-emerging Infections, RCC-ERI; RONPAKU (Dissertation PhD) Program, Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by the Thailand-Japan Research Collaboration Center on Emerging and Re-emerging Infections, RCC-ERI (NT), and the RONPAKU (Dissertation PhD) Program, Japan Society for the Promotion of Science (JSPS) (RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbemabiese CA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217422; Arana A, 2016, INFECT GENET EVOL, V44, P137, DOI 10.1016/j.meegid.2016.06.048; Chia G, 2018, J CLIN VIROL, V105, P57, DOI 10.1016/j.jcv.2018.06.004; Cowley D, 2016, J GEN VIROL, V97, P403, DOI 10.1099/jgv.0.000352; Dennis FE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100699; Doro R, 2016, ACTA MICROBIOL IMM H, V63, P243, DOI 10.1556/030.63.2016.2.8; Esposito S, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1173-1; Estes M.K., 2013, FIELDS VIROLOGY, V6th, P1347; Fujii Y, 2014, INFECT GENET EVOL, V28, P426, DOI 10.1016/j.meegid.2014.08.001; Ghosh S, 2011, FUTURE MICROBIOL, V6, P1049, DOI [10.2217/FMB.11.90, 10.2217/fmb.11.90]; Heiman EM, 2008, J VIROL, V82, P11106, DOI 10.1128/JVI.01402-08; Hoa-Tran TN, 2016, ARCH VIROL, V161, P479, DOI 10.1007/s00705-015-2682-x; Ianiro G, 2013, INFECT GENET EVOL, V16, P426, DOI 10.1016/j.meegid.2013.03.031; Jere KC, 2018, J VIROL, V92, DOI 10.1128/JVI.01246-17; Kamiya H, 2019, JPN J INFECT DIS, V72, P256, DOI 10.7883/yoken.JJID.2018.484; Kaplon J, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.10.009; Katz EM, 2019, VIROLOGY, V534, P114, DOI 10.1016/j.virol.2019.06.007; Kikuchi W, 2018, ARCH VIROL, V163, P791, DOI 10.1007/s00705-017-3668-7; Komoto S, 2018, J MED VIROL, V90, P890, DOI 10.1002/jmv.25016; Komoto S, 2016, INFECT GENET EVOL, V43, P424, DOI 10.1016/j.meegid.2016.06.023; Komoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148416; Komoto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141739; Komoto S, 2014, INFECT GENET EVOL, V27, P277, DOI 10.1016/j.meegid.2014.08.002; Kondo K, 2017, EMERG INFECT DIS, V23, P968, DOI 10.3201/eid2306.160038; Kuzuya M, 2014, J MED VIROL, V86, P1056, DOI 10.1002/jmv.23746; Luchs A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38703-7; Luchs A, 2019, J GEN VIROL, V100, P7, DOI 10.1099/jgv.0.001171; Maes P, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-238; Matthijnssens J, 2008, J VIROL, V82, P3204, DOI 10.1128/JVI.02257-07; Matthijnssens J, 2012, CURR OPIN VIROL, V2, P426, DOI 10.1016/j.coviro.2012.04.007; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; McDonald SM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000634; Moutelikova R, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111015; Nakagomi T, 2017, ARCH VIROL, V162, P739, DOI 10.1007/s00705-016-3155-6; Perkins C, 2017, GENOME ANNOUNCEMENTS, V5, DOI 10.1128/genomeA.01341-17; Phan MVT, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew027; Pietsch C, 2018, INFECT GENET EVOL, V57, P46, DOI 10.1016/j.meegid.2017.11.007; Sadiq A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02641; Guerra SFS, 2016, J GEN VIROL, V97, P3131, DOI 10.1099/jgv.0.000626; Tacharoenmuang R, 2020, J MED VIROL, V92, P174, DOI 10.1002/jmv.25591; Tacharoenmuang R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165826; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Tharmaphornpilas P, 2017, VACCINE, V35, P796, DOI 10.1016/j.vaccine.2016.12.043; Troeger C, 2018, JAMA PEDIATR, V172, P958, DOI 10.1001/jamapediatrics.2018.1960; Utsumi T, 2018, INFECT GENET EVOL, V61, P224, DOI 10.1016/j.meegid.2018.03.027; Wandera EA, 2019, INFECT GENET EVOL, V68, P231, DOI 10.1016/j.meegid.2018.12.004; Yamamoto D, 2017, New Microbes New Infect, V18, P54, DOI 10.1016/j.nmni.2017.04.001; Yamamoto SP, 2014, EMERG INFECT DIS, V20, P1030, DOI 10.3201/eid2006.131326	48	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231099	10.1371/journal.pone.0231099	http://dx.doi.org/10.1371/journal.pone.0231099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320419	gold, Green Published			2022-12-26	WOS:000536028800015
J	Maluin, FN; Hussein, MZ; Yusof, NA; Fakurazi, S; Idris, AS; Hilmi, NHZ; Daim, LDJ				Maluin, Farhatun Najat; Hussein, Mohd Zobir; Yusof, Nor Azah; Fakurazi, Sharida; Idris, Abu Seman; Hilmi, Nur Hailini Zainol; Daim, Leona Daniela Jeffery			Phytotoxicity of chitosan-based agronanofungicides in the vegetative growth of oil palm seedling	PLOS ONE			English	Article							NANOPARTICLES; DAZOMET; PHOTOSYNTHESIS; PATHOGENS; DELIVERY; SYSTEMS; FUNGI; ROT	Although fungicides could be the best solution in combating fungal infections in crops, however, the phytotoxic level of fungicides to the crops should be tested first to ensure that it is safe for the crops. Moreover, nanocarrier systems of fungicides could play a significant role in the advancement of crop protection. For this reason, chitosan was chosen in the present study as a nanocarrier for fungicides of hexaconazole and/or dazomet in the development of a new generation of agronanofungicides with a high antifungal potent agent and no phytotoxic effect. Hence, the encapsulation of fungicides into the non-toxic biopolymer, chitosan was aims to reduce the phytotoxic level of fungicides. In the present study, the in vivo phytotoxicity of chitosan-fungicides nanoparticles on the physiological and vegetative growth of oil palm seedlings was evaluated in comparison to its pure fungicides as well as the conventional fungicides. The results revealed the formation of chitosan-fungicides nanoparticles could reduce the phytotoxic effect on oil palm seedlings compared to their counterparts, pure fungicides. The chitosan-fungicides nanoparticles were seen to greatly reduce the phytotoxic effect compared to the conventional fungicides with the same active ingredient.	[Maluin, Farhatun Najat; Hussein, Mohd Zobir; Yusof, Nor Azah] Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia; [Yusof, Nor Azah] Univ Putra Malaysia, Fac Sci, Dept Chem, Serdang, Selangor, Malaysia; [Fakurazi, Sharida] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Human Anat, Serdang, Selangor, Malaysia; [Idris, Abu Seman; Hilmi, Nur Hailini Zainol] Malaysian Palm Oil Board MPOB, Kajang, Selangor, Malaysia; [Daim, Leona Daniela Jeffery] Univ Putra Malaysia, UPM MTDC Technol Ctr 3, Sime Darby Technol Ctr Sdn Bhd, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Malaysian Palm Oil Board; Universiti Putra Malaysia	Hussein, MZ (corresponding author), Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia.	mzobir@upm.edu.my	Maluin, Farhatun Najat/AAG-5916-2020	Maluin, Farhatun Najat/0000-0002-7169-7533; FAKURAZI, SHARIDA/0000-0001-8986-876X	Universiti Putra Malaysia (UPM); Ministry of Higher Education of Malaysia [9443100, 5526300, 9647400]; Sime Darby Foundation; Malaysian Palm Oil Board (MPOB)	Universiti Putra Malaysia (UPM); Ministry of Higher Education of Malaysia(Ministry of Education, Malaysia); Sime Darby Foundation; Malaysian Palm Oil Board (MPOB)	The research was funded by Universiti Putra Malaysia (UPM) and the Ministry of Higher Education of Malaysia under LRGS-NanoMITe program, vote no. 9443100 and 5526300 and GPIPS, vote no. 9647400. During this work, FNM was supported by the graduate research fellowship (GRF) and Sime Darby Foundation. This material is based upon work supported by the Malaysian Palm Oil Board (MPOB). MPOB has provided support in the form of salaries for authors ASI and NHZH but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Austerweil M, 2006, PHYTOPARASITICA, V34, P491, DOI 10.1007/BF02981205; Degenkolb T, 2016, APPL MICROBIOL BIOT, V100, P3799, DOI 10.1007/s00253-015-7233-6; Dias MC, 2012, J BOT, V2012; Divya K, 2018, ENVIRON CHEM LETT, V16, P101, DOI 10.1007/s10311-017-0670-y; El Hadrami A, 2010, MAR DRUGS, V8, P968, DOI 10.3390/md8040968; Hadwiger LA, 2013, PLANT SCI, V208, P42, DOI 10.1016/j.plantsci.2013.03.007; Idris A., 2009, PIPOC AGR BIOTECHNOL; Idris A., 2012, MPOB TS INF SER, V107; Idris A., 2010, MPOB TS INF SER; Jianglian D., 2013, J FOOD PROCESSING TE, V4, P227, DOI DOI 10.4172/2157-7110.1000227; Kashyap PL, 2015, INT J BIOL MACROMOL, V77, P36, DOI 10.1016/j.ijbiomac.2015.02.039; Khalfallah S, 1998, J AGR FOOD CHEM, V46, P1614, DOI 10.1021/jf9706540; Malerba M, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11050839; Malerba M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17070996; Maluin FN, 2019, RSC ADV, V9, P27083, DOI 10.1039/c9ra05417k; Maluin FN, 2019, MOLECULES, V24, DOI 10.3390/molecules24132498; Maluin FN, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092247; Mappes D., 1993, SPECTRUM ACTIVITY DA, V382, P96; Mustafa IF, 2018, ACS SUSTAIN CHEM ENG, V6, P16064, DOI 10.1021/acssuschemeng.8b02584; Ney B, 2013, EUR J PLANT PATHOL, V135, P561, DOI 10.1007/s10658-012-0125-z; Ouda S. M., 2014, Research Journal of Microbiology, V9, P34, DOI 10.3923/jm.2014.34.42; Paterson RRM, 2007, CROP PROT, V26, P1369, DOI 10.1016/j.cropro.2006.11.009; Perez-de-Luque A, 2009, PEST MANAG SCI, V65, P540, DOI 10.1002/ps.1732; Petit AN, 2008, J AGR FOOD CHEM, V56, P6761, DOI 10.1021/jf800919u; Petit AN, 2012, PHOTOSYNTH RES, V111, P315, DOI 10.1007/s11120-012-9719-8; Punja ZK, 2003, TRENDS BIOTECHNOL, V21, P400, DOI 10.1016/S0167-7799(03)00193-8; Saladin G, 2005, AGRICULTURE AND SOIL POLLUTION: NEW RESEARCH, P53; Van SN, 2013, BIOCATAL AGR BIOTECH, V2, P289, DOI 10.1016/j.bcab.2013.06.001; Shahid M, 2018, RSC ADV, V8, P38483, DOI 10.1039/c8ra03923b; Shweta Agrawal, 2014, International Journal of Current Microbiology and Applied Sciences, V3, P43; Taylor FI, 2014, PLANT SOIL, V382, P281, DOI 10.1007/s11104-014-2157-y; Thind T., 2010, PLANT PATHOLOGY INDI, P267; Troncoso R, 2005, FOOD RES INT, V38, P701, DOI 10.1016/j.foodres.2005.02.004; Wang D, 2006, PEST MANAG SCI, V62, P263, DOI 10.1002/ps.1164; Worrall EA, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8120285	35	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231315	10.1371/journal.pone.0231315	http://dx.doi.org/10.1371/journal.pone.0231315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315346	gold, Green Published			2022-12-26	WOS:000536024800022
J	Canals, D; Salamone, S; Santacreu, BJ; Nemeth, E; Aguilar, D; Hernandez-Corbacho, MJ; Adada, M; Staquicini, DI; Arap, W; Pasqualini, R; Haley, J; Obeid, LM; Hannun, YA				Canals, Daniel; Salamone, Silvia; Santacreu, Bruno Jaime; Nemeth, Erika; Aguilar, Daniel; Hernandez-Corbacho, Maria Jose; Adada, Mohamad; Staquicini, Daniela I.; Arap, Wadih; Pasqualini, Renata; Haley, John; Obeid, Lina M.; Hannun, Yusuf A.			Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy	FASEB JOURNAL			English	Article						doxorubicin; plasma membrane; sphingolipids; sphingomyelinase; vorinostat	NEUTRAL SPHINGOMYELINASE-2; PROTEIN PHOSPHATASE; INDUCED ACTIVATION; DEATH; PATHWAY; KINASE; DEPHOSPHORYLATION; OVEREXPRESSION; SPHINGOLIPIDS; PURIFICATION	Chemotherapy has been reported to upregulate sphingomylinases and increase cellular ceramide, often linked to the induction to cell death. In this work, we show that sublethal doses of doxorubicin and vorinostat still increased cellular ceramide, which was located predominantly at the plasma membrane. To interrogate possible functions of this specific pool of ceramide, we used recombinant enzymes to mimic physiological levels of ceramide at the plasma membrane upon chemotherapy treatment. Using mass spectrometry and network analysis, followed by experimental confirmation, the results revealed that this pool of ceramide acutely regulates cell adhesion and cell migration pathways with weak connections to commonly established ceramide functions (eg, cell death). Neutral sphingomyelinase 2 (nSMase2) was identified as responsible for the generation of plasma membrane ceramide upon chemotherapy treatment, and both ceramide at the plasma membrane and nSMase2 were necessary and sufficient to mediate these "side" effects of chemotherapy on cell adhesion and migration. This is the first time a specific pool of ceramide is interrogated for acute signaling functions, and the results define plasma membrane ceramide as an acute signaling effector necessary and sufficient for regulation of cell adhesion and cell migration under chemotherapeutical stress.	[Canals, Daniel; Salamone, Silvia; Santacreu, Bruno Jaime; Nemeth, Erika; Hernandez-Corbacho, Maria Jose; Adada, Mohamad; Haley, John; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Santacreu, Bruno Jaime] Fac Farm & Bioquim, Catedra Biol Celular & Mol, Buenos Aires, DF, Argentina; [Aguilar, Daniel] Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Barcelona, Spain; [Adada, Mohamad] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Staquicini, Daniela I.; Arap, Wadih; Pasqualini, Renata] Rutgers Canc Inst New Jersey, Newark, NJ USA; [Staquicini, Daniela I.; Pasqualini, Renata] Rutgers New Jersey Med Sch, Div Canc Biol, Dept Radiat Oncol, Newark, NJ USA; [Arap, Wadih] Rutgers New Jersey Med Sch, Div Hematol Oncol, Dept Med, Newark, NJ USA; [Haley, John] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport VA Hosp, Northport, NY USA; [Obeid, Lina M.; Hannun, Yusuf A.] Stony Brook Canc Ctr, Stony Brook, NY USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Buenos Aires; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Mayo Clinic; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Canals, Daniel/AAJ-8176-2021; Canals, Daniel/AAW-1998-2021	Canals, Daniel/0000-0002-9293-5123; Santacreu, Bruno/0000-0003-2506-5006	National Cancer Institute (NCI) [CA218678]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Cancer Institute (NCI), Grant/Award Number: CA218678	Airola Michael V, 2013, Handb Exp Pharmacol, P57, DOI 10.1007/978-3-7091-1368-4_3; Andrieu-Abadie N, 2002, BBA-MOL CELL BIOL L, V1585, P126, DOI 10.1016/S1388-1981(02)00332-3; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bennett WFD, 2012, J LIPID RES, V53, P421, DOI 10.1194/jlr.M022491; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; Bockelmann S, 2018, J LIPID RES, V59, P515, DOI 10.1194/jlr.M082354; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Canals D, 2018, CHEM PHYS LIPIDS, V216, P142, DOI 10.1016/j.chemphyslip.2018.09.013; Canals Daniel, 2013, Handb Exp Pharmacol, P211, DOI 10.1007/978-3-7091-1368-4_12; Canals D, 2012, J BIOL CHEM, V287, P10145, DOI 10.1074/jbc.M111.306456; Canals D, 2011, BRIT J PHARMACOL, V163, P694, DOI 10.1111/j.1476-5381.2011.01279.x; Canals D, 2010, J BIOL CHEM, V285, P32476, DOI 10.1074/jbc.M110.141028; CHEN CS, 1995, J BIOL CHEM, V270, P13291, DOI 10.1074/jbc.270.22.13291; Cheng Z, 2014, J MOL CELL CARDIOL, V67, P1, DOI 10.1016/j.yjmcc.2013.12.002; Chudakova DA, 2008, J BIOL CHEM, V283, P28806, DOI 10.1074/jbc.M803301200; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colombini M, 2010, BBA-BIOENERGETICS, V1797, P1239, DOI 10.1016/j.bbabio.2010.01.021; Dadsena S, 2019, CELL STRESS, V3, P280, DOI 10.15698/cst2019.08.196; Dadsena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09654-4; Davis AP, 2017, NUCLEIC ACIDS RES, V45, pD972, DOI 10.1093/nar/gkw838; Diaz Osterman CJ, 2019, ELIFE, V8, DOI 10.7554/eLife.47327; DOBROWSKY RT, 1993, ADV LIPID RES, V25, P91; DOBROWSKY RT, 1992, J BIOL CHEM, V267, P5048; Dong XL, 2010, J PROTEOME RES, V9, P5943, DOI 10.1021/pr1007043; Dumitru CA, 2007, APOPTOSIS, V12, P1533, DOI 10.1007/s10495-007-0081-9; Elliott A, 2018, BIOINFORMATICS, V34, P64, DOI 10.1093/bioinformatics/btx419; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Grada A, 2017, J INVEST DERMATOL, V137, pE11, DOI 10.1016/j.jid.2016.11.020; Grammatikos G, 2007, ANTIOXID REDOX SIGN, V9, P1449, DOI 10.1089/ars.2007.1673; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Izquierdo E, 2018, CHEM PHYS LIPIDS, V215, P71, DOI 10.1016/j.chemphyslip.2018.07.004; Jaramillo-Gomez J, 2015, NEUROSCI LETT, V603, P71, DOI 10.1016/j.neulet.2015.07.032; Jenkins RW, 2011, J BIOL CHEM, V286, P13292, DOI 10.1074/jbc.M110.163378; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KARAGIANNIS GS, 2017, SCI TRANSL MED, V9, P1; Key M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S10; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kobayashi T, 2006, BIOL PHARM BULL, V29, P1526, DOI 10.1248/bpb.29.1526; Kota V, 2012, PROTEOMICS, V12, P2179, DOI 10.1002/pmic.201100527; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Li Y, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2252-y; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu CL, 2019, J BREAST CANCER, V22, P185, DOI 10.4048/jbc.2019.22.e22; Liu YY, 2008, FASEB J, V22, P2541, DOI 10.1096/fj.07-092981; Marchesini N, 2004, J BIOL CHEM, V279, P25101, DOI 10.1074/jbc.M313662200; MATHIAS S, 1991, P NATL ACAD SCI USA, V88, P10009, DOI 10.1073/pnas.88.22.10009; Milhas D, 2010, BBA-MOL CELL BIOL L, V1801, P1361, DOI 10.1016/j.bbalip.2010.08.001; Mistry D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187091; Mustafa Ebtihal H, 2015, Asian Pac J Cancer Prev, V16, P3213; Newcomb B, 2018, J LIPID RES, V59, P1219, DOI 10.1194/jlr.M084202; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Oh HL, 2006, NEUROTOXICOLOGY, V27, P31, DOI 10.1016/j.neuro.2005.05.008; Park MA, 2010, CANCER RES, V70, P6313, DOI 10.1158/0008-5472.CAN-10-0999; Piccolo SR, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20156506; Pinheiro MAL, 2016, J IMMUNOL, V196, P72, DOI 10.4049/jimmunol.1500702; R Core Team, 2018, R LANG ENV STAT COMP; Rebillard A, 2010, EUR J CANCER, V46, P1445, DOI 10.1016/j.ejca.2010.01.034; Roodhart JML, 2013, BLOOD, V122, P143, DOI 10.1182/blood-2012-11-459347; Rotolo J, 2012, J CLIN INVEST, V122, P1786, DOI 10.1172/JCI59920; Sales G, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-20; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schulte-Zweckel J, 2018, CHEM COMMUN, V54, P13742, DOI 10.1039/c8cc05691a; Seitz AP, 2015, BIOL CHEM, V396, P611, DOI 10.1515/hsz-2014-0285; Shamseddine Achraf A, 2015, Adv Biol Regul, V57, P24, DOI 10.1016/j.jbior.2014.10.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Snider JM, 2019, J LIPID RES, V60, P819, DOI 10.1194/jlr.M089714; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tani M, 2007, FEBS LETT, V581, P1323, DOI 10.1016/j.febslet.2007.02.046; Tani M, 2007, J BIOL CHEM, V282, P10047, DOI 10.1074/jbc.M611249200; Tellier E, 2007, MOL CELL BIOL, V27, P2997, DOI 10.1128/MCB.01485-06; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Walev I, 1996, INFECT IMMUN, V64, P2974, DOI 10.1128/IAI.64.8.2974-2979.1996; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yang DI, 2004, NEUROBIOL DIS, V17, P99, DOI 10.1016/j.nbd.2004.06.001; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zhang SY, 2018, INT CONF BIG DATA, P1, DOI 10.1109/BigComp.2018.00010; Zwick M, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104284	82	14	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7610	7630		10.1096/fj.202000205R	http://dx.doi.org/10.1096/fj.202000205R		APR 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307766	Green Accepted, Bronze			2022-12-26	WOS:000527568500001
J	Lai, XL; Hao, WR; Friedman, A				Lai, Xiulan; Hao, Wenrui; Friedman, Avner			TNF-alpha inhibitor reduces drug-resistance to anti-PD-1: A mathematical model	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; DENDRITIC CELLS; BREAST-CANCER; PD-1 BLOCKADE; T-CELLS; CHEMOTHERAPY; IPILIMUMAB; NIVOLUMAB; THERAPY; SENSITIVITY	Drug resistance is a primary obstacle in cancer treatment. In many patients who at first respond well to treatment, relapse occurs later on. Various mechanisms have been explored to explain drug resistance in specific cancers and for specific drugs. In this paper, we consider resistance to anti-PD-1, a drug that enhances the activity of anti-cancer T cells. Based on results in experimental melanoma, it is shown, by a mathematical model, that resistances to anti-PD-1 can be significantly reduced by combining it with anti-TNF-alpha. The model is used to simulate the efficacy of the combined therapy with different range of doses, different initial tumor volume, and different schedules. In particular, it is shown that under a course of treatment with 3-week cycles where each drug is injected in the first day of either week 1 or week 2, injecting anti-TNF-alpha one week after anti-PD-1 is the most effective schedule in reducing tumor volume.	[Lai, Xiulan] Renmin Univ China, Inst Math Sci, Beijing, Peoples R China; [Hao, Wenrui] Penn State Univ, Dept Math, State Coll, PA USA; [Friedman, Avner] Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA; [Friedman, Avner] Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA	Renmin University of China; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Friedman, A (corresponding author), Ohio State Univ, Math Biosci Inst, Columbus, OH 43210 USA.; Friedman, A (corresponding author), Ohio State Univ, Dept Math, 231 W 18th Ave, Columbus, OH 43210 USA.	afriedman@math.osu.edu	Lai, Xiula/GMX-1854-2022	HAO, WENRUI/0000-0002-6925-7424	Fundamental Research Funds for the Central Universities [19XNLG14]; Renmin University of China; National Natural Science Foundation of China [11571364]; National Science Foundation [DMS-1818769]; Mathematical Biosciences Institute	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Renmin University of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation(National Science Foundation (NSF)); Mathematical Biosciences Institute	XL was partially supported by the Fundamental Research Funds for the Central Universities (19XNLG14), and the Research Funds of Renmin University of China, and National Natural Science Foundation of China (11571364). WH was partially supported by the National Science Foundation (Grant DMS-1818769).; The authors thank Mathematical Biosciences Institute for the support of this collaboration. WHwas partially supported by the National Science Foundation (Grant DMS-1818769). XL was partially supported by the Fundamental Research Funds for the Central Universities (19XNLG14), and the Research Funds of Renmin University of China, and the National Natural Science Foundation of China (No.11571364).	Anagnostou V, 2017, CANCER DISCOV, V7, P264, DOI 10.1158/2159-8290.CD-16-0828; Bertrand F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02358-7; Chen LH, 2014, INT J MOL SCI, V15, P817, DOI 10.3390/ijms15010817; Chen Y, 2017, J AM HEART ASSOC, V6, P1; Cheng X., HUMAN PD L1 B7 H1 CD; Cho H, 2018, J THEOR BIOL, V436, P120, DOI 10.1016/j.jtbi.2017.10.005; Cho H, 2018, APPL MATH MODEL, V64, P733, DOI 10.1016/j.apm.2018.07.025; Chou FC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020430; Cree IA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-016-2999-1; DAcunto B., 2004, SERIES ADV MATH APPL, V67; Donia M, 2015, CANCER RES, V75, P3747, DOI 10.1158/0008-5472.CAN-14-2956; Feizabadi MS, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0052-y; Friedman A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192449; Friedman A, 2018, B MATH BIOL, V80, P1111, DOI 10.1007/s11538-017-0254-9; G T Zanudo Jorge, 2018, Curr Opin Syst Biol, V9, P1, DOI 10.1016/j.coisb.2018.02.002; Gaffney EA, 2004, J MATH BIOL, V48, P375, DOI 10.1007/s00285-003-0246-2; Garcia-Diaz A, 2017, CELL REP, V19, P1189, DOI 10.1016/j.celrep.2017.04.031; Gillet JP, 2010, METHODS MOL BIOL, V596, P47, DOI 10.1007/978-1-60761-416-6_4; Hadjiandreou MM, 2014, IEEE T BIO-MED ENG, V61, P415, DOI 10.1109/TBME.2013.2280189; Hao WR, 2017, P NATL ACAD SCI USA, V114, P5011, DOI 10.1073/pnas.1620264114; He XB, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004176; Janco JMT, 2015, J IMMUNOL, V194, P2985, DOI 10.4049/jimmunol.1403134; Jenkins RW, 2018, BRIT J CANCER, V118, P9, DOI 10.1038/bjc.2017.434; Khunweeraphong N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11794-w; Komarova NL, 2005, P NATL ACAD SCI USA, V102, P9714, DOI 10.1073/pnas.0501870102; Lai XL, 2018, P NATL ACAD SCI USA, V115, P5534, DOI 10.1073/pnas.1721559115; Lai XL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178479; Lavi O, 2012, DRUG RESIST UPDATE, V15, P90, DOI 10.1016/j.drup.2012.01.003; Lee SM, 1998, LEUKEMIA LYMPHOMA, V29, P427, DOI 10.3109/10428199809050903; Leonard GD, 2003, ONCOLOGIST, V8, P411, DOI 10.1634/theoncologist.8-5-411; Li J, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1200778; Liao KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091844; Lim SO, 2016, CANCER CELL, V30, P925, DOI 10.1016/j.ccell.2016.10.010; Lisiero DN, 2011, J IMMUNOL, V186, P5068, DOI 10.4049/jimmunol.1003317; Ma Y, 2013, J CANCER, V4, P36, DOI 10.7150/jca.5046; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Martincich L, 2004, BREAST CANCER RES TR, V83, P67, DOI 10.1023/B:BREA.0000010700.11092.f4; Maute RL, 2015, P NATL ACAD SCI USA, V112, pE6506, DOI 10.1073/pnas.1519623112; Muppidi M.R., 2015, J TARGET THER CANC, V4, P47; Palucka K, 2012, NAT REV CANCER, V12, P265, DOI 10.1038/nrc3258; PhosphoSitePlus, 2014, NUCL AC RES PHOSPHOS, P43; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Rockne RC, 2019, PHYS BIOL, V16, DOI 10.1088/1478-3975/ab1a09; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Seidel JA, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00086; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shi L, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-74; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Simo R, 2012, DIABETES, V61, P372, DOI 10.2337/db11-0727; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sucker A, 2014, CLIN CANCER RES, V20, P6593, DOI 10.1158/1078-0432.CCR-14-0567; Sun XQ, 2018, BRIEF BIOINFORM, V19, P1382, DOI 10.1093/bib/bbx065; Tomasetti C, 2010, P NATL ACAD SCI USA, V107, P16766, DOI 10.1073/pnas.1007726107; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vescovi R, 2019, CANCER IMMUNOL RES, V7, P12, DOI 10.1158/2326-6066.CIR-18-0141; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Wooten DJ, 2017, BBA-REV CANCER, V1867, P167, DOI 10.1016/j.bbcan.2017.04.001; Xiao J, 2015, J CANCER, V6, P636, DOI 10.7150/jca.11738; YOUNG ME, 1980, BIOTECHNOL BIOENG, V22, P947, DOI 10.1002/bit.260220504; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	62	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231499	10.1371/journal.pone.0231499	http://dx.doi.org/10.1371/journal.pone.0231499			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310956	gold, Green Published			2022-12-26	WOS:000536019800017
J	Cui, D; Drake, JC; Wilson, RJ; Shute, RJ; Lewellen, B; Zhang, M; Zhao, HN; Sabik, OL; Onengut, S; Berr, SS; Rich, SS; Farber, CR; Yan, Z				Cui, Di; Drake, Joshua C.; Wilson, Rebecca J.; Shute, Robert J.; Lewellen, Bevan; Zhang, Mei; Zhao, Henan; Sabik, Olivia L.; Onengut, Suna; Berr, Stuart S.; Rich, Stephen S.; Farber, Charles R.; Yan, Zhen			A novel voluntary weightlifting model in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway	FASEB JOURNAL			English	Article						contractile adaptation; hypertrophy; metabolic adaptation; muscle power; resistance exercise	MOUSE SKELETAL-MUSCLE; RESISTANCE EXERCISE; PROTEIN BREAKDOWN; EXPRESSION; HYPERTROPHY; ENDURANCE; STRENGTH; GLUCOSE; PHOSPHORYLATION; TRANSPORT	Our understanding of the molecular mechanisms underlying adaptations to resistance exercise remains elusive despite the significant biological and clinical relevance. We developed a novel voluntary mouse weightlifting model, which elicits squat-like activities against adjustable load during feeding, to investigate the resistance exercise-induced contractile and metabolic adaptations. RNAseq analysis revealed that a single bout of weightlifting induced significant transcriptome responses of genes that function in posttranslational modification, metabolism, and muscle differentiation in recruited skeletal muscles, which were confirmed by increased expression of fibroblast growth factor-inducible 14 (Fn14), Down syndrome critical region 1 (Dscr1) and Nuclear receptor subfamily 4, group A, member 3 (Nr4a3) genes. Long-term (8 weeks) voluntary weightlifting training resulted in significantly increases of muscle mass, protein synthesis (puromycin incorporation in SUnSET assay) and mTOR pathway protein expression (raptor, 4e-bp-1, and p70S6K proteins) along with enhanced muscle power (specific torque and contraction speed), but not endurance capacity, mitochondrial biogenesis, and fiber type transformation. Importantly, weightlifting training profound improved whole-body glucose clearance and skeletal muscle insulin sensitivity along with enhanced autophagy (increased LC3 and LC3-II/I ratio, and decreased p62/Sqstm1). These data suggest that resistance training in mice promotes muscle adaptation and insulin sensitivity with simultaneous enhancement of autophagy and mTOR pathway.	[Cui, Di; Drake, Joshua C.; Wilson, Rebecca J.; Shute, Robert J.; Lewellen, Bevan; Zhang, Mei; Zhao, Henan; Yan, Zhen] Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, 409 Lane Rd,MR4-6031A, Charlottesville, VA 22908 USA; [Cui, Di] East China Normal Univ, Minist Educ, Key Lab Adolescent & Exercise Intervent, Shanghai, Peoples R China; [Wilson, Rebecca J.; Sabik, Olivia L.; Farber, Charles R.] Univ Virginia, Sch Med, Dept Biochem & Mol Genet, Charlottesville, VA 22908 USA; [Zhang, Mei; Yan, Zhen] Univ Virginia, Sch Med, Dept Med, Charlottesville, VA 22908 USA; [Sabik, Olivia L.; Onengut, Suna; Rich, Stephen S.; Farber, Charles R.] Univ Virginia, Sch Med, Ctr Publ Hlth Genom, Charlottesville, VA USA; [Berr, Stuart S.] Univ Virginia, Sch Med, Dept Radiol & Med Imaging, Charlottesville, VA 22908 USA; [Farber, Charles R.] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Yan, Zhen] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA	University of Virginia; East China Normal University; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia; University of Virginia	Yan, Z (corresponding author), Univ Virginia, Sch Med, Robert M Berne Cardiovasc Res Ctr, Ctr Skeletal Muscle Res, 409 Lane Rd,MR4-6031A, Charlottesville, VA 22908 USA.	zhen.yan@virginia.edu	Cui, Di/AHB-4211-2022	Rich, Stephen/0000-0003-3872-7793; Cui, Di/0000-0002-7356-9877; Yan, Zhen/0000-0002-4826-9813; Wilson, Rebecca/0000-0001-5884-0705	National Institutes of Health [R01AR050429]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	National Institutes of Health, Grant/Award Number: R01AR050429	Andersen LL, 2005, J APPL PHYSIOL, V99, P87, DOI 10.1152/japplphysiol.00091.2005; ARMSTRONG RB, 1979, J APPL PHYSIOL, V46, P835, DOI 10.1152/jappl.1979.46.4.835; Barash IA, 2007, AM J PHYSIOL-CELL PH, V293, pC218, DOI 10.1152/ajpcell.00055.2007; Blazevich AJ, 2007, J APPL PHYSIOL, V103, P1565, DOI 10.1152/japplphysiol.00578.2007; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Call JA, 2015, CIRC-HEART FAIL, V8, P188, DOI 10.1161/CIRCHEARTFAILURE.114.001540; Choi S, 2005, J APPL PHYSIOL, V99, P2406, DOI 10.1152/japplphysiol.00545.2005; Cholewa J, 2014, J CELL PHYSIOL, V229, P1148, DOI 10.1002/jcp.24542; DALLE PP, 2016, NAT COMMUN, V7, DOI [10.1038/ncomms13254, DOI 10.1038/NC0MMS13254]; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; Fernandez-Verdejo R, 2017, BIOCHEM BIOPH RES CO, V492, P249, DOI 10.1016/j.bbrc.2017.08.059; Fernandez-Verdejo R, 2017, FASEB J, V31, P840, DOI 10.1096/fj.201600987R; FIATARONE MA, 1990, JAMA-J AM MED ASSOC, V263, P3029, DOI 10.1001/jama.263.22.3029; Fry CS, 2013, J GERONTOL A-BIOL, V68, P599, DOI 10.1093/gerona/gls209; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Ganta VC, 2019, CIRCULATION, V139, P226, DOI 10.1161/CIRCULATIONAHA.118.034165; Glynn EL, 2010, AM J PHYSIOL-REG I, V299, pR533, DOI 10.1152/ajpregu.00077.2010; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Goodman CA, 2011, J PHYSIOL-LONDON, V589, P5485, DOI 10.1113/jphysiol.2011.218255; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Guridi M, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0084-8; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; He CC, 2012, AUTOPHAGY, V8, P1548, DOI 10.4161/auto.21327; Hentila J, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13069; Hitomi Y, 2003, IUBMB LIFE, V55, P409, DOI 10.1080/15216540310001592825; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Kanehisa H, 1997, INT J SPORTS MED, V18, P106, DOI 10.1055/s-2007-972604; Kido K, 2017, AM J PHYSIOL-REG I, V313, pR110, DOI 10.1152/ajpregu.00063.2017; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; Koskinen SOA, 2017, HISTOCHEM CELL BIOL, V148, P545, DOI 10.1007/s00418-017-1595-z; Kwon I, 2018, J PHYSIOL SCI, V68, P269, DOI 10.1007/s12576-017-0531-2; Laker RC, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00520-9; Lee S, 2004, J APPL PHYSIOL, V96, P1097, DOI 10.1152/japplphysiol.00479.2003; Lee S, 2012, DIABETES, V61, P2787, DOI 10.2337/db12-0214; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Luo L, 2013, EXP GERONTOL, V48, P427, DOI 10.1016/j.exger.2013.02.009; Mahoney DJ, 2005, FASEB J, V19, P1498, DOI 10.1096/fj.04-3149fje; Marzetti E, 2017, AGING CLIN EXP RES, V29, P35, DOI 10.1007/s40520-016-0705-4; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Ogasawara R, 2017, J APPL PHYSIOL, V123, P710, DOI 10.1152/japplphysiol.01009.2016; Ogasawara R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31142; Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231; Pearen MA, 2012, MOL ENDOCRINOL, V26, P372, DOI 10.1210/me.2011-1274; Philippe AG, 2019, EXP PHYSIOL, V104, P1274, DOI 10.1113/EP087071; Pollock ML, 2000, CIRCULATION, V101, P828, DOI 10.1161/01.CIR.101.7.828; Raue U, 2015, J APPL PHYSIOL, V118, P569, DOI 10.1152/japplphysiol.00759.2014; Russell RD, 2014, J STRENGTH COND RES, V28, P2760, DOI 10.1519/JSC.0000000000000624; Safdar A, 2016, NAT REV ENDOCRINOL, V12, P504, DOI 10.1038/nrendo.2016.76; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Sandri M, 2010, AM J PHYSIOL-CELL PH, V298, pC1291, DOI 10.1152/ajpcell.00531.2009; Schoenfeld BJ, 2010, J STRENGTH COND RES, V24, P3497, DOI 10.1519/JSC.0b013e3181bac2d7; SONG Z, 2017, SCI REP UK, V7; Spence AL, 2011, J PHYSIOL-LONDON, V589, P5443, DOI 10.1113/jphysiol.2011.217125; Stylianou AP, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4023982; Sylow L, 2015, J PHYSIOL-LONDON, V593, P645, DOI 10.1113/jphysiol.2014.284281; Widrick JJ, 2002, AM J PHYSIOL-REG I, V283, pR408, DOI 10.1152/ajpregu.00120.2002; Wilson RJ, 2019, J APPL PHYSIOL, V126, P193, DOI 10.1152/japplphysiol.00358.2018; WONG TS, 1990, J APPL PHYSIOL, V69, P1718, DOI 10.1152/jappl.1990.69.5.1718; Yan L, 2017, APPL PHYSIOL NUTR ME, V42, P1179, DOI 10.1139/apnm-2017-0285; Yaspelkis BB, 2002, ACTA PHYSIOL SCAND, V175, P315, DOI 10.1046/j.1365-201X.2002.00998.x	62	20	20	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7330	7344		10.1096/fj.201903055R	http://dx.doi.org/10.1096/fj.201903055R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304342	Green Accepted, Bronze			2022-12-26	WOS:000526959900001
J	Chung, R; Leung, SYJ; Abel, SN; Hatton, MN; Ren, YF; Seiver, J; Sloane, C; Lavigne, H; O'Donnell, T; O'Shea, L				Chung, Rakkoo; Leung, Shu-Yin John; Abel, Stephen N.; Hatton, Michael N.; Ren, Yanfang; Seiver, Jeffrey; Sloane, Carol; Lavigne, Howard; O'Donnell, Travis; O'Shea, Laura			HIV screening in the dental setting in New York State	PLOS ONE			English	Article							PATIENTS ATTITUDES; DENTISTS; WILLINGNESS; URBAN; COST	While primary care providers in New York State (NYS) are mandated to offer all patients a HIV test, still many NYS residents miss the HIV screening opportunity. To fill the gap, and as the CDC recommends, this study aimed to examine the feasibility of implementing HIV screening in dental setting, identify patient characteristics associated with acceptance of HIV rapid testing, and discuss best practices of HIV screening in dental setting. New York State Department of Health (NYSDOH) collaborated with the Northeast/Caribbean AIDS Education and Training Center (NECA AETC) and three dental schools in New York State to offer free HIV screening tests as a component of routine dental care between February 2016 and March 2018. Ten clinics in upstate New York and Long Island participated in the study. HIV screening was performed using the OraQuick (TM) In-Home HIV Test. 14,887 dental patients were offered HIV screening tests; 9,057 (60.8%) were screened; and one patient (0.011%) was confirmed HIV positive and linked to medical care. Of all dental patients, 33% had never been screened for HIV; and 56% had not had a primary care visit or had not been offered an HIV screening test by primary care providers in the previous 12 months. Multi-level generalized linear modeling analysis indicated that test acceptance was significantly associated with patient's age, race/ethnicity, gender, country of origin, primary payer (or insurance), past primary care visits, past HIV testing experiences, and the poverty level of patient's community. HIV screening is well accepted by dental patients and can be effectively integrated into routine dental care. HIV screening in the dental setting can be a good option for first-time testers, those who have not seen a primary care provider in the last 12 months, and those who have not been offered HIV screening at their last primary care visit.	[Chung, Rakkoo; Leung, Shu-Yin John; O'Donnell, Travis; O'Shea, Laura] New York State Dept Hlth, AIDS Inst, Albany, NY 12203 USA; [Abel, Stephen N.; Hatton, Michael N.] SUNY Buffalo, Sch Dent Med, Buffalo, NY USA; [Ren, Yanfang] Univ Rochester, Eastman Inst Oral Hlth, Rochester, NY USA; [Seiver, Jeffrey; Sloane, Carol] SUNY Stony Brook, Sch Dent Med, Stony Brook, NY 11794 USA; [Lavigne, Howard] Northeast Caribbean AIDS Educ & Training Ctr, Syracuse, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Chung, R (corresponding author), New York State Dept Hlth, AIDS Inst, Albany, NY 12203 USA.	rakkoo.chung@health.ny.gov	Ren, Yan-Fang/N-9369-2019	Ren, Yan-Fang/0000-0001-6428-2252; Chung, Rakkoo/0000-0002-9080-2298	New York State Department of Health [C30955GG, C30956GG, C30957GG]	New York State Department of Health	The HIV Screening in the Dental Chair ETE Demonstration Project was funded by the New York State Department of Health (C30955GG awarded to S.N.A. and M.N.H.; C30956GG awarded to Y.R.; C30957GG awarded to J.S. and C.S.). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the New York State Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel SN, 2013, J AM DENT ASSOC, V144, P1104, DOI 10.14219/jada.archive.2013.0028; Aguinis H, 2013, J MANAGE, V39, P1490, DOI 10.1177/0149206313478188; [Anonymous], 2018, HIV SURVEILLANCE S; Baggaley RF, 2017, LANCET HIV, V4, pE465, DOI 10.1016/S2352-3018(17)30123-6; Bert F, 2018, HEALTH POLICY, V122, P533, DOI 10.1016/j.healthpol.2018.03.007; Blackstock OJ, 2010, AIDS PATIENT CARE ST, V24, P781, DOI 10.1089/apc.2010.0159; Bradley ELP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196323; Branson Bernard M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Burns F, 2013, HIV MED, V14, P10, DOI 10.1111/hiv.12056; Corstjens PLAM, 2012, J AM DENT ASSOC, V143, P12, DOI DOI 10.14219/JADA.ARCHIVE.2012.0338; Davide Susan H, 2017, J Dent Hyg, V91, P41; Dietz CA, 2008, AIDS PATIENT CARE ST, V22, P205, DOI 10.1089/apc.2007.0235; Durall PS, 2015, SPEC CARE DENT, V35, P29, DOI 10.1111/scd.12096; Ene M, MULTILEVEL MODELS CA; Greenberg BL, 2017, INT J DENT HYG, V15, pe61, DOI 10.1111/idh.12217; Greenberg BL, 2015, J PUBLIC HEALTH DENT, V75, P225, DOI 10.1111/jphd.12093; Greenberg BL, 2012, J PUBLIC HEALTH DENT, V72, P28, DOI 10.1111/j.1752-7325.2011.00280.x; Greenberg BL, 2010, J AM DENT ASSOC, V141, P52, DOI 10.14219/jada.archive.2010.0021; Hutchinson MK, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-11; Joseph RH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225877; Leung SJ, 2012, AM AC OR MED ANN C A; Nassry DD, 2012, J DENT EDUC, V76, P1150; New York State Department of Health, HIV AIDS TEST REP CO; New York State Department of Health, 2017, NEW YORK STAT CASC H; New York State Department of Health, 2015 BLUEPR; Ong KJ, 2016, HIV MED, V17, P247, DOI 10.1111/hiv.12293; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI [10.1056/NEJM49042088, DOI 10.1056/NEJM49042088]; Parish CL, 2018, AIDS CARE, V30, P347, DOI 10.1080/09540121.2017.1367087; Pollack HA, 2014, AM J PUBLIC HEALTH, V104, P872, DOI 10.2105/AJPH.2013.301700; Pollack HA, 2010, AM J PUBLIC HEALTH, V100, P88, DOI 10.2105/AJPH.2008.157230; Raffalovich LE, 2014, INT J CONFL VIOLENCE, V8, P209; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Santella AJ, 2016, BRIT DENT J, V220, P229, DOI 10.1038/sj.bdj.2016.172; Santella AJ, 2013, INT J DENT HYG, V11, P287, DOI 10.1111/idh.12022; Siegel K, 2012, AM J PUBLIC HEALTH, V102, P625, DOI 10.2105/AJPH.2011.300509; Silveira Marushka Leanne, 2011, Ethics Biol Eng Med, V2, P115; Silveira ML, 2011, ETHICS BIOL ENG MED, V2, P115, DOI [10.1615/EthicsBiologyEngMed.2012004545, DOI 10.1615/ETHICSBI0L0GYENGIVIED.2012004545]; Simeon K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223669; Suarez-Durall P, 2019, SPEC CARE DENT, V39, P188, DOI 10.1111/scd.12363; VanDevanter N, 2012, NURS RES PRACT, V2012, DOI [10.1155/2012/803169, DOI 10.1155/2012/803169]; Vernillo A, 2011, AM J BIOETHICS, V11, P46, DOI [10.1080/15265161.2011.552162, 10.1080/15265161.2011.577515]; Wang LR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119274; Wilson E, 2013, ORAL DIS, V19, P431, DOI 10.1111/odi.12047	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231638	10.1371/journal.pone.0231638	http://dx.doi.org/10.1371/journal.pone.0231638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298336	Green Published, gold			2022-12-26	WOS:000536011400081
J	Li, JW; Wang, YS; Wang, Y; Yan, YQ; Tong, HL; Li, SF				Li Jiwei; Wang Yanshuang; Wang Yan; Yan Yunqin; Tong Huili; Li Shufeng			Fibronectin type III domain containing four promotes differentiation of C2C12 through the Wnt/beta-catenin signaling pathway	FASEB JOURNAL			English	Article						Dickkopf-related protein 1; low-density lipoprotein receptor-related protein 6; myogenin	DORSAL NEURAL-TUBE; PARAXIAL MESODERM; STEM-CELLS; MUSCLE; RECEPTOR; MYOGENESIS; PROTEINS; DISTINCT; FAMILY; VASCULARIZATION	Fibronectin type III domain containing 4 (FNDC4) belongs to the fibronectin type III domain containing protein family. FNDC5, which is highly homologous to FNDC4, can promote the differentiation of cardiac cells. We aimed to investigate the role of FNDC4 in the differentiation of C2C12 mouse skeletal muscle cells. Western blotting and immunofluorescence analysis showed that FNDC4 gradually increased with the differentiation of C2C12. Muscle injury repair experiments indicated that FNDC4 may promote the repair of injured muscles. When FNDC4 was either overexpressed or knocked down, the expression of desmin and myogenin myogenic marker molecules followed that of FNDC4, suggesting that FNDC4 can influence the differentiation of C2C12. In addition, immunoprecipitation results showed that FNDC4 can interact with the Wnt/beta-catenin signaling pathway receptor low-density lipoprotein receptor-related protein 6 (LRP6), and that beta-catenin levels in the nucleus decreased after knocking down FNDC4. Exogenous addition of FNDC4 protein could not restore the blocking of differentiation due to inhibition of both Wnt/beta-catenin signal transduction and LRP6 activity via the beta-catenin inhibitor XAV-939. Overall, our findings indicate that FDNC4 can influence the differentiation of C2C12 by activating Wnt/beta-catenin signal transduction.	[Li Jiwei; Wang Yanshuang; Wang Yan; Yan Yunqin; Tong Huili; Li Shufeng] Northeast Agr Univ, Lab Cell & Dev Biol, Changjiang Rd 600, Harbin 150030, Heilongjiang, Peoples R China	Northeast Agricultural University - China	Li, SF (corresponding author), Northeast Agr Univ, Lab Cell & Dev Biol, Changjiang Rd 600, Harbin 150030, Heilongjiang, Peoples R China.	lishufeng11@sina.com		jiwei, li/0000-0002-1353-4445	Heilongjiang Natural Science Foundation [C2016029]	Heilongjiang Natural Science Foundation(Natural Science Foundation of Heilongjiang Province)	Heilongjiang Natural Science Foundation, Grant/Award Number: C2016029	Agley CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10731-1; Alexander MS, 2013, CELL DEATH DIFFER, V20, P1194, DOI 10.1038/cdd.2013.62; Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Asfour HA, 2018, EXP BIOL MED, V243, P118, DOI 10.1177/1535370217749494; Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Church VL, 2002, INT J DEV BIOL, V46, P927; Colaianni G, 2017, ANN NY ACAD SCI, V1402, P5, DOI 10.1111/nyas.13345; Cui YF, 2018, EXP CELL RES, V366, P199, DOI 10.1016/j.yexcr.2018.03.027; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Hey PJ, 1998, GENE, V216, P103, DOI 10.1016/S0378-1119(98)00311-4; Ikeya M, 1998, DEVELOPMENT, V125, P4969; Jones AE, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0038-6; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim JH, 2018, CELL DEATH DIFFER, V25, P1921, DOI 10.1038/s41418-018-0165-9; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Lee W, 2018, BIOCHEM BIOPH RES CO, V502, P129, DOI 10.1016/j.bbrc.2018.05.133; Liu D, 2019, J CELL PHYSIOL, V234, P11130, DOI 10.1002/jcp.27763; Lv ZT, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3936257; MAIN AL, 1992, CELL, V71, P671, DOI 10.1016/0092-8674(92)90600-H; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Meadows E, 2008, DEV BIOL, V322, P406, DOI 10.1016/j.ydbio.2008.07.024; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Nazem S, 2018, J CELL BIOCHEM, V119, P4528, DOI 10.1002/jcb.26590; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Paulin D, 2004, EXP CELL RES, V301, P1, DOI 10.1016/j.yexcr.2004.08.004; Perry RA, 2016, MECH AGEING DEV, V157, P7, DOI 10.1016/j.mad.2016.05.007; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; ROSKELLEY CD, 1995, CURR OPIN CELL BIOL, V7, P736, DOI 10.1016/0955-0674(95)80117-0; RUOSLAHTI E, 1988, ANNU REV BIOCHEM, V57, P375, DOI 10.1146/annurev.bi.57.070188.002111; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; STERN HM, 1995, DEVELOPMENT, V121, P3675; Strutt D, 2003, DEVELOPMENT, V130, P4501, DOI 10.1242/dev.00695; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Teufel A, 2002, GENE, V297, P79, DOI 10.1016/S0378-1119(02)00828-4; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110; Wrann CD, 2013, CELL METAB, V18, P649, DOI 10.1016/j.cmet.2013.09.008; Zhang H, 2018, MOL BIOTECHNOL, V60, P396, DOI 10.1007/s12033-018-0079-2; Zhang WW, 2018, J CELL PHYSIOL, V233, P350, DOI 10.1002/jcp.25883	54	7	7	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7759	7772		10.1096/fj.201902860RRR	http://dx.doi.org/10.1096/fj.201902860RRR		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32298013				2022-12-26	WOS:000526946200001
J	Park, SH; Choi, CH; Yoon, HK; Ha, JW; Lee, C; Chung, K				Park, Sang-Hoon; Choi, Chong Hyuk; Yoon, Han-Kook; Ha, Joong-Won; Lee, Changmin; Chung, Kwangho			What can the radiological parameters of superior migration of the humeral head tell us about the reparability of massive rotator cuff tears?	PLOS ONE			English	Article							ACROMIOHUMERAL DISTANCE; PARTIAL REPAIR; SHOULDER; CLASSIFICATION; RECONSTRUCTION; ASSOCIATION; PREDICT; VIEW	Objective The interrelation and clinical utility of the parameters for superior migration of the humeral head, such as the acromiohumeral interval (AHI), inferior glenohumeral distance (IGHD), and upward migration index (UMI), in the management of massive rotator cuff tears are not clear. The objectives of this study were to identify the relation between AHI, IGHD, and UMI when measured with radiography and MRI and to determine whether superior migration can predict the irreparability of massive rotator cuff tears. Methods We retrospectively reviewed the files of 64 consecutive patients who underwent arthroscopic partial or complete repair for massive rotator cuff tears at our institution between August 2015 and August 2018. We recorded both radiography and MRI measurements of AHI, IGHD, and UMI, and further the tangent sign, fatty infiltration of the rotator cuff muscles, and the Patte grade. We performed correlation assessments and multiple logistic regression analysis to identify potential predictors of the reparability of massive rotator cuff tears. Results Thirty-five patients had partially reparable and 29 had completely reparable tears. Parameters measured with either radiography or MRI were highly correlated with each other. The radiographic measurements showed a moderate or low correlation with the MRI measurements. All parameters of superior migration of the humeral head on radiography and MRI, the tangent sign, fatty infiltration of the infraspinatus muscle, and the Patte grade showed significant differences between patients with partially and completely repaired tears. Among these, the independent predictors for irreparability was Patte grade = 3. Conclusion The AHI, IGHD, and UMI were highly correlated when measured with either radiography or MRI, but not when comparing their radiographic with their MRI values. Furthermore, they were not independent indicators of reparability in massive rotator cuff tears.	[Park, Sang-Hoon; Yoon, Han-Kook; Ha, Joong-Won] Ilsan Hosp, Natl Hlth Insurance Serv, Dept Orthopaed Surg, Goyang, South Korea; [Choi, Chong Hyuk; Lee, Changmin; Chung, Kwangho] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea; [Chung, Kwangho] Yongin Severance Hosp, Dept Orthopaed Surg, Yongin, Gyeonggido, South Korea	National Health Insurance Service; NHIS Ilsan Hospital; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chung, K (corresponding author), Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea.; Chung, K (corresponding author), Yongin Severance Hosp, Dept Orthopaed Surg, Yongin, Gyeonggido, South Korea.	khchung85@yuhs.ac		Choi, Chong Hyuk/0000-0002-9080-4904; Chung, Kwangho/0000-0003-3097-3332				Abrams Jeffrey S, 2012, Instr Course Lect, V61, P121; Bernhardt G A, 2013, Eur J Orthop Surg Traumatol, V23, P185, DOI 10.1007/s00590-012-0942-y; Burkhart SS, 1997, ORTHOP CLIN N AM, V28, P125, DOI 10.1016/S0030-5898(05)70270-4; COTTON RE, 1964, J BONE JOINT SURG BR, V46, P314, DOI 10.1302/0301-620X.46B2.314; Cunningham G, 2015, ARTHROSCOPY, V31, P1688, DOI 10.1016/j.arthro.2015.03.010; Dwyer T, 2015, KNEE SURG SPORT TR A, V23, P415, DOI 10.1007/s00167-013-2745-z; ELLMAN H, 1986, J BONE JOINT SURG AM, V68A, P1136, DOI 10.2106/00004623-198668080-00002; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Fleiss J. L., 2011, DESIGN ANAL CLIN EXP; Gerber C, 2000, J BONE JOINT SURG AM, V82A, P505, DOI 10.2106/00004623-200004000-00006; GOLDING FC, 1962, BRIT J RADIOL, V35, P149, DOI 10.1259/0007-1285-35-411-149; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Goutallier D, 2011, ORTHOP TRAUMATOL-SUR, V97, P246, DOI 10.1016/j.otsr.2011.01.010; Gruber G, 2010, J SHOULDER ELB SURG, V19, P10, DOI 10.1016/j.jse.2009.04.010; HAMADA K, 1990, CLIN ORTHOP RELAT R, P92; Hamada K, 2011, CLIN ORTHOP RELAT R, V469, P2452, DOI 10.1007/s11999-011-1896-9; HARRISON SH, 1949, J BONE JOINT SURG BR, V31, P418, DOI 10.1302/0301-620X.31B3.418; Hirooka A, 1996, ACTA ORTHOP SCAND, V67, P258, DOI 10.3109/17453679608994684; Hirooka Atsushi, 2002, J Orthop Sci, V7, P451, DOI 10.1007/s007760200078; KERNWEIN GA, 1965, J AMER MED ASSOC, V194, P1081, DOI 10.1001/jama.194.10.1081; Kim IB, 2018, ARTHROSCOPY, V34, P2076, DOI 10.1016/j.arthro.2018.02.033; Kim JY, 2017, AM J SPORT MED, V45, P1654, DOI 10.1177/0363546517694160; Kim SJ, 2016, BONE JOINT J, V98B, P1656, DOI 10.1302/0301-620X.98B12.BJJ-2016-0316; Kim SJ, 2012, ARTHROSCOPY, V28, P761, DOI 10.1016/j.arthro.2011.11.018; Kim YK, 2018, J SHOULDER ELB SURG, V27, P1012, DOI 10.1016/j.jse.2017.11.016; Moore DR, 2006, AM J SPORT MED, V34, P392, DOI 10.1177/0363546505281237; Nove-Josserand L, 2005, CLIN ORTHOP RELAT R, P90, DOI 10.1097/01.blo.0000151441.05180.0e; OZAKI J, 1986, CLIN ORTHOP RELAT R, P173; PATTE D, 1990, CLIN ORTHOP RELAT R, P81; Railhac JJ, 2001, J RADIOL, V82, P979; Saupe N, 2006, AM J ROENTGENOL, V187, P376, DOI 10.2214/AJR.05.0435; Shim SB, 2018, J SHOULDER ELB SURG, V27, P1932, DOI 10.1016/j.jse.2018.07.011; Shin YK, 2018, AM J ROENTGENOL, V210, P134, DOI 10.2214/AJR.17.17915; van de Sande MAJ, 2006, CLIN ORTHOP RELAT R, P260, DOI 10.1097/01.blo.0000196043.34789.73; van de Sande MAJ, 2006, CLIN ORTHOP RELAT R, P73, DOI 10.1097/01.blo.0000229294.06475.41; Weiner D S, 1970, J Bone Joint Surg Br, V52, P524; Werner BS, 2016, J SHOULDER ELB SURG, V25, pE276, DOI 10.1016/j.jse.2016.02.017; Werner CML, 2008, J SHOULDER ELB SURG, V17, P237, DOI 10.1016/j.jse.2007.06.002; Zanetti M, 1998, INVEST RADIOL, V33, P163, DOI 10.1097/00004424-199803000-00006; Zumstein MA, 2008, J BONE JOINT SURG AM, V90A, P2423, DOI 10.2106/JBJS.G.00677	40	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231843	10.1371/journal.pone.0231843	http://dx.doi.org/10.1371/journal.pone.0231843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298371	Green Published, gold			2022-12-26	WOS:000536011400119
J	Saraswati, S; Lietman, CD; Li, B; Mathew, S; Zent, R; Young, PP				Saraswati, Sarika; Lietman, Caressa D.; Li, Bin; Mathew, Sijo; Zent, Roy; Young, Pampee P.			Small proline-rich repeat 3 is a novel coordinator of PDGFR beta and integrin beta 1 crosstalk to augment proliferation and matrix synthesis by cardiac fibroblasts	FASEB JOURNAL			English	Article						collagen; fibrosis; heart failure; pressure overload; transverse aortic constriction	FOCAL ADHESION KINASE; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; SIGNALING PATHWAYS; GENE-EXPRESSION; MOLECULAR CHARACTERIZATION; MYOCARDIAL FIBROSIS; COLLAGEN GENE; UP-REGULATION; EGF RECEPTOR	Nearly 6 million Americans suffer from heart failure. Increased fibrosis contributes to functional decline of the heart that leads to heart failure. Previously, we identified a mechanosensitive protein, small proline-rich repeat 3 (SPRR3), in vascular smooth muscle cells of atheromas. In this study, we demonstrate SPRR3 expression in cardiac fibroblasts which is induced in activated fibroblasts following pressure-induced heart failure. Sprr3 deletion in mice showed preserved cardiac function and reduced interstitial fibrosis in vivo and reduced fibroblast proliferation and collagen expression in vitro. SPRR3 loss resulted in reduced activation of Akt, FAK, ERK, and p38 signaling pathways, which are coordinately regulated by integrins and growth factors. SPRR3 deletion did not impede integrin-associated functions including cell adhesion, migration, or contraction. SPRR3 loss resulted in reduced activation of PDGFR beta in fibroblasts. This was not due to the reduced PDGFR beta expression levels or decreased binding of the PDGF ligand to PDGFR beta. SPRR3 facilitated the association of integrin beta 1 with PDGFR beta and subsequently fibroblast proliferation, suggesting a role in PDGFR beta-Integrin synergy. We postulate that SPRR3 may function as a conduit for the coordinated activation of PDGFR beta by integrin beta 1, leading to augmentation of fibroblast proliferation and matrix synthesis downstream of biomechanical and growth factor signals.	[Saraswati, Sarika; Lietman, Caressa D.; Li, Bin; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave South,MCN C2217, Nashville, TN 37232 USA; [Mathew, Sijo] North Dakota State Univ, Sch Pharm, Dept Pharmaceut Sci, Fargo, ND USA; [Zent, Roy] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN USA; [Young, Pampee P.] Amer Red Cross, Div Biomed, Washington, DC USA	Vanderbilt University; North Dakota State University Fargo; Vanderbilt University; American Red Cross	Saraswati, S; Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, 1161 21st Ave South,MCN C2217, Nashville, TN 37232 USA.	sarika.saraswati@vanderbilt.edu; pampee.young@redcross.org		Saraswati, Sarika/0000-0002-5674-8371	VA merit award [1BX002337A]; National Institute of General Medical Sciences of the National Institutes of Health (NIH) [R01GM118300]; National Institute of Biomedical Imaging and Bioengineering of the NIH [R21EB019509]; National Blood Foundation; American Heart Association Postdoctoral Fellowship Award [17POST33670744]; American Heart Association [17SDG33630187]	VA merit award(US Department of Veterans Affairs); National Institute of General Medical Sciences of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Biomedical Imaging and Bioengineering of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Blood Foundation; American Heart Association Postdoctoral Fellowship Award(American Heart Association); American Heart Association(American Heart Association)	Research reported in this publication was supported by VA merit award 1BX002337A (PPY), the National Institute of General Medical Sciences of the National Institutes of Health (NIH) Award R01GM118300 (SS), National Institute of Biomedical Imaging and Bioengineering of the NIH Award R21EB019509 (PPY), National Blood Foundation Grant (SS), American Heart Association Postdoctoral Fellowship Award 17POST33670744 (CL) and Scientist Development Grant from the American Heart Association Award 17SDG33630187 (SS).The authors want to thank Dr Jeffrey M. Davidson for careful reading of the manuscript and his critical feedback. The authors are very thankful to Dr Hind Lal and his laboratory from the University of Alabama at Birmingham for providing cardiomyocytes RNA following TAC surgery. The authors are thankful to Youli Yao and Sarah Lechner for their help in migration and cell adhesion experiments.	Abeyrathna P, 2015, VASC PHARMACOL, V74, P38, DOI 10.1016/j.vph.2015.05.008; Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Babbitt CJ, 2002, HISTOCHEM CELL BIOL, V118, P431, DOI 10.1007/s00418-002-0476-1; BACKENDORF C, 1992, NAT GENET, V2, P91, DOI 10.1038/ng1092-91; Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bellucci A, 2014, METHODS MOL BIOL, V1174, P397, DOI 10.1007/978-1-4939-0944-5_27; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; BITTERMAN P, 1983, CHEST, V83, pS96; Borkham-Kamphorst E, 2016, CYTOKINE GROWTH F R, V28, P53, DOI 10.1016/j.cytogfr.2015.10.002; BORNFELDT KE, 1994, J CLIN INVEST, V93, P1266, DOI 10.1172/JCI117081; Cabodi S, 2004, BIOCHEM SOC T, V32, P438, DOI 10.1042/BST0320438; Camelliti P, 2005, CARDIOVASC RES, V65, P40, DOI 10.1016/j.cardiores.2004.08.020; Carregaro F, 2013, ARCH DERMATOL RES, V305, P857, DOI 10.1007/s00403-013-1415-9; CHAPMAN D, 1990, CIRC RES, V67, P787, DOI 10.1161/01.RES.67.4.787; Chen C, 2016, J MOL CELL CARDIOL, V93, P162, DOI 10.1016/j.yjmcc.2015.11.010; Cho DH, 2010, MOL MED, V16, P271, DOI 10.2119/molmed.2009.00187; CLAESSONWELSH L, 1994, J BIOL CHEM, V269, P32023; Clemente CFMZ, 2007, CIRC RES, V101, P1339, DOI 10.1161/CIRCRESAHA.107.160978; Dalla Costa AP, 2010, CARDIOVASC RES, V86, P421, DOI 10.1093/cvr/cvp416; Fan B, 2014, INT J CLIN EXP PATHO, V7, P16; Fan H, 2014, AM J TRANSL RES, V6, P714; Fischer DF, 2007, ADV BIOCHEM ENG BIOT, V104, P37, DOI 10.1007/10_027; Fischer DF, 1999, GENOMICS, V55, P88, DOI 10.1006/geno.1998.5622; Fischer DF, 1996, MOL CELL BIOL, V16, P5365, DOI 10.1128/mcb.16.10.5365; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Gallini R, 2016, EXP CELL RES, V349, P282, DOI 10.1016/j.yexcr.2016.10.022; Giancotti FG, 2003, ANNU REV CELL DEV BI, V19, P173, DOI 10.1146/annurev.cellbio.19.031103.133334; GIBBS S, 1993, GENOMICS, V16, P630, DOI 10.1006/geno.1993.1240; Gulati A, 2013, JAMA-J AM MED ASSOC, V309, P896, DOI 10.1001/jama.2013.1363; Hayashida T, 1999, KIDNEY INT, V56, P1710, DOI 10.1046/j.1523-1755.1999.00733.x; HOHL D, 1995, J INVEST DERMATOL, V104, P902, DOI 10.1111/1523-1747.ep12606176; Holmes JW, 2005, ANNU REV BIOMED ENG, V7, P223, DOI 10.1146/annurev.bioeng.7.060804.100453; Ivaska J, 2011, ANNU REV CELL DEV BI, V27, P291, DOI 10.1146/annurev-cellbio-092910-154017; Kim JC, 2012, BREAST CANCER RES TR, V133, P909, DOI 10.1007/s10549-011-1868-5; Koizumi H, 1996, BRIT J DERMATOL, V134, P686, DOI 10.1111/j.1365-2133.1996.tb06971.x; Kong P, 2013, AM J PHYSIOL-HEART C, V305, pH1363, DOI 10.1152/ajpheart.00395.2013; Lietman CD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184620; Manso AM, 2009, AM J PHYSIOL-HEART C, V296, pH627, DOI 10.1152/ajpheart.00444.2008; Marenholz I, 2001, GENOME RES, V11, P341, DOI 10.1101/gr.114801; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; Moro L, 1998, EMBO J, V17, P6622, DOI 10.1093/emboj/17.22.6622; Oka T, 2014, CIRC RES, V114, P565, DOI 10.1161/CIRCRESAHA.114.300507; Palcy S, 1999, BIOCHEM J, V343, P21, DOI 10.1042/0264-6021:3430021; Pyle AL, 2008, AM J PATHOL, V173, P1577, DOI 10.2353/ajpath.2008.080042; Rajshankar D, 2017, FASEB J, V31, P937, DOI 10.1096/fj.201600645R; Runyan CE, 2004, J BIOL CHEM, V279, P2632, DOI 10.1074/jbc.M310412200; SADOSHIMA J, 1992, J BIOL CHEM, V267, P10551; Schluter KD, 2004, CARDIOVASC RES, V63, P367, DOI 10.1016/j.cardiores.2004.06.012; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Segedy AK, 2014, ARTERIOSCL THROM VAS, V34, P2527, DOI 10.1161/ATVBAHA.114.303644; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Souders CA, 2012, AM J PATHOL, V181, P1226, DOI 10.1016/j.ajpath.2012.06.015; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stewart JA, 2010, CELL TISSUE RES, V340, P117, DOI 10.1007/s00441-010-0943-2; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Sundberg C, 1996, J CELL BIOL, V132, P741, DOI 10.1083/jcb.132.4.741; Svegliati-Baroni G, 2001, HEPATOLOGY, V33, P1130, DOI 10.1053/jhep.2001.23788; Takada Y, 2017, CYTOKINE GROWTH F R, V34, P67, DOI 10.1016/j.cytogfr.2017.01.003; TERRACIO L, 1991, CIRC RES, V68, P734, DOI 10.1161/01.RES.68.3.734; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Valiente-Alandi I, 2018, CIRCULATION, V138, P1236, DOI 10.1161/CIRCULATIONAHA.118.034609; Veevers-Lowe J, 2011, J CELL SCI, V124, P1288, DOI 10.1242/jcs.076935; Wang L, 2016, J PHYSIOL BIOCHEM, V72, P213, DOI 10.1007/s13105-016-0471-y; WILLIAMS LT, 1989, SCIENCE, V243, P1564, DOI 10.1126/science.2538922; YAAR M, 1995, EXP CELL RES, V217, P217, DOI 10.1006/excr.1995.1081; Yokoyama K, 2012, GRAEF ARCH CLIN EXP, V250, P15, DOI 10.1007/s00417-011-1766-x; Young PP, 2005, CIRCULATION, V111, P2382, DOI 10.1161/01.CIR.0000164235.26339.78; Zemskov EA, 2009, J BIOL CHEM, V284, P16693, DOI 10.1074/jbc.M109.010769	70	10	10	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7885	7904		10.1096/fj.201902815R	http://dx.doi.org/10.1096/fj.201902815R		APR 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297675	Green Published, hybrid			2022-12-26	WOS:000526945700001
J	Li, X; Yang, L; Mao, ZM; Pan, XY; Zhao, YS; Gu, X; Eckel-Mahan, K; Zuo, ZY; Tong, Q; Hartig, SM; Cheng, XD; Du, GW; Moore, DD; Bellen, HJ; Sesaki, H; Sun, K				Li, Xin; Yang, Li; Mao, Zhengmei; Pan, Xueyang; Zhao, Yueshui; Gu, Xue; Eckel-Mahan, Kristin; Zuo, Zhongyuan; Tong, Qiang; Hartig, Sean M.; Cheng, Xiaodong; Du, Guangwei; Moore, David D.; Bellen, Hugo J.; Sesaki, Hiromi; Sun, Kai			Novel role of dynamin-related-protein 1 in dynamics of ER-lipid droplets in adipose tissue	FASEB JOURNAL			English	Article						energy expenditure; ER retention; LD budding; LD morphology; lipolysis	ENDOPLASMIC-RETICULUM STRESS; MITOCHONDRIAL FISSION; AUTOPHAGY; MEMBRANE; OBESITY; TUBULES; GROWTH; S3-12; FAT	Dynamin-Related-Protein 1 (DRP1) critically regulates mitochondrial and peroxisomal fission in multicellular organisms. However, the impact of DRP1 on other organelles, especially its direct influence on ER functions remains largely unclear. Here, we report that DRP1 translocates to endoplasmic reticulum (ER) in response to beta-adrenergic stimulation. To further investigate the function of DRP1 on ER-lipid droplet (LD) dynamics and the metabolic subsequences, we generated an adipose tissue-specific DRP1 knockout model (Adipo-Drp1(flx/flx)). We found that the LDs in adipose tissues of Adipo-Drp1(flx/flx) mice exhibited more unilocular morphology with larger sizes, and formed less multilocular structures upon cold exposure. Mechanistically, we discovered that abnormal LD morphology occurs because newly generated micro-LDs fail to dissociate from the ER due to DRP1 ablation. Conversely, the ER retention of LDs can be rescued by the overexpressed DRP1 in the adipocytes. The alteration of LD dynamics, combined with abnormal mitochondrial and autophagy functions in adipose tissue, ultimately lead to abnormalities in lipid metabolism in Adipo-Drp1(flx/flx) mice.	[Li, Xin; Yang, Li; Zhao, Yueshui; Gu, Xue; Eckel-Mahan, Kristin; Sun, Kai] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Metab & Degenerat Dis, 1825 Pressler ST, Houston, TX 77030 USA; [Mao, Zhengmei] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Microscopy Core, Houston, TX 77030 USA; [Pan, Xueyang] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA; [Eckel-Mahan, Kristin; Cheng, Xiaodong; Du, Guangwei; Sun, Kai] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Dept Integrat Biol & Pharmacol, Grad Program Cell & Regulatory Biol, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Zuo, Zhongyuan; Bellen, Hugo J.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Tong, Qiang] Baylor Coll Med, Childrens Nutr Res Ctr, Houston, TX 77030 USA; [Hartig, Sean M.; Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Cheng, Xiaodong] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Texas Therapeut Inst, Houston, TX 77030 USA; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Johns Hopkins University	Sun, K (corresponding author), Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med Prevent Human Dis, Ctr Metab & Degenerat Dis, 1825 Pressler ST, Houston, TX 77030 USA.	kai.sun@uth.tmc.edu	Pan, Xueyang/Y-1641-2019	Pan, Xueyang/0000-0003-4453-4971; Sun, Kai/0000-0002-4778-4549; /0000-0002-6232-791X; Du, Guangwei/0000-0003-4193-6975	NIH [R01DK109001, GM123266, R01DK114356, AR075830, R01DK114037]; NIGMS [R35GM122536]; USDA [CRIS 3092-5001-059]; AHA [18TPA34170539, 19TPA34910051]; American Diabetes Association [1-18-IBS-105]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USDA(United States Department of Agriculture (USDA)); AHA(American Heart Association); American Diabetes Association(American Diabetes Association)	NIH, Grant/Award Number: R01DK109001, GM123266, R01DK114356, AR075830 and R01DK114037; NIGMS, Grant/Award Number: R35GM122536; USDA, Grant/Award Number: CRIS 3092-5001-059; AHA, Grant/Award Number: 18TPA34170539 and 19TPA34910051; American Diabetes Association, Grant/Award Number: #1-18-IBS-105	Adler J, 2010, CYTOM PART A, V77A, P733, DOI 10.1002/cyto.a.20896; Bhattacharya A, 2018, EMBO J, V37, DOI 10.15252/embj.201899277; Cermelli S, 2006, CURR BIOL, V16, P1783, DOI 10.1016/j.cub.2006.07.062; Chung J, 2019, DEV CELL, V51, P551, DOI 10.1016/j.devcel.2019.10.006; Datta S, 2019, J CELL BIOL, V218, P1335, DOI 10.1083/jcb.201808133; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Frohlich C, 2013, EMBO J, V32, P1280, DOI 10.1038/emboj.2013.74; Gao G, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000355; Gao MM, 2019, PROG LIPID RES, V75, DOI 10.1016/j.plipres.2019.100989; Gao MM, 2018, J CELL BIOL, V217, P3322, DOI 10.1083/jcb.201808151; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Guo Y, 2009, J CELL SCI, V122, P749, DOI 10.1242/jcs.037630; Hapala I, 2011, BIOL CELL, V103, P271, DOI 10.1042/BC20100144; Hariri H, 2019, J CELL BIOL, V218, P1319, DOI 10.1083/jcb.201808119; Hashemi HF, 2015, CURR OPIN CELL BIOL, V33, P119, DOI 10.1016/j.ceb.2015.02.002; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jaishy B, 2016, J LIPID RES, V57, P1619, DOI 10.1194/jlr.R067520; Ji WK, 2017, J CELL BIOL, V216, P4123, DOI 10.1083/jcb.201610057; Kamerkar SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07543-w; Koch A, 2003, J BIOL CHEM, V278, P8597, DOI 10.1074/jbc.M211761200; Kolahi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153522; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Krahmer N, 2013, EMBO MOL MED, V5, P973, DOI 10.1002/emmm.201100671; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Li X, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00564-19; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Martinez-Lopez N, 2016, CELL METAB, V23, P113, DOI 10.1016/j.cmet.2015.10.008; Nguyen TB, 2019, J CELL BIOL, V218, P1089, DOI 10.1083/jcb.201902160; Ohsaki Y, 2008, J CELL SCI, V121, P2415, DOI 10.1242/jcs.025452; Ohsaki Y, 2017, ADV EXP MED BIOL, V997, P111, DOI 10.1007/978-981-10-4567-7_8; Olzmann JA, 2019, NAT REV MOL CELL BIO, V20, P137, DOI 10.1038/s41580-018-0085-z; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pidoux G, 2011, EMBO J, V30, P4371, DOI 10.1038/emboj.2011.365; Pitts KR, 1999, MOL BIOL CELL, V10, P4403, DOI 10.1091/mbc.10.12.4403; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sathyanarayan A, 2017, CELL REP, V19, P1, DOI 10.1016/j.celrep.2017.03.026; Schulze RJ, 2013, J CELL BIOL, V203, P315, DOI 10.1083/jcb.201306140; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Steffen J, 2018, J CELL BIOL, V217, P15, DOI 10.1083/jcb.201711075; Tamura Y, 2011, CELL, V145, DOI 10.1016/j.cell.2011.06.018; Thiam AR, 2016, BBA-MOL CELL BIOL L, V1861, P715, DOI 10.1016/j.bbalip.2016.04.018; Wakabayashi J, 2009, J CELL BIOL, V186, P805, DOI 10.1083/jcb.200903065; Walther TC, 2012, ANNU REV BIOCHEM, V81, P687, DOI 10.1146/annurev-biochem-061009-102430; Wang LX, 2015, DIABETOLOGIA, V58, P2371, DOI 10.1007/s00125-015-3704-7; Wikstrom JD, 2014, EMBO J, V33, P418, DOI 10.1002/embj.201385014; Wolins NE, 2005, J BIOL CHEM, V280, P19146, DOI 10.1074/jbc.M500978200; Wolins NE, 2003, J BIOL CHEM, V278, P37713, DOI 10.1074/jbc.M304025200; Xu DJ, 2018, J CELL BIOL, V217, P975, DOI 10.1083/jcb.201704184; Xu SM, 2018, BBA-MOL BASIS DIS, V1864, P1968, DOI 10.1016/j.bbadis.2017.07.019; Yan RH, 2018, DEV CELL, V47, P248, DOI 10.1016/j.devcel.2018.09.010; Yang L, 2019, DIABETES, V68, P1178, DOI 10.2337/db18-1210; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhao YS, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00242-18; Zhao YS, 2016, AM J PHYSIOL-ENDOC M, V311, pE952, DOI 10.1152/ajpendo.00314.2016; Zhou ZS, 2020, SCIENCE, V368, P54, DOI 10.1126/science.aay2494	61	6	6	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8265	8282		10.1096/fj.201903100RR	http://dx.doi.org/10.1096/fj.201903100RR		APR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32294302	Bronze, Green Accepted			2022-12-26	WOS:000526104400001
J	Arrieta, A; Blackwood, EA; Stauffer, WT; Santo Domingo, M; Bilal, AS; Thuerauf, DJ; Pentoney, AN; Aivati, C; Sarakki, AV; Doroudgar, S; Glembotski, CC				Arrieta, Adrian; Blackwood, Erik A.; Stauffer, Winston T.; Santo Domingo, Michelle; Bilal, Alina S.; Thuerauf, Donna J.; Pentoney, Amber N.; Aivati, Cathrine; Sarakki, Anup V.; Doroudgar, Shirin; Glembotski, Christopher C.			Mesencephalic astrocyte?derived neurotrophic factor is an ER-resident chaperone that protects against reductive stress in the heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); protein folding; cardiomyocyte; ischemia; chaperone; cardiomyocyte; heart function; ischemia; reperfusion; mesencephalic astrocyte-derived neurotrophic factor (MANF); reductive stress; unfolded protein response	ENDOPLASMIC-RETICULUM STRESS; ALPHA-B-CRYSTALLIN; CARDIAC MYOCYTES; OXIDATIVE STRESS; GENE INDUCTION; PROTEINS; ATF6; DEGRADATION; AGGREGATION; DAMAGE	We have previously demonstrated that ischemia/reperfusion (I/R) impairs endoplasmic reticulum (ER)-based protein folding in the heart and thereby activates an unfolded protein response sensor and effector, activated transcription factor 6? (ATF6). ATF6 then induces mesencephalic astrocyte-derived neurotrophic factor (MANF), an ER-resident protein with no known structural homologs and unclear ER function. To determine MANF's function in the heart in vivo, here we developed a cardiomyocyte-specific MANF-knockdown mouse model. MANF knockdown increased cardiac damage after I/R, which was reversed by AAV9-mediated ectopic MANF expression. Mechanistically, MANF knockdown in cultured neonatal rat ventricular myocytes (NRVMs) impaired protein folding in the ER and cardiomyocyte viability during simulated I/R. However, this was not due to MANF-mediated protection from reactive oxygen species generated during reperfusion. Because I/R impairs oxygen-dependent ER protein disulfide formation and such impairment can be caused by reductive stress in the ER, we examined the effects of the reductive ER stressor DTT. MANF knockdown in NRVMs increased cell death from DTT-mediated reductive ER stress, but not from nonreductive ER stresses caused by thapsigargin-mediated ER Ca2+ depletion or tunicamycin-mediated inhibition of ER protein glycosylation. In vitro, recombinant MANF exhibited chaperone activity that depended on its conserved cysteine residues. Moreover, in cells, MANF bound to a model ER protein exhibiting improper disulfide bond formation during reductive ER stress but did not bind to this protein during nonreductive ER stress. We conclude that MANF is an ER chaperone that enhances protein folding and myocyte viability during reductive ER stress.	[Arrieta, Adrian; Blackwood, Erik A.; Stauffer, Winston T.; Santo Domingo, Michelle; Bilal, Alina S.; Thuerauf, Donna J.; Pentoney, Amber N.; Aivati, Cathrine; Sarakki, Anup V.; Doroudgar, Shirin; Glembotski, Christopher C.] San Diego State Univ, Inst Heart, San Diego, CA 92182 USA; [Arrieta, Adrian; Blackwood, Erik A.; Stauffer, Winston T.; Santo Domingo, Michelle; Bilal, Alina S.; Thuerauf, Donna J.; Pentoney, Amber N.; Aivati, Cathrine; Sarakki, Anup V.; Doroudgar, Shirin; Glembotski, Christopher C.] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Doroudgar, Shirin] Univ Hosp Heidelberg, Dept Cardiol Angiol & Pneumol, Innere Med 3, Heidelberg, Germany; [Doroudgar, Shirin] DZHK German Ctr Cardiovasc Res, Partner Site Heidelberg Mannheim, Heidelberg, Germany	California State University System; San Diego State University; California State University System; San Diego State University; Ruprecht Karls University Heidelberg; German Centre for Cardiovascular Research	Glembotski, CC (corresponding author), San Diego State Univ, Inst Heart, San Diego, CA 92182 USA.; Glembotski, CC (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	cglembotski@sdsu.edu		Blackwood, Erik/0000-0003-0912-4133	American Heart Association [17PRE33670796]; National Institutes of Health [1F31HL140850, R01 HL135893, R01 HL141463, R01 HL149931]; San Diego State University (SDSU) Heart Institute; Inamori Foundation; ARCS Foundation, Inc., San Diego Chapter	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); San Diego State University (SDSU) Heart Institute; Inamori Foundation; ARCS Foundation, Inc., San Diego Chapter	This work was supported by American Heart Association Grant 17PRE33670796; National Institutes of Health Grant 1F31HL140850 (to E. A. B.) and Grants R01 HL135893, R01 HL141463, and R01 HL149931 (to C. C. G.); the San Diego State University (SDSU) Heart Institute (to W. T. S., A. A., E. A. B., and C. C. G.); the Inamori Foundation (to E. A. B.); and the ARCS Foundation, Inc., San Diego Chapter (to W. T. S. and E. A. B). Additionally, W. T. S., A. A., and E. A. B are Rees-Stealy Research Foundation Phillips Gausewitz, M.D., Scholars of the SDSU Heart Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Behnke J, 2016, MOL CELL, V63, P739, DOI 10.1016/j.molcel.2016.07.012; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Belmont PJ, 2010, CIRC RES, V106, P307, DOI 10.1161/CIRCRESAHA.109.203901; Bi XK, 2018, CIRC RES, V122, P1545, DOI 10.1161/CIRCRESAHA.117.312641; Blackwood EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08129-2; Blackwood EA, 2019, CIRC RES, V124, P79, DOI 10.1161/CIRCRESAHA.118.313854; Buchner J, 1998, METHOD ENZYMOL, V290, P323, DOI 10.1016/S0076-6879(98)90029-5; Chin KT, 2011, FASEB J, V25, P2583, DOI 10.1096/fj.11-184622; Cuozzo JW, 1999, NAT CELL BIOL, V1, P130, DOI 10.1038/11047; Dimmeler S, 2007, CELL, V130, P401, DOI 10.1016/j.cell.2007.07.028; Doroudgar S, 2015, CIRC RES, V117, P536, DOI 10.1161/CIRCRESAHA.115.306993; Doroudgar S, 2009, J BIOL CHEM, V284, P29735, DOI 10.1074/jbc.M109.018036; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ellgaard L, 2018, TRENDS BIOCHEM SCI, V43, P32, DOI 10.1016/j.tibs.2017.10.006; Garcia-Dorado D, 2012, CARDIOVASC RES, V94, P168, DOI 10.1093/cvr/cvs116; Gidalevitz T, 2013, BBA-MOL CELL RES, V1833, P2410, DOI 10.1016/j.bbamcr.2013.03.007; Glembotski CC, 2014, CIRC RES, V115, P546, DOI 10.1161/CIRCRESAHA.114.304855; Glembotski CC, 2012, PHYSIOLOGY, V27, P343, DOI 10.1152/physiol.00034.2012; Glembotski CC, 2012, J BIOL CHEM, V287, P25893, DOI 10.1074/jbc.M112.356345; Glembotski CC, 2011, J MOL CELL CARDIOL, V51, P512, DOI 10.1016/j.yjmcc.2010.10.008; Handy DE, 2017, FREE RADICAL BIO MED, V109, P114, DOI 10.1016/j.freeradbiomed.2016.12.006; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; Hoover HE, 2000, J BIOL CHEM, V275, P23825, DOI 10.1074/jbc.M003864200; Jin JK, 2017, CIRC RES, V120, P862, DOI 10.1161/CIRCRESAHA.116.310266; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Kozlov G, 2010, J BIOL CHEM, V285, P38612, DOI 10.1074/jbc.M110.168294; Kranias EG, 2012, CIRC RES, V110, P1646, DOI 10.1161/CIRCRESAHA.111.259754; Kubota K, 2006, J NEUROCHEM, V97, P1259, DOI 10.1111/j.1471-4159.2006.03782.x; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee CF, 2014, INT REV CEL MOL BIO, V313, P103, DOI 10.1016/B978-0-12-800177-6.00004-9; Li J, 2001, J BIOCHEM, V129, P821, DOI 10.1093/oxfordjournals.jbchem.a002925; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; LODISH HF, 1993, J BIOL CHEM, V268, P20598; Malhotra JD, 2007, ANTIOXID REDOX SIGN, V9, P2277, DOI 10.1089/ars.2007.1782; Marshall KD, 2014, AM J PHYSIOL-CELL PH, V306, pC639, DOI 10.1152/ajpcell.00167.2013; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Morrison LE, 2004, AM J PHYSIOL-HEART C, V286, pH847, DOI 10.1152/ajpheart.00715.2003; Petrova PS, 2003, J MOL NEUROSCI, V20, P173, DOI 10.1385/JMN:20:2:173; Poet GJ, 2017, EMBO J, V36, P693, DOI 10.15252/embj.201695336; Poon S, 2000, BIOCHEMISTRY-US, V39, P15953, DOI 10.1021/bi002189x; Preissler S, 2017, ELIFE, V6, DOI 10.7554/eLife.29428; Preissler S, 2015, ELIFE, V4, DOI 10.7554/eLife.08961; Rainbolt TK, 2014, TRENDS ENDOCRIN MET, V25, P528, DOI 10.1016/j.tem.2014.06.007; Rajasekaran NS, 2007, CELL, V130, P427, DOI 10.1016/j.cell.2007.06.044; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954; SIFERS RN, 1988, J BIOL CHEM, V263, P7330; Siman R, 2004, NEUROBIOL DIS, V16, P311, DOI 10.1016/j.nbd.2004.03.016; Stauffer WT, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031134; Tam AB, 2018, DEV CELL, V46, P327, DOI 10.1016/j.devcel.2018.04.023; Taylor RP, 2005, J MOL CELL CARDIOL, V38, P433, DOI 10.1016/j.yjmcc.2004.12.014; Thuerauf DJ, 2001, J BIOL CHEM, V276, P48309, DOI 10.1074/jbc.M107146200; Thuerauf DJ, 2006, CIRC RES, V99, P275, DOI 10.1161/01.RES.0000233317.70421.03; Tsujita Y, 2005, ECHOCARDIOGR-J CARD, V22, P245, DOI 10.1111/j.0742-2822.2005.04014.x; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Vanden Hoek Terry L., 1996, American Journal of Physiology, V270, pH1334; Vekich JA, 2012, J MOL CELL CARDIOL, V53, P259, DOI 10.1016/j.yjmcc.2012.05.005; Vincenz L, 2014, CELL, V156, P1125, DOI 10.1016/j.cell.2014.02.035; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Yan YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08450-4; Yang Q, 1997, NUCLEIC ACIDS RES, V25, P2800, DOI 10.1093/nar/25.14.2800; Yu QJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000555; Zhang GY, 2019, HYPERTENSION, V73, P390, DOI 10.1161/HYPERTENSIONAHA.118.12084; Zhu C, 1997, MOL CELL BIOL, V17, P4957, DOI 10.1128/MCB.17.9.4957	67	16	17	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7566	7583		10.1074/jbc.RA120.013345	http://dx.doi.org/10.1074/jbc.RA120.013345			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32327487	hybrid, Green Published			2022-12-26	WOS:000538038900002
J	Sugiyama, M; Wada, Y; Kanazawa, N; Tachibana, S; Suzuki, T; Matsumoto, K; Iyoda, M; Honda, H; Shibata, T				Sugiyama, Motonori; Wada, Yukihiro; Kanazawa, Nobuhiro; Tachibana, Shohei; Suzuki, Taihei; Matsumoto, Kei; Iyoda, Masayuki; Honda, Hirokazu; Shibata, Takanori			A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schonlein purpura nephritis and IgA nephropathy	PLOS ONE			English	Article							STEROID PULSE THERAPY; VASCULITIS; CHILDREN; CLASSIFICATION; TONSILLECTOMY; ANTIBODIES; UPDATE; ADULTS	Introduction Recent studies noted that Henoch-Schonlein purpura nephritis (HSPN) and IgA nephropathy (IgAN) share the feature of galactose-deficient IgA1 (Gd-IgA1)-oriented pathogenesis, although there are distinct clinical differences. We aimed to clarify the clinicopathologic differences between these 2 diseases. Methods We cross-sectionally analyzed adult patients with HSPN (n = 24) or IgAN (n = 56) who underwent renal biopsy (RB) between 2008 and 2018 at Showa University Hospital. Serum Gd-IgA1 (s-Gd-IgA1) levels at the time of RB were compared among study groups using enzyme-linked immunosorbent assay (ELISA) with anti-human Gd-IgA1-specific monoclonal antibody (KM55). We also immunohistochemically stained paraffin-embedded sections for glomerular Gd-IgA1 (g-Gd-IgA1)-deposition using KM55. Serum inflammatory cytokines were measured using ELISA. Results Glomerular endothelial injury with subendothelial IgA deposition was significant in patients with HSPN. Serum IL-8, MCP-1, TNF-alpha, and IL-6 levels were significantly higher in patients with HSPN than IgAN. Levels of s-Gd-IgA1 were comparable among patients with HSPN and IgAN, and a similar degree of g-Gd-IgA1-deposition was detected in both diseases. Furthermore, g-Gd-IgA1-deposition was evident in patients with histopathologically advanced HSPN or IgAN. In HSPN, significant positive correlations between s-Gd-IgA1 levels and crescent formation or IL-6 elevation were confirmed, and g-Gd-IgA1 intensity showed a significant positive correlation with MCP-1 and a tendency to positively correlate with IL-8. Meanwhile, patients with IgAN showed no correlation between inflammatory cytokines and both-Gd-IgA1. Moreover, most g-Gd-IgA1-positive areas were not double stained with CD31 in HSPN. Conclusions Although assessing both-Gd-IgA1 alone was insufficient to distinguish between HSPN and IgAN, patients with HSPN showed considerable glomerular capillaritis with subendothelial IgA deposition and significant elevation of serum inflammatory cytokines. Furthermore, such glomerular subendothelial IgA deposition might not contain Gd-IgA1, and factors associated with Gd-IgA1 were inconsistent among these 2 diseases. Thus, developmental mechanisms for IgAN might not apply to HSPN completely, and these 2 diseases still have different aspects.	[Sugiyama, Motonori; Wada, Yukihiro; Kanazawa, Nobuhiro; Tachibana, Shohei; Suzuki, Taihei; Matsumoto, Kei; Iyoda, Masayuki; Honda, Hirokazu; Shibata, Takanori] Showa Univ, Div Nephrol, Dept Med, Sch Med, Tokyo, Japan	Showa University	Wada, Y (corresponding author), Showa Univ, Div Nephrol, Dept Med, Sch Med, Tokyo, Japan.	yukihiro@med.showa-u.ac.jp		Wada, Yukihiro/0000-0001-5996-8735				Berthelot L, 2018, NEPHROL DIAL TRANSPL, V33, P1579, DOI 10.1093/ndt/gfx300; Coppo R, 1997, NEPHROL DIAL TRANSPL, V12, P2277, DOI 10.1093/ndt/12.11.2277; Coppo R, 2017, J NEPHROL, V30, P339, DOI 10.1007/s40620-016-0360-z; Guo MZ, 2009, ARTERIOSCL THROM VAS, V29, P394, DOI 10.1161/ATVBAHA.108.180950; Gutierrez E, 2012, J AM SOC NEPHROL, V23, P1753, DOI 10.1681/ASN.2012010063; Heineke MH, 2017, AUTOIMMUN REV, V16, P1246, DOI 10.1016/j.autrev.2017.10.009; Hihara K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158154; Hilhorst M, 2011, NEPHROL DIAL TRANSPL, V26, P3960, DOI 10.1093/ndt/gfr149; Hocevar A, 2019, CLIN RHEUMATOL, V38, P347, DOI 10.1007/s10067-018-4248-2; Huang X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23638-2; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; Iyoda M, 2011, J AM SOC NEPHROL, V22, P1486, DOI 10.1681/ASN.2010111158; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kawamura T, 2014, NEPHROL DIAL TRANSPL, V29, P1546, DOI 10.1093/ndt/gfu020; Kim M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147394; Kiryluk K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006609; Kiryluk K, 2014, J CLIN INVEST, V124, P2325, DOI 10.1172/JCI74475; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Mizerska-Wasiaki M, 2018, CENT EUR J IMMUNOL, V43, P162, DOI 10.5114/ceji.2018.77386; Murakoshi M, 2017, CLIN EXP NEPHROL, V21, P1068, DOI 10.1007/s10157-017-1408-7; Nicoara O, 2019, PEDIATR CLIN N AM, V66, P101, DOI 10.1016/j.pcl.2018.08.008; Okonogi H, 2019, CLIN EXP NEPHROL, V23, P16, DOI 10.1007/s10157-018-1657-0; Ozen S, 2006, ANN RHEUM DIS, V65, P936, DOI 10.1136/ard.2005.046300; Pillebout E, 2002, J AM SOC NEPHROL, V13, P1271, DOI 10.1097/01.ASN.0000013883.99976.22; Pillebout E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188718; Piram M, 2017, RHEUMATOLOGY, V56, P1358, DOI 10.1093/rheumatology/kex158; Piram M, 2013, CURR OPIN RHEUMATOL, V25, P171, DOI 10.1097/BOR.0b013e32835d8e2a; Placzek WJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190967; Razminia M, 2004, CATHETER CARDIO INTE, V63, P419, DOI 10.1002/ccd.20217; Roberts PF, 2007, SOUTH MED J, V100, P821, DOI 10.1097/SMJ.0b013e3180f62d0f; Ruszkowski J, 2019, CLIN EXP NEPHROL, V23, P291, DOI 10.1007/s10157-018-1665-0; Sun Q, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166700; Suzuki H, 2008, J CLIN INVEST, V118, P629, DOI 10.1172/JCI33189; Suzuki H, 2018, KIDNEY INT, V93, P700, DOI 10.1016/j.kint.2017.10.019; Suzuki H, 2014, J BIOL CHEM, V289, P5330, DOI 10.1074/jbc.M113.512277; Suzuki H, 2011, J AM SOC NEPHROL, V22, P1795, DOI 10.1681/ASN.2011050464; Suzuki H, 2009, J CLIN INVEST, V119, P1668, DOI 10.1172/JCI38468; Suzuki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067475; Sweetwyne MT, 2017, KIDNEY INT, V91, P1126, DOI 10.1016/j.kint.2016.10.036; Tomino Y, 2016, KIDNEY RES CLIN PRAC, V35, P197, DOI 10.1016/j.krcp.2016.09.001; Trimarchi H, 2017, KIDNEY INT, V91, P1014, DOI 10.1016/j.kint.2017.02.003; Ueda H, 2019, INTERNAL MED, V58, P31, DOI 10.2169/internalmedicine.1379-18; Wada Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206865; Wada Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111728; Wada Y, 2013, CLIN EXP NEPHROL, V17, P73, DOI 10.1007/s10157-012-0660-0; Wang FY, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0538-1; Yang YH, 2005, RHEUMATOLOGY, V44, P618, DOI 10.1093/rheumatology/keh544; Yasutake J, 2015, NEPHROL DIAL TRANSPL, V30, P1315, DOI 10.1093/ndt/gfv221; Ye Q, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127767	49	9	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232194	10.1371/journal.pone.0232194	http://dx.doi.org/10.1371/journal.pone.0232194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324811	Green Published, gold, Green Submitted			2022-12-26	WOS:000536033700088
J	Ferri-Garciia, R; Rueda, MD				Ferri-Garcia, Ramon; del Mar Rueda, Maria			Propensity score adjustment using machine learning classification algorithms to control selection bias in online surveys	PLOS ONE			English	Article							NONRESPONSE; REGRESSION; MODEL; CALIBRATION; ESTIMATORS; DEPRESSION; INFERENCE	Modern survey methods may be subject to non-observable bias, from various sources. Among online surveys, for example, selection bias is prevalent, due to the sampling mechanism commonly used, whereby participants self-select from a subgroup whose characteristics differ from those of the target population. Several techniques have been proposed to tackle this issue. One such is Propensity Score Adjustment (PSA), which is widely used and has been analysed in various studies. The usual method of estimating the propensity score is logistic regression, which requires a reference probability sample in addition to the online nonprobability sample. The predicted propensities can be used for reweighting using various estimators. However, in the online survey context, there are alternatives that might outperform logistic regression regarding propensity estimation. The aim of the present study is to determine the efficiency of some of these alternatives, involving Machine Learning (ML) classification algorithms. PSA is applied in two simulation scenarios, representing situations commonly found in online surveys, using logistic regression and ML models for propensity estimation. The results obtained show that ML algorithms remove selection bias more effectively than logistic regression when used for PSA, but that their efficacy depends largely on the selection mechanism employed and the dimensionality of the data.	[Ferri-Garcia, Ramon; del Mar Rueda, Maria] Univ Granada, Fac Sci, Dept Stat & Operat Res, Granada, Spain	University of Granada	Rueda, MD (corresponding author), Univ Granada, Fac Sci, Dept Stat & Operat Res, Granada, Spain.	mrueda@ugr.es	Rueda, Maria del Mar/F-9571-2015	Rueda, Maria del Mar/0000-0002-2903-8745	Ministerio de Economia y Competitividad, Spain [MTM2015-63609-R]; Ministerio de Ciencia, Innovacion y Universidades, Spain	Ministerio de Economia y Competitividad, Spain(Spanish Government); Ministerio de Ciencia, Innovacion y Universidades, Spain(Spanish Government)	This study was partially supported by Ministerio de Economia y Competitividad, Spain [grant number MTM2015-63609-R] and, in terms of the first author, a FPU grant from the Ministerio de Ciencia, Innovacion y Universidades, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A, 2007, INTRO CATEGORICAL DA; Austin PC, 2012, MULTIVAR BEHAV RES, V47, P115, DOI 10.1080/00273171.2012.640600; Baffetta F, 2009, REMOTE SENS ENVIRON, V113, P463, DOI 10.1016/j.rse.2008.06.014; Bembom O, 2007, STAT APPL GENET MOL, V6; Bethlehem J, 2010, INT STAT REV, V78, P161, DOI 10.1111/j.1751-5823.2010.00112.x; Beyer K, 1999, LECT NOTES COMPUT SC, V1540, P217; Breidt FJ, 2017, STAT SCI, V32, P190, DOI 10.1214/16-STS589; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Buelens B, 2018, INT STAT REV, V86, P322, DOI 10.1111/insr.12253; Buskirk TD, 2015, SURVEY METHODS INSIG, V17; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Couper MP, 2007, SOC SCI RES, V36, P131, DOI 10.1016/j.ssresearch.2005.10.002; Da Silva DN, 2006, CAN J STAT, V34, P563; da Silva DN, 2009, SURV METHODOL, V35, P165; David M., 1983, P BUS EC STAT SECT A, P168; Dever J.A., 2008, SURV RES METHODS-GER, V2, DOI 10.18148/srm/2008.v2i2.128; Elliott MR, 2017, STAT SCI, V32, P249, DOI 10.1214/16-STS598; Fayyad U, 1996, AI MAG, V17, P37; Ferri-Garcia R, 2018, SORT-STAT OPER RES T, V42, P159, DOI 10.2436/20.8080.02.73; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Garcia S, 2015, INTEL SYST REF LIBR, V72, P1, DOI 10.1007/978-3-319-10247-4; GREENWELL B, 2018, R PACKAGE VERS, V2, P4; Harder VS, 2008, AM J EPIDEMIOL, V168, P592, DOI 10.1093/aje/kwn184; Harder VS, 2006, ADDICTION, V101, P1463, DOI 10.1111/j.1360-0443.2006.01545.x; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Hornik K, 2009, COMPUTATION STAT, V24, P225, DOI 10.1007/s00180-008-0119-7; Lee BK, 2010, STAT MED, V29, P337, DOI 10.1002/sim.3782; Lee S., 2006, J OFF STAT, V22, P329; Lee S, 2009, SOCIOL METHOD RES, V37, P319, DOI 10.1177/0049124108329643; Linden A, 2017, J EVAL CLIN PRACT, V23, P703, DOI 10.1111/jep.12744; McCaffrey DF, 2013, STAT MED, V32, P3388, DOI 10.1002/sim.5753; McCaffrey DF, 2004, PSYCHOL METHODS, V9, P403, DOI 10.1037/1082-989X.9.4.403; Montanari GE, 2007, P WORKSH CAL EST SUR; National Institute of Statistics, 2012, SURV EQ US INF COMM; National Institute of Statistics, 2012, LIF COND SURV MICR; National Institute of Statistics, 2017, SURV EQ US INF COMM; National Institute of Statistics, 2017, CNED 2014; National Institute of Statistics, 2016, POP SPAN FOR COMM AG; Phipps P, 2012, ANN APPL STAT, V6, P772, DOI 10.1214/11-AOAS521; Pirracchio R, 2015, AM J EPIDEMIOL, V181, P108, DOI 10.1093/aje/kwu253; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; R Core Team, 2021, R LANGUAGE ENV STAT; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schonlau M, 2017, STAT SCI, V32, P279, DOI 10.1214/16-STS597; Setoguchi S, 2008, PHARMACOEPIDEM DR S, V17, P546, DOI 10.1002/pds.1555; Taylor H, 2000, INT J MARKET RES, V42, P51; Taylor H, 2001, INT J MARKET RES, V43, P127; Therneau T. M., 2018, R PACKAGE VERSION, V4, P1; Tipton J, 2013, REMOTE SENS ENVIRON, V139, P130, DOI 10.1016/j.rse.2013.07.035; Valliant R., 2013, PRACTICAL TOOLS DESI; Valliant R, 2011, SOCIOL METHOD RES, V40, P105, DOI 10.1177/0049124110392533; Wang JQC, 2014, SURV METHODOL, V40, P189; Watkins S, 2013, HEALTH SERV RES, V48, P1798, DOI 10.1111/1475-6773.12068; Westreich D, 2010, J CLIN EPIDEMIOL, V63, P826, DOI 10.1016/j.jclinepi.2009.11.020; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Witten I.H., 2005, DATA MINING PRACTICA; Wu XD, 2008, KNOWL INF SYST, V14, P1, DOI 10.1007/s10115-007-0114-2; Wyss R, 2014, AM J EPIDEMIOL, V180, P645, DOI 10.1093/aje/kwu181; Zhao P, 2016, CONTEMP CLIN TRIALS, V47, P85, DOI 10.1016/j.cct.2015.12.012	60	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231500	10.1371/journal.pone.0231500	http://dx.doi.org/10.1371/journal.pone.0231500			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9QD	32320429	Green Published, Green Submitted, gold			2022-12-26	WOS:000536028800024
J	Morant, D; Picazo, A; Rochera, C; Santamans, AC; Miralles-Lorenzo, J; Camacho-Santamans, A; Ibanez, C; Martinez-Eixarch, M; Camacho, A				Morant, Daniel; Picazo, Antonio; Rochera, Carlos; Santamans, Anna C.; Miralles-Lorenzo, Javier; Camacho-Santamans, Alba; Ibanez, Carles; Martinez-Eixarch, Maite; Camacho, Antonio			Carbon metabolic rates and GHG emissions in different wetland types of the Ebro Delta	PLOS ONE			English	Article							COASTAL WETLANDS; VERTICAL ACCRETION; SEDIMENT ACCRETION; DIOXIDE EMISSIONS; NEW-ZEALAND; SALINITY; MANAGEMENT; RESTORATION; METHANE; SUSTAINABILITY	Deltaic wetlands are highly productive ecosystems, which characteristically can act as C-sinks. However, they are among the most threatened ecosystems, being very vulnerable to global change, and require special attention towards its conservation. Knowing their climate change mitigating potential, conservation measures should also be oriented with a climatic approach, to strengthen their regulatory services. In this work we studied the carbon biogeochemistry and the specific relevance of certain microbial guilds on carbon metabolisms of the three main types of deltaic wetlands located in the Ebro Delta, north-eastern Spain, as well as how they deal with human pressures and climate change effects. We estimated the metabolic rates of the main carbon-related metabolisms (primary production and respiration) and the resulting carbon and global warming potential balances in sites with a different salinity range and trophic status. With the results obtained, we tried to define the influence of possible changes in salinity and trophic level linked to the main impacts currently threatening deltaic wetlands, on the C-metabolisms and GHG emissions, for a better understanding of the mitigating capacity and their possible enhancement when applying specific management actions. Metabolic rates showed a pattern highly influenced by the salinity range and nutrients inputs. Freshwater and brackish wetlands, with higher nutrient inputs from agricultural runoff, showed higher C-capture capacity (around 220-250 g C m(-2) y(-1)), but also higher rates of degradative metabolisms (aerobic respiration and CH4 emissions). Contrastingly, the rates of C-related metabolisms and C-retention of Salicornia-type coastal salt marshes were lower (42 g C m(-2) y(-1)). The study of the microbial metacommunity composition by the 16S RNA gene sequencing revealed a significant higher presence of methanogens in the salt marsh, and also higher metabolic potential, where there was significantly more organic matter content in sediment. Salinity inhibition, however, explained the lower respiration rates, both aerobic and anaerobic, and prevented higher rates of methanogenesis despite the major presence of methanogens. Conservation measures for these wetlands would require, overall, maintaining the sediment contributions of the river basin intending to overcome the regression of the Delta and its salt marshes in a climate change scenario. Particularly, for reducing degradative metabolisms, and favour C-retention, nutrient inputs should be controlled in freshwater and brackish wetlands in order to reduce eutrophication. In salt marshes, the reduction of salinity should be avoided to control increases in methanogenesis and CH4 emissions.	[Morant, Daniel; Picazo, Antonio; Rochera, Carlos; Santamans, Anna C.; Miralles-Lorenzo, Javier; Camacho-Santamans, Alba; Camacho, Antonio] Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Paterna, Spain; [Ibanez, Carles; Martinez-Eixarch, Maite] IRTA Inst Agrifood Res & Technol, Sant Carles De La Rapita, Spain	University of Valencia; IRTA	Camacho, A (corresponding author), Univ Valencia, Cavanilles Inst Biodivers & Evolutionary Biol, Paterna, Spain.	antonio.camacho@uv.es	Martinez-Eixarch, Maite/AAY-9399-2020; Martinez-Eixarch, Maite/A-9813-2011; Martí, Carles Ibáñez/AAV-6637-2021; Rochera, Carlos/M-2932-2014; Morant, Daniel/V-1669-2018; Camacho, Antonio/I-3417-2015	Martinez-Eixarch, Maite/0000-0002-7352-8522; Martinez-Eixarch, Maite/0000-0002-7352-8522; Rochera, Carlos/0000-0002-8294-4755; Morant, Daniel/0000-0001-8267-5340; Camacho, Antonio/0000-0003-0841-2010; Ibanez, Carles/0000-0002-7091-5527	project CLIMAWET - MINECO (Agencia Estatal de Investigacion) of the Spanish Government [CGL2015-69557-R]; FEDER-EU Funds; project CARBONSINK- Fundacion Biodiversidad; project CARBONNAT- Fundacion Biodiversidad; Spanish Ministry of Science, Innovation and Universities [FPU16/01444, FPU15/03930]	project CLIMAWET - MINECO (Agencia Estatal de Investigacion) of the Spanish Government; FEDER-EU Funds(European Commission); project CARBONSINK- Fundacion Biodiversidad; project CARBONNAT- Fundacion Biodiversidad; Spanish Ministry of Science, Innovation and Universities(Spanish Government)	This work was supported by the project CLIMAWET (CGL2015-69557-R), funded by the MINECO (Agencia Estatal de Investigacion) of the Spanish Government, and by FEDER-EU Funds, awarded to AC. http://www.ciencia.gob.es/portal/site/MICINN/aei This work was additionally supported by the projects CARBONSINK and CARBONNAT funded by Fundacion Biodiversidad, also awarded to AC. https://fundacionbiodiversidad.es/DM and JM-L hold a FPU Predoctoral Scholarship by the Spanish Ministry of Science, Innovation and Universities (FPU16/01444 and FPU15/03930). http://www.ciencia.gob.es/.	Al Marzooqi F, 2017, APPL SOIL ECOL, V114, P9, DOI 10.1016/j.apsoil.2017.02.012; Angamuthu B, 2018, P ROY SOC A-MATH PHY, V474, DOI 10.1098/rspa.2018.0396; APHA, 2005, STAND METH WAT WAST; Baldocchi D, 2019, GLOBAL CHANGE BIOL, V25, P1191, DOI 10.1111/gcb.14559; Benito X, 2014, WETLANDS, V34, P775, DOI 10.1007/s13157-014-0541-2; Brix H, 2001, AQUAT BOT, V69, P313, DOI 10.1016/S0304-3770(01)00145-0; Caffrey JM, 2004, ESTUARIES, V27, P90, DOI 10.1007/BF02803563; Callaway JC, 2012, ESTUAR COAST, V35, P1163, DOI 10.1007/s12237-012-9508-9; Calvo-Cubero J, 2014, ECOL ENG, V71, P278, DOI 10.1016/j.ecoleng.2014.07.023; Camacho A, 2017, WATER-SUI, V9, DOI 10.3390/w9090659; Iglesias MCA, 2020, LIMNETICA, V39, P185, DOI 10.23818/limn.39.13; Chambers LG, 2011, SOIL SCI SOC AM J, V75, P2000, DOI 10.2136/sssaj2011.0026; Chmura GL, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB001917; Coleman JM, 2008, J COASTAL RES, V24, P1, DOI 10.2112/05-0607.1; Coleman JM, 1989, COASTAL LOWLANDS; Comin F. A., 1987, LIMNETICA, V3, P1; Comin FA, 2001, RESTOR ECOL, V9, P201, DOI 10.1046/j.1526-100x.2001.009002201.x; Craft C, 2007, LIMNOL OCEANOGR, V52, P1220, DOI 10.4319/lo.2007.52.3.1220; Curco A, 2002, ESTUARIES, V25, P309, DOI 10.1007/BF02695976; Day J, 2011, ESTUAR COAST, V34, P483, DOI 10.1007/s12237-011-9390-x; Day JW, 2006, ECOL ENG, V26, P85, DOI 10.1016/j.ecoleng.2005.01.005; Day JW, 1997, COAST MANAGE, V25, P115, DOI 10.1080/08920759709362315; Day JW, 2005, ECOL ENG, V24, P253, DOI 10.1016/j.ecoleng.2004.11.015; de la Varga D, 2015, SCI TOTAL ENVIRON, V538, P824, DOI 10.1016/j.scitotenv.2015.08.090; De Vrieze J, 2016, WATER RES, V98, P293, DOI 10.1016/j.watres.2016.04.035; DeLaune RD, 2012, CLIMATIC CHANGE, V110, P297, DOI 10.1007/s10584-011-0089-6; DELAUNE RD, 1983, TELLUS B, V35, P8, DOI 10.1111/j.1600-0889.1983.tb00002.x; Edgar R.C., 2016, BIORXIV, V081257, DOI 10.1101/081257; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; eea, CORINE LAND COV; Erwin KL, 2009, WETL ECOL MANAG, V17, P71, DOI 10.1007/s11273-008-9119-1; Falasca SL, 2014, INT J HYDROGEN ENERG, V39, P8682, DOI 10.1016/j.ijhydene.2013.12.061; Fan PX, 2011, PROTEOMICS, V11, P4346, DOI 10.1002/pmic.201100054; Fennessy MS, 2019, ESTUAR COAST SHELF S, V222, P32, DOI 10.1016/j.ecss.2019.03.023; Gaglio M, 2017, WETL ECOL MANAG, V25, P67, DOI 10.1007/s11273-016-9503-1; Grasset C, 2016, FRESHWATER BIOL, V61, P1405, DOI 10.1111/fwb.12780; Griscom BW, 2017, P NATL ACAD SCI USA, V114, P11645, DOI 10.1073/pnas.1710465114; Guan Y, 2015, RES MICROBIOL, V166, P688, DOI 10.1016/j.resmic.2015.07.002; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; Hemes KS, 2019, AGR FOREST METEOROL, V268, P202, DOI 10.1016/j.agrformet.2019.01.017; Herbert ER, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00534.1; Holm GO, 2016, WETLANDS, V36, P401, DOI 10.1007/s13157-016-0746-7; Ibanez C, 1999, J COASTAL RES, V15, P717; Ibanez C., 1997, J COAST CONSERV, V3, P191, DOI [10.1007/BF02908194, DOI 10.1007/BF02905244, 10.1007/BF02905244]; Ibanez C, 2010, WETLANDS, V30, P979, DOI 10.1007/s13157-010-0092-0; Jagtap TG, 2002, WETLANDS, V22, P443, DOI 10.1672/0277-5212(2002)022[0443:EOOMSB]2.0.CO;2; Kendall MM, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P244, DOI 10.1007/0-387-30743-5_12; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Louca S, 2018, BIOINFORMATICS, V34, P1053, DOI 10.1093/bioinformatics/btx701; Luo M, 2019, GEODERMA, V337, P1245, DOI 10.1016/j.geoderma.2018.07.030; MA, 2005, ECOSYSTEMS HUMAN WEL; Maqbool C., 2013, INT J SCI RES PUBLIC, V3, P1; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Mikhailov V.N, 2003, WATER RESOUR+, V30, P601, DOI DOI 10.1023/B:WARE.0000007585.01852.EE; Miller RL, 2010, WETL ECOL MANAG, V18, P1, DOI 10.1007/s11273-009-9143-9; Morant D, 2020, INLAND WATERS, V10, P453, DOI 10.1080/20442041.2020.1772033; Myers SC, 2013, ECOL ENG, V56, P107, DOI 10.1016/j.ecoleng.2012.12.097; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pacheco FS, 2014, INLAND WATERS, V4, P41, DOI 10.5268/IW-4.1.614; PARKER M, 2011, SAN FRANC ESTUARY WA, V9, DOI DOI 10.1186/1478-4505-9-3; Picazo A, 2013, LIMNETICA, V32, P139; R Core Team, 2021, R LANGUAGE ENV STAT; Rathore AP, 2016, INT J PHYTOREMEDIAT, V18, P801, DOI 10.1080/15226514.2016.1146228; Sanchez-Arcilla A, 1998, J COASTAL RES, V14, P754; Santoso AB, 2017, HYDROBIOLOGIA, V795, P341, DOI 10.1007/s10750-017-3158-7; Shen XM, 2016, WETLANDS, V36, pS81, DOI 10.1007/s13157-015-0710-y; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Thi-Dieu-Hien Vo, 2019, Current Opinion in Environmental Science & Health, V12, P38, DOI 10.1016/j.coesh.2019.09.004; Tuttle CL, 2008, ECOL INDIC, V8, P795, DOI 10.1016/j.ecolind.2007.09.005; Wang C, 2017, WETLANDS, V37, P559, DOI 10.1007/s13157-017-0890-8; Whitman WB, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 3, THIRD EDITION, P165, DOI 10.1007/0-387-30743-5_9; Wu HM, 2017, J CLEAN PROD, V147, P152, DOI 10.1016/j.jclepro.2017.01.091; Yang ZF, 2013, J ENVIRON MANAGE, V130, P276, DOI 10.1016/j.jenvman.2013.08.015; Yarwood SA, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy175; Ye YZ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000465	76	10	10	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231713	10.1371/journal.pone.0231713	http://dx.doi.org/10.1371/journal.pone.0231713			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320412	Green Published, gold			2022-12-26	WOS:000536028800031
J	Parravicini, C; Lecca, D; Marangon, D; Coppolino, GT; Daniele, S; Bonfanti, E; Fumagalli, M; Raveglia, L; Martini, C; Gianazza, E; Trincavelli, ML; Abbracchio, MP; Eberini, I				Parravicini, Chiara; Lecca, Davide; Marangon, Davide; Coppolino, Giusy Tindara; Daniele, Simona; Bonfanti, Elisabetta; Fumagalli, Marta; Raveglia, Luca; Martini, Claudia; Gianazza, Elisabetta; Trincavelli, Maria Letizia; Abbracchio, Maria P.; Eberini, Ivano			Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis	PLOS ONE			English	Article							P2Y-LIKE RECEPTOR GPR17; ANIMAL-MODELS; TARGET; DAMAGE; BRAIN; CELLS; GPCR; IDENTIFICATION; REMYELINATION; MATURATION	The GPR17 receptor, expressed on oligodendroglial precursors (OPCs, the myelin producing cells), has emerged as an attractive target for a pro-myelinating strategy in multiple sclerosis (MS). However, the proof-of-concept that selective GPR17 ligands actually exert protective activity in vivo is still missing. Here, we exploited an iterative drug discovery pipeline to prioritize novel and selective GPR17 pro-myelinating agents out of more than 1,000,000 compounds. We first performed an in silico high-throughput screening on GPR17 structural model to identify three chemically-diverse ligand families that were then combinatorially exploded and refined. Top-scoring compounds were sequentially tested on reference pharmacological in vitro assays with increasing complexity, ending with myelinating OPC-neuron co-cultures. Successful ligands were filtered through in silico simulations of metabolism and pharmacokinetics, to select the most promising hits, whose dose and ability to target the central nervous system were then determined in vivo. Finally, we show that, when administered according to a preventive protocol, one of them (named by us as galinex) is able to significantly delay the onset of experimental autoimmune encephalomyelitis (EAE), a mouse model of MS. This outcome validates the predictivity of our pipeline to identify novel MS-modifying agents.	[Parravicini, Chiara; Lecca, Davide; Marangon, Davide; Coppolino, Giusy Tindara; Bonfanti, Elisabetta; Fumagalli, Marta; Gianazza, Elisabetta; Abbracchio, Maria P.; Eberini, Ivano] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Daniele, Simona; Martini, Claudia; Trincavelli, Maria Letizia] Univ Pisa, Dept Pharm, Pisa, Italy; [Raveglia, Luca] Aptuit Srl, Verona, Italy; [Eberini, Ivano] Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy; [Eberini, Ivano] Univ Milan, DSRC, Milan, Italy	University of Milan; University of Pisa; University of Milan; University of Milan	Abbracchio, MP (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Milan, Italy.	mariapia.abbracchio@unimi.it	Fumagalli, Marta/AEP-4117-2022; Marangon, Davide/AAH-9347-2020	Marangon, Davide/0000-0003-2606-8110; Martini, Claudia/0000-0001-9379-3027; Fumagalli, Marta/0000-0002-0158-842X	Fondazione Italiana Sclerosi Multipla (FISM) [2013/S/2]; Italian Ministry of University and Research (MIUR); MIUR (FFABR2017); departmental "Linea 2 - Azione A 2017" funding	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); MIUR (FFABR2017)(Ministry of Education, Universities and Research (MIUR)); departmental "Linea 2 - Azione A 2017" funding	This study was supported by Fondazione Italiana Sclerosi Multipla (FISM, https://www.aism.it/) to IE and to MPA (2013/S/2) and by "Department of Excellence" grant program from Italian Ministry of University and Research (MIUR) 2018-2022. FISM provided support in the form of salaries for authors [CP, DL, DM]. Funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. IE acknowledges funding support from MIUR (FFABR2017). IE and MF gratefully acknowledges departmental "Linea 2 - Azione A 2017" funding (http://www.disfeb.unimi.it/ecm/home). Aptuit srl has been recruited to perform in vivo DMPK experiments as professional service under a commercial agreement and did not provide any financial support to the research. This does not alter our adherence to PLOS ONE policies on sharing data and materials.	Alavi MS, 2019, LIFE SCI, V224, P33, DOI 10.1016/j.lfs.2019.03.045; Alexander SPH, 2015, BRIT J PHARMACOL, V172, P5744, DOI 10.1111/bph.13348; Baqi Y, 2018, J MED CHEM, V61, P8136, DOI 10.1021/acs.jmedchem.7b01768; Bermudez M, 2015, BIOORGAN MED CHEM, V23, P3907, DOI 10.1016/j.bmc.2015.03.026; Boda E, 2011, GLIA, V59, P1958, DOI 10.1002/glia.21237; Capelli D, 2020, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00910; Ceruti S, 2009, BRAIN, V132, P2206, DOI 10.1093/brain/awp147; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; Chang JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S1; Chen Y, 2009, NAT NEUROSCI, V12, P1398, DOI 10.1038/nn.2410; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Ciancetta A, 2017, MOLECULES, V22, DOI 10.3390/molecules22030449; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Coppolino GT, 2018, GLIA, V66, P1118, DOI 10.1002/glia.23305; Costanzi S, 2016, J MOL GRAPH MODEL, V70, P140, DOI 10.1016/j.jmgm.2016.10.004; Daniele S, 2011, J PHARMACOL EXP THER, V338, P559, DOI 10.1124/jpet.110.178715; Dutta R, 2011, PROG NEUROBIOL, V93, P1, DOI 10.1016/j.pneurobio.2010.09.005; Eberini I, 2011, J COMPUT AID MOL DES, V25, P743, DOI 10.1007/s10822-011-9455-8; Fitzner D, 2010, CURR NEUROPHARMACOL, V8, P305, DOI 10.2174/157015910792246218; Fox RJ, 2012, MULT SCLER J, V18, P1534, DOI 10.1177/1352458512458169; Franke H, 2013, PURINERG SIGNAL, V9, P451, DOI 10.1007/s11302-013-9366-3; Fratangeli A, 2013, J BIOL CHEM, V288, P5241, DOI 10.1074/jbc.M112.404996; Fumagalli M, 2016, NEUROPHARMACOLOGY, V104, P82, DOI 10.1016/j.neuropharm.2015.10.005; Fumagalli M, 2015, GLIA, V63, P2327, DOI 10.1002/glia.22896; Fumagalli M, 2011, J BIOL CHEM, V286, P10593, DOI 10.1074/jbc.M110.162867; Furlan Roberto, 2009, V549, P157, DOI 10.1007/978-1-60327-931-4_11; Goldenberg Marvin M, 2012, P T, V37, P175; Haines JD, 2011, MT SINAI J MED, V78, P231, DOI 10.1002/msj.20246; Hennen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004350; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Hurwitz BJ, 2009, ANN INDIAN ACAD NEUR, V12, P226, DOI 10.4103/0972-2327.58276; Kipp M, 2017, BRAIN PATHOL, V27, P123, DOI 10.1111/bpa.12454; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Lecca D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003579; Leray E, 2016, REV NEUROL-FRANCE, V172, P3, DOI 10.1016/j.neurol.2015.10.006; Lipinski CA, 2012, ADV DRUG DELIVER REV, V64, P4, DOI 10.1016/j.addr.2012.09.019; Lu CQ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22452-0; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Mayo L, 2012, IMMUNOL REV, V248, P170, DOI 10.1111/j.1600-065X.2012.01135.x; Merten N, 2018, CELL CHEM BIOL, V25, P775, DOI 10.1016/j.chembiol.2018.03.012; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Oprea TI, 2000, J COMPUT AID MOL DES, V14, P251, DOI 10.1023/A:1008130001697; Parravicini C, 2016, CELL SIGNAL, V28, P631, DOI 10.1016/j.cellsig.2016.03.001; Parravicini C, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-8; Parravicini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-263; Plemel JR, 2017, NAT REV DRUG DISCOV, V16, P617, DOI 10.1038/nrd.2017.115; Saravanan KM, 2018, INT J BIOL MACROMOL, V106, P901, DOI 10.1016/j.ijbiomac.2017.08.088; Sensi C, 2014, CELL SIGNAL, V26, P2614, DOI 10.1016/j.cellsig.2014.08.003; Spyrakis F, 2015, ARCH BIOCHEM BIOPHYS, V583, P105, DOI 10.1016/j.abb.2015.08.002; Stangel M, 2017, NAT REV NEUROL, V13, P742, DOI 10.1038/nrneurol.2017.139; Stockert JA, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00100; Strange PG, 2010, BRIT J PHARMACOL, V161, P1238, DOI 10.1111/j.1476-5381.2010.00963.x; Taveggia C, 2008, GLIA, V56, P284, DOI 10.1002/glia.20612; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Wadood A, 2013, OA DRUG DES DELIV, V1, P1, DOI DOI 10.13172/2054-4057-1-1-1119; Wojciechowski M, 2004, J PHYS CHEM B, V108, P18368, DOI 10.1021/jp046748b; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Zhang H, 2011, EXP NEUROL, V230, P138, DOI 10.1016/j.expneurol.2011.04.009	58	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231483	10.1371/journal.pone.0231483	http://dx.doi.org/10.1371/journal.pone.0231483			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320409	Green Submitted, gold, Green Published			2022-12-26	WOS:000536028800022
J	Lee, CY; Fujino, K; Motooka, Y; Gregor, A; Bernards, N; Ujiie, H; Kinoshita, T; Chung, KY; Han, SH; Yasufuku, K				Lee, Chang Young; Fujino, Kosuke; Motooka, Yamato; Gregor, Alexander; Bernards, Nicholas; Ujiie, Hideki; Kinoshita, Tomonari; Chung, Kyung Young; Han, Seung Hee; Yasufuku, Kazuhiro			Photoacoustic imaging to localize indeterminate pulmonary nodules: A preclinical study	PLOS ONE			English	Article							ASSISTED THORACOSCOPIC SURGERY; LUNG-BIOPSY; FLUORESCENCE; DIAGNOSIS	Purpose Diagnosis and resection of indeterminate pulmonary nodules (IPNs) is a growing challenge with increased utilization of chest computed tomography. Photoacoustic (PA)-guided surgical resection with local injection of indocyanine green (ICG) may have utility for IPNs that are suspicious for lung cancer. This preclinical study explores the potential of PA imaging (PAI) to detect ICG-labeled tumors. Materials and methods ICG uptake by H460 lung cancer cells was evaluated in vitro. A phantom study was performed to analyze PA signal intensity according to ICG concentration and tissue thickness/depth using chicken breast. PA signals were measured up to 48 hours after injection of ICG (mixed with 5% agar) into healthy subcutaneous tissue, subcutaneous H460 tumors and right healthy lung in nude mice. Results Intracellular ICG fluorescence was detected in H460 cells co-incubated with ICG in vitro. The concentration dependence of the PA signal was logarithmic, and PA signal decline was exponential with increasing tissue depth. The PA signal of 2 mg/mL ICG was still detectable at a depth of 22 mm in chicken breast. The PA signal from ICG mixed with agar was detectable 48 hours post injection into subcutaneous tissue and subcutaneous H460 tumors in nude mice. Similar features of PA signals from ICG-agar in mice lung were obtained. Conclusion The results from this preclinical study suggests that PAI of injected ICG-agar may be beneficial for identifying deeply located tumors. These features may be valuable for IPNs.	[Lee, Chang Young; Fujino, Kosuke; Motooka, Yamato; Gregor, Alexander; Bernards, Nicholas; Ujiie, Hideki; Kinoshita, Tomonari; Yasufuku, Kazuhiro] Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada; [Lee, Chang Young; Chung, Kyung Young] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; [Han, Seung Hee] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Yonsei University; Yonsei University Health System; University of Toronto	Lee, CY (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Div Thorac Surg, Toronto, ON, Canada.; Lee, CY (corresponding author), Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	cyleecs@yuhs.ac	Ujiie, Hideki/I-1939-2019; Kinoshita, Tomomari/AAH-3765-2021	Ujiie, Hideki/0000-0001-6119-8776; 	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1B0302949714]; Yonsei University College of Medicine [6-2016-0069]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Yonsei University College of Medicine(General Electric)	This research (Lee CY) was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (Grant number:2017R1D1A1B0302949714) and a faculty research grant of Yonsei University College of Medicine (Grant number:6-2016-0069). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Anayama T, 2015, ANN THORAC SURG, V99, P224, DOI 10.1016/j.athoracsur.2014.07.050; Ash C, 2017, LASER MED SCI, V32, P1909, DOI 10.1007/s10103-017-2317-4; Beztsinna N, 2017, INT J NANOMED, V12, P3813, DOI 10.2147/IJN.S125192; Congregado M, 2008, SURG ENDOSC, V22, P1852, DOI 10.1007/s00464-007-9720-z; Field JK, 2013, LANCET, V382, P732, DOI 10.1016/S0140-6736(13)61614-1; Forbrich A, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.10.106003; Garcia-Uribe A, 2015, SCI REP-UK, V5, DOI 10.1038/srep15748; Han KN, 2018, J THORAC DIS, V10, pS739, DOI 10.21037/jtd.2018.03.115; Heerink WJ, 2017, EUR RADIOL, V27, P138, DOI 10.1007/s00330-016-4357-8; Ke HX, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.5.056010; Klijian AS, 2016, J THORAC DIS, V8, pS677, DOI 10.21037/jtd.2016.06.55; Larscheid RC, 1998, CHEST, V114, P704, DOI 10.1378/chest.114.3.704; LENGLINGER FX, 1994, AM J ROENTGENOL, V163, P297, DOI 10.2214/ajr.163.2.7518642; Mauerer M, 1998, J PHOTOCH PHOTOBIO B, V47, P68, DOI 10.1016/S1011-1344(98)00205-X; Memoli JSW, 2012, CHEST, V142, P385, DOI 10.1378/chest.11-1764; Nakajima T, 2014, ANN THORAC SURG, V97, P1771, DOI 10.1016/j.athoracsur.2014.01.048; Nakashima S, 2010, ANN THORAC SURG, V89, P212, DOI 10.1016/j.athoracsur.2009.09.075; Okusanya OT, 2014, ANN THORAC SURG, V98, P1223, DOI 10.1016/j.athoracsur.2014.05.026; Park CH, 2017, CHEST, V151, P316, DOI 10.1016/j.chest.2016.09.017; Saito H, 2002, J THORAC CARDIOV SUR, V124, P1198, DOI 10.1067/mtc.2002.127331; Strohm EM, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2015.2497323; Suzuki K, 1999, CHEST, V115, P563, DOI 10.1378/chest.115.2.563; Tsuchida M, 1999, CHEST, V116, P139, DOI 10.1378/chest.116.1.139; Vahrmeijer AL, 2013, NAT REV CLIN ONCOL, V10, P507, DOI 10.1038/nrclinonc.2013.123; Wang L, 2016, NANOSCALE, V8, P2488, DOI 10.1039/c5nr07437a; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Weber J, 2016, NAT METHODS, V13, P639, DOI [10.1038/NMETH.3929, 10.1038/nmeth.3929]; WICKY S, 1994, CHEST, V106, P1326, DOI 10.1378/chest.106.5.1326; Wiener RS, 2011, ANN INTERN MED, V155, P137, DOI 10.7326/0003-4819-155-3-201108020-00003	30	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231488	10.1371/journal.pone.0231488	http://dx.doi.org/10.1371/journal.pone.0231488			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315347	Green Published, gold			2022-12-26	WOS:000536024800030
J	Li, LZ; Fang, ZF; Liu, XY; Hu, WB; Lu, WW; Lee, YK; Zhao, JX; Zhang, H; Chen, W				Li, Lingzhi; Fang, Zhifeng; Liu, Xinyang; Hu, Wenbin; Lu, Wenwei; Lee, Yuan-kun; Zhao, Jianxin; Zhang, Hao; Chen, Wei			Lactobacillus reuteri attenuated allergic inflammation induced by HDM in the mouse and modulated gut microbes	PLOS ONE			English	Article							AIRWAY INFLAMMATION; DISEASE; RESPONSES; CHILDREN; IGE	Gut microbiome plays an essential role in asthma development, and probiotic-based manipulation of the gut microbiome has been proposed to prevent asthma. Although the preventive effect of Lactobacillus supplementation against allergies has been reported, the precise Lactobacillus species beneficial for effective prevention of asthma remain unidentified and the underlying mechanisms remain unclear. Therefore, we aimed to investigate the efficacy of oral administration of six Lactobacillus species and the mechanism underlying asthma prevention via gut microbiome modulation. We investigated the effects of oral administration of L. rhamnosus, L. fermentum, L. casei, L. gasseri, L. salivarius, and L. reuteri (five strains of each species) on asthma and gut microbiome of house dust mite (HDM)-treated murine models of asthma. Of these, L. reuteri administration was the most effective: it alleviated airway inflammation, decreased total IgE and HDM-IgG1, and reduced Th2-associated proinflammatory cytokines. Moreover, modulation of specific microbial genera by L. reuteri was more effective in asthma prevention than the modulation of the overall microbiota composition. Lactobacillus and Enterococcus were enriched after L. reuteri supplementation and were closely associated with total IgE and IL-13 production. Furthermore, L. reuteri specifically altered the gut microbial function toward butyrate generation. Thus, L. reuteri may reduce the risk of asthma development by modulating specific gut microbiota to improve the lung immune environment. Our study suggests a novel option for gut microbiome manipulation via L. reuteri supplementation for suppression of asthma and other allergic diseases.	[Li, Lingzhi; Fang, Zhifeng; Liu, Xinyang; Hu, Wenbin; Lu, Wenwei; Zhao, Jianxin; Zhang, Hao; Chen, Wei] Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Li, Lingzhi; Fang, Zhifeng; Liu, Xinyang; Hu, Wenbin; Lu, Wenwei; Zhao, Jianxin; Zhang, Hao; Chen, Wei] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China; [Lu, Wenwei; Zhao, Jianxin; Zhang, Hao; Chen, Wei] Jiangnan Univ, Natl Engn Res Ctr Funct Food, Wuxi, Jiangsu, Peoples R China; [Lu, Wenwei; Zhang, Hao] Jiangnan Univ, Yangzhou Inst Food Biotechnol, Yangzhou, Jiangsu, Peoples R China; [Lee, Yuan-kun] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore; [Zhang, Hao] Wuxi Translat Med Res Ctr, Wuxi, Jiangsu, Peoples R China; [Zhang, Hao] Jiangsu Translat Med Res Inst, Wuxi Branch, Wuxi, Jiangsu, Peoples R China; [Chen, Wei] Beijing Technol & Business Univ BTBU, Beijing Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China	Jiangnan University; Jiangnan University; Jiangnan University; Jiangnan University; National University of Singapore; Beijing Technology & Business University	Zhao, JX (corresponding author), Jiangnan Univ, State Key Lab Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Zhao, JX (corresponding author), Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.; Zhao, JX (corresponding author), Jiangnan Univ, Natl Engn Res Ctr Funct Food, Wuxi, Jiangsu, Peoples R China.	zhaojianxin@jiangnan.edu.cn	Chen, Wei/GZK-7348-2022		National Natural Science Foundation of China [31820103010, 31771953, 31871774]; Fundamental Research Funds for the Central Universities [JUSRP51903B]; National first class discipline program of Food Science and Technology [JUFSTR20180102]; Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National first class discipline program of Food Science and Technology; Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province	This work was supported by the National Natural Science Foundation of China (Grant No. 31820103010, 31771953, 31871774), the Fundamental Research Funds for the Central Universities (JUSRP51903B), the National first class discipline program of Food Science and Technology (JUFSTR20180102) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the Collaborative Innovation Center of Food Safety and Quality Control in Jiangsu Province.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bjorksten B, 2001, J ALLERGY CLIN IMMUN, V108, P516, DOI 10.1067/mai.2001.118130; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chaker AM, 2017, ORL J OTO-RHINO-LARY, V79, P72, DOI 10.1159/000455725; Chen CC, 2016, PEDIAT ALLERG IMM-UK, V27, P254, DOI 10.1111/pai.12522; Chen YS, 2010, PEDIATR PULM, V45, P1111, DOI 10.1002/ppul.21296; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Fonseca W, 2017, MUCOSAL IMMUNOL, V10, P1569, DOI 10.1038/mi.2017.13; Fu LL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01536; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Henderson WR, 1996, J EXP MED, V184, P1483, DOI 10.1084/jem.184.4.1483; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Johansson MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023031; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kechagia M., 2013, ISRN NUTR; Mao BY, 2015, J AGR FOOD CHEM, V63, P856, DOI 10.1021/jf505156h; Marro A, 2011, IMMUNOTHERAPY-UK, V3, P971, DOI [10.2217/IMT.11.93, 10.2217/imt.11.93]; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mennini M, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00165; Moreau NM, 2003, J CHROMATOGR B, V784, P395, DOI 10.1016/S1570-0232(02)00827-9; Nguyen M, 2016, ISME J, V10, P2978, DOI 10.1038/ismej.2016.76; Noverr MC, 2004, TRENDS MICROBIOL, V12, P562, DOI 10.1016/j.tim.2004.10.008; Ong YE, 2005, J ALLERGY CLIN IMMUN, V116, P558, DOI 10.1016/j.jaci.2005.05.035; Papi A, 2018, LANCET, V391, P783, DOI 10.1016/S0140-6736(17)33311-1; Rausch P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005008; Schabussova I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040271; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Thorburn AN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8320; VANDERHEIJDEN FL, 1995, CLIN EXP IMMUNOL, V99, P289; Yee AL, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00229-18; Zhang B, 2012, INT J MOL MED, V30, P248, DOI 10.3892/ijmm.2012.1010; Zhao LL, 2013, SCI REP-UK, V3, DOI 10.1038/srep01163; Zimmermann P, 2019, J ALLERGY CLIN IMMUN, V143, P467, DOI 10.1016/j.jaci.2018.09.025	34	30	31	5	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231865	10.1371/journal.pone.0231865	http://dx.doi.org/10.1371/journal.pone.0231865			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315360	gold, Green Published			2022-12-26	WOS:000536024800060
J	Griffiths, KK; Wang, AL; Wang, LF; Tracey, M; Kleiner, G; Quinzii, CM; Sun, LL; Yang, G; Perez-Zoghbi, JF; Licznerski, P; Yang, M; Jonas, EA; Levy, RJ				Griffiths, Keren K.; Wang, Aili; Wang, Lifei; Tracey, Matthew; Kleiner, Giulio; Quinzii, Catarina M.; Sun, Linlin; Yang, Guang; Perez-Zoghbi, Jose F.; Licznerski, Pawel; Yang, Mu; Jonas, Elizabeth A.; Levy, Richard J.			Inefficient thermogenic mitochondrial respiration due to futile proton leak in a mouse model of fragile X syndrome	FASEB JOURNAL			English	Article						coenzyme Q; Fmr1; Fragile X syndrome; mitochondria; permeability transition pore; proton leak; synaptogenesis; thermogenic; ubiquinone; uncoupled respiration	PERMEABILITY TRANSITION PORE; MENTAL-RETARDATION PROTEIN; BROWN ADIPOSE-TISSUE; BRAIN MITOCHONDRIA; ENERGY-METABOLISM; DENDRITIC SPINES; MESSENGER-RNAS; FMRP; EXPRESSION; AUTISM	Fragile X syndrome (FXS) is the leading known inherited intellectual disability and the most common genetic cause of autism. The full mutation results in transcriptional silencing of the Fmr1 gene and loss of fragile X mental retardation protein (FMRP) expression. Defects in neuroenergetic capacity are known to cause a variety of neurodevelopmental disorders. Thus, we explored the integrity of forebrain mitochondria in Fmr1 knockout mice during the peak of synaptogenesis. We found inefficient thermogenic respiration due to futile proton leak in Fmr1 KO mitochondria caused by coenzyme Q (CoQ) deficiency and an open cyclosporine-sensitive channel. Repletion of mitochondrial CoQ within the Fmr1 KO forebrain closed the channel, blocked the pathological proton leak, restored rates of protein synthesis during synaptogenesis, and normalized the key phenotypic features later in life. The findings demonstrate that FMRP deficiency results in inefficient oxidative phosphorylation during the neurodevelopment and suggest that dysfunctional mitochondria may contribute to the FXS phenotype.	[Griffiths, Keren K.; Wang, Aili; Wang, Lifei; Tracey, Matthew; Sun, Linlin; Yang, Guang; Perez-Zoghbi, Jose F.; Levy, Richard J.] Columbia Univ, Dept Anesthesiol, Med Ctr, PH5-534B,622 W 168th St, New York, NY 10032 USA; [Kleiner, Giulio; Quinzii, Catarina M.] Columbia Univ, Dept Neurol, Med Ctr, New York, NY USA; [Licznerski, Pawel; Jonas, Elizabeth A.] Yale Univ, Sch Med, Dept Internal Med, Sect Endocrinol, New Haven, CT 06510 USA; [Yang, Mu] Columbia Univ, Med Ctr, Inst Genom Med & Psychiat, New York, NY USA	Columbia University; Columbia University; Yale University; Columbia University	Levy, RJ (corresponding author), Columbia Univ, Dept Anesthesiol, Med Ctr, PH5-534B,622 W 168th St, New York, NY 10032 USA.	RL2740@cumc.columbia.edu	, WaNgtJ/AAR-7045-2020	Yang, Guang/0000-0002-5739-9126; Kleiner, Giulio/0000-0002-1830-3961; Tracey, Matthew/0000-0002-2487-5616; Licznerski, Pawel/0000-0003-2761-8428	National Institute of Neurological Disorders and Stroke (NINDS) [R01NS112706, R01NS081746, R37NS045876]; National Institute of Environmental Health Sciences (NIEHS) [P30 ES009089]; National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R01AA027108]	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	National Institute of Neurological Disorders and Stroke (NINDS), Grant/Award Number: R01NS112706, R01NS112706, R01NS081746 and R37NS045876; National Institute of Environmental Health Sciences (NIEHS), Grant/Award Number: P30 ES009089; National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: R01AA027108	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Amo T, 2007, BIOCHEM J, V404, P345, DOI 10.1042/BJ20061609; Anderson CM, 2015, CELL REP, V10, P505, DOI 10.1016/j.celrep.2014.12.048; ARROYO ED, 2018, J NEUROSCI, V10, P1734; Aryal S, 2018, SCIENCE, V361, P648, DOI 10.1126/science.aau6450; Ascano M, 2012, NATURE, V492, P382, DOI 10.1038/nature11737; Bailey DB, 2017, PEDIATRICS, V139, pS216, DOI [10.1542/peds.2016-1159h, 10.1542/peds.2016-1159H]; Ballinger MA, 2017, AM J PHYSIOL-REG I, V312, pR301, DOI 10.1152/ajpregu.00314.2016; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bonaccorso CM, 2015, INT J DEV NEUROSCI, V42, P15, DOI 10.1016/j.ijdevneu.2015.02.004; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao RF, 2015, NAT NEUROSCI, V18, P855, DOI 10.1038/nn.4010; Cardoso S, 2013, J BIOENERG BIOMEMBR, V45, P397, DOI 10.1007/s10863-013-9503-2; Cirelli C, 2015, BIOL PSYCHIAT, V77, P1071, DOI 10.1016/j.biopsych.2014.12.017; Cruz-Martin A, 2010, J NEUROSCI, V30, P7793, DOI 10.1523/JNEUROSCI.0577-10.2010; D'Antoni S, 2020, BIOL CHEM, V401, P497, DOI 10.1515/hsz-2019-0221; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Divakaruni AS, 2011, PHYSIOLOGY, V26, P192, DOI 10.1152/physiol.00046.2010; Ferreiro-Barros CC, 2012, EINSTEIN-SAO PAULO, V10, P203, DOI 10.1590/S1679-45082012000200014; Fink BD, 2002, J BIOL CHEM, V277, P3918, DOI 10.1074/jbc.M107955200; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Galvez R, 2005, AM J MED GENET A, V135A, P155, DOI 10.1002/ajmg.a.30709; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Gautier CA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-22; Gholizadeh S, 2015, BRAIN RES, V1596, P22, DOI 10.1016/j.brainres.2014.11.023; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greenblatt EJ, 2018, SCIENCE, V361, P709, DOI 10.1126/science.aas9963; Greenough WT, 2001, P NATL ACAD SCI USA, V98, P7101, DOI 10.1073/pnas.141145998; Hagerman RJ, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.65; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hernandez-Camacho JD, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00044; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Hou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076721; Hou Y, 2012, STEM CELLS, V30, P2535, DOI 10.1002/stem.1213; James AM, 2005, J BIOL CHEM, V280, P21295, DOI 10.1074/jbc.M501527200; Kazdoba TM, 2014, INTRACTABLE RARE DIS, V3, P118, DOI 10.5582/irdr.2014.01024; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Lee C. P., 1993, V2, P41; Levy RJ, 2004, SHOCK, V21, P110, DOI 10.1097/01.shk.0000108400.56565.ab; Licitra F, 2014, MOL SYNDROMOL, V5, P180, DOI 10.1159/000362942; Lopez-Lluch G, 2019, NUTRITION, V57, P133, DOI 10.1016/j.nut.2018.05.020; Lumaban JG, 2015, HUM MOL GENET, V24, P2175, DOI 10.1093/hmg/ddu737; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; McKinney BC, 2005, AM J MED GENET B, V136B, P98, DOI 10.1002/ajmg.b.30183; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Mnatsakanyan N, 2017, J BIOENERG BIOMEMBR, V49, P13, DOI 10.1007/s10863-016-9652-1; Muddashetty RS, 2007, J NEUROSCI, V27, P5338, DOI 10.1523/JNEUROSCI.0937-07.2007; Nimchinsky EA, 2001, J NEUROSCI, V21, P5139, DOI 10.1523/JNEUROSCI.21-14-05139.2001; Osterweil EK, 2013, NEURON, V77, P243, DOI 10.1016/j.neuron.2012.01.034; Osterweil EK, 2010, J NEUROSCI, V30, P15616, DOI 10.1523/JNEUROSCI.3888-10.2010; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Perez MJ, 2017, DEV BIOL, V426, P1, DOI 10.1016/j.ydbio.2017.04.018; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PUMPHREY AM, 1960, BIOCHEM J, V76, P61, DOI 10.1042/bj0760061; Rangaraju V, 2019, CELL, V176, P73, DOI 10.1016/j.cell.2018.12.013; Rao VK, 2014, BBA-MOL BASIS DIS, V1842, P1267, DOI 10.1016/j.bbadis.2013.09.003; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; Riley C, 2017, PEDIATRICS, V139, pS207, DOI 10.1542/peds.2016-1159G; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Rumana CS, 1998, CRIT CARE MED, V26, P562, DOI 10.1097/00003246-199803000-00032; Scorrano L, 1997, J BIOL CHEM, V272, P12295, DOI 10.1074/jbc.272.19.12295; Sethna F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14359; SHAHBAZIAN FM, 1987, INT J DEV NEUROSCI, V5, P39, DOI 10.1016/0736-5748(87)90046-3; SHAHBAZIAN FM, 1986, INT J DEV NEUROSCI, V4, P209, DOI 10.1016/0736-5748(86)90060-2; Singh K, 2007, MOL BIOL REP, V34, P173, DOI 10.1007/s11033-006-9032-8; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Telford JE, 2010, J BIOL CHEM, V285, P8639, DOI 10.1074/jbc.M109.079780; Valenti D, 2014, NEUROSCI BIOBEHAV R, V46, P202, DOI 10.1016/j.neubiorev.2014.01.012; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Walter L, 2000, J BIOL CHEM, V275, P29521, DOI 10.1074/jbc.M004128200; Wang XY, 2011, J NEUROCHEM, V119, P1253, DOI 10.1111/j.1471-4159.2011.07525.x; Wang YG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7511; Watson DJ, 2016, HIPPOCAMPUS, V26, P560, DOI 10.1002/hipo.22536; Weinert D, 2007, PHYSIOL BEHAV, V90, P246, DOI 10.1016/j.physbeh.2006.09.003; Weisz ED, 2018, HUM MOL GENET, V27, P95, DOI 10.1093/hmg/ddx387; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; Yang M, 2012, J NEUROSCI, V32, P6525, DOI 10.1523/JNEUROSCI.6107-11.2012; Zhang XD, 2016, ELIFE, V5, DOI 10.7754/eLife.13374; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Ziosi M, 2017, EMBO MOL MED, V9, P96, DOI 10.15252/emmm.201606356	85	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7404	7426		10.1096/fj.202000283RR	http://dx.doi.org/10.1096/fj.202000283RR		APR 2020	23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307754	Green Accepted, Bronze			2022-12-26	WOS:000527568000001
J	Chiu, YW; Hori, Y; Ebinuma, I; Sato, H; Hara, N; Ikeuchi, T; Tomita, T				Chiu, Yung Wen; Hori, Yukiko; Ebinuma, Ihori; Sato, Haruaki; Hara, Norikazu; Ikeuchi, Takeshi; Tomita, Taisuke			Identification of calcium and integrin-binding protein 1 as a novel regulator of production of amyloid beta peptide using CRISPR/Cas9-based screening system	FASEB JOURNAL			English	Article						Alzheimer disease; A beta; CIB1; gamma-secretase	ALZHEIMERS-DISEASE; SENILE PLAQUES; PRESENILIN; CIB1	The aberrant metabolism of amyloid beta peptide (A beta) has been implicated in the etiology of Alzheimer disease (AD). A beta is produced via the sequential cleavage of amyloid precursor protein (APP) by beta- and gamma-secretases. However, the precise regulatory mechanism of A beta generation still remains unclear. To gain a better understanding of the molecular mechanism of A beta production, we established a genetic screening method based on the CRISPR/Cas9 system to identify novel regulators of A beta production. We successfully identified calcium and integrin-binding protein 1 (CIB1) as a potential negative regulator of A beta production. The disruption of Cib1 significantly upregulated A beta levels. In addition, immunoprecipitation experiments demonstrated that CIB1 interacts with the gamma-secretase complex. Moreover, the disruption of Cib1 specifically reduced the cell-surface localization of mature Nicastrin (Nct), which is a component of the gamma-secretase complex, without changing the intrinsic activity of gamma-secretase. Finally, we confirmed using the single-cell RNA-seq data in human that CIB1 mRNA level in neuron was decreased in the early stage of AD. Taken together, our results indicate that CIB1 regulates A beta production via controlling the subcellular localization of gamma-secretase, suggesting CIB1 is involved in the development of AD.	[Chiu, Yung Wen; Hori, Yukiko; Ebinuma, Ihori; Sato, Haruaki; Tomita, Taisuke] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan; [Hara, Norikazu; Ikeuchi, Takeshi] Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata, Japan	University of Tokyo; Niigata University	Tomita, T (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Neuropathol & Neurosci, Tokyo, Japan.	taisuke@mol.f.u-tokyo.ac.jp	Tomita, Taisuke/L-5427-2015	Tomita, Taisuke/0000-0002-0075-5943; Hara, Norikazu/0000-0001-8525-3469	Japan Agency for Medical Research and Development (AMED) [JP18dm0207014, JP20dm0207073]; Japan Society for the Promotion of Science (JSPS) [15H02492, 19H01015, 16K18871, 17J10935]	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Agency for Medical Research and Development (AMED), Grant/Award Number: JP18dm0207014 and JP20dm0207073; Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 15H02492, 19H01015, 16K18871 and 17J10935	Bandyopadhyay C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003941; Bernstein HG, 2005, NEUROPATH APPL NEURO, V31, P314, DOI 10.1111/j.1365-2990.2005.00646.x; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; BRETSCHER MS, 1988, EMBO J, V7, P4087, DOI 10.1002/j.1460-2075.1988.tb03302.x; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Cai T, 2017, J NEUROSCI, V37, P12272, DOI 10.1523/JNEUROSCI.1628-17.2017; Castello MA, 2014, AGEING RES REV, V13, P10, DOI 10.1016/j.arr.2013.10.001; Duff K, 1996, NATURE, V383, P710, DOI 10.1038/383710a0; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Gopalappa R, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky222; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kanatsu K, 2018, J NEUROCHEM, V147, P110, DOI 10.1111/jnc.14477; Kanatsu K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4386; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; LaFerla FM, 2007, NAT REV NEUROSCI, V8, P499, DOI 10.1038/nrn2168; Leisner TM, 2016, FASEB J, V30, P2640, DOI 10.1096/fj.201500073R; Li YM, 2000, NATURE, V405, P689, DOI 10.1038/35015085; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Morohashi Y, 2006, J BIOL CHEM, V281, P14670, DOI 10.1074/jbc.M513012200; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sato C, 2008, J NEUROSCI, V28, P6264, DOI 10.1523/JNEUROSCI.1163-08.2008; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Sun ZZ, 2018, MOL NEUROBIOL, V55, P3841, DOI 10.1007/s12035-017-0606-3; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1998, NEUROBIOL DIS, V4, P438, DOI 10.1006/nbdi.1998.0171; Tomita T, 1999, J NEUROSCI, V19, P10627, DOI 10.1523/JNEUROSCI.19-24-10627.1999; Tomita T, 2017, METHOD ENZYMOL, V584, P185, DOI 10.1016/bs.mie.2016.10.033; Tomita T, 1997, P NATL ACAD SCI USA, V94, P2025, DOI 10.1073/pnas.94.5.2025; Tomita T, 2014, J BIOCHEM, V156, P195, DOI 10.1093/jb/mvu049; Watanabe N, 2005, J BIOL CHEM, V280, P41967, DOI 10.1074/jbc.M509066200	41	6	7	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7661	7674		10.1096/fj.201902966RR	http://dx.doi.org/10.1096/fj.201902966RR		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307772	Bronze			2022-12-26	WOS:000526956600001
J	Lowe, DE; Pellegrini, G; LeMasters, E; Carter, AJ; Weiner, ZP				Lowe, David E.; Pellegrini, Gerald; LeMasters, Elizabeth; Carter, Andrew J.; Weiner, Zachary P.			Analysis and modeling of coolants and coolers for specimen transportation	PLOS ONE			English	Article							VACCINE; STORAGE; CHAIN	Maintaining cold chain while transporting medical supplies and samples is difficult in remote settings. Failure to maintain temperature requirements can lead to degraded sample quality and inaccuracies in sample analysis. We performed a systematic analysis on different types of transport coolers (polystyrene foam, injection-molded, and rotational molded) and transport coolants (ice, cold packs, frozen water bottles) frequently in use in many countries. Polystyrene foam coolers stayed below our temperature threshold (6 degrees C) longer than almost all other types of coolers, but were not durable. Injection-molded coolers were durable, but warmed to 6 degrees C the quickest. Rotational molded coolers were able to keep temperatures below our threshold for 24 hours longer than injection molded coolers and were highly durable. Coolant systems were evaluated in terms of cost and their ability to maintain cold temperatures. Long lasting commercial cold packs were found to be less cost effective and were below freezing for the majority of the testing period. Frozen plastic water bottles were found to be a reusable and economical choice for coolant and were only below freezing briefly. Finally, we modeled the coolers performance at maintaining internal temperatures below 6 degrees C and built a highly accurate linear model to predict how long a cooler will remain below 6 degrees C. We believe this data may be useful in the planning and design of specimen transportation systems in the field, particularly in remote or resource limited settings.	[Lowe, David E.; LeMasters, Elizabeth; Carter, Andrew J.; Weiner, Zachary P.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA; [Lowe, David E.] Ctr Dis Control & Prevent, Lab Leadership Serv Fellowship, Atlanta, GA USA; [Pellegrini, Gerald] Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Weiner, ZP (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.	xxd7@cdc.gov			Centers for Disease Control and Prevention's Office of Laboratory Safety and Science [201704]; U.S. Department of Energy; CDC; CDC's Office of Laboratory Safety and Science; Oak Ridge Institute for Science and Education; Laboratory Leadership and Service Fellowship	Centers for Disease Control and Prevention's Office of Laboratory Safety and Science(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); U.S. Department of Energy(United States Department of Energy (DOE)); CDC(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); CDC's Office of Laboratory Safety and Science; Oak Ridge Institute for Science and Education(General Electric); Laboratory Leadership and Service Fellowship	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study was funded by LaSSI grant 201704 from the Centers for Disease Control and Prevention's Office of Laboratory Safety and Science. LeMasters was supported in part by appointment to the Research Participation Program at the Centers for Disease Control and Prevention, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and CDC.; We wish to thank the CDC's Office of Laboratory Safety and Science, Oak Ridge Institute for Science and Education, and the Laboratory Leadership and Service Fellowship for their guidance and discussions.	Billah MM, 2017, J INFECT DIS, V216, pS114, DOI 10.1093/infdis/jiw591; Clancy Jason, 2017, Air Med J, V36, P302, DOI 10.1016/j.amj.2017.05.002; Dauner AL, 2015, AM J TROP MED HYG, V93, P46, DOI 10.4269/ajtmh.15-0110; Grady C., 2012, INT WATER TECHNOL J, V2, P185; Hanson CM, 2017, VACCINE, V35, P2127, DOI 10.1016/j.vaccine.2016.09.070; Hasan MR, 2012, J CLIN MICROBIOL, V50, P4147, DOI 10.1128/JCM.02659-12; Haslacher H, 2017, CLIN CHEM LAB MED, V55, P974, DOI 10.1515/cclm-2016-0608; IATA, 2019, DANG GOODS REG; Institute CaLS, 2005, COLL TRANSP PREP STO; James G., 2014, INTRO STAT LEARNING; Jusu MO, 2018, J INFECT DIS, V217, pS48, DOI 10.1093/infdis/jix336; Kebede Y, 2016, J INFECT DIS, V213, pS59, DOI 10.1093/infdis/jiv576; McCarney S, 2013, VACCINE, V31, P6050, DOI 10.1016/j.vaccine.2013.07.076; McElhinney LM, 2014, J VIROL METHODS, V207, P110, DOI 10.1016/j.jviromet.2014.06.024; OIE, 2018, MANUAL DIAGNOSTIC TE; World Health Organization, 1997, GUID SAF TRANSP INF	16	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231093	10.1371/journal.pone.0231093	http://dx.doi.org/10.1371/journal.pone.0231093			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302335	Green Published, gold			2022-12-26	WOS:000536016100015
J	Falkowski, AL; Jacobson, JA; Kalia, V; Meyer, NB; Gandikota, G; Yosef, M; Thiele, RG				Falkowski, Anna L.; Jacobson, Jon A.; Kalia, Vivek; Meyer, Nathaniel B.; Gandikota, Girish; Yosef, Matheos; Thiele, Ralf G.			Cartilage icing and chondrocalcinosis on knee radiographs in the differentiation between gout and calcium pyrophosphate deposition	PLOS ONE			English	Article							CRYSTAL DEPOSITION; TENDON CALCIFICATION; DISEASE; CPPD; PREVALENCE; EXPERIENCE; DIAGNOSIS; ARTHRITIS; CT	Objective To determine if findings of "cartilage icing" and chondrocalcinosis on knee radiography can differentiate between gout and calcium pyrophosphate deposition (CPPD). Methods IRB-approval was obtained and informed consent was waived for this retrospective study. Electronic medical records from over 2.3 million patients were searched for keywords to identify subjects with knee aspiration-proven cases of gout or CPPD. Radiographs were reviewed by two fellowship-trained musculoskeletal radiologists in randomized order, blinded to the patients' diagnoses. Images were evaluated regarding the presence or absence of cartilage icing, chondrocalcinosis, tophi, gastrocnemius tendon calcification, and joint effusion. Descriptive statistics, sensitivity, specificity, positive and negative predictive values, and accuracy were calculated. Results From 49 knee radiographic studies in 46 subjects (31 males and 15 females; mean age 66 +/- 13 years), 39% (19/49) showed gout and 61% (30/49) CPPD on aspiration. On knee radiographs, cartilage icing showed a higher sensitivity for CPPD than gout (53-67% and 26%, respectively). Chondrocalcinosis also showed a higher sensitivity for CPPD than gout (50-57% versus 5%), with 95% specificity and 94% positive predictive value for diagnosis of CPPD versus gout. Soft tissue tophus-like opacities were present in gout at the patellar tendon (5%, 1/19) and at the popliteus groove in CPPD (15%, 4/27). Gastrocnemius tendon calcification was present in 30% (8/27) of subjects with CPPD, and 5% (1/19) of gout. Conclusion In subjects with joint aspiration-proven crystal disease of the knee, the radiographic finding of cartilage icing was seen in both gout and CPPD. Chondrocalcinosis (overall and hyaline cartilage) as well as gastrocnemius tendon calcification positively correlated with the diagnosis of CPPD over gout.	[Falkowski, Anna L.; Jacobson, Jon A.; Kalia, Vivek; Meyer, Nathaniel B.; Gandikota, Girish] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Falkowski, Anna L.] Univ Basel, Univ Hosp Basel, Dept Radiol, Basel, Switzerland; [Yosef, Matheos] MICHR, Ann Arbor, MI USA; [Thiele, Ralf G.] Univ Rochester, Dept Rheumatol, Rochester, NY USA	University of Michigan System; University of Michigan; University of Basel; University of Rochester	Falkowski, AL (corresponding author), Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA.; Falkowski, AL (corresponding author), Univ Basel, Univ Hosp Basel, Dept Radiol, Basel, Switzerland.	falkowski.anna@gmail.com		Falkowski, Anna L./0000-0003-4293-0911	University of Basel; Swiss Society of Radiology, Gottfried und Julia Bangerter-Rhyner-Stiftung; Freiwillige Akademische Gesellschaft Basel	University of Basel; Swiss Society of Radiology, Gottfried und Julia Bangerter-Rhyner-Stiftung; Freiwillige Akademische Gesellschaft Basel(General Electric)	Anna L. Falkowski, MD, MHBA received grants from the Research Funds of the University of Basel, Swiss Society of Radiology, Gottfried und Julia Bangerter-Rhyner-Stiftung, and Freiwillige Akademische Gesellschaft Basel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhishek A, 2018, ARTHRITIS RHEUMATOL, V70, P1847, DOI 10.1002/art.40572; Azmat O, 2015, ESSR 2015 ED, pP, DOI [10.1594/essr2015/P-0106, DOI 10.1594/ESSR2015/P-0106]; Berendsen D, 2017, CLIN RHEUMATOL, V36, P641, DOI 10.1007/s10067-016-3461-0; Di Matteo A, 2018, POPLITEAL GROOVE REG, DOI [10.1016/j. jbspin.2018.06.008, DOI 10.1016/J.JBSPIN.2018.06.008]; Filippucci E, 2010, CLIN EXP RHEUMATOL, V28, P2; Filippucci E, 2009, OSTEOARTHR CARTILAGE, V17, P178, DOI 10.1016/j.joca.2008.06.003; Foldes K, 1996, SKELETAL RADIOL, V25, P621, DOI 10.1007/s002560050147; Fuerst M, 2009, ARTHRITIS RHEUM, V60, P2694, DOI 10.1002/art.24774; Girish G, 2013, AM J ROENTGENOL, V201, P515, DOI 10.2214/AJR.13.10776; HAMILTON EBD, 1976, ARTHRITIS RHEUM, V19, P353, DOI 10.1002/1529-0131(197605/06)19:3+<353::AID-ART1780190708>3.0.CO;2-Q; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Loffler C, 2015, J RHEUMATOL, V42, P513, DOI 10.3899/jrheum.140634; Magarelli N, 2012, CLIN EXP RHEUMATOL, V30, P118; Mak HKF, 2004, RADIOLOGY, V232, P302, DOI 10.1148/radiol.2321031974; Mallinson PI, 2016, RADIOLOGY, V281, P690, DOI 10.1148/radiol.2016151109; MARCOVE RC, 1988, CLIN ORTHOP RELAT R, P305; MARTEL W, 1970, AMER J ROENTGENOL RA, V109, P587, DOI 10.2214/ajr.109.3.587; MARTEL W, 1981, RADIOLOGY, V141, P1; McCarthy GM, 2018, NAT REV RHEUMATOL, V14, P592, DOI 10.1038/s41584-018-0078-5; McQueen FM, 2014, RHEUM DIS CLIN N AM, V40, P231, DOI 10.1016/j.rdc.2014.01.004; Misra D, 2015, OSTEOARTHR CARTILAGE, V23, P244, DOI 10.1016/j.joca.2014.10.009; Neogi T, 2015, ANN RHEUM DIS, V74, P1789, DOI 10.1136/annrheumdis-2015-208237; Omoumi P, 2016, RHEUM DIS CLIN N AM, V42, P621, DOI 10.1016/j.rdc.2016.07.005; Ottaviani S, 2018, JCR-J CLIN RHEUMATOL, V24, P92, DOI 10.1097/RHU.0000000000000640; Pascart T, 2019, OSTEOARTHR CARTILAGE, V27, P1309, DOI 10.1016/j.joca.2019.05.007; PAUL H, 1983, ARTHRITIS RHEUM, V26, P191, DOI 10.1002/art.1780260211; Pereira ERH, 1998, CLIN IMAG, V22, P371, DOI 10.1016/S0899-7071(98)00029-1; Reginato AJ, 1999, EPUB, V1, P112, DOI [10.1007/ s11926-999-0007-3, DOI 10.1007/S11926-999-0007-3]; RESNICK D, 1977, RADIOLOGY, V122, P1; Richette P, 2017, ANN RHEUM DIS, V76, P29, DOI [10.1136/annrheumdis-2016-209707, 10.1136/annrheumdis-2016-210356]; Richette P, 2020, ANN RHEUM DIS, V79, P31, DOI 10.1136/annrheumdis-2019-215315; Rosenthal AK, 2016, NEW ENGL J MED, V374, P2575, DOI 10.1056/NEJMra1511117; Segal JB, 1999, ARTHRIT CARE RES, V12, P376, DOI 10.1002/1529-0131(199912)12:6<376::AID-ART5>3.0.CO;2-5; Stamp LK, 2019, ARTHRITIS RHEUMATOL, V71, P1158, DOI 10.1002/art.40848; Steinbach L S, 2000, Curr Probl Diagn Radiol, V29, P209; Steinbach LS, 1996, RADIOLOGY, V200, P1; Thiele RG, 2007, RHEUMATOLOGY, V46, P1116, DOI 10.1093/rheumatology/kem058; Thiele RG, 2010, RHEUMATOL INT, V30, P495, DOI 10.1007/s00296-009-1002-8; Ward IM, 2015, JCR-J CLIN RHEUMATOL, V21, P314, DOI 10.1097/RHU.0000000000000292; Yang BY, 1996, J RHEUMATOL, V23, P883; Zhang W, 2011, ANN RHEUM DIS, V70, P571, DOI 10.1136/ard.2010.139360; Zhang W, 2011, ANN RHEUM DIS, V70, P563, DOI 10.1136/ard.2010.139105	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231508	10.1371/journal.pone.0231508	http://dx.doi.org/10.1371/journal.pone.0231508			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298308	Green Published, gold			2022-12-26	WOS:000536011400056
J	Teasdale, CA; Abrams, EJ; Yuengling, KA; Lamb, MR; Wang, CH; Vitale, M; Hawken, M; Melaku, Z; Nuwagaba-Biribonwoha, H; El-Sadr, WM				Teasdale, Chloe A.; Abrams, Elaine J.; Yuengling, Katharine A.; Lamb, Matthew R.; Wang, Chunhui; Vitale, Mirriah; Hawken, Mark; Melaku, Zenebe; Nuwagaba-Biribonwoha, Harriet; El-Sadr, Wafaa M.			Expansion and scale-up of HIV care and treatment services in four countries over ten years	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; FOLLOW-UP; RETENTION; METAANALYSIS; PREGNANCY; OUTCOMES; HEALTH; WOMEN	Background Scale-up and expansion of antiretroviral therapy (ART) for people living with HIV (PLHIV) have been a global priority for more than 15 years. Methods We describe PLHIV at enrollment in care and ART initiation in Ethiopia, Kenya, Mozambique and Tanzania from 2005-2014 and report on enrollment location, CD4 count and loss to follow-up (LTF), death, and combined attrition (LTF and death) pre- and post-ART initiation over time. Pre-ART outcomes were estimated using competing risk and post-ART using Kaplan-Meier estimators; LTF defined as no visit within six months pre-ART and 12 months after ART start. Results From 2005-2014, 884,328 PLHIV enrolled in care at 350 health facilities, median age was 32.0 years (interquartile range [IQR] 26.0-42.0), and majority were female (66.5%). The proportion of PLHIV enrolled at primary and rural facilities increased from 12.9% and 15.3% in 2005-2006 to 43.5% and 41.7% in 2013-2014 (p<0.0001). Median CD4+ cell count at enrollment increased from 171 cell/mm(3) in 2005-2006 (IQR 71-339) to 289 cell/mm(3) in 2013-2014 (IQR 133-485) (p<0.0001). A total of 460,758 (57.4%) PLHIV initiated treatment. Cumulative risk of LTF for PLHIV prior to ART initiation 12 months after enrollment was 33.5% (95%CI 33.36-33.58) and 21.98% (95%CI 21.9-22.1) after ART initiation. Pregnant women and the youngest PLHIV group had the highest attrition after ART initiation, at 24 months 40.8% (95%CI 40.1-41.6) of pregnant women and 47.4% (95%CI 46.4-48.4) of PLHIV 15-19 years were not retained. Attrition at 12 months after enrollment among PLHIV regardless of ART status was 38.5% (95%CI 38.4-38.6). Conclusion Over 10 years of HIV scale-up in four sub-Saharan African countries, close to a million PLHIV were enrolled in care increasingly at rural and primary facilities with increasing CD4 count. Loss to follow-up from HIV care remains alarmingly high, particularly among pregnant women and younger PLHIV.	[Teasdale, Chloe A.] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Teasdale, Chloe A.; Abrams, Elaine J.; Yuengling, Katharine A.; Lamb, Matthew R.; Wang, Chunhui; El-Sadr, Wafaa M.] Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10027 USA; [Teasdale, Chloe A.; Abrams, Elaine J.; Lamb, Matthew R.; Nuwagaba-Biribonwoha, Harriet; El-Sadr, Wafaa M.] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Abrams, Elaine J.] Columbia Univ, Dept Pediat, Irving Med Ctr, Vagelos Coll Phys & Surg, New York, NY 10027 USA; [Vitale, Mirriah] Columbia Univ, ICAP, Maputo, Mozambique; [Hawken, Mark] Columbia Univ, ICAP, Nairobi, Kenya; [Melaku, Zenebe] Columbia Univ, ICAP, Addis Ababa, Ethiopia; [Nuwagaba-Biribonwoha, Harriet] Columbia Univ, ICAP, Mbabane, Eswatini; [El-Sadr, Wafaa M.] Columbia Univ, Irving Med Ctr, Vagelos Coll Phys & Surg, New York, NY USA	City University of New York (CUNY) System; Columbia University; Columbia University; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital	Teasdale, CA (corresponding author), CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.; Teasdale, CA (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, ICAP, New York, NY 10027 USA.; Teasdale, CA (corresponding author), Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY 10027 USA.	chloe.teasdale@sph.cuny.edu			President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention [5U62PS223540, 5U2GPS001537]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention under the terms of Cooperative Agreement Number 5U62PS223540 and 5U2GPS001537. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of PEPFAR or the Centers for Disease Control and Prevention. The authors were not paid by any outside entity to write this paper.	Abrams EJ, 2019, AIDS, V33, P45, DOI 10.1097/QAD.0000000000002027; [Anonymous], 2004, 2004 REP GLOB AIDS E; [Anonymous], 2018, TANZANIA HIV IMPACT; Auld AF, 2017, MMWR-MORBID MORTAL W, V66, P558, DOI 10.15585/mmwr.mm6621a3; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Bilinski A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185699; Brennan AT, 2011, AIDS, V25, P2027, DOI 10.1097/QAD.0b013e32834b6480; Bygrave H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052856; Chammartin F, 2018, CLIN INFECT DIS, V67, P1643, DOI 10.1093/cid/ciy347; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; El-Sadr WM, 2016, AIDS, V30, P2145, DOI 10.1097/QAD.0000000000001192; El-Sadr WM, 2012, JAIDS-J ACQ IMM DEF, V60, pS96, DOI 10.1097/QAI.0b013e31825eb27b; Eswatini Go (CDC) CfDCaP University IaC, 2016, SWAZILAND HIV INCIDE; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Grimsrud A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21484; Haas AD, 2016, LANCET HIV, V3, pE175, DOI 10.1016/S2352-3018(16)00008-4; Kaplan R, 2008, AIDS, V22, P1679, DOI 10.1097/QAD.0b013e32830ebcee; Knettel BA, 2018, JAIDS-J ACQ IMM DEF, V77, P427, DOI 10.1097/QAI.0000000000001616; Lamb MR, 2014, AIDS, V28, P559, DOI 10.1097/QAD.0000000000000054; Radin E, 2018, 22 INT AIDS C AMST N; Reidy W, 2016, CLIN INFECT DIS, V63, P426, DOI 10.1093/cid/ciw302; Teasdale CA, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25210; Thin K, 2019, AIDS, V33, P2393, DOI 10.1097/QAD.0000000000002351; UNAIDS, 2019, GLOBAL HIV AIDS STAT, DOI DOI 11/44679/INDEX.HTM; Wang BX, 2011, SAMJ S AFR MED J, V101, P253, DOI 10.7196/SAMJ.4078; World Health Organization (WHO), 2013, 2013 CONS GUID US AN; Zurcher K, 2017, TROP MED INT HEALTH, V22, P375, DOI 10.1111/tmi.12843	27	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231667	10.1371/journal.pone.0231667	http://dx.doi.org/10.1371/journal.pone.0231667			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298331	gold, Green Published			2022-12-26	WOS:000536011400085
J	Wang, C; Pinar, AA; Widdop, RE; Hossain, MA; Bathgate, RAD; Denton, KM; Kemp-Harper, BK; Samuel, CS				Wang, Chao; Pinar, Anita A.; Widdop, Robert E.; Hossain, Mohammed A.; Bathgate, Ross A. D.; Denton, Kate M.; Kemp-Harper, Barbara K.; Samuel, Chrishan S.			The anti-fibrotic actions of relaxin are mediated through AT(2)R-associated protein phosphatases via RXFP1-AT(2)R functional crosstalk in human cardiac myofibroblasts	FASEB JOURNAL			English	Article						AT(2) receptor; cardiac fibrosis; myofibroblasts; phosphatases; RXFP1	II TYPE-2 RECEPTOR; GROWTH-FACTOR-BETA; TYROSINE-PHOSPHATASE; AT2 RECEPTOR; SIGNAL-TRANSDUCTION; AT(2) RECEPTORS; ANGIOTENSIN; HEART; INHIBITION; CELLS	Fibrosis is a hallmark of several cardiovascular diseases. The relaxin family peptide receptor 1 (RXFP1) agonist, relaxin, has rapidly occurring anti-fibrotic actions which are mediated through RXFP1 and angiotensin II receptor crosstalk on renal and cardiac myofibroblasts. Here, we investigated whether this would allow relaxin to indirectly activate angiotensin II type 2 receptor (AT(2)R)-specific signal transduction in primary human cardiac myofibroblasts (HCMFs). The anti-fibrotic effects of recombinant human relaxin (RLX; 16.8 nM) or the AT(2)R-agonist, Compound 21 (C21; 1 mu M), were evaluated in TGF-beta 1-stimulated HCMFs, in the absence or presence of an RXFP1 antagonist (1 mu M) or AT(2)R antagonist (0.1 mu M) to confirm RXFP1-AT(2)R crosstalk. Competition binding for RXFP1 was determined. Western blotting was performed to determine which AT(2)R-specific protein phosphatases were expressed by HCMFs; then, the anti-fibrotic effects of RLX and/or C21 were evaluated in the absence or presence of pharmacological inhibition (NSC95397 (1 mu M) for MKP-1; okadaic acid (10 nM) for PP2A) or siRNA-knockdown of these phosphatases after 72 hours. The RLX- or C21-induced increase in ERK1/2 and nNOS phosphorylation, and decrease in alpha-SMA (myofibroblast differentiation) and collagen-I expression by HCMFs was abrogated by pharmacological blockade of RXFP1 or the AT(2)R, confirming RXFP1-AT(2)R crosstalk in these cells. HCMFs were found to express AT(2)R-dependent MKP-1 and PP2A phosphatases, while pharmacological blockade or siRNA-knockdown of either phosphatase also abolished RLX and/or C21 signal transduction in HCMFs (all P < .05 vs RLX or C21 alone). These findings demonstrated that RLX can indirectly activate AT(2)R-dependent phosphatase activity in HCMFs by signaling through RXFP1-AT(2)R crosstalk, which have important therapeutic implications for its anti-fibrotic actions.	[Wang, Chao; Pinar, Anita A.; Widdop, Robert E.; Denton, Kate M.; Kemp-Harper, Barbara K.; Samuel, Chrishan S.] Monash Biomed Discovery Inst, Cardiovasc Dis Program, Clayton, Vic, Australia; [Wang, Chao; Pinar, Anita A.; Widdop, Robert E.; Kemp-Harper, Barbara K.; Samuel, Chrishan S.] Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia; [Hossain, Mohammed A.; Bathgate, Ross A. D.] Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Bathgate, Ross A. D.; Samuel, Chrishan S.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic, Australia; [Denton, Kate M.] Monash Univ, Dept Physiol, Clayton, Vic, Australia	Monash University; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University	Kemp-Harper, BK; Samuel, CS (corresponding author), Monash Univ, Dept Pharmacol, Clayton, Vic 3800, Australia.	Barbara.kemp@monash.edu; chrishan.samuel@monash.edu	Bathgate, Ross/ABE-6471-2020	Bathgate, Ross/0000-0001-6301-861X; wang, chao/0000-0002-5898-9283; Denton, Kate/0000-0002-5929-4387	Department of Health \ National Health and Medical Research Council (NHMRC) [GNT1101552, GNT1100676, GNT1135837, GNT1136813, GNT1041766]	Department of Health \ National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	Department of Health vertical bar National Health and Medical Research Council (NHMRC), Grant/Award Number: GNT1101552, GNT1100676, GNT1135837, GNT1136813 and GNT1041766	AbdAlla S, 2001, J BIOL CHEM, V276, P39721, DOI 10.1074/jbc.M105253200; Baccari MC, 2008, CURR PROTEIN PEPT SC, V9, P638, DOI 10.2174/138920308786733921; Bathgate RAD, 2013, PHYSIOL REV, V93, P405, DOI 10.1152/physrev.00001.2012; Chow BSM, 2019, J AM SOC NEPHROL, V30, P2191, DOI 10.1681/ASN.2019060597; Chow BSM, 2014, KIDNEY INT, V86, P75, DOI 10.1038/ki.2013.518; Chow BSM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042714; Christie GR, 2005, MOL CELL BIOL, V25, P8323, DOI 10.1128/MCB.25.18.8323-8333.2005; Cowling RT, 2019, TRANSL RES, V209, P138, DOI 10.1016/j.trsl.2019.03.004; Cui TX, 2001, CARDIOVASC RES, V49, P863, DOI 10.1016/S0008-6363(00)00299-6; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Dubey NK, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061625; Everett AD, 1997, J MOL CELL CARDIOL, V29, P141, DOI 10.1006/jmcc.1996.0259; Fischer TA, 1998, AM J PHYSIOL-HEART C, V275, pH906, DOI 10.1152/ajpheart.1998.275.3.H906; Frangogiannis NG, 2019, MOL ASPECTS MED, V65, P70, DOI 10.1016/j.mam.2018.07.001; Gotz J, 1998, P NATL ACAD SCI USA, V95, P12370, DOI 10.1073/pnas.95.21.12370; Guo DQ, 2000, J BIOL CHEM, V275, P11216, DOI 10.1074/jbc.275.15.11216; Heeg MHJ, 2005, KIDNEY INT, V68, P96, DOI 10.1111/j.1523-1755.2005.00384.x; Horiuchi M, 1998, ENDOCR RES, V24, P307, DOI 10.3109/07435809809032610; Hossain MA, 2016, CHEM SCI, V7, P3805, DOI 10.1039/c5sc04754d; Hossain MA, 2011, BIOCHEMISTRY-US, V50, P1368, DOI 10.1021/bi1013968; Hossain MA, 2010, AMINO ACIDS, V39, P409, DOI 10.1007/s00726-009-0454-1; Jones ES, 2008, PHARMACOL THERAPEUT, V120, P292, DOI 10.1016/j.pharmthera.2008.08.009; KANG J, 1994, AM J PHYSIOL-CELL PH, V267, pC1389, DOI 10.1152/ajpcell.1994.267.5.C1389; Kiemer AK, 2002, CIRC RES, V90, P874, DOI 10.1161/01.RES.0000017068.58856.F3; Kocan M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02916-5; Koulis C, 2015, HYPERTENSION, V65, P1073, DOI 10.1161/HYPERTENSIONAHA.115.05204; Lange C, 2018, HYPERTENSION, V72, pE20, DOI 10.1161/HYPERTENSIONAHA.118.11168; Lehtonen JYA, 1999, MOL ENDOCRINOL, V13, P1051, DOI 10.1210/me.13.7.1051; Leonhardt J, 2017, HYPERTENSION, V69, P1128, DOI 10.1161/HYPERTENSIONAHA.116.08814; Li HG, 2002, CIRCULATION, V106, P2250, DOI 10.1161/01.CIR.0000035650.05921.50; Lim H, 2006, CELL MOL LIFE SCI, V63, P2584, DOI 10.1007/s00018-006-6085-8; LOKUTA AJ, 1994, J BIOL CHEM, V269, P4832; Martin B, 2019, MOL CELL ENDOCRINOL, V487, P45, DOI 10.1016/j.mce.2018.12.016; Matsubara H, 2001, BIOCHEM BIOPH RES CO, V282, P1085, DOI 10.1006/bbrc.2001.4695; Mirabito KM, 2014, AM J PHYSIOL-RENAL, V307, pF901, DOI 10.1152/ajprenal.00288.2014; Mookerjee I, 2009, FASEB J, V23, P1219, DOI 10.1096/fj.08-120857; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; Ng HH, 2019, MOL CELL ENDOCRINOL, V487, P59, DOI 10.1016/j.mce.2019.01.015; Nouet S, 2000, TRENDS ENDOCRIN MET, V11, P1, DOI 10.1016/S1043-2760(99)00205-2; Porrello ER, 2011, CELL SIGNAL, V23, P1767, DOI 10.1016/j.cellsig.2011.06.011; Rompe F, 2010, HYPERTENSION, V55, P924, DOI 10.1161/HYPERTENSIONAHA.109.147843; Sampson AK, 2016, BRIT J PHARMACOL, V173, P729, DOI 10.1111/bph.13063; Samuel CS, 2017, BRIT J PHARMACOL, V174, P962, DOI 10.1111/bph.13529; Samuel CS, 2006, PHARMACOL THERAPEUT, V112, P529, DOI 10.1016/j.pharmthera.2005.05.012; Samuel CS, 2004, ENDOCRINOLOGY, V145, P4125, DOI 10.1210/en.2004-0209; Sarwar M, 2015, BRIT J PHARMACOL, V172, P1005, DOI 10.1111/bph.12964; Sarwar M, 2017, BRIT J PHARMACOL, V174, P933, DOI 10.1111/bph.13523; Sassoli C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063896; Saura M, 2005, CIRC RES, V97, P1115, DOI 10.1161/01.RES.0000191538.76771.66; Schinner E, 2017, FEBS OPEN BIO, V7, P550, DOI 10.1002/2211-5463.12202; Schutz S, 1996, AM J PATHOL, V149, P2067; Shabanpoor F, 2012, BIOCHEM BIOPH RES CO, V420, P253, DOI 10.1016/j.bbrc.2012.02.141; Singh RR, 2007, J PHYSIOL-LONDON, V579, P503, DOI 10.1113/jphysiol.2006.125773; Sumners C, 2019, ACTA PHYSIOL, V227, DOI 10.1111/apha.13280; Tyagi SC, 1998, CARDIOVASC PATHOL, V7, P153, DOI 10.1016/S1054-8807(97)00121-X; Unemori EN, 1996, J CLIN INVEST, V98, P2739, DOI 10.1172/JCI119099; Wang C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00091; Wang Y, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00564; Wu XP, 2018, EXP CELL RES, V362, P17, DOI 10.1016/j.yexcr.2017.10.004; Yang J, 2012, J HYPERTENS, V30, P1176, DOI 10.1097/HJH.0b013e3283532099; Zenzmaier C, 2015, EXP CELL RES, V338, P162, DOI 10.1016/j.yexcr.2015.08.014	61	8	8	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8217	8233		10.1096/fj.201902506R	http://dx.doi.org/10.1096/fj.201902506R		APR 2020	17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297670				2022-12-26	WOS:000526649400001
J	O'Connor, KM; Das, AB; Winterbourn, CC; Hampton, MB				O'Connor, Karina M.; Das, Andrew B.; Winterbourn, Christine C.; Hampton, Mark B.			Inhibition of DNA methylation in proliferating human lymphoma cells by immune cell oxidants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						oxidative stress; DNA methylation; neutrophil; redox signaling; epigenetics; inflammation; DNA methyltransferase (DNMT); glycine chloramine; hydrogen peroxide; tumor microenvironment	EPIGENETIC LANDSCAPE; HYPOCHLOROUS ACID; OXIDATIVE DAMAGE; REDOX REGULATION; KAPPA-B; METABOLISM; INFLAMMATION; CHLORAMINES; NEUTROPHILS; METHIONINE	Excessive generation of oxidants by immune cells results in acute tissue damage. One mechanism by which oxidant exposure could have long-term effects is modulation of epigenetic pathways. We hypothesized that methylation of newly synthesized DNA in proliferating cells can be altered by oxidants that target DNA methyltransferase activity or deplete its substrate, the methyl donor SAM. To this end, we investigated the effect of two oxidants produced by neutrophils, H2O2 and glycine chloramine, on maintenance DNA methylation in Jurkat T lymphoma cells. Using cell synchronization and MS-based analysis, we measured heavy deoxycytidine isotope incorporation into newly synthesized DNA and observed that a sublethal bolus of glycine chloramine, but not H2O2, significantly inhibited DNA methylation. Both oxidants inhibited DNA methyltransferase 1 activity, but only chloramine depleted SAM, suggesting that removal of substrate was the most effective means of inhibiting DNA methylation. These results indicate that immune cell?derived oxidants generated during inflammation have the potential to affect the epigenome of neighboring cells.	[O'Connor, Karina M.; Das, Andrew B.; Winterbourn, Christine C.; Hampton, Mark B.] Univ Otago, Dept Pathol & Biomed Sci, Ctr Free Radical Res, POB 4345, Christchurch 8140, New Zealand	University of Otago	Hampton, MB (corresponding author), Univ Otago, Dept Pathol & Biomed Sci, Ctr Free Radical Res, POB 4345, Christchurch 8140, New Zealand.	mark.hampton@otago.ac.nz	Das, Andrew/I-8352-2018; Hampton, Mark/A-8490-2008	Das, Andrew/0000-0001-6509-4886; Winterbourn, Christine/0000-0003-4160-572X; Hampton, Mark/0000-0002-7349-3729	Gravida National Centre for Growth and Development; Health Research Council of New Zealand [15/479]	Gravida National Centre for Growth and Development; Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Gravida National Centre for Growth and Development (to C. C. W. and M. B. H.) and the Health Research Council of New Zealand Grant 15/479 (to C. C. W. and M. B. H.). The authors declare that they have no conflicts of interest with the contents of this article.	COTGREAVE IA, 1986, J BIOCHEM BIOPH METH, V13, P231, DOI 10.1016/0165-022X(86)90102-8; Cyr AR, 2011, ANTIOXID REDOX SIGN, V15, P551, DOI 10.1089/ars.2010.3492; ELORANTA TO, 1976, BIOCHEM J, V160, P287, DOI 10.1042/bj1600287; Etchegaray JP, 2016, MOL CELL, V62, P695, DOI 10.1016/j.molcel.2016.05.029; Fedeles BI, 2015, P NATL ACAD SCI USA, V112, pE4571, DOI 10.1073/pnas.1507709112; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Felsenfeld G, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a018200; FRAGA CG, 1990, P NATL ACAD SCI USA, V87, P4533, DOI 10.1073/pnas.87.12.4533; Friso S, 2002, ANAL CHEM, V74, P4526, DOI 10.1021/ac020050h; Gray J W, 1979, Methods Enzymol, V58, P233; Grimes A., 1985, BIOCHEM SOC T, V13, P1259, DOI [10.1042/bst0131259, DOI 10.1042/BST0131259]; GRISHAM MB, 1984, J BIOL CHEM, V259, P404; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Herring JL, 2009, CHEM RES TOXICOL, V22, P1060, DOI 10.1021/tx900027w; Janke R, 2015, ANNU REV CELL DEV BI, V31, P473, DOI 10.1146/annurev-cellbio-100814-125544; Kang JI, 2008, CHEM RES TOXICOL, V21, P1211, DOI 10.1021/tx800037h; Kietzmann T, 2017, BRIT J PHARMACOL, V174, P1533, DOI 10.1111/bph.13792; Kilgore JA, 2013, J BIOL CHEM, V288, P19673, DOI 10.1074/jbc.M112.443895; Knutson CG, 2013, P NATL ACAD SCI USA, V110, pE2332, DOI 10.1073/pnas.1222669110; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lyssiotis CA, 2017, TRENDS CELL BIOL, V27, P873, DOI 10.1016/j.tcb.2017.06.003; MALECH HL, 1987, NEW ENGL J MED, V317, P687, DOI 10.1056/NEJM198709103171107; Mangerich A, 2013, FREE RADICAL RES, V47, P958, DOI 10.3109/10715762.2013.832239; Midwinter RG, 2006, BIOCHEM J, V396, P71, DOI 10.1042/BJ20052026; Mikhed Y, 2015, REDOX BIOL, V5, P275, DOI 10.1016/j.redox.2015.05.008; O'Hagan HM, 2011, CANCER CELL, V20, P606, DOI 10.1016/j.ccr.2011.09.012; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Peskin AV, 2001, FREE RADICAL BIO MED, V30, P572, DOI 10.1016/S0891-5849(00)00506-2; Peskin AV, 2005, FREE RADICAL BIO MED, V38, P396, DOI 10.1016/j.freeradbiomed.2004.11.007; Pujadas E, 2012, CELL, V148, P1123, DOI 10.1016/j.cell.2012.02.045; Radford EJ, 2018, NAT REV ENDOCRINOL, V14, P345, DOI 10.1038/s41574-018-0005-5; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; STAAL FJT, 1995, METHOD ENZYMOL, V252, P168; Thomas E L, 1986, Methods Enzymol, V132, P569; Valinluck V, 2006, CHEM RES TOXICOL, V19, P556, DOI 10.1021/tx050341w; Valinluck V, 2007, CANCER RES, V67, P5583, DOI 10.1158/0008-5472.CAN-07-0846; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; WEITZMAN SA, 1985, SCIENCE, V227, P1231, DOI 10.1126/science.3975611; WHEATER RF, 1987, J MED GENET, V24, P113, DOI 10.1136/jmg.24.2.113; Winterbourn CC, 2000, FREE RADICAL BIO MED, V29, P403, DOI 10.1016/S0891-5849(00)00204-5; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Winterbourn CC, 2016, ANNU REV BIOCHEM, V85, P765, DOI 10.1146/annurev-biochem-060815-014442	43	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7839	7848		10.1074/jbc.RA120.013092	http://dx.doi.org/10.1074/jbc.RA120.013092			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32312750	hybrid, Green Published			2022-12-26	WOS:000540935400003
J	Yang, YC; Li, Y; Sancar, A; Oztas, O				Yang, Yuchen; Li, Yun; Sancar, Aziz; Oztas, Onur			The circadian clock shapes the Arabidopsis transcriptome by regulating alternative splicing and alternative polyadenylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circadian clock; alternative splicing; polyadenylation; posttranscriptional regulation; circadian rhythm	NONSENSE-MEDIATED DECAY; TEMPERATURE; GENES; IDENTIFICATION; RESPONSES; PROTEINS; SITES	The circadian clock in plants temporally coordinates biological processes throughout the day, synchronizing gene expression with diurnal environmental changes. Circadian oscillator proteins are known to regulate the expression of clock-controlled plant genes by controlling their transcription. Here, using a high-throughput RNA-Seq approach, we examined genome-wide circadian and diurnal control of the Arabidopsis transcriptome, finding that the oscillation patterns of different transcripts of multitranscript genes can exhibit substantial differences and demonstrating that the circadian clock affects posttranscriptional regulation. In parallel, we found that two major posttranscriptional mechanisms, alternative splicing (AS; especially intron retention) and alternative polyadenylation (APA), display circadian rhythmicity resulting from oscillation in the genes involved in AS and APA. Moreover, AS-related genes exhibited rhythmic AS and APA regulation, adding another layer of complexity to circadian regulation of gene expression. We conclude that the Arabidopsis circadian clock not only controls transcription of genes but also affects their posttranscriptional regulation by influencing alternative splicing and alternative polyadenylation.	[Yang, Yuchen; Li, Yun] Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Biostat, Chapel Hill, NC 27515 USA; [Li, Yun] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27515 USA; [Sancar, Aziz; Oztas, Onur] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sancar, A; Oztas, O (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	aziz_sancar@med.unc.edu; ooztas@med.unc.edu	Yang, Yuchen/GZK-6062-2022; Oztas, Onur/AAX-5317-2021	Oztas, Onur/0000-0002-2185-6532	National Institutes of Health [ES027255, GM118102]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants ES027255 and GM118102 (to A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barta A, 2010, PLANT CELL, V22, P2926, DOI 10.1105/tpc.110.078352; Chaudhary S, 2019, TRENDS PLANT SCI, V24, P496, DOI 10.1016/j.tplants.2019.02.006; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Covington MF, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r130; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; El-Athman R, 2018, EBIOMEDICINE, V33, P68, DOI 10.1016/j.ebiom.2018.06.012; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Hernando CE, 2017, BBA-GENE REGUL MECH, V1860, P84, DOI 10.1016/j.bbagrm.2016.07.001; Filichkin SA, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-20; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Gendreau KL, 2018, G3-GENES GENOM GENET, V8, P3539, DOI 10.1534/g3.118.200559; Guo C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28060; Schlaen RG, 2015, P NATL ACAD SCI USA, V112, P9382, DOI 10.1073/pnas.1504541112; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Higashi T, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.01114, 10.3389/fpls.2016.01114]; Hong S, 2010, P NATL ACAD SCI USA, V107, P21211, DOI 10.1073/pnas.1011987107; Hsu PY, 2014, TRENDS PLANT SCI, V19, P240, DOI 10.1016/j.tplants.2013.11.007; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hunt AG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-220; Hunt AG, 2012, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00109; James AB, 2012, PLANT CELL, V24, P961, DOI 10.1105/tpc.111.093948; Jones MA, 2012, PLANT CELL, V24, P4066, DOI 10.1105/tpc.112.104828; Kersey PJ, 2018, NUCLEIC ACIDS RES, V46, pD802, DOI 10.1093/nar/gkx1011; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim MH, 2013, CELL STRESS CHAPERON, V18, P517, DOI 10.1007/s12192-012-0398-3; Kolev NG, 2008, EMBO REP, V9, P1013, DOI 10.1038/embor.2008.146; Kwon YJ, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-136; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6639-4; Li Y, 2015, PLANT PHYSIOL, V169, P2409, DOI 10.1104/pp.15.00838; Lin JC, 2017, PLANT J, V91, P829, DOI 10.1111/tpj.13611; Mateos JL, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120616; Liu FQ, 2010, SCIENCE, V327, P94, DOI 10.1126/science.1180278; Macho AP, 2012, PLANT PHYSIOL, V159, P1845, DOI 10.1104/pp.112.199810; Marquez Y, 2012, GENOME RES, V22, P1184, DOI 10.1101/gr.134106.111; McClung CR, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8010014; McGlincy NJ, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r54; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Pan HR, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2015.197, 10.1038/NPLANTS.2015.197]; Park JW, 2013, METHODS MOL BIOL, V1038, P171, DOI 10.1007/978-1-62703-514-9_10; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Sanchez SE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a027748; Sanchez SE, 2010, NATURE, V468, P112, DOI 10.1038/nature09470; Schoning JC, 2008, NUCLEIC ACIDS RES, V36, P6977, DOI 10.1093/nar/gkn847; Simpson GG, 2003, CELL, V113, P777, DOI 10.1016/S0092-8674(03)00425-2; Srivastava AK, 2018, TRENDS PLANT SCI, V23, P248, DOI 10.1016/j.tplants.2017.11.003; Streitner C, 2012, NUCLEIC ACIDS RES, V40, P11240, DOI 10.1093/nar/gks873; Tian B, 2017, NAT REV MOL CELL BIO, V18, P18, DOI 10.1038/nrm.2016.116; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; Wang QQ, 2018, ELIFE, V7, DOI 10.7554/eLife.35618; Wu G, 2016, BIOINFORMATICS, V32, P3351, DOI 10.1093/bioinformatics/btw405; Wu XH, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00889; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115; Ye CT, 2018, BIOINFORMATICS, V34, P1841, DOI 10.1093/bioinformatics/bty029; Zhou Q, 2019, PLANT J, V98, P260, DOI 10.1111/tpj.14209	57	17	17	2	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7608	7619		10.1074/jbc.RA120.013513	http://dx.doi.org/10.1074/jbc.RA120.013513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32303634	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000538038900005
J	Lee, MF; Chen, YH; Song, PP; Lin, TM				Lee, Mey Fann; Chen, Yi-Hsing; Song, Pei-Pong; Lin, Tzu-Mei			Therapeutic DNA vaccine attenuates itching and allergic inflammation in mice with established biting midge allergy	PLOS ONE			English	Article							QUALITY-OF-LIFE; T 2; FORCIPOMYIA; DIPTERA; IDENTIFICATION; DERMATITIS	Forcipomyia taiwana is a tiny hematophagous midge that attacks en masse. It is responsible for the most prevalent biting insect allergy in Taiwan. For t 2 is its major allergen. The intense itchy reactions can prevent allergic individuals from performing their regular daily outdoor activities. This study aimed to investigate whether the For t 2 DNA vaccine was effective in treating mice with established biting midge allergy. Mice were sensitized with recombinant For t 2 proteins or whole midge extracts. Two to four consecutive shots of various concentrations of For t 2 DNA vaccine, with or without CpG adjuvants, were then administered to midge-sensitized mice. Mice that received two shots of 50-100 mu g For t 2 DNA vaccine showed a significant reduction in allergen-induced bouts of scratching, For t 2- specific IgE, specific IgG1/IgG2a ratio in sera, skin eosinophil infiltration, and IL-31 production, as well as IL-4 and IL-13 production by splenocytes. Two doses of For t 2 DNA vaccine one week apart was sufficient to treat mice with established biting midge allergy. The treatment resulted in clinical, immunological, and histopathological improvements. We recommend that this low-cost, convenient treatment strategy be developed for use in humans who are allergic to biting midges.	[Lee, Mey Fann; Song, Pei-Pong] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chen, Yi-Hsing; Lin, Tzu-Mei] Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Yi-Hsing] Tunghai Univ, Dept Life Sci, Taichung, Taiwan; [Chen, Yi-Hsing] Natl Yang Ming Univ, Fac Med, Taipei, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; Tunghai University; National Yang Ming Chiao Tung University	Chen, YH (corresponding author), Taichung Vet Gen Hosp, Div Allergy Immunol & Rheumatol, Taichung, Taiwan.; Chen, YH (corresponding author), Tunghai Univ, Dept Life Sci, Taichung, Taiwan.; Chen, YH (corresponding author), Natl Yang Ming Univ, Fac Med, Taipei, Taiwan.	ysanne@vghtc.gov.tw		Chen, Yi-Hsing/0000-0002-8135-9554	Taiwan Ministry of Science and Technology [MOST-105-2321-B-010-017, MOST-106-2321-B-010-013]	Taiwan Ministry of Science and Technology	This study was supported by grants from the Taiwan Ministry of Science and Technology grant nos. MOST-105-2321-B-010-017 and MOST-106-2321-B-010-013). The URL of the funder is www.most.gov.tw.The funder did not participate the study design, data collection and analysis, decision to publish and preparation of the manuscript.	Barkha, 2010, Journal of Communicable Diseases, V42, P269; Bellanti JA, 2014, ALLERGY ASTHMA PROC, V35, P195, DOI 10.2500/aap.2014.34.3763; CHAN KL, 1965, CAN J ZOOLOG, V43, P527, DOI 10.1139/z65-052; Chen YH, 2011, ALLERGY, V66, P703, DOI 10.1111/j.1398-9995.2010.02520.x; Chen YH, 2005, ALLERGY, V60, P1518, DOI 10.1111/j.1398-9995.2005.00918.x; Chen YH, 2009, INT ARCH ALLERGY IMM, V150, P66, DOI 10.1159/000210382; Chuang YY, 2000, J MED ENTOMOL, V37, P205, DOI 10.1603/0022-2585-37.2.205; Confino-Cohen R, 1999, CLIN EXP ALLERGY, V29, P1626, DOI 10.1046/j.1365-2222.1999.00656.x; Dell'anna L., 1995, Parassitologia (Rome), V37, P79; Elberink JNGO, 2003, CURR OPIN ALLERGY CL, V3, P287, DOI [10.1097/00130832-200308000-00009, 10.1097/01.all.0000083957.99396.b7]; Furue M, 2018, ALLERGY, V73, P29, DOI 10.1111/all.13239; Gangemi S, 2017, ALLERGY ASTHMA PROC, V38, P401, DOI 10.2500/aap.2017.38.4080; Globinska A, 2018, ANN ALLERG ASTHMA IM, V121, P306, DOI 10.1016/j.anai.2018.06.026; Huerta H, 2017, ZOOTAXA, V4329, P189, DOI 10.11646/zootaxa.4329.2.6; Kasutani K, 2014, BRIT J PHARMACOL, V171, P5049, DOI 10.1111/bph.12823; Langner KFA, 2009, INT J PARASITOL, V39, P243, DOI 10.1016/j.ijpara.2008.06.008; Larsen JM, 2018, CLIN EXP ALLERGY, V48, P1255, DOI 10.1111/cea.13212; Lee MF, 2016, ALLERGY, V71, P522, DOI 10.1111/all.12832; Lee MF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091871; Luo W, 2008, THESIS; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Pitake S, 2018, ACTA DERM-VENEREOL, V98, P795, DOI 10.2340/00015555-2977; Pulsawat P, 2013, IMMUNOL LETT, V151, P23, DOI 10.1016/j.imlet.2013.01.013; Saleem MD, 2017, J DERMATOL TREAT, V28, P591, DOI 10.1080/09546634.2017.1290205; Szadziewski Ryszard, 1991, Wiadomosci Parazytologiczne, V37, P57; Zhu ZL, 2016, INT ARCH ALLERGY IMM, V171, P241, DOI 10.1159/000453264	26	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232042	10.1371/journal.pone.0232042	http://dx.doi.org/10.1371/journal.pone.0232042			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324792	gold, Green Published			2022-12-26	WOS:000536033700066
J	Thior, I; Rowley, E; Mavhu, W; Kruse-Levy, N; Messner, L; Falconer-Stout, ZJ; Mugurungi, O; Ncube, G; Leclerc-Madlala, S				Thior, Ibou; Rowley, Elizabeth; Mavhu, Webster; Kruse-Levy, Natalie; Messner, Lyn; Falconer-Stout, Zachariah J.; Mugurungi, Owen; Ncube, Getrude; Leclerc-Madlala, Suzanne			Urban-rural disparity in sociodemographic characteristics and sexual behaviors of HIV-positive adolescent girls and young women and their perspectives on their male sexual partners: A cross-sectional study in Zimbabwe	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY ADHERENCE; HUMAN-IMMUNODEFICIENCY-VIRUS; SOCIAL DESIRABILITY BIAS; RISK BEHAVIOR; DISCLOSURE; INFECTION; MEN; AGE; PREVALENCE; VENUES	We conducted a cross sectional survey in Zimbabwe to describe urban-rural disparity in socio-demographic characteristics and sexual behaviors of HIV-positive adolescent girls and young women (AGYW) and their male sexual partners. Between September and November 2016, we interviewed 360 sexually active HIV positive AGYW, aged 15-24 years attending ART and PMTCT clinics in urban and rural health facilities in Harare and Mazowe district respectively. HIV positive AGYW in rural areas as compared to those in urban areas were older, less educated, more frequently married or cohabiting, had lower number of male sexual partners in their lifetime and in the last 12 months preceding the survey. They were mostly heterosexually infected, more likely to disclose their status to a family member and to be more adherent to ART (OR = 2.5-95% CI = 1.1-5.5). Most recent male sexual partners of HIV positive AGYW in urban areas as compared to those from rural areas were mainly current or former boyfriends, single, more educated, less likely to have a child with them and to engage in couple voluntary counseling and testing (CVCT). They were more likely to patronize dancing and drinking venues and involved in transactional sex (OR = 2.2-95% CI: 1.2-4). They were also more likely to be circumcised (OR = 2.3-95% CI: 1.3-4.1) and to use condom more consistently in the last 12 months preceding the survey. Our study findings called for the strengthening of HIV prevention interventions in urban areas among HIV positive AGYW who had more than one partner in their lifetime or are patronizing dancing and drinking venues. In Zimbabwe, promotion of CVCT, index testing, male circumcision and condom use should be sustained to engage male sexual partners of both urban and rural HIV positive AGYW in HIV prevention.	[Thior, Ibou; Rowley, Elizabeth] PATH, Washington, DC 20001 USA; [Mavhu, Webster] Ctr Sexual Hlth & HIVAIDS Res, Harare, Zimbabwe; [Kruse-Levy, Natalie] US Agcy Int Dev USAID, Harare, Zimbabwe; [Messner, Lyn; Falconer-Stout, Zachariah J.] EnCompass LLC, Rockville, MD USA; [Mugurungi, Owen; Ncube, Getrude] Minist Hlth & Child Care, AIDS & TB, Harare, Zimbabwe; [Leclerc-Madlala, Suzanne] USAID, Arlington, VA USA	United States Agency for International Development (USAID); United States Agency for International Development (USAID)	Thior, I (corresponding author), PATH, Washington, DC 20001 USA.	ibou_thior@path.org		Mavhu, Webster/0000-0003-1881-4398; Thior, Ibou/0000-0002-2188-8956	Strengthening High Impact Interventions for an AIDS-free generation (AIDSFree) project - U.S. Agency for International Development [AID-OAA-A-14- 00046]; President's Emergency Plan for AIDS Relief (PEPFAR)	Strengthening High Impact Interventions for an AIDS-free generation (AIDSFree) project - U.S. Agency for International Development; President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was funded by: the Strengthening High Impact Interventions for an AIDS-free generation (AIDSFree) project funded by the U.S. Agency for International Development under Cooperative Agreement AID-OAA-A-14- 00046 with support from the President's Emergency Plan for AIDS Relief (PEPFAR). EnCompass provided support for this study in the form of salaries for LM and ZFS. The specific roles of these authors are articulated in the `author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2854-y; Agwu AL, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18579; Ammon N, 2018, PUBLIC HEALTH, V157, P20, DOI 10.1016/j.puhe.2017.12.010; Ankunda Racheal, 2016, Pan Afr Med J, V24, P49, DOI 10.11604/pamj.2016.24.49.6633; Baryamutuma R, 2011, AFR HEALTH SCI, V11, P211; Bogale A, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-49; Boone MR, 2015, AIDS PATIENT CARE ST, V29, P346, DOI 10.1089/apc.2014.0175; Brittain K, 2018, AIDS BEHAV, V22, P909, DOI 10.1007/s10461-017-2004-2; Britto C, 2016, J DEV BEHAV PEDIATR, V37, P496, DOI 10.1097/DBP.0000000000000303; BUZDUGAN R, 2014, J ACQ IMMUN DEF SYND, V67, pE13, DOI DOI 10.1097/QAI; Cassels S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066342; Chabata ST, 2019, AIDS BEHAV, V23, P1494, DOI 10.1007/s10461-019-02410-1; Chiringa IO, 2016, AFR J PRIM HEALTH CA, V8, DOI 10.4102/phcfm.v8i2.966; Clark S, 2011, INT PERSPECT SEX R H, V37, P181, DOI 10.1363/3718111; Cowan FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077080; Cremin I, 2010, AIDS BEHAV, V14, P708, DOI 10.1007/s10461-009-9592-4; Dellar RC, 2015, J INT AIDS SOC, V18, P64, DOI 10.7448/IAS.18.2.19408; Doyle AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198783; Eaton JW, 2014, J INFECT DIS, V210, pS562, DOI 10.1093/infdis/jiu415; Eaton JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070447; Elmes J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171916; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Fleischmann JP, 2015, ADDRESSING HIV RISK; Goodreau SM, 2012, AIDS BEHAV, V16, P312, DOI 10.1007/s10461-010-9858-x; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Gregson S, 2002, SEX TRANSM DIS, V29, P568, DOI 10.1097/00007435-200210000-00002; Gross R, 2015, AIDS CARE, V27, P322, DOI 10.1080/09540121.2014.969676; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kilmarx PH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198683; Kim MH, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21437; Kuteesa MO, 2019, AIDS BEHAV; Langhaug LF, 2011, SEX TRANSM INFECT, V87, P165, DOI 10.1136/sti.2009.037374; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; Lowe S, 2019, S AFR J HIV MED, V20, DOI 10.4102/sajhivmed.v20i1.849; Madiba S, 2016, AIDS RES TREAT, V2016, DOI 10.1155/2016/2607249; Mahachi N, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25321; Makota RB, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00262; Martinez J, 2012, AIDS PATIENT CARE ST, V26, P108, DOI 10.1089/apc.2011.0178; Mavhu W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194732; Mavhu W, 2011, AIDS CARE, V23, P52, DOI 10.1080/09540121.2010.490257; Mbalinda SN, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0366-6; Mburu G, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18866; Mccoy SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105320; Mhalu A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17342; Muchabaiwa L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218588; Mucheto P, 2011, PAN AFR MED J, V8; Mugweni E, 2015, INT J WOMENS HEALTH, V7, P819, DOI 10.2147/IJWH.S88884; Mugweni E, 2015, HEALTH EDUC RES, V30, P388, DOI 10.1093/her/cyu073; Mullinax M, 2017, AIDS EDUC PREV, V29, P527, DOI 10.1521/aeap.2017.29.6.527; Musuka Godfrey, 2018, BMC Res Notes, V11, P508, DOI 10.1186/s13104-018-3646-5; Mweemba M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2372-3; Napierala S, 2018, JAIDS-J ACQ IMM DEF, V79, P358, DOI 10.1097/QAI.0000000000001815; Ngome E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-64; Nostlinger C, 2015, AIDS CARE, V27, P36, DOI 10.1080/09540121.2015.1051501; Pascoe SJS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115290; Patel R, 2012, AIDS CARE, V24, P358, DOI 10.1080/09540121.2011.608786; Pitpitan EV, 2016, PREV SCI, V17, P472, DOI 10.1007/s11121-015-0629-9; Pitpitan EV, 2016, AIDS BEHAV, V20, pS119, DOI 10.1007/s10461-015-1116-9; Remez L, 2014, SEXUAL REPROD HLTH N, P1; Reynolds Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203208; Rupfutse M, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.337.5245; Sandoy IF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-31; Sandy PT, 2019, AJAR-AFR J AIDS RES, V18, P130, DOI 10.2989/16085906.2019.1621910; Santelli JS, 2013, JAIDS-J ACQ IMM DEF, V63, P393, DOI 10.1097/QAI.0b013e3182926795; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Shamu S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043148; Shubber Z, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002183; Singh K, 2010, AIDS BEHAV, V14, P200, DOI 10.1007/s10461-009-9572-8; Sithole Z, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3372-6; Smee N, 2011, WOMEN HEALTH ISS, V21, P222, DOI 10.1016/j.whi.2010.11.005; Toska E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178106; Toska E, 2015, AIDS CARE, V27, P47, DOI 10.1080/09540121.2015.1071775; Tshweneagae Gloria T., 2015, Curationis, V38, P1, DOI 10.4102/curations.v38I1.1174; UNAIDS, 2019, 2018 GLOB HIV STAT F; van Lettow M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219967; Venkatesh KK, 2011, JAIDS-J ACQ IMM DEF, V57, P435, DOI 10.1097/QAI.0b013e318220379b; Walker Judith-Ann, 2012, Afr J Reprod Health, V16, P231; Woodsong C, 2008, AIDS EDUC PREV, V20, P171, DOI 10.1521/aeap.2008.20.2.171; Yamanis TJ, 2010, SOC SCI MED, V71, P1601, DOI 10.1016/j.socscimed.2010.07.039; Young S, 2014, AIDS BEHAV, V18, pS505, DOI 10.1007/s10461-013-0547-4; Zaba B, 2004, SEX TRANSM INFECT, V80, P28, DOI 10.1136/sti.2004.012674; Zamudio-Haas Sophia, 2012, Reprod Health Matters, V20, P18, DOI 10.1016/S0968-8080(12)39637-7; Zgambo M, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0614-4; Zhang L, 2016, J PRIM PREV, V37, P487, DOI 10.1007/s10935-016-0444-5; Zimbabwe National Statistics Agency (ZIMSTAT) and ICF International, 2012, ZIMB DEM HLTH SURV 2; Zimbabwe National Statistics Agency- ZIMSTAT, 2016, ZIMB DEM HLTH SURV 2	86	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0230823	10.1371/journal.pone.0230823	http://dx.doi.org/10.1371/journal.pone.0230823			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324764	Green Published, gold			2022-12-26	WOS:000536033700006
J	Bach, LL; Bailey, DM; Harvey, ES; MacLeod, R				Bach, Lydia Luise; Bailey, David M.; Harvey, Euan S.; MacLeod, Ross			The MacKinnon Lists Technique: An efficient new method for rapidly assessing biodiversity and species abundance ranks in the marine environment	PLOS ONE			English	Article							REEF FISH ASSEMBLAGES; STEREO-VIDEO; COUNTS; DIVERS; BEHAVIOR; CAMERAS; BIOMASS; IMPACT; SAMPLE; LENGTH	Widespread and ever-increasing anthropogenic impacts in the marine environment are driving a need to develop more efficient survey methods for monitoring changes in marine biodiversity. There is a particular urgent need for survey methods that could more rapidly and effectively detect change in species richness, abundance and community composition. Here, test the suitability of the Mackinnon Lists Technique for use in the marine environment by testing its effectiveness for rapid assessment of fish communities. The MacKinnon Lists Technique is a time-efficient and cost-effective sampling method developed for studying avian tropical biodiversity, in which several list samples of species can be collected from a single survey. Using the well-established MaxN approach on data from deployments of a Baited Remote Underwater Video Systems for comparison, we tested the suitability of the MacKinnon Lists Technique for use in marine environments by analysing tropical reef fish communities. Using both methods for each data set, differences in community composition between depths and levels of protection were assessed. Both methods were comparable for diversity and evenness indices with similar ranks for species. Multivariate analysis showed that the MacKinnon Lists Technique and MaxN detected similar differences in community composition at different depths and protection status. However, the MacKinnon Lists Technique detected significant differences between factors when fewer videos (representing reduced survey effort) were used. We conclude that the MacKinnon Lists Technique is at least as effective as the widely used MaxN method for detecting differences between communities in the marine environment and suggest can do so with lower survey effort. The MacKinnon Lists Technique has the potential to be widely used as an effective new tool for rapid conservation monitoring in marine ecosystems.	[Bach, Lydia Luise; Bailey, David M.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med, Glasgow, Lanark, Scotland; [Harvey, Euan S.] Curtin Univ, Sch Sci, Dept Environm & Agr, Perth, WA, Australia; [MacLeod, Ross] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England	University of Glasgow; Curtin University; Liverpool John Moores University	Bach, LL (corresponding author), Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med, Glasgow, Lanark, Scotland.	Lydia.bach@glasgow.ac.uk	Harvey, Euan/B-2896-2011; Bailey, David/A-6240-2008	Harvey, Euan/0000-0002-9069-4581; Macleod, Ross/0000-0001-5508-0202; Bach, Lydia Luise/0000-0002-5483-8891; Bailey, David/0000-0002-0824-8823	Natural Environment Research Council (NERC) [NE/J015229/1]; Directed International NERC grant [NE/S008233/1]; NERC [NE/S008233/1] Funding Source: UKRI	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directed International NERC grant; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	LLB was supported by a Natural Environment Research Council (NERC) grant (NE/J015229/1, http://gotw.nerc.ac.uk/refno.asp).DB was supported by a Directed International NERC grant (NE/S008233/1, http://gotw.nerc.ac.uk/refno.asp).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2004, J EXP MAR BIOL ECOL, V305, P191, DOI 10.1016/j.jembe.2003.12.011; Anderson MJ, 2003, AUST NZ J STAT, V45, P301, DOI 10.1111/1467-842X.00285; Assis J, 2013, J EXP MAR BIOL ECOL, V445, P93, DOI 10.1016/j.jembe.2013.04.007; Bailey DM, 2007, MAR ECOL PROG SER, V350, P179, DOI 10.3354/meps07187; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; BROCK VE, 1954, J WILDLIFE MANAGE, V18, P297, DOI 10.2307/3797016; Cappo M., 2006, AUSTR SOC FISH BIOL, VVol. 1, P101, DOI DOI 10.1007/978-1-62703-724-2_1; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Clark MR, 1996, J FISH BIOL, V49, P114, DOI 10.1111/j.1095-8649.1996.tb06070.x; Clarke K.R., 2006, PRIMER VERSION 6 USE; Dunlop KM, 2015, MAR ECOL-EVOL PERSP, V36, P810, DOI 10.1111/maec.12185; Feary DA, 2011, CONSERV BIOL, V25, P341, DOI 10.1111/j.1523-1739.2010.01613.x; Fisher RA, 1943, J ANIM ECOL, V12, P42, DOI 10.2307/1411; Fjeldsa J, 1999, BIRD CONSERV INT, V9, P47, DOI 10.1017/S0959270900003348; Friedlander AM, 2018, AQUAT CONSERV, V28, P146, DOI 10.1002/aqc.2832; Friedlander AM, 2010, MAR ECOL PROG SER, V410, P219, DOI 10.3354/meps08634; Harvey E, 2002, FISH RES, V57, P255, DOI 10.1016/S0165-7836(01)00356-3; Harvey E, 2001, FISH B-NOAA, V99, P72; Harvey ES, 2010, MAR TECHNOL SOC J, V44, P75, DOI 10.4031/MTSJ.44.1.3; Heagney EC, 2007, MAR ECOL PROG SER, V350, P255, DOI 10.3354/meps07193; Herzog SK, 2002, AUK, V119, P749, DOI 10.1642/0004-8038(2002)119[0749:ESROTB]2.0.CO;2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Jennings S, 1995, CORAL REEFS, V14, P225, DOI 10.1007/BF00334346; KENNELLY SJ, 1993, FISH RES, V16, P51, DOI 10.1016/0165-7836(93)90109-K; Komyakova V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202206; Krebs C.J., 1999, ECOLOGICAL METHODOLO; Lindfield SJ, 2014, METHODS ECOL EVOL, V5, P1061, DOI 10.1111/2041-210X.12262; Mace GM, 2007, CONSERV BIOL, V21, P1406, DOI 10.1111/j.1523-1739.2007.00830.x; MacLeod R, 2011, BIOL CONSERV, V144, P1374, DOI 10.1016/j.biocon.2010.12.008; O'Dea N, 2004, DIVERS DISTRIB, V10, P55, DOI 10.1111/j.1472-4642.2004.00050.x; PHILLIPS DJH, 1977, ENVIRON POLLUT, V13, P281, DOI 10.1016/0013-9327(77)90047-7; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Poulsen Bent Otto, 1997, Bird Conservation International, V7, P293; Poulsen Bent Otto, 1997, Bird Conservation International, V7, P53; PRIEDE IG, 1990, DEEP-SEA RES, V37, P81, DOI 10.1016/0198-0149(90)90030-Y; Sale P.F., 1983, Coral Reefs, V2, P37, DOI 10.1007/BF00304730; Samoilys MA, 2000, ENVIRON BIOL FISH, V57, P289, DOI 10.1023/A:1007679109359; Seaby R, 2006, SPECIES DIVERSITY RI, P123; Seager J., 2008, EVENTMEASURE VERSION; SMITH MPL, 1988, MAR ECOL PROG SER, V43, P223, DOI 10.3354/meps043223; Sutherland WJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P1, DOI 10.2277/ 0521606365; Watson DL, 2007, MAR BIOL, V152, P1197, DOI 10.1007/s00227-007-0767-0; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Wernberg T, 2016, SCIENCE, V353, P169, DOI 10.1126/science.aad8745; Willis TJ, 2000, MAR FRESHWATER RES, V51, P755, DOI 10.1071/MF00010; Wilson SK, 2018, ECOL INDIC, V85, P146, DOI 10.1016/j.ecolind.2017.10.038	47	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231820	10.1371/journal.pone.0231820	http://dx.doi.org/10.1371/journal.pone.0231820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320414	Green Accepted, gold, Green Published			2022-12-26	WOS:000536028800034
J	Biswas, KK; Bhattacharyya, UK; Palchoudhury, S; Balram, N; Kumar, A; Arora, R; Sain, SK; Kumar, P; Khetarpal, RK; Sanyal, A; Mandal, PK				Biswas, Kajal Kumar; Bhattacharyya, Utpal Kumar; Palchoudhury, Supratik; Balram, Nenavath; Kumar, Anil; Arora, Rupesh; Sain, Satish Kumar; Kumar, Pradeep; Khetarpal, Ravi K.; Sanyal, Amitava; Mandal, Pranab Kumar			Dominance of recombinant cotton leaf curl Multan-Rajasthan virus associated with cotton leaf curl disease outbreak in northwest India	PLOS ONE			English	Article							DNA-BETA SATELLITE; RESISTANCE-BREAKING; BEGOMOVIRUS; TOMATO; CLASSIFICATION; IDENTIFICATION; GEMINIVIRUSES; DETERMINANT; COMPONENTS; DIVERSITY	Cotton leaf curl disease (CLCuD), caused by whitefly (Bemisiatabaci) transmitted single-stranded DNA viruses belonging to the Genus, Begomovirus (family, Geminiviridae) in association with satellite molecules; is responsible for major economic losses in cotton in three northwest (NW) Indian states Haryana, Punjab, and Rajasthan. Annual CLCuD incidences during 2012 to 2014 were estimated to be 37.5%, 63.6%, and 38.8% respectively. Cotton leaves were collected from symptomatic plants annually for three years and subjected to DNA isolation, followed by rolling circle amplification (RCA), cloning, and DNA sequencing of apparently full-length begomoviral genomes and associated betasatellites and alphasatellites. Among the thirteen CLCuD-begomoviral genomes recovered, eight were identified as Cotton leaf curl Multan virus-Rajasthan (CLCuMuV-Ra), one as-Pakistan (PK) and another as-Faisalabad (Fai), whereas, three were as Cotton leaf curl Kokhran virus-Burewala (CLCuKoV-Bu), indicating that CLCuMuV-Ra was the most prevalent begomovirus species. Five of the eight CLCuMuV-Ra sequences were found to be recombinants. The CLCuMuV-Ra-associated satellites consisted of Cotton leaf curl Multan betasatellite (CLCuMB), and Gossypium darwinii symptomless alphasatellite (GDarSLA), and Croton yellow vein mosaic alphasatellite (CrYVMoA). The second most abundant helper virus species, CLCuKoV-Bu, was associated with CLCuMB and GDarSLA.	[Biswas, Kajal Kumar; Bhattacharyya, Utpal Kumar; Palchoudhury, Supratik; Balram, Nenavath] ICAR Indian Agr Res Inst, Div Plant Pathol, Adv Ctr Plant Virol, New Delhi, India; [Kumar, Anil] Chaudhary Charan Singh Haryana Agr Univ, Hisar, Haryana, India; [Arora, Rupesh] Punjab Agr Univ, Reg Res Stn, Ludhiana, Punjab, India; [Sain, Satish Kumar] ICAR Cent Inst Cotton Res, Reg Stn, Karnal, Haryana, India; [Kumar, Pradeep] Swami Keshwanand Rajasthan Agr Univ, Agr Res Stn, Bikaner, Rajasthan, India; [Khetarpal, Ravi K.] Asia Pacific Assoc, Agr Res Inst, Bangkok, Thailand; [Sanyal, Amitava] Sumitomo Chem India Pvt Ltd, New Delhi, India; [Mandal, Pranab Kumar] ICAR Natl Inst Plant Biotechnol, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute; CCS Haryana Agricultural University; Punjab Agricultural University; Indian Council of Agricultural Research (ICAR); ICAR - Central Institute of Cotton Research; Swami Keshwanand Rajasthan Agricultural University (SKRAU); Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Biswas, KK (corresponding author), ICAR Indian Agr Res Inst, Div Plant Pathol, Adv Ctr Plant Virol, New Delhi, India.	drkkbiswas@yahoo.co.in	Sain, Satish Kumar/AAO-6860-2021; Palchoudhury, Supratik/HGC-0038-2022; Arora, Rupesh/GQH-3714-2022; Biswas, Kajal/AHA-4851-2022	Sain, Satish Kumar/0000-0003-4378-8363; Palchoudhury, Supratik/0000-0002-6987-6030; 	DG, ICAR, Govt. of India; ICAR-IARI; Sumitomo Chemical India Pvt. Ltd.	DG, ICAR, Govt. of India; ICAR-IARI; Sumitomo Chemical India Pvt. Ltd.	The funder "Sumitomo Chemical India Pvt. Ltd." provided support in the form of salaries for authors Dr. Amitava Sanyal, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section."; We greatly appreciate anonymous reviewers for their critical review that improved the manuscript. We would also like to thank Judith K. Brown, Professor, University of Arizona South Campus, Tucson, AZ 85704 USA for valuable suggestions for preparing the MS. The authors are grateful to DG, ICAR, Govt. of India; Director, ICAR-IARI for financial assistance; V. K. Baranwal, In-charge, Plant Virology Unit; R. Aggarwal, Head, Division of Plant Pathology, ICAR-IARI for providing laboratory facilities; Anupam Varma, Ex-National Professor, ICARIARI for guidance and valuable suggestions; D. Monga, CICR, Sirsa, Haryana; Aman Sharma, RRS, PAU, Faridkot, Punjab; Tarun K. Mishra, Sumitomo Chemical India Pvt. Ltd., New Delhi; are acknowledged for providing assistance for survey. Authors are thankful to Vidyasagar for his assistance during this study.	Abbas Qamar, 2019, VirusDisease, V30, P101, DOI 10.1007/s13337-017-0413-5; Akbar F, 2016, VIRUS GENES, V52, P688, DOI 10.1007/s11262-016-1357-3; Amin I, 2011, MOL PLANT MICROBE IN, V24, P973, DOI 10.1094/MPMI-01-11-0001; Amrao L, 2010, VIROLOGY, V66, P333; [Anonymous], 2016, 46 COTT CORP IND LTD; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104485; Briddon RW, 2008, ARCH VIROL, V153, P763, DOI 10.1007/s00705-007-0013-6; Briddon RW, 2018, ARCH VIROL, V163, P2587, DOI 10.1007/s00705-018-3854-2; Briddon RW, 2014, VIRUS RES, V186, P114, DOI 10.1016/j.virusres.2013.12.008; Briddon RW, 2006, VIROLOGY, V344, P198, DOI 10.1016/j.virol.2005.09.042; Briddon RW, 2004, VIROLOGY, V324, P462, DOI 10.1016/j.virol.2004.03.041; Briddon RW, 2003, VIROLOGY, V312, P106, DOI 10.1016/S0042-6822(03)00200-9; Briddon RW, 2001, VIROLOGY, V285, P234, DOI 10.1006/viro.2001.0949; Brown JK, 2017, VIRUS RES, V241, P29, DOI 10.1016/j.virusres.2017.04.014; Brown JK, 2015, ARCH VIROL, V160, P1593, DOI 10.1007/s00705-015-2398-y; Datta S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17680-9; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Ellango R, 2015, ENVIRON ENTOMOL, V44, P1258, DOI [10.1093/ee/nvv062, 10.1093/ee/n]; Fauquet CM, 2005, PHYTOPATHOLOGY, V95, P549, DOI 10.1094/PHYTO-95-0549; Godara S, 2017, J PLANT BIOCHEM BIOT, V26, P97, DOI 10.1007/s13562-016-0370-x; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Idris AM, 2011, J GEN VIROL, V92, P706, DOI 10.1099/vir.0.025288-0; Idris AM, 2005, ARCH VIROL, V150, P1003, DOI 10.1007/s00705-004-0484-7; Idris AM, 2002, VIRUS GENES, V24, P249, DOI 10.1023/A:1015380600089; Kirthi N, 2004, ARCH VIROL, V149, P2047, DOI 10.1007/s00705-004-0352-5; Kumar A, 2010, VIRUS GENES, V40, P282, DOI 10.1007/s11262-009-0439-x; Mansoor S, 2006, PLANT DIS, V90, P826, DOI 10.1094/PD-90-0826A; Mansoor S, 1999, VIROLOGY, V259, P190, DOI 10.1006/viro.1999.9766; Manzoor MT, 2014, ARCH VIROL, V159, P1217, DOI 10.1007/s00705-013-1911-4; Mar TB, 2017, J GEN VIROL, V98, P1552, DOI 10.1099/jgv.0.000814; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Monga D., 2011, Journal of Cotton Research and Development, V25, P273; MUHIRE BM, 2014, PLOS ONE, V9, DOI DOI 10.1371/JOURNAL.PONE.0108277; Nawaz-ul-Rehman MS, 2010, VIROLOGY, V405, P300, DOI 10.1016/j.virol.2010.06.024; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Pan LL, 2018, PHYTOPATHOLOGY, V108, P1172, DOI [10.1094/PHYTO-01-18-0015-R, 10.1094/phyto-01-18-0015-r]; Paprotka T, 2010, VIROLOGY, V404, P148, DOI 10.1016/j.virol.2010.05.003; Qadir R, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5640-2; Qazi J, 2007, VIRUS RES, V128, P135, DOI 10.1016/j.virusres.2007.04.002; Radhakrishnan G., 2004, Indian Phytopathology, V57, P174; Rajagopalan PA, 2012, ARCH VIROL, V157, P855, DOI 10.1007/s00705-012-1225-y; Rishi N., 1994, J COTTON RES DEV, V8, P179; Saeed M, 2005, MOL PLANT MICROBE IN, V18, P7, DOI 10.1094/MPMI-18-0007; Saeed M, 2007, J GEN VIROL, V88, P2881, DOI 10.1099/vir.0.83049-0; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Saleem H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151161; Sambrook J., 2001, MOL CLONING LAB MANU; Sattar MN, 2013, J GEN VIROL, V94, P695, DOI 10.1099/vir.0.049627-0; Sattar MN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00631; Shruti Godara, 2015, Indian Phytopathology, V68, P326; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Wezel R, 2002, MOL PLANT MICROBE IN, V15, P203, DOI 10.1094/MPMI.2002.15.3.203; van Wezel R, 2001, MOL PLANT MICROBE IN, V14, P1125, DOI 10.1094/MPMI.2001.14.9.1125; Varma A, 1995, LEAF CURL DIS COTTON; Varma A, 1993, 6 INT C PLANT PATH M; Zaidi SSEA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155520; Zhou XP, 1998, J GEN VIROL, V79, P915, DOI 10.1099/0022-1317-79-4-915; Zhou XP, 2013, ANNU REV PHYTOPATHOL, V51, P357, DOI 10.1146/annurev-phyto-082712-102234; Zubair M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00727-2	63	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231886	10.1371/journal.pone.0231886	http://dx.doi.org/10.1371/journal.pone.0231886			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320461	gold, Green Published			2022-12-26	WOS:000536028800037
J	Gerner, MC; Ziegler, LS; Schmidt, RLJ; Krenn, M; Zimprich, F; Uyanik-Unal, K; Konstantopoulou, V; Derdak, S; Del Favero, G; Schwarzinger, I; Boztug, K; Schmetterer, KG				Gerner, Marlene C.; Ziegler, Liesa S.; Schmidt, Ralf L. J.; Krenn, Martin; Zimprich, Fritz; Uyanik-Uenal, Keziban; Konstantopoulou, Vassiliki; Derdak, Sophia; Del Favero, Giorgia; Schwarzinger, Ilse; Boztug, Kaan; Schmetterer, Klaus G.			The TGF-b/SOX4 axis and ROS-driven autophagy co-mediate CD39 expression in regulatory T-cells	FASEB JOURNAL			English	Article						autophagy; CD39; regulatory T-cells; immune tolerance; SOX4; TGF-b signaling	TGF-BETA; GENERATION; SOX4; METASTASIS; COMBINATION; MUTATIONS; INDUCTION; ADENOSINE; MECHANISM; RESPONSES	The ectonucleotidase CD39 on human regulatory T-cells (Treg) is an important immune regulator which is dysregulated in autoimmune diseases and cancer immunosuppression. We here define that CD39 expression on Treg is independent of the Treg-specific transcription factors FOXP3 and HELIOS and promoted by canonical TGF-b- and mTOR-signaling. Furthermore, the TGF-b mediated upregulation of CD39 is counteracted by reactive oxygen species (ROS)-driven autophagy. In line, CD39(+) peripheral blood Treg constitute a distinct lineage with low autophagic flux and absent ROS production. Patients with rare genetic defects in autophagy show supraphysiological levels of CD39(+) Treg, validating our observations in vivo. These biological processes rely on a distinct transcriptional program with CD39(+) Treg expressing low levels of two genes with putative involvement in autophagy, NEFL and PLAC8. Furthermore, the TGF-b downstream transcription factor SOX4 is selectively upregulated in CD39(+) Treg. Overexpression of SOX4 in Treg strongly increases CD39 expression, while Crispr/Cas9-mediated knockout of SOX4 in Treg has the opposing effect. Thus, we identify a crucial role of SOX4 in immune regulation and provide new insights involving the interplay of tolerogenic cues and autophagy in Treg.	[Gerner, Marlene C.; Ziegler, Liesa S.; Schmidt, Ralf L. J.; Schwarzinger, Ilse; Schmetterer, Klaus G.] Med Univ Vienna, Dept Lab Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Krenn, Martin; Zimprich, Fritz] Med Univ Vienna, Dept Neurol, Vienna, Austria; [Uyanik-Uenal, Keziban] Med Univ Vienna, Dept Surg, Vienna, Austria; [Konstantopoulou, Vassiliki] Med Univ Vienna, Dept Pediat, Vienna, Austria; [Derdak, Sophia] Med Univ Vienna, Core Facil Genom, Vienna, Austria; [Del Favero, Giorgia] Univ Vienna, Dept Food Chem & Toxicol, Fac Chem, Vienna, Austria; [Boztug, Kaan] Austrian Acad Sci, Res Ctr Mol Med, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Vienna; Austrian Academy of Sciences	Schmetterer, KG (corresponding author), Med Univ Vienna, Dept Lab Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	klaus.schmetterer@meduniwien.ac.at	Boztug, Kaan/AAM-4161-2021	Boztug, Kaan/0000-0001-8387-9185; Krenn, Martin/0000-0003-3026-3082; Schmidt, Ralf/0000-0002-6697-0363	Austrian Science Funds [P29654-B30]; Medical-Scientific Funds of the Mayor of the City of Vienna [15099, 18067]	Austrian Science Funds(Austrian Science Fund (FWF)); Medical-Scientific Funds of the Mayor of the City of Vienna	Austrian Science Funds, Grant/Award Number: P29654-B30; Medical-Scientific Funds of the Mayor of the City of Vienna, Grant/Award Number: 15099 and 18067	Abbas AK, 2013, NAT IMMUNOL, V14, P307, DOI 10.1038/ni.2554; Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; Azad MB, 2009, ANTIOXID REDOX SIGN, V11, P777, DOI [10.1089/ars.2008.2270, 10.1089/ARS.2008.2270]; Bai AP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9819; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; Cai XY, 2016, ONCOL LETT, V12, P4080, DOI 10.3892/ol.2016.5189; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Del Favero G, 2018, TOXICOL LETT, V295, P424, DOI 10.1016/j.toxlet.2018.07.007; Derdak SV, 2006, P NATL ACAD SCI USA, V103, P13144, DOI 10.1073/pnas.0602283103; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Dulphy N, 2014, BRIT J HAEMATOL, V165, P722, DOI 10.1111/bjh.12774; Fang FQ, 2016, CELL REP, V14, P1218, DOI 10.1016/j.celrep.2016.01.002; Fletcher JM, 2009, J IMMUNOL, V183, P7602, DOI 10.4049/jimmunol.0901881; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Fournier PGJ, 2015, CANCER CELL, V27, P809, DOI 10.1016/j.ccell.2015.04.009; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gerner MC, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00727; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Gruenbacher G, 2016, CELL REP, V16, P444, DOI 10.1016/j.celrep.2016.06.009; Guo SJ, 2015, AUTOPHAGY, V11, P560, DOI 10.1080/15548627.2015.1017181; Haidar M, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00143; Hayes GM, 2015, AM J TRANSL RES, V7, P1181; Hilchey SP, 2009, J IMMUNOL, V183, P6157, DOI 10.4049/jimmunol.0900475; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Jacquin E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01023; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Kinsey C, 2014, CELL REP, V7, P1143, DOI 10.1016/j.celrep.2014.03.061; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Krenn M, 2018, J NEUROL, V265, P394, DOI 10.1007/s00415-017-8710-x; Kunzli BM, 2011, PURINERG SIGNAL, V7, P231, DOI 10.1007/s11302-011-9228-9; Kuwahara M, 2012, NAT IMMUNOL, V13, P778, DOI 10.1038/ni.2362; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Leone RD, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0360-8; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Long SA, 2008, J AUTOIMMUN, V30, P293, DOI 10.1016/j.jaut.2007.12.012; Loza MJ, 2011, CELL IMMUNOL, V271, P110, DOI 10.1016/j.cellimm.2011.06.010; Lu L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015150; Mandapathil M, 2009, CLIN CANCER RES, V15, P6348, DOI 10.1158/1078-0432.CCR-09-1143; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nascimbeni AC, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.475; Neuzillet C, 2014, ONCOTARGET, V5, P78, DOI 10.18632/oncotarget.1569; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Perrot I, 2019, CELL REP, V27, P2411, DOI 10.1016/j.celrep.2019.04.091; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pollizzi KN, 2015, TRENDS IMMUNOL, V36, P13, DOI 10.1016/j.it.2014.11.005; Quinlan CL, 2011, J BIOL CHEM, V286, P31361, DOI 10.1074/jbc.M111.267898; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Rissiek A, 2015, J AUTOIMMUN, V58, P12, DOI 10.1016/j.jaut.2014.12.007; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roth TL, 2018, NATURE, V559, P405, DOI 10.1038/s41586-018-0326-5; Schiavon V, 2019, P NATL ACAD SCI USA, V116, P6298, DOI 10.1073/pnas.1812471116; Schilham MW, 1997, EUR J IMMUNOL, V27, P1292, DOI 10.1002/eji.1830270534; Schmetterer KG, 2012, FASEB J, V26, P2253, DOI 10.1096/fj.11-193672; Schmetterer KG, 2011, J ALLERGY CLIN IMMUN, V127, P238, DOI 10.1016/j.jaci.2010.10.023; Sebastian M, 2016, J IMMUNOL, V196, P144, DOI 10.4049/jimmunol.1501704; Shen KL, 2020, WORLD J PEDIATR, V16, P232, DOI 10.1007/s12519-020-00362-4; Singha Prajjal K, 2014, Genes Cancer, V5, P320; STRASSER K, 2018, ONCOIMMUNOLOGY, V58, P1; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szczepanski MJ, 2009, CLIN CANCER RES, V15, P3325, DOI 10.1158/1078-0432.CCR-08-3010; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Underwood BR, 2010, HUM MOL GENET, V19, P3413, DOI 10.1093/hmg/ddq253; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; Yeh YM, 2013, INT J CANCER, V133, P867, DOI 10.1002/ijc.28086; Zarek PE, 2008, BLOOD, V111, P251, DOI 10.1182/blood-2007-03-081646; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; ZHAO H, 2017, FRONT IMMUNOL, V8; Zhou YC, 2015, J CELL BIOCHEM, V116, P1007, DOI 10.1002/jcb.25055; Zhoua Q, 2009, AM J TRANSPLANT, V9, P2303, DOI 10.1111/j.1600-6143.2009.02777.x; Zumerle S, 2019, CELL REP, V27, P1, DOI 10.1016/j.celrep.2019.03.011	80	18	18	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8367	8384		10.1096/fj.201902664	http://dx.doi.org/10.1096/fj.201902664		APR 2020	18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32319705	Green Published, hybrid			2022-12-26	WOS:000527569200001
J	Pujol-Canadell, M; Perrier, JR; Cunha, L; Shuryak, I; Harken, A; Garty, G; Brenner, DJ				Pujol-Canadell, Monica; Perrier, Jay R.; Cunha, Lidia; Shuryak, Igor; Harken, Andrew; Garty, Guy; Brenner, David J.			Cytogenetically-based biodosimetry after high doses of radiation	PLOS ONE			English	Article							BIOLOGICAL DOSIMETRY; MICRONUCLEUS ASSAY; HUMAN-LYMPHOCYTES; MITOTIC DELAY; CAFFEINE; EXPOSURES; YIELD; ABERRATIONS; METAPHASE; G2	Dosimetry is an important tool for triage and treatment planning following any radiation exposure accident, and biological dosimetry, which estimates exposure dose using a biological parameter, is a practical means of determining the specific dose an individual receives. The cytokinesis-blocked micronucleus assay (CBMN) is an established biodosimetric tool to measure chromosomal damage in mitogen-stimulated human lymphocytes. The CBMN method is especially valuable for biodosimetry in triage situations thanks to simplicity in scoring and adaptability to high-throughput automated sample processing systems. While this technique produces dose-response data which fit very well to a linear-quadratic model for exposures to low linear energy transfer (LET) radiation and for doses up for 5 Gy, limitations to the accuracy of this method arise at larger doses. Accuracy at higher doses is limited by the number of cells reaching mitosis. Whereas it would be expected that the yield of micronuclei increases with the dose, in many experiments it has been shown to actually decrease when normalized over the total number of cells. This variation from a monotonically increasing dose response poses a limitation for retrospective dose reconstruction. In this study we modified the standard CBMN assay to increase its accuracy following exposures to higher doses of photons or a mixed neutron-photon beam. The assay is modified either through inhibitions of the G2/M and spindle checkpoints with the addition of caffeine and/or ZM447439 (an Aurora kinase inhibitor), respectively to the blood cultures at select times during the assay. Our results showed that caffeine addition improved assay performance for photon up to 10 Gy. This was achieved by extending the assay time from the typical 70 h to just 74 h. Compared to micronuclei yields without inhibitors, addition of caffeine and ZM447439 resulted in improved accuracy in the detection of micronuclei yields up to 10 Gy from photons and 4 Gy of mixed neutrons-photons. When the dose-effect curves were fitted to take into account the turnover phenomenon observed at higher doses, best fitting was achieved when the combination of both inhibitors was used. These techniques permit reliable dose reconstruction after high doses of radiation with a method that can be adapted to high-throughput automated sample processing systems.	[Pujol-Canadell, Monica; Perrier, Jay R.; Cunha, Lidia; Shuryak, Igor; Brenner, David J.] Columbia Univ, Irving Med Ctr, Ctr Radiol Res, New York, NY 10027 USA; [Harken, Andrew; Garty, Guy] Radiol Res Accelerator Facil, Irvington, NY USA	Columbia University; NewYork-Presbyterian Hospital	Pujol-Canadell, M (corresponding author), Columbia Univ, Irving Med Ctr, Ctr Radiol Res, New York, NY 10027 USA.	mp3545@cumc.columbia.edu	Pujol-Canadell, Monica/AAY-1622-2020; Garty, Guy/M-9080-2019	Pujol Canadell, Monica/0000-0002-7403-9683	Opportunity Funds Management Core of the Centers for Medical Countermeasures against Radiation, National Institute of Allergy and Infectious Diseases [U19AI067773]	Opportunity Funds Management Core of the Centers for Medical Countermeasures against Radiation, National Institute of Allergy and Infectious Diseases	This work was funded by a pilot grant from the Opportunity Funds Management Core of the Centers for Medical Countermeasures against Radiation, National Institute of Allergy and Infectious Diseases; grant number U19AI067773. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. The authors would like to acknowledge Dr. Helen Turner, Dr. David Welch and Dr. Manuela Buonanno for their comments that greatly improved the manuscript.	Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Durante M, 1998, INT J RADIAT BIOL, V74, P457, DOI 10.1080/095530098141320; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Garty AG, 2019, MICE A BOMB IRRADIAT, V187, P475; Garty G, 2016, RADIAT PROT DOSIM, V172, P201, DOI 10.1093/rpd/ncw172; Garty G, 2015, MICROSC RES TECHNIQ, V78, P587, DOI 10.1002/jemt.22512; George K, 2001, INT J RADIAT BIOL, V77, P175, DOI 10.1080/0955300001003760; Heimers A, 2005, RADIAT ENVIRON BIOPH, V44, P211, DOI 10.1007/s00411-005-0014-3; IAEA. IAEA, 2011, CYT AN RAD DOS ASS N; Johannes C, 2010, MUTAT RES-GEN TOX EN, V701, P80, DOI 10.1016/j.mrgentox.2010.05.005; Kacprzak J, 2013, MUTAT RES-GEN TOX EN, V756, P196, DOI 10.1016/j.mrgentox.2013.04.017; Karachristou I, 2016, RADIAT PROT DOSIM, V172, P230, DOI 10.1093/rpd/ncw151; Kihlman B, 1982, PROG MUTAT RES; LAU CC, 1982, P NATL ACAD SCI-BIOL, V79, P2942, DOI 10.1073/pnas.79.9.2942; Lee R, 2011, RADIAT ENVIRON BIOPH, V50, P371, DOI 10.1007/s00411-011-0360-2; LUCKEHUHLE C, 1983, INT J RADIAT BIOL, V43, P123, DOI 10.1080/09553008314550131; Lue SW, 2015, RADIAT RES, V184, P134, DOI 10.1667/RR13991.1; Lyulko AO V, 2019, THROUGHPUT BIODOSIME, V181, P146; Muller WU, 2002, MUTAT RES-FUND MOL M, V502, P47, DOI 10.1016/S0027-5107(02)00022-2; Pantelias A, 2019, CANCERS, V11, DOI 10.3390/cancers11081123; Pujol M, 2016, RADIAT RES, V185, P151, DOI 10.1667/RR14145.1; Pujol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114137; Pujol M, 2012, RADIAT PROT DOSIM, V149, P392, DOI 10.1093/rpd/ncr326; Repin M, 2017, RADIAT RES, V187, P492, DOI 10.1667/RR011CC.1; Ritter S, 2002, J RADIAT RES, V43, pS175; Sasaki MS, 2003, INT J RADIAT BIOL, V79, P83, DOI 10.1080/0955300021000045655; TANZARELLA C, 1986, MUTAGENESIS, V1, P41, DOI 10.1093/mutage/1.1.41; Thierens H, 2014, RADIAT PROT DOSIM, V159, P87, DOI 10.1093/rpd/ncu130; Vinnikov VA, 2013, RADIAT PROT DOSIM, V154, P186, DOI 10.1093/rpd/ncs200; Xu AY, 2019, BASED BIOL IRRADIATI, V184, P404; Xu Y, 2016, SPECTRUM SIMILAR IMP	31	8	9	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0228350	10.1371/journal.pone.0228350	http://dx.doi.org/10.1371/journal.pone.0228350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320391	Green Published, gold, Green Submitted			2022-12-26	WOS:000536028800005
J	Cannon, LM; Sheridan-Fulton, EC; Dankyi, R; Seidu, AA; Compton, SD; Odoi, A; Darteh, EKM; Munro-Kramer, ML				Cannon, Lindsay M.; Sheridan-Fulton, Emily C.; Dankyi, Roberta; Seidu, Abdul-Aziz; Compton, Sarah D.; Odoi, Amanda; Darteh, Eugene K. M.; Munro-Kramer, Michelle L.			Understanding the healthcare provider response to sexual violence in Ghana: A situational analysis	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; WOMEN	Objectives Gender-based violence is a global public health crisis, which has health, social, and economic impacts on survivors. In Ghana, responding to and preventing sexual violence on university campuses, has become a priority area. However, data are lacking on the healthcare provider response to students who have experienced sexual violence. The purpose of this study was to conduct a situational analysis to better understand the healthcare provider response to sexual violence in Cape Coast, Ghana. Methods First, an observational facility assessment about healthcare services for survivors of sexual violence was conducted at two hospitals serving university students in Cape Coast, Ghana. Next, healthcare providers at the two hospitals completed: 1) a 113-item questionnaire about healthcare services, knowledge, and attitudes related to sexual violence and 2) in-depth semi-structured interviews describing their experiences providing healthcare to survivors of sexual violence. Descriptive statistics and frequencies were computed, and thematic analysis was used to analyze the qualitative data. Results Both sites lacked supplies, including pre-packed rape kits, post-exposure HIV prophylaxis, and informational handouts on medications and support services for survivors. Further, healthcare providers lacked training on gender-based violence, including best practices for caring for survivors and evidence collection procedures. Providers described the clinical management for survivors of sexual violence, including providers' role in reporting sexual violence to authorities, medical forensic exams, reproductive and sexual health services, and referral for mental healthcare. Finally, providers described a number of barriers to survivors accessing post-assault healthcare, including stigma and structural barriers, such as cost of medical supplies and lack of privacy within the healthcare facilities. Conclusions The current healthcare response to sexual violence in Ghana is limited by lack of supplies, knowledge, and training for healthcare providers. Personal and structural barriers may prevent survivors from accessing needed healthcare following sexual violence.	[Cannon, Lindsay M.] Univ Wisconsin, Dept Sociol, Madison, WI 53706 USA; [Sheridan-Fulton, Emily C.] Michigan State Univ, Res Consortium Gender Based Violence, E Lansing, MI 48824 USA; [Dankyi, Roberta] Michigan State Univ, Coll Nursing, E Lansing, MI 48824 USA; [Seidu, Abdul-Aziz; Darteh, Eugene K. M.] Univ Cape Coast, Dept Populat & Hlth, Cape Coast, Ghana; [Compton, Sarah D.] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Odoi, Amanda] Univ Cape Coast, Ctr Gender Res Advocacy & Documentat CEGRAD, Cape Coast, Ghana; [Munro-Kramer, Michelle L.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA	University of Wisconsin System; University of Wisconsin Madison; Michigan State University; Michigan State University; University of Cape Coast; University of Michigan System; University of Michigan; University of Cape Coast; University of Michigan System; University of Michigan	Munro-Kramer, ML (corresponding author), Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA.	mlmunro@umich.edu	Cannon, Lindsay/AAY-8937-2020; Darteh, Eugene Kofuor Maafo/H-1670-2015; Odoi, Amanda/GPP-1228-2022	Darteh, Eugene Kofuor Maafo/0000-0003-4689-8891; Odoi, Amanda/0000-0003-1726-411X; Compton, Sarah/0000-0002-1539-5397; Cannon, Lindsay/0000-0001-8020-7148; Munro-Kramer, Michelle/0000-0002-4298-6790; Seidu, Abdul-Aziz/0000-0001-9734-9054				Amoakohene MI, 2004, SOC SCI MED, V59, P2373, DOI 10.1016/j.socscimed.2004.04.001; [Anonymous], 2015, GHAN COUNTR SHEET; [Anonymous], 2008, GHAN COUNTR GEND PRO; Beck DC, 2019, GLOB PUBLIC HEALTH, V14, P375, DOI 10.1080/17441692.2018.1516228; Bell E, 2015, DFID GUIDANCE NOTE A; Centers for Disease Control and Prevention and Author, 2004, SEX VIOL PREV BEG DI; Cheema JR, 2014, J MOD APPL STAT METH, V13, P53, DOI 10.22237/jmasm/1414814520; Christofides N, 2006, CONDUCT SITUATION AN; Colombini M, 2013, BMC HLTH SERV RES, V13; Colombini M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-548; Damra JK, 2015, J FAM VIOLENCE, V30, P807, DOI 10.1007/s10896-015-9720-z; Fisher B. S., 2000, 182369 NCJ US DEP JU; Garcia-Moreno C, 2015, LANCET, V385, P1567, DOI 10.1016/S0140-6736(14)61837-7; Gender Studies & Human Rights Documentation Centre, 2016, STAT SEX VIOL GHAN; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV 2, V14, P1; GhanaWeb, 2018, PEARL SAF HAV PROJ P; Glaser B., 1992, BASICS GROUNDED THEO; Glaser BG, 1978, THEORETICAL SENSITIV; ISGlobal-Barcelona Institute for Global Health, 2014, INN COMM BAS APPR AD; Jewkes R, 2002, LANCET, V359, P1423, DOI 10.1016/S0140-6736(02)08357-5; Jewkes R, 2015, LANCET, V385, P1580, DOI 10.1016/S0140-6736(14)61683-4; Lori JR, 2013, INT J GYNECOL OBSTET, V123, P114, DOI 10.1016/j.ijgo.2013.05.024; McFarlane J, 2005, OBSTET GYNECOL, V105, P99, DOI 10.1097/01.AOG.0000146641.98665.b6; Morris JN, 2012, DOMESTIC VIOLENCE AC; Munro Michelle L, 2014, Womens Healthc (Doylestown), V2, P19; Munro-Kramer ML, 2020, VIOLENCE AGAINST WOM, V26, P66, DOI 10.1177/1077801219828533; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Ofori-Atta A, 2010, AFR J PSYCHIATRY, V13, P99; Pool MS, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-71; Rominski SD, 2017, SEX CULT, V21, P516, DOI 10.1007/s12119-016-9402-x; Rominski SD, 2016, RAPE MYTH ACCEPTANCE, V136, P240, DOI [10.1002/ijgo.12054, DOI 10.1002/IJGO.12054]; SAMHSA, 2014, SAMHSAS CONC TRAUM G; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Wolf EJ, 2016, PTSD RES Q, V27, P1050; World Health Organization, 2003, GUID MED CAR VICT SE; World Health Organization, 2021, VIOL WOM PREV EST 20; 2014, GLOB STAT REP VIOL P, P1	37	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231644	10.1371/journal.pone.0231644	http://dx.doi.org/10.1371/journal.pone.0231644			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315332	gold, Green Published			2022-12-26	WOS:000536024800039
J	Liu, DL; Fu, XH; Wang, YG; Wang, XH; Wang, H; Wen, JL; Kang, NL				Liu, Donglian; Fu, Xinhui; Wang, Yuanguo; Wang, Xianghu; Wang, Hua; Wen, Jialing; Kang, Ningling			Protein diaphanous homolog 1 (Diaph1) promotes myofibroblastic activation of hepatic stellate cells by regulating Rab5a activity and TGF beta receptor endocytosis	FASEB JOURNAL			English	Article						cancer-associated fibroblasts; colorectal cancer; endosomal trafficking of receptors; IncuCyte Live-Cell Analysis; biotinylation	GROWTH-FACTOR; ACTIN; MEMBRANE; MDIA1; ADHESION; MICROENVIRONMENT; REORGANIZATION; TRANSPORT; FORMINS; GTPASE	TGF beta induces the differentiation of hepatic stellate cells (HSCs) into tumor-promoting myofibroblasts but underlying mechanisms remain incompletely understood. Because endocytosis of TGF beta receptor II (T beta RII), in response to TGF beta stimulation, is a prerequisite for TGF signaling, we investigated the role of protein diaphanous homolog 1 (known as Diaph1 or mDia1) for the myofibroblastic activation of HSCs. Using shRNA to knockdown Diaph1 or SMIFH2 to target Diaph1 activity of HSCs, we found that the inactivation of Diaph1 blocked internalization and intracellular trafficking of T beta RII and reduced SMAD3 phosphorylation induced by TGF beta 1. Mechanistic studies revealed that the N-terminal portion of Diaph1 interacted with both T beta RII and Rab5a directly and that Rab5a activity of HSCs was increased by Diaph1 overexpression and decreased by Diaph1 knockdown. Additionally, expression of Rab5aQ79L (active Rab5a mutant) increased whereas the expression of Rab5aS34N (inactive mutant) reduced the endosomal localization of T beta RII in HSCs compared to the expression of wild-type Rab5a. Functionally, TGF beta stimulation promoted HSCs to express tumor-promoting factors, and alpha-smooth muscle actin, fibronection, and CTGF, markers of myofibroblastic activation of HSCs. Targeting Diaph1 or Rab5a suppressed HSC activation and limited tumor growth in a tumor implantation mouse model. Thus, Dipah1 and Rab5a represent targets for inhibiting HSC activation and the hepatic tumor microenvironment.	[Liu, Donglian; Fu, Xinhui; Wang, Yuanguo; Wang, Xianghu; Wang, Hua; Wen, Jialing; Kang, Ningling] Univ Minnesota, Hormel Inst, Tumor Microenvironm & Metastasis Sect, 801 16th Ave NE, Austin, MN 55912 USA; [Liu, Donglian] Guangzhou Med Univ, Qingyuan Peoples Hosp, Affiliated Hosp 6, Inst Digest Dis, Qingyuan, Guangdong, Peoples R China; [Fu, Xinhui; Wen, Jialing] Sun Yat Sen Univ, Affiliated Hosp 6, Dept Pathol, Guangzhou, Peoples R China	University of Minnesota System; Guangzhou Medical University; Sun Yat Sen University	Kang, NL (corresponding author), Univ Minnesota, Hormel Inst, Tumor Microenvironm & Metastasis Sect, 801 16th Ave NE, Austin, MN 55912 USA.	nkang@umn.edu	Wang, Xianghu/GZA-6149-2022		NIH [R01 CA160069]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	NIH grant R01 CA160069 to N. Kang.	Anders RA, 1998, J BIOL CHEM, V273, P23118, DOI 10.1074/jbc.273.36.23118; Barbieri MA, 2000, J CELL BIOL, V151, P539, DOI 10.1083/jcb.151.3.539; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Copeland JW, 2004, J BIOL CHEM, V279, P50250, DOI 10.1074/jbc.M404429200; Decker NK, 2008, AM J PATHOL, V173, P1002, DOI 10.2353/ajpath.2008.080158; Dou CW, 2018, GASTROENTEROLOGY, V154, P2209, DOI 10.1053/j.gastro.2018.02.015; Edlund S, 2002, MOL BIOL CELL, V13, P902, DOI 10.1091/mbc.01-08-0398; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Fouraux MA, 2004, MOL BIOL CELL, V15, P611, DOI 10.1091/mbc.E03-05-0343; Hayes S, 2002, J CELL BIOL, V158, P1239, DOI 10.1083/jcb.200204088; Hinze C, 2018, BIOCHEM SOC T, V46, P565, DOI 10.1042/BST20170355; Hoffenberg S, 2000, J BIOL CHEM, V275, P24661, DOI 10.1074/jbc.M909600199; Kang NL, 2015, MOL CANCER RES, V13, P604, DOI 10.1158/1541-7786.MCR-14-0542; Kang NL, 2011, HEPATOLOGY, V54, P707, DOI 10.1002/hep.24384; Kang NL, 2010, AM J PATHOL, V177, P1888, DOI 10.2353/ajpath.2010.100187; Kim D, 2016, ONCOTARGET, V7, P17829, DOI 10.18632/oncotarget.7429; Koli KM, 1997, J BIOL CHEM, V272, P6423, DOI 10.1074/jbc.272.10.6423; Kozlov MM, 2004, J CELL BIOL, V167, P1011, DOI 10.1083/jcb.200410017; Levayer R, 2011, NAT CELL BIOL, V13, P529, DOI 10.1038/ncb2224; Lewkowicz E, 2008, J CELL BIOL, V183, P1287, DOI 10.1083/jcb.200807023; Li F, 2003, CURR BIOL, V13, P1335, DOI 10.1016/S0960-9822(03)00540-2; Lin YN, 2015, ONCOTARGET, V6, P18577, DOI 10.18632/oncotarget.4094; Liu CS, 2014, AM J PHYSIOL-GASTR L, V307, pG749, DOI 10.1152/ajpgi.00138.2014; Liu CS, 2013, J CLIN INVEST, V123, P1138, DOI 10.1172/JCI63836; Lynch ED, 1997, SCIENCE, V278, P1315, DOI 10.1126/science.278.5341.1315; Mei Y, 2017, BLOOD ADV, V1, P1650, DOI 10.1182/bloodadvances.2017007906; Mitchell H, 2004, MOL BIOL CELL, V15, P4166, DOI 10.1091/mbc.E04-03-0245; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; Paul A, 2008, CURR BIOL, V18, P9, DOI 10.1016/j.cub.2007.11.062; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rizvi SA, 2009, CHEM BIOL, V16, P1158, DOI 10.1016/j.chembiol.2009.10.006; Routray C, 2011, AM J PHYSIOL-CELL PH, V301, pC66, DOI 10.1152/ajpcell.00038.2011; Sandbo N, 2011, AM J PHYSIOL-LUNG C, V301, pL656, DOI 10.1152/ajplung.00166.2011; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Stritt S, 2016, BLOOD, V127, P2903, DOI 10.1182/blood-2015-10-675629; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Tu KS, 2015, HEPATOLOGY, V61, P361, DOI 10.1002/hep.27251; Wallar BJ, 2006, J BIOL CHEM, V281, P4300, DOI 10.1074/jbc.M510277200; Wang YG, 2019, HEPATOLOGY, V70, P1409, DOI 10.1002/hep.30668; Yang JC, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/6716472; Zhu GY, 2004, NAT STRUCT MOL BIOL, V11, P975, DOI 10.1038/nsmb832; Zuidscherwoude M, 2019, PLATELETS, V30, P23, DOI 10.1080/09537104.2018.1481937	45	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7345	7359		10.1096/fj.201903033R	http://dx.doi.org/10.1096/fj.201903033R		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304339	hybrid, Green Accepted			2022-12-26	WOS:000527389800001
J	Morka, ED; Yibekal, BT; Tegegne, MM				Morka, Efa Derecha; Yibekal, Betelhem Temesgen; Tegegne, Mebratu Mulusew			Eye care service utilization and associated factors among older adults in Hawassa city, South Ethiopia	PLOS ONE			English	Article							UNITED-STATES; DETERMINANTS; IMPAIRMENT	Purpose The study aimed to assess the proportion of eye care service utilization and associated factors among older adults age >= 40 years in Hawassa city, South Ethiopia, June 2019. Method A community-based cross-sectional study was conducted among adults aged 40 years and above who permanently live in Hawassa city from April 25 to May 30, 2019. Multistage sampling technique was used to select 704 participants. An interviewer-administered questionnaire was used to collect the data. The collected data was entered to EPI info version 7 & was analyzed by SPSS version 20. Binary logistic regression model was used to identify actual predictors of eye care service utilization. All variables were entered to multivariable analysis and variables with p-value < 0.05 were considered as statistically significant. Result A total of 668 adults participated with a response rate of 94.9%. The median (+/- IQR) age of study respondents was 48(+/- 10) years and 52.7% were females. The proportion of eye care service utilization within the past 2 years was found to be 23.8% [95% CI: 20.5%-27.1%]. Having history of eye disease [AOR = 9.8, 95% CI: 6.1-15.6], having awareness of regular eye checkup importance [AOR = 7.3, 95% CI:4.4-12.2], older age (age >= 65 years) [AOR = 5.0, 95% CI:1.9-13.3] and higher family monthly income (income >= 6000 ETB) [AOR = 3.0, 95% CI:1.5-5.7] and income 4001-5999 ETB [AOR = 2.9, 95% CI: 1.4-5.9] were positively associated with eye care service utilization. Conclusion and recommendation The proportion of eye care service utilization among older adults in Hawassa city was low. Having a history of eye disease, having awareness about regular eye checkup importance, older age and higher family monthly income were significantly associated with utilization of eye care service. Therefore, it is recommended to provide eye health education for the community to increase awareness about eye care service utilization which can improve eye care service utilization.	[Morka, Efa Derecha] Hawassa Univ, Coll Med & Hlth Sci, Sch Med, Dept Ophthalmol & Optometry, Hawassa Town, Ethiopia; [Yibekal, Betelhem Temesgen; Tegegne, Mebratu Mulusew] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Optometry, Gondar Town, Ethiopia	Hawassa University; University of Gondar	Yibekal, BT (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Optometry, Gondar Town, Ethiopia.	betelhemtemesgen28@gmail.com						Abdullah KN, 2013, HEALTH EDUC J, V72, P742, DOI 10.1177/0017896912461193; Ahmad K, 2015, OPHTHAL EPIDEMIOL, V22, P370, DOI 10.3109/09286586.2015.1012592; Aljied R, 2018, CAN J OPHTHALMOL, V53, P298, DOI 10.1016/j.jcjo.2018.01.021; [Anonymous], BARRIERS UTILIZATION; Beauchamp George R, 2010, Am Orthopt J, V60, P23; Bourne RRA, 2017, LANCET GLOB HEALTH, V5, pE888, DOI 10.1016/S2214-109X(17)30293-0; Bylsma GW, 2004, CLIN EXP OPHTHALMOL, V32, P573, DOI 10.1111/j.1442-9071.2004.00905.x; Carrasquillo O., 2013, ENCY BEHAV MED, P909, DOI DOI 10.1007/978-1-4419-1005-9_885; Chou CF, 2012, AM J OPHTHALMOL, V154, pS45, DOI 10.1016/j.ajo.2011.09.025; Foreman J, 2018, CLIN EXP OPHTHALMOL, V46, P213, DOI 10.1111/ceo.13035; Fotouhi Akbar, 2006, BMC Ophthalmol, V6, P4, DOI 10.1186/1471-2415-6-4; Ibeneche H, 2018, J NIGERIAN OPTOMETRI, V20, P64; Ilechie A, 2013, INT J HLTH RES, V6, P7; Jiang XJ, 2017, AM J OPHTHALMOL, V176, P183, DOI 10.1016/j.ajo.2017.01.018; Mashige KP, 2011, AFR VIS EYE HEALTH J, V70, P175; Ntsoane MD, 2010, AFR VIS EYE HEALTH J, V69, P182; Ntsoane MD, 2012, AFRICAN J PRIMARY HL, V4; Ocansey S, 2013, OPHTHALMOL RES, V1, P89; Ocansey S, 2014, J BEHAV HLTH, V3, P101, DOI DOI 10.5455/JBH.20140219014308; Olusanya BA, 2016, MIDDLE EAST AFR J OP, V23, P96, DOI 10.4103/0974-9233.164621; Park Yong Seok, 2017, Korean J Ophthalmol, V31, P58, DOI 10.3341/kjo.2017.31.1.58; Pulido JS, 2016, OPHTHALMOLOGY, V123, pP209, DOI [10.1016/j.ophtha.2015.10.045, 10.1016/j.ophtha.2015.10.047]; Vela C, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-5; Wagner LD, 2013, OPHTHALMOLOGY, V120, P1497, DOI 10.1016/j.ophtha.2012.12.030; World Health Organisation, 2020, BLINDN VIS IMP; Yemane Berhane, 2007, Ethiopian Journal of Health Development, V21, P204	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231616	10.1371/journal.pone.0231616	http://dx.doi.org/10.1371/journal.pone.0231616			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298344	Green Published, gold			2022-12-26	WOS:000536011400072
J	Nanasi, P; Imre, L; Niaki, EF; Bosire, R; Mocsar, G; Turk-Mazlo, A; Ausio, J; Szabo, G				Nanasi, Peter, Jr.; Imre, Laszlo; Niaki, Erfaneh Firouzi; Bosire, Rosevalentine; Mocsar, Gabor; Turk-Mazlo, Anett; Ausio, Juan; Szabo, Gabor			Doxorubicin induces large-scale and differential H2A and H2B redistribution in live cells	PLOS ONE			English	Article							ACTIVATING ENZYME E1; MESSENGER-RNA; ANTHRACYCLINE ANTIBIOTICS; DNA INTERCALATOR; DENDRITIC CELLS; HISTONE H1; IN-VITRO; CHROMATIN; DAUNOMYCIN; PROTEIN	We observed prominent effects of doxorubicin (Dox), an anthracycline widely used in anticancer therapy, on the aggregation and intracellular distribution of both partners of the H2A-H2B dimer, with marked differences between the two histones. Histone aggregation, assessed by Laser Scanning Cytometry via the retention of the aggregates in isolated nuclei, was observed in the case of H2A. The dominant effect of the anthracycline on H2B was its massive accumulation in the cytoplasm of the Jurkat leukemia cells concomitant with its disappearance from the nuclei, detected by confocal microscopy and mass spectrometry. A similar effect of the anthracycline was observed in primary human lymphoid cells, and also in monocyte-derived dendritic cells that harbor an unusually high amount of H2B in their cytoplasm even in the absence of Dox treatment. The nucleo-cytoplasmic translocation of H2B was not affected by inhibitors of major biochemical pathways or the nuclear export inhibitor leptomycin B, but it was completely diminished by PYR-41, an inhibitor with pleiotropic effects on protein degradation pathways. Dox and PYR-41 acted synergistically according to isobologram analyses of cytotoxicity. These large-scale effects were detected already at Dox concentrations that may be reached in the typical clinical settings, therefore they can contribute both to the anti-cancer mechanism and to the side-effects of this anthracycline.	[Nanasi, Peter, Jr.; Imre, Laszlo; Niaki, Erfaneh Firouzi; Bosire, Rosevalentine; Mocsar, Gabor; Szabo, Gabor] Univ Debrecen, Doctoral Sch Mol Cell & Immune Biol, Dept Biophys & Cell Biol, Fac Med, Debrecen, Hungary; [Turk-Mazlo, Anett] Univ Debrecen, Dept Immunol, Fac Med, Debrecen, Hungary; [Ausio, Juan] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada	University of Debrecen; University of Debrecen; University of Victoria	Szabo, G (corresponding author), Univ Debrecen, Doctoral Sch Mol Cell & Immune Biol, Dept Biophys & Cell Biol, Fac Med, Debrecen, Hungary.	szabog@med.unideb.hu	Szabo, Gabor/AAP-2447-2021	Turk-Mazlo, Anett/0000-0001-7012-7101; Szabo, Gabor/0000-0002-9163-3465	Hungarian National Science and Research Foundation [GINOP-2.3.2-15-2016-00044, GINOP-2.3.3-15-2016-00020, OTKA K128770, COST EuroCellNet CA15214]; Richter Gedeon Talentum Foundation; Stipendium Hungaricum by the Tempus Public foundation;  [GINOP-2.3.3-152016-00020]	Hungarian National Science and Research Foundation(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Richter Gedeon Talentum Foundation; Stipendium Hungaricum by the Tempus Public foundation; 	GS received funding from GINOP-2.3.215-2016-00044, GINOP-2.3.3-15-2016-00020, Hungarian National Science and Research Foundation OTKA K128770 (https://nkfih.gov.hu/funding/otka) and COST EuroCellNet CA15214 (https://www.eurocellnet.eu).EFN was funded by Richter Gedeon Talentum Foundation (https://www.richter.hu/hu-HU/felelossegvallalas/alapitvanyok/Pages/Richter-Gedeon-TalentumAlapitvany.aspx). The Orbitrap Fusion mass spectrometer was provided by GINOP-2.3.3-152016-00020 for the Proteomics Core Facility. RB was supported by Stipendium Hungaricum awarded by the Tempus Public foundation (https://tka.hu/english).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almaqwashi AA, 2016, NUCLEIC ACIDS RES, V44, P3971, DOI 10.1093/nar/gkw237; [Anonymous], 2019, DOX HYDR; Ashikari D, 2017, ONCOGENE, V36, P6272, DOI 10.1038/onc.2017.225; Barpe DR, 2010, EUR J PHARM SCI, V41, P458, DOI 10.1016/j.ejps.2010.07.015; Bleher R, 1999, CHROMOSOMA, V108, P308, DOI 10.1007/s004120050382; Braunstein M, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0676-6; CHAIRES JB, 1982, BIOCHEMISTRY-US, V21, P3933, DOI 10.1021/bi00260a005; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Cole CN, 2006, CURR OPIN CELL BIOL, V18, P299, DOI 10.1016/j.ceb.2006.04.006; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; da Silva MG, 2012, EXP CLIN CARDIOL, V17, P101; EKSBORG S, 1989, ACTA ONCOL, V28, P873, DOI 10.3109/02841868909092323; Fang SF, 2017, ONCOTARGET, V8, P49783, DOI 10.18632/oncotarget.17939; Foster ER, 2009, J CELL BIOL, V184, P631, DOI 10.1083/jcb.200812088; FREDERICK CA, 1990, BIOCHEMISTRY-US, V29, P2538, DOI 10.1021/bi00462a016; GREENE RF, 1983, CANCER RES, V43, P3417; Herman EH, 1997, J MOL CELL CARDIOL, V29, P2415, DOI 10.1006/jmcc.1997.0477; Hsu LW, 2008, CLIN EXP IMMUNOL, V152, P576, DOI 10.1111/j.1365-2249.2008.03652.x; Huang RY, 2007, CANCER RES, V67, P765, DOI 10.1158/0008-5472.CAN-06-2839; Imre L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12608-9; IQBAL J, 2016, HISTONE H2B IFI16 RE, V12, DOI DOI 10.1371/JOURNAL.PPAT.1005967; Jiang L, 2007, J BIOL CHEM, V282, P27923, DOI 10.1074/jbc.M704194200; Kamiyama D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11046; Kapuria V, 2011, BIOCHEM PHARMACOL, V82, P341, DOI 10.1016/j.bcp.2011.05.012; Kawaguchi T, 2012, CARDIOVASC RES, V96, P456, DOI 10.1093/cvr/cvs282; Kawashima A, 2011, ENDOCRINOLOGY, V152, P1702, DOI 10.1210/en.2010-1132; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim HS, 2002, J IMMUNOL, V168, P2356, DOI 10.4049/jimmunol.168.5.2356; Kobiyama Kouji, 2013, Frontiers in Genetics, V4, P91, DOI 10.3389/fgene.2013.00091; Kobiyama K, 2010, J VIROL, V84, P822, DOI 10.1128/JVI.01339-09; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Li DL, 2016, CIRCULATION, V133, P1668, DOI 10.1161/CIRCULATIONAHA.115.017443; Matilainen O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01903-8; Matsuo S, 2018, SHOCK, V49, P442, DOI 10.1097/SHK.0000000000000931; MI Agnieszka Chrustek, 2014, MED BIOL SCI, V28, P11, DOI [10.12775/MBS.2014.010, DOI 10.12775/MBS.2014.010]; Miles Jana S, 2018, Int J Adv Res (Indore), V6, P144; Moore MJ, 2001, SCIENCE, V294, P1841, DOI 10.1126/science.1067676; Muller-McNicoll M, 2016, GENE DEV, V30, P553, DOI 10.1101/gad.276477.115; Nesher E, 2018, CANCER RES, V78, P1431, DOI 10.1158/0008-5472.CAN-17-2690; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pang BX, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2921; PAUL C, 1989, THER DRUG MONIT, V11, P140, DOI 10.1097/00007691-198903000-00004; Rabbani A, 2005, BIOESSAYS, V27, P50, DOI 10.1002/bies.20160; Rabbani A, 2004, BIOCHEMISTRY-US, V43, P16497, DOI 10.1021/bi048524p; Rabbani A, 1999, J BIOL CHEM, V274, P18401, DOI 10.1074/jbc.274.26.18401; Rodrigues PG, 2019, AM J PHYSIOL-HEART C, V316, pH459, DOI 10.1152/ajpheart.00401.2018; ROZIJN TH, 1964, BIOCHIM BIOPHYS ACTA, V91, P105, DOI 10.1016/0926-6550(64)90174-4; Salerno D, 2010, NUCLEIC ACIDS RES, V38, P7089, DOI 10.1093/nar/gkq597; Scaglioni L, 2016, BBA-GEN SUBJECTS, V1860, P1129, DOI 10.1016/j.bbagen.2016.02.011; Sprigg L, 2010, J MED CHEM, V53, P6457, DOI 10.1021/jm1007853; Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17; Studzian K, 2001, NEOPLASMA, V48, P412; Szatmary P, 2018, J CELL MOL MED, V22, P4617, DOI 10.1111/jcmm.13797; Thomas M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022671; Travers J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05485-x; Ullrich O, 2001, FREE RADICAL BIO MED, V31, P887, DOI 10.1016/S0891-5849(01)00672-4; WATSON K, 1995, BIOCHEM PHARMACOL, V50, P299, DOI 10.1016/0006-2952(95)00142-M; Wojcik K, 2008, CYTOM PART A, V73A, P555, DOI 10.1002/cyto.a.20573; Wojcik K, 2013, CANCER BIOL THER, V14, P823, DOI 10.4161/cbt.25328; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yang F, 2015, MUTAT RES-FUND MOL M, V773, P9, DOI 10.1016/j.mrfmmm.2015.01.007; Yang F, 2014, BBA-REV CANCER, V1845, P84, DOI 10.1016/j.bbcan.2013.12.002; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Zhang H, 2014, GENES-BASEL, V5, P982, DOI 10.3390/genes5040982	66	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231223	10.1371/journal.pone.0231223	http://dx.doi.org/10.1371/journal.pone.0231223			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298286	Green Published, gold			2022-12-26	WOS:000536011400032
J	Tripolt, P; Arzt-Gradwohl, L; Cerpes, U; Laipold, K; Binder, B; Sturm, GJ				Tripolt, Patrik; Arzt-Gradwohl, Lisa; Cerpes, Urban; Laipold, Karin; Binder, Barbara; Sturm, Gunter Johannes			Large local reactions and systemic reactions to insect stings: Similarities and differences	PLOS ONE			English	Article							HYMENOPTERA VENOM ALLERGY; ANAPHYLACTIC REACTIONS; NATURAL-HISTORY; SENSITIZATION; SEVERITY; TRYPTASE	Background Large local reactions (LLR) to Hymenoptera stings were considered as IgE-mediated late-phase inflammatory reactions. However, in older studies, most patients with LLR were skin test positive, but only around 50% had detectable sIgE determined by the RAST system. Methods Data of 620 patients were evaluated retrospectively: 310 patients who suffered from LLR and 310 patients with previous systemic sting reactions (SSR). We aimed to clarify if sIgE can generally be detected by the CAP system in patients with LLR; sIgE levels and clinical parameters were compared between patients with LLR and SSR. Results Positive sIgE levels were detected in 80.7% of patients with LLR, and in 95.2% of patients with SSR (p<0.001). Of the 310 patients with LLR, 80.6% had a LLR with a size of 10-20cm, whereas 19.4% had swellings > 20cm, with a mean duration of seven days. In only 2.9% of patients, LLRs occurred after stings on the trunk, while 14.8% of SSR resulted from stings on this site (p<0.001). Similarly, LLR were also less frequent on the capillitium compared to SSR (8.1% versus 26.2%; p = 0.035) Conclusions LLR usually persisted over seven days and about one fifth of patients had swellings greater than 20cm. Contrary to SSR, LLR were less frequently observed on the capillitium and on the trunk. In most patients with LLR, sIgE could be detected. However, total IgE and sIgE levels to bee or vespid venom did not differ between patients with LLR and SSR.	[Tripolt, Patrik; Arzt-Gradwohl, Lisa; Cerpes, Urban; Laipold, Karin; Binder, Barbara; Sturm, Gunter Johannes] Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria; [Sturm, Gunter Johannes] Allergy Outpatient Clin Reumannpl, Vienna, Austria	Medical University of Graz	Sturm, GJ (corresponding author), Med Univ Graz, Dept Dermatol & Venerol, Graz, Austria.; Sturm, GJ (corresponding author), Allergy Outpatient Clin Reumannpl, Vienna, Austria.	gunter.sturm@medunigraz.at						ABRECHT I, 1980, CLIN ALLERGY, V10, P675, DOI 10.1111/j.1365-2222.1980.tb02151.x; Antonicelli L, 2002, CURR OPIN ALLERGY CL, V2, P341, DOI 10.1097/00130832-200208000-00008; Arzt L, 2018, ALLERGY, V73, P1223, DOI 10.1111/all.13368; Bilo BM, 2005, ALLERGY, V60, P1339, DOI 10.1111/j.1398-9995.2005.00963.x; Bilo MB, 2009, CLIN EXP ALLERGY, V39, P1467, DOI 10.1111/j.1365-2222.2009.03324.x; Bilo MB, 2019, ALLERGY, V74, P1969, DOI 10.1111/all.13863; BOUSQUET J, 1982, CLIN ALLERGY, V12, P331, DOI 10.1111/j.1365-2222.1982.tb02537.x; Carlson J, 2016, CURR OPIN ALLERGY CL, V16, P366, DOI 10.1097/ACI.0000000000000289; Egner W, 1998, CLIN EXP ALLERGY, V28, P26, DOI 10.1046/j.1365-2222.1998.00176.x; Eifan AO, 2016, CLIN EXP ALLERGY, V46, P1139, DOI 10.1111/cea.12780; Elberink JNGO, 2006, J ALLERGY CLIN IMMUN, V118, P699, DOI 10.1016/j.jaci.2006.03.049; Golden DBK, 2007, IMMUNOL ALLERGY CLIN, V27, P261, DOI 10.1016/j.iac.2007.03.008; Golden DBK, 2015, J ALLER CL IMM-PRACT, V3, P331, DOI 10.1016/j.jaip.2015.01.020; Golden DBK, 2009, J ALLERGY CLIN IMMUN, V123, P1371, DOI 10.1016/j.jaci.2009.03.017; GRAFT DF, 1984, J PEDIATR-US, V104, P664, DOI 10.1016/S0022-3476(84)80940-3; GREEN AW, 1980, J ALLERGY CLIN IMMUN, V66, P186, DOI 10.1016/0091-6749(80)90037-8; HOFFMAN DR, 1978, ANN ALLERGY, V41, P278; JEEP S, 1992, ALLERGY, V47, P212, DOI 10.1111/j.1398-9995.1992.tb00653.x; Ludolph-Hauser D, 2001, LANCET, V357, P361, DOI 10.1016/S0140-6736(00)03647-3; MAURIELLO PM, 1984, J ALLERGY CLIN IMMUN, V74, P494, DOI 10.1016/0091-6749(84)90384-1; Navarro LA, 2004, J INVEST ALLERG CLIN, V14, P134; Pucci S, 2019, IMMUN INFLAMM DIS, V7, P258, DOI 10.1002/iid3.268; Pucci Stefano, 2015, Clin Mol Allergy, V13, P21, DOI 10.1186/s12948-015-0030-z; RING J, 1977, LANCET, V1, P466; Rueff F, 2009, J ALLERGY CLIN IMMUN, V124, P1047, DOI 10.1016/j.jaci.2009.08.027; SETTIPANE GA, 1978, CLIN ALLERGY, V8, P259, DOI 10.1111/j.1365-2222.1978.tb03222.x; Severino M, 2009, CURR OPIN ALLERGY CL, V9, P334, DOI 10.1097/ACI.0b013e32832d0668; Soyyigit S, 2019, ALLERGY ASTHMA PROC, V40, P116, DOI 10.2500/aap.2019.40.4191; Sturm GJ, 2018, ALLERGY, V73, P744, DOI 10.1111/all.13262; Sturm GJ, 2014, J ALLERGY CLIN IMMUN, V133, P1635, DOI 10.1016/j.jaci.2013.10.046	30	2	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231747	10.1371/journal.pone.0231747	http://dx.doi.org/10.1371/journal.pone.0231747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298380	Green Published, gold			2022-12-26	WOS:000536011400103
J	Byun, JA; Van, K; Huang, JF; Henning, P; Franz, E; Akimoto, M; Herberg, FW; Kim, C; Melacini, G				Byun, Jung Ah; Van, Katherine; Huang, Jinfeng; Henning, Philipp; Franz, Eugen; Akimoto, Madoka; Herberg, Friedrich W.; Kim, Choel; Melacini, Giuseppe			Mechanism of allosteric inhibition in thePlasmodium falciparumcGMP-dependent protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic GMP (cGMP); malaria; nuclear magnetic resonance (NMR); signaling; plasmodium; protein kinase G (PKG); 8-NBD-cGMP; CNB; cyclic nucleotide?binding domain (CBD); kinase signaling; PfPKG	STRUCTURAL BASIS; REGULATORY SUBUNIT; MALARIA BIOLOGY; BINDING DOMAIN; ACTIVATION; AUTOINHIBITION; SELECTIVITY; DYNAMICS; LINKERS; TARGETS	Most malaria deaths are caused by the protozoan parasitePlasmodium falciparum. Its life cycle is regulated by a cGMP-dependent protein kinase (PfPKG), whose inhibition is a promising antimalaria strategy. Allosteric kinase inhibitors, such as cGMP analogs, offer enhanced selectivity relative to competitive kinase inhibitors. However, the mechanisms underlying allostericPfPKG inhibition are incompletely understood. Here, we show that 8-NBD-cGMP is an effectivePfPKG antagonist. Using comparative NMR analyses of a key regulatory domain,PfD, in itsapo, cGMP-bound, and cGMP analog?bound states, we elucidated its inhibition mechanism of action. Using NMR chemical shift analyses, molecular dynamics simulations, and site-directed mutagenesis, we show that 8-NBD-cGMP inhibitsPfPKG not simply by reverting a two-state activeversusinactive equilibrium, but by sampling also a distinct inactive ?mixed? intermediate. Surface plasmon resonance indicates that the ability to stabilize a mixed intermediate provides a means to effectively inhibitPfPKG, without losing affinity for the cGMP analog. Our proposed model may facilitate the rational design ofPfPKG-selective inhibitors for improved management of malaria.	[Byun, Jung Ah; Van, Katherine; Melacini, Giuseppe] McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4L8, Canada; [Huang, Jinfeng; Akimoto, Madoka; Melacini, Giuseppe] McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada; [Henning, Philipp; Herberg, Friedrich W.] Univ Kassel, Dept Biochem, Heinrich Plett Str 40, D-34132 Kassel, Germany; [Franz, Eugen] Biaffin GmbH & Co KG, Heinrich Plett Str 40, D-34132 Kassel, Germany; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA	McMaster University; McMaster University; Universitat Kassel; Baylor College of Medicine; Baylor College of Medicine	Melacini, G (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.; Melacini, G (corresponding author), McMaster Univ, Dept Chem & Chem Biol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada.	melacin@mcmaster.ca	; Herberg, Friedrich W./B-5572-2015	Huang, Jinfeng/0000-0002-6342-8536; Byun, Jung Ah/0000-0001-7814-7326; Herberg, Friedrich W./0000-0001-7117-7653; AKIMOTO, MADOKA/0000-0003-0510-5613	Canadian Institutes of Health Research Grant [389522]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-05990]; Deutsche Forschungsgemeinschaft (DFG) [He1818/10]; funding line Future "PhosMOrg" of the University of Kassel; Graduate School "Clocks" of the University of Kassel	Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); funding line Future "PhosMOrg" of the University of Kassel; Graduate School "Clocks" of the University of Kassel	This work was supported by Canadian Institutes of Health Research Grant 389522 (to G. M.), Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2019-05990 (to G. M.), Deutsche Forschungsgemeinschaft (DFG) Grant He1818/10 (to F. W. H.), and the funding line Future "PhosMOrg" and Graduate School "Clocks" of the University of Kassel (to F. W. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Akimoto M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002305; Akimoto M, 2014, BIOCHEM SOC T, V42, P139, DOI 10.1042/BST20130257; Akimoto M, 2013, P NATL ACAD SCI USA, V110, P14231, DOI 10.1073/pnas.1312644110; Alam MM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8285; Baker DA, 2005, FRONT BIOSCI, V10, P1229, DOI 10.2741/1615; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Boulton S, 2018, J AM CHEM SOC, V140, P9624, DOI 10.1021/jacs.8b05044; Boulton S, 2017, J BIOL CHEM, V292, P6414, DOI 10.1074/jbc.M116.773697; Boulton S, 2014, SCI REP-UK, V4, DOI 10.1038/srep07306; Brochet M, 2016, MOL MICROBIOL, V100, P397, DOI 10.1111/mmi.13324; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Collins CR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003344; COOK PF, 1982, BIOCHEMISTRY-US, V21, P5794, DOI 10.1021/bi00266a011; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; Darden T., 2016, AMBER 2016; Das R, 2009, J BIOL CHEM, V284, P23682, DOI 10.1074/jbc.M109.011700; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Deng WS, 2003, BIOCHEM J, V374, P559, DOI 10.1042/BJ20030474; Diaz CA, 2006, MOL BIOCHEM PARASIT, V146, P78, DOI 10.1016/j.molbiopara.2005.10.020; Doerig C, 2005, BBA-PROTEINS PROTEOM, V1754, P132, DOI 10.1016/j.bbapap.2005.08.027; Dolgova NV, 2017, BIOCHEMISTRY-US, V56, P3129, DOI 10.1021/acs.biochem.7b00293; El Bakkouri M, 2019, P NATL ACAD SCI USA, V116, P14164, DOI 10.1073/pnas.1905558116; Fairhurst RM, 2015, CURR OPIN INFECT DIS, V28, P417, DOI 10.1097/QCO.0000000000000199; Fayos R, 2003, J BIOL CHEM, V278, P18581, DOI 10.1074/jbc.M300866200; Franz E, 2018, ACS INFECT DIS, V4, P415, DOI 10.1021/acsinfecdis.7b00222; Frisch M. J., 2016, GAUSSIAN 16 REV C01; Goddard T., 2006, SPARKY NMR ASSIGNMEN; Govindasamy K, 2016, MOL MICROBIOL, V102, P349, DOI 10.1111/mmi.13466; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hopp CS, 2012, MICROBES INFECT, V14, P831, DOI 10.1016/j.micinf.2012.04.011; Huang GY, 2014, STRUCTURE, V22, P116, DOI 10.1016/j.str.2013.09.021; Huang JF, 2017, J CHEM INF MODEL, V57, P2273, DOI 10.1021/acs.jcim.7b00207; Kim JJ, 2016, STRUCTURE, V24, P710, DOI 10.1016/j.str.2016.03.009; Kim JJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004639; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Miller LH, 2013, NAT MED, V19, P156, DOI 10.1038/nm.3073; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Moon RW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000599; Moon TM, 2018, J BIOL CHEM, V293, P7916, DOI 10.1074/jbc.RA117.000647; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Rehmann H, 2008, NATURE, V455, P124, DOI 10.1038/nature07187; Riniker S, 2015, J CHEM INF MODEL, V55, P2562, DOI 10.1021/acs.jcim.5b00654; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Selvaratnam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048707; Selvaratnam R, 2012, BIOPHYS J, V102, P630, DOI 10.1016/j.bpj.2011.12.030; Selvaratnam R, 2011, P NATL ACAD SCI USA, V108, P6133, DOI 10.1073/pnas.1017311108; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taylor HM, 2010, EUKARYOT CELL, V9, P37, DOI 10.1128/EC.00186-09; VanSchouwen B, 2015, J BIOL CHEM, V290, P28631, DOI 10.1074/jbc.M115.685305; VanSchouwen B, 2011, J BIOL CHEM, V286, P42655, DOI 10.1074/jbc.M111.277723; WHO, 2019, WORLD MALARIA REPORT; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	54	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2020	295	25					8480	8491		10.1074/jbc.RA120.013070	http://dx.doi.org/10.1074/jbc.RA120.013070			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MH8QJ	32317283	hybrid, Green Published			2022-12-26	WOS:000546986500012
J	Krause, K; Jung, EM; Lindner, J; Hardiman, I; Poetschner, J; Madhavan, S; Matthaus, C; Kai, M; Menezes, RC; Popp, J; Svatos, A; Kothe, E				Krause, Katrin; Jung, Elke-Martina; Lindner, Julia; Hardiman, Imam; Poetschner, Jessica; Madhavan, Soumya; Matthaeus, Christian; Kai, Marco; Menezes, Riya Christina; Popp, Juergen; Svatos, Ales; Kothe, Erika			Response of the wood-decay fungus Schizophyllum commune to co-occurring microorganisms	PLOS ONE			English	Article							HYPHOLOMA-FASCICULARE; METABOLITES; MELANIN; IDENTIFICATION; MORPHOGENESIS; BIOSYNTHESIS; INDUCTION; PIGMENTS; STRAIN; MODEL	Microorganisms are constantly interacting in a given environment by a constant exchange of signaling molecules. In timber, wood-decay fungi will come into contact with other fungi and bacteria. In naturally bleached wood, dark, pigmented lines arising from confrontation of two fungi often hint at such interactions. The metabolites (and pigment) exchange was investigated using the lignicolous basidiomycete Schizophyllum commune, and co-occurring fungi and bacteria inoculated directly on sterilized wood, or on media. In interactions with competitive wood degrading fungi, yeasts or bacteria, different competition strategies and communication types were observed, and stress reactions, as well as competitor-induced enzymes or pigments were analyzed. Melanin, indole, flavonoids and carotenoids were shown to be induced in S. commune interactions. The induced genes included multi-copper oxidases lcc1, lcc2, mco1, mco2, mco3 and mco4, possibly involved in both pigment production and lignin degradation typical for wood bleaching by wood-decay fungi.	[Krause, Katrin; Jung, Elke-Martina; Lindner, Julia; Hardiman, Imam; Poetschner, Jessica; Madhavan, Soumya; Kothe, Erika] Friedrich Schiller Univ, Inst Microbiol, Jena, Germany; [Matthaeus, Christian; Popp, Juergen] Leibniz Inst Photon Technol, Jena, Germany; [Matthaeus, Christian; Popp, Juergen] Friedrich Schiller Univ, Inst Phys Chem, Jena, Germany; [Matthaeus, Christian; Popp, Juergen] Friedrich Schiller Univ, Abbe Ctr Photon, Jena, Germany; [Kai, Marco; Menezes, Riya Christina; Svatos, Ales] Max Planck Inst Chem Ecol, Res Grp Mass Spectrometry, Jena, Germany; [Kai, Marco] Univ Rostock, Inst Biol Sci, Rostock, Germany	Friedrich Schiller University of Jena; Leibniz Institut fur Photonische Technologien; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Max Planck Society; University of Rostock	Krause, K (corresponding author), Friedrich Schiller Univ, Inst Microbiol, Jena, Germany.	katrin.krause@uni-jena.de			German Research Foundation; CRC ChemBioSys; IMPRS-CE	German Research Foundation(German Research Foundation (DFG)); CRC ChemBioSys(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); IMPRS-CE	This research was supported by the German Research Foundation with Graduate School 214 (KK, SM), the CRC ChemBioSys (CM), the IMPRS-CE (MK, RCM).	Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Arun G, 2015, INDIAN J EXP BIOL, V53, P380; Avalos J, 2015, CURR GENET, V61, P309, DOI 10.1007/s00294-014-0454-x; Babitskaya VG, 2002, APPL BIOCHEM MICRO+, V38, P247, DOI 10.1023/A:1015471324658; Bashir A, 2014, MICROBIOL-SGM, V160, P2283, DOI 10.1099/mic.0.079665-0; Boddy L, 2000, FEMS MICROBIOL ECOL, V31, P185, DOI 10.1111/j.1574-6941.2000.tb00683.x; Boddy L, 2018, FUNGAL KINGDOM, P293, DOI 10.1128/microbiolspec.FUNK-0019-2016; Carrasco J, 2020, ENVIRON MICROBIOL, V22, P858, DOI 10.1111/1462-2920.14765; de Araujo HWC, 2010, MOLECULES, V15, P6931, DOI 10.3390/molecules15106931; Cox KD, 2006, BIOL CONTROL, V37, P291, DOI 10.1016/j.biocontrol.2006.01.012; DEJONG E, 1994, APPL ENVIRON MICROB, V60, P264, DOI 10.1128/AEM.60.1.264-270.1994; Dikin A, 2006, BIOTROP, V13, P111, DOI DOI 10.11598/btb.2006.13.2.221; Dunlap JC, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0039-2016; EPSTEIN E, 1967, PLANT PHYSIOL, V42, P911, DOI 10.1104/pp.42.7.911; Freihorst D, 2018, FUNGAL GENET BIOL, V112, P2, DOI 10.1016/j.fgb.2016.08.007; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Gray MJ, 2010, MOL MICROBIOL, V77, P1429, DOI 10.1111/j.1365-2958.2010.07294.x; Hynes J, 2007, J CHEM ECOL, V33, P43, DOI 10.1007/s10886-006-9209-6; Inbar J, 1996, SOIL BIOL BIOCHEM, V28, P757, DOI 10.1016/0038-0717(96)00010-7; Jousset A, 2006, APPL ENVIRON MICROB, V72, P7083, DOI 10.1128/AEM.00557-06; Kavitha A, 2011, ANN MICROBIOL, V61, P597, DOI 10.1007/s13213-010-0178-1; Kaysser L, 2010, J BIOL CHEM, V285, P12684, DOI 10.1074/jbc.M109.094490; KENNEDY IA, 1995, CAN J CHEM, V73, P1329, DOI 10.1139/v95-164; Kinoshita H, 2002, FEMS MICROBIOL LETT, V206, P247, DOI 10.1111/j.1574-6968.2002.tb11017.x; Knabe N, 2013, EUKARYOT CELL, V12, P941, DOI 10.1128/EC.00355-12; Krause K, 2015, APPL ENVIRON MICROB, V81, P7003, DOI 10.1128/AEM.01991-15; Kues U, 2011, CURR GENOMICS, V12, P72, DOI 10.2174/138920211795564377; Lev S, 2015, MBIO, V6, DOI 10.1128/mBio.00531-15; Madhavan S, 2014, MYCOL PROG, V13, P1199, DOI 10.1007/s11557-014-1009-8; Mapari SAS, 2010, TRENDS BIOTECHNOL, V28, P300, DOI 10.1016/j.tibtech.2010.03.004; Menezes RC, 2015, ANAL BIOANAL CHEM, V407, P2273, DOI 10.1007/s00216-014-8383-6; MICHELSON AM, 1951, P NATL ACAD SCI USA, V37, P396, DOI 10.1073/pnas.37.7.396; MILES PG, 1956, ARCH BIOCHEM BIOPHYS, V62, P1, DOI 10.1016/0003-9861(56)90081-9; Murry Reyna, 2019, Advances in Biological Regulation, V72, P78, DOI 10.1016/j.jbior.2019.01.001; Nobre LS, 2014, CURR MICROBIOL, V69, P164, DOI 10.1007/s00284-014-0567-y; Nutzmann HW, 2012, METHOD ENZYMOL, V517, P325, DOI 10.1016/B978-0-12-404634-4.00016-4; Ohm Robin A, 2010, Nat Biotechnol, V28, P957, DOI 10.1038/nbt.1643; Ong KC, 1997, GEN PHARMACOL-VASC S, V29, P121, DOI 10.1016/S0306-3623(96)00421-1; Patel D, 2013, MED CHEM RES, V22, P726, DOI 10.1007/s00044-012-0073-3; Pelkmans JF, 2016, MYCOTA, V1, P387; Pereira E, 2012, MYCORRHIZA, V22, P41, DOI 10.1007/s00572-011-0379-x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PHAE CG, 1990, SOIL SCI PLANT NUTR, V36, P575, DOI 10.1080/00380768.1990.10416794; Pisani F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085533; Pointing Stephen B., 1999, Fungal Diversity, V2, P17; Porter CL, 1924, AM J BOT, V11, P168, DOI 10.2307/2435538; RAPER JR, 1974, HDB GENETICS, V1, P597; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; RUSMIN S, 1978, PLANT PHYSIOL, V61, P538, DOI 10.1104/pp.61.4.538; Russell R, 2006, PHYTOCHEMISTRY, V67, P1985, DOI 10.1016/j.phytochem.2006.07.004; Sammer UF, 2009, APPL ENVIRON MICROB, V75, P7710, DOI 10.1128/AEM.01244-09; SCHWALB MV, 1967, MYCOLOGIA, V59, P610, DOI 10.2307/3757091; SKIDMORE AM, 1976, T BRIT MYCOL SOC, V66, P57, DOI 10.1016/S0007-1536(76)80092-7; Soden DM, 2001, MICROBIOL-SGM, V147, P1755, DOI 10.1099/00221287-147-7-1755; Tautenhahn R, 2012, NAT BIOTECHNOL, V30, P826, DOI 10.1038/nbt.2348; Tripathi AM, 2013, WORLD J MICROB BIOT, V29, P1431, DOI 10.1007/s11274-013-1306-4; Ujor VC, 2012, FUNGAL BIOL-UK, V116, P332, DOI 10.1016/j.funbio.2011.12.008; UMEZAWA H, 1975, J ANTIBIOT, V28, P947, DOI 10.7164/antibiotics.28.947; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Zhang GZ, 2013, INDIAN J MICROBIOL, V53, P175, DOI 10.1007/s12088-013-0362-7	62	14	14	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232145	10.1371/journal.pone.0232145	http://dx.doi.org/10.1371/journal.pone.0232145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324822	Green Published, Green Submitted, gold			2022-12-26	WOS:000536033700085
J	Angthong, C; Rajbhandari, P; Veljkovic, A; Piyaphanee, A; Stufkens, SAS; Wibowo, R				Angthong, Chayanin; Rajbhandari, Prasit; Veljkovic, Andrea; Piyaphanee, Atthaporn; Stufkens, Sjoerd Antoine Sebastian; Wibowo, Ricky			Morphometric geometric differences between right and left human tali: A cadaveric study of fluctuating asymmetry via systematic measurement and three-dimensional scanning	PLOS ONE			English	Article							TOTAL ANKLE REPLACEMENTS; BILATERAL ASYMMETRY; BONE; OUTCOMES; INSTABILITY; PROSTHESIS; IMPLANTS	Background Little is known about differences in the size and morphology of the right and left human tali. The present study demonstrates differences between right and left talar morphometric geometric profiles as fluctuating asymmetry in matched pairs of cadaveric specimens. Methods In total, 24 tali were collected in this study. All eligible tali were systematically measured with a Vernier caliper and three-dimensional laser scanner, which provided data for further analysis regarding the talar morphometric geometric profiles. Data were calculated to demonstrate differences between the right and left talar profiles using a matched-pair method, including the general size of the talus. Results The average talar length was 53.5 mm, the average talar dome height was 31.2 mm, and the average talar body width was 41.3 mm. The average anterior trochlear width, middle trochlear width, posterior trochlear width, and trochlear length were 31.8, 31.2, 28.3, and 30.7 mm, respectively. Eleven matched pairs of intact tali were eligible for the matched-pair study. Paired t-tests showed significant differences in the talar dome height (P = 0.019), middle trochlear width (P = 0.027), and posterior trochlear width (P = 0.016) between the right [and left tali. However, there were no significant differences in the surface area or volume between the right and left tali. Conclusion Significant differences in the morphometric profile were found between the right and left matched pairs of tali. This basic information indicates that the profile of the contralateral talus may not be used as a single reference to reconstruct or duplicate the talus of interest in certain conditions such as talar prosthesis implantation or customized total ankle replacement.	[Angthong, Chayanin] Thammasat Univ, Fac Med, Dept Orthopaed, Pathum Thani, Thailand; [Rajbhandari, Prasit] Manmohan Mem Med Coll & Teaching Hosp, Dept Orthopaed Surg, Kathmandu, Nepal; [Veljkovic, Andrea] Univ British Columbia, Foot & Ankle Reconstruct Arthroscopy & Athlet Inj, St Pauls Hosp, Dept Orthopaed,Footbridge Clin, Vancouver, BC, Canada; [Piyaphanee, Atthaporn] Phra Nangklao Hosp, Dept Orthopaed Surg, Nonthaburi, Thailand; [Stufkens, Sjoerd Antoine Sebastian] Univ Amsterdam, Acad Med Ctr, Dept Orthopaed Surg, Amsterdam, Netherlands; [Wibowo, Ricky] Padjajaran Univ, Dr Hasan Sadikin Hosp Bandung, Fac Med, Dept Orthopaed & Traumatol, Bandung, Indonesia	Thammasat University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; University of Amsterdam; Academic Medical Center Amsterdam; Universitas Padjadjaran	Angthong, C (corresponding author), Thammasat Univ, Fac Med, Dept Orthopaed, Pathum Thani, Thailand.	chatthara@yahoo.com		Angthong, Chayanin/0000-0002-1104-8945	Thammasat University [2/43/2561]	Thammasat University	Dr. Angthong reports grants from Thammasat University (grant number: 2/43/2561, year 2018), personal fees from Phoenix Surgical Equipment (Thailand) Co., Ltd, personal fees from Amgen, personal fees from THAI ADK ENGINEERING COMPANY LIMITED, during the conduct of the study; In addition, Dr. Angthong has a patent Manufacture protocol for the artificial total talus (Thailand patent number: 14879) issued.	Akiyama K, 2012, OSTEOARTHR CARTILAGE, V20, P296, DOI 10.1016/j.joca.2011.12.014; Angthong Chayanin, 2015, Journal of the Medical Association of Thailand, V98, pS131; Angthong C, 2014, ORTHOP REV, V6, P123, DOI 10.4081/or.2014.5486; Angthong C, 2013, FOOT ANKLE SURG, V19, P148, DOI 10.1016/j.fas.2013.04.005; Angthong C, 2013, KNEE SURG SPORT TR A, V21, P1418, DOI 10.1007/s00167-013-2364-8; Beasley DE, 2013, ECOL INDIC, V30, P218, DOI 10.1016/j.ecolind.2013.02.024; Brockett Claire L, 2016, Orthop Trauma, V30, P232; Buica G, 2013, TURK J ZOOL, V37, P723, DOI 10.3906/zoo-1302-19; Churchill SE, 1997, INT J OSTEOARCHAEOL, V7, P18, DOI 10.1002/(SICI)1099-1212(199701)7:1<18::AID-OA303>3.0.CO;2-R; Cracchiolo A, 2008, J AM ACAD ORTHOP SUR, V16, P530; Dekker TJ, 2018, FOOT ANKLE INT, V39, P916, DOI 10.1177/1071100718770133; Eun SS, 2012, CLIN ANAT, V25, P1087, DOI 10.1002/ca.22043; Fessy MH, 1997, SURG RADIOL ANAT, V19, P299, DOI 10.1007/BF01637597; Frost HM, 2004, ANGLE ORTHOD, V74, P3; Gursoy M, 2015, SURG RADIOL ANAT, V37, P955, DOI 10.1007/s00276-015-1428-5; Hallgrimsson B, 1999, INT J PRIMATOL, V20, P121, DOI 10.1023/A:1020540418554; Hsu AR, 2015, FOOT ANKLE INT, V36, P1163, DOI 10.1177/1071100715585561; Islam K, 2014, BONE JOINT RES, V3, P139, DOI 10.1302/2046-3758.35.2000264; Kadakia AR, 2017, FOOT ANKLE CLIN, V22, P545, DOI 10.1016/j.fcl.2017.04.010; KOBYLIANSKY E, 1989, ANN HUM BIOL, V16, P237, DOI 10.1080/03014468900000352; Kuo CC, 2014, CLIN ANAT, V27, P659, DOI 10.1002/ca.22296; LI J, 2015, J GEOSCIENCE ENV PRO, V3, P1; LIVSHITS G, 1989, ANN HUM BIOL, V16, P121, DOI 10.1080/03014468700006972; Shugaba AL, 2013, BAJOPAS, V6, P82; Stagni R, 2005, CLIN BIOMECH, V20, P307, DOI 10.1016/j.clinbiomech.2004.11.009; Taniguchi A, 2012, J BONE JOINT SURG BR, V94B, P1529, DOI 10.1302/0301-620X.94B11.29543; Taniguchi A, 2015, J BONE JOINT SURG AM, V97A, P1348, DOI 10.2106/JBJS.N.01272; Teo I, 2017, LYMPHOLOGY, V50, P197; TRINKAUS E, 1994, AM J PHYS ANTHROPOL, V93, P1, DOI 10.1002/ajpa.1330930102; VANVALEN L, 1962, EVOLUTION, V16, P125; Zaidi Z. F, 2011, AUSTR J BASIC APPL S, V5, P2157; Zhao DH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6087871	32	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0232012	10.1371/journal.pone.0232012	http://dx.doi.org/10.1371/journal.pone.0232012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320447	Green Published, gold			2022-12-26	WOS:000536028800050
J	Yamamoto-Furusho, JK; Mendieta-Escalante, EA				Yamamoto-Furusho, Jesus K.; Mendieta-Escalante, Erick A.			Diagnostic utility of the neutrophil-platelet ratio as a novel marker of activity in patients with Ulcerative Colitis	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; FECAL CALPROTECTIN; LYMPHOCYTE RATIO; BIOMARKERS; SEVERITY	Background Ulcerative colitis (UC) is a chronic disease characterized by periods of activity and remission. The platelet, one of the main activators of neutrophils, contains Interleukin 8 (IL-8), a potent neutrophil chemo-attractant and P-selectin that induces excretion of superoxide in the neutrophils, forming platelet-neutrophil aggregates that are increased in individuals with active UC, hence an index of both cells could produce a monitoring tool. No previous studies have evaluated this ratio in UC. Goal To evaluate the clinical utility of the Neutrophil-Platelet (NeuPla) ratio in patients with UC. Study A total of 158 patients with a diagnosis of UC. This index was based on the ratio between platelets and the neutrophil differential in blood count. The activity was classified using Mayo endoscopic sub-score, histological (Riley score) and for clinical was used the True-love-Witts, Montreal, Mayo and Yamamoto-Furusho scores. Results The correlation of the NeuPla ratio with activity scales were significant (P < 0.05). An optimal cut-off point to classify patients with clinical activity was 14.94 with a sensitivity 87.95% and specificity 63.5 and endoscopy activity with a cut-off 14.64 with a sensibility of 70.5% and specificity of 61.8%. Conclusions The NeuPla ratio showed an adequate diagnostic utility to identify UC patients with clinical and endoscopy activity without the use of invasive studies like a colonoscopy or expensive fecal biomarkers such as calprotectin and have a better diagnostic performance in comparison to other serum biomarkers (C reactive protein, erythrocyte sedimentation rate and albumin).	[Yamamoto-Furusho, Jesus K.; Mendieta-Escalante, Erick A.] Natl Inst Med Sci & Nutr Salvador Zubiran, Inflammatory Bowel Dis Clin, Dept Gastroenterol, Mexico City, DF, Mexico		Yamamoto-Furusho, JK (corresponding author), Natl Inst Med Sci & Nutr Salvador Zubiran, Inflammatory Bowel Dis Clin, Dept Gastroenterol, Mexico City, DF, Mexico.	kazuofurusho@hotmail.com	Yamamoto-Furusho, Jesus K./AAQ-4998-2020	Yamamoto-Furusho, Jesus K./0000-0002-5247-5812				Akpinar MY, 2018, J MED BIOCHEM, V37, P155, DOI 10.1515/jomb-2017-0050; Bennike T, 2014, WORLD J GASTROENTERO, V20, P3231, DOI 10.3748/wjg.v20.i12.3231; Celikbilek M, 2013, J CLIN LAB ANAL, V27, P72, DOI 10.1002/jcla.21564; Danese S, 2004, AM J GASTROENTEROL, V99, P938, DOI 10.1111/j.1572-0241.2004.04129.x; Geboes K, 2000, GUT, V47, P404, DOI 10.1136/gut.47.3.404; Gironella M, 2002, J LEUKOCYTE BIOL, V72, P56; Guardiola J, 2014, CLIN GASTROENTEROL H, V12, P1865, DOI 10.1016/j.cgh.2014.06.020; Hanai H, 2004, DIGEST DIS SCI, V49, P1438, DOI 10.1023/B:DDAS.0000042243.47279.87; Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001; Jin PP, 2019, J CLIN NEUROSCI, V63, P110, DOI 10.1016/j.jocn.2019.01.028; Marks DJB, 2006, LANCET, V367, P668, DOI 10.1016/S0140-6736(06)68265-2; Mercier J, 2018, J GASTROINTEST ONCOL, V9, P478, DOI 10.21037/jgo.2018.03.13; Mumolo MG, 2018, WORLD J GASTROENTERO, V24, P3681, DOI 10.3748/wjg.v24.i33.3681; Nishida Y, 2017, PLOS ONE, V12; Nishida Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213505; Pamuk GE, 2006, AM J HEMATOL, V81, P753, DOI 10.1002/ajh.20655; RILEY SA, 1991, GUT, V32, P174, DOI 10.1136/gut.32.2.174; Schroeder KW, 2010, NEW ENGL J MED, V317, P1625; Segal AW, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12983; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; THAYER WR, 1976, GASTROENTEROLOGY, V71, P379; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Voudoukis E, 2014, WORLD J GASTROENTERO, V20, P3180, DOI 10.3748/wjg.v20.i12.3180; Watt DG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142159; Yamamoto-Furusho JK, 2019, REV GASTROENTEROL ME; Yan SLS, 2013, INFLAMM BOWEL DIS, V19, P1245, DOI 10.1097/MIB.0b013e318281f3df	26	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231988	10.1371/journal.pone.0231988	http://dx.doi.org/10.1371/journal.pone.0231988			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315368	Green Published, gold			2022-12-26	WOS:000536024800068
J	Ball, S; Hand, N; Willman, F; Durrant, C; Uller, T; Claus, K; Mergeay, J; Bauwens, D; Garner, TWJ				Ball, Sarah; Hand, Nigel; Willman, Faye; Durrant, Christopher; Uller, Tobias; Claus, Katja; Mergeay, Joachim; Bauwens, Dirk; Garner, Trenton W. J.			Genetic and demographic vulnerability of adder populations: Results of a genetic study in mainland Britain	PLOS ONE			English	Article							SIZE N-E; VIPERA-BERUS; MULTIPLE PATERNITY; R-PACKAGE; INBREEDING DEPRESSION; REPRODUCTIVE SUCCESS; GENOTYPING ERRORS; COMPUTER-PROGRAM; SINGLE-SAMPLE; MATING SYSTEM	Genetic factors are often overlooked in conservation planning, despite their importance in small isolated populations. We used mitochondrial and microsatellite markers to investigate population genetics of the adder (Vipera berus) in southern Britain, where numbers are declining. We found no evidence for loss of heterozygosity in any of the populations studied. Genetic diversity was comparable across sites, in line with published levels for mainland Europe. However, further analysis revealed a striking level of relatedness. Genetic networks constructed from inferred first degree relationships suggested a high proportion of individuals to be related at a level equivalent to that of half-siblings, with rare inferred full-sib dyads. These patterns of relatedness can be attributed to the high philopatry and low vagility of adders, which creates high local relatedness, in combination with the polyandrous breeding system in the adder, which may offset the risk of inbreeding in closed populations. We suggest that reliance on standard genetic indicators of inbreeding and diversity may underestimate demographic and genetic factors that make adder populations vulnerable to extirpation. We stress the importance of an integrated genetic and demographic approach in the conservation of adders, and other taxa of similar ecology.	[Ball, Sarah; Willman, Faye; Durrant, Christopher; Garner, Trenton W. J.] Zool Soc London ZSL, Inst Zool, London, England; [Hand, Nigel] Cent Ecol, Ledbury, Hereford, England; [Durrant, Christopher] Royal Vet Coll, London, England; [Uller, Tobias] Univ Oxford, Dept Zool, Oxford, England; [Uller, Tobias] Lund Univ, Dept Biol, Lund, Sweden; [Claus, Katja; Bauwens, Dirk] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Mergeay, Joachim] Res Inst Nat & Forest INBO, Geraardsbergen, Belgium	University of London; University of London Royal Veterinary College; University of Oxford; Lund University; University of Antwerp; Research Institute for Nature & Forest	Ball, S (corresponding author), Zool Soc London ZSL, Inst Zool, London, England.	Sarah.Ball@ioz.ac.uk	; Mergeay, Joachim/E-7670-2011	Ball, Sarah/0000-0002-2003-0325; Mergeay, Joachim/0000-0002-6504-0551; Bauwens, Dirk/0000-0002-6638-4874; Durrant, Christopher/0000-0002-6233-9128	Natural England, an executive non-departmental public body [SAE03-02-390]; British Herpetological Society; Amphibian and Reptile Conservation Trust; Amphibian and Reptile Group UK	Natural England, an executive non-departmental public body; British Herpetological Society; Amphibian and Reptile Conservation Trust; Amphibian and Reptile Group UK	This study was funded by a grant to TWJG (ref SAE03-02-390) from Natural England, an executive non-departmental public body (https://www.gov.uk/government/organisations/natural-england) It also benefited from the financial support of the British Herpetological Society (https://thebhs.org), the Amphibian and Reptile Conservation Trust (https://www.arc-trust.org), and the Amphibian and Reptile Group UK (https://www.arguk.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamack AT, 2014, METHODS ECOL EVOL, V5, P384, DOI 10.1111/2041-210X.12158; Alvarez D, 2015, CONSERV GENET RESOUR, V7, P705, DOI 10.1007/s12686-015-0480-0; Amos W, 2001, HEREDITY, V87, P257, DOI 10.1046/j.1365-2540.2001.00940.x; Archer FI, 2017, MOL ECOL RESOUR, V17, P5, DOI 10.1111/1755-0998.12559; Arnold HR, 1995, I TERRESTRIAL ECOLOG, V10; Baker J, 2004, ENGLISH NATURE RES R; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bauwens D, 2019, PEERJ, V7, DOI 10.7717/peerj.6912; Bauwens D, 2018, ECOL EVOL, V8, P2985, DOI 10.1002/ece3.3917; BERGER J, 1990, CONSERV BIOL, V4, P91, DOI 10.1111/j.1523-1739.1990.tb00271.x; Bonnet X, 2016, BIOL CONSERV, V193, P1, DOI 10.1016/j.biocon.2015.11.001; Boukal DS, 2002, J THEOR BIOL, V218, P375, DOI 10.1006/jtbi.2002.3084; Brouwer L, 2011, MOL ECOL, V20, P4796, DOI 10.1111/j.1365-294X.2011.05325.x; Carlsson M, 2003, MOL ECOL NOTES, V3, P73, DOI 10.1046/j.1471-8286.2003.00354.x; Ceballos FC, 2018, NAT REV GENET, V19, P220, DOI 10.1038/nrg.2017.109; Clemann Nick, 2015, Pacific Conservation Biology, V21, P15, DOI 10.1071/PC14901; Cooke A.S., 1982, British Journal of Herpetology, V6, P206; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duthie AB, 2016, EVOLUTION, V70, P1927, DOI 10.1111/evo.13005; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham R, 2007, GENET RES, V89, P491, DOI 10.1017/S0016672308009695; Franklinos LHV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03352-1; Gardner E, 2019, HERPETOL J, V29, P57, DOI 10.33256/hj29.1.5770; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; Germano JM, 2015, FRONT ECOL ENVIRON, V13, P100, DOI 10.1890/140137; Gilpin M.E., 1986, P19; Gleed-Owen C, 2012, ADDER STATUS PROJECT; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Guichoux E, 2011, MOL ECOL RESOUR, V11, P591, DOI 10.1111/j.1755-0998.2011.03014.x; Hand N., 2018, AMPHIBIANS REPTILE S, V27; Hanski I, 2002, CONSERV BIOL, V16, P666, DOI 10.1046/j.1523-1739.2002.00342.x; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; HOGGREN M, 1995, COPEIA, P271; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Isailovic JC, 2009, IUCN RED LIST THREAT; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Janzen DH, 2001, ENCY BIODIVERSITY, DOI [10.1016/B978-0-12-384719-5.00085-X, DOI 10.1016/B978-0-12-384719-5.00085-X]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Jones S, 2012, STUD ENGL LANG, P20; Kalinowski ST, 2006, MOL ECOL NOTES, V6, P576, DOI 10.1111/j.1471-8286.2006.01256.x; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Kirin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013996; LANDE R, 1988, SCIENCE, V241, P1455, DOI 10.1126/science.3420403; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Legendre S, 1999, AM NAT, V153, P449, DOI 10.1086/303195; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; Madsen T, 1999, NATURE, V402, P34, DOI 10.1038/46941; MADSEN T, 1993, ANIM BEHAV, V45, P491, DOI 10.1006/anbe.1993.1060; Madsen T, 2004, BIOL CONSERV, V120, P145, DOI 10.1016/j.biocon.2004.01.022; Madsen T, 1996, BIOL CONSERV, V75, P113, DOI 10.1016/0006-3207(95)00067-4; MADSEN T, 1992, OECOLOGIA, V92, P40, DOI 10.1007/BF00317260; MANTEL N, 1967, CANCER RES, V27, P209; McLennan EA, 2019, MOL ECOL RESOUR, V19, P659, DOI 10.1111/1755-0998.12997; McQuillan R, 2008, AM J HUM GENET, V83, P359, DOI 10.1016/j.ajhg.2008.08.007; Menkhorst Peter, 2016, Pacific Conservation Biology, V22, P301; Metzger C, 2011, CONSERV GENET RESOUR, V3, P589, DOI 10.1007/s12686-011-9411-x; Miller HC, 2006, CONSERV GENET, V7, P1001, DOI 10.1007/s10592-006-9120-2; Mourier J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073899; Nash DJ, 2018, HERPETOL J, V28, P155; Natural England, MOV REPT MIT; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Palamara PF, 2012, AM J HUM GENET, V91, P809, DOI 10.1016/j.ajhg.2012.08.030; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Pew J, 2015, MOL ECOL RESOUR, V15, P557, DOI 10.1111/1755-0998.12323; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; PRESTT I, 1971, J ZOOL, V164, P373; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Ralls K, 2017, CONSERV LETT, V11, P1; Reading CJ, 2010, BIOL LETTERS, V6, P777, DOI 10.1098/rsbl.2010.0373; SHAFFER ML, 1981, BIOSCIENCE, V31, P131, DOI 10.2307/1308256; Sillero N, 2014, AMPHIBIA-REPTILIA, DOI [10.1163/15685381-00002940, DOI 10.1163/15685381-00002940]; SINNOTT RW, 1984, SKY TELESCOPE, V68, P62; STILLE B, 1986, OIKOS, V47, P173, DOI 10.2307/3566042; STOCKLEY P, 1993, P ROY SOC B-BIOL SCI, V254, P173, DOI 10.1098/rspb.1993.0143; Strange CJ, 2007, BIOSCIENCE, V57, P920, DOI 10.1641/B571103; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor HR, 2017, MOL ECOL, V26, P799, DOI 10.1111/mec.13977; Theodorou K, 2015, HEREDITY, V114, P38, DOI 10.1038/hdy.2014.63; Tingley R, 2016, BIOL CONSERV, V204, P1, DOI 10.1016/j.biocon.2016.07.021; Todd BD, 2017, BIOL CONSERV, V206, P31, DOI 10.1016/j.biocon.2016.12.013; Traill LW, 2010, BIOL CONSERV, V143, P28, DOI 10.1016/j.biocon.2009.09.001; Tregenza T, 2002, NATURE, V415, P71, DOI 10.1038/415071a; Ujvari B, 2002, BIOL CONSERV, V105, P127, DOI 10.1016/S0006-3207(01)00176-8; Ursenbacher S, 2006, MOL ECOL, V15, P3425, DOI 10.1111/j.1365-294X.2006.03031.x; Ursenbacher S, 2015, MOL ECOL, V24, P3639, DOI 10.1111/mec.13259; Ursenbacher S, 2009, J HERED, V100, P365, DOI 10.1093/jhered/esn104; Ursenbacher S, 2009, CONSERV GENET, V10, P303, DOI 10.1007/s10592-008-9580-7; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wang J, 2016, HEREDITY, V117, P193, DOI 10.1038/hdy.2016.43; Wang J., 2017, USERS GUIDE SOFTWARE; Wang JL, 2018, MOL ECOL RESOUR, V18, P41, DOI 10.1111/1755-0998.12708; Wang JL, 2017, MOL ECOL RESOUR, V17, P981, DOI 10.1111/1755-0998.12650; Wang JL, 2009, MOL ECOL, V18, P2148, DOI 10.1111/j.1365-294X.2009.04175.x; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weyer J, 2014, CAN J ZOOL, V92, P837, DOI 10.1139/cjz-2014-0025; Wilkinson JW, 2011, 1101 ARC; Wootton JT, 2013, ECOLOGY, V94, P2117, DOI 10.1890/12-1828.1; WRIGHT S, 1965, EVOLUTION, V19, P395, DOI 10.2307/2406450; Wright S, 1931, GENETICS, V16, P0097; Wusterbarth TL, 2010, HERPETOL CONSERV BIO, V5, P86	115	2	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231809	10.1371/journal.pone.0231809	http://dx.doi.org/10.1371/journal.pone.0231809			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310990	Green Published			2022-12-26	WOS:000536019800033
J	Coolman, AA; Niedbalski, A; Powell, DM; Kozlowski, CP; Franklin, AD; Deem, SL				Coolman, Audrey A.; Niedbalski, Amy; Powell, David M.; Kozlowski, Corinne P.; Franklin, Ashley D.; Deem, Sharon L.			Changes in human health parameters associated with an immersive exhibit experience at a zoological institution	PLOS ONE			English	Article							GREEN SPACE; NATURAL ENVIRONMENTS; SALIVARY CORTISOL; PHYSICAL-ACTIVITY; STRESS; RESPONSES	Zoological institutions often use immersive, naturalistic exhibits to create an inclusive atmosphere that is inviting for visitors while providing for the welfare of animals in their collections. In this study, we investigated physiological changes in salivary cortisol and blood pressure, as well as psychological changes among visitors before and after a walk through the River's Edge, an immersive, naturalistic exhibit at the Saint Louis Zoo. Study participants had a significant reduction in salivary cortisol and blood pressure after walking through the exhibit. Psychological assessments of mood found that most visitors felt happier, more energized, and less tense after the visit. Additionally, participants who spent more time in River's Edge, had visited River's Edge prior to the study, and had seen more exhibits at the Zoo prior to entering River's Edge experienced greater psychological and/or physiological benefits. We conclude that immersive, naturalistic exhibits in zoos can elicit positive changes in physiological and psychological measures of health and well-being and argue for a greater scientific focus on the role of zoos and other green spaces in human health.	[Coolman, Audrey A.; Deem, Sharon L.] St Louis Zoo, Inst Conservat Med, St Louis, MO 63110 USA; [Coolman, Audrey A.] Washington Univ, Brown Sch, St Louis, MO 63110 USA; [Niedbalski, Amy] St Louis Zoo, Conservat Audience Res & Evaluat, St Louis, MO USA; [Powell, David M.; Kozlowski, Corinne P.] St Louis Zoo, Dept Reprod & Behav Sci, St Louis, MO USA; [Franklin, Ashley D.] St Louis Zoo, Assoc Zoos & Aquariums Reprod Management Ctr, St Louis, MO USA	Washington University (WUSTL)	Deem, SL (corresponding author), St Louis Zoo, Inst Conservat Med, St Louis, MO 63110 USA.	deem@stlzoo.org	Franklin, Ashley D/J-3069-2015	Franklin, Ashley D/0000-0002-0818-5156				American Heart Association, 2018, MON YOUR BLOOD PRESS; Ashe D., 2018, DESK DAN ASHE; Beil K, 2013, INT J ENV RES PUB HE, V10, P1250, DOI 10.3390/ijerph10041250; Coon JT, 2011, ENVIRON SCI TECHNOL, V45, P1761, DOI 10.1021/es102947t; Cracknell D, 2016, ENVIRON BEHAV, V48, P1242, DOI 10.1177/0013916515597512; Cruess DG, 2000, J BEHAV MED, V23, P107, DOI 10.1023/A:1005419917023; Cummings D, 2007, ZOO BIOL, V26, P331, DOI 10.1002/zoo.20138; DAHAL R, 2014, EPIDEMIOLOGY, V4, pe115; Deem S.L., 2019, INTRO ONE HLTH INTER, P296; Deem S.L., 2015, FOWLERS ZOO WILD ANI, V8, P698; Duncan H. H., 1994, Activities, Adaptation & Aging, V19, P37, DOI 10.1300/J016v19n01_03; Farren L, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150027; Frumkin P, 2001, AM J PREV MED, V20, P234, DOI 10.1016/S0749-3797(00)00317-2; Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143; Hellhammer DH, 2009, PSYCHONEUROENDOCRINO, V34, P163, DOI 10.1016/j.psyneuen.2008.10.026; Heruti I, 2018, INJURY, V49, P1546, DOI 10.1016/j.injury.2018.06.022; Hucklebridge F, 2005, PSYCHONEUROENDOCRINO, V30, P51, DOI 10.1016/j.psyneuen.2004.04.007; Hutchins M., 2003, International Zoo Yearbook, V38, P130, DOI 10.1111/j.1748-1090.2003.tb02073.x; Hutchins Michael, 1995, International Zoo Yearbook, V34, P117, DOI 10.1111/j.1748-1090.1995.tb00669.x; Joye Y, 2011, URBAN FOR URBAN GREE, V10, P261, DOI 10.1016/j.ufug.2011.07.004; Knutsson U, 1997, J CLIN ENDOCR METAB, V82, P536, DOI 10.1210/jc.82.2.536; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kuo M, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01093, 10.3389/fpg.2015.01093]; Lynch JW, 2002, HORM BEHAV, V41, P275, DOI 10.1006/hbeh.2002.1772; Maas J, 2006, J EPIDEMIOL COMMUN H, V60, P587, DOI 10.1136/jech.2005.043125; MATTHEWS G, 1990, BRIT J PSYCHOL, V81, P17, DOI 10.1111/j.2044-8295.1990.tb02343.x; Mayo Clinic, 2018, GET MOST OUT HOM BLO; McEwen Bruce S, 2006, Dialogues Clin Neurosci, V8, P367; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; Meehan T.P., 2018, ONE HLTH RECOGNITION, P245; Miller LJ, 2018, ZOO BIOL, V37, P466, DOI 10.1002/zoo.21445; Mitchell R, 2013, SOC SCI MED, V91, P130, DOI 10.1016/j.socscimed.2012.04.012; Monroe SM, 2016, STRESS CONCEPTS COGN, P109, DOI [10.1016/B978-0-12-800951-2.00013-3, DOI 10.1016/B978-0-12-800951-2.00013-3]; Nakayama H, 2009, J MUSIC THER, V46, P160, DOI 10.1093/jmt/46.2.160; Padda H, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00022; Park Bum-Jin, 2007, Journal of Physiological Anthropology, V26, P123, DOI 10.2114/jpa2.26.123; Powell DM, 2014, ANTHROZOOS, V27, P389, DOI 10.2752/175303714X13903827488042; Purcell T, 2001, ENVIRON BEHAV, V33, P93, DOI 10.1177/00139160121972882; Purnell J., 2014, SAKE ALL MULTIDISCIP; Rainforth MV, 2007, CURR HYPERTENS REP, V9, P520, DOI 10.1007/s11906-007-0094-3; Redford J., 2018, SUMMER KINDERGARTEN; Robinette C, 2017, ONE HEALTH-AMSTERDAM, V3, P1, DOI 10.1016/j.onehlt.2016.11.003; Sahrmann JM, 2016, ZOO BIOL, V35, P4, DOI 10.1002/zoo.21257; Sakagami T, 2010, ANIM SCI J, V81, P129, DOI 10.1111/j.1740-0929.2009.00714.x; Salleh MR, 2008, MALAYS J MED SCI, V15, P9; Sandifer PA, 2015, ECOSYST SERV, V12, P1, DOI 10.1016/j.ecoser.2014.12.007; Sapolsky R. M, 2010, ENCY ANIMAL BEHAV, P350; Selye H, 1937, ENDOCRINOLOGY, V21, P169, DOI 10.1210/endo-21-2-169; Selye H, 1936, NATURE, V138, P32, DOI 10.1038/138032a0; Stanton MA, 2015, INT J PRIMATOL, V36, P473, DOI 10.1007/s10764-015-9836-2; Takahashi H, 2014, VALIDATION OMRON M6; Thompson CW, 2012, LANDSCAPE URBAN PLAN, V105, P221, DOI 10.1016/j.landurbplan.2011.12.015; Torpy Janet M, 2007, JAMA, V298, P360; Tyrvainen L, 2014, J ENVIRON PSYCHOL, V38, P1, DOI 10.1016/j.jenvp.2013.12.005; van den Berg AE, 2010, SOC SCI MED, V70, P1203, DOI 10.1016/j.socscimed.2010.01.002; West J, 2004, ANN BEHAV MED, V28, P114, DOI 10.1207/s15324796abm2802_6	56	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231383	10.1371/journal.pone.0231383	http://dx.doi.org/10.1371/journal.pone.0231383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9LH	32302324	gold, Green Published			2022-12-26	WOS:000536016100024
J	Molnar, J; Magyar, B; Schneider, G; Laczi, K; Valappil, SK; Kovacs, AL; Nagy, IK; Rakhely, G; Kovacs, T				Molnar, Janos; Magyar, Balazs; Schneider, Gyorgy; Laczi, Krisztian; Valappil, Sarshad K.; Kovacs, Arpad L.; Nagy, Ildiko K.; Rakhely, Gabor; Kovacs, Tamas			Identification of a novel archaea virus, detected in hydrocarbon polluted Hungarian and Canadian samples	PLOS ONE			English	Article							DIVERSITY; ALIGNMENT; EVOLUTION	Metagenomics is a helpful tool for the analysis of unculturable organisms and viruses. Viruses that target bacteria and archaea play important roles in the microbial diversity of various ecosystems. Here we show that Methanosarcina virus MV (MetMV), the second Methanosarcina sp. virus with a completely determined genome, is characteristic of hydrocarbon pollution in environmental (soil and water) samples. It was highly abundant in Hungarian hydrocarbon polluted samples and its genome was also present in the NCBI SRA database containing reads from hydrocarbon polluted samples collected in Canada, indicating the stability of its niche and the marker feature of this virus. MetMV, as the only currently identified marker virus for pollution in environmental samples, could contribute to the understanding of the complicated network of prokaryotes and their viruses driving the decomposition of environmental pollutants.	[Molnar, Janos; Kovacs, Arpad L.; Nagy, Ildiko K.; Kovacs, Tamas] Enviroinvest Corp, Nanophagetherapy Ctr, Dept Biotechnol, Pecs, Hungary; [Magyar, Balazs] Biocentrum Ltd, Gyongyosoroszi, Hungary; [Schneider, Gyorgy] Univ Pecs, Inst Med Microbiol & Immunol, Pecs, Hungary; [Laczi, Krisztian; Valappil, Sarshad K.; Rakhely, Gabor] Univ Szeged, Dept Biotechnol, Szeged, Hungary; [Rakhely, Gabor] Biol Res Ctr, Inst Biophys, Szeged, Hungary	University of Pecs; Szeged University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center	Kovacs, T (corresponding author), Enviroinvest Corp, Nanophagetherapy Ctr, Dept Biotechnol, Pecs, Hungary.	microbiology@kovacstamas.com	Laczi, Krisztián/L-8972-2018; Koderivalappil, Sarshad/ABA-6897-2021	Laczi, Krisztián/0000-0002-9399-7406; Koderivalappil, Sarshad/0000-0002-1627-1572; Kovacs, Tamas/0000-0001-6647-8136	Hungarian Government [KFI-16-1-2016-0150246, 2019-1.1.1-PIACIKFI-2019-00184];  [HU09-0044-A1-2013]	Hungarian Government; 	This work was funded by the Norway Grants (project: HU09-0044-A1-2013) and by the Hungarian Government (project: KFI-16-1-2016-0150246 and 2019-1.1.1-PIACIKFI-2019-00184). Enviroinvest Corp. and Biocentrum Ltd provided support in the form of salaries for authors J.M., A. L.K., I.K.N., T.K., B.M., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Braga LPP, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00006; Buan NR, 2018, EMERG TOP LIFE SCI, V2, P629, DOI 10.1042/ETLS20180031; Cairns J, 2017, MOL ECOL, V26, P1848, DOI 10.1111/mec.13950; Cardinale Daniel J, 2011, Bacteriophage, V1, P219; Czotter N, 2018, METHODS MOL BIOL, V1746, P115, DOI 10.1007/978-1-4939-7683-6_9; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Edwards R, 2019, BIORXIV; Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048; Enzmann F, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-017-0531-x; Erez Z, 2017, NATURE, V541, P488, DOI 10.1038/nature21049; Faust GG, 2014, BIOINFORMATICS, V30, P2503, DOI 10.1093/bioinformatics/btu314; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haramoto E, 2018, WATER RES, V135, P168, DOI 10.1016/j.watres.2018.02.004; Kachienga L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25961-0; Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116; Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002; Krupovic M, 2018, VIRUS RES, V244, P181, DOI 10.1016/j.virusres.2017.11.025; Krzmarzick MJ, 2018, ARCHAEA, V2018, DOI 10.1155/2018/3194108; Li H., 2013, PREPRINT, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang XL, 2019, SOIL BIOL BIOCHEM, V137, DOI 10.1016/j.soilbio.2019.107546; Liao YC, 2015, J MICROBIOL METH, V113, P72, DOI 10.1016/j.mimet.2015.04.006; Lopez-Perez M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007018; Louca S, 2017, ENVIRON MICROBIOL, V19, P3863, DOI 10.1111/1462-2920.13743; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Obeng N, 2016, TRENDS MICROBIOL, V24, P440, DOI 10.1016/j.tim.2015.12.009; Parmar K, 2018, CURR MICROBIOL, V75, P132, DOI 10.1007/s00284-017-1357-0; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rosario K, 2018, ENVIRON SCI TECHNOL, V52, P1014, DOI 10.1021/acs.est.7b04203; Roux S, 2017, PEERJ, V5, DOI 10.7717/peerj.3817; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sela-Adler M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00766; Touchon M, 2017, CURR OPIN MICROBIOL, V38, P66, DOI 10.1016/j.mib.2017.04.010; Voordouw G, 2009, ENVIRON SCI TECHNOL, V43, P9512, DOI 10.1021/es902211j; Weidenbach K, 2017, J VIROL, V91, DOI 10.1128/JVI.00955-17; Wells PS, 2011, P TAILINGS MINE WAST, P9; Zhang SF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00520	41	5	5	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231864	10.1371/journal.pone.0231864	http://dx.doi.org/10.1371/journal.pone.0231864			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302368	Green Published, Green Accepted, gold			2022-12-26	WOS:000536016100059
J	Zhao, JC; Wang, Z				Zhao, Jincai; Wang, Zheng			Future trends of water resources and influences on agriculture in China	PLOS ONE			English	Article							CLIMATE-CHANGE; REFERENCE EVAPOTRANSPIRATION; RIVER-BASIN; SPATIOTEMPORAL VARIABILITY; IMPACTS; EMISSIONS; WEST	Water resources are indispensable for all social-economic activities and ecosystem functions. In addition, changes in water resources have great significance for agricultural production. This paper uses five global climate models from CMIP5 to evaluate the future spatiotemporal variation in water resources in China under four RCP scenarios. The results show that the available precipitation significantly decreases due to evapotranspiration. Comparing the four RCP scenarios, the national average of the available precipitation is the highest under the RCP 2.6 and 4.5 scenarios, followed by that under the RCP 8.5 scenario. In terms of spatial distribution, the amount of available precipitation shows a decreasing trend from southeast to northwest. Regarding temporal changes, the available precipitation under RCP 8.5 exhibits a trend of first increasing and then decreasing, while the available precipitation under the RCP 6.0 scenario exhibits a trend of first decreasing and then increasing. Under the RCP 2.6 and 4.5 scenarios, the available precipitation increases, and the RCP 4.5 scenario has a higher rate of increase than that of RCP 2.6. In the context of climate change, changes in water resources and temperature cause widespread increases in potential agricultural productivity around Hu's line, especially in southwestern China. However, the potential agricultural productivity decreases in a large area of southeastern China. Hu's line has a partial breakthrough in the locking of agriculture, mainly in eastern Tibet, western Sichuan, northern Yunnan and northwestern Inner Mongolia. The results provide a reference for the management and deployment of future water resources and can aid in agricultural production in China.	[Zhao, Jincai] Henan Normal Univ, Sch Business, Xinxiang, Henan, Peoples R China; [Zhao, Jincai] Henan Univ, Minist Educ, Key Lab Geospatial Technol Middle & Lower Yellow, Kaifeng, Peoples R China; [Wang, Zheng] Henan Univ, Coll Environm & Planning, Kaifeng, Henan, Peoples R China; [Wang, Zheng] East China Normal Univ, Key Lab Geog Informat Sci, Minist Educ, Shanghai, Peoples R China	Henan Normal University; Henan University; Henan University; East China Normal University	Zhao, JC (corresponding author), Henan Normal Univ, Sch Business, Xinxiang, Henan, Peoples R China.; Zhao, JC (corresponding author), Henan Univ, Minist Educ, Key Lab Geospatial Technol Middle & Lower Yellow, Kaifeng, Peoples R China.	zhaojincai1989@163.com; wangzheng@casipm.ac.cn		Zhao, Jincai/0000-0001-7389-9043	National Key R&D Program of China [2016YFA0602703]; Open Fund of Key Laboratory of Geospatial Technology for the Middle and Lower Yellow River Regions (Henan University), Ministry of Education [GTYR201910]; Program of Postgraduate Education Innovation and Quality Improvement in Henan University [SYL19060114]	National Key R&D Program of China; Open Fund of Key Laboratory of Geospatial Technology for the Middle and Lower Yellow River Regions (Henan University), Ministry of Education; Program of Postgraduate Education Innovation and Quality Improvement in Henan University	This work was supported by the National Key R&D Program of China (Grant Number: 2016YFA0602703); Open Fund of Key Laboratory of Geospatial Technology for the Middle and Lower Yellow River Regions (Henan University), Ministry of Education (Grant Number: GTYR201910); Program of Postgraduate Education Innovation and Quality Improvement in Henan University (Grant Number: SYL19060114).	Arnell NW, 2004, GLOBAL ENVIRON CHANG, V14, P31, DOI 10.1016/j.gloenvcha.2003.10.006; Baldos ULC, 2014, AUST J AGR RESOUR EC, V58, P554, DOI 10.1111/1467-8489.12048; Barnett T, 2004, CLIMATIC CHANGE, V62, P1, DOI 10.1023/B:CLIM.0000013695.21726.b8; Budyko MI., 1974, CLIMATE LIFE; Chavas DR, 2009, AGR FOREST METEOROL, V149, P1118, DOI 10.1016/j.agrformet.2009.02.001; Chen YN, 2007, J ENVIRON SCI-CHINA, V19, P488, DOI 10.1016/S1001-0742(07)60082-5; Choudhury BJ, 1999, J HYDROL, V216, P99, DOI 10.1016/S0022-1694(98)00293-5; Davie J. C. S., 2013, EARTH SYST DYNAM DIS, V4, P279, DOI [10.5194/esdd4-2792013, DOI 10.5194/ESDD-4-279-2013]; [陈桂亚 CHEN Guiya], 2007, [长江科学院院报, Journal of Yangtze River Scientific Research Institute], V24, P14; Devkota LP, 2015, J HYDROL-REG STUD, V4, P502, DOI 10.1016/j.ejrh.2015.06.023; Ding YJ, 2007, CHINESE SCI EARTH SC, V37, P206; Fan ZX, 2013, CLIMATIC CHANGE, V116, P309, DOI 10.1007/s10584-012-0479-4; Feng Y, 2017, QUATERN INT, V441, P129, DOI 10.1016/j.quaint.2017.01.023; Fu B.P., 1981, SCI ATMOS SIN, V1, P23; Gao G, 2001, ADV ATMOS SCI, V18, P718; Gao ZD, 2017, AGR FOREST METEOROL, V232, P106, DOI 10.1016/j.agrformet.2016.08.006; [耿雷华 Geng Leihua], 2003, [自然资源学报, Journal of Natural Resources], V18, P267; Gornall J, 2010, PHILOS T R SOC B, V365, P2973, DOI 10.1098/rstb.2010.0158; Hao Lisheng, 2010, Journal of Hebei Normal University (Natural Science Edition), V34, P491; Hempel S, 2013, EARTH SYST DYNAM, V4, P219, DOI 10.5194/esd-4-219-2013; [胡实 Hu Shi], 2015, [干旱区地理, Arid Land Geography], V38, P239; Huang BW, 1985, GEOGRAPHIC SELECTION, P15; Kopytkovskiy M, 2015, J HYDROL-REG STUD, V3, P473, DOI 10.1016/j.ejrh.2015.02.014; Leng S.Y., 1992, J NATURAL RESOURCES, V7, P71; Li Y, 2018, YANGTZE RIVER, V49, P33; Li Z, 2010, SCI CHINA EARTH SCI, V53, P710, DOI 10.1007/s11430-009-0186-9; [李志 LI Zhi], 2009, [生态学报, Acta Ecologica Sinica], V29, P3456; Lobell DB, 2012, PLANT PHYSIOL, V160, P1686, DOI 10.1104/pp.112.208298; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lu HL, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10030827; Lu HL, 2014, APPL ENERG, V131, P297, DOI 10.1016/j.apenergy.2014.06.036; Miao CY, 2012, HYDROLOG SCI J, V57, P1355, DOI 10.1080/02626667.2012.718077; [莫兴国 Mo Xingguo], 2012, [气候变化研究进展, Progressus Inquisitiones de Mutatione Climatis], V8, P409; Mourato S, 2015, WATER RESOUR MANAG, V29, P2377, DOI 10.1007/s11269-015-0947-5; Ol'dekop, 1911, T METEOROL OBS U TAR, V4, P200; Piao SL, 2010, NATURE, V467, P43, DOI 10.1038/nature09364; Portmann FT, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024023; [任国玉 REN Guoyu], 2008, [水科学进展, Advances in Water Science], V19, P772; Rosenzweig C, 2014, P NATL ACAD SCI USA, V111, P3268, DOI 10.1073/pnas.1222463110; Schreiber P., 1904, Z METEOROL, V21, P441; Sun W, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/327067; Thomson AM, 2011, CLIMATIC CHANGE, V109, P77, DOI 10.1007/s10584-011-0151-4; Vicente-Serrano SM, 2015, J HYDROL, V526, P42, DOI 10.1016/j.jhydrol.2014.11.025; Wang SR, 2011, CLIM RES, V47, P77, DOI 10.3354/cr00965; Wang Z, 2018, YANGTZE RIVER, V49, P49; [吴绍洪 Wu Shaohong], 2017, [地理学报, Acta Geographica Sinica], V72, P3; Yuan B, 2012, CHINESE SCI BULL, V57, P3497, DOI 10.1007/s11434-012-5135-x; Zhang L, 2001, WATER RESOUR RES, V37, P701, DOI 10.1029/2000WR900325; [张蕾 Zhang Lei], 2016, [地理研究, Geographical Research], V35, P2238; Zhang Q, 2010, STOCH ENV RES RISK A, V24, P349, DOI 10.1007/s00477-009-0324-0; Zhang Y, 2001, SCI GEOGRAPHICA SINI, V21, P457; Zhang YY, 2015, J AGR, V5, P119; Zhao JC, 2020, INT J CLIMATOL, V40, P3813, DOI 10.1002/joc.6429; Zhao JC, 2019, APPL ENERG, V235, P612, DOI 10.1016/j.apenergy.2018.09.180; Zhao J, 2020, SCI TOTAL ENVIRON, V711, DOI 10.1016/j.scitotenv.2019.135189; [钟章奇 Zhong Zhangqi], 2015, [自然资源学报, Journal of Natural Resources], V30, P2018; 王铮, 2016, [中国科学. 地球科学, Scientia Sinica Terrae], V46, P1505; 李原园, 2014, [中国科学. 地球科学, Scientia Sinica Terrae], V44, P2030	58	8	8	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231671	10.1371/journal.pone.0231671	http://dx.doi.org/10.1371/journal.pone.0231671			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302331	gold, Green Published			2022-12-26	WOS:000536016100043
J	Poduval, D; Sichmanova, Z; Straume, AH; Lonning, PE; Knappskog, S				Poduval, Deepak; Sichmanova, Zuzana; Straume, Anne Hege; Lonning, Per Eystein; Knappskog, Stian			The novel microRNAs hsa-miR-nov7 and hsa-miR-nov3 are over-expressed in locally advanced breast cancer	PLOS ONE			English	Article							RNA; IDENTIFICATION; GENES; REGENERATION; METASTASIS; PREDICTION; PROGNOSIS; TARGETS; MIR-21	miRNAs are an important class of small non-coding RNAs, which play a versatile role in gene regulation at the post-transcriptional level. Expression of miRNAs is often deregulated in human cancers. We analyzed small RNA massive parallel sequencing data from 50 locally advanced breast cancers aiming to identify novel breast cancer related miRNAs. We successfully predicted 10 novel miRNAs, out of which 2 (hsa-miR-nov3 and hsa-miR-nov7) were recurrent. Applying high sensitivity qPCR, we detected these two microRNAs in 206 and 214 out of 223 patients in the study from which the initial cohort of 50 samples were drawn. We found hsa-miR-nov3 and hsa-miR-nov7 both to be overexpressed in tumor versus normal breast tissue in a separate set of 13 patients (p = 0.009 and p = 0.016, respectively) from whom both tumor tissue and normal tissue were available. We observed hsa-miR-nov3 to be expressed at higher levels in ER-positive compared to ER-negative tumors (p = 0.037). Further stratifications revealed particularly low levels in the her2-like and basal-like cancers compared to other subtypes (p = 0.009 and 0.040, respectively). We predicted target genes for the 2 microRNAs and identified inversely correlated genes in mRNA expression array data available from 203 out of the 223 patients. Applying the KEGG and GO annotations to target genes revealed pathways essential to cell development, communication and homeostasis. Although a weak association between high expression levels of hsa-miR-nov7 and poor survival was observed, this did not reach statistical significance. hsa-miR-nov3 expression levels had no impact on patient survival.	[Poduval, Deepak; Sichmanova, Zuzana; Straume, Anne Hege; Lonning, Per Eystein; Knappskog, Stian] Univ Bergen, Sect Oncol, Dept Clin Sci, Bergen, Norway; [Lonning, Per Eystein; Knappskog, Stian] Haukeland Hosp, Dept Oncol, Bergen, Norway; [Straume, Anne Hege] Norwegian Inst Marine Res, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; Institute of Marine Research - Norway	Knappskog, S (corresponding author), Univ Bergen, Sect Oncol, Dept Clin Sci, Bergen, Norway.; Knappskog, S (corresponding author), Haukeland Hosp, Dept Oncol, Bergen, Norway.	stian.knappskog@uib.no		Knappskog, Stian/0000-0002-4153-1655	Norwegian Cancer Society; Norwegian Research Council; Norwegian Health Region West; Trond Mohn Research Foundation	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Health Region West; Trond Mohn Research Foundation	This work was performed in the Mohn Cancer Research Laboratory. The project was funded by grants from the Trond Mohn Research Foundation, The Norwegian Cancer Society, The Norwegian Research Council and the Norwegian Health Region West.	Alexa A, TOPGO ENRICHMENT ANA; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Ambros V, 2003, CURR BIOL, V13, P807, DOI 10.1016/S0960-9822(03)00287-2; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Backes C, 2018, NUCLEIC ACIDS RES, V46, pD160, DOI 10.1093/nar/gkx851; Barbosa-Morais NL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp942; Beezhold KJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-134; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Chrisanthar R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019249; Chrisanthar R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003062; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Enright AJ, 2004, GENOME BIOL, V5; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Goh JN, 2016, BIOL REV, V91, P409, DOI 10.1111/brv.12176; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; GULLU G, 2015, CLIN SIGNIFICANCE MI, V38, P21, DOI DOI 10.1590/S1415-475738120140167; Hankey W, 2018, CANCER METAST REV, V37, P159, DOI 10.1007/s10555-017-9725-6; Harquail J, 2012, CANCER BIOMARK, V11, P269, DOI 10.3233/CBM-120291; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Isobe T, 2014, ELIFE, V3, DOI 10.7554/eLife.01977; John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kashyap D, 2020, LIFE SCI, V246, DOI 10.1016/j.lfs.2020.117417; Knappskog S, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3147; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Krishna S, 2013, NUCLEIC ACIDS RES, V41, P599, DOI 10.1093/nar/gks1020; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim EL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0568-y; Liu SH, 2018, J MOL CELL BIOL, V10, P302, DOI 10.1093/jmcb/mjy041; Lonning PE, 2007, ANN ONCOL, V18, P1293, DOI 10.1093/annonc/mdm013; Lonning PE, 2013, ONCOGENE, V32, P5315, DOI 10.1038/onc.2013.48; Lonning PE, 2009, J STEROID BIOCHEM, V117, P31, DOI 10.1016/j.jsbmb.2009.06.005; Mishra S, 2016, CRIT REV ONCOL HEMAT, V98, P12, DOI 10.1016/j.critrevonc.2015.10.003; Nassar FJ, 2017, PHARMACOL THERAPEUT, V172, P34, DOI 10.1016/j.pharmthera.2016.11.012; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rask L, 2011, APMIS, V119, P663, DOI 10.1111/j.1600-0463.2011.02782.x; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roy D, 2008, INT J MOL MED, V21, P627; Sasidharan V, 2013, RNA, V19, P1394, DOI 10.1261/rna.038653.113; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Tan ZY, 2016, ONCOTARGET, V7, P24076, DOI 10.18632/oncotarget.8119; Tashkandi Hossam, 2015, Oncoscience, V2, P924; Volinia S, 2012, P NATL ACAD SCI USA, V109, P3024, DOI 10.1073/pnas.1200010109; von Marschall Z, 2010, BIOCHEM BIOPH RES CO, V400, P299, DOI 10.1016/j.bbrc.2010.08.043; Wang XW, 2008, BIOINFORMATICS, V24, P325, DOI 10.1093/bioinformatics/btm595; Wang Y, 2011, ONCOGENE, V30, P1470, DOI 10.1038/onc.2010.531; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Wu JZ, 2014, GENET MOL RES, V13, P10097, DOI 10.4238/2014.December.4.4; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yates LR, 2017, CANCER CELL, V32, P169, DOI 10.1016/j.ccell.2017.07.005; Yates LR, 2015, NAT MED, V21, P751, DOI 10.1038/nm.3886	61	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0225357	10.1371/journal.pone.0225357	http://dx.doi.org/10.1371/journal.pone.0225357			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298266	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400002
J	Rolland, NCM; Markus, CR; Post, MJ				Rolland, Nathalie C. M.; Markus, C. Rob; Post, Mark J.			The effect of information content on acceptance of cultured meat in a tasting context	PLOS ONE			English	Article							CONSUMER ACCEPTANCE; FOOD; LIKING; TECHNOLOGY; EXPOSURE; WILLINGNESS; CHALLENGES; ATTITUDES; AUCTIONS	Cultured meat, in particular beef, is an emerging food technology potentially challenged by issues of consumer acceptance. To understand drivers of consumer acceptance as well as sensory perception of cultured meat, we investigated the effect of information content on participants' acceptance of cultured meat in a tasting context. Hundred ninety-three citizens from the Netherlands participated, divided across three age and sex-matched groups which each received information on either societal benefits, personal benefits or information on the quality and taste of cultured meat. They filled out a questionnaire and tasted two pieces of hamburger, labeled 'conventional' or 'cultured', although both pieces were in fact conventional. Sensory analysis of both hamburgers was performed. We observed that provision of information and the tasting experience increased acceptance of cultured meat and that information on personal benefits of cultured meat increased acceptance more than information on quality and taste but not than societal benefits of cultured meat. Previous awareness of cultured meat was the best predictor of its acceptance. In contrast to previous studies, sex and social economic status were not associated with different acceptance rates. Surprisingly, 58% of the respondents were willing to pay a premium for cultured meat of, on average, 37% above the price of regular meat. All participants tasted the 'cultured' hamburger and evaluated its taste to be better than the conventional one in spite of the absence of an objective difference. This is the first acceptance study of cultured meat where participants were offered to eat and evaluate meat that was labeled 'cultured'. We conclude that having positive information importantly improves acceptance and willingness to taste and that the specific content of the information is of subordinate importance. Awareness of cultured meat is the best predictor of acceptance.	[Rolland, Nathalie C. M.; Post, Mark J.] Maastricht Univ, Dept Physiol, Maastricht, Netherlands; [Rolland, Nathalie C. M.] Univ Bourgogne Franche Comte, Dept Nutr & Food Sci, AgriSup, Dijon, France; [Markus, C. Rob] Maastricht Univ, Dept Psychol, Maastricht, Netherlands; [Post, Mark J.] Mosa Meat BV, Maastricht, Netherlands	Maastricht University; Institut Agro; AgroSup Dijon; Maastricht University	Post, MJ (corresponding author), Maastricht Univ, Dept Physiol, Maastricht, Netherlands.; Post, MJ (corresponding author), Mosa Meat BV, Maastricht, Netherlands.	m.post@maastrichtuniversity.nl		Post, Mark/0000-0001-9312-2709	Stichting Wetenschappelijk Onderzoek Limburg	Stichting Wetenschappelijk Onderzoek Limburg	This study was funded by: MJP received an award from Stichting Wetenschappelijk Onderzoek Limburg. It has no grant number. URL: https://www.ufl-swol.nl. Zandbergen World's Finest Meats (Zoeterwoude, The Netherlands) provided the hamburgers. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvola A, 1999, APPETITE, V32, P113, DOI 10.1006/appe.1998.0181; Bekker GA, 2017, APPETITE, V108, P245, DOI 10.1016/j.appet.2016.10.002; BIRCH LL, 1982, APPETITE, V3, P353, DOI 10.1016/S0195-6663(82)80053-6; Bryant C, 2019, FRONT SUSTAIN FOOD S, V3, DOI 10.3389/fsufs.2019.00011; Bryant C, 2018, MEAT SCI, V143, P8, DOI 10.1016/j.meatsci.2018.04.008; CBS, 2020, CBS STATL 2019; Deliza R, 1996, J SENS STUD, V11, P103, DOI 10.1111/j.1745-459X.1996.tb00036.x; Flycatcher, 2017, DUTCH PEOPL WOULDNT; Fox JA, 2002, J RISK UNCERTAINTY, V24, P75, DOI 10.1023/A:1013229427237; Hocquette A, 2015, J INTEGR AGR, V14, P273, DOI 10.1016/S2095-3119(14)60886-8; Huffman WE, 2007, J ECON BEHAV ORGAN, V63, P193, DOI 10.1016/j.jebo.2005.04.019; Koster EP, 2003, FOOD QUAL PREFER, V14, P359, DOI 10.1016/S0950-3293(03)00017-X; Lusk JL, 2004, EUR REV AGRIC ECON, V31, P179, DOI 10.1093/erae/31.2.179; Lynn M., 1991, PSYCHOL MARK, V8, P43, DOI [10.1002/mar.4220080105, DOI 10.1002/MAR.4220080105]; Mancini MC, 2019, MEAT SCI, V150, P101, DOI 10.1016/j.meatsci.2018.12.014; Martins Y, 2005, APPETITE, V45, P214, DOI 10.1016/j.appet.2005.08.002; Megido RC, 2014, J SENS STUD, V29, P14, DOI 10.1111/joss.12077; PELCHAT ML, 1995, APPETITE, V24, P153, DOI 10.1016/S0195-6663(95)99373-8; PLINER P, 1982, APPETITE, V3, P283, DOI 10.1016/S0195-6663(82)80026-3; PLINER P, 1993, APPETITE, V20, P111, DOI 10.1006/appe.1993.1013; Post MJ, 2014, J SCI FOOD AGR, V94, P1039, DOI 10.1002/jsfa.6474; Post MJ, 2012, MEAT SCI, V92, P297, DOI 10.1016/j.meatsci.2012.04.008; Rousu M, 2007, ECON INQ, V45, P409, DOI 10.1111/j.1465-7295.2007.00017.x; ROZIN P, 1980, APPETITE, V1, P193, DOI 10.1016/S0195-6663(80)80027-4; Sherif M., 1961, SOCIAL JUDGMENT ASSI; Siegrist M, 2018, MEAT SCI, V139, P213, DOI 10.1016/j.meatsci.2018.02.007; Tan HSG, 2016, FOOD QUAL PREFER, V48, P293, DOI 10.1016/j.foodqual.2015.11.001; van der Weele Cor, 2013, Animals (Basel), V3, P647, DOI 10.3390/ani3030647; Van Wezemael L, 2012, MEAT SCI, V90, P444, DOI 10.1016/j.meatsci.2011.09.005; Verbeke W, 2015, J INTEGR AGR, V14, P285, DOI 10.1016/S2095-3119(14)60884-4; Wilks M, 2019, APPETITE, V136, P137, DOI 10.1016/j.appet.2019.01.027; Wilks M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171904; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848	33	36	36	8	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231176	10.1371/journal.pone.0231176	http://dx.doi.org/10.1371/journal.pone.0231176			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298291	Green Published, gold			2022-12-26	WOS:000536011400030
J	Si, H; Genna, B; Zhuang, XJ; Wang, J; Burenbatu, B; Feng, QY; Wang, HY				Si, Ha; Genna, Ba; Zhuang, Xiangjin; Wang, Jing; Burenbatu, B.; Feng, Qiyu; Wang, Hongyang			DaHuangWan targets EGF signaling to inhibit the proliferation of hepatoma cells	PLOS ONE			English	Article							COSTUNOLIDE INDUCES APOPTOSIS; CANCER CELLS; PATHWAY; ENDOCYTOSIS; ACTIVATION; LINE; ROS	DaHuangWan (DHW) is a traditional herbal medicine used by Mongolian to treat liver cancer for many years. Clinical application of the drug has been shown to help control tumor progression, prolong survival and improve quality of life. However, the underlying mechanisms and side effects of this drug remain unclear, which greatly limits the clinical application and further optimization of DHW. In this study, we found that DHW inhibits the proliferation of hepatoma cells by modulating the epithelial growth factor (EGF) signaling pathway. Berberine and Costunolide are the main active ingredients in DHW. Interestingly, the combination of Berberine and Costunolide has a dramatic synergistic effect on inhibiting the proliferation of hepatoma cells. Neither Berberine nor Costunolide directly block EGFR phosphorylation. Berberine promotes endocytosis of activated EGFR, while as Costunolide increases ubiquitination of EGFR and reduces EGFR recycling to cell membrane distribution, thereby inhibiting EGF signaling. Berberine and Costunolide target two different steps in regulating the EGF signaling, which explains the synergistic anti-cancer effect of DHW. Since Berberine and Costunolide do not directly target EGFR phosphorylation, DHW could be a supplementary medicine to tyrosine kinase inhibitors in cancer therapy.	[Si, Ha; Burenbatu, B.] Inner Mongolia Univ Nationalities, Affiliated Hosp, Tongliao, Inner Mongolia, Peoples R China; [Si, Ha; Genna, Ba] Inner Mongolia Univ Nationalities, Tongliao, Inner Mongolia, Peoples R China; [Si, Ha; Zhuang, Xiangjin; Wang, Jing; Feng, Qiyu; Wang, Hongyang] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp Inst, Natl Ctr Liver Canc, Shanghai, Peoples R China; [Wang, Jing] USTC, Affiliated Hosp 1, Canc Res Ctr, Div Life Sci & Med, Hefei, Anhui, Peoples R China	Inner Mongolia University for Nationalities; Inner Mongolia University for Nationalities; Naval Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Burenbatu, B (corresponding author), Inner Mongolia Univ Nationalities, Affiliated Hosp, Tongliao, Inner Mongolia, Peoples R China.; Feng, QY; Wang, HY (corresponding author), Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp Inst, Natl Ctr Liver Canc, Shanghai, Peoples R China.	brbt2013@163.com; qiyu@icloud.com; hywangk@vip.sina.com		Feng, qiyu/0000-0003-2715-0087; xiang jin, zhuang/0000-0002-9371-3143	Natural Science Foundation of Inner Mongolia [2018MS08038]; National Natural Science foundation of China (NSFC) [81773112]	Natural Science Foundation of Inner Mongolia; National Natural Science foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Natural Science Foundation of Inner Mongolia (NO. 2018MS08038, to HS) and National Natural Science foundation of China (NSFC, 81773112, to QF).	[Anonymous], 2015, PHARMACOPOEIAPEOPLES, P64; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Choi JY, 2009, MOLECULES, V14, P266, DOI 10.3390/molecules14010266; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Conte A, 2016, PROG MOL BIOL TRANSL, V141, P225, DOI 10.1016/bs.pmbts.2016.03.002; Conte A, 2017, METHODS MOL BIOL, V1652, P81, DOI 10.1007/978-1-4939-7219-7_5; Dong GZ, 2015, PHYTOTHER RES, V29, P680, DOI 10.1002/ptr.5299; HanZhiqiang HS, 2017, STUDY OPTIMUM EXTRAC, V24, P46; Hasson S S, 2018, Asian Pac J Cancer Prev, V19, P1917; Hou Q, 2011, CANCER SCI, V102, P1287, DOI 10.1111/j.1349-7006.2011.01933.x; Hou YL, 2017, BREAST CANCER-TARGET, V9, P429, DOI 10.2147/BCTT.S135665; Hua PY, 2016, J BIOCHEM MOL TOXIC, V30, P462, DOI 10.1002/jbt.21810; Hua PY, 2016, ONCOL LETT, V11, P2780, DOI 10.3892/ol.2016.4295; Jie SH, 2011, J GASTROEN HEPATOL, V26, P179, DOI 10.1111/j.1440-1746.2010.06389.x; Kim JH, 2011, BIOL PHARM BULL, V34, P580, DOI 10.1248/bpb.34.580; Lei CT, 2017, CELL PHYSIOL BIOCHEM, V42, P281, DOI 10.1159/000477329; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Llovet JM, 2015, NAT REV CLIN ONCOL, V12, P408, DOI [10.1038/nrclinonc.2015.103, 10.1038/nrclinonc.2015.121]; Miyamoto Y, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040752; Moon SM, 2013, PHARM BIOL, V51, P1372, DOI 10.3109/13880209.2013.792847; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Pinilla-Macua I, 2015, METHOD CELL BIOL, V130, P347, DOI 10.1016/bs.mcb.2015.05.008; Seo CS, 2015, MOL MED REP, V12, P7789, DOI 10.3892/mmr.2015.4342; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Singireesu SSNR, 2018, CELL BIOL TOXICOL, V34, P125, DOI 10.1007/s10565-017-9411-z; Tang J, 2009, J ETHNOPHARMACOL, V126, P5, DOI 10.1016/j.jep.2009.08.009; Tian X, 2017, MEDICINE, V96, P30; Wang N, 2010, INTEGR CANCER THER, V9, P354, DOI 10.1177/1534735410379121; Wang Z, 2016, CELL BIOL INT, V40, P289, DOI 10.1002/cbin.10564; Yang WJ, 2009, BIOL PHARM BULL, V32, P1021, DOI 10.1248/bpb.32.1021; Yang YI, 2011, GYNECOL ONCOL, V123, P588, DOI 10.1016/j.ygyno.2011.08.031; YOSHIKAWA M, 1993, CHEM PHARM BULL, V41, P214, DOI 10.1248/cpb.41.214	32	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231466	10.1371/journal.pone.0231466	http://dx.doi.org/10.1371/journal.pone.0231466			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298294	Green Submitted, gold, Green Published			2022-12-26	WOS:000536011400051
J	Kobayashi, A; Hirata, T; Nishikaze, T; Ninomiya, A; Maki, Y; Takada, Y; Kitamoto, T; Kinoshita, T				Kobayashi, Atsushi; Hirata, Tetsuya; Nishikaze, Takashi; Ninomiya, Akinori; Maki, Yuta; Takada, Yoko; Kitamoto, Tetsuyuki; Kinoshita, Taroh			alpha 2,3 linkage of sialic acid to a GPI anchor and an unpredicted GPI attachment site in human prion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycosylphosphatidylinositol (GPI); glycosylation; sialic acid; prion; MS; neurodegeneration; Creutzfeldt?Jakob disease; scrapie	MOLECULAR-WEIGHT ANTIGEN; TOXOPLASMA-GONDII; SCRAPIE; YEAST; PRP; GANGLIOSIDES; EXPRESSION; RESISTANT; MANNOSE; DISEASE	Prion diseases are transmissible, lethal neurodegenerative disorders caused by accumulation of the aggregated scrapie form of the prion protein (PrPSc) after conversion of the cellular prion protein (PrP(C)). The glycosylphosphatidylinositol (GPI) anchor of PrP(C) is involved in prion disease pathogenesis, and especially sialic acid in a GPI side chain reportedly affects PrP(C) conversion. Thus, it is important to define the location and structure of the GPI anchor in human PrP(C). Moreover, the sialic acid linkage type in the GPI side chain has not been determined for any GPI-anchored protein. Here we report GPI glycan structures of human PrP(C) isolated from human brains and from brains of a knock-in mouse model in which the mouse prion protein (Prnp) gene was replaced with the human PRNP gene. LC?electrospray ionization?MS analysis of human PrP(C) from both biological sources indicated that Gly(229) is the ? site in PrP(C) to which GPI is attached. Gly(229) in human PrP(C) does not correspond to Ser(231), the previously reported ? site of Syrian hamster PrP(C). We found that ?41% and 28% of GPI anchors in human PrP(C)s from human and knock-in mouse brains, respectively, have N-acetylneuraminic acid in the side chain. Using a sialic acid linkage-specific alkylamidation method to discriminate ?2,3 linkage from ?2,6 linkage, we found that N-acetylneuraminic acid in PrP(C)'s GPI side chain is linked to galactose through an ?2,3 linkage. In summary, we report the GPI glycan structure of human PrP(C), including the ?-site amino acid for GPI attachment and the sialic acid linkage type.	[Kobayashi, Atsushi] Hokkaido Univ, Fac Vet Med, Lab Comparat Pathol, Sapporo, Hokkaido, Japan; [Hirata, Tetsuya; Ninomiya, Akinori; Kinoshita, Taroh] Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan; [Hirata, Tetsuya; Takada, Yoko; Kinoshita, Taroh] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan; [Nishikaze, Takashi] Shimadzu Co Ltd, Koichi Tanaka Mass Spectrometry Res Lab, Kyoto, Japan; [Maki, Yuta] Osaka Univ, Grad Sch Sci, Dept Chem, Toyonaka, Osaka, Japan; [Kitamoto, Tetsuyuki] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Sendai, Miyagi, Japan; [Hirata, Tetsuya] Gifu Univ, Ctr Highly Adv Integrat Nano & Life Sci G CHAIN, Gifu, Japan	Hokkaido University; Osaka University; Osaka University; Shimadzu Corporation; Osaka University; Tohoku University; Gifu University	Kobayashi, A (corresponding author), Hokkaido Univ, Fac Vet Med, Lab Comparat Pathol, Sapporo, Hokkaido, Japan.; Kinoshita, T (corresponding author), Osaka Univ, Res Inst Microbial Dis, Suita, Osaka, Japan.; Kinoshita, T (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan.	kobayashi@vetmed.hokudai.ac.jp; tkinoshi@biken.osaka-u.ac.jp	勇太, 真木/AAT-9449-2020; Kinoshita, Taroh/C-7353-2009	Kajihara, Yasuhiro/0000-0002-6656-2394	Japan Society for the Promotion of Science; MEXT KAKENHI [JP16H04753, 17H06422]; The Kato Memorial Trust for Nambyo Research; Japan Society for the Promotion of Science KAKENHI [18K05963]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); The Kato Memorial Trust for Nambyo Research; Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science and MEXT KAKENHI grants JP16H04753 and 17H06422 (to T. Kinoshita), a grant from The Kato Memorial Trust for Nambyo Research (to A. K.), and Japan Society for the Promotion of Science KAKENHI Grant 18K05963 (to A. K.).	Aguzzit A, 2016, TRENDS CELL BIOL, V26, P40, DOI 10.1016/j.tcb.2015.08.007; Amado M, 1998, J BIOL CHEM, V273, P12770, DOI 10.1074/jbc.273.21.12770; Asano M, 2006, BIOCHEM BIOPH RES CO, V342, P293, DOI 10.1016/j.bbrc.2006.01.149; Bate C, 2016, J BIOL CHEM, V291, P160, DOI 10.1074/jbc.M115.672394; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056; Ferguson M. A. J., 2015, ESSENTIALS GLYCOBIOL, P137; Fujita M, 2011, J CELL BIOL, V194, P61, DOI 10.1083/jcb.201012074; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Hanamatsu H, 2018, ANAL CHEM, V90, P13193, DOI 10.1021/acs.analchem.8b02775; Hirata T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02799-0; Hizume M, 2010, BIOCHEM BIOPH RES CO, V391, P1681, DOI 10.1016/j.bbrc.2009.12.128; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; Hong YJ, 1999, J BIOL CHEM, V274, P35099, DOI 10.1074/jbc.274.49.35099; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; KITAMOTO T, 1993, BIOCHEM BIOPH RES CO, V191, P709, DOI 10.1006/bbrc.1993.1275; Maeda Y, 2007, MOL BIOL CELL, V18, P1497, DOI 10.1091/mbc.E06-10-0885; McNally KL, 2009, J VIROL, V83, P4469, DOI 10.1128/JVI.02412-08; Miyagawa-Yamaguchi A, 2015, GLYCOCONJUGATE J, V32, P531, DOI 10.1007/s10719-015-9595-5; Miyazaki H, 1997, J BIOL CHEM, V272, P24794, DOI 10.1074/jbc.272.40.24794; Nishikaze T, 2017, ANAL CHEM, V89, P2353, DOI 10.1021/acs.analchem.6b04150; Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069; Pierleoni A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-392; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0; Puig B, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007520; Rangel A, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-8; Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020; Shiina T, 2000, IMMUNOGENETICS, V51, P75, DOI 10.1007/s002510050012; STAHL N, 1992, BIOCHEMISTRY-US, V31, P5043, DOI 10.1021/bi00136a600; STAHL N, 1990, BIOCHEMISTRY-US, V29, P8879, DOI 10.1021/bi00490a001; Striepen B, 1997, J MOL BIOL, V266, P797, DOI 10.1006/jmbi.1996.0806; SVENNERHOLM L, 1989, BIOCHIM BIOPHYS ACTA, V1005, P109, DOI 10.1016/0005-2760(89)90175-6; Tanaka S, 2004, J BIOL CHEM, V279, P14256, DOI 10.1074/jbc.M313755200; Taron BW, 2004, J BIOL CHEM, V279, P36083, DOI 10.1074/jbc.M405081200; Tashima Y, 2006, MOL BIOL CELL, V17, P1410, DOI 10.1091/mbc.E05-11-1005; TOMAVO S, 1994, PARASITOLOGY, V108, P139, DOI 10.1017/S0031182000068220; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang YC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14678-2; Wang YC, 2019, J BIOL CHEM, V294, P5038, DOI 10.1074/jbc.RA119.007472	44	6	6	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7789	7798		10.1074/jbc.RA120.013444	http://dx.doi.org/10.1074/jbc.RA120.013444			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32321762	hybrid, Green Published			2022-12-26	WOS:000538038900018
J	Shi, W; Ye, B; Rame, M; Wang, YJ; Cioca, D; Reibel, S; Peng, JZ; Qi, SJ; Vitale, N; Luo, HY; Wu, JP				Shi, Wei; Ye, Bei; Rame, Marion; Wang, Yujia; Cioca, Dominique; Reibel, Sophie; Peng, Junzheng; Qi, Shijie; Vitale, Nicolas; Luo, Hongyu; Wu, Jiangping			The receptor tyrosine kinase EPHB6 regulates catecholamine exocytosis in adrenal gland chromaffin cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						catecholamine; adrenal; actin; receptor tyrosine kinase; exocytosis; adrenal gland chromaffin cell; EPHB6; F-actin	F-ACTIN; PLASMA-CATECHOLAMINES; BLOOD-PRESSURE; HYPERTENSION; CONTRACTILITY; ACTIVATION; SECRETION; PROTEIN; RAT; ASSOCIATION	The erythropoietin-producing human hepatocellular receptor EPH receptor B6 (EPHB6) is a receptor tyrosine kinase that has been shown previously to control catecholamine synthesis in the adrenal gland chromaffin cells (AGCCs) in a testosterone-dependent fashion. EPHB6 also has a role in regulating blood pressure, but several facets of this regulation remain unclear. Using amperometry recordings, we now found that catecholamine secretion by AGCCs is compromised in the absence of EPHB6. AGCCs from male knockout (KO) mice displayed reduced cortical F-actin disassembly, accompanied by decreased catecholamine secretion through exocytosis. This phenotype was not observed in AGCCs from female KO mice, suggesting that testosterone, but not estrogen, contributes to this phenotype. Of note, reverse signaling from EPHB6 to ephrin B1 (EFNB1) and a 7-amino acid-long segment in the EFNB1 intracellular tail were essential for the regulation of catecholamine secretion. Further downstream, the Ras homolog family member A (RHOA) and FYN proto-oncogene Src family tyrosine kinase (FYN)?proto-oncogene c-ABL?microtubule-associated monooxygenase calponin and LIM domain containing 1 (MICAL-1) pathways mediated the signaling from EFNB1 to the defective F-actin disassembly. We discuss the implications of EPHB6's effect on catecholamine exocytosis and secretion for blood pressure regulation.	[Shi, Wei; Ye, Bei; Peng, Junzheng; Qi, Shijie; Luo, Hongyu; Wu, Jiangping] Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ, Canada; [Ye, Bei; Wang, Yujia] Zhejiang Univ, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Rame, Marion; Vitale, Nicolas] CNRS, Inst Neurosci Cellulaires & Integrat, UPR 3212, Strasbourg, France; [Rame, Marion; Vitale, Nicolas] Univ Strasbourg, Strasbourg, France; [Cioca, Dominique; Reibel, Sophie] Chronobiotron UMS 3415, Strasbourg, France; [Wu, Jiangping] CHUM, Dept Nephrol, Montreal, PQ, Canada	Universite de Montreal; Zhejiang University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montreal	Luo, HY; Wu, JP (corresponding author), Ctr Hosp Univ Montreal CRCHUM, Res Ctr, Montreal, PQ, Canada.; Vitale, N (corresponding author), CNRS, Inst Neurosci Cellulaires & Integrat, UPR 3212, Strasbourg, France.; Vitale, N (corresponding author), Univ Strasbourg, Strasbourg, France.; Wu, JP (corresponding author), CHUM, Dept Nephrol, Montreal, PQ, Canada.	jianping.wu@umontreal.ca; hongyu.luo@umontreal.ca; vitalen@inci-cnrs.unistra.fr	Vitale, Nicolas/G-5967-2014	Vitale, Nicolas/0000-0002-4752-4907	Fonds de recherche du Quebec-Sante; J.-Louis Levesque Foundation; Canadian Institutes of Health Research Grant [MOP272014]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-04790]; Agence Nationale de la Recherche grant; Fondation pour la Recherche Medicale [DEI20151234424]; National Natural Science Foundation of China [81700363]	Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); J.-Louis Levesque Foundation; Canadian Institutes of Health Research Grant(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Agence Nationale de la Recherche grant(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Fonds de recherche du Quebec-Sante and the J.-Louis Levesque Foundation (to J. W.), Canadian Institutes of Health Research Grant MOP272014 (to J. W.) Natural Sciences and Engineering Research Council of Canada Grant RGPIN-2017-04790 (to J. W.) and a Agence Nationale de la Recherche grant (to N. V.) and Fondation pour la Recherche Medicale grant DEI20151234424 (to N. V.), and National Natural Science Foundation of China Grant 81700363 (to Y. W.).	[Anonymous], 1997, Cell, V90, P403; AXELROD J, 1976, CLIN SCI MOL MED, V51, pS415, DOI 10.1042/cs051415s; Bader MF, 2004, BBA-MOL CELL RES, V1742, P37, DOI 10.1016/j.bbamcr.2004.09.028; Borkowski K R, 1984, J Hypertens Suppl, V2, pS81; Brantley-Sieders Dana M., 2004, Angiogenesis, V7, P17, DOI 10.1023/B:AGEN.0000037340.33788.87; BUHLER FR, 1982, J CARDIOVASC PHARM, V4, pS1; Byrne CJ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00343; Cho HJ, 2018, ONCOGENE, V37, P861, DOI 10.1038/onc.2017.386; Corssmit EPM, 1996, J CLIN ENDOCR METAB, V81, P3265, DOI 10.1210/jc.81.9.3265; Couchonnal LF, 2008, PHYSIOLOGY, V23, P151, DOI 10.1152/physiol.00043.2007; De Miguel C, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0507-z; DOMINIAK P, 1982, BRIT J CLIN PHARMACO, V13, pS381, DOI 10.1111/j.1365-2125.1982.tb01945.x; DOUGLAS WW, 1961, J PHYSIOL-LONDON, V159, P40, DOI 10.1113/jphysiol.1961.sp006791; Dravis C, 2007, HEARING RES, V223, P93, DOI 10.1016/j.heares.2006.10.007; Esler M, 2008, ANN NY ACAD SCI, V1148, P338, DOI 10.1196/annals.1410.064; Flanagan JG, 1998, ANNU REV NEUROSCI, V21, P309, DOI 10.1146/annurev.neuro.21.1.309; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; Gasman S, 2003, CELL SIGNAL, V15, P893, DOI 10.1016/S0898-6568(03)00052-4; Gasman S, 1997, J BIOL CHEM, V272, P20564, DOI 10.1074/jbc.272.33.20564; Geneste O, 2002, J CELL BIOL, V157, P831, DOI 10.1083/jcb.200203126; Ginnan R, 2013, J BIOL CHEM, V288, P29703, DOI 10.1074/jbc.M113.477257; GOLDSTEIN DS, 1983, CIRCULATION, V68, P234, DOI 10.1161/01.CIR.68.2.234; Gong LW, 2007, NAT CELL BIOL, V9, P915, DOI 10.1038/ncb1617; Gutierrez LM, 2018, PFLUG ARCH EUR J PHY, V470, P181, DOI 10.1007/s00424-017-2040-9; Han DH, 2008, J SEX MED, V5, P822, DOI 10.1111/j.1743-6109.2007.00732.x; Han Y, 2015, J NEUROCHEM, V133, P617, DOI 10.1111/jnc.13061; Hashimoto T, 2007, KIDNEY INT, V72, P954, DOI 10.1038/sj.ki.5002454; HAYCOCK JW, 1982, J BIOL CHEM, V257, P2641; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Hu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1778, DOI 10.1002/art.39116; Hung RJ, 2011, SCIENCE, V334, P1710, DOI 10.1126/science.1211956; Hung RJ, 2010, NATURE, V463, P823, DOI 10.1038/nature08724; Jablonskis L T, 1994, Blood Press, V3, P106, DOI 10.3109/08037059409101529; Kannan H, 1996, AM J PHYSIOL-REG I, V270, pR479, DOI 10.1152/ajpregu.1996.270.2.R479; Kohno S, 2011, CELL BIOL INT, V35, P325, DOI 10.1042/CBI20090344; Kolski-Andreaco Aaron, 2007, J Vis Exp, P129, DOI 10.3791/129; Konstantinova I, 2007, CELL, V129, P359, DOI 10.1016/j.cell.2007.02.044; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Luo HY, 2016, NEUROBIOL DIS, V91, P292, DOI 10.1016/j.nbd.2016.03.013; Luo HY, 2012, J BIOL CHEM, V287, P6819, DOI 10.1074/jbc.M111.293365; Luo HY, 2004, J CLIN INVEST, V114, P1762, DOI 10.1172/JCI200421846; Marjoram RJ, 2014, CURR MOL MED, V14, P199, DOI 10.2174/1566524014666140128104541; Martinez-Espinosa PL, 2014, J GEN PHYSIOL, V144, P275, DOI 10.1085/jgp.201411253; Mathar I, 2010, J CLIN INVEST, V120, P3267, DOI 10.1172/JCI41348; Menezes A, 1996, J NEUROCHEM, V67, P2316; Mosharov EV, 2005, NAT METHODS, V2, P651, DOI 10.1038/nmeth782; Niggli V, 2008, INT J BIOCHEM CELL B, V40, P344, DOI 10.1016/j.biocel.2007.02.012; O'Neill AK, 2016, J CELL BIOL, V215, P217, DOI 10.1083/jcb.201604097; Okamoto K, 2009, PHYSIOLOGY, V24, P357, DOI 10.1152/physiol.00029.2009; Ory S, 2013, J NEUROSCI, V33, P3545, DOI 10.1523/JNEUROSCI.3654-12.2013; Palmer A, 2002, MOL CELL, V9, P725, DOI 10.1016/S1097-2765(02)00488-4; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; PENDE A, 1990, J BIOL REG HOMEOS AG, V4, P67; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Poea-Guyon S, 2013, J CELL BIOL, V203, P283, DOI 10.1083/jcb.201303104; RIVIER C, 1989, ENDOCRINOLOGY, V125, P3096, DOI 10.1210/endo-125-6-3096; Sala F, 2008, ACTA PHYSIOL, V192, P203, DOI 10.1111/j.1748-1716.2007.01804.x; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Shi W, 2019, J BIOL CHEM, V294, P6871, DOI 10.1074/jbc.RA118.005767; SOLARO CR, 1995, J NEUROSCI, V15, P6110; Sparrenberger F, 2009, J HUM HYPERTENS, V23, P12, DOI 10.1038/jhh.2008.74; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Tanaka M, 2003, EMBO J, V22, P847, DOI 10.1093/emboj/cdg088; Tanaka M, 2010, CANCER SCI, V101, P87, DOI 10.1111/j.1349-7006.2009.01352.x; TOMLINSON A, 1987, NEUROSCIENCE, V20, P895, DOI 10.1016/0306-4522(87)90250-8; Tremblay J, 2017, SCI REP-UK, V7, DOI 10.1038/srep44114; Trifaro JM, 2008, ACTA PHYSIOL, V192, P165, DOI 10.1111/j.1748-1716.2007.01808.x; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; VOLLMER RR, 1992, AM J PHYSIOL, V263, pR716, DOI 10.1152/ajpregu.1992.263.3.R716; Wang YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19215-2; Wang YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep38976; Wang YJ, 2016, EUR J HUM GENET, V24, P1817, DOI 10.1038/ejhg.2016.105; Wang YJ, 2016, AM J PHYSIOL-HEART C, V310, pH861, DOI 10.1152/ajpheart.00873.2015; Wang YJ, 2015, J BIOL CHEM, V290, P14235, DOI 10.1074/jbc.M114.621615; Wu Jiangping, 2005, Curr Opin Hematol, V12, P292, DOI 10.1097/01.moh.0000166497.26397.9f; Wu T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32836-x; Wu ZH, 2012, J BIOL CHEM, V287, P15557, DOI 10.1074/jbc.M112.340869; Yoon J, 2017, DEV CELL, V42, P117, DOI 10.1016/j.devcel.2017.06.007; Zhang ZQ, 2019, J HYPERTENS, V37, P775, DOI 10.1097/HJH.0000000000001948; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012	80	2	2	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7653	7668		10.1074/jbc.RA120.013251	http://dx.doi.org/10.1074/jbc.RA120.013251			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32321761	hybrid, Green Published			2022-12-26	WOS:000538038900008
J	Jenni, L; Ganz, K; Milanesi, P; Winkler, R				Jenni, Lukas; Ganz, Kathrin; Milanesi, Pietro; Winkler, Raffael			Determinants and constraints of feather growth	PLOS ONE			English	Article							R PACKAGE; MOLT; FLIGHT; BIRDS; SIZE; MASS; EVOLUTION; STIFFNESS; BEHAVIOR	During the periodic moult of the plumage of birds, a fast regrowth of feathers would shorten the time of reduced plumage functionality. However, it has long been known that feather growth-rate is limited and that long feathers take disproportionally longer to grow than small feathers, which has severe consequences on moult duration and the completeness of moult in large birds. The reasons for the limitations of feather-growth must be related to the size and/or functions of the feather follicle, but are largely unknown. Here we measured the size of the feather follicle (taking calamus width as a proxy) and related it to parameters of feather growth (feather growth-rate by mass and by length) and feather structure (feather length, mass, massiveness [mass of feather material per mm feather-length]). We used three independent datasets which allowed for interspecific analyses, and for intraspecific comparisons of differently structured feathers within the framework of biological scaling. We found that the cross-sectional area of the calamus (as a proxy of feather follicle size) was directly proportional to feather growth-rate by mass. Hence, factors acting at a two-dimensional scale (possibly nutrient supply to the growing feather) determines feather growth rate by mass, rather than the linear arrangement of stem cells (in a circular configuration) as had previously been assumed. Feather follicle size was correlated with both feather length and massiveness, hence it seems to be adapted to some extent to feather structure. Feather growth-rate by length was dependent on both the feather material produced per unit time (growth-rate by mass) and the amount of material deposited per unit feather-length. Follicle size not only determines feather growth-rate by mass, but also directly the structural design (shape, number of barbs, etc.) of a feather. Therefore, feather growth-rate is severely constrained by the requirements imposed by the structural feather design.	[Jenni, Lukas; Ganz, Kathrin; Milanesi, Pietro] Swiss Ornithol Inst, Sempach, Switzerland; [Winkler, Raffael] Nat Hist Museum Basel, Basel, Switzerland	Swiss Ornithological Institute	Jenni, L (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	lukas.jenni@vogelwarte.ch	Milanesi, Pietro/AAW-4309-2021	Milanesi, Pietro/0000-0002-1878-9762; Jenni, Lukas/0000-0003-4198-3501				Alibardi L, 2008, PROG HISTOCHEM CYTO, V43, P1, DOI 10.1016/j.proghi.2008.01.001; Baader E, 1982, VERGLEICHENDE UNTERS; Bridge Eli S., 2006, Marine Ornithology, V34, P7; Burckhardt D., 1954, Revue Suisse de Zoologie, V61, P551; Chen CF, 2015, ANNU REV ANIM BIOSCI, V3, P169, DOI 10.1146/annurev-animal-022513-114127; Dawson A, 2005, IBIS, V147, P283, DOI 10.1111/j.1474-919x.2005.00400.x; Dawson A, 2003, IBIS, V145, pE69, DOI 10.1046/j.1474-919X.2003.00161.x; de la Hera I, 2012, AUK, V129, P222, DOI 10.1525/auk.2012.11212; DURRER HEINZ, 1965, REV SUISSE ZOOL, V72, P263; Ganz K, 2018, J ORNITHOL, V159, P771, DOI 10.1007/s10336-018-1547-y; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Grubb T. C., 2006, PTILOCHRONOLOGY FEAT; Harris MP, 2005, P NATL ACAD SCI USA, V102, P11734, DOI 10.1073/pnas.0500781102; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Langston NE, 1996, OIKOS, V76, P498, DOI 10.2307/3546343; Legendre P., 2012, NUMERICAL ECOLOGY; Legendre P, 2011, PACKAGE LMODEL2 R LI; LENTON GM, 1984, IBIS, V126, P551, DOI 10.1111/j.1474-919X.1984.tb02080.x; Lucas A., 1972, AVIAN ANATOMY INTEGU; MURPHY ME, 1986, CAN J ZOOL, V64, P1292, DOI 10.1139/z86-192; NEWTON I, 1967, BIRD STUDY, V14, P10, DOI 10.1080/00063656709476142; Pap PL, 2015, FUNCT ECOL, V29, P746, DOI 10.1111/1365-2435.12419; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Portmann A., 1963, Verhandlungen der Naturforschenden Gesellschaft in Basel, V74, P106; PREVOST Y, 1983, ARDEA, V71, P199; Prum RO, 1999, J EXP ZOOL, V285, P291; Prum RO, 2001, J EXP ZOOL, V291, P30, DOI 10.1002/jez.4; Rayner J.M.V., 1988, Current Ornithology, V5, P1; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Riddle O, 1907, BIOL BULL-US, V12, P165, DOI 10.2307/1535865; Rohwer S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000132; Rohwer VG, 2013, AUK, V130, P699, DOI 10.1525/auk.2013.13042; Schmidt-Nielsen K., 1984, SCALING WHY IS ANIMA; SEEL DC, 1976, IBIS, V118, P491; Serra L., 2006, ACTA ZOOL SINICA, V52, P451; Sutter E., 1971, Ornithologische Beobachter, V68, P179; Viain A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107929; Videler JJ., 2005, AVIAN FLIGHT; Wang X, 2012, J EVOLUTION BIOL, V25, P547, DOI 10.1111/j.1420-9101.2011.02449.x; Wang X, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1935; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; WATSON GE, 1963, SCIENCE, V139, P50, DOI 10.1126/science.139.3549.50; Widelitz RB, 2007, SEMIN CELL DEV BIOL, V18, P255, DOI 10.1016/j.semcdb.2007.02.005; Winkler R., 1985, Ornithologische Beobachter, V82, P55; Worcester SE, 1996, J ZOOL, V239, P609, DOI 10.1111/j.1469-7998.1996.tb05947.x; Yue ZC, 2005, NATURE, V438, P1026, DOI 10.1038/nature04222	46	8	8	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231925	10.1371/journal.pone.0231925	http://dx.doi.org/10.1371/journal.pone.0231925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330170	Green Published, Green Submitted, gold			2022-12-26	WOS:000536647300030
J	Okonkwo, UA; Chen, L; Ma, D; Haywood, VA; Barakat, M; Urao, N; Dipietro, LA				Okonkwo, Uzoagu A.; Chen, Lin; Ma, Da; Haywood, Veronica A.; Barakat, May; Urao, Norifumi; Dipietro, Luisa A.			Compromised angiogenesis and vascular Integrity in impaired diabetic wound healing	PLOS ONE			English	Article							PERICYTE RECRUITMENT; FOOT ULCER; SKIN; DB/DB; PDGF; PATHOPHYSIOLOGY; ENDOTHELIUM; FIBROBLAST; ACTIVATION; EXPRESSION	Vascular deficits are a fundamental contributing factor of diabetes-associated diseases. Although previous studies have demonstrated that the pro-angiogenic phase of wound healing is blunted in diabetes, a comprehensive understanding of the mechanisms that regulate skin revascularization and capillary stabilization in diabetic wounds is lacking. Using a mouse model of diabetic wound healing, we performed microCT analysis of the 3-dimensional architecture of the capillary bed. As compared to wild type, vessel surface area, branch junction number, total vessel length, and total branch number were significantly decreased in wounds of diabetic mice as compared to WT mice. Diabetic mouse wounds also had significantly increased capillary permeability and decreased pericyte coverage of capillaries. Diabetic wounds exhibited significant perturbations in the expression of factors that affect vascular regrowth, maturation and stability. Specifically, the expression of VEGF-A, Sprouty2, PEDF, LRP6, Thrombospondin 1, CXCL10, CXCR3, PDGFR-beta, HB-EGF, EGFR, TGF-beta 1, Semaphorin3a, Neuropilin 1, angiopoietin 2, NG2, and RGS5 were down-regulated in diabetic wounds. Together, these studies provide novel information about the complexity of the perturbation of angiogenesis in diabetic wounds. Targeting factors responsible for wound resolution and vascular pruning, as well those that affect pericyte recruitment, maturation, and stability may have the potential to improve diabetic skin wound healing.	[Okonkwo, Uzoagu A.; Chen, Lin; Haywood, Veronica A.; Barakat, May; Dipietro, Luisa A.] Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA; [Ma, Da] SunYat sen Univ, Guanghua Sch Stomatol, Stomatol Hosp, Guangdong Prov Key Lab Stomatol, Guangzhou, Guangdong, Peoples R China; [Urao, Norifumi] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Sun Yat Sen University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Dipietro, LA (corresponding author), Univ Illinois, Ctr Wound Healing & Tissue Regenerat, Chicago, IL 60607 USA.	Ldipiet@uic.edu	Chen, Lin/AAW-8207-2020; Barakat, May/AAW-9015-2020	Chen, Lin/0000-0001-8530-2363; Barakat, May/0000-0002-3132-461X; DiPietro, Luisa Ann/0000-0002-4842-1547	National Institutes of Health [R01-GM-50875, T32DE018381-06]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (https://www.nih.gov) Grant R01-GM-50875 (to LAD) and National Institutes of Health Grant T32DE018381-06 (VAH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agah A, 2002, AM J PATHOL, V161, P831, DOI 10.1016/S0002-9440(10)64243-5; Alavi A, 2014, J AM ACAD DERMATOL, V70, DOI 10.1016/j.jaad.2013.06.055; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bakker K, 2000, DIABETES-METAB RES, V16, pS1, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR138>3.0.CO;2-B; Beer HD, 1997, J INVEST DERMATOL, V109, P132, DOI 10.1111/1523-1747.ep12319188; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Birbrair A, 2015, CLIN SCI, V128, P81, DOI 10.1042/CS20140278; Bodnar RJ, 2016, WOUND REPAIR REGEN, V24, P204, DOI 10.1111/wrr.12415; Bodnar RJ, 2009, J CELL SCI, V122, P2064, DOI 10.1242/jcs.048793; Caporali A, 2017, PHARMACOL THERAPEUT, V171, P56, DOI 10.1016/j.pharmthera.2016.10.001; Centers for Disease Control and Prevention (CDC), 2017, NAT DIAB STAT REP 20; Chen L, 2012, J DENT RES, V91, P871, DOI 10.1177/0022034512454435; Chen L, 2013, J INVEST DERMATOL, V133, P258, DOI 10.1038/jid.2012.267; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P349, DOI 10.1097/01.ASW.0000418541.31366.a3; Dinh T, 2005, CURR PHARM DESIGN, V11, P2301, DOI 10.2174/1381612054367328; Dulmovits BM, 2012, INT J BIOCHEM CELL B, V44, P1800, DOI 10.1016/j.biocel.2012.06.031; Falcon BL, 2009, AM J PATHOL, V175, P2159, DOI 10.2353/ajpath.2009.090391; Geevarghese A, 2014, TRANSL RES, V163, P296, DOI 10.1016/j.trsl.2014.01.011; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; GREENHALGH DG, 1990, AM J PATHOL, V136, P1235; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Jeffcoate WJ, 2003, LANCET, V361, P1545, DOI 10.1016/S0140-6736(03)13169-8; Lim HS, 2005, ATHEROSCLEROSIS, V180, P113, DOI 10.1016/j.atherosclerosis.2004.11.004; Loughna S, 2001, MATRIX BIOL, V20, P319, DOI 10.1016/S0945-053X(01)00149-4; Ma ZJ, 2017, INT J MOL MED, V40, P1415, DOI 10.3892/ijmm.2017.3131; Maione F, 2009, MOL BIOL MED, V119; Martins-Mendes D, 2014, J DIABETES COMPLICAT, V28, P632, DOI 10.1016/j.jdiacomp.2014.04.011; Michalczyk ER, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29465-9; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; Nissen NN, 1998, AM J PATHOL, V152, P1445; Noor S, 2015, DIABETES METAB SYND, V9, P192, DOI 10.1016/j.dsx.2015.04.007; Okonkwo UA, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071419; Park SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104447; Park SA, 2014, WOUND REPAIR REGEN, V22, P368, DOI 10.1111/wrr.12172; Prompers L, 2008, DIABETOLOGIA, V51, P747, DOI 10.1007/s00125-008-0940-0; Rajkumar VS, 2006, AM J PATHOL, V169, P2254, DOI 10.2353/ajpath.2006.060196; Simsek S, 2010, MEDIATORS INFLAMM, V2010; Stratman AN, 2010, BLOOD, V116, P4720, DOI 10.1182/blood-2010-05-286872; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; UALCMBZYDLA Okonkwo, 2017, VASCULAR MATURITY IN; Urao N, 2016, MICROVASC RES, V106, P57, DOI 10.1016/j.mvr.2016.03.006; Wang JM, 2014, ARTERIOSCL THROM VAS, V34, P99, DOI 10.1161/ATVBAHA.113.302104; Wietecha MS, 2015, AM J PHYSIOL-HEART C, V309, pH812, DOI 10.1152/ajpheart.00153.2015; Wietecha MS, 2013, CURR TOP MICROBIOL, V367, P3, DOI 10.1007/82_2012_287; Wietecha MS, 2011, AM J PHYSIOL-HEART C, V300, pH459, DOI 10.1152/ajpheart.00244.2010; Wu SC, 2007, VASC HEALTH RISK MAN, V3, P65; YEN TTT, 1970, P SOC EXP BIOL MED, V133, P307	48	44	45	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231962	10.1371/journal.pone.0231962	http://dx.doi.org/10.1371/journal.pone.0231962			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324828	Green Published, gold, Green Submitted			2022-12-26	WOS:000536033700051
J	Orindi, BO; Maina, BW; Muuo, SW; Birdthistle, I; Carter, DJ; Floyd, S; Ziraba, A				Orindi, Benedict O.; Maina, Beatrice W.; Muuo, Sheru W.; Birdthistle, Isolde; Carter, Daniel J.; Floyd, Sian; Ziraba, Abdhalah			Experiences of violence among adolescent girls and young women in Nairobi's informal settlements prior to scale-up of the DREAMS Partnership: Prevalence, severity and predictors	PLOS ONE			English	Article							GENDER-BASED VIOLENCE; SOUTH-AFRICA; RISK; HIV; VICTIMIZATION; URBAN; PREVENTION; EXPOSURE; BOTSWANA; POVERTY	Introduction We sought to estimate the prevalence, severity and identify predictors of violence among adolescent girls and young women (AGYW) in informal settlement areas of Nairobi, Kenya, selected for DREAMS (Determined Resilient Empowered AIDS-free, Mentored and Safe) investment. Methods Data were collected from 1687 AGYW aged 10-14 years (n = 606) and 15-22 years (n = 1081), randomly selected from a general population census in Korogocho and Viwandani in 2017, as part of an impact evaluation of the "DREAMS" Partnership. For 10-14 year-olds, we measured violence experienced either in the past 6 months or ever using a different set of questions from those used for 15-22 year-olds. Among 15-22 year-olds we measured prevalence of violence, experienced in the past 12 months, using World Health Organization (WHO) definitions for violence typologies. Predictors of violence were identified using multivariable logit models. Results Among 606 girls aged 10-14 years, about 54% and 7% ever experienced psychological and sexual violence, respectively. About 33%, 16% and 5% experienced psychological, physical and sexual violence in the past 6 months. The 10-14 year old girls who engaged in chores or activities for payment in the past 6 months, or whose family did not have enough food due to lack of money were at a greater risk for violence. Invitation to DREAMS and being a non-Christian were protective. Among 1081 AGYW aged 15-22 years, psychological violence was the most prevalent in the past year (33.1%), followed by physical violence (22.9%), and sexual violence (15.8%). About 7% experienced all three types of violence. Severe physical violence was more prevalent (13.8%) than moderate physical violence (9.2%). Among AGYW aged 15-22 years, being previously married/lived with partner, engaging in employment last month, food insecure were all risk factors for psychological violence. For physical violence, living in Viwandani and being a Muslim were protective; while being previously married or lived with a partner, or sleeping hungry at night during the past 4 weeks were risk factors. The odds of sexual violence were lower among AGYW aged 18-22 years and among Muslims. Engaging in sex and food insecurity increased chances for sexual violence. Conclusions Prevalence of recent violence among AGYW is high in this population. This calls for increased effort geared towards addressing drivers of violence as an early entry point of HIV prevention effort in this vulnerable group.	[Orindi, Benedict O.] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya; [Orindi, Benedict O.; Maina, Beatrice W.; Ziraba, Abdhalah] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Orindi, Benedict O.] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven Biostat & Stat Bioinformat Ctr, Leuven, Belgium; [Muuo, Sheru W.] Univ Calif San Francisco UCSF, Global Programs Res & Training, Nairobi, Kenya; [Birdthistle, Isolde; Carter, Daniel J.; Floyd, Sian] London Sch Hyg & Trop Med, London, England	Kenya Medical Research Institute; African Population & Health Research Centre; KU Leuven; University of London; London School of Hygiene & Tropical Medicine	Orindi, BO (corresponding author), Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya.; Orindi, BO (corresponding author), African Populat & Hlth Res Ctr, Nairobi, Kenya.; Orindi, BO (corresponding author), Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Leuven Biostat & Stat Bioinformat Ctr, Leuven, Belgium.	benedict.orindi@gmail.com		Ziraba, Abdhalah/0000-0002-3417-6536; Maina, Beatrice/0000-0001-6205-3296; Orindi, Benedict/0000-0002-4601-7890	Bill and Melinda Gates Foundation [OPP1136774]; MRC [MR/R010161/1] Funding Source: UKRI	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The impact evaluation of DREAMS is funded by the Bill and Melinda Gates Foundation (Grant No. OPP1136774; PI: IB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 2010, ANAL ORDINAL CATEGOR, DOI [DOI 10.1002/9780470594001, 10.1002/9780470594001]; Antai DE, 2008, RURAL REMOTE HEALTH, V8; BANDURA A, 1978, J COMMUN, V28, P12, DOI 10.1111/j.1460-2466.1978.tb01621.x; Baumgartner JN, 2009, INT PERSPECT SEX R H, V35, P21, DOI 10.1363/ifpp.35.021.09; Beguy D, 2015, INT J EPIDEMIOL, V44, P462, DOI 10.1093/ije/dyu251; Birdthistle I, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5789-7; Bonomi AE, 2014, VIOLENCE AGAINST WOM, V20, P42, DOI 10.1177/1077801213520580; Brownridge DA, 2006, AGGRESS VIOLENT BEH, V11, P514, DOI 10.1016/j.avb.2006.01.009; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Conroy AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213365; Ribeiro MRC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115382, 10.1371/journal.pone.0114130]; Cunradi CB, 2000, ANN EPIDEMIOL, V10, P297, DOI 10.1016/S1047-2797(00)00052-1; Dekeseredy Walter S., 2009, DANGEROUS EXITS ESCA; Dubow EF, 2016, J CRIM JUST, V45, P26, DOI 10.1016/j.jcrimjus.2016.02.005; Ellison CG, 2007, VIOLENCE AGAINST WOM, V13, P1094, DOI 10.1177/1077801207308259; Fawole OI, 2008, TRAUMA VIOLENCE ABUS, V9, P167, DOI 10.1177/1524838008319255; Fawole Olufunmilayo I, 2005, Afr J Reprod Health, V9, P54; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Francisco L, 2013, VIOLENCE AGAINST WOM, V19, P814, DOI 10.1177/1077801213497557; Gaillard P, 2002, AIDS, V16, P937, DOI 10.1097/00002030-200204120-00019; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Heinze JE, 2017, J APPL DEV PSYCHOL, V49, P31, DOI 10.1016/j.appdev.2017.01.005; Heise L, 2015, GREENTREE 2 VIOLENCE; Kabiru CW, 2018, INT J ADOLESC YOUTH, V23, P281, DOI 10.1080/02673843.2017.1345769; Kenya National Bureau of Statistics, 2015, KEN DEM HLTH SURV 20; Logan TK, 2004, J INTERPERS VIOLENCE, V19, P1478, DOI 10.1177/0886260504269699; Madise NJ, 2012, HEALTH PLACE, V18, P1144, DOI 10.1016/j.healthplace.2012.04.003; Mathur S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203929; McAra L, 2016, J CRIM JUST, V45, P71, DOI 10.1016/j.jcrimjus.2016.02.011; Miller CL, 2011, AIDS BEHAV, V15, P1512, DOI 10.1007/s10461-010-9693-0; Nybergh L, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002053; Nybergh L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-002055; Plichta SB, 2001, WOMEN HEALTH ISS, V11, P244, DOI 10.1016/S1049-3867(01)00085-8; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Rennison CM, 2013, VIOLENCE AGAINST WOM, V19, P1312, DOI 10.1177/1077801213514487; RESNICK MD, 2004, J HLTH EC, V0035; Saul J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208167; Schraiber LB, 2010, REV SAUDE PUBL, V44, P658, DOI 10.1590/S0034-89102010000400009; Sherr L, 2016, INT HEALTH, V8, P36, DOI 10.1093/inthealth/ihv070; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Swart E, 2012, J SOC SERV RES, V38, P427, DOI 10.1080/01488376.2012.676022; Tsai AC, 2011, AM J PUBLIC HEALTH, V101, P1068, DOI 10.2105/AJPH.2010.300060; UNICEF, 2007, STAT WORLDS CHILDR 2; UNICEF Kenya National Center for Injury Prevention and Control U.S. Centers for Disease Control and Prevention Kenya National Bureau of Statistics, 2012, VIOL CHILDR KEN FIND; VANDERSTRATEN A, 1995, AIDS, V9, P935, DOI 10.1097/00002030-199508000-00016; Vezina J, 2007, TRAUMA VIOLENCE ABUS, V8, P33, DOI 10.1177/1524838006297029; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; WHO, 2014, HLTH WORLDS AD 2 CHA; WHO, 2005, WHO MULTICOUNTRY STU; World Health Organization, 2021, GLOB REG EST VIOL WO; World Health Organization/London School of Hygiene and Tropical Medicine, 2010, PREV INT PARTN SEX V	52	12	12	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231737	10.1371/journal.pone.0231737	http://dx.doi.org/10.1371/journal.pone.0231737			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9QD	32320405	Green Published, gold			2022-12-26	WOS:000536028800032
J	Lennaerts-Kats, H; van der Steen, JT; Vijftigschild, Z; Steppe, M; Meinders, MJ; Munneke, M; Bloem, BR; Vissers, KCP; Groot, MM				Lennaerts-Kats, Herma; van der Steen, Jenny T.; Vijftigschild, Zefanja; Steppe, Maxime; Meinders, Marjan J.; Munneke, Marten; Bloem, Bastiaan R.; Vissers, Kris C. P.; Groot, Marieke M.			RADPAC-PD: A tool to support healthcare professionals in timely identifying palliative care needs of people with Parkinson's disease	PLOS ONE			English	Article							QUALITY-OF-LIFE; ADVANCE CARE; EUROPEAN ASSOCIATION; SURPRISE QUESTION; OLDER-PEOPLE; EXPERIENCES; END; RECOMMENDATIONS; CAREGIVERS; DEMENTIA	Background Parkinson's disease (PD) is a progressive degenerative disease without curative treatment perspectives. Even when palliative care for people with PD seems to be beneficial, the need for palliative care is often not timely recognized. Aim Our aim was to develop a tool that can help healthcare professionals in timely identifying palliative care needs in people with PD. Design We used a mixed-methods design, including individual and focus group interviews and a three-round modified Delphi study with healthcare professionals from a multidisciplinary field. Results Data from the interviews suggested two distinct moments in the progressive PD trajectory: 1) an ultimate moment to initiate Advance Care Planning (ACP); and 2) the actual start of the palliative phase. During the Delphi process, six indicators for ACP were identified, such as presence of frequent falls and first unplanned hospital admission. The start of the palliative phase involved four indicators: 1) personal goals have started to focus on maximization of comfort; 2) care needs have changed; 3) PD drug treatment has become less effective or an increasingly complex regime of drug treatments is needed; and 4) specific PD-symptoms or complications have appeared, such as significant weight loss, recurrent infections, or progressive dysphagia. Indicators for both moments are included in the RADboud indicators for PAlliative Care Needs in Parkinson's Disease (RADPAC-PD) tool. Conclusion The RADPAC-PD may support healthcare professionals in timely initiating palliative care for persons with PD. Identification of one or more indicators can mark the need for ACP or the palliative phase. We expect that applying the RADPAC-PD, for example on an annual basis throughout the PD trajectory, can facilitate identification of the palliative phase in PD patients in daily practice. However, further prospective research is needed on the implementation of the RADPAC-PD.	[Lennaerts-Kats, Herma; Steppe, Maxime; Munneke, Marten; Bloem, Bastiaan R.] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Med Ctr, Nijmegen, Netherlands; [Lennaerts-Kats, Herma; Vijftigschild, Zefanja; Vissers, Kris C. P.; Groot, Marieke M.] Radboud Univ Nijmegen, Dept Anesthesiol Pain & Palliat Care, Med Ctr, Nijmegen, Netherlands; [van der Steen, Jenny T.] Radboud Univ Nijmegen, Dept Primary & Community Care, Med Ctr, Nijmegen, Netherlands; [van der Steen, Jenny T.] Leiden Univ, Dept Publ Hlth & Primary Care, Med Ctr, Leiden, Netherlands; [Meinders, Marjan J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Sci Ctr Qual Healthcare, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Radboud University Nijmegen	Lennaerts-Kats, H (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Dept Neurol, Med Ctr, Nijmegen, Netherlands.; Lennaerts-Kats, H (corresponding author), Radboud Univ Nijmegen, Dept Anesthesiol Pain & Palliat Care, Med Ctr, Nijmegen, Netherlands.	Herma.lennaerts@radboudumc.nl	van der Steen, Jenny T./E-5118-2016; Vissers, Kris/H-8110-2014; Bloem, Bastiaan/H-8013-2014; Groot, Marieke/L-4338-2015	van der Steen, Jenny T./0000-0002-9063-7501; Vissers, Kris/0000-0002-2919-6356; Bloem, Bastiaan/0000-0002-6371-3337; Groot, Marieke/0000-0002-5740-3607; Lennaerts, Herma/0000-0002-1182-8300	Netherlands Organization for Health Research and Development (ZonMw) [80-84400-98-086]; Parkinson's Foundation	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Parkinson's Foundation	This study is funded by The Netherlands Organization for Health Research and Development (ZonMw). (Grant reference number 80-84400-98-086). www.zonmw.nl Prof. Bastiaan R. Bloem was supported by a research grant of the Parkinson's Foundation. The funding party had no role in the design of the study, or in data collection, analysis or in writing the manuscript.	Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; [Anonymous], 2010, WHO DEF PALL CAR; Bloem BR, 2017, HEALTH AFFAIR, V36, P1987, DOI 10.1377/hlthaff.2017.0832; Bloem BR, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1838; Bouca-Machado R, 2018, MOVEMENT DISORD, V33, P750, DOI 10.1002/mds.27309; Darweesh SKL, 2018, J PARKINSON DIS, V8, P495, DOI 10.3233/JPD-181374; Downar J, 2017, CAN MED ASSOC J, V189, pE484, DOI 10.1503/cmaj.160775; Edmonds P, 2001, PALLIATIVE MED, V15, P287, DOI 10.1191/026921601678320278; EPDA, 2017, PARK LAT LIF; Fox S, 2015, MOV DISORD CLIN PRAC, V2, P142, DOI 10.1002/mdc3.12133; Fox S, 2016, BMC PALLIAT CARE, V15, DOI 10.1186/s12904-016-0087-6; Giles S, 2009, PALLIATIVE MED, V23, P120, DOI 10.1177/0269216308100773; Gomez-Batiste X, 2017, PALLIATIVE MED, V31, P754, DOI 10.1177/0269216316676647; Goy ER, 2008, J PALLIAT CARE, V24, P69, DOI 10.1177/082585970802400202; Goy ER, 2007, NEUROLOGY, V69, P611, DOI 10.1212/01.wnl.0000266665.82754.61; Hall K, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0016-2; Hasson F, 2010, PALLIATIVE MED, V24, P731, DOI 10.1177/0269216310371414; Highet G, 2014, BMJ SUPPORT PALLIAT, V4, P285, DOI 10.1136/bmjspcare-2013-000488; Hoare S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142723; Hudson PL, 2006, PALLIATIVE MED, V20, P87, DOI 10.1191/0269216306pm1108oa; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kalia LV, 2015, LANCET, V386, P896, DOI 10.1016/S0140-6736(14)61393-3; Kempster PA, 2010, BRAIN, V133, P1755, DOI 10.1093/brain/awq059; Keus SHJ, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/543426; Keus SHJ, 2009, MOVEMENT DISORD, V24, P1, DOI 10.1002/mds.22141; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kluger BM, 2017, PARKINSONISM RELAT D, V37, P19, DOI 10.1016/j.parkreldis.2017.01.008; Lennaerts H, 2019, BMC PALLIAT CARE, V18, DOI 10.1186/s12904-019-0441-6; Lennaerts H, 2017, BMC PALLIAT CARE, V16, DOI 10.1186/s12904-017-0248-2; Linstone H. A., 1975, DELPHI METHOD TECHNI; Lum HD, 2019, NEUROLOGY, V92, pE2571, DOI 10.1212/WNL.0000000000007552; Martinez-Martin P, 2012, EXPERT REV PHARM OUT, V12, P221, DOI [10.1586/erp.11.106, 10.1586/ERP.11.106]; McKinley RK, 2004, BRIT J GEN PRACT, V54, P909; Meireles Joana, 2012, Front Neurol, V3, P88, DOI 10.3389/fneur.2012.00088; Miyasaki Janis M, 2012, Parkinsonism Relat Disord, V18 Suppl 3, pS6, DOI 10.1016/j.parkreldis.2012.06.013; Murray SA, 2011, PALLIATIVE MED, V25, P382, DOI 10.1177/0269216311401949; Nijkrake MJ, 2010, MOVEMENT DISORD, V25, P823, DOI 10.1002/mds.22813; Pennington S, 2010, PARKINSONISM RELAT D, V16, P434, DOI 10.1016/j.parkreldis.2010.04.010; Powell RA, 1996, INT J QUAL HEALTH C, V8, P499, DOI 10.1093/intqhc/8.5.499; Richfield EW, 2013, PALLIATIVE MED, V27, P805, DOI 10.1177/0269216313495287; Rietjens JAC, 2017, LANCET ONCOL, V18, pE543, DOI 10.1016/S1470-2045(17)30582-X; Rudkins H., 2006, BRIT J NEUROSCIENCE, V2, P10, DOI DOI 10.12968/BJNN.2006.2.1.20497; Schrag A, 2000, MOVEMENT DISORD, V15, P1112, DOI 10.1002/1531-8257(200011)15:6<1112::AID-MDS1008>3.0.CO;2-A; Seymour J, 2004, SOC SCI MED, V59, P57, DOI 10.1016/j.socscimed.2003.10.005; Simon J, 2015, BMJ SUPPORT PALLIAT, V5, P54, DOI 10.1136/bmjspcare-2013-000487; Sofaer S, 2002, INT J QUAL HEALTH C, V14, P329, DOI 10.1093/intqhc/14.4.329; Thomas K.T., 2016, GOLD STANDARDS FRAME; Thoonsen B, 2012, BRIT J GEN PRACT, V62, DOI 10.3399/bjgp12X654597; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; van der Steen JT, 2014, PALLIATIVE MED, V28, P197, DOI 10.1177/0269216313493685; Waldron M, 2011, INT J THER REHABIL, V18, P48, DOI 10.12968/ijtr.2011.18.1.48; Waldron M, 2013, BRIT J SOC WORK, V43, P81, DOI 10.1093/bjsw/bcr157; Walker RW, 2014, BMJ SUPPORT PALLIAT, V4, P64, DOI 10.1136/bmjspcare-2012-000412; Wolf-Klein Gisele, 2007, Am J Hosp Palliat Care, V24, P77, DOI 10.1177/1049909106295297; Zwakman M, 2018, PALLIATIVE MED, V32, P1305, DOI 10.1177/0269216318784474	55	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230611	10.1371/journal.pone.0230611	http://dx.doi.org/10.1371/journal.pone.0230611			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315302	Green Published, gold			2022-12-26	WOS:000536024800007
J	Smith, RC; Cramer, MS; Mitchell, PJ; Lucchesi, J; Ortega, AM; Livingston, EW; Ballard, D; Zhang, L; Hanson, J; Barton, K; Berens, S; Credille, KM; Bateman, TA; Ferguson, VL; Ma, YL; Stodieck, LS				Smith, Rosamund C.; Cramer, Martin S.; Mitchell, Pamela J.; Lucchesi, Jonathan; Ortega, Alicia M.; Livingston, Eric W.; Ballard, Darryl; Zhang, Ling; Hanson, Jeff; Barton, Kenneth; Berens, Shawn; Credille, Kelly M.; Bateman, Ted A.; Ferguson, Virginia L.; Ma, Yanfei L.; Stodieck, Louis S.			Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength	PLOS ONE			English	Article							INDUCED BONE LOSS; SPACEFLIGHT; MICROSTRUCTURE; BIMAGRUMAB; EXPRESSION; ATROPHY; PERFORMANCE; EXPOSURE; EXERCISE; SPINE	The microgravity conditions of prolonged spaceflight are known to result in skeletal muscle atrophy that leads to diminished functional performance. To assess if inhibition of the growth factor myostatin has potential to reverse these effects, mice were treated with a myostatin antibody while housed on the International Space Station. Grip strength of ground control mice increased 3.1% compared to baseline values over the 6 weeks of the study, whereas grip strength measured for the first time in space showed flight animals to be -7.8% decreased in strength compared to baseline values. Control mice in space exhibited, compared to ground-based controls, a smaller increase in DEXA-measured muscle mass (+3.9% vs +5.6% respectively) although the difference was not significant. All individual flight limb muscles analyzed (except for the EDL) weighed significantly less than their ground counterparts at the study end (range -4.4% to -28.4%). Treatment with myostatin antibody YN41 was able to prevent many of these space-induced muscle changes. YN41 was able to block the reduction in muscle grip strength caused by spaceflight and was able to significantly increase the weight of all muscles of flight mice (apart from the EDL). Muscles of YN41-treated flight mice weighed as much as muscles from Ground IgG mice, with the exception of the soleus, demonstrating the ability to prevent spaceflight-induced atrophy. Muscle gene expression analysis demonstrated significant effects of microgravity and myostatin inhibition on many genes. Gamt and Actc1 gene expression was modulated by microgravity and YN41 in opposing directions. Myostatin inhibition did not overcome the significant reduction of microgravity on femoral BMD nor did it increase femoral or vertebral BMD in ground control mice. In summary, myostatin inhibition may be an effective countermeasure to detrimental consequences of skeletal muscle under microgravity conditions.	[Smith, Rosamund C.; Cramer, Martin S.; Mitchell, Pamela J.; Lucchesi, Jonathan; Ballard, Darryl; Zhang, Ling; Hanson, Jeff; Berens, Shawn; Credille, Kelly M.; Ma, Yanfei L.] Lilly Res Labs, Indianapolis, IN 46225 USA; [Ortega, Alicia M.; Ferguson, Virginia L.; Stodieck, Louis S.] Univ Colorado, Dept Aerosp Engn Sci, BioServe Space Technol, Boulder, CO 80309 USA; [Livingston, Eric W.; Bateman, Ted A.] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA; [Barton, Kenneth] TechShot Inc, Greenville, IN USA; [Ferguson, Virginia L.] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA	Eli Lilly; University of Colorado System; University of Colorado Boulder; University of North Carolina; University of North Carolina Chapel Hill; University of Colorado System; University of Colorado Boulder	Smith, RC (corresponding author), Lilly Res Labs, Indianapolis, IN 46225 USA.	Nonie23@att.net		Mitchell, Pamela/0000-0002-9133-0720	Center for the Advancement of Science in Space or CASIS [GA2016-239, 003]; CASIS; NASA [NNJ10GA25A, NNJ13GA01C, NNJ10GA35C]	Center for the Advancement of Science in Space or CASIS; CASIS; NASA(National Aeronautics & Space Administration (NASA))	Funding for this work was provided in part to VLF, TAB, and LSS by the Center for the Advancement of Science in Space or CASIS (GA2016-239, T/O #003). CASIS purchased mice used in the study and funded associated animal testing services. We acknowledge NASA for providing access to astronaut crew members who carried out the flight portion and all resources associated with transportation to and from, and use of, the International Space Station. Additional support was provided by NASA for the development of the anesthesia/recovery system and anesthesia protocol used in the study (NNJ10GA25A). Development and provision of the ISS Bone Densitometer was supported by CASIS and NASA contracts NNJ13GA01C and NNJ10GA35C to Techshot, Inc. Eli Lilly and Company and TechShot Inc. provided support in the form of salaries for authors [RCS, MSC, PJM, JL, DB, LZ, JH, SB, KMC, YLM, KB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Allen D. L., 2006, CELL PHYSL, V292; Allen DL, 1996, J APPL PHYSIOL, V81, P145, DOI 10.1152/jappl.1996.81.1.145; Arounleut P, 2013, EXP GERONTOL, V48, P898, DOI 10.1016/j.exger.2013.06.004; Becker C, 2015, LANCET DIABETES ENDO, V3, P948, DOI 10.1016/S2213-8587(15)00298-3; Berg-Johansen B, 2016, J ORTHOP RES, V34, P48, DOI 10.1002/jor.23029; Bharucha-Goebel D, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0798-y; Bodine SC, 2014, AM J PHYSIOL-ENDOC M, V307, pE469, DOI 10.1152/ajpendo.00204.2014; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chang DG, 2016, SPINE, V41, P1917, DOI 10.1097/BRS.0000000000001873; Dai SB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10998-4; Deacon RMJ, 2013, JOVE-J VIS EXP, DOI 10.3791/2610; Elkasrawy MN, 2010, J MUSCULOSKEL NEURON, V10, P56; Ferguson VL, 2003, BONE, V33, P387, DOI 10.1016/S8756-3282(03)00199-6; Fitts RH, 2010, J PHYSIOL-LONDON, V588, P3567, DOI 10.1113/jphysiol.2010.188508; Fitzgerald J, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0016-1; Gambara G, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169314; Garito T, 2018, DIABETES OBES METAB, V20, P94, DOI 10.1111/dom.13042; Gerbaix M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03014-2; Glatt V, 2007, J BONE MINER RES, V22, P1197, DOI 10.1359/JBMR.070507; Hanson AM, 2013, MUSCLE NERVE, V48, P393, DOI 10.1002/mus.23753; Harrison BC, 2003, J APPL PHYSIOL, V95, P2462, DOI 10.1152/japplphysiol.00603.2003; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Kan HE, 2005, AM J PHYSIOL-CELL PH, V289, pC113, DOI 10.1152/ajpcell.00040.2005; Kivela R, 2007, J APPL PHYSIOL, V103, P1395, DOI 10.1152/japplphysiol.00531.2007; Lalani R, 2000, J ENDOCRINOL, V167, P417, DOI 10.1677/joe.0.1670417; Lang T, 2004, J BONE MINER RES, V19, P1006, DOI 10.1359/JBMR.040307; Latres E, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0060-8; LeBlanc A., 2000, Journal of Musculoskeletal & Neuronal Interactions, V1, P157; Legrand D, 2014, J AM GERIATR SOC, V62, P1030, DOI 10.1111/jgs.12840; Lloyd SA, 2015, BONE, V81, P562, DOI 10.1016/j.bone.2015.08.021; Moyer EL, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.2; Okragly AJ, 2016, CYTOKINE, V79, P66, DOI 10.1016/j.cyto.2015.12.011; Philippou A, 2015, FASEB J, V29, P2769, DOI 10.1096/fj.14-267336; Prestes J, 2018, J STRENGTH COND RES, V32, P113, DOI 10.1519/JSC.0000000000001718; Radugina EA, 2018, LIFE SCI SPACE RES, V16, P18, DOI 10.1016/j.lssr.2017.08.005; Ronca AE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40789-y; Rooks D, 2017, J AM GERIATR SOC, V65, P1988, DOI 10.1111/jgs.14927; Rooks DS, 2017, J CACHEXIA SARCOPENI, V8, P727, DOI 10.1002/jcsm.12205; Sabsovich I, 2008, BONE, V42, P439, DOI 10.1016/j.bone.2007.09.041; Sandona D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033232; Shen H, 2017, FASEB J, V31, P5466, DOI 10.1096/fj.201700320R; Smith RC, 2015, MOL CANCER THER, V14, P1661, DOI 10.1158/1535-7163.MCT-14-0681; Smith RC, 2013, CURR OPIN SUPPORT PA, V7, P352, DOI 10.1097/SPC.0000000000000013; Smith RC, 2012, J CLIN INVEST, V122, P4710, DOI 10.1172/JCI64986; Sun GS, 2014, NUTRITION, V30, P125, DOI 10.1016/j.nut.2013.04.005; Sung M., 2013, J MUSCULOSKELETAL NE, V13; Tavella S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033179; Tesch PA, 2005, EUR J APPL PHYSIOL, V93, P463, DOI 10.1007/s00421-004-1236-9; Trappe S, 2009, J APPL PHYSIOL, V106, P1159, DOI 10.1152/japplphysiol.91578.2008; Vico L, 2017, J BONE MINER RES, V32, P2010, DOI 10.1002/jbmr.3188; Willinghamm MD, 2010, CALCIFIED TISSUE INT, V86, P470, DOI 10.1007/s00223-010-9359-y	51	18	18	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230818	10.1371/journal.pone.0230818	http://dx.doi.org/10.1371/journal.pone.0230818			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LO9XS	32315311	Green Published, gold			2022-12-26	WOS:000533977700001
J	Zhu, HJ; Lan, LQ; Zhang, YX; Chen, QR; Zeng, YL; Luo, XF; Ren, JH; Chen, SZ; Xiao, M; Lin, KN; Chen, MM; Li, Q; Chen, YQ; Xu, JJ; Zheng, ZH; Chen, ZZ; Xie, YX; Hu, JD; Yang, T				Zhu, Haojie; Lan, Lingqiong; Zhang, Yuxin; Chen, Qiuru; Zeng, Yanling; Luo, Xiaofeng; Ren, Jinhua; Chen, Shaozhen; Xiao, Min; Lin, Kangni; Chen, Minmin; Li, Qian; Chen, Yongquan; Xu, Jingjing; Zheng, Zhihong; Chen, Zhizhe; Xie, Yongxin; Hu, Jianda; Yang, Ting			Epidermal growth factor stimulates exosomal microRNA-21 derived from mesenchymal stem cells to ameliorate aGVHD by modulating regulatory T cells	FASEB JOURNAL			English	Article						acute graft-versus-host disease; bone marrow-derived mesenchymal stem cells; epidermal growth factor; exosomes; microRNA-21; regulatory T cells	VERSUS-HOST-DISEASE; STROMAL CELLS; EGF; PROLIFERATION; PREVENTION; EXPRESSION; SIGNATURE; MIGRATION; MODEL; ROLES	Regulatory T cells (Tregs), a subset of CD4(+) T cells, may exert inhibitory effects on alloimmune responses including acute graft-versus-host disease (aGVHD), and several microRNAs are implicated in the pathophysiological process of GVHD. Therefore, we aimed in the present study to characterize the functional relevance of epidermal growth factor (EGF)-stimulated microRNA-21 (miR-21) in regulating bone marrow-derived mesenchymal stem cells (BMSCs) in a mouse model of aGVHD. We first isolated and cultured BMSCs and Tregs. Then, we examined effects of miR-21 knockdown or overexpression and EGF on cell activities of BMSCs and the expression of PTEN, Foxp3, AKT phosphorylation, and extent of c-jun phosphorylation by gain- and loss-of-function approaches. The results showed that miR-21 promoted the proliferation, invasion, and migration of BMSCs. Furthermore, miR-21 in BMSCs-derived exosomes inhibited PTEN, but enhanced AKT phosphorylation and Foxp3 expression in Tregs. In addition, EGF enhanced c-jun phosphorylation to elevate the miR-21 expression. Furthermore, EGF significantly increased the efficacy of BMSCs in a mouse model of aGVHD, manifesting in reduced IFN-gamma expression and lesser organ damage. Moreover, EGF treatment promoted the Foxp3 expression of Tregs in BMSCs-treated aGVHD mice. Taken together, EGF induced the BMSCs-derived exosomal miR-21 expression, which enhanced Foxp3 expression in Tregs, thereby improving the therapeutic effect of BMSCs on aGVHD.	[Zhu, Haojie; Lan, Lingqiong; Zhang, Yuxin; Chen, Qiuru; Zeng, Yanling; Luo, Xiaofeng; Ren, Jinhua; Chen, Shaozhen; Xiao, Min; Lin, Kangni; Chen, Minmin; Li, Qian; Chen, Yongquan; Xu, Jingjing; Zheng, Zhihong; Chen, Zhizhe; Hu, Jianda; Yang, Ting] Fujian Med Univ, Fujian Prov Key Lab Hematol, Union Hosp, Dept Hematol,Fujian Inst Hematol, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China; [Lan, Lingqiong; Xie, Yongxin] Second Hosp Longyan, Dept Hematol, Longyan, Peoples R China	Fujian Medical University	Hu, JD; Yang, T (corresponding author), Fujian Med Univ, Fujian Prov Key Lab Hematol, Union Hosp, Dept Hematol,Fujian Inst Hematol, 29 Xinquan Rd, Fuzhou 350001, Fujian, Peoples R China.	drjiandahu@163.com; yang.hopeting@gmail.com			National Natural Science Foundation of China (NSFC) [81870138, 81570162, 81700131]; Fujian Provincial Healthy Commission and the Education Department of Fujian Province [2019-WJ24]; Fujian Province Department of Science Technology [2017Y9056, 2017Y9017, 2017Y9104, 2018Y0031, 2018J01312]; Startup Fund for scientific research Project of Fujian Medical University [2017XQ1047, 2017XQ2036]; Construction Project of Fujian Medical Center of Hematology [Min201704]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fujian Provincial Healthy Commission and the Education Department of Fujian Province; Fujian Province Department of Science Technology; Startup Fund for scientific research Project of Fujian Medical University; Construction Project of Fujian Medical Center of Hematology	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81870138, 81570162 and 81700131; Fujian Provincial Healthy Commission and the Education Department of Fujian Province, Grant/Award Number: 2019-WJ24; Fujian Province Department of Science & Technology, Grant/Award Number: 2017Y9056, 2017Y9017, 2017Y9104, 2018Y0031 and 2018J01312; Startup Fund for scientific research Project of Fujian Medical University, Grant/Award Number: 2017XQ1047 and 2017XQ2036; Construction Project of Fujian Medical Center of Hematology, Grant/Award Number: Min201704	Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Bae JA, 2014, CLIN CANCER RES, V20, P4115, DOI 10.1158/1078-0432.CCR-13-2863; Cao L, 2017, BIOMED PHARMACOTHER, V93, P570, DOI 10.1016/j.biopha.2017.06.089; Chen YJ, 2016, TOXICOL APPL PHARM, V310, P98, DOI 10.1016/j.taap.2016.09.007; Cheng Q, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9012152; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Echevarria-Vargas IM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097094; Flowers MED, 2011, BLOOD, V117, P3214, DOI 10.1182/blood-2010-08-302109; Gimondi S, 2016, EXP HEMATOL, V44, P624, DOI 10.1016/j.exphem.2016.03.005; Guo XF, 2018, ONCOGENE, V37, P4239, DOI 10.1038/s41388-018-0261-9; Han ML, 2012, MOL CELL BIOCHEM, V363, P427, DOI 10.1007/s11010-011-1195-5; Hebert TL, 2009, J TISSUE ENG REGEN M, V3, P553, DOI 10.1002/term.198; Holtan SG, 2016, TRANSL RES, V167, P80, DOI 10.1016/j.trsl.2015.06.001; Hu Y, 2015, IMMUNOL CELL BIOL, V93, P753, DOI 10.1038/icb.2015.37; Jalapothu D, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00361; Kebriaei P, 2009, BIOL BLOOD MARROW TR, V15, P804, DOI 10.1016/j.bbmt.2008.03.012; Kern HB, 2012, DNA CELL BIOL, V31, P1403, DOI 10.1089/dna.2011.1469; Liu HZ, 2014, INT J MOL SCI, V15, P4007, DOI 10.3390/ijms15034007; Liu Yue-Jun, 2006, Zhonghua Nei Ke Za Zhi, V45, P835; Martin PJ, 2012, BIOL BLOOD MARROW TR, V18, P1150, DOI 10.1016/j.bbmt.2012.04.005; Messina C, 2008, BONE MARROW TRANSPL, V41, pS65, DOI 10.1038/bmt.2008.57; Nishikii H, 2016, BLOOD, V128, P2846, DOI 10.1182/blood-2016-06-723783; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Park JH, 2009, AM J PHYSIOL-CELL PH, V297, pC935, DOI 10.1152/ajpcell.00121.2009; Pierini A, 2016, BLOOD, V128, P866, DOI 10.1182/blood-2016-04-711275; Prasad VK, 2011, BIOL BLOOD MARROW TR, V17, P534, DOI 10.1016/j.bbmt.2010.04.014; Ranganathan P, 2012, BLOOD, V119, P4786, DOI 10.1182/blood-2011-10-387522; Rodrigues M, 2013, STEM CELLS, V31, P104, DOI 10.1002/stem.1215; Rouas R, 2009, EUR J IMMUNOL, V39, P1608, DOI 10.1002/eji.200838509; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Shi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191616; Socie G, 2009, BLOOD, V114, P4327, DOI 10.1182/blood-2009-06-204669; Stickel N, 2014, BLOOD, V124, P2586, DOI 10.1182/blood-2014-04-569046; Tian Y, 2008, IMMUNOL INVEST, V37, P29, DOI 10.1080/08820130701410223; Wang L, 2016, STEM CELLS DEV, V25, P1874, DOI 10.1089/scd.2016.0107; Wu KN, 2009, CELL CYCLE, V8, P3601, DOI 10.4161/cc.8.21.9999; Wu TT, 2015, STEM CELLS, V33, P3281, DOI 10.1002/stem.2081; Xiao B, 2013, BLOOD, V122, P3365, DOI 10.1182/blood-2013-06-510586; Xu ZC, 2018, BIOCHEM BIOPH RES CO, V503, P146, DOI 10.1016/j.bbrc.2018.05.200; Yan XL, 2012, BREAST CANCER RES TR, V132, P153, DOI 10.1007/s10549-011-1577-0; Yuan HX, 2017, ONCOL LETT, V14, P3371, DOI 10.3892/ol.2017.6605; Zeng YL, 2017, ONCOTARGET, V8, P29161, DOI 10.18632/oncotarget.16254; Zhao QY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1182-9; Zou XY, 2018, KIDNEY BLOOD PRESS R, V43, P152, DOI 10.1159/000487369	44	6	7	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7372	7386		10.1096/fj.201900847RRRR	http://dx.doi.org/10.1096/fj.201900847RRRR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32314840				2022-12-26	WOS:000527568800001
J	Li, MC; Nopparat, J; Aguilar, BJ; Chen, YH; Zhang, J; Du, J; Ai, X; Luo, Y; Jiang, YG; Boykin, C; Lu, Q				Li, Mingchuan; Nopparat, Jongdee; Aguilar, Byron J.; Chen, Yan-hua; Zhang, Jiao; Du, Jie; Ai, Xin; Luo, Yong; Jiang, Yongguang; Boykin, Christi; Lu, Qun			Intratumor delta-catenin heterogeneity driven by genomic rearrangement dictates growth factor dependent prostate cancer progression	ONCOGENE			English	Article							ARMADILLO PROTEIN; E-CADHERIN; EXPRESSION; REDISTRIBUTION; IDENTIFICATION; P120-CATENIN; P190RHOGEF; CHALLENGES; INVASION; HYPOXIA	Only a small number of genes are bona fide oncogenes and tumor suppressors such as Ras, Myc, beta-catenin, p53, and APC. However, targeting these cancer drivers frequently fail to demonstrate sustained cancer remission. Tumor heterogeneity and evolution contribute to cancer resistance and pose challenges for cancer therapy due to differential genomic rearrangement and expression driving distinct tumor responses to treatments. Here we report that intratumor heterogeneity of Wnt/beta-catenin modulator delta-catenin controls individual cell behavior to promote cancer. The differential intratumor subcellular localization of delta-catenin mirrors its compartmentalization in prostate cancer xenograft cultures as result of mutation-rendered delta-catenin truncations. Wild-type and delta-catenin mutants displayed distinct protein interactomes that highlight rewiring of signal networks. Localization specific delta-catenin mutants influenced p120(ctn)-dependent Rho GTPase phosphorylation and shifted cells towards differential bFGF-responsive growth and motility, a known signal to bypass androgen receptor dependence. Mutant delta-catenin promoted Myc-induced prostate tumorigenesis while increasing bFGF-p38 MAP kinase signaling, beta-catenin-HIF-1 alpha expression, and the nuclear size. Therefore, intratumor delta-catenin heterogeneity originated from genetic remodeling promotes prostate cancer expansion towards androgen independent signaling, supporting a neomorphism model paradigm for targeting tumor progression.	[Li, Mingchuan; Nopparat, Jongdee; Aguilar, Byron J.; Chen, Yan-hua; Zhang, Jiao; Boykin, Christi; Lu, Qun] East Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA; [Li, Mingchuan; Luo, Yong; Jiang, Yongguang] Capital Med Univ, Beijing An Zhen Hosp, Dept Urol Surg, Beijing 100029, Peoples R China; [Nopparat, Jongdee] Prince Songkla Univ, Dept Anat, Hat Yai 90110, Thailand; [Du, Jie] Capital Med Univ, Beijing An Zhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China; [Ai, Xin] Peoples Liberat Army Gen Hosp, Med Ctr 7, Dept Urol, Beijing 100029, Peoples R China; [Lu, Qun] East Carolina Univ, Brody Sch Med, Harriet & John Wooten Lab Alzheimers & Neurodegen, Greenville, NC 27834 USA	University of North Carolina; East Carolina University; Capital Medical University; Prince of Songkla University; Capital Medical University; Chinese People's Liberation Army General Hospital; University of North Carolina; East Carolina University	Lu, Q (corresponding author), East Carolina Univ, Brody Sch Med, Dept Anat & Cell Biol, Greenville, NC 27834 USA.; Lu, Q (corresponding author), East Carolina Univ, Brody Sch Med, Harriet & John Wooten Lab Alzheimers & Neurodegen, Greenville, NC 27834 USA.	luq@ecu.edu	Nopparat, Jongdee/AAX-1690-2020; , Proteomics Core UNC/AFQ-7201-2022; , Proteomics Core UNC/AAH-3777-2022	Nopparat, Jongdee/0000-0003-3532-1405; 	USA National Cancer Institute [CA111891, CA165202, P30 CA016086]; Harriet and John Wooten Foundation for Alzheimer's and Neurodegenerative Diseases Research; Chinese Beijing Natural Science Foundation [7172068]	USA National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harriet and John Wooten Foundation for Alzheimer's and Neurodegenerative Diseases Research; Chinese Beijing Natural Science Foundation(Beijing Natural Science Foundation)	We thank George W. Lanford and William Guiler for technical assistance. This work was supported in part by grants from USA National Cancer Institute CA111891 (QL), CA165202 (QL), the Harriet and John Wooten Foundation for Alzheimer's and Neurodegenerative Diseases Research (QL), and Chinese Beijing Natural Science Foundation 7172068 (YGJ). This research is based in part upon work conducted using the UNC Proteomics Core Facility, which is supported in part by USA National Cancer Institute P30 CA016086 Cancer Center Core Support Grant to the UNC Lineberger Comprehensive Cancer Center.	Anastasiadis PZ, 2001, CURR OPIN CELL BIOL, V13, P604, DOI 10.1016/S0955-0674(00)00258-1; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Bensinger SJ, 2012, SEMIN CELL DEV BIOL, V23, P352, DOI 10.1016/j.semcdb.2012.02.003; Bluemn EG, 2017, CANCER CELL, V32, P474, DOI 10.1016/j.ccell.2017.09.003; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; DeBusk LM, 2010, J EXP MED, V207, P669, DOI 10.1084/jem.2009109722610c; Dohn MR, 2009, J CELL BIOL, V184, P437, DOI 10.1083/jcb.200807096; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Fang YY, 2012, J CANCER RES CLIN, V138, P1769, DOI 10.1007/s00432-012-1257-4; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang F, 2018, ONCOL REP, V39, P809, DOI 10.3892/or.2017.6140; Ip CKM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06949-w; Israely I, 2004, CURR BIOL, V14, P1657, DOI 10.1016/j.cub.2004.08.065; Iwata T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009427; Jones SB, 2004, J NEUROSCI, V24, P8510, DOI 10.1523/JNEUROSCI.1264-04.2004; Jones SB, 2002, NEUROSCIENCE, V115, P1009, DOI 10.1016/S0306-4522(02)00532-8; Kim H, 2008, J BIOL CHEM, V283, P977, DOI 10.1074/jbc.M707158200; Kim H, 2012, BBA-MOL BASIS DIS, V1822, P509, DOI 10.1016/j.bbadis.2011.12.015; Kim H, 2008, BIOCHEM BIOPH RES CO, V377, P636, DOI 10.1016/j.bbrc.2008.10.030; Kim K, 2002, EXP CELL RES, V275, P171, DOI 10.1006/excr.2002.5503; Kosik KS, 2005, TRENDS CELL BIOL, V15, P172, DOI 10.1016/j.tcb.2005.01.004; Liu Y, 2009, CANCER SCI, V100, P441, DOI 10.1111/j.1349-7006.2008.01067.x; Lu Q, 2005, HUM PATHOL, V36, P1037, DOI 10.1016/j.humpath.2005.07.012; Lu Q, 1999, J CELL BIOL, V144, P519, DOI 10.1083/jcb.144.3.519; Lu Q, 2016, HUM GENET, V135, P1107, DOI 10.1007/s00439-016-1705-3; Lu Q, 2010, J PATHOL, V222, P119, DOI 10.1002/path.2755; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; McCrea PD, 2007, BBA-MOL CELL RES, V1773, P17, DOI 10.1016/j.bbamcr.2006.06.009; Nopparat J, 2015, ONCOGENE, V34, P1542, DOI 10.1038/onc.2014.89; Olson Michael F, 2018, Small GTPases, V9, P203, DOI 10.1080/21541248.2016.1218407; Paffenholz R, 1997, DIFFERENTIATION, V61, P293, DOI 10.1046/j.1432-0436.1997.6150293.x; Patiar S, 2006, ENDOCR-RELAT CANCER, V13, pS61, DOI 10.1677/erc.1.01290; Podar K, 2010, CELL CYCLE, V9, P1722, DOI 10.4161/cc.9.9.11358; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Powis G, 2004, MOL CANCER THER, V3, P647; Suhovskih AV, 2017, CELL ADHES MIGR, V11, P39, DOI 10.1080/19336918.2016.1182292; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tai S, 2011, PROSTATE, V71, P1668, DOI 10.1002/pros.21383; Takiar V, 2017, ONCOGENE, V36, P1607, DOI 10.1038/onc.2016.312; Viswanathan SR, 2018, NAT GENET, V50, P937, DOI 10.1038/s41588-018-0155-3; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wolf A, 2006, NAT CELL BIOL, V8, P1432, DOI 10.1038/ncb1504; Wu YM, 2018, CELL, V173, P1770, DOI 10.1016/j.cell.2018.04.034; Yanagisawa M, 2008, J BIOL CHEM, V283, P18344, DOI 10.1074/jbc.M801192200; Zeng Y, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-19; Zhang GA, 2006, PROTEOMICS, V6, P571, DOI 10.1002/pmic.200500267; Zhang J, 2010, FUTURE ONCOL, V6, P587, DOI [10.2217/fon.10.15, 10.2217/FON.10.15]; Zhang J, 2008, DEVELOPMENT, V135, P3611, DOI 10.1242/dev.025361; Zhang Y, 2018, FRONT MED-PRC, V12, P361, DOI 10.1007/s11684-018-0656-6; Zheng JY, 2003, J MEMBRANE BIOL, V194, P187, DOI 10.1007/s00232-003-2038-4	51	5	5	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4358	4374		10.1038/s41388-020-1281-9	http://dx.doi.org/10.1038/s41388-020-1281-9		APR 2020	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32313227				2022-12-26	WOS:000527509300002
J	Galimba, K; Tosetti, R; Loerich, K; Michael, L; Pabhakar, S; Dove, C; Dardick, C; Callahan, A				Galimba, Kelsey; Tosetti, Roberta; Loerich, Karen; Michael, Leann; Pabhakar, Savita; Dove, Cynthia; Dardick, Chris; Callahan, Ann			Identification of early fruit development reference genes in plum	PLOS ONE			English	Article							TRANSCRIPTION-PCR DATA; QUANTITATIVE PCR; SELECTION; GENOME; NORMALIZATION; VALIDATION; PATTERNS	An RNAseq study of early fruit development and stone development in plum, Prunus domestica, was mined to identify sets of genes that could be used to normalize expression studies in early fruit development. The expression values of genes previously identified from Prunus as reference genes were first extracted and found to vary considerably in endocarp tissue relative to whole fruit tissue. Nine other genes were chosen that varied less than 2-fold amongst the 20 RNAseq libraries of early fruit development and endocarp tissues. These gene were tested on a series of developmental plum fruit samples to determine if any could be used as a reference gene in the analyses of fruit-based tissues in plum. The three most stable genes as determined using RefFinder were IPGD (imidazole glycerol-phosphate dehydratase), HAM1 (histone acetyltransferase) and SNX1 (sorting nexin 1). These were further tested to analyze genes expressed differentially in endocarp tissue between normal and minimal endocarp cultivars. To determine the universality of those nine genes as fruit development reference genes, three other data sets of RNAseq from peach and apple were analyzed to determine the reference gene expression. Multiple genes exhibited tissue specific patterns of expression while one gene, the SNX1, emerged as possessing a universal pattern between the Rosaceae species, at all developmental stages, and tissue types tested. The results suggest that the use of existing RNAseq data to identify standard genes can provide stable reference genes for a specific tissues or experimental conditions under exploration.	[Galimba, Kelsey; Tosetti, Roberta; Dardick, Chris; Callahan, Ann] USDA ARS, Appalachian Fruit Res Stn, 45 Wiltshire Rd, Kearneysville, WV 25430 USA; [Loerich, Karen; Michael, Leann; Pabhakar, Savita; Dove, Cynthia] Hagerstown Community Coll, Hagerstown, MD USA; [Tosetti, Roberta] Cranfield Univ, Plant Sci Lab, Cranfield, Beds, England; [Pabhakar, Savita] Frederick Community Coll, Dept Sci, Frederick, MD USA	United States Department of Agriculture (USDA); Cranfield University	Callahan, A (corresponding author), USDA ARS, Appalachian Fruit Res Stn, 45 Wiltshire Rd, Kearneysville, WV 25430 USA.	ann.callahan@USDA.gov			National Science Foundation [1444987]; United States Department of Agriculture-Agricultural Research Service	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture-Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by National Science Foundation grant no. 1444987 to CDD and AMC and by the United States Department of Agriculture-Agricultural Research Service to KDG, CDD and AMC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Bowen J, 2014, TREE GENET GENOMES, V10, P751, DOI 10.1007/s11295-014-0720-6; Callahan AM, 2009, J AM SOC HORTIC SCI, V134, P120, DOI 10.21273/JASHS.134.1.120; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Chen L, 2011, PLANTA, V234, P377, DOI 10.1007/s00425-011-1410-3; Daccord N, 2017, NAT GENET, V49, P1099, DOI 10.1038/ng.3886; Dardick C, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00284; Dardick CD, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-13; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Everaert C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01617-3; Fernandes-Brum CN, 2017, TREE GENET GENOMES, V13, DOI 10.1007/s11295-017-1213-1; Galimba KD, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0124-8; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Heucken N, 2018, J CELL SCI, V131, DOI 10.1242/jcs.203695; Hu R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-20; Kim HY, 2015, PLANT MOL BIOL REP, V33, P1634, DOI 10.1007/s11105-015-0860-3; Kou XY, 2017, SCI HORTIC-AMSTERDAM, V225, P195, DOI 10.1016/j.scienta.2017.07.004; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VanGuilder HD, 2008, BIOTECHNIQUES, V44, P619, DOI 10.2144/000112776; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Wang YZ, 2019, TREE GENET GENOMES, V15, DOI 10.1007/s11295-019-1361-6; You YH, 2016, SCI HORTIC-AMSTERDAM, V210, P285, DOI 10.1016/j.scienta.2016.07.031	28	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0230920	10.1371/journal.pone.0230920	http://dx.doi.org/10.1371/journal.pone.0230920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302301	Green Published, gold			2022-12-26	WOS:000536016100013
J	Heinsch, M; Sampson, D; Huens, V; Handley, T; Hanstock, T; Harris, K; Kay-Lambkin, F				Heinsch, Milena; Sampson, Dara; Huens, Valerie; Handley, Tonelle; Hanstock, Tanya; Harris, Keith; Kay-Lambkin, Frances			Understanding ambivalence in help-seeking for suicidal people with comorbid depression and alcohol misuse	PLOS ONE			English	Article							ECOLOGICAL-SYSTEMS THEORY; QUALITATIVE RESEARCH; PREVENTION; COMMUNITY; PREVALENCE; STRATEGIES; IDEATION; THERAPY; STIGMA	Help-seeking prior to a suicide attempt is poorly understood. Participants were recruited from a previous research trial who reported a history of suicidal behaviours upon follow-up. Qualitative interviews were conducted with six adults to understand their lived experience of a suicide attempt and the issues affecting help-seeking prior to that attempt. Participants described being aware of personal and professional supports available; however, were ambivalent about accessing them for multiple reasons. This paper employs an ecological systems framework to better understand the complex and multi-layered interpersonal, societal and cultural challenges to help-seeking that people with suicidal ideation can experience.	[Heinsch, Milena; Sampson, Dara; Handley, Tonelle; Kay-Lambkin, Frances] Univ Newcastle, Prior Res Ctr Brain & Mental Hlth, Callaghan, NSW, Australia; [Heinsch, Milena] Univ Newcastle, Fac Arts & Humanities, Sch Social Work, Callaghan, NSW, Australia; [Huens, Valerie; Hanstock, Tanya] Univ Newcastle, Faulty Sci, Sch Psychol, Callaghan, NSW, Australia; [Handley, Tonelle] Ctr Rural & Remote Mental Hlth, Orange, NSW, Australia; [Harris, Keith] Charles Sturt Univ, Sch Psychol, Port Macquarie, NSW, Australia; [Harris, Keith] Univ Queensland, Sch Psychol, Brisbane St Lucia, Qld, Australia; [Kay-Lambkin, Frances] UNSW, Natl Drug & Alcohol Res Ctr, Randwick, NSW, Australia	University of Newcastle; University of Newcastle; University of Newcastle; Charles Sturt University; University of Queensland; University of New South Wales Sydney	Kay-Lambkin, F (corresponding author), Univ Newcastle, Prior Res Ctr Brain & Mental Hlth, Callaghan, NSW, Australia.; Kay-Lambkin, F (corresponding author), UNSW, Natl Drug & Alcohol Res Ctr, Randwick, NSW, Australia.	frances.kaylambkin@newcastle.edu.au	Heinsch, Milena/AAS-1182-2020; Harris, Keith M/K-9957-2013	Heinsch, Milena/0000-0002-8014-9475; Harris, Keith M/0000-0002-1199-2856; Kay-Lambkin, Frances/0000-0002-4252-5572; Hanstock, Tanya/0000-0002-8905-2231				Beck AT, 1996, PSYCHOL ASSESS; Brakenhoff B, 2015, J SOC SERV RES, V41, P216, DOI 10.1080/01488376.2014.980962; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Bronfenbrenner U., 1994, INT ENCY ED, V3, P37; BRONFENBRENNER Urie, 2005, MAKING HUMAN BEINGS, P3, DOI DOI 10.1016/J.PEDN.2017.06.013; Brown GK, 2005, JAMA-J AM MED ASSOC, V294, P563, DOI 10.1001/jama.294.5.563; Burns MK, 2015, SCHOOL PSYCHOL REV, V44, P249, DOI 10.17105/spr-15-0092.1; Calear AL, 2014, PSYCHIAT RES, V219, P525, DOI 10.1016/j.psychres.2014.06.027; Darke S., 1991, OPIATE TREATMENT IND; De Leo D, 2005, J AFFECT DISORDERS, V86, P215, DOI 10.1016/j.jad.2005.02.001; Eriksson M, 2018, SOC THEOR HEALTH, V16, P414, DOI 10.1057/s41285-018-0065-6; Handley TE, 2012, SOC PSYCH PSYCH EPID, V47, P1281, DOI 10.1007/s00127-011-0436-y; Hegerl U, 2013, NEUROSCI BIOBEHAV R, V37, P2404, DOI 10.1016/j.neubiorev.2013.02.009; Hintikka J., 2009, SOCIAL PSYCHIAT PSYC, V44; IoM, 2002, REDUCING SUICIDE NAT; Kamenopoulou L, 2016, PEDAGOGIKA, V88, P515; Kay-Lambkin FJ, 2011, MED J AUSTRALIA, V195, pS44; Krysinska K, 2016, AUST NZ J PSYCHIAT, V50, P115, DOI 10.1177/0004867415620024; Lecrubier Y, 2001, EUR PSYCHIAT, V16, P395, DOI 10.1016/S0924-9338(01)00596-X; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; McLeod J., 2011, QUALITATIVE RES COUN, DOI [10.1037/a0022067, DOI 10.1037/A0022067]; Mojtabai R, 2002, ARCH GEN PSYCHIAT, V59, P77, DOI 10.1001/archpsyc.59.1.77; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Onwuegbuzie AJ, 2007, QUAL REP, V12, P238; Osman A, 2001, ASSESSMENT, V8, P443, DOI 10.1177/107319110100800409; Rodgers B., 2009, THESIS; Rogoff B., 2003, CULTURAL NATURE HUMA; Steer R.A., 2000, BECK DEPRESSION INVE; Tadros G, 2001, BRIT J PSYCHIAT, V179, P178, DOI 10.1192/bjp.179.2.178; Teeson M., 2000, CTR LINES, V2, P3; Welsh E, 2002, FORUM QUALITATIVE SO, V3, P1; While D, 2012, LANCET, V379, P1005, DOI 10.1016/S0140-6736(11)61712-1; Wilson C.J., 2005, CANADIAN J COUNSELLI, V39, P15, DOI [DOI 10.1037/T42876-000, 10.1037/t42876-000]; Witte TK, 2010, J CLIN PSYCHOL, V66, P611, DOI 10.1002/jclp.20691; World Health Organization, 2014, PREV SUIC PREV SUIC; Wray N, 2007, QUAL HEALTH RES, V17, P1392, DOI 10.1177/1049732307308308	37	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231647	10.1371/journal.pone.0231647	http://dx.doi.org/10.1371/journal.pone.0231647			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9LH	32302340	Green Published, gold			2022-12-26	WOS:000536016100039
J	McFadden, SM; Malik, AA; Aguolu, OG; Willebrand, KS; Omer, SB				McFadden, SarahAnn M.; Malik, Amyn A.; Aguolu, Obianuju G.; Willebrand, Kathryn S.; Omer, Saad B.			Perceptions of the adult US population regarding the novel coronavirus outbreak	PLOS ONE			English	Article								The Coronavirus Disease 2019 (COVID-19) outbreak is spreading globally. Although COVID-19 has now been declared a pandemic and risk for infection in the United States (US) is currently high, at the time of survey administration the risk of infection in the US was low. It is important to understand the public perception of risk and trust in sources of information to better inform public health messaging. In this study, we surveyed the adult US population to understand their risk perceptions about the COVID-19 outbreak. We used an online platform to survey 718 adults in the US in early February 2020 using a questionnaire that we developed. Our sample was fairly similar to the general adult US population in terms of age, gender, race, ethnicity and education. We found that 69% of the respondents wanted the scientific/public health leadership (either the CDC Director or NIH Director) to lead the US response to COVID-19 outbreak as compared to 14% who wanted the political leadership (either the president or Congress) to lead the response. Risk perception was low (median score of 5 out of 10) with the respondents trusting health professionals and health officials for information on COVID-19. The majority of respondents were in favor of strict infection prevention policies to control the outbreak. Given our results, the public health/scientific leadership should be at the forefront of the COVID-19 response to promote trust.	[McFadden, SarahAnn M.; Malik, Amyn A.; Aguolu, Obianuju G.; Willebrand, Kathryn S.; Omer, Saad B.] Yale Inst Global Hlth, New Haven, CT 06510 USA; [McFadden, SarahAnn M.; Malik, Amyn A.; Aguolu, Obianuju G.; Omer, Saad B.] Yale Sch Med, Dept Internal Med, Infect Dis, New Haven, CT 06510 USA; [Willebrand, Kathryn S.; Omer, Saad B.] Yale Sch Publ Hlth, New Haven, CT 06510 USA; [Omer, Saad B.] Yale Sch Nursing, New Haven, CT 06510 USA	Yale University; Yale University; Yale University	Omer, SB (corresponding author), Yale Inst Global Hlth, New Haven, CT 06510 USA.; Omer, SB (corresponding author), Yale Sch Med, Dept Internal Med, Infect Dis, New Haven, CT 06510 USA.; Omer, SB (corresponding author), Yale Sch Publ Hlth, New Haven, CT 06510 USA.; Omer, SB (corresponding author), Yale Sch Nursing, New Haven, CT 06510 USA.	saad.omer@yale.edu	Malik, Amyn A./AAF-4883-2021	Malik, Amyn A./0000-0003-4875-9916; Willebrand, Kathryn/0000-0002-3391-2247				ACS, 2018, ACS 2018 5 YEAR EST; Centers for Disease Control and Prevention, 2019 NOV COR PREV TR; Centers for Disease Control and Prevention, COR DIS 2019 COVID 1, DOI DOI 10.1016/S0140-6736(20)30211-7; Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z; SANDMAN PM, 1993, RISK ANAL, V13, P585, DOI 10.1111/j.1539-6924.1993.tb01321.x; WHO, 2020, WEEKLY EPIDEMIOLOGIC	6	100	100	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231808	10.1371/journal.pone.0231808	http://dx.doi.org/10.1371/journal.pone.0231808			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ6LI	32302370	Green Published, gold, Green Submitted			2022-12-26	WOS:000530274100001
J	Torres, KG; Bezerra, IWL; Pereira, GS; Costa, RM; Souza, AM; Oliveira, AG				Torres, Karina G.; Bezerra, Ingrid W. L.; Pereira, Gabriela S.; Costa, Raiane M.; Souza, Anissa M.; Oliveira, Antonio G.			Long-term effect of the Brazilian Workers' Food Program on the nutritional status of manufacturing workers: A population-based prospective cohort study	PLOS ONE			English	Article								Background The Brazilian Workers Food Program (WFP) is a public policy program of nutritional assistance to workers, with the main objective of improving nutritional conditions, which was implemented 40 years ago and serves over 21.4 million workers. Objectives To compare the long-term change in anthropometric indicators of the nutritional status and dietary intake between workers of manufacturing industries adherent to and non-adherent to the WFP. Methods A prospective cohort study, based on a combined stratified and multistage probability sampling, was carried out, with two waves with a 4-year interval. The change in body mass index (BMI), waist circumference (WC) and dietary intake at lunch by the 24-hour recall method were compared between groups with analysis of covariance. Results A total of 273 workers in 16 industries from an initial cohort of 1069 workers in 26 industries of the State of Rio Grande do Norte in Brazil were evaluated in the two waves. The mean age was 37 +/- 10 years and 53.1% were male, with no differences between groups in age and sex distribution. BMI increased in both groups (0.44 kg/m2 in non-WFP, p = 0.003, and 0.56 kg/m2 in WFP, p = 0.0006) and WC increased in the WFP group (1.50 cm, p = 0.0006). BMI change over time did not show statistical differences between groups (p = 0.54) but WC had a greater increase in the WFP group (difference 1.37 cm, p = 0.047). There were no differences between groups in the change over time of the dietary intake. Conclusion BMI and WC increased over time in manufacturing workers of industries both adherent and non-adherent to the WFP, but with a greater increase of WC in the WFP group. In order to achieve the objectives of the WFP, there will be a need for periodic evaluation and monitoring of nutritional indicators in these workers and implementation of monitoring and enforcement actions of the WFP.	[Torres, Karina G.; Pereira, Gabriela S.; Costa, Raiane M.; Souza, Anissa M.] Univ Fed Rio Grande do Norte, Postgrad Program Hlth Sci, Natal, RN, Brazil; [Bezerra, Ingrid W. L.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Nutr Dept, Natal, RN, Brazil; [Oliveira, Antonio G.] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Bezerra, IWL (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Nutr Dept, Natal, RN, Brazil.	ingrid.nutri@hotmail.com			Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001 to IWLB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, GUIDELINES DATA PROC; Bortolozo Eliana Aparecida Queiroz, 2016, Dyna rev.fac.nac.minas, V83, P86, DOI 10.15446/dyna.v83n196.56612; Bowen DJ, 2015, ANNU REV PUBL HEALTH, V36, P289, DOI 10.1146/annurev-publhealth-032013-182516; Brasil Ministerio da Saude Secretaria de Atencao a Saude Departamento de Atencao Basica, 2011, OR COL AN DAD ANTR S; Canella DS, 2011, REV NUTR, V24, P715, DOI 10.1590/S1415-52732011000500005; Cunha RO, 2014, DEMETRA, V9, P963, DOI [10.12957/demetra.2014.11748, DOI 10.12957/DEMETRA.2014.11748]; Dias PC, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00006016, 10.1590/0102-311x00006016]; EDENRED, 2018, REL SUST AN; Jansky P, 2016, PRAGUE ECON PAP, V25, P706, DOI 10.18267/j.pep.587; Keranen AM, 2010, APPETITE, V55, P726, DOI 10.1016/j.appet.2010.08.012; Bezerra IWL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171821; Lynch BM, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-899; Matsudo S, 2001, REV BRAS ATIV SAUDE, V6, P5, DOI DOI 10.12820/RBAFS.V.6N2P5-18; Mazzon JA, 2016, 40 ANOS PROGRAMA ALI; Ministerio do Planejamento Orcamento e Gestao. Instituto Brasileiro de Geografia e Estatistica. IBGE, 2011, DIR PESQ COORD TRAB; Ministerio do Trabalho e Emprego, 2019, PROGR AL TRAB PAT; Ministerio do Trabalho e Emprego, 2006, PORT INT N 68 25 AG; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; Nucleo de Estudos e Pesquisas em Alimentacao-NEPA; Universidade Estadual de Campinas-UNICAMP, 2011, TAB BRAS COMP AL TAC, V4; Philippi ST, 2018, FOOD COMPOSITION TAB, V6th; Salvetti L. H., 2017, Ciencia & Saude, V10, P23, DOI 10.15448/1983-652X.2017.1.23634; Sarno Flávio, 2008, Rev. bras. epidemiol., V11, P453, DOI 10.1590/S1415-790X2008000300012; Sarti FM, 2015, REV POLITICAS PUBLIC, V5, P227; U. S. Department of Agriculture, NUTR DAT; Veloso IS, 2007, REV SAUDE PUBL, V41, P769, DOI 10.1590/S0034-89102007000500011; Vinholes DB, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-015755; World Health Organization, 2004, GLOB STRAT DIET PHYS	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231216	10.1371/journal.pone.0231216	http://dx.doi.org/10.1371/journal.pone.0231216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302329	gold, Green Published			2022-12-26	WOS:000536016100020
J	Zaller, ND; Neher, TL; Presley, M; Horton, H; Marshall, SA; Zielinski, MJ; Brinkley-Rubinstein, L				Zaller, Nickolas D.; Neher, Taylor L.; Presley, Makenzie; Horton, Heather; Marshall, S. Alexandra; Zielinski, Melissa J.; Brinkley-Rubinstein, Lauren			Barriers to linking high-risk jail detainees to HIV pre-exposure prophylaxis	PLOS ONE			English	Article							INCARCERATION; MEN; SEX; BEHAVIORS	Individuals involved in the criminal justice (CJ) system continue to be at disproportionate risk for HIV infection, and often have a greater prevalence of substance use and sexual related risk behaviors relative to their non-CJ involved peers. Pre-exposure prophylaxis (PrEP), a once daily antiretroviral medicine, is an evidence-based approach for reducing the risk of contracting HIV but limited data exist regarding the use of PrEP among CJ populations, especially in the U.S. South. This study was conducted at the Pulaski County Regional Detention Facility (PCRDF) in Little Rock, Arkansas (AR), the largest county jail in the state. We explored knowledge about PrEP and HIV, perceptions about PrEP feasibility in both the jail and community settings and barriers to PrEP program implementation, through in-depth qualitative interviews with 21 jail detainees. We purposively sampled individuals based on specific self-reported risk behavior, including sexual risk (both heterosexual and same-sex) and drug related risk (e.g. IDU), among all eligible individuals. We identified five primary themes from the interviews: 1) accessing healthcare during community reentry was a low priority; 2) perception of risk and interaction with people with HIV was low; 3) there are many barriers to disclosing HIV risk behaviors in jail settings; 4) knowledge of PrEP is low but willingness to use is high; and 5) multiple barriers exist to PrEP uptake post-release. Our findings are contextually unique and therefore have important implications for future implementation of PrEP access either within jail settings or linkage to PrEP post release.	[Zaller, Nickolas D.; Neher, Taylor L.; Presley, Makenzie; Horton, Heather; Marshall, S. Alexandra] Univ Arkansas Med Sci, Dept Hlth Behav & Hlth Educ, Little Rock, AR 72205 USA; [Zielinski, Melissa J.] Univ Arkansas Med Sci, Psychiat Res Inst, Little Rock, AR 72205 USA; [Brinkley-Rubinstein, Lauren] Univ N Carolina, Dept Social Med, Chapel Hill, NC 27515 USA; [Brinkley-Rubinstein, Lauren] Univ N Carolina, Ctr Hlth Equ Res, Chapel Hill, NC 27515 USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Zaller, ND (corresponding author), Univ Arkansas Med Sci, Dept Hlth Behav & Hlth Educ, Little Rock, AR 72205 USA.	ndzaller@uams.edu		Neher, Taylor/0000-0002-0050-8213; Zielinski, Melissa/0000-0002-1125-110X	National Institute on Minority Health and Health Disparities [U54MD002329]	National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Funding was received from the National Institute on Minority Health and Health Disparities supported this study which is undertaken at the Arkansas Center for Health Disparities (U54MD002329). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiona TC, 2009, INT J PRISON HEALTH, V5, P59, DOI 10.1080/17449200902880524; Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; Bauermeister JA, 2014, CURR HIV RES, V11, P520, DOI 10.2174/1570162X12666140129100411; Brewer RA, 2014, AM J PUBLIC HEALTH, V104, P448, DOI 10.2105/AJPH.2013.301786; Brinkley-Rubinstein L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205593; Carey J.W., 1996, CULTURAL ANTHR METHO, V8, P1; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Genberg BL, 2015, ADDICTION, V110, P1152, DOI 10.1111/add.12938; Goparaju Lakshmi, 2017, J AIDS Clin Res, V8, DOI 10.4172/2155-6113.1000730; Guest G., 2012, APPL THEMATIC ANAL V, DOI 10.4135/9781483384436; Khan MR, 2009, J URBAN HEALTH, V86, P584, DOI 10.1007/s11524-009-9348-5; Maruschak LM, 2010, BUR JUSTICE STAT B, V1-12, P1; Ojikutu BO, 2018, AIDS BEHAV, V22, P3576, DOI 10.1007/s10461-018-2067-8; Peterson M, 2019, AIDS CARE, V31, P364, DOI 10.1080/09540121.2018.1524114; Ramaswamy M, 2015, AM J HEALTH BEHAV, V39, P221, DOI 10.5993/AJHB.39.2.9; Ricks JM, 2015, AM J MENS HEALTH, V9, P132, DOI 10.1177/1557988314532680; Rutledge R, 2018, AIDS CARE, V30, P1282, DOI 10.1080/09540121.2018.1447079; Sakala, 2014, BREAKING MASS INCARC, P1; Siegler AJ, 2018, ANN EPIDEMIOL, V28, P841, DOI 10.1016/j.annepidem.2018.06.005; Wagner P., 2018, STATES INCARCERATION; Wise A, 2019, PUBLIC HEALTH REP, V134, p63S, DOI 10.1177/0033354919833435	21	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231951	10.1371/journal.pone.0231951	http://dx.doi.org/10.1371/journal.pone.0231951			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9LH	32302371	Green Published, gold			2022-12-26	WOS:000536016100062
J	Franz, KC; Suschek, CV; Grotheer, V; Akbas, M; Pallua, N				Franz, Katrin C.; Suschek, Christoph V.; Grotheer, Vera; Akbas, Mehmet; Pallua, Norbert			Impact of growth factor content on proliferation of mesenchymal stromal cells derived from adipose tissue	PLOS ONE			English	Article							FAT-GRAFT-SURVIVAL; TERM FOLLOW-UP; AUTOLOGOUS FAT; LONG-TERM; FACTOR-I; ANGIOGENIC PEPTIDE; ELEVATED LEVELS; SOLUBLE FORM; INSULIN; TRANSPLANTATION	Autologous adipose tissue (AT) transfer has gained widespread acceptance and is used for a broad variety of regenerative clinical indications. It is assumed that the successful outcome of AT transfer essentially depends on the amount of autocrine-generated growth factors (GF). It is supposed that several GF enhance and improve the anatomic and functional integration of the transplanted AT grafts at the site of implantation. In the present study we have investigated for the first time the correlation between the concentration of GF of freshly isolated AT and the proliferation and migration capacity of mesenchymal stroma cells (MSCs) derived from the respective AT sample. We here show that the proliferation and migration capacity of MSCs strongly depends on the GF content of the AT the cells were isolated from but in an inversely proportional manner. The lower the GF content of an AT sample was, the higher was the proliferation and migration capacity of the respective MSC population contained in the AT and vice versa. Furthermore, we found that supplementation with recombinant GFs only in the case of AT samples with low but not with higher growth factor contents led to a significant enhancement of proliferation and migration of the AT-resident MSCs. As we further show, this inefficiency of GFs to enhance MSC proliferation and migration in AT samples with high GF contents indicates a GF-mediated negative feedback mechanism leading to an impaired GF signaling in MSC obtained from those AT samples. Our results might explain why the successful use of AT grafting is frequently limited by low and unpredictable survival rates, and we suggest to use the knowledge of GF content of harvested AT as a predictive clinical parameter for risk assessment of the therapeutic outcome of autologous AT transfer.	[Franz, Katrin C.; Suschek, Christoph V.; Pallua, Norbert] Hand Surg & Burn Ctr, Dept Plast & Reconstruct Surg, Fac Med, Pauwelsstr, Aachen, Germany; [Suschek, Christoph V.; Grotheer, Vera] Heinrich Heine Univ Dusseldorf, Dept Orthopaed & Trauma Surg, Fac Med, Moorenstr, Dusseldorf, Germany; [Akbas, Mehmet] Arteo Clin Plast & Aesthet Surg, Johannstr, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Suschek, CV (corresponding author), Hand Surg & Burn Ctr, Dept Plast & Reconstruct Surg, Fac Med, Pauwelsstr, Aachen, Germany.; Suschek, CV (corresponding author), Heinrich Heine Univ Dusseldorf, Dept Orthopaed & Trauma Surg, Fac Med, Moorenstr, Dusseldorf, Germany.	suschek@hhu.de			Faculty of Medicine of the RWTH Aachen University	Faculty of Medicine of the RWTH Aachen University	This work was supported by the Faculty of Medicine of the RWTH Aachen University and the Faculty of Medicine of the Heinrich-HeineUniversity Dusseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; Bluher S, 2005, BEST PRACT RES CL EN, V19, P577, DOI 10.1016/j.beem.2005.07.011; BONEY CM, 1994, ENDOCRINOLOGY, V135, P1863, DOI 10.1210/en.135.5.1863; Boschert MT, 2002, PLAST RECONSTR SURG, V109, P761, DOI 10.1097/00006534-200202000-00054; Branney PA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004951; BROWNSEY RW, 1984, BIOCHEM J, V218, P733, DOI 10.1042/bj2180733; CARPANEDA CA, 1994, AESTHET PLAST SURG, V18, P17, DOI 10.1007/BF00444242; Coleman SR, 2007, PLAST RECONSTR SURG, V119, P775, DOI 10.1097/01.prs.0000252001.59162.c9; Cortese A, 2000, J ORAL MAXIL SURG, V58, P164, DOI 10.1016/S0278-2391(00)90331-8; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; DUNN GA, 1978, EXP CELL RES, V111, P475, DOI 10.1016/0014-4827(78)90196-9; EPPLEY BL, 1991, AESTHET PLAST SURG, V15, P215, DOI 10.1007/BF02273860; EPPLEY BL, 1992, PLAST RECONSTR SURG, V90, P1022, DOI 10.1097/00006534-199212000-00013; Eremia S, 2000, DERMATOL SURG, V26, P1150, DOI 10.1046/j.1524-4725.2000.00277.x; ERSEK RA, 1991, PLAST RECONSTR SURG, V87, P219, DOI 10.1097/00006534-199102000-00001; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; FAWCETT DW, 1948, ENDOCRINOLOGY, V42, P454, DOI 10.1210/endo-42-6-454; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Hausman GJ, 2004, J ANIM SCI, V82, P925; ILLOUZ YG, 1988, AESTHET PLAST SURG, V12, P175, DOI 10.1007/BF01570929; Jackson IT, 2001, AESTHET PLAST SURG, V25, P165, DOI 10.1007/s002660010115; Kaminer MS, 2001, ARCH DERMATOL, V137, P812; Kaufman MR, 2007, PLAST RECONSTR SURG, V119, P2287, DOI 10.1097/01.prs.0000260712.44089.e7; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Kershen RT, 1999, UROL CLIN N AM, V26, P81, DOI 10.1016/S0094-0143(99)80008-1; KHOURI RK, 1991, BRIT J PLAST SURG, V44, P585, DOI 10.1016/0007-1226(91)90094-Z; KLEINMAN HK, 1981, J CELL BIOL, V88, P473, DOI 10.1083/jcb.88.3.473; KONONAS TC, 1993, PLAST RECONSTR SURG, V91, P763, DOI 10.1097/00006534-199304001-00001; Lanner F, 2010, DEVELOPMENT, V137, P3351, DOI 10.1242/dev.050146; Masuda T, 2004, TISSUE ENG, V10, P1672, DOI 10.1089/ten.2004.10.1672; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; McCulloch TM, 2002, LARYNGOSCOPE, V112, P1235, DOI 10.1097/00005537-200207000-00017; Nakagami H, 2005, ARTERIOSCL THROM VAS, V25, P2542, DOI 10.1161/01.ATV.0000190701.92007.6d; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; NGUYEN A, 1990, PLAST RECONSTR SURG, V85, P378, DOI 10.1097/00006534-199003000-00007; NGUYEN M, 1993, J NATL CANCER I, V85, P241, DOI 10.1093/jnci/85.3.241; NGUYEN M, 1994, J NATL CANCER I, V86, P356, DOI 10.1093/jnci/86.5.356; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Pallua N, 2009, PLAST RECONSTR SURG, V123, P826, DOI 10.1097/PRS.0b013e318199ef31; Patrick CW, 2000, SEMIN SURG ONCOL, V19, P302, DOI 10.1002/1098-2388(200010/11)19:3<302::AID-SSU12>3.0.CO;2-S; PINSKI KS, 1992, J DERMATOL SURG ONC, V18, P179, DOI 10.1111/j.1524-4725.1992.tb02795.x; Ramon Y, 2005, PLAST RECONSTR SURG, V115, P197, DOI 10.1097/01.PRS.0000145713.49152.77; Rodrigues M, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt32; Rophael JA, 2007, AM J PATHOL, V171, P2048, DOI 10.2353/ajpath.2007.070066; Saito T, 2013, FEBS LETT, V587, P2179, DOI 10.1016/j.febslet.2013.05.038; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SCHWEIGERER L, 1988, KLIN WOCHENSCHR, V66, P340, DOI 10.1007/BF01735791; SCHWEIGERER L, 1989, Z KARDIOL, V78, P12; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; SMAHEL J, 1986, ANN PLAS SURG, V16, P444, DOI 10.1097/00000637-198605000-00012; Sommer B, 2000, DERMATOL SURG, V26, P1159, DOI 10.1046/j.1524-4725.2000.00278.x; Stellavato A, 2017, CELL PHYSIOL BIOCHEM, V44, P1078, DOI 10.1159/000485414; Suga H, 2010, PLAST RECONSTR SURG, V126, P1911, DOI 10.1097/PRS.0b013e3181f4468b; Tsang Michael, 2004, Sci STKE, V2004, ppe17, DOI 10.1126/stke.2282004pe17; Ullah M, 2019, ISCIENCE, V15, P421, DOI 10.1016/j.isci.2019.05.004; WABITSCH M, 1995, METABOLISM, V44, P45, DOI 10.1016/0026-0495(95)90220-1; Weroha SJ, 2012, ENDOCRIN METAB CLIN, V41, P335, DOI 10.1016/j.ecl.2012.04.014; Yamaguchi M, 2005, EXP BIOL MED, V230, P742, DOI 10.1177/153537020523001007; Yuksel E, 2000, PLAST RECONSTR SURG, V105, P1712, DOI 10.1097/00006534-200004050-00017	61	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230265	10.1371/journal.pone.0230265	http://dx.doi.org/10.1371/journal.pone.0230265			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298282	Green Published, gold			2022-12-26	WOS:000536011400013
J	Scarcello, E; Lambremont, A; Vanbever, R; Jacques, PJ; Lison, D				Scarcello, Eleonora; Lambremont, Alexia; Vanbever, Rita; Jacques, Pascal J.; Lison, Dominique			Mind your assays: Misleading cytotoxicity with the WST-1 assay in the presence of manganese	PLOS ONE			English	Article							IN-VIVO; MTT ASSAY; FE; ALLOYS; MN; DESIGN; VITRO	The WST-1 assay is the most common test to assess the in vitro cytotoxicity of chemicals. Tetrazolium-based assays can, however, be affected by the interference of tested chemicals, including carbon nanotubes or Mg particles. Here, we report a new interference of Mn materials with the WST-1 assay. Endothelial cells exposed to Mn particles (Mn alone or Fe-Mn alloy from 50 to 1600 mu g/ml) were severely damaged according to the WST-1 assay, but not the ATP content assay. Subsequent experiments revealed that Mn particles interfere with the reduction of the tetrazolium salt to formazan. Therefore, the WST-1 assay is not suitable to evaluate the in vitro cytotoxicity of Mn-containing materials, and luminescence-based assays such as CellTiter-Glo (R) appear more appropriate.	[Scarcello, Eleonora; Lison, Dominique] Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, Brussels, Belgium; [Lambremont, Alexia; Jacques, Pascal J.] Catholic Univ Louvain, Inst Mech Mat & Civil Engn, Louvain La Neuve, Belgium; [Vanbever, Rita] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain	Scarcello, E (corresponding author), Catholic Univ Louvain, Louvain Ctr Toxicol & Appl Pharmacol, Brussels, Belgium.	eleonora.scarcello@uclouvain.be	Lison, Dominique/A-8985-2010	Scarcello, Eleonora/0000-0003-2077-6212	Communaute francaise de Belgique Sections de Recherche Concertees [15/20-066]	Communaute francaise de Belgique Sections de Recherche Concertees	ES is financed by the "Communaute francaise de Belgique. Sections de Recherche Concertees" [contract 15/20-066]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almutary A, 2016, INT J TOXICOL, V35, P454, DOI 10.1177/1091581816648906; Berridge MV, 2005, BIOTECHNOL ANN REV, V11, P127, DOI 10.1016/S1387-2656(05)11004-7; Berridge MV, 1998, PROTOPLASMA, V205, P74, DOI 10.1007/BF01279296; BOUAZIZ S, 2011, MATER DESIGN, V15, P141, DOI DOI 10.1016/J.C0SSMS.2011.04.002; Chacon E., 1997, IN VITRO METHODS PHA, P209; Cheng J, 2013, J MATER SCI TECHNOL, V29, P619, DOI 10.1016/j.jmst.2013.03.019; Feng QM, 2013, J MATER SCI-MATER M, V24, P713, DOI 10.1007/s10856-012-4823-z; Fischer J, 2010, ACTA BIOMATER, V6, P1813, DOI 10.1016/j.actbio.2009.10.020; Hermawan H, 2010, J BIOMED MATER RES A, V93A, P1, DOI 10.1002/jbm.a.32224; Idrissi H, 2010, ACTA MATER, V58, P2464, DOI 10.1016/j.actamat.2009.12.032; ISO, 1099352009 ISO; JABBAR SAB, 1989, BRIT J CANCER, V60, P523, DOI 10.1038/bjc.1989.306; Kraus T, 2014, ACTA BIOMATER, V10, P3346, DOI 10.1016/j.actbio.2014.04.007; Liu RY, 2018, ACTA METALL SIN-ENGL, V31, P584, DOI 10.1007/s40195-018-0702-z; Lovat V, 2005, NANO LETT, V5, P1107, DOI 10.1021/nl050637m; Lu G, 2005, NANO LETT, V5, P897, DOI 10.1021/nl050354u; Monteiro-Riviere NA, 2009, TOXICOL APPL PHARM, V234, P222, DOI 10.1016/j.taap.2008.09.030; Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029; Schinhammer M, 2013, MAT SCI ENG C-MATER, V33, P1882, DOI 10.1016/j.msec.2012.10.013; van Tonder Alet, 2015, BMC Res Notes, V8, P47, DOI 10.1186/s13104-015-1000-8; Wasserman SM, 2002, PHYSIOL GENOMICS, V12, P13, DOI 10.1152/physiolgenomics.00102.2002; Williams DF, 2014, BIOMATERIALS, V35, P10009, DOI 10.1016/j.biomaterials.2014.08.035; Witte F, 2010, ACTA BIOMATER, V6, P1680, DOI 10.1016/j.actbio.2010.02.028; Worle-Knirsch JM, 2006, NANO LETT, V6, P1261, DOI 10.1021/nl060177c; Xue DC, 2012, J MATER SCI TECHNOL, V28, P261, DOI 10.1016/S1005-0302(12)60051-6	25	18	18	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231634	10.1371/journal.pone.0231634	http://dx.doi.org/10.1371/journal.pone.0231634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298350	Green Published, gold			2022-12-26	WOS:000536011400079
J	Schruf, E; Schroeder, V; Le, HQ; Schonberger, T; Raedel, D; Stewart, EL; Fundel-Clemens, K; Bluhmki, T; Weigle, S; Schuler, M; Thomas, MJ; Heilker, R; Webster, MJ; Dass, M; Frick, M; Stierstorfer, B; Quast, K; Garnett, JP				Schruf, Eva; Schroeder, Victoria; Le, Huy Q.; Schoenberger, Tanja; Raedel, Dagmar; Stewart, Emily L.; Fundel-Clemens, Katrin; Bluhmki, Teresa; Weigle, Sabine; Schuler, Michael; Thomas, Matthew J.; Heilker, Ralf; Webster, Megan J.; Dass, Martin; Frick, Manfred; Stierstorfer, Birgit; Quast, Karsten; Garnett, James P.			Recapitulating idiopathic pulmonary fibrosis related alveolar epithelial dysfunction in a human iPSC-derived air-liquid interface model	FASEB JOURNAL			English	Article						alveolar epithelium; bronchiolization; induced pluripotent stem cells; IPF; pro-fibrotic milieu	BRONCHOALVEOLAR LAVAGE FLUID; PLURIPOTENT STEM-CELLS; CYTOKINE PROFILE; PROGENITOR CELLS; LUNG EPITHELIUM; LAMELLAR BODIES; IN-VITRO; DIFFERENTIATION; REPAIR; INTERLEUKIN-13	Idiopathic pulmonary fibrosis (IPF) is a fatal disease of unknown cause that is characterized by progressive fibrotic lung remodeling. An abnormal emergence of airway epithelial-like cells within the alveolar compartments of the lung, herein termed bronchiolization, is often observed in IPF. However, the origin of this dysfunctional distal lung epithelium remains unknown due to a lack of suitable human model systems. In this study, we established a human induced pluripotent stem cell (iPSC)-derived air-liquid interface (ALI) model of alveolar epithelial type II (ATII)-like cell differentiation that allows us to investigate alveolar epithelial progenitor cell differentiation in vitro. We treated this system with an IPF-relevant cocktail (IPF-RC) to mimic the pro-fibrotic cytokine milieu present in IPF lungs. Stimulation with IPF-RC during differentiation increases secretion of IPF biomarkers and RNA sequencing (RNA-seq) of these cultures reveals significant overlap with human IPF patient data. IPF-RC treatment further impairs ATII differentiation by driving a shift toward an airway epithelial-like expression signature, providing evidence that a pro-fibrotic cytokine environment can influence the proximo-distal differentiation pattern of human lung epithelial cells. In conclusion, we show for the first time, the establishment of a human model system that recapitulates aspects of IPF-associated bronchiolization of the lung epithelium in vitro.	[Schruf, Eva; Schroeder, Victoria; Le, Huy Q.; Stewart, Emily L.; Thomas, Matthew J.; Webster, Megan J.; Garnett, James P.] Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany; [Schoenberger, Tanja; Bluhmki, Teresa; Weigle, Sabine; Schuler, Michael; Heilker, Ralf; Frick, Manfred; Stierstorfer, Birgit] Boehringer Ingelheim Pharma GmbH & Co KG, Drug Discovery Sci, Biberach, Germany; [Raedel, Dagmar; Dass, Martin] Boehringer Ingelheim Pharma GmbH & Co KG, Nonclin Drug Safety, Biberach, Germany; [Fundel-Clemens, Katrin; Quast, Karsten] Boehringer Ingelheim Pharma GmbH & Co KG, Global Computat Biol, Biberach, Germany; [Garnett, James P.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England	Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Boehringer Ingelheim; Newcastle University - UK	Garnett, JP (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Birkendorfer Str 65, D-88397 Biberach, Germany.	james.garnett@boehringer-ingelheim.com	Frick, Manfred/E-1374-2012; Le, Huy/AAW-4220-2021	Frick, Manfred/0000-0002-4763-1104; Le, Huy/0000-0002-0851-9320; Thomas, Matthew/0000-0003-3472-3904	Boehringer Ingelheim Pharma GmbH Co.KG; UK Medical Research Foundation Fellowship [MRF-091-0001-RG-GARNE]	Boehringer Ingelheim Pharma GmbH Co.KG(Boehringer Ingelheim); UK Medical Research Foundation Fellowship	Boehringer Ingelheim Pharma GmbH & Co.KG; UK Medical Research Foundation Fellowship, Grant/Award Number: MRF-091-0001-RG-GARNE	Agostini Carlo, 2006, Proc Am Thorac Soc, V3, P357, DOI 10.1513/pats.200601-010TK; Akram KM, 2013, EUR RESPIR J, V41, P683, DOI 10.1183/09031936.00213411; BARITUSSIO AG, 1981, BIOCHIM BIOPHYS ACTA, V666, P382, DOI 10.1016/0005-2760(81)90297-6; Barkauskas CE, 2013, J CLIN INVEST, V123, P3025, DOI 10.1172/JCI68782; Barlo NP, 2011, CLIN EXP IMMUNOL, V166, P346, DOI 10.1111/j.1365-2249.2011.04468.x; Bellanger AP, 2016, J IMMUNOL METHODS, V434, P61, DOI 10.1016/j.jim.2016.04.008; Bertoncello I, 2016, J CELL PHYSIOL, V231, P2582, DOI 10.1002/jcp.25404; Bingle CD, 2013, THORAX, V68, P1167, DOI 10.1136/thoraxjnl-2013-204179; Buendia-Roldan I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168552; Chambers Rachel C, 2015, Ann Am Thorac Soc, V12 Suppl 1, pS16, DOI 10.1513/AnnalsATS.201410-448MG; CHANDER A, 1986, J BIOL CHEM, V261, P6126; Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510; Chen Y, 2018, STEM CELLS DEV, V27, P1339, DOI 10.1089/scd.2018.0042; Evans CM, 2016, PHYSIOL REV, V96, P1567, DOI 10.1152/physrev.00004.2016; Firth AL, 2014, P NATL ACAD SCI USA, V111, pE1723, DOI 10.1073/pnas.1403470111; Gotoh S, 2014, STEM CELL REP, V3, P394, DOI 10.1016/j.stemcr.2014.07.005; Guiot J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171344; Hong GH, 2018, RESP RES, V19, DOI 10.1186/s12931-018-0863-3; Huang SXL, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.023; Huang SXL, 2014, NAT BIOTECHNOL, V32, P84, DOI 10.1038/nbt.2754; Jacob A, 2017, CELL STEM CELL, V21, P472, DOI 10.1016/j.stem.2017.08.014; Keenan AB, 2019, NUCLEIC ACIDS RES, V47, pW212, DOI 10.1093/nar/gkz446; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Knudsen L, 2017, CELL TISSUE RES, V367, P607, DOI 10.1007/s00441-016-2543-2; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Kusko RL, 2016, AM J RESP CRIT CARE, V194, P948, DOI 10.1164/rccm.201510-2026OC; Lederer DJ, 2018, NEW ENGL J MED, V378, P1811, DOI 10.1056/NEJMra1705751; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lee JU, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0380-z; Li L, 2015, CELL PHYSIOL BIOCHEM, V37, P1113, DOI 10.1159/000430236; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lin LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14602-7; Maher TM, 2017, LANCET RESP MED, V5, P946, DOI 10.1016/S2213-2600(17)30430-7; Mao P, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12288; McDonough JE, 2019, THORAX, V74, P132, DOI 10.1136/thoraxjnl-2018-211929; Meloni F, 2004, SARCOIDOSIS VASC DIF, V21, P111; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Miller AJ, 2018, STEM CELL REP, V10, P101, DOI 10.1016/j.stemcr.2017.11.012; Moore BB, 2013, AM J RESP CELL MOL, V49, P167, DOI 10.1165/rcmb.2013-0094TR; Murray LA, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92192; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Nikolic MZ, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.163485; Nikolic MZ, 2017, ELIFE, V6, DOI [10.7554/eLife.26575, 10.7554/eLife.26575.001]; Ochieng JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107248; Park SW, 2009, J KOREAN MED SCI, V24, P614, DOI 10.3346/jkms.2009.24.4.614; Parker JM, 2018, AM J RESP CRIT CARE, V197, P94, DOI 10.1164/rccm.201704-0784OC; Passalacqua G, 2017, PULM PHARMACOL THER, V45, P95, DOI 10.1016/j.pupt.2017.05.007; Plantier L, 2011, THORAX, V66, P651, DOI 10.1136/thx.2010.151555; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rockich BE, 2013, P NATL ACAD SCI USA, V110, pE4456, DOI 10.1073/pnas.1311847110; de Carvalho ALRT, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.171652; Rosas IO, 2008, PLOS MED, V5, P623, DOI 10.1371/journal.pmed.0050093; Ryu JH, 2014, MAYO CLIN PROC, V89, P1130, DOI 10.1016/j.mayocp.2014.03.016; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schruf E, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1058-2; Seibold MA, 2018, ANN AM THORAC SOC, V15, pS98, DOI 10.1513/AnnalsATS.201711-868MG; Seibold MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058658; Seibold MA, 2011, NEW ENGL J MED, V364, P1503, DOI 10.1056/NEJMoa1013660; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Selman M, 2008, PLOS MED, V5, P373, DOI 10.1371/journal.pmed.0050062; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; Smirnova NF, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0404-x; Smith M, 2013, J CLIN PATHOL, V66, P896, DOI 10.1136/jclinpath-2013-201442; Sollner JF, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.185; Sokai A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0280-9; Stahlman MT, 2007, J HISTOCHEM CYTOCHEM, V55, P71, DOI 10.1369/jhc.6A6962.2006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundarakrishnan A, 2018, ADV DRUG DELIVER REV, V129, P78, DOI 10.1016/j.addr.2017.12.013; Tasaka S, 2012, RESPIROLOGY, V17, P814, DOI 10.1111/j.1440-1843.2012.02182.x; Tompkins DH, 2011, AM J RESP CELL MOL, V45, P101, DOI 10.1165/rcmb.2010-0149OC; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Van der Velden JL, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-123; Vasakova M, 2009, SCAND J IMMUNOL, V69, P268, DOI 10.1111/j.1365-3083.2008.02222.x; Weigle Sabine, 2019, Journal of Biological Methods, V6, pe115, DOI 10.14440/jbm.2019.285; Whitsett JA, 2011, AM J RESP CRIT CARE, V184, P401, DOI 10.1164/rccm.201103-0495PP; Winters NI, 2019, AM J MED SCI, V357, P374, DOI 10.1016/j.amjms.2019.01.010; Wong AP, 2012, NAT BIOTECHNOL, V30, P876, DOI 10.1038/nbt.2328; Xu XF, 2016, CLIN RESPIR J, V10, P133, DOI 10.1111/crj.12190; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yamamoto Y, 2017, NAT METHODS, V14, P1097, DOI [10.1038/NMETH.4448, 10.1038/nmeth.4448]; Yang IV, 2013, THORAX, V68, P1114, DOI 10.1136/thoraxjnl-2012-202943; Zacharias WJ, 2018, NATURE, V555, P251, DOI 10.1038/nature25786; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034; Zhang YW, 2016, RESPIROLOGY, V21, P143, DOI 10.1111/resp.12659	90	14	15	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7825	7846		10.1096/fj.201902926R	http://dx.doi.org/10.1096/fj.201902926R		APR 2020	22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297676	Green Published, hybrid			2022-12-26	WOS:000526650100001
J	Yasmin, H; Naeem, S; Bakhtawar, M; Jabeen, Z; Nosheen, A; Naz, R; Keyani, R; Mumtaz, S; Hassan, MN				Yasmin, Humaira; Naeem, Sana; Bakhtawar, Murk; Jabeen, Zahra; Nosheen, Asia; Naz, Rabia; Keyani, Rumana; Mumtaz, Saqib; Hassan, Muhammad Nadeem			Halotolerant rhizobacteria Pseudomonas pseudoalcaligenes and Bacillus subtilis mediate systemic tolerance in hydroponically grown soybean (Glycine max L.) against salinity stress	PLOS ONE			English	Article							PLANT-GROWTH; SALT STRESS; ANTIOXIDANT ENZYMES; SUPEROXIDE-DISMUTASE; RESPONSIVE PROTEINS; PROTEOMIC ANALYSIS; ABIOTIC STRESS; PEROXIDASE; EXPRESSION; GENE	Salt stress is one of the devastating factors that hampers growth and productivity of soybean. Use of Pseudomonas pseudoalcaligenes to improve salt tolerance in soybean has not been thoroughly explored yet. Therefore, we observed the response of hydroponically grown soybean plants, inoculated with halotolerant P. pseudoalcaligenes (SRM-16) and Bacillus subtilis (SRM-3) under salt stress. In vitro testing of 44 bacterial isolates revealed that four isolates showed high salt tolerance. Among them, B. subtilis and P. pseudoalcaligenes showed ACC deaminase activity, siderophore and indole acetic acid (IAA) production and were selected for the current study. We determined that 10(6) cells/mL of B. subtilis and P. pseudoalcaligenes was sufficient to induce tolerance in soybean against salinity stress (100 mM NaCl) in hydroponics by enhancing plant biomass, relative water content and osmolytes. Upon exposure of salinity stress, P. pseudoalcaligenes inoculated soybean plants showed tolerance by the increased activities of defense related system such as ion transport, antioxidant enzymes, proline and MDA content in shoots and roots. The Na+ concentration in the soybean plants was increased in the salt stress; while, bacterial priming significantly reduced the Na+ concentration in the salt stressed soybean plants. However, the antagonistic results were observed for K+ concentration. Additionally, soybean primed with P. pseudoalcaligenes and exposed to 100 mM NaCl showed a new protein band of 28 kDa suggesting that P. pseudoalcaligenes effectively reduced salt stress. Our results showed that salinity tolerance was more pronounced in P. pseudoalcaligenes as compared to B. subtilis. However, a detailed study at molecular level to interpret the mechanism by which P. pseudoalcaligenes alleviates salt stress in soybean plants need to be explored.	[Yasmin, Humaira; Naeem, Sana; Bakhtawar, Murk; Jabeen, Zahra; Nosheen, Asia; Naz, Rabia; Keyani, Rumana; Mumtaz, Saqib; Hassan, Muhammad Nadeem] COMSATS Univ Islamabad CUI, Dept Biosci, Islamabad Campus, Islamabad, Pakistan	COMSATS University Islamabad (CUI)	Yasmin, H (corresponding author), COMSATS Univ Islamabad CUI, Dept Biosci, Islamabad Campus, Islamabad, Pakistan.	humaira.yasmin@comsats.edu.pk	Yasmin, Humaira/ABB-1384-2021; Yasmin, Humaira/AAS-9944-2020; Mumtaz, Saqib/AGP-1977-2022; Yasmin, Humaira/AAO-6630-2020; Hassan, Muhammad/GWZ-4054-2022; Hassan, Mohammad/GZA-7507-2022	Yasmin, Humaira/0000-0002-4220-4808; Yasmin, Humaira/0000-0002-8738-4216; Hassan, Mohammad/0000-0002-1712-0004; Mumtaz, Saqib/0000-0002-3319-5671	COMSATS research grant program	COMSATS research grant program	Dr Humaira Yasmin won the research grant from COMSATS research grant program for this research work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdElgawad H, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2016.00276, 10.3389/fpls.2016.00556]; Adhikari B., 2020, J SAUDI SOC AGR SCI, V19, P261, DOI DOI 10.1016/J.JSSAS.2019.02.001; Akhtar W, 2017, PAK J BOT, V49, P21; Albdaiwi RN, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01639; Annunziata MG, 2017, J EXP BOT, V68, P4463, DOI 10.1093/jxb/erx220; Barampuram S, 2014, PLANT CELL TISS ORG, V118, P179, DOI 10.1007/s11240-014-0472-x; Bashan Y, 2004, CAN J MICROBIOL, V50, P521, DOI 10.1139/W04-035; Ben Rejeb K, 2014, PLANT PHYSIOL BIOCH, V80, P278, DOI 10.1016/j.plaphy.2014.04.007; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Bharti N, 2014, ACTA PHYSIOL PLANT, V36, P45, DOI 10.1007/s11738-013-1385-8; Boeckx T, 2015, ANN BOT-LONDON, V116, P529, DOI 10.1093/aob/mcv081; Buege J A, 1978, Methods Enzymol, V52, P302; BURNISON BK, 1980, CAN J FISH AQUAT SCI, V37, P729, DOI 10.1139/f80-095; Carillo P., 2011, PROTOCOL EXTRACTION; Chen HT, 2018, J INTEGR AGR, V17, P2215, DOI [10.1016/S2095-3119(17)61864-1, 10.1016/s2095-3119(17)61864-1]; Chojak-Kozniewska J, 2017, ENVIRON EXP BOT, V136, P9, DOI 10.1016/j.envexpbot.2017.01.004; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; DHAKED BS, 2017, INT J CURR MICROBIOL, V6, P1271, DOI DOI 10.20546/IJCMAS.2017.608.154; Egamberdieva D, 2017, J PLANT INTERACT, V12, P100, DOI 10.1080/17429145.2017.1294212; El-Esawi MA, 2018, PLANT PHYSIOL BIOCH, V132, P375, DOI 10.1016/j.plaphy.2018.09.026; GAD N, 2005, RES J AGR BIOL SCI, V1, P270; GAUTAM M, 2017, ADV BIOTECHNOL MICRO, V4, P1, DOI DOI 10.19080/AIBM.2017.04.555633; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Gomathi R., 2006, Sugar Tech, V8, P124, DOI 10.1007/BF02943645; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; GORIN N, 1976, J AGR FOOD CHEM, V24, P200, DOI 10.1021/jf60203a043; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Heidari M., 2012, African Journal of Biotechnology, V11, P379; JACOBSON CB, 1994, CAN J MICROBIOL, V40, P1019, DOI 10.1139/m94-162; Jamil M, 2007, SCI AGR, V64, P111, DOI 10.1590/S0103-90162007000200002; Ji W, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00573; Jincy M, 2017, SCI HORTIC-AMSTERDAM, V218, P316, DOI 10.1016/j.scienta.2017.02.026; Joseph Baby, 2010, Asian Journal of Plant Sciences, V9, P307; KAHN V, 1975, J SCI FOOD AGR, V26, P1319, DOI 10.1002/jsfa.2740260910; Karnwal Arun, 2018, F1000Res, V7, P112, DOI 10.12688/f1000research.13644.1; Kasotia A, 2016, MICROBIAL MEDIATED A, P155; Kumar GP, 2014, INT J BACTERIOL, DOI [10.1155/2014/195946, DOI 10.1155/2014/195946]; Kumar M, 2010, BIOMETALS, V23, P315, DOI 10.1007/s10534-010-9290-8; Kumari S, 2015, J PLANT GROWTH REGUL, V34, P558, DOI 10.1007/s00344-015-9490-0; Kusvuran S, 2016, ABIOTIC AND BIOTIC STRESS IN PLANTS - RECENT ADVANCES AND FUTURE PERSPECTIVES, P481, DOI 10.5772/62235; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu CW, 2014, PROTEOMICS, V14, P1759, DOI 10.1002/pmic.201300276; Liu Y, 2016, FRONTIERS PLANT SCI, V2019; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luck H., 1965, METHOD ENZYMATIC ANA, P885, DOI DOI 10.1016/B978-0-12-395630-9.50158-4; Mesa-Marin J, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01500; Murithi HM, 2016, PLANT PATHOL, V65, P176, DOI 10.1111/ppa.12457; Niknam V, 2006, BIOL PLANTARUM, V50, P591, DOI 10.1007/s10535-006-0093-2; Niu B, 2017, P NATL ACAD SCI USA, V114, pE2450, DOI 10.1073/pnas.1616148114; Okuno A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086870; Pan J, 2019, MDPI, V11, P1, DOI 10.3390/su11020378; Pandolfi C, 2016, J PLANT PHYSIOL, V201, P1, DOI 10.1016/j.jplph.2016.06.010; Paradiso R, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00674; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Queiroz HM, 2012, BRAZ ARCH BIOL TECHN, V55, P809, DOI 10.1590/S1516-89132012000600002; Radhakrishnan R, 2013, J PLANT GROWTH REGUL, V32, P22, DOI 10.1007/s00344-012-9274-8; Raghuwanshi R, 2018, SOIL BIOL, V52, P303, DOI 10.1007/978-3-319-75910-4_12; Rahman Shafkat Shamim, 2017, BMC Res Notes, V10, P531, DOI 10.1186/s13104-017-2855-7; Renau-Morata B, 2014, BIO PROTOC; Salwan R, 2019, PLANT SOIL, V442, P1, DOI 10.1007/s11104-019-04202-x; Sambrook J, 2001, MOL CLON, V2, P1319; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Silveira JAG, 2001, ENV EXPT BOT, V46, P37, DOI 10.1016/s0098-8472(01)00082-x; Singhal P, 2016, FRONT LIFE SCI, V9, P52, DOI 10.1080/21553769.2015.1077478; Starlin T, 2010, ENZYMATIC NONENZYMAT, V6, P4; STASWICK PE, 1994, ANNU REV PLANT PHYS, V45, P303, DOI 10.1146/annurev.pp.45.060194.001511; STEEL R. G. D., 1960, Principles and procedures of statistics.; Sukweenadhi J, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00813; Suzuki LS, 2003, PHYTON-ANN REI BOT A, V43, P179; Tewari S, 2016, PLANT GROWTH PROMOTI, P131, DOI 10.1016/B978-0-12-801536-000006-2; THOMAS RL, 1967, AGRON J, V59, P240, DOI 10.2134/agronj1967.00021962005900030010x; Vaishnav A, 2015, J APPL MICROBIOL, V119, P539, DOI 10.1111/jam.12866; Valifard M., 2015, Australian Journal of Crop Science, V9, P656; VETTER JL, 1958, J AGR FOOD CHEM, V6, P39, DOI 10.1021/jf60083a006; Wakelin S, 2017, BIOCONTROL SCI TECHN, V27, P139, DOI 10.1080/09583157.2016.1248899; Wang W, 2016, BIOCHEMISTRY-MOSCOW+, V81, P465, DOI 10.1134/S0006297916050047; Weatherley PE, 1950, NEW PHYTOL, V49, P81, DOI DOI 10.1111/J.1469-8137.1950.TB05146.X; Yang A, 2012, J EXP BOT, V63, P2541, DOI 10.1093/jxb/err431; Yasmin H, 2017, J PLANT INTERACT, DOI 10.1080/ 1742914520171402212	80	37	39	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231348	10.1371/journal.pone.0231348	http://dx.doi.org/10.1371/journal.pone.0231348			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298338	Green Published, gold			2022-12-26	WOS:000536011400036
J	Zhang, X; Liu, LR; Ma, XL; Hu, W; Xu, X; Huang, SS; Hua, BZ; Wang, H; Chen, ZY; Sun, LY				Zhang, Xin; Liu, Lirong; Ma, Xiaolei; Hu, Wei; Xu, Xue; Huang, Saisai; Hua, Bingzhu; Wang, Hong; Chen, Zhiyong; Sun, Lingyun			Clinical significance of non-thyroidal illness syndrome on disease activity and dyslipidemia in patients with SLE	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYOCARDIAL-INFARCTION; METABOLIC SYNDROME; RISK; THERAPY; RATIO; DYSLIPOPROTEINEMIA; ASSOCIATION; PREVALENCE; WOMEN	Objectives Nonthyroidal illness syndrome (NTIS), also known as low triiodothyronine (T3) syndrome, frequently affects patients with systemic lupus erythematosus (SLE) and may affect lipid metabolism. Dyslipidemia is highly prevalent and associated with the long-term prognosis of SLE. The aim of the present study was to explore the clinical significance of NTIS on disease activity and dyslipidemia in patients with SLE. Methods Clinical and laboratory data were collected retrospectively from 223 patients with SLE. The correlation between free triiodothyronine (FT3), SLE disease activity, and lipid profiles were estimated. The correlation coefficient (r) was calculated using a Pearson's regression model. Univariate and multivariate logistic regression analyses were performed to identify the risk factors for dyslipidemia in SLE. Results Serum FT3 levels were negatively correlated with the levels of 24 h urine protein (UP), blood urea nitrogen (BUN), creatinine (Cr) and SLE disease activity index (SLEDAI) (all p < 0.001) in NTIS patients but not in euthyroid patients. ApoB/ApoA1 was significantly correlated with SLEDAI (p < 0.01) in NTIS patients and CRP (p < 0.001) and ESR (p < 0.01) in euthyroid patients. A multivariate analysis revealed that only FT3 exhibited an independent negative association with dyslipidemia (P = 0.01; OR = 0.48; 95% CI 0.27-0.85). Conclusion NTIS frequently occurs in patients with SLE. Low FT3 is associated with disease activity in SLE patients complicated with NTIS. Low FT3 is an independent risk factor for dyslipidemia in patients with SLE.	[Zhang, Xin; Liu, Lirong; Ma, Xiaolei; Xu, Xue; Huang, Saisai; Hua, Bingzhu; Wang, Hong; Chen, Zhiyong; Sun, Lingyun] Nanjing Univ, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, Med Sch, Nanjing, Peoples R China; [Liu, Lirong] First Hosp Changshu, Dept Rheumatol & Immunol, Changshu, Jiangsu, Peoples R China; [Hu, Wei] Nanjing Univ, Med Sch, Affiliated Drum Tower Hosp, Dept Clin Lab, Nanjing, Peoples R China	Nanjing University; Nanjing University	Chen, ZY; Sun, LY (corresponding author), Nanjing Univ, Affiliated Drum Tower Hosp, Dept Rheumatol & Immunol, Med Sch, Nanjing, Peoples R China.	chainzhiyong@163.com; lingyunsun2012@163.com			Nanjing Medical Science and Technique Development Foundation [ZKX16039]	Nanjing Medical Science and Technique Development Foundation	This study was supported by Nanjing Medical Science and Technique Development Foundation (Z.C., ZKX16039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya-Amaya J, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/794383; [Anonymous], 2016, Chin J Cardiol, V44, P833, DOI [10.3760/cma.j.issn.0253-3758.2016.10.005, DOI 10.3760/CMA.J.ISSN.0253-3758.2016.10.005]; ATTMAN PO, 1991, NEPHRON, V57, P401, DOI 10.1159/000186303; Baigent C, 2010, AM HEART J, V160, P785, DOI 10.1016/j.ahj.2010.08.012; Borba EF, 1997, LUPUS, V6, P533, DOI 10.1177/096120339700600610; Bruce IN, 2005, RHEUMATOLOGY, V44, P1492, DOI 10.1093/rheumatology/kei142; Bultink IEM, 2008, CLIN EXP RHEUMATOL, V26, P32; Chong YB, 2011, NEPHROLOGY, V16, P511, DOI 10.1111/j.1440-1797.2011.01456.x; Franco JS, 2015, CLIN ENDOCRINOL, V83, P943, DOI 10.1111/cen.12662; Kaptein EM, 2010, J CLIN ENDOCR METAB, V95, P4526, DOI 10.1210/jc.2010-1052; Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Kashef S, 2007, RHEUMATOL INT, V27, P235, DOI 10.1007/s00296-006-0195-3; Lee S, 2016, COMPR PHYSIOL, V6, P1071, DOI 10.1002/cphy.c150017; Lim SS, 2014, ARTHRITIS RHEUMATOL, V66, P357, DOI 10.1002/art.38239; Lind L, 2006, ARTERIOSCL THROM VAS, V26, P406, DOI 10.1161/01.ATV.0000197827.12431.d0; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Maroz N, 2013, AM J MED SCI, V346, P319, DOI 10.1097/MAJ.0b013e31827f4ee3; McQueen MJ, 2008, LANCET, V372, P224, DOI 10.1016/S0140-6736(08)61076-4; Neto AM, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/2157583; Ohman M, 2014, SCAND J RHEUMATOL, V43, P259, DOI 10.3109/03009742.2013.877158; Pingitore A, 2008, J CLIN ENDOCR METAB, V93, P1351, DOI 10.1210/jc.2007-2210; Tisseverasinghe A, 2006, ARTHRITIS RHEUM, V54, P2211, DOI 10.1002/art.21929; Vaziri Nosratola D, 2006, Hemodial Int, V10, P1, DOI 10.1111/j.1542-4758.2006.01168.x; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x; Watad A, 2016, AUTOIMMUN REV, V15, P484, DOI 10.1016/j.autrev.2016.01.019	25	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231622	10.1371/journal.pone.0231622	http://dx.doi.org/10.1371/journal.pone.0231622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298352	gold, Green Published			2022-12-26	WOS:000536011400074
J	Liu, XG; Li, H; Li, YM; Yue, X; Tian, SB; Li, TL				Liu, Xingan; Li, He; Li, Yiming; Yue, Xiang; Tian, Subo; Li, Tianlai			Effect of internal surface structure of the north wall on Chinese solar greenhouse thermal microclimate based on computational fluid dynamics	PLOS ONE			English	Article							NUMERICAL-SIMULATION; TROMBE WALL; PERFORMANCE; CFD; OPTIMIZATION; ENVIRONMENT; CLIMATE; AIR	Chinese solar greenhouses are unique facility agriculture buildings and widely used in northeastern China, providing a favorable requirement for crop growth. The north wall configurations play an essential role in heat storage and thermal insulation and directly affect the management of the internal environment. This research is devoted to further improve the thermal performance of the greenhouse and explore the potential of the north wall. A mathematical model was designed to investigate the concave-convex wall configurations based on computational fluid dynamics. Four passive heat-storage north walls were analyzed by using the same constituent materials, including a plane wall, a vertical wall, a horizontal wall and an alveolate wall. The numerical model was validated by experimental measurements. The temperature distributions of the north walls were examined and a comparative analysis of the heat storage-release capabilities was carried out. The results showed that the heatstorage capacity of the north wall is affected by the surface structure. Moreover, the critical factor influencing the air temperature is the sum of the heat load released by the wall and the energy increment of greenhouse air. The results suggested that the alveolate wall has preferable thermal accumulation capacity. The concave-convex wall configurations have a wider range of heat transfer performance along the thickness direction, while the plane wall has a superior thermal environment. This study provides a basic theoretical reference to rationally design the internal surface structures of the north wall.	[Liu, Xingan; Li, Tianlai] Shenyang Agr Univ, Coll Hort, Shenyang, Peoples R China; [Li, He; Li, Yiming; Yue, Xiang; Tian, Subo] Shenyang Agr Univ, Coll Engn, Shenyang, Peoples R China	Shenyang Agricultural University; Shenyang Agricultural University	Li, TL (corresponding author), Shenyang Agr Univ, Coll Hort, Shenyang, Peoples R China.	lxa10157@syau.edu.cn	Li, He/AAT-9112-2020	Li, He/0000-0003-4617-9811	Postdoctoral Foundation of Xingan Liu [1105/770218004]	Postdoctoral Foundation of Xingan Liu	The present work is financially supported by the Postdoctoral Foundation of Xingan Liu under the Grant 1105/770218004. Xingan Liu had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbassi F, 2015, ENERG BUILDINGS, V105, P119, DOI 10.1016/j.enbuild.2015.07.042; Dana LA, 2014, APPL ENERG, V116, P111, DOI 10.1016/j.apenergy.2013.11.045; Bajc T, 2015, ENERG BUILDINGS, V98, P39, DOI 10.1016/j.enbuild.2014.11.018; Bartzanas T, 2013, COMPUT ELECTRON AGR, V93, P151, DOI 10.1016/j.compag.2012.05.012; Boulard T, 2017, BIOSYST ENG, V158, P110, DOI 10.1016/j.biosystemseng.2017.04.001; Chen W, 2006, RENEW ENERG, V31, P517, DOI 10.1016/j.renene.2005.04.015; Choab N, 2019, SOL ENERGY, V191, P109, DOI 10.1016/j.solener.2019.08.042; Fatnassi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126655; Fidaros DK, 2010, RENEW ENERG, V35, P1380, DOI 10.1016/j.renene.2009.11.013; GUAN Y, 2017, PROCEDIA ENGINEER, V205, P130, DOI DOI 10.1016/J.PR0ENG.2017.09.944; He XL, 2018, COMPUT ELECTRON AGR, V149, P16, DOI 10.1016/j.compag.2017.10.001; Hong XQ, 2015, ENERG BUILDINGS, V89, P32, DOI 10.1016/j.enbuild.2014.12.014; Joudi KA, 2015, ENERG CONVERS MANAGE, V91, P76, DOI 10.1016/j.enconman.2014.11.052; Ling HSA, 2015, APPL ENERG, V140, P329, DOI 10.1016/j.apenergy.2014.11.078; Ling HS, 2014, SOL ENERGY, V110, P276, DOI 10.1016/j.solener.2014.09.015; Liu XG, 2019, OPEN PHYS, V17, P752, DOI 10.1515/phys-2019-0079; Lu W, 2017, BIOSYST ENG, V160, P12, DOI 10.1016/j.biosystemseng.2017.05.006; Majdoubi H, 2009, AGR FOREST METEOROL, V149, P1050, DOI 10.1016/j.agrformet.2009.01.002; Nadal-Serrano JM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220700; Nebbali R, 2012, RENEW ENERG, V43, P111, DOI 10.1016/j.renene.2011.12.003; Nelson JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138930; Pakari A, 2019, ENERG BUILDINGS, V199, P1, DOI 10.1016/j.enbuild.2019.06.033; Piscia D, 2015, COMPUT ELECTRON AGR, V115, P129, DOI 10.1016/j.compag.2015.05.005; Piscia D, 2013, BIOSYST ENG, V116, P130, DOI 10.1016/j.biosystemseng.2013.07.005; Ren J, 2019, ENERG BUILDINGS, V193, P127, DOI 10.1016/j.enbuild.2019.03.040; Saberian A, 2019, RENEW ENERG, V138, P722, DOI 10.1016/j.renene.2019.01.108; Tong G, 2014, APPL ENG AGRIC, V30, P457; Tong G, 2009, COMPUT ELECTRON AGR, V68, P129, DOI 10.1016/j.compag.2009.05.004; Tong GH, 2018, COMPUT ELECTRON AGR, V149, P3, DOI 10.1016/j.compag.2017.09.031; Tong XJ, 2018, BIOSYST ENG, V176, P88, DOI 10.1016/j.biosystemseng.2018.10.008; Wang J., 2017, ENG AGR ENV FOOD, V10, P31, DOI DOI 10.1016/j.eaef.2016.07.003; Wang JW, 2014, ENERG BUILDINGS, V78, P143, DOI 10.1016/j.enbuild.2014.04.006; Wang SH, 2019, APPL THERM ENG, V155, P437, DOI 10.1016/j.applthermaleng.2019.04.005; Wang XW, 2013, J INTEGR AGR, V12, P914, DOI 10.1016/S2095-3119(13)60309-3; Wei B, 2016, BIOSYST ENG, V141, P48, DOI 10.1016/j.biosystemseng.2015.11.008; Wu T, 2016, ENERG BUILDINGS, V112, P198, DOI 10.1016/j.enbuild.2015.12.003; Zhang GQ, 2018, COMPUT ELECTRON AGR, V149, P1, DOI 10.1016/j.compag.2018.04.007; Zhang J, 2017, ENERG BUILDINGS, V139, P91, DOI 10.1016/j.enbuild.2016.12.061; Zhang XD, 2019, SOL ENERGY, V190, P561, DOI 10.1016/j.solener.2019.08.056; Zhang X, 2016, BIOSYST ENG, V142, P12, DOI 10.1016/j.biosystemseng.2015.11.006; ZHOU NJ, 2017, SOL ENERGY, V142, P39, DOI DOI 10.1016/J.S0LENER.2016.12.016	41	14	14	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231316	10.1371/journal.pone.0231316	http://dx.doi.org/10.1371/journal.pone.0231316			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294132	Green Published, gold			2022-12-26	WOS:000536003500031
J	Bertho, L; Schmidt, K; Schmidtke, J; Brants, I; Canton, RF; Novillo, C; Head, G				Bertho, Lieselot; Schmidt, Kerstin; Schmidtke, Jorg; Brants, Ivo; Fernandez Canton, Rocio; Novillo, Conchi; Head, Graham			Results from ten years of post-market environmental monitoring of genetically modified MON 810 maize in the European Union	PLOS ONE			English	Article							CORN-BORER; BT; PERFORMANCE; RESISTANCE	In European regulations for the deliberate release into the environment of genetically modified organisms (GMO), the objective of General Surveillance in Post-Market Environmental Monitoring is defined as the identification of the occurrence of adverse effects of the GMO or its use which were not anticipated in the environmental risk assessment (ERA). Accompanying the commercial cultivation in the EU of maize event MON 810, General Surveillance was implemented by Monsanto, the authorization holder, on a voluntary basis. We carried out a statistical analysis on the pooled results of ten years of farmer questionnaires, which were a part of this General Surveillance, amounting to 2,627 farmer fields in eight European countries in the period 2006-2015. This analysis did not reveal any unexpected adverse effects associated with the cultivation of MON 810. Results from farmer questionnaires confirmed that the cultivation of MON 810 resulted in a significant reduction in the use of pesticides, efficient protection against the target pests, and healthier, higher yielding crops compared to conventional maize. MON 810 also had reduced susceptibility to disease and pests when compared to conventional maize. Monitoring characteristics related to environment and wildlife revealed no significant differences between MON 810 and conventional maize. Literature searches, that were also conducted as part of General Surveillance, identified a comprehensive set of publications addressing environmental safety as well as food and feed safety aspects of MON 810. None of the publications indicated any adverse effect of MON 810 that was not anticipated in the initial ERA, nor did they lead to a change in the conclusions of the initial risk assessment that demonstrated the safety of MON 810. The development of resistance by the target pests (Ostrinia nubilalis, ECB and Sesamia nonagrioides, MCB) was the only potential adverse effect identified in the ERA of MON 810 cultivation in the EU. The extensive safety data package for MON 810, the robust weight of evidence demonstrating both its safety and benefits, and the history of safe use of MON 810 for 15 years in the EU, indicates that focussing the General Surveillance of MON 810 on literature searches and farmer complaint systems would be appropriately protective. This will allow the identification of potential adverse effect not anticipated in the initial ERA without the intensive effort and organizational challenges of farmer questionnaires.	[Bertho, Lieselot; Head, Graham] Monsanto Co, St Louis, MO 63167 USA; [Schmidt, Kerstin; Schmidtke, Jorg] BioMath, Rostock, Germany; [Brants, Ivo; Fernandez Canton, Rocio] Monsanto Co, Brussels, Belgium; [Novillo, Conchi] Monsanto Co, Madrid, Spain	Monsanto; Monsanto	Bertho, L (corresponding author), Monsanto Co, St Louis, MO 63167 USA.	lieselot.bertho@bayer.com	Bertho, Lieselot/GPX-9156-2022	Head, Graham/0000-0003-0521-0616	Monsanto Company; BioMath	Monsanto Company; BioMath	This work was funded by Monsanto Company., and the funder (Monsanto) accepted no outside funding for this research represented in this manuscript. This work was also supported by BioMath who played a role in defining the study design, data collection and analysis, and preparation of the manuscript. The funder provided financial support in the form of salaries [IB, RFC, GH, CN and LB] and/or compensation [KS and JS] for all authors, as well as scientific support. The funder also played a role in the design and preparation of the manuscript and the decision to publish. The specific roles of the authors are articulated in the `author contributions' section.. Note that Monsanto has become a subsidiary of Bayer AG as of 21 August 2018. However, as the monitoring tasks described in this manuscript were conducted before the specified date, the name `Monsanto' is kept throughout the documents.	Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2193; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2316; Bakan B, 2002, J AGR FOOD CHEM, V50, P728, DOI 10.1021/jf0108258; Berensmeier A, 2007, J VERBRAUCH LEBENSM, V2, P56, DOI 10.1007/s00003-007-0238-z; Berensmeier A., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P80, DOI 10.1007/s00003-006-0081-7; Bessin R, BT CORN REFUGES CORN; Bottinger P, 2008, 10 INT S BIOS GEN MO, P183; Brookes G, 2018, GM CROPS GLOBAL SOCI; Committee of Advertising Practice Broadcast Committee of Advertising Practice, 2020, CONS NEW GUID EXPL A; Cordero A, 1998, MAYDICA, V43, P5; Dillehay BL, 2004, AGRON J, V96, P818, DOI 10.2134/agronj2004.0818; Dively GP, 2018, P NATL ACAD SCI USA, V115, P3320, DOI 10.1073/pnas.1720692115; EFSA, 2006, EFSA J, V4, DOI 10.2903/j.efsa.2006.311; EFSA (European Food Safety Authority). S, 2009, EFSA J, V1149, P1, DOI DOI 10.2903/J.EFSA.2009.1149; EFSA Panel on Genetically Modified Organisms, 2016, EFSA J, DOI [10.2903/j.efsa.2016.4580, DOI 10.2903/J.EFSA.2016.4580]; Farinos GP, 2018, PEST MANAG SCI, V74, P557, DOI 10.1002/ps.4735; Folcher L, 2010, AGRON SUSTAIN DEV, V30, P711, DOI 10.1051/agro/2010005; Graeber JV, 1999, J PROD AGRIC, V12, P659, DOI 10.2134/jpa1999.0659; Hutchison WD, 2010, SCIENCE, V330, P222, DOI 10.1126/science.1190242; Monsanto, 2016, ANN MON REP CULT MON; Monsanto Europe S.A, 2012, ANN MON REP CULT MON; Monsanto Europe S.A, 2011, ANN MON REP CULT MON; Monsanto Europe S.A, 2014, ANN MON REP CULT MON; Monsanto Europe S.A, 2010, ANN MON REP CULT MON; Monsanto Europe S.A, 2007, ANN MON REP CULT MON; Monsanto Europe S.A, 2015, ANN MON REP CULT MON; Monsanto Europe S.A, 2013, ANN MON REP CULT MON; Monsanto Europe S.A, 2008, ANN MON REP CULT MON; Monsanto Europe S.A, 2009, ANN MON REP CULT MON; Novillo C., 2003, Boletin de Sanidad Vegetal, Plagas, V29, P427; Pellegrino E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21284-2; Riesgo L, 2012, SPAN J AGRIC RES, V10, P867, DOI 10.5424/sjar/2012104-448-11; Sanvido O., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P5, DOI 10.1007/s00003-006-0061-y; Scarpino V, 2015, FIELD CROP RES, V183, P69, DOI 10.1016/j.fcr.2015.07.014; Schiemann J., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P26, DOI 10.1007/s00003-006-0065-7; Schiemann J, 2005, FARM QUESTIONNAIRES; Schmidt K, 2007, J VERBRAUCH LEBENSM, V2, P11, DOI 10.1007/s00003-007-0290-8; Schmidt K., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P21, DOI 10.1007/s00003-006-0064-8; Schmidt K., 2008, 10th International Symposium on the Biosafety of Genetically Modified Organisms, Wellington, New Zealand, 16-21 November 2008. Biosafety research of GMOS: past achievements and future challenges, P93; Schmidt K., 2004, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V56, P206; Schmidt Kerstin, 2008, Environmental Biosafety Research, V7, P163, DOI 10.1051/ebr:2008015; Tefera T, 2016, CROP PROT, V89, P202, DOI 10.1016/j.cropro.2016.07.023; Thieme TGM, 2018, J APPL ENTOMOL, V142, P192, DOI 10.1111/jen.12420; Tinland B., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P42, DOI 10.1007/s00003-006-0068-4; VIB, 2016, EFF GEN MOD CROPS EN; Wilhelm R., 2004, Nachrichtenblatt des Deutschen Pflanzenschutzdienstes, V56, P184; Wilhelm R, 2004, BIOL BUNDESANSTALT L, P290; Wilhelm Ralf, 2009, Environmental Biosafety Research, V8, P219, DOI 10.1051/ebr/2009018	48	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0217272	10.1371/journal.pone.0217272	http://dx.doi.org/10.1371/journal.pone.0217272			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330131	Green Published, gold			2022-12-26	WOS:000536647300001
J	Herrera, AH; Lencinas, MV; Manriquez, MT; Miller, JA; Pastur, GM				Huertas Herrera, Alejandro; Vanessa Lencinas, Maria; Toro Manriquez, Monica; Andres Miller, Juan; Martinez Pastur, Guillermo			Mapping the status of the North American beaver invasion in the Tierra del Fuego archipelago	PLOS ONE			English	Article							CASTOR-CANADENSIS; NOTHOFAGUS-FORESTS; CAPE-HORN; ECOSYSTEM ENGINEER; ABUNDANCE; PATTERNS; STREAMS; IMPACT; DAMS; TOOL	Quantifying the presence and environmental impact of invasive species is the starting point for research on management and nature conservation. North American beavers (Castor canadensis) were introduced to Argentina from Canada in 1946, and the species has been identified as a major agent of environmental change in the Tierra del Fuego archipelago in the Anthropocene. We studied the invasion status (distribution and density) of beavers through analyses of the dam densities in the Tierra del Fuego landscapes. We identified beaver dams with a GIS using visual interpretation of high-resolution aerial imagery from Microsoft Bing, Google Earth and HERE and related them to natural environmental gradients. These factors comprised geographic (vegetation zones and distance to streams), climatic (temperature, precipitation, evapotranspiration and net primary productivity) and topographic (elevation and slope) data. The datasets (dams and factors) were combined, and the data from the different zonation classes were subsequently compared using ANOVAs and Tukey's mean comparison tests. Deviations from the mean density (x mean density-x total mean density) were calculated to visualize the deviations for the studied factors. The datasets were also evaluated using principal component analyses (PCA). Our results showed a total of 206,203 beaver dams (100,951 in Argentina and 105,252 in Chile) in the study area (73,000 km(2)). The main island of Tierra del Fuego presented a greater degree of invasion (73.6% of the total study area) than the rest of the archipelago, especially in areas covered by mixed-evergreen and deciduous forests. The studied geographic, climatic and topographic factors showed positive trends (higher beaver preference) with beaver spread, which were all significant (p < 0.05) when compared across the landscape. Although beavers are flexible in their habitat use, our empirical records showed that they had marked preferences and were positively influenced by the most productive forests. Here, we describe a scientific panorama that identified the drivers of species invasion based on satellite data and the available ecological datasets. The identification of such drivers could be useful for developing new tools for management and/or control strategies of the beavers in the Tierra del Fuego archipelago.	[Huertas Herrera, Alejandro; Vanessa Lencinas, Maria; Toro Manriquez, Monica; Andres Miller, Juan; Martinez Pastur, Guillermo] Consejo Nacl Invest Cient & Tecn, CADIC, Ctr Austral Invest Cient, Ushuaia, Tierra Del Fueg, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Herrera, AH (corresponding author), Consejo Nacl Invest Cient & Tecn, CADIC, Ctr Austral Invest Cient, Ushuaia, Tierra Del Fueg, Argentina.	ahuertasherrera@cadic-conicet.gob.ar	Lencinas, Maria Vanessa/K-6208-2019; Herrera, Alejandro Huertas/AAE-8150-2019; Toro Manríquez, Mónica/AAI-1404-2019; Martínez Pastur, Guillermo J./H-8188-2014; Herrera, Alejandro Huertas/AAS-3665-2020	Lencinas, Maria Vanessa/0000-0002-2123-3976; Toro Manríquez, Mónica/0000-0001-6492-1333; Martínez Pastur, Guillermo J./0000-0003-2614-5403; Herrera, Alejandro Huertas/0000-0003-2229-6714	Rufford Small Grants Foundation; IdeaWild Grant Program	Rufford Small Grants Foundation; IdeaWild Grant Program	This work was supported by The Rufford Small Grants Foundation (Small Grant by  pound 5000) (https://www.rufford.org) and The IdeaWild Grant Program (Grant by US$ 1500) (www.ideawild.org) providing financial support and equipment to this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakoski R, 2019, BIOL INVASIONS, V21, P1601, DOI 10.1007/s10530-019-01919-9; Allen AW, 1983, FWSOBS82 US DEP INT; Anderson CB, 2006, BIOL CONSERV, V128, P467, DOI 10.1016/j.biocon.2005.10.011; Anderson CB, 2009, MAMMAL REV, V39, P33, DOI 10.1111/j.1365-2907.2008.00136.x; Beck HE, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.214; Brancaleoni L, 2003, POLAR BIOL, V26, P404, DOI 10.1007/s00300-003-0499-7; Briones Mireya, 2001, Anales del Instituto de la Patagonia Serie Ciencias Naturales, V29, P75; Choi C, 2008, NATURE, V453, P968, DOI 10.1038/453968a; Corcoran Barrios DA, 2014, THESIS; Davis Ernesto F, 2016, Mastozool. neotrop., V23, P51; Dittbrenner BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192538; Eljall Ana, 2019, Ecol. austral, V29, P63, DOI 10.25260/EA.19.29.1.0.736; Giriat D, 2016, SCI TOTAL ENVIRON, V544, P339, DOI 10.1016/j.scitotenv.2015.11.103; Grootjans A, 2010, MIRES PEAT, V6; Henn J. J., 2014, Ecological Restoration, V32, P369, DOI 10.3368/er.32.4.369; Henn JJ, 2016, BIOL INVASIONS, V18, P1679, DOI 10.1007/s10530-016-1110-9; Huertas Herrera Alejandro, 2017, Anales Instituto Patagonia (Chile), V45, P67; Hulme Philip E., 2009, V3, P1; Jaksic Fabian M., 2002, Biological Invasions, V4, P157, DOI 10.1023/A:1020576709964; Jia YQ, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9070751; Latham ADM, 2017, BIOL INVASIONS, V19, P3121, DOI 10.1007/s10530-017-1421-5; Lizarralde M., 2008, ACT TALL INT CONTR C, P13; Borromei AM, 2014, ANDEAN GEOL, V41, P362, DOI 10.5027/andgeoV41n2-a05; Martinez Pastur G, 2019, LATIN AM TIMES GLOBA, P147; Pastur GM, 2006, APPL VEG SCI, V9, P143; Pastur GM, 2016, BIODIVERS CONSERV, V25, P1843, DOI 10.1007/s10531-016-1162-2; Moore D. M., 1983, FLORA TIERRA FUEGO; NAIMAN RJ, 1988, BIOSCIENCE, V38, P753, DOI 10.2307/1310784; Nyssen J, 2011, J HYDROL, V402, P92, DOI 10.1016/j.jhydrol.2011.03.008; Papier CM, 2019, CLIMATIC CHANGE, V153, P219, DOI 10.1007/s10584-019-02377-x; Peri P.L., 2013, STEPPE ECOSYSTEMS BI, V4, P73; Pietrek AG, 2017, J MAMMAL, V98, P283, DOI 10.1093/jmammal/gyw169; Pietrek AG, 2015, BIOL INVASIONS, V17, P3225, DOI 10.1007/s10530-015-0948-6; Pisano E., 1977, COMUNIDADES VEGETALE; Rousselet J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074918; Schuttler E, 2019, POLAR BIOL, V42, P1093, DOI 10.1007/s00300-019-02497-1; Skewes O, 2006, EUR J WILDLIFE RES, V52, P292, DOI 10.1007/s10344-006-0038-2; St-Pierre ML, 2017, WETLANDS, V37, P941, DOI 10.1007/s13157-017-0929-x; Trabucco A., 2019, GLOBAL ARIDITY INDEX; Tuhkanen S, 1990, ANALES I PATAGONIA, P1; Visser V, 2014, BIOL INVASIONS, V16, P513, DOI 10.1007/s10530-013-0604-y; Wallem PK, 2007, REV CHIL HIST NAT, V80, P309; Watson JEM, 2018, NAT ECOL EVOL, V2, P599, DOI 10.1038/s41559-018-0490-x; Wright JP, 2002, OECOLOGIA, V132, P96, DOI 10.1007/s00442-002-0929-1; Zeveloff Samuel I., 1988, MAMMALS INTERMOUNTAI, DOI [10.2307/1381542, DOI 10.2307/1381542]; Zhao MS, 2010, SCIENCE, V329, P940, DOI 10.1126/science.1189590	46	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232057	10.1371/journal.pone.0232057	http://dx.doi.org/10.1371/journal.pone.0232057			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330157	Green Published, gold			2022-12-26	WOS:000536647300044
J	Safina, DR; Selina, PI; Roschina, MP; Karaseva, MA; Komissarov, AA; Demidyuk, IV; Sverdlov, ED; Kostrov, SV				Safina, Dina R.; Selina, Polina I.; Roschina, Marina P.; Karaseva, Maria A.; Komissarov, Alexey A.; Demidyuk, Ilya V.; Sverdlov, Eugene D.; Kostrov, Sergey V.			Functional efficiency of PCR vectors in vitro and at the organism level	PLOS ONE			English	Article							AMPLIFIED DNA FRAGMENTS; TRANSGENE EXPRESSION; SUSTAINED EXPRESSION; GENE-EXPRESSION; PLASMID VECTORS; TRANSFECTION; DESIGN	The functional efficiency of the expression cassettes integrated into a plasmid and a PCR-amplified fragment was comparatively analyzed after transient transfection in vitro or introduction into the developing embryo of Danio rerio. The cassettes contained the reporter genes, luciferase of Photinus pyralis (luc) or enhanced green fluorescent protein, under the control of the promoter of human cytomegalovirus immediate-early genes. In the in vitro system, the efficiency of the circular plasmid was 2.5 times higher than that of the PCR-amplified fragment. The effect of mutations in the expression cassette on the efficiency of the transgene expression in the PCR-amplified fragment was quantitatively evaluated. The mutations generated after 25 amplification cycles with Taq DNA polymerase decreased luciferase activity in transfected cells by 65-85%. Thus, mutations are the key factor of decreased functional efficiency of the PCR-amplified fragment relative to the circular plasmid in this experimental model, while other factors apparently have a lesser impact. At the organism level, no significant difference in the expression efficiency of the plasmid and PCR-amplified fragment has been revealed. Comparison of the vector efficiencies in in vivo and in vitro systems demonstrates that the level of luciferase in the D. rerio cell lysate, normalized to the molar concentration of the vector, is by three orders of magnitude higher than that after the cell transfection in vitro, which indicates that the quantitative data obtained for in vitro systems should not be directly extrapolated to the organism level.	[Safina, Dina R.; Selina, Polina I.; Roschina, Marina P.; Karaseva, Maria A.; Komissarov, Alexey A.; Demidyuk, Ilya V.; Sverdlov, Eugene D.; Kostrov, Sergey V.] Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Fundamentals Biotechnol & Prot Eng, Moscow, Russia	Russian Academy of Sciences	Safina, DR (corresponding author), Russian Acad Sci, Inst Mol Genet, Dept Mol Genet Fundamentals Biotechnol & Prot Eng, Moscow, Russia.	nauruz@mail.ru		Rosina, Marina/0000-0002-2062-9506; Selina, Polina/0000-0001-6499-8525; Komissarov, Alexey/0000-0003-1018-5195	Russian Foundation for Basic Research [18-04-00319, 17-00-00189]; Presidium of the Russian Academy of Sciences	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Presidium of the Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by the Russian Foundation for Basic Research as the part of the scientific projects No. 18-04-00319 and 17-00-00189, the Presidium of the Russian Academy of Sciences as the part of the Research Programs "Fundamental Research for the Development of Biomedical Technologies" and "Molecular and Cell Biology and Post-Genomic Technologies". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzani RP, 2016, BIOMATERIALS, V93, P20, DOI 10.1016/j.biomaterials.2016.03.029; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carnes AE, 2010, J GENE MED, V12, P818, DOI 10.1002/jgm.1499; Chen J, 2012, ENVIRON SCI TECHNOL, V46, P13448, DOI 10.1021/es302760s; Chen ZY, 2003, MOL THER, V8, P495, DOI 10.1016/S1525-0016(03)00168-0; Cheng LH, 2018, CHEM COMMUN, V54, P9687, DOI 10.1039/c8cc05066j; Cohen RN, 2009, J CONTROL RELEASE, V135, P166, DOI 10.1016/j.jconrel.2008.12.016; Gasparov V. S., 1994, Biokhimiya, V59, P763; Hardee CL, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020065; Hirata K, 2007, J PHARM SCI-US, V96, P2251, DOI 10.1002/jps.20879; Hofman CR, 2001, GENE THER, V8, P71, DOI 10.1038/sj.gt.3301373; Hornstein BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167537; Hsu CYM, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-23; Kameda S, 2003, BIOCHEM BIOPH RES CO, V309, P929, DOI 10.1016/j.bbrc.2003.08.087; Kira N, 2016, MAR GENOM, V25, P49, DOI 10.1016/j.margen.2015.12.004; Kobelt D, 2013, MOL BIOTECHNOL, V53, P80, DOI 10.1007/s12033-012-9535-6; Komissarov AA, 2016, MOL GENET MICROBIOL+, V31, P156, DOI 10.3103/S0891416816030058; Lu JM, 2012, MOL THER, V20, P2111, DOI 10.1038/mt.2012.65; Lu YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057171; Maniar LEG, 2013, MOL THER, V21, P131, DOI 10.1038/mt.2012.244; Marie C, 2010, J GENE MED, V12, P323, DOI 10.1002/jgm.1441; Maruyama H, 2005, J BIOCHEM, V137, P373, DOI 10.1093/jb/mvi038; Nafissi N, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.16; Sambrook J, 2001, MOL CLONING LAB MANU, P221; Schakowski F, 2007, IN VIVO, V21, P17; Schindelhauer D, 2002, GENE THER, V9, P727, DOI 10.1038/sj.gt.3301755; Tachibana R, 2002, PHARMACEUT RES, V19, P377, DOI 10.1023/A:1015162722295; Wang HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047159; Wong SP, 2015, ADV GENET, V89, P113, DOI 10.1016/bs.adgen.2014.11.002; Yin H, 2014, NAT REV GENET, V15, P541, DOI 10.1038/nrg3763; Zhao N, 2011, GENE THER, V18, P220, DOI 10.1038/gt.2010.123	31	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232045	10.1371/journal.pone.0232045	http://dx.doi.org/10.1371/journal.pone.0232045			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330156	Green Published, gold			2022-12-26	WOS:000536647300043
J	Vasileiou, T; Summerer, L				Vasileiou, Thomas; Summerer, Leopold			A biomimetic approach to shielding from ionizing radiation: The case of melanized fungi	PLOS ONE			English	Article							COMPTON-SCATTERING; DOSE ENHANCEMENT; PROTECTION; NANOPARTICLES; ELECTRONS; MICE	Melanized fungi have been shown to thrive in environments with high radionuclide concentrations, which led to the association of the pigment melanin with the protection against ionizing radiation. Several hypotheses regarding the function of melanin have been proposed. Yet, the exact mechanism behind the protective property of melanin is unclear and poorly explored. A better understanding of the mechanisms that are involved in increasing the tolerance of the organisms to ionizing radiation could lead to technology transfer to human-related applications. Effective protection from radiation is essential for human space flight in general and human missions beyond Low Earth Orbit specifically. In this paper, we follow a biomimetic approach: we test two of current hypotheses and discuss how they could be applied to radiation shield designs. First we focus on the interaction of melanin with high energy electrons, which has been suspected to reduce the kinetic energy of the electrons through a cascade of collisions, thus providing physical shielding. Second, we investigate if the spatial arrangement of melanin, organized as a thin film or a collection of hollow microspheres, affects its shielding properties. To this end, we measured experimentally and by numerical simulations the attenuation of beta-radiation as pass through solutions and suspensions of melanin and contrasted the values to the ones of cellulose, a substance with similar elemental composition. Further, we investigate the spatial arrangement hypothesis using Monte Carlo simulations. In agreement with the simulations, our experiments indicated that melanin does not provide improved shielding in comparison to cellulose from beta-radiation. However, our simulations suggest a substantial effect of the spatial arrangement on the shielding performance of melanin, a pathway that could be transferred to the design of composite radiation shields.	[Vasileiou, Thomas; Summerer, Leopold] European Space Res & Technol Ctr ESTEC, ESA Adv Concepts Team, NL-2200 AG Noordwijk, Netherlands	European Space Agency	Vasileiou, T (corresponding author), European Space Res & Technol Ctr ESTEC, ESA Adv Concepts Team, NL-2200 AG Noordwijk, Netherlands.	Thomas.Vasileiou@esa.int	Vasileiou, Thomas/AAY-9231-2020	Vasileiou, Thomas/0000-0002-9342-7948				Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; Allison J, 2016, NUCL INSTRUM METH A, V835, P186, DOI 10.1016/j.nima.2016.06.125; BLUMENTHAL GR, 1970, REV MOD PHYS, V42, P237, DOI 10.1103/RevModPhys.42.237; Boone JM, 1997, MED PHYS, V24, P1661, DOI 10.1118/1.597953; Bryan R, 2011, FUNGAL BIOL-UK, V115, P945, DOI 10.1016/j.funbio.2011.04.003; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crucian BE, 2014, J INTERF CYTOK RES, V34, P778, DOI 10.1089/jir.2013.0129; Cucinotta FA, 2017, LIFE SCI SPACE RES, V13, P1, DOI 10.1016/j.lssr.2017.01.005; Cucinotta FA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096099; Cucinotta FA, 2010, SPACE WEATHER, V8, DOI 10.1029/2010SW000572; Dadachova E, 2014, inventors; Melanin nanoshells for protection against radiation and electronic pulses, Patent No. [US8586090B, 8586090B]; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; Dadachova E, 2008, CURR OPIN MICROBIOL, V11, P525, DOI 10.1016/j.mib.2008.09.013; Devaney JJ, 1985, BETA SPECTRA 90 SR 9; Diaz-Frances E, 2013, STAT PAP, V54, P309, DOI 10.1007/s00362-012-0429-2; Dighton J, 2008, FEMS MICROBIOL LETT, V281, P109, DOI 10.1111/j.1574-6968.2008.01076.x; Durante M, 2011, REV MOD PHYS, V83, P1245, DOI 10.1103/RevModPhys.83.1245; Eisenman HC, 2005, BIOCHEMISTRY-US, V44, P3683, DOI 10.1021/bi047731m; Fan WC, 1996, IEEE T NUCL SCI, V43, P2790, DOI 10.1109/23.556868; Huang YR, 2017, ACS CENTRAL SCI, V3, P564, DOI 10.1021/acscentsci.6b00230; Ibarmia S, 2013, IEEE T NUCL SCI, V60, P2486, DOI 10.1109/TNS.2013.2273087; Kapp FG, 2018, NATURE, V558, P445, DOI 10.1038/s41586-018-0213-0; Korolev V, 2012, SCAND ACTUAR J, P81, DOI 10.1080/03461238.2010.485370; Kunwar A, 2012, TOXICOL APPL PHARM, V264, P202, DOI 10.1016/j.taap.2012.08.002; Lakk H, 2018, 69 INT ASTR C; LONG DM, 1982, IEEE T NUCL SCI, V29, P1980, DOI 10.1109/TNS.1982.4336482; MURTHY MSS, 1976, RADIAT RES, V67, P215, DOI 10.2307/3574410; Nambiar S, 2012, ACS APPL MATER INTER, V4, P5717, DOI 10.1021/am300783d; Pacelli C, 2017, ENVIRON MICROBIOL, V19, P1612, DOI 10.1111/1462-2920.13681; Porter F. C., 2008, ARXIV08040380, Patent No. [0804.0380, 08040380]; Prados-Rosales R, 2015, J AGR FOOD CHEM, V63, P7326, DOI 10.1021/acs.jafc.5b02713; Rageh MM, 2015, MOL CELL BIOCHEM, V399, P59, DOI 10.1007/s11010-014-2232-y; Revskaya E, 2012, CANCER BIOTHER RADIO, V27, P570, DOI 10.1089/cbr.2012.1318; Robertson KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048674; Rozanowska M, 1999, FREE RADICAL BIO MED, V26, P518, DOI 10.1016/S0891-5849(98)00234-2; SCHOLZ FW, 1987, J AM STAT ASSOC, V82, P918, DOI 10.2307/2288805; Schweitzer AD, 2010, INT J RADIAT ONCOL, V78, P1494, DOI 10.1016/j.ijrobp.2010.02.020; Schweitzer AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007229; Shuryak I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085561; Spieth BD, 1998, IEEE T NUCL SCI, V45, P2752, DOI 10.1109/23.736524; Steffens M, 2017, IEEE T NUCL SCI, V64, P2325, DOI 10.1109/TNS.2017.2703312; White RJ, 2001, NATURE, V409, P1115, DOI 10.1038/35059243; Zhdanova NN, 2004, MYCOL RES, V108, P1089, DOI 10.1017/S0953756204000966	45	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0229921	10.1371/journal.pone.0229921	http://dx.doi.org/10.1371/journal.pone.0229921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330147	Green Published, gold, Green Submitted			2022-12-26	WOS:000536647300008
J	Exner, EC; Geurts, AM; Hoffmann, BR; Casati, M; Stodola, T; Dsouza, NR; Zimmermann, M; Lombard, JH; Greene, AS				Exner, Eric C.; Geurts, Aron M.; Hoffmann, Brian R.; Casati, Marc; Stodola, Timothy; Dsouza, Nikita R.; Zimmermann, Michael; Lombard, Julian H.; Greene, Andrew S.			Interaction between Mas1 and AT1R(A) contributes to enhancement of skeletal muscle angiogenesis by angiotensin-(1-7) in Dahl salt-sensitive rats	PLOS ONE			English	Article							STIMULATED ANGIOGENESIS; PROSTATE-CANCER; NUCLEAR EXPORT; RECEPTOR; PROTEIN; EXPRESSION; RENIN; GENE; PROLIFERATION; PATHWAYS	The heptapeptide angiotensin-(1-7) (Ang-(1-7)) is protective in the cardiovascular system through its induction of vasodilator production and angiogenesis. Despite acting antagonistically to the effects of elevated, pathophysiological levels of angiotensin II (AngII), recent evidence has identified convergent and beneficial effects of low levels of both Ang-(1-7) and AngII. Previous work identified the AngII receptor type I (AT1R) as a component of the protein complex formed when Ang-(1-7) binds its receptor, Mas1. Importantly, pharmacological blockade of AT1R did not alter the effects of Ang-(1-7). Here, we use a novel mutation of AT1R(A) in the Dahl salt-sensitive (SS) rat to test the hypothesis that interaction between Mas1 and AT1R contributes to proangiogenic Ang-(1-7) signaling. In a model of hind limb angiogenesis induced by electrical stimulation, we find that the restoration of skeletal muscle angiogenesis in SS rats by Ang-(1-7) infusion is impaired in AT1R(A) knockout rats. Enhancement of endothelial cell (EC) tube formation capacity by Ang-(1-7) is similarly blunted in AT1R(A) mutant ECs. Transcriptional changes elicited by Ang-(1-7) in SS rat ECs are altered in AT1R(A) mutant ECs, and tandem mass spectrometry-based proteomics demonstrate that the protein complex formed upon binding of Ang-(1-7) to Mas1 is altered in AT1R(A) mutant ECs. Together, these data support the hypothesis that interaction between AT1R and Mas1 contributes to proangiogenic Ang-(1-7) signaling.	[Exner, Eric C.; Geurts, Aron M.; Hoffmann, Brian R.; Stodola, Timothy; Lombard, Julian H.] Med Coll Wisconsin, Dept Physiol, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Geurts, Aron M.; Dsouza, Nikita R.; Zimmermann, Michael] Med Coll Wisconsin, Genom Sci & Precis Med Ctr, Milwaukee, WI 53226 USA; [Hoffmann, Brian R.] Med Coll Wisconsin, Dept Bioengn, Milwaukee, WI 53226 USA; [Hoffmann, Brian R.] Marquette Univ, Milwaukee, WI 53233 USA; [Hoffmann, Brian R.; Casati, Marc] Med Coll Wisconsin, Cardiovasc Ctr, Milwaukee, WI 53226 USA; [Greene, Andrew S.] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Marquette University; Medical College of Wisconsin; Jackson Laboratory	Greene, AS (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Andy.Greene@jax.org		Greene, Andrew/0000-0002-3191-2112; Exner, Eric/0000-0003-0129-5536; Stodola, Timothy/0000-0001-9671-884X	National Institutes of Health [F30-HL131153, P01-HL116264, R01-HL125409, R01-HL128242, R21-OD024781, K01-DK105043]; Kern Family Foundation; NIGMS [T32-GM080202]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kern Family Foundation; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Sources of Funding: This study was supported by National Institutes of Health grants F30-HL131153, P01-HL116264, R01-HL125409, R01-HL128242, R21-OD024781, K01-DK105043 and the Kern Family Foundation. Eric C. Exner is a member of the Medical Scientist Training Program at the Medical College of Wisconsin, which is partially supported by a training grant, NIGMS T32-GM080202. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Kern Family Foundation: https://www.kffdn.org/National Institutes of Health: https://www.nih.gov/.	Benicky J, 2012, CELL MOL NEUROBIOL, V32, P1353, DOI 10.1007/s10571-012-9862-y; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Burns WC, 2010, AM J PHYSIOL-RENAL, V299, pF585, DOI 10.1152/ajprenal.00538.2009; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; de Resende MM, 2008, PHYSIOL GENOMICS, V33, P33, DOI 10.1152/physiolgenomics.00150.2007; de Resende MM, 2008, AM J PHYSIOL-HEART C, V294, pH2814, DOI 10.1152/ajpheart.00095.2008; de Resende MM, 2010, PHYSIOL GENOMICS, V42, P437, DOI 10.1152/physiolgenomics.00037.2010; Drenjancevic-Peric I, 2005, HYPERTENSION, V45, P687, DOI 10.1161/01.HYP.0000154684.40599.03; Durand MJ, 2010, AM J PHYSIOL-HEART C, V299, pH1024, DOI 10.1152/ajpheart.00328.2010; Fuxe J, 2010, CELL CYCLE, V9, P2363, DOI 10.4161/cc.9.12.12050; Gaidarov I, 2018, CELL SIGNAL, V50, P9, DOI 10.1016/j.cellsig.2018.06.007; Galandrin S, 2016, HYPERTENSION, V68, P1365, DOI 10.1161/HYPERTENSIONAHA.116.08118; Gallagher PE, 2014, CURR MED CHEM, V21, P2417, DOI 10.2174/0929867321666140205133357; Geurts AM, 2010, METHODS MOL BIOL, V597, P211, DOI 10.1007/978-1-60327-389-3_15; Gironacci MM, 2011, HYPERTENSION, V58, P176, DOI 10.1161/HYPERTENSIONAHA.111.173344; Gironacci MM, 1999, REGUL PEPTIDES, V84, P51, DOI 10.1016/S0167-0115(99)00067-1; Gnesutta N, 2001, J BIOL CHEM, V276, P14414, DOI 10.1074/jbc.M011046200; Ha CH, 2008, J BIOL CHEM, V283, P14590, DOI 10.1074/jbc.M800264200; Halligan BD, 2011, PROTEOMICS, V11, P1058, DOI 10.1002/pmic.201000556; Hamburger A, 2011, ATLAS GENET CYTOGENE, V16; Hoffimann BR, 2012, J MED CHEM, V55, P8260, DOI 10.1021/jm301204r; Hoffmann BR, 2017, ARTERIOSCL THROM VAS, V37, P433, DOI 10.1161/ATVBAHA.116.307787; Hoffmann BR, 2013, PHYSIOL GENOMICS, V45, P1021, DOI 10.1152/physiolgenomics.00070.2013; Hollenbach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068033; Hrenak J, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071098; Huang X, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1098-8; Kaczorowski CC, 2013, PHYSIOL GENOMICS, V45, P999, DOI 10.1152/physiolgenomics.00097.2013; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Karcher JR, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12358; Kostenis E, 2005, CIRCULATION, V111, P1806, DOI 10.1161/01.CIR.0000160867.23556.7D; Krishnan B, 2013, PROSTATE, V73, P71, DOI 10.1002/pros.22542; Krishnan B, 2013, PROSTATE, V73, P60, DOI 10.1002/pros.22540; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Liang MY, 2003, PHYSIOL GENOMICS, V12, P229, DOI 10.1152/physiolgenomics.00089.2002; Linderman JR, 2000, MICROCIRCULATION, V7, P119, DOI 10.1038/sj.mn.7300100; Linderman JR, 2001, MICROCIRCULATION, V8, P275, DOI 10.1038/sj.mn.7800097; Liu GC, 2012, AM J PHYSIOL-RENAL, V302, pF784, DOI 10.1152/ajprenal.00455.2011; MacKenzie F, 2004, BLOOD, V104, P1760, DOI 10.1182/blood-2003-12-4244; MacKenzie F, 2004, J BIOL CHEM, V279, P11657, DOI 10.1074/jbc.M312102200; MAHON JM, 1994, J HYPERTENS, V12, P1377; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Mattson DL, 2013, AM J PHYSIOL-REG I, V304, pR407, DOI 10.1152/ajpregu.00304.2012; Meng WX, 2014, AM J HYPERTENS, V27, P775, DOI 10.1093/ajh/hpt270; Mori J, 2014, CIRC-HEART FAIL, V7, P327, DOI 10.1161/CIRCHEARTFAILURE.113.000672; Murphy KT, 2019, CANCER RES, V79, P706, DOI 10.1158/0008-5472.CAN-18-1207; Neilson KM, 2017, DEV BIOL, V421, P171, DOI 10.1016/j.ydbio.2016.11.021; Ni Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073149; Pei NN, 2016, MOL CANCER THER, V15, P37, DOI 10.1158/1535-7163.MCT-14-0981; Petersen MC, 2006, AM J PHYSIOL-HEART C, V291, pH114, DOI 10.1152/ajpheart.01116.2005; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Prisco AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094599; Qu J, 2001, MOL CELL BIOL, V21, P3523, DOI 10.1128/MCB.21.10.3523-3533.2001; Raffai G, 2011, AM J PHYSIOL-HEART C, V301, pH1341, DOI 10.1152/ajpheart.00202.2011; Rom DM, 2013, BRIT J MATH STAT PSY, V66, P189, DOI 10.1111/j.2044-8317.2012.02042.x; Ruster C, 2006, J AM SOC NEPHROL, V17, P2985, DOI 10.1681/ASN.2006040356; Sampaio WO, 2007, HYPERTENSION, V49, P185, DOI 10.1161/01.HYP.0000251865.35728.2f; Santos EL, 2007, REGUL PEPTIDES, V141, P159, DOI 10.1016/j.regpep.2006.12.030; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sokal R.R., 2012, BIOMETRY; Son HJ, 2020, PATHOL ONCOL RES, V26, P2811, DOI 10.1007/s12253-019-00774-2; Stodola TJ, 2011, PHYSIOL GENOMICS, V43, P808, DOI 10.1152/physiolgenomics.00171.2010; vanKats JP, 1997, HYPERTENSION, V30, P42, DOI 10.1161/01.HYP.30.1.42; Verano-Braga T, 2012, J PROTEOME RES, V11, P3370, DOI 10.1021/pr3001755; Won SY, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-018-0204-0; Xu JJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00276; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; Xu XB, 2007, ARTERIOSCL THROM VAS, V27, P2355, DOI 10.1161/ATVBAHA.107.151704; YOUNG D, 1986, CELL, V45, P711, DOI 10.1016/0092-8674(86)90785-3; Yu CH, 2016, CANCER LETT, V376, P268, DOI 10.1016/j.canlet.2016.04.006; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	71	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232067	10.1371/journal.pone.0232067	http://dx.doi.org/10.1371/journal.pone.0232067			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324784	Green Published, gold, Green Submitted			2022-12-26	WOS:000536033700070
J	Vilpert, S; Borrat-Besson, C; Borasio, GD; Maurer, J				Vilpert, Sarah; Borrat-Besson, Carmen; Borasio, Gian Domenico; Maurer, Jurgen			Associations of end-of-life preferences and trust in institutions with public support for assisted suicide evidence from nationally representative survey data of older adults in Switzerland	PLOS ONE			English	Article							RIGHT-TO-DIE; EUROPEAN COUNTRIES; GOOD DEATH; EUTHANASIA; PHYSICIAN; ATTITUDES; STATES; CARE; MEDICALIZATION; NETHERLANDS	The legality of euthanasia and assisted suicide (AS) and nature of regulations of these practices remain controversial and the subject of lively debate among experts and the general public. Our study investigates attitudes and behaviours towards AS among older adults in Switzerland where the practice of AS has a relatively long history and remains rather unregulated. We aim to explore how individuals' preferences regarding their end of life, as well as individuals' trust in institutions involved in the practice or control of AS are associated with attitudes and behaviours towards AS. We analyse nationally representative data of adults aged 55 and over from wave 6 (2015) of the Survey of Health, Ageing and Retirement in Europe (SHARE) in Switzerland (n = 2,145). While large majorities supported current legal arrangements around AS in Switzerland (81.7%) and stated that they could consider AS for themselves under certain circumstances (61.0%), only a minority either was a member of a right-to-die organisation already (4.9%) or stated they were likely to become a member of such an organisation (28.2%). Stated preferences for control over the end of life and for maintaining essential capabilities at the end of life showed a positive association with AS-related attitudes and behaviours, whereas preferences for feeling socially and spiritually connected, as well as for not being a burden displayed a negative association with our outcomes. Higher levels of trust in one's relative were positively associated with both support for the legality of AS and potential use of AS. A positive association was also found between trust in the Swiss legal system and support for the legality of AS. By contrast, trust in religious institutions displayed a negative association with all five AS-related attitudes and behaviours. Similarly, trust in healthcare insurance companies was negatively associated with potential use of AS. Taken together, older adults were generally supportive towards current practices regarding AS. This approval appears to be closely related to individuals' preferences and, at different extends, to trust in social and public institutions with regard to end-of-life issues, which is relatively high in Switzerland.	[Vilpert, Sarah] Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland; [Vilpert, Sarah; Borrat-Besson, Carmen] Univ Lausanne, Swiss Ctr Expertise Social Sci FORS, Lausanne, Switzerland; [Borasio, Gian Domenico] Univ Lausanne, Med Ctr, Palliat & Support Care Serv, Lausanne, Switzerland; [Maurer, Jurgen] Univ Lausanne, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne; University of Lausanne; University of Lausanne; University of Lausanne	Vilpert, S (corresponding author), Univ Lausanne, Fac Biol & Med, Lausanne, Switzerland.; Vilpert, S (corresponding author), Univ Lausanne, Swiss Ctr Expertise Social Sci FORS, Lausanne, Switzerland.	sarah.vilpert@unil.ch		/0000-0002-3923-677X; Vilpert Aeberhard, Sarah/0000-0001-8194-0421				Abrams S, 2011, PREDICTORS ATTITUDES; Al Rabadi L, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8648; al-Awamer A, 2015, CAN FAM PHYSICIAN, V61, P1045; Andorno R, 2013, CAMB Q HEALTHC ETHIC, V22, P246, DOI 10.1017/S0963180113000054; Baranzke H, 2012, ETHICAL THEORY MORAL, V15, P295, DOI 10.1007/s10677-012-9369-0; Beauchamp TL, 2006, J MED PHILOS, V31, P643, DOI 10.1080/03605310601096619; Borasio GD, 2019, LANCET, V393, P982, DOI 10.1016/S0140-6736(18)32554-6; Borrat-Besson C, 2018, 10 WORLD RES C EUR A, P3; Borsch-Supan A., 2018, SURVEY HLTH AGEING R; Bosshard G, 2002, SWISS MED WKLY, V132, P527; Braun KL, 2001, GERONTOLOGIST, V41, P51, DOI 10.1093/geront/41.1.51; Broom A, 2017, SOC SCI MED, V173, P104, DOI 10.1016/j.socscimed.2016.12.001; Buiting HM, 2012, J MED ETHICS, V38, P267, DOI 10.1136/medethics-2011-100066; Bunker JP, 2001, INT J EPIDEMIOL, V30, P1260, DOI 10.1093/ije/30.6.1260; Cardona-Morrell M, 2016, INT J QUAL HEALTH C, V28, P456, DOI 10.1093/intqhc/mzw060; Carr D, 2009, SOCIOL FORUM, V24, P754, DOI 10.1111/j.1573-7861.2009.01135.x; Cavalli S, 2017, 21 IAGG WORLD C GER; Center PR, 2013, REL GROUPS VIEWS END; Cholbi M., 2015, J ETHICS; Cohen J, 2006, SOC SCI MED, V63, P743, DOI 10.1016/j.socscimed.2006.01.026; Cohen J, 2014, INT J PUBLIC HEALTH, V59, P143, DOI 10.1007/s00038-013-0461-6; Cohen J, 2013, EUR J PUBLIC HEALTH, V23, P378, DOI 10.1093/eurpub/cks186; Cohen-Mansfield J, 2018, J GERONTOL B-PSYCHOL, V73, P564, DOI 10.1093/geronb/gbx093; Danyliv A, 2015, SOC SCI MED, V128, P52, DOI 10.1016/j.socscimed.2014.12.030; Economist T., 2018, EC T; Emanuel EJ, 2016, JAMA-J AM MED ASSOC, V316, P79, DOI 10.1001/jama.2016.8499; federal C, 2011, SOINS PALL PREV SUIC; Fischer S, 2009, SWISS MED WKLY, V139, P333, DOI smw-12614; Flury R., 2018, NEU ZURCHER ZEITUNG; Francey O., 2016, TEMPS; Gamondi C, 2013, ANN ONCOL, V24, P1639, DOI 10.1093/annonc/mdt033; Gamondi C, 2015, BMJ SUPPORT PALLIAT, V5, P146, DOI 10.1136/bmjspcare-2013-000483; Ganzini L, 2008, J GEN INTERN MED, V23, P154, DOI 10.1007/s11606-007-0476-x; gfs.bern, 2018, VOLK ERW LOS POL VER; Givens JL, 2009, J PAIN SYMPTOM MANAG, V38, P167, DOI 10.1016/j.jpainsymman.2008.08.012; Groenewoud JH, 2000, NEW ENGL J MED, V342, P551, DOI 10.1056/NEJM200002243420805; Guay F, 2015, J EXP EDUC, V83, P51, DOI 10.1080/00220973.2013.876231; Hardwig J., 2014, JUSTICE LUCK RESPONS, P109; Hendry M, 2013, PALLIATIVE MED, V27, P13, DOI 10.1177/0269216312463623; Janisch W., 2019, SUDDEUTSCHE ZEITUNG; Jansen LA, 2019, J MED ETHICS, V45, P190, DOI 10.1136/medethics-2018-105003; Karsoho H, 2016, SOC SCI MED, V170, P188, DOI 10.1016/j.socscimed.2016.10.010; Koneke V, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-86; Kriesi H., 2008, POLITICSWITZERLAND; Lapierre S, 2018, RELIGIONS, V9, DOI 10.3390/rel9030066; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Loggers ET, 2013, NEW ENGL J MED, V368, P1417, DOI 10.1056/NEJMsa1213398; Marsh HW, 2009, STRUCT EQU MODELING, V16, P439, DOI 10.1080/10705510903008220; Materstvedt LJ, 2003, PALLIATIVE MED, V17, P97, DOI 10.1191/0269216303pm673oa; McCormick AJ, 2011, SOC WORK, V56, P119, DOI 10.1093/sw/56.2.119; Medicale ASdS, 2004, DIR MED ETH PRIS CHA; Meier EA, 2016, AM J GERIAT PSYCHIAT, V24, P261, DOI 10.1016/j.jagp.2016.01.135; Monforte-Royo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037117; Muthen B., 2010, MPLUS USERS GUIDE; Myers ND, 2011, J SPORT EXERCISE PSY, V33, P779, DOI 10.1123/jsep.33.6.779; NEWS SW, 2018, NEWS SW; O'Neill C, 2003, SOC SCI MED, V57, P721, DOI 10.1016/S0277-9536(02)00421-5; OECD O, 2013, GOV GLANC, P2013; Office FS, 2016, SUIC ASS SEL SEX AG; Pacary C., 2019, MONDE; Pereira J, 2011, CURR ONCOL, V18, pE38; Pott M, 2018, ANGEW GERONTOLOGIE A, V14; Puttick H., 2019, TIMES; Rietjens JAC, 2005, SOC SCI MED, V61, P1723, DOI 10.1016/j.socscimed.2005.03.024; Rietjens JAC, 2006, PALLIATIVE MED, V20, P685, DOI 10.1177/0269216306070241; Rodriguez-Prat A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151435; Rubin DB, 2004, MULTIPLE IMPUTATION; Rubin EB, 2016, JAMA INTERN MED, V176, P1557, DOI 10.1001/jamainternmed.2016.4362; Sarah V, 2018, SWISS MED WKLY, V148, DOI 10.4414/smw.2018.14642; Scherrens AL, 2018, DEATH STUD, V42, P491, DOI 10.1080/07481187.2017.1386734; Seay G, 2005, J MED PHILOS, V30, P517, DOI 10.1080/03605310500253071; SHARE, 2015, END OF LIF QUEST MUN; Sheeran P, 2016, SOC PERSONAL PSYCHOL, V10, P503, DOI 10.1111/spc3.12265; Simmons KM, 2018, J LAW BIOSCI, V5, P436, DOI 10.1093/jlb/lsy008; Steck N, 2013, MED CARE, V51, P938, DOI 10.1097/MLR.0b013e3182a0f427; Stettler P., 2018, BEVOLKERUNGSBEFRAGUN; Stevens KR, 2006, ISSUES LAW MED, V21, P187; Stolz E, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0233-6; Stolz E, 2017, J MED ETHICS, V43, P413, DOI 10.1136/medethics-2016-103731; Sulmasy DP, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8628; UNESCO, 2011, INT STAND CLASS ED I; Verbakel E, 2010, PUBLIC OPIN QUART, V74, P109, DOI 10.1093/poq/nfp074; von Hippel PT, 2007, SOCIOL METHODOL, V37, P83, DOI 10.1111/j.1467-9531.2007.00180.x; Wagner B, 2012, EUR PSYCHIAT, V27, P542, DOI 10.1016/j.eurpsy.2010.12.003	84	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232109	10.1371/journal.pone.0232109	http://dx.doi.org/10.1371/journal.pone.0232109			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324815	gold, Green Published			2022-12-26	WOS:000536033700076
J	Hansel, MC; Schmidt, JO; Stiasny, MH; Stoven, MT; Voss, R; Quaas, MF				Haensel, Martin C.; Schmidt, Joern O.; Stiasny, Martina H.; Stoeven, Max T.; Voss, Rudi; Quaas, Martin F.			Ocean warming and acidification may drag down the commercial Arctic cod fishery by 2100	PLOS ONE			English	Article							ATLANTIC COD; BALTIC COD; SEA COD; YELLOWFIN TUNA; GADUS-MORHUA; BARENTS SEA; LIFE STAGES; TEMPERATURE; CLIMATE; BEHAVIOR	The Arctic Ocean is an early warning system for indicators and effects of climate change. We use a novel combination of experimental and time-series data on effects of ocean warming and acidification on the commercially important Northeast Arctic cod (Gadus morhua) to incorporate these physiological processes into the recruitment model of the fish population. By running an ecological-economic optimization model, we investigate how the interaction of ocean warming, acidification and fishing pressure affects the sustainability of the fishery in terms of ecological, economic, social and consumer-related indicators, ranging from present day conditions up to future climate change scenarios. We find that near-term climate change will benefit the fishery, but under likely future warming and acidification this large fishery is at risk of collapse by the end of the century, even with the best adaptation effort in terms of reduced fishing pressure.	[Haensel, Martin C.; Schmidt, Joern O.; Stiasny, Martina H.; Stoeven, Max T.; Voss, Rudi] Univ Kiel, Dept Econ, Sustainable Fishery, Kiel, Germany; [Haensel, Martin C.] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Stiasny, Martina H.] Inst Marine Res, Pelag Fish Res Grp, Bergen, Norway; [Voss, Rudi; Quaas, Martin F.] German Ctr Integrat Biodivers Res iDiv, Biodivers Econ, Leipzig, Germany; [Quaas, Martin F.] Univ Leipzig, Dept Econ, Leipzig, Germany	University of Kiel; Potsdam Institut fur Klimafolgenforschung; Institute of Marine Research - Norway; Leipzig University	Hansel, MC (corresponding author), Univ Kiel, Dept Econ, Sustainable Fishery, Kiel, Germany.; Hansel, MC (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	haensel@pik-potsdam.de	Quaas, Martin/C-4220-2012; Schmidt, Jorn/A-7714-2008	Quaas, Martin/0000-0003-0812-8829; Schmidt, Jorn/0000-0002-4420-6532; Voss, Rudi/0000-0002-4299-8791	German Federal Ministry of Education and Research within the project Biological Impacts of Ocean Acidification [03FO728E]	German Federal Ministry of Education and Research within the project Biological Impacts of Ocean Acidification	The study was partially funded by the German Federal Ministry of Education and Research within the project Biological Impacts of Ocean Acidification, grant number 03FO728E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arthun M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206319; Baumann H, 2012, NAT CLIM CHANGE, V2, P38, DOI 10.1038/NCLIMATE1291; Bellerby RGJ, 2017, NAT CLIM CHANGE, V7, P241, DOI 10.1038/nclimate3247; Bene C, 2015, FOOD SECUR, V7, P261, DOI 10.1007/s12571-015-0427-z; Benjamin P., 1999, CANADIAN J FISHERIES, V56, P2069, DOI [10.1139/cjfas-56-11-2069, DOI 10.1139/CJFAS-56-11-2069]; Bjornsson B, 2007, AQUACULTURE, V271, P216, DOI 10.1016/j.aquaculture.2007.06.026; Bogstad B, 2013, MAR BIOL RES, V9, P895, DOI 10.1080/17451000.2013.775451; Boitsov VD, 2012, ICES J MAR SCI, V69, P833, DOI 10.1093/icesjms/fss075; Bromhead D, 2015, DEEP-SEA RES PT II, V113, P268, DOI 10.1016/j.dsr2.2014.03.019; Seijo JC, 2016, FISH RES, V176, P1, DOI 10.1016/j.fishres.2015.11.029; Chambers R.C., 2013, BIOGEOSCI DISCUSS, V10, P13897, DOI DOI 10.5194/BGD-10-13897-2013; Clark RA, 2003, GLOBAL CHANGE BIOL, V9, P1669, DOI 10.1046/j.1365-2486.2003.00685.x; Clark TD, 2020, NATURE, V577, P370, DOI 10.1038/s41586-019-1903-y; Cooley SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124145; Devine BM, 2012, CORAL REEFS, V31, P229, DOI 10.1007/s00338-011-0837-0; Diekert FK, 2013, CAN J FISH AQUAT SCI, V70, P1346, DOI 10.1139/cjfas-2012-0471; Diekert FK, 2010, ENVIRON RESOUR ECON, V47, P455, DOI 10.1007/s10640-010-9388-z; Diekert FK, 2010, RESOUR ENERGY ECON, V32, P78, DOI 10.1016/j.reseneeco.2009.09.002; Dixson DL, 2012, ANIM BEHAV, V84, P45, DOI 10.1016/j.anbehav.2012.04.001; Drinkwater KF, 2005, ICES J MAR SCI, V62, P1327, DOI 10.1016/j.icesjms.2005.05.015; Falk-Petersen IB, 2005, FISH SHELLFISH IMMUN, V19, P397, DOI 10.1016/j.fsi.2005.03.006; FAO (Food and Agriculture Organization of the United Nations), 2014, STAT WORLD FISH AQ; Fernandes JA, 2017, FISH FISH, V18, P389, DOI 10.1111/faf.12183; Fossheim M, 2015, NAT CLIM CHANGE, V5, P673, DOI 10.1038/NCLIMATE2647; Fourer R, 2003, AMPL MODELING LANGUA; Fromentin JM, 2001, ECOLOGY, V82, P567, DOI 10.1890/0012-9658(2001)082[0567:EODDAS]2.0.CO;2; Frommel AY, 2016, J EXP MAR BIOL ECOL, V482, P18, DOI 10.1016/j.jembe.2016.04.008; Frommel AY, 2014, ECOL APPL, V24, P1131, DOI 10.1890/13-0297.1; Frommel AY, 2013, MAR BIOL, V160, P1825, DOI 10.1007/s00227-011-1876-3; Frommel AY, 2012, NAT CLIM CHANGE, V2, P42, DOI 10.1038/nclimate1324; Hjermann DO, 2007, P ROY SOC B-BIOL SCI, V274, P661, DOI 10.1098/rspb.2006.0069; ICES, 2018, REP ARCT FISH WORK G; ICES (International Council for the Exploration of the Sea), 2018, REP ARCT FISH WORK G; Institute of Marine Research, 2019, ENV MON SVALB JAN MA; Ishimatsu A, 2008, MAR ECOL PROG SER, V373, P295, DOI 10.3354/meps07823; Kjesbu OS, 2014, P NATL ACAD SCI USA, V111, P3478, DOI 10.1073/pnas.1316342111; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; Koenigstein S, 2018, GLOBAL CHANGE BIOL, V24, P526, DOI 10.1111/gcb.13848; Koster FW, 2003, SCI MAR, V67, P129, DOI 10.3989/scimar.2003.67s1129; Kuparinen A, 2014, ICES J MAR SCI, V71, P1507, DOI 10.1093/icesjms/fsu021; Lam VWY, 2016, FISH FISH, V17, P335, DOI 10.1111/faf.12106; Madsen N, 2007, REV FISH BIOL FISHER, V17, P517, DOI 10.1007/s11160-007-9053-y; Maneja RH, 2013, MAR BIOL, V160, P1963, DOI 10.1007/s00227-012-2054-y; Munday PL, 2010, P NATL ACAD SCI USA, V107, P12930, DOI 10.1073/pnas.1004519107; MYERS RA, 1993, CAN J FISH AQUAT SCI, V50, P1576, DOI 10.1139/f93-179; Nilsson GE, 2012, NAT CLIM CHANGE, V2, P201, DOI [10.1038/nclimate1352, 10.1038/NCLIMATE1352]; Ottersen G, 2000, FISH OCEANOGR, V9, P121, DOI 10.1046/j.1365-2419.2000.00127.x; Ottersen G, 2014, ICES J MAR SCI, V71, P2064, DOI 10.1093/icesjms/fsu037; Pachauri R.K., 2014, CLIMATE CHANGE 2014, P151; PAULY D, 1980, J CONSEIL, V39, P175; Pimentel MS, 2016, CLIMATIC CHANGE, V137, P495, DOI 10.1007/s10584-016-1682-5; Pithan F, 2014, NAT GEOSCI, V7, P181, DOI [10.1038/ngeo2071, 10.1038/NGEO2071]; Punt AE, 2014, ECOL MODEL, V285, P39, DOI 10.1016/j.ecolmodel.2014.04.017; Richter A, 2018, ENVIRON RESOUR ECON, V69, P811, DOI 10.1007/s10640-016-0106-3; RICKER W. E., 1954, JOUR FISH RES BD CANADA, V11, P559; Robinson LM, 2015, GLOBAL ENVIRON CHANG, V31, P28, DOI 10.1016/j.gloenvcha.2014.12.003; Rockmann C, 2007, FISH RES, V85, P1, DOI 10.1016/j.fishres.2006.11.035; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Seung CK, 2015, CLIM CHANG ECON, V6, DOI 10.1142/S2010007815500177; Shelton AO, 2011, P NATL ACAD SCI USA, V108, P7075, DOI 10.1073/pnas.1100334108; Simpson SD, 2011, BIOL LETTERS, V7, P917, DOI 10.1098/rsbl.2011.0293; Sistiaga M, 2008, FISH RES, V93, P195, DOI 10.1016/j.fishres.2008.04.014; Steinacher M, 2009, BIOGEOSCIENCES, V6, P515, DOI 10.5194/bg-6-515-2009; Stiasny MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155448; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Tahvonen I, 2018, J ENVIRON ECON MANAG, V92, P659, DOI 10.1016/j.jeem.2017.08.011; Tahvonen O, 2013, ENVIRON RESOUR ECON, V54, P21, DOI 10.1007/s10640-012-9579-x; United Nations, 2019, GOAL 14 CONS SUST US; Voss R, 2019, J ENVIRON MANAGE, V238, P110, DOI 10.1016/j.jenvman.2019.02.105; Voss R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120376; Yaragina N.A., 2011, BARENTS SEA ECOSYSTE, P225	71	7	7	7	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231589	10.1371/journal.pone.0231589	http://dx.doi.org/10.1371/journal.pone.0231589			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320411	gold, Green Published			2022-12-26	WOS:000536028800027
J	Hamard, L; Santoro, T; Allagnat, F; Meda, P; Nardelli-Haefliger, D; Alonso, F; Haefliger, JA				Hamard, Lauriane; Santoro, Tania; Allagnat, Florent; Meda, Paolo; Nardelli-Haefliger, Denise; Alonso, Florian; Haefliger, Jacques-Antoine			Targeting connexin37 alters angiogenesis and arteriovenous differentiation in the developing mouse retina	FASEB JOURNAL			English	Article						angiogenesis; connexin37; retina; vascular remodeling	GAP-JUNCTION PROTEINS; VASCULAR DEVELOPMENT; ENDOTHELIAL CONNEXINS; MICE LACKING; CX37; CELLS; CX40; MATURATION; SURVIVAL; INSIGHTS	Connexin37 (Cx37) forms intercellular channels between endothelial cells (EC), and contributes to coordinate the motor tone of vessels. We investigated the contribution of this protein during physiological angiogenesis. We show that, compared to WT littermates, mice lacking Cx37 (Cx37(-/-)) featured (i) a decreased extension of the superficial vascular plexus during the first 4 days after birth; (ii) an increased vascular density at the angiogenic front at P6, due to an increase in the proliferative rate of EC and in the sprouting of the venous compartment, as well as to a somewhat displaced position of tip cells; (iii) a decreased coverage of newly formed arteries and veins by mural cells; (iv) altered ERK-dependent endothelial cells proliferation through the EphB4 signaling pathway, which is involved in the specification of veins and arteries. In vitro studies documented that, in the absence of Cx37, human venous EC (HUVEC) released less platelet-derived growth factor (PDGF) and more Angiopoietin-2, two molecules involved in the recruitment of mural cells. Treatment of mice with DAPT, an inhibitor of the Notch pathway, decreased the expression of Cx37, and partially mimicked in WT retinas, the alterations observed in Cx37(-/-) mice. Thus, Cx37 contributes to (i) the early angiogenesis of retina, by interacting with the Notch pathway; (ii) the growth and maturation of neo-vessels, by modulating tip, stalk, and mural cells; (iii) the regulation of arteriovenous specification, thus, representing a novel target for treatments of retina diseases.	[Hamard, Lauriane; Santoro, Tania; Allagnat, Florent; Haefliger, Jacques-Antoine] Lausanne Univ Hosp, Dept Med, Lausanne, Switzerland; [Meda, Paolo] Univ Geneva, Med Ctr, Dept Cell Physiol & Metab, Geneva, Switzerland; [Nardelli-Haefliger, Denise] Lausanne Univ Hosp, Dept Urol, Lausanne, Switzerland; [Alonso, Florian] Univ Bordeaux, Ctr Rech Cardiothorac Bordeaux, INSERM, U1045, Bordeaux, France	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Haefliger, JA (corresponding author), Lausanne Univ Hosp, Dept Med, Lab Expt Med, Dept Biomed Sci, Bugnon 7a, CH-1005 Lausanne, Switzerland.	Jacques-Antoine.Haefliger@chuv.ch	Alonso, Florian/AAA-2776-2020; Allagnat, Florent/AAY-7188-2021	Alonso, Florian/0000-0002-6794-1513; Allagnat, Florent/0000-0001-6528-679X	Krebsliga Schweiz (Swiss Cancer League) [KFS-3796-02-2016]; Fonds De La Recherche Scientifique FNRS (FNRS) [31003A-175452/1]	Krebsliga Schweiz (Swiss Cancer League); Fonds De La Recherche Scientifique FNRS (FNRS)(Fonds de la Recherche Scientifique - FNRS)	Krebsliga Schweiz (Swiss Cancer League), Grant/Award Number: KFS-3796-02-2016; Fonds De La Recherche Scientifique FNRS (FNRS), Grant/Award Number: 31003A-175452/1	Allagnat F, 2017, CARDIOVASC RES, V113, P805, DOI 10.1093/cvr/cvx079; Alonso F, 2016, ONCOTARGET, V7, P14015, DOI 10.18632/oncotarget.7370; Alonso F, 2010, AM J PHYSIOL-HEART C, V299, pH1365, DOI 10.1152/ajpheart.00029.2010; Alonso F, 2010, CARDIOVASC RES, V87, P166, DOI 10.1093/cvr/cvq031; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Benton RL, 2008, J COMP NEUROL, V507, P1031, DOI 10.1002/cne.21570; Bosco D, 2011, PHYSIOL REV, V91, P1393, DOI 10.1152/physrev.00027.2010; Burt JM, 2008, AM J PHYSIOL-CELL PH, V295, pC1103, DOI 10.1152/ajpcell.299.2008; Cabral T, 2017, INT J RETINA VITREOU, V3, P1; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Campochiaro PA, 2015, PROG RETIN EYE RES, V49, P67, DOI 10.1016/j.preteyeres.2015.06.002; Chung AS, 2011, ANNU REV CELL DEV BI, V27, P563, DOI 10.1146/annurev-cellbio-092910-154002; Cossutta M, 2019, ARTERIOSCL THROM VAS, V39, P1843, DOI 10.1161/ATVBAHA.119.313021; Crist AM, 2017, GENE EXPR PATTERNS, V23-24, P22, DOI 10.1016/j.gep.2017.01.002; Cuervo H, 2017, ANGIOGENESIS, V20, P655, DOI 10.1007/s10456-017-9570-9; Dhein S, 2015, N-S ARCH PHARMACOL, V388, P101, DOI 10.1007/s00210-014-1059-0; Ehling M, 2013, DEVELOPMENT, V140, P3051, DOI 10.1242/dev.093351; Fang JS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03076-4; Fang JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01742-7; Fang JS, 2012, J VASC RES, V49, P2, DOI 10.1159/000329616; Fang JS, 2011, AM J PHYSIOL-HEART C, V301, pH1872, DOI 10.1152/ajpheart.00683.2011; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gartner C, 2012, PHARMACOL RES, V65, P347, DOI 10.1016/j.phrs.2011.11.012; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Haefliger JA, 2017, ARTERIOSCL THROM VAS, V37, P2136, DOI 10.1161/ATVBAHA.117.310072; Hamelin R, 2009, CURR PROTEIN PEPT SC, V10, P18, DOI 10.2174/138920309787315167; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hellstrom M, 2007, CELL ADHES MIGR, V1, P133, DOI 10.4161/cam.1.3.4978; Ivanova E, 2019, J COMP NEUROL, V527, P2675, DOI 10.1002/cne.24699; Kalna V, 2019, CIRC RES, V124, P1337, DOI 10.1161/CIRCRESAHA.118.313788; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Kuijper S, 2007, TRENDS CARDIOVAS MED, V17, P145, DOI 10.1016/j.tcm.2007.03.003; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Le Gal L, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010823; Le Gal L, 2015, HYPERTENSION, V65, P910, DOI 10.1161/HYPERTENSIONAHA.114.04775; Le Gal L, 2014, HYPERTENSION, V63, P1198, DOI 10.1161/HYPERTENSIONAHA.113.02976; Li Z, 2018, EXP THER MED, V15, P1847, DOI 10.3892/etm.2017.5636; Meda P, 2018, BBA-BIOMEMBRANES, V1860, P124, DOI 10.1016/j.bbamem.2017.03.005; Meda P, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14365; Meens MJ, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0110-1; Meens MJ, 2015, CELL MOL LIFE SCI, V72, P2779, DOI 10.1007/s00018-015-1959-2; Nohata N, 2016, DEV BIOL, V411, P183, DOI 10.1016/j.ydbio.2016.02.005; Okamoto T, 2019, CANCERS, V11, DOI 10.3390/cancers11020237; Park HJ, 2006, STEM CELL REV, V2, P93, DOI 10.1007/s12015-006-0015-x; Peghaire C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12897-w; Pfenniger A, 2010, ARTERIOSCL THROM VAS, V30, P827, DOI 10.1161/ATVBAHA.109.200816; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Pitulescu ME, 2010, NAT PROTOC, V5, P1518, DOI 10.1038/nprot.2010.113; Sakabe M, 2017, P NATL ACAD SCI USA, V114, P10918, DOI 10.1073/pnas.1704030114; Sarrazin S, 2006, BBA-REV CANCER, V1765, P25, DOI 10.1016/j.bbcan.2005.08.004; Scheppke L, 2012, BLOOD, V119, P2149, DOI 10.1182/blood-2011-04-348706; Selbonne S, 2015, CELL MOL LIFE SCI, V72, P3999, DOI 10.1007/s00018-015-1972-5; Shawber CJ, 2004, BIOESSAYS, V26, P225, DOI 10.1002/bies.20004; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Simon AM, 2006, CELL COMMUN ADHES, V13, P61, DOI 10.1080/15419060600631748; Simon AM, 2002, DEV BIOL, V251, P206, DOI 10.1006/dbio.2002.0826; Slavi N, 2018, P NATL ACAD SCI USA, V115, pE5934, DOI 10.1073/pnas.1803907115; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Tahergorabi Z, 2012, INT J PREVENTIVE MED, V3, P827, DOI 10.4103/2008-7802.104853; Weinl C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107048; Wolf K, 2019, J VASC SURG, V69, P253, DOI 10.1016/j.jvs.2018.06.195; Yang D, 2016, ANGIOGENESIS, V19, P297, DOI 10.1007/s10456-016-9514-9	62	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8234	8249		10.1096/fj.202000257R	http://dx.doi.org/10.1096/fj.202000257R		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32323401				2022-12-26	WOS:000528404900001
J	Li, WB; Chen, FB; Wang, YP; Zheng, HY; Yi, QQ; Ren, Y; Gao, J				Li, Wenbo; Chen, Fabo; Wang, Yinping; Zheng, Haoyue; Yi, Qinqin; Ren, Yun; Gao, Jian			Genome-wide identification and functional analysis of ARF transcription factors in Brassica juncea var. tumida	PLOS ONE			English	Article							AUXIN-RESPONSE-FACTOR; FACTOR GENE FAMILY; FLORAL ORGAN ABSCISSION; DNA-BINDING; ARABIDOPSIS-THALIANA; EXPRESSION ANALYSIS; MODULATION; MONOPTEROS; REGULATOR; SEQUENCE	Auxin signalling is vital for plant growth and development, from embryogenesis to senescence. Recent studies have shown that auxin regulates biological processes by mediating gene expression through a family of functionally original DNA-binding auxin response factors, which exist in a large multi-gene family in plants. However, to date, no information has been available about characteristics of the ARF gene family in Brassica juncea var. tumida. In this study, 65 B. juncea genes that encode ARF proteins were identified in the B. juncea whole-genome, classified into three phylogenetical groups and found to be widely and randomly distributed in the A-and B-genome. Highly conserved proteins were also found within each ortholog based on gene structure and conserved motifs, as well as clustering level. Furthermore, promoter cis-element analysis of BjARFs demonstrated that these genes affect the levels of plant hormones, such as auxin, salicylic, gibberellin acid, MeJA, abscisic acid, and ethylene. Expression analysis showed that differentially expressed BjARF genes were detected during the seedling stage, tumor stem development and the flowering period of B. juncea. Interestingly, we found that BjARF2b_A, BjARF3b_A, BjARF6b_A, and BjAR-F17a_B were significantly expressed in tumor stem, and an exogenous auxin assay indicated that these genes were sensitive to auxin and IAA signaling. Moreover, eight of the nine BjARF10/16/17 genes and all of the BjARF6/8 genes were involved in post-transcriptional regulation, targeted by Bj-miR160 and Bj-miR167c, respectively. This analysis provides deeper insight of diversification for ARFs and will facilitate further dissection of ARF gene function in B. juncea.	[Li, Wenbo; Chen, Fabo; Wang, Yinping; Zheng, Haoyue; Yi, Qinqin; Gao, Jian] Yangtze Normal Univ, Sch Adv Agr & Bioengn, Chongqing, Peoples R China; [Ren, Yun] Chongqing Univ Arts & Sci, Coll Landscape Architecture & Life Sci, Chongqing, Peoples R China	Yangtze Normal University; Chongqing University of Arts & Sciences	Gao, J (corresponding author), Yangtze Normal Univ, Sch Adv Agr & Bioengn, Chongqing, Peoples R China.	Gaojian_genomics@163.com	Wang, Yin/HCI-9352-2022; Li, Wenbo/AAP-2905-2021	Li, Wenbo/0000-0003-2407-1017; gao, jian/0000-0001-7636-911X	Natural Science Foundation of CSTB [cstc2019jcyj-msxmX0652]; Science and Technology Plan Projects of Fuling District (FLKJ) [2018BBB3009]	Natural Science Foundation of CSTB; Science and Technology Plan Projects of Fuling District (FLKJ)	This work was supported by Natural Science Foundation of CSTB (cstc2019jcyj-msxmX0652), Science and Technology Plan Projects of Fuling District (FLKJ, 2018BBB3009).	Attia KA, 2009, CURR ISSUES MOL BIOL, V11, pI29, DOI 10.21775/cimb.011.i29; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Chen X, 2018, PLANT CELL TISS ORG, V133, P177, DOI 10.1007/s11240-017-1371-8; Cui J, 2018, PLANT MOL BIOL REP, V36, P790, DOI 10.1007/s11105-018-1118-7; Dai XB, 2018, NUCLEIC ACIDS RES, V46, pW49, DOI 10.1093/nar/gky316; Damodharan S, 2016, PLANT J, V86, P458, DOI 10.1111/tpj.13127; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Franco-Zorrilla JM, 2014, P NATL ACAD SCI USA, V111, P2367, DOI 10.1073/pnas.1316278111; Fukaki H, 2006, PLANT J, V48, P380, DOI 10.1111/j.1365-313X.2006.02882.x; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Goetz M, 2006, PLANT CELL, V18, P1873, DOI 10.1105/tpc.105.037192; Guilfoyle TJ, 1998, CELL MOL LIFE SCI, V54, P619, DOI 10.1007/s000180050190; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 2004, DEVELOPMENT, V131, P1089, DOI 10.1242/dev.00925; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Harper RM, 2000, PLANT CELL, V12, P757, DOI 10.1105/tpc.12.5.757; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Kalluri UC, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-59; Kim CK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25585-4; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Li SB, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00047; Liu J, 2015, P NATL ACAD SCI USA, V112, pE5123, DOI 10.1073/pnas.1502160112; Liu XD, 2013, P NATL ACAD SCI USA, V110, P15485, DOI 10.1073/pnas.1304651110; Liu ZN, 2018, PLANT CELL PHYSIOL, V59, P179, DOI 10.1093/pcp/pcx174; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo XC, 2014, J GENET, V93, P785, DOI 10.1007/s12041-014-0462-0; Ma C, 2015, PLANT PHYSIOL, V167, P844, DOI 10.1104/pp.114.253815; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Mun JH, 2012, MOL GENET GENOMICS, V287, P765, DOI 10.1007/s00438-012-0718-4; Nagpal P, 2005, DEVELOPMENT, V132, P4107, DOI 10.1242/dev.01955; Nizampatnam NR, 2015, PLANT J, V84, P140, DOI 10.1111/tpj.12965; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Pekker I, 2005, PLANT CELL, V17, P2899, DOI 10.1105/tpc.105.034876; Perez-Rodriguez P, 2010, NUCLEIC ACIDS RES, V38, pD822, DOI 10.1093/nar/gkp805; Qiao LY, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01395; Qiao M, 2012, PLANT J, V71, P14, DOI 10.1111/j.1365-313X.2012.04944.x; Remington DL, 2004, PLANT PHYSIOL, V135, P1738, DOI 10.1104/pp.104.039669; Rena Z, 2017, PLANT SCI, V256, P103, DOI 10.1016/j.plantsci.2016.12.008; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Roosjen M, 2018, J EXP BOT, V69, P179, DOI 10.1093/jxb/erx237; Ru P, 2006, CELL RES, V16, P457, DOI 10.1038/sj.cr.7310057; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Tian C, 2004, PLANT J, V40, P333, DOI 10.1111/j.1365-313X.2004.02220.x; Tombuloglu H, 2019, J PLANT BIOCHEM BIOT, V28, P14, DOI 10.1007/s13562-018-0458-6; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Wan SB, 2014, PLANT CELL REP, V33, P1365, DOI 10.1007/s00299-014-1622-7; Wang B, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1185-1; Wang DK, 2007, GENE, V394, P13, DOI 10.1016/j.gene.2007.01.006; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wen J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214885; Wilmoth JC, 2005, PLANT J, V43, P118, DOI 10.1111/j.1365-313X.2005.02432.x; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xing HY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-178; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yang JH, 2016, NAT GENET, V48, P1225, DOI 10.1038/ng.3657	62	1	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0232039	10.1371/journal.pone.0232039	http://dx.doi.org/10.1371/journal.pone.0232039			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320456	Green Published, gold			2022-12-26	WOS:000536028800052
J	de Conti, A; Tryndyak, V; Willett, RA; Borowa-Mazgaj, B; Watson, A; Patton, R; Khare, S; Muskhelishvili, L; Olson, GR; Avigan, MI; Cerniglia, CE; Ross, SA; Sanyal, AJ; Beland, FA; Rusyn, I; Pogribny, IP				Conti, Aline; Tryndyak, Volodymyr; Willett, Rose A.; Borowa-Mazgaj, Barbara; Watson, Anna; Patton, Ralph; Khare, Sangeeta; Muskhelishvili, Levan; Olson, Greg R.; Avigan, Mark I.; Cerniglia, Carl E.; Ross, Sharon A.; Sanyal, Arun J.; Beland, Frederick A.; Rusyn, Ivan; Pogribny, Igor P.			Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model	FASEB JOURNAL			English	Article						Cd36; collaborative cross mice; gene expression; nonalcoholic fatty liver disease	ANIMAL-MODEL; PPAR-GAMMA; DISEASE; EXPRESSION; STEATOSIS; OBESITY; NASH; CD36	Interindividual variability and sexual dimorphisms in the development of nonalcoholic fatty liver disease (NAFLD) are still poorly understood. In the present study, male and female strains of Collaborative Cross (CC) mice were fed a high-fat and high-sucrose (HF/HS) diet or a control diet for 12 weeks to investigate interindividual- and sex-specific variations in the development of NAFLD. The severity of liver steatosis varied between sexes and individual strains and was accompanied by an elevation of serum markers of insulin resistance, including increases in total cholesterol, low-density lipoproteins, high-density lipoproteins, phospholipids, and glucose. The development of NAFLD was associated with overexpression of the critical fatty acid uptake and de novo lipogenesis genes Pparg, Mogat1, Cd36, Acaab1, Fabp2, and Gdf15 in male and female mice. The expression of Pparg, Mogat1, and Cd36 was positively correlated with liver triglycerides in male mice, and Mogat1 and Cd36 expression were positively correlated with liver triglycerides in female mice. Our results indicate the value of CC mice in combination with HF/HS diet-induced alterations as an approach to study the susceptibility and interindividual variabilities in the pathogenesis of nonalcoholic fatty liver and early nonalcoholic steatohepatitis at the population level, uncovering of susceptible and resistant cohorts, and identifying sex-specific molecular determinants of disease susceptibility.	[Conti, Aline; Tryndyak, Volodymyr; Willett, Rose A.; Borowa-Mazgaj, Barbara; Watson, Anna; Beland, Frederick A.; Pogribny, Igor P.] US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA; [Patton, Ralph; Muskhelishvili, Levan; Olson, Greg R.] Toxicol Pathol Associates, Jefferson, AR USA; [Khare, Sangeeta; Cerniglia, Carl E.] US FDA, Div Microbiol, Natl Ctr Toxicol Res, Jefferson, AR USA; [Avigan, Mark I.] US FDA, Off Pharmacovigilance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Ross, Sharon A.] NCI, Div Canc Prevent, Bethesda, MD 20892 USA; [Sanyal, Arun J.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA; [Rusyn, Ivan] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Virginia Commonwealth University; Texas A&M University System; Texas A&M University College Station	Pogribny, IP (corresponding author), US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, 3900 NCTR Rd, Jefferson, AR 72079 USA.	igor.pogribny@fda.hhs.gov		Willett, Rose/0000-0002-2081-8358; Rusyn, Ivan/0000-0001-9340-7384; Khare, SangeetA/0000-0002-9496-6636	HHS | U.S. Food and Drug Administration (FDA) [E7635.01]	HHS | U.S. Food and Drug Administration (FDA)(United States Department of Health & Human Services)	HHS | U.S. Food and Drug Administration (FDA), Grant/Award Number: E7635.01	Adolph TE, 2018, TRENDS IMMUNOL, V39, P712, DOI 10.1016/j.it.2018.05.002; Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005; Atamni HA, 2018, MAMM GENOME, V29, P471, DOI 10.1007/s00335-018-9768-1; Barrington WT, 2018, GENETICS, V208, P399, DOI 10.1534/genetics.117.300536; Bashiardes S, 2016, MOL METAB, V5, P782, DOI 10.1016/j.molmet.2016.06.003; Bedossa P, 2016, DIGEST DIS SCI, V61, P1348, DOI 10.1007/s10620-016-4062-0; Brunt EM, 2019, HEPATOLOGY, V70, P522, DOI 10.1002/hep.30418; Brunt EM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.80; Castera L, 2019, GASTROENTEROLOGY, V156, P1264, DOI 10.1053/j.gastro.2018.12.036; Charlton M, 2011, AM J PHYSIOL-GASTR L, V301, pG825, DOI 10.1152/ajpgi.00145.2011; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Eslam M, 2018, J HEPATOL, V68, P268, DOI 10.1016/j.jhep.2017.09.003; Estes C, 2018, HEPATOLOGY, V67, P123, DOI 10.1002/hep.29466; Farrell G, 2019, HEPATOLOGY, V69, P2241, DOI 10.1002/hep.30333; Garcia-Monzon C, 2014, EUR J CLIN INVEST, V44, P65, DOI 10.1111/eci.12192; Golob-Schwarzi N, 2019, TRANSL ONCOL, V12, P256, DOI 10.1016/j.tranon.2018.10.010; Graupera I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01709-0; Greenstein AW, 2017, J ENDOCRINOL, V232, P107, DOI 10.1530/JOE-16-0447; Hall AM, 2014, DIABETES, V63, P2284, DOI 10.2337/db13-1502; Hall AM, 2012, J LIPID RES, V53, P990, DOI 10.1194/jlr.P025536; Hayashi Y, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.4; Hui ST, 2018, HEPATOLOGY, V68, P2182, DOI 10.1002/hep.30113; Hui ST, 2015, ELIFE, V4, DOI 10.7554/eLife.05607; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Ipsen DH, 2018, CELL MOL LIFE SCI, V75, P3313, DOI 10.1007/s00018-018-2860-6; Jahn D, 2019, BBA-MOL BASIS DIS, V1865, P943, DOI 10.1016/j.bbadis.2018.06.023; Jha P, 2018, CELL SYST, V6, P722, DOI 10.1016/j.cels.2018.05.016; Kaeppler SM, 1997, THEOR APPL GENET, V95, P384, DOI 10.1007/s001220050574; Leroux A, 2012, J HEPATOL, V57, P141, DOI 10.1016/j.jhep.2012.02.028; Li L, 2016, OBES REV, V17, P510, DOI 10.1111/obr.12407; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Lima-Cabello E, 2011, CLIN SCI, V120, P239, DOI 10.1042/CS20100387; Lonardo A, 2019, HEPATOLOGY, V70, P1457, DOI 10.1002/hep.30626; Lu FB, 2018, EXPERT REV GASTROENT, V12, P491, DOI 10.1080/17474124.2018.1460202; NISHIMURA R, 1995, BIOTECH HISTOCHEM, V70, P28, DOI 10.3109/10520299509108313; Novo E, 2015, HISTOL HISTOPATHOL, V30, P1011, DOI 10.14670/HH-11-623; Pettinelli P, 2011, J CLIN ENDOCR METAB, V96, P1424, DOI 10.1210/jc.2010-2129; Pogribny IP, 2013, FASEB J, V27, P2233, DOI 10.1096/fj.12-227116; Salimova E, 2019, NPJ REGEN MED, V4, DOI 10.1038/s41536-019-0067-6; Santhekadur PK, 2018, J HEPATOL, V68, P230, DOI 10.1016/j.jhep.2017.10.031; Sanyal AJ, 2019, NAT REV GASTRO HEPAT, V16, P377, DOI 10.1038/s41575-019-0144-8; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwenk RW, 2010, PROSTAG LEUKOTR ESS, V82, P149, DOI 10.1016/j.plefa.2010.02.029; Schwimmer JB, 2019, GASTROENTEROLOGY, V157, P1109, DOI 10.1053/j.gastro.2019.06.028; Sharpton SR, 2019, CLIN GASTROENTEROL H, V17, P296, DOI 10.1016/j.cgh.2018.08.065; Sheedfar F, 2014, AGING-US, V6, P281, DOI 10.18632/aging.100652; Silva AKS, 2018, CELL MOL LIFE SCI, V75, P2951, DOI 10.1007/s00018-018-2838-4; Teufel A, 2016, GASTROENTEROLOGY, V151, P513, DOI 10.1053/j.gastro.2016.05.051; Threadgill DW, 2011, ILAR J, V52, P24, DOI 10.1093/ilar.52.1.24; Valenti LVC, 2018, CURR PHARM DESIGN, V24, P4566, DOI 10.2174/1381612825666190119113836; Vilar-Gomez E, 2018, J HEPATOL, V68, P305, DOI 10.1016/j.jhep.2017.11.013; Wang P, 2019, GUT, V68, P1942, DOI 10.1136/gutjnl-2018-316691; Wang W, 2017, HEPATOLOGY, V66, P108, DOI 10.1002/hep.29129; Williams Valerie F, 2019, MSMR, V26, P2; Wong VWS, 2018, NAT REV GASTRO HEPAT, V15, P461, DOI 10.1038/s41575-018-0014-9; Younes R, 2019, SEMIN LIVER DIS, V39, P86, DOI 10.1055/s-0038-1677517; Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251; Younossi ZM, 2019, J HEPATOL, V70, P531, DOI 10.1016/j.jhep.2018.10.033; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Zelber-Sagi S, 2014, LIVER INT, V34, pE128, DOI 10.1111/liv.12318	60	7	7	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7773	7785		10.1096/fj.202000194R	http://dx.doi.org/10.1096/fj.202000194R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304142	Green Accepted			2022-12-26	WOS:000526960300001
J	Couvineau, P; Llorens-cortes, C; Iturrioz, X				Couvineau, Pierre; Llorens-cortes, Catherine; Iturrioz, Xavier			Elabela/Toddler and apelin bind differently to the apelin receptor	FASEB JOURNAL			English	Article						apelin; APJ; Elabela; Toddler; G protein-coupled receptor; site-directed mutagenesis	FLUID HOMEOSTASIS; APJ RECEPTOR; LIGAND; RESIDUES; ELABELA; IDENTIFICATION; FRAGMENT	Like apelin (pE13F, K17F), Elabela/Toddler is an endogenous ligand of the apelin receptor playing a key role in cardiovascular development. Elabela/Toddler exists as peptide fragments of 32 (Q32P), 22 (K22P) and 11 (C11P) amino acids. In this study, we investigated the possible structural and functional similarities between these endogenous ligands. We performed in vitro pharmacological characterization and biased signaling analyses for apelin and Elabela/Toddler fragments in CHO cells, by assessing binding affinities, the inhibition of cyclic adenosine monophosphate (cAMP) production and the triggering of ss-arrestin 2 recruitment. We also performed Alanine scanning for Elabela/Toddler and structure-function studies based on site-directed mutagenesis of the rat and human apelin receptor, to compare the modes of binding of the different endogenous ligands. Alanine scanning of K22P showed that neither of its cysteine residues were involved in binding or in peptide activity and that its C-terminus carried the key pharmacophore for receptor binding and activation. We showed that Asp(282) and Asp(284) of rat and human apelin receptor, respectively, were not involved in Elabela/Toddler activity, whereas they are key residues for apelin binding and activity. We found that the structural features of Elabela/Toddler and apelin were different, resulting in different modes of binding of these endogenous ligands to the apelin receptor. These differences should be taken into account in the future development metabolically stable analogs of Elabela/Toddler and apelin as potential therapeutic tools for the treatment of cardiovascular diseases and water retention/hyponatremic disorders.	[Couvineau, Pierre; Llorens-cortes, Catherine; Iturrioz, Xavier] PSL Res Univ, Coll France, CIRB, INSERM,CNRS, Paris, France; [Couvineau, Pierre] Univ Montreal, IRIC, Montreal, PQ, Canada; [Couvineau, Pierre] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universite de Montreal; Universite de Montreal	Iturrioz, X (corresponding author), Coll France, Lab Cent Neuropeptides Regulat Body Fluid Homeost, CIRB, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	xavier.iturrioz@college-de-france.fr	Llorens-Cortes, Catherine/E-5839-2016; Iturrioz, Xavier/AAS-3555-2020; ITURRIOZ, Xavier/Q-4406-2017	Llorens-Cortes, Catherine/0000-0002-7667-0401; Iturrioz, Xavier/0000-0001-7143-8323; ITURRIOZ, Xavier/0000-0001-7143-8323; Couvineau, Pierre/0000-0002-4905-7740	Institut National de la Sante et de la Recherche Medicale, the College de France; "Labex MemoLife" - French national "Programme des Investissements d'Avenir 2011-2012"	Institut National de la Sante et de la Recherche Medicale, the College de France; "Labex MemoLife" - French national "Programme des Investissements d'Avenir 2011-2012"(French National Research Agency (ANR))	This work was supported by the Institut National de la Sante et de la Recherche Medicale, the College de France. Pierre Couvineau was supported by a "Labex MemoLife," funded by the French national "Programme des Investissements d'Avenir 2011-2012." We would like to thank Dr Adrien Flahault for his contribution to our statistical analysis. We would like to thank Julie Sappa from Alex Edelman & Associates for the English editing. We would like to thank Dr Joanne Durgan (Babraham Institute, Cambridge, UK) and Dr Shane Wright Christopher (IRIC, Montreal, Canada) for manuscript reading.	Besserer-Offroy E, 2018, PHARMACOL RES, V131, P7, DOI 10.1016/j.phrs.2018.02.032; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Curtis MJ, 2018, BRIT J PHARMACOL, V175, P987, DOI 10.1111/bph.14153; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Deng C, 2015, J BIOL CHEM, V290, P18261, DOI 10.1074/jbc.M115.648238; Fillion D, 2013, J BIOL CHEM, V288, P8187, DOI 10.1074/jbc.M112.442053; Flahault A, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00120; Galanth C, 2012, CURR PHARM DESIGN, V18, P789, DOI 10.2174/138161212799277770; Gerbier R, 2015, FASEB J, V29, P314, DOI 10.1096/fj.14-256339; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Helker CSM, 2015, ELIFE, V4, DOI 10.7554/eLife.06726; HJORTH SA, 1994, J BIOL CHEM, V269, P30953; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Huang SYK, 2017, BBA-BIOMEMBRANES, V1859, P767, DOI 10.1016/j.bbamem.2017.01.028; Iturrioz X, 2010, J BIOL CHEM, V285, P32627, DOI 10.1074/jbc.M110.127167; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Ma YL, 2017, STRUCTURE, V25, P858, DOI 10.1016/j.str.2017.04.008; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Murza A, 2016, J MED CHEM, V59, P2962, DOI 10.1021/acs.jmedchem.5b01549; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Perjes A, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-015-0521-6; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Shin K, 2019, AMINO ACIDS, V51, P395, DOI 10.1007/s00726-018-2674-8; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; van der Westhuizen ET, 2014, MOL PHARMACOL, V85, P492, DOI 10.1124/mol.113.088880; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep08170; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Yang PR, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00092; Zhou HP, 2000, ARCH BIOCHEM BIOPHYS, V373, P211, DOI 10.1006/abbi.1999.1555	35	5	5	1	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7989	8000		10.1096/fj.201903029R	http://dx.doi.org/10.1096/fj.201903029R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301550				2022-12-26	WOS:000526644000001
J	Fuenfgeld, B; Machler, P; Fischer, DR; Esposito, G; Rushing, EJ; Kaufmann, PA; Stolzmann, P; Huellner, MW				Fuenfgeld, Brigitte; Machler, Philipp; Fischer, Dorothee R.; Esposito, Giuseppe; Rushing, Elisabeth Jane; Kaufmann, Philipp A.; Stolzmann, Paul; Huellner, Martin W.			Reference values of physiological 18F-FET uptake: Implications for brain tumor discrimination	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL BLOOD-VOLUME; AMINO-ACID PET; FET-PET; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; F-18-FET PET; DIFFERENTIAL-DIAGNOSIS; PROGNOSTIC VALUE; NEUROONCOLOGY	Purpose The aim of this study was to derive reference values of 18F-fluoro-ethyl-L-tyrosine positron emission tomography (18F-FET-PET) uptake in normal brain and head structures to allow for differentiation from tumor tissue. Materials and methods We examined the datasets of 70 patients (median age 53 years, range 15-79), whose dynamic 18F-FET-PET was acquired between January 2016 and October 2017. Maximum standardized uptake value (SUVmax), target-to-background standardized uptake value ratio (TBR), and time activity curve (TAC) of the 18F-FET-PET were assessed in tumor tissue and in eight normal anatomic structures and compared using the t-test and Mann-Whitney U-test. Correlation analyses were performed using Pearson or Spearman coefficients, and comparisons between several variables with Pearson's chi-squared tests and Kruskal-Wallis tests as well as the Benjamini-Hochberg correction. Results All analyzed structures showed an 18F-FET uptake higher than background (threshold: TBR > 1.5). The venous sinuses and cranial muscles exhibited a TBR of 2.03 +/- 0.46 (confidence interval (CI) 1.92-2.14), higher than the uptake of caudate nucleus, pineal gland, putamen, and thalamus (TBR 1.42 +/- 0.17, CI 1.38-1.47). SUVmax, TBR, and TAC showed no difference in the analyzed structures between subjects with high-grade gliomas and subjects with low-grade gliomas, except the SUVmax of the pineal gland (t-tests of the pineal gland: SUVmax: p = 0.022; TBR: p = 0.411). No significant differences were found for gender and age. Conclusion Normal brain tissue demonstrates increased 18F-FET uptake compared to background tissue. Two distinct clusters have been identified, comprising venous structures and gray matter with a reference uptake of up to SUVmax of 2.99 and 2.33, respectively.	[Fuenfgeld, Brigitte; Machler, Philipp; Kaufmann, Philipp A.; Stolzmann, Paul; Huellner, Martin W.] Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland; [Fuenfgeld, Brigitte; Rushing, Elisabeth Jane; Kaufmann, Philipp A.; Stolzmann, Paul; Huellner, Martin W.] Univ Zurich, Zurich, Switzerland; [Fischer, Dorothee R.] Hosp St Anna, Dept Radiol & Nucl Med, Luzern, Switzerland; [Esposito, Giuseppe] Univ Hosp Zurich, Dept Neurosurg, Zurich, Switzerland; [Rushing, Elisabeth Jane] Univ Hosp Zurich, Inst Neuropathol, Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Huellner, MW (corresponding author), Univ Hosp Zurich, Dept Nucl Med, Zurich, Switzerland.; Huellner, MW (corresponding author), Univ Zurich, Zurich, Switzerland.	martin.huellner@usz.ch		Maechler, Philipp/0000-0001-7996-7684; Kaufmann, Philipp/0000-0002-9451-5210	GE Healthcare; Alfred and Annemarie von Sick translational grant in oncology	GE Healthcare(General ElectricGE Healthcare); Alfred and Annemarie von Sick translational grant in oncology	The authors received no specific funding for this work. The institution of the authors has received grants from GE Healthcare. MH is a recipient of the Alfred and Annemarie von Sick translational grant in oncology, and IIS grants by GE Healthcare.	Albatly AA, 2018, CLIN IMAG, V51, P68, DOI 10.1016/j.clinimag.2018.01.015; Albert NL, 2016, NEURO-ONCOLOGY, V18, P1199, DOI 10.1093/neuonc/now058; Barbagallo M, 2018, CLIN NUCL MED, V43, pE385, DOI 10.1097/RLU.0000000000002244; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blanc-Durand P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199379; Buck A, 2016, MOL ANATOMIC IMAGING, P143; Burger IA, 2012, NUCL MED BIOL, V39, P666, DOI 10.1016/j.nucmedbio.2011.11.002; Burghaus L, 2018, CLIN NUCL MED, V43, pE322, DOI 10.1097/RLU.0000000000002197; Calcagni ML, 2011, CLIN NUCL MED, V36, P841, DOI 10.1097/RLU.0b013e3182291b40; Cha S, 2009, NEUROTHERAPEUTICS, V6, P465, DOI 10.1016/j.nurt.2009.05.002; Chan M, 2017, CLIN NUCL MED, V42, P197, DOI 10.1097/RLU.0000000000001516; COHEN J, 1988, APPL PSYCH MEAS, V12, P425, DOI 10.1177/014662168801200410; Dunet V, 2013, PET CLIN, V8, P147, DOI 10.1016/j.cpet.2012.09.005; Dunet V, 2012, J NUCL MED, V53, P207, DOI 10.2967/jnumed.111.096859; Floeth FW, 2007, J NUCL MED, V48, P519, DOI 10.2967/jnumed.106.037895; Floeth FW, 2008, J NUCL MED, V49, P730, DOI 10.2967/jnumed.107.050005; Floeth FW, 2006, J NUCL MED, V47, P776; Galldiks N, 2017, EXPERT REV ANTICANC, V17, P395, DOI 10.1080/14737140.2017.1302799; Galldiks N, 2013, J NUCL MED, V54, P2046, DOI 10.2967/jnumed.113.123836; Gempt J, 2015, WORLD NEUROSURG, V84, P1790, DOI 10.1016/j.wneu.2015.07.067; Gottler J, 2017, EUR J NUCL MED MOL I, V44, P392, DOI 10.1007/s00259-016-3585-0; Gotz I, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00104; Grosu AL, 2011, INT J RADIAT ONCOL, V81, P1049, DOI 10.1016/j.ijrobp.2010.07.002; Gujar SK, 2005, J NEURO-OPHTHALMOL, V25, P217, DOI 10.1097/01.wno.0000177307.21081.81; Heiss P, 1999, J NUCL MED, V40, P1367; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Hutterer M, 2017, CLIN NUCL MED, V42, pE506, DOI 10.1097/RLU.0000000000001873; Hutterer M, 2013, NEURO-ONCOLOGY, V15, P341, DOI 10.1093/neuonc/nos300; Jadvar H, 2014, EUR J RADIOL, V83, P84, DOI 10.1016/j.ejrad.2013.05.028; Kebir S, 2016, ONCOL LETT, V11, P2195, DOI 10.3892/ol.2016.4189; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; Laffon E, 2014, EUR RADIOL, V24, P1964, DOI 10.1007/s00330-014-3222-x; Langen KJ, 2017, METHODS, V130, P124, DOI 10.1016/j.ymeth.2017.05.019; Law I, 2019, EUR J NUCL MED MOL I, V46, P540, DOI 10.1007/s00259-018-4207-9; Louis DN, 2016, ACTA NEUROPATHOL, V131, P803, DOI 10.1007/s00401-016-1545-1; Marner L, 2017, CLIN TRANSL IMAGING, V5, P135, DOI 10.1007/s40336-016-0213-8; Misch M, 2015, CHILD NERV SYST, V31, P261, DOI 10.1007/s00381-014-2552-y; Muoio B, 2018, CURR MED CHEM, V25, P3061, DOI 10.2174/0929867325666171123202644; Nandu H, 2018, THER ADV NEUROL DISO, V11, DOI 10.1177/1756286418759865; Nowosielski M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095830; Pauleit D, 2004, J NUCL MED, V45, P374; Pauleit D, 2005, BRAIN, V128, P678, DOI 10.1093/brain/awh399; Pauleit D, 2009, NUCL MED BIOL, V36, P779, DOI 10.1016/j.nucmedbio.2009.05.005; Pichler R, 2010, EUR J NUCL MED MOL I, V37, P1521, DOI 10.1007/s00259-010-1457-6; Popperl G, 2004, EUR J NUCL MED MOL I, V31, P1464, DOI 10.1007/s00259-004-1590-1; Pyka T, 2017, CLIN TRANSL IMAGING, V5, P151, DOI 10.1007/s40336-017-0222-2; Sadeghi N, 2007, AM J NEURORADIOL, V28, P455; Salber D, 2010, J NUCL MED, V51, P790, DOI 10.2967/jnumed.109.071423; Salber D, 2007, J NUCL MED, V48, P2056, DOI 10.2967/jnumed.107.046615; Unterrainer M, 2018, CLIN NUCL MED, V43, P840, DOI 10.1097/RLU.0000000000002266; Unterrainer M, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0295-y; Verma N, 2013, NEURO-ONCOLOGY, V15, P515, DOI 10.1093/neuonc/nos307; Villanueva-Meyer JE, 2017, NEUROSURGERY, V81, P397, DOI 10.1093/neuros/nyx103; Weber WA, 2000, EUR J NUCL MED, V27, P542, DOI 10.1007/s002590050541; Weckesser M, 2005, EUR J NUCL MED MOL I, V32, P422, DOI 10.1007/s00259-004-1705-8	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0230618	10.1371/journal.pone.0230618	http://dx.doi.org/10.1371/journal.pone.0230618			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302317	Green Published, gold, Green Accepted			2022-12-26	WOS:000536016100008
J	Okahashi, N; Nakata, M; Hirose, Y; Morisaki, H; Kataoka, H; Kuwata, H; Kawabata, S				Okahashi, Nobuo; Nakata, Masanobu; Hirose, Yujiro; Morisaki, Hirobumi; Kataoka, Hideo; Kuwata, Hirotaka; Kawabata, Shigetada			Streptococcal H2O2 inhibits IgE-triggered degranulation of RBL-2H3 mast cell/basophil cell line by inducing cell death	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; HISTAMINE-RELEASE; PNEUMONIAE; APOPTOSIS; IDENTIFICATION; DETERMINANT; PNEUMOLYSIN; INFECTION; SANGUINIS; VIRULENCE	Mast cells and basophils are central players in allergic reactions triggered by immunoglobulin E (IgE). They have intracellular granules containing allergic mediators (e.g., histamine, serotonin, inflammatory cytokines, proteases and beta-hexosaminidase), and stimulation by IgE-allergen complex leads to the release of such allergic mediators from the granules, that is, degranulation. Mast cells are residents of mucosal surfaces, including those of nasal and oral cavities, and play an important role in the innate defense system. Members of the mitis group streptococci such as Streptococcus oralis, are primary colonizers of the human oral cavity. They produce hydrogen peroxide (H2O2) as a by-product of sugar metabolism. In this study, we investigated the effects of streptococcal infection on RBL-2H3 mast cell/basophil cell line. Infection by oral streptococci did not induce degranulation of the cells. Stimulation of the RBL-2H3 cells with anti-dinitrophenol (DNP) IgE and DNP-conjugated human serum albumin triggers degranulation with the release of beta-hexosaminidase. We found that S. oralis and other mitis group streptococci inhibited the IgE-triggered degranulation of RBL-2H3 cells. Since mitis group streptococci produce H2O2, we examined the effect of S. oralis mutant strain deficient in producing H2O2, and found that they lost the ability to suppress the degranulation. Moreover, H2O2 alone inhibited the IgE-induced degranulation. Subsequent analysis suggested that the inhibition of degranulation was related to the cytotoxicity of streptococcal H2O2. Activated RBL-2H3 cells produce interleukin-4 (IL-4); however, IL-4 production was not induced by streptococcal H2O2. Furthermore, an in vivo study using the murine pollen-induced allergic rhinitis model suggested that the streptococcal H2O2 reduces nasal allergic reaction. These findings reveal that H2O2 produced by oral mitis group streptococci inhibits IgE-stimulated degranulation by inducing cell death. Consequently, streptococcal H2O2 can be considered to modulate the allergic reaction in mucosal surfaces.	[Okahashi, Nobuo] Osaka Univ, Grad Sch Dent, Ctr Frontier Oral Sci, Suita, Osaka, Japan; [Nakata, Masanobu; Hirose, Yujiro; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka, Japan; [Morisaki, Hirobumi; Kuwata, Hirotaka] Showa Univ, Sch Dent, Dept Oral Microbiol & Immunol, Shinagawa Ku, Tokyo, Japan; [Kataoka, Hideo] Asahi Univ, Sch Dent, Dept Oral Microbiol, Mizuho Ku, Gifu, Japan	Osaka University; Osaka University; Showa University; Asahi University	Okahashi, N (corresponding author), Osaka Univ, Grad Sch Dent, Ctr Frontier Oral Sci, Suita, Osaka, Japan.	okahashi@dent.osaka-u.ac.jp	; okahashi, nobuo/A-4032-2010	Nakata, Masanobu/0000-0003-1686-5415; okahashi, nobuo/0000-0002-8045-7021; Hirose, Yujiro/0000-0001-6338-4767	Japan Society for the Promotion of Science (JSPS) KAKENHI [17K11958, 17H04369]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Numbers 17K11958 (NO), 17H04369 (MN). The JSPS KAKENHI homepage: https://www.jsps.go.jp/j-grantsinaid/index.html The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbuti G, 2006, INT J MED MICROBIOL, V296, P325, DOI 10.1016/j.ijmm.2005.11.009; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Braun JS, 2002, J CLIN INVEST, V109, P19; BRIDGE PD, 1982, INT J SYST BACTERIOL, V32, P410, DOI 10.1099/00207713-32-4-410; Calderon MA, 2012, ALLERGY, V67, P302, DOI 10.1111/j.1398-9995.2011.02761.x; Chen L, 2011, MICROBIOL-SGM, V157, P13, DOI 10.1099/mic.0.039669-0; COYKENDALL AL, 1989, CLIN MICROBIOL REV, V2, P315, DOI 10.1128/CMR.2.3.315-328.1989; DOUGLAS CWI, 1993, J MED MICROBIOL, V39, P179, DOI 10.1099/00222615-39-3-179; Dyson C, 1999, J INFECTION, V38, P87, DOI 10.1016/S0163-4453(99)90074-9; Eifan AO, 2016, CLIN EXP ALLERGY, V46, P1139, DOI 10.1111/cea.12780; FALCIERI E, 1993, BIOCHEM BIOPH RES CO, V193, P19, DOI 10.1006/bbrc.1993.1584; Fritscher J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00550; Gaje PN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/9235080; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gendrin C, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400225; Guerin-Marchand C, 2001, INFLAMM RES, V50, P341, DOI 10.1007/PL00000254; Haenuki Y, 2012, J ALLERGY CLIN IMMUN, V130, P184, DOI 10.1016/j.jaci.2012.02.013; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Hirose Y, 2018, VIRULENCE, V9, P1576, DOI 10.1080/21505594.2018.1526530; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Kato Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103540; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kee JY, 2015, J NAT MED-TOKYO, V69, P209, DOI 10.1007/s11418-014-0880-6; KOLENBRANDER PE, 1993, J BACTERIOL, V175, P3247, DOI 10.1128/jb.175.11.3247-3252.1993; Kreth J, 2008, J BACTERIOL, V190, P4632, DOI 10.1128/JB.00276-08; Krystel-Whittemore M, 2016, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00620; KULCZYCKI A, 1974, J EXP MED, V139, P600, DOI 10.1084/jem.139.3.600; Loose M, 2015, J INFECT DIS, V211, P306, DOI 10.1093/infdis/jiu428; Matsushima H, 2017, BIOCHEM BIOPH RES CO, V485, P461, DOI 10.1016/j.bbrc.2017.02.048; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mitchell J, 2011, MOL ORAL MICROBIOL, V26, P89, DOI 10.1111/j.2041-1014.2010.00601.x; Mrschtik M, 2015, FEBS J, V282, P1858, DOI 10.1111/febs.13253; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; Okahashi N, 2016, INFECT IMMUN, V84, P2042, DOI 10.1128/IAI.00134-16; Okahashi N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088136; Okahashi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062563; Okahashi N, 2011, FEMS MICROBIOL LETT, V323, P164, DOI 10.1111/j.1574-6968.2011.02375.x; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Passante E, 2009, INFLAMM RES, V58, P611, DOI [10.1007/s00011-009-0028-4, 10.1007/s00011-009-0644-z]; Paton JC, 1996, TRENDS MICROBIOL, V4, P103, DOI 10.1016/0966-842X(96)81526-5; PEDEN DB, 1994, AM J PHYSIOL, V267, pL85, DOI 10.1152/ajplung.1994.267.1.L85; Public Health England, 2013, PYOG NONP STREPT BAC, V8; Puri N, 2003, J IMMUNOL, V171, P5345, DOI 10.4049/jimmunol.171.10.5345; Rai P, 2015, P NATL ACAD SCI USA, V112, pE3421, DOI 10.1073/pnas.1424144112; Reber LL, 2015, MUCOSAL IMMUNOL, V8, P444, DOI 10.1038/mi.2014.131; Redanz S, 2018, MOL ORAL MICROBIOL, V33, P337, DOI 10.1111/omi.12231; Spellerberg B, 1996, MOL MICROBIOL, V19, P803, DOI 10.1046/j.1365-2958.1996.425954.x; Steiner M, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8232830; Stone KD, 2010, J ALLERGY CLIN IMMUN, V125, pS73, DOI 10.1016/j.jaci.2009.11.017; STROBEL S, 1981, J CLIN PATHOL, V34, P851, DOI 10.1136/jcp.34.8.851; Sumioka R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172223; Suzuki Y, 2005, CHEM IMMUNOL ALLERGY, V87, P32, DOI 10.1159/000087569; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; Walsh LJ, 2003, CRIT REV ORAL BIOL M, V14, P188, DOI 10.1177/154411130301400304; Wan BYC, 2001, BIOCHEM PHARMACOL, V62, P1537, DOI 10.1016/S0006-2952(01)00770-5; Watanabe Y, 2002, INFECT IMMUN, V70, P3944, DOI 10.1128/IAI.70.7.3944-3947.2002; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Yu ZQ, 2003, FREE RADICAL BIO MED, V34, P1243, DOI 10.1016/S0891-5849(03)00109-6; ZDOLSEK J, 1993, FREE RADICAL RES COM, V18, P71, DOI 10.3109/10715769309147344; Zhu L, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/717843	63	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231101	10.1371/journal.pone.0231101	http://dx.doi.org/10.1371/journal.pone.0231101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302339	Green Published, gold			2022-12-26	WOS:000536016100016
J	Hyun, DG; Choi, CM; Lee, DH; Kim, SW; Yoon, S; Kim, WS; Ji, W; Lee, JC				Hyun, Dong-Gon; Choi, Chang-Min; Lee, Dae Ho; Kim, Sang-We; Yoon, Shinkyo; Kim, Woo Sung; Ji, Wonjun; Lee, Jae Cheol			Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasis	PLOS ONE			English	Article							TYROSINE KINASE INHIBITORS; RADIATION-THERAPY; CELL; MUTATION; RADIOTHERAPY; ERLOTINIB; EFFICACY; NSCLC; TKI; LEPTOMENINGEAL	In patients with epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) with brain metastases, it remains controversial whether the use of EGFR-tyrosine kinase inhibitor (TKI) alone without radiotherapy (RT) is an optimal approach. Here, we investigated the clinical outcomes according to the use of upfront RT as well as the subsequent therapy following intracranial progression. This single-centre retrospective study included a total of 173 patients who were treated with EGFR-TKI alone (TKI alone group) or with upfront whole-brain RT (WBRT) or stereotactic radiosurgery (SRS) followed by EGFR-TKI (RT plus TKI group). Clinical outcomes according to initial and subsequent therapies following intracranial progression were analysed. There was no significant difference in OS according to the use of upfront RT (TKI alone group, 24.5 months vs. WBRT group, 20.0 months vs. SRS group, 17.8 months; P = 0.186). Intracranial progression was found in 35 (32.7%) of 107 patients in the TKI alone group. Among them, 19 patients who received salvage RT had the better prognosis than others [median overall survival (OS); 28.6 vs. 11.2 months; P = 0.041]. In the RT plus TKI group, 12 (18.1%) of the 66 patients experienced intracranial progression and 3 of them received salvage RT (median OS; 37.4 vs. 20.0 months; P = 0.044). In multivariate analysis, upfront WBRT was associated with trends towards a lower probability of intracranial progression, whereas upfront SRS was found to be an independent risk factor for poor OS. In conclusion, using EGFR-TKI alone for brain metastasis in EGFR-mutant lung cancer patients showed outcomes comparable to those using upfront RT followed by EGFR-TKI. Patients who could not receive salvage RT following intracranial progression had the worst survival regardless of the type of initial treatment.	[Hyun, Dong-Gon; Choi, Chang-Min; Kim, Woo Sung; Ji, Wonjun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea; [Choi, Chang-Min; Lee, Dae Ho; Kim, Sang-We; Yoon, Shinkyo; Lee, Jae Cheol] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Ji, W (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea.; Lee, JC (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea.	jack1097@naver.com; jclee@amc.seoul.kr	Lee, Jae Cheol/AAA-2678-2021	Hyun, Dong-gon/0000-0001-5434-2223	Korea Health Technology R&D Project throughthe Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0516, 2019-709]; Asan Institute for Life Sciences, Seoul, Korea	Korea Health Technology R&D Project throughthe Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Asan Institute for Life Sciences, Seoul, Korea	This study was supported by a grant of the Korea Health Technology R&D Project throughthe Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant HI15C0516) and a grant (2019-709) from the Asan Institute for Life Sciences, Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Bai H, 2017, ONCOTARGETS THER, V10, P2335, DOI 10.2147/OTT.S129809; Bai H, 2013, AM J CLIN ONCOL-CANC, V36, P110, DOI 10.1097/COC.0b013e3182438c91; Barnholtz-Sloan JS, 2004, J CLIN ONCOL, V22, P2865, DOI 10.1200/JCO.2004.12.149; Byeon S, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0811-3; Chang EL, 2009, LANCET ONCOL, V10, P1037, DOI 10.1016/S1470-2045(09)70263-3; Chen YS, 2016, CANCER SCI, V107, P1800, DOI 10.1111/cas.13079; de Vries NA, 2012, INVEST NEW DRUG, V30, P443, DOI 10.1007/s10637-010-9569-1; Doherty MK, 2017, RADIOTHER ONCOL, V123, P195, DOI [10.1016/J.radonc.2017.03.007, 10.1016/j.radonc.2017.03.007]; Du XJ, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00603; Fan Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep45193; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; How J, 2017, CLIN LUNG CANCER, V18, P354, DOI 10.1016/j.cllc.2017.01.013; Iuchi T, 2013, LUNG CANCER, V82, P282, DOI 10.1016/j.lungcan.2013.08.016; Jackman DM, 2006, J CLIN ONCOL, V24, P4517, DOI 10.1200/JCO.2006.06.6126; Jiang T, 2016, J THORAC ONCOL, V11, P1718, DOI 10.1016/j.jtho.2016.05.013; Kim JE, 2009, LUNG CANCER, V65, P351, DOI 10.1016/j.lungcan.2008.12.011; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Liu Y, 2017, ONCOTARGETS THER, V10, DOI 10.2147/OTT.S133082; Magnuson WJ, 2017, J CLIN ONCOL, V35, P1070, DOI 10.1200/JCO.2016.69.7144; Mulvenna P, 2016, LANCET, V388, P2004, DOI 10.1016/S0140-6736(16)30825-X; Noronha Vanita, 2014, Chemother Res Pract, V2014, P856156, DOI 10.1155/2014/856156; Omuro AMP, 2005, CANCER-AM CANCER SOC, V103, P2344, DOI 10.1002/cncr.21033; Oxnard GR, 2011, CLIN CANCER RES, V17, P1616, DOI 10.1158/1078-0432.CCR-10-2692; Park SJ, 2012, LUNG CANCER, V77, P556, DOI 10.1016/j.lungcan.2012.05.092; Reungwetwattana T, 2018, J CLIN ONCOL, V36, P3290, DOI 10.1200/JCO.2018.78.3118; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Soon YY, 2015, RADIOTHER ONCOL, V114, P167, DOI 10.1016/j.radonc.2014.12.011; Sung S, 2018, J NEURO-ONCOL, V139, P205, DOI 10.1007/s11060-018-2861-1; Tartarone A, 2015, THER ADV RESPIR DIS, V9, P242, DOI 10.1177/1753465815587820; Wang CY, 2019, J CANCER, V10, P1985, DOI 10.7150/jca.30131; Wang CY, 2018, LUNG CANCER, V122, P94, DOI 10.1016/j.lungcan.2018.05.014; Wang WX, 2018, ARCH MED SCI, V14, P1298, DOI 10.5114/aoms.2018.78939; Zhao J, 2013, CLIN LUNG CANCER, V14, P188, DOI 10.1016/j.cllc.2012.06.004; Zheng H, 2017, ONCOTARGET, V8, P57356, DOI 10.18632/oncotarget.19054	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231546	10.1371/journal.pone.0231546	http://dx.doi.org/10.1371/journal.pone.0231546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298306	Green Published, gold			2022-12-26	WOS:000536011400064
J	Kang, AR; Lee, J; Jung, W; Lee, M; Park, SY; Woo, J; Kim, SH				Kang, Ah Reum; Lee, Jihyun; Jung, Woohyun; Lee, Misoon; Park, Sun Young; Woo, Jiyoung; Kim, Sang Hyun			Development of a prediction model for hypotension after induction of anesthesia using machine learning	PLOS ONE			English	Article							INTRAOPERATIVE HYPOTENSION	Arterial hypotension during the early phase of anesthesia can lead to adverse outcomes such as a prolonged postoperative stay or even death. Predicting hypotension during anesthesia induction is complicated by its diverse causes. We investigated the feasibility of developing a machine-learning model to predict postinduction hypotension. Naive Bayes, logistic regression, random forest, and artificial neural network models were trained to predict postinduction hypotension, occurring between tracheal intubation and incision, using data for the period from between the start of anesthesia induction and immediately before tracheal intubation obtained from an anesthesia monitor, a drug administration infusion pump, an anesthesia machine, and from patients' demographics, together with preexisting disease information from electronic health records. Among 222 patients, 126 developed postinduction hypotension. The random-forest model showed the best performance, with an area under the receiver operating characteristic curve of 0.842 (95% confidence interval [CI]: 0.736-0.948). This was higher than that for the Naive Bayes (0.778; 95% CI: 0.65-0.898), logistic regression (0.756; 95% CI: 0.630-0.881), and artificial-neural-network (0.760; 95% CI: 0.640-0.880) models. The most important features affecting the accuracy of machine-learning prediction were a patient's lowest systolic blood pressure, lowest mean blood pressure, and mean systolic blood pressure before tracheal intubation. We found that machine-learning models using data obtained from various anesthesia machines between the start of anesthesia induction and immediately before tracheal intubation can predict hypotension occurring during the period between tracheal intubation and incision.	[Kang, Ah Reum; Lee, Jihyun; Woo, Jiyoung] Soonchunhyang Univ, SCH Media Labs, Asan, Chungnam, South Korea; [Jung, Woohyun; Lee, Misoon; Kim, Sang Hyun] Soonchunhyang Univ, Coll Med, Dept Anesthesiol & Pain Med, Bucheon Hosp, Bucheon, Gyeonggi, South Korea; [Park, Sun Young] Soonchunhyang Univ, Coll Med, Dept Anesthesiol & Pain Med, Seoul Hosp, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University	Kim, SH (corresponding author), Soonchunhyang Univ, Coll Med, Dept Anesthesiol & Pain Med, Bucheon Hosp, Bucheon, Gyeonggi, South Korea.	skim@schmc.ac.kr		Kang, Ah Reum/0000-0002-0732-5313; Jung, Woohyun/0000-0002-7786-7679; Park, Sun Young/0000-0003-2588-3324	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2018R1A6A3A01011337]; Soonchunhyang University Research Fund; National Research Foundation of Korea (NRF) - Korea government (MSIT) [2017R1C1B5076787]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea); Soonchunhyang University Research Fund; National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2018R1A6A3A01011337), the Soonchunhyang University Research Fund and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (2017R1C1B5076787).	Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; COX DR, 1958, J R STAT SOC B, V20, P215; Hassoun MH., 1995, FUNDAMENTALS ARTIFIC, DOI 10.1109/JPROC.1996.503146; Hatib F, 2018, ANESTHESIOLOGY, V129, P663, DOI 10.1097/ALN.0000000000002300; Jain A, 1997, IEEE T PATTERN ANAL, V19, P153, DOI 10.1109/34.574797; Kendale S, 2018, ANESTHESIOLOGY, V129, P675, DOI 10.1097/ALN.0000000000002374; Lee CK, 2018, ANESTHESIOLOGY, V129, P649, DOI 10.1097/ALN.0000000000002186; Lee HC, 2018, ANESTHESIOLOGY, V128, P492, DOI 10.1097/ALN.0000000000001892; Lee HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20062-4; McCallum A., 1998, AAAI 98 WORKSH LEARN; Powers D. M, 2011, ARXIV201016061; Sudfeld S, 2017, BRIT J ANAESTH, V119, P57, DOI 10.1093/bja/aex127; Sun LY, 2015, ANESTHESIOLOGY, V123, P515, DOI 10.1097/ALN.0000000000000765; Walsh M, 2013, ANESTHESIOLOGY, V119, P507, DOI 10.1097/ALN.0b013e3182a10e26	15	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231172	10.1371/journal.pone.0231172	http://dx.doi.org/10.1371/journal.pone.0231172			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298292	gold, Green Published			2022-12-26	WOS:000536011400029
J	Kirby, AV; Diener, ML; Adkins, DE; Wright, C				Kirby, Anne V.; Diener, Marissa L.; Adkins, Daniel E.; Wright, Cheryl			Transition preparation activities among families of youth on the autism spectrum: Preliminary study using repeated assessments across a school year	PLOS ONE			English	Article							YOUNG-ADULTS; EMPLOYMENT OUTCOMES; DISORDERS; ADOLESCENTS; DISABILITIES; PERSPECTIVES; STUDENTS; CHILDREN; PARENTS	Much is still unknown about the transition to adulthood for youth with autism spectrum disorder (ASD), including what preparation activities best support positive adult outcomes. Parents play a crucial role in the transition planning and preparation process, yet the existing literature lacks detailed information about parent perceptions about transition preparation activities. To examine family transition preparation activities, we conducted a ten-month study of the transition preparation process of 15 families of youth with ASD across an academic year. Youth were ages 14-17 and 93% male. We collected data on transition preparation activity time spent and parent satisfaction over twenty data collection points. We used multi-level modeling to determine longitudinal trajectories of parent-reported preparation for the transition to adulthood based on endorsed transition preparation activities. Findings from this preliminary study revealed that discussions about the future were the most commonly endorsed activities, while social activities were most associated with increased parental perception of transition preparation over time. This study expands understanding of various transition preparation activities engaged in by families of youth with ASD during high school, though research with a larger and more diverse sample is needed to extend findings.	[Kirby, Anne V.] Univ Utah, Dept Occupat & Recreat Therapies, Coll Hlth, Salt Lake City, UT 84112 USA; [Diener, Marissa L.; Wright, Cheryl] Univ Utah, Dept Family & Consumer Studies, Coll Social & Behav Sci, Salt Lake City, UT 84112 USA; [Adkins, Daniel E.] Univ Utah, Dept Sociol, Coll Social & Behav Sci, Salt Lake City, UT USA; [Adkins, Daniel E.] Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Kirby, AV (corresponding author), Univ Utah, Dept Occupat & Recreat Therapies, Coll Hlth, Salt Lake City, UT 84112 USA.	avkirby@gmail.com		Kirby, Anne/0000-0003-0395-6684	University of Utah College of Health	University of Utah College of Health	This project was financially supported by a grant from the University of Utah College of Health (https://health.utah.edu/) [AK]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Ankeny EM, 2009, TEACH EXCEPT CHILD, V41, P28; Autism Speaks, 2012, MOUNT EV CRIT NEED A; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Camarena PM, 2009, FOCUS AUTISM DEV DIS, V24, P115, DOI 10.1177/1088357609332675; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Chen J, 2019, AUTISM, V23, P1363, DOI 10.1177/1362361318812141; Christensen Deborah L, 2018, MMWR Surveill Summ, V65, P1, DOI [10.15585/mmwr.ss6503a1, 10.15585/mmwr.ss6513a1]; Cimera RE, 2009, AUTISM, V13, P285, DOI 10.1177/1362361309103791; Constantino J. N., 2005, SOCIAL RESPONSIVENES; Eaves LC, 2008, J AUTISM DEV DISORD, V38, P739, DOI 10.1007/s10803-007-0441-x; Farley MA, 2009, AUTISM RES, V2, P109, DOI 10.1002/aur.69; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Griffin MM, 2014, J SPEC EDUC, V47, P256, DOI 10.1177/0022466913475668; Hatfield M, 2018, J RES SPEC EDUC NEED, V18, P3, DOI 10.1111/1471-3802.12388; Hatfield M, 2017, J RES SPEC EDUC NEED, V17, P187, DOI 10.1111/1471-3802.12377; Hedges SH., 2014, HIGH SCH J, V98, P64, DOI DOI 10.1353/HSJ.2014.0014; Hendricks DR, 2009, FOCUS AUTISM DEV DIS, V24, P77, DOI 10.1177/1088357608329827; Hoffman J, SUPPORTS BARRIERS YO; Holmes LG, 2018, J AUTISM DEV DISORD, V48, P2925, DOI 10.1007/s10803-018-3545-6; Howlin P, 2017, CURR OPIN PSYCHIATR, V30, P69, DOI 10.1097/YCO.0000000000000308; Kirby AV, 2019, AUTISM ADULTHOOD, V1, P37, DOI 10.1089/aut.2018.0008; Kirby AV, 2016, J AUTISM DEV DISORD, V46, P1643, DOI 10.1007/s10803-015-2691-3; Levy A, 2011, RES AUTISM SPECT DIS, V5, P1271, DOI 10.1016/j.rasd.2011.01.023; Newman L, 2007, FACTS NLTS2 SECONDAR; Newman L., 2011, POSTHIGH SCH OUTCOME; Poon KK, 2013, RES AUTISM SPECT DIS, V7, P382, DOI 10.1016/j.rasd.2012.10.006; Seltzer MM, 2004, MENT RETARD DEV D R, V10, P234, DOI 10.1002/mrdd.20038; Shattuck PT, 2012, PEDIATRICS, V129, P1042, DOI 10.1542/peds.2011-2864; Shogren KA, 2012, INTELLECT DEV DISAB, V50, P16, DOI 10.1352/1934-9556-50.1.16; Smith LE, 2014, REM SPEC EDUC, V35, P114, DOI 10.1177/0741932513514616; Sosnowy C, 2018, AUTISM, V22, P29, DOI 10.1177/1362361317699585; Steinhausen HC, 2016, ACTA PSYCHIAT SCAND, V133, P445, DOI 10.1111/acps.12559; Taylor JL, 2011, J AUTISM DEV DISORD, V41, P566, DOI 10.1007/s10803-010-1070-3; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wei X, 2016, REM SPEC EDUC, V37, P3, DOI 10.1177/0741932515581495	36	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231551	10.1371/journal.pone.0231551	http://dx.doi.org/10.1371/journal.pone.0231551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298327	Green Published, gold			2022-12-26	WOS:000536011400066
J	Qessaoui, R; Amarraque, A; Lahmyed, H; Ajerrar, A; Mayad, EH; Chebli, B; Walters, AS; Bouharroud, R				Qessaoui, Redouan; Amarraque, Abderrahim; Lahmyed, Hind; Ajerrar, Abdelhadi; Mayad, El Hassan; Chebli, Bouchra; Walters, Alan Stuart; Bouharroud, Rachid			Inoculation of tomato plants with rhizobacteria suppresses development of whitefly Bemisia tabaci (GENNADIUS) (HEMIPTERA: ALEYRODIDAE): Agro-ecological application	PLOS ONE			English	Article							ENTOMOPATHOGENIC NEMATODE; STEINERNEMA-FELTIAE; INSECTICIDES; RESISTANCE; HOMOPTERA; COTTON	In agroecosystems, soil biodiversity is increasingly becoming more recognized as providing benefits to both plants and human health. It performs a wide variety of ecological services beyond the recycling of nutrients to plant growth and manage pests and diseases below the economic injury level. This study investigated the effects of three Pseudomonas isolates (Q172B, Q110B and Q036B), isolated from untreated tomato rhizospheric soil, as a biological control agent of Bemisia tabaci which is a key pest of tomato crops. The study was conducted under laboratory and glasshouse conditions and the water treatment was used as a control. Adult mortality rates were assessed during three days at 24h interval and larva mortality rates were evaluated during six days after treatment at 48h interval. Results indicate that Q036B isolate has a faster effect on B. tabaci adult and larvae. Under laboratory conditions, all three Pseudomonas isolates (Q110B, Q036B and Q172B) have a significant effect on B. tabaci adult mortality compared to control. The earliest and the most important mortality rate of 76% was recorded by Q036B. Two isolates Q036B and Q110B caused a significant mortality on B. tabaci larvae; with highest mortality effect (79%) was observed for Q036B compared to control. However, Q172B has no mortality effects on B. tabaci larvae under laboratory conditions. In glasshouse conditions, only Q036B provided high mortality rates of 91% at 168h after treatment. The results of this study indicate that the Pseudomonas isolate Q036B significantly suppresses B. tabaci in tomato plant and could substitute the excessive use of chemicals. Current research indicates that soil biodiversity could be promising to preserve agro-ecological sustainability.	[Qessaoui, Redouan; Amarraque, Abderrahim; Lahmyed, Hind; Ajerrar, Abdelhadi; Bouharroud, Rachid] Ctr Reg Rech Agron Agadir, Plant Protect Lab, Res Unit Integrated Crop Prod, Inezgane, Morocco; [Qessaoui, Redouan; Lahmyed, Hind; Ajerrar, Abdelhadi; Chebli, Bouchra] Ibn Zohr Univ, Natl Sch Appl Sci, Lab Proc Environm & Energy Engn, Biotechnol & Environm Engn Team, Agadir, Morocco; [Mayad, El Hassan] Ibn Zohr Univ, Fac Sci Agadir, Lab Biotechnol & Valorizat Nat Resources, Agadir, Morocco; [Walters, Alan Stuart] Southern Illinois Univ, Coll Agr Sci, Dept Plant Soil & Agr Syst, Carbondale, IL USA	Ibn Zohr University of Agadir; Ibn Zohr University of Agadir; Southern Illinois University System; Southern Illinois University	Qessaoui, R (corresponding author), Ctr Reg Rech Agron Agadir, Plant Protect Lab, Res Unit Integrated Crop Prod, Inezgane, Morocco.; Qessaoui, R (corresponding author), Ibn Zohr Univ, Natl Sch Appl Sci, Lab Proc Environm & Energy Engn, Biotechnol & Environm Engn Team, Agadir, Morocco.	qessaoui_bio@hotmail.fr	Bouharroud, Rachid/ABD-1669-2020; Mayad, El Hassan/G-8097-2015; CHEBLI, Bouchra/ABD-5583-2021	Mayad, El Hassan/0000-0002-8549-5692; BOUHARROUD, Rachid/0000-0001-8914-1050				Ateyyat MA, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1501; Batta YA, 2003, CROP PROT, V22, P415; BETHKE JA, 1991, ANN ENTOMOL SOC AM, V84, P407, DOI 10.1093/aesa/84.4.407; Bouharroud R, 2007, ACTA HORTIC, P409, DOI 10.17660/ActaHortic.2007.747.51; Bouharroud R, 2006, EUR J SCI RES, V14, P587; Broadway RM, 1998, J CHEM ECOL, V24, P985, DOI 10.1023/A:1022346301626; Brown A, 2019, INT J ARCHIT COMPUT, V17, P3, DOI 10.1177/1478077119836842; Byrne JM, 2005, BIOL CONTROL, V32, P408, DOI 10.1016/j.biocontrol.2004.12.001; Cuthbertson AGS, 2003, NEMATOLOGY, V5, P713, DOI 10.1163/156854103322746887; Cuthbertson AGS, 2003, J INVERTEBR PATHOL, V83, P267, DOI 10.1016/S0022-2011(03)00084-3; Davidson EW, 2000, FLA ENTOMOL, V83, P159, DOI 10.2307/3496151; Emana B, 2017, AGR FOOD SECUR, V6; Gomathi S., 2011, Advances in Applied Science Research, V2, P291; Hanafi A, 2002, ACTA HORTIC, P153, DOI 10.17660/ActaHortic.2002.582.13; Jisha V.N., 2013, ADV MICROBIOL-NY, V3, P462, DOI [10.4236/aim.2013.35062, DOI 10.4236/AIM.2013.35062]; Kupferschmied P, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00287; Kurze E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197971; Lalithambika B., 2014, Research Journal of Recent Sciences, V3, P344; Ling KS, 2019, PLANT DIS, V103, P1439, DOI 10.1094/PDIS-11-18-1959-PDN; LIU TX, 1995, PESTIC SCI, V44, P317, DOI 10.1002/ps.2780440403; Malik K, 2006, PAKISTAN J BOT, V38, P757; Mnif I, 2015, CROP PROT, V77, P52, DOI 10.1016/j.cropro.2015.07.017; Mostakim M, 2012, AFRICAN J MICROBIOL, V6, P5472; Muniz M, 2009, ENVIRON ENTOMOL, V30, P720; Nadarasah G, 2011, FEMS MICROBIOL REV, V35, P555, DOI 10.1111/j.1574-6976.2011.00264.x; Omoya F. O., 2013, African Journal of Microbiology Research, V7, P4877; Qessaoui R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49216-8; Qessaoui R., 2019, J APPL SCI, V19, P473, DOI DOI 10.3923/JAS.2019.473.479; Qessaoui Redouan, 2017, Journal of Plant Protection Research, V57, P409, DOI 10.1515/jppr-2017-0055; Silva VL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00088; Stavrinides J, 2009, APPL ENVIRON MICROB, V75, P2230, DOI 10.1128/AEM.02860-08; Vodovar N, 2006, NAT BIOTECHNOL, V24, P673, DOI 10.1038/nbt1212; Wellman-Desbiens E, 2005, J ECON ENTOMOL, V98, P1469, DOI [10.1093/jee/98.5.1469, DOI 10.1093/JEE/98.5.1469]; Wraight SP, 1999, METH BIOTEC, V5, P233; Zehnder G, 1997, J ECON ENTOMOL, V90, P391, DOI 10.1093/jee/90.2.391	35	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231496	10.1371/journal.pone.0231496	http://dx.doi.org/10.1371/journal.pone.0231496			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298309	Green Published, gold			2022-12-26	WOS:000536011400054
J	Zonneveld, TP; Aigner, A; Groenwold, RHH; Algra, A; Nederkoorn, PJ; Grittner, U; Kruyt, ND; Siegerink, B				Zonneveld, Thomas P.; Aigner, Annette; Groenwold, Rolf H. H.; Algra, Ale; Nederkoorn, Paul J.; Grittner, Ulrike; Kruyt, Nyika D.; Siegerink, Bob			Confounding adjustment performance of ordinal analysis methods in stroke studies	PLOS ONE			English	Article								Background In stroke studies, ordinal logistic regression (OLR) is often used to analyze outcome on the modified Rankin Scale (mRS), whereas the non-parametric Mann-Whitney measure of superiority (MWS) has also been suggested. It is unclear how these perform comparatively when confounding adjustment is warranted. Aims Our aim is to quantify the performance of OLR and MWS in different confounding variable settings. Methods We set up a simulation study with three different scenarios; (1) dichotomous confounding variables, (2) continuous confounding variables, and (3) confounding variable settings mimicking a study on functional outcome after stroke. We compared adjusted ordinal logistic regression (aOLR) and stratified Mann-Whitney measure of superiority (sMWS), and also used propensity scores to stratify the MWS (psMWS). For comparability, OLR estimates were transformed to a MWS. We report bias, the percentage of runs that produced a point estimate deviating by more than 0.05 points (point estimate variation), and the coverage probability. Results In scenario 1, there was no bias in both sMWS and aOLR, with similar point estimate variation and coverage probabilities. In scenario 2, sMWS resulted in more bias (0.04 versus 0.00), and higher point estimate variation (41.6% versus 3.3%), whereas coverage probabilities were similar. In scenario 3, there was no bias in both methods, point estimate variation was higher in the sMWS (6.7%) versus aOLR (1.1%), and coverage probabilities were 0.98 (sMWS) versus 0.95 (aOLR). With psMWS, bias remained 0.00, with less point estimate variation (1.5%) and a coverage probability of 0.95. Conclusions The bias of both adjustment methods was similar in our stroke simulation scenario, and the higher point estimate variation in the MWS improved with propensity score based stratification. The stratified MWS is a valid alternative for adjusted OLR only when the ratio of number of strata versus number of observations is relatively low, but propensity score based stratification extends the application range of the MWS.	[Zonneveld, Thomas P.; Nederkoorn, Paul J.] Univ Amsterdam, Amsterdam UMC, Dept Neurol, Amsterdam, Netherlands; [Aigner, Annette] Charite Univ Med Berlin, Inst Publ Hlth, Berlin, Germany; [Groenwold, Rolf H. H.; Siegerink, Bob] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Groenwold, Rolf H. H.] Leiden Univ, Med Ctr, Dept Biomed Data Sci, Leiden, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Algra, Ale] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Grittner, Ulrike] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany; [Grittner, Ulrike; Siegerink, Bob] Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany; [Kruyt, Nyika D.] Leiden Univ, Med Ctr, Dept Neurol & Clin Neuropsychol, Leiden, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Siegerink, B (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.; Siegerink, B (corresponding author), Charite Univ Med Berlin, Ctr Stroke Res Berlin, Berlin, Germany.	bob.siegerink@charite.de	Siegerink, Bob/K-1323-2012; Grittner, Ulrike/I-2026-2019	Siegerink, Bob/0000-0002-8454-9142; Grittner, Ulrike/0000-0003-2595-0224; Aigner, Annette/0000-0003-4891-8921				Austin PC, INTRO PROPENSITY SCO; Bender R, USING BINARY LOGISTI; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; BRANT R, 1990, BIOMETRICS, V46, P1171, DOI 10.2307/2532457; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Gensicke H, 2016, STROKE, V47, P450, DOI 10.1161/STROKEAHA.115.011674; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Groenwold RH, ADJUSTMENT CONTINUOU; Howard G, 2012, STROKE, V43, P664, DOI 10.1161/STROKEAHA.111.632935; Jovin TG, 2015, NEW ENGL J MED, V372, P2296, DOI 10.1056/NEJMoa1503780; Rahlfs VW, 2014, STROKE, V45, P627, DOI 10.1161/STROKEAHA.113.003151; Senn S, 2007, STAT MED, V26, P5529, DOI 10.1002/sim.3133; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Westendorp WF, 2015, LANCET, V385, P1519, DOI 10.1016/S0140-6736(14)62456-9; Williams R, 2006, STATA J, V6, P58, DOI 10.1177/1536867X0600600104	15	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231670	10.1371/journal.pone.0231670	http://dx.doi.org/10.1371/journal.pone.0231670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298347	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400086
J	Wafa, SW; Ghazalli, R				Wafa, Sharifah Wajihah; Ghazalli, Rasyidah			Association between the school environment and children's body mass index in Terengganu: A cross sectional study	PLOS ONE			English	Article							PHYSICAL-EDUCATION; FOOD; POLICIES; OBESITY; CONSUMPTION; PREVALENCE; PREVENTION; BEVERAGES; TEACHERS; STUDENTS	With the on-going interest in implementing school policies to address the problem of childhood obesity in Malaysia, there is urgent need for information about the association between school environment and children's weight status. This study aims to investigate the association between school environmental factors (physical, economic, political and sociocultural) with BMI of school children in Terengganu. The school environment factors were assessed using a set of validated whole-school environmental mapping questionnaires, consisting of 76 criteria with four domains; physical environment (41 criteria), economic environment (nine criteria), political environment (nine criteria) and sociocultural environment (17 criteria). This involved face-to-face interview sessions with 32 teachers from 16 schools (eight rural and eight urban). In addition, 400 school children aged between 9 and 11 years of the selected schools were assessed for BMI (WHO 2007 reference chart), dietary intake (food frequency questionnaire (FFQ)) and physical activity level (physical activity questionnaire for children (PAQ-C)). Multiple regression was used to examine the association between school environment factors and BMI of the school children. Seven school environment criteria were found to be associated with BMI of school children when it was adjusted for calorie intake and physical activity level. About 33.4% of the variation in BMI of school children was explained by health professional involvement, simple exercise before class, encouragement to walk/ride bicycle to/from school, no high-calorie food sold, healthy options of foods and drinks at tuck shop, availability of policy on physical activity and training teacher as a role model. Policy makers should make urgent actions to address the obesogenic features of school environments. It should strive towards setting up healthy school environment and improving school curricula to promote healthy behaviours among the school children.	[Wafa, Sharifah Wajihah; Ghazalli, Rasyidah] Univ Sultan Zainal Abidin, Fac Hlth Sci, Terengganu, Malaysia	Universiti Sultan Zainal Abidin	Wafa, SW (corresponding author), Univ Sultan Zainal Abidin, Fac Hlth Sci, Terengganu, Malaysia.	sharifahwajihah@unisza.edu.my		Syed Saadun Tarek Wafa, Sharifah Wajihah Wafa/0000-0002-1791-2714				Adom T, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6937-4; Anderson PM, 2006, J HUM RESOUR, V41, P467; Bassett DR, 2013, AM J PREV MED, V44, P108, DOI 10.1016/j.amepre.2012.10.017; Bezem J, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2711-4; Boswell Nikki, 2019, BMC Obes, V6, P17, DOI 10.1186/s40608-019-0241-9; Briefel RR, 2009, J AM DIET ASSOC, V109, pS79, DOI 10.1016/j.jada.2008.10.064; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; Chen SR, 2008, CHILD NERV SYST, V24, P741, DOI 10.1007/s00381-007-0499-y; Coffield JE, 2011, J ADOLESCENT HEALTH, V49, P363, DOI 10.1016/j.jadohealth.2011.01.010; Datar A, 2004, AM J PUBLIC HEALTH, V94, P1501, DOI 10.2105/AJPH.94.9.1501; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Dority BL, 2010, J PUBLIC POLICY MARK, V29, P204, DOI 10.1509/jppm.29.2.204; Draxten M, 2014, APPETITE, V78, P1, DOI 10.1016/j.appet.2014.02.017; Elumalai G., 2015, INDONESIA J PHYS ED, V11; Esquivel M.K., 2016, J FAMILY MED COMMUNI, V3, P1094; Fox MK, 2009, J AM DIET ASSOC, V109, pS108, DOI 10.1016/j.jada.2008.10.065; Ghaffar SA, 2019, MAL J MED HLTH SCI, V15, P16; GORDON J, 2001, HLTH ED, V101, P283, DOI DOI 10.1108/EUM0000000005991; Hanks AS, 2012, J PUBLIC HEALTH-UK, V34, P370, DOI 10.1093/pubmed/fds003; Hayati Adilin M. A. W., 2015, Malaysian Journal of Nutrition, V21, P1; IPH, 2008, NAT HLTH MORB SURV 2; IPH, 2017, NAT HLTH MORB SURV 2; Ismail M. N, 2009, NUTR STATUS DIETARY; Khambalia AZ, 2012, FOOD NUTR BULL, V33, P31, DOI 10.1177/156482651203300103; Kirby J, 2012, HEALTH EDUC RES, V27, P101, DOI 10.1093/her/cyr090; Kowalski K. C., 2004, COLL KINESIOLOGY U S, V87, P1, DOI DOI 10.1186/2049-3258-72-47; Kubik MY, 2005, ARCH PEDIAT ADOL MED, V159, P1111, DOI 10.1001/archpedi.159.12.1111; Leatherdale ST, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-982; Lee ST, 2015, INT J ENV RES PUB HE, V12, P146, DOI 10.3390/ijerph120100146; Li M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-792; Masse LC, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-29; Mitchell JA, 2009, OBESITY, V17, P1596, DOI 10.1038/oby.2009.42; Moore L, 2008, J EPIDEMIOL COMMUN H, V62, P926, DOI 10.1136/jech.2007.070953; Natale RA, 2014, J DEV BEHAV PEDIATR, V35, P378, DOI 10.1097/DBP.0000000000000074; National Coordinating Committee On Food And Nutrition (NCCFN), 2005, REC NUTR INT MAL; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Sabramani VAL., 2015, MALAYSIAN J PUBLIC H, V15, P75, DOI DOI 10.1038/CDDIS.2015.415; Sallis JF, 1999, RES Q EXERCISE SPORT, V70, P127, DOI 10.1080/02701367.1999.10608030; Sanchez-Vaznaugh EV, 2010, HEALTH AFFAIR, V29, P436, DOI 10.1377/hlthaff.2009.0745; Scaglioni S, 2011, AM J CLIN NUTR, V94, p2006S, DOI 10.3945/ajcn.110.001685; School Food Action Group (SFAG), 2003, SUBGR FOOD IN GROUP; Soenens B, 2005, J YOUTH ADOLESCENCE, V34, P589, DOI 10.1007/s10964-005-8948-y; Story M, 2008, ANNU REV PUBL HEALTH, V29, P253, DOI 10.1146/annurev.publhealth.29.020907.090926; Strugnell C, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-122; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Taber DR, 2011, AM J PUBLIC HEALTH, V101, P1769, DOI 10.2105/AJPH.2011.300221; Truman Benedict I., 2011, Morbidity and Mortality Weekly Report, V60, P3; Turner Kyle, 2015, BMC Obes, V2, P13, DOI 10.1186/s40608-015-0045-5; Watts AW, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-50; Wechsler H, 2000, PREV MED, V31, pS121, DOI 10.1006/pmed.2000.0649; World Health Organization, 2011, NONCOMMUNICABLE DIS; Yager Zali, 2005, Eat Disord, V13, P261, DOI 10.1080/10640260590932878	52	5	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232000	10.1371/journal.pone.0232000	http://dx.doi.org/10.1371/journal.pone.0232000			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8RF	32330177	gold, Green Published			2022-12-26	WOS:000536647300038
J	Guo, BJ; Li, Y; Wang, S; Li, DF; Lv, C; Xu, RG				Guo, Baojian; Li, Ying; Wang, Shuang; Li, Dongfang; Lv, Chao; Xu, Rugen			Characterization of the Nitrate Transporter gene family and functional identification of HvNRT2.1 in barley (Hordeum vulgare L.)	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; UPTAKE SYSTEM; EXPRESSION; ROOT; EXPANSION; HOMOLOGS; PROTEINS; PLANTS; CHL1	Nitrogen use efficiency (NUE) is the efficiency with which plants acquire and use nitrogen. Plants have high-affinity nitrate transport systems, which involve certain nitrate transporter (NRT) genes. However, limited data are available on the contribution of the NRT2/3 gene family in barley nitrate transport. In the present study, ten putative NRT2 and three putative NRT3 genes were identified using bioinformatics methods. All the HvNRT2/3 genes were located on chromosomes 3H, 5H, 6H or 7H. Remarkably, the presence of tandem repeats indicated that duplication events contributed to the expansion of the NRT2 gene family in barley. In addition, the HvNRT2/3 genes displayed various expression patterns at selected developmental stages and were induced in the roots by both low and high nitrogen levels. Furthermore, the overexpression of HvNRT2.1 improved the yield related traits in Arabidopsis. Taken together, the data generated in the present study will be useful for genome-wide analyses to determine the precise role of the HvNRT2/3 genes during barley development, with the ultimate goal of improving NUE and crop production.	[Guo, Baojian; Li, Ying; Wang, Shuang; Li, Dongfang; Lv, Chao; Xu, Rugen] Yangzhou Univ, Jiangsu Key Lab Crop Genom & Mol Breeding, Jiangsu Key Lab Crop Genet & Physiol, Key Lab Plant Funct Genom,Minist Educ,Agr Coll, Yangzhou, Jiangsu, Peoples R China; [Guo, Baojian; Li, Ying; Wang, Shuang; Li, Dongfang; Lv, Chao; Xu, Rugen] Yangzhou Univ, Jiangsu Coinnovat Ctr Modern Prod Technol Grain C, Yangzhou, Jiangsu, Peoples R China; [Guo, Baojian; Li, Ying; Wang, Shuang; Li, Dongfang; Lv, Chao; Xu, Rugen] Yangzhou Univ, Barley Res Inst, Yangzhou, Jiangsu, Peoples R China	Yangzhou University; Yangzhou University; Yangzhou University	Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Key Lab Crop Genom & Mol Breeding, Jiangsu Key Lab Crop Genet & Physiol, Key Lab Plant Funct Genom,Minist Educ,Agr Coll, Yangzhou, Jiangsu, Peoples R China.; Xu, RG (corresponding author), Yangzhou Univ, Jiangsu Coinnovat Ctr Modern Prod Technol Grain C, Yangzhou, Jiangsu, Peoples R China.; Xu, RG (corresponding author), Yangzhou Univ, Barley Res Inst, Yangzhou, Jiangsu, Peoples R China.	rgxu@yzu.edu.cn			National Natural Science Foundation of China [31771771, 31401370, 31571648]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [17KJB210006]; National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China [CARS-05]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China; Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported from the National Natural Science Foundation of China (31771771, 31401370 and 31571648), Natural Science Foundation of the Jiangsu Higher Education Institutions of China (17KJB210006), National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China (CARS-05), and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki R, 2006, BREEDING SCI, V56, P295, DOI 10.1270/jsbbs.56.295; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Cai C, 2008, J INTEGR PLANT BIOL, V50, P443, DOI 10.1111/j.1744-7909.2008.00642.x; Cassman KG, 1998, FIELD CROP RES, V56, P7, DOI 10.1016/S0378-4290(97)00140-8; CATALDO DA, 1975, COMMUN SOIL SCI PLAN, V6, P71, DOI 10.1080/00103627509366547; Cerezo M, 2001, PLANT PHYSIOL, V127, P262, DOI 10.1104/pp.127.1.262; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Daniel-Vedele F, 1998, CURR OPIN PLANT BIOL, V1, P235, DOI 10.1016/S1369-5266(98)80110-6; Fan XR, 2016, P NATL ACAD SCI USA, V113, P7118, DOI 10.1073/pnas.1525184113; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Forde BG, 2000, BBA-BIOMEMBRANES, V1465, P219, DOI 10.1016/S0005-2736(00)00140-1; Galvan A, 2001, CELL MOL LIFE SCI, V58, P225, DOI 10.1007/PL00000850; Glass ADM, 2001, J PLANT NUTR SOIL SC, V164, P199, DOI 10.1002/1522-2624(200104)164:2<199::AID-JPLN199>3.0.CO;2-K; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Herridge RP, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-3; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Hu B, 2015, NAT GENET, V47, P834, DOI 10.1038/ng.3337; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Kjeldahl Johan Z., 1883, ANAL CHEM, V22, P366, DOI DOI 10.1007/BF01338151; Kotur Z, 2012, NEW PHYTOL, V194, P724, DOI 10.1111/j.1469-8137.2012.04094.x; Letunic I, 2015, NUCLEIC ACIDS RES, V43, pD257, DOI 10.1093/nar/gku949; Liu Ren-Hu, 2003, Yichuan, V25, P317; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Mascher M, 2017, NATURE, V544, P426, DOI 10.1038/nature22043; Okamoto M, 2006, PLANT PHYSIOL, V140, P1036, DOI 10.1104/pp.105.074385; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Orsel M, 2004, PLANTA, V219, P714, DOI 10.1007/s00425-004-1266-x; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Plett D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015289; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Sorgona A, 2011, PLANT CELL ENVIRON, V34, P1127, DOI 10.1111/j.1365-3040.2011.02311.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang Z, 2012, PLANT PHYSIOL, V160, P2052, DOI 10.1104/pp.112.204461; Tilman D, 1999, P NATL ACAD SCI USA, V96, P5995, DOI 10.1073/pnas.96.11.5995; Tong Y, 2005, PLANT J, V41, P442, DOI 10.1111/j.1365-313X.2004.02310.x; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Vidmar JJ, 2000, PLANT PHYSIOL, V122, P783, DOI 10.1104/pp.122.3.783; Wang W, 2018, PLANT CELL, V30, P638, DOI 10.1105/tpc.17.00809; Wei J, 2018, J EXP BOT, V69, P1095, DOI 10.1093/jxb/erx486; Wen ZY, 2017, PLANT CELL, V29, P2581, DOI 10.1105/tpc.16.00724; Williams LE, 2001, ANNU REV PLANT PHYS, V52, P659, DOI 10.1146/annurev.arplant.52.1.659; Yan M, 2011, PLANT CELL ENVIRON, V34, P1360, DOI 10.1111/j.1365-3040.2011.02335.x; YOUNG S, 1994, NATURE OF COMPACT OBJECTS IN ACTIVE GALACTIC NUCLEI, P28; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	49	17	17	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232056	10.1371/journal.pone.0232056	http://dx.doi.org/10.1371/journal.pone.0232056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324773	Green Published, gold			2022-12-26	WOS:000536033700069
J	Matsuda, Y; Machida, M; Nakagami, Y; Nakajima, T; Azuma, M				Matsuda, Yuka; Machida, Mamiko; Nakagami, Yasuhiro; Nakajima, Takeshi; Azuma, Mitsuyoshi			NFE2L2 activator RS9 protects against corneal epithelial cell damage in dry eye models	PLOS ONE			English	Article							OXIDATIVE STRESS; NRF2 ACTIVATOR; EFFICACY; APOPTOSIS	Oxidative stress may cause ocular surface damage during the development of dry eye. Mammalian cells have defense systems against oxidative stress. A central regulator of the stress response is nuclear factor-erythroid 2-related factor 2 (NFE2L2). NFE2L2 is activated by the novel triterpenoid RS9 (a biotransformation compound of RTA 402). The purpose of this study was to assess the efficacy of RS9 against dry eye using in vitro and in vivo models. Bioactivity was estimated by the induction of mRNAs for two NFE2L2-targeted genes: NQO1 (prevents radical species) and GCLC (glutathione synthesis), using a corneal epithelial cell line (HCE-T). Protection against oxidation and cell damage was tested in vitro by culturing cells under hyperosmotic stress or by the addition of menadione, a generator of reactive oxygen species (ROS). Dry eye in vivo was induced by the injection of scopolamine into rats. Then, 930 nM of RS9 was applied to both eyes for 2 weeks. Oxidative stress was measured by the accumulation of 8-hydroxy-2'-deoxyguanosine (8-OHdG). Corneal wound healing was measured by scoring for superficial punctate keratitis (SPK). Corneal epithelial cell densities were evaluated histologically. RS9 and RTA 402 induced the expression of NQO1 and GCLC mRNAs in HCE-T cells. And both compounds suppressed hyperosmotic-ROS generation and menadione induced cellular damage. However RS9 had a stronger protective effect than RTA 402. Ocular instillation of RS9 also significantly upregulated the expression of Nqo1 mRNA in the corneal epithelium. Accumulation of 8-OHdG, increase of SPK scores and decrement of basal cell density were observed in corneal epithelium from scopolamine-injected rats. These changes were significantly ameliorated by the topical administration of RS9. RS9 induced Nfe2l2 activation and Nfe2l2-targeted genes, reduced oxidation, and ameliorated symptoms of dry eye using in vitro and in vivo models. Thus, RS9 might be a potent candidate agent against dry eye disease.	[Matsuda, Yuka; Machida, Mamiko; Nakajima, Takeshi; Azuma, Mitsuyoshi] Senju Pharmaceut Co Ltd, Senju Lab Ocular Sci, Kobe, Hyogo, Japan; [Nakagami, Yasuhiro] Daiichi Sankyo Co Ltd, Tokyo, Japan	Senju Pharmaceutical Co. Ltd.; Daiichi Sankyo Company Limited	Nakajima, T (corresponding author), Senju Pharmaceut Co Ltd, Senju Lab Ocular Sci, Kobe, Hyogo, Japan.	t-nakajima@senju.co.jp		Matsuda, Yuka/0000-0002-2785-6795	Senju pharmaceuticals; Daiichi Sankyo pharmaceuticals	Senju pharmaceuticals; Daiichi Sankyo pharmaceuticals(Daiichi Sankyo Company Limited)	The authors received no specific funding for this work. Senju pharmaceuticals provided support in the form of salaries for authors YM, MM, TN and MA. Daiichi Sankyo pharmaceuticals provided support in the form of salaries for YN. But did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	ARAKISASAKI K, 1995, INVEST OPHTH VIS SCI, V36, P614; Bron AJ, 2017, OCUL SURF, V15, P438, DOI 10.1016/j.jtos.2017.05.011; Criddle DN, 2006, J BIOL CHEM, V281, P40485, DOI 10.1074/jbc.M607704200; Deng RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126561; Hamrah P, 2017, OCUL SURF, V15, P139, DOI 10.1016/j.jtos.2016.10.002; Hamrah P, 2012, OPHTHALMOLOGY, V119, P1791, DOI 10.1016/j.ophtha.2012.03.005; Higham A, 2018, INT J CHRONIC OBSTR, V13, P989, DOI 10.2147/COPD.S157728; Higuchi A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009911; Inoue Y, 2017, J NEUROCHEM, V141, P750, DOI 10.1111/jnc.14029; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Komoriya S, 2013, Tripernoid derivatives, Patent No. [WO2014/148455 A1, 2014148455]; Lee H, 2017, INVEST OPHTH VIS SCI, V58, P1682, DOI 10.1167/iovs.16-20843; Li J, 2016, SCI REP-UK, V6, DOI 10.1038/srep19408; Li YW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174437; Macri A, 2015, GRAEF ARCH CLIN EXP, V253, P425, DOI 10.1007/s00417-014-2853-6; Murakami T, 2004, J EYE, V20, P87; Nakagami Y, 2016, J RADIAT RES, V57, P567, DOI 10.1093/jrr/rrw039; Nakagami Y, 2016, CURR EYE RES, V41, P1123, DOI 10.3109/02713683.2015.1078362; Nakagami Y, 2015, BRIT J PHARMACOL, V172, P1237, DOI 10.1111/bph.12999; Nakamura S, 2007, INVEST OPHTH VIS SCI, V48, P1552, DOI 10.1167/iovs.06-1027; Nakamura S, 2019, INVEST OPHTH VIS SCI, V60, P1943, DOI 10.1167/iovs.18-25745; Okanobo A, 2012, AM J OPHTHALMOL, V154, P63, DOI 10.1016/j.ajo.2012.01.034; Park JH, 2018, INVEST OPHTH VIS SCI, V59, P5108, DOI 10.1167/iovs.17-22925; Sugiyama T, 2018, BRAIN RES, V1701, P137, DOI 10.1016/j.brainres.2018.08.021; Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047; Tomlinson A, 2006, INVEST OPHTH VIS SCI, V47, P4309, DOI 10.1167/iovs.05-1504; Viau S, 2008, GRAEF ARCH CLIN EXP, V246, P857, DOI 10.1007/s00417-008-0784-9; Wakamatsu TH, 2013, INVEST OPHTH VIS SCI, V54, P201, DOI 10.1167/iovs.12-10325; Yamauchi K, 2016, NEUROSCIENCE, V333, P302, DOI 10.1016/j.neuroscience.2016.07.035; Zhang XB, 2011, OPHTHALMOLOGY, V118, P902, DOI 10.1016/j.ophtha.2010.08.033; Ziniauskaite A, 2018, INVEST OPHTH VIS SCI, V59, P3088, DOI 10.1167/iovs.18-24432	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0229421	10.1371/journal.pone.0229421	http://dx.doi.org/10.1371/journal.pone.0229421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320433	gold, Green Published			2022-12-26	WOS:000536028800007
J	Carias, KV; Zoeteman, M; Seewald, A; Sanderson, MR; Bischof, JM; Wevrick, R				Carias, K. Vanessa; Zoeteman, Mercedes; Seewald, Abigail; Sanderson, Matthea R.; Bischof, Jocelyn M.; Wevrick, Rachel			A MAGEL2-deubiquitinase complex modulates the ubiquitination of circadian rhythm protein CRY1	PLOS ONE			English	Article							PRADER-WILLI; GENE-EXPRESSION; CLOCK; MOUSE; MAGEL2; PERIOD; CRYPTOCHROME; DEGRADATION; OSCILLATION; SLEEPINESS	MAGEL2 encodes the L2 member of the MAGE (melanoma antigen) protein family. Protein truncating mutations in MAGEL2 cause Schaaf-Yang syndrome, and MAGEL2 is one of a small set of genes deleted in Prader-Willi syndrome. Excessive daytime sleepiness, night-time or early morning waking, and narcoleptic symptoms are seen in people with Prader-Willi syndrome and Schaaf-Yang syndrome, while mice carrying a gene-targeted Magel2 deletion have disrupted circadian rhythms. These phenotypes suggest that MAGEL2 is important for the robustness of the circadian rhythm. However, a cellular role for MAGEL2 has yet to be elucidated. MAGEL2 influences the ubiquitination of substrate proteins to target them for further modification or to alter their stability through proteasomal degradation pathways. Here, we characterized relationships among MAGEL2 and proteins that regulate circadian rhythm. The effect of MAGEL2 on the key circadian rhythm protein cryptochrome 1 (CRY1) was assessed using in vivo proximity labelling (BioID), immunofluorescence microscopy and ubiquitination assays. We demonstrate that MAGEL2 modulates the ubiquitination of CRY1. Further studies will clarify the cellular role MAGEL2 normally plays in circadian rhythm, in part through ubiquitination and regulation of stability of the CRY1 protein.	[Carias, K. Vanessa; Zoeteman, Mercedes; Seewald, Abigail; Sanderson, Matthea R.; Bischof, Jocelyn M.; Wevrick, Rachel] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada	University of Alberta	Wevrick, R (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	rwevrick@ualberta.ca		Wevrick, Rachel/0000-0002-3343-5794	Natural Sciences and Engineering Research Council of Canada [SFR1451]; Stollery Children's Hospital Foundation through a Women and Children's Health Research Institute Graduate Studentship; Faculty of Medicine & Dentistry at the University of Alberta through the 75th Anniversary Graduate Student Award; VP (Academic) Summer Research Awards (University of Alberta); Office of the Provost	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Stollery Children's Hospital Foundation through a Women and Children's Health Research Institute Graduate Studentship; Faculty of Medicine & Dentistry at the University of Alberta through the 75th Anniversary Graduate Student Award; VP (Academic) Summer Research Awards (University of Alberta); Office of the Provost	This work was supported by the Natural Sciences and Engineering Research Council of Canada (Discovery Grant SFR1451 to RW). KVC was supported by the Stollery Children's Hospital Foundation through a Women and Children's Health Research Institute Graduate Studentship and by the Faculty of Medicine & Dentistry at the University of Alberta through the 75th Anniversary Graduate Student Award. MZ and AS were funded by Office of the Provost and VP (Academic) Summer Research Awards (University of Alberta). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansar M, 2019, HUM MOL GENET, V28, P972, DOI 10.1093/hmg/ddy406; Bruni O, 2010, CURR OPIN PULM MED, V16, P568, DOI 10.1097/MCP.0b013e32833ef547; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; De Cock VC, 2011, AM J MED GENET A, V155A, P1552, DOI 10.1002/ajmg.a.34047; Devos Julia, 2011, J Circadian Rhythms, V9, P12, DOI 10.1186/1740-3391-9-12; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Fountain MD, 2017, GENET MED, V19, P45, DOI 10.1038/gim.2016.53; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; Hao H, 2015, MOL CELL, V59, P956, DOI 10.1016/j.molcel.2015.07.033; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Hirano A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154263; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Kamaludin AA, 2016, HUM MOL GENET, V25, P3798, DOI 10.1093/hmg/ddw225; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Lane JM, 2019, NAT GENET, V51, P387, DOI 10.1038/s41588-019-0361-7; Li JZ, 2013, P NATL ACAD SCI USA, V110, P9950, DOI 10.1073/pnas.1305814110; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Maywood ES, 2011, J NEUROSCI, V31, P1539, DOI 10.1523/JNEUROSCI.4107-10.2011; McCarthy M, 2006, LANCET NEUROL, V5, P907, DOI 10.1016/S1474-4422(06)70594-4; Meng QJ, 2008, NEURON, V58, P78, DOI 10.1016/j.neuron.2008.01.019; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Papp SJ, 2015, ELIFE, V4, DOI 10.7554/eLife.04883; Pizarro A, 2013, NUCLEIC ACIDS RES, V41, pD1009, DOI 10.1093/nar/gks1161; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Stojkovic K, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00069; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Tacer KF, 2017, BIOCHEM J, V474, P2177, DOI 10.1042/BCJ20160616; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Weselake SV, 2012, CLIN GENET, V82, P379, DOI 10.1111/j.1399-0004.2012.01886.x; Wijesuriya TM, 2017, HUM MOL GENET, V26, P4215, DOI 10.1093/hmg/ddx311; Williams K, 2008, J CLIN SLEEP MED, V4, P111; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055	39	9	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230874	10.1371/journal.pone.0230874	http://dx.doi.org/10.1371/journal.pone.0230874			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315313	Green Published, gold			2022-12-26	WOS:000536024800011
J	Kuga, K; Kusakari, Y; Uesugi, K; Semba, K; Urashima, T; Akaike, T; Minamisawa, S				Kuga, Kazuhiro; Kusakari, Yoichiro; Uesugi, Ken; Semba, Kentaro; Urashima, Takashi; Akaike, Toru; Minamisawa, Susumu			Fibrosis growth factor 23 is a promoting factor for cardiac fibrosis in the presence of transforming growth factor-beta 1	PLOS ONE			English	Article							FGF23; RECEPTOR; HEART; ACTIVATION; PRESSURE	Myocardial fibrosis is often associated with cardiac hypertrophy; indeed, fibrosis is one of the most critical factors affecting prognosis. We aimed to identify the molecules involved in promoting fibrosis under hypertrophic stimuli. We previously established a rat model of cardiac hypertrophy by pulmonary artery banding, in which approximately half of the animals developed fibrosis in the right ventricle. Here, we first comprehensively analyzed mRNA expression in the right ventricle with or without fibrosis in pulmonary artery banding model rats by DNA microarray analysis (GSE141650 at NCBI GEO). The expression levels of 19 genes were up-regulated more than 1.5-fold in fibrotic hearts compared with non-fibrotic hearts. Among them, fibrosis growth factor (FGF) 23 showed one of the biggest increases in expression. Real-time PCR analysis also revealed that, among the FGF receptor (FGFR) family, FGFR1 was highly expressed in fibrotic hearts. We then found that FGF23 was expressed predominantly in cardiomyocytes, while FGFR1 was predominantly expressed in fibroblasts in the rat ventricle. Next, we added FGF23 and transforming growth factor (TGF)-beta 1 (10-50 ng/mL of each) to isolated fibroblasts from normal adult rat ventricles and cultured them for three days. While FGF23 itself did not directly affect the expression levels of any fibrosis-related mRNAs, FGF23 enhanced the effect of TGF-beta 1 on increasing the expression levels of alpha-smooth muscle actin (alpha-SMA) mRNA. This increase in xx-SMA mRNA levels due to the combination of TGF-beta 1 and FGF23 was attenuated by the inhibition of FGFR1 or the knockdown of FGFR1 in fibroblasts. Thus, FGF23 synergistically promoted the activation of fibroblasts with TGF-beta 1, transforming fibroblasts into myofibroblasts via FGFR1. Thus, we identified FGF23 as a paracrine factor secreted from cardiomyocytes to promote cardiac fibrosis under conditions in which TGF-beta 1 is activated. FGF23 could be a possible target to prevent fibrosis following myocardial hypertrophy.	[Kuga, Kazuhiro; Kusakari, Yoichiro; Uesugi, Ken; Akaike, Toru; Minamisawa, Susumu] Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo, Japan; [Uesugi, Ken; Semba, Kentaro; Minamisawa, Susumu] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Urashima, Takashi] Jikei Univ, Sch Med, Dept Pediat, Tokyo, Japan	Jikei University; Waseda University; Jikei University	Minamisawa, S (corresponding author), Jikei Univ, Sch Med, Dept Cell Physiol, Tokyo, Japan.; Minamisawa, S (corresponding author), Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan.	sminamis@jikei.ac.jp		Kuga, Kazuhiro/0000-0001-6318-2866; Minamisawa, Susumu/0000-0003-4728-2116	Ministry of Education, Culture, Sports, Science and Technology of Japan; Vehicle Racing Commemorative Foundation; Uehara Memorial Foundation; Jikei University Graduate Student Research Grant	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Vehicle Racing Commemorative Foundation; Uehara Memorial Foundation(Uehara Memorial Foundation); Jikei University Graduate Student Research Grant	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Vehicle Racing Commemorative Foundation, the Uehara Memorial Foundation, and The Jikei University Graduate Student Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Vehicle Racing Commemorative Foundation, the Uehara Memorial Foundation, and The Jikei University Graduate Student Research Grant.	Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Andersen IA, 2016, NEPHROL DIAL TRANSPL, V31, P767, DOI 10.1093/ndt/gfv398; Andrukhova O, 2015, EXPT, V30, P1831, DOI 10.1002/jbmr; [Anonymous], 2015, J BONE MINER RES, V30, P1831, DOI [10.1002/jbmr, DOI 10.1002/JBMR]; Dobaczewski M, 2011, J MOL CELL CARDIOL, V51, P600, DOI 10.1016/j.yjmcc.2010.10.033; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Fujimoto Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148666; Grabner A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02068-6; Grabner A, 2015, CELL METAB, V22, P1020, DOI 10.1016/j.cmet.2015.09.002; Hao HX, 2016, ONCOTARGET, V7, P64649, DOI 10.18632/oncotarget.11623; Hsieh YT, 2014, CIRC J, V78, P1224, DOI 10.1253/circj.CJ-13-1029; Kusakari Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169564; Kuwahara F, 2002, CIRCULATION, V106, P130, DOI 10.1161/01.CIR.0000020689.12472.E0; Leifheit-Nestler M, 2018, NEPHROL DIAL TRANSPL, V33, P1722, DOI 10.1093/ndt/gfy006; Liu NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073685; Mirza MAI, 2009, ATHEROSCLEROSIS, V207, P546, DOI 10.1016/j.atherosclerosis.2009.05.013; Pan XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060335; Richter B, 2016, PFLUG ARCH EUR J PHY, V468, P1621, DOI 10.1007/s00424-016-1858-x; Richter M, 2015, J HEART LUNG TRANSPL, V34, P1211, DOI 10.1016/j.healun.2015.06.007; Shimura D, 2013, AM J PHYSIOL-HEART C, V305, pH494, DOI 10.1152/ajpheart.00867.2012; Slavic S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10140-4; Smith ER, 2017, INT J BIOCHEM CELL B, V92, P63, DOI 10.1016/j.biocel.2017.09.009; Smith ER, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02709-w; Smith RL, 2000, J REHABIL RES DEV, V37, P153; Taylor EN, 2011, AM HEART J, V161, P956, DOI 10.1016/j.ahj.2011.02.012; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; van Venrooij NA, 2014, NEPHROL DIAL TRANSPL, V29, P1525, DOI 10.1093/ndt/gft523	27	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231905	10.1371/journal.pone.0231905	http://dx.doi.org/10.1371/journal.pone.0231905			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315372	Green Published, gold			2022-12-26	WOS:000536024800064
J	Foroutaghe, MD; Moghaddam, AM; Fakoor, V				Foroutaghe, Milad Delavary; Moghaddam, Abolfazl Mohammadzadeh; Fakoor, Vahid			Impact of law enforcement and increased traffic fines policy on road traffic fatality, injuries and offenses in Iran: Interrupted time series analysis	PLOS ONE			English	Article							CRASH RATES; ALCOHOL; MORTALITY; ACCIDENTS; PRICES; SAFETY; AREA	Background Road traffic law enforcement was implemented on 1st April 2011 (the first intervention) and traffic ticket fines have been increased on 1st March 2016 (the second intervention) in Iran. The aim of the current study was to evaluate the effects of the law enforcement on reduction in the incidence rate of road traffic fatality (IRRTF), the incidence rate of road traffic injuries (IRRTI) and the incidence rate of rural road traffic offenses (IRRRTO) in Iran. Methods Interrupted time series analysis was conducted to evaluate the impact of law enforcement and increased traffic tickets fines. Monthly data of fatality on urban, rural and local rural roads, injuries with respect to gender and traffic offenses namely speeding, illegal overtaking and tailgating were investigated separately for the period 2009-2016. Results Results showed a reduction in the incidence rate of total road traffic fatality (IRTRTF), the incidence rate of rural road traffic fatality (IRRRTF) and the incidence rate of urban road traffic fatality (IRURTF) by -21.44% (-39.3 to -3.59, 95% CI), -21.25% (-31.32 to -11.88, 95% CI) and -26.75% (-37.49 to -16, 95% CI) through the first intervention which resulted in 0.383, 0.255 and 0.222 decline in casualties per 100 000 population, respectively. Conversely, no reduction was found in the incidence rate of local rural road traffic fatality (IRLRRTF) and the IRRTI. Second intervention was found to only affect the IRURTF with 26.75% (-37.49 to -16, 95% CI) which led to 0.222 casualties per 100 000 population. In addition, a reduction effect was observed on the incidence rate of illegal overtaking (IRIO) and the incidence rate of speeding (IRS) with -42.8% (-57.39 to -28.22, 95% CI) and 10.54% (-21.05 to -0.03, 95% CI which implied a decrease of 415.85 and 1003.8 in monthly traffic offenses per 100 000 vehicles), respectively. Conclusion Time series analysis suggests a decline in IRTRTF, IRRRTF, and IRURTF caused by the first intervention. However, the second intervention found to be only effective in IRURTF, IRIO, and IRS with the implication that future initiatives should be focused on modifying the implementation of the traffic interventions.	[Foroutaghe, Milad Delavary; Moghaddam, Abolfazl Mohammadzadeh] Ferdowsi Univ Mashhad, Fac Engn, Dept Civil Engn, Mashhad, Razavi Khorasan, Iran; [Fakoor, Vahid] Ferdowsi Univ Mashhad, Fac Math Sci, Dept Stat, Mashhad, Razavi Khorasan, Iran	Ferdowsi University Mashhad; Ferdowsi University Mashhad	Moghaddam, AM (corresponding author), Ferdowsi Univ Mashhad, Fac Engn, Dept Civil Engn, Mashhad, Razavi Khorasan, Iran.	ab-moghadam@um.ac.ir	Moghaddam, Abolfazl Mohammadzadeh/P-5426-2019; Delavary, Milad/GZG-5828-2022	Moghaddam, Abolfazl Mohammadzadeh/0000-0001-6211-3738; 	Ferdowsi University of Mashhad [3/45430]	Ferdowsi University of Mashhad	Milad Delavary Foroutaghe, Abolfazl Mohammadzadeh Moghaddam. This work was supported by Ferdowsi University of Mashhad [grant number: 3/45430]. Ferdowsi University of Mashhad - http://um.ac.ir/.This work was supported about 250$ by Ferdowsi University of Mashhad for data collection and specific study [grant number: 3/45430]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing interests: The authors have declared that no competing	BOX GEP, 1975, J AM STAT ASSOC, V70, P70, DOI 10.2307/2285379; Brals D, 2017, HEALTH POLICY PLANN, V32, P990, DOI 10.1093/heapol/czx034; Chen F, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142632; Chen F, 2018, J SAFETY RES, V65, P153, DOI 10.1016/j.jsr.2018.02.010; Chen F, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13060609; Chen F, 2011, ACCIDENT ANAL PREV, V43, P1677, DOI 10.1016/j.aap.2011.03.026; DICKEY DA, 1986, AM STAT, V40, P12, DOI 10.2307/2683112; DICKEY DA, 1979, J AM STAT ASSOC, V74, P427, DOI 10.2307/2286348; Foroutaghe MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216462; Grundy CH., 2015, BMJ J; Gustafsson NKJ, 2011, INT J EPIDEMIOL, V40, P432, DOI 10.1093/ije/dyq153; Hansen BT, 2017, EPIDEMIOLOGY, V28, P906, DOI [10.1097/EDE.0000000000000705, 10.1097/ede.0000000000000705]; Hansen BT, 2017, EPIDEMIOLOGY, V28, P346, DOI 10.1097/EDE.0000000000000580; Herttua K, 2015, EPIDEMIOLOGY, V26, P337, DOI 10.1097/EDE.0000000000000260; Herttua K, 2011, INT J EPIDEMIOL, V40, P441, DOI 10.1093/ije/dyp336; Hyndman R.J., 2013, FORECASTING PRINCIPL; Iranian Traffic Police(ITP), 2018, IRAN; Jones LE, 2017, J POLICY ANAL MANAG, V36, P584, DOI 10.1002/pam.22004; Ke T, 2009, MOT2009: PROCEEDINGS OF ZHENGZHOU CONFERENCE ON MANAGEMENT OF TECHNOLOGY, VOLS I AND II, P145; Kisely S, 2016, J EPIDEMIOL COMMUN H, V70, P181, DOI 10.1136/jech-2015-205666; Lee J, 2018, J TRANSP HEALTH, V10, P194, DOI 10.1016/j.jth.2018.05.017; Lim SH, 2013, TRANSPORT POLICY, V27, P158, DOI 10.1016/j.tranpol.2013.01.011; LJUNG GM, 1978, BIOMETRIKA, V65, P297, DOI 10.2307/2335207; Lovenheim MF, 2011, J POLICY ANAL MANAG, V30, P798, DOI 10.1002/pam.20598; Makridakis S., 1998, FORECASTING METHODS; Ministry of Interior(MI), 2011, LAW ENF TRAFF OFF; Morrison CN, 2018, AM J EPIDEMIOL, V187, P224, DOI 10.1093/aje/kwx233; Nistal-Nuno B, 2017, PUBLIC HEALTH, V150, P51, DOI 10.1016/j.puhe.2017.04.025; Oh J, 2016, J EPIDEMIOL COMMUN H, V70, P1178, DOI 10.1136/jech-2015-207000; Olsen JR, 2016, J EPIDEMIOL COMMUN H, V70, P1088, DOI 10.1136/jech-2016-207378; Otero S, 2017, ACCIDENT ANAL PREV, V106, P262, DOI 10.1016/j.aap.2017.05.031; Pun VC, 2013, J EPIDEMIOL COMMUN H, V67, P514, DOI 10.1136/jech-2012-201859; Sanchez AI, 2011, INT J EPIDEMIOL, V40, P1037, DOI 10.1093/ije/dyr051; Sebego M, 2014, ACCIDENT ANAL PREV, V70, P33, DOI 10.1016/j.aap.2014.02.017; Slyunkina E. S., 2013, INT J CARE INJURED, V44, P64; Steinbach R., 2015, J EPIDEMIOLOGY COMMU, V69; World Health Organisation, 2018, NONC DIS COUNTR PROF; World Health Organization, 2018, PHYS ACTIVITY; Zeng Q, 2019, TRANSPORTMETRICA A, V15, P1867, DOI 10.1080/23249935.2019.1652867; Zeng Q, 2018, TRANSPORTMETRICA A, V14, P177, DOI 10.1080/23249935.2017.1353556; Zhu H., 2015, J TRANSP HEALTH, V2, pS5	41	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231182	10.1371/journal.pone.0231182	http://dx.doi.org/10.1371/journal.pone.0231182			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9LH	32302374	gold, Green Published			2022-12-26	WOS:000536016100019
J	Hong, JH; Yoon, SH; Goo, JM; Yim, JJ; Jeon, YK				Hong, Jung Hee; Yoon, Soon Ho; Goo, Jin Mo; Yim, Jae-Joon; Jeon, Yoon Kyung			Clustered micronodules as predominant manifestation on CT: A sign of active but indolently evolving pulmonary tuberculosis	PLOS ONE			English	Article							DISEASE	Objective To investigate the prevalence, patient characteristics, and natural history of clustered micro-nodules (CMs) in active pulmonary tuberculosis. Materials and methods From January 2013 through July 2018, 833 consecutive patients with bacteriologically or polymerase chain reaction-proven active pulmonary tuberculosis were retrospectively evaluated. CMs were defined as a localized aggregation of multiple dense discrete micronodules, which primarily distributed around small airways distal to the level of the segmental bronchus: small airways surrounded by CMs maintained luminal patency and the CMs might coalesce into a larger nodule. The patients were dichotomized according to whether the predominant computed tomography (CT) abnormalities were CMs. We analyzed radiologic and pathologic findings in patients whose predominant diagnostic CT abnormalities were CMs, along with those of incidental pre-diagnostic CT scans, if available. Chi-square, McNemar, Student t-test and Wilcoxon-signed rank test were performed. Results CMs were the predominant CT abnormality in 2.6% of the patients (22/833, 95% CI, 1.8-4.0%) with less sputum smear-positivity (4.8% vs 31.0%; p =.010) and a similar proportion of immunocompromised status (40.9% vs 46.0%; p =.637) than those without having CMs as the predominant CT abnormality. The time interval for minimal radiologic progression was 6.4 months. The extent of CMs increased with disease progression, frequently accompanied by consolidation and small airway wall thickening. Pathologically, smaller CMs were non-caseating granulomas confined to the peribronchiolar interstitium, whereas larger CMs were caseating granulomas involving lung parenchyma. Two of the five patients with a pre-diagnostic CT scan obtained more than 50 months pre-diagnosis showed an incipient stage of CMs, in which they were small peribronchiolar nodules. Conclusion Active pulmonary tuberculosis manifested predominantly as CMs in 2.6% of patients, with scarce of acid-fast bacilli smear-positivity and no association with impaired host immunity. CMs indolently progressed, accompanied by consolidation and small airway wall thickening, and originated from small nodules.	[Hong, Jung Hee; Yoon, Soon Ho; Goo, Jin Mo] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Radiol, Seoul, South Korea; [Yim, Jae-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Pulm & Crit Care Med, Seoul, South Korea; [Jeon, Yoon Kyung] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Pathol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Yoon, SH (corresponding author), Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	yshoka@gmail.com	Yoon, Soon Ho/AAL-1640-2020	Yoon, Soon Ho/0000-0002-3700-0165; Yim, Jae-Joon/0000-0002-9605-0074				Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.10; Baronnet L, 2011, JOINT BONE SPINE, V78, P279, DOI 10.1016/j.jbspin.2010.12.004; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; Geng E, 2005, JAMA-J AM MED ASSOC, V293, P2740, DOI 10.1001/jama.293.22.2740; Leon RG, 2010, REUMATOL CLIN, V6, P256, DOI 10.1016/j.reuma.2009.11.002; Han S, 2019, INT J TUBERC LUNG D, V23, P698, DOI 10.5588/ijtld.18.0541; Heo JN, 2005, AM J ROENTGENOL, V184, P639, DOI 10.2214/ajr.184.2.01840639; Hwang EJ, 2019, CLIN INFECT DIS, V69, P739, DOI 10.1093/cid/ciy967; IM JG, 1993, RADIOLOGY, V186, P653, DOI 10.1148/radiology.186.3.8430169; Im JG, 2018, KOREAN J RADIOL, V19, P859, DOI 10.3348/kjr.2018.19.5.859; Jeong YJ, 2008, AM J ROENTGENOL, V191, P834, DOI 10.2214/AJR.07.3896; Ko JM, 2015, AM J ROENTGENOL, V204, P38, DOI 10.2214/AJR.14.12908; Lee JY, 2000, J COMPUT ASSIST TOMO, V24, P691, DOI 10.1097/00004728-200009000-00005; Lee KS, 2014, RADIOLOGY ILLUSTRATE; Lee SC, 2017, J KOREAN MED SCI, V32, P1779, DOI 10.3346/jkms.2017.32.11.1779; Liu K, 2019, RADIOL-ARTIF INTELL, V1, DOI 10.1148/ryai.2019180084; Nachiappan AC, 2017, RADIOGRAPHICS, V37, P52, DOI 10.1148/rg.2017160032; Nakatsu M, 2002, AM J ROENTGENOL, V178, DOI 10.2214/ajr.178.6.1781389; Orme IM, 2014, SEMIN IMMUNOL, V26, P601, DOI 10.1016/j.smim.2014.09.009; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807	20	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231537	10.1371/journal.pone.0231537	http://dx.doi.org/10.1371/journal.pone.0231537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302345	Green Published, gold			2022-12-26	WOS:000536016100033
J	Wu, YW; Wu, B; Zhang, ZW; Lu, HM; Fan, C; Qi, Q; Gao, YZ; Li, H; Feng, CL; Zuo, JP; Tang, W				Wu, Yanwei; Wu, Bing; Zhang, Zongwang; Lu, Huimin; Fan, Chen; Qi, Qing; Gao, Yuanzhuo; Li, Heng; Feng, Chunlan; Zuo, Jianping; Tang, Wei			Heme protects intestinal mucosal barrier in DSS-induced colitis through regulating macrophage polarization in both HO-1-dependent and HO-1-independent way	FASEB JOURNAL			English	Article						IBD; M1; M2; ulcerative colitis	INFLAMMATORY-BOWEL-DISEASE; INDUCTION; RECOVERY; SUPPRESSION; EXPRESSION; RESPONSES; MONOCYTE; TARGETS; CELLS	Hemoglobin-derived heme was reported to play protective roles in hemorrhagic diseases by modulating the macrophages toward recovery. Mucosal bleeding is one of the pathological features of inflammatory bowel diseases (IBD). However, whether heme provides anti-inflammatory profiles in macrophages, thus contributing to the intestinal mucosal barrier protection, is unclear. In the current study, we investigated the beneficial effects of heme on DSS-induced colitis mice and explored the underlying mechanisms. In vivo, systemic heme supplementation by hemin injection relieved intestinal inflammation and remedied intestinal mucosal barrier damage by correcting abnormal intestinal macrophage polarization. In vitro, we confirmed the reciprocally regulating effects of hemin on M1/M2 macrophage polarization in BMDM. Intriguingly, with knockdown of HO-1, the inhibiting effects of hemin on M1 polarization were maintained, while the promoting effects on M2 polarization were reversed. Further research proved that hemin repressed the inflammatory profiles in macrophages through inhibiting the translocation of NF-kappa B p65 by disrupting IRF5-NF-kappa B p65 complex formation in Spi-C-dependent way. In conclusion, these results showed that the modification of colon tissue microenvironment with heme supplementation plays a protective role in DSS-induced colitis mice through regulating the macrophage polarization in both HO-1-dependent and HO-1-independent way, indicating a new choice to therapeutically modulate the macrophage function and prevent IBD.	[Wu, Yanwei; Wu, Bing; Lu, Huimin; Fan, Chen; Qi, Qing; Gao, Yuanzhuo; Li, Heng; Feng, Chunlan; Tang, Wei] Chinese Acad Sci, Lab Antiinflammat, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China; [Wu, Bing; Lu, Huimin; Gao, Yuanzhuo; Li, Heng; Zuo, Jianping; Tang, Wei] Univ Chinese Acad Sci, Sch Pharm, Beijing, Peoples R China; [Zhang, Zongwang] Shanghai Univ, Sch Life Sci, Shanghai, Peoples R China; [Zuo, Jianping] Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, State Key Lab Drug Res, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Tang, W (corresponding author), Chinese Acad Sci, Lab Antiinflammat, Shanghai Inst Mat Med, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.; Zuo, JP (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, Lab Immunopharmacol, 555 Zuchongzhi Rd, Shanghai 201203, Peoples R China.	jpzuo@simm.ac.cn; tangwei@simm.ac.cn			National Natural Science Foundation of China (NSFC) [81673445, 81803543]; Shanghai Committee of Science and Technology [16431900300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12020107]; National Science & Technology Major Project [2017ZX09101002002-010]; Chinese Academy of Sciences [X2017ZX09101002-002-010]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Science & Technology Major Project; Chinese Academy of Sciences(Chinese Academy of Sciences)	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81673445 and 81803543; Shanghai Committee of Science and Technology, Grant/Award Number: 16431900300; Strategic Priority Research Program of the Chinese Academy of Sciences, Grant/Award Number: XDA12020107; National Science & Technology Major Project, Grant/Award Number: 2017ZX09101002002-010; Chinese Academy of Sciences, Grant/Award Number: X2017ZX09101002-002-010	Alam MZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00033; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Angele MK, 1999, ANN SURG, V229, P651, DOI 10.1097/00000658-199905000-00007; Angele MK, 2018, PNAS, V115, P8418; Bhattacharyya A, 2014, PHYSIOL REV, V94, P329, DOI 10.1152/physrev.00040.2012; Boyle JJ, 2009, AM J PATHOL, V174, P1097, DOI 10.2353/ajpath.2009.080431; Chang CF, 2018, J CLIN INVEST, V128, P607, DOI 10.1172/JCI95612; Chistiakov DA, 2017, IMMUNOBIOLOGY, V223, P101, DOI 10.1016/j.imbio.2017.10.005; Cho DI, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2013.135; Cholapranee A, 2017, ALIMENT PHARM THER, V45, P1291, DOI 10.1111/apt.14030; Dai Y, 2018, INVEST OPHTH VIS SCI, V59, P3952, DOI 10.1167/iovs.17-23327; Garton T, 2017, TRANSL STROKE RES, V8, P612, DOI 10.1007/s12975-017-0535-5; Gliem M, 2016, BBA-MOL BASIS DIS, V1862, P329, DOI 10.1016/j.bbadis.2015.11.004; Gupta J., 2014, BIOPROTOC, V4, pe1289, DOI [10.21769/BioProtoc.1289, DOI 10.21769/BIOPROTOC.1289]; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Holleran G, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102020; Jaworski FM, 2017, CLIN CANCER RES, V23, P5135, DOI 10.1158/1078-0432.CCR-17-0112; Kitada S, 2017, J EXP MED, V214, P1313, DOI 10.1084/jem.20161076; Kuhl AA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00613; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Li H, 2019, BRIT J PHARMACOL, V176, P2209, DOI 10.1111/bph.14667; Lissner D, 2015, INFLAMM BOWEL DIS, V21, P1297, DOI 10.1097/MIB.0000000000000384; Mateus V, 2018, CLIN EXP GASTROENTER, V11, P325, DOI 10.2147/CEG.S166197; Min H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0225-3; Moura FA, 2015, REDOX BIOL, V6, P617, DOI 10.1016/j.redox.2015.10.006; Na YR, 2019, NAT REV GASTRO HEPAT, V16, P531, DOI 10.1038/s41575-019-0172-4; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Oshima T, 2016, J GASTROENTEROL, V51, P768, DOI 10.1007/s00535-016-1207-z; Paine ER, 2014, GASTROENTEROL REP, V2, P161, DOI 10.1093/gastro/gou028; Rossi M, 2018, BIOCHEM BIOPH RES CO, V503, P2820, DOI 10.1016/j.bbrc.2018.08.046; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Takeda Y, 2004, CLIN EXP IMMUNOL, V138, P237, DOI 10.1111/j.1365-2249.2004.02594.x; Xiong HB, 1996, CELL IMMUNOL, V172, P118, DOI 10.1006/cimm.1996.0222; Yan F, 2012, AM J PHYSIOL-GASTR L, V302, pG504, DOI 10.1152/ajpgi.00312.2011; Yan YX, 2018, ACTA PHARMACOL SIN, V39, P1633, DOI 10.1038/aps.2017.185; Ying W, 2013, JOVE-J VIS EXP, DOI 10.3791/50323; Zhang LY, 2014, J BIOL CHEM, V289, P26847, DOI 10.1074/jbc.M114.590554; Zhong WW, 2010, J PEDIATR GASTR NUTR, V50, P132, DOI 10.1097/MPG.0b013e3181c61591	40	15	15	8	25	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8028	8043		10.1096/fj.202000313RR	http://dx.doi.org/10.1096/fj.202000313RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301543				2022-12-26	WOS:000526645200001
J	Yugami, M; Okano, H; Nakanishi, A; Yano, M				Yugami, Masato; Okano, Hideyuki; Nakanishi, Atsushi; Yano, Masato			Analysis of the nucleocytoplasmic shuttling RNA-binding protein HNRNPU using optimized HITS-CLIP method	PLOS ONE			English	Article							INACTIVE X-CHROMOSOME; SAF-A; MESSENGER-RNAS; U-PROTEIN; NUCLEAR; LOCALIZATION; STABILITY; CELLS	RNA-binding proteins (RBPs) control many types of post-transcriptional regulation, including mRNA splicing, mRNA stability, and translational efficiency, by directly binding to their target RNAs and their mutation and dysfunction are often associated with several human neurological diseases and tumorigenesis. Crosslinking immunoprecipitation (CLIP), coupled with high-throughput sequencing (HITS-CLIP), is a powerful technique for investigating the molecular mechanisms underlying disease pathogenesis by comprehensive identification of RBP target sequences at the transcriptome level. However, HITS-CLIP protocol is still required for some optimization due to experimental complication, low efficiency and time-consuming, whose library has to be generated from very small amounts of RNAs. Here we improved a more efficient, rapid, and reproducible CLIP method by optimizing BrdU-CLIP. Our protocol produced a 10-fold greater yield of pre-amplified CLIP library, which resulted in a low duplicate rate of CLIP-tag reads because the number of PCR cycles required for library amplification was reduced. Variance of the yields was also reduced, and the experimental period was shortened by 2 days. Using this, we validated IL-6 expression by a nuclear RBP, HNRNPU, which directly binds the 3'-UTR of IL-6 mRNA in HeLa cells. Importantly, this interaction was only observed in the cytoplasmic fraction, suggesting a role of cytoplasmic HNRNPU in mRNA stability control. This optimized method enables us to accurately identify target genes and provides a snapshot of the protein-RNA interactions of nucleocytoplasmic shuttling RBPs.	[Yugami, Masato; Nakanishi, Atsushi] Takeda Pharmaceut Co Ltd, Osaka, Japan; [Okano, Hideyuki; Yano, Masato] Keio Univ, Sch Med, Dept Physiol, Minato, Japan; [Yano, Masato] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan	Takeda Pharmaceutical Company Ltd; Keio University; Niigata University	Yugami, M (corresponding author), Takeda Pharmaceut Co Ltd, Osaka, Japan.; Yano, M (corresponding author), Keio Univ, Sch Med, Dept Physiol, Minato, Japan.; Yano, M (corresponding author), Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan.	masato.yugami@takeda.com; myano@med.niigata-u.ac.jp		Yano, Masato/0000-0003-0589-478X; Yugami, Masato/0000-0002-6971-5499	SIL Research Fund from Takeda Pharmaceutical Company, Ltd.; MEXT [JP17H05598, JP19H03543]; Foundation for Dietary Scientific Research, the Ichiro Kanehara Foundation; Takeda Science Foundation; Serika Fund; Ichiro Kanehara Foundation	SIL Research Fund from Takeda Pharmaceutical Company, Ltd.; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Foundation for Dietary Scientific Research, the Ichiro Kanehara Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Serika Fund; Ichiro Kanehara Foundation	This work was supported by grants from the SIL Research Fund from Takeda Pharmaceutical Company, Ltd. (to M. Yano and H. O.), the MEXT Grant-in-Aid (grant no. JP17H05598 and JP19H03543), the Foundation for Dietary Scientific Research, the Ichiro Kanehara Foundation, the Takeda Science Foundation and the Serika Fund (to M. Yano). In additon, M. Yugami and A.N. received funding in the form of salary from Takeda Pharmaceutical Company, Ltd. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan CM, 2001, CELL MOL LIFE SCI, V58, P266, DOI 10.1007/PL00000854; CAMERON V, 1977, BIOCHEMISTRY-US, V16, P5120, DOI 10.1021/bi00642a027; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Fred RG, 2016, HELIYON, V2, DOI 10.1016/j.heliyon.2016.e00159; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Hasegawa Y, 2010, DEV CELL, V19, P469, DOI 10.1016/j.devcel.2010.08.006; Hayakawa-Yano Y, 2017, GENE DEV, V31, P1910, DOI 10.1101/gad.300822.117; Helbig R, 2003, CHROMOSOMA, V112, P173, DOI 10.1007/s00412-003-0258-0; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Hwang HW, 2016, CELL REP, V15, P423, DOI 10.1016/j.celrep.2016.03.023; Ince-Dunn G, 2012, NEURON, V75, P1067, DOI 10.1016/j.neuron.2012.07.009; Iwasaki H, 2011, NAT IMMUNOL, V12, P1167, DOI 10.1038/ni.2137; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Konig J, 2012, NAT REV GENET, V13, P77, DOI 10.1038/nrg3141; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Masuda K, 2013, P NATL ACAD SCI USA, V110, P9409, DOI 10.1073/pnas.1307419110; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Mino T, 2015, CELL, V161, P1058, DOI 10.1016/j.cell.2015.04.029; Moore MJ, 2014, NAT PROTOC, V9, P263, DOI 10.1038/nprot.2014.012; Pinarbasi ES, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25008-4; Pullirsch D, 2010, DEVELOPMENT, V137, P935, DOI 10.1242/dev.035956; ROMIG H, 1992, EMBO J, V11, P3431, DOI 10.1002/j.1460-2075.1992.tb05422.x; Sakaguchi T, 2016, DEV CELL, V39, P11, DOI 10.1016/j.devcel.2016.09.022; Sanford JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003369; Sugimoto Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r67; Uchida Y, 2019, J BIOCHEM, V166, P375, DOI 10.1093/jb/mvz067; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Weyn-Vanhentenryck SM, 2014, CELL REP, V6, P1139, DOI 10.1016/j.celrep.2014.02.005; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Yamazaki Tomohiro, 2015, Front Biosci (Elite Ed), V7, P1; Yano M, 2010, NEURON, V66, P848, DOI 10.1016/j.neuron.2010.05.007; Ye JQ, 2015, P NATL ACAD SCI USA, V112, pE3020, DOI 10.1073/pnas.1508461112; Yugami M, 2007, FEBS LETT, V581, P1, DOI 10.1016/j.febslet.2006.11.062; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zhao W, 2012, J IMMUNOL, V188, P3179, DOI 10.4049/jimmunol.1101175	37	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231450	10.1371/journal.pone.0231450	http://dx.doi.org/10.1371/journal.pone.0231450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302342	Green Published, gold			2022-12-26	WOS:000536016100028
J	Eckstein, C; Mol, JPS; Costa, FB; Nunes, PP; Lima, PA; Melo, MM; Carvalho, TP; Santos, DO; Silva, MF; Carvalho, TF; Costa, LF; Melo, OAO; Giunchette, RC; Paixao, TA; Santos, RL				Eckstein, Camila; Mol, Juliana P. S.; Costa, Fabiola B.; Nunes, Philipe P.; Lima, Pamela A.; Melo, Marilia M.; Carvalho, Thaynara P.; Santos, Daniel O.; Silva, Monique F.; Carvalho, Tatiane F.; Costa, Luciana F.; Melo Junior, Otoni A. O.; Giunchette, Rodolfo C.; Paixao, Tatiane A.; Santos, Renato L.			Brucella ovis mutant in ABC transporter protects against Brucella canis infection in mice and it is safe for dogs	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; POLYMERASE-CHAIN-REACTION; STRAIN RB51 VACCINE; MELITENSIS; ABORTUS; RESPONSES; HOST; DNA; EXTRACTION; CHALLENGE	Background/Objectives Vaccination is the most important tool for controlling brucellosis, but currently there is no vaccine available for canine brucellosis, which is a zoonotic disease of worldwide distribution caused by Brucella canis. This study aimed to evaluate protection and immune response induced by Brucella ovis Delta abcBA (Bo Delta abcBA) encapsulated with alginate against the challenge with Brucella canis in mice and to assess the safety of this strain for dogs. Methods Intracellular growth of the vaccine strain Bo Delta abcBA was assessed in canine and ovine macrophages. Protection induced by Bo Delta abcBA against virulent Brucella canis was evaluated in the mouse model. Safety of the vaccine strain Bo Delta abcBA was assessed in experimentally inoculated dogs. Results Wild type B. ovis and B. canis had similar internalization and intracellular multiplication profiles in both canine and ovine macrophages. The Bo Delta abcBA strain had an attenuated phenotype in both canine and ovine macrophages. Immunization of BALB/c mice with alginate-encapsulated Bo Delta abcBA (10(8) CFU) induced lymphocyte proliferation, production of IL-10 and IFN-gamma, and protected against experimental challenge with B. canis. Dogs immunized with alginate-encapsulated Bo Delta abcBA (10(9) CFU) seroconverted, and had no hematologic, biochemical or clinical changes. Furthermore, Bo Delta abcBA was not detected by isolation or PCR performed using blood, semen, urine samples or vaginal swabs at any time point over the course of this study. Bo Delta abcBA was isolated from lymph nodes near to the site of inoculation in two dogs at 22 weeks post immunization. Conclusion Encapsulated Bo Delta abcBA protected mice against experimental B. canis infection, and it is safe for dogs. Therefore, B. ovis Delta abcBA has potential as a vaccine candidate for canine brucellosis prevention.	[Eckstein, Camila; Mol, Juliana P. S.; Costa, Fabiola B.; Nunes, Philipe P.; Lima, Pamela A.; Melo, Marilia M.; Carvalho, Thaynara P.; Santos, Daniel O.; Carvalho, Tatiane F.; Costa, Luciana F.; Santos, Renato L.] Univ Fed Minas Gerais, Dept Clin & Cirurgia Vet, Escola Vet, Belo Horizonte, MG, Brazil; [Silva, Monique F.; Paixao, Tatiane A.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Patol Geral, Belo Horizonte, MG, Brazil; [Melo Junior, Otoni A. O.; Giunchette, Rodolfo C.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Morfol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Santos, RL (corresponding author), Univ Fed Minas Gerais, Dept Clin & Cirurgia Vet, Escola Vet, Belo Horizonte, MG, Brazil.	rsantos@vet.ufmg.br	de Lima Santos, Renato/A-1134-2008	de Lima Santos, Renato/0000-0002-4830-0470; Santos, Daniel/0000-0002-3083-1572; Mol, Juliana/0000-0002-6946-8213	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil) [CVZ -APQ-01591-14]	CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Work in RLS lab is supported by CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Brazil), FAPEMIG (Fundacao de Amparo a Pesquisa do Estado de Minas Gerais, Brazil) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brazil) grant CVZ -APQ-01591-14.	Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; BAILY GG, 1992, J TROP MED HYG, V95, P271; Baldwin CL, 2006, CRIT REV IMMUNOL, V26, P407, DOI 10.1615/CritRevImmunol.v26.i5.30; Banai M, 2002, VET MICROBIOL, V90, P497, DOI 10.1016/S0378-1135(02)00231-6; Byndloss MX, 2016, ANNU REV ANIM BIOSCI, V4, P111, DOI 10.1146/annurev-animal-021815-111326; CARMICHAEL L.E., 1966, J AM VET MEDICAL ASS, V149, P1126; Carmichael LE, 1996, SEMIN VET MED SURG, V11, P161, DOI 10.1016/S1096-2867(96)80028-4; Carvalho TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166582; Chacon-Diaz C, 2015, INFECT IMMUN, V83, P4861, DOI 10.1128/IAI.00995-15; Clausse M, 2017, VET IMMUNOL IMMUNOP, V184, P36, DOI 10.1016/j.vetimm.2016.11.004; Clausse M, 2014, CLIN VACCINE IMMUNOL, V21, P1689, DOI 10.1128/CVI.00527-14; Clausse M, 2013, VACCINE, V31, P6129, DOI 10.1016/j.vaccine.2013.07.041; Colegio Brasileiro de Reproduao Animal-CBRA, 2013, MAN EX ANDR AV SEM A, V3rd; Cosford KL, 2018, CAN VET J, V59, P74; de Bagues MPJ, 2004, INFECT IMMUN, V72, P2429, DOI 10.1128/IAI.72.4.2429-2433.2004; de Souza TD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25651-x; Dorneles EMS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136696; Frost A, 2017, VET REC, V181, P484, DOI 10.1136/vr.j4972; Hensel ME, 2018, EMERG INFECT DIS, V24, P1401, DOI 10.3201/eid2408.171171; Higgins JL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185823; Hinic V, 2010, VET MICROBIOL, V141, P391, DOI 10.1016/j.vetmic.2009.09.019; Hollett RB, 2006, THERIOGENOLOGY, V66, P575, DOI 10.1016/j.theriogenology.2006.04.011; Holst BS, 2018, ACTA VET SCAN, V54, P1; Kaden R, 2014, VET MICROBIOL, V174, P523, DOI 10.1016/j.vetmic.2014.10.015; Kahl-McDonagh MM, 2006, INFECT IMMUN, V74, P4048, DOI 10.1128/IAI.01787-05; Kauffman LK, 2019, VET CLIN N AM-SMALL, V49, P763, DOI 10.1016/j.cvsm.2019.02.013; Keid LB, 2007, THERIOGENOLOGY, V68, P1260, DOI 10.1016/j.theriogenology.2007.08.021; Keid LB, 2007, THERIOGENOLOGY, V67, P1203, DOI 10.1016/j.theriogenology.2007.01.003; Kim WK, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/ftx124; Krueger WS, 2014, ZOONOSES PUBLIC HLTH, V61, P509, DOI 10.1111/zph.12102; Lalsiamthara J, 2017, J VET SCI, V18, P281, DOI 10.4142/jvs.2017.18.S1.281; Lucero NE, 2005, J MED MICROBIOL, V54, P457, DOI 10.1099/jmm.0.45927-0; Matrone M, 2009, BRAZ J MICROBIOL, V40, P480, DOI 10.1590/S1517-838220090003000010; MichauxCharachon S, 1997, J BACTERIOL, V179, P3244, DOI 10.1128/jb.179.10.3244-3249.1997; Mol JPS, 2020, J VET DIAGN INVEST, V32, P77, DOI 10.1177/1040638719891083; Morgan J, 2017, VET REC, V180, P384, DOI 10.1136/vr.j1811; Paixao TA, 2009, INFECT IMMUN, V77, P4197, DOI 10.1128/IAI.00417-09; Palomares-Resendiz E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00035; PITCHER DG, 1989, LETT APPL MICROBIOL, V8, P151, DOI 10.1111/j.1472-765X.1989.tb00262.x; Poester FP, 2006, VACCINE, V24, P5327, DOI 10.1016/j.vaccine.2006.04.020; Pollak CN, 2015, CLIN VACCINE IMMUNOL, V22, P274, DOI 10.1128/CVI.00653-14; Qian J, 2017, VET MICROBIOL, V204, P121, DOI 10.1016/j.vetmic.2017.04.027; Truong QL, 2015, MICROBIOL-SGM, V161, P2137, DOI 10.1099/mic.0.000170; Rosinha GMS, 2002, INFECT IMMUN, V70, P5036, DOI 10.1128/IAI.70.9.5036-5044.2002; Scheftel J, 2003, COMP CONT EDUC PRACT, V25, P846; Silva APC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136865; Silva APC, 2015, CLIN VACCINE IMMUNOL, V22, P789, DOI 10.1128/CVI.00191-15; Silva APC, 2013, VET MICROBIOL, V167, P546, DOI 10.1016/j.vetmic.2013.09.003; Silva TMA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114532; Silva TMA, 2011, INFECT IMMUN, V79, P1706, DOI 10.1128/IAI.01109-10; Tsolis RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005519; Tsolis RM, 2002, P NATL ACAD SCI USA, V99, P12503, DOI 10.1073/pnas.212508599; van Dijk MAM, 2018, EMERG INFECT DIS, V24, P1127, DOI 10.3201/eid2406.171887; Vitry MA, 2012, INFECT IMMUN, V80, P4271, DOI 10.1128/IAI.00761-12; Wanke MM, 2004, ANIM REPROD SCI, V82-3, P195, DOI 10.1016/j.anireprosci.2004.05.005; Wareth G, 2017, TRANSBOUND EMERG DIS, V64, pE27, DOI 10.1111/tbed.12535; Xavier MN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003454; Xavier MN, 2010, VET MICROBIOL, V145, P158, DOI 10.1016/j.vetmic.2010.02.037; Xavier MN, 2009, CIENC RURAL, V39, P2252, DOI 10.1590/S0103-84782009005000167	59	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231893	10.1371/journal.pone.0231893	http://dx.doi.org/10.1371/journal.pone.0231893			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298378	Green Published, Green Submitted, gold			2022-12-26	WOS:000536011400120
J	Ersoz, EK; Aguilar, C; Chossat, P; Krupa, M; Lavigne, F				Ersoz, Elif Koksal; Aguilar, Carlos; Chossat, Pascal; Krupa, Martin; Lavigne, Frederic			Neuronal mechanisms for sequential activation of memory items: Dynamics and reliability	PLOS ONE			English	Article							BRAINS DEFAULT NETWORK; LONG-TERM-MEMORY; DOPAMINERGIC MODULATION; SPREADING ACTIVATION; CREATIVE COGNITION; GAIN MODULATION; MODEL; CORTEX; REWARD; PREDICTION	In this article we present a biologically inspired model of activation of memory items in a sequence. Our model produces two types of sequences, corresponding to two different types of cerebral functions: activation of regular or irregular sequences. The switch between the two types of activation occurs through the modulation of biological parameters, without altering the connectivity matrix. Some of the parameters included in our model are neuronal gain, strength of inhibition, synaptic depression and noise. We investigate how these parameters enable the existence of sequences and influence the type of sequences observed. In particular we show that synaptic depression and noise drive the transitions from one memory item to the next and neuronal gain controls the switching between regular and irregular (random) activation.	[Ersoz, Elif Koksal; Chossat, Pascal; Krupa, Martin] INRIA CNRS UNS, Project Team MathNeuro, Sophia Antipolis, France; [Aguilar, Carlos] Amaris Res Unit, Lab MANTU, Route Colles, Biot, France; [Chossat, Pascal; Krupa, Martin] Univ Cote Azur, Lab Jean Alexandre Dieudonne, Nice, France; [Lavigne, Frederic] Univ Cote Azur, CNRS BCL, Nice, France; [Ersoz, Elif Koksal] Univ Rennes 1, LTSI, INSERM U1099, Rennes, France	UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Ersoz, EK (corresponding author), INRIA CNRS UNS, Project Team MathNeuro, Sophia Antipolis, France.; Ersoz, EK (corresponding author), Univ Rennes 1, LTSI, INSERM U1099, Rennes, France.	elif.koksal@inria.fr		Koksal-Ersoz, Elif/0000-0003-3696-7953	ERC [227747]; French government, through the UCAJEDI Investments in the Future project [ANR-15-IDEX-01]	ERC(European Research Council (ERC)European Commission); French government, through the UCAJEDI Investments in the Future project	EKE and MK were supported by the ERC Advanced Grant NerVi no. 227747. FL was supported by the French government, through the UCAJEDI Investments in the Future project managed by the National Research Agency (ANR) with the reference number ANR-15-IDEX-01.	Abraham A, 2012, BRAIN RES, V1482, P55, DOI 10.1016/j.brainres.2012.09.007; Aguilar C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183710; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Ashwin P, 2016, J NONLINEAR SCI, V26, P345, DOI 10.1007/s00332-015-9277-2; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Atilgan H, 2018, NAT NEUROSCI, V21, P1648, DOI 10.1038/s41593-018-0282-2; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Benedek M, 2013, J CREATIVE BEHAV, V47, P273, DOI 10.1002/jocb.35; Benedek M, 2012, PSYCHOL AESTHET CREA, V6, P273, DOI 10.1037/a0027059; Bick C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218101; Bowden EM, 2003, BEHAV RES METH INS C, V35, P634, DOI 10.3758/BF03195543; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Brunel N, 1996, NEURAL COMPUT, V8, P1677, DOI 10.1162/neco.1996.8.8.1677; Brunel N, 2009, J COGNITIVE NEUROSCI, V21, P2300, DOI 10.1162/jocn.2008.21156; Bubic A, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00025; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buhusi CV, 2005, NAT REV NEUROSCI, V6, P755, DOI 10.1038/nrn1764; Burgess N, 1999, PSYCHOL REV, V106, P551, DOI 10.1037/0033-295X.106.3.551; BUZSAKI G, 1984, PROG NEUROBIOL, V22, P131, DOI 10.1016/0301-0082(84)90023-6; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; COHEN JD, 1992, PSYCHOL REV, V99, P45, DOI 10.1037/0033-295X.99.1.45; Conway CM, 2001, TRENDS COGN SCI, V5, P539, DOI 10.1016/S1364-6613(00)01800-3; Eagleman SL, 2012, P NATL ACAD SCI USA, V109, P19450, DOI 10.1073/pnas.1212059109; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fink A, 2014, NEUROSCI BIOBEHAV R, V44, P111, DOI 10.1016/j.neubiorev.2012.12.002; Fujimichi R, 2010, EUR J NEUROSCI, V32, P659, DOI 10.1111/j.1460-9568.2010.07320.x; Gavornik JP, 2014, NAT NEUROSCI, V17, P732, DOI 10.1038/nn.3683; Gonen-Yaacovi G, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00465; Graziano M, 2011, FRONT INTEGR NEUROSC, V5, DOI 10.3389/fnint.2011.00045; Guilford JP, 1950, AM PSYCHOL, V5, P444, DOI 10.1037/h0063487; Guilford J.P., 1967, NATURE HUMAN INTELLI; Hasan MT, ROLE MOTOR CORTEX NM; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Huber DE, 2003, COGNITIVE SCI, V27, P403, DOI 10.1016/S0364-0213(03)00012-0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; JENKINS IH, 1994, J NEUROSCI, V14, P3775; Jhou TC, 2019, CURR OPIN BEHAV SCI, V26, P90, DOI 10.1016/j.cobeha.2018.11.001; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Katkov M, 2017, NEURON, V94, P1027, DOI 10.1016/j.neuron.2017.03.048; Kischka U, 1996, NEUROPSYCHOLOGIA, V34, P1107, DOI 10.1016/0028-3932(96)00024-3; Kok P, 2012, NEURON, V75, P265, DOI 10.1016/j.neuron.2012.04.034; Kreher DA, 2008, SCHIZOPHRENIA BULL, V34, P473, DOI 10.1093/schbul/sbm108; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Lak A, 2014, P NATL ACAD SCI USA, V111, P2343, DOI 10.1073/pnas.1321596111; Lavigne F., 2002, INT J COMPUTING ANTI, V12, P253; Lavigne F., 2001, INT J COMPUT ANTICIP, V14, P196; Lavigne F, 2008, NEUROPSYCHOLOGIA, V46, P3074, DOI 10.1016/j.neuropsychologia.2008.06.019; Lavigne F, 2011, J COGNITIVE NEUROSCI, V23, P1447, DOI 10.1162/jocn.2010.21504; Lerner I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00314; Lerner I, 2012, COGNITIVE SCI, V36, P1339, DOI 10.1111/cogs.12007; Meyer T, 2011, P NATL ACAD SCI USA, V108, P19401, DOI 10.1073/pnas.1112895108; Miller P, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00014; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Mongillo G, 2008, SCIENCE, V319, P1543, DOI 10.1126/science.1150769; Moritz S, 2002, SCHIZOPHR RES, V59, P181, DOI DOI 10.1016/S0920-9964(01)00337-1; Nabavi S, 2014, NATURE, V511, P348, DOI 10.1038/nature13294; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Pezzulo G, 2014, TRENDS COGN SCI, V18, P647, DOI 10.1016/j.tics.2014.06.011; Quiroga RQ, 2016, NEUROPSYCHOLOGIA, V83, P227, DOI 10.1016/j.neuropsychologia.2015.12.016; Quiroga RQ, 2012, NAT REV NEUROSCI, V13, P587, DOI 10.1038/nrn3251; Quiroga RQ, 2010, PSYCHOL REV, V117, P291, DOI 10.1037/a0016917; R Core Team, 2012, R LANG ENV STAT COMP; Rainer G, 1999, J NEUROSCI, V19, P5493; Reddy L, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9556; Roesch-Ely D, 2006, BIOL PSYCHIAT, V60, P604, DOI 10.1016/j.biopsych.2006.01.004; Rohrmeier MA, 2012, INT J PSYCHOPHYSIOL, V83, P164, DOI 10.1016/j.ijpsycho.2011.12.010; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Romani S, 2013, NEURAL COMPUT, V25, P2523, DOI 10.1162/NECO_a_00499; Sakai K, 1998, J NEUROSCI, V18, P1827; Salinas E, 2001, NEUROSCIENTIST, V7, P430, DOI 10.1177/107385840100700512; Salinas Emilio, 2000, Neuron, V27, P15, DOI 10.1016/S0896-6273(00)00004-0; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; Shuler MG, 2006, SCIENCE, V311, P1606, DOI 10.1126/science.1123513; Silver RA, 2010, NAT REV NEUROSCI, V11, P474, DOI 10.1038/nrn2864; SPITZER M, 1993, SCHIZOPHR RES, V11, P71, DOI 10.1016/0920-9964(93)90040-P; Stroud JP, 2018, NAT NEUROSCI, V21, P1774, DOI 10.1038/s41593-018-0276-0; Takeuchi T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0288; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Torres JJ, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00030; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P713, DOI 10.1142/S0217984990000891; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Veliz-Cuba A, 2015, J COMPUT NEUROSCI, V39, P235, DOI 10.1007/s10827-015-0574-4; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; WILSON CJ, 1981, BRAIN RES, V220, P67, DOI 10.1016/0006-8993(81)90211-0; Xu SJ, 2012, NAT NEUROSCI, V15, P449, DOI 10.1038/nn.3036; Yakovlev V, 1998, NAT NEUROSCI, V1, P310, DOI 10.1038/1131; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	96	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231165	10.1371/journal.pone.0231165	http://dx.doi.org/10.1371/journal.pone.0231165			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298290	gold, Green Published, Green Submitted			2022-12-26	WOS:000536011400028
J	Kim, E; Kim, M; Choi, HK				Kim, Eunbi; Kim, Myeongsun; Choi, Hyung-Kyoon			Alteration of metabolic profiles in Lemna paucicostata culture and enhanced production of GABA and ferulic acid by ethephon treatment	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; PLANT-RESPONSES; ETHYLENE; GROWTH; STIMULATION; HORMONE	Lemna species have been used in the food, feed, and pharmaceutical industries, as they are inexpensive sources of proteins, starches, and fatty acids. In this study, we treated L. paucicostata with different concentrations (0.05, 0.1, 0.2, 0.5, or 1 mM) of ethephon. The total dry weight decreased in all ethephon-treated groups compared to the control group. We also investigated the alteration of metabolic profiles induced by ethephon treatment by using gas chromatography-mass spectrometry. This analysis identified 48 metabolites, and the relative levels of most of alcohols, amino acids, fatty acids, and phenols increased by the ethephon treatment, whereas levels of organic acids and sugars decreased. Among these, the highest production of gamma-aminobutyric acid (GABA, 5.041 +/- 1.373 mg/L) and ferulic acid (0.640 +/- 0.071 mg/L) was observed in the 0.5 mM and the 0.2 mM ethephon treatment groups, respectively. These results could be useful for large-scale culture of L. paucicostata with enhanced GABA and ferulic acid content for utilization in the food, feed, cosmetic, and pharmaceutical industries.	[Kim, Eunbi; Kim, Myeongsun; Choi, Hyung-Kyoon] Chung Ang Univ, Coll Pharm, Seoul, South Korea	Chung Ang University	Choi, HK (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	hykychoi@cau.ac.kr		Choi, Hyung-Kyoon/0000-0002-4523-0534	National Research Foundation of Korea (NRF) [NRF-2015R1A5A1008958, NRF-2019R1F1A1062127]; Korean government (MSIP); Chung-Ang University Graduate Research Scholarship	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (MSIP); Chung-Ang University Graduate Research Scholarship	This work was supported by grants from the National Research Foundation of Korea (NRF) (NRF-2015R1A5A1008958 and NRF2019R1F1A1062127), funded by the Korean government (MSIP) and by the Chung-Ang University Graduate Research Scholarship in 2018.	Amin Z, 2006, PHARMACOL BIOCHEM BE, V84, P635, DOI 10.1016/j.pbb.2006.06.007; Appenroth KJ, 2017, FOOD CHEM, V217, P266, DOI 10.1016/j.foodchem.2016.08.116; ARAZI T, 1995, PLANT PHYSIOL, V108, P551, DOI 10.1104/pp.108.2.551; CAVAGNINI F, 1980, J CLIN ENDOCR METAB, V51, P789, DOI 10.1210/jcem-51-4-789; Chapouthier G, 2001, TRENDS PHARMACOL SCI, V22, P491, DOI 10.1016/S0165-6147(00)01807-1; CHO GH, 1988, BIOTECHNOL PROGR, V4, P184, DOI 10.1002/btpr.5420040309; COLEMAN WK, 1980, PHYSIOL PLANTARUM, V48, P519, DOI 10.1111/j.1399-3054.1980.tb03298.x; Culley DD, 2013, WATER POLLUT CONTROL, V45, P337; Droste P, 2011, BIOSYSTEMS, V105, P154, DOI 10.1016/j.biosystems.2011.04.003; Dunn WB, 2005, TRAC-TREND ANAL CHEM, V24, P285, DOI 10.1016/j.trac.2004.11.021; Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j; Goldental-Cohen S, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1035-1; Gottesmann C, 2002, NEUROSCIENCE, V111, P231, DOI 10.1016/S0306-4522(02)00034-9; Heredia JB, 2009, FOOD CHEM, V115, P1500, DOI 10.1016/j.foodchem.2009.01.078; Iqbal N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00475; Jackson MB, 2008, ANN BOT-LONDON, V101, P229, DOI 10.1093/aob/mcm237; Jeon JY, 2018, BIOTECHNOL BIOPROC E, V23, P23, DOI 10.1007/s12257-017-0384-9; KE DY, 1988, PLANT PHYSIOL, V88, P1136, DOI 10.1104/pp.88.4.1136; KEVERS C, 1992, PLANT CELL TISS ORG, V28, P175, DOI 10.1007/BF00055514; Khuhawar MY, 2009, PAK J BOT, V41, P1903; Kim JY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187622; Kim SH, 2016, J AGR FOOD CHEM, V64, P4807, DOI 10.1021/acs.jafc.6b00541; Kinnersley AM, 2000, CRIT REV PLANT SCI, V19, P479, DOI 10.1016/S0735-2689(01)80006-X; Ku H S, 1970, Planta, V90, P333, DOI 10.1007/BF00386385; Lin FH, 2005, J INVEST DERMATOL, V125, P826, DOI 10.1111/j.0022-202X.2005.23768.x; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Liu J, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00217; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Malho R, 1998, PHILOS T ROY SOC B, V353, P1463, DOI 10.1098/rstb.1998.0302; Obata T, 2012, CELL MOL LIFE SCI, V69, P3225, DOI 10.1007/s00018-012-1091-5; Park HJ, 2018, J NAT MED-TOKYO, V72, P127, DOI 10.1007/s11418-017-1120-7; Podlesakova K, 2019, NEW BIOTECHNOL, V48, P53, DOI 10.1016/j.nbt.2018.07.003; Roberts MR, 2007, PLANT SIGNAL BEHAV, V2, P408, DOI 10.4161/psb.2.5.4335; Rosales R, 2006, CROP PROT, V25, P140, DOI 10.1016/j.cropro.2005.03.014; Sanders D, 1999, PLANT CELL, V11, P691, DOI 10.1105/tpc.11.4.691; Schnackenberg LK, 2006, PHARMACOGENOMICS, V7, P1077, DOI 10.2217/14622416.7.7.1077; Singh Z, 2001, ACTA HORTIC, P599, DOI 10.17660/ActaHortic.2001.553.141; Startek L, 2005, ACTA HORTIC, P617, DOI 10.17660/ActaHortic.2005.673.85; Tsui MM, 2010, ADV ENZYME REGUL, V50, P324, DOI 10.1016/j.advenzreg.2009.12.002; Utami D, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00251; VANANDEL OM, 1978, J EXP BOT, V29, P639, DOI 10.1093/jxb/29.3.639; Wang XC, 2015, SCI REP-UK, V5, DOI 10.1038/srep13778; Wang ZY, 2001, HORTSCIENCE, V36, P328, DOI 10.21273/HORTSCI.36.2.328; WIERSMA DW, 1986, AGRON J, V78, P761, DOI 10.2134/agronj1986.00021962007800050002x; Ya VB, 2015, BANGLADESH J MED SCI, V14, P9, DOI 10.3329/bjms.v14i1.21554; YANG SF, 1969, PLANT PHYSIOL, V44, P1203, DOI 10.1104/pp.44.8.1203; Yuk HJ, 2016, J AGR FOOD CHEM, V64, P7315, DOI 10.1021/acs.jafc.6b02543; Zik M, 1998, PLANT MOL BIOL, V37, P967, DOI 10.1023/A:1006047623263	48	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231652	10.1371/journal.pone.0231652	http://dx.doi.org/10.1371/journal.pone.0231652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298342	gold, Green Published			2022-12-26	WOS:000536011400082
J	Kroupin, PY; Chernook, AG; Bazhenov, MS; Karlov, GI; Goncharov, NP; Chikida, NN; Divashuk, MG				Kroupin, Pavel Yu.; Chernook, Anastasiya G.; Bazhenov, Mikhail S.; Karlov, Gennady I.; Goncharov, Nikolay P.; Chikida, Nadezhda N.; Divashuk, Mikhail G.			Allele mining of TaGRF-2D gene 5 '-UTR in Triticum aestivum and Aegilops tauschii genotypes	PLOS ONE			English	Article							BREAD WHEAT; DWARFING GENES; POLYPLOID WHEAT; CHROMOSOME; DIVERSITY; EVOLUTION; IDENTIFICATION; GLAUCOUSNESS; RESISTANCE; RHT-B1B	The low diversity of the D-subgenome of bread wheat requires the involvement of new alleles for breeding. In grasses, the allelic state of Growth Regulating Factor (GRF) gene is correlated with nitrogen uptake. In this study, we characterized the sequence of TaGRF-2D and assessed its diversity in bread wheat and goatgrass Aegilops tauschii (genome DD). In silico analysis was performed for reference sequence searching, primer pairs design and sequence assembly. The gene sequence was obtained using Illumina and Sanger sequencing. The complete sequences of TaGRF-2D were obtained for 18 varieties of wheat. The polymorphism in the presence/absence of two GCAGCC repeats in 5' UTR was revealed and the GRF-2D-SSR marker was developed. Our results showed that the alleles 5' UTR-250 and 5' UTR-238 were present in wheat varieties, 5' UTR-250 was presented in the majority of wheat varieties. In Ae. tauschii ssp. strangulata (likely donor of the D-subgenome of polyploid wheat), most accessions carried the 5' UTR-250 allele, whilst most Ae. tauschii ssp. tauschii have 5' UTR-244. The developed GRF-2D-SSR marker can be used to study the genetic diversity of wheat and Ae. tauschii.	[Kroupin, Pavel Yu.; Chernook, Anastasiya G.; Bazhenov, Mikhail S.; Karlov, Gennady I.; Divashuk, Mikhail G.] All Russia Res Inst Agr Biotechnol, Lab Appl Genom & Crop Breeding, Moscow, Russia; [Goncharov, Nikolay P.] Russian Acad Sci, Siberian Branch, Inst Cytol & Genet, Novosibirsk, Russia; [Chikida, Nadezhda N.] All Russian Inst Plant Genet Resources, Fed Res Ctr Vavilov, St Petersburg, Russia; [Divashuk, Mikhail G.] Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia; [Divashuk, Mikhail G.] All Russia Res Inst Agr Biotechnol, Kurchatov Genom Ctr ARRIAB, Moscow, Russia	All-Russia Research Institute of Agricultural Biotechnology; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Vavilov All-Russian Institute of Plant Genetic Resources; Russian State Agrarian University - Moscow Timiryazev Agricultural Academy; All-Russia Research Institute of Agricultural Biotechnology	Divashuk, MG (corresponding author), All Russia Res Inst Agr Biotechnol, Lab Appl Genom & Crop Breeding, Moscow, Russia.; Divashuk, MG (corresponding author), Russian State Agr Univ, Moscow Timiryazev Agr Acad, Ctr Mol Biotechnol, Moscow, Russia.; Divashuk, MG (corresponding author), All Russia Res Inst Agr Biotechnol, Kurchatov Genom Ctr ARRIAB, Moscow, Russia.	divashuk@gmail.com	Divashuk, Mikhail/T-7621-2019; Karlov, Gennady/F-7403-2013; Bazhenov, Mikhail/N-4721-2016	Divashuk, Mikhail/0000-0001-6221-3659; Karlov, Gennady/0000-0002-9016-103X; Kroupin, Pavel/0000-0001-6858-3941; Bazhenov, Mikhail/0000-0002-7301-1363; Cernook, Anastasia/0000-0002-8793-1742	Kurchatov Genomics Center of All-Russia Research Institute of Agricultural Biotechnology [075-15-2019-1667]; Russian Science Foundation [17-76-20023];  [0662-2019-0006 VIR];  [0431-2019-0004]	Kurchatov Genomics Center of All-Russia Research Institute of Agricultural Biotechnology; Russian Science Foundation(Russian Science Foundation (RSF)); ; 	This research was funded by State Task 0431-2019-0004. The Ae. tauschii collection of Federal Research Center Vavilov All-Russian Institute of Plant Genetic Resources (VIR, SaintPetersburg, Russia) is supported by grant number 0662-2019-0006 VIR. The next-generation sequencing of the amplicons was funded by Kurchatov Genomics Center of All-Russia Research Institute of Agricultural Biotechnology for support, agreement 075-15-2019-1667. The growing, genotyping and phenotyping of the set of 20 breeding lines of bread winter wheat developed at the Lisitsyn Field Experimental Station (RSAUMTAA) was funded by the Russian Science Foundation, grant number 17-76-20023.	Akhunov ED, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-702; Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Avni R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120636; Balfourier F, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0536; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bazhenov MS, 2015, CEREAL RES COMMUN, V43, P504, DOI 10.1556/0806.43.2015.002; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; BERNATZKY R, 1986, THEOR APPL GENET, V72, P314, DOI 10.1007/BF00288567; Berry P.M., 2019, CROP SCI, P209, DOI [10.1007/978-1-4939-8621-7_228, DOI 10.1007/978-1-4939-8621-7_228]; Borrill P, 2019, PLANT J, V97, P56, DOI 10.1111/tpj.14150; Casebow R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156056; Chantret N, 2005, PLANT CELL, V17, P1033, DOI 10.1105/tpc.104.029181; Che R, 2015, NAT PLANTS, V2, DOI [10.1038/nplants.2015.202, DOI 10.1038/NPLANTS.2015.202]; Chebotar GO, 2013, CYTOL GENET+, V47, P70, DOI 10.3103/S0095452713020047; Chen GL, 2012, J BIOSCIENCES, V37, P149, DOI 10.1007/s12038-011-9175-1; Chernook AG, 2019, VAVILOVSKII ZH GENET, V23, P916, DOI 10.18699/VJ19.567; del Blanco IA, 2001, CROP SCI, V41, P670, DOI 10.2135/cropsci2001.413670x; Divashuk MG, 2013, EUPHYTICA, V190, P137, DOI 10.1007/s10681-012-0789-7; Dobrovolskaya O, 2015, PLANT PHYSIOL, V167, P189, DOI 10.1104/pp.114.250043; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Ellis MH, 2002, THEOR APPL GENET, V105, P1038, DOI 10.1007/s00122-002-1048-4; Feldman M, 2012, J EXP BOT, V63, P5045, DOI 10.1093/jxb/ers192; Feng YM, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1950-4; Friebe B, 1996, EUPHYTICA, V91, P59, DOI 10.1007/BF00035277; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Gao CH, 2013, FUNCT PLANT BIOL, V40, P645, DOI 10.1071/FP12325; Gao LW, 2017, SCI REP-UK, V7, DOI 10.1038/srep42229; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Godoy M, 2011, PLANT J, V66, P700, DOI 10.1111/j.1365-313X.2011.04519.x; Goncharov NP, 2018, RUSS J GENET+, V54, P1277, DOI 10.1134/S1022795418110066; Gooding M, 2011, J AGR SCI, V150, P3; Han B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141540; He RL, 2009, THEOR APPL GENET, V118, P1173, DOI 10.1007/s00122-009-0971-z; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Jobson EM, 2018, CEREAL CHEM, V95, P770, DOI 10.1002/cche.10091; Klimushina MV, 2013, RUSS J GENET+, V49, P530, DOI 10.1134/S1022795413050074; Kroupin P. Yu., 2019, Sel'skokhozyaistvennaya Biologiya, V54, P409, DOI [10.15389/agrobiology.2019.3.409eng, 10.15389/agrobiology.2019.3.409rus]; LAGUDAH ES, 1991, GENOME, V34, P375, DOI 10.1139/g91-059; Lavallee-Adam M, 2017, NUCLEIC ACIDS RES, V45, P10415, DOI 10.1093/nar/gkx751; Li J, 2014, J SYST EVOL, V52, P735, DOI 10.1111/jse.12110; Li S, 2018, NATURE, V560, P595, DOI 10.1038/s41586-018-0415-5; Liu HL, 2012, GENE, V507, P106, DOI 10.1016/j.gene.2012.07.034; Lopes MS, 2012, CROP SCI, V52, P1123, DOI 10.2135/cropsci2011.09.0467; Marin-de la Rosa N, 2014, PLANT PHYSIOL, V166, P1022, DOI 10.1104/pp.114.244723; Miralles DJ, 1998, J EXP BOT, V49, P1119, DOI 10.1093/jexbot/49.324.1119; Mizuno N, 2010, MOL ECOL, V19, P999, DOI 10.1111/j.1365-294X.2010.04537.x; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Naghavi MR, 2009, GENET RESOUR CROP EV, V56, P499, DOI 10.1007/s10722-008-9381-3; Nicholas KB., 1997, GENEDOC TOOL EDITING; Nielsen NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094000; Othmeni M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01110; Padmanaban S, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-018-0838-6; Pearce S, 2011, PLANT PHYSIOL, V157, P1820, DOI 10.1104/pp.111.183657; Peng ZS, 2008, J APPL GENET, V49, P135, DOI 10.1007/BF03195606; Pestsova E, 2000, THEOR APPL GENET, V101, P100, DOI 10.1007/s001220051456; Pinera-Chavez FJ, 2016, FIELD CROP RES, V196, P64, DOI 10.1016/j.fcr.2016.06.007; Pont C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1627-1; Przewieslik-Allen AM, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01993; Ramya P, 2010, J APPL GENET, V51, P421, DOI 10.1007/BF03208872; RAO M V P, 1972, Wheat Information Service, V35, P9; Ravel C, 2009, PLANT PHYSIOL, V151, P2133, DOI 10.1104/pp.109.146076; Salim N, 2020, J PLANT NUTR, V43, P297, DOI 10.1080/01904167.2019.1676907; Salina EA, 2015, EUPHYTICA, V204, P91, DOI 10.1007/s10681-014-1344-5; Shcherban AB, 2015, PLANT BREEDING, V134, P49, DOI 10.1111/pbr.12223; Shewry PR, 2015, FOOD ENERGY SECUR, V4, P178, DOI 10.1002/fes3.64; Singh N, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00009; Sip V, 2010, EUPHYTICA, V172, P221, DOI 10.1007/s10681-009-0049-7; Takumi S, 2008, 11 INT WHEAT GEN S S, P312; Tang JF, 2006, EUPHYTICA, V151, P87, DOI 10.1007/s10681-006-9131-6; Thind AK, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1477-2; Tsunewaki K, 1999, GENES GENET SYST, V74, P33, DOI 10.1266/ggs.74.33; Vavilova V, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0583-6; Venske E, 2019, HEREDITAS, V156, DOI 10.1186/s41065-019-0093-9; Wang JR, 2013, NEW PHYTOL, V198, P925, DOI 10.1111/nph.12164; Warburton ML, 2006, EUPHYTICA, V149, P289, DOI 10.1007/s10681-005-9077-0; Winfield MO, 2018, PLANT BIOTECHNOL J, V16, P165, DOI 10.1111/pbi.12757; WORLAND AJ, 1986, Z PFLANZENZUCHT, V96, P331; WORLAND AJ, 1988, PLANT BREEDING, V100, P247, DOI 10.1111/j.1439-0523.1988.tb00250.x; Xi XY, 2016, MOL GENET GENOMICS, V291, P1991, DOI 10.1007/s00438-016-1234-8; Yan L, 2004, THEOR APPL GENET, V109, P1677, DOI 10.1007/s00122-004-1796-4; Zaharia M, 2011, ARXIV11115572V1; Zhang L, 2012, NEW PHYTOL, V195, P574, DOI 10.1111/j.1469-8137.2012.04194.x	83	6	6	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231704	10.1371/journal.pone.0231704	http://dx.doi.org/10.1371/journal.pone.0231704			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298343	Green Published, gold			2022-12-26	WOS:000536011400091
J	Nevard, TD; Haase, M; Archibald, G; Leiper, I; Van Zalinge, RN; Purchkoon, N; Siriaroonrat, B; Latt, TN; Wink, M; Garnett, ST				Nevard, Timothy D.; Haase, Martin; Archibald, George; Leiper, Ian; Van Zalinge, Robert N.; Purchkoon, Nuchjaree; Siriaroonrat, Boripat; Latt, Tin Nwe; Wink, Michael; Garnett, Stephen T.			Subspecies in the Sarus Crane Antigone antigone revisited; with particular reference to the Australian population	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; CONSERVATION IMPLICATIONS; MICROSATELLITE LOCI; EASTERN BRISTLEBIRD; SPECIES CONCEPTS; SOUTHEAST-ASIA; GENOTYPE; INFERENCE; DIFFERENTIATION; DIVERSITY	Subspecies are often less well-defined than species but have become one of the basic units for legal protection. Evidence for the erection or synonymy of subspecies therefore needs to be founded on the best science available. Here we show that there is clear genetic disjunction in the Sarus Crane Antigone antigone, where previously the variation had appeared to be clinal. Based on a total sample of 76 individuals, analysis of 10 microsatellite loci from 67 samples and 49 sequences from the mitochondrial control region, this research establishes that the Australian Sarus Crane A. a. gillae differs significantly from both A. a. antigone (South Asia) and A. a. sharpii (Myanmar and Indochina). A single sample from the extinct Philippine subspecies A. a luzonica clustered with A. a. gillae, hinting at the potential for a more recent separation between them than from A. a. antigone and A. a. sharpii, even though A. a. sharpii is closer geographically. The results demonstrate that failure to detect subspecies through initial genetic profiling does not mean discontinuities are absent and has significance for other cases where subspecies are dismissed based on partial genetic evidence. It could also be potentially important for sourcing birds for reintroduction to the Philippines.	[Nevard, Timothy D.; Leiper, Ian; Van Zalinge, Robert N.; Garnett, Stephen T.] Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia; [Nevard, Timothy D.] Atherton Tablelands Fdn, Ravenshoe, Qld, Australia; [Haase, Martin] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany; [Archibald, George] Int Crane Fdn, Baraboo, WI USA; [Purchkoon, Nuchjaree; Siriaroonrat, Boripat] Zool Pk Org, Dusit Bangkok, Thailand; [Latt, Tin Nwe] Mahidol Univ, Fac Environm & Resource Studies, Salaya, Phutthamonthon, Thailand; [Wink, Michael] Inst Pharm & Mol Biotechnol IPMB, Heidelberg, Germany	Charles Darwin University; Ernst Moritz Arndt Universitat Greifswald; Mahidol University	Nevard, TD (corresponding author), Charles Darwin Univ, Res Inst Environm & Livelihoods, Darwin, NT, Australia.; Nevard, TD (corresponding author), Atherton Tablelands Fdn, Ravenshoe, Qld, Australia.	tnevard@woothakata.com	Wink, Michael/E-3803-2012	Wink, Michael/0000-0002-7875-4510	North Queensland Wildlife Trust [AUD5,000]	North Queensland Wildlife Trust	The corresponding author received a AUD5,000 grant towards genetic analysis from the North Queensland Wildlife Trust. This was made available to the University of Greifswald avian genetics lab.	Akiyama T, 2017, MOL PHYLOGENET EVOL, V106, P158, DOI 10.1016/j.ympev.2016.09.026; Archibald GW, 2003, J ECOL SOC, V16, P5; Attwood SW, 2001, BIOL J LINN SOC, V73, P23, DOI 10.1111/j.1095-8312.2001.tb01344.x; Baker AN, 2002, J ROY SOC NEW ZEAL, V32, P713, DOI 10.1080/03014223.2002.9517717; BARTON NH, 1986, HEREDITY, V56, P409, DOI 10.1038/hdy.1986.63; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; BirdLife International, 2016, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2016-3.RLTS.T22692064A93335364.en, DOI 10.2305/IUCN.UK.2016-3.RLTS.T22692064A93335364.EN.CITED]; BirdLife International NatureServe, 2014, BIRD SPEC DISTR MAPS; Blanford W., 1895, B BRIT ORNITHOLOGIST, V5, P7; Blyth E., 1881, NATURAL HIST CRANES; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Clement M., 2002, P 16 INT PARALLEL DI, P7; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; del Hoyo J, 2014, HBW BIRDLIFE INT ILL, V1; Department of Environment and Energy, 2016, EPBC ACT LIST THREAT; Dessauer HC, 1992, MOL PHYLOGENET EVOL, V1, P279, DOI 10.1016/1055-7903(92)90003-Y; Donnellan SC, 2009, EMU, V109, P143, DOI 10.1071/MU07011; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Frankham R, 2012, BIOL CONSERV, V153, P25, DOI 10.1016/j.biocon.2012.04.034; Frost G., 2015, RARE COASTAL SAGE SC; Garnett ST, 2007, BIRD CONSERV INT, V17, P187, DOI 10.1017/S0959270907000809; Gavrilets S, 2003, EVOLUTION, V57, P2197; Gill HB, 1967, EMU, V69, P49; Gippoliti S, 2018, BIOL REV, V93, P115, DOI 10.1111/brv.12335; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Guerrero AM, 2017, THREATENED SPECIES R; Haase M, 2012, ARDEOLA, V59, P131, DOI 10.13157/arla.59.1.2012.131; Hachisuka Marquess, 1941, Tori Tokyo, V11, P61; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hasegawa O, 2000, MOL ECOL, V9, P1677, DOI 10.1046/j.1365-294x.2000.01042-11.x; Jones KL, 2005, ANIM CONSERV, V8, P1, DOI 10.1017/S1367943004001842; Joseph L, EMU, DOI [10.1080/01584197.2017.1379356, DOI 10.1080/01584197.2017.1379356]; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Krajewski C, 2010, AUK, V127, P440, DOI 10.1525/auk.2009.09045; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Martien KK, 2017, MAR MAMMAL SCI, V33, P27, DOI 10.1111/mms.12409; McCormack JE, 2015, AUK, V132, P380, DOI 10.1642/AUK-14-184.1; Meares K, 2009, MOL ECOL RESOUR, V9, P308, DOI 10.1111/j.1755-0998.2008.02440.x; Meine C.D., 1996, CRANES STATUS SURVEY; Meirmans PG, 2012, J HERED, V103, P744, DOI 10.1093/jhered/ess047; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Menkhorst P, 2017, AUSTR BIRD GUIDE; Miller A, 2019, AVIAN BIOL RES, DOI [10.1177/17581559198321422019, DOI 10.1177/17581559198321422019]; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mudrik EA, 2015, MOL BIOL+, V49, P260, DOI 10.1134/S0026893315020090; Nei M., 1987, MOL EVOLUTIONARY GEN; Nevard Timothy D., 2019, Pacific Conservation Biology, V25, P377, DOI 10.1071/PC18081; Nevard TD, 2020, ORYX, V54, P40, DOI 10.1017/S003060531800073X; Nevard Timothy D., 2019, Pacific Conservation Biology, V25, P184, DOI 10.1071/PC18055; Patten MA, 2002, AUK, V119, P26, DOI 10.1642/0004-8038(2002)119[0026:DVMDOS]2.0.CO;2; Patten MA, 2017, J HERED, V108, P462, DOI 10.1093/jhered/esx013; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reardon M., 2007, BROLGA COUNTRY TRAVE; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Roberts DG, 2011, CONSERV GENET, V12, P1075, DOI 10.1007/s10592-011-0210-4; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schodde R., 1988, CANBERRA BIRD NOTES, V13, P1; Schodde R, 1999, DIRECTORY AUSTR BIRD; Sharpe R. B, 1894, CATALOGUE BIRDS BRIT, V23; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; Stone ZL, 2018, EMU, V118, P269, DOI 10.1080/01584197.2018.1425628; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Van der Geer A., 2010, EVOLUTION ISLAND MAM; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wallin H, 2017, ZOOKEYS, P103, DOI 10.3897/zookeys.691.12880; Whitlock MC, 1999, HEREDITY, V82, P117, DOI 10.1038/sj.hdy.6884960; Winker K, 2009, BIOSCIENCE, V59, P657, DOI 10.1525/bio.2009.59.8.7; Wood TC, 1996, AUK, V113, P655; Zachos FE, 2018, SPECIES CONCEPTS BIO; Zink RM, 2013, AUK, V130, P449, DOI 10.1525/auk.2013.12241; Zong Y, 2016, GEOL SOC SPEC PUBL, V429, P123, DOI 10.1144/SP429.1	79	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230150	10.1371/journal.pone.0230150	http://dx.doi.org/10.1371/journal.pone.0230150			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298293	Green Published, gold			2022-12-26	WOS:000536011400010
J	Purrington, KS; Knight, J; Dyson, G; Ali-Fehmi, R; Schwartz, AG; Boerner, JL; Bandyopadhyay, S				Purrington, Kristen S.; Knight, Jimmie, III; Dyson, Gregory; Ali-Fehmi, Rouba; Schwartz, Ann G.; Boerner, Julie L.; Bandyopadhyay, Sudeshna			CLCA2 expression is associated with survival among African American women with triple negative breast cancer	PLOS ONE			English	Article							TUMOR-INFILTRATING LYMPHOCYTES; GENE-EXPRESSION; RACE; FEATURES; SUBTYPES; OUTCOMES; FAMILY; HCLCA2; RISK	Purpose Black/African American (AA) women are twice as likely to be diagnosed with triple negative breast cancer (TNBC) compared to whites, an aggressive breast cancer subtype associated with poor prognosis. There are no routinely used targeted clinical therapies for TNBC; thus there is a clear need to identify prognostic markers and potential therapeutic targets. Methods We evaluated expression of 27,016 genes in 155 treatment-naive TN tumors from AA women in Detroit. Associations with survival were evaluated using Cox proportional hazards models adjusting for stage and age at diagnosis, and p-values were corrected using a false discovery rate. Our validation sample consisted of 494 TN tumors using four publically available data sets. Meta-analyses were performed using summary statistics from the four validation results. Results In the Detroit AA cohort, CLCA2 [Hazard ratio (HR) = 1.56, 95% confidence interval (CI) 1.31-1.86, nominal p = 5.1x10-7, FDR p = 0.014], SPIC [HR = 1.47, 95%CI 1.26-1.73, nominal p = 1.8x10-6, FDR p = 0.022], and MIR4311 [HR = 1.57, 95% CI 1.31-1.92, nominal p = 2.5x10-5, FDR p = 0.022] expression were associated with overall survival. Further adjustment for treatment and breast cancer specific survival analysis did not substantially alter effect estimates. CLCA2 was also associated with increased risk of death in the validation cohorts [HR = 1.14, 95% CI 1.05-1.24, p = 0.038, p-heterogeneity = 0.88]. Conclusions We identified CLCA2 as a potential prognostic marker for TNBC in AA women.	[Purrington, Kristen S.; Knight, Jimmie, III; Dyson, Gregory; Schwartz, Ann G.; Boerner, Julie L.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA; [Purrington, Kristen S.; Dyson, Gregory; Schwartz, Ann G.] Barbara Ann Karmanos Canc Inst, Populat Studies & Dispar Res Program, Detroit, MI 48201 USA; [Ali-Fehmi, Rouba; Bandyopadhyay, Sudeshna] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Ali-Fehmi, Rouba; Bandyopadhyay, Sudeshna] Barbara Ann Karmanos Canc Inst, Tumor Biol & Microenvironm Program, Detroit, MI USA; [Boerner, Julie L.] Barbara Ann Karmanos Canc Inst, Mol Therapeut Program, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University; Barbara Ann Karmanos Cancer Institute; Barbara Ann Karmanos Cancer Institute	Purrington, KS (corresponding author), Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI 48202 USA.; Purrington, KS (corresponding author), Barbara Ann Karmanos Canc Inst, Populat Studies & Dispar Res Program, Detroit, MI 48201 USA.	purringk@karmanos.org	Purrington, Kristen/AAN-6494-2021	Purrington, Kristen/0000-0002-5710-1692	American Cancer Society [11-053-01-IRG]; National Institutes of Health [P30CA022453, HHSN261201300011I]	American Cancer Society(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	KSP: American Cancer Society Institutional Research Grant 11-053-01-IRG https://www.cancer.org/AGS: National Institutes of Health P30CA022453 https://www.nih.gov/AGS: National Institutes of Health HHSN261201300011I https://www.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SG, 2016, J BREAST CANCER, V19, P223, DOI 10.4048/jbc.2016.19.3.223; American Cancer Society, 2012, BREAST CANC FACT FIG; Baglia ML, 2014, BREAST CANCER RES TR, V148, P211, DOI 10.1007/s10549-014-3127-z; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bednarski JJ, 2016, J EXP MED, V213, P209, DOI 10.1084/jem.20151048; Choi Y, 2016, J KOREAN MED SCI, V31, P886, DOI 10.3346/jkms.2016.31.6.886; Christiansen N, 2012, CLIN BREAST CANCER, V12, P270, DOI 10.1016/j.clbc.2012.04.007; Chu QD, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/764570; Cortez-Retamozo V, 2012, P NATL ACAD SCI USA, V109, P2491, DOI 10.1073/pnas.1113744109; Dawood S, 2009, J CLIN ONCOL, V27, P220, DOI 10.1200/JCO.2008.17.9952; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Gruber AD, 1999, CANCER RES, V59, P5488; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Higgins M, 1996, AM J EPIDEMIOL, V143, P1219, DOI 10.1093/oxfordjournals.aje.a008709; Jin ZN, 2018, AM J TRANSL RES, V10, P1677; Kim JY, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2195-3; Kohler BA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv048; Komenaka IK, 2010, J NATL CANCER I, V102, P1178, DOI 10.1093/jnci/djq215; Ku YJ, 2016, AM J ROENTGENOL, V207, P1146, DOI 10.2214/AJR.16.16248; Kurotaki D, 2015, MICROBIOL IMMUNOL, V59, P55, DOI 10.1111/1348-0421.12228; Lee HJ, 2015, BREAST CANCER RES TR, V151, P619, DOI 10.1007/s10549-015-3438-8; Lee JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep28623; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Li XR, 2004, ONCOGENE, V23, P1474, DOI 10.1038/sj.onc.1207249; Liu Y, 2015, ONCOTARGET, V6, P41360, DOI 10.18632/oncotarget.6023; Lu LS, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000007085; Ludovini V, 2016, ONCOTARGET, V7, P30561, DOI 10.18632/oncotarget.8723; Lund MJ, 2009, BREAST CANCER RES TR, V113, P357, DOI 10.1007/s10549-008-9926-3; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Nofech-Mozes S, 2009, BREAST CANCER RES TR, V118, P131, DOI 10.1007/s10549-008-0295-8; Ono M, 2012, BREAST CANCER RES TR, V132, P793, DOI 10.1007/s10549-011-1554-7; Park YH, 2015, INT J CANCER, V136, P1976, DOI 10.1002/ijc.29233; Purrington KS, 2016, BREAST CANCER RES TR, V157, P117, DOI 10.1007/s10549-016-3775-2; Qiang YY, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0692-8; Ramnarine VR, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy050; Sasaki Y, 2012, CANCER BIOL THER, V13, P1512, DOI 10.4161/cbt.22280; Stanton SE, 2016, JAMA ONCOL, V2, P1354, DOI 10.1001/jamaoncol.2016.1061; Sun H, 2017, MOL CLIN ONCOL, V7, P935, DOI 10.3892/mco.2017.1429; Walia V, 2012, ONCOGENE, V31, P2237, DOI 10.1038/onc.2011.392; Walia V, 2009, CANCER RES, V69, P6624, DOI 10.1158/0008-5472.CAN-08-4101; Wang SY, 2018, BREAST CANCER RES TR, V171, P199, DOI 10.1007/s10549-018-4816-9; Yue Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149661; Zhang MH, 2014, TARGET ONCOL, V9, P349, DOI 10.1007/s11523-013-0300-y	44	7	7	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231712	10.1371/journal.pone.0231712	http://dx.doi.org/10.1371/journal.pone.0231712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298355	gold, Green Published			2022-12-26	WOS:000536011400094
J	Artuzi, FE; Puricelli, E; Baraldi, CE; Quevedo, AS; Ponzoni, D				Artuzi, Felipe Ernesto; Puricelli, Edela; Baraldi, Carlos Eduardo; Quevedo, Alexandre Silva; Ponzoni, Deise			Reduction of osteoarthritis severity in the temporomandibular joint of rabbits treated with chondroitin sulfate and glucosamine	PLOS ONE			English	Article							CRUCIATE LIGAMENT TRANSECTION; KNEE OSTEOARTHRITIS; DOUBLE-BLIND; PLUS GLUCOSAMINE; PAINFUL CLICKING; CARTILAGE; MODEL; BONE; GLYCOSAMINOGLYCANS; HYDROCHLORIDE	Osteoarthritis is a degenerative disease that causes substantial changes in joint tissues, such as cartilage degeneration and subchondral bone sclerosis. Chondroitin sulfate and glucosamine are commonly used products for the symptomatic treatment of osteoarthritis. The aim of the present study was to investigate the effects of these products when used as structure-modifying drugs on the progression of osteoarthritis in the rabbit temporomandibular joint. Thirty-six New Zealand rabbits were divided into 3 groups (n = 12/group): control (no disease); osteoarthritis (disease induction); and treatment (disease induction and administration of chondroitin sulfate and glucosamine). Osteoarthritis was induced by intra-articular injection of monosodium iodoacetate. Animals were killed at 30 and 90 days after initiation of therapy. The treatment was effective in reducing disease severity, with late effects and changes in the concentration of glycosaminoglycans in the articular disc. The results indicate that chondroitin sulfate and glucosamine may have a structure-modifying effect on the tissues of rabbit temporomandibular joints altered by osteoarthritis.	[Artuzi, Felipe Ernesto; Baraldi, Carlos Eduardo; Quevedo, Alexandre Silva] Fed Univ Rio Grande do Sul UFRGS, Sch Dent, Porto Alegre, RS, Brazil; [Puricelli, Edela; Ponzoni, Deise] Fed Univ Rio Grande do Sul UFRGS, Oral & Maxillofacial Surg Unit, Clin Hosp Porto Alegre HCPA, Sch Dent, Porto Alegre, RS, Brazil; [Artuzi, Felipe Ernesto; Puricelli, Edela] Inst Puricelli Cirurgia Bucomaxilofacial, Porto Alegre, RS, Brazil; [Baraldi, Carlos Eduardo; Quevedo, Alexandre Silva; Ponzoni, Deise] Univ Fed Rio Grande do Sul UFRGS, Fac Odontol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Artuzi, FE (corresponding author), Fed Univ Rio Grande do Sul UFRGS, Sch Dent, Porto Alegre, RS, Brazil.	feartuzi@yahoo.com.br		Artuzi, Felipe/0000-0001-6148-5396	Brazilian agency Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (HCPA/FIPE) [160238]	Brazilian agency Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (HCPA/FIPE)	M We are grateful to the Brazilian funding agency Fundo de Incentivo a Pesquisa e Eventos do Hospital de Clinicas de Porto Alegre (HCPA/FIPE; 160238) for approving. this study. We are also thankful to the Post-Graduation Group in Faculdade de Odontologia (PPGO), Universidade Federal do Rio Grande do Sul, and to the Animal Experimentation Unit (UEA), Experimental Pathology Unit and Molecular Analyses and Proteins Unit of HCPA.	Allen KD, 2006, J BIOMECH, V39, P312, DOI 10.1016/j.jbiomech.2004.11.012; Arnett GW, 1996, AM J ORTHOD DENTOFAC, V110, P117, DOI 10.1016/S0889-5406(96)70099-9; Artuzi FE, 2016, BRIT J ORAL MAX SURG, V54, pE33, DOI 10.1016/j.bjoms.2016.01.022; AXELSSON S, 1992, ACTA ODONTOL SCAND, V50, P113, DOI 10.3109/00016359209012753; Axelsson S, 1993, Swed Dent J Suppl, V92, P1; Bascoul-Colombo C, 2016, CARTILAGE, V7, P70, DOI 10.1177/1947603515603762; Bechtold TE, 2016, MATRIX BIOL, V52-54, P339, DOI 10.1016/j.matbio.2016.03.001; Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)00163-8; Terencio MC, 2016, BIOMED PHARMACOTHER, V79, P120, DOI 10.1016/j.biopha.2016.02.005; Chan PS, 2006, J RHEUMATOL, V33, P1329; Chen K, 2013, INT J ORAL MAX SURG, V42, P240, DOI 10.1016/j.ijom.2012.05.030; Cledes G, 2006, INT J ORAL MAX SURG, V35, P1026, DOI 10.1016/j.ijom.2006.05.003; Coskun U, 2019, J CRANIO MAXILL SURG, V47, P357, DOI 10.1016/j.jcms.2018.12.004; DAMLAR I, 2015, MED ORAL PATOL ORAL, V20, pE27, DOI DOI 10.4317/MED0RAL.20242; DEJONG JGN, 1992, CLIN CHEM, V38, P803; Delatte M, 2004, EUR J ORAL SCI, V112, P156, DOI 10.1111/j.0909-8836.2004.00108.x; DIJKGRAAF LC, 1995, J ORAL MAXIL SURG, V53, P1182, DOI 10.1016/0278-2391(95)90632-0; Filinte GT, 2011, J CRANIO MAXILL SURG, V39, P351, DOI 10.1016/j.jcms.2010.09.002; GAGE JP, 1995, J PROSTHET DENT, V74, P517, DOI 10.1016/S0022-3913(05)80355-5; Herrero-Beaumont G, 2008, BRIT J PHARMACOL, V154, P843, DOI 10.1038/bjp.2008.113; Janusz MJ, 2001, OSTEOARTHR CARTILAGE, V9, P751, DOI 10.1053/joca.2001.0472; Kahan A, 2009, ARTHRITIS RHEUM-US, V60, P524, DOI 10.1002/art.24255; Kalpakci KN, 2011, J DENT RES, V90, P193, DOI 10.1177/0022034510381501; Kamarul T, 2011, EUR CELLS MATER, V21, P259, DOI 10.22203/eCM.v021a20; Kardel R, 2003, INT J ORAL MAX SURG, V32, P390, DOI 10.1054/ijom.2002.0357; Kobo M, 2009, LIFE SCI, V85, P477, DOI [10.1016/j.lfs.209.08.005, 10.1016/j.lfs.2009.08.005]; Largo R, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.01.017; LEQUESNE M, 1994, J RHEUMATOL, V21, P65; Lippiello L, 2003, OSTEOARTHR CARTILAGE, V11, P335, DOI 10.1016/S1063-4584(03)00026-8; Little CJ, 2014, J FUNCT BIOMATER, V5, P197, DOI 10.3390/jfb5030197; Manno RL, 2012, OSTEOARTHR CARTILAGE, V20, P93, DOI 10.1016/j.joca.2011.11.013; Martel-Pelletier J, 2015, ANN RHEUM DIS, V74, P547, DOI 10.1136/annrheumdis-2013-203906; MILLS DK, 1994, J ORAL MAXIL SURG, V52, P1279, DOI 10.1016/0278-2391(94)90051-5; Mittelstaedt D, 2016, QUANT IMAGING MED SU, V6, P648, DOI 10.21037/qims.2016.06.12; Nakano T, 1996, ARCH ORAL BIOL, V41, P845, DOI 10.1016/S0003-9969(96)00040-4; Nanci A., 2013, 10 CATE HISTOLOGIA O; Nguyen P, 2001, CRANIO, V19, P130, DOI 10.1080/08869634.2001.11746162; Oegema TR, 2002, ARTHRITIS RHEUM-US, V46, P2495, DOI 10.1002/art.10499; Paegle DI, 2003, INT J ORAL MAX SURG, V32, P397, DOI 10.1054/ijom.2003.0375; Pavelka K, 2002, ARCH INTERN MED, V162, P2113, DOI 10.1001/archinte.162.18.2113; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Puricelli E, 2019, J ORAL MAXIL SURG, V77, P2230, DOI 10.1016/j.joms.2019.04.024; Roman-Blas JA, 2017, EUR J PHARMACOL, V794, P8, DOI 10.1016/j.ejphar.2016.11.015; Santos GRC, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020038; Shankland WE, 1998, CRANIO, V16, P230, DOI 10.1080/08869634.1998.11746062; Shen G, 2005, J DENT RES, V84, P691, DOI 10.1177/154405910508400802; Simanek Vilim, 2005, Biomedical Papers (Olomouc), V149, P51; Stocum DL, 2018, CURR OSTEOPOROS REP, V16, P360, DOI 10.1007/s11914-018-0447-7; Taskesen A, 2015, EKLEM HAST CERRAHISI, V26, P77, DOI 10.5606/ehc.2015.17; Thie NMR, 2001, J RHEUMATOL, V28, P1347; Torelli SR, 2005, J VET MED A, V52, P45, DOI 10.1111/j.1439-0442.2004.00682.x; Tosun HB, 2017, THER CLIN RISK MANAG, V13, DOI 10.2147/TCRM.S133635; Vaishya Raju, 2018, J Clin Orthop Trauma, V9, P338, DOI 10.1016/j.jcot.2018.07.015; Vasiliadis HS, 2017, WORLD J ORTHOP, V8, P1, DOI 10.5312/wjo.v8.i1.1; Viana F. A. B., 2007, GUIA TERAPEUTICO VET, V2; Wandel S, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4675; Wang XD, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049935, 10.1371/journal.pone.0045036]; Wolff RB, 2014, CLINICS, V69, P847, DOI 10.6061/clinics/2014(12)10; Ying BB, 2013, BRIT J ORAL MAX SURG, V51, P241, DOI 10.1016/j.bjoms.2012.05.014	59	9	10	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231734	10.1371/journal.pone.0231734	http://dx.doi.org/10.1371/journal.pone.0231734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294140	gold, Green Published			2022-12-26	WOS:000536003500054
J	Stewart, MYY; Bush, MJ; Crack, JC; Buttner, MJ; Le Brun, NE				Stewart, Melissa Y. Y.; Bush, Matthew J.; Crack, Jason C.; Buttner, Mark J.; Le Brun, Nick E.			Interaction of the Streptomyces Wbl protein WhiD with the principal sigma factor sigma(HrdB)depends on the WhiD [Fe-4-S-4] cluster	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						iron-sulfur protein; nitric oxide; protein-protein interaction; metalloprotein; microbiology; mass spectrometry (MS); sporulation; iron-sulfur cluster; sigma factor; Streptomyces; Wbl proteins; WhiD; bacterial gene regulation; protein dimerization	MYCOBACTERIUM-TUBERCULOSIS WHIB3; SENSING 4FE-4S CLUSTER; NITRIC-OXIDE; RNA-POLYMERASE; ANTIBIOTIC-RESISTANCE; NITRATE REDUCTION; COELICOLOR A3(2); DNA-BINDING; ANTI-SIGMA; EXPRESSION	The bacterial protein WhiD belongs to the Wbl family of iron-sulfur [Fe-S] proteins present only in the actinomycetes. InStreptomyces coelicolor, it is required for the late stages of sporulation, but precisely how it functions is unknown. Here, we report results fromin vitroandin vivoexperiments with WhiD fromStreptomyces venezuelae(SvWhiD), which differs fromS. coelicolorWhiD (ScWhiD) only at the C terminus. We observed that, likeScWhiD and other Wbl proteins,SvWhiD binds a [4Fe-4S] cluster that is moderately sensitive to O(2)and highly sensitive to nitric oxide (NO). However, although all previous studies have reported that Wbl proteins are monomers, we found thatSvWhiD exists in a monomer-dimer equilibrium associated with its unusual C-terminal extension. Several Wbl proteins ofMycobacterium tuberculosisare known to interact with its principal sigma factor SigA. Using bacterial two-hybrid, gel filtration, and MS analyses, we demonstrate thatSvWhiD interacts with domain 4 of the principal sigma factor ofStreptomyces, ?(HrdB)(?(HrdB)(4)). Using MS, we determined the dissociation constant (K-d) for theSvWhiD-?(HrdB)(4)complex as ?0.7 ?m, consistent with a relatively tight binding interaction. We found that complex formation was cluster dependent and that a reaction with NO, which was complete at 8?10 NO molecules per cluster, resulted in dissociation into the separate proteins. TheSvWhiD [4Fe-4S] cluster was significantly less sensitive to reaction with O(2)and NO whenSvWhiD was bound to ?(HrdB)(4), consistent with protection of the cluster in the complex.	[Stewart, Melissa Y. Y.; Crack, Jason C.; Le Brun, Nick E.] Univ East Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England; [Bush, Matthew J.; Buttner, Mark J.] John Innes Ctr, Dept Mol Microbiol, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England	University of East Anglia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Le Brun, NE (corresponding author), Univ East Anglia, Ctr Mol & Struct Biochem, Sch Chem, Norwich Res Pk, Norwich NR4 7TJ, Norfolk, England.	n.le-brun@uea.ac.uk	Bush, Matthew/H-7849-2019	Bush, Matthew/0000-0001-8216-0152; Buttner, Mark/0000-0002-3505-2981	Biotechnology and Biological Sciences Research Council [BB/P006140/1]; Horizon 2020 Framework Programme Grant FeSBioNet COST Action [CA15133]; University of East Anglia; Biotechnology and Biological Sciences Research Council; BBSRC [BB/P006140/1, BBS/E/J/000PR9791] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Horizon 2020 Framework Programme Grant FeSBioNet COST Action; University of East Anglia; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/P006140/1 (to J. C. C. and N. E. L. B.) and Horizon 2020 Framework Programme Grant FeSBioNet COST Action CA15133. This work was also supported by the University of East Anglia through the purchase of the ESI-MS instrument and by the Biotechnology and Biological Sciences Research Council through the award of a DTP PhD studentship (to M. Y. Y. S.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Bassam MM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004554; Banaiee N, 2006, INFECT IMMUN, V74, P6449, DOI 10.1128/IAI.00190-06; Bibb MJ, 2012, MOL MICROBIOL, V84, P1033, DOI 10.1111/j.1365-2958.2012.08070.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN KL, 1992, MOL MICROBIOL, V6, P1133, DOI 10.1111/j.1365-2958.1992.tb01551.x; Burian J, 2013, NUCLEIC ACIDS RES, V41, P10062, DOI 10.1093/nar/gkt751; Bush MJ, 2018, MOL MICROBIOL, V110, P663, DOI 10.1111/mmi.14117; Bush MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00523-16; BUTTNER MJ, 1992, J BACTERIOL, V174, P5165, DOI 10.1128/JB.174.15.5165-5167.1992; BUTTNER MJ, 1990, J BACTERIOL, V172, P3367, DOI 10.1128/jb.172.6.3367-3378.1990; Crack JC, 2008, METHOD ENZYMOL, V437, P191, DOI 10.1016/S0076-6879(07)37011-0; Crack JC, 2006, J BIOL CHEM, V281, P18909, DOI 10.1074/jbc.C600042200; Crack JC, 2019, CHEM-EUR J, V25, P3675, DOI 10.1002/chem.201806113; Crack JC, 2018, CHEM COMMUN, V54, P5992, DOI 10.1039/c8cc01339j; Crack JC, 2017, P NATL ACAD SCI USA, V114, pE3215, DOI 10.1073/pnas.1620987114; Crack JC, 2015, J BIOL CHEM, V290, P12689, DOI 10.1074/jbc.M115.643072; Crack JC, 2014, BIOCHEM J, V463, P83, DOI 10.1042/BJ20140169; Crack JC, 2011, J AM CHEM SOC, V133, P1112, DOI 10.1021/ja109581t; Crack JC, 2009, BIOCHEMISTRY-US, V48, P12252, DOI 10.1021/bi901498v; Feng LP, 2016, MICROBIOL-SGM, V162, P889, DOI 10.1099/mic.0.000257; Gallagher KA, 2020, MOL CELL, V77, P586, DOI 10.1016/j.molcel.2019.11.006; Jakimowicz P, 2005, J BIOL CHEM, V280, P8309, DOI 10.1074/jbc.M412622200; Johnson KA, 2000, ANAL CHEM, V72, P1410, DOI 10.1021/ac991183e; Kang SH, 2007, J BACTERIOL, V189, P4315, DOI 10.1128/JB.01789-06; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kay KL, 2016, METALLOMICS, V8, P709, DOI 10.1039/c6mt00036c; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kudhair BK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02418-y; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; Lee DS, 2018, ANTON LEEUW INT J G, V111, P641, DOI 10.1007/s10482-017-0953-0; Molle V, 2000, J BACTERIOL, V182, P1286, DOI 10.1128/JB.182.5.1286-1295.2000; Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102; Martinez MTP, 2017, CHEM SCI, V8, P8451, DOI 10.1039/c7sc02801f; Perez-Ruiz T, 2000, ANALYST, V125, P507, DOI 10.1039/a907780d; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Serrano PN, 2016, ANGEW CHEM INT EDIT, V55, P14575, DOI 10.1002/anie.201607033; Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000545; Smith LJ, 2010, BIOCHEM J, V432, P417, DOI 10.1042/BJ20101440; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Wan T, 2020, NUCLEIC ACIDS RES, V48, P501, DOI 10.1093/nar/gkz1133; Yoo JS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28628	43	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2020	295	28					9752	9765		10.1074/jbc.RA120.012708	http://dx.doi.org/10.1074/jbc.RA120.012708			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	MQ2WT	32303639	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000552758600038
J	Niedzialkowski, K; Putkowska-Smoter, R				Niedzialkowski, Krzysztof; Putkowska-Smoter, Renata			What makes a major change of wildlife management policy possible? Institutional analysis of Polish wolf governance	PLOS ONE			English	Article							ADVOCACY COALITION FRAMEWORK; WOLVES; DISCOURSE; RECOVERY; DYNAMICS; POLITICS; SCIENCE; EUROPE; POLAND; POWER	Poland was one of the first countries of Central and Eastern Europe with stable wolf populations to effectively introduce year-round protection of the species. This paper traces the process of policy change using institutional theory as an organizational perspective. Based on the analysis of data from desk research and semi-structured interviews, we propose a model of institutional change and argue that in the 1990s, environmental activists and wildlife biologists successfully used a political window of opportunity connected with socio-economic transformation after 1989 and managed to induce the government to move the species from the domain of hunting to the domain of nature conservation. The new policy, informed by an ecological paradigm, diverged from the historical path dominated by hunters and the vision of the wolf as a pest and a hunting target. The improved protection led to the numerical growth of Poland's wolves and ultimately to their westward expansion.	[Niedzialkowski, Krzysztof; Putkowska-Smoter, Renata] Polish Acad Sci, Inst Philosophy & Sociol, Warsaw, Poland	Polish Academy of Sciences; Institute of Philosophy & Sociology of the Polish Academy of Sciences	Niedzialkowski, K (corresponding author), Polish Acad Sci, Inst Philosophy & Sociol, Warsaw, Poland.	kniedzialkowski@ifispan.waw.pl	Putkowska-Smoter, Renata/AAG-8507-2021	Niedzialkowski, Krzysztof/0000-0002-0410-6772; Putkowska-Smoter, Renata/0000-0002-2609-0601	National Science Centre, Poland [2015/16/S/HS6/00125, 2017/27/B/HS6/03067]	National Science Centre, Poland(National Science Centre, Poland)	This research was carried out within the projects No. 2015/16/S/HS6/00125 and No. 2017/27/B/HS6/03067 awarded to KN by the National Science Centre, Poland (https://www.ncn.gov.pl/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamic M., 2004, Game & Wildlife Science, V21, P571; Adger WN, 2003, ENVIRON PLANN A, V35, P1095, DOI 10.1068/a35289; Archer MS., 1995, REALIST SOCIAL THEOR, DOI [https://doi.org/10.1017/cbo9780511557675, DOI 10.1017/CBO9780511557675]; Arts B, 2004, POLICY SCI, V37, P339, DOI 10.1007/s11077-005-0156-9; ARTS B., 2006, I DYNAMICS ENV GOVER; Baker S, 2013, ECOLOGY SOC, V18; Balciauskas Linas, 2002, Acta Zoologica Lituanica, V12, P410; Bath AJ, 1998, URSUS-SERIES, V10, P349; Baumgartner F. R., 1993, AGENDAS INSTABILITY; BAUMGARTNER FR, 1991, J POLIT, V53, P1044, DOI 10.2307/2131866; Bereszynski A, 1994, PRZEGLAD LESNICZY, V7- 8; Bereszynski A, 1996, DZIKIE ZYCIE, V22; Bereszynski A, 1994, PRZYRODA POLSKA, V3, P4; Bereszynski A., 1998, WILK CANIS LUPUS LIN; Bereszynski A, 1994, PRZEGLAD LESNICZY, V7- 8, P6; Bereszynski Andrzej, 1997, Przeglad Przyrodniczy, V8, P181; Beunen R., 2015, EVOLUTIONARY GOVERNA; Blyth M., 2002, THEORY METHODS POLIT, V2, P292, DOI [DOI 10.1007/978-0-230-62889-2_15, 10.1007/978-0-230-62889-2_15]; Bobek B, 1994, LOWIEC POLSKI, V6, P8; Bobek B, 1994, LOWIEC POLSKI, V4, P16; Boitani L., 2015, REWILDING EUROPEAN L, P67, DOI DOI 10.1007/978-3-319-12039-3_4; Boitani L., 2000, ACTION PLAN CONSERVA; Borgstrom S, 2012, J ENVIRON LAW, V24, P451, DOI 10.1093/jel/eqs015; Campion-Vincent V., MAD WILDLIFE LOOKING, P99; Cent J, 2014, J NAT CONSERV, V22, P93, DOI 10.1016/j.jnc.2013.09.005; Chapron G, 2014, SCIENCE, V346, P1517, DOI 10.1126/science.1257553; Clarke R., 2000, EUROPEAN ENV, V10, P211, DOI DOI 10.1002/1099-0976(200009/10)10:5<LESS; Council of Europe, 2020, POL RES DECL TREAT N; Duit A, 2015, ADMIN SOC, V50, P1072; Figura M., 2019, ZOOPHILOLOGICA, V5, P367; Find'o S, 2008, PERSPECTIVES OF WOLVES IN CENTRAL EUROPE, P15; Fligstein N., 2012, THEORY FIELDS; Foucault M., 1977, DISCIPLINE PUNISH BI, DOI DOI 10.2307/2065008; Frank J, 2015, WILDLIFE BIOL, V21, P122, DOI 10.2981/wlb.13116; Geacu S, 2009, REV ROUMAINE GEOGRAP, V53, P219; Giddens A, 1984, CONSTITUTION SOC; Glinski P., 2007, PROTECTING NATURE OR, P187; Glowacinski Z, 1992, POLISH RED DATA BOOK; Glowacinski Z., 1994, LOWIEC POLSKI, V12, P18; Gula R, 2008, EUR J WILDLIFE RES, V54, P163, DOI 10.1007/s10344-007-0129-8; Hajer MA, 1995, POLITICS ENV DISCOUR; Hall PA, 1996, POLIT STUD-LONDON, V44, P936, DOI 10.1111/j.1467-9248.1996.tb00343.x; HALL PA, 1993, COMP POLIT, V25, P275, DOI 10.2307/422246; Hansson-Forman K, 2018, SOC NATUR RESOUR, V31, P837, DOI 10.1080/08941920.2018.1447179; Hartel T, 2019, CONSERV BIOL, V33, P1256, DOI 10.1111/cobi.13334; Hays Samuel P., 2000, HIST ENV POLITICS 19, P1; Hiedanpaa J, 2013, ECOL SOC, V18, DOI 10.5751/ES-05302-180124; Holeksa J., 1994, ECHA LESNE, V19, P28; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jancar-Webster, 1998, ENVIRON POLIT, V7, P69, DOI DOI 10.1080/09644019808414373; Jedrzejewski W, 2001, CAN J ZOOL, V79, P1993, DOI 10.1139/z01-147; Jordan M., 1994, LOWIEC POLSKI, V4, P15; KIMLA P, 2016, ECOLOGY SAFETY, V10, P463; Kluvankova-Oravska T., 2009, Environmental Policy and Governance, V19, P186, DOI 10.1002/eet.508; Konczal A., 2017, ANTROPOLOGIA LASU PE; Kowalski Z., 1953, LOWIEC POLSKI, V1, P4; Krange O, 2017, SOC NATUR RESOUR, V30, P1127, DOI 10.1080/08941920.2017.1315652; Krasner, 1984, COMP POLIT, V16, P223, DOI DOI 10.2307/421608; Lawrence T.B., 2006, HDB ORG STUDIES, P215, DOI [10.4135/9781848608030.n7, DOI 10.4135/9781848608030.N7]; Lynn WS, 2010, SOC ANIM, V18, P75, DOI 10.1163/106311110X12586086158529; Mahoney James., 2010, EXPLAINING I CHANGE, P1, DOI DOI 10.1017/CBO9780511806414.003; Meadowcroft J, 2002, LANDSCAPE URBAN PLAN, V61, P169, DOI 10.1016/S0169-2046(02)00111-1; Meadowcroft J, 2009, POLICY SCI, V42, P323, DOI 10.1007/s11077-009-9097-z; Mintrom M, 1997, AM J POLIT SCI, V41, P738, DOI 10.2307/2111674; Myslajek R, 2015, FAIRYTALE QUESTION H; Nie M, 2003, POLICY SCI, V36, P307, DOI 10.1023/B:OLIC.0000017484.35981.b6; Nie Martin A., 2002, Ethics Place and Environment, V5, P65, DOI 10.1080/13668790220146465; Niedzialkowski K, 2019, ENVIRON SOCIOL, V5, P428, DOI 10.1080/23251042.2019.1633062; NORTH DC, 1991, J ECON PERSPECT, V5, P97, DOI 10.1257/jep.5.1.97; Nowak S., 1996, P INT WOLF FED S BEL, P21; Nowak S, 2016, MAMMAL RES, V61, P83, DOI 10.1007/s13364-016-0263-3; Nowak Sabina, 1999, Przeglad Przyrodniczy, V10, P163; OKARMA H, 1993, BIOL CONSERV, V66, P153, DOI 10.1016/0006-3207(93)90001-H; Okarma H., 1994, LOWIEC POLSKI, V12, P12; Okarma H, 1996, CHRONMY PRZYRODE OJC, V53, P16; Okarma H., 1993, AURA, P21; Okarma H, 1998, STRATEGIA OCHRONY GO; OLIVER C, 1991, ACAD MANAGE REV, V16, P145, DOI 10.2307/258610; Paavola J, 2007, ECOL ECON, V63, P93, DOI 10.1016/j.ecolecon.2006.09.026; Peters BG, 2005, J POLIT, V67, P1275, DOI 10.1111/j.1468-2508.2005.00360.x; Peters BG, 2005, NEW I; Petursdottir T, 2013, ECOL SOC, V18, DOI 10.5751/ES-05399-180229; Pielowski Z, 1993, RAPORT ZWIERZETACH L; Pierson P, 2000, AM POLIT SCI REV, V94, P251, DOI 10.2307/2586011; Pierson P., 2003, PUBLIC POLICIES I CR; Rancew-Sikora D., 2009, SENS POLOWANIA WSPOE; Ratamoki Outi., 2008, J ENVIRON DEV, V17, P316, DOI [10.1177/1070496508320251, DOI 10.1177/1070496508320251]; Redpath SM, 2017, BIOL REV, V92, P2157, DOI 10.1111/brv.12326; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Reinhardt I, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12635; Richardson J, 2000, POLIT STUD-LONDON, V48, P1006, DOI 10.1111/1467-9248.00292; Rydin Y., 2006, NETWORKS I NATURAL R; SABATIER PA, 1988, POLICY SCI, V21, P129, DOI 10.1007/BF00136406; Sabatier PA, 1998, J EUR PUBLIC POLICY, V5, P98, DOI 10.1080/13501768880000051; Schmidt VA, 2004, WEST EUR POLIT, V27, P183, DOI 10.1080/0140238042000214874; Schmidt VA, 2010, EUR POLIT SCI REV, V2, P1, DOI 10.1017/S175577390999021X; Scott W, 1995, I ORG; Siedlecki L., 1959, LOWIEC POLSKI, V14, P4; Sjolander-Lindqvist A, 2015, WILDLIFE BIOL, V21, P175, DOI 10.2981/wlb.00065; Sjolander-Lindqvist A, 2008, J ENVIRON POL PLAN, V10, P71, DOI 10.1080/15239080701652672; Skogen K, 2003, SOCIOL RURALIS, V43, P309, DOI 10.1111/1467-9523.00247; Skogen K, 2006, REV GEOGR ALP, V94, P78, DOI 10.3406/rga.2006.5593; Smietana W., 2019, C FOR DYSK WIL MOW 1; Smietana W., 1994, LOWIEC POLSKI, V12; Stohr C., 2013, REV EUROPEAN STUDIES, V5, P1, DOI DOI 10.5539/RES.V5N4P1; Streeck W., 2005, CONTINUITY I CHANGE; Suminski P., 1975, IUCN (International Union for Conservation of Nature and Natural Resources) Publications New Series Supplements, P44; Szulecka J, 2019, ENVIRON POLIT, DOI 10.1080/09644016.2019.1674541; White DF, 2016, ENV NATURES SOCIAL T; Wiering M, 2006, ENVIRON POLICY, V47, P93, DOI 10.1007/1-4020-5079-8_5; Williams CK, 2002, WILDLIFE SOC B, V30, P575; Wolsan M., 1992, GLOBAL TRENDS WILDLI, V2, P375; Young O.R., 2010, I DYNAMICS EMERGENT	113	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231601	10.1371/journal.pone.0231601	http://dx.doi.org/10.1371/journal.pone.0231601			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324831	Green Submitted, Green Published, gold			2022-12-26	WOS:000536033700022
J	Yaban, B; Kikhney, J; Musci, M; Petrich, A; Schmidt, J; Hajduczenia, M; Schoenrath, F; Falk, V; Moter, A				Yaban, Berrin; Kikhney, Judith; Musci, Michele; Petrich, Annett; Schmidt, Julia; Hajduczenia, Maria; Schoenrath, Felix; Falk, Volkmar; Moter, Annette			Aerococcus urinae - A potent biofilm builder in endocarditis	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; SP NOV.; URINAEHOMINIS; COMBINATION; GENTAMICIN; PENICILLIN; ORGANISMS; INFECTION; VIRIDANS; TIME	The diagnosis of infective endocarditis (IE) remains a challenge. One of the rare bacterial species recently associated with biofilms and negative cultures in infective endocarditis is Aerococcus urinae. Whether the low number of reported cases might be due to lack of awareness and misidentification, mainly as streptococci, is currently being discussed. To verify the relevance and biofilm potential of Aerococcus in endocarditis, we used fluorescence in situ hybridization to visualize the microorganisms within the heart valve tissue. We designed and optimized a specific FISH probe (AURI) for in situ visualization and identification of A. urinae in sections of heart valves from two IE patients whose 16S rRNA gene sequencing had deteced A. urinae. Both patients had a history of urinary tract infections. FISH visualized impressive in vivo grown biofilms in IE, thus confirming the potential of A. urinae as a biofilm pathogen. In both cases, FISH/PCR was the only method to unequivocally identify A. urinae as the only causative pathogen for IE. The specific FISH assay for A. urinae is now available for further application in research and diagnostics. A. urinae should be considered in endocarditis patients with a history of urinary tract infections. These findings support the biofilm potential of A. urinae as a virulence factor and are meant to raise the awareness of this pathogen.	[Yaban, Berrin; Kikhney, Judith; Petrich, Annett; Schmidt, Julia; Hajduczenia, Maria; Moter, Annette] Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Biofilmzentrum, Berlin, Germany; [Yaban, Berrin; Kikhney, Judith; Petrich, Annett; Schmidt, Julia; Hajduczenia, Maria; Falk, Volkmar; Moter, Annette] Humboldt Univ, Freie Univ Berlin, Berlin, Germany; [Yaban, Berrin; Kikhney, Judith; Petrich, Annett; Schmidt, Julia; Hajduczenia, Maria; Falk, Volkmar; Moter, Annette] Berlin Inst Hlth, Berlin, Germany; [Kikhney, Judith; Schmidt, Julia; Moter, Annette] MoKi Analyt GmbH, Marienpl, Berlin, Germany; [Musci, Michele] German Heart Ctr Berlin, Dept Congenital Heart Surg Pediat Heart Surg, Berlin, Germany; [Schoenrath, Felix; Falk, Volkmar] German Heart Ctr Berlin, Dept Cardiothorac & Vasc Surg, Berlin, Germany; [Schoenrath, Felix; Falk, Volkmar] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Falk, Volkmar] Charite Univ Med Berlin, Dept Cardiothorac Surg, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; German Heart Center Berlin; German Heart Center Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Moter, A (corresponding author), Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Biofilmzentrum, Berlin, Germany.; Moter, A (corresponding author), Humboldt Univ, Freie Univ Berlin, Berlin, Germany.; Moter, A (corresponding author), Berlin Inst Hlth, Berlin, Germany.; Moter, A (corresponding author), MoKi Analyt GmbH, Marienpl, Berlin, Germany.	annette.moter@charite.de		Kikhney, Judith/0000-0002-4849-7947; Petrich, Annett/0000-0002-2372-826X; Moter, Annette/0000-0003-1318-5780; Falk, Volkmar/0000-0002-7911-8620	Bundesministerium fur Bildung und Forschung [13N14917]; Freunde und Forderer des Deutschen Herzzentrums Berlin	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Freunde und Forderer des Deutschen Herzzentrums Berlin	This study was supported by Bundesministerium fur Bildung und Forschung (13N14917) and Freunde und Forderer des Deutschen Herzzentrums Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUIRRE M, 1992, J GEN MICROBIOL, V138, P401, DOI 10.1099/00221287-138-2-401; AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; [Anonymous], 2012, FEMS IMMUNOL MED MIC, V65, P127; [Anonymous], 2016, OPEN MICROBIOLOGY J, V10, P27; Christensen J., OPEN MICROBIOLOGY J; CHRISTENSEN JJ, 1991, SCAND J INFECT DIS, V23, P717, DOI 10.3109/00365549109024299; CHRISTENSEN JJ, 1995, CLIN INFECT DIS, V21, P943; CHRISTENSEN JJ, 1991, J CLIN MICROBIOL, V29, P1049, DOI 10.1128/JCM.29.5.1049-1053.1991; Collins MD, 1999, INT J SYST BACTERIOL, V49, P1125, DOI 10.1099/00207713-49-3-1125; Ebnother C, 2002, INFECTION, V30, P310, DOI 10.1007/s15010-002-3106-x; Fournier PE, 2010, CLIN INFECT DIS, V51, P131, DOI 10.1086/653675; Frickmann H, 2017, CRIT REV MICROBIOL, V43, P263, DOI 10.3109/1040841X.2016.1169990; Habib G, 2015, EUR HEART J, V36, P3075, DOI [10.1093/eurheartj/ehv319, 10.5603/KP.2015.0227]; Hirzel C, 2016, INT J ANTIMICROB AG, V48, P271, DOI 10.1016/j.ijantimicag.2016.05.007; Hranjec T, 2012, LANCET INFECT DIS, V12, P774, DOI 10.1016/S1473-3099(12)70151-2; Lawson PA, 2001, INT J SYST EVOL MICR, V51, P475, DOI 10.1099/00207713-51-2-475; Lawson PA, 2001, INT J SYST EVOL MICR, V51, P683, DOI 10.1099/00207713-51-2-683; Mallmann C, 2010, CLIN MICROBIOL INFEC, V16, P767, DOI 10.1111/j.1469-0691.2009.02936.x; Melnick S, 2016, BMJ CASE REP, P2016; Moser C, FEMS IMMUNOL MED MIC; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Moter A, 2000, J MICROBIOL METH, V41, P85, DOI 10.1016/S0167-7012(00)00152-4; PARKER MT, 1976, J MED MICROBIOL, V9, P275, DOI 10.1099/00222615-9-3-275; Senneby E, 2013, J CLIN MICROBIOL, V51, P1303, DOI 10.1128/JCM.02637-12; Shannon O, 2010, INFECT IMMUN, V78, P4268, DOI 10.1128/IAI.00469-10; Skov R, 2001, J ANTIMICROB CHEMOTH, V48, P653, DOI 10.1093/jac/48.5.653; Stewart PS, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.12; Sunnerhagen T, 2016, INFECTION, V44, P167, DOI 10.1007/s15010-015-0812-8; Sutrave S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221786; Tohno M, 2014, INT J SYST EVOL MICR, V64, P1229, DOI 10.1099/ijs.0.058081-0; Westmoreland K, 2014, LABMEDICINE, V45, pE101, DOI 10.1309/LMVRODA352WDOUYZ; WILLIAMS REO, 1953, J GEN MICROBIOL, V8, P475, DOI 10.1099/00221287-8-3-475; Yabes JM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3414-0; Zhang Q, 2000, J CLIN MICROBIOL, V38, P1703, DOI 10.1128/JCM.38.4.1703-1705.2000	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231827	10.1371/journal.pone.0231827	http://dx.doi.org/10.1371/journal.pone.0231827			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32325482	gold, Green Published			2022-12-26	WOS:000536033700039
J	Dickson-Gomez, J; Twaibu, W; Christenson, E; Dan, K; Anguzu, R; Homedi, E; Tumwesigye, NM				Dickson-Gomez, Julia; Twaibu, Wamala; Christenson, Erica; Dan, Katende; Anguzu, Ronald; Homedi, Ethan; Tumwesigye, Nazarius Mbona			Injection and sexual risk among people who use or inject drugs in Kampala, Uganda: An exploratory qualitative study	PLOS ONE			English	Article							HIV PREVENTION; CAPE-TOWN; REDUCTION; CLIENT; BURDEN; CARE	Background Countries in Sub-Saharan Africa (SSA) have seen rapid increases in injection drug use since 2008. In Uganda, the Global Sate of Harm report and studies conducted by Makerere University Crane Surveys have estimated HIV prevalence among people who inject drugs (PWID) at approximately 17%. The objective of the research was to document injection and other drug-related risks among people who use drugs in Uganda to develop comprehensive HIV/HCV prevention interventions. Methods Between August and September 2018, we conducted qualitative interviews among male and female people who use drugs. Interview topics included the availability and accessibility of clean syringes, injection risks, overdose, sexual-risk behaviors, and the availability and accessibility of harm reduction and drug treatment services. Results Participants reported several injection-related risks including sharing and reusing syringes, pooling and mixing drugs in the same container, measuring drugs using syringes, getting prefilled injections from dealers, being injected by other people who inject drugs, and using contaminated water or blood to dilute drugs. Participants reported a scarcity of harm reduction services, although a few appear to have participated in the syringe exchange pilot conducted by the Uganda Harm Reduction Network (UHRN). Even fewer reported knowing organizations that helped people who use drugs abstain from or reduce their use. Medication assisted therapy (MAT) and naloxone to reverse overdoses are not currently available. Conclusions Comprehensive prevention and treatment services are needed in Uganda and should include expanded syringe exchange programs, social network HIV testing, HCV testing, provision of naloxone and MAT, and linkage to and retention in HIV care.	[Dickson-Gomez, Julia; Anguzu, Ronald; Homedi, Ethan] Med Coll Wisconsin, Inst Hlth & Equ, Div Epidemiol, Milwaukee, WI 53226 USA; [Twaibu, Wamala; Dan, Katende] Uganda Harm Reduct Network, Kampala, Uganda; [Christenson, Erica] Med Coll Wisconsin, Ctr AIDS Intervent Res, Milwaukee, WI 53226 USA; [Tumwesigye, Nazarius Mbona] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Dickson-Gomez, Julia] Med Coll Wisconsin, Div Epidemiol, Inst Hlth & Equ, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Makerere University; Medical College of Wisconsin	Dickson-Gomez, J (corresponding author), Med Coll Wisconsin, Inst Hlth & Equ, Div Epidemiol, Milwaukee, WI 53226 USA.; Dickson-Gomez, J (corresponding author), Med Coll Wisconsin, Div Epidemiol, Inst Hlth & Equ, Milwaukee, WI 53226 USA.	jdickson@mcw.edu		Tumwesigye, Nazarius Mbona/0000-0001-7085-8780	Elaine Kohler Summer Research Fellowship in Global Health	Elaine Kohler Summer Research Fellowship in Global Health	EH received a fellowship from the Elaine Kohler Summer Research Fellowship in Global Health. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, BREAK POINT FIND VIS; Anstice S, 2009, SUBST USE MISUSE, V44, P794, DOI 10.1080/10826080802483936; Beckerleg Susan, 2005, Harm Reduct J, V2, P12, DOI 10.1186/1477-7517-2-12; Burnhams NH, 2016, SUBST ABUSE TREAT PR, V11, DOI 10.1186/s13011-016-0074-1; Degenhardt L, 2017, LANCET GLOB HEALTH, V5, pE1192, DOI 10.1016/S2214-109X(17)30375-3; Degenhardt L, 2014, INT J DRUG POLICY, V25, P53, DOI 10.1016/j.drugpo.2013.08.004; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Dickson-Gomez J, 2006, SUBST USE MISUSE, V41, P669, DOI 10.1080/10826080500411403; Dickson-Gomez J, 2003, AIDS BEHAV, V7, P303, DOI 10.1023/A:1025499904469; Dickson-Gomez JB, 2004, SUBST USE MISUSE, V39, P1259, DOI 10.1081/JA-120038686; Dickson-Gomez J, 2011, J COMMUNITY PSYCHOL, V39, P369, DOI 10.1002/jcop.20440; Dickson-Gomez J, 2010, SUBST USE MISUSE, V45, P154, DOI 10.3109/10826080903080656; Doshi RH, 2019, JMIR PUBLIC HLTH SUR, V5, P75, DOI 10.2196/12118; Dua T, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001122; Fox AD, 2015, SUBST ABUS, V36, P155, DOI 10.1080/08897077.2015.1011820; Guise A, 2017, AIDS CARE, V29, P1119, DOI 10.1080/09540121.2017.1300634; Hladik W, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4428-z; Hobkirk AL, 2016, INT J DRUG POLICY, V30, P99, DOI 10.1016/j.drugpo.2015.10.006; ICAP at Columbia University, 2016, MENT KEN PUBL HLTH P; International HIV/AIDS Alliance, 2017, BREAKTHR UG ANN HARM; Kiene SM, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2162-2; Lion RR, 2017, SUBST USE MISUSE, V52, P773, DOI 10.1080/10826084.2016.1264964; Makere University School of Public Health, 2017, CRAN SURV REP BIOB S; Makere University School of Public Health PEPFAR, 2017, CRAN SURV REP POP SI; Most at Risk Populations Network Uganda Harm Reduction Network, 2016, DRUG US REL VULN HIV; Muhangi D, 2017, POPULATION ESTIMATIO; Obot IS, 2007, LANCET, V369, P1323, DOI 10.1016/S0140-6736(07)60373-0; Pasche S, 2012, HUM PSYCHOPHARM CLIN, V27, P338, DOI 10.1002/hup.2228; Pernparn U, 2008, CURR OPIN PSYCHIATR, V21, P229, DOI 10.1097/YCO.0b013e3282fc1ea3; Phillips KT, 2010, AM J DRUG ALCOHOL AB, V36, P92, DOI 10.3109/00952991003592311; Reddon H, 2019, LANCET HIV, V6, pE128, DOI 10.1016/S2352-3018(18)30292-3; Shirley-Beavan S., 2018, GLOBAL STATE HARM RE; Smolak A, 2014, AIDS CARE, V26, P282, DOI 10.1080/09540121.2013.824541; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Strathdee SA, 2012, CURR OPIN HIV AIDS, V7, P320, DOI 10.1097/COH.0b013e32835369ad; Uchtenhagen A, 2004, B WORLD HEALTH ORGAN, V82, P641; Uganda Harm Reduction Network, 2018, NEEDL SYR PROGR DEM; Uganda Ministry of Health, 2013, ADD NAT ANT TREATM G; UNAIDS, 2015, HIV AIDS UG COUNTR P; water.org, 2019, UG WAT SAN CRIS	41	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231969	10.1371/journal.pone.0231969	http://dx.doi.org/10.1371/journal.pone.0231969			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9QD	32320448	Green Published, gold			2022-12-26	WOS:000536028800043
J	Herold, CJ; Essig, M; Schroder, J				Herold, Christina J.; Essig, Marco; Schroeder, Johannes			Neurological soft signs (NSS) and brain morphology in patients with chronic schizophrenia and healthy controls	PLOS ONE			English	Article							ANTIPSYCHOTIC TREATMENT; PREFRONTAL CORTEX; SYMPTOMS; MOTOR; TALAIRACH; PSYCHOPATHOLOGY; SUBSYNDROMES; METAANALYSIS; ACTIVATION; VERSION	Subtle abnormalities in sensory integration, motor coordination and sequencing of complex motor acts or neurological soft signs (NSS) are characteristic phenomena in patients with schizophrenia at any stage of the illness. Previous MRI studies in schizophrenia found NSS to be associated with cortical, thalamic and cerebellar changes. Since these studies mainly focused on first-episode or recent onset schizophrenia, the cerebral correlates of NSS in chronic schizophrenia remained rather unclear. 49 middle-aged patients with chronic schizophrenia with a mean duration of illness of 20.3 +/- 14.0 years and 29 healthy subjects matched for age and sex were included. NSS were examined on the Heidelberg Scale and correlated to grey matter (GM) by using whole brain high resolution magnetic resonance imaging (3 Tesla) with SPM12/CAT12 analyses. As expected, NSS in patients were significantly (p <= 0.001) elevated in contrast to healthy controls, a finding, which not only applied to NSS total score, but also to the respective subscales "motor coordination", "sensory integration", "complex motor tasks", "right/left and spatial orientation" and "hard signs". Within the patient group NSS total scores were significantly correlated to reduced GM in right lingual gyrus, left parahippocampal gyrus, left superior temporal gyrus, left thalamus (medial dorsal nucleus) and left posterior lobe of the cerebellum (declive). Respective negative associations could also be revealed for the subscales "motor coordination", "complex motor tasks" and "right/left and spatial orientation". These findings remained significant after FWE-correction for multiple comparisons and were confirmed when years of education, chlorpromazine-equivalents or variables indicating the severity of psychopathology were introduced as additional covariates. According to our results lingual, parahippocampal, superior temporal, inferior and middle frontal gyri, thalamus and cerebellum have to be considered as important sites of NSS in chronic schizophrenia. That these findings only applied for patients but not healthy controls may indicate a different pathogenesis of NSS.	[Herold, Christina J.; Schroeder, Johannes] Heidelberg Univ, Sect Geriatr Psychiat, Dept Gen Psychiat, Heidelberg, Germany; [Essig, Marco] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada	Ruprecht Karls University Heidelberg; University of Manitoba	Herold, CJ (corresponding author), Heidelberg Univ, Sect Geriatr Psychiat, Dept Gen Psychiat, Heidelberg, Germany.	christina-j.herold@med.uni-heidelberg.de		Herold, Christina Josefa/0000-0002-3650-0432	Dietmar-Hopp-Foundation, Germany; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Dietmar-Hopp-Foundation, Germany; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	The study was supported by the Dietmar-Hopp-Foundation, Germany. We acknowledge financial support by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen P, 2008, NEUROSCI BIOBEHAV R, V32, P175, DOI 10.1016/j.neubiorev.2007.07.012; American Psychiatric Association, 1980, DIAGN STAT MAN MENT, V3; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1998, SCHIZOPHRENIA BULL, V24, P203, DOI 10.1093/oxfordjournals.schbul.a033321; Bachmann S, 2005, AM J PSYCHIAT, V162, P2337, DOI 10.1176/appi.ajp.162.12.2337; Bachmann S, 2018, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00272; Bombin I, 2005, SCHIZOPHRENIA BULL, V31, P962, DOI 10.1093/schbul/sbi028; Borich MR, 2015, NEUROPSYCHOLOGIA, V79, P246, DOI 10.1016/j.neuropsychologia.2015.07.007; Bottmer C, 2005, PSYCHIAT RES-NEUROIM, V140, P239, DOI 10.1016/j.pscychresns.2005.02.011; Bourne JA, 2010, J ANAT, V217, P449, DOI 10.1111/j.1469-7580.2010.01275.x; BUCHANAN RW, 1989, PSYCHIAT RES, V27, P335, DOI 10.1016/0165-1781(89)90148-0; Calvert GA, 2001, CEREB CORTEX, V11, P1110, DOI 10.1093/cercor/11.12.1110; Chan RCK, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-32; Chan RCK, 2010, SCHIZOPHRENIA BULL, V36, P1089, DOI 10.1093/schbul/sbp011; Chan RCK, 2010, NEUROSCI BIOBEHAV R, V34, P889, DOI 10.1016/j.neubiorev.2009.11.012; Dazzan P, 2004, BRAIN, V127, P143, DOI 10.1093/brain/awh015; Dazzan P, 2002, BRIT J PSYCHIAT, V181, pS50, DOI 10.1192/bjp.181.43.s50; Dazzan P, 2006, CEREB CORTEX, V16, P1225, DOI 10.1093/cercor/bhj063; de Bourbon-Teles J, 2014, CURR BIOL, V24, P993, DOI 10.1016/j.cub.2014.03.024; Eickhoff SB, 2012, NEUROIMAGE, V59, P2349, DOI 10.1016/j.neuroimage.2011.09.017; Eickhoff SB, 2009, HUM BRAIN MAPP, V30, P2907, DOI 10.1002/hbm.20718; Fuster JM, 2001, NEURON, V30, P319, DOI 10.1016/S0896-6273(01)00285-9; Goghari VM, 2010, NEUROSCI BIOBEHAV R, V34, P468, DOI 10.1016/j.neubiorev.2009.09.004; Haijma SV, 2013, SCHIZOPHRENIA BULL, V39, P1129, DOI 10.1093/schbul/sbs118; Herold CJ, 2019, SCHIZOPHR RES-COGN, V16, P17, DOI 10.1016/j.scog.2018.12.002; Herold CJ, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00098; Heuser M, 2011, PSYCHIAT RES-NEUROIM, V192, P69, DOI 10.1016/j.pscychresns.2010.11.009; Hirjak D, 2016, EUR ARCH PSY CLIN N, V266, P35, DOI 10.1007/s00406-015-0582-4; Hirjak D, 2015, SCHIZOPHR RES, V169, P217, DOI 10.1016/j.schres.2015.10.022; Hirjak D, 2013, NEUROPSYCHOBIOLOGY, V68, P91, DOI 10.1159/000350999; Huhtaniska S, 2017, HUM PSYCHOPHARM CLIN, V32, DOI 10.1002/hup.2574; Jahn T, 2006, PSYCHIAT RES, V142, P191, DOI 10.1016/j.psychres.2002.12.003; JONES EG, 1982, J NEUROPHYSIOL, V48, P521, DOI 10.1152/jn.1982.48.2.521; KING DJ, 1991, BRIT J PSYCHIAT, V158, P770, DOI 10.1192/bjp.158.6.770; Kong L, 2015, NEUROPSYCHOBIOLOGY, V71, P225, DOI 10.1159/000382020; Kong L, 2012, SCHIZOPHR RES, V134, P27, DOI 10.1016/j.schres.2011.09.015; Laird AR, 2010, NEUROIMAGE, V51, P677, DOI 10.1016/j.neuroimage.2010.02.048; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Lawrie SM, 2001, BRIT J PSYCHIAT, V178, P524, DOI 10.1192/bjp.178.6.524; Lueken U, 2006, FORTSCHR NEUROL PSYC, V74, P714, DOI 10.1055/s-2006-932164; Lueken U, 2007, AM J GERIAT PSYCHIAT, V15, P376, DOI 10.1097/JGP.0b013e3180437db3; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; Mittal VA, 2007, SCHIZOPHR RES, V94, P37, DOI 10.1016/j.schres.2007.04.017; Mohr F, 1996, EUR ARCH PSY CLIN N, V246, P240, DOI 10.1007/BF02190275; Mouchet-Mages S, 2011, ACTA PSYCHIAT SCAND, V123, P451, DOI 10.1111/j.1600-0447.2010.01667.x; Navari S, 2009, PSYCHOL MED, V39, P1763, DOI 10.1017/S0033291709005315; Neelam K, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-139; Nenadic I, 2010, NEUROIMAGE, V49, P1153, DOI 10.1016/j.neuroimage.2009.10.014; Oud MJT, 2009, BMC FAM PRACT, V10, DOI 10.1186/1471-2296-10-32; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631; Picard H, 2008, SCHIZOPHRENIA BULL, V34, P155, DOI 10.1093/schbul/sbm049; Ramnani N, 2001, TRENDS COGN SCI, V5, P135, DOI 10.1016/S1364-6613(00)01635-1; Ridler K, 2006, P NATL ACAD SCI USA, V103, P15651, DOI 10.1073/pnas.0602639103; Roiz-Santianez R, 2015, CURR NEUROPHARMACOL, V13, P422, DOI 10.2174/1570159X13666150429002536; SCHELL GR, 1984, J NEUROSCI, V4, P539; Schmid LA, 2011, FORTSCHR NEUROL PSYC, V79, P267, DOI 10.1055/s-0029-1246058; Schr?der J., 2008, DIR PSYCHIAT, V28, P19; Schroder J, 1998, BIOL PSYCHIAT, V43, P660, DOI 10.1016/S0006-3223(97)00442-3; SCHRODER J, 1992, PSYCHIAT RES, V42, P209, DOI 10.1016/0165-1781(92)90113-H; SCHRODER J, 1991, SCHIZOPHR RES, V6, P25, DOI 10.1016/0920-9964(91)90017-L; Schroder J, 1996, SCHIZOPHR RES, V21, P19, DOI 10.1016/0920-9964(96)00027-8; SCHRODER J, 1993, Z KLIN PSYCHOL PSYCH, V41, P190; Sebastian C., 2007, J PSYCHIAT INTENSIVE, V3, P101, DOI [https://doi.org/10.1017/S1742646407001148, DOI 10.1017/S1742646407001148, 10.1017/sl742646407001148]; Smieskova R, 2009, CURR PHARM DESIGN, V15, P2535, DOI 10.2174/138161209788957456; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Strangman G, 2005, NEUROREHAB NEURAL RE, V19, P93, DOI 10.1177/1545968305275284; Thomann PA, 2009, PSYCHOL MED, V39, P371, DOI 10.1017/S0033291708003656; Thomann PA, 2015, BEHAV BRAIN RES, V278, P514, DOI 10.1016/j.bbr.2014.10.044; Torres US, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-342; Tosato S, 2005, CURR OPIN PSYCHIATR, V18, P285, DOI 10.1097/01.yco.0000165599.90928.c7; Turkeltaub PE, 2012, HUM BRAIN MAPP, V33, P1, DOI 10.1002/hbm.21186; Umetsu A, 2002, NEUROIMAGE, V17, P385, DOI 10.1006/nimg.2002.1218; Urbanowitsch N, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00012; Venkatasubramanian G, 2008, PSYCHIAT RES-NEUROIM, V164, P215, DOI 10.1016/j.pscychresns.2007.12.021; Vita A, 2007, INT REV PSYCHIATR, V19, P431, DOI 10.1080/09540260701486332; von Hausswolff-Juhlin Y, 2009, ACTA PSYCHIAT SCAND, V119, P15, DOI 10.1111/j.1600-0447.2008.01309.x; Zhao Q, 2014, SCHIZOPHRENIA BULL, V40, P626, DOI 10.1093/schbul/sbt063	81	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231669	10.1371/journal.pone.0231669	http://dx.doi.org/10.1371/journal.pone.0231669			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9QD	32320431	gold, Green Published			2022-12-26	WOS:000536028800029
J	Jambura, PL; Kriwet, J				Jambura, Patrick L.; Kriwet, Juergen			Articulated remains of the extinct shark Ptychodus (Elasmobranchii, Ptychodontidae) from the Upper Cretaceous of Spain provide insights into gigantism, growth rate and life history of ptychodontid sharks	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; LAMNIFORM SHARK; CRETOXYRHINA-MANTELLI; CARCHARHINUS-FALCIFORMIS; DUROPHAGOUS SHARK; RHINCODON-TYPUS; NIOBRARA CHALK; WHALE SHARK; EAST-COAST; BODY-SIZE	Due to their cartilaginous endoskeleton and the continuous tooth replacement, the chondrichthyan fossil record predominantly consists of isolated teeth, which offer diagnostic features for taxonomic identifications, but only provide very limited information of an organism's life history. In contrast, the calcified vertebral centra of elasmobranchs (sharks, skates and rays) yield important information about ecological and biological traits that can be utilized for constructing age-structured population dynamic models of extant species and palaeoecological reconstructions of such aspects in extinct groups. Here, we describe two large shark vertebrae from the Santonian (Upper Cretaceous) of Spain, which show a unique combination of characters (asterospondylic calcification pattern, with concentric lamellae and numerous parallel bands that are oriented perpendicular) that is only known from ptychodontid sharks, a distinct, extinct group of giant durophagous sharks of the Cretaceous era. Based on linear regression models for large extant sharks a total length between 430 and 707cm was estimated for the examined specimen. Our results indicate that ptychodontid sharks were large viviparous animals, with slow growth rates, matured very late and, therefore, show typical traits for K-selected species. These traits combined with a highly specialized feeding ecology might have played a crucial role for the success but also, eventually, extinction of this group.	[Jambura, Patrick L.; Kriwet, Juergen] Univ Vienna, Dept Palaeontol, Vienna, Austria	University of Vienna	Jambura, PL (corresponding author), Univ Vienna, Dept Palaeontol, Vienna, Austria.	patrick.jambura@gmail.com	Jambura, Patrick/ABB-2710-2020	Jambura, Patrick/0000-0002-4765-5042; Kriwet, Jurgen/0000-0002-6439-8455	University of Vienna	University of Vienna	The authors received no specific funding for this work. Open access funding provided by University of Vienna.; We are deeply indebted to Kurt Oppermann (Berlin, Germany) for the possibility to study the vertebral centra and placoid scales of this interesting extinct shark, and for providing geographic and geological information. We are grateful to Manuel Amadori and Sebastian Stumpf (both from the University of Vienna, Austria) for discussions and to Kenshu Shimada for providing pictures of an articulated skeleton of Squalicorax falcatus which comprises 86 vertebrae. We also want to thank Jacopo Amalfitano and Giuseppe Marrama, for their constructive comments on an earlier version of the manuscript and Giorgio Carnevale for editorial comments that helped improving a previous version of this manuscript. Open access funding provided by University of Vienna.	Amadori M, 2020, CRETACEOUS RES, V110, DOI 10.1016/j.cretres.2020.104386; Amalfitano J, 2019, CRETACEOUS RES, V98, P250, DOI 10.1016/j.cretres.2019.02.003; [Anonymous], 1833, RECHERCHES POISSONS; Applegate SP, 1970, VERTEBRATE FAUNA S 8; Barreto RR, 2011, FISH RES, V110, P170, DOI 10.1016/j.fishres.2011.04.003; Bonaparte C.L.J.L., 1838, NUOVI ANN SCI NATURE, V2, P105; Booth AJ, 2011, FISH B-NOAA, V109, P101; Branstetter S., 1986, P361; Cailliet G.M., 1983, NOAA TECHN REP NMFS, V8, P157; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; CAPPETTA H, 2012, HDB PALEOICHTHYOLO E, V3; Cappetta H., 1987, HDB PALEOICHTHYOLO B, V3B; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; CASEY JG, 1985, CAN J FISH AQUAT SCI, V42, P963, DOI 10.1139/f85-121; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; COMPAGNO LJV, 1990, ENVIRON BIOL FISH, V28, P33, DOI 10.1007/BF00751027; Conrath CL, 2002, FISH B-NOAA, V100, P674; Cook TD, 2011, J VERTEBR PALEONTOL, V31, P8, DOI 10.1080/02724634.2011.539968; Cortes E, 2016, METHODS ECOL EVOL, V7, P1136, DOI 10.1111/2041-210X.12592; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Deodati A, 2019, HORM RES PAEDIAT, V91, P156; Ebert DA., 2013, SHARKS WORLD; Enajjar S, 2012, CAH BIOL MAR, V53, P17; Everhart Michael J., 2004, Paludicola, V4, P125; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; Frederickson JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127162; Gallemi J, 1997, MINERALIA SLOVACA, V29, P311; Gallemi J, 2007, CRETACEOUS RES, V28, P5, DOI 10.1016/j.cretres.2006.05.014; Garcia VB, 2008, P ROY SOC B-BIOL SCI, V275, P83, DOI 10.1098/rspb.2007.1295; Gottfried MD, 1996, GREAT WHITE SHARKS, P55, DOI 10.1016/B978-012415031-7/50008-2; Hall NG, 2012, J FISH BIOL, V80, P1320, DOI 10.1111/j.1095-8649.2012.03240.x; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Hamm Shawn A., 2020, Bulletin of the New Mexico Museum of Natural History and Science, P1; Hamm Shawn A., 2019, Transactions of the Kansas Academy of Science, V122, P1, DOI 10.1660/062.122.0101; Hamm Shawn A., 2010, Transactions of the Kansas Academy of Science, V113, P44, DOI 10.1660/062.113.0203; Harry AV, 2018, FISH FISH, V19, P185, DOI 10.1111/faf.12243; Hasse C., 1879, NATURLICHE SYSTEM EL; Hoffman BL, 2016, J PALEONTOL, V90, P741, DOI 10.1017/jpa.2016.64; Holmes BJ, 2015, J FISH BIOL, V87, P422, DOI 10.1111/jfb.12732; Hsu HH, 2014, MAR FRESHWATER RES, V65, P1145, DOI 10.1071/MF13330; Huxley TH., 1880, P R SOC LOND, V43, P649, DOI DOI 10.1111/J.1469-7998.1869.TB07343.X; JAEKEL O., 1898, SITZUNGSBERICHTE GES, V5, P44; Joung SJ, 2008, FISH RES, V90, P78, DOI 10.1016/j.fishres.2007.09.025; Joung SJ, 2015, TERR ATMOS OCEAN SCI, V26, P153, DOI 10.3319/TAO.2014.10.15.01(Oc); KILLAM KA, 1989, FISH B-NOAA, V87, P845; Kotas JE, 2011, BRAZ J BIOL, V71, P755, DOI 10.1590/S1519-69842011000400022; Kriwet J, 1997, J VERT PALEONTOL, p58A; Kriwet J, 2015, ACTA PALAEONTOL POL, V60, P858, DOI 10.4202/app.00066.2014; Kriwet J, 2009, P ROY SOC B-BIOL SCI, V276, P945, DOI 10.1098/rspb.2008.1441; Lamolda MA, 2014, EPISODES, V37, P2, DOI 10.18814/epiiugs/2014/v37i1/001; Lamolda MA, 1996, B I ROY SCI NAT BELG; MacFadden BJ, 2004, PALAEOGEOGR PALAEOCL, V206, P179, DOI 10.1016/j.palaeo.2004.01.002; Maisey JG, 2012, J FISH BIOL, V80, P918, DOI 10.1111/j.1095-8649.2012.03245.x; Makarieva AM, 2005, ECOL COMPLEX, V2, P259, DOI 10.1016/j.ecocom.2005.04.006; Natanson LJ, 2008, MAR ECOL PROG SER, V361, P267, DOI 10.3354/meps07399; Natanson LJ, 2019, FISH B-NOAA, V117, P50, DOI 10.7755/FB.117.1.6; Natanson LJ, 2018, MAR FRESHWATER RES, V69, P1440, DOI 10.1071/MF17279; Natanson LJ, 2015, MAR FRESHWATER RES, V66, P387, DOI 10.1071/MF14127; Newbrey MG, 2015, ACTA PALAEONTOL POL, V60, P877, DOI 10.4202/app.2012.0047; Ogle D. H., 2016, T AM FISH SOC, DOI DOI 10.1577/1548-8659(2001)1302.0.CO;2; Ohlberger J, 2013, FUNCT ECOL, V27, P991, DOI 10.1111/1365-2435.12098; Oppermann K., 1996, THESIS; Parker H. W., 1965, Zoologische Mededeelingen Leiden, V40, P305; Passerotti MS, 2014, MAR FRESHWATER RES, V65, P674, DOI 10.1071/MF13214; Pimiento C, 2019, EVOLUTION, V73, P588, DOI 10.1111/evo.13680; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Purvis A, 2000, BIOESSAYS, V22, P1123, DOI 10.1002/1521-1878(200012)22:12<1123::AID-BIES10>3.0.CO;2-C; Reynolds J.D., 2001, CONSERVATION EXPLOIT, P147; Ribot-Carballal MC, 2005, FISH RES, V76, P14, DOI 10.1016/j.fishres.2005.05.004; Ridewood WG, 1921, PHILOS T R SOC LON B, V210, P311, DOI 10.1098/rstb.1921.0008; ROZEFELDS AC, 1993, ALCHERINGA, V17, P199, DOI 10.1080/03115519308619604; Scharer RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047850; Shimada K, 1997, J VERTEBR PALEONTOL, V17, P642, DOI 10.1080/02724634.1997.10011014; Shimada K, 2008, J VERTEBR PALEONTOL, V28, P21, DOI 10.1671/0272-4634(2008)28[21:OPALHS]2.0.CO;2; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P584, DOI 10.1671/0272-4634(2007)27[584:SADAOL]2.0.CO;2; Shimada Kenshu, 2005, Palaeontologische Zeitschrift, V79, P241; Shimada K, 2019, J VERTEBR PALEONTOL, V39, DOI 10.1080/02724634.2019.1673399; Shimada K, 2010, CRETACEOUS RES, V31, P249, DOI 10.1016/j.cretres.2009.11.005; Shimada K, 2009, J VERTEBR PALEONTOL, V29, P336, DOI 10.1671/039.029.0226; SMITH SE, 1984, T AM FISH SOC, V113, P308, DOI 10.1577/1548-8659(1984)113<308:TOVDIT>2.0.CO;2; STEVENS JD, 1975, J MAR BIOL ASSOC UK, V55, P657, DOI 10.1017/S0025315400017318; Tanaka S, 2011, MAR FRESHWATER RES, V62, P548, DOI 10.1071/MF10130; Vermeij GJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146092; Welton B.J., 1993, COLLECTORS GUIDE FOS; Wintner SP, 2000, ENVIRON BIOL FISH, V59, P441, DOI 10.1023/A:1026564707027; WOODWARD A. S., 1911, MONOGRAPH PALAEONTOG, V64, P185, DOI DOI 10.1080/02693445.1911.12035551	87	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231544	10.1371/journal.pone.0231544	http://dx.doi.org/10.1371/journal.pone.0231544			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320430	gold, Green Published			2022-12-26	WOS:000536028800026
J	Medrano-Soto, A; Ghazi, F; Hendargo, KJ; Moreno-Hagelsieb, G; Myers, S; Saier, MH				Medrano-Soto, Arturo; Ghazi, Faezeh; Hendargo, Kevin J.; Moreno-Hagelsieb, Gabriel; Myers, Scott; Saier, Milton H., Jr.			Expansion of the Transporter-Opsin-G protein-coupled receptor superfamily with five new protein families	PLOS ONE			English	Article							STRUCTURE ALIGNMENT; STRUCTURAL BASIS; SEQUENCE; IDENTIFICATION; DATABASE; ANTIGEN; GOLGI; CLASSIFICATION; GENERATION; PREDICTION	Here we provide bioinformatic evidence that the Organo-Arsenical Exporter (ArsP), Endoplasmic Reticulum Retention Receptor (KDELR), Mitochondrial Pyruvate Carrier (MPC), L-Alanine Exporter (AlaE), and the Lipid-linked Sugar Translocase (LST) protein families are members of the Transporter-Opsin-G Protein-coupled Receptor (TOG) Superfamily. These families share domains homologous to well-established TOG superfamily members, and their topologies of transmembranal segments (TMSs) are compatible with the basic 4-TMS repeat unit characteristic of this Superfamily. These repeat units tend to occur twice in proteins as a result of intragenic duplication events, often with subsequent gain/loss of TMSs in many superfamily members. Transporters within the ArsP family allow microbial pathogens to expel toxic arsenic compounds from the cell. Members of the KDELR family are involved in the selective retrieval of proteins that reside in the endoplasmic reticulum. Proteins of the MPC family are involved in the transport of pyruvate into mitochondria, providing the organelle with a major oxidative fuel. Members of family AlaE excrete L-alanine from the cell. Members of the LST family are involved in the translocation of lipid-linked glucose across the membrane. These five families substantially expand the range of substrates of transport carriers in the superfamily, although KDEL receptors have no known transport function. Clustering of protein sequences reveals the relationships among families, and the resulting tree correlates well with the degrees of sequence similarity documented between families. The analyses and programs developed to detect distant relatedness, provide insights into the structural, functional, and evolutionary relationships that exist between families of the TOG superfamily, and should be of value to many other investigators.	[Medrano-Soto, Arturo; Ghazi, Faezeh; Hendargo, Kevin J.; Myers, Scott; Saier, Milton H., Jr.] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA; [Moreno-Hagelsieb, Gabriel] Wilfrid Laurier Univ, Dept Biol, Waterloo, ON, Canada; [Myers, Scott] Univ Calif San Francisco, Sch Pharm, San Francisco, CA 94143 USA	University of California System; University of California San Diego; Wilfrid Laurier University; University of California System; University of California San Francisco	Saier, MH (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	msaier@ucsd.edu	Medrano-Soto, Arturo/ABC-1969-2020; Medrano-Soto, Arturo/AAU-7223-2020	Medrano-Soto, Arturo/0000-0002-6095-3829; Moreno-Hagelsieb, Gabriel/0000-0002-2457-4450; Saier, Milton/0000-0001-5530-0017	National Institutes of Health [GM077402]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant GM077402 to MHS from the National Institutes of Health (https://www.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MM, 2001, MICROBIOL-UK, V147, P851, DOI 10.1099/00221287-147-4-851; Akhoundi M, 2017, MOL ASPECTS MED, V57, P1, DOI 10.1016/j.mam.2016.11.012; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Anderson DS, 2008, J GEN PHYSIOL, V132, P351, DOI 10.1085/jgp.200809984; Aniya Y, 2011, DRUG METAB REV, V43, P292, DOI 10.3109/03602532.2011.552913; BAILEY TL, 2002, CURR PROTOC BIOINFOR, pCH2; Ballesteros A, 2018, ELIFE, V7, DOI 10.7554/eLife.38433; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Becchetti A, 2019, TRENDS CELL BIOL; Biegert A, 2008, BIOINFORMATICS, V24, P807, DOI 10.1093/bioinformatics/btn039; Bogomolnaya LM, 2008, MOL MICROBIOL, V70, P1105, DOI 10.1111/j.1365-2958.2008.06461.x; Brauer P, 2019, SCIENCE, V363, P1103, DOI 10.1126/science.aaw2859; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Bueno-Orovio A, 2014, PFLUG ARCH EUR J PHY, V466, P183, DOI 10.1007/s00424-013-1293-1; Cancino J, 2013, HISTOCHEM CELL BIOL, V140, P395, DOI 10.1007/s00418-013-1130-9; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Capitani M, 2009, FEBS LETT, V583, P3863, DOI 10.1016/j.febslet.2009.10.053; Carvalho AD, 2011, CURR PHARM DESIGN, V17, P4270, DOI 10.2174/138161211798999447; Castillo Rostislav, 2010, Int J Microbiol, V2010, P187373, DOI 10.1155/2010/187373; Chang YQ, 2014, SCIENCE, V344, P1131, DOI 10.1126/science.1252043; Cook CE, 2016, NUCLEIC ACIDS RES, V44, pD20, DOI 10.1093/nar/gkv1352; Duyckaerts C, 2013, REV NEUROL-FRANCE, V169, P825, DOI 10.1016/j.neurol.2013.07.018; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ernst OP, 2015, PHOTOCH PHOTOBIO SCI, V14, P1922, DOI 10.1039/c5pp00195a; Feil SC, 2014, J MOL BIOL, V426, P785, DOI 10.1016/j.jmb.2013.11.020; Feng L, 2016, TRENDS BIOCHEM SCI, V41, P118, DOI 10.1016/j.tibs.2015.11.014; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Goren MA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6115; Guan S, 1999, MICROBIOL-UK, V145, P1263, DOI 10.1099/13500872-145-5-1263; Han L, 2017, P NATL ACAD SCI USA, V114, P10089, DOI 10.1073/pnas.1709241114; Hao DC, 2017, ACTA PHARM SIN B, V7, P146, DOI 10.1016/j.apsb.2016.12.001; Herzig S, 2012, SCIENCE, V337, P93, DOI 10.1126/science.1218530; Hori H, 2011, APPL ENVIRON MICROB, V77, P4027, DOI 10.1128/AEM.00003-11; Hubbard TJP, 1998, ACTA CRYSTALLOGR D, V54, P1147, DOI 10.1107/S0907444998009172; Jaehme M, 2016, TRENDS BIOCHEM SCI, V41, P117, DOI 10.1016/j.tibs.2015.11.013; Jaehme M, 2015, TRENDS BIOCHEM SCI, V40, P183, DOI 10.1016/j.tibs.2015.02.002; Jaehme M, 2014, NAT STRUCT MOL BIOL, V21, P1013, DOI 10.1038/nsmb.2909; Jin H, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00222; Jojoa-Cruz S, 2018, ELIFE, V7, DOI 10.7554/eLife.41845; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kim S, 2017, ARCH MICROBIOL, V199, P105, DOI 10.1007/s00203-016-1279-4; Korres H, 2005, BIOCHEM BIOPH RES CO, V328, P1252, DOI 10.1016/j.bbrc.2005.01.087; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Low LY, 2002, J MOL BIOL, V319, P87, DOI 10.1016/S0022-2836(02)00236-X; Luecke H, 2008, P NATL ACAD SCI USA, V105, P16561, DOI 10.1073/pnas.0807162105; Maity K, 2019, P NATL ACAD SCI USA; McCommis KS, 2015, BIOCHEM J, V466, P443, DOI 10.1042/BJ20141171; Medrano-Soto A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192851; Menon I, 2011, CURR BIOL, V21, P149, DOI 10.1016/j.cub.2010.12.031; Moreno-Hagelsieb G, 2017, J MOL MICROB BIOTECH, V27, P252, DOI 10.1159/000481286; Murshid A, 2004, CELL MOL LIFE SCI, V61, P133, DOI 10.1007/s00018-003-3352-9; Neutze R, 2002, BBA-BIOMEMBRANES, V1565, P144, DOI 10.1016/S0005-2736(02)00566-7; Ni ZL, 2017, MOL MED REP, V16, P9701, DOI 10.3892/mmr.2017.7822; Pan BF, 2018, NEURON, V99, P736, DOI 10.1016/j.neuron.2018.07.033; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; PEARSON WR, 1991, GENOMICS, V11, P635, DOI 10.1016/0888-7543(91)90071-L; Reddy VS, 2012, FEBS J, V279, P2036, DOI 10.1111/j.1742-4658.2012.08590.x; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Shaik MM, 2019, NATURE, V565, P318, DOI 10.1038/s41586-018-0804-9; Shalaeva DN, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0091-4; Shen ZQ, 2014, ANTIMICROB AGENTS CH, V58, P2021, DOI 10.1128/AAC.02137-13; Shlykov MA, 2012, BBA-BIOMEMBRANES, V1818, P703, DOI 10.1016/j.bbamem.2011.12.005; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Vander Byl C, 2000, J BACTERIOL, V182, P6472, DOI 10.1128/JB.182.22.6472-6481.2000; Verdes A, 2016, TOXINS, V8, DOI 10.3390/toxins8040117; Vickery ON, 2018, STRUCTURE, V26, P171, DOI 10.1016/j.str.2017.11.013; Widholz G, 2018, INT CONF OPTIC MEMS, P207; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wong WC, 2012, NUCLEIC ACIDS RES, V40, pW370, DOI 10.1093/nar/gks379; Wong WC, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-57; Wong WC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000867; Yee DC, 2013, FEBS J, V280, P5780, DOI 10.1111/febs.12499; Zhai YF, 2001, BBA-BIOMEMBRANES, V1511, P206, DOI 10.1016/S0005-2736(00)00389-8; Zhai YF, 2001, J MOL MICROB BIOTECH, V3, P285; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhou S, 2018, P NATL ACAD SCI USA, V115, P3048, DOI 10.1073/pnas.1712061115	81	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231085	10.1371/journal.pone.0231085	http://dx.doi.org/10.1371/journal.pone.0231085			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320418	Green Published, gold			2022-12-26	WOS:000536028800014
J	Normando, D; Barbosa, MS; Mecenas, P; Quintao, C				Normando, David; Barbosa, Mayara Silva; Mecenas, Paulo; Quintao, Catia			Tooth wear as an indicator of acculturation process in remote Amazonian populations	PLOS ONE			English	Article							AGE ESTIMATION; RIVERINE COMMUNITIES; TRANSITION; MECHANISMS; STATEMENT; SYSTEM	Riverine populations are typical of the Amazon region that depend on nature for subsistence. These people are considered an intermediate population between the urban and indigenous, the original Amazon habitants. The aim of this cross-sectional study was to evaluate the relationship between tooth wear and age in a remote riverine population from the Amazon, located by the Tucumanduba River (n = 94), and to compare them to previous findings obtained from semi-isolated indigenous (n = 223) and urban populations (n = 40) from the Amazon region, which were examined using the same methodology. Using linear regression, tooth wear explained 54.5% of the variation in the ages of the riverine subjects (p<0.001). This coefficient is mid-way between those obtained in semi-isolated indigenous populations (65-86%) and urban subjects (12%) living in the Amazon. Our findings suggest that tooth wear, a direct evidence of what an individual ate in the past, may be an indicator of the acculturation process in remote populations.	[Normando, David] Fed Univ Para, Sch Dent, Dept Orthodont, Belem, Para, Brazil; [Barbosa, Mayara Silva; Quintao, Catia] State Univ Rio de Janeiro UERJ, Sch Dent, Dept Orthodont, Rio De Janeiro, Brazil; [Mecenas, Paulo] Fed Univ UFPA, Postgrad Program Dent, Belem, Para, Brazil	Universidade Federal do Para; Universidade do Estado do Rio de Janeiro; Universidade Federal do Para	Quintao, C (corresponding author), State Univ Rio de Janeiro UERJ, Sch Dent, Dept Orthodont, Rio De Janeiro, Brazil.	catiacaq@gmail.com	Mecenas, Paulo/L-6353-2015; Quintão, Cátia/ABB-3221-2020; Quintão, Cátia/AAY-8872-2020; Normando, David/C-5324-2018	Mecenas, Paulo/0000-0001-5051-7129; Quintão, Cátia/0000-0003-4627-8190; Quintão, Cátia/0000-0003-4627-8190; Normando, David/0000-0002-1335-1040				Alaraudanjoki V, 2016, CARIES RES, V50, P508, DOI 10.1159/000448292; Bartlett DW, 2011, J DENT, V39, P811, DOI 10.1016/j.jdent.2011.08.014; Berry J.W., 2003, ACCULTURATION ADV TH, P17, DOI [10.1037/10472-000, DOI 10.1037/10472-004]; Bezerra Ilana Nogueira, 2013, Rev Saude Publica, V47 Suppl 1, p200S, DOI 10.1590/S0034-89102013000700006; Bornstein MH, 2017, PERSPECT PSYCHOL SCI, V12, P3, DOI 10.1177/1745691616655997; Brkic H, 2006, FORENSIC SCI INT, V162, P13, DOI 10.1016/j.forsciint.2006.06.022; Cohen-Carneiro F, 2009, CAD SAUDE PUBLICA, V25, P1827, DOI 10.1590/S0102-311X2009000800019; Coimbra CEA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-52; d'Incau E, 2012, ARCH ORAL BIOL, V57, P214, DOI 10.1016/j.archoralbio.2011.08.021; DAHL BL, 1993, ACTA ODONTOL SCAND, V51, P299, DOI 10.3109/00016359309040581; DEMIRJIAN A, 1973, HUM BIOL, V45, P211; DONACHIE MA, 1995, J DENT, V23, P157, DOI 10.1016/0300-5712(95)93573-K; Esclassan R, 2015, ANTHROPOL ANZ, V72, P185, DOI 10.1127/anthranz/2014/0442; Fonseca RA, 2013, REV BIOL TROP, V61, P263; Green James Ij, 2016, Prim Dent J, V5, P30; Regalo SCH, 2008, ARCH ORAL BIOL, V53, P282, DOI 10.1016/j.archoralbio.2007.10.003; Hossain MZ, 2017, ARCH ORAL BIOL, V80, P51, DOI 10.1016/j.archoralbio.2017.03.018; Kim YK, 2000, J FORENSIC SCI, V45, P303; Lopez-Class M, 2011, SOC SCI MED, V72, P1555, DOI 10.1016/j.socscimed.2011.03.011; Lu CK, 2017, INT J DENT, V2017, DOI 10.1155/2017/4265753; Machado MA, 2018, ARCH ORAL BIOL, V85, P166, DOI 10.1016/j.archoralbio.2017.10.014; Melo M, 2017, FORENSIC SCI INT, V270, DOI 10.1016/j.forsciint.2016.10.001; Mockers O, 2004, EUR J ORTHODONT, V26, P151, DOI 10.1093/ejo/26.2.151; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; Nardoto GB, 2011, AM J HUM BIOL, V23, P642, DOI 10.1002/ajhb.21192; Pedrao AMN, 2018, ORAL HLTH PREV DENT, V16, P145, DOI 10.3290/j.ohpd.a40321; Nolla CM., 1960, J DENT CHILDREN, V27, P254; Normando D, 2016, AM J ORTHOD DENTOFAC, V150, P839, DOI 10.1016/j.ajodo.2016.03.033; Normando D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028387; Piperata BA, 2011, AM J PHYS ANTHROPOL, V146, P1, DOI 10.1002/ajpa.21459; Sam D.L., 2016, CAMBRIDGE HDB ACCULT, V2nd; Satia JA, 2010, APPL PHYSIOL NUTR ME, V35, P219, DOI 10.1139/H10-007; Shellis RP, 2014, MONOGR ORAL SCI, V25, P32, DOI 10.1159/000359936; Silva RD, 2017, ENVIRON DEV SUSTAIN, V19, P1087, DOI 10.1007/s10668-016-9783-x; Telang Lahari A, 2014, J Forensic Dent Sci, V6, P16, DOI 10.4103/0975-1475.127765; Vieira EP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116138; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wetselaar P, 2016, J ORAL REHABIL, V43, P69, DOI 10.1111/joor.12340	38	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230809	10.1371/journal.pone.0230809	http://dx.doi.org/10.1371/journal.pone.0230809			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315345	Green Published, gold			2022-12-26	WOS:000536024800010
J	Oiram, F; Silva, ED; Lopes, MMD; Ribeiro, PRV; Oster, AH; Guedes, JAC; Zampieri, DD; Bordallo, PD; Zocolo, GJ				Oiram Filho, Francisco; Silva, Ebenezer de Oliveira; de Almeida Lopes, Monica Maria; Vasconselos Ribeiro, Paulo Riceli; Oster, Andreia Hansen; Carvalho Guedes, Jhonyson Arruda; Zampieri, Davila de Souza; Bordallo, Patricia do Nascimento; Zocolo, Guilherme Juliao			Effect of pulsed light on postharvest disease control-related metabolomic variation in melon (Cucumis melo) artificially inoculated with Fusarium pallidoroseum	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; AMINO-ACID-METABOLISM; INTENSITY UV-C; PHENOLIC-COMPOUNDS; SURFACE DECONTAMINATION; ELECTROSPRAY-IONIZATION; BIOACTIVE COMPOUNDS; MASS-SPECTROMETRY; PIPECOLIC ACID; QUALITY	Pulsed light, as a postharvest technology, is an alternative to traditional fungicides, and can be used on a wide variety of fruit and vegetables for sanitization or pathogen control. In addition to these applications, other effects also are detected in vegetal cells, including changes in metabolism and secondary metabolite production, which directly affect disease control response mechanisms. This study aimed to evaluate pulsed ultraviolet light in controlling postharvest rot, caused by Fusarium pallidoroseum in `Spanish' melon, in natura, and its implications in disease control as a function of metabolomic variation to fungicidal or fungistatic effects. The dose of pulsed light (PL) that inhibited F. pallidoroseum growth in melons (Cucumis melo var. Spanish) was 9 KJ m(-2). Ultra-performance liquid chromatography (UPLC) coupled to a quadrupole-time-of-flight (QTOF) mass analyzer identified 12 compounds based on tandem mass spectrometry (MS/MS) fragmentation patterns. Chemometric analysis by Principal Components Analysis (PCA) and Orthogonal Partial Least Squared Discriminant Analysis (OPLS-DA) and corresponding S-Plot were used to evaluate the changes in fruit metabolism. PL technology provided protection against postharvest disease in melons, directly inhibiting the growth of F. pallidoroseum through the upregulation of specific fruit biomarkers such as pipecolic acid (11), saponarin (7), and orientin (3), which acted as major markers for the defense system against pathogens. PL can thus be proposed as a postharvest technology to prevent chemical fungicides and may be applied to reduce the decay of melon quality during its export and storage.	[Oiram Filho, Francisco] Univ Fed Ceara, Sci Ctr, Dept Chem Engn, Fortaleza, Ceara, Brazil; [Silva, Ebenezer de Oliveira; Vasconselos Ribeiro, Paulo Riceli; Bordallo, Patricia do Nascimento; Zocolo, Guilherme Juliao] EMBRAPA Agroind Trop, Multiuser Lab Nat Prod Chem, Fortaleza, Ceara, Brazil; [de Almeida Lopes, Monica Maria] Univ Fed Ceara, Sci Ctr, Dept Biochem & Mol Biol, Fortaleza, Ceara, Brazil; [Oster, Andreia Hansen] EMBRAPA Uva & Vinho, Post Harvest Lab, Bento Goncalves, RS, Brazil; [Carvalho Guedes, Jhonyson Arruda] Univ Fed Ceara, Sci Ctr, Dept Analyt & Phys Chem Chem, Fortaleza, Ceara, Brazil; [Zampieri, Davila de Souza] Univ Fed Ceara, Sci Ctr, Dept Organ & Inorgan Chem, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Ceara; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal do Ceara; Universidade Federal do Ceara	Zocolo, GJ (corresponding author), EMBRAPA Agroind Trop, Multiuser Lab Nat Prod Chem, Fortaleza, Ceara, Brazil.	guilherme.zocolo@embrapa.br	Zocolo, Guilherme J./V-1330-2019; Bordallo, Patricia N/D-7050-2018; Guedes, Jhonyson A C/R-3006-2016; Ribeiro, Paulo/GYA-1014-2022; Zampieri, Davila/P-3857-2016	Zocolo, Guilherme J./0000-0001-8835-0184; Bordallo, Patricia N/0000-0003-4032-3106; Guedes, Jhonyson A C/0000-0002-8317-9338; Zampieri, Davila/0000-0002-2702-7268	Brazilian Agricultural Research Corporation (EMBRAPA); National Council for Scientific and Technological Development (CNPq); National Institute of Science and Technology (INCT BioNat, Brazil) [465637/2014-0]; commercial sector of Norfruit Northeast Fruit; INCT	Brazilian Agricultural Research Corporation (EMBRAPA); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Science and Technology (INCT BioNat, Brazil); commercial sector of Norfruit Northeast Fruit; INCT	This work was made possible with funding from the Brazilian Agricultural Research Corporation (EMBRAPA), National Council for Scientific and Technological Development (CNPq; http://www.cnpq.br/), the National Institute of Science and Technology (INCT BioNat, Brazil - grant No. 465637/2014-0) (http://inct-bionat.iq.unesp.br/), and the commercial sector of Norfruit Northeast Fruit. INCT had provided FOF a scholarship to research at EMBRAPA Tropical Agroindustry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Garcia B, 2009, J CHROMATOGR A, V1216, P5398, DOI 10.1016/j.chroma.2009.05.039; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abu-Reidah IM, 2012, FOOD RES INT, V46, P108, DOI 10.1016/j.foodres.2011.11.026; Aguilo-Aguayo I, 2014, LWT-FOOD SCI TECHNOL, V59, P320, DOI 10.1016/j.lwt.2014.04.049; Aguilo-Aguayo I, 2013, POSTHARVEST BIOL TEC, V86, P29, DOI 10.1016/j.postharvbio.2013.06.011; Akpanika GA, 2017, FOOD CHEM, V222, P35, DOI 10.1016/j.foodchem.2016.12.002; Bernsdorff F, 2016, PLANT CELL, V28, P102, DOI 10.1105/tpc.15.00496; Bollina V, 2011, PLANT MOL BIOL, V77, P355, DOI 10.1007/s11103-011-9815-8; Bouslimani A, 2014, NAT PROD REP, V31, P718, DOI 10.1039/c4np00044g; Bresciani Letizia, 2015, PharmaNutrition, V3, P11, DOI 10.1016/j.phanu.2015.01.001; Cheigh CI, 2012, FOOD CONTROL, V25, P654, DOI 10.1016/j.foodcont.2011.11.032; Conrath U, 2015, ANNU REV PHYTOPATHOL, V53, P97, DOI 10.1146/annurev-phyto-080614-120132; Lopes MMD, 2017, J FOOD SCI TECH MYS, V54, P2332, DOI 10.1007/s13197-017-2673-x; de Oliveira MJ, 2014, ACTA SCI-AGRON, V36, P281, DOI 10.4025/actasciagron.v36i3.17656; Dou JP, 2007, J AGR FOOD CHEM, V55, P7462, DOI 10.1021/jf0718603; de Sousa AED, 2019, SCI HORTIC-AMSTERDAM, V246, P921, DOI 10.1016/j.scienta.2018.11.066; Duarte-Molina F, 2016, INNOV FOOD SCI EMERG, V34, P267, DOI 10.1016/j.ifset.2016.01.019; Farag MA, 2014, FOOD CHEM, V151, P333, DOI 10.1016/j.foodchem.2013.11.032; Garvey M, 2014, EXP PARASITOL, V144, P6, DOI 10.1016/j.exppara.2014.06.001; Genga A, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P309; Huang YX, 2019, FOOD CHEM, V270, P47, DOI 10.1016/j.foodchem.2018.07.069; Ibrahim RM, 2015, REV BRAS FARMACOGN, V25, P134, DOI 10.1016/j.bjp.2015.02.008; Ignat A, 2014, POSTHARVEST BIOL TEC, V91, P122, DOI 10.1016/j.postharvbio.2014.01.005; Ingle RA, 2015, PLANT J, V84, P937, DOI 10.1111/tpj.13050; Jin P, 2017, SCI HORTIC-AMSTERDAM, V225, P106, DOI 10.1016/j.scienta.2017.06.062; Jung ES, 2013, PLANT SCI, V210, P61, DOI 10.1016/j.plantsci.2013.05.004; Kamiyama M, 2012, J AGR FOOD CHEM, V60, P6260, DOI 10.1021/jf301700j; Kind Tobias, 2010, Bioanal Rev, V2, P23, DOI 10.1007/s12566-010-0015-9; Koh PC, 2016, INNOV FOOD SCI EMERG, V36, P92, DOI 10.1016/j.ifset.2016.05.015; Koh PC, 2016, J FOOD SCI TECH MYS, V53, P1798, DOI 10.1007/s13197-015-2139-y; Krishnamurthy K, 2010, FOOD BIOPROCESS TECH, V3, P93, DOI 10.1007/s11947-008-0084-8; Lopes MMA, 2016, INNOV FOOD SCI EMERG, V33, P216, DOI 10.1016/j.ifset.2015.12.019; Mallek-Ayadi S, 2017, FOOD CHEM, V221, P1691, DOI 10.1016/j.foodchem.2016.10.117; Mao Q, 2014, J PHARMACEUT BIOMED, V97, P129, DOI 10.1016/j.jpba.2014.04.032; Mierziak J, 2014, MOLECULES, V19, P16240, DOI 10.3390/molecules191016240; Cecchini NM, 2011, PLANT PHYSIOL, V155, P1947, DOI 10.1104/pp.110.167163; Mncwangi NP, 2014, PHYTOCHEMISTRY, V106, P104, DOI 10.1016/j.phytochem.2014.06.012; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Mohamed NTS, 2017, FOOD SCI NUTR, V5, P967, DOI 10.1002/fsn3.482; Moore JP, 2005, J CHEM ECOL, V31, P2823, DOI 10.1007/s10886-005-8396-x; Navarova H, 2012, PLANT CELL, V24, P5123, DOI 10.1105/tpc.112.103564; Negri G, 2012, REV BRAS FARMACOGN, V22, P1024, DOI 10.1590/S0102-695X2012005000034; Piasecka A, 2015, J MASS SPECTROM, V50, P513, DOI 10.1002/jms.3557; Piraud M, 2003, RAPID COMMUN MASS SP, V17, P1297, DOI 10.1002/rcm.1054; Ribeiro C., 2012, Emirates Journal of Food and Agriculture, V24, P586, DOI 10.9755/ejfa.v24i6.586597; Rodov V, 2012, POSTHARVEST BIOL TEC, V68, P43, DOI 10.1016/j.postharvbio.2012.02.001; Rodriguez-Perez C, 2013, FOOD RES INT, V54, P1519, DOI 10.1016/j.foodres.2013.09.011; Roessner U, 2013, METHODS MOL BIOL, V1055, P1, DOI 10.1007/978-1-62703-577-4; Sainani KL, 2014, PM&R, V6, P275, DOI 10.1016/j.pmrj.2014.02.001; Sanchez-Rabaneda F, 2003, J MASS SPECTROM, V38, P35, DOI 10.1002/jms.395; Scott G, 2018, POSTHARVEST BIOL TEC, V137, P46, DOI 10.1016/j.postharvbio.2017.10.017; Scott G, 2017, POSTHARVEST BIOL TEC, V125, P52, DOI 10.1016/j.postharvbio.2016.10.012; Sebastiani MS, 2017, FRONT PLANT SCI, V8, DOI [10.3389/fpls.2017.00362, 10.3389/fpls.2017.00922]; Servillo L, 2012, J AGR FOOD CHEM, V60, P315, DOI 10.1021/jf204286r; Shama G, 2005, TRENDS FOOD SCI TECH, V16, P128, DOI 10.1016/j.tifs.2004.10.001; Sprenger RD, 2013, J CHROMATOGR A, V1291, P97, DOI 10.1016/j.chroma.2013.03.030; Stuttmann J, 2011, PLANT CELL, V23, P2788, DOI 10.1105/tpc.111.087684; Tarlanovic J, 2017, J PHYTOPATHOL, V165, P595, DOI 10.1111/jph.12597; Thaler JS, 1999, J CHEM ECOL, V25, P1597, DOI 10.1023/A:1020840900595; Uarrota VG, 2014, FOOD CHEM, V161, P67, DOI 10.1016/j.foodchem.2014.03.110; Xu WQ, 2016, FOOD MICROBIOL, V57, P135, DOI 10.1016/j.fm.2016.02.009; Yuliana ND, 2013, PHYTOCHEM REV, V12, P293, DOI 10.1007/s11101-013-9297-1; Zaccardelli M, 2006, J PHYTOPATHOL, V154, P454, DOI 10.1111/j.1439-0434.2006.01128.x; Zhang HY, 2017, TRENDS FOOD SCI TECH, V69, P36, DOI 10.1016/j.tifs.2017.08.020; Zhao Y, 2008, POSTHARVEST BIOL TEC, V49, P113, DOI 10.1016/j.postharvbio.2008.01.001	65	7	7	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0220097	10.1371/journal.pone.0220097	http://dx.doi.org/10.1371/journal.pone.0220097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310943	Green Submitted, gold, Green Published			2022-12-26	WOS:000536019800001
J	Chukwusa, E; Yu, PH; Verne, J; Taylor, R; Higginson, IJ; Wei, G				Chukwusa, Emeka; Yu, Peihan; Verne, Julia; Taylor, Ros; Higginson, Irene J.; Wei, Gao			Regional variations in geographic access to inpatient hospices and Place of death: A Population-based study in England, UK	PLOS ONE			English	Article							PALLIATIVE CARE; END	Background There is much variation in hospice use with respect to geographic factors such as area-based deprivation, location of patient's residence and proximity to services location. However, little is known about how the association between geographic access to inpatient hospice and hospice deaths varies by patients' region of settlement. Study aim To examine regional differences in the association between geographic access to inpatient hospice and hospice deaths. Methods A regional population-based observational study in England, UK. Records of patients aged >= 25 years (n = 123088) who died from non-accidental causes in 2014, were extracted from the Office for National Statistics (ONS) death registry. Our cohort comprised of patients who died at home and in inpatient hospice. Decedents were allocated to each of the nine government office regions of England (London, East Midlands, West Midlands, East, Yorkshire and The Humber, South West, South East, North West and North East) through record linkage with their postcode of usual residence. We defined geographic access as a measure of drive times from patients' residential location to the nearest inpatient hospice. A modified Poisson regression estimated the association between geographic access to hospice, comparing hospice deaths (1) versus home deaths (0). We developed nine regional specific models and adjusted for regional differences in patient's clinical & socio-demographic characteristics. The strength of the association was estimated with adjusted Proportional Ratios (aPRs). Findings The percentage of deaths varied across regions (home: 86.7% in the North East to 73.0% in the South East; hospice: 13.3% in the North East to 27.0% in the South East). We found wide differences in geographic access to inpatient hospices across regions. Median drive times to hospice varied from 4.6 minutes in London to 25.9 minutes in the North East. We found a dose-response association in the East: (aPRs: 0.22-0.78); East Midlands: (aPRs: 0.33-0.63); North East (aPRs: 0.19-0.87); North West (aPRs: 0.69-0.88); South West (aPRs: 0.56-0.89) and West Midlands (aPRs: 0.28-0.92) indicating that decedents who lived further away from hospices locations (>= 10 minutes) were less likely to die in a hospice. Conclusion The clear dose-response associations in six regions underscore the importance of regional specific initiatives to improve and optimise access to hospices. Commissioners and policy-makers need to do more to ensure that home death is not due to limited geographic access to inpatient hospice care.	[Chukwusa, Emeka; Yu, Peihan; Higginson, Irene J.; Wei, Gao] Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England; [Verne, Julia] Publ Hlth England, Natl End Life Care Intelligence Network, Knowledge & Intelligence South West, Bristol, Avon, England; [Taylor, Ros] Royal Marsden NHS Hosp Trust, London, England; [Taylor, Ros] Hosp UK, London, England	University of London; King's College London; Public Health England; Royal Marsden NHS Foundation Trust	Chukwusa, E (corresponding author), Kings Coll London, Cicely Saunders Inst, Dept Palliat Care Policy & Rehabil, London, England.	emeka.chukwusa@kcl.ac.uk	; Higginson, Irene Julie/C-7309-2012	Chukwusa, Emeka/0000-0003-2576-8633; /0000-0001-8298-3415; Higginson, Irene Julie/0000-0002-3687-1313; Yu, Peihan/0000-0003-1284-5193	National Institute for Health Research, Health Services and Delivery Research Program (NIHR HS DR) [14/19/22]; National Institute for Health Research (NIHR) Applied Research Collaborations (ARC) South London	National Institute for Health Research, Health Services and Delivery Research Program (NIHR HS DR); National Institute for Health Research (NIHR) Applied Research Collaborations (ARC) South London	WG, IJH, JV. Obtained funding from the National Institute for Health Research, Health Services and Delivery Research Program (NIHR HS & DR, 14/19/22). This project is partly supported by the National Institute for Health Research (NIHR) Applied Research Collaborations (ARC) South London. ARC South London is part of the National Institute for Health Research (NIHR) and is a partnership between King's Health Partners, St. George's, University London, and St George's Healthcare NHS Trust. The views expressed in this publication are those of the authors and not necessarily those of the National Health Service, the National Institute for Health Research, or the Department of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, STRENGTH PALL CAR CO; Barbara Gomes N.C., 2011, LOCAL PREFERENCES PL; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bone AE, 2018, PALLIATIVE MED, V32, P329, DOI 10.1177/0269216317734435; Brennan F, 2007, J PAIN SYMPTOM MANAG, V33, P494, DOI 10.1016/j.jpainsymman.2007.02.022; Brunsdon C, 2014, GISTOOLS SOME FURTHE; Buck J., 2018, BMJ SUPPORTIVE PALLI; Chukwusa E, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0172-1; Clark D., 1998, MORTALITY, V3, P43, DOI [10.1080/713685885, DOI 10.1080/713685885]; Connor SR, 2007, J PAIN SYMPTOM MANAG, V34, P277, DOI 10.1016/j.jpainsymman.2007.03.007; Davies JM, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002782; Department of H., 2008, END LIFE CARE STRATE; Dixon D, 2015, EQUITY PROVISION PAL; England JA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2599-6; Etkind S.N., 2017, BMC MED, P15; Gao W, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001410; Gatrell AC, 2003, J PUBLIC HEALTH MED, V25, P53, DOI 10.1093/pubmed/fdg011; Gatrell AC, 2012, HEALTH PLACE, V18, P832, DOI 10.1016/j.healthplace.2012.03.009; Gwyther L, 2009, J PAIN SYMPTOM MANAG, V38, P767, DOI 10.1016/j.jpainsymman.2009.03.003; Lewin-Koh N, 2011, MAPTOOLS TOOLS READI, P74; Lewis JM, 2011, J PAIN SYMPTOM MANAG, V42, P105, DOI 10.1016/j.jpainsymman.2010.10.265; Martin D, 2013, J R STAT SOC A STAT, V176, P585, DOI 10.1111/j.1467-985X.2012.01054.x; Openshaw S., 1983, MODIFIABLE AREAL UNI; Osinowo A.V., 2011, JULIA EXTERNAL CAUSE; R Core Team, 2016, R FDN STAT COMP; Sleeman KE, 2019, LANCET GLOB HEALTH, V7, pE883, DOI 10.1016/S2214-109X(19)30172-X; Teno JM, 2016, JAMA INTERN MED, V176, P364, DOI 10.1001/jamainternmed.2015.7479; UK H.a., 2015, DIR UK HOSP COUNT; Wang SY, 2015, J PALLIAT MED, V18, P771, DOI 10.1089/jpm.2014.0425; World Health Organization, 2014, GLOBAL ATLAS PALLIAT, P111; World Health Organization (WHO), 2018, PALL CAR FACT SHEETS; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	32	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231666	10.1371/journal.pone.0231666	http://dx.doi.org/10.1371/journal.pone.0231666			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302344	gold, Green Published			2022-12-26	WOS:000536016100042
J	DiRenzo, GV; Chen, RW; Ibsen, K; Toothman, M; Miller, AJ; Gershman, A; Mitragotri, S; Briggs, CJ				DiRenzo, Graziella V.; Chen, Renwei; Ibsen, Kelly; Toothman, Mary; Miller, Abigail J.; Gershman, Ariel; Mitragotri, Samir; Briggs, Cheryl J.			Investigating the potential use of an ionic liquid (1-Butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide) as an anti-fungal treatment against the amphibian chytrid fungus, Batrachochytrium dendrobatidis	PLOS ONE			English	Article							CUTANEOUS CHYTRIDIOMYCOSIS; EMERGING DISEASE; EXTINCTION; DEFENSES; WATER; FROG; ITRACONAZOLE; TRANSMISSION; PROBIOTICS; DECLINES	The disease chytridiomycosis, caused by the pathogenic chytrid fungus, Batrachochytrium dendrobatidis (Bd), has contributed to global amphibian declines. Bd infects the keratinized epidermal tissue in amphibians and causes hyperkeratosis and excessive skin shedding. In individuals of susceptible species, the regulatory function of the amphibian's skin is disrupted resulting in an electrolyte depletion, osmotic imbalance, and eventually death. Safe and effective treatments for chytridiomycosis are urgently needed to control chytrid fungal infections and stabilize populations of endangered amphibian species in captivity and in the wild. Currently, the most widely used anti-Bd treatment is itraconazole. Preparations of itraconazole formulated for amphibian use has proved effective, but treatment involves short baths over seven to ten days, a process which is logistically challenging, stressful, and causes long-term health effects. Here, we explore a novel anti-fungal therapeutic using a single application of the ionic liquid, 1-Butyl-1-methylpyrrolidinium bis(trifluoromethylsulfonyl)imide (BMP-NTf2), for the treatment of chytridiomycosis. BMP-NTf2 was found be effective at killing Bd in vitro at low concentrations (1:1000 dilution). We tested BMP-NTf2 in vivo on two amphibian species, one that is relatively tolerant of chytridiomycosis (Pseudacris regilla) and one that is highly susceptible (Dendrobates tinctorius). A toxicity trial revealed a surprising interaction between Bd infection status and the impact of BMP-NTf2 on D. tinctorius survival. Uninfected D. tinctorius tolerated BMP-NTf2 (mean +/- SE; 96.01 +/- 9.00 mu l/g), such that only 1 out of 30 frogs died following treatment (at a dose of 156.95 mu L/g), whereas, a lower dose (mean +/- SE; 97.45 +/- 3.52 mu L/g) was not tolerated by Bd-infected D. tinctorius, where 15 of 23 frogs died shortly upon BMP-NTf2 application. Those that tolerated the BMP-NTf2 application did not exhibit Bd clearance. Thus, BMP-NTf2 application, under the conditions tested here, is not a suitable option for clearing Bd infection in D. tinctorius. However, different results were obtained for P. regilla. Two topical applications of BMP-NTf2 on Bd-infected P. regilla (using a lower BMP-NTf2 dose than on D. tinctorius, mean +/- SE; 9.42 +/- 1.43 mu L/g) reduced Bd growth, although the effect was lower than that obtained by daily doses of itracanozole (50% frogs exhibited complete clearance on day 16 vs. 100% for itracanozole). Our findings suggest that BMP-NTf2 has the potential to treat Bd infection, however the effect depends on several parameters. Further optimization of dose and schedule are needed before BMP-NTf2 can be considered as a safe and effective alternative to more conventional antifungal agents, such as itraconazole.	[DiRenzo, Graziella V.; Toothman, Mary; Miller, Abigail J.; Gershman, Ariel; Briggs, Cheryl J.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Chen, Renwei; Ibsen, Kelly; Mitragotri, Samir] Univ Calif Santa Barbara, Ctr Bioengn, Santa Barbara, CA 93106 USA; [Ibsen, Kelly; Mitragotri, Samir] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Ibsen, Kelly; Mitragotri, Samir] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Ibsen, Kelly; Mitragotri, Samir] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Gershman, Ariel] Johns Hopkins Univ, Biochem Cell & Mol Biol Program, Baltimore, MD USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University; Harvard University; Johns Hopkins University	DiRenzo, GV (corresponding author), Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA.	grace.direnzo@gmail.com		DiRenzo, Graziella/0000-0001-5264-4762	Undergraduate Research for Creative Activates grant; National Science Foundation [1611692]; UCSB faculty research grant [8-580611-19941-7]; National Science Foundation Graduate Research Fellowship [DGE-1144085]; MRSEC Program of the NSF [DMR 1121053]; NSF	Undergraduate Research for Creative Activates grant; National Science Foundation(National Science Foundation (NSF)); UCSB faculty research grant; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); MRSEC Program of the NSF(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	The Undergraduate Research for Creative Activates grant supported AJM and AG, and the National Science Foundation Postdoctoral Fellowship #1611692 supported GVD. UCSB faculty research grant 8-580611-19941-7 was awarded to CJB, SM, and RC. This research was supported in part by a National Science Foundation Graduate Research Fellowship to K. Ibsen under Grant No. DGE-1144085. This work was also supported by a grant to the MRL Shared Experimental Facilities supported by the MRSEC Program of the NSF under Award No. DMR 1121053; a member of the NSF-funded Materials Research Facilities Network. Duncan and Suzanne Mellichamp also provided support.	Agatemor C, 2018, BIOENG TRANSL MED, V3, P7, DOI 10.1002/btm2.10083; Banerjee A, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201601411; Bates KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02967-w; Becker MH, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2881; Becker MH, 2011, ECOHEALTH, V8, P501, DOI 10.1007/s10393-012-0743-0; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bletz MC, 2017, FRONT MICROBIOL, V8, P1, DOI 10.3389/fmicb.2017.01530; Bletz MC, 2013, ECOL LETT, V16, P807, DOI 10.1111/ele.12099; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Brannelly LA, 2012, DIS AQUAT ORGAN, V101, P95, DOI 10.3354/dao02521; Clulow S, 2018, J APPL ECOL, V55, P830, DOI 10.1111/1365-2664.13030; Costa SPF, 2015, CHEMOSPHERE, V139, P288, DOI 10.1016/j.chemosphere.2015.05.100; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Egorova KS, 2017, CHEM REV, V117, P7132, DOI 10.1021/acs.chemrev.6b00562; Ellison AR, 2015, GENOME BIOL EVOL, V7, P286, DOI 10.1093/gbe/evu285; Ellison AR, 2014, G3-GENES GENOM GENET, V4, P1275, DOI 10.1534/g3.114.010744; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Geiger CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05798-9; Grant EHC, 2017, FRONT ECOL ENVIRON, V15, P214, DOI 10.1002/fee.1481; Heard GW, 2017, CONSERV LETT, V11, P1; Hyatt AD, 2007, DIS AQUAT ORGAN, V73, P175, DOI 10.3354/dao073175; Jani AJ, 2014, P NATL ACAD SCI USA, V111, pE5049, DOI 10.1073/pnas.1412752111; Jastrzebska A, 2018, FOOD CHEM, V239, P225, DOI 10.1016/j.foodchem.2017.06.100; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kearns PJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02494; Kinney VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016708; Kurnia KA, 2014, PHYS CHEM CHEM PHYS, V16, P19952, DOI 10.1039/c4cp02309a; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Li XY, 2009, ECOTOX ENVIRON SAFE, V72, P552, DOI 10.1016/j.ecoenv.2007.11.002; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Longo AV, 2017, ISME J, V11, P349, DOI 10.1038/ismej.2016.138; Nichols DK, 2001, J WILDLIFE DIS, V37, P1; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; PASSINO DRM, 1987, ENVIRON TOXICOL CHEM, V6, P901, DOI 10.1002/etc.5620061111; Pereira KE, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.183707; Pernak J, 2001, EUR J MED CHEM, V36, P899, DOI 10.1016/S0223-5234(01)80005-2; Pernak J, 2004, ANTIMICROBIAL ACTIVI, P323; Pessier AP, 1999, J VET DIAGN INVEST, V11, P194, DOI 10.1177/104063879901100219; Pretti C, 2006, GREEN CHEM, V8, P238, DOI 10.1039/b511554j; Rabideau BD, 2018, CHEM COMMUN, V54, P5019, DOI 10.1039/c8cc01716f; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; Ranke J, 2007, CHEM REV, V107, P2183, DOI 10.1021/cr050942s; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Rollins-Smith LA, 2005, DEV COMP IMMUNOL, V29, P589, DOI 10.1016/j.dci.2004.11.004; Rollins-Smith LA, 2017, DEV COMP IMMUNOL, V66, P111, DOI 10.1016/j.dci.2016.07.002; Sainsbury AW, 2017, TRANSBOUND EMERG DIS, V64, P1530, DOI 10.1111/tbed.12545; Savage AE, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.3115; Savage AE, 2015, EVOL APPL, V8, P560, DOI 10.1111/eva.12264; Scheele B, 2019, SCIENCE, V363, P1459, DOI 10.1126/science.aav0379; Scheele BC, 2014, CONSERV BIOL, V28, P1195, DOI 10.1111/cobi.12322; Sheldon R, 2001, CHEM COMMUN, P2399, DOI 10.1039/b107270f; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Suarez MB, 2017, ECOHEALTH, V14, pS47, DOI 10.1007/s10393-015-1086-4; Team,R.C, 2018, R LANG ENV STAT COMP; Voyles J, 2007, DIS AQUAT ORGAN, V77, P113, DOI 10.3354/dao01838; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Wake DB, 2008, P NATL ACAD SCI USA, V105, P11466, DOI 10.1073/pnas.0801921105; Welton T, 1999, CHEM REV, V99, P2071, DOI 10.1021/cr980032t; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2006, J WILDLIFE DIS, V42, P207, DOI 10.7589/0090-3558-42.2.207; Woodhams DC, 2012, DIS AQUAT ORGAN, V98, P11, DOI 10.3354/dao02429; Woodhams DC, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-8; WYGODA ML, 1984, PHYSIOL ZOOL, V57, P329, DOI 10.1086/physzool.57.3.30163722; Zakrewsky M, 2016, ADV HEALTHC MATER, V5, P1282, DOI 10.1002/adhm.201600086; Zakrewsky M, 2014, P NATL ACAD SCI USA, V111, P13313, DOI 10.1073/pnas.1403995111	66	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231811	10.1371/journal.pone.0231811	http://dx.doi.org/10.1371/journal.pone.0231811			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302369	gold, Green Published			2022-12-26	WOS:000536016100054
J	Hargreaves, BKV; Roberts, SE; Derfalvi, B; Boudreau, JE				Hargreaves, Breanna K. V.; Roberts, Sarah E.; Derfalvi, Beata; Boudreau, Jeanette E.			Highly efficient serum-free manipulation of miRNA in human NK cells without loss of viability or phenotypic alterations is accomplished with TransIT-TKO	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; EXPRESSION; INFECTION; EDUCATION; MICRORNA-146A; CYTOTOXICITY; MEMORY	Natural killer (NK) cells are innate lymphocytes with functions that include target cell killing, inflammation and regulation. NK cells integrate incoming activating and inhibitory signals through an array of germline-encoded receptors to gauge the health of neighbouring cells. The reactive potential of NK cells is influenced by microRNA (miRNA), small non-coding sequences that interfere with mRNA expression. miRNAs are highly conserved between species, and a single miRNA can have hundreds to thousands of targets and influence entire cellular programs. Two miRNA species, miR-155-5p and miR-146a-5p are known to be important in controlling NK cell function, but research to best understand the impacts of miRNA species within NK cells has been bottlenecked by a lack of techniques for altering miRNA concentrations efficiently and without off-target effects. Here, we describe a non-viral and straightforward approach for increasing or decreasing expression of miRNA in primary human NK cells. We achieve >90% transfection efficiency without off-target impacts on NK cell viability, education, phenotype or function. This opens the opportunity to study and manipulate NK cell miRNA profiles and their impacts on NK cellular programs which may influence outcomes of cancer, inflammation and autoimmunity.	[Hargreaves, Breanna K. V.; Derfalvi, Beata; Boudreau, Jeanette E.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada; [Roberts, Sarah E.; Derfalvi, Beata] Dalhousie Univ, Dept Pediat, Halifax, NS, Canada; [Boudreau, Jeanette E.] Dalhousie Univ, Dept Pathol, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Dalhousie University	Boudreau, JE (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS, Canada.; Boudreau, JE (corresponding author), Dalhousie Univ, Dept Pathol, Halifax, NS, Canada.	Jeanette.boudreau@dal.ca		Derfalvi, Beata/0000-0001-7272-7119; Boudreau, Jeanette/0000-0003-0203-2180	Nova Scotia Graduate Scholarship; Nova Scotia Health Research (NSHRF) foundation; Canada Foundation for Innovation, John R. Evans Leaders Fund [34283]; NSHRF Establishment Grant [1045]; IWK Establishment Grant 2017; Dalhousie University Dept. of Pediatrics Endowment Fund, 2018; Natural Sciences and Engineering Research Council of Canada [06489]; Canadian Institutes of Health Research (CIHR), REACH Program Team Grant: Health Challenges in Chronic Inflammation Initiative [CIHR 135230]	Nova Scotia Graduate Scholarship; Nova Scotia Health Research (NSHRF) foundation; Canada Foundation for Innovation, John R. Evans Leaders Fund(Canada Foundation for Innovation); NSHRF Establishment Grant; IWK Establishment Grant 2017; Dalhousie University Dept. of Pediatrics Endowment Fund, 2018; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research (CIHR), REACH Program Team Grant: Health Challenges in Chronic Inflammation Initiative(Canadian Institutes of Health Research (CIHR))	1 This work was supported by studentships to BKVH from the Nova Scotia Graduate Scholarship and the Nova Scotia Health Research (NSHRF) foundation, and grants to BD (Canada Foundation for Innovation, John R. Evans Leaders Fund #34283, NSHRF Establishment Grant #1045, IWK Establishment Grant 2017, Dalhousie University Dept. of Pediatrics Endowment Fund, 2018), the Natural Sciences and Engineering Research Council #06489 of Canada to JEB, and Canadian Institutes of Health Research (CIHR), REACH Program Team Grant: Health Challenges in Chronic Inflammation Initiative (CIHR 135230). The sponsors did not play a role in any aspect of the study.	Beaulieu AM, 2013, IMMUNOL REV, V253, P40, DOI 10.1111/imr.12045; Boudreau JE, 2018, TRENDS IMMUNOL, V39, P222, DOI 10.1016/j.it.2017.12.001; Boudreau JE, 2018, CURR OPIN IMMUNOL, V50, P102, DOI 10.1016/j.coi.2017.11.003; Boudreau JE, 2016, J IMMUNOL, V196, P3398, DOI 10.4049/jimmunol.1502469; Carlsten M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00266; Chatzikyriakidou A, 2010, SCAND J IMMUNOL, V71, P382, DOI 10.1111/j.1365-3083.2010.02381.x; Chen EB, 2019, THERANOSTICS, V9, P4779, DOI 10.7150/thno.32543; De Spiegelaere W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122515; Denman CJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030264; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; Elias T, 2019, AUTOIMMUN REV, V18, P306, DOI 10.1016/j.autrev.2018.10.005; Fehniger TA, 2018, BIOL BLOOD MARROW TR, V24, P1581, DOI 10.1016/j.bbmt.2018.03.019; Glinge C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0167969; Goodridge JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08384-x; Guven H, 2005, EXP HEMATOL, V33, P1320, DOI 10.1016/j.exphem.2005.07.006; Hausser J, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.68; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Hu WL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01205; Huang Q, 2019, BIOMED PHARMACOTHER, V109, P1478, DOI 10.1016/j.biopha.2018.09.172; Huang Y, 2011, BLOOD, V118, P6793, DOI 10.1182/blood-2011-05-356162; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Kim GG, 2007, J IMMUNOL METHODS, V325, P51, DOI 10.1016/j.jim.2007.05.013; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Lee DA, 2019, IMMUNOL REV, V290, P85, DOI 10.1111/imr.12793; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Long H, 2018, CANCER LETT, V428, P90, DOI 10.1016/j.canlet.2018.04.016; Ma Y, 2016, LIFE SCI, V151, P174, DOI 10.1016/j.lfs.2016.03.012; Mehta A, 2016, NAT REV IMMUNOL, V16, P279, DOI 10.1038/nri.2016.40; Merkt W, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1101-3; Morandi F, 2015, J IMMUNOL, V195, P965, DOI 10.4049/jimmunol.1500591; Nersesian S, 2019, FRONT IMMUNOL, V10; Ni F, 2015, SCI REP-UK, V5, DOI 10.1038/srep09993; Omar HA, 2019, FEBS J, V286, P3540, DOI 10.1111/febs.15000; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4; Saba R, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00578; Saetersmoen ML, 2019, SEMIN IMMUNOPATHOL, V41, P59, DOI 10.1007/s00281-018-0721-x; Savoy SKA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100959; Schlimgen R, 2016, J OCCUP ENVIRON MED, V58, P1159, DOI 10.1097/JOM.0000000000000879; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Shahrabi S, 2019, J CELL PHYSL; Siegler EL, 2018, CELL STEM CELL, V23, P160, DOI 10.1016/j.stem.2018.07.007; Singh A, 2019, CLIN RHEUMATOL, V38, P877, DOI 10.1007/s10067-018-4380-z; Singh RP, 2013, AUTOIMMUN REV, V12, P1160, DOI 10.1016/j.autrev.2013.07.003; Sourour SK, 2017, INT J RHEUM DIS, V20, P1237, DOI 10.1111/1756-185X.13099; Stebulis JA, 2005, J RHEUMATOL, V32, P301; Stenfeldt C, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0743-3; Sullivan RP, 2013, J IMMUNOL, V191, P5904, DOI 10.4049/jimmunol.1301950; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Xu DQ, 2017, CELL MOL IMMUNOL, V14, P712, DOI 10.1038/cmi.2015.113; Zitti B, 2018, CYTOKINE GROWTH F R, V42, P37, DOI 10.1016/j.cytogfr.2018.08.001	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231664	10.1371/journal.pone.0231664	http://dx.doi.org/10.1371/journal.pone.0231664			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302338	Green Published, gold			2022-12-26	WOS:000536016100041
J	Orvik, AB; Andersen, MR; Bratholm, PS; Hedengran, KK; Ritz, C; Stender, S; Szecsi, PB				Orvik, Astrid Bakke; Andersen, Malene Rohr; Bratholm, Palle Skov; Hedengran, Katrine Kaare; Ritz, Christian; Stender, Steen; Szecsi, Pal Bela			Variation in plasma 25-hydroxyvitamin D2 and D3 in normal pregnancy with gestational age, sampling season, and complications: A longitudinal cohort study	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; HEALTH; IMPACT	Introduction Low levels of vitamin D in pregnancy have been associated with the risk of a variety of pregnancy outcomes. Few studies have investigated vitamin D concentrations throughout pregnancy in healthy women, and most guidelines recommend high vitamin D levels. In the present study, we investigated 25-hydroxyvitamin D concentrations in healthy Caucasian Danish women in relation to season, gestational age and possible vitamin D-linked complications. Materials and methods Eight hundred and one healthy Caucasian Danish women with an expected normal pregnancy were recruited among 2147 women attending first trimester screening. Seven blood samplings were planned throughout the pregnancy and delivery period. The 25-hydroxyvitamin D2 (25(OH)D2) and 25-hydroxyvitamin D3 (25(OH)D3) concentrations were measured by LC-MS/MS and total 25-hydroxyvitamin D (25(OH)D) were calculated. Results A total of 3304 samples from 694 women were available for 25(OH)D measurements. The mean (25th-75th percentiles) concentrations of 25(OH)D, 25(OH)D3, and 25(OH)D2 were 54.6 (38.8-68.6) nmol/L, 52.2 (36.4-66.4) nmol/L, and 2.4 (2.2-2.2) nmol/L, respectively. Season was the strongest predictor of 25(OH)D concentration, with the lowest values observed in winter and spring, where only 42% and 41% of samples, respectively, were above 50 nmol/L. Nearly all women had values below the suggested optimal level of 75 nmol/L, independent of season. 25(OH)D peaked at gestational weeks 21-34. Plasma 25 (OH)D2 levels were low in all seasons. Women with complications during pregnancy had higher 25(OH)D (estimated difference 9.8 nmol/L, standard error 2.7, p<0.001) than did women without complications, and women giving birth vaginally had lower 25(OH)D than did those delivering via elective (10.0 nmol/L, standard error 2.1, p<0.001) or emergency cesarean section (6.8 nmol/L, standard error 2.2, p<0.001). Conclusion The 25(OH)D concentrations vary with both season and gestational age. Healthy women had lower 25(OH)D concentrations than recommended, without an association with an increased risk of pregnancy complications. Guidelines for vitamin D in pregnancy may require revision.	[Orvik, Astrid Bakke] Copenhagen Univ Hosp Holbaek, Dept Gynecol & Obstet, Holbaek, Denmark; [Andersen, Malene Rohr] Herlev & Gentofte Hosp, Dept Clin Biochem, Hellerup, Denmark; [Bratholm, Palle Skov; Szecsi, Pal Bela] Copenhagen Univ Hosp Holbaek, Dept Clin Biochem, Copenhagen, Denmark; [Hedengran, Katrine Kaare] Copenhagen Univ Hosp Nordsjaelland, Dept Gynecol & Obstet, Hillerod, Denmark; [Ritz, Christian; Stender, Steen] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Szecsi, PB (corresponding author), Copenhagen Univ Hosp Holbaek, Dept Clin Biochem, Copenhagen, Denmark.	psz@regionsjaelland.dk	Ritz, Christian/P-6159-2014	Ritz, Christian/0000-0002-5095-0624; Szecsi, Pal/0000-0003-3446-0411; stender, steen/0000-0003-1037-1158				Achkar M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.009; Andersen LB, 2013, CLIN ENDOCRINOL, V79, P333, DOI 10.1111/cen.12147; [Anonymous], 2018, R LANG ENV STAT COMP, DOI DOI 10.18637/JSS.V028.I05; [Anonymous], 2012, GUIDELINE VITAMIN D; Autier P, 2014, LANCET DIABETES ENDO, V2, P76, DOI 10.1016/S2213-8587(13)70165-7; Beentjes CHL, 2019, J STEROID BIOCHEM, V190, P152, DOI 10.1016/j.jsbmb.2019.03.024; Brooks L., 2013, D VITAMIN DEFICIENCY, P1; Brot CD, 2010, LAEGEMIDDELSTYRELSEN; Brustad N, 2020, JAMA PEDIATR, V174, P419, DOI 10.1001/jamapediatrics.2019.6083; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1368, DOI 10.1111/aogs.12006; Christesen HT, 2012, ACTA OBSTET GYN SCAN, V91, P1357, DOI 10.1111/aogs.12000; De-Regil LM, 2016, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20161343T2, 10.1002/14651858.CD008873.pub3]; Enkhmaa D, 2019, EBIOMEDICINE, V39, P510, DOI 10.1016/j.ebiom.2018.11.060; Farrell CJL, 2012, CLIN CHEM, V58, P531, DOI 10.1373/clinchem.2011.172155; Godel JC, 2007, PAED CHILD HEALT-CAN, V12, P583, DOI 10.1093/pch/12.7.583; Gustafsson MK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195041; Hansen S, 2015, J ALLERGY CLIN IMMUN, V136, P169, DOI 10.1016/j.jaci.2014.12.1924; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Harvey NC, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e4695; Holmes VA, 2009, BRIT J NUTR, V102, P876, DOI 10.1017/S0007114509297236; Jensen CB, 2012, NUTRIENTS, V4, P259, DOI 10.3390/nu4040259; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; Litonjua AA, 2016, JAMA-J AM MED ASSOC, V315, P362, DOI 10.1001/jama.2015.18589; Lundqvist A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150385; Magnus MC, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k2167; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; Milman N, 2012, J PERINAT MED, V40, P57, DOI 10.1515/JPM.2011.120; Moller UK, 2012, EUR J CLIN NUTR, V66, P862, DOI 10.1038/ejcn.2012.18; Moon RJ, 2015, AM J CLIN NUTR, V102, P1081, DOI 10.3945/ajcn.115.115295; O'Callaghan KM, 2018, AM J CLIN NUTR, V108, P77, DOI 10.1093/ajcn/nqy064; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Roth DE, 2018, NEW ENGL J MED, V379, P535, DOI 10.1056/NEJMoa1800927; Roth DE, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5237; Saraf R, 2016, MATERN CHILD NUTR, V12, P647, DOI 10.1111/mcn.12210; Schoos AMM, 2019, CHILDREN-BASEL, V6, DOI 10.3390/children6100116; Tsuprykov O, 2018, J STEROID BIOCHEM, V181, P80, DOI 10.1016/j.jsbmb.2018.03.005; Zhu B, 2019, J ONCOL, V2019, DOI 10.1155/2019/7634746	37	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231657	10.1371/journal.pone.0231657	http://dx.doi.org/10.1371/journal.pone.0231657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302333	gold, Green Published			2022-12-26	WOS:000536016100040
J	Joshi, B; Lyngdoh, S; Singh, SK; Sharma, R; Kumar, V; Tiwari, VP; Dar, SA; Maheswari, A; Pal, R; Bashir, T; Reshamwala, HS; Shrotriya, S; Sathyakumar, S; Habib, B; Kvist, L; Goyal, SP				Joshi, BheemDutt; Lyngdoh, Salvador; Singh, Sujeet Kumar; Sharma, Reeta; Kumar, Vinay; Tiwari, Ved Prakash; Dar, S. A.; Maheswari, Aishwarya; Pal, Ranjana; Bashir, Tawqir; Reshamwala, Hussain Saifee; Shrotriya, Shivam; Sathyakumar, S.; Habib, Bilal; Kvist, Laura; Goyal, Surendra Prakash			Revisiting the Woolly wolf (Canis lupus chanco) phylogeny in Himalaya: Addressing taxonomy, spatial extent and distribution of an ancient lineage in Asia	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; POPULATION-GROWTH; SNOW LEOPARD; WOLVES; CARNIVORES; PHYLOGEOGRAPHY; PREY; SEQUENCES; SOFTWARE; MONGOLIA	Of the sub-species of Holarctic wolf, the Woolly wolf (Canis lupus chanco) is uniquely adapted to atmospheric hypoxia and widely distributed across the Himalaya, Qinghai Tibetan Plateau (QTP) and Mongolia. Taxonomic ambiguity still exists for this sub-species because of complex evolutionary history anduse of limited wild samples across its range in Himalaya. We document for the first time population genetic structure and taxonomic affinity of the wolves across western and eastern Himalayan regions from samples collected from the wild (n = 19) using mitochondrial control region (225bp). We found two haplotypes in our data, one widely distributed in the Himalaya that was shared with QTP and the other confined to Himachal Pradesh and Uttarakhand in the western Himalaya, India. After combining our data withpublished sequences (n = 83), we observed 15 haplotypes. Some of these were shared among different locations from India to QTP and a few were private to geographic locations. A phylogenetic tree indicated that Woolly wolves from India, Nepal, QTP and Mongolia are basal to other wolves with shallow divergence (K2P; 0.000-0.044) and high bootstrap values. Demographic analyses based on mismatch distribution and Bayesian skyline plots (BSP) suggested a stable population over a long time (similar to million years) with signs of recent declines. Regional dominance of private haplotypes across its distribution range may indicate allopatric divergence. This may be due to differences in habitat characteristics, availability of different wild prey species and differential deglaciation within the range of the Woolly wolf during historic time. Presence of basal and shallow divergence within-clade along with unique ecological requirements and adaptation to hypoxia, the Woolly wolf of Himalaya, QTP, and Mongolian regions may be considered as a distinct an Evolutionary Significant Unit (ESU). Identifying management units (MUs) is needed within its distribution range using harmonized multiple genetic data for effective conservation planning.	[Joshi, BheemDutt; Lyngdoh, Salvador; Singh, Sujeet Kumar; Sharma, Reeta; Kumar, Vinay; Tiwari, Ved Prakash; Dar, S. A.; Maheswari, Aishwarya; Pal, Ranjana; Bashir, Tawqir; Reshamwala, Hussain Saifee; Shrotriya, Shivam; Sathyakumar, S.; Habib, Bilal; Goyal, Surendra Prakash] Wildlife Inst India, Dehra Dun, Uttarakhand, India; [Kvist, Laura] Univ Oulu, Dept Biol, Oulu, Finland	Wildlife Institute of India; University of Oulu	Joshi, B; Lyngdoh, S; Habib, B; Goyal, SP (corresponding author), Wildlife Inst India, Dehra Dun, Uttarakhand, India.	joshidutt01@gmail.com; salvador@wii.gov.in; bh@wii.gov.in; goyalsp@wii.gov.in	Shrotriya, Shivam/AFK-8208-2022; Singh, Sujeet Kumar/ABC-2594-2020; Maheshwari, Aishwarya/AGY-9507-2022; Biocon, Ranjana/AAN-2515-2021; Lyngdoh, Salvador/E-5831-2013	Shrotriya, Shivam/0000-0003-0420-5815; Singh, Sujeet Kumar/0000-0002-3671-1328; Biocon, Ranjana/0000-0002-6011-104X; lyngdoh, salvador/0000-0002-0784-5204; Sharma, Reeta/0000-0001-9862-9218; Maheshwari, Aishwarya/0000-0002-6338-4254; Lyngdoh, Salvador/0000-0001-9809-0347; Joshi, Bheem Dutt/0000-0002-6534-1119; Habib, Bilal/0000-0003-0040-6214	Wildlife Institute of India	Wildlife Institute of India	Wildlife Institute of India Grant in aid funds.	Aggarwal RK, 2007, J ZOOL SYST EVOL RES, V45, P163, DOI 10.1111/j.1439-0469.2006.00400.x; Ahmed Tanveer, 2018, Proceedings of the Zoological Society (Calcutta), V71, P320, DOI 10.1007/s12595-017-0212-4; Albrecht J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10772-6; An B, 2009, MOL PHYLOGENET EVOL, V50, P526, DOI 10.1016/j.ympev.2008.12.003; [Anonymous], 2014, TRACER V1 6; Aslam ML, 2012, WHOLE GENOME SNP DIS; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banfield W. FA, 1974, MAMMALS CANADA; Blanford W.T., 1888, FAUNA BRIT INDIA INC; Bocci A, 2017, EUR J WILDLIFE RES, V63, DOI 10.1007/s10344-017-1151-0; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Carmichael LE, 2001, MOL ECOL, V10, P2787, DOI 10.1046/j.1365-294X.2001.t01-1-01408.x; Chetri M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170549; Chetri M, 2016, ZOOKEYS, P143, DOI 10.3897/zookeys.582.5966; Cho YS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3433; Davey JL, 2010, BRIEF FUNCT GENOMICS, V9, P416, DOI 10.1093/bfgp/elq031; De Groot GA, 2016, MAMMAL REV, V46, P44, DOI 10.1111/mam.12052; Drummond A, 2013, DIVERGENCE DATING TU, P1; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Ersmark E, 2016, FRONT ECOL EVOL, V4, DOI 10.3389/fevo.2016.00134; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang XM, 1997, EARTH PLANET SC LETT, V146, P73, DOI 10.1016/S0012-821X(96)00222-1; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Fleischer RC, 2001, EVOLUTION, V55, P1882, DOI 10.1111/j.0014-3820.2001.tb00837.x; Fu YX, 1997, GENETICS, V147, P915; Gaubert P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042740; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hodgson B.H., 1847, CALCUTTA J NATURAL H, V7, P469; Honghai Z, 1998, J FOR RES, V9, P40, DOI [10.1007/bf02856453, DOI 10.1007/BF02856453]; Ishiguro N, 2016, ZOOL SCI, V33, P44, DOI 10.2108/zs150110; Jamtsho Y, 2019, PASTORALISM, V9, DOI 10.1186/s13570-018-0136-2; Janecka JE, 2017, J HERED, V108, P597, DOI 10.1093/jhered/esx044; Jedrzejewski W, 2012, J MAMMAL, V93, P1480, DOI 10.1644/10-MAMM-A-132.1; Jumabay-Uulu K, 2014, ORYX, V48, P529, DOI 10.1017/S0030605313000306; Kaczensky P, 2008, WILDLIFE BIOL, V14, P444, DOI 10.2981/0909-6396-14.4.444; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Kim SY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171394; KUDAKTIN A N, 1979, Byulleten' Moskovskogo Obshchestva Ispytatelei Prirody Otdel Biologicheskii, V84, P56; Li J., 1995, UPLIFT QINGHAI XIZAN; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu BW, 2003, ACTA THERIOL, V48, P255, DOI 10.1007/BF03194165; Lyngdoh SB, 2020, J ZOOL, V310, P24, DOI 10.1111/jzo.12724; MacArthur R. H., 1972, GEOGRAPHICAL ECOLOGY; McCarthy TM, 2009, URSUS, V20, P30, DOI 10.2192/07GR013R.1; Morin PA, 2018, METHODS MOL BIOL, V1712, P113, DOI 10.1007/978-1-4939-7514-3_9; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Nagy JA, 2000, STATUS DIET ARCTIC W; Nakazawa C., 2008, BIOSPHERE CONSERV NA, V9, P1, DOI DOI 10.20798/BIOSPHERECONS.9.1_1; Nei M., 1987, MOL EVOLUTIONARY GEN; Newsome TM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15469; Newsome TM, 2016, MAMMAL REV, V46, P255, DOI 10.1111/mam.12067; Nowak Ronald M., 2003, P239; Palomares F, 2002, MOL ECOL, V11, P2171, DOI 10.1046/j.1365-294X.2002.01608.x; Pilot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093828; Pocock RI., 1941, FAUNA BRIT INDIA MAM, V2; Rambaut A, 2009, FIGTREE VER 1 3 1; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ruan XD, 2005, J MAMMAL, V86, P881, DOI 10.1644/1545-1542(2005)86[881:EHACPR]2.0.CO;2; Rueness EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016385; Senn H, 2017, HEREDITY EDINB, V2017; Sharma DK, 2004, P ROY SOC B-BIOL SCI, V271, pS1, DOI 10.1098/rsbl.2003.0071; Shrotriya S, 2012, CURR SCI INDIA, V103, P885; Shukla M, 2019, ANIM BIOTECHNOL, V30, P193, DOI 10.1080/10495398.2018.1521822; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; SLATKIN M, 1991, GENETICS, V129, P555; Soule M. E., 1980, CONSERVATION BIOL EV; Stronen AV, 2015, ECOL EVOL, V5, P4410, DOI 10.1002/ece3.1695; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan S, 2017, ECOL EVOL, V7, P7047, DOI 10.1002/ece3.3269; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsuda K, 1997, GENES GENET SYST, V72, P229, DOI 10.1266/ggs.72.229; Wang J, 2014, CHINESE SCI BULL, V59, P3162, DOI 10.1007/s11434-014-0370-y; Werhahn G, 2018, GLOB ECOL CONSERV, V16, DOI 10.1016/j.gecco.2018.e00455; Werhahn G, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170186; Yumnam B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138497; Zhang FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060712; Zhang WP, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004466	80	9	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231621	10.1371/journal.pone.0231621	http://dx.doi.org/10.1371/journal.pone.0231621			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298359	Green Published, gold			2022-12-26	WOS:000536011400073
J	Kato, N; Negishi, K; Sakai, C; Tsubota, K				Kato, Naoko; Negishi, Kazuno; Sakai, Chikako; Tsubota, Kazuo			Baseline factors predicting the need for corneal crosslinking in patients with keratoconus	PLOS ONE			English	Article							PROGRESSIVE KERATOCONUS; CLINICAL-TRIAL	Introduction The primary purpose of crosslinking is to halt the progression of ectasia. We retrospectively assessed the condition of keratoconus patients who were followed-up at least twice after the initial examination to evaluate keratoconus progression, to identify definitive factors to predict a later need for corneal crosslinking (CXL). Methods The medical charts of 158 eyes of 158 keratoconus patients (112 males and 46 females; mean age, 27.8 +/- 11.7 years), who were followed up at the Department of Ophthalmology, Keio University School of Medicine at least twice after the initial examination to evaluate keratoconus progression were retrospectively reviewed. Best-spectacle corrected visual acuity, intraocular pressure, steepest corneal axis on the anterior float (Ks), thinnest corneal thickness according to Pentacam (R) HR, and corneal endothelial cell density were assessed. Gender, age, onset age of keratoconus, history of atopic dermatitis, and Pentacam (R) indices were also recorded. CXL was performed when the eye showed significant keratoconus progression, an increase in the steepest keratometric value, or an increase in the spherical equivalent or cylinder power of the manifest refraction by more than 1.0 D versus the respective values 2 years prior. Predictor variables and the requirement for CXL were analyzed using logistic regression. Results Fifty-eight eyes required CXL treatment. The best predictor of the requirement for CXL was patient age, followed by the Pentacam (R) Rmin (the minimum sagittal curvature evaluated by Pentacam (R)) value. The incidence of CXL was 86.4% in the < 20 years age group, with an Rmin of <= 5.73 mm, whereas 10.8% in the >= 27 years age group with an Rmin > 5.73 mm underwent treatment. Conclusions An age of < 20 years and an Rmin value of <= 5.73 mm predicted keratoconus progression and the requirement for CXL treatment in the near future.	[Kato, Naoko] Minamiaoyama Eye Clin, Tokyo, Japan; [Kato, Naoko; Negishi, Kazuno; Sakai, Chikako; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan; [Tsubota, Kazuo] Tsubota Lab Inc, Tokyo, Japan	Keio University	Kato, N (corresponding author), Minamiaoyama Eye Clin, Tokyo, Japan.; Kato, N (corresponding author), Keio Univ, Sch Med, Dept Ophthalmol, Tokyo, Japan.	naokato@bc.iij4u.or.jp	Negishi, Kazuno/AAG-3260-2021; Tsubota, Kazuo/M-1915-2013	Negishi, Kazuno/0000-0002-2892-9810; Kato, Naoko/0000-0002-6670-2043; Tsubota, Kazuo/0000-0002-8874-7111	EyeLens Pte. Ltd.; Tsubota Laboratory, Inc.	EyeLens Pte. Ltd.; Tsubota Laboratory, Inc.	This work was partly supported by funding from EyeLens Pte. Ltd., a distributor of the products and/or procedures of corneal crosslinking. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Outside the submitted work, Kazuo Tsubota reports his position as CEO of Tsubota Laboratory, Inc., Tokyo, Japan, a company producing a keratoconus treatment-related device. Tsubota Laboratory, Inc. provided support in the form of salary for KT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhayek A, 2015, INT J OPHTHALMOL-CHI, V8, P407, DOI 10.3980/j.issn.2222-3959.2015.02.35; Asri D, 2011, J CATARACT REFR SURG, V37, P2137, DOI 10.1016/j.jcrs.2011.08.026; Blackburn BJ, 2019, FRONT BIOENG BIOTECH, V29, P7, DOI DOI 10.3389/FBI0E.2019.00066; Ferdi AC, 2019, OPHTHALMOLOGY, V126, P935, DOI 10.1016/j.ophtha.2019.02.029; Fujimoto H, 2016, INVEST OPHTH VIS SCI, V57, pOCT169, DOI 10.1167/iovs.15-18650; Gokul A, 2017, BRIT J OPHTHALMOL, V101, P839, DOI 10.1136/bjophthalmol-2016-308682; Henriquez MA, 2018, EUR J OPHTHALMOL, V28, P415, DOI 10.1177/1120672118760149; Hersh PS, 2017, OPHTHALMOLOGY, V124, P1259, DOI [10.1016/j.ophtha.2017.03.052, 10.1016/j.ophtha.2017.05.036]; Jedzierowska M, 2019, BIOMED ENG ONLINE, V18, DOI 10.1186/s12938-019-0636-3; Khattak A, 2015, SAUDI J OPHTHALMOL, V29, P249, DOI 10.1016/j.sjopt.2015.02.005; Mazzotta C, 2018, CORNEA, V37, P560, DOI 10.1097/ICO.0000000000001505; Moshirfar Majid, 2013, Oman J Ophthalmol, V6, P12, DOI 10.4103/0974-620X.111895; Mukhtar S, 2018, INT OPHTHALMOL, V38, P2257, DOI 10.1007/s10792-017-0699-8; Olivo-Payne A, 2019, CLIN OPHTHALMOL, V13, P1183, DOI 10.2147/OPTH.S183347; Perez-Straziota C, 2018, CORNEA, V37, P802, DOI 10.1097/ICO.0000000000001579; Romano V, 2018, J REFRACT SURG, V34, P177, DOI 10.3928/1081597X-20180104-01; Terai N, 2012, CURR EYE RES, V37, P553, DOI 10.3109/02713683.2012.669007; Tian L, 2014, J REFRACT SURG, V30, P785, DOI 10.3928/1081597X-20140930-01; Wagner H, 2007, Cont Lens Anterior Eye, V30, P223, DOI 10.1016/j.clae.2007.03.001; Wisse RPL, 2019, JAMA OPHTHALMOL, V137, P610, DOI 10.1001/jamaophthalmol.2019.0415; Wittig-Silva C, 2008, J REFRACT SURG, V24, pS720, DOI 10.3928/1081597X-20080901-15; Wollensak G, 2003, AM J OPHTHALMOL, V135, P620, DOI 10.1016/S0002-9394(02)02220-1	22	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231439	10.1371/journal.pone.0231439	http://dx.doi.org/10.1371/journal.pone.0231439			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298314	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400044
J	Razem, K; Kocijan, J; Podbregar, M; Lucovnik, M				Razem, Katja; Kocijan, Jus; Podbregar, Matej; Lucovnik, Miha			Near-infrared spectroscopy of the placenta for monitoring fetal oxygenation during labour	PLOS ONE			English	Article							CEREBRAL HEMODYNAMICS; 1ST STAGE; OXIMETRY; RESUSCITATION	Although being the golden standard for intrapartum fetal surveillance, cardiotocography (CTG) has been shown to have poor specificity for detecting fetal acidosis. Non-invasive near-infrared-spectroscopy (NIRS) monitoring of placental oxygenation during labour has not been studied yet. The objective of the study was to determine whether changes in placental NIRS values during labour could identify intrapartum fetal hypoxia and resulting acidosis. We included 43 healthy women in active stage of labour at term. CTG and NIRS parameters in groups with vs. without neonatal umbilical artery pH <= 7.20 were compared using Mann-Whitney-U. Receiver-operating-characteristics (ROC) curves were used to estimate predictive value of CTG and NIRS parameters for neonatal pH <= 7.20. A computer-based statistical classification was also performed to further evaluate predictive values of CTG and NIRS for neonatal acidosis. Ten (23%) neonates were born with umbilical artery pH. 7.20. Compared to group with pH > 7.20, fetal acidosis was associated with more episodes of placental NIRS deoxygenation (9 (range 2-37) vs. 2 (range 0-65); p<0.001), higher velocity of placental NIRS deoxygenation (2.31 (range 0-22) vs. 1 (range 0-49) %/s; p = 0.03), more decelerations on CTG (25 (range 3-91) vs. 10 (range 10-60); p = 0.02), and more prolonged decelerations on CTG (2 (range 0-4) vs. 1 (range 0-3); p = 0.04). Number of placental deoxygenations had the highest prognostic value for fetal/neonatal acidosis (area under the ROC curve 0.85 (95% confidence interval 0.70-0.99). Computer-based classification also identified number of placental deoxygenations as the most accurate classifier, with 25% false positive and 93% true positive rate in the training dataset, with 100% accuracy when applied to the testing dataset. Placental deoxygenations during labour measured by NIRS are associated with fetal/neonatal acidosis. Predictive value of placental NIRS for neonatal acidosis was superior to that of CTG.	[Razem, Katja; Lucovnik, Miha] UniversityMed Ctr Ljubljana, Dept Perinatol, Div Obstet & Gynecol, Ljubljana, Slovenia; [Kocijan, Jus] Jozef Stefan Inst, Dept Syst & Control, Ljubljana, Slovenia; [Kocijan, Jus] Univ Nova Gorica, Sch Engn & Management, Nova Gorica, Slovenia; [Podbregar, Matej] Gen Hosp Celje, Dept Intens Internal Med, Celje, Slovenia; [Podbregar, Matej; Lucovnik, Miha] Univ Ljubljana, Fac Med, Ljubljana, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Nova Gorica; University of Ljubljana	Razem, K (corresponding author), UniversityMed Ctr Ljubljana, Dept Perinatol, Div Obstet & Gynecol, Ljubljana, Slovenia.	katja.razem@gmail.com	Kocijan, Jus/A-2681-2008; Ražem, Katja/AAO-8591-2020	Kocijan, Jus/0000-0002-1221-946X; Ražem, Katja/0000-0002-3699-759X	Slovenian Research Agency [P2-0001]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The author JK acknowledges research core funding No. P2-0001, which was financially supported by the Slovenian Research Agency. The Slovenian Research Agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich CJ, 1996, EUR J OBSTET GYN R B, V64, P189, DOI 10.1016/0301-2115(95)02284-8; ALDRICH CJ, 1995, BRIT J OBSTET GYNAEC, V102, P9, DOI 10.1111/j.1471-0528.1995.tb09018.x; Alfirevic Z, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066; American College of Obstetricians and Gynecologists, 2010, Obstet Gynecol, V116, P1232, DOI 10.1097/AOG.0b013e3182004fa9; [Anonymous], [No title captured]; Ayres-De-Campos D, 1999, BRIT J OBSTET GYNAEC, V106, P1307, DOI 10.1111/j.1471-0528.1999.tb08187.x; Ayres-De-Campos D, 2015, INT J GYNECOL OBSTET, V131, P13, DOI 10.1016/j.ijgo.2015.06.020; Belfort MA, 2015, NEW ENGL J MED, V373, P632, DOI 10.1056/NEJMoa1500600; Bickler P, 2017, ANESTH ANALG, V124, P72, DOI 10.1213/ANE.0000000000001348; Blackwell SC, 2011, AM J OBSTET GYNECOL, V204, P371, DOI 10.1016/j.ajog.2011.02.073; D'Antona D, 1997, J Biomed Opt, V2, P15, DOI 10.1117/12.263748; DONKER DK, 1993, EUR J OBSTET GYN R B, V52, P21, DOI 10.1016/0028-2243(93)90220-7; DOYLE PM, 1994, J PERINAT MED, V22, P265; Duret J, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0854-4; Green DW, 2017, ANAESTHESIA, V72, P48, DOI 10.1111/anae.13740; Grochtmann M., 1993, Software Testing, Verification and Reliability, V3, P63, DOI 10.1002/stvr.4370030203; Hasegawa J, 2010, J PERINAT MED, V38, P29, DOI [10.1515/JPM.2010.003, 10.1515/jpm.2010.003]; Kakogawa J, 2010, AM J PERINAT, V27, P463, DOI 10.1055/s-0030-1247600; Kawamura T, 2007, AM J PERINAT, V24, P161, DOI 10.1055/s-2006-958155; Martin CB, 1998, EUR J OBSTET GYN R B, V78, P133, DOI 10.1016/S0301-2115(98)00059-1; May R., ARTIFICIAL NEURAL NE; McKinley BA, 2000, J TRAUMA, V48, P637, DOI 10.1097/00005373-200004000-00009; Moerman A, 2015, CURR OPIN ANESTHESIO, V28, P703, DOI 10.1097/ACO.0000000000000256; Mozina H, 2010, CRIT CARE, V14, DOI 10.1186/cc8929; National Collaborating Centre for Women's and Children's Health (UK), 2014, INTR CAR CAR HLTH WO; Parer JT, 2000, AM J OBSTET GYNECOL, V182, P982, DOI 10.1016/S0002-9378(00)70358-9; Parer JT, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.037; PEEBLES DM, 1992, AM J OBSTET GYNECOL, V166, P1369, DOI 10.1016/0002-9378(92)91606-B; Peebles DM, 1997, CLIN PERINATOL, V24, P547, DOI 10.1016/S0095-5108(18)30158-1; Podbregar M, 2007, CRIT CARE, V11, DOI 10.1186/cc5153; Sultana Jobaida, 2009, Mymensingh Med J, V18, pS103; The MathWorks Inc, 2016, STAT MACH LEARN TOOL; Zia S, 2013, J TURK-GER GYNECOL A, V14, P190, DOI 10.5152/jtgga.2013.92609	33	2	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231461	10.1371/journal.pone.0231461	http://dx.doi.org/10.1371/journal.pone.0231461			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298307	Green Published, gold			2022-12-26	WOS:000536011400050
J	Takagi, S; Sato, Y; Kokubun, A; Inomata, E; Agatsuma, Y				Takagi, Satomi; Sato, Yoichi; Kokubun, Atsuko; Inomata, Eri; Agatsuma, Yukio			Odor-active compounds from the gonads of Mesocentrotus nudus sea urchins fed Saccharina japonica kelp	PLOS ONE			English	Article							VOLATILE FLAVOR COMPONENTS; GAS CHROMATOGRAPHY-OLFACTOMETRY; AROMA COMPOUNDS; QUALITY; GC; STORAGE; COLOR	Gonad size, color, texture and taste of Mesocentrotus nudus sea urchins collected from a barren can be improved by a short-term cage culture while being fed fresh Saccharina japonica kelp during May-July. We investigated the effect of S. japonica feeding during May-July on the improvement of gonad flavor in M. nudus collected from a barren. After feeding, we analyzed the odor-active volatile organic compounds (VOCs) from the gonads using gas chromatography-mass spectrometry and GC-sniffing analyses and compared to those from the gonads of wild sea urchins from an Eisenia kelp bed (fishing ground) and a barren. A total of 48 VOCs were detected from the gonads of cultured and wild sea urchins. Of them, a larger number of odor-active compounds were detected in the gonads of cultured sea urchins (25) than in those from the Eisenia bed (14) and the barren (6). Dimethyl sulfide from the gonads of sea urchins from the barren was described as having a strong, putrid odor. Sea urchin-like aromas were attributed to 2-butanol, 2-ethylhexanol, benzaldehyde and ethylbenzene from the gonads of cultured sea urchin and those of the Eisenia bed. Kelp feeding decreased the putrid odor from dimethyl sulfide, and enhanced pleasant, sweet aromas.	[Takagi, Satomi; Inomata, Eri; Agatsuma, Yukio] Tohoku Univ, Grad Sch Agr Sci, Lab Marine Plant Ecol, Aoba Ku, Sendai, Miyagi, Japan; [Sato, Yoichi] Riken Food Co Ltd, Tagajo, Miyagi, Japan; [Sato, Yoichi] RIKEN, Nishina Ctr Accelerator Based Sci, Wako, Saitama, Japan; [Kokubun, Atsuko] RIKEN VITAMIN Co Ltd, Qual Assurance Div, Food Anal Lab, Saitama, Japan	Tohoku University; RIKEN	Agatsuma, Y (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Lab Marine Plant Ecol, Aoba Ku, Sendai, Miyagi, Japan.	yukio.agatsuma.c7@tohoku.ac.jp		sato, yoichi/0000-0001-9813-6181; Takagi, Satomi/0000-0001-5946-4297	Japan Society for the Promotion of Science [17J02308]; Riken Food Co., Ltd.; RIKEN VITAMIN Co., Ltd.	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Riken Food Co., Ltd.; RIKEN VITAMIN Co., Ltd.	This study was financially supported by the Grand-in-Aid for JSPS Fellow [grant number 17J02308] from Japan Society for the Promotion of Science [S.T.], and basic science research funding of Riken Food Co., Ltd. [Y.S.] and RIKEN VITAMIN Co., Ltd. [A.K.]. The funders provided financial support in the form of salaries for authors [S.T., Y.S., A.K.] and research materials, but did not have any additional role in the study design, data collection and analysis, decision for publication, or preparation of the manuscript.	Agatsuma Y, 2005, AQUACULTURE, V249, P449, DOI 10.1016/j.aquaculture.2005.04.054; Agatsuma Yukio, 1997, Scientific Reports of Hokkaido Fisheries Experimental Station, V51, P1; Agatsuma Y, 2013, DEV AQUAC FISH SCI, V38, P449, DOI 10.1016/B978-0-12-396491-5.00029-0; Bakalar N, 2012, NATURE, V486, pS4, DOI 10.1038/486S4a; BUTTERY RG, 1976, J AGR FOOD CHEM, V24, P829, DOI 10.1021/jf60206a037; CHA YJ, 1993, J FOOD SCI, V58, P525, DOI 10.1111/j.1365-2621.1993.tb04316.x; Cruz-Romero M, 2008, FOOD CONTROL, V19, P1139, DOI 10.1016/j.foodcont.2007.12.004; De Quiros ARB, 2001, EUR FOOD RES TECHNOL, V212, P643; EDWARDS RA, 1987, J SCI FOOD AGR, V38, P57, DOI 10.1002/jsfa.2740380110; Hui Y.H., 2010, HDB FRUIT VEGETABLE; Kelly MS, 2013, DEV AQUAC FISH SCI, V38, P171, DOI 10.1016/B978-0-12-396491-5.00011-3; Kinoshita Y, 2009, NIPPON SUISAN GAKK, V75, P237, DOI 10.2331/suisan.75.237; Le Guen S, 2000, J CHROMATOGR A, V896, P361, DOI 10.1016/S0021-9673(00)00729-9; Le Pape MA, 2004, J AGR FOOD CHEM, V52, P550, DOI 10.1021/jf030478x; Lopez-Perez O, 2017, FOOD RES INT, V99, P1002, DOI 10.1016/j.foodres.2016.12.013; lwai T., 2018, ASAHI SHIMBUN N 0728; MACLEOD AJ, 1982, J AGR FOOD CHEM, V30, P515, DOI 10.1021/jf00111a026; MACLEOD AJ, 1985, J AGR FOOD CHEM, V33, P380, DOI 10.1021/jf00063a015; McBride SC, 2004, AQUACULTURE, V233, P405, DOI 10.1016/j.aquaculture.2003.10.014; Miyasaki T, 2012, AQUACULTURE SCI, V60, P349; Montero-Calderon M., 2010, Handbook of fruit and vegetable flavors, P391; Narain N., 2010, Handbook of fruit and vegetable flavors, P345; NARAIN N, 1990, J FOOD SCI, V55, P1303, DOI 10.1111/j.1365-2621.1990.tb03921.x; Niimi J, 2010, FOOD CHEM, V121, P601, DOI 10.1016/j.foodchem.2009.12.071; Pearce CM, 2003, J SHELLFISH RES, V22, P505; Phillips K, 2010, LWT-FOOD SCI TECHNOL, V43, P202, DOI 10.1016/j.lwt.2009.08.008; Phillips K, 2009, AQUACULTURE, V288, P205, DOI 10.1016/j.aquaculture.2008.11.026; Robinson SMC, 2002, AQUACULTURE, V206, P289, DOI 10.1016/S0044-8486(01)00723-2; Sato Y., 2019, Food and Nutrition Sciences, V10, P860; Senger-Emonnot P, 2006, FOOD CHEM, V97, P465, DOI 10.1016/j.foodchem.2005.05.026; Shalit M, 2001, J AGR FOOD CHEM, V49, P794, DOI 10.1021/jf001075p; Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405; Spence C, 2015, FLAVOUR, V30, DOI [10.1186/s13411-015-0040-2, DOI 10.1186/S13411-015-0040-2]; Sun J, 2015, ECHINODERM AQUACULTURE, P25; Takagi S, 2019, J APPL PHYCOL, V31, P4037, DOI 10.1007/s10811-019-01895-6; Takagi S, 2017, AQUACULTURE, V477, P50, DOI 10.1016/j.aquaculture.2017.04.033; TAMURA H, 1995, J JPN SOC FOOD SCI, V42, P887; Unuma T, 2015, ECHINODERM AQUACULTURE, P77; Unuma Tatsuya, 2015, Bulletin of Fisheries Research Agency, P145; Walker CW, 2015, ECHINODERM AQUACULTURE, P263; Whitfield FB, 1998, INT J FOOD SCI TECH, V33, P31, DOI 10.1046/j.1365-2621.1998.00156.x; Yamamoto T, 2013, SCI REP-UK, V3, DOI 10.1038/srep01518; Zhu XL, 2009, CHROMATOGRAPHIA, V69, P735, DOI 10.1365/s10337-009-0968-4	43	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231673	10.1371/journal.pone.0231673	http://dx.doi.org/10.1371/journal.pone.0231673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298339	gold, Green Published			2022-12-26	WOS:000536011400087
J	Triana, MF; Franca, PHB; Queiroz, AFO; Santos, JM; Goulart, HF; Santana, AEG				Triana, Merybeth F.; Franca, Paulo H. B.; Queiroz, Abel F. O.; Santos, Jakeline M.; Goulart, Henrique F.; Santana, Antonio E. G.			Morphological, chemical and electrophysiological investigations of Telchin licus (Lepidoptera: Castniidae)	PLOS ONE			English	Article							SEX-PHEROMONE GLAND; EXTERNAL MORPHOLOGY; ANTENNAL SENSILLA; IDENTIFICATION; MOTH; PHYLOGENY; EVOLUTION; SYNOPSIS; VISION; BORER	The giant sugarcane borer Telchin licus (Drury, 1773) (Lepidoptera: Castniidae) is a day-flying moth pest of sugarcane, pineapples and bananas. To better understand the chemical communication in this species, we examined the morphology of its olfactory system and the chemical composition of its body parts. The ventral surface of the clubbed antennae of T. licus has six morphological types of sensilla: sensilla trichodea, basiconica, chaetica, squamiforma, coeloconica, and auricillica. The telescopic ovipositor shows no evidence of a sexual gland, or female-specific compounds. On the other hand, the midleg basitarsus of males releases (E,Z)-2,13-octadecadienol and (Z,E)-2,13-octadecadienol, which are electroantennographically active in both sexes. These compounds are known female sex pheromones in the Sesiidae family and are male-specific compounds in another castniid moth, although further investigations are necessary to elucidate their ecological role in the Castniidae family.	[Triana, Merybeth F.; Franca, Paulo H. B.; Queiroz, Abel F. O.; Santos, Jakeline M.] Univ Fed Alagoas, Chem & Biotechnol Inst, Maceio, Alagoas, Brazil; [Franca, Paulo H. B.; Goulart, Henrique F.; Santana, Antonio E. G.] Univ Fed Alagoas, Agr Sci Ctr, Maceio, Alagoas, Brazil	Universidade Federal de Alagoas; Universidade Federal de Alagoas	Triana, MF (corresponding author), Univ Fed Alagoas, Chem & Biotechnol Inst, Maceio, Alagoas, Brazil.; Santana, AEG (corresponding author), Univ Fed Alagoas, Agr Sci Ctr, Maceio, Alagoas, Brazil.	merybeth.triana@iqb.ufal.br; aegsal@gmail.com	Sant'Ana, Antonio/AAP-6955-2021	Barcellos Franca, Paulo Henrique/0000-0003-2464-3273; Queiroz, Abel Felipe de Oliveira/0000-0002-7265-0374; Santana, Antonio/0000-0002-3750-438X	Coordination of Superior Level Staff Improving (CAPES) [1486254/2015, 1538957/2015, 88882.316150]; National Counsel of Technological and Scientific Development (CNPq) [160208/2014-9]; INCT - Semiochemicals in Agriculture (CNPq) [465511/2014-7]; INCT - Semiochemicals in Agriculture (Fapesp) [2014/50871-0]	Coordination of Superior Level Staff Improving (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT - Semiochemicals in Agriculture (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); INCT - Semiochemicals in Agriculture (Fapesp)	The research was supported by the Coordination of Superior Level Staff Improving (CAPES) (MFT no 1486254/2015, AFQ no 1538957/2015, JMS no 88882.316150), the National Counsel of Technological and Scientific Development (CNPq) (PHBF no 160208/2014-9), INCT -Semiochemicals in Agriculture (CNPq no 465511/2014-7 and Fapesp no 2014/50871-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T., 2018, NUMBER SPECIES COUNT; Atencio R, 2019, SUGAR TECH, V21, P605, DOI 10.1007/s12355-018-0661-8; Balkenius A, 2006, J COMP PHYSIOL A, V192, P431, DOI 10.1007/s00359-005-0081-6; BIRCH MC, 1990, ANNU REV ENTOMOL, V35, P25, DOI 10.1146/annurev.en.35.010190.000325; Boroczky K, 2013, P NATL ACAD SCI USA, V110, P3615, DOI 10.1073/pnas.1212466110; Butt B., 1962, SEX DETERMINATION LE; Castrejon-Gomez VR, 1999, FLA ENTOMOL, V82, P546, DOI 10.2307/3496472; Clarke GM, 2003, CONSERV GENET, V4, P719, DOI 10.1023/B:COGE.0000006114.33543.32; Costanzo K, 2007, P ROY SOC B-BIOL SCI, V274, P845, DOI 10.1098/rspb.2006.3729; Delle-Vedove R, 2014, J INSECT SCI, V14, DOI 10.1093/jis/14.1.52; Dinardo-Miranda LL, 2013, SCI AGR, V70, P369, DOI 10.1590/S0103-90162013000500012; Douglas F., 2008, THESIS; Duckworth WD, 1977, CLASSIFICATION SESII; EL-Sayed AM, 2018, PHEROBASE; Frank DL, 2010, ANN ENTOMOL SOC AM, V103, P993, DOI 10.1603/AN09182; FREROT B, 2013, LEPIDOPTERA, V23, P137, DOI DOI 10.1007/S00049-013-0128-Z; Gonza les J., 1999, CIENCIA, V7; Gonzalez JM, 2004, ZOOTAXA, P1; Gonzalez Jorge M., 2007, Entomologische Zeitschrift, V117, P89; Heikkila M, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0520-0; Hillier NK, 2011, J CHEM ECOL, V37, P1127, DOI 10.1007/s10886-011-0017-2; Islam MA, 2007, J CHEM ECOL, V33, P1763, DOI 10.1007/s10886-007-9334-x; Jordan K., 1923, Novitates Zoologicae, V30, P159; Lamas G., 1993, REV PERUANA ENTOMOL, V35, P13; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Li XP, 2004, PROCEEDINGS OF THE 2004 INTERNATIONAL SYMPOSIUM ON MICRO-NANOMECHATRONICS AND HUMAN SCIENCE, P57; Lofstedt C, 2016, PHEROMONE COMMUNICATION IN MOTHS: EVOLUTION, BEHAVIOR, AND APPLICATION, P43; Ma M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40637; MALOSSE C, 1993, HRC-J HIGH RES CHROM, V16, P123, DOI 10.1002/jhrc.1240160213; Miller JY, 1980, STUDIES CASTNIIDAE; Mitter C, 2017, ANNU REV ENTOMOL, V62, P265, DOI 10.1146/annurev-ento-031616-035125; Moraes SS, 2009, REV BRAS ENTOMOL, V53, P245, DOI 10.1590/S0085-56262009000200007; Mozuraitis R, 2007, Z NATURFORSCH C, V62, P138; Mozuraitis R, 2013, J CHEM ECOL, V39, P1066, DOI 10.1007/s10886-013-0301-4; Osorio D, 2008, VISION RES, V48, P2042, DOI 10.1016/j.visres.2008.06.018; Percy-Cunningham J.E., 1987, P27; Pirih P, 2018, J COMP PHYSIOL A, DOI [10.1007/s00359-018.1287.2, DOI 10.1007/S00359-018.1287.2]; Quero C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171166; Raina AK, 2000, ARTHROPOD STRUCT DEV, V29, P343, DOI 10.1016/S1467-8039(01)00014-7; Reboucas LMC, 1999, QUIM NOVA, V22, P645, DOI 10.1590/S0100-40421999000500003; Regier JC, 2013, PLOS ONE, V8, DOI [10.1371/journalpone.0058568, DOI 10.1371/JOURNALPONE.0058568]; Leite LAR, 2010, BRAZ ARCH BIOL TECHN, V53, P1119, DOI 10.1590/S1516-89132010000500016; Riolo P, 2014, J ECON ENTOMOL, V107, P1009, DOI 10.1603/EC13298; Rios SD, 2011, ZOOTAXA, P43, DOI 10.11646/zootaxa.3055.1.3; Ruschioni S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124607; Salazar JA, 2013, B MUSEO ENTOMOLOGIC, V5, P17; Sarto I, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0029282, DOI 10.1371/JOURNAL.PONE.0029282]; Sarto I Monteys V, 2016, Bull Entomol Res, P1; Silva Junior MPd, 2008, NUCLEUS, V2008, P49, DOI [10.3738/1982.2278.90, DOI 10.3738/1982.2278.90]; SZOCS G, 1985, ENTOMOL EXP APPL, V39, P131, DOI 10.1007/BF00414499; Takacs S, 2001, CHEMOECOLOGY, V11, P153, DOI 10.1007/PL00001846; VANDERPERS JNC, 1980, INT J INSECT MORPHOL, V9, P15, DOI 10.1016/0020-7322(80)90032-X; Wadt L., 2012, THESIS; Yuan XQ, 2014, ZOOKEYS, P17, DOI 10.3897/zookeys.399.7063; Yuvaraj JK, 2018, MICRON, V111, P9, DOI 10.1016/j.micron.2018.05.006; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	56	1	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231689	10.1371/journal.pone.0231689	http://dx.doi.org/10.1371/journal.pone.0231689			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298345	Green Published, gold			2022-12-26	WOS:000536011400088
J	Valdovinos, EM; Niedzwiecki, MJ; Guo, J; Hsia, RY				Valdovinos, Erica M.; Niedzwiecki, Matthew J.; Guo, Joanna; Hsia, Renee Y.			Effects of Medicaid expansion on access, treatment and outcomes for patients with acute myocardial infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; INSURANCE STATUS; AMBULANCE DIVERSION; RACIAL DISPARITIES; CARE; REVASCULARIZATION; ASSOCIATION; HOSPITALS; MORTALITY	Introduction Uninsured patients have decreased access to care, lower rates of percutaneous coronary intervention (PCI), and worse outcomes after acute myocardial infarction (AMI). The aim of this study was to determine whether expanding insurance coverage through the Affordable Care Act's expansion of Medicaid eligibility affected access to PCI hospitals, rates of PCI, 30-day readmissions, and in-hospital mortality after AMI. Methods Quasi-experimental, difference-in-differences analysis of Medicaid and uninsured patients with acute myocardial infarction in California, which expanded Medicaid through the Affordable Care Act, and Florida, which did not, from 2010-2015. This study accounts for the early expansion of Medicaid in certain California counties that began as early as July 2011. Main outcomes included rates of admission to PCI hospitals, rates of transfer for patients who initially presented to non-PCI hospitals, rates of PCI, rates of early PCI defined as within 48 hours of hospital admission, in-hospital mortality, and 30-day readmission. Results 55,991 hospital admissions between 2010-2015 met inclusion criteria. Of these, 32,540 were in California, which expanded Medicaid, and 23,451 were in Florida, which did not. 30day readmission rates after AMI decreased by an absolute difference of 1.22 percentage points after the Medicaid expansion (95% CI -2.14 to -0.30, P < 0.01). This represented a relative decrease in readmission rates of 9.5% after AMI. No relationship between the Medicaid expansion and admission to PCI hospitals, transfer to PCI hospitals, rates of PCI, rates of early PCI, or in-hospital mortality were observed. Conclusions Hospital readmissions decreased by 9.5% after the Affordable Care Act expanded Medicaid eligibility, although there was no association found between Medicaid expansion and access to PCI hospitals or treatment with PCI. Better understanding the ways that Medicaid expansion might affect care for vulnerable populations with AMI is important for policymakers considering whether to expand Medicaid eligibility in their state.	[Valdovinos, Erica M.] Adventist Hlth Ukiah, Dept Emergency Med, Ukiah, CA USA; [Niedzwiecki, Matthew J.] Math Policy Res, Oakland, CA USA; [Niedzwiecki, Matthew J.; Guo, Joanna; Hsia, Renee Y.] Univ Calif San Francisco, Dept Emergency Med, San Francisco, CA 94143 USA; [Niedzwiecki, Matthew J.; Hsia, Renee Y.] Univ Calif San Francisco, Philip R Lee Inst Hlth Policy Studies, San Francisco, CA 94143 USA	Mathematica; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Valdovinos, EM (corresponding author), Adventist Hlth Ukiah, Dept Emergency Med, Ukiah, CA USA.	ericavaldovinos@gmail.com			NIH NHLBI [R01HL134182, R01HL114822]; Emergency Medicine Foundation Resident Research Grant 2017 - 2018; UCSF Open Access Publishing Fund	NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Emergency Medicine Foundation Resident Research Grant 2017 - 2018; UCSF Open Access Publishing Fund	This study was supported in part by NIH NHLBI R01HL134182 and R01HL114822 (RYH), and the Emergency Medicine Foundation Resident Research Grant 2017 - 2018 (EMV). Publication made possible in part by support from the UCSF Open Access Publishing Fund. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. The contents of the article are solely the responsibility of the authors and do not necessarily represent the official views of the funders.	Amsterdam EA, 2014, CIRCULATION, V130, pE344, DOI [10.1161/CIR.0000000000000134, 10.1161/CIR.0000000000000151]; [Anonymous], 2021, KAISER FAMILY FDN; Bertoni AG, 2005, J NATL MED ASSOC, V97, P317; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; BLUSTEIN J, 1995, MED CARE, V33, P864, DOI 10.1097/00005650-199508000-00010; Calvin JE, 2006, ANN INTERN MED, V145, P739, DOI 10.7326/0003-4819-145-10-200611210-00006; Charles EJ, 2017, ANN THORAC SURG, V104, P1251, DOI 10.1016/j.athoracsur.2017.03.079; Chen J, 2010, ARCH INTERN MED, V170, P433, DOI 10.1001/archinternmed.2009.538; Cho L, 2003, AM J CARDIOL, V91, P721, DOI 10.1016/S0002-9149(02)03413-6; Choi S, 2018, POPUL HEALTH MANAG, V21, P235, DOI 10.1089/pop.2017.0104; Cole MB, 2017, HEALTH AFFAIR, V36, P40, DOI 10.1377/hlthaff.2016.0804; Concannon TW, 2012, CIRC-CARDIOVASC QUAL, V5, P14, DOI 10.1161/CIRCOUTCOMES.111.963868; Cram P, 2009, J NATL MED ASSOC, V101, P1132, DOI 10.1016/S0027-9684(15)31109-3; Fang J, 2017, MMWR-MORBID MORTAL W, V66, P869, DOI 10.15585/mmwr.mm6633a1; Garcia JA, 2003, J COMMUN HEALTH, V28, P167, DOI 10.1023/A:1022904206936; Garfield R, 2018, COVERAGE GAP UNINSUR, DOI [10.1016/j.ypmed.2018.08.020, DOI 10.1016/J.YPMED.2018.08.020]; Gibson T, 2016, 201602 AG HEALTHC RE; Goodman-Bacon A, 2018, 25018 NBER, DOI DOI 10.3386/W25018; Gurwitz JH, 2002, AM J MED, V112, P528, DOI 10.1016/S0002-9343(02)01072-0; Hannan EL, 2013, J INTERV CARDIOL, V26, P470, DOI 10.1111/joic.12059; Hasan O, 2010, J HOSP MED, V5, P452, DOI 10.1002/jhm.687; Hsia RY, 2017, HEALTH AFFAIR, V36, P1070, DOI 10.1377/hlthaff.2016.0925; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Kerr E A, 1993, J Health Care Poor Underserved, V4, P133; Khatana SAM, 2019, JAMA CARDIOL, V4, P671, DOI 10.1001/jamacardio.2019.1651; Labarere J, 2007, ARCH INTERN MED, V167, P913, DOI 10.1001/archinte.167.9.913; Ladapo JA, 2017, AM J MANAGED CARE; Li SH, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150111; Loehrer AP, 2018, JAMA SURG, V153, DOI 10.1001/jamasurg.2017.5568; Loehrer AP, 2015, ANN SURG, V262, P139, DOI 10.1097/SLA.0000000000000970; Loehrer AP, 2013, JAMA SURG, V148, P1116, DOI 10.1001/jamasurg.2013.2750; Misky GJ, 2010, J HOSP MED, V5, P392, DOI 10.1002/jhm.666; Moore BJ, 2017, ICD 10 CM DIAGNOSIS; Niedzwiecki MJ, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008152; Pancholy S, 2017, AM J CARDIOL, V120, P1049, DOI 10.1016/j.amjcard.2017.06.041; Philbin EF, 2001, AM J PUBLIC HEALTH, V91, P1082, DOI 10.2105/AJPH.91.7.1082; Popescu I, 2007, JAMA-J AM MED ASSOC, V297, P2489, DOI 10.1001/jama.297.22.2489; Popescu I, 2011, CIRCULATION, V123, P2710, DOI 10.1161/CIRCULATIONAHA.110.973628; Shen YC, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010263; Shen YC, 2011, JAMA-J AM MED ASSOC, V305, P2440, DOI 10.1001/jama.2011.811; Singh JA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0190-6; Smolderen KG, 2010, JAMA-J AM MED ASSOC, V303, P1392, DOI 10.1001/jama.2010.409; Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419; Sommers BD, 2016, HEALTH SERV RES, V51, P825, DOI 10.1111/1475-6773.12397; U.S. Census Bureau, 2019, QUICKFACTS US; Wadhera RK, 2019, JAMA CARDIOL, V4, P120, DOI 10.1001/jamacardio.2018.4577; Yue D, 2018, HLTH SERV RES, V53; Zuckerman RB, 2016, NEW ENGL J MED, V374, P1543, DOI 10.1056/NEJMsa1513024	48	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232097	10.1371/journal.pone.0232097	http://dx.doi.org/10.1371/journal.pone.0232097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324827	gold, Green Submitted, Green Published			2022-12-26	WOS:000536033700073
J	Wang, H; Xie, YH; Zhang, HW; Jin, JH; Zhang, HX				Wang, Huan; Xie, Yuanhong; Zhang, Hanwei; Jin, Junhua; Zhang, Hongxing			Quantitative proteomic analysis reveals the influence of plantaricin BM-1 on metabolic pathways and peptidoglycan synthesis in Escherichia coli K12	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; NISIN RESISTANCE; BACTERIOCINS; PEPTIDE; PROTEIN; TARGET; ACID; BIOSYNTHESIS; MECHANISMS; MEMBRANE	Plantaricin BM-1 is a class IIa bacteriocin with a strong bactericidal effect on gram-positive bacteria. Although plantaricin BM-1 also inhibits the growth of some gram-negative bacteria, including Escherichia coli, the mechanism is not clear. In this study, we used tandem mass tag-based quantitative proteomics analysis to examine the inhibitory mechanism of plantaricin BM-1 against E. coli K12, and evaluated the morphological effects by electron microscopy. The results demonstrated that plantaricin BM-1 inhibits the growth of E. coli K12 by bacteriostatic action, mainly acting on the surface of the cell wall, leading to its collapse. Proteomic analysis identified 976 differentially expressed proteins (> 1.2-fold change, p < 0.05) under treatment with plantaricin BM-1, including 490 up-regulated proteins and 486 down-regulated proteins. These proteins were mainly involved in peptidoglycan synthesis and energy metabolism pathways, including amino acid, glyoxylate and dicarboxylate, ABC transporter, and quorum-sensing pathways. Specifically, plantaricin BM-1 treatment significantly improved peptidoglycan synthesis and enhanced the tricarboxylic acid cycle in E. coli K12, and altered the expression of cell membrane proteins. These results provide new insight into the inhibition mechanism of class IIa bacteriocins on gram-negative bacteria, which can lay the foundation for its broader use as an alternative to conventional antibiotics.	[Wang, Huan; Xie, Yuanhong; Zhang, Hanwei; Jin, Junhua; Zhang, Hongxing] Beijing Agr Univ, Coll Food Sci & Engn, Beijing Key Lab Agr Prod Detect & Control Spoilag, Beijing Lab Food Qual & Safety, Beijing, Peoples R China	Beijing University of Agriculture	Zhang, HX (corresponding author), Beijing Agr Univ, Coll Food Sci & Engn, Beijing Key Lab Agr Prod Detect & Control Spoilag, Beijing Lab Food Qual & Safety, Beijing, Peoples R China.	hxzhang51@163.com			Research project of Beijing Municipal Commission of Education [KM201810020016]	Research project of Beijing Municipal Commission of Education	This research was financial support was provided by the Research project of Beijing Municipal Commission of Education (KM201810020016).	Atrih A, 2001, INT J FOOD MICROBIOL, V68, P93, DOI 10.1016/S0168-1605(01)00482-2; Balciunas EM, 2013, FOOD CONTROL, V32, P134, DOI 10.1016/j.foodcont.2012.11.025; Brotz H, 1998, MOL MICROBIOL, V30, P317, DOI 10.1046/j.1365-2958.1998.01065.x; Cheng GY, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00217; CHIKINDAS ML, 1993, APPL ENVIRON MICROB, V59, P3577, DOI 10.1128/AEM.59.11.3577-3584.1993; Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937; D'Agata EMC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004036; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Dong Y, 2013, J ANTIMICROB CHEMOTH, V68, P816, DOI 10.1093/jac/dks490; Drider D, 2006, MICROBIOL MOL BIOL R, V70, P564, DOI 10.1128/MMBR.00016-05; Ennahar S, 2000, FEMS MICROBIOL REV, V24, P85, DOI 10.1111/j.1574-6976.2000.tb00534.x; Gravesen A, 2001, MICROB DRUG RESIST, V7, P127, DOI 10.1089/10766290152045002; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Kawamoto S, 2002, APPL ENVIRON MICROB, V68, P3830, DOI 10.1128/AEM.68.8.3830-3840.2002; Kemperman R, 2003, APPL ENVIRON MICROB, V69, P1589, DOI 10.1128/AEM.69.3.1589-1597.2003; Khalaf H, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0810-8; Kjos M, 2009, MICROBIOL-SGM, V155, P2949, DOI 10.1099/mic.0.030015-0; Kramer NE, 2008, MICROBIOL-SGM, V154, P1755, DOI 10.1099/mic.0.2007/015412-0; Kramer NE, 2006, ANTIMICROB AGENTS CH, V50, P1753, DOI 10.1128/AAC.50.5.1753-1761.2006; Masuda Y, 2012, BENEF MICROBES, V3, P3, DOI 10.3920/BM2011.0047; Miao JY, 2015, J AGR FOOD CHEM, V63, P7190, DOI 10.1021/acs.jafc.5b00678; MING XT, 1995, J FOOD PROTECT, V58, P416, DOI 10.4315/0362-028X-58.4.416; MOHAN S, 1994, J BIOL CHEM, V269, P32896; Riley MA, 2002, ANNU REV MICROBIOL, V56, P117, DOI 10.1146/annurev.micro.56.012302.161024; Robichon D, 1997, J BACTERIOL, V179, P7591, DOI 10.1128/jb.179.23.7591-7594.1997; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Tokuda H, 2004, BBA-MOL CELL RES, V1693, P5, DOI 10.1016/j.bbamcr.2004.02.005; Weatherspoon-Griffin N, 2011, J BIOL CHEM, V286, P5529, DOI 10.1074/jbc.M110.200352; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Yang WE, 2019, J FOOD SCI, V84, P1864, DOI 10.1111/1750-3841.14608; Yin SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074011; Zhang HX, 2013, MICROBIOL IMMUNOL, V57, P746, DOI 10.1111/1348-0421.12091	32	5	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231975	10.1371/journal.pone.0231975	http://dx.doi.org/10.1371/journal.pone.0231975			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324803	Green Published, gold			2022-12-26	WOS:000536033700054
J	Zwaferink, JBJ; Custers, W; Paardekooper, I; Berendsen, HA; Bus, SA				Zwaferink, Jennefer B. J.; Custers, Wim; Paardekooper, Irma; Berendsen, Heleen A.; Bus, Sicco A.			Optimizing footwear for the diabetic foot: Data-driven custom-made footwear concepts and their effect on pressure relief to prevent diabetic foot ulceration	PLOS ONE			English	Article							PLANTAR PRESSURE; IWGDF GUIDANCE; HIGH-RISK; ULCERS; PEOPLE; RECURRENCE; HISTORY; INSOLES	Aims To assess the effect of data-driven custom-made footwear concepts on plantar pressure relief to prevent diabetic foot ulceration. Methods Twenty-four neuropathic diabetic patients at high risk of foot ulceration were measured for in-shoe plantar pressures during walking in four data-driven custom-made footwear conditions, an athletic shoe and an off-the-shelf non-therapeutic shoe. Two evidence-based footwear conditions (Shoe-A; Insole-A) follow a scientific-based design protocol, are handmade, and use in-shoe plantar pressure guided optimization. One evidence-based insole condition (Insole-B) uses a barefoot plantar pressure and 3D foot shape-based computer-assisted design and manufacturing (CADCAM) routine. And one insole condition (Insole-C) uses a barefoot and in-shoe plantar pressure and 3D foot shape-based CADCAM design and optimization routine. Patient satisfaction was scored on walking comfort, shoe fit, weight and appearance. Results All data-driven footwear conditions significantly reduced metatarsal head peak pressure compared with the non-therapeutic shoe (17-53% relief). Shoe-A and Insole-A showed the lowest metatarsal head peak pressures (mean 112-155 kPa, 90-98% of cases < 200 kPa), significantly lower than for Insole-B and Insole-C (mean 119-199 kPa, 52-100% < 200 kPa). Patient satisfaction was not significantly different between footwear concepts. Conclusions This study proves the offloading efficacy of a scientific-based, handmade, and in-shoe plantar pressure data-driven approach to custom-made footwear design, and advocates its implementation to optimize diabetic footwear for plantar foot ulcer prevention.	[Zwaferink, Jennefer B. J.; Bus, Sicco A.] Univ Amsterdam, Amsterdam Movement Sci, Amsterdam UMC, Dept Rehabil Med, Amsterdam, Netherlands; [Custers, Wim; Paardekooper, Irma] Penders Voetzorg, Delft, Netherlands; [Berendsen, Heleen A.] Reinier Graaf Gasthuis, Dept Rehabil Med, Delft, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; Reinier de Graaf Hospital	Bus, SA (corresponding author), Univ Amsterdam, Amsterdam Movement Sci, Amsterdam UMC, Dept Rehabil Med, Amsterdam, Netherlands.	s.a.bus@amsterdamumc.nl		Bus, Sicco/0000-0002-8357-9163	Penders Voetzorg; Choose Your Shoes, Heijthuijsen, the Netherlands	Penders Voetzorg; Choose Your Shoes, Heijthuijsen, the Netherlands	An unrestricted grant from Penders Voetzorg and Choose Your Shoes, Heijthuijsen, the Netherlands, was provided for this study. Insole-B, marketed under the name DIABETEC (R) and manufactured by IETEC Orthopadische Einlagen GmbH, Kunzell, Germany, and Insole-C, marketed under the name TrueContour (R) Therapeutic Insoles and manufactured by DIApedia, State College, Pennsylvania, USA, were provided for this study free of charge by the manufacturing companies. Insoles A, B and C were tested in the X-DIAB shoe, provided for this study free of charge by the manufacturer (Podartis Srl, Montebelluna, Italy). WK and IP are paid employees of Penders Voetzorg. None of these funders had any involvement in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Arts MLJ, 2015, DIABETIC MED, V32, P790, DOI 10.1111/dme.12741; Arts MLJ, 2011, CLIN BIOMECH, V26, P880, DOI 10.1016/j.clinbiomech.2011.05.001; Arts MLJ, 2014, J REHABIL MED, V46, P357, DOI 10.2340/16501977-1272; Bus SA, 2016, DIABETES-METAB RES, V32, P25, DOI 10.1002/dmrr.2697; Bus SA, 2005, CLIN BIOMECH, V20, P892, DOI 10.1016/j.clinbiomech.2005.05.004; Bus SA, 2004, CLIN BIOMECH, V19, P629, DOI 10.1016/j.clinbiomech.2004.02.010; Bus SA, 2013, DIABETES CARE, V36, P4109, DOI 10.2337/dc13-0996; Bus SA, 2011, DIABETES CARE, V34, P1595, DOI 10.2337/dc10-2206; Chapman JD, 2013, CLIN BIOMECH, V28, P679, DOI 10.1016/j.clinbiomech.2013.05.005; Guldemond NA, 2007, CLIN BIOMECH, V22, P81, DOI 10.1016/j.clinbiomech.2006.08.004; Hastings MK, 2007, FOOT ANKLE INT, V28, P84, DOI 10.3113/FAI.2007.0015; Monteiro-Soares M, 2012, DIABETES-METAB RES, V28, P574, DOI 10.1002/dmrr.2319; Mueller MJ, 2006, PHYS THER, V86, P833, DOI 10.1093/ptj/86.6.833; Owings TM, 2009, DIABETIC MED, V26, P1141, DOI 10.1111/j.1464-5491.2009.02835.x; Owings TM, 2008, DIABETES CARE, V31, P839, DOI 10.2337/dc07-2288; Schaper NC, 2016, DIABETES-METAB RES, V32, P7, DOI 10.1002/dmrr.2695; Ulbrecht JS, 2014, DIABETES CARE, V37, P1982, DOI 10.2337/dc13-2956; Van Netten JJ, 2018, J FOOT ANKLE RES, V11, P1, DOI DOI 10.1186/s13047-017-0243-0; van Schie C, 2000, FOOT ANKLE INT, V21, P833, DOI 10.1177/107110070002101007; Waaijman R, 2012, DIABETIC MED, V29, P1542, DOI 10.1111/j.1464-5491.2012.03700.x; Waaijman R, 2014, DIABETES CARE, V37, P1697, DOI 10.2337/dc13-2470	22	7	8	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0224010	10.1371/journal.pone.0224010	http://dx.doi.org/10.1371/journal.pone.0224010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324739	Green Published, gold			2022-12-26	WOS:000536033700002
J	Jirsova, K; Stangova, PS; Palos, M; Mahelkova, G; Kalasova, S; Rybickova, I; Utheim, TP; Vesela, V				Jirsova, Katerina; Stangova, Petra Seidler; Palos, Michalis; Mahelkova, Gabriela; Kalasova, Sarka; Rybickova, Ivana; Utheim, Tor Paaske; Vesela, Viera			Aberrant HLA-DR expression in the conjunctival epithelium after autologous serum treatment in patients with graft-versus-host disease or Sjogren's syndrome	PLOS ONE			English	Article							FLOW-CYTOMETRIC ANALYSIS; OCULAR SURFACE DISEASE; EYE DROPS; IMPRESSION CYTOLOGY; CELLS; KERATOCONJUNCTIVITIS; CYTOKINE; ANTIGENS; RELEVANCE; THERAPY	The aim of this study was to determine the effect of autologous serum (AS) eye drops on the density of human leucocyte antigen (HLA)-DR-positive epithelial cells and Langerhans cells on the ocular surface of patients with bilateral severe dry eye disease (DED) due to graft-versushost disease (GvHD) or Sjogren's syndrome (SS). The study was conducted on 24 patients (48 eyes). AS was applied 6-10 times daily for 3 months together with regular artificial tear therapy. HLA-DR-positive cells were detected by direct immunocytochemistry on upper bulbar conjunctiva imprints obtained before and after treatment. The application of AS drops led to a statistically significant increase in the mean density of aberrant HLA-DR-positive conjunctival epithelial cells (p < 0.05) and HLA-DR-positive Langerhans cells (p < 0.05) in the GvHD group. Aberrant HLA-DR-positive epithelial cells in the SS group were decreased non-significantly. All patients reported a significant decrease in the Ocular Surface Disease Index (p < 0.01), which indicates improvement of the patient's subjective feelings after therapy. There was an expected but non-significant decrease of aberrant HLA-DR-positive conjunctival epithelial cells in the SS group only. However, the increased density of HLA-DR-positive cells, indicating slight subclinical inflammation, does not outweigh the positive effect of AS in patients with DED from GvHD.	[Jirsova, Katerina; Kalasova, Sarka; Rybickova, Ivana; Vesela, Viera] Charles Univ Prague, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Fac Med 1, Prague, Czech Republic; [Jirsova, Katerina; Stangova, Petra Seidler; Palos, Michalis; Kalasova, Sarka; Rybickova, Ivana; Vesela, Viera] Gen Univ Hosp Prague, Prague, Czech Republic; [Stangova, Petra Seidler; Palos, Michalis] Charles Univ Prague, Fac Med 1, Dept Ophthalmol, Prague, Czech Republic; [Mahelkova, Gabriela] Charles Univ Prague, Fac Med 2, Dept Ophthalmol, Prague, Czech Republic; [Mahelkova, Gabriela] Motol Univ Hosp, Prague, Czech Republic; [Mahelkova, Gabriela] Charles Univ Prague, Fac Med 2, Dept Physiol, Prague, Czech Republic; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Plast & Reconstruct Surg, Oslo, Norway	Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague; Motol University Hospital; Charles University Prague; University of Oslo; University of Oslo	Jirsova, K (corresponding author), Charles Univ Prague, Inst Biol & Med Genet, Lab Biol & Pathol Eye, Fac Med 1, Prague, Czech Republic.; Jirsova, K (corresponding author), Gen Univ Hosp Prague, Prague, Czech Republic.	katerina.jirsova@lf1.cuni.cz	Mahelkova, Gabriela/AAV-4628-2020		Progres-Q25;  [IGA NT/12376-4];  [BBMRI_CZ LM2015089]	Progres-Q25; ; 	This work was supported by the research project IGA NT/12376-4, project BBMRI_CZ LM2015089 (KJ) and by Progres-Q25 (KJ,SK,VV).	Ali TK, 2018, AM J OPHTHALMOL, V189, P65, DOI 10.1016/j.ajo.2018.02.009; AMOILS B, 1986, CLIN EXP IMMUNOL, V66, P88; APPLETON AL, 1994, J CLIN PATHOL, V47, P541, DOI 10.1136/jcp.47.6.541; Azari AA, 2017, CUTAN OCUL TOXICOL, V36, P152, DOI 10.1080/15569527.2016.1209770; BALLARDINI G, 1984, LANCET, V2, P1009; Baudouin C, 1997, INVEST OPHTH VIS SCI, V38, P1458; BAUDOUIN C, 1992, BRIT J OPHTHALMOL, V76, P545, DOI 10.1136/bjo.76.9.545; BOTTAZZO GF, 1983, LANCET, V2, P1115; Bradley JC, 2009, CORNEA, V28, P200, DOI 10.1097/ICO.0b013e318186321e; Brignole F, 2000, INVEST OPHTH VIS SCI, V41, P1356; Brignole F, 1998, EXP EYE RES, V67, P687, DOI 10.1006/exer.1998.0566; Brignole-Baudouin F, 2017, INVEST OPHTH VIS SCI, V58, P2438, DOI 10.1167/iovs.15-16555; Chiang CC, 2007, CORNEA, V26, P861, DOI 10.1097/ICO.0b013e3180645cd7; Donisi PM, 2003, CORNEA, V22, P533, DOI 10.1097/00003226-200308000-00009; Eberwein P, 2013, MOL VIS, V19, P1492; Epstein SP, 2013, EXP EYE RES, V111, P95, DOI 10.1016/j.exer.2013.03.018; Feng JX, 2004, J PEDIATR SURG, V39, P1658, DOI 10.1016/j.jpedsurg.2004.07.010; FOULIS AK, 1986, DIABETES, V35, P1215, DOI 10.2337/diabetes.35.11.1215; Geerling G, 2004, BRIT J OPHTHALMOL, V88, P1467, DOI 10.1136/bjo.2004.044347; Goto E, 2001, CORNEA, V20, P807, DOI 10.1097/00003226-200111000-00006; HANAFUSA T, 1983, LANCET, V2, P1111; IMAMURA M, 1994, BONE MARROW TRANSPL, V13, P745; Jirsova K, 2006, HISTOL HISTOPATHOL, V21, P355, DOI 10.14670/HH-21.355; Jirsova K, 2014, CURR EYE RES, V39, P21, DOI 10.3109/02713683.2013.824987; JONES DT, 1994, INVEST OPHTH VIS SCI, V35, P3493; Kojima T, 2005, AM J OPHTHALMOL, V139, P242, DOI 10.1016/j.ajo.2004.08.040; Lange Andrzej, 1995, Archivum Immunologiae et Therapiae Experimentalis, V43, P99; Lee SY, 2013, AM J OPHTHALMOL, V156, P247, DOI 10.1016/j.ajo.2013.04.003; Murphy GF, 2004, BIOL BLOOD MARROW TR, V10, P357, DOI 10.1016/j.bbmt.2004.02.005; Na KS, 2012, J OCUL PHARMACOL TH, V28, P479, DOI 10.1089/jop.2012.0002; Nicolle P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041221; Noble BA, 2004, BRIT J OPHTHALMOL, V88, P647, DOI 10.1136/bjo.2003.026211; Oberhuber G, 1999, AM J SURG PATHOL, V23, P970, DOI 10.1097/00000478-199908000-00016; Ogawa Y, 2003, BONE MARROW TRANSPL, V31, P579, DOI 10.1038/sj.bmt.1703862; Oh Joo Youn, 2011, Korean J Ophthalmol, V25, P73, DOI 10.3341/kjo.2011.25.2.73; Pan Q, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009327.pub3; Pflugfelder SC, 1999, CURR EYE RES, V19, P201, DOI 10.1076/ceyr.19.3.201.5309; Pflugfelder SC, 2007, OCUL SURF, V5, P163; Pflugfelder SC, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092760; Pisella PJ, 2000, OPHTHALMOLOGY, V107, P1841, DOI 10.1016/S0161-6420(00)00347-X; Rocha EM, 2000, BONE MARROW TRANSPL, V25, P1101, DOI 10.1038/sj.bmt.1702334; Rolando M, 2005, CORNEA, V24, P951, DOI 10.1097/01.ico.0000157421.93522.00; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Stern ME, 2002, INVEST OPHTH VIS SCI, V43, P2609; Szodoray P, 2005, CLIN IMMUNOL, V117, P168, DOI 10.1016/j.clim.2005.06.016; Tahmaz V, 2017, BRIT J OPHTHALMOL, V101, P322, DOI 10.1136/bjophthalmol-2015-307666; Tersigni C, 2018, J REPROD IMMUNOL; Tsubota K, 1999, BRIT J OPHTHALMOL, V83, P390, DOI 10.1136/bjo.83.4.390; Tsubota K, 1999, OPHTHALMOLOGICA, V213, P16, DOI 10.1159/000027387; Versura P, 2011, INVEST OPHTH VIS SCI, V52, P5488, DOI 10.1167/iovs.11-7215; Westekemper H, 2010, BONE MARROW TRANSPL, V45, P1340, DOI 10.1038/bmt.2009.346; ZSCHALER U, 1991, Z GASTROENTEROL, V29, P92	52	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231473	10.1371/journal.pone.0231473	http://dx.doi.org/10.1371/journal.pone.0231473			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315325	gold, Green Submitted, Green Published			2022-12-26	WOS:000536024800027
J	Liu, Z; Shriner, D; Hansen, NF; Rotimi, CN; Mullikin, JC				Liu, Zhi; Shriner, Daniel; Hansen, Nancy F.; Rotimi, Charles N.; Mullikin, James C.		NISC Comparative Sequencing	Admixture mapping identifies genetic regions associated with blood pressure phenotypes in African Americans	PLOS ONE			English	Article							GENOME-WIDE; ATOPIC-DERMATITIS; HYPERTENSION; DISEASE; LINKAGE; LOCI; MUTATIONS; MINDY-1; DESIGN	Hypertension occurs at a higher rate in African Americans than in European Americans. Based on the assumption that causal variants are more frequently found on DNA segments inherited from the ancestral population with higher disease risk, we employed admixture mapping to identify genetic loci with excess local African ancestry associated with blood pressure. Chromosomal regions 1q21.2-21.3, 4p15.1, 19q12 and 20p13 were significantly associated with diastolic blood pressure (beta = 5.28, -7.94, -6.82 and 5.89, P-value = 6.39E-04, 2.07E-04, 6.56E-05 and 5.04E-04, respectively); 1q21.2-21.3 and 19q12 were also significantly associated with mean arterial pressure (beta = 5.86 and -6.40, P-value = 5.32E-04 and 6.37E-04, respectively). We further selected SNPs that had large allele frequency differences within these regions and tested their association with blood pressure. SNP rs4815428 was significantly associated with diastolic blood pressure after Bonferroni correction (beta = -2.42, P-value = 9.57E-04), and it partially explained the admixture mapping signal at 20p13. SNPs rs771205 (beta = -1.99, P-value = 3.37E-03), rs3126067, rs2184953 and rs58001094 (the latter three exhibit strong linkage disequilibrium, beta = -2.3, P-value = 1.4E-03) were identified to be significantly associated with mean arterial pressure, and together they fully explained the admixture signal at 1q21.2-21.3. Although no SNP at 4p15.1 showed large ancestral allele frequency differences in our dataset, we detected association at low-frequency African-specific variants that mapped predominantly to the gene PCDH7, which is most highly expressed in aorta. Our results suggest that these regions may harbor genetic variants that contribute to the different prevalence of hypertension.	[Liu, Zhi; Hansen, Nancy F.; Mullikin, James C.] NHGRI, Canc Genet & Comparat Genom Branch, NIH, Bethesda, MD 20892 USA; [Shriner, Daniel; Rotimi, Charles N.] NHGRI, Ctr Res Genom & Global Hlth, NIH, Bethesda, MD 20892 USA; [Mullikin, James C.; NISC Comparative Sequencing] NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Mullikin, JC (corresponding author), NHGRI, Canc Genet & Comparat Genom Branch, NIH, Bethesda, MD 20892 USA.; Mullikin, JC (corresponding author), NHGRI, NIH Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA.	mullikin@mail.nih.gov		Vemulapalli, Meghana/0000-0003-3687-313X; Shriner, Daniel/0000-0003-1928-5520	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD	Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD	This research was supported by the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892 .	Adeyemo AA, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00335; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Baker JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01837-7; Barnes KC, 2010, J ALLERGY CLIN IMMUN, V125, P16, DOI 10.1016/j.jaci.2009.11.008; Boguniewicz M, 2011, IMMUNOL REV, V242, P233, DOI 10.1111/j.1600-065X.2011.01027.x; Butler AW, 2009, NEUROBIOL AGING, V30, P1037, DOI 10.1016/j.neurobiolaging.2009.03.013; Durbin R, 2014, BIOINFORMATICS, V30, P1266, DOI 10.1093/bioinformatics/btu014; Ehret G. B, 2017, GENETIC FACTORS PATH; Ehret GB, 2013, EUR HEART J, V34, P951, DOI 10.1093/eurheartj/ehs455; Fryar CD, 2016, HYPERTENSION PREVALE; Hu YN, 2013, AM J HUM GENET, V93, P891, DOI 10.1016/j.ajhg.2013.10.008; Hughes-Austin JM, 2017, AM J NEPHROL, V46, P481, DOI 10.1159/000485259; Kang HM, 2003, EPACTS EFFICIENT PAR; Karczewski K.J., 2019, GENOMICS, DOI [10.1101/531210, DOI 10.1101/531210]; Kim M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190077; Kiritsi D, 2015, J ALLERGY CLIN IMMUN, V135, P280, DOI 10.1016/j.jaci.2014.09.042; Kramer H, 2004, AM J HYPERTENS, V17, P963, DOI 10.1016/j.amjhyper.2004.06.001; Kristariyanto YA, 2017, EMBO REP, V18, P392, DOI 10.15252/embr.201643205; Levy D, 2009, NAT GENET, V41, P677, DOI 10.1038/ng.384; Liu F, 2007, AM J HUM GENET, V81, P17, DOI 10.1086/518720; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Maass PG, 2015, NAT GENET, V47, P647, DOI 10.1038/ng.3302; Martinac B, 2014, BBA-BIOMEMBRANES, V1838, P682, DOI 10.1016/j.bbamem.2013.07.015; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Rice NE, 2008, J ALLERGY CLIN IMMUN, V122, P834, DOI 10.1016/j.jaci.2008.07.027; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Salvi E, 2012, HYPERTENSION, V59, P248, DOI 10.1161/HYPERTENSIONAHA.111.181990; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Shetty PB, 2012, J HYPERTENS, V30, P1970, DOI 10.1097/HJH.0b013e3283578c80; Shriner D, 2012, HUM HERED, V73, P73, DOI 10.1159/000335899; Shriner D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002325; Shringarpure SS, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1082-x; Sofer T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188400; Sung YJ, 2018, AM J HUM GENET, V102, P375, DOI 10.1016/j.ajhg.2018.01.015; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Wang CL, 2015, AM J HUM GENET, V96, P926, DOI 10.1016/j.ajhg.2015.04.018; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Yang XL, 2014, CIRC-CARDIOVASC GENE, V7, P521, DOI 10.1161/CIRCGENETICS.113.000332; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113	43	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0232048	10.1371/journal.pone.0232048	http://dx.doi.org/10.1371/journal.pone.0232048			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315356	gold, Green Published			2022-12-26	WOS:000536024800070
J	Melendez, DM; Nordquist, RE; Vanderschuren, LJMJ; van der Staay, FJ				Melendez, Daniela M.; Nordquist, Rebecca E.; Vanderschuren, Louk J. M. J.; van der Staay, Franz-Josef			Spatial memory deficits after vincristine-induced lesions to the dorsal hippocampus	PLOS ONE			English	Article							CONE FIELD; WORKING-MEMORY; COGNITIVE DYSFUNCTION; OBJECT RECOGNITION; RATS; MAZE; PERFORMANCE; LEUKEMIA; CORTEX; TASK	Vincristine is a commonly used cytostatic drug for the treatment of leukemia, neuroblastoma and lung cancer, which is known to have neurotoxic properties. The aim of this study was to assess the effects of vincristine, injected directly into the dorsal hippocampus, in spatial memory using the spatial cone field discrimination task. Long Evans rats were trained in the cone field, and after reaching training criterion received bilateral vincristine infusions into the dorsal hippocampus. Vincristine-treated animals presented unilateral or bilateral hippocampal lesions. Animals with bilateral lesions showed lower spatial working and reference memory performance than control animals, but task motivation was unaffected by the lesions. Working and reference memory of animals with unilateral lesions did not differ from animals with bilateral lesions and control animals. In sum, intrahippocampal injection of vincristine caused profound tissue damage in the dorsal hippocampus, associated with substantial cognitive deficits.	[Melendez, Daniela M.; Nordquist, Rebecca E.; van der Staay, Franz-Josef] Univ Utrecht, Fac Vet Med, Behav & Welf Grp, Div Farm Anim Hlth,Dept Populat Hlth Sci, Utrecht, Netherlands; [Nordquist, Rebecca E.; Vanderschuren, Louk J. M. J.] Univ Utrecht, Fac Vet Med, Dept Populat Hlth Sci Anim Sci & Soc, Utrecht, Netherlands; [Melendez, Daniela M.] Agr & Agri Food Canada, Lethbridge Res & Dev Ctr, Lethbridge, AB, Canada	Utrecht University; Utrecht University; Agriculture & Agri Food Canada	Nordquist, RE (corresponding author), Univ Utrecht, Fac Vet Med, Behav & Welf Grp, Div Farm Anim Hlth,Dept Populat Hlth Sci, Utrecht, Netherlands.; Nordquist, RE (corresponding author), Univ Utrecht, Fac Vet Med, Dept Populat Hlth Sci Anim Sci & Soc, Utrecht, Netherlands.	R.E.Nordquist1@uu.nl	Meléndez, Daniela/AAT-9279-2020; Nordquist, Rebecca E./B-7455-2013	Meléndez, Daniela/0000-0002-0153-9708; Nordquist, Rebecca E./0000-0002-8541-5285; van der Staay, F. Josef/0000-0002-8704-3366	Faculty of Veterinary Science, University Utrecht	Faculty of Veterinary Science, University Utrecht	The study has been financed by the Faculty of Veterinary Science, University Utrecht.	Anagnostaras SG, 1999, J NEUROSCI, V19, P1106; BADDELEY AD, 1991, BRAIN, V114, P2521, DOI 10.1093/brain/114.6.2521; Baddeley A, 2012, ANNU REV PSYCHOL, V63, P1, DOI 10.1146/annurev-psych-120710-100422; Bassareo V, 1999, EUR J NEUROSCI, V11, P4389, DOI 10.1046/j.1460-9568.1999.00843.x; Blokland A, 1998, BEHAV PHARMACOL, V9, P429, DOI 10.1097/00008877-199809000-00006; BLOKLAND A, 1993, PHARMACOL BIOCHEM BE, V46, P27, DOI 10.1016/0091-3057(93)90312-H; Bouger PCM, 2005, EUR NEUROPSYCHOPHARM, V15, P331, DOI 10.1016/j.euroneuro.2004.11.006; Boykoff N, 2009, J CANCER SURVIV, V3, P223, DOI 10.1007/s11764-009-0098-x; Bubb Emma J, 2017, Brain Neurosci Adv, V1, DOI 10.1177/2398212817723443; Cooper S, 1993, OPIOIDS 2, P239; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Eijkenboom M, 1999, NEUROSCIENCE, V91, P1299, DOI 10.1016/S0306-4522(98)00657-5; Fardell JE, 2010, PHARMACOL BIOCHEM BE, V97, P333, DOI 10.1016/j.pbb.2010.08.019; Foley JJ, 2008, PSYCHOPHARMACOLOGY, V199, P527, DOI 10.1007/s00213-008-1175-y; Forwood SE, 2005, HIPPOCAMPUS, V15, P347, DOI 10.1002/hipo.20059; Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607; Fremouw T, 2012, PHARMACOL BIOCHEM BE, V100, P451, DOI 10.1016/j.pbb.2011.10.008; Galani R, 2002, NEUROBIOL LEARN MEM, V77, P1, DOI 10.1006/nlme.2000.3998; Geisler S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.129920; GOLDSCHMIDT RB, 1989, BRAIN RES, V486, P133, DOI 10.1016/0006-8993(89)91285-7; Harvey RE, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00094; HERNANDEZ L, 1988, LIFE SCI, V42, P1705, DOI 10.1016/0024-3205(88)90036-7; Holt W, 1999, J NEUROSCI, V19, P9054, DOI 10.1523/JNEUROSCI.19-20-09054.1999; Honig W. K., 1978, COGNITIVE PROCESS, P211; JACKSON DV, 1979, CANCER RES, V39, P4346; Jordan M. A., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P1, DOI 10.2174/1568011023354290; JORDAN MA, 1991, CANCER RES, V51, P2212; Konat GW, 2008, METAB BRAIN DIS, V23, P325, DOI 10.1007/s11011-008-9100-y; Koros C, 2007, NEUROTOXICOLOGY, V28, P83, DOI 10.1016/j.neuro.2006.07.016; Kothari A, 2016, CANCER RES, V76, P3553, DOI 10.1158/0008-5472.CAN-15-2104; LaPointe NE, 2013, NEUROTOXICOLOGY, V37, P231, DOI 10.1016/j.neuro.2013.05.008; Lee GD, 2006, CLIN CANCER RES, V12, P198, DOI 10.1158/1078-0432.CCR-05-1286; Lee SA, 2015, J COMP PSYCHOL, V129, P189, DOI 10.1037/a0039129; Lehmann H, 2007, HIPPOCAMPUS, V17, P370, DOI 10.1002/hipo.20274; Levin ED, 1996, PSYCHOPHARMACOLOGY, V127, P25, DOI 10.1007/BF02805971; Li CQ, 2008, BRAIN RES BULL, V77, P237, DOI 10.1016/j.brainresbull.2008.07.010; Liu FK, 2019, NEUROSCIENCE, V404, P530, DOI 10.1016/j.neuroscience.2018.12.047; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; MOSER MB, 1995, P NATL ACAD SCI USA, V92, P9697, DOI 10.1073/pnas.92.21.9697; OLTON DS, 1979, NEUROPSYCHOLOGIA, V17, P669, DOI 10.1016/0028-3932(79)90042-3; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Prickaerts J, 1999, EUR J PHARMACOL, V380, P61, DOI 10.1016/S0014-2999(99)00565-8; Riviere JE, 2009, VET PHARM THERAPEUTI, DOI [10.1016/j.pharmthera.2009.10.009, DOI 10.1016/J.PHARMTHERA.2009.10.009]; Roberts WA, 2017, LEARN BEHAV, V45, P263, DOI 10.3758/s13420-017-0263-4; Shabani M, 2012, CAN J PHYSIOL PHARM, V90, P379, DOI 10.1139/Y11-132; Shen JM, 1996, BEHAV NEUROSCI, V110, P1181, DOI 10.1037/0735-7044.110.5.1181; Sioka C, 2009, CANCER CHEMOTH PHARM, V63, P761, DOI 10.1007/s00280-008-0876-6; Spellman T, 2015, NATURE, V522, P309, DOI 10.1038/nature14445; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; SQUIRE LR, 1993, ANNU REV PSYCHOL, V44, P453, DOI 10.1146/annurev.ps.44.020193.002321; StubleyWeatherly L, 1996, BRAIN RES, V716, P29, DOI 10.1016/0006-8993(95)01589-2; SUTHERLAND RJ, 1983, BEHAV BRAIN RES, V7, P133, DOI 10.1016/0166-4328(83)90188-2; Szczodry O, 2014, BEHAV BRAIN RES, V274, P307, DOI 10.1016/j.bbr.2014.08.036; Toh HC, 1998, LEUKEMIA LYMPHOMA, V31, P195, DOI 10.3109/10428199809057599; van der Staay FJ, 2012, NEUROSCI BIOBEHAV R, V36, P379, DOI 10.1016/j.neubiorev.2011.07.008; van der Staay FJ, 2005, BEHAV BRAIN RES, V156, P1, DOI 10.1016/j.bbr.2004.05.010; VANDERSTAAY FJ, 1990, J NEUROSCI METH, V31, P13, DOI 10.1016/0165-0270(90)90004-Y; Winocur G, 2010, HIPPOCAMPUS, V20, P1350, DOI 10.1002/hipo.20721; Winters BD, 2004, J NEUROSCI, V24, P5901, DOI 10.1523/JNEUROSCI.1346-04.2004	60	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231941	10.1371/journal.pone.0231941	http://dx.doi.org/10.1371/journal.pone.0231941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315349	Green Published, gold			2022-12-26	WOS:000536024800066
J	Mazzei, LG; Bergamaschi, CD; Silva, MT; Barberato, S; Fulone, I; Moura, MD; Guimaraes, C; Lopes, LC				Mazzei, Lauren Giustti; Bergamaschi, Cristiane de Cassia; Silva, Marcus Tolentino; Barberato Filho, Silvio; Fulone, Izabela; Moura, Mariana Del Grossi; Guimaraes, Caio; Lopes, Luciane Cruz			Use of IMMPACT domains in clinical trials of acupuncture for chronic pain: A methodological survey	PLOS ONE			English	Article							LOW-BACK-PAIN; TENSION-TYPE HEADACHE; CORE OUTCOME DOMAINS; TRADITIONAL ACUPUNCTURE; KNEE OSTEOARTHRITIS; PHYSICAL FUNCTION; RANDOMIZED-TRIAL; NECK PAIN; MULTICENTER; MANAGEMENT	Acupuncture is one of the therapeutic resources used for the management of chronic pain. Variability in outcome measurements in randomized clinical trials of non-oncologic chronic pain (RCT-NOCP) generates inconsistencies in determining effects of treatments. The objective of this survey was to assess the adherence to the recommendations made by the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) in the measurement of RCT-NOCP of acupuncture. This methodological research made a systematic search for eligible studies from different sources of information. Eligible studies included those with number of patients.100, who randomized and allocated patients with chronic non-oncologic pain to be treated with acupuncture or with "sham" acupuncture, or non-acupuncture. This research included the recommendations for IMMPACT in the measurement of RCT-NOCP: presence of outcomes pain, physical function, emotional state and improvement perception of patient, the source of the outcome information pain and the tools used to measure such domains. From a total of 1,386 studies, 24 were included in this survey. Eleven studies presented low risk of bias. Pain outcome was measured in 23 studies, physical function in 22 studies, emotional state in 14 studies and improvement perception of patient in one study. As for the pain outcome, the patient was the information source in 50% of the studies. The measurement tools recommended for IMMPACT were included in eight studies (35%) that evaluated pain, one study that evaluated the emotional state (7%), and one study that evaluated the improvement perception and satisfaction of patient. It was observed that studies which did not adhere to the recommendations had more favorable results for acupuncture in the outcome pain. This study concludes that randomized clinical trials that used acupuncture to manage chronic pain failed to adhere to IMMPACT recommendations. Clinical societies and IMMPACT do not share the same recommendations. This fact reflects in the diversity of outcomes and instruments adopted in the studies, making it difficult to compare the results.	[Mazzei, Lauren Giustti; Bergamaschi, Cristiane de Cassia; Silva, Marcus Tolentino; Barberato Filho, Silvio; Fulone, Izabela; Moura, Mariana Del Grossi; Guimaraes, Caio; Lopes, Luciane Cruz] Univ Sorocaba, Pharmaceut Sci Grad Program, Sorocaba, SP, Brazil	Universidade de Sorocaba	Lopes, LC (corresponding author), Univ Sorocaba, Pharmaceut Sci Grad Program, Sorocaba, SP, Brazil.	luciane.lopes@prof.uniso.br	Silva, Marcus Tolentino/J-1791-2014; Barberato-Filho, Silvio/J-3956-2015; de Cássia Bergamaschi, cristiane/AAL-1552-2021; Lopes, Luciane Cruz/H-3159-2019	Silva, Marcus Tolentino/0000-0002-7186-9075; Barberato-Filho, Silvio/0000-0001-5179-3125; de Cássia Bergamaschi, cristiane/0000-0002-6608-1806; Lopes, Luciane Cruz/0000-0002-3684-3275; Fulone, Izabela/0000-0002-3211-6951; Mazzei, Lauren/0000-0001-8611-5594				Abdulla A, 2013, AGE AGEING, V42, pI1, DOI 10.1093/ageing/afs200; Akl EA, 2012, J CLIN EPIDEMIOL, V65, P262, DOI 10.1016/j.jclinepi.2011.04.015; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Blanpied Peter R, 2017, J Orthop Sports Phys Ther, V47, pA1, DOI 10.2519/jospt.2017.0302; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Brinkhaus B, 2006, ARCH INTERN MED, V166, P450; Busse JWGG, 2013, MODIFICATION COCHRAN; Chen LX, 2013, JCR-J CLIN RHEUMATOL, V19, P308, DOI 10.1097/RHU.0b013e3182a21848; Cho YJ, 2013, SPINE, V38, P549, DOI 10.1097/BRS.0b013e318275e601; Collins NJ, 2011, ARTHRIT CARE RES, V63, pS208, DOI 10.1002/acr.20632; CPSO, 2000, EV BAS REC MED MAN C; Diener HC, 2006, LANCET NEUROL, V5, P310, DOI 10.1016/S1474-4422(06)70382-9; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Dworkin RH, 2010, PAIN, V149, P177, DOI 10.1016/j.pain.2010.02.018; Endres Heinz G, 2007, J Headache Pain, V8, P306, DOI 10.1007/s10194-007-0416-5; Facco E, 2008, HEADACHE, V48, P398, DOI 10.1111/j.1526-4610.2007.00916.x; Fairbanks CA, 2015, EUR J PHARMACOL, V759, P169, DOI 10.1016/j.ejphar.2015.03.049; Foster NE, 2007, BMJ-BRIT MED J, V335, P436, DOI 10.1136/bmj.39280.509803.BE; Guerriere DN, 2010, CAN J ANAESTH, V57, P549, DOI 10.1007/s12630-010-9306-4; Haake M, 2007, ARCH INTERN MED, V167, P1892, DOI 10.1001/archinte.167.17.1892; Hinman RS, 2014, JAMA-J AM MED ASSOC, V312, P1313, DOI 10.1001/jama.2014.12660; Hooten WM, 2011, NATL GUIDELINE CLEAR, P112; IASP, 1994, CLASS CHRON PAIN INT; Irnich D, 2001, BMJ-BRIT MED J, V322, P1574, DOI 10.1136/bmj.322.7302.1574; Jena S, 2008, CEPHALALGIA, V28, P969, DOI 10.1111/j.1468-2982.2008.01640.x; KOPF AP, 2010, GUIA TRAT DOR CONT P; Liang ZH, 2011, COMPLEMENT THER MED, V19, pS26, DOI 10.1016/j.ctim.2010.11.005; Linde K, 2005, JAMA-J AM MED ASSOC, V293, P2118, DOI 10.1001/jama.293.17.2118; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Mazzei LG, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014904; Melchart D, 2005, BMJ-BRIT MED J, V331, P376, DOI 10.1136/bmj.38512.405440.8F; Molsberger AF, 2002, PAIN, V99, P579, DOI 10.1016/S0304-3959(02)00269-5; Molsberger AF, 2011, DTSCH Z AKUPUNKT, V54, P35, DOI 10.1016/j.dza.2011.01.008; Mulla SM, 2015, PAIN, V156, P1615, DOI 10.1097/j.pain.0000000000000241; Network SIG., 2013, 136 SIGN; OMS, 2013, ESTR OMS MED TRAD 20; Qaseem A, 2017, ANN INTERN MED, V166, P514, DOI 10.7326/M16-2367; Rasu RS, 2014, J MANAG CARE SPEC PH, V20, P921, DOI 10.18553/jmcp.2014.20.9.921; RNAO, 2013, ASS MAN PAIN REG NUR; Rosenquist RW, 2010, ANESTHESIOLOGY, V112, P810, DOI 10.1097/ALN.0b013e3181c43103; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Taylor AM, 2016, PAIN, V157, P1836, DOI 10.1097/j.pain.0000000000000577; Thomas KJ, 2006, BMJ-BRIT MED J, V333, P623, DOI 10.1136/bmj.38878.907361.7C; Turk DC, 2003, PAIN, V106, P337, DOI 10.1016/j.pain.2003.08.001; Turk DC, 2008, PAIN, V139, P485, DOI 10.1016/j.pain.2008.06.025; Turk DC, 2006, PAIN, V125, P208, DOI 10.1016/j.pain.2006.09.028; Vickers AJ, 2012, ARCH INTERN MED, V172, P1444, DOI 10.1001/archinternmed.2012.3654; White P, 2004, ANN INTERN MED, V141, P911, DOI 10.7326/0003-4819-141-12-200412210-00007; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7; Witt CM, 2006, PAIN, V125, P98, DOI 10.1016/j.pain.2006.05.013; Witt CM, 2006, ARTHRITIS RHEUM-US, V54, P3485, DOI 10.1002/art.22154; Witt CM, 2006, AM J EPIDEMIOL, V164, P487, DOI 10.1093/aje/kwj224; Yeh TS, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-144; Yin C, 2017, CURR OPIN ANESTHESIO, V30, P583, DOI 10.1097/ACO.0000000000000501	55	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231444	10.1371/journal.pone.0231444	http://dx.doi.org/10.1371/journal.pone.0231444			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298300	Green Published, gold			2022-12-26	WOS:000536011400047
J	Mengesha, A; Tewfik, N; Argaw, Z; Beletew, B; Wudu, M				Mengesha, Ayelign; Tewfik, Nete; Argaw, Zeleke; Beletew, Biruk; Wudu, Mesfin			Practice of and associated factors regarding prevention of surgical site infection among nurses working in the surgical units of public hospitals in Addis Ababa city, Ethiopia: A cross-sectional study	PLOS ONE			English	Article								Background Surgical site infections are one of the commonest types of healthcare-associated infections. Up to 60% of these infections are estimated to be preventable by using evidence-based guidelines. As a front line caregiver, nurses are responsible for the majority of preventive activities. Hence, the enhanced practical skill of nurses is an essential component in preventive actions. Objective The aim of this study was to assess the practice of nurses and identify factors associated with it regarding prevention of surgical site infections in Addis Ababa city public hospitals. Methods An institution-based cross-sectional study was carried out from March 01-30, 2018. An adapted and pretested, self-administered questionnaire was utilized as a data collection tool. A stratified random sampling technique was employed by considering the level of hospitals as a stratum. Data were entered into a computer using Epi-data 3.1 statistical package. Then, it was exported to SPSS Version 23 for further analysis. Descriptive statistics were computed for the study variables. Bivariate regression analysis was also run to assess the association between independent variables and the level of nurse's practice. To see the relative effect of independent variables on the nurse's practice, a multivariable regression analysis was carried out. Result A total of 409 nurses returned the questionnaire with a response rate of 98%. Majority (60.4%) of the participants were females and 84.1% were BSc holders. Less than half, (48.9%) of the participants were found to have good practice regarding prevention of surgical site infection. Being male, having more work experience, higher educational level and using available infection prevention guidelines were significantly associated with practice at p < 0.05. Conclusion More than half of the participants have inadequate practice regarding prevention of surgical site infection. Training nurses, making surgical site infection prevention guidelines easily accessible and ensuring possessed knowledge by nurses is potent enough and can be translated into desirable actions are recommended.	[Mengesha, Ayelign; Beletew, Biruk; Wudu, Mesfin] Woldia Univ, Coll Hlth Sci, Dept Nursing, Woldia, Amhara Regional, Ethiopia; [Tewfik, Nete; Argaw, Zeleke] Addis Ababa Univ, Dept Nursing, Coll Hlth Sci, Addis Ababa, Ethiopia	Addis Ababa University	Mengesha, A (corresponding author), Woldia Univ, Coll Hlth Sci, Dept Nursing, Woldia, Amhara Regional, Ethiopia.	Ayelignmengesha59@gmail.com	Mengesha, Ayelign/ABE-8609-2020; Beletew, Biruk/ABC-3508-2020	Mengesha, Ayelign/0000-0003-1505-9390; Kassaw, Mesfin Wudu/0000-0002-6327-7723	Addis Ababa University	Addis Ababa University	The study was funded by Addis Ababa University. However, the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JW, 2011, ANN SURG, V253, P1082, DOI 10.1097/SLA.0b013e31821175f8; Anderson DJ, 2014, INFECT CONT HOSP EP, V35, P605, DOI [10.1086/676022, 10.1017/S0899823X00193869]; Anderson DJ, 2013, AM J INFECT CONTROL, V41, P764, DOI 10.1016/j.ajic.2012.11.022; [Anonymous], 2017, ADDIS ABABA POPULATI; Baker AW, 2016, INFECT CONT HOSP EP, V37, P519, DOI 10.1017/ice.2016.13; Boone H.N., 2012, J EXT, V50, P1; Broex ECJ, 2009, J HOSP INFECT, V72, P193, DOI 10.1016/j.jhin.2009.03.020; Centers for Disease Control and Prevention, 2014, CDC NHSN SURG SIT IN; Kabir Humaun, 2017, PACIFIC RIM INT J NU, V21; Kiernan Martin, 2012, Nurs Times, V108, P12; Kolade OA., 2017, INT J NURS MIDWIFERY, V9, P65, DOI [10.5897/IJNM2017.0262, DOI 10.5897/IJNM2017.0262]; Laloto TL, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2167-x; Lead Benedetta Allegranzi, 2014, SWITZ 14 IFIC C MALT; Linda RG, 2015, AM NURSES TODAY, V10; Mengesha Reiye Esayas, 2014, BMC Res Notes, V7, P575, DOI 10.1186/1756-0500-7-575; Milne J., 2012, WOUNDS K, V8, P1; Mulu W., 2013, CLIN MED RES, V2, P140, DOI DOI 10.11648/J.CMR.20130206.1514; Mwakanyamale AA, 2013, THESIS; Naderi H, 2015, J PATIENT SAFET 1001, P3; Nejad SB, 2011, B WORLD HEALTH ORGAN, V89, P757, DOI 10.2471/BLT.11.088179; Ntsama EC, 2013, J MED MED SCI, V4, P241; Pear SM, 2007, MANAG INFECT CONTROL, P56; Sadia H., 2017, SAUDI J MED PHARM SC, V3, P585, DOI [10.17656/jsmc.10284, DOI 10.17656/JSMC.10284]; Sickder HK, 2014, NURSES KNOWLEDGE PRA; Sickder HK, 2017, PAC RIM INT J NURS R, V21, P244; Teshager FA, 2015, SURG RES PRACTICE, V2015; Teshager FA, 2015, SURG RES PRACTICE, V2015; Woelber E, 2016, SURG INFECT, V17, P510, DOI 10.1089/sur.2015.241; World Health Organization, 2016, GLOBAL GUIDELINES PR	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231270	10.1371/journal.pone.0231270	http://dx.doi.org/10.1371/journal.pone.0231270			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298296	gold, Green Published			2022-12-26	WOS:000536011400034
J	Ulyte, A; Wei, WJ; Dressel, H; Gruebner, O; von Wyl, V; Bahler, C; Blozik, E; Brungger, B; Schwenkglenks, M				Ulyte, Agne; Wei, Wenjia; Dressel, Holger; Gruebner, Oliver; von Wyl, Viktor; Bahler, Caroline; Blozik, Eva; Brungger, Beat; Schwenkglenks, Matthias			Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines	PLOS ONE			English	Article							HEALTH-CARE; RECOMMENDATIONS; PARTICIPATION; PROGRAMS	Variation in utilization of healthcare services is influenced by patient, provider and healthcare system characteristics. It could also be related to the evidence supporting their use, as reflected in the availability and strength of recommendations in clinical guidelines. In this study, we analyzed the geographic variation of colorectal, breast and prostate cancer screening utilization in Switzerland and the influence of available guidelines and different modifiers of access. Colonoscopy, mammography and prostate specific antigen (PSA) testing use in eligible population in 2014 was assessed with administrative claims data. We ran a multilevel multivariable logistic regression model and calculated Moran's I and regional level median odds ratio (MOR) statistics to explore residual geographic variation. In total, an estimated 8.1% of eligible persons received colonoscopy, 22.3% mammography and 31.3% PSA testing. Low deductibles, supplementary health insurance and enrollment in a managed care plan were associated with higher screening utilization. Cantonal breast cancer screening programs were also associated with higher utilization. Spatial clustering was observed in the raw regional utilization of all services, but only for prostate cancer screening in regional residuals of the multilevel model. MOR was highest for prostate cancer screening (1.24) and lowest for colorectal cancer screening (1.16). The reasons for the variation of the prostate cancer screening utilization, not recommended routinely without explicit shared decision-making, could be further investigated by adding provider characteristics and patient preference information. This first cross-comparison of different cancer screening patterns indicates that the strength of recommendations, mediated by specific health policies facilitating screening, may indeed contribute to variation.	[Ulyte, Agne; Wei, Wenjia; Gruebner, Oliver; von Wyl, Viktor; Bahler, Caroline; Brungger, Beat; Schwenkglenks, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, Dept Epidemiol, Zurich, Switzerland; [Dressel, Holger] Univ Zurich, Epidemiol Biostat & Prevent Inst, Dept Epidemiol, Div Occupat & Environm Med, Zurich, Switzerland; [Dressel, Holger] Univ Hosp Zurich, Zurich, Switzerland; [Gruebner, Oliver] Univ Zurich, Dept Geog, Zurich, Switzerland; [Bahler, Caroline; Blozik, Eva; Brungger, Beat] Helsana Grp, Dept Hlth Sci, Dubendorf, Switzerland; [Blozik, Eva] Univ Med Ctr Freiburg, Div Gen Practice, Freiburg, Germany	University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; University of Zurich; University of Freiburg	Ulyte, A (corresponding author), Univ Zurich, Epidemiol Biostat & Prevent Inst, Dept Epidemiol, Zurich, Switzerland.	agne.ulyte@uzh.ch	; Gruebner, Oliver/G-5126-2010; Brungger, Beat/T-1305-2018	Ulyte, Agne/0000-0001-7419-9778; Gruebner, Oliver/0000-0001-9783-4770; von Wyl, Viktor/0000-0002-8754-9797; Brungger, Beat/0000-0001-6173-5375; Wei, Wenjia/0000-0002-1977-8416; Schwenkglenks, Matthias/0000-0001-7217-1173	SNSF National Research Programme "Smarter Health Care" (NRP 74) [26, 407440_167349]	SNSF National Research Programme "Smarter Health Care" (NRP 74)	This work was supported by the SNSF National Research Programme "Smarter Health Care" (NRP 74), project number 26, grant number 407440_167349 (applicant MS, co-applicants VvW and HD, project and funding description available at http://www.nfp74.ch/en/projects/healthcare-across-sectors/project-schwenkglenks).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views reported here are of the authors' and do not necessarily reflect the funding organization. Helsana Group provided support in the form of salaries for authors CB, EB, BB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	[Anonymous], 2019, R LANG ENV STAT COMP; [Anonymous], 2017, NEW THER TRAUM; Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x; Appleby J., 2011, VARIATIONS HLTH CARE; Badgery-Parker T, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4159-1; Biller-Andorno N, 2014, NEW ENGL J MED, V370, P1965, DOI 10.1056/NEJMp1401875; Braud AM, 2019, INT J PHYTOREMEDIAT, V21, P1072, DOI 10.1080/15226514.2019.1606778; Bulliard JL, 2011, CANCER EPIDEMIOL, V35, P293, DOI 10.1016/j.canep.2010.07.015; Bundesamt fur Statistik, MS REG; Charlton C, 2019, MLWIN VERSION 3 04; Davis MM, 2017, PREV MED, V101, P44, DOI 10.1016/j.ypmed.2017.05.001; de Klerk CM, 2018, GUT, V67, P679, DOI 10.1136/gutjnl-2016-313311; Eichholzer M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1760-4; Fenner L, 2018, SWISS MED WEEKLY, V148; Fischer F, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030036; Fleurence RL, 2007, PHARMACOECONOMICS, V25, P3, DOI 10.2165/00019053-200725010-00002; Gasser T, 2012, SCHWEIZ MED FORUM, V12, P126; Gregorio DI, 2013, SPAT SPATIO-TEMPORAL, V6, P1, DOI 10.1016/j.sste.2013.04.002; Guessous I, 2012, PREV MED, V55, P521, DOI 10.1016/j.ypmed.2012.08.005; Gulliford Martin, 2002, J Health Serv Res Policy, V7, P186, DOI 10.1258/135581902760082517; Honein-AbouHaidar GN, 2016, CANCER EPIDEM BIOMAR, V25, P907, DOI 10.1158/1055-9965.EPI-15-0990; Huber CA, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-44; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Jorgensen KJ, 2017, BREAST, V31, P261, DOI 10.1016/j.breast.2016.08.002; Kearns B, 2018, CANCER MANAG RES, V10, P637, DOI 10.2147/CMAR.S153361; Larsen K, 2000, BIOMETRICS, V56, P909, DOI 10.1111/j.0006-341X.2000.00909.x; Larsen K, 2005, AM J EPIDEMIOL, V161, P81, DOI 10.1093/aje/kwi017; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; MORAN PAP, 1948, J ROY STAT SOC B, V10, P243; Neumann I, 2016, J CLIN EPIDEMIOL, V72, P45, DOI 10.1016/j.jclinepi.2015.11.017; Ponti A, 2017, CANC SCREENING EUROP, DOI DOI 10.1055/s-0032-1309822; QGIS Development Team, QGIS GEOGR INF SYST; Reich O., 2012, INT J INTEGR CARE, V12, P1; Senore C, 2018, GUT, V68; Tikkinen KAO, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3581; Vogt V, 2014, SOC SCI MED, V110, P74, DOI 10.1016/j.socscimed.2014.03.033; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; Weber MF, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-429; Wei W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35856-9; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961; Willems B, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3746-x; Zechmann S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217879	43	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231409	10.1371/journal.pone.0231409	http://dx.doi.org/10.1371/journal.pone.0231409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298325	Green Published, Green Submitted, gold			2022-12-26	WOS:000536011400041
J	Malainey, SL; Anderson, GS				Malainey, Stacey L.; Anderson, Gail S.			Impact of confinement in vehicle trunks on decomposition and entomological colonization of carcasses	PLOS ONE			English	Article							BLOW FLIES DIPTERA; INSECT SUCCESSION; ARTHROPOD SUCCESSION; POSTMORTEM INTERVAL; FORENSIC ENTOMOLOGY; PORCINE REMAINS; PIG CARRION; CALLIPHORIDAE; BEHAVIOR; INDOOR	In order to investigate the impact of confinement in a car trunk on decomposition and insect colonization of carcasses, three freshly killed pig (Sus scrofa domesticus Erxleben) carcasses were placed individually in the trunks of older model cars and deployed in a forested area in the southwestern region of British Columbia, Canada, together with three freshly killed carcasses which were exposed in insect-accessible protective cages in the same forest. Decomposition rate and insect colonization of all carcasses were examined twice a week for four weeks. The exposed carcasses were colonized immediately by Calliphora latifrons Hough and Calliphora vomitoria (L.) followed by Lucilia illustris (Meigen), Phormia regina (Meigen) and Protophormia terraenovae (R.-D.) (Diptera: Calliphoridae). There was a delay of three to six days before the confined carcasses were colonized, first by P. regina, followed by Pr. terraenovae. These species represented the vast majority of blow fly species on the confined carcasses. Despite the delay in colonization, decomposition progressed much more rapidly in two of the confined carcasses in comparison with the exposed carcasses due to the greatly increased temperatures inside the vehicles, with the complete skeletonization of two of the confined carcasses ocurring between nine and 13 days after death. One confined carcass was an anomaly, attracting much fewer insects, supporting fewer larval calliphorids and decomposing much more slowly than other carcasses, despite similarly increased temperatures. It was later discovered that the vehicle in which this carcass was confined had a solid metal fire wall between the passenger area and the trunk, which served to reduce insect access and release of odors. These data may be extremely valuable when analyzing cadavers found inside vehicle trunks.	[Malainey, Stacey L.; Anderson, Gail S.] Simon Fraser Univ, Ctr Forens Res, Sch Criminol, Burnaby, BC, Canada	Simon Fraser University	Anderson, GS (corresponding author), Simon Fraser Univ, Ctr Forens Res, Sch Criminol, Burnaby, BC, Canada.	ganderso@sfu.ca		Anderson, Gail/0000-0003-1172-7953	British Columbia Provincial Government, Office of the Fire Commission	British Columbia Provincial Government, Office of the Fire Commission	We would like to thank the British Columbia Provincial Government, Office of the Fire Commission for partially funding this project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2011, J MED ENTOMOL, V48, P1236, DOI [10.1603/MI10247, 10.1603/ME10247]; Ahmad Nazni Wasi, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, pS232; Al-Qahtni AH, 2019, SAUDI J BIOL SCI; Amendt J, 2011, FORENSIC SCI MED PAT, V7, P379, DOI 10.1007/s12024-010-9209-2; Anderson G. S., 1995, CAN SOC FORENSIC SCI, V28, P277; Anderson GS, 2011, J FORENSIC SCI, V56, P136, DOI 10.1111/j.1556-4029.2010.01539.x; Anderson GS, 1996, J FORENSIC SCI, V41, P617; Anderson GS, 2020, FORENSIC ENTOMOLOGY; Barnes KM, 2015, J FORENSIC SCI, V60, P1601, DOI 10.1111/1556-4029.12841; Berg MC, 2013, J MED ENTOMOL, V50, P451, DOI 10.1603/ME12188; Bhadra P, 2014, FORENSIC SCI INT, V239, P62, DOI 10.1016/j.forsciint.2014.03.020; Bugelli V, 2017, INT J LEGAL MED, V131, P1299, DOI 10.1007/s00414-017-1628-0; Bugelli V, 2015, J FORENSIC SCI, V60, P525, DOI 10.1111/1556-4029.12647; Caballero U, 2014, FORENSIC SCI INT, V245, P143, DOI 10.1016/j.forsciint.2014.10.040; Cammack JA, 2016, J MED ENTOMOL, V53, P67, DOI 10.1093/jme/tjv183; Card A, 2015, J FORENSIC SCI, V60, P979, DOI 10.1111/1556-4029.12750; Carvalho LML, 2000, MEM I OSWALDO CRUZ, V95, P135, DOI 10.1590/S0074-02762000000100023; CATTS EP, 1992, ANNU REV ENTOMOL, V37, P253, DOI 10.1146/annurev.en.37.010192.001345; Comstock JL, 2015, CAN SOC FORENSIC SCI, V48, P1, DOI 10.1080/00085030.2014.929850; Dadour IR, 2011, FORENSIC SCI INT, V207, P205, DOI 10.1016/j.forsciint.2010.10.009; Dadour IR, 2001, FORENSIC SCI INT, V120, P48, DOI 10.1016/S0379-0738(01)00420-0; Dautartas A, 2018, J FORENSIC SCI, V63, P1673, DOI 10.1111/1556-4029.13784; DEJONG GD, 1994, J KANSAS ENTOMOL SOC, V67, P378; Deonier CC, 1940, J ECON ENTOMOL, V33, P166, DOI 10.1093/jee/33.1.166; Dillon L, 1995, TR0595 CAN POL RES C; Dillon L. C., 1997, THESIS; Erzinu║lioglu Z., 1996, BLOWFLIES; Farrell JF, 2015, FORENSIC SCI INT, V257, P149, DOI 10.1016/j.forsciint.2015.07.053; Faucherre J, 1999, J INSECT BEHAV, V12, P687, DOI 10.1023/A:1020931804597; Gemmellaro MD, 2018, J MED ENTOMOL, V55, P1622, DOI 10.1093/jme/tjy099; George KA, 2013, J FORENSIC SCI, V58, pS112, DOI 10.1111/j.1556-4029.2012.02277.x; GOFF ML, 1992, J AGR ENTOMOL, V9, P237; GOFF ML, 1991, J FORENSIC SCI, V36, P748; GREENBERG B, 1990, J MED ENTOMOL, V27, P807, DOI 10.1093/jmedent/27.5.807; GREENBERG B, 1991, J MED ENTOMOL, V28, P565, DOI 10.1093/jmedent/28.5.565; Hobischak NR, 2006, CAN ENTOMOL, V138, P376; Joy JE, 2006, FORENSIC SCI INT, V164, P183, DOI 10.1016/j.forsciint.2006.01.008; Kelly JA, 2008, CAN SOC FORENSIC SCI, V41, P135, DOI 10.1080/00085030.2008.10757171; Kelly JA, 2011, CAN SOC FORENSIC SCI, V44, P144, DOI 10.1080/00085030.2011.10768149; Kelly JA, 2009, J FORENSIC SCI, V54, P1105, DOI 10.1111/j.1556-4029.2009.01113.x; Kumazawa T, 2000, Leg Med (Tokyo), V2, P181, DOI 10.1016/S1344-6223(00)80022-X; LeBlanc HN, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P205, DOI 10.1007/978-1-4020-9684-6_11; Lutz L, 2018, FORENSIC SCI INT, V291, P124, DOI 10.1016/j.forsciint.2018.08.014; Majola T, 2013, CAN SOC FORENSIC SCI, V46, P93, DOI 10.1080/00085030.2013.10757199; Martin-Vega D, 2011, J FORENSIC SCI, V56, P1654, DOI 10.1111/j.1556-4029.2011.01839.x; Mashaly AM, 2019, J MED ENTOMOL, V56, P921, DOI 10.1093/jme/tjz038; Matuszewski S, 2020, INT J LEGAL MED, V134, P793, DOI 10.1007/s00414-019-02074-5; Matuszewski S, 2016, INT J LEGAL MED, V130, P221, DOI 10.1007/s00414-015-1145-y; Michaud JP, 2017, OECOLOGIA, V183, P1143, DOI 10.1007/s00442-017-3818-3; Miller SL, 2009, EFFECTS CONFINEMENT; Ostrom M, 1996, SOC SCI MED, V42, P447, DOI 10.1016/0277-9536(95)00104-2; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal JL, 2014, ECOSPHERE, V5, DOI 10.1890/ES14-00022.1; Perez AE, 2016, ANN ENTOMOL SOC AM, V109, P72, DOI 10.1093/aesa/sav102; Reibe S, 2010, FORENSIC SCI INT, V195, P52, DOI 10.1016/j.forsciint.2009.11.009; Reibe S, 2009, PARASITOL RES, V106, P637; SCHOENLY K, 1991, J FORENSIC SCI, V36, P1395; Schoenly KG, 2007, J MED ENTOMOL, V44, P881, DOI 10.1603/0022-2585(2007)44[881:CPACOF]2.0.CO;2; Scholl K, 2017, INT J LEGAL MED, V131, P1141, DOI 10.1007/s00414-017-1535-4; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Skopek MA, 1998, AUST NZ J PSYCHIAT, V32, P830, DOI 10.3109/00048679809073873; Smith KGV, 1986, MANUAL FORENSIC ENTO; Tomberlin JK, 2011, ANNU REV ENTOMOL, V56, P401, DOI 10.1146/annurev-ento-051710-103143; Vanin S, 2011, FORENSIC SCI INT, V207, pE30, DOI 10.1016/j.forsciint.2010.12.004; Voss SC, 2011, FORENSIC SCI INT, V211, P67, DOI 10.1016/j.forsciint.2011.04.018; Voss SC, 2008, FORENSIC SCI MED PAT, V4, P22, DOI 10.1007/s12024-007-0028-z; Weidner LM, 2016, INT J LEGAL MED, V130, P1633, DOI 10.1007/s00414-016-1371-y; Whitworth T, 2006, P ENTOMOL SOC WASH, V108, P689	68	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231207	10.1371/journal.pone.0231207	http://dx.doi.org/10.1371/journal.pone.0231207			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294130	gold, Green Published			2022-12-26	WOS:000536003500022
J	Kiepas, A; Voorand, E; Senecal, J; Ahn, R; Annis, MG; Jacquet, K; Tali, G; Bisson, N; Ursini-Siegel, J; Siegel, PM; Brown, CM				Kiepas, Alex; Voorand, Elena; Senecal, Julien; Ahn, Ryuhjin; Annis, Matthew G.; Jacquet, Kevin; Tali, George; Bisson, Nicolas; Ursini-Siegel, Josie; Siegel, Peter M.; Brown, Claire M.			The SHCA adapter protein cooperates with lipoma-preferred partner in the regulation of adhesion dynamics and invadopodia formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; focal adhesion; cell invasion; invadopodia; microscopy; adhesion dynamics; cancer; lipoma-preferred partner (LPP); SHC adaptor protein (SHCA); transforming growth factor beta (TGF beta)	GROWTH-FACTOR-BETA; CANCER-CELL-MIGRATION; BREAST-CANCER; MESENCHYMAL TRANSITION; TYROSINE PHOSPHORYLATION; MATRIX-METALLOPROTEINASE; MAMMARY TUMORIGENESIS; ACTIN CYTOSKELETON; STATISTICAL-MODEL; INTEGRIN ADHESOME	SHC adaptor protein (SHCA) and lipoma-preferred partner (LPP) mediate transforming growth factor beta (TGF beta)-induced breast cancer cell migration and invasion. Reduced expression of either protein diminishes breast cancer lung metastasis, but the reason for this effect is unclear. Here, using total internal reflection fluorescence (TIRF) microscopy, we found that TGF beta enhanced the assembly and disassembly rates of paxillin-containing adhesions in an SHCA-dependent manner through the phosphorylation of the specific SHCA tyrosine residues Tyr-239, Tyr-240, and Tyr-313. Using a BioID proximity labeling approach, we show that SHCA exists in a complex with a variety of actin cytoskeletal proteins, including paxillin and LPP. Consistent with a functional interaction between SHCA and LPP, TGF beta-induced LPP localization to cellular adhesions depended on SHCA. Once localized to the adhesions, LPP was required for TGF beta-induced increases in cell migration and adhesion dynamics. Mutations that impaired LPP localization to adhesions (mLIM1) or impeded interactions with the actin cytoskeleton via alpha-actinin (Delta ABD) abrogated migratory responses to TGF beta. Live-cell TIRF microscopy revealed that SHCA clustering at the cell membrane preceded LPP recruitment. We therefore hypothesize that, in the presence of TGF beta, SHCA promotes the formation of small, dynamic adhesions by acting as a nucleator of focal complex formation. Finally, we defined a previously unknown function for SHCA in the formation of invadopodia, a process that also required LPP. Our results reveal that SHCA controls the formation and function of adhesions and invadopodia, two key cellular structures required for breast cancer metastasis.	[Kiepas, Alex; Tali, George; Brown, Claire M.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Voorand, Elena; Ursini-Siegel, Josie; Siegel, Peter M.] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Annis, Matthew G.; Siegel, Peter M.] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Kiepas, Alex; Voorand, Elena; Senecal, Julien; Annis, Matthew G.; Siegel, Peter M.] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Senecal, Julien; Ahn, Ryuhjin] McGill Univ, Div Expt Med, Montreal, PQ H4A 3J1, Canada; [Ursini-Siegel, Josie] McGill Univ, Dept Oncol, Montreal, PQ H4A 3T2, Canada; [Brown, Claire M.] McGill Univ, Adv Bioimaging Facil ABIF, Montreal, PQ H3G 0B1, Canada; [Ahn, Ryuhjin; Ursini-Siegel, Josie] Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Jacquet, Kevin; Bisson, Nicolas] Univ Laval, Ctr Hosp Univ CHU Quebec, Ctr Rech, Quebec City, PQ G1R 2J6, Canada; [Bisson, Nicolas] Univ Laval, PROTEO Network, Quebec City, PQ G1V 0A6, Canada; [Bisson, Nicolas] Univ Laval, Canc Res Ctr, Quebec City, PQ G1V 0A6, Canada	McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; Laval University; Laval University; Laval University	Siegel, PM (corresponding author), 1160 Pine Ave,West,Canc Pavil,Rm 513, Montreal, PQ H3A 1A3, Canada.; Brown, CM (corresponding author), 3649 Prom Sir William Osler,Bellini Bldg Rm 137, Montreal, PQ H3G 0B1, Canada.	peter.siegel@mcgill.ca; claire.brown@mcgill.ca	Ahn, Ryuhjin/B-1141-2011; Kiepas, Alex/GVS-8491-2022; St-Pierre, Julie/AGB-3651-2022; Brown, Claire/B-1498-2008	Ahn, Ryuhjin/0000-0001-9788-4401; St-Pierre, Julie/0000-0002-2815-7099; Kiepas, Alexander/0000-0001-8169-3897; Annis, Matthew/0000-0002-8776-004X; Bisson, Nicolas/0000-0001-7752-9517; Brown, Claire/0000-0003-1622-663X	Natural Sciences and Engineering Research Council of Canada (NSERC) [493616-16, 386084-12]; Canadian Institutes of Health Research (CIHR) [CPG-146475]; Canadian Cancer Society Research Institute (CCSRI) [702060]; Canadian Cancer Society (CCS) i2I Grant [705838]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute (CCSRI)(Canadian Cancer Society (CCS)); Canadian Cancer Society (CCS) i2I Grant	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC) Grants 493616-16 and 386084-12, Canadian Institutes of Health Research (CIHR) Grant CPG-146475, Canadian Cancer Society Research Institute (CCSRI) Grant 702060, and Canadian Cancer Society (CCS) i2I Grant 705838 (to J. U.-S., P. M. S., and C. M. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn R, 2013, CANCER RES, V73, P4521, DOI 10.1158/0008-5472.CAN-12-4178; Albiges-Rizo C, 2009, J CELL SCI, V122, P3037, DOI 10.1242/jcs.052704; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Beaty BT, 2014, EUR J CELL BIOL, V93, P438, DOI 10.1016/j.ejcb.2014.07.003; Berginski ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022025; Blouw B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121003; Bowden ET, 1999, ONCOGENE, V18, P4440, DOI 10.1038/sj.onc.1202827; Branch KM, 2012, BIOL OPEN, V1, P711, DOI 10.1242/bio.20121867; Buccione R, 2009, CANCER METAST REV, V28, P137, DOI 10.1007/s10555-008-9176-1; Chapnick DA, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-42; Chin YR, 2009, CELL SIGNAL, V21, P470, DOI 10.1016/j.cellsig.2008.11.015; Choi Hyungwon, 2012, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0815s39; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Collins LR, 1999, J CELL BIOL, V147, P1561, DOI 10.1083/jcb.147.7.1561; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Courtneidge SA, 2005, COLD SH Q B, V70, P167, DOI 10.1101/sqb.2005.70.014; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dans M, 2001, J BIOL CHEM, V276, P1494, DOI 10.1074/jbc.M008663200; Deshmukh L, 2010, J BIOL CHEM, V285, P34875, DOI 10.1074/jbc.M110.159087; Dumbauld DW, 2010, J CELL PHYSIOL, V223, P746, DOI 10.1002/jcp.22084; Eddy RJ, 2017, TRENDS CELL BIOL, V27, P595, DOI 10.1016/j.tcb.2017.03.003; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Friedl P, 2012, NAT REV MOL CELL BIO, V13, P743, DOI 10.1038/nrm3459; GLENNEY JR, 1989, J CELL BIOL, V108, P2401, DOI 10.1083/jcb.108.6.2401; Gorenne I, 2006, CIRC RES, V98, P378, DOI 10.1161/01.RES.0000202802.34727.fd; Grille SJ, 2003, CANCER RES, V63, P2172; Grunewald TGP, 2009, TRANSL ONCOL, V2, P107, DOI 10.1593/tlo.09112; Ha JR, 2018, MOL CANCER RES, V16, P894, DOI 10.1158/1541-7786.MCR-17-0623; HABIB T, 1994, J BIOL CHEM, V269, P25243; HEINO J, 1989, J BIOL CHEM, V264, P21806; HEINO J, 1989, J BIOL CHEM, V264, P380; Honda E, 2010, TOHOKU J EXP MED, V220, P319, DOI 10.1620/tjem.220.319; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Hu YL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06024; Huang C, 2004, J CELL SCI, V117, P4619, DOI 10.1242/jcs.01481; Huang C, 2003, NATURE, V424, P219, DOI 10.1038/nature01745; Hudson J, 2014, MOL CELL BIOL, V34, P3689, DOI 10.1128/MCB.00341-14; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Im YK, 2015, ONCOGENE, V34, P1729, DOI 10.1038/onc.2014.110; Ioachim E, 2002, EUR J CANCER, V38, P2362, DOI 10.1016/S0959-8049(02)00210-1; Jia DS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-364; Jin L, 2007, CIRC RES, V100, P817, DOI 10.1161/01.RES.0000261351.54147.de; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kiepas A, 2020, J CELL SCI, V133, DOI 10.1242/jcs.242834; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Kuo JC, 2011, NAT CELL BIOL, V13, P383, DOI 10.1038/ncb2216; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Laukaitis CM, 2001, J CELL BIOL, V153, P1427, DOI 10.1083/jcb.153.7.1427; Lawson C, 2012, CELL ADHES MIGR, V6, P302, DOI 10.4161/cam.20488; Lawson C, 2012, J CELL BIOL, V196, P223, DOI 10.1083/jcb.201108078; Lee MK, 2007, EMBO J, V26, P3957, DOI 10.1038/sj.emboj.7601818; Lewis K, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-1245-6; Mainiero F, 1997, EMBO J, V16, P2365, DOI 10.1093/emboj/16.9.2365; Mamuya FA, 2012, J CELL MOL MED, V16, P445, DOI 10.1111/j.1582-4934.2011.01419.x; Mendoza MC, 2011, MOL CELL, V41, P661, DOI 10.1016/j.molcel.2011.02.031; Mierke CT, 2011, J CELL SCI, V124, P369, DOI 10.1242/jcs.071985; Muraoka RS, 2003, MOL CELL BIOL, V23, P8691, DOI 10.1128/MCB.23.23.8691-8703.2003; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ngan E, 2018, J CELL COMMUN SIGNAL, V12, P143, DOI 10.1007/s12079-017-0415-5; Ngan E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15059; Ngan E, 2013, J CELL SCI, V126, P1981, DOI 10.1242/jcs.118315; Northey JJ, 2008, MOL CELL BIOL, V28, P3162, DOI 10.1128/MCB.01734-07; Northey JJ, 2013, J BIOL CHEM, V288, P5210, DOI 10.1074/jbc.M112.424804; Parekh A, 2016, EXP CELL RES, V343, P89, DOI 10.1016/j.yexcr.2015.10.038; Pechkovsky DV, 2008, J BIOL CHEM, V283, P12898, DOI 10.1074/jbc.M708226200; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petit MMR, 2000, MOL BIOL CELL, V11, P117, DOI 10.1091/mbc.11.1.117; Plotnikov SV, 2012, CELL, V151, P1513, DOI 10.1016/j.cell.2012.11.034; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Provenzano PP, 2009, CELL ADHES MIGR, V3, P347, DOI 10.4161/cam.3.4.9458; Rexer Brent N., 2012, Critical Reviews in Oncogenesis, V17, P1; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Schmandt R, 1999, ONCOGENE, V18, P1867, DOI 10.1038/sj.onc.1202507; Schober M, 2007, J CELL BIOL, V176, P667, DOI 10.1083/jcb.200608010; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; Seals DF, 2005, CANCER CELL, V7, P155, DOI 10.1016/j.ccr.2005.01.006; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Shaw LM, 1997, CELL, V91, P949, DOI 10.1016/S0092-8674(00)80486-9; Shcherbakova DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12405; Siegel PM, 2003, P NATL ACAD SCI USA, V100, P8430, DOI 10.1073/pnas.0932636100; Stylli SS, 2009, J CELL SCI, V122, P2727, DOI 10.1242/jcs.046680; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Teo GC, 2014, J PROTEOMICS, V100, P37, DOI 10.1016/j.jprot.2013.10.023; Tomar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044041; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Ueda Y, 2004, J BIOL CHEM, V279, P24505, DOI 10.1074/jbc.M400081200; Ursini-Siegel J, 2012, ONCOGENE, V31, P5038, DOI 10.1038/onc.2012.4; Ursini-Siegel J, 2008, CELL CYCLE, V7, P1936, DOI 10.4161/cc.7.13.6205; Ursini-Siegel J, 2008, EMBO J, V27, P910, DOI 10.1038/emboj.2008.22; Ursini-Siegel J, 2010, CANCER RES, V70, P7776, DOI 10.1158/0008-5472.CAN-10-2229; Waalkes S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-503; Wang SZE, 2006, CANCER RES, V66, P9591, DOI 10.1158/0008-5472.CAN-06-2071; Wang SE, 2009, CANCER RES, V69, P475, DOI 10.1158/0008-5472.CAN-08-2649; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; Weaver AM, 2006, CLIN EXP METASTAS, V23, P97, DOI 10.1007/s10585-006-9014-1; Wendt MK, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2360; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wright KD, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1155-7; Wu RF, 2016, MOL CELL BIOL, V36, P2824, DOI 10.1128/MCB.00194-16; Xia H, 2004, J BIOL CHEM, V279, P33024, DOI 10.1074/jbc.M313265200; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yeh YC, 2010, AM J PATHOL, V177, P1743, DOI 10.2353/ajpath.2010.091183; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zhang L, 2013, TRENDS BIOCHEM SCI, V38, P612, DOI 10.1016/j.tibs.2013.10.001; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	119	8	8	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2020	295	31					10535	10559		10.1074/jbc.RA119.011903	http://dx.doi.org/10.1074/jbc.RA119.011903			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NB3HM	32299913	hybrid, Green Published			2022-12-26	WOS:000560405600003
J	Fu, PF; Ramchandran, R; Shaaya, M; Huang, LS; Ebenezer, DL; Jiang, Y; Komarova, Y; Vogel, SM; Malik, AB; Minshall, RD; Du, GW; Tonks, NK; Natarajan, V				Fu, Panfeng; Ramchandran, Ramaswamy; Shaaya, Mark; Huang, Longshuang; Ebenezer, David L.; Jiang, Ying; Komarova, Yulia; Vogel, Stephen M.; Malik, Asrar B.; Minshall, Richard D.; Du, Guangwei; Tonks, Nicholas K.; Natarajan, Viswanathan			Phospholipase D2 restores endothelial barrier function by promoting PTPN14-mediated VE-cadherin dephosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial dysfunction; endothelial cell; cadherin; phosphotyrosine signaling; lipid signaling; endothelial barrier restoration; phosphatidic acid signaling; phospholipase D2 (PLD2); protein tyrosine phosphatase non-receptor type 14 (PTPN14); VE-cadherin	MEDIATED LAMELLIPODIA FORMATION; INDUCED VASCULAR-PERMEABILITY; PHOSPHATIDIC-ACID; ADHERENS JUNCTIONS; KINASE ACTIVATION; GROWTH-FACTOR; LEUKOCYTE EXTRAVASATION; DEPENDENT ENDOCYTOSIS; CELL PERMEABILITY; CA2+ ENTRY	Increased permeability of vascular lung tissues is a hallmark of acute lung injury and is often caused by edemagenic insults resulting in inflammation. Vascular endothelial (VE)-cadherin undergoes internalization in response to inflammatory stimuli and is recycled at cell adhesion junctions during endothelial barrier re-establishment. Here, we hypothesized that phospholipase D (PLD)-generated phosphatidic acid (PA) signaling regulates VE-cadherin recycling and promotes endothelial barrier recovery by dephosphorylating VE-cadherin. Genetic deletion of PLD2 impaired recovery from protease-activated receptor-1?activating peptide (PAR-1?AP)-induced lung vascular permeability and potentiated inflammation in vivo. In human lung microvascular endothelial cells (HLMVECs), inhibition or deletion of PLD2, but not of PLD1, delayed endothelial barrier recovery after thrombin stimulation. Thrombin stimulation of HLMVECs increased co-localization of PLD2-generated PA and VE-cadherin at cell-cell adhesion junctions. Inhibition of PLD2 activity resulted in prolonged phosphorylation of Tyr-658 in VE-cadherin during the recovery phase 3 h post-thrombin challenge. Immunoprecipitation experiments revealed that after HLMVECs are thrombin stimulated, PLD2, VE-cadherin, and protein-tyrosine phosphatase nonreceptor type 14 (PTPN14), a PLD2-dependent protein-tyrosine phosphatase, strongly associate with each other. PTPN14 depletion delayed VE-cadherin dephosphorylation, reannealing of adherens junctions, and barrier function recovery. PLD2 inhibition attenuated PTPN14 activity and reversed PTPN14-dependent VE-cadherin dephosphorylation after thrombin stimulation. Our findings indicate that PLD2 promotes PTPN14-mediated dephosphorylation of VE-cadherin and that redistribution of VE-cadherin at adherens junctions is essential for recovery of endothelial barrier function after an edemagenic insult.	[Fu, Panfeng; Ramchandran, Ramaswamy; Shaaya, Mark; Huang, Longshuang; Ebenezer, David L.; Komarova, Yulia; Vogel, Stephen M.; Malik, Asrar B.; Minshall, Richard D.; Natarajan, Viswanathan] Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA; [Jiang, Ying; Minshall, Richard D.] Univ Illinois, Dept Anesthesiol, Chicago, IL USA; [Natarajan, Viswanathan] Univ Illinois, Dept Med, Chicago, IL 60607 USA; [Fu, Panfeng] Ningbo Univ, Med Sch, Affiliated Hosp, Ningbo, Peoples R China; [Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Tonks, Nicholas K.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Ningbo University; University of Texas System; University of Texas Health Science Center Houston; Cold Spring Harbor Laboratory	Natarajan, V (corresponding author), Univ Illinois, Dept Pharmacol, Chicago, IL 60607 USA.; Natarajan, V (corresponding author), Univ Illinois, Dept Med, Chicago, IL 60607 USA.	visnatar@uic.edu		Du, Guangwei/0000-0003-4193-6975; Malik, Asrar/0000-0002-8205-7128	National Institutes of Health [HLBI P01 HL060678, AR075830]; American Heart Association [19TPA34910051]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by National Institutes of Health Grants HLBI P01 HL060678 (to V. N.) and AR075830 (to G. D.), and American Heart Association Grant 19TPA34910051. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulnour REE, 2018, J LEUKOCYTE BIOL, V103, P919, DOI 10.1002/JLB.3A0617-252RR; Adam AP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/272858; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; Antonescu CN, 2010, MOL BIOL CELL, V21, P2944, DOI 10.1091/mbc.E10-05-0421; Au AC, 2010, AM J HUM GENET, V87, P436, DOI 10.1016/j.ajhg.2010.08.008; Barr AJ, 2006, PROTEINS, V63, P1132, DOI 10.1002/prot.20958; Benzinou M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1633; Bolomini-Vittori M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39358-0; Broermann A, 2011, J EXP MED, V208, P2393, DOI 10.1084/jem.20110525; Chen XL, 2012, DEV CELL, V22, P146, DOI 10.1016/j.devcel.2011.11.002; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Ebnet K, 2008, HISTOCHEM CELL BIOL, V130, P1, DOI 10.1007/s00418-008-0418-7; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Frye M, 2015, J EXP MED, V212, P2267, DOI 10.1084/jem.20150718; Fu PF, 2016, J BIOL CHEM, V291, P27187, DOI 10.1074/jbc.M116.758946; GARCIA JGN, 1992, BLOOD, V79, P2056; GARCIA JGN, 1992, J LAB CLIN MED, V120, P513; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Gavard J, 2008, DEV CELL, V14, P25, DOI 10.1016/j.devcel.2007.10.019; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Gavard Julie, 2014, Cell Adh Migr, V8, P158; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; Gong HX, 2014, J EXP MED, V211, P579, DOI 10.1084/jem.20131190; Han X, 2019, J CELL BIOCHEM, V120, P17723, DOI 10.1002/jcb.29038; Harris ES, 2010, CURR OPIN CELL BIOL, V22, P651, DOI 10.1016/j.ceb.2010.07.006; Hu GC, 2008, CHEM-BIOL INTERACT, V171, P177, DOI 10.1016/j.cbi.2007.08.006; Jang JH, 2012, PROG LIPID RES, V51, P71, DOI 10.1016/j.plipres.2011.12.003; Jiang Y, 2016, J BIOL CHEM, V291, P20729, DOI 10.1074/jbc.M116.752485; Juettner VV, 2019, J CELL BIOL, V218, P1725, DOI 10.1083/jcb.201807210; Katso RM, 2006, MOL BIOL CELL, V17, P3729, DOI 10.1091/mbc.E05-11-1083; Kowalczyk Andrew P, 2012, Subcell Biochem, V60, P197, DOI 10.1007/978-94-007-4186-7_9; Ktistakis NT, 2003, BIOCHEM SOC T, V31, P94, DOI 10.1042/bst0310094; Lee WL, 2010, NEW ENGL J MED, V363, P689, DOI 10.1056/NEJMcibr1007320; Lim HK, 2003, J BIOL CHEM, V278, P45117, DOI 10.1074/jbc.M303789200; Lu M, 2016, METHODS MOL BIOL, V1406, P225, DOI 10.1007/978-1-4939-3444-7_20; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, ANNU REV PATHOL-MECH, V6, P147, DOI 10.1146/annurev-pathol-011110-130158; Mukherjee S, 2006, CIRC RES, V98, P743, DOI 10.1161/01.RES.0000214545.99387.e3; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nelson RK, 2015, J LIPID RES, V56, P2229, DOI 10.1194/jlr.R059220; Nottebaum AF, 2008, J EXP MED, V205, P2929, DOI 10.1084/jem.20080406; Pleskot R, 2013, TRENDS PLANT SCI, V18, P496, DOI 10.1016/j.tplants.2013.04.005; Ramesh M, 2015, J BIOL CHEM, V290, P9646, DOI 10.1074/jbc.M114.627968; Reeves HL, 2000, HEPATOLOGY, V31, P95, DOI 10.1002/hep.510310116; Roach AN, 2012, J LIPID RES, V53, P2598, DOI 10.1194/jlr.M028597; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Soni D, 2017, AM J PHYSIOL-LUNG C, V312, pL1003, DOI 10.1152/ajplung.00008.2017; Spring K, 2012, BLOOD, V120, P2745, DOI 10.1182/blood-2011-12-398040; Su WJ, 2017, MOL BIOL CELL, V28, P76, DOI 10.1091/mbc.E16-09-0658; Sui XF, 2005, AM J PATHOL, V166, P1247, DOI 10.1016/S0002-9440(10)62343-7; Suryadevara V, 2019, AM J PHYSIOL-LUNG C, V317, pL175, DOI 10.1152/ajplung.00320.2018; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tiruppathi C, 2002, CIRC RES, V91, P70, DOI 10.1161/01.RES.0000023391.40106.A8; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Usatyuk PV, 2014, J BIOL CHEM, V289, P13476, DOI 10.1074/jbc.M113.527556; Usatyuk PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063007; Usatyuk PV, 2013, PULM CIRC, V3, P108, DOI 10.4103/2045-8932.109925; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Wadham C, 2003, MOL BIOL CELL, V14, P2520, DOI 10.1091/mbc.E02-09-0577; Wallez Y, 2007, ONCOGENE, V26, P1067, DOI 10.1038/sj.onc.1209855; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wang WQ, 2012, GENE DEV, V26, P1959, DOI 10.1101/gad.192955.112; Wang ZQ, 2019, FASEB J, V33, P6713, DOI 10.1096/fj.201800390RR; Wang ZQ, 2017, DEV CELL, V43, P186, DOI 10.1016/j.devcel.2017.09.012; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Wilson KE, 2014, J BIOL CHEM, V289, P23693, DOI 10.1074/jbc.M113.534701; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; Wu ZY, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8696481; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Zegarlinska J, 2018, ACTA BIOCHIM POL, V65, P163, DOI 10.18388/abp.2018_2592; Zeiller C, 2009, BBA-MOL CELL RES, V1793, P1236, DOI 10.1016/j.bbamcr.2009.04.001; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13	75	11	11	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7669	7685		10.1074/jbc.RA119.011801	http://dx.doi.org/10.1074/jbc.RA119.011801			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32327488	hybrid, Green Published			2022-12-26	WOS:000538038900009
J	Kurata, A; Tachibana, Y; Takahashi, T; Horiba, N				Kurata, Atsuo; Tachibana, Yukako; Takahashi, Tadakatsu; Horiba, Naoshi			Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; PROMOTES TUMOR INVASION; 6 GAS6; DISEASE; PROTEIN; PROLIFERATION; MOUSE; MER; MECHANISMS; REGULATOR	Chronic kidney diseases affect more than 800 million people globally and remain a high unmet need. Various therapeutic targets are currently under evaluation in pre-clinical and clinical studies. Because the growth arrest specific gene 6 (Gas6)/AXL pathway has been implicated in the pathogenesis of kidney diseases, we generated a novel selective and potent AXL inhibitor, CH5451098, and we evaluated its efficacy and elucidated its mechanism in an NEP25 mouse model that follows the clinical course of glomerular nephritis. In this model, CH5451098 significantly ameliorated the excretion of urinary albumin and elevation of serum creatinine. Additionally, it also inhibited tubulointerstitial fibrosis and tubular damage. To elucidate the mechanism behind these changes, we analyzed the effect of CH5451098 against transforming growth factor beta 1 (TGF beta 1) and Gas6, which is a ligand of AXL receptor, in NRK-52E renal tubular epithelial cells. CH5451098 inhibited epithelial-tomesenchymal transition (EMT) caused by the synergistic effects of TGF beta 1 and Gas6 in NRK-52E cells. This inhibition was also observed in NEP25 mice. Taken together, these results suggest that CH5451098 could ameliorate kidney dysfunction in glomerular nephritis by inhibiting EMT in tubular cells. These results reveal that AXL strongly contributes to the disease progression of glomerular nephritis.	[Kurata, Atsuo; Tachibana, Yukako; Takahashi, Tadakatsu; Horiba, Naoshi] Chugai Pharmaceut Co Ltd, Res Div, Gotemba, Shizuoka, Japan	Chugai Pharmaceutical Co., Ltd.; Roche Holding	Kurata, A (corresponding author), Chugai Pharmaceut Co Ltd, Res Div, Gotemba, Shizuoka, Japan.	kurata.atsuo@chugai-pharm.co.jp			Chugai Pharmaceutical Co Ltd.	Chugai Pharmaceutical Co Ltd.	Chugai Pharmaceutical Co Ltd. provided support for this study in the form of salaries for AK, YT, TT, and NH. The specific roles of these authors are articulated in the 'author contributions' section.	Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Arai H, 2008, VITAM HORM, V78, P375, DOI 10.1016/S0083-6729(07)00015-5; Becker GJ, 2013, NEPHROL DIAL TRANSPL, V28, P2432, DOI 10.1093/ndt/gft071; BENTLEY JP, 1969, BIOCHIM BIOPHYS ACTA, V175, P339, DOI 10.1016/0005-2795(69)90011-7; Cohen PL, 2002, J EXP MED, V196, P135, DOI 10.1084/jem.20012094; DELARCO JE, 1978, J CELL PHYSIOL, V94, P335, DOI 10.1002/jcp.1040940311; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; Ekman C, 2011, RHEUMATOLOGY, V50, P1064, DOI 10.1093/rheumatology/keq459; Fiebeler A, 2004, AM J KIDNEY DIS, V43, P286, DOI 10.1053/j.ajkd.2003.10.016; Giangola MD, 2015, J SURG RES, V199, P572, DOI 10.1016/j.jss.2015.05.049; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Gong SW, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13064; Guo JK, 2012, J AM SOC NEPHROL, V23, P429, DOI 10.1681/ASN.2011040396; Jung J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070643; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee HJ, 2014, CARCINOGENESIS, V35, P769, DOI 10.1093/carcin/bgt372; Lee IJ, 2012, NEPHROL DIAL TRANSPL, V27, P4166, DOI 10.1093/ndt/gfs337; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Li YY, 2015, TUMOR BIOL, V36, P1115, DOI 10.1007/s13277-014-2677-3; Maarouf OH, 2016, J AM SOC NEPHROL, V27, P781, DOI 10.1681/ASN.2014121188; Matsusaka T, 2005, J AM SOC NEPHROL, V16, P1013, DOI 10.1681/ASN.2004080720; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Mimura I, 2010, NAT REV NEPHROL, V6, P667, DOI 10.1038/nrneph.2010.124; Myers SH, 2016, J MED CHEM, V59, P3593, DOI 10.1021/acs.jmedchem.5b01273; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nagata K, 1996, J BIOL CHEM, V271, P30022, DOI 10.1074/jbc.271.47.30022; Nakanishi Y, 2014, MOL CANCER THER, V13, P2547, DOI 10.1158/1535-7163.MCT-14-0248; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Orme JJ, 2016, CLIN IMMUNOL, V169, P58, DOI 10.1016/j.clim.2016.05.011; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Parodis I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212068; Pedersen HL, 2015, SEMIN NEPHROL, V35, P427, DOI 10.1016/j.semnephrol.2015.08.004; Pettazzoni P, 2015, CANCER RES, V75, P1091, DOI 10.1158/0008-5472.CAN-14-1854; Qi RC, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1157-x; Reichl P, 2015, HEPATOLOGY, V61, P930, DOI 10.1002/hep.27492; Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001; Sakai N, 2017, KIDNEY INT, V91, P628, DOI 10.1016/j.kint.2016.09.030; Shuvy M, 2011, AM J PHYSIOL-HEART C, V300, pH1829, DOI 10.1152/ajpheart.00240.2010; Souza ACP, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12558; van der Meer JHM, 2014, BLOOD, V123, P2460, DOI 10.1182/blood-2013-09-528752; Wan X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059794; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wu CS, 2014, RHEUMATOL INT, V34, P625, DOI 10.1007/s00296-013-2882-1; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Yanagita M, 2001, J BIOL CHEM, V276, P42364, DOI 10.1074/jbc.M107488200; Yanagita Motoko, 2004, Clin Exp Nephrol, V8, P304; Ye F, 2011, J IMMUNOL, V187, P4178, DOI 10.4049/jimmunol.1101201; Zhen YX, 2018, J AUTOIMMUN, V93, P37, DOI 10.1016/j.jaut.2018.06.001; Zhen YX, 2016, J IMMUNOL, V197, P2187, DOI 10.4049/jimmunol.1600793; Zhong F, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.123482; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]; Zhu HQ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/431896; Zizzo G, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4407	54	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232055	10.1371/journal.pone.0232055	http://dx.doi.org/10.1371/journal.pone.0232055			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324796	gold, Green Published			2022-12-26	WOS:000536033700068
J	Kaur, H; Groubert, B; Paulson, JC; McMillan, S; Hoskins, AA				Kaur, Harpreet; Groubert, Brent; Paulson, Joshua C.; McMillan, Sarah; Hoskins, Aaron A.			Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae	PLOS ONE			English	Article							U2 SNRNP; SPLICEOSOME; FIDELITY; SELECTION; EXON; SF3B	Mutations in the splicing machinery have been implicated in a number of human diseases. Most notably, the U2 small nuclear ribonucleoprotein (snRNP) component SF3b1 has been found to be frequently mutated in blood cancers such as myelodysplastic syndromes (MDS). SF3b1 is a highly conserved HEAT repeat (HR)-containing protein and most of these blood cancer mutations cluster in a hot spot located in HR4-8. Recently, a second mutational hotspot has been identified in SF3b1 located in HR9-12 and is associated with acute myeloid leukemias, bladder urothelial carcinomas, and uterine corpus endometrial carcinomas. The consequences of these mutations on SF3b1 functions during splicing have not yet been tested. We incorporated the corresponding mutations into the yeast homolog of SF3b1 and tested their impact on splicing. We find that all of these HR9-12 mutations can support splicing in yeast, and this suggests that none of them are loss of function alleles in humans. The Hsh155V502F mutation alters splicing of several pre-mRNA reporters containing weak branch sites as well as a genetic interaction with Prp2 and physical interactions with Prp5 and Prp3. The ability of a single allele of Hsh155 to perturb interactions with multiple factors functioning at different stages of the splicing reaction suggests that some SF3b1mutant disease phenotypes may have a complex origin on the spliceosome.	[Kaur, Harpreet; Groubert, Brent; Paulson, Joshua C.; McMillan, Sarah; Hoskins, Aaron A.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [McMillan, Sarah; Hoskins, Aaron A.] Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hoskins, AA (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.; Hoskins, AA (corresponding author), Univ Wisconsin, Integrated Program Biochem, Madison, WI 53706 USA.	ahoskins@wisc.edu			National Institutes of Health [R01 GM112735]; Edward P. Evans Foundation (EvansMDS Discovery Research Grant)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward P. Evans Foundation (EvansMDS Discovery Research Grant)	This work was supported by the National Institutes of Health (R01 GM112735 to AAH; www.nigms.nih.gov) and the Edward P. Evans Foundation (EvansMDS Discovery Research Grant to AAH; www.evansmds.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsafadi S, 2016, NATURE COMMUNICATION, P7; Amberg DC., 2005, METHODS YEAST GENETI; Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624; Bonnal S, 2008, MOL CELL, V32, P81, DOI 10.1016/j.molcel.2008.08.008; Carrocci TJ, 2018, RNA, V24, P1028, DOI 10.1261/rna.065664.118; Carrocci TJ, 2017, NUCLEIC ACIDS RES, V45, P4837, DOI 10.1093/nar/gkw1349; Chiou NT, 2013, MOL CELL, V49, P972, DOI 10.1016/j.molcel.2012.12.025; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; Darman RB, 2015, CELL REP, V13, P1033, DOI 10.1016/j.celrep.2015.09.053; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; Dvinge H, 2016, NAT REV CANCER, V16, P413, DOI 10.1038/nrc.2016.51; Fourmann JB, 2016, ELIFE, V5, DOI 10.7554/eLife.15564; Gozani O, 1998, MOL CELL BIOL, V18, P4752, DOI 10.1128/MCB.18.8.4752; Hasegawa M, 2011, ACS CHEM BIOL, V6, P229, DOI 10.1021/cb100248e; Hoskins AA, 2011, SCIENCE, V331, P1289, DOI 10.1126/science.1198830; Jenkins JL, 2017, TRENDS GENETICS; Kaida D, 2007, NAT CHEM BIOL, V3, P576, DOI 10.1038/nchembio.2007.18; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Lardelli RM, 2010, RNA, V16, P516, DOI 10.1261/rna.2030510; LESSER CF, 1993, GENETICS, V133, P851; Loerch S, 2019, J BIOL CHEM, V294, P2892, DOI 10.1074/jbc.RA118.006764; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Seiler M, 2018, CELL REP, V23, P282, DOI 10.1016/j.celrep.2018.01.088; Semlow DR, 2016, CELL, V164, P985, DOI 10.1016/j.cell.2016.01.025; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Siatecka M, 1999, GENE DEV, V13, P1983, DOI 10.1101/gad.13.15.1983; Talkish J, 2019, RNA, V25, P1020, DOI 10.1261/rna.070649.119; Tang Q, 2016, GENE DEV, V30, P2710, DOI 10.1101/gad.291872.116; Tseng CK, 2008, SCIENCE, V320, P1782, DOI 10.1126/science.1158993; van der Feltz C, 2019, CRIT REV BIOCHEM MOL, V54, P443, DOI 10.1080/10409238.2019.1691497; Vollbrecht C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129544; Wahl MC, 2009, CELL, V136, P701, DOI 10.1016/j.cell.2009.02.009; Wlodaver AM, 2014, RNA, V20, P282, DOI 10.1261/rna.042598.113; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Zhang J, 2019, MOL CELL, V76, P82, DOI 10.1016/j.molcel.2019.07.017; Zhang J, 2013, CANCER DISCOV, V3, P1228, DOI 10.1158/2159-8290.CD-13-0253	40	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0229315	10.1371/journal.pone.0229315	http://dx.doi.org/10.1371/journal.pone.0229315			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320410	Green Submitted, Green Published, gold			2022-12-26	WOS:000536028800006
J	Mavrot, F; Orsel, K; Hutchins, W; Adams, LG; Beckmen, K; Blake, JE; Checkley, SL; Davison, T; Di Francesco, J; Elkin, B; Leclerc, LM; Schneider, A; Tomaselli, M; Kutz, SJ				Mavrot, Fabien; Orsel, Karin; Hutchins, Wendy; Adams, Layne G.; Beckmen, Kimberlee; Blake, John E.; Checkley, Sylvia L.; Davison, Tracy; Di Francesco, Juliette; Elkin, Brett; Leclerc, Lisa-Marie; Schneider, Angela; Tomaselli, Matilde; Kutz, Susan J.			Novel insights into serodiagnosis and epidemiology of Erysipelothrix rhusiopathiae, a newly recognized pathogen in muskoxen (Ovibos moschatus)	PLOS ONE			English	Article							DISEASE; SEPTICEMIA; TUBERCULOSIS; POPULATIONS; PREVALENCE; ANTIBODIES; INFECTION; KNOWLEDGE; DECLINES; TRENDS	Background Muskoxen are a key species of Arctic ecosystems and are important for food security and socio-economic well-being of many Indigenous communities in the Arctic and Subarctic. Between 2009 and 2014, the bacterium Erysipelothrix rhusiopathiae was isolated for the first time in this species in association with multiple mortality events in Canada and Alaska, raising questions regarding the spatiotemporal occurrence of the pathogen and its potential impact on muskox populations. Materials and methods We adapted a commercial porcine E. rhusiopathiae enzyme-linked immunosorbent assay to test 958 blood samples that were collected from muskoxen from seven regions in Alaska and the Canadian Arctic between 1976 and 2017. The cut-off between negative and positive results was established using mixture-distribution analysis, a data-driven approach. Based on 818 samples for which a serological status could be determined and with complete information, we calculated trends in sample seroprevalences in population time-series and compared them with population trends in the investigated regions. Results Overall, 219/818 (27.8%, 95% Confidence Interval: 24.7-31.0) samples were classified as positive for exposure to E. rhusiopathiae. There were large variations between years and regions. Seropositive animals were found among the earliest serum samples tested; 1976 in Alaska and 1991 in Canada. In Alaskan muskoxen, sample seroprevalence increased after 2000 and, in two regions, peak seroprevalences occurred simultaneously with population declines. In one of these regions, concurrent unusual mortalities were observed and E. rhusiopathiae was isolated from muskox carcasses. In Canada, there was an increase in sample seroprevalence in two muskox populations following known mortality events that had been attributed to E. rhusiopathiae. Conclusion Our results indicate widespread exposure of muskoxen to E. rhusiopathiae in western Canada and Alaska. Although not new to the Arctic, we documented an increased exposure to the pathogen in several regions concurrent with population declines. Understanding causes for the apparent increased occurrence of this pathogen and its association with large scale mortality events for muskoxen is critical to evaluate the implications for wildlife and wildlife-dependent human populations in the Arctic.	[Mavrot, Fabien; Orsel, Karin; Checkley, Sylvia L.; Di Francesco, Juliette; Schneider, Angela; Tomaselli, Matilde; Kutz, Susan J.] Univ Calgary, Fac Vet Med, Calgary, AB, Canada; [Hutchins, Wendy] Univ Calgary, Cumming Sch Med, Calgary, AB, Canada; [Adams, Layne G.] US Geol Survey, Alaska Sci Ctr, Sitca, AK USA; [Beckmen, Kimberlee] Alaska Dept Fish & Game, Juneau, AK USA; [Blake, John E.] Univ Fairbanks, Fairbanks, AK USA; [Davison, Tracy; Elkin, Brett] Govt Northwest Terr, Yellowknife, NT, Canada; [Leclerc, Lisa-Marie] Govt Nunavut, Iqaluit, NU, Canada; [Tomaselli, Matilde] Polar Knowledge Canada, Canadian High Arctic Res Stn, Ottawa, NU, Canada	University of Calgary; University of Calgary; United States Department of the Interior; United States Geological Survey; Alaska Department of Fish & Game; University of Alaska System; University of Alaska Fairbanks	Mavrot, F (corresponding author), Univ Calgary, Fac Vet Med, Calgary, AB, Canada.	fabien.mavrot@ucalgary.ca		Mavrot, Fabien/0000-0001-6066-9898; kutz, susan/0000-0003-2352-8687; Beckmen, Kimberlee/0000-0003-0747-7883	Morris Animal Foundation [D18ZO-407]; Natural Sciences and Engineering Research Council Discovery Grant [RGPIN/04171-2014]; Natural Sciences and Engineering Research Council Northern Supplement [RGPNS/316244-2014]; ArcticNet: 1.5 Muskoxen Polar Knowledge Canada [NST-1718-0015]; University of Calgary Eyes High postdoctoral program; Shikar Safari Club International Foundation [DRSO 1052116]	Morris Animal Foundation; Natural Sciences and Engineering Research Council Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council Northern Supplement; ArcticNet: 1.5 Muskoxen Polar Knowledge Canada; University of Calgary Eyes High postdoctoral program; Shikar Safari Club International Foundation	The following sources supported this work Morris Animal Foundation: D18ZO-407 Natural Sciences and Engineering Research Council Discovery Grant -RGPIN/04171-2014 Natural Sciences and Engineering Research Council Northern Supplement - RGPNS/316244-2014 ArcticNet: 1.5 Muskoxen Polar Knowledge Canada: NST-1718-0015 University of Calgary Eyes High postdoctoral program Shikar Safari Club International Foundation: DRSO 1052116	Afema JA, 2017, J WILDLIFE DIS, V53, P311, DOI 10.7589/2016-02-035; Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; Altizer S, 2003, TRENDS ECOL EVOL, V18, P589, DOI 10.1016/j.tree.2003.08.013; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2016, J WILDLIFE DIS, V52, P719, DOI [10.7589/2015-12-327, DOI 10.7589/2015-12-327]; Austin Brian R., 2009, V498, P157, DOI 10.1007/978-1-59745-196-3_11; Baldacchino G., 2006, EXTREME TOURISM LESS; Benaglia T, 2009, J STAT SOFTW, V32, P1; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Boerner L, 2004, J VET DIAGN INVEST, V16, P145, DOI 10.1177/104063870401600209; Bruun HH, 2008, OECOLOGIA, V155, P101, DOI 10.1007/s00442-007-0892-y; CALLE PP, 1993, ZOO BIOL, V12, P483, DOI 10.1002/zoo.1430120510; CAMPBELL GD, 1994, J WILDLIFE DIS, V30, P436, DOI 10.7589/0090-3558-30.3.436; Cronenwett PN, 1992, JSTOR; Curry PS, 2011, J WILDLIFE DIS, V47, P12, DOI 10.7589/0090-3558-47.1.12; Cuyler C, 2020, AMBIO, V49, P805, DOI 10.1007/s13280-019-01205-x; Davison TM, 2015, AERIAL SURVEY MUSKOX; Davison TM, 2014, AERIAL SURVEY PEARY, P25; De MacPhee R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-49; Dumond M., 2006, REV MUSKOX POPULATIO, P29; Forde TL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01759; Fournier B, 1997, MUSKOX NUMBERS DISTR, P66; Garnier R, 2017, FUNCT ECOL, V31, P2255, DOI 10.1111/1365-2435.12942; Gimenez-Lirola LG, 2012, J MICROBIOL METH, V91, P73, DOI 10.1016/j.mimet.2012.07.014; Groeschel M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3913-7; Gunn A, 2008, IUCN RED LIST THREAT; Hansen CCR, 2018, CURRENT BIOL; Harper P, 2012, MUSKOX MANAGEMENT RE, P116; Hudson P., 2002, ECOLOGY WILDLIFE DIS; JINGFORS KT, 1982, J WILDLIFE MANAGE, V46, P1092, DOI 10.2307/3808249; Jones J. G, 2001, THESIS; Khanna R., 2011, IMMUNOLOGY; Kock RA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao2314; Kutz S, 2017, ARCTIC, V70, P225; Kutz S, 2015, CAN VET J, V56, P560; Kutz SJ, 2013, GLOBAL CHANGE BIOL, V19, P3254, DOI 10.1111/gcb.12315; LANGFORD EV, 1977, CAN VET J, V18, P101; Leclerc L-M, 2015, MUSKOX AERIAL SURVEY, P17; Lloyd-Smith JO, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-125; Mech LD, 2004, CLIMATIC CHANGE, V67, P87, DOI 10.1007/s10584-004-7093-z; Miller SD, 2017, URSUS, V28, P135, DOI 10.2192/URSU-D-17-00002.1; Opriessnig T, 2012, DIS SWINE; Pachauri R. K., 2014, IPCC 2014 CLIMATE CH, P151; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Peel AJ, 2013, J VIROL METHODS, V193, P295, DOI 10.1016/j.jviromet.2013.06.030; Post E, 2008, P NATL ACAD SCI USA, V105, P12353, DOI 10.1073/pnas.0802421105; Preece ND, 2017, BIOL CONSERV, V214, P136, DOI 10.1016/j.biocon.2017.08.014; Pruvot M, 2014, PARASITOL RES, V113, P2899, DOI 10.1007/s00436-014-3951-4; QGIS Development Team, 2016, QGIS VERS 2 6 1 OP S; Ryser-Degiorgis MP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-223; Spraker TR, 2017, VET PATHOL, V54, P258, DOI 10.1177/0300985816660745; Stroeve J, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029703; Tomaselli M, CONTAGIOUS ECTHYMA R; Tomaselli M., 2018, THESIS; Tomaselli M, 2018, ARCTIC, V71, P1, DOI 10.14430/arctic4697; Tomaselli M, 2018, BIOL CONSERV, V217, P337, DOI 10.1016/j.biocon.2017.11.010; Tomazatos A., 2019, ECOLOGY W NILE VIRUS, P1; Trebucq A, 2005, INT J TUBERC LUNG D, V9, P1097; VANNUFFEL P, 1994, J CLIN MICROBIOL, V32, P1211, DOI 10.1128/JCM.32.5.1211-1216.1994; Zhang JL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024216	61	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231724	10.1371/journal.pone.0231724	http://dx.doi.org/10.1371/journal.pone.0231724			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315366	Green Published, gold			2022-12-26	WOS:000536024800051
J	Feng, QT; Chen, C; Yu, QY; Chen, SY; Huang, X; Zhong, YL; Luo, SP; Gao, J				Feng, Qiu-Ting; Chen, Chi; Yu, Qing-Ying; Chen, Si-Yun; Huang, Xian; Zhong, Yan-Lan; Luo, Song-Ping; Gao, Jie			The benefits of higher LMR for early threatened abortion: A retrospective cohort study	PLOS ONE			English	Article							NEUTROPHIL-TO-LYMPHOCYTE; PREGNANCY; RATIO; ASSOCIATION; NLR	Problem To investigate the relation of inflammation-related parameters and pregnancy outcome in women with the early threatened abortion. Method of study 630 women with early threatened abortion were divided into two groups based on the pregnancy outcome. All of them had the blood routine examination before treating. The differences between two groups were analyzed by the Chi-squared test, Student T test, Mann-Whitney U test, Binary Logistic Regression, Marginal Structural Model and Threshold effect analysis. Results We found that there is no significant difference in the pregnancy outcome for NLR (OR:0.92, CI95%:0.72, 1.17) and PLR (OR:1.00, CI%:0.99, 1.01). However, a difference had a statistical significance in the pregnancy outcome when LMR less than 2.19 (OR:0.39, CI95%:0.19,0.82). Conclusions This study suggested that higher LMR was related to the lower risk of miscarriage in the women with early threatened abortion in a way.	[Feng, Qiu-Ting; Yu, Qing-Ying; Chen, Si-Yun; Huang, Xian; Zhong, Yan-Lan; Luo, Song-Ping; Gao, Jie] Guangzhou Univ Chinese Med, Guangzhou, Peoples R China; [Chen, Chi] Guiyang Coll Tradit Chinese Med, Guiyang, Peoples R China; [Luo, Song-Ping; Gao, Jie] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Peoples R China	Guangzhou University of Chinese Medicine; Guizhou University of Traditional Chinese Medicine; Guangzhou University of Chinese Medicine	Gao, J (corresponding author), Guangzhou Univ Chinese Med, Guangzhou, Peoples R China.; Gao, J (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou, Peoples R China.	gjfkts@qq.com	Gao, Jie/AAH-5179-2021	FENG, QIUTING/0000-0001-5183-0985	National Natural Science Foundation of China [81774358]; Fok Ying-Tong Education Foundation of China [151042]; Department of Education, Guangdong Province [79]; Scientific Research Team Training Project of GZUCM [2019KYTD202]; Guangzhou Univ Chinese Med Planning[2019]5 [XK2019016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying-Tong Education Foundation of China; Department of Education, Guangdong Province; Scientific Research Team Training Project of GZUCM; Guangzhou Univ Chinese Med Planning[2019]5	National Natural Science Foundation of China (No.81774358); Fok Ying-Tong Education Foundation of China (No.151042); Pearl River Scholars, Department of Education, Guangdong Province (Guangdong teacher's letter[2017] number79); Scientific Research Team Training Project of GZUCM(2019KYTD202); Guangzhou Univ Chinese Med Planning[2019]5 (XK2019016)	Bae H, 2019, DEV COMP IMMUNOL, V94, P73, DOI 10.1016/j.dci.2019.01.016; Bagheri A, 2017, BRATISL MED J, V118, P258, DOI 10.4149/BLL_2017_051; Bagis T, 2001, THYROID, V11, P1049, DOI 10.1089/105072501753271743; Bas FY, 2018, PAK J MED SCI, V34, P1381, DOI 10.12669/pjms.346.15939; Everett C, 1997, BRIT MED J, V315, P32, DOI 10.1136/bmj.315.7099.32; Farren J, 2018, HUM REPROD UPDATE, V24, P731, DOI 10.1093/humupd/dmy025; Giakoumelou S, 2016, HUM REPROD UPDATE, V22, P116, DOI 10.1093/humupd/dmv041; Gu Y, 2018, GYNECOL ENDOCRINOL, V34, P349, DOI 10.1080/09513590.2017.1395837; Hahn S, 2019, CLIN EXP IMMUNOL, V198, P24, DOI 10.1111/cei.13278; Hedger M, 2018, J REPROD IMMUNOL, V130, P23, DOI 10.1016/j.jri.2018.09.051; Ilhan M, 2016, J MATERN-FETAL NEO M, V29, P1476, DOI 10.3109/14767058.2015.1051026; Jayaram A, 2018, REPROD SCI, V25, P1376, DOI 10.1177/1933719117746763; Kaiser J, 2016, CLIN OBSTET GYNECOL, V59, P464, DOI 10.1097/GRF.0000000000000214; Kan O, 2019, GYNECOL OBSTET INVES, V17, P1; Ke RW, 2014, OBSTET GYN CLIN N AM, V41, P103, DOI 10.1016/j.ogc.2013.10.003; Keskin U, 2015, ARCH GYNECOL OBSTET, V291, P557, DOI 10.1007/s00404-014-3452-9; Kim MA, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12973; Liao ZJ, 2019, AM J PUBLIC HEALTH, V109, P476, DOI 10.2105/AJPH.2018.304868; Mannaerts D, 2019, J MATERN-FETAL NEO M, V32, P1412, DOI 10.1080/14767058.2017.1410701; Mevorach-Zussman N, 2012, J PERINAT MED, V40, P495, DOI 10.1515/jpm-2011-0313; Murrieta-Coxca JM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071649; Pan YC, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000013896; Qi H, 2018, EUR J OBSTET GYN R B, V224, P21, DOI 10.1016/j.ejogrb.2018.03.008; Romano A, 2018, ANN HEMATOL, V97, P1009, DOI 10.1007/s00277-018-3276-y; Sargin MA, 2016, THER CLIN RISK MANAG, V12, P657, DOI 10.2147/TCRM.S104247; Serin S, 2016, PREGNANCY HYPERTENS, V6, P22, DOI 10.1016/j.preghy.2016.01.005; Shobeiri SS., 2015, J IMMUNOL RES, V2015, P1, DOI [10.1155/2015/692198, DOI 10.1155/2015/692198]; Sisti G, 2019, MEDICINA KAUNAS, V55; Skrzypczyk P, 2018, CENT EUR J IMMUNOL, V43, P434, DOI 10.5114/ceji.2018.81353; Sun YG, 2018, CANCER MANAG RES, V10, P6167, DOI 10.2147/CMAR.S171035; Wang S, 2015, SCI REP UK, V5; Weiss JL, 2004, AM J OBSTET GYNECOL, V190, P745, DOI 10.1016/j.ajog.2003.09.023; Yazar FM, 2015, KAOHSIUNG J MED SCI, V31, P591, DOI 10.1016/j.kjms.2015.10.005; Yilmaz H, 2014, EXP CLIN ENDOCR DIAB, V122, P39, DOI 10.1055/s-0033-1361087	34	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231642	10.1371/journal.pone.0231642	http://dx.doi.org/10.1371/journal.pone.0231642			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310980	Green Published, gold			2022-12-26	WOS:000536019800024
J	Bouguellid, G; Russo, C; Lavorgna, M; Piscitelli, C; Ayouni, K; Wilson, E; Kim, HK; Verpoorte, R; Choi, YH; Kilani-Atmani, D; Atmani, D; Isidori, M				Bouguellid, Ghania; Russo, Chiara; Lavorgna, Margherita; Piscitelli, Concetta; Ayouni, Karima; Wilson, Erica; Kim, Hye Kyonn; Verpoorte, Rob; Choi, Young Hae; Kilani-Atmani, Dina; Atmani, Djebbar; Isidori, Marina			Antimutagenic, antigenotoxic and antiproliferative activities of Fraxinus angustifolia Vahl. leaves and stem bark extracts and their phytochemical composition	PLOS ONE			English	Article							IN-VITRO; UMU-TEST; 4-NITROQUINOLINE 1-OXIDE; ANTIOXIDANT ACTIVITY; XANTHINE-OXIDASE; MUTAGENICITY; CANCER; VERBASCOSIDE; MUTATION; PLANTS	In recent years, chronic degenerative diseases such as certain types of cancers, are becoming an evident issue. DNA damage has been for long recognized as a causal factor for cancer development because mutations or chromosomal aberrations affect oncogenes and tumor suppressor genes leading cells to malignant transformation and to the subsequent cancerous growth. Medicinal plants are often used for the prevention or treatment of various diseases with great scientific interest. Among the medicinal plants distributed in the Mediterranean region, Fraxinus angustifolia Vahl. has been used in traditional medicine for its remarkable curative properties. However, in spite of this popularity, little works have been performed on the activity so that further studies should be performed to investigate in depth the antimutagenic, antigenotoxic and antiproliferative activities of the plant. Thus, the present study was aimed to the evaluation of the potential antimutagenic, antigenotoxic and antiproliferative properties of leaves and stem bark extracts of this well-known tree. Antimutagenic activity was evaluated by Salmonella mutagenicity assay in Salmonella typhimurium TA98 and TA100 strains. The antigenotoxic potential was assessed by umu test in the strain of S. typhimurium TA1535/pSK1002. Antiproliferative activity was studied on human hepatoblastoma (HepG-2) and on breast adenocarcinoma (MCF-7) cell lines by MTT assay. Furthermore, the antiproliferative activity observed on cancer cells was compared with that on the human normal-like fibroblasts (TelCOFS02MA) and the selectivity index was calculated to understand if extracts were able to exert selective toxicity towards cancer cells. Moreover, phenolic compounds are plant substances with a large spectrum of biochemical activities with antioxidant, antimutagenic and anticarcinogenic effects. Based on the strong evidence of biological activities of phenolic compounds, the study was focused on the determination of total phenolics and flavonoids contents, and the phytochemical composition of the extracts assessed by LC/MS. The ethanol extracts of both leaves and stem barks showed significant from moderate to strong antimutagenic and antigenotoxic effects. In addition, selective cytotoxicity towards cancer cells was shown by ethanolic leaves extract and aqueous/chloroform leaves and stem bark extracts. The latter showed high levels of total phenolic contents among all the other extracts. Identified phenylethanoids (calceolariosides, verbascoside) and secoiridoids (oleuropein and ligstroside) could be responsible for the demonstrated broad spectrum of healthy properties.	[Bouguellid, Ghania; Ayouni, Karima; Kilani-Atmani, Dina; Atmani, Djebbar] Univ Bejaia, Lab Biochim Appl, Fac Sci Nat & Vie, Bejaia, Algeria; [Russo, Chiara; Lavorgna, Margherita; Piscitelli, Concetta; Isidori, Marina] Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy; [Wilson, Erica; Kim, Hye Kyonn; Verpoorte, Rob; Choi, Young Hae] Leiden Univ, Nat Prod Lab, Inst Biol, Leiden, Netherlands	Universite de Bejaia; Universita della Campania Vanvitelli; Leiden University; Leiden University - Excl LUMC	Russo, C (corresponding author), Univ Campania Luigi Vanvitelli, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy.	chiara.russo@unicampania.it	Russo, Chiara/AAP-3102-2021; Choi, Young Hae/O-7886-2016	Choi, Young Hae/0000-0003-1484-1700; Isidori, Marina/0000-0002-0484-2796	University of Campania "Luigi Vanvitelli" through the VALERE program	University of Campania "Luigi Vanvitelli" through the VALERE program	This work was supported by the University of Campania "Luigi Vanvitelli" through the VALERE program. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abudayyak M, 2015, TURK J MED SCI, V45, P496, DOI 10.3906/sag-1401-153; Ahmane N, 2019, TURK J BIOL, V43, P133, DOI 10.3906/biy-1810-26; [Anonymous], 2000, 13829 ISO DIS; Anter J, 2014, MUTAT RES-GEN TOX EN, V772, P25, DOI 10.1016/j.mrgentox.2014.07.002; Atanasov AG, 2015, BIOTECHNOL ADV, V33, P1582, DOI 10.1016/j.biotechadv.2015.08.001; Atmani D, 2009, FOOD CHEM, V112, P303, DOI 10.1016/j.foodchem.2008.05.077; Ayouni K, 2016, IND CROP PROD, V88, P65, DOI 10.1016/j.indcrop.2016.01.001; BabaAissa F., 1999, ENCY PLANTES UTILES; Baharum Z, 2014, MOLECULES, V19, P18317, DOI 10.3390/molecules191118317; BAILLEUL B, 1989, JPN J CANCER RES, V80, P691, DOI 10.1111/j.1349-7006.1989.tb01698.x; Beloued A., 1998, PLANTES MED ALGERIA; Berboucha M, 2010, J MED FOOD, V13, P896, DOI 10.1089/jmf.2009.0164; Caillet S, 2011, FOOD CHEM, V124, P1699, DOI 10.1016/j.foodchem.2010.07.082; Camarda L, 2011, NATURAL RESINS CHEM; Cardinali A, 2013, FOOD RES INT, V54, P132, DOI 10.1016/j.foodres.2013.06.017; Casaburi I, 2013, MOL NUTR FOOD RES, V57, P71, DOI 10.1002/mnfr.201200503; Chatterjee S, 2005, CLIN CHIM ACTA, V352, P155, DOI 10.1016/j.cccn.2004.09.012; CHIANG HC, 1994, J ENZYM INHIB, V8, P61, DOI 10.3109/14756369409040777; Collins AR, 2012, EUR J NUTR, V51, P261, DOI 10.1007/s00394-012-0318-4; Coxam V, 2014, HUILE OLIVE SANTEPRI, V21, P7; de Carvalho MCRD, 2003, ENVIRON MOL MUTAGEN, V42, P185, DOI 10.1002/em.10183; Demirgan R, 2016, AFR J TRADIT COMPLEM, V13, P22, DOI 10.4314/ajtcam.v13i3.3; Duke J.A., 2008, DUKES HDB MED PLANTS; Elamin MH, 2013, FOOD CHEM TOXICOL, V53, P310, DOI 10.1016/j.fct.2012.12.009; Elgorashi EE, 2002, S AFR J BOT, V68, P408, DOI 10.1016/S0254-6299(15)30409-9; EMA (European medicine agency), 2012, ASS REP FRAX EXC FRA, P5; Fale P. L., 2013, Journal of Medicinal Plants Research, V7, P1370; Farooqi A, 2017, MOLECULES, V22, P1; Santos-Cruz LF, 2012, FOOD CHEM TOXICOL, V50, P1082, DOI 10.1016/j.fct.2011.12.006; Ferguson LR, 2001, MUTAT RES-FUND MOL M, V475, P89, DOI 10.1016/S0027-5107(01)00073-2; Ferguson LR, 2004, TOXICOLOGY, V198, P147, DOI 10.1016/j.tox.2004.01.035; Gallagher JEG, 2014, GENE DEV, V28, P409, DOI 10.1101/gad.228940.113; Galvez M, 2006, STUD NAT PROD CHEM, V33, P675; Goldsmith CD, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071937; Henn JG, 2019, J ETHNOPHARMACOL, V229, P145, DOI 10.1016/j.jep.2018.10.003; IKENAGA M, 1975, J MOL BIOL, V92, P341, DOI 10.1016/0022-2836(75)90233-8; Kahkonen MP, 1999, J AGR FOOD CHEM, V47, P3954, DOI 10.1021/jf990146l; Khan MS, 2018, TOXICOL RES-UK, V7, P156, DOI 10.1039/c7tx00269f; Kostova I, 2007, FITOTERAPIA, V78, P85, DOI 10.1016/j.fitote.2006.08.002; Lazzarini E, 1984, MANNA SALUTE NATURA; Lunenfeld B, 2013, BEST PRACT RES CL OB, V27, P643, DOI 10.1016/j.bpobgyn.2013.02.005; Macaluso AM, 1921, FRASSINO MANNA SICIL; Maksimovic Z, 2005, BIORESOURCE TECHNOL, V96, P873, DOI 10.1016/j.biortech.2004.09.006; MARON DM, 1983, MUTAT RES, V113, P173, DOI 10.1016/0165-1161(83)90010-9; Medjahed Z, 2016, TURK J MED SCI, V46, P910, DOI 10.3906/sag-1502-13; Mortelmans K, 2000, MUTAT RES-FUND MOL M, V455, P29, DOI 10.1016/S0027-5107(00)00064-6; Moulaoui K, 2015, EUR J MED CHEM, V89, P179, DOI 10.1016/j.ejmech.2014.10.047; Nagarathna K.M., 2013, INT J PHARM SCI REV, V22, P236; Nsimba RY, 2008, FOOD CHEM, V106, P760, DOI 10.1016/j.foodchem.2007.06.004; NUNOSHIBA T, 1993, CANCER RES, V53, P3250; ODA Y, 1985, MUTAT RES, V147, P219, DOI 10.1016/0165-1161(85)90062-7; Oda Y, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0054-8; Oddo E, 2002, PLANT BIOSYST, V136, P29, DOI 10.1080/11263500212331358501; Orhan F, 2013, FOOD CHEM, V141, P366, DOI 10.1016/j.foodchem.2013.02.089; Ota M, 2005, SUMITOMO KAGAKU, V2, P1; Owen RW, 2000, CLIN CHEM, V46, P976; Papanikolaou C., 2019, FUNCTIONAL FOODS, P9, DOI [10.5772/intechopen.81394, DOI 10.5772/INTECH0PEN.81394]; Perucatti A, 2018, FOOD CHEM TOXICOL, V114, P311, DOI 10.1016/j.fct.2018.02.053; Resende FA, 2015, REGUL TOXICOL PHARM, V72, P506, DOI 10.1016/j.yrtph.2015.05.014; Resende FA, 2012, MOLECULES, V17, P2335, DOI 10.3390/molecules17032335; Santoro A, 2008, TOXICOL LETT, V178, P71, DOI 10.1016/j.toxlet.2008.02.006; Schicchi R, 2006, QUAD BOT AMBIENT APP, V17, P139; Sherif IO, 2018, LIFE SCI, V198, P87, DOI 10.1016/j.lfs.2018.02.027; Skrzypczak A, 2015, TOXICOL IN VITRO, V30, P364, DOI 10.1016/j.tiv.2015.09.029; Sloczynska K, 2014, J APPL GENET, V55, P273, DOI 10.1007/s13353-014-0198-9; Sofowora A, 2013, AFR J TRADIT COMPLEM, V10, P210, DOI 10.4314/ajtcam.v10i5.2; Torgovnick A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00157; Visioli F, 1998, BIOCHEM BIOPH RES CO, V247, P60, DOI 10.1006/bbrc.1998.8735; Zahin M, 2010, MUTAT RES-GEN TOX EN, V703, P99, DOI 10.1016/j.mrgentox.2010.08.001	69	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230690	10.1371/journal.pone.0230690	http://dx.doi.org/10.1371/journal.pone.0230690			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298276	Green Published, gold			2022-12-26	WOS:000536011400019
J	Petkov, R; Minchev, T; Yamakova, Y; Mekov, E; Yankov, G; Petrov, D				Petkov, Rosen; Minchev, Tzvetan; Yamakova, Yordanka; Mekov, Evgeni; Yankov, Georgi; Petrov, Danail			Diagnostic value and complication rate of ultrasound-guided transthoracic core needle biopsy in mediastinal lesions	PLOS ONE			English	Article							CERVICAL MEDIASTINOSCOPY; EXPERIENCE; ASPIRATION; SURGERY; MASSES; LUNG	Background Ultrasound-guided transthoracic core needle biopsy (US-TCNB) is a promising method for establishing the correct diagnosis of mediastinal masses. However, the existing studies in this area are scant and with small samples. Purpose To evaluate the diagnostic value and the complication rate of US-TCNB, particularly large bore cutting biopsy in patients with mediastinal lesions. Material and methods This retrospective study includes 566 patients with mediastinal lesions suspicious of malignancy evaluated between March 2004 and December 2018. Inclusion criteria: 1. Patients with mediastinal lesions detected on thoracic CT scan; 2. Lesions more than 15 mm; 3. Negative histological diagnosis after bronchoscopic biopsy; 4. Normal coagulation status; 5. Cooperative patient; 6. Written informed consent. US visualization of the mediastinal lesions was successful in 308 (54.4%). In all of them, US-TCNB was performed. All patients with mediastinal lesions unsuitable for US visualization were evaluated for a CT-guided transthoracic needle biopsy (CT-TTNB), which was done if the presence of a safe trajectory was available (n = 41, 7.2%). All patients inappropriate for image-guided TTNB were referred to primary surgical diagnostic procedures (n = 217, 38.3%). Results The US-TCNB is a highly effective (accuracy 96%, sensitivity 95%) and safe tool (2.6% complications) in the diagnosis of all subgroups mediastinal lesions. It is non-inferior to CT-TTNB (90%) and comes close to the effectiveness of surgical biopsy techniques (98.4%), but is less invasive and with a lower complication rate. Conclusion US-TCNB of mediastinal lesions is highly effective and safe tool which is particularly helpful in critically ill patients.	[Petkov, Rosen; Mekov, Evgeni; Yankov, Georgi; Petrov, Danail] Med Univ Sofia, MHATPD Sveta Sofia, Dept Pulm Dis, Sofia, Bulgaria; [Minchev, Tzvetan] Acibadem Tokuda Hosp, Thorac Surg Dept, Sofia, Bulgaria; [Yamakova, Yordanka] Med Univ Sofia, Natl Oncol Hosp, Dept Anesthesiol & Intens Care, Sofia, Bulgaria	Medical University Sofia; Medical University Sofia; National Oncology Center - Bulgaria	Mekov, E (corresponding author), Med Univ Sofia, MHATPD Sveta Sofia, Dept Pulm Dis, Sofia, Bulgaria.	dr_mekov@abv.bg	Yamakova, Yordanka/GVS-7962-2022	Mekov, Evgeni/0000-0002-4410-6515				DECAMP MM, 1995, J AM COLL SURGEONS, V181, P113; Demmy TL, 1998, ANN THORAC SURG, V66, P187, DOI 10.1016/S0003-4975(98)00378-6; GLASSBERG RM, 1990, AM J ROENTGENOL, V155, P397, DOI 10.2214/ajr.155.2.2115273; Gorguner M, 2003, J ULTRAS MED, V22, P703, DOI 10.7863/jum.2003.22.7.703; Gupta S, 2005, RADIOGRAPHICS, V25, P763, DOI 10.1148/rg.253045030; Hammoud ZT, 1999, J THORAC CARDIOVASC, V118, P894, DOI [10.1016/s0022-5223(99)70059-0, DOI 10.1016/S0022-5223]; HAZELRIGG SR, 1993, ANN THORAC SURG, V56, P1039, DOI 10.1016/0003-4975(95)90011-X; Koegelenberg CFN, 2011, RESPIRATION, V81, P134, DOI 10.1159/000322005; Lardinois D, 2006, EUR J CARDIO-THORAC, V30, P787, DOI 10.1016/j.ejcts.2006.08.008; Lemaire A, 2006, ANN THORAC SURG, V82, P1185, DOI 10.1016/j.athoracsur.2006.05.023; Metin M, 2002, ANN THORAC SURG, V73, P250, DOI 10.1016/S0003-4975(01)03182-4; Mineo TC, 1999, ANN THORAC SURG, V68, P223, DOI 10.1016/S0003-4975(99)00455-5; Priola AM, 2008, RADIOL MED, V113, P3, DOI 10.1007/s11547-008-0233-1; Protopapas Z, 2000, RADIOL CLIN N AM, V38, P281, DOI 10.1016/S0033-8389(05)70163-9; SAITO T, 1988, AM REV RESPIR DIS, V138, P679, DOI 10.1164/ajrccm/138.3.679; SAWHNEY S, 1991, CLIN RADIOL, V44, P16, DOI 10.1016/S0009-9260(05)80219-3; Silvestri GA, 2013, CHEST, V143, pE211, DOI 10.1378/chest.12-2355; Stammberger U, 2000, EUR J CARDIO-THORAC, V18, P7, DOI 10.1016/S1010-7940(00)00426-7; Sutcliffe S B, 1992, Semin Thorac Cardiovasc Surg, V4, P55; Valerianova Z, 2015, CANC INCIDENCE BULGA, P61; VANSONNENBERG E, 1988, RADIOLOGY, V167, P457, DOI 10.1148/radiology.167.2.3357956; WESTCOTT JL, 1981, RADIOLOGY, V141, P323, DOI 10.1148/radiology.141.2.7291553; Wiersema MJ, 2001, RADIOLOGY, V219, P252, DOI 10.1148/radiology.219.1.r01ap44252; YANG PC, 1992, AM REV RESPIR DIS, V146, P763, DOI 10.1164/ajrccm/146.3.763; YANG PC, 1992, THORAX, V47, P377, DOI 10.1136/thx.47.5.377; YU CJ, 1991, CHEST, V100, P399, DOI 10.1378/chest.100.2.399	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231523	10.1371/journal.pone.0231523	http://dx.doi.org/10.1371/journal.pone.0231523			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298324	Green Published, gold			2022-12-26	WOS:000536011400060
J	Sara, JDS; Maor, E; Borlaug, B; Lewis, BR; Orbelo, D; Lerman, LO; Lerman, A				Sara, Jaskanwal Deep Singh; Maor, Elad; Borlaug, Barry; Lewis, Bradley R.; Orbelo, Diana; Lerman, Lliach O.; Lerman, Amir			Non-invasive vocal biomarker is associated with pulmonary hypertension	PLOS ONE			English	Article							DECOMPENSATED HEART-FAILURE; EJECTION FRACTION; DISEASE; PRESSURE; OUTCOMES	Emerging data suggest that noninvasive voice biomarker analysis is associated with coronary artery disease. We recently showed that a vocal biomarker was associated with hospitalization and heart failure in patients with heart failure. We evaluate the association between a vocal biomarker and invasively measured indices of pulmonary hypertension (PH). Patients were referred for an invasive cardiac hemodynamic study between January 2017 and December 2018, and had their voices recorded on three separate occasions to their smartphone prior to each study. A pre-established vocal biomarker was determined based on each individual recording. The intra-class correlation co-efficient between the separate voice recording biomarker values for each individual participant was 0.829 (95% CI 0.740-0.889) implying very good agreement between values. Thus, the mean biomarker was calculated for each patient. Patients were divided into two groups: high pulmonary arterial pressure (PAP) defined as >= 35 mmHg (moderate or greater PH), versus lower PAP. Eighty three patients, mean age 61.6 +/- 15.1 years, 37 (44.6%) male, were included. Patients with a high mean PAP (>= 35 mmHg) had on average significantly higher values of the mean voice biomarker compared to those with a lower mean PAP (0.74 +/- 0.85 vs. 0.40 +/- 0.88 p = 0.046). Multivariate logistic regression showed that an increase in the mean voice biomarker by 1 unit was associated with a high PAP, odds ratio 2.31, 95% CI 1.05-5.07, p = 0.038. This study shows a relationship between a noninvasive vocal biomarker and an invasively derived hemodynamic index related to PH obtained during clinically indicated cardiac catheterization. These results may have important practical clinical implications for telemedicine and remote monitoring of patients with heart failure and PH.	[Sara, Jaskanwal Deep Singh; Borlaug, Barry; Lerman, Amir] Mayo Coll Med, Dept Cardiovasc Dis, Rochester, MN 55905 USA; [Maor, Elad] Chaim Sheba Med Ctr, Tel Hashomer, Israel; [Maor, Elad] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Lewis, Bradley R.] Mayo Coll Med, Div Biomed Stat & Informat, Rochester, MN USA; [Orbelo, Diana] Mayo Coll Med, Div Laryngol, Rochester, MN USA; [Lerman, Lliach O.] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA	Mayo Clinic; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Mayo Clinic; Mayo Clinic; Mayo Clinic	Lerman, A (corresponding author), Mayo Coll Med, Dept Cardiovasc Dis, Rochester, MN 55905 USA.	lerman.amir@mayo.edu	Maor, Elad/J-9157-2015	Maor, Elad/0000-0002-5087-0464; Lerman, Amir/0000-0002-9446-5313	Beyond Verbal Communications	Beyond Verbal Communications	This study was in part funded by Beyond Verbal Communications. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Elad Maor serves as a consultant for Beyond Verbal Communications. This author received no specific funding for this work. The remaining authors have nothing to disclose	Abraham WT, 2011, LANCET, V377, P658, DOI 10.1016/S0140-6736(11)60101-3; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Brewis MJ, 2015, EUR RESPIR J, V46, P1378, DOI 10.1183/13993003.02307-2014; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Cleland JGF, 2003, EUR HEART J, V24, P442, DOI 10.1016/S0195-668X(02)00823-0; Cooper LB, 2016, J CARD FAIL, V22, P182, DOI 10.1016/j.cardfail.2015.11.012; DeFrances CJ, 2006, NATL HLTH STAT REPOR, V2008, P1; Desai AS, 2017, J AM COLL CARDIOL, V69, P2357, DOI 10.1016/j.jacc.2017.03.009; Eskidere O, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/956249; Ghio S, 2001, J AM COLL CARDIOL, V37, P183, DOI 10.1016/S0735-1097(00)01102-5; Giddens CL, 2013, J VOICE, V27, DOI 10.1016/j.jvoice.2012.12.010; Godino-Llorente JI, 2006, IEEE T BIO-MED ENG, V53, P1943, DOI 10.1109/TBME.2006.871883; Guazzi M, 2012, CIRCULATION, V126, P975, DOI 10.1161/CIRCULATIONAHA.111.085761; Haddad F, 2011, PROG CARDIOVASC DIS, V54, P154, DOI 10.1016/j.pcad.2011.06.003; Hindricks G, 2014, LANCET, V384, P583, DOI 10.1016/S0140-6736(14)61176-4; Inglis SC, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007228.pub2; Johannes B, 2007, EUR J APPL PHYSIOL, V101, P267, DOI 10.1007/s00421-007-0496-6; Khera R, 2017, CIRCULATION, V136; Lam CSP, 2009, J AM COLL CARDIOL, V53, P1119, DOI 10.1016/j.jacc.2008.11.051; Liao DP, 1997, AM J EPIDEMIOL, V145, P696, DOI 10.1093/aje/145.8.696; Maor E, 2018, MAYO CLIN PROC, V93, P840, DOI 10.1016/j.mayocp.2017.12.025; Maor EMI, 2018, EUROPEAN HEART J, V39; Mascherbauer J, 2017, JACC-HEART FAIL, V5, P795, DOI 10.1016/j.jchf.2017.08.005; Miller WL, 2013, JACC-HEART FAIL, V1, P290, DOI 10.1016/j.jchf.2013.05.001; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Murton OM, 2017, J ACOUST SOC AM, V142, pEL401, DOI 10.1121/1.5007092; Naeije R, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.004082; O'Shaughnessy D, 2008, PATTERN RECOGN, V41, P2965, DOI 10.1016/j.patcog.2008.05.008; Olivari Z, 2018, INT J CARDIOL, V257, P137, DOI 10.1016/j.ijcard.2017.10.099; Picone JW, 1993, SIGNAL MODELING TECH; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Protopapas A, 1997, J ACOUST SOC AM, V101, P2267, DOI 10.1121/1.418247; Rabiner L.R., 2010, THEORY APPL DIGITAL; Rani KU, 2013, 2013 IEEE POINT-OF-CARE HEALTHCARE TECHNOLOGIES (PHT), P76, DOI 10.1109/PHT.2013.6461288; Sara JD, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008073; Segers VFM, 2012, CURR OPIN CARDIOL, V27, P273, DOI 10.1097/HCO.0b013e3283512035; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Vachiery JL, 2013, J AM COLL CARDIOL, V62, pD100, DOI 10.1016/j.jacc.2013.10.033; van Veldhuisen DJ, 2011, CIRCULATION, V124, P1719, DOI 10.1161/CIRCULATIONAHA.111.043042; Vanderpool RR, 2018, JAMA CARDIOL, V3, P298, DOI 10.1001/jamacardio.2018.0128	40	10	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231441	10.1371/journal.pone.0231441	http://dx.doi.org/10.1371/journal.pone.0231441			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298301	Green Published, gold			2022-12-26	WOS:000536011400045
J	Oh, KH; Sheoran, S; Richmond, JE; Kim, H				Oh, Kelly H.; Sheoran, Seema; Richmond, Janet E.; Kim, Hongkyun			Alcohol induces mitochondrial fragmentation and stress responses to maintain normal muscle function in Caenorhabditis elegans	FASEB JOURNAL			English	Article							UNFOLDED PROTEIN RESPONSE; SKELETAL-MUSCLE; UPR; MECHANISMS; RETICULUM; FUSION; COORDINATION; HOMEOSTASIS; ACTIVATION; RESISTANCE	Chronic excessive ethanol consumption has distinct toxic and adverse effects on a variety of tissues. In skeletal muscle, ethanol causes alcoholic myopathy, which is characterized by myofiber atrophy and the loss of muscle strength. Alcoholic myopathy is more prevalent than all inherited muscle diseases combined. Current evidence indicates that ethanol directly impairs muscle organization and function. However, the underlying mechanism by which ethanol causes toxicity in muscle is poorly understood. Here, we show that the nematode Caenorhabditis elegans exhibits the key features of alcoholic myopathy when exposed to ethanol. As in mammals, ethanol exposure impairs muscle strength and induces the expression of protective genes, including oxidative stress response genes. In addition, ethanol exposure causes the fragmentation of mitochondrial networks aligned with myofibril lattices. This ethanol-induced mitochondrial fragmentation is dependent on the mitochondrial fission factor DRP-1 (dynamin-related protein 1) and its receptor proteins on the outer mitochondrial membrane. Our data indicate that this fragmentation contributes to the activation of the mitochondrial unfolded protein response (UPR). We also found that robust, perpetual mitochondrial UPR activation effectively reduces muscle weakness caused by ethanol exposure. Our results strongly suggest that the modulation of mitochondrial stress responses may provide a method to ameliorate alcohol toxicity and damage to muscle.	[Oh, Kelly H.; Kim, Hongkyun] Rosalind Franklin Univ Med & Sci, Ctr Canc Cell Biol Immunol & Infect, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA; [Oh, Kelly H.; Kim, Hongkyun] Rosalind Franklin Univ Med & Sci, Sch Grad & Postdoctoral Studies, N Chicago, IL 60064 USA; [Sheoran, Seema; Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA	Chicago Medical School; Rosalind Franklin University Medical & Science; Rosalind Franklin University Medical & Science; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Oh, KH; Kim, H (corresponding author), Rosalind Franklin Univ Med & Sci, Ctr Canc Cell Biol Immunol & Infect, Chicago Med Sch, Dept Cell Biol & Anat, N Chicago, IL 60064 USA.	Kelly.oh@rosalindfranklin.edu; hongkyun.kim@rosalindfranklin.edu		Kim, Hongkyun/0000-0002-4879-7122; Sheoran, Seema/0000-0003-0227-856X; Oh, Kelly/0000-0001-8203-5247	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS) [RO1GM125749]; HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA) [R21AA023940]	HHS \ NIH \ National Institute of General Medical Sciences (NIGMS); HHS \ NIH \ National Institute on Alcohol Abuse and Alcoholism (NIAAA)	HHS vertical bar NIH vertical bar National Institute of General Medical Sciences (NIGMS), Grant/Award Number: RO1GM125749; HHS vertical bar NIH vertical bar National Institute on Alcohol Abuse and Alcoholism (NIAAA), Grant/Award Number: R21AA023940	Alaimo JT, 2012, ALCOHOL CLIN EXP RES, V36, P1840, DOI 10.1111/j.1530-0277.2012.01799.x; Bennett CF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4483; Berendzen KM, 2016, CELL, V166, P1553, DOI 10.1016/j.cell.2016.08.042; Bolz DD, 2010, J BIOL CHEM, V285, P10832, DOI 10.1074/jbc.M109.091629; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0; Eisner V, 2017, P NATL ACAD SCI USA, V114, pE859, DOI 10.1073/pnas.1617288114; Eisner V, 2014, J CELL BIOL, V205, P179, DOI 10.1083/jcb.201312066; Estes KA, 2010, P NATL ACAD SCI USA, V107, P2153, DOI 10.1073/pnas.0914643107; Fernandez-Sola J, 2007, ALCOHOL CLIN EXP RES, V31, P1953, DOI 10.1111/j.1530-0277.2007.00530.x; Fiorese CJ, 2016, CURR BIOL, V26, P2037, DOI 10.1016/j.cub.2016.06.002; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7; Haida M, 1998, ALCOHOL CLIN EXP RES, V22, p108S, DOI 10.1111/acer.1998.22.s3_part1.108s; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Iser WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017369; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kim H, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0619-5; Kimball SR, 2018, ANNU REV NUTR, V38, P197, DOI 10.1146/annurev-nutr-071816-064642; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; Lamech LT, 2015, J CELL BIOL, V209, P781, DOI 10.1083/jcb.201503107; Lamitina Todd, 2006, V351, P127; Lebeau J, 2018, CELL REP, V22, P2827, DOI 10.1016/j.celrep.2018.02.055; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Lesanpezeshki L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51608-9; Link CD, 2002, METHOD ENZYMOL, V353, P497; Liu Y, 2014, NATURE, V508, P406, DOI 10.1038/nature13204; Lowry J, 2015, G3-GENES GENOM GENET, V5, P2241, DOI 10.1534/g3.115.021451; Lu Y, 2011, P NATL ACAD SCI USA, V108, pE813, DOI 10.1073/pnas.1103218108; Ma DK, 2012, NEURON, V73, P925, DOI 10.1016/j.neuron.2011.12.037; Mai S, 2010, J CELL SCI, V123, P917, DOI 10.1242/jcs.059246; Melber A, 2018, CELL RES, V28, P281, DOI 10.1038/cr.2018.16; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Much C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006095; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Oh KH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46615-9; Oh KH, 2013, P NATL ACAD SCI USA, V110, P19024, DOI 10.1073/pnas.1308866110; Oks O, 2018, GENETICS, V209, P457, DOI 10.1534/genetics.118.300863; Oliver DMA, 2019, J ALZHEIMERS DIS, V72, pS95, DOI 10.3233/JAD-190048; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; PREEDY VR, 1994, J PATHOL, V173, P309, DOI 10.1002/path.1711730405; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Rauthan M, 2013, P NATL ACAD SCI USA, V110, P5981, DOI 10.1073/pnas.1218778110; Scott LL, 2017, GENETICS, V206, P1445, DOI 10.1534/genetics.116.193102; Sebastian D, 2012, P NATL ACAD SCI USA, V109, P5523, DOI 10.1073/pnas.1108220109; Shen QF, 2014, MOL BIOL CELL, V25, P145, DOI 10.1091/mbc.E13-09-0525; Shpilka T, 2018, NAT REV MOL CELL BIO, V19, P109, DOI 10.1038/nrm.2017.110; Simon L, 2017, ALCOHOL RES-CURR REV, V38, P207; Smyrnias I, 2019, J AM COLL CARDIOL, V73, P1795, DOI 10.1016/j.jacc.2018.12.087; Souza-Smith FM, 2016, AM J PHYSIOL-ENDOC M, V311, pE605, DOI 10.1152/ajpendo.00270.2016; Sudarikova YV, 1997, BIOCHEMISTRY-MOSCOW+, V62, P989; Tan FJ, 2008, J CELL SCI, V121, P3373, DOI 10.1242/jcs.032904; Tian Y, 2016, CELL, V165, P1197, DOI 10.1016/j.cell.2016.04.011; Urbano-Marquez A, 2004, MUSCLE NERVE, V30, P689, DOI 10.1002/mus.20168; URBANOMARQUEZ A, 1989, NEW ENGL J MED, V320, P409, DOI 10.1056/NEJM198902163200701; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; Wang YT, 2019, AM J PHYSIOL-HEART C, V317, pH472, DOI 10.1152/ajpheart.00244.2019; Weimer Robby M., 2006, V351, P203; Yu R, 2019, EMBO J, V38, DOI 10.15252/embj.201899748	63	8	8	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8204	8216		10.1096/fj.201903166R	http://dx.doi.org/10.1096/fj.201903166R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32294300	Green Accepted, Green Submitted			2022-12-26	WOS:000526102900001
J	Rao, MV; Rice, RA; Fleischer, RC; Muletz-Wolz, CR				Rao, Maya V.; Rice, Robert A.; Fleischer, Robert C.; Muletz-Wolz, Carly R.			Soil fungal communities differ between shaded and sun-intensive coffee plantations in El Salvador	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; MICROBIAL COMMUNITIES; LITTER DECOMPOSITION; DISAPPEARING REFUGE; ARABICA L.; PLANT; DIVERSITY; TREES; CONSERVATION; BIODIVERSITY	Coffea arabica is a highly traded commodity worldwide, and its plantations are habitat to a wide range of organisms. Coffee farmers are shifting away from traditional shade coffee farms in favor of sun-intensive, higher yield farms, which can impact local biodiversity. Using plant-associated microorganisms in biofertilizers, particularly fungi collected from local forests, to increase crop yields has gained traction among coffee producers. However, the taxonomic and spatial distribution of many fungi in coffee soil, nearby forests and biofertilizers is unknown. We collected soil samples from a sun coffee system, shade coffee system, and nearby forest from Izalco, Sonsonate, El Salvador. At each coffee system, we collected soil from the surface (upper) and 10 cm below the surface (lower), and from the coffee plant drip line (drip line) and the walkway between two plants (walkway). Forest soils were collected from the surface only. We used ITS metabarcoding to characterize fungal communities in soil and in the biofertilizer (applied in both coffee systems), and assigned fungal taxa to functional guilds using FUNGuild. In the sun and shade coffee systems, we found that drip line soil had higher richness in pathotrophs, symbiotrophs, and saprotrophs than walkway soil, suggesting that fungi select for microhabitats closer to coffee plants. Upper and lower soil depths did not differ in fungal richness or composition, which may reflect the shallow root system of Coffea arabica. Soil from shade, sun, and forest had similar numbers of fungal taxa, but differed dramatically in community composition, indicating that local habitat differences drive fungal species sorting among systems. Yet, some fungal taxa were shared among systems, including seven fungal taxa present in the biofertilizer. Understanding the distribution of coffee soil mycobiomes can be used to inform sustainable, ecologically friendly farming practices and identify candidate plant-growth promoting fungi for future studies.	[Rao, Maya V.] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Rao, Maya V.; Fleischer, Robert C.; Muletz-Wolz, Carly R.] Smithsonian Natl Zool Pk, Ctr Conservat Genom, Washington, DC 20008 USA; [Rao, Maya V.; Rice, Robert A.; Fleischer, Robert C.; Muletz-Wolz, Carly R.] Conservat Biol Inst, Washington, DC 20008 USA; [Rice, Robert A.] Smithsonian Natl Zool Pk, Migratory Bird Ctr, Washington, DC USA	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute	Muletz-Wolz, CR (corresponding author), Smithsonian Natl Zool Pk, Ctr Conservat Genom, Washington, DC 20008 USA.; Muletz-Wolz, CR (corresponding author), Conservat Biol Inst, Washington, DC 20008 USA.	muletzc@si.edu	Muletz-Wolz, Carly/N-3816-2013	Muletz-Wolz, Carly/0000-0001-5047-9601				[Anonymous], 2015, FAO STAT COFFEE POCK; Barcenas-Moreno G, 2009, GLOBAL CHANGE BIOL, V15, P2950, DOI 10.1111/j.1365-2486.2009.01882.x; Bates ST, 2013, STAND GENOMIC SCI, V8, P118, DOI 10.4056/sigs.3737409; BEER J, 1987, AGROFOREST SYST, V5, P3, DOI 10.1007/BF00046410; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Beverley J, 1982, EL SALVADOR SOCIAL T, P55, DOI [10.2307/466334, DOI 10.2307/466334]; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Bonfante P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1046; Caldwell AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0106355; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cameron E, 2019, GLOBAL MISMATCHES GR; Cardoso I, MYCORRHIZAS TROPICAL; Caudill SA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165662; Caudill SA, 2015, AGR ECOSYST ENVIRON, V199, P85, DOI 10.1016/j.agee.2014.08.023; Caudill SA, 2014, AGROFOREST SYST, V88, P173, DOI 10.1007/s10457-013-9664-3; Classen A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3148; Coyner M.S., 1960, AGR TRADE NICARAGUA; CUENCA G, 1983, PLANT SOIL, V71, P477, DOI 10.1007/BF02182689; Davis H, 2019, AGROFOREST SYST, V93, P581, DOI 10.1007/s10457-017-0152-z; De Beenhouwer M, 2015, SOIL BIOL BIOCHEM, V91, P133, DOI 10.1016/j.soilbio.2015.08.037; de Souza HN, 2012, AGR ECOSYST ENVIRON, V146, P179, DOI 10.1016/j.agee.2011.11.007; Delgado-Baquerizo M, 2018, SCIENCE, V359, P320, DOI 10.1126/science.aap9516; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Evizal R, 2012, SOIL BACTERIAL DIVER; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Finkel OM, 2017, CURR OPIN PLANT BIOL, V38, P155, DOI 10.1016/j.pbi.2017.04.018; Greenberg R, 1997, CONSERV BIOL, V11, P448, DOI 10.1046/j.1523-1739.1997.95464.x; Griscom L, 1932, B AM MUSEUM NATURAL; Hamayun M, 2010, MYCOLOGIA, V102, P989, DOI 10.3852/09-261; Hindorf H, 2011, J ADV RES, V2, P109, DOI 10.1016/j.jare.2010.08.006; Hortal S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18103-5; Jha S, 2010, BIOL CONSERV, V143, P1423, DOI 10.1016/j.biocon.2010.03.017; Jha S, 2014, BIOSCIENCE, V64, P416, DOI 10.1093/biosci/biu038; Kepler RM, 2017, CURR OPIN MICROBIOL, V37, P48, DOI 10.1016/j.mib.2017.03.006; KIMANI M, 2002, INTRO COFFEE MANAGEM; Lakshmi V, 2003, HYDROL PROCESS, V17, P3041, DOI 10.1002/hyp.1275; Landesman WJ, 2014, SOIL BIOL BIOCHEM, V76, P201, DOI 10.1016/j.soilbio.2014.05.025; McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Muleta D, 2007, ENG LIFE SCI, V7, P577, DOI 10.1002/elsc.200700004; Muletz Wolz C, 2017, EFFECTS HOST SPECIES; Murrieta-Galindo R, 2013, AGROFOREST SYST, V87, P767, DOI 10.1007/s10457-013-9595-z; Naidoo R, 2004, ANIM CONSERV, V7, P93, DOI 10.1017/S1367943003001185; Narango DL, 2019, BIOTROPICA, V51, P387, DOI 10.1111/btp.12642; Nguyen NH, 2016, FUNGAL ECOL, V20, P241, DOI 10.1016/j.funeco.2015.06.006; Nie SA, 2018, APPL SOIL ECOL, V130, P251, DOI 10.1016/j.apsoil.2018.06.008; Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022; Oehl F, 2005, NEW PHYTOL, V165, P273, DOI 10.1111/j.1469-8137.2004.01235.x; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Osono T, 2007, ECOL RES, V22, P955, DOI 10.1007/s11284-007-0390-z; Palagani A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113842; Perfecto I, 2005, ECOL ECON, V54, P435, DOI 10.1016/j.ecolecon.2004.10.009; Perfecto I, 2003, BIODIVERS CONSERV, V12, P1239, DOI 10.1023/A:1023039921916; Perfecto I, 1996, BIOSCIENCE, V46, P598, DOI 10.2307/1312989; Philpott SM, 2008, CONSERV BIOL, V22, P1093, DOI 10.1111/j.1523-1739.2008.01029.x; Pietikainen J, 2005, FEMS MICROBIOL ECOL, V52, P49, DOI 10.1016/j.femsec.2004.10.002; Prates P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209093; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rice R., 2008, SMITHSONIAN ZOOGOER, P17; Rice RA, 1999, GEOGR REV, V89, P554, DOI 10.2307/216102; Rice RA, 1990, TRANSFORMING AGR CAS; Rice RA, 2011, AGROFOREST SYST, V83, P41, DOI 10.1007/s10457-011-9385-4; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; van Elsas JD, 2012, P NATL ACAD SCI USA, V109, P1159, DOI 10.1073/pnas.1109326109; Vivanco L, 2008, J ECOL, V96, P727, DOI 10.1111/j.1365-2745.2008.01393.x; Wang ZT, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01301; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Waud M, 2014, MOL ECOL RESOUR, V14, P679, DOI 10.1111/1755-0998.12229; Weber CF, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00078; Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y; Wickham H., 2016, GGPLOT2 ELEGANT GRAP; Xue C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11124; Zhao QY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24537-2	74	9	9	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231875	10.1371/journal.pone.0231875	http://dx.doi.org/10.1371/journal.pone.0231875			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330174	Green Published, gold			2022-12-26	WOS:000536647300027
J	Bhalla, S; Kaur, H; Kaur, R; Sharma, S; Raghava, GPS				Bhalla, Sherry; Kaur, Harpreet; Kaur, Rishemjit; Sharma, Suresh; Raghava, Gajendra P. S.			Expression based biomarkers and models to classify early and late-stage samples of Papillary Thyroid Carcinoma	PLOS ONE			English	Article							LONG NONCODING RNA; SOCIAL IMPACT THEORY; DIFFERENTIAL EXPRESSION; CANCER; GENE; CLASSIFICATION; THERAPY; NODULES; INHIBITOR; MIGRATION	Introduction Recently, the rise in the incidences of thyroid cancer worldwide renders it to be the sixth most common cancer among women. Commonly, Fine Needle Aspiration biopsy predominantly facilitates the diagnosis of the nature of thyroid nodules. However, it is inconsiderable in determining the tumor's state, i.e., benign or malignant. This study aims to identify the key RNA transcripts that can segregate the early and late-stage samples of Thyroid Carcinoma (THCA) using RNA expression profiles. Materials and methods In this study, we used the THCA RNA-Seq dataset of The Cancer Genome Atlas, consisting of 500 cancer and 58 normal (adjacent non-tumorous) samples obtained from the Genomics Data Commons (GDC) data portal. This dataset was dissected to identify key RNA expression features using various feature selection techniques. Subsequently, samples were classified based on selected features employing different machine learning algorithms. Results Single gene ranking based on the Area Under the Receiver Operating Characteristics (AUROC) curve identified the DCN transcript that can classify the early-stage samples from late-stage samples with 0.66 AUROC. To further improve the performance, we identified a panel of 36 RNA transcripts that achieved F1 score of 0.75 with 0.73 AUROC (95% CI: 0.62-0.84) on the validation dataset. Moreover, prediction models based on 18-features from this panel correctly predicted 75% of the samples of the external validation dataset. In addition, the multiclass model classified normal, early, and late-stage samples with AUROC of 0.95 (95% CI: 0.84-1), 0.76 (95% CI: 0.66-0.85) and 0.72 (95% CI: 0.61-0.83) on the validation dataset. Besides, a five protein-coding transcripts panel was also recognized, which segregated cancer and normal samples in the validation dataset with F1 score of 0.97 and 0.99 AUROC (95% CI: 0.91-1). Conclusion We identified 36 important RNA transcripts whose expression segregated early and late-stage samples with reasonable accuracy. The models and dataset used in this study are available from the webserver CancerTSP (http://webs.iiitd.edu.in/raghava/cancertsp/).	[Bhalla, Sherry; Raghava, Gajendra P. S.] Indraprastha Inst Informat Technol, Dept Computat Biol, New Delhi, India; [Bhalla, Sherry; Sharma, Suresh] Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh, India; [Kaur, Harpreet] Inst Microbial Technol, CSIR, Bioinformat Ctr, Chandigarh, India; [Kaur, Rishemjit] Cent Sci Instruments Org, CSIR, Chandigarh, India	Indraprastha Institute of Information Technology Delhi; Panjab University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Scientific Instruments Organisation (CSIO)	Raghava, GPS (corresponding author), Indraprastha Inst Informat Technol, Dept Computat Biol, New Delhi, India.	raghava@iiitd.ac.in	Kaur, Harpreet/AAS-6674-2021; Raghava, Gajendra P.S./AAA-2413-2022; Raghava, Gajendra/B-1717-2009	Kaur, Harpreet/0000-0003-0421-8341; Raghava, Gajendra P.S./0000-0002-8902-2876; 	J. C. Bose National Fellowship from Department of Science & Technology (DST), India [SRP076]; Indian Council of Medical Research (ICMR), India; Council of Scientific and Industrial Research (CSIR), India	J. C. Bose National Fellowship from Department of Science & Technology (DST), India; Indian Council of Medical Research (ICMR), India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	All the authors acknowledge funding from J. C. Bose National Fellowship from Department of Science & Technology (DST), India with Grant Number SRP076. S.B. and H.K. are thankful to Indian Council of Medical Research (ICMR), India and Council of Scientific and Industrial Research (CSIR), India, respectively for providing fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Agrawal P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00323; Arnaldi LAT, 2005, THYROID, V15, P210, DOI 10.1089/thy.2005.15.210; Baraniuk RG, 2007, IEEE SIGNAL PROC MAG, V24, P6, DOI 10.1109/MSP.2007.909718; Bhalla S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52134-4; Bhalla S, 2017, SCI REP-UK, V7, DOI 10.1038/srep44997; Bhondekar AP, 2011, CHEMOMETR INTELL LAB, V109, P65, DOI 10.1016/j.chemolab.2011.08.002; Borrelli N, 2016, CANCER CYTOPATHOL, V124, P340, DOI 10.1002/cncy.21681; Buffet C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184861; Chai YJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159235; Chedotal A, 2007, PROG EXP TUMOR RES, V39, P78, DOI 10.1159/000100048; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chiu CG, 2010, AM J PATHOL, V176, P2067, DOI 10.2353/ajpath.2010.090353; Choi JY, 2017, ENDOCR CONNECT, V6, P172, DOI 10.1530/EC-17-0001; Chudova D, 2010, J CLIN ENDOCR METAB, V95, P5296, DOI 10.1210/jc.2010-1087; Cong D, 2015, ONCOTARGETS THER, V8, P2271, DOI 10.2147/OTT.S85753; Cui B, 2014, J CLIN ENDOCR METAB, V99, pE962, DOI 10.1210/jc.2013-3147; Cui HX, 2017, CANCER MED-US, V6, P2932, DOI 10.1002/cam4.1180; Dohi O, 2010, INT J ONCOL, V36, P85, DOI 10.3892/ijo_00000478; Eibe Frank MAH, 2016, WEKA WORKBENCH ONLIN; Fan M, 2013, EXP THER MED, V5, P1143, DOI 10.3892/etm.2013.933; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Franks JM, 2018, BIOINFORMATICS, V34, P1868, DOI 10.1093/bioinformatics/bty026; GHARIB H, 1994, MAYO CLIN PROC, V69, P44, DOI 10.1016/S0025-6196(12)61611-5; Grogan Raymon H, 2010, Cancers (Basel), V2, P885, DOI 10.3390/cancers2020885; Haider AS, 2011, DIAGN CYTOPATHOL, V39, P81, DOI 10.1002/dc.21324; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hay ID, 2002, WORLD J SURG, V26, P879, DOI 10.1007/s00268-002-6612-1; Hwang BJ, 2015, DNA REPAIR, V31, P80, DOI 10.1016/j.dnarep.2015.05.004; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jagga Zeenia, 2014, BMC Proc, V8, pS2, DOI 10.1186/1753-6561-8-S6-S2; Kamino H, 2011, INT J ONCOL, V38, P1511, DOI 10.3892/ijo.2011.980; Kaur H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221476; Kaur R, 2012, SENSOR ACTUAT B-CHEM, V166, P309, DOI 10.1016/j.snb.2012.02.067; Kim SJ, 2004, J KOREAN MED SCI, V19, P710, DOI 10.3346/jkms.2004.19.5.710; Kobayashi T, 2006, INT J ONCOL, V29, P341; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee S, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1015; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu CP, 2016, SCI REP-UK, V6, DOI 10.1038/srep36990; Liu RY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03033-1; Liu RY, 2016, ENDOCR-RELAT CANCER, V23, pR143, DOI 10.1530/ERC-15-0533; Liu TJ, 2009, MOL CANCER THER, V8, P2204, DOI 10.1158/1535-7163.MCT-09-0160; Martins MB, 2018, CLIN BIOCHEM, V52, P1, DOI 10.1016/j.clinbiochem.2017.10.003; Maruyama R, 2012, P NATL ACAD SCI USA, V109, P2820, DOI 10.1073/pnas.1010559107; Matson DR, 2017, EXP MOL PATHOL, V103, P288, DOI 10.1016/j.yexmp.2017.11.009; Nga ME, 2008, DIAGN CYTOPATHOL, V36, P550, DOI 10.1002/dc.20841; Okamura Y, 2011, ANN SURG ONCOL, V18, P572, DOI 10.1245/s10434-010-1273-z; Oncology ASoC, 2019, THYR CANC STAG 2019; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Qiu ZL, 2015, NUCL MED BIOL, V42, P499, DOI 10.1016/j.nucmedbio.2015.01.009; Qureshi A, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-305; Salomaki HH, 2008, J HISTOCHEM CYTOCHEM, V56, P639, DOI 10.1369/jhc.2008.950287; Savari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073466; Sethi Kruttibas, 2010, J Exp Ther Oncol, V8, P341; Sheikh-Ali M, 2007, THYROID, V17, P631, DOI 10.1089/thy.2007.0062; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smallridge RC, 2014, J CLIN ENDOCR METAB, V99, pE338, DOI 10.1210/jc.2013-2792; Society AC, 2017, CANC FACTS FIG 2015; Stephen Josena K, 2015, Cancer Clin Oncol, V4, P1; Stokowy T, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1427042; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tanaka A, 2019, THYROID, V29, P1105, DOI 10.1089/thy.2018.0695; Theocharis AD, 2019, MATRIX BIOL, V75-76, P220, DOI 10.1016/j.matbio.2017.10.008; Tiedje Vera, 2016, Eur J Endocrinol, V175, P173, DOI 10.1530/EJE-16-0252; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wu TF, 2004, J MACH LEARN RES, V5, P975; Xiao X, 2010, CURR CANCER DRUG TAR, V10, P384, DOI 10.2174/156800910791208535; Xu CL, 2017, P NATL ACAD SCI USA, V114, P722, DOI 10.1073/pnas.1615735114; Yao T, 2016, FEBS OPEN BIO, V6, P707, DOI 10.1002/2211-5463.12076; Yi JW, 2017, ANN SURG ONCOL, V24, P3754, DOI 10.1245/s10434-017-5780-z; Yu H, 2015, J THORAC ONCOL, V10, P645, DOI 10.1097/JTO.0000000000000470; Zolotov S, 2016, RAMBAM MAIMONIDES ME, V7, DOI 10.5041/RMMJ.10236	77	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231629	10.1371/journal.pone.0231629	http://dx.doi.org/10.1371/journal.pone.0231629			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324757	Green Submitted, Green Published, gold			2022-12-26	WOS:000536033700024
J	Simoes, TC; Sena, R; Meira, KC				Simoes, Taynana Cesar; Sena, Roberto; Meira, Karina Cardoso			The influence of the age-period-cohort effects on the temporal trend mortality from schistosomiasis in Brazil from 1980 to 2014	PLOS ONE			English	Article							WATER-CONTACT PATTERNS; MODELS; MORBIDITY; DEATHS; FORMS	Background Schistosomiasis is highly debilitating and related to poverty, leading to chronic health problems. This disease is important for public health due to the high prevalence, severity of clinical forms and heterogeneous spatial and temporal patterns. In Brazil, about 1.5 million people are at risk of infection with Schistosoma mansoni, with an annual average of 500 deaths. In this study, the temporal change in mortality was evaluated in relation to the effects of age, period and birth cohort, in Brazil and regions, from 1980 to 2014. Methods In this study, we analyzed the influence of age, period and birth cohort (APC effects) on the temporal evolution of schistosomiasis mortality in Brazil from 1980 to 2014, according to sex and geographic regions of the country. The death records were extracted from the SIM (Mortality Information System) of the DATASUS website (Department of National Health Informatics) of the Ministry of Health of Brazil. The temporal effects were estimated using Bayesian models and the INLA (Integrated Nested Laplace Approximations) method for parameter inference. Results More than 24 thousand deaths were registered in the analyzed period, mainly in men from the Northeast region. In Brazil, children under 14 years of age had protection against death from schistosomiasis. There was no significant effect for others ages. From 1990 to 1999, there was a protective effect for death from schistosomiasis and a null effect in the other periods. There was a decreasing trend in the risk of death among birth cohorts. The greatest risk was among people born from 1903 to 1912. There was a protective effect for death among people born after 1968. Men were at risk of death between 25 and 54 years old, while women were at risk after seventy years of age. The southern and central-western regions had a risk of death until 1989 and had a protective effect between 1995 and 1999. The northern region had a risk of death between 1985 and 1994, and a protective effect after 2005. The northeast and Southeast regions had protective effects for death between the years 1990 and 1999, and after 2000, respectively. People born until 1952 and 1957 were at risk of dying in the South and North regions, respectively, and a protective effect among people born after 1968, in both regions. In the Northeast region, there was a protective effect among people born after 1963. In the other regions, there was a risk of death among people born until 1962 and a protective effect among people born after 1973. The Central-West region had the least declining trend in risk of death among birth cohorts. Conclusions The birth cohorts had a great influence on the decreasing trend of schistosomiasis mortality in Brazil. This result may be due to the interaction between demographic changes and greater access to health and sanitation services, in addition to the impact of schistosomiasis control measures experienced by younger cohorts.	[Simoes, Taynana Cesar; Sena, Roberto] Oswaldo Cruz Fdn Fiocruz, Rene Rachou Inst, Belo Horizonte, MG, Brazil; [Meira, Karina Cardoso] Univ Fed Rio Grande do Norte, Sch Hlth, Natal, RN, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Norte	Simoes, TC (corresponding author), Oswaldo Cruz Fdn Fiocruz, Rene Rachou Inst, Belo Horizonte, MG, Brazil.	taynana.simoes@fiocruz.br	Simões, Taynãna César/ABE-8964-2021	Simoes Cesar, Taynana/0000-0002-5849-343X	National Scientific and Technological Development (CNPQ)	National Scientific and Technological Development (CNPQ)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This article is a product of a project coordinated by the main author and funded by the National Scientific and Technological Development (CNPQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. http://www.cnpq.br/	Barbosa CS, 2016, ACTA TROP, V164, P10, DOI 10.1016/j.actatropica.2016.06.024; Brasil, 2014, VIG ESQ MANS DIR TEC, V4; Clayton D., ESTATISTICS MED, V6, P468; Coura JR, 2004, MEM I OSWALDO CRUZ, V99, P13, DOI 10.1590/S0074-02762004000900003; Coutinho EM, 1997, MEM I OSWALDO CRUZ, V92, P707, DOI 10.1590/S0074-02761997000500027; DALTON PR, 1978, B WORLD HEALTH ORGAN, V56, P417; DATASUS, 2018, DEP INF SUS MIN SAUD; Decarli A, 1987, RIV STATISTICA APPLI, V20, P397; do Amaral RS, 2006, MEM I OSWALDO CRUZ, V101, P79, DOI 10.1590/S0074-02762006000900012; Ferreira I. de L. M., 2007, Revista de Patologia Tropical, V36, P67; Firmo JOA, 1996, INT J EPIDEMIOL, V25, P1292, DOI 10.1093/ije/25.6.1292; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Casavechia MTG, 2018, PARASITOLOGY, V145, P1000, DOI 10.1017/S0031182017002268; HOLFORD TR, 1991, ANNU REV PUBL HEALTH, V12, P425, DOI 10.1146/annurev.pu.12.050191.002233; HOLFORD TR, 1983, BIOMETRICS, V39, P311, DOI 10.2307/2531004; HUANG YX, 1992, ACTA TROP, V51, P175, DOI 10.1016/0001-706X(92)90037-X; Jorge Maria Helena Prado de Mello, 2002, Rev. bras. epidemiol., V5, P197, DOI 10.1590/S1415-790X2002000200007; Katz N., INQUERITO NACL PREVE; Knorr-Held L, 2001, Biostatistics, V2, P109, DOI 10.1093/biostatistics/2.1.109; Lee WC, 1996, STAT MED, V15, P273, DOI 10.1002/(SICI)1097-0258(19960215)15:3<273::AID-SIM172>3.0.CO;2-R; Martins-Melo FR, 2015, EMERG INFECT DIS, V21, P1820, DOI 10.3201/eid2110.141438; Martins-Melo FR, 2014, INT J PARASITOL, V44, P1055, DOI 10.1016/j.ijpara.2014.07.009; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Mello J., SISTEMA INFORMACOES; Ministerio da Sau de. Secretaria de Vigilancia em Sau de. Departamento de Vigilancia Epidemiologica, 2010, DOENC INF PAR GUIA B; Ministerio da Saude-Secretaria de Vigilancia em Saude, 2017, GUIA VIG SAUD, V3; Nascimento GL, 2014, T ROY SOC TROP MED H, V108, P29, DOI 10.1093/trstmh/trt109; Osmond C, 1982, Stat Med, V1, P245, DOI 10.1002/sim.4780010306; R.C. Team, 2017, R LANG ENV STAT COMP; Resendes Ana Paula da Costa, 2005, Cad. Saúde Pública, V21, P1392, DOI 10.1590/S0102-311X2005000500011; Riebler A., 2010, INT WORKSH STAT MOD; Riebler A, 2012, ANN APPL STAT, V6, P304, DOI 10.1214/11-AOAS498; ROBERTSON C, 1986, STAT MED, V5, P527, DOI 10.1002/sim.4780050517; Robertson C, 1999, J CLIN EPIDEMIOL, V52, P569, DOI 10.1016/S0895-4356(99)00033-5; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; Saude M., 2016, B EPIDEMIOLOGICO HAN; Silveira A C, 1990, Rev Soc Bras Med Trop, V23, P133, DOI 10.1590/S0037-86821990000300001; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; World Health Organization, SCHISTOSOMIASIS; World Health Organization, 2002, PREV CONTR SCHIST SO; World Health Organization (WHO), 2016, DIS BURD MORT EST	41	4	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231874	10.1371/journal.pone.0231874	http://dx.doi.org/10.1371/journal.pone.0231874			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324797	Green Published, gold			2022-12-26	WOS:000536033700041
J	Dwane, N; Wabiri, N; Manda, S				Dwane, Ntabozuko; Wabiri, Njeri; Manda, Samuel			Small-area variation of cardiovascular diseases and select risk factors and their association to household and area poverty in South Africa: Capturing emerging trends in South Africa to better target local level interventions	PLOS ONE			English	Article							HYPERTENSION; COOCCURRENCE; PREVALENCE; OVERWEIGHT; JOINT	Background Of the total 56 million deaths worldwide during 2012, 38 million (68%) were due to noncommunicable diseases (NCDs), particularly cardiovascular diseases (17.5 million deaths) cancers (8.2 million) which represents46.2% and 21.7% of NCD deaths, respectively). Nearly 80 percent of the global CVD deaths occur in low- and middle-income countries. Some of the major CVDs such as ischemic heart disease (IHD) and stroke and CVD risk conditions, namely, hypertension and dyslipidaemia share common modifiable risk factors including smoking, unhealthy diets, harmful use of alcohol and physical inactivity. The CVDs are now putting a heavy strain of the health systems at both national and local levels, which have previously largely focused on infectious diseases and appalling maternal and child health. We set out to estimate district-level co-occurrence of two cardiovascular diseases (CVDs), namely, ischemic heart disease (IHD) and stroke; and two major risk conditions for CVD, namely, hypertension and dyslipidaemia in South Africa. Method The analyses were based on adults health collected as part of the 2012 South African National Health and Nutrition Examination Survey (SANHANES). We used joint disease mapping models to estimate and map the spatial distributions of risks of hypertension, self-report of ischaemic heart disease (IHD), stroke and dyslipidaemia at the district level in South Africa. The analyses were adjusted for known individual social demographic and life-style factors, household and district level poverty measurements using binary spatial models. Results The estimated prevalence of IHD, stroke, hypertension and dyslipidaemia revealed high inequality at the district level (median value (range): 5.4 (0-17.8%); 1.7 (0-18.2%); 32.0 (12.5-48.2%) and 52.2 (0-71.7%), respectively). The adjusted risks of stroke, hypertension and IHD were mostly high in districts in the South-Eastern parts of the country, while that of dyslipidaemia, was high in Central and top North-Eastern corridor of the country. Conclusions The study has confirmed common modifiable risk factors of two cardiovascular diseases (CVDs), namely, ischemic heart disease (IHD) and stroke; and two major risk conditions for CVD, namely, hypertension and dyslipidaemia. Accordingly, an integrated intervention approach addressing cardiovascular diseases and associated risk factors and conditions would be more cost effective and provide stronger impacts than individual tailored interventions only. Findings of excess district-level variations in the CVDs and their risk factor profiles might be useful for developing effective public health policies and interventions aimed at reducing behavioural risk factors including harmful use of alcohol, physical inactivity and high salt intake.	[Dwane, Ntabozuko] Univ Witwatersrand, Dept Paediat & Child Hlth, Empilweni Serv Res Unit, Johannesburg, South Africa; [Wabiri, Njeri] Human Sci Res Council, Pretoria, South Africa; [Manda, Samuel] South African Med Res Council, Biostat Res Unit, Pretoria, South Africa; [Manda, Samuel] Univ Pretoria, Dept Stat, Pretoria, South Africa	University of Witwatersrand; Human Sciences Research Council-South Africa; South African Medical Research Council; University of Pretoria	Manda, S (corresponding author), South African Med Res Council, Biostat Res Unit, Pretoria, South Africa.; Manda, S (corresponding author), Univ Pretoria, Dept Stat, Pretoria, South Africa.	samuel.manda@mrc.ac.za		Manda, Samuel/0000-0002-9672-3312	South African Medical Research Council (SAMRC); Medical Research Council of South Africa by the National Department of Health; National Treasury in terms of the SAMRC's competitive Intramural Research Fund [SAMRC-RFA-IFF-02-2016]	South African Medical Research Council (SAMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)South African Medical Research Council); Medical Research Council of South Africa by the National Department of Health; National Treasury in terms of the SAMRC's competitive Intramural Research Fund	SOM work was supported by the South African Medical Research Council (SAMRC) with funds from National Treasury in terms of the SAMRC's competitive Intramural Research Fund: SAMRC-RFA-IFF-02-2016.; We thank the Human Sciences Research Council (HSRC) for providing the main data for this study and Vincent Maduna for his involvement in data management. This paper contributes to ND's PhD. This study was partially funded by the Medical Research Council of South Africa in terms of the National Health Scholars Programme from funds provided for this purpose by the National Department of Health. We thank the three reviewers and the editor for their constructive comments, which greatly improved the paper.	BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Boateng D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189264; Carlin BP, 2003, BAYESIAN STATISTICS 7, P45; Carroll R, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14050503; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Dabney AR, 2005, STAT METHODS MED RES, V14, P83, DOI 10.1191/0962280205sm340oa; Downing Amy, 2008, Int J Health Geogr, V7, P41, DOI 10.1186/1476-072X-7-41; Earnest A, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-54; ESRI, 2011, ARCGIS DESKT VERS 10; Feltbower RG, 2005, AM J EPIDEMIOL, V161, P1168, DOI 10.1093/aje/kwi146; Ford ES, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.130244, 10.5888/pcd10.120316e, 10.5888/pcd10.120316]; Ford MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164801; Hallett TB, 2016, AIDS, V30, P1467, DOI 10.1097/QAD.0000000000001075; Haregu TN, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.28697; Held L, 2005, STAT METHODS MED RES, V14, P61, DOI 10.1191/0962280205sm389oa; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Ibrahim MM, 2012, LANCET, V380, P611, DOI 10.1016/S0140-6736(12)60861-7; Institute of Medicine (US) Food Forum, 2010, PROMOTING CARDIOVASC, P2; Jellinger PS, 2017, ENDOCR PRACT, V23, P479, DOI 10.4158/EP171764.GL; Kandala NB, 2014, J APPL STAT, V41, P1203, DOI 10.1080/02664763.2013.862223; Kandala NB, 2013, AM J HYPERTENS, V26, P382, DOI 10.1093/ajh/hps063; Kazembe LN, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-33; Knorr-Held L, 2001, J R STAT SOC A STAT, V164, P73, DOI 10.1111/1467-985X.00187; Langford IH, 1999, J R STAT SOC C-APPL, V48, P253, DOI 10.1111/1467-9876.00153; Larmarange J, 2014, AIDS, V28, pS469, DOI 10.1097/QAD.0000000000000480; Leon-Munoz LM, 2016, OBESITY, V24, P1178, DOI 10.1002/oby.21477; Li Y Q, 2007, Curationis, V30, P79; Maimela E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147926; Manda SOM, 2009, EUR J EPIDEMIOL, V24, P743, DOI 10.1007/s10654-009-9391-2; Mentz G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-312; Ministry of Shipping and the Aegean, 2013, NAT STRAT PLAN PORTS; Monticelli F, 2010, DISTRICT HLTH BAROME; Puoane T., 2008, S AFR HLTH REV, V1, P73; Remais JV, 2013, INT J EPIDEMIOL, V42, P221, DOI 10.1093/ije/dys135; Roh E, 2013, DIABETES METAB J, V37, P433, DOI 10.4093/dmj.2013.37.6.433; Sarich PEA, 2015, PREV MED, V81, P209, DOI 10.1016/j.ypmed.2015.09.004; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Shisana O, 2014, S AFRICAN NATL HLTH; Statistics South Africa, 2014, S AFR MPI CREAT MULT; Taylor A, 2010, AUST NZ J PUBL HEAL, V34, P394, DOI 10.1111/j.1753-6405.2010.00572.x; Tenkorang EY, 2015, J CLIN HYPERTENS, V17, P977, DOI 10.1111/jch.12616; Thomas A., 2000, GEOBUGS USER MANUAL; Toth PP, 2012, J CLIN LIPIDOL, V6, P325, DOI 10.1016/j.jacl.2012.05.002; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Wu F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1407-0; Zhou JC, 2012, HEALTH PLACE, V18, P1300, DOI 10.1016/j.healthplace.2012.09.001	48	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0230564	10.1371/journal.pone.0230564	http://dx.doi.org/10.1371/journal.pone.0230564			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320425	gold, Green Published			2022-12-26	WOS:000536028800010
J	Kruithof, N; Polinder, S; de Munter, L; van de Ree, CLP; Lansink, KWW; de Jongh, MAC				Kruithof, Nena; Polinder, Suzanne; de Munter, Leonie; van de Ree, Cornelis L. P.; Lansink, Koen W. W.; de Jongh, Mariska A. C.		BIOS-Grp	Health status and psychological outcomes after trauma: A prospective multicenter cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; GLOBAL BURDEN; FUNCTIONAL RECOVERY; MAJOR TRAUMA; INJURY; DISABILITY; PREDICTORS; SEVERITY; DISEASE	Introduction Survival after trauma has considerably improved. This warrants research on non-fatal outcome. We aimed to identify characteristics associated with both short and long-term health status (HS) after trauma and to describe the recovery patterns of HS and psychological outcomes during 24 months of follow-up. Methods Hospitalized patients with all types of injuries were included. Data were collected at 1 week 1, 3, 6, 12, and 24 months post-trauma. HS was assessed with the EuroQol-5D-3L (EQ-5D-3L) and the Health Utilities Index Mark 2 and 3 (HUI2/3). For the screening of symptoms of post-traumatic stress, anxiety and depression, the Impact of Event Scale (IES) and the Hospital Anxiety and Depression Scale (HADS) subscale anxiety (HADSA) and subscale depression (HADSD) were used. Recovery patterns of HS and psychological outcomes were examined with linear mixed model analyses. Results A total of 4,883 patients participated (median age 68 (Interquartile range 53-80); 50% response rate). The mean (Standard Deviation (SD)) pre-injury EQ-5D-3L score was 0.85 (0.23). One week post-trauma, mean (SD) EQ-5D-3L, HUI2 and HUI3 scores were 0.49 (0.32), 0.61 (0.22) and 0.38 (0.31), respectively. These scores significantly improved to 0.77 (0.26), 0.77 (0.21) and 0.62 (0.35), respectively, at 24 months. Most recovery occurred up until 3 months. At long-term follow-up, patients of higher age, with comorbidities, longer hospital stay, lower extremity fracture and spine injury showed lower HS. The mean (SD) scores of the IES, HADSA and HADSD were respectively 14.80 (15.80), 4.92 (3.98) and 5.00 (4.28), respectively, at 1 week post-trauma and slightly improved over 24 months post-trauma to 10.35 (14.72), 4.31 (3.76) and 3.62 (3.87), respectively. Discussion HS and psychological symptoms improved over time and most improvements occurred within 3 months post-trauma. The effects of severity and type of injury faded out over time. Patients frequently reported symptoms of post-traumatic stress.	[Kruithof, Nena; de Munter, Leonie; van de Ree, Cornelis L. P.; Lansink, Koen W. W.; de Jongh, Mariska A. C.] ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Trauma TopCare, Tilburg, Netherlands; [Polinder, Suzanne] Erasmus Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Lansink, Koen W. W.] ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Surg, Tilburg, Netherlands; [Lansink, Koen W. W.; de Jongh, Mariska A. C.] Network Emergency Care Brabant, Brabant Trauma Registry, Tilburg, Netherlands	Elisabeth-TweeSteden Ziekenhuis (ETZ); Erasmus University Rotterdam; Erasmus MC; Elisabeth-TweeSteden Ziekenhuis (ETZ)	Kruithof, N (corresponding author), ETZ Hosp Elisabeth TweeSteden Ziekenhuis, Dept Trauma TopCare, Tilburg, Netherlands.	nenakruithof@hotmail.com		de Munter, Leonie/0000-0001-6573-2032	Netherlands Organization for Health Research and Development (ZonMw) [80-84200-98-14225]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This work was supported by The Netherlands Organization for Health Research and Development (ZonMw) under grant number 80-84200-98-14225. https://www.zonmw.nl/nl/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAAM, 2008, ABBREVIATED INJURY S; Ahmed W, 2017, CLIN REHABIL, V31, P1646, DOI 10.1177/0269215517712044; [Anonymous], 2014, INJ VIOL FACTS; Bhalla K, 2009, PLOS MED, V6, P22, DOI 10.1371/journal.pmed.1000001; Cubbin C, 2002, ANNU REV PUBL HEALTH, V23, P349, DOI 10.1146/annurev.publhealth.23.100901.140548; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; de Vries J., 2001, ASSESSMENT BEHAV MED; DeGraaf R, 2010, PSYCHISCHE GEZONDHEI; Derrett S, 2011, INJURY PREV, V17, P415, DOI 10.1136/injuryprev-2011-040044; Furlong WJFD, 2012, HLTH UTILITIES INDEX; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gabbe BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113467; Gabbe BJ, 2012, J TRAUMA ACUTE CARE, V72, P1102, DOI 10.1097/TA.0b013e3182464503; Giummarra MJ, 2017, PAIN REP, V2, DOI 10.1097/PR9.0000000000000622; Nguyen H, 2018, QUAL LIFE RES, V27, P619, DOI 10.1007/s11136-017-1724-0; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haagsma JA, 2015, POPUL HEALTH METR, V13, DOI 10.1186/s12963-015-0042-4; Haagsma JA, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-1; Haagsma JA, 2011, INJURY PREV, V17, P21, DOI 10.1136/ip.2010.026419; Haider AH, 2020, ANN SURG, V271, P1165, DOI 10.1097/SLA.0000000000003101; Harcombe H, 2015, INJURY, V46, P1275, DOI 10.1016/j.injury.2015.04.004; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Hung M, 2014, J ORTHOP TRAUMA, V28, P439, DOI 10.1097/BOT.0000000000000059; Hung M, 2014, FOOT ANKLE INT, V35, P1, DOI 10.1177/1071100713507905; Jacoby SF, 2017, INT J NURS STUD, V65, P54, DOI 10.1016/j.ijnurstu.2016.11.004; Jayakumar P, 2018, BONE JOINT J, V100B, P693, DOI 10.1302/0301-620X.100B6.BJJ-2017-1349.R1; Kellezi B, 2017, SOC PSYCH PSYCH EPID, V52, P855, DOI 10.1007/s00127-016-1299-z; Kendrick D, 2017, QUAL LIFE RES, V26, P1233, DOI 10.1007/s11136-016-1439-7; Kendrick D, 2017, BRIT J GEN PRACT, V67, pE555, DOI 10.3399/bjgp17X691673; Kendrick D, 2013, INJURY PREV, V19, P370, DOI 10.1136/injuryprev-2012-040658; Kendrick D, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-584; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Langley J, 2013, ARCH PHYS MED REHAB, V94, P1277, DOI 10.1016/j.apmr.2013.02.012; Langley J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-68; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Lyons RA, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-317; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; MACKENZIE EJ, 1988, J TRAUMA, V28, P281, DOI 10.1097/00005373-198803000-00003; MacKenzie EJ, 2007, J TRAUMA, V63, pS54, DOI 10.1097/TA.0b013e31815acb09; Manuel DG, 2002, J EPIDEMIOL COMMUN H, V56, P843, DOI 10.1136/jech.56.11.843; Meerding WJ, 2004, J TRAUMA, V56, P150, DOI 10.1097/01.TA.0000062969.65847.8B; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2012, EPIDEMIOL REV, V34, P17, DOI 10.1093/epirev/mxr022; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Polinder S, 2010, INJURY PREV, V16, P147, DOI 10.1136/ip.2009.022418; Revicki DA, 1997, QUAL LIFE RES, V6, P595, DOI 10.1023/A:1018420418455; Richmond TS, 2003, AM J CRIT CARE, V12, P197, DOI 10.4037/ajcc2003.12.3.197; Skogstad L, 2014, INJURY, V45, P289, DOI 10.1016/j.injury.2012.10.001; Soberg HL, 2015, J TRAUMA ACUTE CARE, V78, P628, DOI 10.1097/TA.0000000000000541; SociaalenCultureelPlanbureau, 2015, VEELG VRAG STAT; Stolk E, 1924, 24 SCI PLEN M EUROQO, V153; Toien K, 2011, SCAND J TRAUMA RESUS, V19, DOI 10.1186/1757-7241-19-22; Van Beeck EF, 2007, J TRAUMA, V62, P534, DOI 10.1097/TA.0b013e31802e70c7; Van Buuren S, 1999, 99054 TNOVGZPG; van Delft-Schreurs CCHM, 2014, QUAL LIFE RES, V23, P1353, DOI 10.1007/s11136-013-0546-y; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; Verweij G., 2013, DEPRESSIVITEIT ANTID; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wilson SJ, 2017, QUAL LIFE RES, V26, P1831, DOI 10.1007/s11136-017-1521-9; Wiseman TA, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0109-z; Wohlfarth TD, 2003, PSYCHOL ASSESSMENT, V15, P101, DOI 10.1037/1040-3590.15.1.101; Zarzaur BL, 2016, J SURG RES, V202, P103, DOI 10.1016/j.jss.2015.12.038; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	66	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231649	10.1371/journal.pone.0231649	http://dx.doi.org/10.1371/journal.pone.0231649			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315373	gold, Green Published			2022-12-26	WOS:000536024800040
J	Xu, W; Wen, XY; Hou, YY; Desneux, N; Ali, A; Zang, LS				Xu, Wei; Wen, Xuan-Ye; Hou, Yang-Yang; Desneux, Nicolas; Ali, Asad; Zang, Lian-Sheng			Suitability of Chinese oak silkworm eggs for the multigenerational rearing of the parasitoid Trichogramma leucaniae	PLOS ONE			English	Article							LEGUMINIVORA-GLYCINIVORELLA LEPIDOPTERA; SOYBEAN POD BORER; STRIPED STEM BORER; CHILO-SUPPRESSALIS; BIOLOGICAL-CONTROL; HOST SUITABILITY; TUTA-ABSOLUTA; HYMENOPTERA; IMPACT; QUALITY	Trichogramma leucaniae is believed to be an efficient biological control agent for controlling the soybean pod borer [SPB; Leguminivora glycinivorella]. The large eggs of Chinese oak silkworm, Antheraea pernyi, are one of the best alternative host for mass production of Trichogramma. However, they are considered poor host for the growth and development of T. leucaniae. Here, we determine the feasibility of successive rearings of T. leucaniae on the large eggs for eight generations and evaluated their capacity of parasitizing SPB eggs of different ages. In the first four generations, the suitability of T. leucaniae reared on large eggs exhibited a significant increasing tendency and then decreased with the successive generations thereafter. The percentage of parasitized eggs and number of emerged adults per egg were increased from 40.0% and 10.8 adults/egg in F1 generation to 86.7% and 36.4 adults/egg in F4 generation respectively. In addition, T. leucaniae reared on A. pernyi for four generations significantly parasitized more SPB eggs regardless of egg age compared with those reared on Corcyra cephalonica eggs. These results provided useful information on the feasibility of mass production of T. leucaniae by reared for successive generations on A. pernyi large eggs.	[Xu, Wei; Wen, Xuan-Ye; Hou, Yang-Yang; Zang, Lian-Sheng] Jilin Agr Univ, Coll Plant Protect, Inst Biol Control, Changchun, Jilin, Peoples R China; [Wen, Xuan-Ye] Natl Forestry & Grassland Adm, Gen Stn Forest & Grassland Pest Management, Shenyang, Liaoning, Peoples R China; [Desneux, Nicolas] Univ Cote Azur, UMR ISA, CNRS, INRAE, Nice, France; [Ali, Asad] Abdul Wali Khan Univ, Dept Agr, Mardan, Pakistan	Jilin Agricultural University; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Cote d'Azur; Abdul Wali Khan University	Zang, LS (corresponding author), Jilin Agr Univ, Coll Plant Protect, Inst Biol Control, Changchun, Jilin, Peoples R China.	lsz0415@163.com	Ali, Asad/GWQ-7078-2022; Desneux, Nicolas/J-6262-2013	Ali, Asad/0000-0002-8194-5094; Wen, Xuanye/0000-0002-0232-4987	National Key R&D Program of China [2017YFD0201000]; National Natural Science Foundation of China [31901946]; Department of Science and Technology, Jilin Province, China [20180201015NY, 20190103102JH]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology, Jilin Province, China(Department of Science & Technology (India))	LSZ was partially supported by the National Key R&D Program of China (2017YFD0201000). YYH was supported by the National Natural Science Foundation of China (31901946). WX was supported by the Department of Science and Technology, Jilin Province, China (20180201015NY and 20190103102JH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin MF, 1999, RES POPUL ECOL, V41, P29, DOI 10.1007/PL00011979; BAI BR, 1992, ENTOMOL EXP APPL, V64, P37, DOI 10.1007/BF00688992; Bertin A, 2017, BIOCONTROL, V62, P435, DOI 10.1007/s10526-017-9795-y; BIGLER F, 1988, ENTOMOL EXP APPL, V49, P283, DOI 10.1007/BF00187504; Copping LG, 1992, PEST MANAGEMENT SOYB, DOI [10.1007/978-94-011-2870-4, DOI 10.1007/978-94-011-2870-4]; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Du WM, 2018, J PEST SCI, V91, P771, DOI 10.1007/s10340-017-0919-z; Dutton A, 1995, ENTOMOPHAGA, V40, P223, DOI 10.1007/BF02373070; Ebrahimi V, 2019, ENTOMOL EXP APPL, V167, P241, DOI 10.1111/eea.12755; El-Arnaouty SA, 2014, AFR ENTOMOL, V22, P801, DOI 10.4001/003.022.0410; Fan YJ, 2018, ENTOMOL GEN, V38, P157, DOI 10.1127/entomologia/2018/0604; Godin C, 2000, ENTOMOL EXP APPL, V97, P149, DOI 10.1023/A:1004008905809; Guo XJ, 2019, ENTOMOL GEN, V39, P239, DOI 10.1127/entomologia/2019/0853; Harvey JA, 2005, ENTOMOL EXP APPL, V117, P1, DOI 10.1111/j.1570-7458.2005.00348.x; Hassan SA, 2004, BIOCONTROL SCI TECHN, V14, P269, DOI 10.1080/09583150410001665150; HOHMANN CL, 1988, J ECON ENTOMOL, V81, P1307, DOI 10.1093/jee/81.5.1307; Honda JY, 2001, ENTOMOL EXP APPL, V100, P1, DOI 10.1023/A:1019277316113; Hou YY, 2018, J PEST SCI, V91, P1181, DOI 10.1007/s10340-018-0980-2; Iqbal A, 2019, J PEST SCI, V92, P1261, DOI 10.1007/s10340-019-01122-8; Ishimoto M, 2018, JPN J APPL ENTOMOL Z, V62, P239, DOI 10.1303/jjaez.2018.239; Jiang JG, 2019, BIOL CONTROL, V134, P32, DOI 10.1016/j.biocontrol.2019.04.001; Kumar GA, 2009, BIOL CONTROL, V49, P207, DOI 10.1016/j.biocontrol.2009.02.010; Li LY, 1980, NAT ENEMIES INSECTS, V3, P1; Li TH, 2019, J PEST SCI, V92, P707, DOI 10.1007/s10340-018-1018-5; Li XY, 2019, ENTOMOL GEN, V39, P313, DOI 10.1127/entomologia/2019/0857; Lin Ying, 2014, Scientia Agricultura Sinica, V47, P3810; Liu SS, 1998, BIOCONTROL, V43, P273, DOI 10.1023/A:1009984125066; Liu XL, 2017, ENTOMOL GEN, V36, P285, DOI 10.1127/entomologia/2017/0480; LOSEY E, 1995, ENVIRON ENTOMOL, V24, P436; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Mansour R, 2018, ENTOMOL GEN, V38, P83, DOI 10.1127/entomologia/2018/0749; Martel V, 2011, J INSECT PHYSIOL, V57, P682, DOI 10.1016/j.jinsphys.2011.01.018; Masip G, 2013, TRENDS PLANT SCI, V18, P312, DOI 10.1016/j.tplants.2013.03.004; Meng FL, 2017, PEST MANAG SCI, V73, P2447, DOI 10.1002/ps.4637; Mohammed AAH, 2018, ENTOMOL GEN, V37, P47, DOI 10.1127/entomologia/2017/0471; PINTO JD, 1992, J NEW YORK ENTOMOL S, V100, P621; Pizzol J, 2012, J PEST SCI, V85, P489, DOI 10.1007/s10340-012-0434-1; Pizzol J, 2010, J PEST SCI, V83, P447, DOI 10.1007/s10340-010-0327-0; Pratissoli D, 2004, BIOCONTROL SCI TECHN, V14, P313, DOI 10.1080/09583150310001639196; Prezotti L, 2004, BIOL CONTROL, V30, P174, DOI 10.1016/j.biocontrol.2004.01.011; Rahman MS, 2013, DESIGN AND PRACTICE OF GEOSYNTHETIC-REINFORCED SOIL STRUCTURES, P116; Gervassio NGS, 2019, J PEST SCI, V92, P1343, DOI 10.1007/s10340-018-01078-1; Sedaratian A, 2009, J PEST SCI, V82, P163, DOI 10.1007/s10340-008-0235-8; Smith SM, 1996, ANNU REV ENTOMOL, V41, P375, DOI 10.1146/annurev.en.41.010196.002111; Song LW, 2015, J ECON ENTOMOL, V108, P933, DOI 10.1093/jee/tov027; Sorati M, 1996, ENTOMOL EXP APPL, V78, P283, DOI 10.1111/j.1570-7458.1996.tb00792.x; Tabone E, 2010, J PEST SCI, V83, P251, DOI 10.1007/s10340-010-0292-7; Talekar N. S., 1987, SOYBEANS TROPICS RES, P25; TAYLOR TA, 1971, ANN ENTOMOL SOC AM, V64, P1381, DOI 10.1093/aesa/64.6.1381; Thiery D, 2018, ENTOMOL GEN, V38, P47, DOI 10.1127/entomologia/2018/0675; Ullah F, 2019, ENTOMOL GEN, V39, P325, DOI 10.1127/entomologia/2019/0892; Van Vang L, 2006, APPL ENTOMOL ZOOL, V41, P507, DOI 10.1303/aez.2006.507; Wang Y, 2019, ENTOMOL GEN, V39, P339, DOI 10.1127/entomologia/2019/0896; Wang ZhenYing, 2005, Second International Symposium on Biological Control of Arthropods, Davos, Switzerland, 12-16 September, 2005, P487; Wen Xuan-Ye, 2015, Huanjing Kunchong Xuebao, V37, P1060; Wu H, 2018, BIOL CONTROL, V124, P40, DOI 10.1016/j.biocontrol.2018.05.011; Yang X, 2016, J ECON ENTOMOL, V109, P1524, DOI 10.1093/jee/tov388; Yuan XH, 2012, J PEST SCI, V85, P497, DOI 10.1007/s10340-012-0456-8; Zhang JJ, 2018, PEST MANAG SCI, V74, P959, DOI 10.1002/ps.4795; Zhang JJ, 2014, BIOCONTROL, V59, P159, DOI 10.1007/s10526-013-9557-4; Zhang Jun-jie, 2012, Journal of Jilin Agricultural University, V34, P603; [张英杰 Zhang Yingjie], 2012, [中国生物防治学报, Chinese Journal of Biological Control], V28, P473; [赵晓丽 Zhao Xiaoli], 2004, [大豆科学, Soybean Science], V23, P77	64	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231098	10.1371/journal.pone.0231098	http://dx.doi.org/10.1371/journal.pone.0231098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315304	gold, Green Published			2022-12-26	WOS:000536024800017
J	Cassandri, M; Butera, A; Amelio, I; Lena, AM; Montanaro, M; Mauriello, A; Anemona, L; Candi, E; Knight, RA; Agostini, M; Melino, G				Cassandri, Matteo; Butera, Alessio; Amelio, Ivano; Lena, Anna Maria; Montanaro, Manuela; Mauriello, Alessandro; Anemona, Lucia; Candi, Eleonora; Knight, Richard A.; Agostini, Massimiliano; Melino, Gerry			ZNF750 represses breast cancer invasion via epigenetic control of prometastatic genes	ONCOGENE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; CELL-MIGRATION; EXPRESSION; P63; CHROMOSOME-17; LAMININ-332; METASTASIS; COMPLEX; HEAD; KLF4	Breast cancer is the second leading cause of cancer-related deaths among women, largely due to the progression of a significant fraction of primary tumours to the metastatic stage. Here, we show that zinc-finger protein 750 (ZNF750) opposes the migration and invasion of breast cancer cells by repressing a prometastatic transcriptional programme, which includes genes involved in focal adhesion and extracellular matrix interactions, such as LAMB3 and CTNNAL1. Mechanistically, ZNF750 recruits the epigenetic modifiers KDM1A and HDAC1 to the promoter regions of LAMB3 and CTNNAL1, influencing histone marks and transactivating these genomic sites. Gene expression analysis in cancer patient datasets indicated that ZNF750 and its targets were negative prognostic factors in breast cancer. Together, our findings shed light on the molecular mechanism by which ZNF750 regulates cell migration and invasion, suggesting a role in breast cancer metastasis.	[Cassandri, Matteo; Butera, Alessio; Amelio, Ivano; Lena, Anna Maria; Montanaro, Manuela; Mauriello, Alessandro; Anemona, Lucia; Candi, Eleonora; Agostini, Massimiliano; Melino, Gerry] Univ Roma Tor Vergata, TOR, Dept Expt Med, I-00133 Rome, Italy; [Amelio, Ivano; Knight, Richard A.; Melino, Gerry] Univ Cambridge, MRC Toxicol Unit, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England; [Candi, Eleonora] IRCCS, IDI, Via Monti Creta 106, I-00166 Rome, Italy; [Cassandri, Matteo] Bambino Gesu Pediat Hosp, Dept Oncohematol, I-00146 Rome, Italy	University of Rome Tor Vergata; University of Cambridge; IRCCS Istituto Dermopatico dell'Immacolata (IDI); IRCCS Bambino Gesu	Agostini, M; Melino, G (corresponding author), Univ Roma Tor Vergata, TOR, Dept Expt Med, I-00133 Rome, Italy.; Melino, G (corresponding author), Univ Cambridge, MRC Toxicol Unit, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	m.agostini@med.uniroma2.it; gm614@mrc-tox.cam.ac.uk	Cassandri, Matteo/AAB-3730-2019; Anemona, lucia/AAB-3491-2022; Agostini, Massimiliano/G-9579-2014	Cassandri, Matteo/0000-0002-2919-676X; Anemona, lucia/0000-0002-3711-2714; Montanaro, Manuela/0000-0001-8441-3731; Lena, Anna Maria/0000-0001-6285-9927; Amelio, Ivano/0000-0002-9126-5391; Butera, Alessio/0000-0001-7196-4235; Agostini, Massimiliano/0000-0003-3124-2072	Medical Research Council UK; Associazione Italiana per la Ricerca contro il Cancro (AIRC) [20473]; AIRC [22206, 23219]; Ministero Salute, IDI-IRCCS; Italian Ministry of Foreign Affairs and International Cooperation; Regione Lazio through the LazioInnova Progetto Gruppo di Ricerca [85-2017-14986]	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Associazione Italiana per la Ricerca contro il Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); AIRC(Fondazione AIRC per la ricerca sul cancro); Ministero Salute, IDI-IRCCS; Italian Ministry of Foreign Affairs and International Cooperation(Ministry of Foreign Affairs and International Cooperation (Italy)); Regione Lazio through the LazioInnova Progetto Gruppo di Ricerca	We would like to thank Dr Annalisa Conti for helpful comments and suggestions and K. Dudek and C. Jones for assistance in gene microarray analysis. This work has been supported by the Medical Research Council (to GM) UK, the Associazione Italiana per la Ricerca contro il Cancro (AIRC) (to GM; IG#20473 (2018-2022)), the AIRC (to EC; IG#22206 (2019-2023)), the AIRC (Start-Up to IA; ID 23219), the Ministero Salute, IDI-IRCCS (RC to EC), and the Italian Ministry of Foreign Affairs and International Cooperation (to EC). The work has also been supported by Regione Lazio through the LazioInnova Progetto Gruppo di Ricerca n 85-2017-14986 (to GM).	Aubrey BJ, 2018, CELL DEATH DIFFER, V25, P104, DOI 10.1038/cdd.2017.169; Boxer LD, 2014, GENE DEV, V28, P2013, DOI 10.1101/gad.246579.114; Cassandri M, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.71; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chalcrabarti R, 2014, NAT CELL BIOL, V16, P1004, DOI 10.1038/ncb3040; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Courjal F, 1997, CANCER RES, V57, P4368; Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172; Fan LC, 2011, ONCOGENE, V30, P2610, DOI 10.1038/onc.2010.637; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hazawa M, 2017, ONCOGENE, V36, P2243, DOI 10.1038/onc.2016.377; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Jain N, 2009, INT J BIOCHEM CELL B, V41, P72, DOI 10.1016/j.biocel.2008.10.006; Jia Yuping, 2016, J Carcinog, V15, P3, DOI 10.4103/1477-3163.182809; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Kaiser AM, 2018, CELL DEATH DIFFER, V25, P93, DOI 10.1038/cdd.2017.171; Kinoshita T, 2012, ONCOTARGET, V3, P1386, DOI 10.18632/oncotarget.709; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kreiseder B, 2013, INT J CANCER, V132, P521, DOI 10.1002/ijc.27698; Kwon OH, 2011, BIOCHEM BIOPH RES CO, V406, P539, DOI 10.1016/j.bbrc.2011.02.082; Lin DC, 2014, NAT GENET, V46, P467, DOI 10.1038/ng.2935; Marinkovich MP, 2007, NAT REV CANCER, V7, P370, DOI 10.1038/nrc2089; Maziveyi M, 2017, ONCOTARGET, V8, P48471, DOI 10.18632/oncotarget.17265; Memmi EM, 2015, P NATL ACAD SCI USA, V112, P3499, DOI 10.1073/pnas.1500762112; Millarte V, 2012, SCI WORLD J, DOI 10.1100/2012/498278; Orsetti B, 2004, CANCER RES, V64, P6453, DOI 10.1158/0008-5472.CAN-04-0756; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Sen GL, 2012, DEV CELL, V22, P669, DOI 10.1016/j.devcel.2011.12.001; Su X, 2017, ONCOGENE, V36, P2377, DOI 10.1038/onc.2016.388; SUGIMOTO Y, 1987, MOL CELL BIOL, V7, P4549, DOI 10.1128/MCB.7.12.4549; Sullivan KD, 2018, CELL DEATH DIFFER, V25, P133, DOI 10.1038/cdd.2017.174; Sweeney C, 2014, CANCER EPIDEM BIOMAR, V23, P714, DOI 10.1158/1055-9965.EPI-13-1023; Tucci P, 2012, P NATL ACAD SCI USA, V109, P15312, DOI 10.1073/pnas.1110977109; Wang XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053938, 10.1371/journal.pone.0050627]; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Ye X, 2015, TRENDS CELL BIOL, V25, P675, DOI 10.1016/j.tcb.2015.07.012; Yeo SK, 2017, TRENDS CANCER, V3, P753, DOI 10.1016/j.trecan.2017.09.001; Zhang H, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1320-z; Zhang PP, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1224-3; Zhang W, 2011, INT J MOL SCI, V12, P5672, DOI 10.3390/ijms12095672; Zhang Z, 2016, TUMOR BIOL, V37, P1671, DOI 10.1007/s13277-015-3901-5	41	14	15	3	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4331	4343		10.1038/s41388-020-1277-5	http://dx.doi.org/10.1038/s41388-020-1277-5		APR 2020	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32313225				2022-12-26	WOS:000527509300003
J	Kirino, S; Tsuchiya, K; Kurosaki, M; Kaneko, S; Inada, K; Yamashita, K; Osawa, L; Hayakawa, Y; Sekiguchi, S; Okada, M; Wang, W; Higuchi, M; Takaura, K; Maeyashiki, C; Tamaki, N; Yasui, Y; Nakanishi, H; Itakura, J; Takahashi, Y; Asahina, Y; Izumi, N				Kirino, Sakura; Tsuchiya, Kaoru; Kurosaki, Masayuki; Kaneko, Shun; Inada, Kento; Yamashita, Koji; Osawa, Leona; Hayakawa, Yuka; Sekiguchi, Shuhei; Okada, Mao; Wang, Wan; Higuchi, Mayu; Takaura, Kenta; Maeyashiki, Chiaki; Tamaki, Nobuharu; Yasui, Yutaka; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Asahina, Yasuhiro; Izumi, Namiki			Relative dose intensity over the first four weeks of lenvatinib therapy is a factor of favorable response and overall survival in patients with unresectable hepatocellular carcinoma	PLOS ONE			English	Article							CHEMOTHERAPY; SORAFENIB	Lenvatinib is an approved first-line therapy for unresectable hepatocellular carcinoma (HCC), but the effect of dose modification on its efficacy is unclear. We analyzed the relationship between the relative dose intensity during the initial 4 weeks of therapy [4W-relative dose intensity (RDI)] and the efficacy of lenvatinib therapy in the real-world setting. A total of 48 consecutive patients with unresectable HCC who received lenvatinib therapy for more than 4 weeks were included. The 4W-RDI was calculated as the cumulative dose in the initial 4 weeks divided by the weight-based standard dose, and we evaluated its association with overall survival (OS) and best response by modified Response Evaluation Criteria in Solid Tumor (mRECIST). The baseline factors predicting high 4W-RDI were analyzed further. The median durations of follow-up and of therapy among the 48 participants were 7.6 and 6.6 months, respectively. The median OS was not reached. Drug interruption and/or dose reduction were necessary in 30 patients (62.5%) and the median 4W-RDI was 70% (range 22%-100%). Patients with 4W-RDI >= 70% had longer OS [hazard ratio (HR) 0.28, 95% confidential interval (CI):0.09-0.90, p = 0.03], and longer duration of lenvatinib therapy (HR 0.39, 95%CI:0.16-0.92, p = 0.03). Patients with 4W-RDI >= 70% showed higher disease control rate compared to those with 4W-RDI <70% (91.7% vs. 54.2%, p = 0.008). A baseline albumin level > 3.4g/dL or ALBI score less than -2.171 were significantly associated with achieving 4W-RDI >= 70%. In conclusion, 4W-RDI of lenvatinib therapy is associated with favorable radiological response and longer OS.	[Kirino, Sakura; Tsuchiya, Kaoru; Kurosaki, Masayuki; Kaneko, Shun; Inada, Kento; Yamashita, Koji; Osawa, Leona; Hayakawa, Yuka; Sekiguchi, Shuhei; Okada, Mao; Wang, Wan; Higuchi, Mayu; Takaura, Kenta; Maeyashiki, Chiaki; Tamaki, Nobuharu; Yasui, Yutaka; Nakanishi, Hiroyuki; Itakura, Jun; Takahashi, Yuka; Izumi, Namiki] Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Gastroenterol & Hepatol, Tokyo, Japan; [Asahina, Yasuhiro] Tokyo Med & Dent Univ, Dept Liver Dis Control, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Izumi, N (corresponding author), Musashino Red Cross Hosp, Dept Gastroenterol & Hepatol, Tokyo, Japan.	izumi012@musashino.jrc.or.jp	Kaneko, Shun/AAO-1475-2020	Kaneko, Shun/0000-0003-2660-6580; Yasui, Yutaka/0000-0002-6117-4990; Tamaki, Nobuharu/0000-0003-4634-6616	Japan Agency for Medical Research and Development [JP19fk0210025h0003]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	The authors' financial disclosure is as follows: NI received a grant-in-aid from the Japan Agency for Medical Research and Development (grant number: JP19fk0210025h0003, URL: https://www.amed.go.jp/). The funder had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hirano G, 2015, ANTICANCER RES, V35, P371; Hiraoka A, 2018, HEPATOLOGY RES, V49; Hiraoka A, 2019, CANCER MED-US, V8, P3719, DOI 10.1002/cam4.2241; Hiraoka A, 2019, CANCER MED-US, V8, P137, DOI 10.1002/cam4.1909; Hiraoka A, 2019, HEPATOL RES, V49, P111, DOI 10.1111/hepr.13243; Hiraoka A, 2017, LIVER CANCER, V6, P325, DOI 10.1159/000479984; HRYNIUK W, 1984, J CLIN ONCOL, V2, P1281, DOI 10.1200/JCO.1984.2.11.1281; Ikeda K, 2017, J GASTROENTEROL, V52, P512, DOI 10.1007/s00535-016-1263-4; Ikeda M, 2016, CLIN CANCER RES, V22, P1385, DOI 10.1158/1078-0432.CCR-15-1354; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kaneko S, 2019, HEPATOL RES; Kawashima A, 2011, EUR J CANCER, V47, P1521, DOI 10.1016/j.ejca.2011.04.001; Kodama K, 2019, ONCOLOGY-BASEL, V97, P75, DOI 10.1159/000499715; Kokudo N, 2015, HEPATOL RES, V45, DOI 10.1111/hepr.12464; KUDO M, 2019, J CLIN ONCOLOGY S, V37; Kudo M, 2018, LANCET, V391, P1163, DOI 10.1016/S0140-6736(18)30207-1; Kuzuya T, 2019, HEPATOL RES; Lencioni R, 2017, J HEPATOL, V66, P1166, DOI 10.1016/j.jhep.2017.01.012; LEVIN L, 1987, J CLIN ONCOL, V5, P756, DOI 10.1200/JCO.1987.5.5.756; Nakano K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010060; Tamai T, 2017, J CLIN PHARMACOL, V57, P1138, DOI 10.1002/jcph.917	23	25	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231828	10.1371/journal.pone.0231828	http://dx.doi.org/10.1371/journal.pone.0231828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310967	Green Published, gold			2022-12-26	WOS:000536019800035
J	Rivera, MG; Sampson, AC; Hair, PS; Pallera, HK; Jackson, KG; Enos, AI; Vazifedan, T; Werner, AL; Goldberg, CL; Lattanzio, FA; Cunnion, KM; Krishna, NK				Rivera, Magdielis Gregory; Sampson, Alana C.; Hair, Pamela S.; Pallera, Haree K.; Jackson, Kaitlyn G.; Enos, Adrianne I.; Vazifedan, Turaj; Werner, Alice L.; Goldberg, Corinne L.; Lattanzio, Frank A.; Cunnion, Kenji M.; Krishna, Neel K.			Incompatible erythrocyte transfusion with lipopolysaccharide induces acute lung injury in a novel rat model	PLOS ONE			English	Article							RED-BLOOD-CELLS; ENDOTOXIC LIPOPOLYSACCHARIDE; COMPLEMENT-SYSTEM; GENERATION; PLASMA; TRAPS	Acute transfusion reactions can manifest in many forms including acute hemolytic transfusion reaction, allergic reaction and transfusion-related acute lung injury. We previously developed an acute hemolytic transfusion reaction rat model mediated by transfusion of incompatible human erythrocytes against which rats have preexisting antibodies resulting in classical complement pathway mediated intravascular hemolysis. In this study, the acute hemolytic transfusion reaction model was adapted to yield an acute lung injury phenotype. Adolescent male Wistar rats were primed in the presence or absence of lipopolysaccharide followed by transfusion of incompatible erythrocytes. Blood was collected at various time points during the course of the experiment to determine complement C5a levels and free DNA in isolated plasma. At 4 hours, blood and lung tissue were recovered and assayed for complete blood count and histological acute lung injury, respectively. Compared to sham animals or animals receiving increasing amounts of incompatible erythrocytes (equivalent to a 15-45% transfusion) in the absence of lipopolysaccharide, lungs of animals receiving lipopolysaccharide and a 30% erythrocyte transfusion showed dramatic alveolar wall thickening due to neutrophil infiltration. C5a levels were significantly elevated in these animals indicating that complement activation contributes to lung damage. Additionally, these animals demonstrated a significant increase of free DNA in the blood over time suggestive of neutrophil extracellular trap formation previously associated with transfusion-related acute lung injury in humans and mice. This novel 'two-hit' model utilizing incompatible erythrocyte transfusion in the presence of lipopolysaccharide yields a robust acute lung injury phenotype.	[Rivera, Magdielis Gregory; Hair, Pamela S.; Pallera, Haree K.; Enos, Adrianne I.; Vazifedan, Turaj; Werner, Alice L.; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA; [Sampson, Alana C.; Jackson, Kaitlyn G.; Cunnion, Kenji M.; Krishna, Neel K.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Vazifedan, Turaj; Werner, Alice L.; Cunnion, Kenji M.] Childrens Hosp Kings Daughters, Norfolk, VA USA; [Werner, Alice L.; Cunnion, Kenji M.] Childrens Specialty Grp, Norfolk, VA USA; [Goldberg, Corinne L.] Amer Red Cross, Durham, NC USA; [Lattanzio, Frank A.] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA	Eastern Virginia Medical School; Eastern Virginia Medical School; American Red Cross; Eastern Virginia Medical School	Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Pediat, Norfolk, VA 23501 USA.; Krishna, NK (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	krishnnk@evms.edu		Jackson, Kaitlyn/0000-0003-2663-9593; Pallera, Haree/0000-0002-4576-1626	Commonwealth Transfusion Foundation; Children's Health Foundation of The Children's Hospital of the King's Daughters (KMC)	Commonwealth Transfusion Foundation; Children's Health Foundation of The Children's Hospital of the King's Daughters (KMC)	This work was supported by grants from the Commonwealth Transfusion Foundation (https://www.ctf.life/) (NKK) and the Children's Health Foundation of The Children's Hospital of the King's Daughters (KMC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	APTEKMAN PM, 1956, CANCER RES, V16, P216; Bolton-Maggs PHB, 2013, BRIT J HAEMATOL, V163, P303, DOI 10.1111/bjh.12547; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Davenport RD, 2009, HEMOLYTIC TRANSFUSIO, P811; ENGELFRIET CP, 1992, TRANSFUSION MED, V2, P1, DOI 10.1111/j.1365-3148.1992.tb00128.x; Fung YL, 2013, VOX SANG, V105, P150, DOI 10.1111/vox.12032; Hair PS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00558; HENSON PM, 1974, TRANSPLANT P, V6, P27; Kelher MR, 2009, BLOOD, V113, P2079, DOI 10.1182/blood-2008-09-177857; Kumar PS, 2016, TRANSFUSION, V56, P2133, DOI 10.1111/trf.13674; LICHTENS.LM, 1969, IMMUNOLOGY, V16, P327; Mangalmurti NS, 2009, BLOOD, V113, P1158, DOI 10.1182/blood-2008-07-166264; Muller MCA, 2014, VOX SANG, V107, P71, DOI 10.1111/vox.12128; Nicholson SE, 2011, J TRAUMA, V70, P466, DOI 10.1097/TA.0b013e3182032584; Osterman JL, 2014, EMERG MED CLIN N AM, V32, P727, DOI 10.1016/j.emc.2014.04.012; Peters AL, 2015, BRIT J HAEMATOL, V170, P597, DOI 10.1111/bjh.13459; Peters AL, 2015, BLOOD REV, V29, P51, DOI 10.1016/j.blre.2014.09.007; Refaai MA, 2013, BEST PRACT RES-CLIN, V27, P17, DOI 10.1016/j.bpa.2012.12.006; Schmidt AE, 2012, AM J CLIN PATHOL, V138, P498, DOI 10.1309/AJCPFF6JKXM7BYOI; SEEGER W, 1990, BLOOD, V76, P1438; Shah TA, 2014, TRANSFUSION, V54, P2892, DOI 10.1111/trf.12695; Silliman CC, 2003, TRANSFUSION, V43, P633, DOI 10.1046/j.1537-2995.2003.00385.x; SNYDERMAN R, 1968, J EXP MED, V128, P259, DOI 10.1084/jem.128.2.259; Stowell SR, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/307093; Strait RT, 2011, J EXP MED, V208, P2525, DOI 10.1084/jem.20110159; Thomas GM, 2012, BLOOD, V119, P6335, DOI 10.1182/blood-2012-01-405183; Vlaar APJ, 2010, ANESTHESIOLOGY, V113, P92, DOI 10.1097/ALN.0b013e3181de6f25	27	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0230482	10.1371/journal.pone.0230482	http://dx.doi.org/10.1371/journal.pone.0230482			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310973	gold, Green Published			2022-12-26	WOS:000536019800007
J	Wake, T; Tateishi, R; Fukumoto, T; Nakagomi, R; Kinoshita, MN; Nakatsuka, T; Sato, M; Minami, T; Uchino, K; Enooku, K; Nakagawa, H; Fujinaga, H; Asaoka, Y; Tanaka, Y; Otsuka, M; Koike, K				Wake, Taijiro; Tateishi, Ryosuke; Fukumoto, Tsuyoshi; Nakagomi, Ryo; Kinoshita, Mizuki Nishibatake; Nakatsuka, Takuma; Sato, Masaya; Minami, Tatsuya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Fujinaga, Hidetaka; Asaoka, Yoshinari; Tanaka, Yasuo; Otsuka, Motoyuki; Koike, Kazuhiko			Improved liver function in patients with cirrhosis due to chronic hepatitis C virus who achieve sustained virologic response is not accompanied by increased liver volume	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; INTERFERON THERAPY; REGENERATION; FIBROSIS; HEPATECTOMY; PROGNOSIS	Background Serum albumin level improves in patients with chronic hepatitis C virus (HCV) infection who achieve sustained virologic response (SVR) with antiviral therapy. However, it remains controversial whether liver volume increases along with SVR. Methods Patients with chronic HCV infection with a history of hepatocellular carcinoma (HCC) who achieved SVR with anti-HCV treatment from March 2003 to November 2017 were enrolled. Patients were followed up with periodic computed tomography (CT) scans to detect HCC recurrence. Patients who underwent treatment for HCC recurrence within 1 year after initiation of anti-HCV treatment were excluded. Laboratory data, including alanine aminotransferase (ALT) level, serum albumin level, and platelet count, were collected at baseline and timepoints after treatment initiation. Liver volume was evaluated at baseline and 24 and 48 weeks after treatment initiation using a CT volume analyzer. A linear mixed-effects model was applied to analyze the chronologic change in liver volume. The correlations between changes in ALT level, albumin level, and liver volume were also evaluated. Results Of 108 enrolled patients, 78 had cirrhosis. Serum albumin level continued to increase through 48 weeks after treatment initiation. A significant increase in liver volume was observed only in patients without cirrhosis (P = 0.005). There was a significant correlation between ALT level decrease and albumin level increase (P = 0.018). Conclusions Improved liver albumin production with SVR was contributed by improved liver cell function rather than increased liver volume in patients with cirrhosis.	[Wake, Taijiro; Tateishi, Ryosuke; Fukumoto, Tsuyoshi; Nakagomi, Ryo; Kinoshita, Mizuki Nishibatake; Nakatsuka, Takuma; Sato, Masaya; Minami, Tatsuya; Uchino, Koji; Enooku, Kenichiro; Nakagawa, Hayato; Fujinaga, Hidetaka; Asaoka, Yoshinari; Tanaka, Yasuo; Otsuka, Motoyuki; Koike, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan; [Asaoka, Yoshinari] Teikyo Univ, Dept Gastroenterol, Tokyo, Japan	University of Tokyo; Teikyo University	Tateishi, R (corresponding author), Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.	tateishi-tky@umin.ac.jp	Nakagawa, Hayato/I-2837-2012; Nakatsuka, Takuma/T-6886-2017; Asaoka, Yoshinari/ABC-5412-2021; Tateishi, Ryosuke/G-7758-2014; Otsuka, Motoyuki/H-9067-2019	Nakagawa, Hayato/0000-0002-6973-5094; Nakatsuka, Takuma/0000-0002-5727-5385; Asaoka, Yoshinari/0000-0002-2805-8226; Tateishi, Ryosuke/0000-0003-3021-2517; Otsuka, Motoyuki/0000-0003-2869-2881	Ministry of Health, Labour and Welfare of Japan [H30-Kansei-Shitei-003]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Health, Labour and Welfare Policy Research Grants from the Ministry of Health, Labour and Welfare of Japan (Policy Research for Hepatitis Measures [H30-Kansei-Shitei-003]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla EK, 2001, BRIT J SURG, V88, P165, DOI 10.1046/j.1365-2168.2001.01658.x; Breguet R, 2017, ABDOM RADIOL, V42, P460, DOI 10.1007/s00261-016-0892-7; Chayama K, 2018, J GASTROENTEROL, V53, P557, DOI 10.1007/s00535-017-1391-5; Deterding K, 2015, ALIMENT PHARM THER, V42, P889, DOI 10.1111/apt.13343; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Fartoux L, 2007, CLIN GASTROENTEROL H, V5, P502, DOI 10.1016/j.cgh.2006.10.016; Fitzpatrick JA, 2016, J CLIN EXP HEPATOL, V6, P15, DOI 10.1016/j.jceh.2015.11.004; Gounden V. J., 2019, HYPOALBUMINEMIA, DOI DOI 10.1016/j.gecco.2016.09.007; Idilman R, 1997, J VIRAL HEPATITIS, V4, P81, DOI 10.1111/j.1365-2893.1997.tb00209.x; Ju MK, 2012, TRANSPL P, V44, P338, DOI 10.1016/j.transproceed.2012.01.063; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; Kumada H, 2018, J GASTROENTEROL, V53, P566, DOI 10.1007/s00535-017-1396-0; Minami T, 2015, HEPATOL RES, V45, pE99, DOI 10.1111/hepr.12468; MOSHAGE HJ, 1987, J CLIN INVEST, V79, P1635, DOI 10.1172/JCI113000; Nagino M, 2001, BRIT J SURG, V88, P1084, DOI 10.1046/j.0007-1323.2001.01832.x; Ohshima S, 2014, J HEPATO-BIL-PAN SCI, V21, P235, DOI 10.1002/jhbp.81; Ozaki K, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150896; Pockros PJ, 2010, HEPATOLOGY, V52, P1193, DOI 10.1002/hep.23809; Poynard T, 1997, LANCET, V349, P825, DOI 10.1016/S0140-6736(96)07642-8; SEKIYAMA K, 1994, DIGEST DIS SCI, V39, P240, DOI 10.1007/BF02090192; Shiratori Y, 2005, ANN INTERN MED, V142, P105, DOI 10.7326/0003-4819-142-2-200501180-00009; Shiratori Y, 2000, ANN INTERN MED, V132, P517, DOI 10.7326/0003-4819-132-7-200004040-00002; SIMONETTI RG, 1992, ANN INTERN MED, V116, P97, DOI 10.7326/0003-4819-116-2-97; Singal AK, 2010, CLIN GASTROENTEROL H, V8, P192, DOI 10.1016/j.cgh.2009.10.026; Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176; Toyoda H, 2018, HEPATOLOGY, V67, P505, DOI 10.1002/hep.29510; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Yamagishi Y, 2005, J GASTROEN HEPATOL, V20, P1843, DOI 10.1111/j.1440-1746.2005.03949.x; YAMANAKA N, 1993, HEPATOLOGY, V18, P79, DOI 10.1016/0270-9139(93)90510-T; Yoshida H, 2004, GUT, V53, P425, DOI 10.1136/gut.2003.030353; Zhou XP, 2007, AM J ROENTGENOL, V189, pW153, DOI 10.2214/AJR.07.2181	32	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231836	10.1371/journal.pone.0231836	http://dx.doi.org/10.1371/journal.pone.0231836			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310974	Green Published, gold			2022-12-26	WOS:000536019800038
J	Bahemuka, UM; Abaasa, A; Seeley, J; Byaruhanga, M; Kamali, A; Mayaud, P; Kuteesa, M				Bahemuka, Ubaldo Mushabe; Abaasa, Andrew; Seeley, Janet; Byaruhanga, Moses; Kamali, Anatoli; Mayaud, Philippe; Kuteesa, Monica			Feasibility of establishing an HIV vaccine preparedness cohort in a population of the Uganda Police Force: Lessons learnt from a prospective study	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED DISEASE; SOCIAL DESIRABILITY BIAS; RISK; INFECTION; PREVALENCE	Background Members of uniformed armed forces are considered to be at high risk for HIV infection and have been proposed as suitable candidates for participation in HIV intervention studies. We report on the feasibility of recruitment and follow up of individuals from the community of the Uganda Police Force (UPF) for an HIV vaccine preparedness study. Methods HIV-negative volunteers aged 18-49 years, were identified from UPF facilities situated in Kampala and Wakiso districts through community HIV counselling and testing. Potential volunteers were referred to the study clinic for screening, enrolment and quarterly visits for one year. HIV incidence, retention rates were estimated and expressed as cases per 100 person years of observation (PYO). Rate ratios were used to determine factors associated with retention using Poisson regression models. Results We screened 560 to enroll 500 volunteers between November 2015 and May 2016. One HIV seroconversion occurred among 431 PYO, for an incidence rate of 0.23/100 PYO (95% confidence interval [CI]: 0.03-1.64). Overall, retention rate was 87% at one year, and this was independently associated with residence duration (compared to <1 year, 1 to 5 years adjusted rate ratio (aRR) = 1.19, 95%CI: 1.00-1.44); and >5 years aRR = 1.34, 95%CI: 0.95-1.37); absence of genital discharge in the last 3 months (aRR = 1.97, 95% CI: 1.38-2.83, absence of genital ulcers (aRR = 1.90, 95%CI: 1.26-2.87, reporting of new sexual partner in the last month (aRR = 0.57, 95%CI: 0.45-0.71, being away from home for more than two nights (aRR = 1.27, 95%CI: 1.04-1.56, compared to those who had not travelled) and absence of knowledge on HIV prevention (aRR = 2.67, 95%CI: 1.62-4.39). Conclusions While our study demonstrates the feasibility of recruiting and retaining individuals from the UPF for HIV research, we did observe lower than anticipated HIV incidence, perhaps because individuals at lower risk of HIV infection may have been the first to come forward to participate or participants followed HIV risk reduction measures. Our findings suggest lessons for recruitment of populations at high risk of HIV infection.	[Bahemuka, Ubaldo Mushabe; Abaasa, Andrew; Seeley, Janet; Mayaud, Philippe; Kuteesa, Monica] MRC, Uganda Virus Res Inst, Uganda Res Unit, Entebbe, Uganda; [Bahemuka, Ubaldo Mushabe; Abaasa, Andrew; Seeley, Janet; Mayaud, Philippe; Kuteesa, Monica] UVRI, London Sch Hyg & Trop Med MRC, Entebbe, Uganda; [Bahemuka, Ubaldo Mushabe; Abaasa, Andrew; Seeley, Janet; Mayaud, Philippe; Kuteesa, Monica] LSHTM, Uganda Res Unit, Entebbe, Uganda; [Seeley, Janet; Mayaud, Philippe] London Sch Hyg & Trop Med, London, England; [Byaruhanga, Moses] Uganda Police Force, Directorate Hlth Serv, Kampala, Uganda; [Kamali, Anatoli] Int AIDS Vaccine Initiat, New York, NY USA	Uganda Virus Research Institute; University of London; London School of Hygiene & Tropical Medicine; International AIDS Vaccine Initiative	Bahemuka, UM (corresponding author), MRC, Uganda Virus Res Inst, Uganda Res Unit, Entebbe, Uganda.; Bahemuka, UM (corresponding author), UVRI, London Sch Hyg & Trop Med MRC, Entebbe, Uganda.; Bahemuka, UM (corresponding author), LSHTM, Uganda Res Unit, Entebbe, Uganda.	Ubaldo.Bahemuka@mrcuganda.org		MAYAUD, Philippe/0000-0001-5730-947X; Bahemuka, Ubaldo/0000-0003-1092-4832; Seeley, Janet/0000-0002-0583-5272	International AIDS Vaccine Initiative; United States Agency for International Development; MRC [MC_UU_00027/3] Funding Source: UKRI	International AIDS Vaccine Initiative; United States Agency for International Development(United States Agency for International Development (USAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by International AIDS Vaccine Initiative, with the generous support of United States Agency for International Development and other donors; a full list of IAVI donors is available at www.iavi.org.	Bahemuka UM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0198460; Bakari M, 2000, AIDS, V14, P313, DOI 10.1097/00002030-200002180-00014; Bakari M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1149; Ghys PD, 2001, AIDS, V15, P1421, DOI 10.1097/00002030-200107270-00012; Hom DL, 1997, J ACQ IMMUN DEF SYND, V15, P375, DOI 10.1097/00042560-199708150-00008; Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Rao A, 2017, AIDS BEHAV, V21, P2207, DOI 10.1007/s10461-017-1792-8; Rimoin AW, 2015, INT J STD AIDS, V26, P187, DOI 10.1177/0956462414533672; Sagala JK, 2008, ARMED FORCES SOC, V34, P292, DOI 10.1177/0095327X07302976; Tarimo EAM, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1953; Traore IT, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20088; Vardas E, 2005, MICROBES INFECT, V7, P1436, DOI 10.1016/j.micinf.2005.07.021; Vissers DCJ, 2008, SEX TRANSM DIS, V35, P714, DOI 10.1097/OLQ.0b013e3181723d93; WAWER MJ, 1994, BRIT MED J, V308, P171, DOI 10.1136/bmj.308.6922.171; World Health Organisation, 2018, REP KEY POP AFR HIV	17	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231640	10.1371/journal.pone.0231640	http://dx.doi.org/10.1371/journal.pone.0231640			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302334	gold, Green Published, Green Accepted			2022-12-26	WOS:000536016100038
J	Adam, A; Koranteng, F				Adam, Awolu; Koranteng, Felix			Availability, accessibility, and impact of social support on breast cancer treatment among breast cancer patients in Kumasi, Ghana: A qualitative study	PLOS ONE			English	Article							OF-LIFE; WOMEN; SURVIVORS; ROLES; STYLE	Background Breast cancer is one of the top types of cancer affecting women both in the developed and developing countries. Breast cancer is a chronic and debilitating condition for anybody diagnosed of it and as well as their family. Social support has been shown to offset or moderate the impact of stress caused by the illness and other related negative outcomes. Objective The objective of this study is to assess the availability, accessibility, and impact of social support on treatment for breast cancer patients at Komfo Anokye Teaching Hospital (KATH), Ashanti Region in Ghana. Materials and methods A phenomenological study was employed. An in-depth interview guide was used to collect data on socio-demographic variables and social support availability and accessibility from 15 breast cancer patients. Thematic analysis was employed. Results Majority of the women who participated in the study were postmenopausal women with an average age of 55 years. The study also revealed that all the participants in this study received one kind of support or another including informational, financial, emotional, and tangible support and reported varying positive impacts on their lives as a result of the support received. For those who received support, the prognosis and general quality of life appeared promising and well-adjusted than those who reported not having received any form of support. Conclusion Social support is critical for the survival and quality of life of chronic disease patients including breast cancer patients who were the focus of this study. The availability and/or accessibility of social support or otherwise significantly determines the prognosis and quality of life of breast cancer patients. Healthcare professionals and family members or significant others are major players in organizing social support for chronic disease patients.	[Adam, Awolu] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Family & Community Hlth, Ho, Ghana; [Adam, Awolu] Ctr Hlth Literacy & Rural Hlth Promot, Accra, Ghana; [Koranteng, Felix] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Ho, Ghana		Adam, A (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Family & Community Hlth, Ho, Ghana.; Adam, A (corresponding author), Ctr Hlth Literacy & Rural Hlth Promot, Accra, Ghana.	aawolu@uhas.edu.gh	ADAM, AWOLU/AGG-2856-2022					Adjei E., 2012, GHANA MED J, V46, P1; Ameer K., 2014, J INTERDISCIP MULTID, V2, P109; Attai DJ, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4721; Azubuike SO, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1345-2; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Creswell J, 2017, RES DESIGN QUALITATI; Curado MP, 2011, SALUD PUBLICA MEXICO, V53, P372; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Fong AJ, 2017, PSYCHO-ONCOLOGY, V26, P664, DOI 10.1002/pon.4064; Gakunga R, 2015, INT J CANCER, V137, P2045, DOI 10.1002/ijc.29668; Kim J, 2010, J HEALTH PSYCHOL, V15, P543, DOI 10.1177/1359105309355338; Kroenke CH, 2017, PSYCHO-ONCOLOGY, V26, P544, DOI 10.1002/pon.4059; Leung J, 2014, PSYCHO-ONCOLOGY, V23, P1014, DOI 10.1002/pon.3523; Lin CC, 2016, PERS INDIV DIFFER, V89, P13, DOI 10.1016/j.paid.2015.09.032; McGuire S., 2015, WORLD CANC REPORT 20; Naku Ghartey Jnr F, 2016, INT J BREAST CANC; O'Donovan A, 2008, J HEALTH PSYCHOL, V13, P1147, DOI 10.1177/1359105308095968; Pace LE, 2016, ONCOLOGIST, V21, P739, DOI 10.1634/theoncologist.2015-0429; Quayson SE, 2014, J MED BIOMED SCI, V3, P21, DOI 10.4314/jmbs.v3i3.4; Spatuzzi R, 2016, BREAST CARE, V11, P28, DOI 10.1159/000443493; Sterba KR, 2014, QUAL LIFE RES, V23, P1909, DOI 10.1007/s11136-014-0654-3; Suwankhong D, 2016, J NURS SCHOLARSHIP, V48, P39, DOI 10.1111/jnu.12179; Tamulee P., INT J SCI RES PUBLIC, P30; Thompson T, 2017, SOC SCI MED, V192, P134, DOI 10.1016/j.socscimed.2017.09.035; Wells AA, 2014, J CANCER EDUC, V29, P619, DOI 10.1007/s13187-013-0592-8; WHO, 2014, COPUNTR CANC PROF	26	12	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231691	10.1371/journal.pone.0231691	http://dx.doi.org/10.1371/journal.pone.0231691			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298340	gold, Green Published			2022-12-26	WOS:000536011400089
J	Campos-Nonato, I; Ramirez-Villalobos, M; Flores-Coria, A; Valdez, A; Monterrubio-Flores, E				Campos-Nonato, Ismael; Ramirez-Villalobos, Maria; Flores-Coria, Alejandra; Valdez, Andrys; Monterrubio-Flores, Eric			Prevalence of previously diagnosed diabetes and glycemic control strategies in Mexican adults: ENSANUT-2016	PLOS ONE			English	Article							TYPE-2; HYPERTENSION; MANAGEMENT; POPULATION.; MELLITUS; POSITION; QUALITY; DISEASE; RISK	Objectives To describe the prevalence of previously diagnosed diabetes among Mexican adults, to characterize the associated risk factors, and to describe which glycemic control strategies are the most used. Methods We analyzed data from 8,631 adults aged >= 20 years who participated in the ENSANUT-2016 and from whom we gathered data about previously diagnosed diabetes, risk factors, glycemic control strategies, and measures to prevent complications. Results The prevalence of previously diagnosed diabetes in Mexican adults was 9.4% (10.3% in women and 8.4% in men). The adjusted OR for having diabetes was higher in adults aged >= 60 years (OR = 11.0 in women and OR = 30.7 in men) than in adults aged 20-39 years (OR = 1.0). The adjusted OR for having diabetes was higher in overweight men (OR = 1.7) than in men with normal BMI (OR = 1.0). A total of 30.5% of adults with diabetes did not report any control strategies, 44.9% measured their venous blood glucose, and 15.2% used the HbA1C as an indicator of glycemic control. Only 46.4% of them reported preventive measures. Discussion Diabetes is a common disease among Mexican adults. Being older or overweight are risk factors for an adult to be diagnosed with diabetes. Most adults with diabetes evaluate their glycemic control but only half practice preventive measures.	[Campos-Nonato, Ismael; Flores-Coria, Alejandra; Valdez, Andrys; Monterrubio-Flores, Eric] Inst Nacl Salud Publ, Ctr Invest Nutr & Salud, Mexico City, DF, Mexico; [Ramirez-Villalobos, Maria] Inst Nacl Salud Publ, Ctr Invest Sistemas, Mexico City, DF, Mexico	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica	Ramirez-Villalobos, M (corresponding author), Inst Nacl Salud Publ, Ctr Invest Sistemas, Mexico City, DF, Mexico.	dolores.ramirez@insp.mx		Campos, Ismael/0000-0001-5939-3396; Ramirez Villalobos, Maria Dolores/0000-0002-0625-4648				Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; [Anonymous], 2015, Nat Rev Dis Primers, V1, P15039, DOI 10.1038/nrdp.2015.39; [Anonymous], 1995, WHO TECH REP SER, V854, P1; Barcellos SH, 2012, HEALTH AFFAIR, V31, P2727, DOI 10.1377/hlthaff.2011.0973; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Campos-Nonato I, 2018, SALUD PUBLICA MEXICO, V60, P233, DOI 10.21149/8813; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Cefalu WT, 2019, DIABETES CARE, V42, pS46, DOI 10.2337/dc19-S005; Cefalu WT, 2019, DIABETES CARE, V42, pS34, DOI 10.2337/dc19-S004; FOROUHI NG, 2018, BMJ-BRIT MED J, V361, DOI DOI 10.1136/BMJ.K2234; Gaona-Pineda EB, 2018, SALUD PUBLICA MEXICO, V60, P272, DOI 10.21149/8803; Goldman N, 2003, J CLIN EPIDEMIOL, V56, P148, DOI 10.1016/S0895-4356(02)00580-2; Grontved A, 2012, ARCH INTERN MED, V172, P1306, DOI 10.1001/archinternmed.2012.3138; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Harris MI, 2001, DIABETES CARE, V24, P979, DOI 10.2337/diacare.24.6.979; Hernandez A, 2016, ENCUESTA NACL SALUD; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Huerta JM, 2009, REV ESP CARDIOL, V62, P143, DOI 10.1016/S0300-8932(09)70156-3; Inzucchi SE, 2012, DIABETOLOGIA, V55, P1577, DOI 10.1007/s00125-012-2534-0; Katzmarzyk PT, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000828; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kleefstra N, 2016, J DIABETES, V8, P863, DOI 10.1111/1753-0407.12370; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Ley SH, 2014, LANCET, V383, P1999, DOI 10.1016/S0140-6736(14)60613-9; Lohman T.J., 1988, ANTHROPOMETRIC STAND; Menke A, 2015, JAMA-J AM MED ASSOC, V314, P1021, DOI 10.1001/jama.2015.10029; OMS, 2016, INF MUND DIAB; Osorio E, 2010, SALUD PUBLICA MEXICO, V52, P14, DOI 10.1590/S0036-36342010000100004; Otto MCD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141341; Pozzilli P, 2010, DIABETES-METAB RES, V26, P239, DOI 10.1002/dmrr.1092; Short IPAQ, 2002, INT PHYS ACT QUEST S; Tiew KF, 2014, J HEALTH POPUL NUTR, V32, P665; WHO, 2010, PHYS ACT AD REC LEV; World Health Organization, 1995, PHYS STAT US INT ANT	35	11	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230752	10.1371/journal.pone.0230752	http://dx.doi.org/10.1371/journal.pone.0230752			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298264	gold, Green Published			2022-12-26	WOS:000536011400020
J	Liu, Y; Gao, H; He, YDD				Liu, Yang; Gao, Hua; He, Yudong D.			A compound attributes-based predictive model for drug induced liver injury in humans	PLOS ONE			English	Article							WITHDRAWALS; OUTCOMES	Drug induced liver injury (DILI) is one of the key safety concerns in drug development. To assess the likelihood of drug candidates with potential adverse reactions of liver, we propose a compound attributes-based approach to predicting hepatobiliary disorders that are routinely reported to US Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS). Specifically, we developed a support vector machine (SVM) model with recursive feature extraction, based on physicochemical and structural properties of compounds as model input. Cross validation demonstrates that the predictive model has a robust performance with averaged 70% of both sensitivity and specificity over 500 trials. An independent validation was performed on public benchmark drugs and the results suggest potential utility of our model for identifying safety alerts. This in silico approach, upon further validation, would ultimately be implemented, together with other in vitro safety assays, for screening compounds early in drug development.	[Liu, Yang; He, Yudong D.] Amgen Inc, Genome Anal Unit, Amgen Res, San Francisco, CA 94080 USA; [Gao, Hua] Amgen Inc, Amgen Res, Mol Engn, Cambridge, MA USA	Amgen; Amgen	Liu, Y; He, YDD (corresponding author), Amgen Inc, Genome Anal Unit, Amgen Res, San Francisco, CA 94080 USA.	yaliu@amgen.com; yudongh@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	The funder (Amgen Inc.) provided support in the form of salaries for authors [LY, GH, HYD] and the decision to publish, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Ai HX, 2018, TOXICOL SCI, V165, P100, DOI 10.1093/toxsci/kfy121; An G, 2011, DRUG DEVELOP RES, V72, P187, DOI 10.1002/ddr.20415; Banda JM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.26; Bender A, 2007, CHEMMEDCHEM, V2, P861, DOI 10.1002/cmdc.200700026; Cao DS, 2015, CPT-PHARMACOMET SYST, V4, P498, DOI 10.1002/psp4.12002; Chalasani N, 2008, GASTROENTEROLOGY, V135, P1924, DOI 10.1053/j.gastro.2008.09.011; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Fang H, 2014, CLIN PHARMACOL THER, V95, P496, DOI 10.1038/clpt.2014.17; Gayvert KM, 2016, CELL CHEM BIOL, V23, P1294, DOI 10.1016/j.chembiol.2016.07.023; Hammann F, 2010, CLIN PHARMACOL THER, V88, P52, DOI 10.1038/clpt.2009.248; Harpaz R, 2013, CLIN PHARMACOL THER, V93, P539, DOI 10.1038/clpt.2013.24; Hauben Manfred, 2005, Expert Opin Drug Saf, V4, P929, DOI 10.1517/14740338.4.5.929; Huang LC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S5-S11; Iqbal E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134208; Jahid Md Jamiul, 2013, Proceedings (IEEE Int Conf Bioinformatics Biomed), P440, DOI 10.1109/BIBM.2013.6732532; Kuang QF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105889; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lounkine E, 2012, NATURE, V486, P361, DOI 10.1038/nature11159; MANIER JW, 1982, AM J GASTROENTEROL, V77, P401; Monticello TM, 2017, TOXICOL APPL PHARM, V334, P100, DOI 10.1016/j.taap.2017.09.006; Morgan RE, 2013, TOXICOL SCI, V136, P216, DOI 10.1093/toxsci/kft176; Morgan RE, 2010, TOXICOL SCI, V118, P485, DOI 10.1093/toxsci/kfq269; Pauwels E, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-169; Sarangdhar M, 2016, NAT BIOTECHNOL, V34, P697, DOI 10.1038/nbt.3623; Sassolas B, 2010, CLIN PHARMACOL THER, V88, P60, DOI 10.1038/clpt.2009.252; Scannell JW, 2012, NAT REV DRUG DISCOV, V11, P191, DOI 10.1038/nrd3681; Tatonetti NP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003377; Valerio LG, 2013, EXPERT OPIN DRUG MET, V9, P801, DOI 10.1517/17425255.2013.783819; Valerio LG, 2010, EXPERT OPIN DRUG MET, V6, P505, DOI 10.1517/17425250903499286; Vilar S, 2014, CPT-PHARMACOMET SYST, V3, DOI 10.1038/psp.2014.35; Vilar S, 2016, J CHEMINFORMATICS, V8, DOI 10.1186/s13321-016-0147-1; Vilar S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08809; Wang ZC, 2016, BIOINFORMATICS, V32, P2338, DOI 10.1093/bioinformatics/btw168; Williams DP, 2019, CHEM RES TOXICOL; Wysowski DK, 2005, ARCH INTERN MED, V165, P1363, DOI 10.1001/archinte.165.12.1363; Zhang C, 2016, MOL INFORM, V35, P136, DOI 10.1002/minf.201500055	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231252	10.1371/journal.pone.0231252	http://dx.doi.org/10.1371/journal.pone.0231252			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294131	Green Published, gold			2022-12-26	WOS:000536003500025
J	Granero-Gil, P; Gomez-Carmona, CD; Bastida-Castillo, A; Rojas-Valverde, D; de la Cruz, E; Pino-Ortega, J				Granero-Gil, Paulino; Gomez-Carmona, Carlos D.; Bastida-Castillo, Alejandro; Rojas-Valverde, Daniel; de la Cruz, Ernesto; Pino-Ortega, Jose			Influence of playing position and laterality in centripetal force and changes of direction in elite soccer players	PLOS ONE			English	Article							FA PREMIER LEAGUE; MATCH PERFORMANCE; TEAM SPORTS; ASYMMETRY; VALIDITY; DEMANDS; SYSTEM	The purpose of the present study was to: (a) assess centripetal force (CentF) and changes of direction (COD) in elite soccer players according to playing position (central defender, CD; lateral defender, LD; central midfielder, CM; lateral midfielder, LM; forward, FW), laterality (right-footed vs. left-footed) and field zone (central vs. lateral), and (b) analyze the relationship between anthropometric characteristics (age, weight, height, body mass and fat mass) and non-linear locomotion workload. Thirty professional soccer players (age: 26.57 +/- 5.56 years) were tracked during the 2017-2018 season during friendly, national and international matches (38 total games) using inertial measurement devices. CentF and COD were the variables extracted for analysis. A one-way ANOVA was used for playing position comparison, a t-test for laterality and field zone, and Pearson's correlation coefficient to analyze relationships between anthropometric characteristics and dependent variables. There were differences by playing position in COD (556.33-to-412.18), R20COD (484.36-to-354.81) and R60COD (48.38-to-38.61) (p <.01; omega(2)(p) = 0.03-to-0.05; CD>CM>LD>LM = FW); in CODHIA (49.75-to-37.11), R(20)CODHIA (16.04-to-9.11) and R(60)CODHIA (10.64-to-9.11) (p <.01; omega(2)(p) = 0.03-to-0.07; CM>FW>LM> CD = LD); in CODSPRINT (14.56-to-8.40) and R20CODSPRINT (3.29-to-1.40) (p <.01; omega(2)(p) = 0.03-to-0.04; FW = LM = CM> CD = LD); and in CentFMAX both in clockwise (992.04-to-902.09N) and counterclockwise (999.24-to-872.61N) directions (p <.02; omega(2)(p) = 0.02-to-0.07; FW = CD> CM = LM = LD). The highest values of counterclockwise CentF were performed by left-footed players in the central zone (p <.001; d = 0.71-to-1.44) and clockwise CentF by right-footed players (p <.001; d = 0.04-to-0.55) in the lateral field zone. Moderate correlations were found between age, body mass and high intensity/sprints COD and repeated COD ability (p <.05; r = 0.235-to-0.383). Therefore, team staff should consider anthropometric characteristics, playing position, laterality and field zone to individualize training workload related to non-linear locomotion in soccer.	[Granero-Gil, Paulino] Fitness Coach PFC CSKA Moscow & Russian Football, Moscow, Russia; [Granero-Gil, Paulino; Bastida-Castillo, Alejandro; de la Cruz, Ernesto; Pino-Ortega, Jose] Univ Murcia, Sport Sci Fac, Dept Phys Act & Sport, San Javier, Spain; [Gomez-Carmona, Carlos D.] Univ Extremadura, Sport Sci Fac, Optimizat Training & Sport Performance Res Grp GO, Caceres, Spain; [Rojas-Valverde, Daniel] Univ Nacl, Res Ctr Sport & Hlth Diag CIDISAD, Sch Human Movement Sci & Qual Life, Heredia, Costa Rica; [Rojas-Valverde, Daniel] Univ Extremadura, Sport Sci Fac, Grp Updates Sport Training & Phys Conditioning GA, Caceres, Spain	University of Murcia; Universidad de Extremadura; Universidad Nacional Costa Rica; Universidad de Extremadura	Gomez-Carmona, CD (corresponding author), Univ Extremadura, Sport Sci Fac, Optimizat Training & Sport Performance Res Grp GO, Caceres, Spain.	cdgomezcarmona@unex.es	De la Cruz-Sánchez, Ernesto/F-7406-2010; pino ortega, José/ABD-1599-2020; Rojas-Valverde, Daniel/O-5352-2019; Ortega, Jose Pino/AAN-9960-2020; Gómez-Carmona, Carlos D/Q-8584-2016	De la Cruz-Sánchez, Ernesto/0000-0002-4718-7058; pino ortega, José/0000-0002-9091-0897; Rojas-Valverde, Daniel/0000-0002-0717-8827; Gómez-Carmona, Carlos D/0000-0002-4084-8124	PFC CSKA Moscow; Spanish Ministry of Education, Culture and Sport [FPU17/00407]; Russian Football Union	PFC CSKA Moscow; Spanish Ministry of Education, Culture and Sport(Spanish Government); Russian Football Union	The author P.G-G was supported by a salary from the PFC CSKA Moscow and Russian Football Union. The author C.D.G-C was supported by a grant from the Spanish Ministry of Education, Culture and Sport (FPU17/00407). The funder provided support in the form of salaries for authors [P.G-G and C.D.G-C], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akenhead R, 2016, INT J SPORT PHYSIOL, V11, P587, DOI 10.1123/ijspp.2015-0331; Akubat I, 2014, INT J SPORT PHYSIOL, V9, P457, DOI [10.1123/IJSPP.2012-0347, 10.1123/ijspp.2012-0347]; Alt T, 2015, J SPORT SCI, V33, P552, DOI 10.1080/02640414.2014.960881; Ato M, 2013, AN PSICOL-SPAIN, V29, P1038, DOI 10.6018/analesps.29.3.178511; Balloch AS, 2019, J STRENGTH COND RES; Barreira TV, 2013, PEDIATR OBES, V8, pe29, DOI 10.1111/j.2047-6310.2012.00122.x; Castillo AB, 2018, EUR J SPORT SCI, V18, P450, DOI 10.1080/17461391.2018.1427796; Bloomfield J, 2007, J SPORT SCI MED, V6, P63; Bradley PS, 2009, J SPORT SCI, V27, P159, DOI 10.1080/02640410802512775; Buchheit M, 2017, INT J SPORT PHYSIOL, V12, P35, DOI 10.1123/ijspp.2016-0499; Bush M, 2015, HUM MOVEMENT SCI, V39, P1, DOI 10.1016/j.humov.2014.10.003; Caldbeck P., 2019, THESIS; Campa F, 2019, INT J SPORTS MED, V40, P100, DOI 10.1055/a-0781-2473; Carey DP, 2009, CORTEX, V45, P650, DOI 10.1016/j.cortex.2008.05.011; Carling C, 2008, SPORTS MED, V38, P839, DOI 10.2165/00007256-200838100-00004; Carling C, 2010, J STRENGTH COND RES, V24, P1332, DOI 10.1519/JSC.0b013e3181cc6154; Churchill SM, 2015, SPORT BIOMECH, V14, P106, DOI 10.1080/14763141.2015.1024717; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cummins C, 2013, SPORTS MED, V43, P1025, DOI 10.1007/s40279-013-0069-2; Dalen T, 2018, OPEN ACCESS J SPORTS, V9, P107, DOI 10.2147/OAJSM.S167347; David S, 2018, HUM MOVEMENT SCI, V62, P202, DOI 10.1016/j.humov.2018.10.005; Dellal A, 2011, EUR J SPORT SCI, V11, P51, DOI 10.1080/17461391.2010.481334; Di Salvo V, 2007, INT J SPORTS MED, V28, P222, DOI 10.1055/s-2006-924294; Di Salvo V, 2010, J SPORT SCI, V28, P1489, DOI 10.1080/02640414.2010.521166; Emmonds S, 2019, J STRENGTH COND RES, V33, P1669, DOI 10.1519/JSC.0000000000002114; Filter A, 2020, J SPORT SCI, V38, P1320, DOI 10.1080/02640414.2019.1677391; Fitzpatrick JF., 2019, SPORTS PERFORM SCI R, V55, P1; Camerino OF, 2012, EUR J SPORT SCI, V12, P216, DOI 10.1080/17461391.2011.566362; Fransson D, 2017, SCI MED FOOTBALL, V1, P10, DOI 10.1080/02640414.2016.1254808; Ishimura K, 2016, J APPL BIOMECH, V32, P394, DOI 10.1123/jab.2015-0127; Larsson P, 2003, SPORTS MED, V33, P1093, DOI 10.2165/00007256-200333150-00002; Loturco I, 2018, GER J EXERC SPORT RE, V48, P228, DOI 10.1007/s12662-018-0502-7; Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236; Mohr M, 2003, J SPORT SCI, V21, P519, DOI 10.1080/0264041031000071182; Nimphius S, 2018, STRENGTH COND J, V40, P26, DOI 10.1519/SSC.0000000000000309; Pino-Ortega J, 2018, E-BALONMANO COM, V14, P79; Reilly T, 2000, J SPORT SCI, V18, P695, DOI 10.1080/02640410050120050; Resnick, 2002, PHYSICS; Sheppard JM, 2006, J SPORT SCI, V24, P919, DOI 10.1080/02640410500457109; Slimani M, 2017, J SPORTS MED PHYS FI, P7950; Svilar L, 2018, INT J SPORT PHYSIOL, V13, P947, DOI 10.1123/ijspp.2017-0534; Taylor JB, 2017, SPORTS MED, V47, P2533, DOI 10.1007/s40279-017-0772-5; Verbeek J, 2017, J SPORT SCI, V35, P2220, DOI 10.1080/02640414.2016.1262544; Wong PL, 2009, J STRENGTH COND RES, V23, P1204, DOI 10.1519/JSC.0b013e31819f1e52	44	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232123	10.1371/journal.pone.0232123	http://dx.doi.org/10.1371/journal.pone.0232123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324801	gold, Green Published			2022-12-26	WOS:000536033700079
J	Helander, A; Backberg, M; Beck, O				Helander, Anders; Backberg, Matilda; Beck, Olof			Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project	PLOS ONE			English	Article							LC-MS/MS METHOD; ETHYL SULFATE; LEGAL-HIGHS; INTOXICATIONS; FENTANYL; IDENTIFICATION; METABOLITE; PRODUCTS; ANALOGS; ETHANOL	Background In the past decade, hundreds of new psychoactive substances (NPS) have been introduced as unclassified alternatives to the illicit drugs. The NPS represent a growing health concern by causing adverse effects and deaths but are usually undetectable by conventional drug tests. This report summarizes results and experiences from analytically confirmed drugrelated acute intoxications in emergency departments (ED) and intensive care units (ICU) enrolled in the Swedish STRIDA project on NPS in 2010-2016. Methods and findings ED/ICU intoxications suspected to involve NPS were enrolled in the project, after initial contact with the Poisons Information Centre (PIC). Serum/plasma and urine samples, and sometimes drug products, were subjected to a comprehensive toxicological investigation, and the PIC retrieved information on associated clinical symptoms and treatment. Between January 2010-February 2016, 2626 cases were enrolled. The patients were aged 8-71 (mean 27, median 24) years and 74% were men. Most biological samples (81%) tested positive for one, or more (70%), psychoactive drugs, including 159 NPS, other novel or uncommon substances, classical recreational and illicit drugs, and prescription medications. When first detected, most NPS or other novel substances (75%) were not banned in Sweden, but they usually disappeared upon classification, which however often took a year or longer. Some NPS were found to be especially harmful and even fatal. Conclusions The STRIDA project provided a good overview of the current drug situation in Sweden and demonstrated a widespread use and rapid turnover of many different psychoactive substances. The accomplishment of the project can be attributed to several key factors (close collaboration between the PIC and laboratory to identify suspected poisonings, free analysis, continuous updating of analytical methods, evaluation of adverse effects, and sharing information) that are useful for future activities addressing the NPS problem. The results also illustrated how drug regulations can drive the NPS market.	[Helander, Anders; Beck, Olof] Karolinska Inst, Dept Lab Med, Stockholm, Sweden; [Helander, Anders; Beck, Olof] Karolinska Univ Lab, Clin Pharmacol, Stockholm, Sweden; [Backberg, Matilda] Swedish Poisons Informat Ctr, Stockholm, Sweden; [Beck, Olof] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Helander, A (corresponding author), Karolinska Inst, Dept Lab Med, Stockholm, Sweden.; Helander, A (corresponding author), Karolinska Univ Lab, Clin Pharmacol, Stockholm, Sweden.	anders.helander@ki.se		Helander, Anders/0000-0001-7480-8078	Public Health Agency of Sweden (Folkhalsomyndigheten)	Public Health Agency of Sweden (Folkhalsomyndigheten)	This work was supported by the Public Health Agency of Sweden (Folkhalsomyndigheten). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saffar Y, 2013, J CHROMATOGR B, V930, P112, DOI 10.1016/j.jchromb.2013.04.043; Armenian P, 2018, NEUROPHARMACOLOGY, V134, P121, DOI 10.1016/j.neuropharm.2017.10.016; Auwarter V, 2009, J MASS SPECTROM, V44, P832, DOI 10.1002/jms.1558; Backberg M, 2019, CLIN TOXICOL, V57, P203, DOI 10.1080/15563650.2018.1506130; Backberg M, 2017, J MED TOXICOL, V13, P52, DOI 10.1007/s13181-016-0584-2; Backberg M, 2016, CLIN TOXICOL, V54, P819, DOI 10.1080/15563650.2016.1211288; Backberg M, 2015, CLIN TOXICOL, V53, P856, DOI 10.3109/15563650.2015.1079325; Backberg M, 2015, CLIN TOXICOL, V53, P609, DOI 10.3109/15563650.2015.1054505; Backberg M, 2015, CLIN TOXICOL, V53, P46, DOI 10.3109/15563650.2014.981823; Backberg M, 2018, DRUG TEST ANAL, V10, P340, DOI 10.1002/dta.2226; Barratt MJ, 2017, INT J DRUG POLICY, V40, P16, DOI 10.1016/j.drugpo.2016.10.002; Bazckberg M, 2014, CLIN TOXICOL, V52, P618, DOI 10.3109/15563650.2014.920088; Beck O, 2016, CLIN TOXICOL, V54, P568, DOI 10.1080/15563650.2016.1190979; Beck O, 2015, CLIN TOXICOL, V53, P865, DOI 10.3109/15563650.2015.1089576; Beck O, 2014, DRUG TEST ANAL, V6, P492, DOI 10.1002/dta.1641; Bergstrand MP, 2017, DRUG TEST ANAL, V9, P640, DOI 10.1002/dta.2003; Bergstrand MP, 2016, J CHROMATOGR B, V1035, P104, DOI 10.1016/j.jchromb.2016.08.047; Bjoernstad K, 2009, J CHROMATOGR B, V877, P1162, DOI 10.1016/j.jchromb.2009.03.004; BRADLEY M, 2016, LAKARTIDNINGEN, V13, DOI DOI 10.1117/12.2246872; EMCDDA, 2009, UND SPIC PHEN 2009; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), 2019, EUR DRUG REP 2019; Franzen L, 2019, CLIN TOXICOL, V57, P372, DOI 10.1080/15563650.2018.1520999; Franzen L, 2018, J MED TOXICOL, V14, P265, DOI 10.1007/s13181-018-0668-2; Gladden RM, 2016, MMWR-MORBID MORTAL W, V65, P837, DOI 10.15585/mmwr.mm6533a2; Helander A, 2005, J ANAL TOXICOL, V29, P270, DOI 10.1093/jat/29.5.270; Helander A, 2017, BRIT J DERMATOL, V176, P1021, DOI 10.1111/bjd.15174; Helander A, 2014, CLIN TOXICOL, V52, P901, DOI 10.3109/15563650.2014.943908; Helander A, 2004, CLIN CHEM, V50, P936, DOI 10.1373/clinchem.2004.031252; Helander A, 2018, DRUG TEST ANAL, V10, P1297, DOI 10.1002/dta.2382; Helander A, 2017, CLIN TOXICOL, V55, P589, DOI 10.1080/15563650.2017.1303141; Helander A, 2017, CLIN TOXICOL, V55, P1, DOI 10.1080/15563650.2016.1217003; Helander A, 2016, CLIN TOXICOL, V54, P324, DOI 10.3109/15563650.2016.1139715; Helander A, 2015, CLIN TOXICOL, V53, P446, DOI 10.3109/15563650.2015.1033630; Helander A, 2014, FORENSIC SCI INT, V243, P23, DOI 10.1016/j.forsciint.2014.02.022; Helander A, 2013, SCAND J CLIN LAB INV, V73, P400, DOI 10.3109/00365513.2013.793817; HENDERSON GL, 1988, J FORENSIC SCI, V33, P569; Johansson M, 2014, J PHARMACEUT BIOMED, V100, P215, DOI 10.1016/j.jpba.2014.07.026; Kamijo Y, 2014, INTERNAL MED, V53, P2439, DOI 10.2169/internalmedicine.53.2344; Kronstrand R, 2013, J ANAL TOXICOL, V37, P542, DOI 10.1093/jat/bkt058; Lindeman Erik, 2014, Lakartidningen, V111, P1712; Lindeman Erik, 2012, Lakartidningen, V109, P1954; Lindigkeit R, 2009, FORENSIC SCI INT, V191, P58, DOI 10.1016/j.forsciint.2009.06.008; Marriott KSC, 2008, CURR TOP MED CHEM, V8, P187; Meltzer PC, 2006, J MED CHEM, V49, P1420, DOI 10.1021/jm050797a; Ojanpera I, 2016, INT J LEGAL MED, V130, P1209, DOI 10.1007/s00414-016-1358-8; Persson HE, 1998, J TOXICOL-CLIN TOXIC, V36, P205, DOI 10.3109/15563659809028940; Simonsen KW, 2015, FORENSIC SCI INT, V248, P172, DOI 10.1016/j.forsciint.2015.01.003; STARMARK JE, 1988, J NEUROSURG, V69, P699, DOI 10.3171/jns.1988.69.5.0699; Stephanson NN, 2017, J MASS SPECTROM, V52, P497, DOI 10.1002/jms.3946; van Amsterdam J, 2013, J PSYCHOPHARMACOL, V27, P317, DOI 10.1177/0269881112474525	50	11	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232038	10.1371/journal.pone.0232038	http://dx.doi.org/10.1371/journal.pone.0232038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324788	Green Submitted, Green Published, gold			2022-12-26	WOS:000536033700064
J	Leonard, JP; Tewes, ME; Lombardi, JV; Wester, DW; Campbell, TA				Leonard, John P.; Tewes, Michael E.; Lombardi, Jason V.; Wester, David W.; Campbell, Tyler A.			Effects of sun angle, lunar illumination, and diurnal temperature on temporal movement rates of sympatric ocelots and bobcats in South Texas	PLOS ONE			English	Article							LEOPARDUS-PARDALIS; ACTIVITY PATTERNS; HABITAT USE; COMPETITION; POPULATION; MOONLIGHT; RECOVERY; FELIDAE	Sympatric ocelots (Leopardus pardalis) and bobcats (Lynx rufus) in South Texas show substantial overlap in body size, food habits, and habitat use. Consequently, we explore whether temporal niche partitioning may explain ocelot and bobcat coexistence. We investigated the influence of sun angle, lunar illumination, and maximum diurnal temperature on temporal movement rates of sympatric ocelots (n = 8) and bobcats (n = 6) using a combination of highfrequency GPS locations and bi-axial accelerometer data. We demonstrated that accelerometer data could be used to predict movement rates, providing a nearly continuous measure of animal activity and supplementing GPS locations. Ocelots showed a strong nocturnal activity pattern with the highest movement rates at night whereas bobcats showed a crepuscular activity pattern with the highest movement rates occurring around sunrise and sunset. Although bobcat activity levels were lower during the day, bobcat diurnal activity was higher than ocelot diurnal activity. During warmer months, bobcats were more active on nights with high levels of lunar illumination. In contrast, ocelots showed the highest nocturnal activity levels during periods of low lunar illumination. Ocelots showed reduced diurnal activity on hotter days. Our results indicate that ocelot and bobcat coexistence in South Texas can be partially explained by temporal niche partitioning, although both felids showed periods of overlapping activity during nocturnal and crepuscular periods.	[Leonard, John P.; Tewes, Michael E.; Lombardi, Jason V.; Wester, David W.] Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, Kingsville, TX 77843 USA; [Leonard, John P.] Univ New Mexico, Museum SouthWestern Biol, Nat Heritage New Mexico, Albuquerque, NM 87131 USA; [Campbell, Tyler A.] East Fdn, San Antonio, TX USA	Texas A&M University System; Texas A&M University Kingsville; University of New Mexico	Leonard, JP (corresponding author), Texas A&M Univ, Caesar Kleberg Wildlife Res Inst, Kingsville, TX 77843 USA.; Leonard, JP (corresponding author), Univ New Mexico, Museum SouthWestern Biol, Nat Heritage New Mexico, Albuquerque, NM 87131 USA.	jpleonard2000@yahoo.com			East Foundation	East Foundation	This work was funded by the East Foundation, a nonprofit foundation dedicated to wildlife conservation and private land stewardship. eastfoundation.net.	Baker LA, 2001, AM MIDL NAT, V145, P80, DOI 10.1674/0003-0031(2001)145[0080:PSBRBL]2.0.CO;2; Banks MS, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500391; Blake JG, 2016, J MAMMAL, V97, P455, DOI 10.1093/jmammal/gyv190; Blankenship TL, 2000, THESIS; Booth-Binczik SD, 2013, SOUTHWEST NAT, V58, P403, DOI 10.1894/0038-4909-58.4.403; Bradley Lisa C., 1988, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V42, P411; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brown DD, 2013, ANIM BIOTELEM, V1, P20, DOI DOI 10.1186/2050-3385-1-20; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cain AT, 2003, BIOL CONSERV, V114, P189, DOI 10.1016/S0006-3207(03)00023-5; Caso A., 1994, THESIS; Connolly AR, 2009, THESIS; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Crawshaw Jr PG, 1995, THESIS U FLORIDA; Creel S, 2002, MONOGRAPHS BEHAV ECO; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Emmons L.H., 1989, P233; EMMONS LH, 1988, REV ECOL-TERRE VIE, V43, P133; Fuller A, 2016, CLIM CHANG RESP, V1, P3; Gause G. F., 1934, STRUGGLE EXISTENCE; Gonzalez CAL, 2003, ORYX, V37, P358, DOI 10.1017/S0030605303000620; Haines AM, 2006, BIOL CONSERV, V132, P424, DOI 10.1016/j.biocon.2006.04.035; Haines AM, 2005, BIOL CONSERV, V126, P512, DOI 10.1016/j.biocon.2005.06.032; Hall ER, 1976, P ANN C SE ASS FISH, V30, P427; HANSEN K., 2007, BOBCAT MASTER SURVIV; Harveson PM, 2004, WILDLIFE SOC B, V32, P948, DOI 10.2193/0091-7648(2004)032[0948:HUBOIS]2.0.CO;2; Horne JS, 2009, SOUTHWEST NAT, V54, P119, DOI 10.1894/PS-49.1; Huck M, 2017, MAMM BIOL, V82, P57, DOI 10.1016/j.mambio.2016.10.005; Kelly M, 2019, INFORM RES, V24; KITCHENER A., 1991, NATURAL HIST WILD CA; Kleiber M., 1975, FIRE LIFE INTRO ANIM; Kyba CCM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017307; Laack LL, 2015, ACTA THERIOL, V50, P505; Labisky RF, 1998, AM MIDL NAT, V139, P275, DOI 10.1674/0003-0031(1998)139[0275:BOBPOW]2.0.CO;2; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; LITVAITIS J A, 1981, Proceedings of the Oklahoma Academy of Science, V61, P81; LITVAITIS JA, 1986, J WILDLIFE MANAGE, V50, P110, DOI 10.2307/3801498; Lombardi JV, 2017, URBAN ECOSYST, V20, P1239, DOI 10.1007/s11252-017-0676-z; LONARD RI, 1985, SOUTHWEST NAT, V30, P397, DOI 10.2307/3671272; Luna-Soria H, 2005, ABUNDANCE FOOD HABIT, V36, P416; Macdonald D.W., 2004, CANIDS FOXES WOLVES; Marshall AD, 1966, P SE ASS GAME FISH C, V20, P206; McCord CM, 1982, WILD MAMMALS N AM; McNab BK, 2000, CAN J ZOOL, V78, P2227, DOI 10.1139/cjz-78-12-2227; Mitchell BD, 2005, AUSTRAL ECOL, V30, P581, DOI 10.1111/j.1442-9993.2005.01473.x; Monroy-Vilchis O, 2003, CIENCIAS NATURALES A, V9, P293; Navarro-Lopez D., 1985, THESIS; Nowell K, 1996, WILD CATS STATUS SUR; Oliveira TG., 2005, GUIA CAMPO FELINOS B; Perez-Irineo G, 2014, REV BIOL TROP, V62, P1421, DOI 10.15517/rbt.v62i4.12941; Pinheiro J, 2020, R PACKAGE VERSION 31; R Core Team, 2021, R LANGUAGE ENV STAT; Roberts NM, 2010, J FISH WILDL MANAG, V1, P169, DOI 10.3996/122009-JFWM-026; Rockhill AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069213; ROSENZWEIG ML, 1966, J MAMMAL, V47, P602, DOI 10.2307/1377891; Rowcliffe JM, 2014, METHODS ECOL EVOL, V5, P1170, DOI 10.1111/2041-210X.12278; SCHOENER TW, 1974, SCIENCE, V185, P27, DOI 10.1126/science.185.4145.27; Schwab RG, 1980, BOBCAT BIOL MOJAVE D; Shepard Emily L. C., 2010, Endangered Species Research, V10, P47, DOI 10.3354/esr00084; Shindle DB, 2000, J WILDLIFE DIS, V36, P546, DOI 10.7589/0090-3558-36.3.546; Shindle DB, 1998, SOUTHWEST NAT, V43, P273; Shinn KJ, 2002, THESIS; Stasey WC, 2012, THESIS; Sunquist M., 2002, WILD CATS WORLD, DOI [DOI 10.7208/CHICAGO/9780226518237.001.0001, 10.7208/chicago/9780226518237.001.0001]; Tannerfeldt M, 2002, OECOLOGIA, V132, P213, DOI 10.1007/s00442-002-0967-8; Tewes M.E., 1986, P147; TEWES ME, 2019, 37 ANN FAC LECT TEX; TEWES ME, 1986, THESIS; Zhang JD, 2017, ECOL EVOL, V7, P2575, DOI 10.1002/ece3.2873; Zhang JD, 2015, J MAMMAL, V96, P1116, DOI 10.1093/jmammal/gyv118	70	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231732	10.1371/journal.pone.0231732	http://dx.doi.org/10.1371/journal.pone.0231732			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324759	Green Published, gold			2022-12-26	WOS:000536033700032
J	Matsuda, S; Mafune, A; Kohda, N; Hama, T; Urashima, M				Matsuda, Shinichi; Mafune, Aki; Kohda, Nagisa; Hama, Takanori; Urashima, Mitsuyoshi			Associations among smoking, MGMT hypermethylation, TP53-mutations, and relapse in head and neck squamous cell carcinoma	PLOS ONE			English	Article							O-6-METHYLGUANINE-DNA METHYLTRANSFERASE EXPRESSION; PROMOTER HYPERMETHYLATION; DNA METHYLATION; TP53 MUTATIONS; NEVER-SMOKERS; LUNG-CANCER; GENE; INCREASE; REPAIR; SURVIVAL	Background Epigenetic silencing of the O-6-methylguanine-DNA methyltransferase (MGMT) DNA repair enzyme via promoter hypermethylation (hmMGMT) may increase mutations in the TP53 oncosuppressor gene and contribute to carcinogenesis. The effects of smoking, which is a risk factor for head and neck squamous cell carcinoma (HNSCC), were investigated to determine whether they up- or down-regulate hmMGMT. Additionally, the impact of hmMGMT and disruptive TP53-mutations on relapse was investigated in patients with HNSCC. Methods This study included 164 patients with HNSCC who were negative for both p16 protein expression and human papilloma virus infection. The association of smoking and hm MGMT was investigated using multiple logistic regression analysis. Competing risk regression was used to evaluate the effects of hmMGMT and TP53-mutations in exon 2 to 11 on relapse of HNSCC. Results hmMGMT was observed in 84% of the 164 patients. TP53-mutations, specifically, G:C>A: T transition, were more frequent in patients with hmMGMT (32%) than in those without hmMGMT (8%). The frequency of disruptive TP53-mutations was not significantly different between groups. Compared with nonsmoking, heavy smoking of 20 pack-years or more was significantly associated with decreased hmMGMT (adjusted odds ratio, 0.08; 95% CI, 0.01 to 0.56; P = 0.01). Patients who had both hmMGMT and disruptive TP53-mutations showed a significantly higher relapse rate than all other patients (subdistribution hazard ratio, 1.77; 95% CI, 1.07 to 2.92; P = 0.026). Conclusions It was found that hmMGMT was suppressed by heavy smoking, and hmMGMT combined with disruptive TP53-mutations may indicate a poor prognosis in patients with HNSCC.	[Matsuda, Shinichi; Mafune, Aki; Kohda, Nagisa; Hama, Takanori; Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan; [Matsuda, Shinichi] Chugai Pharmaceut Co Ltd, Real World Data Sci Dept, Tokyo, Japan; [Mafune, Aki] Jikei Univ, Sch Med, Dept Internal Med, Div Kidney & Hypertens, Tokyo, Japan; [Hama, Takanori] Jikei Univ, Sch Med, Dept Otorhinolaryngol, Tokyo, Japan	Jikei University; Chugai Pharmaceutical Co., Ltd.; Roche Holding; Jikei University; Jikei University	Urashima, M (corresponding author), Jikei Univ, Sch Med, Div Mol Epidemiol, Tokyo, Japan.	urashima@jikei.ac.jp	Mafune, Aki/AAL-2293-2021; Matsuda, Shinichi/U-2515-2019	Mafune, Aki/0000-0002-6160-2879; Matsuda, Shinichi/0000-0003-1822-1090	Ministry of Education, Culture, Sports, Science and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities the Ministry of Education, Science, Sports and Culture; Jikei University Research Fund	Ministry of Education, Culture, Sports, Science and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities the Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Jikei University Research Fund(Jikei University)	This research was supported by the Ministry of Education, Culture, Sports, Science and Technology in the Japan-Supported Program for the Strategic Research Foundation at Private Universities the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Scientific Research (C) and the Jikei University Research Fund. The funder provided support in the form of salaries for author SM, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Choudhury JH, 2015, J ORAL PATHOL MED, V44, P495, DOI 10.1111/jop.12249; Christmann M, 2012, MUTAT RES-FUND MOL M, V736, P64, DOI 10.1016/j.mrfmmm.2011.06.004; DRIN I, 1994, CARCINOGENESIS, V15, P1535, DOI 10.1093/carcin/15.8.1535; Esteller M, 2001, CANCER RES, V61, P4689; Esteller M, 1999, CANCER RES, V59, P793; Esteller M, 2003, LANCET ONCOL, V4, P351, DOI 10.1016/S1470-2045(03)01115-X; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fotopoulos G, 2015, ORAL ONCOL, V51, P119, DOI 10.1016/j.oraloncology.2014.10.018; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; International Agency for Research on Cancer, IARC TP53 DAT; Kamholz SL, 2004, MED CLIN N AM, V88, P1415, DOI 10.1016/j.mcna.2004.07.008; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liu Y, 2006, NEOPLASIA, V8, P46, DOI 10.1593/neo.05586; Masica DL, 2015, HUM GENET, V134, P497, DOI 10.1007/s00439-014-1470-0; Mattern J, 1998, CARCINOGENESIS, V19, P1247, DOI 10.1093/carcin/19.7.1247; Nagy E, 2014, BRIT J CANCER, V110, P2874, DOI 10.1038/bjc.2014.263; Nakamura M, PROMOTER METHYLATION; Neumann T, 2013, INT J ENV RES PUB HE, V10, P4186, DOI 10.3390/ijerph10094186; Nozoe T, 2002, CANCER LETT, V184, P49, DOI 10.1016/S0304-3835(02)00188-X; Paun BC, 2010, CANCER-AM CANCER SOC, V116, P4495, DOI 10.1002/cncr.25348; Pegg AE, 2000, MUTAT RES-REV MUTAT, V462, P83, DOI 10.1016/S1383-5742(00)00017-X; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Pulling LC, 2003, CANCER RES, V63, P4842; Puri SK, 2005, AM J OTOLARYNG, V26, P12, DOI 10.1016/j.amjoto.2004.06.007; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Russo AL, 2005, CLIN CANCER RES, V11, P2466, DOI 10.1158/1078-0432.CCR-04-1962; Scesnaite A, 2014, HEAD NECK-J SCI SPEC, V36, P1258, DOI 10.1002/hed.23445; Scesnaite A, 2012, MUTAGENESIS, V27, P423, DOI 10.1093/mutage/ger092; Suda T, 2012, BMC CANCER, V12, P1; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Urashima M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080828; Wang K, 2014, ASIAN PAC J CANCER P, V15, P10893, DOI 10.7314/APJCP.2014.15.24.10893; Watanabe T, 2005, INT J CANCER, V113, P581, DOI 10.1002/ijc.20625; Wu JY, 2008, ANN SURG ONCOL, V15, P3272, DOI 10.1245/s10434-008-0078-9; Zuo CL, 2004, CANCER EPIDEM BIOMAR, V13, P967	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231932	10.1371/journal.pone.0231932	http://dx.doi.org/10.1371/journal.pone.0231932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324779	Green Published, gold			2022-12-26	WOS:000536033700047
J	Nodari, R; Corbett, Y; Varotto-Boccazzi, I; Porretta, D; Taramelli, D; Epis, S; Bandi, C				Nodari, Riccardo; Corbett, Yolanda; Varotto-Boccazzi, Ilaria; Porretta, Daniele; Taramelli, Donatella; Epis, Sara; Bandi, Claudio			Effects of combined drug treatments on Plasmodium falciparum: In vitro assays with doxycycline, ivermectin and efflux pump inhibitors	PLOS ONE			English	Article							MALARIA PARASITE; CHLOROQUINE RESISTANCE; MULTIDRUG-RESISTANCE; REVERSAL; COMBINATION; VERAPAMIL; MOXIDECTIN; APICOPLAST; TRANSPORT; MOSQUITOS	There is great concern regarding the rapid emergence and spread of drug-resistance in Plasmodium falciparum, the parasite responsible for the most severe form of human malaria. Parasite populations resistant to some or all the currently available antimalarial treatments are present in different world regions. Considering the need for novel and integrated approaches to control malaria, combinations of drugs were tested on P. falciparum. The primary focus was on doxycycline, an antibiotic that specifically targets the apicoplast of the parasite. In combination with doxycycline, three different drugs known to inhibit efflux pumps (verapamil, elacridar and ivermectin) were tested, with the assumption that they could increase the intracellular concentration of the antibiotic and consequently its efficacy against P. falciparum. We emphasize that elacridar is a third-generation ABC transporters inhibitor, never tested before on malaria parasites. In vitro experiments were performed on asexual stages of two strains of P. falciparum, chloroquine-sensitive (D10) and chloroquine-resistant (W2). Incubation times on asynchronous or synchronous cultures were 72h or 96h, respectively. The antiplasmodial effect (i.e. the IC50) was determined by measuring the activity of the parasite lactate dehydrogenase, while the interaction between drugs was determined through combination index (CI) analyses. Elacridar achieved an IC50 concentration comparable to that of ivermectin, approx. 10-fold lower than that of verapamil, the other tested ABC transporter inhibitor. CI results showed synergistic effect of verapamil plus doxycycline, which is coherent with the starting hypothesis, i.e. that ABC transporters represent potential targets, worth of further investigations, towards the development of companion molecules useful to enhance the efficacy of antimalarial drugs. At the same time, the observed antagonistic effect of doxycycline in combination with ivermectin or elacridar highlighted the importance of drug testing, to avoid the de-facto generation of a sub-dosage, a condition that facilitates the development of drug resistance.	[Nodari, Riccardo; Corbett, Yolanda; Varotto-Boccazzi, Ilaria; Epis, Sara; Bandi, Claudio] Univ Milan, Dept Biosci, Milan, Italy; [Nodari, Riccardo; Corbett, Yolanda; Varotto-Boccazzi, Ilaria; Epis, Sara; Bandi, Claudio] Univ Milan, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy; [Nodari, Riccardo; Corbett, Yolanda; Varotto-Boccazzi, Ilaria; Taramelli, Donatella; Epis, Sara; Bandi, Claudio] Italian Malaria Network, Ctr Interuniv Ric Malaria, Milan, Italy; [Porretta, Daniele] Sapienza Univ Rome, Dept Environm Biol, Rome, Italy; [Taramelli, Donatella] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy	University of Milan; University of Milan; Sapienza University Rome; University of Milan	Bandi, C (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.; Bandi, C (corresponding author), Univ Milan, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy.; Bandi, C (corresponding author), Italian Malaria Network, Ctr Interuniv Ric Malaria, Milan, Italy.	claudio.bandi@unimi.it	Taramelli, Donatella/H-5768-2017; EPIS, SARA/B-7708-2017	Taramelli, Donatella/0000-0001-5108-4492; EPIS, SARA/0000-0001-8807-4802; Nodari, Riccardo/0000-0002-3485-2485	Fondazione Romeo ed Enrica Invernizzi; Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN 2015.4JRJPP_004]; Cariplo Foundation; Lombardy Region [2017-N.1656]	Fondazione Romeo ed Enrica Invernizzi; Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Cariplo Foundation(Fondazione Cariplo); Lombardy Region(Regione Lombardia)	Work supported by a grant by the Fondazione Romeo ed Enrica Invernizzi to CB, by a grant of the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN 2015.4JRJPP_004) to DT and by Cariplo Foundation and Lombardy Region to SE (2017-N.1656).	Alout H, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006499; [Anonymous], 2016, IV MAL TRANSM CONTR; Ashour DS, 2019, INT J ANTIMICROB AG, V54, P134, DOI 10.1016/j.ijantimicag.2019.05.003; Thu AM, 2017, FEBS J, V284, P2569, DOI 10.1111/febs.14127; Basore K, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00091; Bazzocchi C, 2008, INT J PARASITOL, V38, P1401, DOI 10.1016/j.ijpara.2008.03.002; Botte CY, 2012, CHEM REV, V112, P1269, DOI 10.1021/cr200258w; Bottova I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010062; Buss DS, 2002, MED VET ENTOMOL, V16, P218, DOI 10.1046/j.1365-2915.2002.00365.x; Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111; Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552; Chaccour C, 2010, J INFECT DIS, V202, P113, DOI 10.1086/653208; Chou TC, 2005, COMPUSYN DRUG COMBIN; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06; de Carvalho LP, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00085-19; El-Awady R., 2017, FRONT PHARMACOL, V7, P1, DOI DOI 10.3389/FPHAR.2016.00535; Fairhurst RM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0013-2016; Foy BD, 2019, LANCET, V393, P1517, DOI 10.1016/S0140-6736(18)32321-3; Haldar K, 2018, NAT REV MICROBIOL, V16, P156, DOI 10.1038/nrmicro.2017.161; Heckler RP, 2014, VET PARASITOL, V205, P638, DOI 10.1016/j.vetpar.2014.08.002; HYAFIL F, 1993, CANCER RES, V53, P4595; Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8; Kirk K, 2014, BIOCHEM J, V457, P1, DOI 10.1042/BJ20131007; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; MacRae JI, 2012, CURR PHARM DESIGN, V18, P3490; MAKLER MT, 1993, AM J TROP MED HYG, V48, P739, DOI 10.4269/ajtmh.1993.48.739; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; MARTINEY JA, 1995, J BIOL CHEM, V270, P22393, DOI 10.1074/jbc.270.38.22393; Menez C, 2016, ANTIMICROB AGENTS CH, V60, P4809, DOI 10.1128/AAC.00713-16; Molento MB, 2004, PARASITOL RES, V92, P121, DOI 10.1007/s00436-003-1022-3; Moore RB, 2008, NATURE, V451, P959, DOI 10.1038/nature06635; Mutabingwa TK, 2005, ACTA TROP, V95, P305, DOI 10.1016/j.actatropica.2005.06.009; Nasveld Peter, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P552; Ouedraogo AL, 2015, CLIN INFECT DIS, V60, P357, DOI 10.1093/cid/ciu797; Patouillard E, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000176; Pouliot JF, 1997, BIOCHEM PHARMACOL, V53, P17, DOI 10.1016/S0006-2952(96)00656-9; Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010; Sharma D, 2018, DRUG DISCOV TODAY, V23, P134, DOI 10.1016/j.drudis.2017.09.019; Talisuna AO, 2004, CLIN MICROBIOL REV, V17, P235, DOI 10.1128/CMR.17.1.235-254.2004; Tan KR, 2011, AM J TROP MED HYG, V84, P517, DOI 10.4269/ajtmh.2011.10-0285; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Traunecker HCL, 1999, BRIT J CANCER, V81, P942, DOI 10.1038/sj.bjc.6690791; van Schalkwyk DA, 2016, J INFECT DIS, V213, P800, DOI 10.1093/infdis/jiv509; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; WHO, 2019, WORLD MALARIA REPORT; World Health Organization, 2015, GUID TREATM MAL, Vthird; World Health Organization & African Programme for Onchocerciasis Control, 2010, REP EXT MID TERM EV; Zhang N, 2016, AM J CANCER RES, V6, P97	50	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232171	10.1371/journal.pone.0232171	http://dx.doi.org/10.1371/journal.pone.0232171			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324826	Green Published, gold			2022-12-26	WOS:000536033700087
J	Varin, J; Reynolds, MM; Bouzidi, N; Tick, S; Wohlschlegel, J; Becquart, O; Michiels, C; Dereure, O; Duvoisin, RM; Morgans, CW; Sahel, JA; Samaran, Q; Guillot, B; Pulido, JS; Audo, I; Zeitz, C				Varin, Juliette; Reynolds, Margaret M.; Bouzidi, Nassima; Tick, Sarah; Wohlschlegel, Juliette; Becquart, Ondine; Michiels, Christelle; Dereure, Olivier; Duvoisin, Robert M.; Morgans, Catherine W.; Sahel, Jose-Alain; Samaran, Quentin; Guillot, Bernard; Pulido, Jose S.; Audo, Isabelle; Zeitz, Christina			Identification and characterization of novel TRPM1 autoantibodies from serum of patients with melanoma-associated retinopathy	PLOS ONE			English	Article							STATIONARY NIGHT BLINDNESS; PARANEOPLASTIC RETINOPATHY; MUTATIONS; GENE; ANTIBODIES; ERG; ELECTRORETINOGRAM; GPR179; TUMOR; CAR	Melanoma-associated retinopathy (MAR) is a rare paraneoplastic retinal disorder usually occurring in the context of metastatic melanoma. Patients present with night blindness, photopsias and a constriction of the visual field. MAR is an auto-immune disorder characterized by the production of autoantibodies targeting retinal proteins, especially autoantibodies reacting to the cation channel TRPM1 produced in melanocytes and ON-bipolar cells. TRPM1 has at least three different isoforms which vary in the N-terminal region of the protein. In this study, we report the case of three new MAR patients presenting different anti-TRPM1 autoantibodies reacting to the three isoforms of TRPM1 with variable binding affinity. Two sera recognized all isoforms of TRPM1, while one recognized only the two longest isoforms upon immunolocalization studies on overexpressing cells. Similarly, the former two sera reacted with all TRPM1 isoforms on western blot, but an immunoprecipitation enrichment step was necessary to detect all isoforms with the latter serum. In contrast, all sera labelled ON-bipolar cells on Tprm1(+/+) but not on Trpm1(-/-) mouse retina as shown by coimmunolocalization. This confirms that the MAR sera specifically detect TRPM1. Most likely, the anti-TRPM1 autoantibodies of different patients vary in affinity and concentration. In addition, the binding of autoantibodies to TRPM1 may be conformation-dependent, with epitopes being inaccessible in some constructs (truncated polypeptides versus full-length TRPM1) or applications (western blotting versus immunohistochemistry). Therefore, we propose that a combination of different methods should be used to test for the presence of anti-TRPM1 autoantibodies in the sera of MAR patients.	[Varin, Juliette; Bouzidi, Nassima; Wohlschlegel, Juliette; Michiels, Christelle; Sahel, Jose-Alain; Audo, Isabelle; Zeitz, Christina] Sorbonne Univ, INSERM, CNRS, Inst Vis, Paris, France; [Reynolds, Margaret M.] Washington Univ, Dept Ophthalmol, St Louis, MO 63110 USA; [Tick, Sarah; Sahel, Jose-Alain; Audo, Isabelle] DHU Sight Restore, CHNO Quinze Vingts, INSERM DGOS CIC 1423, Paris, France; [Becquart, Ondine; Dereure, Olivier; Samaran, Quentin; Guillot, Bernard] Univ Montpellier, Dept Dermatol, Montpellier, France; [Becquart, Ondine; Dereure, Olivier; Samaran, Quentin; Guillot, Bernard] Univ Montpellier, INSERM Pathogenesis & Control Chron Infect U1058, Montpellier, France; [Duvoisin, Robert M.; Morgans, Catherine W.] Oregon Hlth & Sci Univ, Dept Chem Physiol & Biochem, Portland, OR 97201 USA; [Sahel, Jose-Alain] Fdn Ophtalmol Adolphe Rothschild, Paris, France; [Sahel, Jose-Alain] Acad Sci, Inst France, Paris, France; [Sahel, Jose-Alain] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA USA; [Pulido, Jose S.] Mayo Clin, Dept Ophthalmol, Rochester, MN USA; [Pulido, Jose S.] Mayo Clin, Dept Mol Med, Rochester, MN USA; [Audo, Isabelle] UCL, Inst Ophthalmol, London, England	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Washington University (WUSTL); CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite; Universite de Montpellier; Universite de Montpellier; Oregon Health & Science University; Fondation Adolphe de Rothschild; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Mayo Clinic; University of London; University College London	Zeitz, C (corresponding author), Sorbonne Univ, INSERM, CNRS, Inst Vis, Paris, France.	christina.zeitz@inserm.fr	Zeitz, Christina/F-2757-2017	Zeitz, Christina/0000-0002-3510-1712; Samaran, Quentin/0000-0002-0560-5493; WOHLSCHLEGEL, Juliette/0000-0003-4317-9066; Reynolds, Margaret/0000-0002-2588-5517	Retina France; French Muscular Dystrophy Association (AFM-Telethon); UNADEV-Aviesan call 2015; Fondation Voir et Entendre; Prix Dalloz for "La recherche en ophtalmologie"; Ville de Paris; Region Ile de France; French state funds by the Agence Nationale de la Recherche within the Investissements d'Avenir program [ANR-11-IDEX-0004-0, ANR-10LABX-65]; Ministere de l'Enseignement Superieur et de la Recherche	Retina France; French Muscular Dystrophy Association (AFM-Telethon); UNADEV-Aviesan call 2015; Fondation Voir et Entendre; Prix Dalloz for "La recherche en ophtalmologie"; Ville de Paris; Region Ile de France(Region Ile-de-France); French state funds by the Agence Nationale de la Recherche within the Investissements d'Avenir program(French National Research Agency (ANR)); Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research Council)	CZ:Retina France CZ:French Muscular Dystrophy Association (AFM-Telethon) CZ: UNADEV-Aviesan call 2015 CZ:Fondation Voir et Entendre CZ:Prix Dalloz for "La recherche en ophtalmologie" CZ,IA:Ville de Paris and Region Ile de France, LABEX LIFESENSES (reference ANR-10LABX-65) supported by French state funds, managed by the Agence Nationale de la Recherche within the Investissements d'Avenir program (ANR-11-IDEX-0004-0) JV:Ministere de l'Enseignement Superieur et de la Recherche.	Adamus Grazyna, 2004, BMC Ophthalmol, V4, P5, DOI 10.1186/1471-2415-4-5; Adamus G, 2009, J AUTOIMMUN, V32, P133, DOI 10.1016/j.jaut.2009.02.001; ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Anastasakis A, 2011, DOC OPHTHALMOL, V123, P59, DOI 10.1007/s10633-011-9277-y; Audo I, 2012, AM J HUM GENET, V90, P321, DOI 10.1016/j.ajhg.2011.12.007; Audo I, 2010, ARCH OPHTHALMOL-CHIC, V128, P1036, DOI 10.1001/archophthalmol.2010.162; Audo I, 2009, AM J HUM GENET, V85, P720, DOI 10.1016/j.ajhg.2009.10.013; Bech-Hansen NT, 2000, NAT GENET, V26, P319, DOI 10.1038/81619; BERSON EL, 1988, AM J OPHTHALMOL, V106, P307, DOI 10.1016/0002-9394(88)90366-2; Boeck K, 1997, BRIT J DERMATOL, V137, P457, DOI 10.1111/j.1365-2133.1997.tb03759.x; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Canamary Aristofanes Mendonca Jr, 2018, Int J Retina Vitreous, V4, P1, DOI 10.1186/s40942-017-0104-9; Cao Y, 2011, J NEUROSCI, V31, P11521, DOI 10.1523/JNEUROSCI.1682-11.2011; Chan JW, 2003, SURV OPHTHALMOL, V48, P12, DOI 10.1016/S0039-6257(02)00416-2; Dalal MD, 2013, OPHTHALMOLOGY, V120, P2560, DOI 10.1016/j.ophtha.2013.07.037; Devi S, 2009, AM J PHYSIOL-CELL PH, V297, pC679, DOI 10.1152/ajpcell.00092.2009; Dhingra A, 2011, J NEUROSCI, V31, P3962, DOI 10.1523/JNEUROSCI.6007-10.2011; Dryja TP, 2005, P NATL ACAD SCI USA, V102, P4884, DOI 10.1073/pnas.0501233102; Duvoisin RM, 2019, INVEST OPHTH VIS SCI, V60, P2330, DOI 10.1167/iovs.19-26775; Duvoisin R, 2017, INVEST OPHTH VIS SCI, V58, P2732, DOI 10.1167/iovs.17-21443; Enninga EAL, 2017, CANCER MED-US, V6, P2203, DOI 10.1002/cam4.1152; Fang D, 2000, BIOCHEM BIOPH RES CO, V279, P53, DOI 10.1006/bbrc.2000.3894; Goetgebuer G, 2008, DOC OPHTHALMOL, V116, P49, DOI 10.1007/s10633-007-9074-9; Grewal DS, 2014, RETINA-J RET VIT DIS, V34, P827, DOI 10.1097/IAE.0000000000000119; Keltner JL, 2001, J NEURO-OPHTHALMOL, V21, P173, DOI 10.1097/00041327-200109000-00004; Koike C, 2010, CELL CALCIUM, V48, P95, DOI 10.1016/j.ceca.2010.08.004; Kondo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019911; Lei B, 2000, INVEST OPHTH VIS SCI, V41, P262; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Li Z, 2009, AM J HUM GENET, V85, P711, DOI 10.1016/j.ajhg.2009.10.003; Lu Y, 2009, ARCH OPHTHALMOL-CHIC, V127, P1572, DOI 10.1001/archophthalmol.2009.311; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; McCulloch DL, 2015, DOC OPHTHALMOL, V130, P1, DOI 10.1007/s10633-014-9473-7; MIYAKE Y, 1986, ARCH OPHTHALMOL-CHIC, V104, P1013, DOI 10.1001/archopht.1986.01050190071042; Morgans CW, 2009, P NATL ACAD SCI USA, V106, P19174, DOI 10.1073/pnas.0908711106; Morita Y, 2014, JPN J OPHTHALMOL, V58, P166, DOI 10.1007/s10384-013-0300-6; Murayama Koichiro, 2006, Nippon Ganka Gakkai Zasshi, V110, P211; Nishiguchi KM, 2018, CLIN EXP OPHTHALMOL, V46, P1087, DOI 10.1111/ceo.13341; Oancea E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000146; Peachey NS, 2012, AM J HUM GENET, V90, P331, DOI 10.1016/j.ajhg.2011.12.006; POLANS AS, 1995, P NATL ACAD SCI USA, V92, P9176, DOI 10.1073/pnas.92.20.9176; Pusch CM, 2000, NAT GENET, V26, P324, DOI 10.1038/81627; Rahimy E, 2013, SURV OPHTHALMOL, V58, P430, DOI 10.1016/j.survophthal.2012.09.001; REMULLA JFC, 1995, ARCH OPHTHALMOL-CHIC, V113, P854, DOI 10.1001/archopht.1995.01100070024015; Roberts P, 2016, JAMA OPHTHALMOL, V134, P1184, DOI 10.1001/jamaophthalmol.2016.2944; Robsahm TE, 2013, MELANOMA RES, V23, P70, DOI 10.1097/CMR.0b013e32835c7e48; Roels D, 2017, DOC OPHTHALMOL, V135, P233, DOI 10.1007/s10633-017-9605-y; SCHUBERT G, 1952, OPHTHALMOLOGICA, V123, P396, DOI 10.1159/000301211; THIRKILL CE, 1989, NEW ENGL J MED, V321, P1589, DOI 10.1056/NEJM198912073212307; THIRKILL CE, 1987, ARCH OPHTHALMOL-CHIC, V105, P372; Touhami S, 2019, PROG RETIN EYE RES, V72, DOI 10.1016/j.preteyeres.2019.05.002; Ueno S, 2015, DOC OPHTHALMOL, V130, P71, DOI 10.1007/s10633-014-9470-x; Ueno S, 2014, CLIN OPHTHALMOL, V8, P369, DOI 10.2147/OPTH.S55124; Ueno S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081507; Utomo S, 2018, TREE GENET GENOMES, V14, DOI 10.1007/s11295-018-1261-1; van Genderen MM, 2009, AM J HUM GENET, V85, P730, DOI 10.1016/j.ajhg.2009.10.012; Wang YJ, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-56; Xiong WH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069506; Zeitz C, 2005, INVEST OPHTH VIS SCI, V46, P4328, DOI 10.1167/iovs.05-0526; Zeitz C, 2015, PROG RETIN EYE RES, V45, P58, DOI 10.1016/j.preteyeres.2014.09.001; Zeitz C, 2013, AM J HUM GENET, V92, P67, DOI 10.1016/j.ajhg.2012.10.023; Zhiqi S, 2004, MELANOMA RES, V14, P509, DOI 10.1097/00008390-200412000-00011	62	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231750	10.1371/journal.pone.0231750	http://dx.doi.org/10.1371/journal.pone.0231750			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324760	Green Published, gold			2022-12-26	WOS:000536033700034
J	Beach, TG; Adler, CH; Zhang, N; Serrano, GE; Sue, LI; Driver-Dunckley, E; Mehta, SH; Zamrini, EE; Sabbagh, MN; Shill, HA; Belden, CM; Shprecher, DR; Caselli, RJ; Reiman, EM; Davis, KJ; Long, KE; Nicholson, LR; Intorcia, AJ; Glass, MJ; Walker, JE; Callan, MM; Oliver, JC; Arce, R; Gerkin, RC				Beach, Thomas G.; Adler, Charles H.; Zhang, Nan; Serrano, Geidy E.; Sue, Lucia, I; Driver-Dunckley, Erika; Mehta, Shayamal H.; Zamrini, Edouard E.; Sabbagh, Marwan N.; Shill, Holly A.; Belden, Christine M.; Shprecher, David R.; Caselli, Richard J.; Reiman, Eric M.; Davis, Kathryn J.; Long, Kathy E.; Nicholson, Lisa R.; Intorcia, Anthony J.; Glass, Michael J.; Walker, Jessica E.; Callan, Michael M.; Oliver, Javon C.; Arce, Richard; Gerkin, Richard C.			Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer's disease dementia	PLOS ONE			English	Article							GLAND NEEDLE-BIOPSY; PARKINSONS-DISEASE; OLFACTORY FUNCTION; ALPHA-SYNUCLEIN; COGNITIVE IMPAIRMENT; BODY DISEASE; DOPAMINE TRANSPORTER; AMYLOID-BETA; DIAGNOSIS; BRAIN	Many subjects with neuropathologically-confirmed dementia with Lewy bodies (DLB) are never diagnosed during life, instead being categorized as Alzheimer's disease dementia (ADD) or unspecified dementia. Unrecognized DLB therefore is a critical impediment to clinical studies and treatment trials of both ADD and DLB. There are studies that suggest that olfactory function tests may be able to distinguish DLB from ADD, but few of these had neuropathological confirmation of diagnosis. We compared University of Pennsylvania Smell Identification Test (UPSIT) results in 257 subjects that went on to autopsy and neuropathological examination. Consensus clinicopathological diagnostic criteria were used to define ADD and DLB, as well as Parkinson's disease with dementia (PDD), with (PDD+AD) or without (PDD-AD) concurrent AD; a group with ADD and Lewy body disease (LBD) not meeting criteria for DLB (ADLB) and a clinically normal control group were also included. The subjects with DLB, PDD+AD and PDD-AD all had lower (one-way ANOVA p < 0.0001, pairwise Bonferroni p < 0.05) first and mean UPSIT scores than the ADD, ADLB or control groups. For DLB subjects with first and mean UPSIT scores less than 20 and 17, respectively, Firth logistic regression analysis, adjusted for age, gender and mean MMSE score, conferred statistically significant odds ratios of 17.5 and 18.0 for the diagnosis, vs ADD. For other group comparisons (PDD+AD and PDD-AD vs ADD) and UPSIT cutoffs of 17, the same analyses resulted in odds ratios ranging from 16.3 to 31.6 (p < 0.0001). To our knowledge, this is the largest study to date comparing olfactory function in subjects with neuropathologically-confirmed LBD and ADD. Olfactory function testing may be a convenient and inexpensive strategy for enriching dementia studies or clinical trials with DLB subjects, or conversely, reducing the inclusion of DLB subjects in ADD studies or trials.	[Beach, Thomas G.; Serrano, Geidy E.; Sue, Lucia, I; Zamrini, Edouard E.; Belden, Christine M.; Shprecher, David R.; Davis, Kathryn J.; Long, Kathy E.; Nicholson, Lisa R.; Intorcia, Anthony J.; Glass, Michael J.; Walker, Jessica E.; Callan, Michael M.; Oliver, Javon C.; Arce, Richard] Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA; [Adler, Charles H.; Driver-Dunckley, Erika; Mehta, Shayamal H.; Caselli, Richard J.] Mayo Clin, Dept Neurol, Scottsdale, AZ USA; [Zhang, Nan] Mayo Clin, Dept Biostat, Scottsdale, AZ USA; [Sabbagh, Marwan N.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA; [Shill, Holly A.] Barrow Neurol Inst, Phoenix, AZ 85013 USA; [Reiman, Eric M.] Banner Alzheimers Inst, Phoenix, AZ USA; [Gerkin, Richard C.] Arizona State Univ, Sch Life Sci, Tempe, AZ USA	Banner Research; Banner Health; Banner Sun Health Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Cleveland Clinic Foundation; Barrow Neurological Institute; Banner Research; Banner Health; Banner Alzheimer's Institute; Arizona State University; Arizona State University-Tempe	Beach, TG (corresponding author), Banner Sun Hlth Res Inst, Sun City, AZ 85351 USA.	Thomas.Beach@bannerhealth.com	Zhang, Nan/GXH-0361-2022; Adler, Charles/ABD-5276-2021	Shprecher, David/0000-0002-4217-0097; Serrano, Geidy/0000-0002-9527-2011	US National Institutes of Health [U24 NS072026, P30 AG19610]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	TGB received funding for this work from the US National Institutes of Health (U24 NS072026 and P30 AG19610). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler CH, 1998, MOVEMENT DISORD, V13, P563, DOI 10.1002/mds.870130332; Adler CH, 2016, MOVEMENT DISORD, V31, P250, DOI 10.1002/mds.26476; Adler CH, 2014, NEUROLOGY, V82, P858, DOI 10.1212/WNL.0000000000000204; Adler CH, 2011, PARKINSONISM RELAT D, V17, P456, DOI 10.1016/j.parkreldis.2011.03.007; Akhtar RS, 2016, MOV DISORD CLIN PRAC, V3, P367, DOI 10.1002/mdc3.12290; Albin RL, 2015, ANN NEUROL, V78, P824, DOI 10.1002/ana.24481; [Anonymous], 1997, NEUROBIOL AGING, V18, pS1; Arvanitakis Z, 2011, STROKE, V42, P722, DOI 10.1161/STROKEAHA.110.595082; Attems J, 2014, ACTA NEUROPATHOL, V127, P459, DOI 10.1007/s00401-014-1261-7; Barker WW, 2002, ALZ DIS ASSOC DIS, V16, P203, DOI 10.1097/00002093-200210000-00001; Beach TG, 2004, J NEUROPATH EXP NEUR, V63, P329, DOI 10.1093/jnen/63.4.329; Beach TG, 2015, NEUROPATHOLOGY; Beach TG, 2016, J PARKINSON DIS, V6, P153, DOI 10.3233/JPD-150680; Beach TG, 2015, NEUROPATHOLOGY, V35, P354, DOI 10.1111/neup.12189; Beach TG, 2013, J NEUROPATH EXP NEUR, V72, P130, DOI 10.1097/NEN.0b013e3182805c72; Beach TG, 2009, ACTA NEUROPATHOL, V117, P169, DOI 10.1007/s00401-008-0450-7; Beach TG, 2008, ACTA NEUROPATHOL, V115, P445, DOI 10.1007/s00401-007-0313-7; Beavan M, 2015, JAMA NEUROL, V72, P201, DOI 10.1001/jamaneurol.2014.2950; Bennett DA, 2006, NEUROLOGY, V66, P1837, DOI 10.1212/01.wnl.0000219668.47116.e6; Bertrand E, 2004, FOLIA NEUROPATHOL, V42, P141; Boeve BF, 2013, SLEEP MED, V14, P754, DOI 10.1016/j.sleep.2012.10.015; Boeve BF, 2013, J CLIN SLEEP MED, V9, P471, DOI 10.5664/jcsm.2670; Bovi T, 2010, J NEUROL, V257, P1882, DOI 10.1007/s00415-010-5631-3; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Brenowitz WD, 2017, ALZHEIMERS DEMENT, V13, P654, DOI 10.1016/j.jalz.2016.09.015; Brenowitz WD, 2017, NEUROBIOL AGING, V53, P83, DOI 10.1016/j.neurobiolaging.2017.01.017; Burack MA, 2010, NEUROLOGY, V74, P77, DOI 10.1212/WNL.0b013e3181c7da8e; Caselli RJ, 2017, MAYO CLIN PROC, V92, P978, DOI 10.1016/j.mayocp.2017.02.011; Catafau AM, 2017, CURR ALZHEIMER RES, V14, P169, DOI 10.2174/1567205013666160620111408; Colloby SJ, 2012, BRAIN, V135, P2798, DOI 10.1093/brain/aws211; Compta Y, 2011, BRAIN, V134, P1493, DOI 10.1093/brain/awr031; DelleDonne A, 2008, ARCH NEUROL-CHICAGO, V65, P1074, DOI 10.1001/archneur.65.8.1074; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Deramecourt V, 2006, J NEUROPATH EXP NEUR, V65, P278, DOI 10.1097/01.jnen.0000205145.54457.ea; Dickson DW, 2008, ACTA NEUROPATHOL, V115, P437, DOI 10.1007/s00401-008-0345-7; Doty R L, 1991, Geriatrics, V46 Suppl 1, P47; DOTY RL, 1993, NEUROLOGY, V43, P962, DOI 10.1212/WNL.43.5.962; Driver-Dunckley E, 2014, PARKINSONISM RELAT D; Driver-Dunckley E, 2014, PARKINSONISM RELAT D, V20, P1260, DOI 10.1016/j.parkreldis.2014.08.006; Dugger BN, 2014, J NEUROPATH EXP NEUR, V73, P72, DOI 10.1097/NEN.0000000000000028; Elobeid A, 2015, J NEUROPATH EXP NEUR, V74, P470, DOI 10.1097/NEN.0000000000000191; Eusebi P, 2017, MOVEMENT DISORD, V32, P1389, DOI 10.1002/mds.27110; Fantini ML, 2006, BRAIN RES BULL, V70, P386, DOI 10.1016/j.brainresbull.2006.07.008; Ferman TJ, 2018, ALZHEIMERS DEMENT, V14, P330, DOI 10.1016/j.jalz.2017.09.014; Georgiopoulos C, 2015, J NEUROL, V262, P2154, DOI 10.1007/s00415-015-7830-4; Gerkin RC, 2017, ANN CLIN TRANSL NEUR, V4, P714, DOI 10.1002/acn3.447; Graff-Radford J, 2017, JAMA NEUROL, V74, P308, DOI 10.1001/jamaneurol.2016.4926; Gutflais E, 2019, NEUROLOGY, V92; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Hely MA, 2008, MOVEMENT DISORD, V23, P837, DOI 10.1002/mds.21956; Hubbard PS, 2007, J ANAT, V211, P117, DOI 10.1111/j.1469-7580.2007.00748.x; Hurtig HI, 2000, NEUROLOGY, V54, P1916, DOI 10.1212/WNL.54.10.1916; Iacono D, 2015, NEUROLOGY, V85, P1670, DOI 10.1212/WNL.0000000000002102; Iranzo A, 2013, PARKINSONISM RELAT D, V19, P600, DOI 10.1016/j.parkreldis.2013.02.009; Irwin DJ, 2012, ANN NEUROL, V72, P587, DOI 10.1002/ana.23659; JELLINGER KA, 2020, J NEURAL TRANSM; Jellinger Kurt A., 2009, V24, P114, DOI 10.1159/000197890; Josephs KA, 2017, LANCET NEUROL, V16, P917, DOI 10.1016/S1474-4422(17)30284-3; Josephs KA, 2014, ACTA NEUROPATHOL, V127, P441, DOI 10.1007/s00401-013-1211-9; Katzenschlager R, 2004, CURR OPIN NEUROL, V17, P417, DOI 10.1097/01.wco.0000137531.76491.c2; Kawas CH, 2015, NEUROLOGY, V85, P535, DOI 10.1212/WNL.0000000000001831; King A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-53; Kovari E, 2003, ACTA NEUROPATHOL, V106, P83, DOI 10.1007/s00401-003-0705-2; Kraemmer J, 2014, MOVEMENT DISORD, V29, P1767, DOI 10.1002/mds.25975; Kramberger MG, 2017, J ALZHEIMERS DIS, V57, P787, DOI 10.3233/JAD-161109; Kraybill ML, 2005, NEUROLOGY, V64, P2069, DOI 10.1212/01.WNL.0000165987.89198.65; Krismer F, 2017, PARKINSONISM RELAT D, V35, P36, DOI 10.1016/j.parkreldis.2016.11.010; Lebouvier T, 2013, REV NEUROL-FRANCE, V169, P844, DOI 10.1016/j.neurol.2013.05.004; Lee JM, 2017, J NEUROPATHOL EXP NE; Malek-Ahmadi M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217566; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; McCleery J, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010633.pub2; McKeith I, 2016, J GERIATR PSYCH NEUR, V29, P249, DOI 10.1177/0891988716656083; McKeith IG, 2017, NEUROLOGY, V89, P88, DOI 10.1212/WNL.0000000000004058; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKinnon JH, 2007, NEUROLOGIST, V13, P382, DOI 10.1097/NRL.0b013e31815a351a; McShane RH, 2001, J NEUROL NEUROSUR PS, V70, P739, DOI 10.1136/jnnp.70.6.739; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; Miyamoto T, 2010, SLEEP MED, V11, P458, DOI 10.1016/j.sleep.2009.09.013; Moscovich M, 2012, J NEUROL NEUROSUR PS, V83, P970, DOI 10.1136/jnnp-2012-302770; Nag S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0531-3; Negash S, 2011, CURR ALZHEIMER RES, V8, P336, DOI 10.2174/156720511795745302; Nelson PT, 2010, J NEUROL, V257, P359, DOI 10.1007/s00415-009-5324-y; Nelson PT, 2010, BRAIN PATHOL, V20, P66, DOI 10.1111/j.1750-3639.2008.00244.x; Olichney JM, 2005, J NEUROL NEUROSUR PS, V76, P1342, DOI 10.1136/jnnp.2003.032003; Olichney JM, 1998, NEUROLOGY, V51, P351, DOI 10.1212/WNL.51.2.351; Orimo S, 2016, AGEING RES REV, V30, P122, DOI 10.1016/j.arr.2016.01.001; Pak K, 2018, EUR RADIOL, V28, P1756, DOI 10.1007/s00330-017-5147-7; Patin A, 2015, NEUROPSYCHOLOGIA, V78, P171, DOI 10.1016/j.neuropsychologia.2015.10.009; Postuma RB, 2019, BRAIN, V142, P744, DOI 10.1093/brain/awz030; Rahayel S, 2012, BEHAV BRAIN RES, V231, P60, DOI 10.1016/j.bbr.2012.02.047; Ross GW, 2006, MOVEMENT DISORD, V21, P2062, DOI 10.1002/mds.21076; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P295, DOI 10.1097/WAD.0b013e31819c5ef4; Schneider JA, 2007, NEUROLOGY, V69, P2197, DOI 10.1212/01.wnl.0000271090.28148.24; Serrano GE, 2015, J NEUROPATH EXP NEUR, V74, P934, DOI 10.1097/NEN.0000000000000235; Serrano GE, 2014, J ALZHEIMERS DIS, V42, P813, DOI 10.3233/JAD-140162; Shah M, 2008, PARKINSONISM RELAT D, V14, P563, DOI 10.1016/j.parkreldis.2007.12.006; Shprecher DR, 2018, PARKINSONISM RELAT D; Siderowf A, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-79; Simonsen AH, 2016, BIOMARK MED, V10, P19, DOI 10.2217/BMM.14.105; Smith VD, 2018, BRAIN PATHOL, V28, P264, DOI 10.1111/bpa.12505; Sonnen JA, 2007, ANN NEUROL, V62, P406, DOI 10.1002/ana.21208; Sonnen JA, 2011, ARCH NEUROL-CHICAGO, V68, P1049, DOI 10.1001/archneurol.2011.157; STERN MB, 1994, NEUROLOGY, V44, P266, DOI 10.1212/WNL.44.2.266; Tsuang DW, 2006, J ALZHEIMERS DIS, V9, P235; Turner BN, 2014, RAPID PROTOTYPING J, V20, P192, DOI 10.1108/RPJ-01-2013-0012; Uchikado H, 2006, J NEUROPATH EXP NEUR, V65, P685, DOI 10.1097/01.jnen.0000225908.90052.07; Venneti S, 2011, ACTA NEUROPATHOL, V122, P737, DOI 10.1007/s00401-011-0880-5; Walker Z, 2007, J NEUROL NEUROSUR PS, V78, P1176, DOI 10.1136/jnnp.2006.110122; WENNING GK, 1995, ACTA NEUROL SCAND, V91, P247, DOI 10.1111/j.1600-0404.1995.tb06998.x; Westervelt HJ, 2016, NEUROPSYCHOLOGY, V30, P304, DOI 10.1037/neu0000230; Westervelt Holly James, 2003, Cogn Behav Neurol, V16, P93, DOI 10.1097/00146965-200306000-00002; White LR, 2016, NEUROLOGY, V86, P1000, DOI 10.1212/WNL.0000000000002480; Williams SS, 2009, J NEUROL NEUROSUR PS, V80, P667, DOI 10.1136/jnnp.2008.155895; Wilson RS, 2016, NEUROPSYCHOLOGY, V30, P591, DOI 10.1037/neu0000282; Wilson RS, 2011, CHEM SENSES, V36, P367, DOI 10.1093/chemse/bjq139; Wong KK, 2010, NEUROSCI LETT, V484, P163, DOI 10.1016/j.neulet.2010.08.037; Yoo HS, 2018, ALZHEIMERS DEMENT, V14, P1243, DOI 10.1016/j.jalz.2018.05.010; Yoon JH, 2015, J NEUROL SCI, V355, P174, DOI 10.1016/j.jns.2015.06.013; Zaccai J, 2008, NEUROLOGY, V70, P1042, DOI 10.1212/01.wnl.0000306697.48738.b6	121	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231720	10.1371/journal.pone.0231720	http://dx.doi.org/10.1371/journal.pone.0231720			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LL9AT	32320406	Green Published, Green Submitted, gold			2022-12-26	WOS:000531845800001
J	Hazarika, DJ; Gautom, T; Parveen, A; Goswami, G; Barooah, M; Modi, MK; Boro, RC				Hazarika, Dibya Jyoti; Gautom, Trishnamoni; Parveen, Assma; Goswami, Gunajit; Barooah, Madhumita; Modi, Mahendra Kumar; Boro, Robin Chandra			Mechanism of interaction of an endofungal bacterium Serratia marcescens D1 with its host and non-host fungi	PLOS ONE			English	Article							ENDOSYMBIOTIC BACTERIA; INTERACTIONS ECOLOGY; PRODIGIOSIN; ENDOPHYTES; SECRETION; FOOD; DNA	Association of bacteria with fungi is a major area of research in infection biology, however, very few strains of bacteria have been reported that can invade and reside within fungal hyphae. Here, we report the characterization of an endofungal bacterium Serratia marcescens D1 from Mucor irregularis SS7 hyphae. Upon re-inoculation, colonization of the endobacterium S. marcescens D1 in the hyphae of Mucor irregularis SS7 was demonstrated using stereo microscopy. However, S. marcescens D1 failed to invade into the hyphae of the tested Ascomycetes (except Fusarium oxysporum) and Basidiomycetes. Remarkably, Serratia marcescens D1 could invade and spread over the culture of F. oxysporum that resulted in mycelial death. Prodigiosin, the red pigment produced by the Serratia marcescens D1, helps the bacterium to invade fungal hyphae as revealed by the increasing permeability in fungal cell membrane. On the other hand, genes encoding the type VI secretion system (T6SS) assembly protein TssJ and an outer membrane associated murein lipoprotein also showed significant up-regulation during the interaction process, suggesting the involvement of T6SS in the invasion process.	[Hazarika, Dibya Jyoti; Gautom, Trishnamoni; Parveen, Assma; Barooah, Madhumita; Modi, Mahendra Kumar; Boro, Robin Chandra] Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India; [Goswami, Gunajit] Assam Agr Univ, DBT North East Ctr Agr Biotechnol, Jorhat, Assam, India	Assam Agricultural University; Assam Agricultural University	Boro, RC (corresponding author), Assam Agr Univ, Dept Agr Biotechnol, Jorhat, Assam, India.	robinboro@gmail.com	Hazarika, Dibya Jyoti/AAS-9800-2021; Boro, Robin Chandra/AAX-3263-2020; Gautom, Trishnamoni/AAX-9967-2020	Boro, Robin Chandra/0000-0002-0866-3357; Gautom, Trishnamoni/0000-0001-7602-1228; Barooah, Madhumita/0000-0002-3768-5336; Parveen, Assma/0000-0002-9745-4118; Hazarika, Dibya Jyoti/0000-0001-6370-4230; Goswami, Gunajit/0000-0003-2724-7217	Department of Biotechnology, Ministry of Science and Technology, Government of India [BT/552/NE/U-Excel/2014]	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This work was supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India under the Project sanction number BT/552/NE/U-Excel/2014 to RCB, but without any influence over the experimental procedures and the results. http://dbtindia.gov.in/The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTNICKIGARCIA S, 1962, BIOCHIM BIOPHYS ACTA, V58, P102, DOI 10.1016/0006-3002(62)90822-3; Braga RM, 2016, BRAZ J MICROBIOL, V47, P86, DOI 10.1016/j.bjm.2016.10.005; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Deveau A, 2018, FEMS MICROBIOL REV, V42, P335, DOI 10.1093/femsre/fuy008; Devi K. A., 2016, Hayati Journal of Biosciences, V23, P173, DOI 10.1016/j.hjb.2016.12.006; Dyall SD, 2004, SCIENCE, V304, P253, DOI 10.1126/science.1094884; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Frey-Klett P, 2011, MICROBIOL MOL BIOL R, V75, P583, DOI 10.1128/MMBR.00020-11; George P, 2013, WORLD J MICROB BIOT, V29, P109, DOI 10.1007/s11274-012-1163-6; Ghignone S, 2012, ISME J, V6, P136, DOI 10.1038/ismej.2011.110; Gil R, 2004, ENVIRON MICROBIOL, V6, P1109, DOI 10.1111/j.1462-2920.2004.00691.x; Gkarmiri K, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1758-z; Hamilton JJ, 2014, J CELL BIOL, V207, P615, DOI 10.1083/jcb.201404127; Han SB, 1998, INT J IMMUNOPHARMACO, V20, P1, DOI 10.1016/S0192-0561(97)00062-3; Hoerauf A, 2000, LANCET, V355, P1242, DOI 10.1016/S0140-6736(00)02095-X; Hover T, 2016, APPL ENVIRON MICROB, V82, P2585, DOI 10.1128/AEM.04070-15; Gutierrez-Roman MI, 2012, WORLD J MICROB BIOT, V28, P145, DOI 10.1007/s11274-011-0803-6; Kunitsky C, 2006, IDENTIFICATION MICRO; Lackner G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002096; Lackner G, 2009, APPL ENVIRON MICROB, V75, P2982, DOI 10.1128/AEM.01765-08; Lapenda JC, 2015, WORLD J MICROB BIOT, V31, P399, DOI 10.1007/s11274-014-1793-y; Lavania M, 2006, CURR MICROBIOL, V52, P363, DOI 10.1007/s00284-005-5578-2; Li PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123061; Moebius N, 2014, ELIFE, V3, DOI 10.7554/eLife.03007; Mondo SJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02052-8; Montaner B, 2001, LIFE SCI, V68, P2025, DOI 10.1016/S0024-3205(01)01002-5; MOSSE B, 1970, ARCH MIKROBIOL, V74, P129, DOI 10.1007/BF00446901; Murdoch SL, 2011, J BACTERIOL, V193, P6057, DOI 10.1128/JB.05671-11; Nazir R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00038; Niehs SP, 2019, ACS CHEM BIOL, V14, P1811, DOI 10.1021/acschembio.9b00406; Niehs SP, 2018, ORG BIOMOL CHEM, V16, P8345, DOI [10.1039/C8OB01515E, 10.1039/c8ob01515e]; Niehs SP, 2018, CHEMBIOCHEM, V19, P2167, DOI 10.1002/cbic.201800400; Partida-Martinez LP, 2007, INT J SYST EVOL MICR, V57, P2583, DOI 10.1099/ijs.0.64660-0; Partida-Martinez LP, 2005, NATURE, V437, P884, DOI 10.1038/nature03997; Patil CD, 2011, PARASITOL RES, V109, P1179, DOI 10.1007/s00436-011-2365-9; Pawlowska TE, 2018, ANNU REV PHYTOPATHOL, V56, P289, DOI 10.1146/annurev-phyto-080417-045914; Peleg AY, 2010, NAT REV MICROBIOL, V8, P340, DOI 10.1038/nrmicro2313; Piel J, 2009, NAT PROD REP, V26, P338, DOI 10.1039/b703499g; Ryan RP, 2008, FEMS MICROBIOL LETT, V278, P1, DOI 10.1111/j.1574-6968.2007.00918.x; Scherlach K, 2013, ANNU REV MICROBIOL, V67, P375, DOI 10.1146/annurev-micro-092412-155702; Selvakumar G, 2008, LETT APPL MICROBIOL, V46, P171, DOI 10.1111/j.1472-765X.2007.02282.x; Sharma M, 2008, CELL MICROBIOL, V10, P2235, DOI 10.1111/j.1462-5822.2008.01202.x; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan ZY, 2001, SYST APPL MICROBIOL, V24, P245, DOI 10.1078/0723-2020-00002; Tapanila L, 2005, LETHAIA, V38, P89, DOI 10.1080/00241160510013123; Trunk K, 2018, NAT MICROBIOL, V3, P920, DOI 10.1038/s41564-018-0191-x; Ul Haq I, 2017, MICROB ECOL, V73, P236, DOI 10.1007/s00248-016-0885-7; Wang SL, 2012, PROCESS BIOCHEM, V47, P1684, DOI 10.1016/j.procbio.2011.07.010; Wang SB, 2011, MED MYCOL, V49, P799, DOI 10.3109/13693786.2011.571292; WARCUP JH, 1950, NATURE, V166, P117, DOI 10.1038/166117b0; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	53	8	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0224051	10.1371/journal.pone.0224051	http://dx.doi.org/10.1371/journal.pone.0224051			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320394	Green Submitted, Green Published, gold			2022-12-26	WOS:000536028800003
J	Khan, A; Akhtar, N; Kamran, S; Almuhannadi, H; Ponirakis, G; Petropoulos, IN; Babu, B; Jose, NR; Ibrahim, RG; Gad, H; Bourke, P; Saqqur, M; Shuaib, A; Malik, RA				Khan, Adnan; Akhtar, Naveed; Kamran, Saadat; Almuhannadi, Hamad; Ponirakis, Georgios; Petropoulos, Ioannis N.; Babu, Blessy; Jose, Namitha R.; Ibrahim, Rumissa G.; Gad, Hoda; Bourke, Paula; Saqqur, Maher; Shuaib, Ashfaq; Malik, Rayaz A.			Corneal confocal microscopy identifies greater corneal nerve damage in patients with a recurrent compared to first ischemic stroke	PLOS ONE			English	Article							SMALL-FIBER NEUROPATHY; LONG-TERM RISK; MICROBLEEDS; INFARCTION; DIAGNOSIS; SILENT	Objectives Corneal nerve damage may be a surrogate marker for the risk of ischemic stroke. This study was undertaken to determine if there is greater corneal nerve damage in patients with recurrent ischemic stroke. Methods Corneal confocal microscopy (CCM) was used to quantify corneal nerve fiber density (CNFD), corneal nerve branch density (CNBD), corneal nerve fiber length (CNFL) and corneal nerve fiber tortuosity (CNFT) in 31 patients with recurrent ischemic stroke, 165 patients with a first acute ischemic stroke and 23 healthy control subjects. Results Triglycerides (P = 0.004, P = 0.017), systolic BP (P = 0.000, P = 0.000), diastolic BP (P = 0.000, P = 0.000) and HbA1c (P = 0.000, P = 0.000) were significantly higher in patients with first and recurrent stroke compared to controls. There was no difference in age, BMI, HbA1c, total cholesterol, triglycerides, LDL, HDL, systolic and diastolic BP between patients with a first and recurrent ischemic stroke. However, CNFD was significantly lower (24.98 +/- 7.31 vs 29.07 +/- 7.58 vs 37.91 +/- 7.13, P< 0.05) and CNFT was significantly higher (0.085 +/- 0.042 vs 0.064 +/- 0.037 vs 0.039 +/- 0.022, P< 0.05) in patients with recurrent stroke compared to first stroke and healthy controls. CNBD (42.21 +/- 24.65 vs 50.46 +/- 27.68 vs 87.24 +/- 45.85, P< 0.001) and CNFL (15.66 +/- 5.70, P< 0.001 vs 17.38 +/- 5.06, P = 0.003) were equally reduced in patients with first and recurrent stroke compared to controls (22.72 +/- 5.14). Conclusions Corneal confocal microscopy identified greater corneal nerve fibre loss in patients with recurrent stroke compared to patients with first stroke, despite comparable risk factors. Longitudinal studies are required to determine the prognostic utility of corneal nerve fiber loss in identifying patients at risk of recurrent ischemic stroke.	[Khan, Adnan; Almuhannadi, Hamad; Ponirakis, Georgios; Petropoulos, Ioannis N.; Gad, Hoda; Malik, Rayaz A.] Weill Cornell Med Qatar, Dept Med, Doha, Qatar; [Akhtar, Naveed; Kamran, Saadat; Babu, Blessy; Jose, Namitha R.; Ibrahim, Rumissa G.; Bourke, Paula; Saqqur, Maher] Hamad Med Corp, Dept Neurol, Doha, Qatar; [Akhtar, Naveed; Kamran, Saadat; Babu, Blessy; Jose, Namitha R.; Ibrahim, Rumissa G.; Bourke, Paula; Saqqur, Maher] Hamad Med Corp, Inst Neurosci, Doha, Qatar; [Saqqur, Maher; Shuaib, Ashfaq] Univ Alberta, Dept Neurol, Stroke Program, Edmonton, AB, Canada	Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Hamad Medical Corporation; University of Alberta	Malik, RA (corresponding author), Weill Cornell Med Qatar, Dept Med, Doha, Qatar.	ram2045@qatar-med.cornell.edu	Malik, Rayaz/H-9231-2019	Malik, Rayaz/0000-0002-7188-8903; Khan, Adnan/0000-0003-4647-6672; Kamran, Saadat/0000-0002-0260-2086	Qatar National Research Fund [BMRP20038654]	Qatar National Research Fund(Qatar National Research Fund (QNRF))	Supported by Qatar National Research Fund Grant BMRP20038654 to Dr Rayaz A. Malik. The funders had no role in study design, data collection and analysis, decision to publish, or publish, or preparation of the manuscript.	[Anonymous], 2019, AM J HYPERTENS, DOI DOI 10.1093/AJH/HPZ058; Asghar O, 2014, DIABETES CARE, V37, P2643, DOI 10.2337/dc14-0279; Azmi S, 2015, DIABETES CARE, V38, P1502, DOI 10.2337/dc14-2733; Chan KL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00171; Charidimou A, 2013, STROKE, V44, P995, DOI 10.1161/STROKEAHA.111.000038; Chen J, 2019, AM HEART J, V8; CHEN WQ, 2017, AM HEART J, V6, DOI DOI 10.1161/JAHA.116.005446; Chen X, 2018, INVEST OPHTH VIS SCI, V59, P1113, DOI 10.1167/iovs.17-23342; de Groot M, 2013, STROKE, V44, P1037, DOI 10.1161/STROKEAHA.112.680223; Fadavi H, 2018, DIABETES-METAB RES, V34, DOI 10.1002/dmrr.3044; Ferdousi M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139394; Ferrari G, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00278; Gacon J, 2019, POSTEP KARDIOL INTER, V15, P74, DOI 10.5114/aic.2019.81705; Gad H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213319; Hankey GJ, 1998, STROKE, V29, P2491, DOI 10.1161/01.STR.29.12.2491; Hankey GJ, 2014, LANCET NEUROL, V13, P178, DOI 10.1016/S1474-4422(13)70255-2; Kamran S, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2019.104543; Kang DW, 2016, NEUROLOGY, V86, P277, DOI 10.1212/WNL.0000000000002289; Kang DW, 2006, ARCH NEUROL-CHICAGO, V63, P1730, DOI 10.1001/archneur.63.12.1730; Kass-Iliyya L, 2015, PARKINSONISM RELAT D, V21, P1454, DOI 10.1016/j.parkreldis.2015.10.019; Kauw F, 2018, CEREBROVASC DIS, V45, P279, DOI 10.1159/000490422; Khan A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35298-3; Khan A, 2018, J DIABETES INVEST, V9, P1167, DOI 10.1111/jdi.12806; Khan A, 2017, STROKE, V48, P3012, DOI 10.1161/STROKEAHA.117.018289; Khanevski AN, 2019, ACTA NEUROL SCAND, V140, P3, DOI 10.1111/ane.13093; Kim GM, 2014, STROKE, V45, P479, DOI 10.1161/STROKEAHA.113.003004; Melkas S, 2012, CEREBROVASC DIS, V34, P191, DOI 10.1159/000341404; Mikolajczak J, 2017, MULT SCLER J, V23, P1847, DOI 10.1177/1352458516677590; Moerch-Rasmussen A, 2016, ACTA NEUROL SCAND, V133, P289, DOI 10.1111/ane.12457; Mok Y, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010546; Park JH, 2019, EUR J NEUROL, DOI [10.1111/ane.12457, DOI 10.1111/ANE.12457]; Park JH, 2014, STROKE, V45, P3269, DOI 10.1161/STROKEAHA.114.006827; Pennlert J, 2014, STROKE, V45, P1839, DOI 10.1161/STROKEAHA.114.005060; Petropoulos IN, 2014, INVEST OPHTH VIS SCI, V55, P2071, DOI 10.1167/iovs.13-13787; Petty GW, 1998, NEUROLOGY, V50, P208, DOI 10.1212/WNL.50.1.208; Ponirakis G, 2019, ANN CLIN TRANSL NEUR, V6, P689, DOI 10.1002/acn3.746; Powers WJ, 2018, STROKE, V49, pE46, DOI 10.1161/STR.0000000000000158; Shukla AN, 2012, SEMIN OPHTHALMOL, V27, P107, DOI 10.3109/08820538.2012.707276; Tavakoli M, 2011, DIABETIC MED, V28, P1261, DOI 10.1111/j.1464-5491.2011.03372.x; Tavakoli M, 2011, JOVE-J VIS EXP, DOI 10.3791/2194; Thijs V, 2010, STROKE, V41, P2005, DOI 10.1161/STROKEAHA.110.588020; Vagenas D, 2012, OPTOMETRY VISION SCI, V89, P812, DOI 10.1097/OPX.0b013e31824ee8c9; Wada S, 2019, STROKE, V50, P1586, DOI 10.1161/STROKEAHA.119.024968; Xie X, 2019, EUR J NEUROL, V26, P1168, DOI 10.1111/ene.13961; Yu L, 2018, CLIN INTERV AGING, V13, P2487, DOI 10.2147/CIA.S184463; Zhao WJ, 2019, AGING-US, V11, P1686, DOI 10.18632/aging.101862	46	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231987	10.1371/journal.pone.0231987	http://dx.doi.org/10.1371/journal.pone.0231987			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320450	Green Published, gold			2022-12-26	WOS:000536028800047
J	Guo, YX; Wang, JY; Zhou, KC; Lv, JQ; Wang, L; Gao, S; Keller, ET; Zhang, ZS; Wang, Q; Yao, Z				Guo, Yaxiu; Wang, Jingyu; Zhou, Kaichen; Lv, Junqiang; Wang, Lei; Gao, Shan; Keller, Evan T.; Zhang, Zhi-Song; Wang, Quan; Yao, Zhi			Cytotoxic necrotizing factor 1 promotes bladder cancer angiogenesis through activating RhoC	FASEB JOURNAL			English	Article						angiogenesis; bladder cancer; cytotoxic necrotizing factor 1; RhoC; uropathogenic Escherichia coli	ESCHERICHIA-COLI; EXPRESSION; HYPOXIA; HIF-1; VEGF; HIF-1-ALPHA; METASTASIS; CARCINOMA; TRANSCRIPTION; PROGRESSION	Uropathogenic Escherichia coli (UPEC), a leading cause of urinary tract infections, is associated with prostate and bladder cancers. Cytotoxic necrotizing factor 1 (CNF1) is a key UPEC toxin; however, its role in bladder cancer is unknown. In the present study, we found CNF1 induced bladder cancer cells to secrete vascular endothelial growth factor (VEGF) through activating Ras homolog family member C (RhoC), leading to subsequent angiogenesis in the bladder cancer microenvironment. We then investigated that CNF1-mediated RhoC activation modulated the stabilization of hypoxia-inducible factor 1 alpha (HIF1 alpha) to upregulate the VEGF. We demonstrated in vitro that active RhoC increased heat shock factor 1 (HSF1) phosphorylation, which induced the heat shock protein 90 alpha (HSP90 alpha) expression, leading to stabilization of HIF1 alpha. Active RhoC elevated HSP90 alpha, HIF1 alpha, VEGF expression, and angiogenesis in the human bladder cancer xenografts. In addition, HSP90 alpha, HIF1 alpha, and VEGF expression were also found positively correlated with the human bladder cancer development. These results provide a potential mechanism through which UPEC contributes to bladder cancer progression, and may provide potential therapeutic targets for bladder cancer.	[Guo, Yaxiu; Wang, Jingyu; Zhou, Kaichen; Lv, Junqiang; Wang, Quan; Yao, Zhi] Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Tianjin Key Lab Cellular & Mol Immunol, Dept Immunol,Educ Minist China,Sch Basic Med Sci, Tianjin 300070, Peoples R China; [Wang, Lei; Gao, Shan; Zhang, Zhi-Song] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin Key Lab Mol Drug Res, State Key Lab Med Chem Biol, Tianjin, Peoples R China; [Wang, Lei; Gao, Shan; Zhang, Zhi-Song] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Tianjin Key Lab Mol Drug Res, Coll Pharm, Tianjin, Peoples R China; [Keller, Evan T.] Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; [Yao, Zhi] Tianjin Med Univ, 2011 Collaborat Innovat Ctr Tianjin Med Epigenet, Tianjin, Peoples R China	Tianjin Medical University; Nankai University; Nankai University; University of Michigan System; University of Michigan; Tianjin Medical University	Wang, Q; Yao, Z (corresponding author), Tianjin Med Univ, Key Lab Immune Microenvironm & Dis, Tianjin Key Lab Cellular & Mol Immunol, Dept Immunol,Educ Minist China,Sch Basic Med Sci, Tianjin 300070, Peoples R China.; Zhang, ZS (corresponding author), Nankai Univ, State Key Lab Med Chem Biol, Tianjin 300350, Peoples R China.; Zhang, ZS (corresponding author), Nankai Univ, Coll Pharm, Collaborat Innovat Ctr Biotherapy, Tianjin 300350, Peoples R China.; Zhang, ZS (corresponding author), Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin 300350, Peoples R China.	zzs@nankai.edu.cn; wangquan@tmu.edu.cn; yaozhi@tmu.edu.cn			National Natural Science Foundation of China [31970133, 81672740, 81572882]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 31970133, 81672740 and 81572882	Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Bien J, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/681473; Boellmann F, 2004, P NATL ACAD SCI USA, V101, P4100, DOI 10.1073/pnas.0304768101; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Doye A, 2002, CELL, V111, P553, DOI 10.1016/S0092-8674(02)01132-7; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fabbri A, 2010, TOXINS, V2, P283, DOI [10.3390/toxins2020283, 10.3390/toxins2020282]; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Griner EM, 2015, MOL CANCER RES, V13, P483, DOI 10.1158/1541-7786.MCR-14-0420; Guo YX, 2017, J PATHOL, V243, P208, DOI 10.1002/path.4940; Hoeppner LH, 2015, J CELL SCI, V128, P3556, DOI 10.1242/jcs.167601; Jochmanova I, 2013, JNCI-J NATL CANCER I, V105, P1270, DOI 10.1093/jnci/djt201; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Karlsson R, 2009, BBA-REV CANCER, V1796, P91, DOI 10.1016/j.bbcan.2009.03.003; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Lang S, 2017, ONCOTARGET, V8, P87364, DOI 10.18632/oncotarget.20957; Lee JS, 2016, BMB REP, V49, P607, DOI 10.5483/BMBRep.2016.49.11.145; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Liu N, 2007, J MOL MED-JMM, V85, P1149, DOI 10.1007/s00109-007-0217-y; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Matsumoto K, 2014, J BIOCHEM, V156, P1, DOI 10.1093/jb/mvu031; Mitsumori K, 1999, J INFECT DIS, V180, P1378, DOI 10.1086/314976; Nielubowicz GR, 2010, NAT REV UROL, V7, P430, DOI 10.1038/nrurol.2010.101; Prodromou C, 2016, BIOCHEM J, V473, P2439, DOI 10.1042/BCJ20160005; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Semenza GL, 2002, TRENDS MOL MED, V8, pS62, DOI 10.1016/S1471-4914(02)02317-1; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2000, CRIT REV BIOCHEM MOL, V35, P71, DOI 10.1080/10409230091169186; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Shen KH, 2016, CANCER SCI, V107, P1390, DOI 10.1111/cas.13016; Simons BW, 2015, J PATHOL, V235, P478, DOI 10.1002/path.4472; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tolg C, 2011, LAB INVEST, V91, P825, DOI 10.1038/labinvest.2010.197; van Golen KL, 2002, CLIN EXP METASTAS, V19, P301, DOI 10.1023/A:1015518114931; van Golen KL, 2000, NEOPLASIA, V2, P418, DOI 10.1038/sj.neo.7900115; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Volanis D, 2011, J BUON, V16, P511; Wang W, 2008, CANCER SCI, V99, P2012, DOI 10.1111/j.1349-7006.2008.00902.x; Wenandy L, 2008, CANCER IMMUNOL IMMUN, V57, P1871, DOI 10.1007/s00262-008-0517-2; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Wu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048917; Xie SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054493; Yang H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01987; Yang J, 2014, CELL MOL IMMUNOL, V11, P285, DOI 10.1038/cmi.2014.6; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zaravinos A, 2012, ONCOL REP, V28, P1159, DOI 10.3892/or.2012.1948; Zhao Y, 2010, GYNECOL ONCOL, V116, P563, DOI 10.1016/j.ygyno.2009.11.015; Zhao ZH, 2015, WORLD J GASTROENTERO, V21, P905, DOI 10.3748/wjg.v21.i3.905	56	11	12	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7927	7940		10.1096/fj.201903266RR	http://dx.doi.org/10.1096/fj.201903266RR		APR 2020	14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32314833	Green Published			2022-12-26	WOS:000527569100001
J	Liu, DJX; Stock, E; Broeckx, BJG; Daminet, S; Meyer, E; Delanghe, JR; Croubels, S; Devreese, M; Nguyen, P; Bogaerts, E; Hesta, M; Vanderperren, K				Liu, Daisy J. X.; Stock, Emmelie; Broeckx, Bart J. G.; Daminet, Sylvie; Meyer, Evelyne; Delanghe, Joris R.; Croubels, Siska; Devreese, Mathias; Nguyen, Patrick; Bogaerts, Evelien; Hesta, Myriam; Vanderperren, Katrien			Weight-gain induced changes in renal perfusion assessed by contrast-enhanced ultrasound precede increases in urinary protein excretion suggestive of glomerular and tubular injury and normalize after weight-loss in dogs	PLOS ONE			English	Article							OBESITY-INDUCED HYPERTENSION; CORTICAL BLOOD-FLOW; C-REACTIVE PROTEIN; CYSTATIN-C; KIDNEY INJURY; BODY-COMPOSITION; FILTRATION-RATE; HEART-RATE; PRESSURE; ULTRASONOGRAPHY	Early detection of obesity-related glomerulopathy in humans is challenging as it might not be detected by routine biomarkers of kidney function. This study's aim was to use novel kidney biomarkers and contrast-enhanced ultrasound (CEUS) to evaluate the effect of obesity development and weight-loss on kidney function, perfusion, and injury in dogs. Sixteen healthy lean adult beagles were assigned randomly but age-matched to a control group (CG) (n = 8) fed to maintain a lean body weight (BW) for 83 weeks; or to a weight-change group (WCG) (n = 8) fed the same diet to induce obesity (week 0-47), to maintain stable obese weight (week 47-56) and to lose BW (week 56-83). At 8 time points, values of systolic blood pressure (sBP); serum creatinine (sCr); blood urea nitrogen (BUN); serum cystatin C (sCysC); urine protein-to-creatinine ratio (UPC); and urinary biomarkers of glomerular and tubular injury were measured. Glomerular filtration rate (GFR) and renal perfusion using CEUS were assayed (except for week 68). For CEUS, intensity- and time-related parameters representing blood volume and velocity were derived from imaging data, respectively. At 12-22% weight-gain, cortical time-to-peak, representing blood velocity, was shorter in the WCG vs. the CG. After 37% weight-gain, sCysC, UPC, glomerular and tubular biomarkers of injury, urinary immunoglobulin G and urinary neutrophil gelatinase-associated lipocalin, respectively, were higher in the WCG. sBP, sCr, BUN and GFR were not significantly different. After 23% weight-loss, all alterations were attenuated. Early weight-gain in dogs induced renal perfusion changes measured with CEUS, without hyperfiltration, preceding increased urinary protein excretion with potential glomerular and tubular injury. The combined use of routine biomarkers of kidney function, CEUS and site-specific urinary biomarkers might be valuable in assessing kidney health of individuals at risk for obesity-related glomerulopathy in a non-invasive manner.	[Liu, Daisy J. X.; Stock, Emmelie; Bogaerts, Evelien; Vanderperren, Katrien] Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim & Orthoped Small Ani, Merelbeke, Belgium; [Broeckx, Bart J. G.; Hesta, Myriam] Univ Ghent, Fac Vet Med, Dept Nutr Genet & Ethol, Merelbeke, Belgium; [Daminet, Sylvie] Univ Ghent, Fac Vet Med, Small Anim Dept, Merelbeke, Belgium; [Meyer, Evelyne; Croubels, Siska; Devreese, Mathias] Univ Ghent, Fac Vet Med, Dept Pharmacol Toxicol & Biochem, Merelbeke, Belgium; [Delanghe, Joris R.] Univ Ghent, Fac Hlth Med & Life Sci, Dept Clin Chem Microbiol & Immunol, Ghent, Belgium; [Nguyen, Patrick] Natl Coll Vet Med Food Sci & Engn, Oniris, Nantes, France	Ghent University; Ghent University; Ghent University; Ghent University; Ghent University; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Vanderperren, K (corresponding author), Univ Ghent, Fac Vet Med, Dept Med Imaging Domest Anim & Orthoped Small Ani, Merelbeke, Belgium.	katrien.vanderperren@ugent.be	Broeckx, Bart/AAH-3940-2021	Broeckx, Bart/0000-0001-6742-3911; Daminet, Sylvie/0000-0001-6733-7925; Hesta, Myriam/0000-0001-9423-9765; Liu, Daisy/0000-0002-2970-4357; Croubels, Siska/0000-0001-6357-3517	Special Research Fund of Ghent University, Belgium (BOF) [01N02215]; Virbac	Special Research Fund of Ghent University, Belgium (BOF); Virbac	This work was funded by the Special Research Fund of Ghent University, Belgium (BOF grant 01N02215). Virbac financially supported blood and urine analyses and the diet used in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshinnia F, 2010, NEPHROL DIAL TRANSPL, V25, P1173, DOI 10.1093/ndt/gfp640; Almy FS, 2002, J VET INTERN MED, V16, P45, DOI 10.1892/0891-6640(2002)016&lt;0045:EOCCAA&gt;2.3.CO;2; Bobulescu IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101285; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Bracco, 2015, VUEBOX US MAN; Brown S, 2007, J VET INTERN MED, V21, P542, DOI 10.1892/0891-6640(2007)21[542:GFTIEA]2.0.CO;2; Chade AR, 2016, AM J NEPHROL, V44, P354, DOI 10.1159/000452365; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Chandler ML, 2008, TOP COMPANION ANIM M, V23, P148, DOI 10.1053/j.tcam.2008.04.008; Chew-Harris JSC, 2013, ANN CLIN BIOCHEM, V50, P39, DOI 10.1258/acb.2012.011241; Collis T, 2001, CIRCULATION, V103, P820, DOI 10.1161/01.CIR.103.6.820; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; De Baere S, 2012, J PHARMACEUT BIOMED, V61, P50, DOI 10.1016/j.jpba.2011.11.022; Decleves AE, 2013, AM J PHYSIOL-RENAL, V305, pF1343, DOI 10.1152/ajprenal.00326.2013; Defauw P, 2017, J VET DIAGN INVEST, V29, P346, DOI 10.1177/1040638717695608; Ding W, 2015, PEDIATR NEPHROL, V30, P1, DOI 10.1007/s00467-014-2976-3; Dong Y, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140350; Ferrier L, 2002, J NUTR, V132, p1725S, DOI 10.1093/jn/132.6.1725S; Gluhovschi C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4626125; Goknar N, 2015, PEDIATR NEPHROL, V30, P139, DOI 10.1007/s00467-014-2829-0; Goumenos DS, 2009, NEPHROL DIAL TRANSPL, V24, P3732, DOI 10.1093/ndt/gfp329; GRANGER JP, 1994, HYPERTENSION, V23, pI8, DOI 10.1161/01.HYP.23.1_Suppl.I8; Groman RP, 2004, VET RADIOL ULTRASOUN, V45, P62, DOI 10.1111/j.1740-8261.2004.04010.x; Haers H, 2013, AM J VET RES, V74, P70, DOI 10.2460/ajvr.74.1.70; HALL JE, 1993, HYPERTENSION, V22, P292, DOI 10.1161/01.HYP.22.3.292; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Henegar JR, 2014, AM J HYPERTENS, V27, P1285, DOI 10.1093/ajh/hpu048; Henegar JR, 2001, J AM SOC NEPHROL, V12, P1211, DOI 10.1681/ASN.V1261211; Hokamp JA, 2016, J VET INTERN MED, V30, P591, DOI 10.1111/jvim.13832; Hosotani Y, 2002, HYPERTENS RES, V25, P77, DOI 10.1291/hypres.25.77; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Iliescu R, 2013, AM J PHYSIOL-HEART C, V305, P1080, DOI 10.1152/ajpheart.00464.2013; Iliescu R, 2010, MICROCIRCULATION, V17, P250, DOI 10.1111/j.1549-8719.2010.00020.x; International Renal Interest Society, INT REN INT SOC STAG; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Klanke B, 1998, NEPHROL DIAL TRANSPL, V13, P875, DOI 10.1093/ndt/13.4.875; Laflamme D, 1997, CANINE PRACT, V22, P10; Laiho K, 1998, CLIN RHEUMATOL, V17, P234, DOI 10.1007/BF01451054; Leinonen MR, 2010, AM J VET RES, V71, P1305, DOI 10.2460/ajvr.71.11.1305; Li ZL, 2011, AM J PHYSIOL-RENAL, V301, pF1078, DOI 10.1152/ajprenal.00333.2011; Littman MP, 2013, J VET INTERN MED, V27, pS19, DOI 10.1111/jvim.12223; Liu DJX, 2018, J VET INTERN MED, V32, P1659, DOI 10.1111/jvim.15293; Liu DJX, 2019, VET RADIOL ULTRASOUN, V60, P201, DOI 10.1111/vru.12690; Macdonald J, 2006, AM J KIDNEY DIS, V48, P712, DOI 10.1053/j.ajkd.2006.07.001; Maddens B, 2011, J VET INTERN MED, V25, P1075, DOI [10.1111/j.1939-1676.2011.0772.x, 10.1111/j.1939-1676.2011.00772.x]; Martinez-Subiela S, 2013, RES VET SCI, V95, P924, DOI 10.1016/j.rvsc.2013.07.002; Morais C, 2005, NEPHROL DIAL TRANSPL, V20, P50, DOI 10.1093/ndt/gfh561; Domingos MAM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162782; Naour N, 2009, OBESITY, V17, P2121, DOI 10.1038/oby.2009.96; National Research Council, 2006, NUTR REQ DOGS CATS; Osto M, 2015, EUR J PHARMACOL, V759, P240, DOI 10.1016/j.ejphar.2015.03.036; Raila J, 2007, KIDNEY INT, V72, P505, DOI 10.1038/sj.ki.5002372; ROCCHINI AP, 1987, HYPERTENSION, V9, P64; Schneider AG, 2012, NEPHROL DIAL TRANSPL, V27, P674, DOI 10.1093/ndt/gfr345; Serra A, 2015, OBESITY FACTS, V8, P188, DOI 10.1159/000431027; Smets PMY, 2012, VET J, V192, P532, DOI 10.1016/j.tvjl.2011.05.027; Smets PMY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031702; Stock E, 2018, ULTRASOUND MED BIOL, V44, P426, DOI 10.1016/j.ultrasmedbio.2017.09.019; Stock E, 2017, ULTRASOUND MED BIOL, V43, P500, DOI 10.1016/j.ultrasmedbio.2016.09.013; Stock E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164488; Tang MX, 2011, INTERFACE FOCUS, V1, P520, DOI 10.1098/rsfs.2011.0026; Tefft KM, 2014, VET CLIN PATH, V43, P255, DOI 10.1111/vcp.12139; Tobar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075547; Tsuboi N, 2017, KIDNEY INT REP, V2, P251, DOI 10.1016/j.ekir.2017.01.007; Tvarijonaviciute A, 2013, J VET INTERN MED, V27, P31, DOI 10.1111/jvim.12029; Tvarijonaviciute A, 2011, AM J VET RES, V72, P169, DOI 10.2460/ajvr.72.2.169; Vaden SL, 2005, J VET INTERN MED, V19, P794, DOI 10.1892/0891-6640(2005)19[794:RBARSO]2.0.CO;2; Van de Velde H, 2013, VET IMMUNOL IMMUNOP, V152, P237, DOI [10.1016/j.vetimm.2012.12.01.1, 10.1016/j.vetimm.2012.12.011]; Verwaerde P, 1999, J HYPERTENS, V17, P1135, DOI 10.1097/00004872-199917080-00013; VOGEL JA, 1966, AM J PHYSIOL, V210, P186, DOI 10.1152/ajplegacy.1966.210.1.186; Wakelin SJ, 2004, NEPHRON PHYSIOL, V98, P73; Wang Y, 2008, KIDNEY INT, V73, P19, DOI 10.1038/sj.ki.5002586; Wolf G, 1999, KIDNEY INT, V56, P860, DOI 10.1046/j.1523-1755.1999.00626.x; Wu YC, 2006, ENDOCRINOLOGY, V147, P44, DOI 10.1210/en.2005-0641; Xiao NZ, 2015, OBESITY, V23, P1234, DOI 10.1002/oby.21070; Zhang Q, 2014, BIOMARK MED, V8, P85, DOI 10.2217/bmm.13.106; Zhang ZH, 2017, CLIN EXP PHARMACOL P, V44, P1213, DOI 10.1111/1440-1681.12661	77	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231662	10.1371/journal.pone.0231662	http://dx.doi.org/10.1371/journal.pone.0231662			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315336	Green Published, gold			2022-12-26	WOS:000536024800043
J	Tilahun, A; Yimer, M; Gelaye, W; Tegegne, B				Tilahun, Adane; Yimer, Mulat; Gelaye, Woynshet; Tegegne, Banchamlak			Prevalence of asymptomatic Plasmodium species infection and associated factors among pregnant women attending antenatal care at Fendeka town health facilities, Jawi District, North west Ethiopia: A cross-sectional study	PLOS ONE			English	Article							FALCIPARUM INFECTIONS; PLACENTAL MALARIA; PARASITEMIA; TRANSMISSION	Background Malaria in pregnancy remains a major public health problem especially in sub-Saharan Africa. In malaria endemic areas, majority of pregnant women may remain asymptomatic but still associated with complications on the mother and her foetus. They also serve as reservoirs and act as transmitters of infection. Despite these effects, the prevalence of asymptomatic Plasmodium species infections among pregnant women attending antenatal care has not been yet studied at the study area. Therefore, the aim of this study was to assess the prevalence of asymptomatic Plasmodium species infections among pregnant women attending antenatal care at Fendeka town health facilities. Methods Health facility based cross -sectional study was conducted from February to March 2019. A total of 331 participants were enrolled by using convenient sampling technique. Sociodemographic and associated factors were collected by a face to face interview. All the 331 samples were tested using rapid diagnostic tests (RDTs) and microscopy. However, only 83 dried blood spot (DBS) samples out of 331 participants, were collected by using systematic random sampling technique for molecular analysis. Data was analysed using SPSS version 20. Descriptive statistics were used to determine the prevalence of asymptomatic Plasmodium species infections. Univariate logistic regression was employed to assess factors associated with asymptomatic Plasmodium species infection. Variables with P-value < 0.25 in the univariate logistic regression were selected for multivariate logistic regression analysis model. Odds ratios with 95% confidence intervals were calculated and P- values < 0.05 were considered as statistically significant. Results Overall, 37 (11.2%) asymptomatic Plasmodium species infections were detected using: RDTs, microscopy and real-time PCR altogether. The asymptomatic Plasmodium species infection prevalence was 17 (5.1%), 30 (9.1%) and 15(18.1%) using RDTs, microscopy and real-time PCR, respectively. Asymptomatic Plasmodium species infections were more likely to occur in primigravida (AOR: 4.51, 95% CI: 1.27-16.03), secundigravida (AOR: 3.87, 95% CI: 1.16-12.93), rural inhabitants (AOR: 4.51, 95% CI: 1.72-11.84) and in participants who did not use indoor residual spray (IRS) for the last one year (AOR: 3.13, 95% CI: 1.47-6.66). Conclusions The prevalence of asymptomatic Plasmodium species infection was 11.2%. Pregnant women who reside in the rural area, primigravidae, secugravidae and those who did not utilize indoor residual spray for the last one year were at high risk of infection. Therefore, routine laboratory diagnosis of asymptomatic Plasmodium species infection among pregnant women should be adopted as a part of the antenatal care.	[Tilahun, Adane] Debre Markos Referral Hosp, Med Lab Serv, Debre Markos, Ethiopia; [Yimer, Mulat; Gelaye, Woynshet] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia; [Tegegne, Banchamlak] Amhara Publ Hlth Inst, Bahir Dar, Ethiopia	Bahir Dar University	Yimer, M (corresponding author), Bahir Dar Univ, Coll Med & Hlth Sci, Sch Hlth Sci, Dept Med Lab Sci, Bahir Dar, Ethiopia.	yimermulat37@gmail.com			Bahir Dar University	Bahir Dar University	This study was partially funded by Bahir Dar University. The University had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J DENT MED SCI; Balogun S T, 2011, Niger J Physiol Sci, V26, P179; Bottius E, 1996, T ROY SOC TROP MED H, V90, P15, DOI 10.1016/S0035-9203(96)90463-0; Byrne Neville, 2007, Travel Med Infect Dis, V5, P135, DOI 10.1016/j.tmaid.2006.04.003; Conroy AL, 2012, EXPERT REV ANTI-INFE, V10, P1331, DOI [10.1586/eri.12.123, 10.1586/ERI.12.123]; Cottrell G, 2015, CLIN INFECT DIS, V60, P1481, DOI 10.1093/cid/civ122; Douamba Z, 2012, BIOMED RES INT, P2; Emiasegen SE, 2017, MALARIA WORLD J, V15, P25; Federal Democratic Republic of Ethiopia, 2007, POP CENS COMM SUMM S; Francine N, 2016, ACTA TROP, V153, P111, DOI 10.1016/j.actatropica.2015.10.009; Gemeda AW, 2012, ARTIG PUPLICAD ANAIS, V6, P187; Grueninger H, 2013, TRENDS PARASITOL, V29, P60, DOI 10.1016/j.pt.2012.11.002; Harris I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-254; Isah AY, 2011, ANN AFR MED, V10, P171, DOI 10.4103/1596-3519.82070; Leopardi O, 1996, PATHOL RES PRACT, V192, P892, DOI 10.1016/S0344-0338(96)80068-9; Lindblade KA, 2013, EXPERT REV ANTI-INFE, V11, P623, DOI [10.1586/eri.13.45, 10.1586/ERI.13.45]; Lucchi NW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056677; Matangila JR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-132; Mayengue PI, 2004, TROP MED INT HEALTH, V9, P949, DOI 10.1111/j.1365-3156.2004.01294.x; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Ministry of Health of Ethiopia (MOH), 2014, NAT STRAT PLAN MAL P; Ministry of Health of Ethiopia (MOH), 2012, NAT MAL GUID; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P332, DOI 10.1128/AAC.00856-06; Nega D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123630; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Nwagha UI, 2009, T ROY SOC TROP MED H, V103, P16, DOI 10.1016/j.trstmh.2008.07.016; Obebe OO, 2018, TANZANIA J HLTH RES, V20, P4; Ordi J, 2001, J INFECT DIS, V183, P1100, DOI 10.1086/319295; PMI, 2018, PRES MAL IN ETH MAL; Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169; Tagbor H, 2008, TROP MED INT HEALTH, V13, P1016, DOI 10.1111/j.1365-3156.2008.02111.x; Van Geertruyden JP, 2005, TROP MED INT HEALTH, V10, P681, DOI 10.1111/j.1365-3156.2005.01431.x; WHO, 2017, FACTSH WORLD MAL REP	33	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231477	10.1371/journal.pone.0231477	http://dx.doi.org/10.1371/journal.pone.0231477			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315341	Green Published, gold			2022-12-26	WOS:000536024800028
J	Gao, J; Jiang, MC; Magin, RL; Gatto, RG; Morfini, G; Larson, AC; Li, WG				Gao, Jin; Jiang, Mingchen; Magin, Richard L.; Gatto, Rodolfo G.; Morfini, Gerardo; Larson, Andrew C.; Li, Weiguo			Multicomponent diffusion analysis reveals microstructural alterations in spinal cord of a mouse model of amyotrophic lateral sclerosis ex vivo	PLOS ONE			English	Article							CORTICOSPINAL TRACT; TENSOR MRI; INVOLVEMENT; ANISOTROPY; SPACE; ALS	The microstructure changes associated with degeneration of spinal axons in amyotrophic lateral sclerosis (ALS) may be reflected in altered water diffusion properties, potentially detectable with diffusion-weighted (DW) MRI. Prior work revealed the classical mono-exponential model fails to precisely depict decay in DW signal at high b-values. In this study, we aim to investigate signal decay behaviors at ultra-high b-values for non-invasive assessment of spinal cord alterations in the transgenic SOD1(G93A) mouse model of ALS. A multiexponential diffusion analysis using regularized non-negative least squares (rNNLS) algorithm was applied to a series of thirty DW MR images with b-values ranging from 0 to 858,022 s/mm(2) on ex vivo spinal cords of transgenic SOD1(G93A) and age-matched control mice. We compared the distributions of measured diffusion coefficient fractions between the groups. The measured diffusion weighted signals in log-scale showed non-linear decay behaviors with increased b-values. Faster signal decays were observed with diffusion gradients applied parallel to the long axis of the spinal cord compared to when oriented in the transverse direction. Multiexponential analysis at the lumbar level in the spinal cord identified ten subintervals. A significant decrease of diffusion coefficient fractions was found in the ranges of [1.63x10(-8),3.70x10(-6)] mm(2)/s (P = 0.0002) and of [6.01x10(-6),4.20x10(-5)] mm(2)/s (P = 0.0388) in SOD1(G93A) mice. Anisotropic diffusion signals persisted at ultra-high b-value DWIs of the mouse spinal cord and multiexponential diffusion analysis offers the potential to evaluate microstructural alterations of ALS-affected spinal cord non-invasively.	[Gao, Jin] Univ Illinois, Dept Elect & Comp Engn, Chicago, IL USA; [Gao, Jin; Li, Weiguo] Univ Illinois, Res Resource Ctr, Chicago, IL 60607 USA; [Jiang, Mingchen] Northwestern Univ, Dept Physiol, Chicago, IL 60611 USA; [Magin, Richard L.; Gatto, Rodolfo G.; Li, Weiguo] Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA; [Morfini, Gerardo] Univ Illinois, Dept Anat & Cell Biol, Chicago, IL USA; [Larson, Andrew C.; Li, Weiguo] Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Northwestern University	Li, WG (corresponding author), Univ Illinois, Res Resource Ctr, Chicago, IL 60607 USA.; Li, WG (corresponding author), Univ Illinois, Dept Bioengn, Chicago, IL 60607 USA.; Li, WG (corresponding author), Northwestern Univ, Dept Radiol, Chicago, IL 60611 USA.	wli20@uic.edu	Gatto, Rodolfo/R-7155-2018; Morfini, Gerardo/AAP-8070-2021; Li, Weiguo/H-8502-2019	Gatto, Rodolfo/0000-0003-2170-6662; Morfini, Gerardo/0000-0001-6059-5518; Li, Weiguo/0000-0001-8125-3824; Gao, Jin/0000-0002-4097-5940	National Cancer Institute (NCI) [RO1CA181658]; ALS Association [ID8088]	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ALS Association	ACL received grant support by Grant Number RO1CA181658 from National Cancer Institute (NCI) website: https://www.nih.gov/aboutnih/what-we-do/nih-almanac/national-cancer-institute-nci Yes. role of manuscript preparation MJ received grant support from ALS Association with ID8088 (http://www.alsa.org).Yes role of resources, validation, and manuscript revision.	Abe O, 2004, NMR BIOMED, V17, P411, DOI 10.1002/nbm.907; Agosta F, 2010, AM J NEURORADIOL, V31, P1769, DOI 10.3174/ajnr.A2043; Agosta F, 2010, EUR J NEUROSCI, V32, P1490, DOI 10.1111/j.1460-9568.2010.07445.x; Bennett KM, 2003, MAGNET RESON MED, V50, P727, DOI 10.1002/mrm.10581; Buchanan CR, 2015, J MAGN RESON IMAGING, V41, P1342, DOI 10.1002/jmri.24695; Budrewicz S, 2016, NEUROL SCI, V37, P417, DOI 10.1007/s10072-015-2418-4; Cao P, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3481; Caron I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132159; Clark CA, 2000, MAGN RESON MED, V44, P852, DOI 10.1002/1522-2594(200012)44:6<852::AID-MRM5>3.0.CO;2-A; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Cosottini M, 2005, RADIOLOGY, V237, P258, DOI 10.1148/radiol.2371041506; De Luca A, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3965; Figini M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161646; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gao J, 2017, P 25 ANN M ISMRM HON; Gatto RG, 2018, TRANSL NEURODEGENER, V7, DOI 10.1186/s40035-018-0122-z; Gatto RG, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3954; Gatto RG, 2018, BRAIN RES, V1679, P45, DOI 10.1016/j.brainres.2017.11.017; Graham JM, 2004, NEUROLOGY, V63, P2111, DOI 10.1212/01.WNL.0000145766.03057.E7; Graham SJ, 1996, MAGNET RESON MED, V35, P370, DOI 10.1002/mrm.1910350315; Hoff BA, 2010, MAGN RESON MED, V64, P1499, DOI 10.1002/mrm.22507; Iwata NK, 2008, NEUROLOGY, V70, P528, DOI 10.1212/01.wnl.0000299186.72374.19; Jansen M, 2017, STAT COMPUT, V27, P1383, DOI 10.1007/s11222-016-9692-8; Jansen M, 2013, IEEE T SIGNAL PROCES, V61, DOI 10.1109/TSP.2012.2225059; Jian B, 2007, IEEE T MED IMAGING, V26, P1464, DOI 10.1109/TMI.2007.907552; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Kim JH, 2011, NMR BIOMED, V24, P163, DOI 10.1002/nbm.1567; Kiselev VG, 2007, MAGN RESON MED, V57, P464, DOI 10.1002/mrm.21164; Kolind S, 2013, AMYOTROPH LAT SCL FR, V14, P562, DOI 10.3109/21678421.2013.794843; Le Bihan D, 2012, NEUROIMAGE, V61, P324, DOI 10.1016/j.neuroimage.2011.11.006; Magin RL, 2008, J MAGN RESON, V190, P255, DOI 10.1016/j.jmr.2007.11.007; Marchand A, 2014, MAGN RESON IMAGING, V32, P1091, DOI 10.1016/j.mri.2014.07.009; Marcuzzo S, 2017, EXP NEUROL, V293, P43, DOI 10.1016/j.expneurol.2017.03.018; Muller HP, 2016, J NEUROL NEUROSUR PS, V87, P570, DOI 10.1136/jnnp-2015-311952; Nair G, 2010, NEUROIMAGE, V53, P576, DOI 10.1016/j.neuroimage.2010.06.060; Niendorf T, 1996, MAGN RESON MED, V36, P847, DOI 10.1002/mrm.1910360607; Novikov DS, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3998; Ong HH, 2010, NEUROIMAGE, V51, P1360, DOI 10.1016/j.neuroimage.2010.03.063; Reiter DA, 2009, MAGN RESON MED, V61, P803, DOI 10.1002/mrm.21926; Sach M, 2004, BRAIN, V127, P340, DOI 10.1093/brain/awh041; Sage CA, 2009, HUM BRAIN MAPP, V30, P3657, DOI 10.1002/hbm.20794; Tonnesen J, 2018, CELL, V172, P1108, DOI 10.1016/j.cell.2018.02.007; Toosy AT, 2003, J NEUROL NEUROSUR PS, V74, P1250, DOI 10.1136/jnnp.74.9.1250; Veraart J, 2019, NEUROIMAGE, V185, P379, DOI 10.1016/j.neuroimage.2018.09.075; Verstraete E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024239; Whittall KP, 2002, MAGNET RESON MED, V47, P403, DOI 10.1002/mrm.10076; WHITTALL KP, 1989, J MAGN RESON, V84, P134, DOI 10.1016/0022-2364(89)90011-5; Winklewski PJ, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00092; Wirth AM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00614; Xiao L, 2011, MAGN RESON MED, V66, P937, DOI 10.1002/mrm.23121; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561; Zhang J, 2015, MAGN RESON MED, V73, P223, DOI 10.1002/mrm.25125	52	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231598	10.1371/journal.pone.0231598	http://dx.doi.org/10.1371/journal.pone.0231598			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310954	gold, Green Published			2022-12-26	WOS:000536019800021
J	Keren-Khadmy, N; Zeytuni, N; Kutnowski, N; Perriere, G; Monteil, C; Zarivach, R				Keren-Khadmy, Noa; Zeytuni, Natalie; Kutnowski, Nitzan; Perriere, Guy; Monteil, Caroline; Zarivach, Raz			From conservation to structure, studies of magnetosome associated cation diffusion facilitators (CDF) proteins in Proteobacteria	PLOS ONE			English	Article							SEQUENCE ALIGNMENT; ZINC; MODEL; MEMBRANE; ORGANIZATION; BINDING; YIIP; MAMB	Magnetotactic bacteria (MTB) are prokaryotes that sense the geomagnetic field lines to geolocate and navigate in aquatic sediments. They are polyphyletically distributed in several bacterial divisions but are mainly represented in the Proteobacteria. In this phylum, magnetotactic Deltaproteobacteria represent the most ancestral class of MTB. Like all MTB, they synthesize membrane-enclosed magnetic nanoparticles, called magnetosomes, for magnetic sensing. Magnetosome biogenesis is a complex process involving a specific set of genes that are conserved across MTB. Two of the most conserved genes are mamB and mamM, that encode for the magnetosome-associated proteins and are homologous to the cation diffusion facilitator (CDF) protein family. In magnetotactic Alphaproteobacteria MTB species, MamB and MamM proteins have been well characterized and play a central role in iron-transport required for biomineralization. However, their structural conservation and their role in more ancestral groups of MTB like the Deltaproteobacteria have not been established. Here we studied magnetite cluster MamB and MamM cytosolic C-terminal domain (CTD) structures from a phylogenetically distant magnetotactic Deltaproteobacteria species represented by BW-1 strain, which has the unique ability to biomineralize magnetite and greigite. We characterized them in solution, analyzed their crystal structures and compared them to those characterized in Alphaproteobacteria MTB species. We showed that despite the high phylogenetic distance, MamB(BW-1) and MamM(BW-1) CTDs share high structural similarity with known CDF-CTDs and will probably share a common function with the Alphaproteobacteria MamB and MamM.	[Keren-Khadmy, Noa; Zeytuni, Natalie; Kutnowski, Nitzan; Zarivach, Raz] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; [Keren-Khadmy, Noa; Zeytuni, Natalie; Zarivach, Raz] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel; [Keren-Khadmy, Noa; Zeytuni, Natalie; Zarivach, Raz] Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel; [Perriere, Guy; Monteil, Caroline] Univ Lyon, CNRS, UMR 5558, Lab Biometrie & Biol Evolut, Villeurbanne, France; [Monteil, Caroline] Aix Marseille Univ, CEA, CNRS, UMR7265,Biosci & Biotechnol Inst Aix Marseille, St Paul Les Durance, France	Ben Gurion University; Ben Gurion University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); VetAgro Sup; CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Zarivach, R (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel.; Zarivach, R (corresponding author), Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, Beer Sheva, Israel.; Zarivach, R (corresponding author), Ben Gurion Univ Negev, Ilse Katz Inst Nanoscale Sci & Technol, Beer Sheva, Israel.	zarivach@bgu.ac.il	MONTEIL, Caroline L./AAU-8284-2021; Zeytuni, Natalie/AAP-7850-2021; ZARIVACH, RAZ/F-1671-2012	MONTEIL, Caroline L./0000-0002-2834-6834; ZARIVACH, RAZ/0000-0001-6543-0296; Zeytuni, Natalie/0000-0002-5708-4095; Keren-Khadmy, Noa/0000-0001-9886-9713	Israel Ministry of Science, Technology, and Space; Israel Science Foundation [167/16]; European Molecular Biology Organization; CMST COST Action [CM1306]	Israel Ministry of Science, Technology, and Space(Ministry of Science, Technology and Space (MOST), Israel); Israel Science Foundation(Israel Science Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); CMST COST Action	The authors of this work are supported by the Israel Ministry of Science, Technology, and Space (R.Z.), the Israel Science Foundation (grant No. 167/16; R.Z.) and the European Molecular Biology Organization and CMST COST Action CM1306 (R.Z.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber-Zucker S, 2019, FEBS J, V286, P2193, DOI 10.1111/febs.14795; Barber-Zucker S, 2017, ACS CHEM BIOL, V12, P13, DOI 10.1021/acschembio.6b01000; Barber-Zucker S, 2016, PROTEIN SCI, V25, P338, DOI 10.1002/pro.2827; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bazylinski DA, 2004, NAT REV MICROBIOL, V2, P217, DOI 10.1038/nrmicro842; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cherezov V, 2008, STRUCTURE, V16, P1378, DOI 10.1016/j.str.2008.05.014; Cotrim CA, 2019, ACTA CRYSTALLOGR D, V75, P357, DOI 10.1107/S2059798319003814; Coudray N, 2013, P NATL ACAD SCI USA, V110, P2140, DOI 10.1073/pnas.1215455110; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evgeny Krissinel, 2007, MOL BIOL; Faivre D, 2008, CHEM REV, V108, P4875, DOI 10.1021/cr078258w; Grass G, 2005, ARCH MICROBIOL, V183, P9, DOI 10.1007/s00203-004-0739-4; Greene SE, 2012, CURR OPIN CELL BIOL, V24, P490, DOI 10.1016/j.ceb.2012.05.008; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guinier A, 1955, J POLYM SCI, V1, P268; Higuchi T, 2009, PROTEINS, V76, P768, DOI 10.1002/prot.22444; Ilavsky J, 2009, J APPL CRYSTALLOGR, V42, P347, DOI 10.1107/S0021889809002222; Jogler C, 2011, P NATL ACAD SCI USA, V108, P1134, DOI 10.1073/pnas.1012694108; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Katzmann E, 2010, MOL MICROBIOL, V77, P208, DOI 10.1111/j.1365-2958.2010.07202.x; Lefevre CT, 2011, SCIENCE, V334, P1720, DOI 10.1126/science.1212596; Lin W, 2017, P NATL ACAD SCI USA, V114, P2171, DOI 10.1073/pnas.1614654114; Loftin IR, 2009, J BIOL INORG CHEM, V14, P905, DOI 10.1007/s00775-009-0503-y; Lopez-Redondo ML, 2018, P NATL ACAD SCI USA, V115, P3042, DOI 10.1073/pnas.1715051115; Losse A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025561; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; Lu M, 2009, NAT STRUCT MOL BIOL, V16, P1063, DOI 10.1038/nsmb.1662; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Morrison DA, 1997, MOL BIOL EVOL, V14, P428, DOI 10.1093/oxfordjournals.molbev.a025779; Murat D, 2010, P NATL ACAD SCI USA, V107, P5593, DOI 10.1073/pnas.0914439107; Nguyen Lam-Tung, 2015, Mol Biol Evol, V32, P268, DOI 10.1093/molbev/msu300; Nies DH, 2003, FEMS MICROBIOL REV, V27, P313, DOI 10.1016/S0168-6445(03)00048-2; Nudelman H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00009; Onquist FRR, 2012, MRBAYES 3 2 EFFICIEN, V61, P539, DOI [10.1093/sysbio/sys029, DOI 10.1093/SYSBIO/SYS029]; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ramulu HG, 2014, MOL PHYLOGENET EVOL, V75, P103, DOI 10.1016/j.ympev.2014.02.013; Raschdorf O, 2018, J PROTEOMICS, V172, P89, DOI 10.1016/j.jprot.2017.10.007; Raschdorf O, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006101; Schuler D, 2004, ARCH MICROBIOL, V181, P1, DOI 10.1007/s00203-003-0631-7; Shusterman E, 2014, METALLOMICS, V6, P1656, DOI 10.1039/c4mt00108g; Sonkaria S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034189; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Uebe R, 2018, MOL MICROBIOL, V107, P542, DOI 10.1111/mmi.13899; Uebe R, 2011, MOL MICROBIOL, V82, P818, DOI 10.1111/j.1365-2958.2011.07863.x; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Waite DW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00682; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zeytuni N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097154; Zeytuni N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092141	59	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231839	10.1371/journal.pone.0231839	http://dx.doi.org/10.1371/journal.pone.0231839			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310978	gold, Green Published			2022-12-26	WOS:000536019800039
J	Zhou, YH; Zhang, JL; Li, H; Huang, TT; Wong, CC; Wu, F; Wu, M; Weng, NQ; Liu, LP; Cheng, ASL; Yu, J; Wong, N; Lo, KW; Tang, PMK; Kang, W; To, KF				Zhou, Yuhang; Zhang, Jinglin; Li, Hui; Huang, Tingting; Wong, Chi Chun; Wu, Feng; Wu, Man; Weng, Nuoqing; Liu, Liping; Cheng, Alfred S. L.; Yu, Jun; Wong, Nathalie; Lo, Kwok Wai; Tang, Patrick M. K.; Kang, Wei; To, Ka Fai			AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis	ONCOGENE			English	Article							HIPPO PATHWAY; CANCER PROGRESSION; FAMILY PROTEINS; ANGIOMOTIN; ACTIVATION; REVEALS	Hippo signaling functions to limit cellular growth, but the aberrant nuclear accumulation of its downstream YAP1 leads to carcinogenesis. YAP1/TEAD complex activates the oncogenic downstream transcription, such as CTGF and c-Myc. How YAP1 is protected in the cytoplasm from ubiquitin-mediated degradation remains elusive. In this study, a member of Angiomotin (Motin) family, AMOTL1 (Angiomotin Like 1), was screened out as the only one to promote YAP1 nuclear accumulation by several clinical cohorts, which was further confirmed by the cellular functional assays. The interaction between YAP1 and AMOTL1 was suggested by co-immunoprecipitation and immunofluorescent staining. The clinical significance of the AMOTL1-YAP1-CTGF axis in gastric cancer (GC) was analyzed by multiple clinical cohorts. Moreover, the therapeutic effect of targeting the oncogenic axis was appraised by drug-sensitivity tests and xenograft-formation assays. The upregulation of AMOTL1 is associated with unfavorable clinical outcomes of GC, and knocking down AMOTL1 impairs its oncogenic properties. The cytoplasmic interaction between AMOTL1 and YAP1 protects each other from ubiquitin-mediated degradation. AMOTL1 promotes YAP1 translocation into the nuclei to activate the downstream expression, such as CTGF. Knocking down AMOTL1, YAP1, and CTGF enhances the therapeutic efficacies of the first-line anticancer drugs. Taken together, AMOTL1 plays an oncogenic role in gastric carcinogenesis through interacting with YAP1 and promoting its nuclear accumulation. A combination of AMOTL1, YAP1, and CTGF expression might serve as a surrogate of Hippo activation status. The co-activation of the AMOTL1/YAP1-CTGF axis is associated with poor clinical outcomes of GC patients, and targeting this oncogenic axis may enhance the chemotherapeutic effects.	[Zhou, Yuhang; Zhang, Jinglin; Li, Hui; Huang, Tingting; Wu, Feng; Wu, Man; Wong, Nathalie; Lo, Kwok Wai; Tang, Patrick M. K.; Kang, Wei; To, Ka Fai] Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Translat Oncol, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China; [Zhou, Yuhang; Zhang, Jinglin; Huang, Tingting; Wong, Chi Chun; Yu, Jun; Kang, Wei; To, Ka Fai] Chinese Univ Hong Kong, Inst Digest Dis, State Key Lab Digest Dis, Hong Kong, Peoples R China; [Zhou, Yuhang; Zhang, Jinglin; Huang, Tingting; Wong, Nathalie; Lo, Kwok Wai; Kang, Wei; To, Ka Fai] Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Weng, Nuoqing; Cheng, Alfred S. L.; Yu, Jun] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Liping] Jinan Univ, Clin Med Coll 2, Shenzhen Peoples Hosp, Dept Hepatobiliary & Pancreat Surg, Shenzhen, Guangdong, Peoples R China; [Cheng, Alfred S. L.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Sun Yat Sen University; Jinan University; Chinese University of Hong Kong; Chinese University of Hong Kong	Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, State Key Lab Translat Oncol, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China.; Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Inst Digest Dis, State Key Lab Digest Dis, Hong Kong, Peoples R China.; Kang, W; To, KF (corresponding author), Chinese Univ Hong Kong, Sir YK Pao Canc Ctr, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China.	weikang@cuhk.edu.hk; kfto@cuhk.edu.hk	KANG, Wei/C-5451-2016; huang, ting/GRR-3141-2022; Tang, Patrick MK/AAJ-8461-2021	KANG, Wei/0000-0002-4651-677X; Tang, Patrick MK/0000-0002-3194-3736	Research Grants Council of the Hong Kong Special Administrative Region, China [CUHK 14100019, 14118518]; Innovation and Technology Fund of Hong Kong [ITS/068/18, PiH/009/19, PiH/010/19, InP/008/19, InP/009/19]; CUHK Direct Grant for Research from The Chinese University of Hong Kong [2018.002]	Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Innovation and Technology Fund of Hong Kong; CUHK Direct Grant for Research from The Chinese University of Hong Kong	The paper is under support of the Research Grants Council of the Hong Kong Special Administrative Region, China [Project No.: CUHK 14100019 and 14118518 (for GRF projects)], Innovation and Technology Fund of Hong Kong (Project No.: (ITS/068/18, PiH/009/19, PiH/010/19, InP/008/19, and InP/009/19)), and CUHK Direct Grant for Research (2018.002) from The Chinese University of Hong Kong.	Aase K, 2007, GENE DEV, V21, P2055, DOI 10.1101/gad.432007; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cheng TY, 2014, WORLD J GASTROENTERO, V20, P1694, DOI 10.3748/wjg.v20.i7.1694; Couderc C, 2016, NEOPLASIA, V18, P10, DOI 10.1016/j.neo.2015.11.010; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Hong SA, 2017, APMIS, V125, P996, DOI 10.1111/apm.12750; Hsu YL, 2015, ONCOGENE, V34, P4056, DOI 10.1038/onc.2014.333; Huang HZ, 2007, DEVELOPMENT, V134, P979, DOI 10.1242/dev.02782; Huang TT, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1466-y; Hultin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4743; Jiang CG, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-122; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kang W, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0134-0; Kang W, 2017, J THORAC DIS, V9, P1748, DOI 10.21037/jtd.2017.06.26; Kang W, 2016, WORLD J GASTROENTERO, V22, P1279, DOI 10.3748/wjg.v22.i3.1279; Kang W, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0323-3; Kang W, 2011, CLIN CANCER RES, V17, P2130, DOI 10.1158/1078-0432.CCR-10-2467; Li ZQ, 2012, J BIOL CHEM, V287, P13005, DOI 10.1074/jbc.M112.347419; Lim B, 2014, CARCINOGENESIS, V35, P1020, DOI 10.1093/carcin/bgt409; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Lu TT, 2018, CANCER LETT, V423, P36, DOI 10.1016/j.canlet.2018.02.015; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Perra A, 2014, J HEPATOL, V61, P1088, DOI 10.1016/j.jhep.2014.06.033; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Shi Z, 2017, ONCOGENE, V36, P4362, DOI 10.1038/onc.2017.24; Trautmann M, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809889; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; Wang Y, 2017, ONCOGENE, V36, P534, DOI 10.1038/onc.2016.224; Weiler SME, 2017, GASTROENTEROLOGY, V152, P2037, DOI 10.1053/j.gastro.2017.02.018; Yi CL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004060; Yu MX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0515-z; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zheng YJ, 2009, CIRC RES, V105, P260, DOI 10.1161/CIRCRESAHA.109.195156; Zhou Y, 2017, ONCOGENE, V36, P6518, DOI 10.1038/onc.2017.257; Zhou YH, 2018, CANCER LETT, V426, P73, DOI 10.1016/j.canlet.2018.04.004; Zhou YH, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0647-2; Zhou YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17010138	40	11	11	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	22					4375	4389		10.1038/s41388-020-1293-5	http://dx.doi.org/10.1038/s41388-020-1293-5		APR 2020	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LR9IT	32313226	hybrid, Green Published			2022-12-26	WOS:000527509300001
J	Lopez-Duran, PA; Fonseca-Coronado, S; Lozano-Trenado, LM; Araujo-Betanzos, S; Rugerio-Trujillo, DA; Vaughan, G; Saldana-Rivera, E				Alexis Lopez-Duran, Paul; Fonseca-Coronado, Salvador; Maritza Lozano-Trenado, Lucila; Araujo-Betanzos, Sergio; Alejandra Rugerio-Trujillo, Deniria; Vaughan, Gilberto; Saldana-Rivera, Elsa			Nosocomial transmission of extensively drug resistant Acinetobacter baumannii strains in a tertiary level hospital	PLOS ONE			English	Article							ANTIMICROBIAL RESISTANCE	Acinetobacter baumannii is an opportunistic infectious agent that affects primarily immuno-compromised individuals. A. baumannii is highly prevalent in hospital settings being commonly associated with nosocomial transmission and drug resistance. Here, we report the identification and genetic characterization of A. baumannii strains among patients in a tertiary level hospital in Mexico. Whole genome sequencing analysis was performed to establish their genetic relationship and drug resistance mutations profile. Ten genetically different, extensively drug resistant strains were identified circulating among seven wards. The genetic profiles showed resistance primarily against aminoglycosides and beta-lactam antibiotics. Importantly, no mutants conferring resistance to colistin were observed. The results highlight the importance of implementing robust classification schemes for advanced genetic characterization of A. baumannii clinical isolates and simultaneous detection of drug resistance markers for adequate patient's management in clinical settings.	[Alexis Lopez-Duran, Paul] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Dept Bioinformat & Biotecnol Genom, Mexico City, DF, Mexico; [Alexis Lopez-Duran, Paul; Fonseca-Coronado, Salvador] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Lab Invest Enfermedades Infecciosas, Mexico City, Edo De Mexico, Mexico; [Alexis Lopez-Duran, Paul; Fonseca-Coronado, Salvador] Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Unidad Invest Multidisciplinaria, Mexico City, Edo De Mexico, Mexico; [Alexis Lopez-Duran, Paul; Vaughan, Gilberto] Univ Anahuac, Fac Ciencias Salud, Campus Norte, Naucalpan De Juarez, Estado De Mexic, Mexico; [Maritza Lozano-Trenado, Lucila; Araujo-Betanzos, Sergio; Saldana-Rivera, Elsa] Secretaria Def Nacl, Escuela Mil Grad Sanidad, Mexico City, DF, Mexico; [Alejandra Rugerio-Trujillo, Deniria] Hosp Cent Mil, Secretaria Def Nacl, Mexico City, DF, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Anahuac	Fonseca-Coronado, S (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Lab Invest Enfermedades Infecciosas, Mexico City, Edo De Mexico, Mexico.; Fonseca-Coronado, S (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Cuautitlan, Unidad Invest Multidisciplinaria, Mexico City, Edo De Mexico, Mexico.	fonsecacoronado@yahoo.com	Fonseca-Coronado, Salvador SFC/A-3443-2015	Fonseca-Coronado, Salvador SFC/0000-0003-3853-6313; Lopez-Duran, Paul Alexis/0000-0002-2577-6599	Secretaria de la Defensa Nacional, Mexico; Programa Presupuestario A022: Investigacion y Desarrollo Militar en Coordinacio n con Universidades Publicas, Instituciones Publicas de Educacio n Superior y/o demas Centros Publicos de Investigacion	Secretaria de la Defensa Nacional, Mexico; Programa Presupuestario A022: Investigacion y Desarrollo Militar en Coordinacio n con Universidades Publicas, Instituciones Publicas de Educacio n Superior y/o demas Centros Publicos de Investigacion	Programa Presupuestario A022: Investigacion y Desarrollo Militar en Coordinacio n con Universidades Publicas, Instituciones Publicas de Educacio n Superior y/o demas Centros Publicos de Investigacion. Recipient: ESR. Secretaria de la Defensa Nacional, Mexico.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Beigverdi R, 2019, INFECT GENET EVOL, V73, P433, DOI 10.1016/j.meegid.2019.06.008; Bocanegra-Ibarias P, 2015, INT J ANTIMICROB AG, V45, P309, DOI 10.1016/j.ijantimicag.2014.10.022; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown J, 2017, BIOINFORMATICS, V33, P3137, DOI 10.1093/bioinformatics/btx373; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Alcantar-Curiel MD, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02116; Gaiarsa S, 2019, FRONTIERS MICROBIOLO, V10; Gonzalez-Villoria AM, 2016, ANTIMICROB AGENTS CH, V60, P2587, DOI 10.1128/AAC.02042-15; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Jackman SD, 2017, GENOME RES, V27, P768, DOI 10.1101/gr.214346.116; Jia HQ, 2019, INFECT DRUG RESIST, V12, P1545, DOI 10.2147/IDR.S202803; Kumburu HH, 2019, J ANTIMICROB CHEMOTH, V74, P1484, DOI 10.1093/jac/dkz055; Lee CM, 2005, SCAND J INFECT DIS, V37, P195, DOI 10.1080/00365540510026869; Leski TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069507; Lima WG, 2019, BURNS, V45, P1495, DOI 10.1016/j.burns.2019.07.006; Lv WB, 2019, J GLOB ANTIMICROB RE, V16, P1, DOI 10.1016/j.jgar.2018.11.008; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Maragakis LL, 2008, CLIN INFECT DIS, V46, P1254, DOI 10.1086/529198; Mulani MS, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00539; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; PINZÓN JANNETH ORQUÍDEA, 2006, Infect., V10, P71; Saavedra SY, 2008, INT J ANTIMICROB AG, V31, P389, DOI 10.1016/j.ijantimicag.2007.12.008; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Silva M, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000166; Takoi H, 2019, AM J INFECT CONTROL, V47, P1171, DOI 10.1016/j.ajic.2019.04.009; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhou H, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014937	29	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231829	10.1371/journal.pone.0231829	http://dx.doi.org/10.1371/journal.pone.0231829			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302355	Green Published, gold			2022-12-26	WOS:000536016100056
J	Paudel, GP; Devkota, M; Keil, A; McDonald, AJ				Paudel, Gokul P.; Devkota, Mina; Keil, Alwin; McDonald, Andrew J.			Climate and landscape mediate patterns of low lentil productivity in Nepal	PLOS ONE			English	Article							BREEDING LENTIL; ABIOTIC STRESS; FARM-LEVEL; ADAPTATION; PRECIPITATION; DETERMINANTS; TEMPERATURE; PROJECTIONS; BANGLADESH; EFFICIENCY	Lentil (Lens culinaris Medik.) is a cool-season pulse grown in winter cropping cycle in South Asia and provides a major source of nutrition for many low-income households. Lentil productivity is perceived to be sensitive to high rainfall, but few studies document spatial and temporal patterns of yield variation across climate, soil, and agronomic gradients. Using farm survey data from Nepal, this study characterizes patterns of lentil productivity and efficiency for two cropping seasons. Additional insights were derived from on-farm trials conducted over a 5-year period that assess agronomic, drainage, and cultivar interventions. To contextualize the inferences derived from farm surveys and trials, the Stempedia model was used to simulate the severity of Stemphylium blight (Stemphylium botryosum) risk-the principal fungal disease in lentil-with 30 years of historical climate data. Although development efforts in Nepal have prioritized pulse intensification, results confirm that lentil remains a risky enterprise highlighting the prevalence of crop failures (16%), modest yields (353 kg ha(-1)), and low levels of profitability (US$ 33 ha(-1)) in wet winters. Nevertheless, site factors such as drainage class influence responses with upland sites performing well in wet winters and lowland sites performing well in dry winters. In wet winters, a phenomena perceived to be increasing, 76% of surveyed farmers reported significant disease pressure and simulations with Stempedia predict that conditions favoring Stemphylium occur in >60% of all years. Nevertheless, simulation results also suggest that these risks can be addressed through earlier planting. Based on the combined results, gains in yield, yield stability, and technical efficiency can be enhanced in western Nepal by: 1) ensuring timely lentil planting to mitigate climate-mediated disease risk, 2) evaluating new lentil lines that may provide enhanced resistance to diseases and waterlogging, and 3) encouraging the emergence of mechanization solutions to overcome labor bottlenecks.	[Paudel, Gokul P.; Devkota, Mina; McDonald, Andrew J.] South Asia Reg Off, Int Maize & Wheat Improvement Ctr CIMMYT, Kathmandu, Nepal; [Keil, Alwin] Natl Agr Sci Ctr Complex NASC, Int Maize & Wheat Improvement Ctr CIMMYT, New Delhi, India; [Devkota, Mina] Int Ctr Agr Res Dry Areas ICARDA, Rabat, Morocco; [McDonald, Andrew J.] Cornell Univ, Sch Integrat Plant Sci, Sect Soil & Crop Sci, New York, NY USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); CGIAR; International Center for Agricultural Research in the Dry Areas (ICARDA); Cornell University	Paudel, GP (corresponding author), South Asia Reg Off, Int Maize & Wheat Improvement Ctr CIMMYT, Kathmandu, Nepal.	g.paudel@cgiar.org		Paudel, Gokul P./0000-0002-5277-6287	United States Agency for International Development (USAID) [BFS-G-11-00002]; Bill & Melinda Gates Foundation (BMGF) [OPP1133205]	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Bill & Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	This research was conducted as part of the Cereal Systems Initiative for South Asia (CSISA) in Nepal, which is funded by the United States Agency for International Development (USAID) (Grant no: BFS-G-11-00002) and Bill & Melinda Gates Foundation (BMGF) (Grant no: OPP1133205), and conducted by the researchers at the International Maize and Wheat Improvement Center (CIMMYT). The funders had no role in the study design, data collection, analysis, manuscript preparation, and decision to publish the manuscript.	Abid M, 2016, SCI TOTAL ENVIRON, V547, P447, DOI 10.1016/j.scitotenv.2015.11.125; Ahmed S, 1996, CAN J PLANT PATHOL, V18, P362, DOI 10.1080/07060669609500589; Aigner D., 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; [Anonymous], J ENV PROTECTION; [Anonymous], 2017, POWER CLIMATOLOGY RE; Aslam AQ, 2018, SCI TOTAL ENVIRON, V628-629, P1422, DOI 10.1016/j.scitotenv.2018.02.129; Atkinson NJ, 2013, PLANT PHYSIOL, V162, P2028, DOI 10.1104/pp.113.222372; Battese G. E., 1995, EMPIR ECON, V20, P325, DOI DOI 10.1007/BF01205442; Bayaa B., 1998, P423; Bayaa B., 1994, Genetic Resources and Crop Evolution, V41, P61, DOI 10.1007/BF00053049; Beneito P, 2001, APPL ECON, V33, P1541, DOI 10.1080/00036840010009892; Bravo-Ureta B. E., 1993, Agricultural and Resource Economics Review, V22, P88; Bueckert RA, 2011, CAN J PLANT SCI, V91, P117, DOI 10.4141/CJPS10125; Chung U, 2014, WEATHER CLIM EXTREME, V5-6, P67, DOI 10.1016/j.wace.2014.07.002; Devendra C, 2007, OUTLOOK AGR, V36, P7, DOI 10.5367/000000007780223641; Dewan TH, 2015, WEATHER CLIM EXTREME, V7, P36, DOI 10.1016/j.wace.2014.11.001; Dey MM., 2000, AQUACULT ECON MANAG, V4, P63, DOI [10.1080/13657300009380261, DOI 10.1080/13657300009380261]; Dimri AP, 2016, SCI TOTAL ENVIRON, V556, P98, DOI 10.1016/j.scitotenv.2016.02.206; Duveiller E, 2007, EUPHYTICA, V157, P417, DOI 10.1007/s10681-007-9380-z; Ellis F., 1993, PEASANT EC FARM HOUS; ERSKINE W, 1993, J AGR SCI, V121, P347, DOI 10.1017/S0021859600085543; ERSKINE W, 1994, EUPHYTICA, V73, P127, DOI 10.1007/BF00027189; Erskine W, 2011, FOOD SECUR, V3, P127, DOI 10.1007/s12571-011-0124-5; FAO, 2017, FAOSTAT STAT DAT UN; FARRELL MJ, 1957, J R STAT SOC SER A-G, V120, P253, DOI 10.2307/2343100; GREENE WH, 1990, J ECONOMETRICS, V46, P141, DOI 10.1016/0304-4076(90)90052-U; Heady E.O., 1961, AGR PRODUCTION FUNCT; Horwitz P, 2003, INT J PARASITOL, V91, P890; Ichiyanagi K, 2007, INT J CLIMATOL, V27, P1753, DOI 10.1002/joc.1492; ICT, 2007, EXP POT ASS NEP; Im ES, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603322; Janes T, 2019, SCI TOTAL ENVIRON, V650, P1499, DOI 10.1016/j.scitotenv.2018.08.376; Kant P, 2017, AUSTRALAS PLANT PATH, V46, P129, DOI 10.1007/s13313-017-0469-0; Karim MR, 2015, WEATHER CLIM EXTREME, V7, P24, DOI 10.1016/j.wace.2014.10.004; Karki R, 2017, CLIMATE, V5, DOI 10.3390/cli5010004; Karmakar N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07529-6; Keil A, 2016, FOOD SECUR, V8, P1011, DOI 10.1007/s12571-016-0611-9; Kumar P, 2013, SCI TOTAL ENVIRON, V468, pS18, DOI 10.1016/j.scitotenv.2013.01.051; Kumar S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191122; KUMBHAKAR SC, 1991, J BUS ECON STAT, V9, P279, DOI 10.2307/1391292; Lal M, 2011, REG ENVIRON CHANGE, V11, pS79, DOI 10.1007/s10113-010-0166-9; Leng GY, 2019, SCI TOTAL ENVIRON, V654, P811, DOI 10.1016/j.scitotenv.2018.10.434; Lu GY, 2008, COMPUT GEOSCI-UK, V34, P1044, DOI 10.1016/j.cageo.2007.07.010; Lutz AF, 2014, NAT CLIM CHANGE, V4, P587, DOI [10.1038/NCLIMATE2237, 10.1038/nclimate2237]; Malik AI, 2016, J AGR SCI-CAMBRIDGE, V154, P850, DOI 10.1017/S0021859614001324; Manandhar S, 2011, REG ENVIRON CHANGE, V11, P335, DOI 10.1007/s10113-010-0137-1; Masood Ali, 2009, The lentil: botany, production and uses, P213, DOI 10.1079/9781845934873.0213; Materne M., 2009, The lentil: botany, production and uses, P47, DOI 10.1079/9781845934873.0047; Mathison C, 2013, SCI TOTAL ENVIRON, V468, pS4, DOI 10.1016/j.scitotenv.2012.04.066; McDonald A, 2009, AGR ECOSYST ENVIRON, V130, P131, DOI 10.1016/j.agee.2008.12.007; MEEUSEN W, 1977, INT ECON REV, V18, P435, DOI 10.2307/2525757; Mirza MMQ, 2011, REG ENVIRON CHANGE, V11, pS95, DOI 10.1007/s10113-010-0184-7; Mirza MMQ, 2002, GLOBAL ENVIRON CHANG, V12, P127, DOI 10.1016/S0959-3780(02)00002-X; Mishra AK, 2015, AGR ECOSYST ENVIRON, V199, P146, DOI 10.1016/j.agee.2014.09.006; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; MoAD, 2016, STAT INF NEP AGR; Moors EJ, 2013, SCI TOTAL ENVIRON, V468, pS162, DOI 10.1016/j.scitotenv.2013.11.058; Muehlbauer FJ, 2006, EUPHYTICA, V147, P149, DOI 10.1007/s10681-006-7108-0; Myers R., 1990, CLASSICAL MODERN REG; Narsai R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-93; Palazzi E, 2013, J GEOPHYS RES-ATMOS, V118, P85, DOI 10.1029/2012JD018697; Pandey P, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00537; Pandey VP, 2019, SCI TOTAL ENVIRON, V650, P365, DOI 10.1016/j.scitotenv.2018.09.053; Pradhan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129487; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Prasch CM, 2013, PLANT PHYSIOL, V162, P1849, DOI 10.1104/pp.113.221044; Rahman S, 2003, AGR ECOSYST ENVIRON, V95, P241, DOI 10.1016/S0167-8809(02)00089-0; Rahman S, 1999, OUTLOOK AGR, V28, P233, DOI 10.1177/003072709902800406; Ramegowda V, 2015, J PLANT PHYSIOL, V176, P47, DOI 10.1016/j.jplph.2014.11.008; REIESCHNEIDER D, 1991, INT ECON REV, V32, P715; Salam MU, 2016, AUSTRALAS PLANT PATH, V45, P499, DOI 10.1007/s13313-016-0434-3; Seiford LM, 1996, J PROD ANAL, V7, P99, DOI 10.1007/BF00157037; Shrestha AB, 2017, INT J CLIMATOL, V37, P1066, DOI 10.1002/joc.4761; Shrestha AB, 2011, REG ENVIRON CHANGE, V11, pS65, DOI 10.1007/s10113-010-0174-9; Singh RB, 2014, ATMOS SCI LETT, V15, P218, DOI 10.1002/asl2.494; STEVENSON RE, 1980, J ECONOMETRICS, V13, P57, DOI 10.1016/0304-4076(80)90042-1; Subedi S., 2015, Indian Phytopathology, V68, P415; THAPA G, 1992, AGR ECON, V7, P245, DOI 10.1016/0169-5150(92)90052-Z; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; USAID, 2013, LENT MARK ASS REP NE; Wang HJ, 2002, J PROD ANAL, V18, P129, DOI 10.1023/A:1016565719882; Whitehead PG, 2018, SCI TOTAL ENVIRON, V636, P1362, DOI 10.1016/j.scitotenv.2018.04.362; Wiraguna E, 2017, GENET RESOUR CROP EV, V64, P579, DOI 10.1007/s10722-016-0385-0; Zhang X, 2019, SCI TOTAL ENVIRON, V693, DOI 10.1016/j.scitotenv.2019.07.342	84	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231377	10.1371/journal.pone.0231377	http://dx.doi.org/10.1371/journal.pone.0231377			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298316	Green Published, gold			2022-12-26	WOS:000536011400040
J	Tan, YC; Sattar, MA; Ahmeda, AF; Khan, NAK; Murugaiyah, V; Ahmad, A; Hassan, Z; Kaur, G; Abdulla, MH; Johns, EJ				Tan, Yong Chia; Sattar, Munavvar Abdul; Ahmeda, Ahmad F.; Khan, Nurzalina Abdul Karim; Murugaiyah, Vikneswaran; Ahmad, Ashfaq; Hassan, Zurina; Kaur, Gurjeet; Abdulla, Mohammed Hadi; Johns, Edward James			Apocynin and catalase prevent hypertension and kidney injury in Cyclosporine A-induced nephrotoxicity in rats	PLOS ONE			English	Article							OXIDATIVE STRESS; NADPH OXIDASE; AORTIC STIFFNESS; RENAL EXPRESSION; HYDROGEN-SULFIDE; NAD(P)H OXIDASES; ANGIOTENSIN-II; NITRIC-OXIDE; ACTIVATION; HEMODYNAMICS	Oxidative stress is involved in the pathogenesis of a number of diseases including hypertension and renal failure. There is enhanced expression of nicotinamide adenine dinucleotide (NADPH oxidase) and therefore production of hydrogen peroxide (H2O2) during renal disease progression. This study investigated the effect of apocynin, an NADPH oxidase inhibitor and catalase, an H2O2 scavenger on Cyclosporine A (CsA) nephrotoxicity in Wistar-Kyoto rats. Rats received CsA (25mg/kg/day via gavage) and were assigned to vehicle, apocynin (2.5mmol/L p.o.), catalase (10,000U/kg/day i.p.) or apocynin plus catalase for 14 days. Renal functional and hemodynamic parameters were measured every week, and kidneys were harvested at the end of the study for histological and NADPH oxidase 4 (NOX4) assessment. Oxidative stress markers and blood urea nitrogen (BUN) were measured. CsA rats had higher plasma malondialdehyde (by 340%) and BUN (by 125%), but lower superoxide dismutase and total antioxidant capacity (by 40%, all P<0.05) compared to control. CsA increased blood pressure (by 46mmHg) and decreased creatinine clearance (by 49%, all P<0.05). Treatment of CsA rats with apocynin, catalase, and their combination decreased blood pressure to near control values (all P<0.05). NOX4 mRNA activity was higher in the renal tissue of CsA rats by approximately 63% (P<0.05) compared to controls but was reduced in apocynin (by 64%), catalase (by 33%) and combined treatment with apocynin and catalase (by 84%) compared to untreated CsA rats. Treatment of CsA rats with apocynin, catalase, and their combination prevented hypertension and restored renal functional parameters and tissue Nox4 expression in this model. NADPH inhibition and H2O2 scavenging is an important therapeutic strategy during CsA nephrotoxicity and hypertension.	[Tan, Yong Chia; Sattar, Munavvar Abdul; Khan, Nurzalina Abdul Karim; Murugaiyah, Vikneswaran] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia; [Ahmeda, Ahmad F.] Qatar Univ, Coll Med, Basic Med Sci Dept, Doha, Qatar; [Ahmad, Ashfaq] Virginia Commonwealth Univ, Sch Med, Dept Pharmacol & Toxicol, Richmond, VA USA; [Ahmad, Ashfaq] Abasyn Univ, Dept Pharm, Islamabad Campus, Islamabad, Pakistan; [Hassan, Zurina] Univ Sains Malaysia, Ctr Drug Res, George Town, Malaysia; [Kaur, Gurjeet] Univ Sains Malaysia, Inst Mol Med Res, George Town, Malaysia; [Abdulla, Mohammed Hadi; Johns, Edward James] Univ Coll Cork, Dept Physiol, Cork, Ireland	Universiti Sains Malaysia; Qatar University; Virginia Commonwealth University; Universiti Sains Malaysia; Universiti Sains Malaysia; University College Cork	Tan, YC (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia.	tanyongchia@student.usm.my	Kaur, Gurjeet/AAN-7934-2020; Hassan, Zurina/G-5674-2012; Kaur, Gurjeet/A-1085-2011; Stefanadis, Christodoulos/ABH-2232-2020	Kaur, Gurjeet/0000-0002-6232-5703; Hassan, Zurina/0000-0003-3205-4612; Kaur, Gurjeet/0000-0002-6232-5703; Stefanadis, Christodoulos/0000-0001-5974-6454; Murugaiyah, Vikneswaran/0000-0003-1768-7577; TAN, YONG CHIA/0000-0002-2663-6950; Ahmeda, Ahmad F./0000-0001-5962-9573	Research University grant from University Sains Malaysia [1001/PFARMASI/811347]; Institute of Postgraduate Studies (IPS) of University Sains Malaysia	Research University grant from University Sains Malaysia; Institute of Postgraduate Studies (IPS) of University Sains Malaysia	Tan Yong Chia; will be the corresponding author for this paper. This study was funded by the Research University grant from University Sains Malaysia number 1001/PFARMASI/811347. Tan Yong Chia is a recipient of a research fellowship from the Institute of Postgraduate Studies (IPS) of University Sains Malaysia. NO-Include this sentence at the end of your statement: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189386; Ahmad A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150137; Ahmad FUD, 2013, INT J PHARM SCI RES, V4, P2916, DOI 10.13040/IJPSR.0975-8232.4(8).2916-26; Ahmad FUD, 2014, RENAL FAILURE, V36, P598, DOI 10.3109/0886022X.2014.882218; Altintas R, 2013, J ENDOUROL, V27, P617, DOI 10.1089/end.2012.0556; ARCHER S, 1993, FASEB J, V7, P349, DOI 10.1096/fasebj.7.2.8440411; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Basuroy S, 2009, AM J PHYSIOL-CELL PH, V296, pC422, DOI 10.1152/ajpcell.00381.2008; Bayorh MA, 2012, J RENIN-ANGIO-ALDO S, V13, P353, DOI 10.1177/1470320312443911; Bobadilla NA, 2007, AM J PHYSIOL-RENAL, V293, pF2, DOI 10.1152/ajprenal.00072.2007; Brandes RP, 2001, THROMB HAEMOSTASIS, V85, P1104; Burdmann EA, 2003, SEMIN NEPHROL, V23, P465, DOI 10.1016/S0270-9295(03)00090-1; CAMPESE VM, 1995, HYPERTENSION, V25, P878, DOI 10.1161/01.HYP.25.4.878; Chen F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00412; Chia TY, 2013, RENAL FAILURE, V35, P978, DOI 10.3109/0886022X.2013.809563; Chia TY, 2012, INT J PHARM PHARM SC, V4, P431; Ciarcia R, 2015, J CELL BIOCHEM, V116, P1848, DOI 10.1002/jcb.25140; CIRESI DL, 1992, KIDNEY INT, V41, P1599, DOI 10.1038/ki.1992.231; Colgan J, 2005, J IMMUNOL, V174, P6030, DOI 10.4049/jimmunol.174.10.6030; Cosson E, 2007, AM J PHYSIOL-HEART C, V292, pH2506, DOI 10.1152/ajpheart.00732.2006; Covic A, 2005, KIDNEY INT, V67, P732, DOI 10.1111/j.1523-1755.2005.67134.x; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; De Keulenaer GW, 1998, BIOCHEM J, V329, P653; Edemir B, 2008, J AM SOC NEPHROL, V19, P538, DOI 10.1681/ASN.2007040513; Eudy RJ, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-180; Fassi A, 1999, AM J KIDNEY DIS, V33, P267, DOI 10.1016/S0272-6386(99)70299-4; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Griendling KK, 2006, ANTIOXID REDOX SIGN, V8, P1443, DOI 10.1089/ars.2006.8.1443; Griendling KK, 2004, HEART, V90, P491, DOI 10.1136/hrt.2003.029397; Guzik TJ, 2006, ARTERIOSCL THROM VAS, V26, P333, DOI 10.1161/01.ATV.0000196651.64776.51; Guzik TJ, 2008, J AM COLL CARDIOL, V52, P1803, DOI 10.1016/j.jacc.2008.07.063; Hagar HH, 2006, CLIN EXP PHARMACOL P, V33, P189, DOI 10.1111/j.1440-1681.2006.04345.x; Hamilton CA, 2004, CLIN SCI, V106, P219, DOI 10.1042/CS20030379; Hausberg M, 2002, CIRCULATION, V106, P1974, DOI 10.1161/01.CIR.0000034043.16664.96; HEERING P, 1993, CLIN INVESTIGATOR, V71, P1010; Hoorn EJ, 2012, J NEPHROL, V25, P269, DOI 10.5301/jn.5000174; Jha JC, 2017, DIABETES, V66, P2691, DOI 10.2337/db16-1585; Juncos R, 2005, AM J PHYSIOL-RENAL, V288, pF982, DOI 10.1152/ajprenal.00348.2004; Kim SW, 2005, AM J PHYSIOL-RENAL, V289, pF957, DOI 10.1152/ajprenal.00413.2004; Kitiyakara C, 2003, J AM SOC NEPHROL, V14, P2775, DOI 10.1097/01.ASN.0000092145.90389.65; Lassegue B, 2003, AM J PHYSIOL-REG I, V285, pR277, DOI 10.1152/ajpregu.00758.2002; Ma SF, 2007, KIDNEY INT, V72, P1474, DOI 10.1038/sj.ki.5002556; MILLER NJ, 1993, CLIN SCI, V84, P407, DOI 10.1042/cs0840407; Modlinger P, 2006, HYPERTENSION, V47, P238, DOI 10.1161/01.HYP.0000200023.02195.73; MORPHAKE P, 1994, PROSTAG LEUKOTR ESS, V50, P29, DOI 10.1016/0952-3278(94)90102-3; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Nishiyama A, 2003, HYPERTENSION, V42, P754, DOI 10.1161/01.HYP.0000085195.38870.44; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Ortiz PA, 2002, AM J PHYSIOL-RENAL, V283, pF957, DOI 10.1152/ajprenal.00102.2002; OYANAGUI Y, 1984, ANAL BIOCHEM, V142, P290; Patel RS, 2011, ATHEROSCLEROSIS, V218, P90, DOI 10.1016/j.atherosclerosis.2011.04.033; PICHLER RH, 1995, J AM SOC NEPHROL, V6, P1186; Prevot A, 2000, PEDIATR NEPHROL, V14, P370, DOI 10.1007/s004670050777; SMITH SR, 1992, KIDNEY INT, V41, P199, DOI 10.1038/ki.1992.27; Sousa T, 2012, BRIT J PHARMACOL, V166, P2386, DOI 10.1111/j.1476-5381.2012.01957.x; Sun J, 2003, SENSORS-BASEL, V3, P276, DOI 10.3390/s30800276; Swarup KRLA, 2010, PHARMACOGN RES, V2, P31, DOI 10.4103/0974-8490.60582; Taylor NE, 2006, HYPERTENSION, V47, P692, DOI 10.1161/01.HYP.0000203161.02046.8d; Touyz RM, 2008, HYPERTENSION, V51, P172, DOI 10.1161/HYPERTENSIONAHA.107.103200; Vlachopoulos C, 2012, HYPERTENSION, V60, P556, DOI 10.1161/HYPERTENSIONAHA.112.194779; Wang YX, 2000, AM J PHYSIOL-HEART C, V278, pH428, DOI 10.1152/ajpheart.2000.278.2.H428; Yang X., 2019, DRUG SAFETY, P1; Yoon Hye Eun, 2009, Korean Journal of Internal Medicine, V24, P81, DOI 10.3904/kjim.2009.24.2.81; Zhang ZH, 2010, J HYPERTENS, V28, P806, DOI 10.1097/HJH.0b013e3283358b6e	65	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231472	10.1371/journal.pone.0231472	http://dx.doi.org/10.1371/journal.pone.0231472			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298299	Green Published, gold			2022-12-26	WOS:000536011400052
J	Acevedo-Villanueva, KY; Lester, B; Renu, S; Han, Y; Shanmugasundaram, R; Gourapura, R; Selvaraj, R				Acevedo-Villanueva, Keila Y.; Lester, Bailey; Renu, Sankar; Han, Yi; Shanmugasundaram, Revathi; Gourapura, Renukaradhya; Selvaraj, Ramesh			Efficacy of chitosan-based nanoparticle vaccine administered to broiler birds challenged with Salmonella	PLOS ONE			English	Article								Two experiments were conducted to evaluate the immune response of broilers vaccinated with Salmonella chitosan-nanoparticle (CNP) vaccine and challenged with Salmonella. The Salmonella CNP vaccine was synthesized with Salmonella enterica outer membrane proteins (OMPs) and flagellin proteins. In Experiment I, birds were orally gavaged with PBS or 500, 1000, or 2000 mu g of CNP vaccine 1 and 7d-of-age. At 14d-of-age, birds were orally challenged with 1 X 10(5) CFU/bird of live S. Enteritidis (SE). Macrophage-nitrite production 11d-post-challenge was higher (P<0.05) in the 500 mu g group when compared to the control. At d14 (8h-post-challenge), broilers vaccinated with 1000 mu g CNP had higher (P<0.05) serum anti-OMPs IgG and IgA and cloacal anti-OMP IgA amounts. At 11d-post-challenge, birds vaccinated with 1000 mu g CNP vaccine had greater (P<0.05) bile anti-OMP and anti-flagellin IgA amounts. At 11d-post-challenge, birds administered 1000 mu g CNP vaccine has increased (P<0.05) IL-1 beta and IL-10 mRNA in cecal tonsils. In Experiment II, birds were orally gavaged with PBS or 1000 mu g CNP or a live commercial vaccine at 1 and 7d-of-age. At 14d-of-age, birds were orally challenged with 1 X 10(5) CFU/bird of live SE or S. Heidelberg (SH). Birds vaccinated with CNP showed higher (P<0.05) serum anti-OMPs IgG amounts at 8h-post-challenge. At 4d-post-SH challenge, birds vaccinated with CNP had higher (P<0.05) bile anti-flagellin IgA amounts. CNP decreased (P<0.05) anti- OMPs IgG levels in serum at 2d-post-SE challenge and 4d-post-SH or SE challenge. Salmonella Enteritidis loads in cecal content at 2d-post-challenge was decreased (P<0.05) by 65.9% in birds vaccinated with CNP, when compared to the control. Chitosan-nanovaccine had no adverse effects on bird's production performance. In conclusion, 1000 mu g CNP vaccine can induce a specific immune response against Salmonella and has the potential to mitigate SE cecal colonization in broiler birds.	[Acevedo-Villanueva, Keila Y.; Lester, Bailey; Shanmugasundaram, Revathi; Selvaraj, Ramesh] Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA; [Renu, Sankar; Han, Yi; Gourapura, Renukaradhya] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Res Program, Wooster, OH 44691 USA; [Renu, Sankar] Ohio State Univ, Coll Vet Med, Dept Vet Prevent Med, Columbus, OH 43210 USA	University System of Georgia; University of Georgia; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Selvaraj, R (corresponding author), Univ Georgia, Dept Poultry Sci, Athens, GA 30602 USA.	selvaraj@uga.edu	Sankar, Renu/F-6912-2012	Sankar, Renu/0000-0003-4197-9684; /0000-0003-0546-6902; Acevedo-Villanueva, Keila Yanis/0000-0002-4164-7658	Hatch grant; USDA-NIFA [2017-05035]	Hatch grant; USDA-NIFA(United States Department of Agriculture (USDA))	This research was partially supported by Hatch grant and USDA-NIFA grant 2017-05035 awarded to RKS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas Abul K., 2015, CELLULAR MOL IMMUNOL, V8; Andino A., 2015, SCI WORLD J, V2015, P520179; Annamalai T, 2012, POULT SCI; Bates J, 2010, J IMMUNOL, V184; Beal RK, 2006, VET IMMUNOL IMMUNOPA; Binnebose AM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004173; Borsoi A, 2011, BRAZ J MICROBIOL, V42, P266, DOI 10.1590/S1517-83822011000100034; Cheung RCF, 2015, MAR DRUGS, V13, P5156, DOI 10.3390/md13085156; Coble DJ, 2011, POULT SCI; Cox NA, 1990, POULT SCI; Crum-Cianflone NF, 2008, CURR GASTROENTEROL R; Dube DK, 2014, ANAT REC; Fabrega A, 2013, CLIN MICROBIOLOGY RE; Gong JS, 2014, APPL ENVIRON MICROB, V80, P687, DOI 10.1128/AEM.03223-13; Hallstrom K, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00088; Hamal KR, 2006, POULT SCI; Hansen KR, 2006, J APPL MICROBIOL; He H, 2013, PLOS ONE; Higginson EE, 2016, CLIN VACCINE IMMUNOL, V23, P746, DOI 10.1128/CVI.00258-16; Jones DR, 2016, POULT SCI; Kollaritsch H, 2012, TRAVEL MED; Lauring AS, 2010, NATURE BIOTECHNOLOGY; Nandre RM, 2015, CAN J VET RES; Nnalue NA, 1990, J MED MICROBIOL; Penaloza HF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02047; Pilonieta MC, 2014, MBIO, V5, DOI 10.1128/mBio.02211-14; Renu S, 2018, INT J NANOMEDICINE; Renu Sankar, 2017, Nanoparticle Patent, Patent No. [10336-342WO1, 103363421]; Revolledo L, 2012, J APPL POULTRY RES, V21, P418, DOI 10.3382/japr.2011-00409; Russell SM, 2013, PREVENTING SALMONELL; Sahdev P., 2014, PHARM RES; Shaji J, 2008, INDIAN J PHARM SCI, V70, P269, DOI 10.4103/0250-474X.42967; Shanmugasundaram R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223577; Shanmugasundaram R, 2013, POULT SCI; Shanmugasundaram R, 2019, POULTRY SCI; Sharma JN, 2007, INFLAMMOPHARMACOLOGY; Sutton S., 2010, J VALID TECHNOL; Tan K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00783; Tiwari G, 2012, INT J PHARM INVESTIG, V2, P2, DOI 10.4103/2230-973X.96920; Van Immerseel F, 2002, DEV COMP IMMUNOL; Vela Ramirez JE, 2017, ADV DRUG DELIVERY RE; Wang C, 2011, POULTRY SCI, V90, P2223, DOI 10.3382/ps.2011-01511; Woodward MJ, 1996, VET REC; Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069	44	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231998	10.1371/journal.pone.0231998	http://dx.doi.org/10.1371/journal.pone.0231998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330169	Green Submitted, Green Published, gold			2022-12-26	WOS:000536647300037
J	Jia, BX; Gao, ZX; Han, XH; Jin, JX; Zhang, JJ				Jia, Bao-xin; Gao, Zong-xian; Han, Xiu-hui; Jin, Jia-xu; Zhang, Jian-jun			Experimental analysis of the stick-slip characteristics of faults at different loading rates	PLOS ONE			English	Article							ROCK; FRICTION; BEHAVIOR; STRESS; BACK	In deep underground engineering, in a large spatial, high-stress environment, rapid excavation is likely to affect the loading rate of the fault structure and to cause stick-slip. In this study, an experiment was conducted to explore the stick-slip characteristics at different loading rates. A double-sided shear experiment and the digital speckle correlation method were used to analyze the evolution of the displacement field, the slip displacement, and the slip rate of the fault's stick-slip activity at different loading rates as well as their correlation with the loading rate. The loading rate, moment magnitude, and stress drop of the fault's stick-slip and their corresponding relationships were studied. The results show that the occurrence of stick-slip is inversely proportional to the loading rate. The evolution of the fault-slip displacement field at different loading rates is similar. At a given loading rate, the magnitude is positively correlated with the stress drop. The magnitude and stress drop are inversely related to the loading rate.	[Jia, Bao-xin; Gao, Zong-xian; Jin, Jia-xu; Zhang, Jian-jun] Liaoning Tech Univ, Sch Civil Engn, Fuxing, Liaoling, Peoples R China; [Jia, Bao-xin] China Earthquake Adm, Inst Geol, Beijing, Peoples R China; [Han, Xiu-hui] China Univ Min & Technol, Coll Resources & Safety Engn, Beijing, Peoples R China	Liaoning Technical University; China Earthquake Administration; China University of Mining & Technology	Jia, BX (corresponding author), Liaoning Tech Univ, Sch Civil Engn, Fuxing, Liaoling, Peoples R China.; Jia, BX (corresponding author), China Earthquake Adm, Inst Geol, Beijing, Peoples R China.	jbx_811010@126.com			National Natural Science Foundation of China [51774173]; Natural Science Foundation of Liaoning Province [201602351]; Open Fund for the State Key Laboratory of Seismological Dynamics [LED2015B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Liaoning Province(Natural Science Foundation of Liaoning Province); Open Fund for the State Key Laboratory of Seismological Dynamics	This work was supported by The National Natural Science Foundation of China (No. 51774173), the Natural Science Foundation of Liaoning Province (No. 201602351), and the Open Fund for the State Key Laboratory of Seismological Dynamics (No. LED2015B01) to BJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	De Paola N, 2011, GEOLOGY, V39, P35, DOI 10.1130/G31398.1; Dieterich J H, 1979, J GEOPHYS RES SOLID, V84; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; Fakhimi A, 2018, INT J ROCK MECH MIN, V107, P201, DOI 10.1016/j.ijrmms.2018.05.002; Guo LL, 2014, CHINESE J GEOPHYS-CH, V57, P867, DOI 10.6038/cjg20140316; He C.R., 2003, SCI CHINA, V33, P53; Hedayat A, 2017, GEOTECH TEST J, V40, P92, DOI 10.1520/GTJ20160035; Huang JY, 2014, ROCK MECH ROCK ENG, V47, P1727, DOI 10.1007/s00603-013-0502-8; [姜耀东 Jiang Yaodong], 2013, [中国矿业大学学报. 自然科学版, Journal of China University of Mining & Technology], V42, P1; Khazaei C, 2016, PURE APPL GEOPHYS, V173, P775, DOI 10.1007/s00024-015-1036-7; Leeman JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11104; [林远东 Lin Yuandong], 2012, [煤炭学报, Journal of China Coal Society], V37, P2060; Lu CP, 2018, INT J ROCK MECH MIN, V108, P86, DOI 10.1016/j.ijrmms.2018.06.002; [徐锡伟 Xu Xiwei], 2012, [地震地质, Seismology and Geology], V34, P606; Mehrishal S, 2016, ROCK MECH ROCK ENG, V49, P4607, DOI 10.1007/s00603-016-1073-2; Meng FZ, 2016, INT J ROCK MECH MIN, V86, P210, DOI 10.1016/j.ijrmms.2016.04.013; Ohta Y, 2010, ROCK MECH ROCK ENG, V43, P727, DOI 10.1007/s00603-010-0095-4; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; RUINA A, 1983, J GEOPHYS RES, V88, P359, DOI 10.1029/JB088iB12p10359; Sainoki A, 2016, J APPL GEOPHYS, V134, P159, DOI 10.1016/j.jappgeo.2016.09.009; Scuderi M, 2017, EGU GEN ASS C; Sharafisafa M, 2018, INT J ROCK MECH MIN, V112, P122, DOI 10.1016/j.ijrmms.2018.10.012; Sone H, 2009, NAT GEOSCI, V2, P705, DOI 10.1038/NGEO637; Song YM, 2012, CHINESE J GEOPHYS-CH, V55, P171, DOI 10.6038/j.issn.0001-5733.2012.01.016; Toro GD, 2006, SCIENCE, V311, P647, DOI DOI 10.1126/SCIENCE.1121012; Wang T., 2014, J MINING SAFETY ENG, V31, P180; Wang XB, 2006, ROCK SOIL MECH, V27, P242; Yan Y.G., 2010, J CHINA COAL SOC, V35, P19	28	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231464	10.1371/journal.pone.0231464	http://dx.doi.org/10.1371/journal.pone.0231464			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330141	Green Published, gold			2022-12-26	WOS:000536647300014
J	Kumar, N; Chander, Y; Riyesh, T; Khandelwal, N; Kumar, R; Kumar, H; Tripathi, BN; Barua, S				Kumar, Naveen; Chander, Yogesh; Riyesh, Thachamvally; Khandelwal, Nitin; Kumar, Ram; Kumar, Harish; Tripathi, Bhupendra N.; Barua, Sanjay			Isolation and characterization of bovine herpes virus 5 (BoHV5) from cattle in India	PLOS ONE			English	Article							HERPESVIRUS-1 BHV-1; RHINOTRACHEITIS VIRUS; RAPID DETECTION; TYPE-5 BHV-5; IBR VIRUS; CALVES; PCR; NEUROVIRULENCE; INFECTION; MENINGOENCEPHALITIS	Bovine herpesvirus 1 (BoHV1) and 5 (BoHV5) are genetically and antigenically related alphaherpesviruses. Infection with one virus induces protective immunity against the other. However, disease associated with BoHV1 and BoHV5 varies significantly; whereas BoHV1 infection is usually associated with rhinotracheitis and abortion, BoHV5 causes encephalitis in cattle. BoHV5 outbreaks are sporadic and mainly restricted to the South American countries. We report BoHV5 infection for the first time from aborted cattle in India. Based on the characteristic cytopathic effects in MDBK cells, amplification of the viral genome by PCR, differential PCR for BoHV1/BoHV5, nucleotide sequencing and restriction endonuclease patterns, identity of the virus was confirmed as BoHV5 subtype A. Serum samples from the aborted cattle strongly neutralized both BoHV1 and BoHV5 suggesting an active viral infection in the herd. Upon UL27, UL44 and UL54 gene-based sequence and phylogenetic analysis, the isolated virus clustered with BoHV5 strains and showed highest similarity with the Brazilian BoHV5 strains.	[Kumar, Naveen; Chander, Yogesh; Riyesh, Thachamvally; Khandelwal, Nitin; Kumar, Ram; Kumar, Harish; Tripathi, Bhupendra N.; Barua, Sanjay] ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Cultures, Hisar, Haryana, India	Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre on Equines	Kumar, N; Tripathi, BN; Barua, S (corresponding author), ICAR Natl Res Ctr Equines, Natl Ctr Vet Type Cultures, Hisar, Haryana, India.	naveenkumar.icar@gmail.com; bntripath1@yahoo.co.in; sbarua06@gmail.com	Kumar, Naveen/AAR-9084-2021		Science and Engineering Research Board, Department of Science and Technology, Government of India [CRG/2018/004747]; Indian Council of Agricultural Research [IXX11882]	Science and Engineering Research Board, Department of Science and Technology, Government of India; Indian Council of Agricultural Research(Indian Council of Agricultural Research (ICAR))	This work was supported by the Science and Engineering Research Board, Department of Science and Technology, Government of India, Grant number CRG/2018/004747 to N. Kumar and Indian Council of Agricultural Research, Grant Number IXX11882 to N. Kumar and SB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslan ME, 2015, J VET MED SCI, V77, P1371, DOI 10.1292/jvms.14-0657; BARENFUS M, 1963, J AM VET MED ASSOC, V143, P725; BARTHA A, 1969, ACTA VET ACAD SCI H, V19, P145; Campos FS, 2009, VET MICROBIOL, V139, P67, DOI 10.1016/j.vetmic.2009.05.015; CARRILLO BJ, 1983, ZBL VET MED B, V30, P327; Chowdhury SI, 1997, J COMP PATHOL, V117, P295, DOI 10.1016/S0021-9975(97)80078-3; Chowdhury SI, 2006, J VIROL, V80, P4396, DOI 10.1128/JVI.80.9.4396-4405.2006; Chowdhury SI, 2000, J VIROL, V74, P2094, DOI 10.1128/JVI.74.5.2094-2106.2000; Chowdhury SI, 2000, J NEUROVIROL, V6, P284, DOI 10.3109/13550280009030754; Claus MP, 2005, J VIROL METHODS, V128, P183, DOI 10.1016/j.jviromet.2005.05.001; D'Arce RCF, 2002, VET MICROBIOL, V88, P315, DOI 10.1016/S0378-1135(02)00126-8; Zajac MPD, 2010, VET J, V184, P138, DOI 10.1016/j.tvjl.2009.03.035; DOFFAY JM, 1995, J VET DIAGN INVEST, V7, P247, DOI 10.1177/104063879500700214; DOFFAY JM, 1993, AM J VET RES, V54, P534; ENGELS M, 1986, VIRUS RES, V6, P57, DOI 10.1016/0168-1702(86)90057-2; Favier P A, 2012, Open Vet J, V2, P46; GOUGH A, 1975, CAN VET J, V16, P313; Guarino H, 2008, PREV VET MED, V85, P34, DOI 10.1016/j.prevetmed.2007.12.012; Kessell AE, 2011, AUST VET J, V89, P331, DOI 10.1111/j.1751-0813.2011.00817.x; Khandelwal N, 2017, ANTIVIR RES, V144, P196, DOI 10.1016/j.antiviral.2017.06.006; Konnai S, 2008, ACTA TROP, V105, P269, DOI 10.1016/j.actatropica.2007.12.004; Kumar N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00209; Kumar N, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00111-17; Kumar N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156110; Kumar N, 2014, VIRUS GENES, V48, P312, DOI 10.1007/s11262-013-1025-9; Kumar R, 2018, ANTIVIR RES, V160, P126, DOI 10.1016/j.antiviral.2018.10.022; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; LEALKLEVEZAS DS, 1995, J CLIN MICROBIOL, V33, P3087, DOI 10.1128/JCM.33.12.3087-3090.1995; Linton D, 1997, J CLIN MICROBIOL, V35, P2568, DOI 10.1128/JCM.35.10.2568-2572.1997; Machado GF, 2013, MICROB PATHOGENESIS, V57, P10, DOI 10.1016/j.micpath.2013.01.003; Madico G, 1998, J CLIN MICROBIOL, V36, P3205, DOI 10.1128/JCM.36.11.3205-3210.1998; MERIEN F, 1992, J CLIN MICROBIOL, V30, P2219; Meurens F, 2004, J VIROL, V78, P9828, DOI 10.1128/JVI.78.18.9828-9836.2004; Moran PE, 2015, REV ARGENT MICROBIOL, V47, P155, DOI 10.1016/j.ram.2015.02.007; Morris MJ, 2018, VET SCI, V5; Nayak DN, 2015, VET WORLD, V8, P695, DOI 10.14202/vetworld.2015.695-701; Petzhold S. A., 2001, Brazilian Journal of Veterinary Research and Animal Science, V38, P184, DOI 10.1590/S1413-95962001000400007; Rocha MA, 1999, VET RES COMMUN, V23, P133, DOI 10.1023/A:1006210619910; ROIZMANN B, 1992, ARCH VIROL, V123, P425, DOI 10.1007/BF01317276; SCHUDEL AA, 1986, J VET MED B, V33, P303, DOI 10.1111/j.1439-0450.1986.tb00036.x; Sharifzadeh A, 2015, ARCH VIROL, V160, P235, DOI 10.1007/s00705-014-2272-3; Maidana SS, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-111; STUDDERT MJ, 1989, VET REC, V125, P584; Vidal S, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1294-y; VILCEK S, 1994, VET MICROBIOL, V42, P53, DOI 10.1016/0378-1135(94)90077-9; Zajac MPD, 2006, RES VET SCI, V81, P327, DOI 10.1016/j.rvsc.2006.01.004	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232093	10.1371/journal.pone.0232093	http://dx.doi.org/10.1371/journal.pone.0232093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330151	gold, Green Published, Green Submitted			2022-12-26	WOS:000536647300049
J	Han, MK; Anderson, R; Viennois, E; Merlin, D				Han, Moon K.; Anderson, Raeda; Viennois, Emilie; Merlin, Didier			Examination of food consumption in United States adults and the prevalence of inflammatory bowel disease using National Health Interview Survey 2015	PLOS ONE			English	Article							LOW-GRADE INFLAMMATION; GUT MICROBIOTA; BEHAVIOR-CHANGE; DIET; RISK; EPIDEMIOLOGY; PATHOGENESIS; COLITIS; IMPACT; MIDDLE	Various diets and food components have been implicated as one of the environmental factors associated with inflammatory bowel disease (IBD). Patients are often recommended nutritional guidelines to manage disease symptoms. However, the current food consumption pattern of US adults with IBD that are nationally representative is unclear. A secondary analysis of National Health Interview Survey 2015 was performed to characterize the estimated US adults with IBD and their food intake and consumption frequency using bivariate and multivariate logistic regression. Fries were consumed by a greater number of people with IBD. IBD population drank less 100% fruit juice and ate more cheese and cookies than non-IBD population. Intake of fries (OR 1.60, 95% CI 1.14-2.25) and sports and energy drinks (OR 1.46, 95% CI 1.07-1.97) and more frequent drinking of regular soda were significantly associated with the likelihood of having been told one have IBD, while popcorn (OR 0.73, 95% CI 0.548-0.971) and milk (OR 0.70, 95% CI 0.497-0.998) were associated with smaller odds, adjusting for covariates. Foods typically labeled as junk food were positively associated with IBD. Nonetheless, of the assessed 26 foods, we found eating patterns between IBD and non-IBD population to be mostly analogous. It is unclear whether the results reflect potential change in food intake in IBD population long before the survey interview. Understanding the role of food intake in IBD risk/prevalence would benefit from identifying other environmental factors (i.e. food desert), food processing (i.e. frying), and potential bioactive food components that can induce intestinal inflammation that can increase the individual's susceptibility to IBD.	[Han, Moon K.; Viennois, Emilie; Merlin, Didier] Georgia State Univ, Inst Biomed Sci, Ctr Diagnost & Therapeut, Ctr Inflammat Immun & Infect,Digest Dis Res Grp, Atlanta, GA 30303 USA; [Anderson, Raeda] Georgia State Univ, Dept Res & Engagement, Atlanta, GA 30303 USA; [Merlin, Didier] Atlanta Vet Affairs Med Ctr, Decatur, GA USA	University System of Georgia; Georgia State University; University System of Georgia; Georgia State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System	Han, MK (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Diagnost & Therapeut, Ctr Inflammat Immun & Infect,Digest Dis Res Grp, Atlanta, GA 30303 USA.	moonkwon.han@gmail.com		Han, Moon/0000-0002-2246-3618; Viennois, Emilie/0000-0002-3104-620X; Anderson, Raeda/0000-0003-0023-6649	National Institutes of Health of Diabetes and Digestive and Kidney Diseases [R01-DK-116306]; Department of Veterans Affairs; Crohn's and Colitis Foundation	National Institutes of Health of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Veterans Affairs(US Department of Veterans Affairs); Crohn's and Colitis Foundation	D.M is funded from National Institutes of Health of Diabetes and Digestive and Kidney Diseases (R01-DK-116306). D.M. is a recipient of a Senior Research Career Scientist Award from the Department of Veterans Affairs. E.V. is a recipient of a Career Development Award from the Crohn's and Colitis Foundation. E. Viennois and D. Merlin provided guidance in study approach, manuscript preparation and editing.	Abegunde AT, 2016, WORLD J GASTROENTERO, V22, P6296, DOI 10.3748/wjg.v22.i27.6296; Akbaraly T, 2013, AM J MED, V126, P411, DOI 10.1016/j.amjmed.2012.10.028; Albenberg LG, 2012, CURR OPIN GASTROEN, V28, P314, DOI 10.1097/MOG.0b013e328354586f; American Cancer Society, 2016, CANC FACTS FIGURES 2; Andersen V, 2012, DIGEST LIVER DIS, V44, P185, DOI 10.1016/j.dld.2011.10.001; Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271; Baxter SD, 2010, J AM DIET ASSOC, V110, P1178, DOI 10.1016/j.jada.2010.05.006; Belkova B, 2018, FOOD CHEM, V241, P51, DOI 10.1016/j.foodchem.2017.08.062; Binder V, 2004, BEST PRACT RES CL GA, V18, P463, DOI [10.1016/j.bpg.2003.12.002, 10.1016/j.bpg.2003.13.002]; Bordoni A, 2017, CRIT REV FOOD SCI, V57, P2497, DOI 10.1080/10408398.2014.967385; Busch K, 2014, ALIMENT PHARM THER, V39, P57, DOI 10.1111/apt.12528; Cabre E, 2012, WORLD J GASTROENTERO, V18, P3814, DOI 10.3748/wjg.v18.i29.3814; Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232; Chassaing B, 2014, TOXICOL PATHOL, V42, P49, DOI 10.1177/0192623313508481; Chiou A, 2012, FOOD CHEM, V133, P1255, DOI 10.1016/j.foodchem.2011.08.068; Christensen L, 2013, DIET NUTR INFLAMMATO; Cohen AB, 2013, DIGEST DIS SCI, V58, P1322, DOI 10.1007/s10620-012-2373-3; Conklin LS, 2010, EXPERT REV GASTROENT, V4, P305, DOI 10.1586/EGH.10.23; Crohn's & Colitis Foundation, 2019, REL FOOD IBD; Da Silva PF, 2008, LWT-FOOD SCI TECHNOL, V41, P1758, DOI 10.1016/j.lwt.2008.01.016; Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Demissie Z, 2015, AM J HEALTH PROMOT, V29, pE203, DOI 10.4278/ajhp.131211-QUAN-632; DiBaise JK, 2008, MAYO CLIN PROC, V83, P460, DOI 10.4065/83.4.460; Division of Health Interview Statistics National Center for Health Statistics, 2016, MULT IMP FAM INC PER; Division of Health Interview Statistics National Center for Health Statistics, 2016, 2015 NAT HLTH INT SU; Favoriti P, 2016, UPDATES SURG, V68, P7, DOI 10.1007/s13304-016-0359-y; Ferguson LR, 2014, ADV NUTR DIETET BOOK, P169; Forbes Alastair, 2017, Clin Nutr, V36, P321, DOI 10.1016/j.clnu.2016.12.027; Fu ML, 2007, J AM DIET ASSOC, V107, P1935, DOI 10.1016/j.jada.2007.08.010; Gadiraju TV, 2015, NUTRIENTS, V7, P8424, DOI 10.3390/nu7105404; Garden-Robinson J, 2019, NDSU EXT         FEB; Gearry RB, 2009, J CROHNS COLITIS, V3, P8, DOI 10.1016/j.crohns.2008.09.004; Geiger H.J., 2003, UNEQUAL TREATMENT CO; Gentschew L, 2012, MOL NUTR FOOD RES, V56, P524, DOI 10.1002/mnfr.201100630; Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164; Graham H, 2004, MILBANK Q, V82, P101, DOI 10.1111/j.0887-378X.2004.00303.x; Green AC, 2015, AM J HEALTH BEHAV, V39, P380, DOI 10.5993/AJHB.39.3.11; Guadagnoli L, 2019, QUAL LIFE RES, V28, P2195, DOI 10.1007/s11136-019-02170-4; Haskey N, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030259; Hendrickson BA, 2002, CLIN MICROBIOL REV, V15, P79, DOI 10.1128/CMR.15.1.79-94.2002; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Hwang C, 2012, INFLAMM BOWEL DIS, V18, P1961, DOI 10.1002/ibd.22906; Jantchou P, 2010, AM J GASTROENTEROL, V105, P2195, DOI 10.1038/ajg.2010.192; Jia B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122700; Karlinger K, 2000, EUR J RADIOL, V35, P154, DOI 10.1016/S0720-048X(00)00238-2; Knight-Sepulveda Karina, 2015, Gastroenterol Hepatol (N Y), V11, P511; Ko JK, 2014, CURR PHARM DESIGN, V20, P1082, DOI 10.2174/13816128113199990416; Korzenik JR, 2005, J CLIN GASTROENTEROL, V39, pS59, DOI 10.1097/01.mcg.0000155553.28348.fc; Limdi JK, 2018, INDIAN J GASTROENTER, V37, P284, DOI 10.1007/s12664-018-0890-5; Loftus EV, 2002, ALIMENT PHARM THERAP, V16, P51, DOI 10.1046/j.1365-2036.2002.01140.x; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Malekzadeh MM, 2016, ARCH IRAN MED, V19, P2, DOI 0161901/AIM.003; McLean RM, 2018, J CLIN HYPERTENS, V20, P1360, DOI 10.1111/jch.13391; Meester RGS, 2015, CANCER-AM CANCER SOC, V121, P2281, DOI 10.1002/cncr.29336; Minihane AM, 2007, CRIT REV FOOD SCI, V47, P287, DOI 10.1080/10408390600737821; Moradkhani A, 2013, J CROHNS COLITIS, V7, P467, DOI 10.1016/j.crohns.2012.07.012; Mourad FH, 2017, J CROHNS COLITIS, V11, P369, DOI 10.1093/ecco-jcc/jjw162; National Cancer Institute Division of Cancer Control and Population Sciences, 2018, DIET SCR QUEST NHIS; National Cancer Institute Division of Cancer Control and Population Sciences, 2018, DIET SCREEN QUEST DS; National Cancer Institute Division of Cancer Control and Population Sciences. Risk Factor Assessment Branch (RFAB), 2018, EP GEN RES PROGR; National Institute on Aging, 2017, HLTH EAT KNOW YOUR F; Newsom JT, 2012, J GERONTOL B-PSYCHOL, V67, P279, DOI 10.1093/geronb/gbr103; Nguyen GC, 2014, J CROHNS COLITIS, V8, P288, DOI 10.1016/j.crohns.2013.09.001; Opstelten JL, 2019, CLIN NUTR, V38, P1892, DOI 10.1016/j.clnu.2018.06.983; Owczarek D, 2016, WORLD J GASTROENTERO, V22, P895, DOI 10.3748/wjg.v22.i3.895; Park S, 2013, J ACAD NUTR DIET, V113, P112, DOI 10.1016/j.jand.2012.09.019; Peuhkuri K, 2010, WORLD J GASTROENTERO, V16, P1057, DOI 10.3748/wjg.v16.i9.1057; Pituch-Zdanowska A, 2015, PRZ GASTROENTEROL, V10, P135, DOI 10.5114/pg.2015.52753; Qin XF, 2012, WORLD J GASTROENTERO, V18, P1708, DOI 10.3748/wjg.v18.i15.1708; Reif S, 1997, GUT, V40, P754, DOI 10.1136/gut.40.6.754; Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107; Ruemmele FM, 2016, ANN NUTR METAB, V68, P33, DOI 10.1159/000445392; Russel, 2000, Eur J Intern Med, V11, P191, DOI 10.1016/S0953-6205(00)00090-X; Russel MG, 1998, EUR J GASTROEN HEPAT, V10, P243, DOI 10.1097/00042737-199803000-00010; Sartor RB, 2012, AM J GASTROENTEROL S, V1, P15, DOI DOI 10.1038/AJGSUP.2012.4; Sayon-Orea C, 2015, BRIT J NUTR, V113, pS36, DOI 10.1017/S0007114514002931; Shah Shinil, 2007, MedGenMed, V9, P60; Spooren CEGM, 2013, ALIMENT PHARM THER, V38, P1172, DOI 10.1111/apt.12501; Statovci D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00838; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Tasson L, 2017, DIGEST DIS SCI, V62, P2087, DOI 10.1007/s10620-017-4620-0; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; Triantafillidis JK, 2011, DRUG DES DEV THER, V5, P185, DOI 10.2147/DDDT.S11290; United States Department of Agriculture, 2012, POT RUSS FRESH, P2; Vagianos K, 2016, JPEN-PARENTER ENTER, V40, P405, DOI 10.1177/0148607114549254; Veronese N, 2017, AM J CLIN NUTR, V106, P162, DOI 10.3945/ajcn.117.154872; Vidarsdottir JB, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0178-5; Viennois E, 2019, CELL MOL GASTROENTER, V8, P61, DOI 10.1016/j.jcmgh.2019.02.008; Viennois E, 2017, CANCER RES, V77, P27, DOI [10.1158/0008-5472.CAN-16-1359, 10.1158/0008-5472.can-16-1359]; Vrijheid M, 2006, J EXPO SCI ENV EPID, V16, P371, DOI 10.1038/sj.jes.7500509; Wahbeh GT, 2017, J PEDIATR GASTR NUTR, V65, P289, DOI 10.1097/MPG.0000000000001619; Walton M, 2014, BRIT J NUTR, V112, P1628, DOI 10.1017/S0007114514002074; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xiang XL, 2016, J AGING HEALTH, V28, P995, DOI 10.1177/0898264315614573; Xu F, 2018, MMWR-MORBID MORTAL W, V67, P190, DOI 10.15585/mmwr.mm6706a4	96	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232157	10.1371/journal.pone.0232157	http://dx.doi.org/10.1371/journal.pone.0232157			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324818	Green Published, gold			2022-12-26	WOS:000536033700086
J	Khatri, S; Hansen, J; Astakhova, K				Khatri, Sangita; Hansen, Jonas; Astakhova, Kira			Antibodies to synthetic citrullinated peptide epitope correlate with disease activity and flares in rheumatoid arthritis	PLOS ONE			English	Article							TARGET; RECOGNITION; AUTOANTIGEN; ASSOCIATION	Rheumatoid arthritis (RA), caused by the abnormal recognition of human joint cells by autoimmune antibodies, remains the world's most prevalent autoimmune disease, with over five million people affected and as much as 4% of the population at risk of RA. To prevent rapid disease development, hormonal and anti-inflammatory therapies require fast and reliable RA diagnosis. However, difficulty in detecting early specific biomarkers for RA means that it is unclear when treatment needs to begin. Here, we combined synthesis of citrullinated peptide epitopes with molecular diagnostics to verify a new specific biomarker for early RA diagnosis and flare prediction. A fibrinogen-derived 21-amino-acid-long citrullinated peptide showed high reactivity toward autoantibodies in RA samples. Additionally, the level of antibodies to this epitope was elevated prior to flares. In contrast, other citrullinated protein variants had lower reactivity and poorer sensitivity to disease activity. In conclusion, fibrinogen-derived epitope E2 subjected to citrullination facilitated a reliable RA diagnosis with a strong correlation to disease activity. This is of a high value for the diagnosis and management of RA patients who respond poorly to treatment.	[Khatri, Sangita; Hansen, Jonas; Astakhova, Kira] Tech Univ Denmark, Dept Chem, Lyngby, Denmark; [Hansen, Jonas] Sechenov First Moscow State Med Univ, Inst Mol Med, Moscow, Russia	Technical University of Denmark; Sechenov First Moscow State Medical University	Astakhova, K (corresponding author), Tech Univ Denmark, Dept Chem, Lyngby, Denmark.	kiraas@kemi.dtu.dk	; Astakhova, Kira/D-1432-2014	Hansen, Jonas/0000-0002-7239-3945; Khatri, Sangita/0000-0001-7145-3523; Astakhova, Kira/0000-0003-4878-0301	Villum Foundation [13152]; DTU PoC [40937]	Villum Foundation(Villum Fonden); DTU PoC	KA received funding from Villum Foundation Grant 13152 and DTU PoC 40937. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2009, ARTHRIT RHEUM-ARTHR, V61, P1472, DOI 10.1002/art.24827; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Astakhova IK, 2013, ORG BIOMOL CHEM, V11, P4240, DOI 10.1039/c3ob40786a; Bang H, 2007, ARTHRITIS RHEUM-US, V56, P2503, DOI 10.1002/art.22817; Bechman K, 2018, J RHEUMATOL, V45, P1515, DOI 10.3899/jrheum.171375; Boman A, 2019, RMD OPEN, V5, DOI 10.1136/rmdopen-2019-000946; Domljanovic I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02214-0; Draborg AH, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/535738; Felten R, 2019, LUPUS SCI MED, V6, DOI 10.1136/lupus-2018-000303; Fernandes-Cerqueira C, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0666-6; Flick MJ, 2007, J CLIN INVEST, V117, P3224, DOI 10.1172/JCI30134; Gilliam BE, 2013, PEDIATR RHEUMATOL, V11, DOI 10.1186/1546-0096-11-31; Gomez-Banuelos E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091309; Jonsson MK, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1635-7; Jorgensen AS, 2013, CHEM COMMUN, V49, P10751, DOI 10.1039/c3cc45507f; Joshua V, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1181-0; Junager NPL, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081173; Khatri S, 2019, BIOCONJUGATE CHEM, V30, P2584, DOI 10.1021/acs.bioconjchem.9b00518; Kittelson J. M., 2011, J BIOPHARMACEUTICAL, V21, P1046, DOI [10.1080/10543406.2011.592364, DOI 10.1080/10543406.2011.592364]; Li YQ, 2014, SURGERY, V156, P229, DOI 10.1016/j.surg.2014.04.009; Lim J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39132-2; Lossius A, 2012, VIRUSES-BASEL, V4, P3701, DOI 10.3390/v4123701; Mittal N, 2012, SINGAP MED J, V53, P532; Perricone C, 2019, CURR OPIN RHEUMATOL, V31, P517, DOI 10.1097/BOR.0000000000000638; Pisetsky DS, 2019, AUTOIMMUN REV, V18, DOI 10.1016/j.autrev.2019.102400; Pisetsky David S, 2017, N C Med J, V78, P337, DOI 10.18043/ncm.78.5.337; Pope JE, 2018, RMD OPEN, V4, DOI 10.1136/rmdopen-2018-000738; Rombouts Y, 2016, ANN RHEUM DIS, V75, P578, DOI 10.1136/annrheumdis-2014-206598; Sakkas LI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01853; Sandal I, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1143-6; Santos-Moreno P, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014181; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Sohrabian A, 2018, ANN RHEUM DIS, V77, P1345, DOI 10.1136/annrheumdis-2017-212627; Sokolove J, 2019, NAT REV RHEUMATOL, V15, P132, DOI 10.1038/s41584-019-0169-y; Solomon DH, 2014, ARTHRITIS RHEUMATOL, V66, P775, DOI 10.1002/art.38323; Szarka E, 2014, IMMUNOLOGY, V141, P181, DOI 10.1111/imm.12175; Szili D, 2014, MABS-AUSTIN, V6, P991, DOI 10.4161/mabs.28841; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Taskova M, 2017, BIOCONJUGATE CHEM, V28, P768, DOI 10.1021/acs.bioconjchem.6b00567; van Venrooij WJ, 2008, CLIN REV ALLERG IMMU, V34, P36, DOI 10.1007/s12016-007-8029-y; Wang F, 2016, CLIN RHEUMATOL, V35, P2185, DOI 10.1007/s10067-016-3247-4; Yousefghahari B, 2013, CASP J INTERN MED, V4, P702	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232010	10.1371/journal.pone.0232010	http://dx.doi.org/10.1371/journal.pone.0232010			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324839	Green Published, gold, Green Submitted			2022-12-26	WOS:000536033700059
J	Netter, A; Jauffret, C; Brun, C; Sabiani, L; Blache, G; Houvenaeghel, G; Lambaudie, E				Netter, Antoine; Jauffret, Camille; Brun, Clement; Sabiani, Laura; Blache, Guillaume; Houvenaeghel, Gilles; Lambaudie, Eric			Choosing the most appropriate minimally invasive approach to treat gynecologic cancers in the context of an enhanced recovery program: Insights from a comprehensive cancer center	PLOS ONE			English	Article							RADICAL HYSTERECTOMY; ASSISTED SURGERY; ROBOTIC SURGERY; CERVICAL-CANCER; LAPAROSCOPY; ONCOLOGY	Objective The aim of the study was to compare the characteristics of procedures for gynecologic cancers conducted with conventional laparoscopy (CL) or robotically assisted laparoscopy (RAL) in the context of an enhanced recovery program (ERP). Methods This is a secondary analysis of prospectively collected data from a cohort study conducted between 2016 (when the ERP was first implemented at the Institut Paoli-Calmettes, a comprehensive cancer center in France) and 2018. We included patients who had undergone minimally invasive surgery for gynecological cancers and followed our ERP. The endpoints were the analysis of postoperative complications, the length of postoperative hospitalization (LPO), and the proportion of combined procedures depending on the approach (RAL or CL). Combined procedures were defined by the association of at least two of the following operative items: hysterectomy, pelvic lymphadenectomy, and para-aortic lymphadenectomy. Results A total of 362 women underwent either CL (n = 187) or RAL (n = 175) for gynecologic cancers and followed our ERP. The proportion of combined procedures performed by RAL was significantly higher (85/175 [48.6%]) than that performed by CL (23/187 [12.3%]; p < 0.001). The proportions of postoperative complications were similar between the two groups (19.4% versus 17.1%; p = 0.59). Logistic regression analysis revealed a statistically insignificant trend in the association of RAL with a reduced likelihood of an LPO > 3 days after adjusting for predictors of prolonged hospitalization (adjusted OR = 0.573 [0.236-1.388]; p = 0.217). Conclusion Experts from our cancer center preferentially choose RAL to perform gynecologic oncological procedures that present elements of complexity. More studies are needed to determine whether this strategy is efficient in managing complex procedures in the framework of an ERP.	[Netter, Antoine; Jauffret, Camille; Sabiani, Laura; Blache, Guillaume; Houvenaeghel, Gilles; Lambaudie, Eric] Aix Marseille Univ, Inst Paoli Calmettes, Dept Surg Oncol, CNRS,INSERM,CRCM, Marseille, France; [Netter, Antoine] Aix Marseille Univ, La Conception Hosp, AP HM, Dept Obstet & Gynecol, Marseille, France; [Netter, Antoine] Avignon Univ, Aix Marseille Univ, CNRS, IRD,Inst Mediterraneen Biodivers & Ecol Marine &, Marseille, France; [Brun, Clement] Inst Paoli Calmettes, Dept Anesthesie Reanimat, Marseille, France; [Brun, Clement] CRCM, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Avignon Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Netter, A; Lambaudie, E (corresponding author), Aix Marseille Univ, Inst Paoli Calmettes, Dept Surg Oncol, CNRS,INSERM,CRCM, Marseille, France.; Netter, A (corresponding author), Aix Marseille Univ, La Conception Hosp, AP HM, Dept Obstet & Gynecol, Marseille, France.; Netter, A (corresponding author), Avignon Univ, Aix Marseille Univ, CNRS, IRD,Inst Mediterraneen Biodivers & Ecol Marine &, Marseille, France.	antoine.netter@gmail.com; ericlambaudie@gmail.com	Netter, Antoine/ABB-8570-2020	Netter, Antoine/0000-0002-3532-0800				[Anonymous], 2016, GYNECOL ONCOL, V140, P313, DOI [10.1016/j.ygyno.2015.11.015, DOI 10.1016/J.YGYN0.2015.11.015]; [Anonymous], 2016, GYNECOL ONCOL, V140, P323, DOI [10.1016/j.ygyno.2015.12.019, DOI 10.1016/J.YGYN0.2015.12.019]; [Anonymous], 2017, ECANCERMEDICALSCIENC, V11; [Anonymous], 2017, J REPROD INFERTIL, V18, P261; [Anonymous], 2018, HUM FERTIL, V21, P35; [Anonymous], 2017, CURR TREAT OPTION ON, V18, P58; Bauchat Jeanette R, 2015, Anesthesiol Clin, V33, P173, DOI 10.1016/j.anclin.2014.11.011; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; Chase DM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.04.037; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Diana M, 2015, BRIT J SURG, V102, pE15, DOI 10.1002/bjs.9711; Gala RB, 2014, J MINIM INVAS GYN, V21, P353, DOI 10.1016/j.jmig.2013.11.010; Hassan SO, 2015, J SURG EDUC, V72, P592, DOI 10.1016/j.jsurg.2014.12.008; Higgins RM, 2017, SURG ENDOSC, V31, P185, DOI 10.1007/s00464-016-4954-2; Kalogera E, 2016, OBSTET GYN CLIN N AM, V43, P551, DOI 10.1016/j.ogc.2016.04.006; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Kehlet H, 2002, AM J SURG, V183, P630, DOI 10.1016/S0002-9610(02)00866-8; La Rosa VL, PSYCHOL IMPACT FERTI; Lambaudie E, 2020, SURG ENDOSC, V34, P1985, DOI 10.1007/s00464-019-06974-w; Lambaudie E, 2017, BMC SURG, V17, DOI 10.1186/s12893-017-0332-9; Maenpaa MM, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.06.005; Minig L, 2016, J MINIM INVAS GYN, V23, P309, DOI 10.1016/j.jmig.2015.10.014; Miralpeix E, 2016, GYNECOL ONCOL, V141, P371, DOI 10.1016/j.ygyno.2016.02.019; Nelson G, ENHANCED RECOVERY SU; Rabinovich A, 2015, CURR OPIN OBSTET GYN, V27, P302, DOI 10.1097/GCO.0000000000000187; Ramirez PT, 2018, NEW ENGL J MED, V379, P1895, DOI 10.1056/NEJMoa1806395; Ramirez PT, 2012, GYNECOL ONCOL, V124, P180, DOI 10.1016/j.ygyno.2011.11.006; Shazly SAM, 2015, GYNECOL ONCOL, V138, P457, DOI 10.1016/j.ygyno.2015.06.009; Triolo O, FERTILITY SPARING ST; Vitale SG, 2017, UPDATES SURG, V69, P29, DOI 10.1007/s13304-017-0419-y; Vlug MS, 2011, ANN SURG, V254, P868, DOI 10.1097/SLA.0b013e31821fd1ce; Zanagnolo V, 2017, J MINIM INVAS GYN, V24, P379, DOI 10.1016/j.jmig.2017.01.006; Zhou J, 2016, INT J MED ROBOT COMP, V12, P145, DOI 10.1002/rcs.1652	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231793	10.1371/journal.pone.0231793	http://dx.doi.org/10.1371/journal.pone.0231793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324762	Green Published, gold			2022-12-26	WOS:000536033700036
J	de Melo, BA; Couto, AD; Silva, FD; Hongyu, K; de Araujo, FCT; da Silva, SGM; Rios, RRS; dos Santos, MT; Fraga, AB				de Melo, Breno Araujo; Couto, Alberto de Gusmao; Silva, Fabiane de Lima; Hongyu, Kuang; Teodozio de Araujo, Filipe Chagas; Mesquita da Silva, Sybelle Georgia; Santos Rios, Raisa Rodrigues; dos Santos, Micheline Thais; Fraga, Angelina Bossi			Multivariate analysis of body morphometric traits in conjunction with performance of reproduction and milk traits in crossbred progeny of Murrah x Jafarabadi buffalo (Bubalus bubalis) in North-Eastern Brazil	PLOS ONE			English	Article							PRINCIPAL COMPONENT ANALYSIS; GENETIC-PARAMETERS; CALVING INTERVAL; LACTATION LENGTH; DISCARDING VARIABLES; CONFORMATION TRAITS; YIELD; SELECTION; BREED; LONGEVITY	We studied the relationship between body morphometric traits, and their underlying association with milk production (MP), lactation length (LL), first calving interval (FCI) and subsequent calving interval (CI) of crossbred progeny of Murrah x Jafarabadi buffalo aiming to assist in selection programs. We carried out principal component analysis (PCA) of the body morphometric traits, which include breast width (BW), thigh width (THW), hip width (HW), rump width (RW), rump length (RL), body depth (BD), body length (BL), height withers (HEW), rear height (RH), shoulder width (SW), thorax width (TW), loin width (LW), distance from the head to ischium (DHI), and thoracic perimeter (TP). We determined the association of morphometric traits with milk/reproduction traits using canonical correlation analysis (CCA). The analysis revealed that the first six PCA accounted for 82.14% of the total observed variation, and the traits THW, HW, TW, LW, RW, HEW, TP, RH, and BW, accounted for almost half (48.00%) of the total variance indicating a higher contribution in body structural conformation. The first canonical function was significant (p< 0.05), accounted for 72.46% of the total variance, and the canonical correlation was 0.56, indicating the dependence between both groups of traits. Higher canonical loadings were obtained for LL (0.49), FCI (0.46), BW (-0.71), BL (-0.56), DHI (-0.34), HEW, (-0.38) and TP (-0.50). These traits were most important for the derivation of canonical statistical variables, and presented a higher canonical correlations (r) between the dependent (LL/FCI) and independent (BW, BL, DHI, HEW and TP) groups. The results could suggest that the body morphometric traits THW, HW, TW, LW, RW, HEW, BD, TP, RH, and BW could play important role in body structural composition, indicating a suitable functional type, and aid designing of selection programs for buffalo breeding.	[de Melo, Breno Araujo; Mesquita da Silva, Sybelle Georgia; Santos Rios, Raisa Rodrigues; Fraga, Angelina Bossi] Univ Fed Alagoas, Agr Sci Ctr, Northeast Network Biotechnol RENORBIO, Rio Largo, Alagoas, Brazil; [Couto, Alberto de Gusmao] Castanha Grande Farm, Sao Luiz Do Quitunde, Alagoas, Brazil; [Silva, Fabiane de Lima] Fed Univ Reconcavo Baiano, Dept Agr Sci, Cruz Das Almas, BA, Brazil; [Hongyu, Kuang] Univ Fed Mato Grosso, Dept Stat, Cuiaba, MG, Brazil; [Teodozio de Araujo, Filipe Chagas] Univ Estadual Maringa, Anim Sci Dept, Maringa, Parana, Brazil; [dos Santos, Micheline Thais] Rural Fed Univ Pernambuco, Anim Sci Dept, Recife, PE, Brazil	Universidade Federal de Alagoas; Universidade Federal de Mato Grosso; Universidade Estadual de Maringa; Universidade Federal Rural de Pernambuco (UFRPE)	Fraga, AB (corresponding author), Univ Fed Alagoas, Agr Sci Ctr, Northeast Network Biotechnol RENORBIO, Rio Largo, Alagoas, Brazil.	angelina.fraga@gmail.com	BOSSI FRAGA, ANGELINA/B-5466-2019	BOSSI FRAGA, ANGELINA/0000-0001-6557-3000	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - (CAPES) [001]; Fundacao de Amparo a Pesquisa do Estado de Alagoas - Brasil (FAPEAL) [01]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Alagoas - Brasil (FAPEAL)	BAM, This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - (CAPES) - Finance Code 001, https://www.capes.gov.br/, and Fundacao de Amparo a Pesquisa do Estado de Alagoas - Brasil (FAPEAL) - Finance Code 01, http://fapeal.br/, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudelo-Gomez DA, 2015, J ANIM SCI, V93, P3801, DOI 10.2527/jas.2015-8940; Agudelo-Gomez D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132811; Agudelo-Gomez DA, 2016, LIVEST SCI, V191, P6, DOI 10.1016/j.livsci.2016.06.016; Ahmad N, 2013, BUFFALO BULL, V32, P792; Lopes CRD, 2008, REV BRAS ZOOTECN, V37, P1595, DOI 10.1590/S1516-35982008000900010; Andrea M V, 2010, REV VET, V21, P355; Aspilcueta-Borquis RR, 2010, GENET MOL RES, V9, P1636, DOI 10.4238/vol9-3gmr846; Aspilcueta-Borquis RR, 2010, GENET MOL BIOL, V33, P71, DOI 10.1590/S1415-47572010005000005; Barbosa L. T., 2010, Revista Brasileira de Saude e Producao Animal, V11, P1150; Barros CD, 2016, REV CAATINGA, V29, P216, DOI 10.1590/1983-21252016v29n125rc; Bezerra JD, 2014, REV CAATINGA, V27, P184; Bezerra JS, 2018, REV COLOMB CIENC PEC, V31, P103, DOI 10.17533/udea.rccp.v31n2a03; Bignardi AB, 2012, J DAIRY SCI, V95, P2157, DOI 10.3168/jds.2011-4494; Cankaya S., 2007, Hayvansal Uretim (Journal of Animal Production), V48, P27; Cruz CD, 2004, MODELOS BIOMETRICOS, P193; Paiva ALD, 2010, REV BRAS ZOOTECN, V39, P285, DOI 10.1590/S1516-35982010000200009; de Melo BA, 2018, J APPL ANIM RES, V46, P1307, DOI 10.1080/09712119.2018.1502669; Dhillod S, 2017, VET WORLD, V10, P17, DOI 10.14202/vetworld.2017.17-21; Dymnicki E., 2015, Annals of Warsaw University of Life Sciences - SGGW, Animal Science, P15; Fraga AB, 2016, TROP ANIM HEALTH PRO, V48, P533, DOI 10.1007/s11250-015-0985-2; de Rezende MPG, 2017, PESQUI AGROPECU BRAS, V52, P663, DOI [10.1590/S0100-204X2017000800012, 10.1590/s0100-204x2017000800012]; Hair J. F., 2009, MULTIVAR DATA ANAL, P688; Hair Jr JF, 1998, MULTIVAR DATA ANAL, P739; Hair Jr JF, 2005, MULTIVAR DATA ANAL, P593; Hansen LB, 2000, J DAIRY SCI, V83, P1145, DOI 10.3168/jds.S0022-0302(00)74980-0; Husson F, 2020, FACTORMNIER MULTIVAR; JOLLIFFE IT, 1972, J ROY STAT SOC C-APP, V21, P160; JOLLIFFE IT, 1973, ROY STAT SOC C-APP, V22, P21; Kern EL, 2014, ASIAN AUSTRAL J ANIM, V27, P784, DOI 10.5713/ajas.2013.13817; Khan M., 2013, ANIMAL GENETICS RES, V52, P65, DOI [DOI 10.1017/, 10.1017/S2078633613000027, DOI 10.1017/S2078633613000027]; KHAN M, 2014, LIFE SCI J, V11, P1; KLOSTERM.EW, 1972, J ANIM SCI, V34, P875; Kocaman I., 2017, J SCI ENG RES, V4, P62; Lagrotta MR, 2010, PESQUI AGROPECU BRAS, V45, P423, DOI 10.1590/S0100-204X2010000400011; Lemes JS, 2017, ACTA SCI VET, V45; Mazza S, 2016, J DAIRY SCI, V99, P8127, DOI 10.3168/jds.2016-11116; Malhado CHM, 2013, REV BRAS ZOOTECN, V42, P565, DOI 10.1590/S1516-35982013000800005; Mirza R., 2015, J ANIMAL HLTH PRODUC, V3, P1; Mota LFM, 2014, B TECNICO, V2; Murtaza MA, 2013, J DAIRY SCI, V96, P1380, DOI 10.3168/jds.2012-5992; Neto JCS, 2001, REV BRAS ZOOTECN, V30, P368; Niozas G, 2019, J DAIRY SCI, V102, P811, DOI 10.3168/jds.2018-15117; Oliveira DP, 2014, 10 WORLD C GEN APPL, P3; Oltenacu PA, 2010, ANIM WELFARE, V19, P39; Peixoto AM, 1990, EXTERIOR E JULGAMENT, P222; Ramos AD, 2006, PESQUI AGROPECU BRAS, V41, P1261, DOI 10.1590/S0100-204X2006000800008; da Silva DAR, 2011, CIENC RURAL, V41, P501, DOI 10.1590/S0103-84782011000300023; Regazzi AJ, 2002, ANALISE MULTIVARIADA; Rencher AC, 2002, METHODS MULTIVARIATE, P361; Renno FP, 2003, REV BRAS ZOOTECN, V32, P1419, DOI 10.1590/S1516-35982003000600017; Ribeiro JC, 2016, CIENC RURAL, V46, P1289, DOI 10.1590/0103-8478cr20150215; Rodrigues AE, 2010, ARQ BRAS MED VET ZOO, V62, P712, DOI 10.1590/S0102-09352010000300028; Ros-Freixedes R, 2014, MEAT SCI, V96, P264, DOI 10.1016/j.meatsci.2013.07.004; RStudio Team, 2020, RSTUDIO INTEGRATED D; Sahin A, 2016, BUFFALO BULL, V35, P573; THOMAS P.R., 2000, INDIAN J ANIM RES, V34, P100; Tolenkhomba T.C., 2012, INT MULTIDISCIP RES, V2, P77; Tonhati H, 2000, J ANIM BREED GENET, V117, P331, DOI 10.1046/j.1439-0388.2000.00249.x; Tramonte NC, 2019, REV BRAS ZOOTECN, V48, DOI 10.1590/rbz4820180034; Vohra V, 2015, ASIAN AUSTRAL J ANIM, V28, P311, DOI 10.5713/ajas.14.0451; Wenceslau AA, 2000, REV BRAS ZOOTECN, V29, P153, DOI 10.1590/S1516-35982000000100021; Zavadilova L, 2009, CZECH J ANIM SCI, V54, P387, DOI 10.17221/1685-CJAS	62	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231407	10.1371/journal.pone.0231407	http://dx.doi.org/10.1371/journal.pone.0231407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315344	Green Published, gold			2022-12-26	WOS:000536024800026
J	Wang, HZ; Li, SX; Dai, QX; Gonzalez, A; Tran, ON; Sun, HY; DeFronzo, RA; Dean, DD; Yeh, CK; Chen, XD				Wang, Hanzhou; Li, Shengxian; Dai, Qiuxia; Gonzalez, Aaron; Tran, Olivia N.; Sun, Haiyan; DeFronzo, Ralph A.; Dean, David D.; Yeh, Chih-Ko; Chen, Xiao-Dong			Culture on a native bone marrow-derived extracellular matrix restores the pancreatic islet basement membrane, preserves islet function, and attenuates islet immunogenicity	FASEB JOURNAL			English	Article						extracellular matrix; immune tolerance; insulin secretion; pancreatic islets; vascular endothelial cells	COLLAGEN-VI; ANIMAL-MODELS; TRANSPLANTATION; CELLS; REGENERATION; EXPRESSION; IMPACT; NICHE	Islet transplantation in man is limited by multiple factors including islet availability, islet cell damage caused by collagenase during isolation, maintenance of islet function between isolation and transplantation, and allograft rejection. In this study, we describe a new approach for preparing islets that enhances islet function in vitro and reduces immunogenicity. The approach involves culture on native decellularized 3D bone marrow-derived extracellular matrix (3D-ECM), which contains many of the matrix components present in pancreas, prior to islet transplantation. Compared to islets cultured on tissue culture plastic (TCP), islets cultured on 3D-ECM exhibited greater attachment, higher survival rate, increased insulin content, and enhanced glucose-stimulated insulin secretion. In addition, culture of islets on 3D-ECM promoted recovery of vascular endothelial cells within the islets and restored basement membrane-related proteins (eg, fibronectin and collagen type VI). More interestingly, culture on 3D-ECM also selectively decontaminated islets of "passenger" cells (co-isolated with the islets) and restored basement membrane-associated type VI collagen, which were associated with an attenuation in islet immunogenicity. These results demonstrate that this novel approach has promise for overcoming two major issues in human islet transplantation: (a) poor yield of islets from donated pancreas tissue and (b) the need for life-long immunosuppression.	[Wang, Hanzhou; Li, Shengxian; Dai, Qiuxia; Gonzalez, Aaron; Tran, Olivia N.; Dean, David D.; Yeh, Chih-Ko; Chen, Xiao-Dong] Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA; [Li, Shengxian] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Endocrinol, Shanghai, Peoples R China; [Gonzalez, Aaron; Tran, Olivia N.; Dean, David D.; Chen, Xiao-Dong] Univ Texas San Antonio, Dept Biomed Engn, San Antonio, TX USA; [Sun, Haiyan] Acad Mil Med Sci, Affiliated Hosp, Dept Stomatol, Beijing, Peoples R China; [DeFronzo, Ralph A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Yeh, Chih-Ko; Chen, Xiao-Dong] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; Shanghai Jiao Tong University; University of Texas System; University of Texas at San Antonio (UTSA); Academy of Military Medical Sciences - China; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Chen, XD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Comprehens Dent, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chenx4@uthscsa.edu	Li, Shengxian/AFT-2979-2022	Yeh, Chih-Ko/0000-0001-6611-9942; Chen, Xiao-Dong/0000-0003-1602-806X; Dean, David/0000-0002-4512-9065	San Antonio Medical Foundation; VA Merit Review	San Antonio Medical Foundation; VA Merit Review(US Department of Veterans Affairs)	San Antonio Medical Foundation; VA Merit Review	Atchison NA, 2010, LANGMUIR, V26, P14081, DOI 10.1021/la101264h; BALLINGER WF, 1972, SURGERY, V72, P175; BANK HL, 1988, IN VITRO CELL DEV B, V24, P266; Barton FB, 2012, DIABETES CARE, V35, P1436, DOI 10.2337/dc12-0063; Block TJ, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0688-x; Bogdani M, 2012, CURR DIABETES REP, V14, P552, DOI 10.1007/s11892-014-0552-7; Brehm MA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007757; Carter JD, 2009, BIOL PROCED ONLINE, V11, P3, DOI 10.1007/s12575-009-9021-0; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Chen PW, 2015, ACTA NEUROPATHOL, V129, P97, DOI 10.1007/s00401-014-1369-9; Chen XD, 2007, J BONE MINER RES, V22, P1943, DOI 10.1359/JBMR.070725; Daoud J, 2010, BIOMATERIALS, V31, P1676, DOI 10.1016/j.biomaterials.2009.11.057; Graham ML, 2015, EUR J PHARMACOL, V759, P221, DOI 10.1016/j.ejphar.2015.02.054; Groulx JF, 2011, MATRIX BIOL, V30, P195, DOI 10.1016/j.matbio.2011.03.002; Hatlapatka K, 2009, AM J PHYSIOL-ENDOC M, V297, pE315, DOI 10.1152/ajpendo.90981.2008; Hughes SJ, 2006, TRANSPLANTATION, V81, P423, DOI 10.1097/01.tp.0000197482.91227.df; HUTTON JC, 1989, DIABETOLOGIA, V32, P271, DOI 10.1007/BF00265542; Irving-Rodgers HF, 2014, CELL TRANSPLANT, V23, P59, DOI 10.3727/096368912X659880; King A, 2016, BIOCHEM PHARMACOL, V99, P1, DOI 10.1016/j.bcp.2015.08.108; LACY P E, 1980, Diabetes, V29, P93; Lai YL, 2010, STEM CELLS DEV, V19, P1095, DOI 10.1089/scd.2009.0217; Marinkovic M, 2016, MATRIX BIOL, V52-54, P426, DOI 10.1016/j.matbio.2016.01.004; Nakashima Y, 2018, ISLETS, V10, DOI 10.1080/19382014.2018.1460294; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Noguchi H, 2015, CELL MED, V8, P25, DOI 10.3727/215517915X689047; RABINOVITCH A, 1982, DIABETES, V31, P48, DOI 10.2337/diab.31.4.S48; Riopel M, 2014, FRONT BIOSCI-LANDMRK, V19, P77, DOI 10.2741/4196; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; SELAWRY H, 1978, DIABETES, V27, P625, DOI 10.2337/diab.27.6.625; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Sorokin L, 2010, NAT REV IMMUNOL, V10, P712, DOI 10.1038/nri2852; Stendahl JC, 2009, CELL TRANSPLANT, V18, P1, DOI 10.3727/096368909788237195; Sun Y, 2011, FASEB J, V25, P1474, DOI 10.1096/fj.10-161497; Swift S M, 1996, Transpl Immunol, V4, P169, DOI 10.1016/S0966-3274(96)80012-8; Urciuolo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2964; Willenborg M, 2012, AM J PHYSIOL-ENDOC M, V303, pE223, DOI 10.1152/ajpendo.00010.2012	36	4	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8044	8056		10.1096/fj.201902893R	http://dx.doi.org/10.1096/fj.201902893R		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32307751	hybrid, Green Accepted			2022-12-26	WOS:000527383500001
J	Hooper-Bul, LM; Strecker-Lau, RM; Stewart, DM; Landry, MJ; Papillion, AM; Peterson, SN; Daniel, RA				Hooper-Bul, L. M.; Strecker-Lau, R. M.; Stewart, D. M.; Landry, M. J.; Papillion, A. M.; Peterson, S. N.; Daniel, R. A.			Effects of sea-level rise on physiological ecology of populations of a ground-dwelling ant	PLOS ONE			English	Article							FIRE ANT; SOLENOPSIS-INVICTA; CLIMATE-CHANGE; WORKER SIZE; HYMENOPTERA; RESPONSES; INVASION; IMPACTS	Introduction Sea-level rise is a consequence of climate change that can impact the ecological and physiological changes of coastal, ground-dwelling species. Sea-level rise has a potential to inundate birds, rodents, spiders, and insects that live on the ground in coastal areas. Yet, there is still much to be learned concerning the specifics of these impacts. The red imported fire ant Solenopsis invicta (Buren) excavates soil for its home and is capable of surviving flooding. Because of their ground-dwelling life history and rapid reproduction, fire ants make an ideal model for discovery and prediction of changes that may be due to sea-level rise. There are up to 500,000 individuals in a colony, and these invasive ants naturally have a painful sting. However, observations suggest that colonies of fire ants that dwell in tidally-influenced areas are more aggressive with more frequent stings and more venom injected per sting (behavioral and physiological changes) than those located inland. This may be an adaption to sea-level rise. Therefore, the objective of this study is to elucidate differences in inland and coastal defensiveness via micro-dissection and comparison of head width, head length, stinger length, and venom sac volume. But first because fire ants' ability to raft on brackish tidal water is unknown, it had to be determined if fire ants could indeed raft in brackish water and examine the behavior differences between those flooded with freshwater vs. saltwater. Methods To test the coastal-aggression hypothesis, inland colonies and coastal colonies, which experience relatively greater amounts of flooding, specifically regular tidal and windblown water and oscillations (i.e. El Nino Southern Oscillation) from the Gulf of Mexico, were collected. To mimic sea-level rise, the colonies were flooded in salinities that correspond to both their collection site and conditions found in a variety of locales and situations (such as storm surge from a tropical storm). Individual ants were immediately taken from each colony for dissection before flooding, 1-hour into flooding, and 24-hours into flooding. Results and discussion Fire ants use their venom to defend themselves and to communicate alarm or aggression. Dissections and measurement of heads, venom sacs, and stingers revealed both coastal and inland colonies experience an increase in venom sac volume after 24 hours; in fact coastal colonies increased their venom volume by 75% after 24 h of flooding Whether this venom sac enlargement is due to diffusion of water or venom sac production is unknown. These ground-dwelling ants exhibit physiological and behavioral adaptations to ongoing sea-level rise possibly indicating that they are responding to increased flooding. Fire ants will raft on high-salinity water; and sea-level rise may cause stings by flooded ants to be more severe because of increased venom volume.	[Hooper-Bul, L. M.; Strecker-Lau, R. M.; Peterson, S. N.; Daniel, R. A.] LSU, Coll Coast & Environm, Dept Environm Sci, Baton Rouge, LA USA; [Stewart, D. M.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Landry, M. J.] Univ Texas Austin, Dept Nutr Sci, Austin, TX 78712 USA; [Papillion, A. M.] Univ Alabama Birmingham, Div Clin Immunol & Rheumatol, Birmingham, AL USA	Louisiana State University System; Louisiana State University; Northwestern University; Feinberg School of Medicine; University of Texas System; University of Texas Austin; University of Alabama System; University of Alabama Birmingham	Hooper-Bul, LM (corresponding author), LSU, Coll Coast & Environm, Dept Environm Sci, Baton Rouge, LA USA.	lindabui@lsu.edu	Landry, Matthew J./W-6534-2018; Bui, Dr. Linda/AAW-7252-2021	Landry, Matthew J./0000-0003-2285-7702; Hooper-Bui, Linda/0000-0002-4836-7288	Louisiana State Board of Regents EPSCoR Program; LSU College of Agriculture Undergraduate Research Grant; United States Department of Education TRIO McNair Scholars program	Louisiana State Board of Regents EPSCoR Program; LSU College of Agriculture Undergraduate Research Grant; United States Department of Education TRIO McNair Scholars program	DS and LMHB received a National Science Foundation Supervised Undergraduate Research Grant from the Louisiana State Board of Regents EPSCoR Program. ML received a LSU College of Agriculture Undergraduate Research Grant. AP received support from the United States Department of Education TRIO McNair Scholars program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.17101; Allen CR, 2004, AM MIDL NAT, V152, P88, DOI 10.1674/0003-0031(2004)152[0088:RIFAIO]2.0.CO;2; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Banks W.A., 1981, AATSS21 USDA SEA; BRAND JM, 1973, INSECT BIOCHEM, V3, P45, DOI 10.1016/0020-1790(73)90017-6; CALABI P, 1989, J INSECT PHYSIOL, V35, P643, DOI 10.1016/0022-1910(89)90127-3; Chen JA, 2007, INSECT SCI, V14, P1, DOI 10.1111/j.1744-7917.2007.00120.x; Chick LD, 2017, MYRMECOL NEWS, V25, P29; Deslippe RJ, 2000, TOXICON, V38, P223, DOI 10.1016/S0041-0101(99)00147-6; Diamond SE, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600842; Donihue CM, 2018, NATURE, V560, P88, DOI 10.1038/s41586-018-0352-3; Estay SA, 2009, J APPL ENTOMOL, V133, P491, DOI 10.1111/j.1439-0418.2008.01380.x; Field CR, 2017, GLOBAL CHANGE BIOL, V23, P2058, DOI 10.1111/gcb.13519; Garbalinska Paulina, 2008, Baltic Journal of Coleopterology, V8, P101; Haight KL, 2006, INSECT SOC, V53, P32, DOI 10.1007/s00040-005-0832-y; Haight KL, 2003, TOXICON, V42, P673, DOI 10.1016/j.toxicon.2003.09.005; HOFFMAN DR, 1995, ALLERGY, V50, P535, DOI 10.1111/j.1398-9995.1995.tb01196.x; Kaspari M, 1999, FUNCT ECOL, V13, P530, DOI 10.1046/j.1365-2435.1999.00343.x; Morris JT, 2002, ECOLOGY, V83, P2869, DOI 10.1890/0012-9658(2002)083[2869:ROCWTR]2.0.CO;2; OBIN MS, 1985, J CHEM ECOL, V11, P1757, DOI 10.1007/BF01012125; Papillion AM, 2011, SOCIOBIOLOGY, V57, P301; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pelini SL, 2011, METHODS ECOL EVOL, V2, P534, DOI 10.1111/j.2041-210X.2011.00100.x; PORTER SD, 1985, ANN ENTOMOL SOC AM, V78, P381, DOI 10.1093/aesa/78.3.381; Roy DB, 2000, GLOB CHANGE BIOL, V6, P407, DOI 10.1046/j.1365-2486.2000.00322.x; Steen CJ, 2005, INT J DERMATOL, V44, P91, DOI 10.1111/j.1365-4632.2005.02391.x; TSCHINKEL WR, 1993, ECOL MONOGR, V63, P425, DOI 10.2307/2937154; Vander Meer RK, 2002, BEHAV ECOL SOCIOBIOL, V51, P122, DOI 10.1007/s002650100417; VANDERMEER RK, 1983, FLA ENTOMOL, V66, P139, DOI 10.2307/3494560; Vinson S. Bradleigh, 1997, American Entomologist, V43, P23; Vinson SB, 2013, INSECT SCI, V20, P439, DOI 10.1111/j.1744-7917.2012.01572.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilson EO., 1990, ANTS, DOI [10.1007/978-3-662-10306-7, DOI 10.1007/978-3-662-10306-7]; WOOD LA, 1981, INSECT SOC, V28, P117, DOI 10.1007/BF02223700	34	2	2	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0223304	10.1371/journal.pone.0223304	http://dx.doi.org/10.1371/journal.pone.0223304			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302310	Green Published, gold			2022-12-26	WOS:000536016100002
J	Lin, SC; Lin, LL; Liu, CJ; Fang, CK; Lin, MH				Lin, Shu Chuan; Lin, Li Li; Liu, Chih Ju; Fang, Chun Kai; Lin, Mei Hsiang			Exploring the factors affecting musculoskeletal disorders risk among hospital nurses	PLOS ONE			English	Article								Background Musculoskeletal disorder (MSD) is currently recognized as one of the most common occupational injuries for which nursing personnel in the medical service industry have been identified as a high-risk group. In this study, we explore the prevalence of MSD in various body parts as well as their risk factors among hospital nurses. Methods A cross-sectional descriptive design with stratified cluster sampling was used to collect data from 1,803 nurses. The survey included a demographic questionnaire, and Nordic Musculoskeletal Questionnaire. Results The results showed that the greatest prevalence of MSD symptoms by body regions were in the right shoulder (85.8%), the left shoulder (80.9%), the neck (62.4%), the right wrist (62.2%) and the lower back (60.4%). Risk factors for shoulder discomfort includes department type, exercise habits, and age (p < .05). Risk factors for neck discomfort includes seniority in the current unit, "job title, and "history of MDS (p < .05). Risk factors for upper back discomfort includes age and seniority in the current unit (p < .05). Risk factors for lower back discomfort including seniority in the current unit, department type, and number of days worked per week (p < .05). Conclusions The results of this study can serve as a reference for nursing administration managers and decision-makers for reducing musculoskeletal discomfort among nurses and thereby achieving superior quality in clinical care.	[Lin, Shu Chuan] Mackay Mem Hosp, Dept Nursing, Taipei, Taiwan; [Lin, Li Li; Liu, Chih Ju; Fang, Chun Kai] Mackay Mem Hosp, Taipei, Taiwan; [Lin, Mei Hsiang] Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan	Mackay Memorial Hospital; Mackay Memorial Hospital; National Taipei University of Nursing & Health Science (NTUNHS)	Lin, MH (corresponding author), Natl Taipei Univ Nursing & Hlth Sci, Dept Nursing, Taipei, Taiwan.	meihsiang@ntunhs.edu.tw						Alexopoulos EC, 2011, WORK, V38, P329, DOI 10.3233/WOR-2011-1136; Arsalani N, 2014, INT J OCCUP SAF ERGO, V20, P671, DOI 10.1080/10803548.2014.11077073; Ba NA, 2016, INT J COLLAB RES INT, V8, P294; Bazazan A, 2019, INT EMERG NURS, V44, P8, DOI 10.1016/j.ienj.2019.02.004; Bureau of Labor Insurance Ministry of Labor, 2018, YB LAB INS STAT REP; Carneiro P, 2017, INT J IND ERGONOM, V61, P22, DOI 10.1016/j.ergon.2017.05.002; Chen C.J., 2012, CHIN J OCCUP MED, V19, P73; Chen W.L., 2006, MIDTAIWAN J MED, V11, P252, DOI DOI 10.6558/; Cheng YS, 2014, J LONG TERM CARE, V18, P13; Chiwaridzo M, 2018, BMC Res Notes, V11, P315, DOI 10.1186/s13104-018-3412-8; Clari M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162844; Coggon D, 1998, AM J EPIDEMIOL, V147, P523; D'Agostin F., 2016, INT J OCCUPATIONAL S, V23, P274; Dawson AP, 2009, J PAIN, V10, P517, DOI 10.1016/j.jpain.2008.11.008; Dehdashti A, 2017, MIDDLE E J REHABILIT, DOI [10.5812/mejrh.57480, DOI 10.5812/MEJRH.57480]; Dogru S., 2019, ANN MED RES, V26, P374, DOI [0.5455/annalsmedres.2019.01.01, DOI 10.5455/ANNALSMEDRES.2019.01.01]; Hoogendoorn WE, 2002, OCCUP ENVIRON MED, V59, P323, DOI 10.1136/oem.59.5.323; Hou Jui-Yeh, 2006, J Nurs Res, V14, P228; Hsieh ML, 2018, SURVEY PERCEPTIONS S; KHANDAN M, 2017, JUNDISHAPUR J HLTH S, V6, DOI DOI 10.5812/JHEALTHSCOPE.37463; Kjellberg K, 2003, SCAND J WORK ENV HEA, V29, P468, DOI 10.5271/sjweh.755; Ko H.W., 2011, SHOW CHWAN MED J, V10, P69; KUORINKA I, 1987, APPL ERGON, V18, P233, DOI 10.1016/0003-6870(87)90010-X; Lee YH, 2013, WORKPLACE HEALTH SAF, V21, P432; Leu LJ, 2010, J MED SYST, V34, P909, DOI 10.1007/s10916-009-9306-5; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Raithatha Apexa S, 2016, Int J Chronic Dis, V2016, P5038381, DOI 10.1155/2016/5038381; Saberipour B, 2019, CLIN EPIDEMIOL GLOB, V7, P513, DOI 10.1016/j.cegh.2018.06.007; Salama LAA, 2018, J NURSING ED PRACTIC, V8, P51; Sezgin D, 2015, INT NURS REV, V62, P92, DOI 10.1111/inr.12157; Singh H, 2016, MODEL EARTH SYST ENV, V2, DOI 10.1007/s40808-016-0096-8; Smith DR, 2006, J SAFETY RES, V37, P195, DOI 10.1016/j.jsr.2006.01.004; Tantawy S, 2019, BIOMED RES, V30, P1; Tantawy SA, 2017, KOREAN J PAIN, V30, P126, DOI 10.3344/kjp.2017.30.2.126; Tinubu BMS, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-12; Viester L, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-238; Yang YC, 2018, J LONG TERM CARE, V22, P171, DOI [10.6317/LTC.20181022(2).0006, DOI 10.6317/LTC.20181022(2).0006]	37	19	19	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231319	10.1371/journal.pone.0231319	http://dx.doi.org/10.1371/journal.pone.0231319			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298295	Green Published, Green Submitted, gold			2022-12-26	WOS:000536011400035
J	Timpano, EK; Scheible, MKR; Meiklejohn, KA				Timpano, Emma K.; Scheible, Melissa K. R.; Meiklejohn, Kelly A.			Optimization of the second internal transcribed spacer (ITS2) for characterizing land plants from soil	PLOS ONE			English	Article							DNA BARCODE; IDENTIFICATION; GENOME	Molecular-based taxonomy, specifically DNA barcoding, has streamlined organism identification. For land plants, the recommended 2-locus barcode of rbcL and matK is not suitable for all groups, thus the second subunit of the nuclear internal transcribed spacer (ITS2) has received attention as a possible alternative. To date, evaluations of ITS2 have mostly been limited in scope to specific plant orders/families and single source material. Prior to using ITS2 to routinely characterize land plants present in environmental samples (i.e., DNA metabarcoding), a wet lab protocol optimized for bulk sample types is needed. To address this gap, in this study we determined the broad recoverability across land plants when using published ITS2 primer pairs, and subsequently optimized the PCR reaction constituents and cycling conditions for the best two performing primer pairs (ITS2F/ITSp4 and ITSp3/ITSu4). Using these conditions, both primer pairs were used to characterize land plants present in 17 diverse soils collected from across the US. The resulting PCR amplicons were prepared into libraries and pooled for sequencing on an Illumina (R) MiniSeq. Our existing bioinformatics workflow was used to process raw sequencing data and taxonomically assign unique ITS2 plant sequences by comparison to GenBank. Given strict quality criteria were imposed on sequences for inclusion in data analysis, only 43.6% and 7.5% of sequences from ITS2F/ITSp4 and ITSp3/ITSu4 respectively remained for taxonomic comparisons; similar to 7-11% of sequences originated from fungal co-amplification. The number of orders and families recovered did differ between primer pairs, with ITS2F/ITSp4 consistently outperforming ITSp3/ITSu4 by > 15%. Primer pair bias was observed in the recovery of certain taxonomic groups; ITS2F/ITSp4 preferentially recovered flowering plants and grasses, whereas ITSp3/ITSu4 recovered more moss taxa. To maximize data recovery and reduce potential bias, we advocate that studies using ITS2 to characterize land plants from environmental samples such as soil use a multiple primer pair approach.	[Timpano, Emma K.; Scheible, Melissa K. R.; Meiklejohn, Kelly A.] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University	Meiklejohn, KA (corresponding author), North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC 27695 USA.	kameikle@ncsu.edu		Meiklejohn, Kelly A/0000-0001-6125-2963	North Carolina State University College of Veterinary Medicine	North Carolina State University College of Veterinary Medicine	The North Carolina State University College of Veterinary Medicine provided seed funding for this study.	[Anonymous], 2013, GEOCHEMICAL MINERALO; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bell KL, 2019, MOL ECOL, V28, P431, DOI 10.1111/mec.14840; Boggs LM, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060431; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chamberlain Scott A, 2013, F1000Res, V2, P191, DOI 10.12688/f1000research.2-191.v1; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cheng T, 2016, MOL ECOL RESOUR, V16, P138, DOI 10.1111/1755-0998.12438; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Craine JM, 2017, AEROBIOLOGIA, V33, P71, DOI 10.1007/s10453-016-9451-5; Deiner K, 2017, MOL ECOL, V26, P5872, DOI 10.1111/mec.14350; DEMEKE T, 1992, BIOTECHNIQUES, V12, P332; Fahner NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157505; Fazekas Aron J, 2012, Methods Mol Biol, V858, P223, DOI 10.1007/978-1-61779-591-6_11; Flojgaard C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0202844; Gao T, 2010, J ETHNOPHARMACOL, V130, P116, DOI 10.1016/j.jep.2010.04.026; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Jorgensen T, 2012, MOL ECOL, V21, P1980, DOI 10.1111/j.1365-294X.2011.05278.x; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Liston A, 1996, SYST BOT, V21, P109, DOI 10.2307/2419742; Liu ZH, 2012, J ETHNOPHARMACOL, V141, P242, DOI 10.1016/j.jep.2012.01.057; Lucaciu R, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01313; Luo K, 2010, SCI CHINA LIFE SCI, V53, P701, DOI 10.1007/s11427-010-4009-1; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Moorhouse-Gann RJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26648-2; Nichols RV, 2018, MOL ECOL RESOUR, V18, P927, DOI 10.1111/1755-0998.12895; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1500043; Richardson RT, 2015, APPL PLANT SCI, V3, DOI 10.3732/apps.1400066; Rousk J, 2009, APPL ENVIRON MICROB, V75, P1589, DOI 10.1128/AEM.02775-08; Sickel W, 2015, BMC ECOL, V15, DOI 10.1186/s12898-015-0051-y; Smith DR, 2014, PLANT PHYSIOL, V164, P1812, DOI 10.1104/pp.113.233718; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; United States Department of Agriculture, NAT RES CONS SERV PL; White TJ., 1990, PCR PROTOCOLS GUIDE, P315	35	7	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231436	10.1371/journal.pone.0231436	http://dx.doi.org/10.1371/journal.pone.0231436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298321	Green Submitted, Green Published, gold			2022-12-26	WOS:000536011400043
J	Lee, CAA; Banerjee, P; Wilson, BJ; Wu, SY; Guo, Q; Berg, G; Karpova, S; Mishra, A; Lian, JW; Tran, J; Emmerich, M; Murphy, GF; Frank, MH; Frank, NY				Lee, Catherine A. A.; Banerjee, Pallavi; Wilson, Brian J.; Wu, Siyuan; Guo, Qin; Berg, Gretchen; Karpova, Svetlana; Mishra, Ananda; Lian, John W.; Tran, Johnathan; Emmerich, Max; Murphy, George F.; Frank, Markus H.; Frank, Natasha Y.			Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glioblastoma; cancer stem cells; chemoresistance; anticancer drug; cell cycle; apoptosis; tumor marker; temozolomide; ATP-binding cassette subfamily B member 5 (ABCB5); glioblastoma multiforme; CD133	CANCER STEM-CELL; ELEVATED EXPRESSION; P-GLYCOPROTEIN; CHEMORESISTANCE; IDENTIFICATION; RESISTANCE; DENSITY; ARREST; GROWTH; NORMALIZATION	Glioblastoma multiforme (GBM) is a malignant brain tumor with a poor prognosis resulting from tumor resistance to anticancer therapy and a high recurrence rate. Compelling evidence suggests that this is driven by subpopulations of cancer stem cells (CSCs) with tumor-initiating potential. ABC subfamily B member 5 (ABCB5) has been identified as a molecular marker for distinct subsets of chemoresistant tumor-initiating cell populations in diverse human malignancies. In the current study, we examined the potential role of ABCB5 in growth and chemoresistance of GBM. We found that ABCB5 is expressed in primary GBM tumors, in which its expression was significantly correlated with the CSC marker protein CD133 and with overall poor survival. Moreover, ABCB5 was also expressed by CD133-positive CSCs in the established human U-87 MG, LN-18, and LN-229 GBM cell lines. Antibody- or shRNA-mediated functional ABCB5 blockade inhibited proliferation and survival of GBM cells and sensitized them to temozolomide (TMZ)-induced apoptosis in vitro. Likewise, in in vivo human GBM xenograft experiments with immunodeficient mice, mAb treatment inhibited growth of mutant TP53, WT PTEN LN-229 tumors, and sensitized LN-229 tumors to TMZ therapy. Mechanistically, we demonstrate that ABCB5 blockade inhibits TMZ-induced G(2)/M arrest and augments TMZ-mediated cell death. Our results identify ABCB5 as a GBM chemoresistance marker and point to the potential utility of targeting ABCB5 to improve current GBM therapies.	[Lee, Catherine A. A.; Wu, Siyuan; Guo, Qin; Karpova, Svetlana; Mishra, Ananda; Tran, Johnathan; Frank, Natasha Y.] Harvard Med Sch, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lian, John W.; Murphy, George F.] Harvard Med Sch, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Frank, Markus H.] Harvard Med Sch, Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Lee, Catherine A. A.; Banerjee, Pallavi; Wilson, Brian J.; Guo, Qin; Berg, Gretchen; Mishra, Ananda; Tran, Johnathan; Emmerich, Max; Frank, Markus H.; Frank, Natasha Y.] Harvard Med Sch, Boston Childrens Hosp, Transplant Res Program, Boston, MA 02115 USA; [Banerjee, Pallavi; Guo, Qin; Berg, Gretchen; Karpova, Svetlana; Frank, Natasha Y.] Vet Affairs Boston Healthcare Syst, Dept Med, Boston, MA 02132 USA; [Wilson, Brian J.; Murphy, George F.; Frank, Markus H.; Frank, Natasha Y.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Frank, Markus H.] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA 6027, Australia	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Harvard University; Edith Cowan University	Frank, NY (corresponding author), Brigham & Womens Hosp, 77 Ave Louis Pasteur,168F, Boston, MA 02115 USA.	nyfrank@bwh.harvard.edu	; Frank, Markus/O-1625-2014	Tran, Johnathan/0000-0002-0769-4848; Frank, Markus/0000-0002-1312-0488; Emmerich, Max/0000-0002-2026-974X	National Institutes of Health [T32 EB016652-05]; Vetarans Affairs BLRD Grant [1I01BX000516]; Vetarans Affairs RRDGrant [1I01RX000989]; Merit Review Awards; Department of Defense translational team science award; NCI, National Institutes of Health [R01CA113796, R01CA158467, R01CA138231]; NEI, National Institutes of Health [1RO1EY025794, R24EY028767]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vetarans Affairs BLRD Grant; Vetarans Affairs RRDGrant; Merit Review Awards; Department of Defense translational team science award; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health Grant T32 EB016652-05 (to C. A. A. L.); Vetarans Affairs BLR&D Grant 1I01BX000516 andRR&DGrant 1I01RX000989, Merit Review Awards, and a Department of Defense translational team science award (to N. Y. F.); NCI, National Institutes of Health, Grants R01CA113796, R01CA158467, and R01CA138231 (to M. H. F.); and NEI, National Institutes of Health, Grants 1RO1EY025794 and R24EY028767 (to M. H. F. and N. Y. F.). N. Y. F. and M. H. F. are co-inventors of the ABCB5-related United States Patent 7,928,202 (Targeting ABCB5 for cancer therapy) assigned to Brigham and Women's Hospital, Boston, Massachusetts, and licensed to Ticeba GmbH (Heidelberg, Germany) and Rheacell GmbH & Co. KG (Heidelberg, Germany). M. H. F. serves as a scientific advisor to Ticeba GmbH and Rheacell GmbH & Co. KG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Auffinger B, 2014, CELL DEATH DIFFER, V21, P1119, DOI 10.1038/cdd.2014.31; Back M, 2018, CLIN ONCOL-UK, V30, P556, DOI 10.1016/j.clon.2018.06.005; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Behnan J, 2019, BRAIN, V142, P847, DOI 10.1093/brain/awz044; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Carvalho BS, 2010, BIOINFORMATICS, V26, P2363, DOI 10.1093/bioinformatics/btq431; Chen J, 2012, NATURE, V488, P522, DOI 10.1038/nature11287; Cheung ST, 2011, GASTROENTEROLOGY, V140, P344, DOI 10.1053/j.gastro.2010.07.049; DiPaola RS, 2002, CLIN CANCER RES, V8, P3311; El-Khattouti A, 2015, CANCER LETT, V357, P83, DOI 10.1016/j.canlet.2014.10.043; Filippi-Chiela EC, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-147; Flatten K, 2005, J BIOL CHEM, V280, P14349, DOI 10.1074/jbc.M411890200; Frank NY, 2005, CANCER RES, V65, P4320, DOI 10.1158/0008-5472.CAN-04-3327; Frank NY, 2003, J BIOL CHEM, V278, P47156, DOI 10.1074/jbc.M308700200; Gazzaniga P, 2010, EJSO-EUR J SURG ONC, V36, P1211, DOI 10.1016/j.ejso.2010.05.001; Grimm M, 2012, EUR J CANCER, V48, P3186, DOI 10.1016/j.ejca.2012.05.027; Guo Q, 2018, J BIOL CHEM, V293, P11166, DOI 10.1074/jbc.RA118.003187; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hirose Y, 2001, CANCER RES, V61, P5843; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jackson JR, 2000, CANCER RES, V60, P566; Jongkhajornpong P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20541; Kleffel S, 2016, J INVEST DERMATOL, V136, P838, DOI 10.1016/j.jid.2015.12.038; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Lai CY, 2012, CANCER RES, V72, P5111, DOI 10.1158/0008-5472.CAN-12-0624; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Lin F, 2014, CLIN CANCER RES, V20, P2703, DOI 10.1158/1078-0432.CCR-14-0084; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Luna JI, 2019, CANCERS, V11, DOI 10.3390/cancers11010085; Munoz JL, 2015, CANCER LETT, V367, P69, DOI 10.1016/j.canlet.2015.07.013; Newlands ES, 1997, CANCER TREAT REV, V23, P35, DOI 10.1016/S0305-7372(97)90019-0; Olar A, 2014, J PATHOL, V232, P165, DOI 10.1002/path.4282; Pore N, 2003, CANCER RES, V63, P236; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scherer HJ, 1940, J NEUROL PSYCHIATRY, V3, P147, DOI 10.1136/jnnp.3.2.147; Schwartz GK, 2005, J CLIN ONCOL, V23, P9408, DOI 10.1200/JCO.2005.01.5594; Shah MA, 2001, CLIN CANCER RES, V7, P2168; Sherr CJ, 2000, CANCER RES, V60, P3689; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Tyagi AK, 2002, CLIN CANCER RES, V8, P3512; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wei LH, 2008, CLIN CANCER RES, V14, P3416, DOI 10.1158/1078-0432.CCR-07-1824; Wijaya J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122544; Wilson BJ, 2011, CANCER RES, V71, P5307, DOI 10.1158/0008-5472.CAN-11-0221; Woo JY, 2015, J KOREAN NEUROSURG S, V58, P426, DOI 10.3340/jkns.2015.58.5.426; Zeppernick F, 2008, CLIN CANCER RES, V14, P123, DOI 10.1158/1078-0432.CCR-07-0932; Zhang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.182	53	16	17	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7774	7788		10.1074/jbc.RA120.013778	http://dx.doi.org/10.1074/jbc.RA120.013778			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32317280	hybrid, Green Published			2022-12-26	WOS:000538038900017
J	Carvalho, JL; Miranda, M; Fialho, AK; Castro-Faria-Neto, H; Anatriello, E; Keller, C; Aimbire, F				Carvalho, J. L.; Miranda, M.; Fialho, A. K.; Castro-Faria-Neto, H.; Anatriello, E.; Keller, C.; Aimbire, F.			Oral feeding with probiotic Lactobacillus rhamnosus attenuates cigarette smoke-induced COPD in C57Bl/6 mice: Relevance to inflammatory markers in human bronchial epithelial cells	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EFFECTOR-CELLS; EXPRESSION; PATHOGENESIS; RELEASE; MACROPHAGES; ACTIVATION; MECHANISMS; CHEMOKINES; ASTHMA	COPD is a prevalent lung disease with significant impacts on public health. Affected airways exhibit pulmonary neutrophilia and consequent secretion of pro-inflammatory wcytokines and proteases, which result in lung emphysema. Probiotics act as nonspecific modulators of the innate immune system that improve several inflammatory responses. To investigate the effect of Lactobacillus rhamnosus (Lr) on cigarette smoke (CS)-induced COPD C57Bl/6 mice were treated with Lr during the week before COPD induction and three times/week until euthanasia. For in vitro assays, murine bronchial epithelial cells as well as human bronchial epithelial cells exposed to cigarette smoke extract during 24 hours were treated with Lr 1 hour before CSE addition. Lr treatment attenuated the inflammatory response both in the airways and lung parenchyma, reducing inflammatory cells infiltration and the production of pro-inflammatory cytokines and chemokines. Also, Lr-treated mice presented with lower metalloproteases in lung tissue and lung remodeling. In parallel to the reduction in the expression of TLR2, TLR4, TLR9, STAT3, and NF-kappa B in lung tissue, Lr increased the levels of IL-10 as well as SOCS3 and TIMP1/2, indicating the induction of an anti-inflammatory environment. Similarly, murine bronchial epithelial cells as well as human bronchial epithelial cells (BEAS) exposed to CSE produced pro-inflammatory cytokines and chemokines, which were inhibited by Lr treatment in association with the production of anti-inflammatory molecules. Moreover, the presence of Lr also modulated the expression of COPD-associated transcription found into BALF of COPD mice group, i.e., Lr downregulated expression of NF-kappa B and STAT3, and inversely upregulated increased expression of SOCS3. Thus, our findings indicate that Lr modulates the balance between pro- and anti-inflammatory cytokines in human bronchial epithelial cells upon CS exposure and it can be a useful tool to improve the lung inflammatory response associated with COPD.	[Carvalho, J. L.; Miranda, M.; Fialho, A. K.; Anatriello, E.; Aimbire, F.] Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, SP, Brazil; [Castro-Faria-Neto, H.] Fiocruz MS, Lab Immunopharmacol, Rio De Janeiro, Brazil; [Keller, C.] Univ Fed Sao Paulo, Dept Microbiol Immunol & Parasitol, Sao Paulo, SP, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP)	Aimbire, F (corresponding author), Univ Fed Sao Paulo, Dept Sci & Technol, Sao Jose Dos Campos, SP, Brazil.	flavio.aimbire@unifesp.br	Keller, Alexandre C/E-4621-2012; Aimbire, Flavio/E-6193-2012	Keller, Alexandre C/0000-0002-7827-0292; Aimbire, Flavio/0000-0002-4290-541X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2015/184550]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Flavio Aimbire (FA) This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grant: 2015/184550. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Oliveira A R, 2019, Exerc Immunol Rev, V25, P50; [Anonymous], 2019, GLOBAL STRATEGY DIAG; Ponce-Gallegos MA, 2017, INT J CHRONIC OBSTR, V12, P1857, DOI 10.2147/COPD.S136592; Apostolou A., 2016, HERZ, V8, P1; Barnes PJ, 2017, CLIN SCI, V131, P1541, DOI 10.1042/CS20160487; Bazett M, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0577-y; Bhat TA, 2015, ANN AM THORAC SOC, V12, pS169, DOI 10.1513/AnnalsATS.201503-126AW; Brusselle GG, 2011, LANCET, V378, P1015, DOI 10.1016/S0140-6736(11)60988-4; Chadhuri R., 2013, TRANSLATIONAL RESP M, V1, P1; Costa C, 2008, CHEST, V133, P26, DOI 10.1378/chest.07-0393; Di Stefano A, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02006-2016; Foronjy RF, 2016, AM J PHYSIOL-LUNG C, V311, pL154, DOI 10.1152/ajplung.00073.2016; Forsythe P, 2011, CHEST, V139, P901, DOI 10.1378/chest.10-1861; Freeman CM, 2007, AM J PATHOL, V171, P767, DOI 10.2353/ajpath.2007.061177; Freeman CM, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-13; Gao W, 2015, RESPIROLOGY, V20, P722, DOI 10.1111/resp.12542; Han MK, 2010, AM J RESP CRIT CARE, V182, P598, DOI 10.1164/rccm.200912-1843CC; Hansbro P.M., 2017, EUR RESPIR J, V49, P1; Hao W., 2019, J IMMUNOL RES, V17, P714, DOI [10.1183/09031936.00062209, DOI 10.1183/09031936.00062209]; Haw TJ, 2018, AM J PHYSIOL-LUNG C, V314, pL298, DOI 10.1152/ajplung.00154.2017; Haw TJ, 2017, AM J PHYSL LUNG CELL; Hirota N, 2013, CHEST, V144, P1026, DOI 10.1378/chest.12-3073; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Hou WR, 2011, GENET MOL RES, V10, P1576, DOI 10.4238/vol10-3gmr1159; Inui T, 2018, EXP LUNG RES, V44, P323, DOI 10.1080/01902148.2018.1520936; Ito JT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209351; Kamiya T, 2006, GUT, V55, P191, DOI 10.1136/gut.2005.070987; Kruger K, 2015, AM J PHYSIOL-LUNG C, V309, pL119, DOI 10.1152/ajplung.00074.2015; Kwiatkowska S, 2012, RESPIRATION, V84, P231, DOI 10.1159/000339417; Lea SR, 2018, INT J CHRONIC OBSTR, V13, P771, DOI 10.2147/COPD.S97071; Lebre MC, 2005, IMMUNOL CELL BIOL, V83, P525, DOI 10.1111/j.1440-1711.2005.01365.x; Lee K, 2017, EDUC PSYCHOL PRACT, V33, P111, DOI 10.1080/02667363.2016.1258545; Lopez-Campos JL, 2016, RESPIROLOGY, V21, P14, DOI 10.1111/resp.12660; McCormick SM, 2016, J BIOL CHEM, V291, P20574, DOI 10.1074/jbc.M116.746164; Mortaz E, 2011, BBA-MOL BASIS DIS, V1812, P1104, DOI 10.1016/j.bbadis.2011.06.002; Mortaz E, 2010, EUR RESPIR J, V36, P1143, DOI 10.1183/09031936.00062209; Mortaz E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136455; Motz GT, 2008, J IMMUNOL, V181, P8036, DOI 10.4049/jimmunol.181.11.8036; Nasreen N, 2014, INT IMMUNOPHARMACOL, V19, P153, DOI 10.1016/j.intimp.2013.12.029; Navratilova Z, 2016, ARCH IMMUNOL THER EX, V64, P177, DOI 10.1007/s00005-015-0375-5; Noguera A, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-101; Pons J., 2006, RESP RES, V107, P1; Pouwels SD, 2016, AM J PHYSIOL-LUNG C, V310, P1377, DOI 10.1152/ajplung.00174.2015; Prele Cecilia M, 2012, Proc Am Thorac Soc, V9, P177, DOI 10.1513/pats.201201-007AW; Rao AV, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-6; Rocha-Ramirez L. M., 2017, J IMMUNOL RES, V2017, P1; Shoda H, 2007, BIOCHEM BIOPH RES CO, V353, P1004, DOI 10.1016/j.bbrc.2006.12.128; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Sun KY, 2017, CYTOKINE, V92, P1, DOI 10.1016/j.cyto.2017.01.003; Tuder RM, 2012, J CLIN INVEST, V122, P2749, DOI 10.1172/JCI60324; Verdu EF, 2004, GASTROENTEROLOGY, V127, P826, DOI 10.1053/j.gastro.2004.06.007; Westergreen-Thorsson G., 2017, RESPIROLOGY, V32, P1; Wu D.D., 2017, PHARMACOL THERAPEUT, V17, P30217; Zuo L, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00312	54	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0225560	10.1371/journal.pone.0225560	http://dx.doi.org/10.1371/journal.pone.0225560			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330145	Green Submitted, Green Published, gold			2022-12-26	WOS:000536647300004
J	Gao, J; Li, WB; Liu, HF; Chen, FB				Gao, Jian; Li, Wen-Bo; Liu, Hong-Fang; Chen, Fa-Bo			Identification of differential expression genes related to anthocyanin biosynthesis in carmine radish (Raphanus sativus L.) fleshy roots using comparative RNA-Seq method	PLOS ONE			English	Article							FRAGARIA X ANANASSA; PATHWAY; RED	Radish (Raphanus sativus L.), is an important root vegetable crop grown worldwide, and it contains phyto-anthocyanins. However, only limited studies have been conducted to elucidate the molecular mechanisms underlying anthocyanin biosynthesis in the different color variants of the radish fleshy root. In this study, Illumina paired-end RNA-sequencing was employed to characterize the transcriptomic changes in seven different types of radish fleshy roots. Approximately, 126 co-modulated differentially expressed genes were obtained, and most DEGs were more likely to participate in anthocyanin biosynthesis, including two transcription factors RsMYB_9 and RsERF070, and four functional genes RsBRICK1, RsBRI1-like2, RsCOX1, and RsCRK10. In addition, some related genes such as RsCHS, RsCHI, RsANS, RsMT2-4, RsUF3GT, glutathione S-transferase F12, RsUFGT78D2-like and RsUDGT-75C1-like significantly contributed to the regulatory mechanism of anthocyanin biosynthesis in the radish cultivars. Furthermore, gene ontology analysis revealed that the anthocyanin-containing compound biosynthetic process, anthocyanin-containing compound metabolic process, and significantly enriched pathways of the co-modulated DEGs were overrepresented in these cultivars. These results will expand our understanding of the complex molecular mechanism underlying anthocyanin synthesis-related genes in radish.	[Gao, Jian; Li, Wen-Bo; Liu, Hong-Fang; Chen, Fa-Bo] Yangtze Normal Univ, Sch Adv Agr & Bioengn, Chongqing, Peoples R China; [Liu, Hong-Fang] Yangtze Normal Univ, Green Intelligence Environm Sch, Fuling, Peoples R China	Yangtze Normal University; Yangtze Normal University	Chen, FB (corresponding author), Yangtze Normal Univ, Sch Adv Agr & Bioengn, Chongqing, Peoples R China.	chenfabo963@126.com	Li, Wenbo/AAP-2905-2021	Chen, Fa-Bo/0000-0002-4693-2650; Li, Wenbo/0000-0003-2407-1017	CSTC [cstc2016jcyjA0136]; Science and Technology Research Program of Chongqing Municipal Education Commission [KJ1712302]; Special Project of Science and Technology Innovation for Social Undertaking and People's Livelihood Guarantee of CSTC [cstc2017shms-xdny80074]	CSTC(Natural Science Foundation Project of CQ CSTC); Science and Technology Research Program of Chongqing Municipal Education Commission; Special Project of Science and Technology Innovation for Social Undertaking and People's Livelihood Guarantee of CSTC	This research was funded by the Normal Program supported this research for Frontiers and Applications Research of CSTC (No. cstc2016jcyjA0136), Science and Technology Research Program of Chongqing Municipal Education Commission (KJ1712302), Special Project of Science and Technology Innovation for Social Undertaking and People's Livelihood Guarantee of CSTC (No. cstc2017shms-xdny80074).	Aza-Gonzalez C, 2013, BIOL PLANTARUM, V57, P49, DOI 10.1007/s10535-012-0265-1; Azuma A, 2018, HORTICULT J, V87, P1, DOI 10.2503/hortj.OKD-IR02; Bajpai A, 2018, GENOME, V61, P157, DOI 10.1139/gen-2017-0205; Crifo T, 2011, GENE, V476, P1, DOI 10.1016/j.gene.2011.02.005; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Dixon RA, 2013, CURR OPIN BIOTECH, V24, P329, DOI 10.1016/j.copbio.2012.07.004; Espley RV, 2009, PLANT CELL, V21, P168, DOI 10.1105/tpc.108.059329; Gao J, 2015, J PLANT BIOL, V58, P211, DOI 10.1007/s12374-014-0572-5; He JA, 2010, ANNU REV FOOD SCI T, V1, P163, DOI 10.1146/annurev.food.080708.100754; Hoffmann T, 2006, PLANT J, V48, P818, DOI 10.1111/j.1365-313X.2006.02913.x; Jiang F, 2013, J PLANT GROWTH REGUL, V32, P182, DOI 10.1007/s00344-012-9289-1; Khoo HE, 2017, FOOD NUTR RES, V61, P1, DOI 10.1080/16546628.2017.1361779; Kitamura S, 2004, PLANT J, V37, P104, DOI 10.1046/j.1365-313X.2003.01943.x; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ST, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.27522; Li XY, 2012, GENE, V511, P54, DOI 10.1016/j.gene.2012.09.021; Lin X, 2013, SCI HORTIC-AMSTERDAM, V160, P123, DOI 10.1016/j.scienta.2013.05.024; Liu YL, 2013, MOLECULES, V18, P1549, DOI 10.3390/molecules18021549; MARRS KA, 1995, NATURE, V375, P397, DOI 10.1038/375397a0; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; Soubeyrand E, 2014, PHYTOCHEMISTRY, V103, P38, DOI 10.1016/j.phytochem.2014.03.024; Tarazona S., 2011, EMBNET J, V17, P18, DOI [10.14806/ej.17.B.265, DOI 10.14806/EJ.17.B.265]; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yousuf B, 2016, CRIT REV FOOD SCI, V56, P2223, DOI 10.1080/10408398.2013.805316; Zhao J, 2010, TRENDS PLANT SCI, V15, P72, DOI 10.1016/j.tplants.2009.11.006	27	2	2	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231729	10.1371/journal.pone.0231729	http://dx.doi.org/10.1371/journal.pone.0231729			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330148	Green Published, gold			2022-12-26	WOS:000536647300019
J	Patzold, W; Liszkowski, U				Paetzold, Wiebke; Liszkowski, Ulf			Pupillometric VoE paradigm reveals that 18-but not 10-month-olds spontaneously represent occluded objects (but not empty sets)	PLOS ONE			English	Article							INFANT COGNITION; PERMANENCE; SEARCH; LOOKING; DARK	Object permanence has been investigated with a variety of paradigms and measures, yielding heterogeneous findings. The current study employed a novel Violation-of-Expectation paradigm measuring pupil dilation as indicator of cognitive effort and surprise. Across repeated trials, infants watched videos of animated toys either stopping in an open door frame or moving across the open door frame off screen. The door then closed and opened up again to reveal either the toy, or an empty space. In Experiment 1, 18-month-olds's pupils dilated in response to the unexpected empty outcome more than to the expected empty outcome, establishing the paradigm as a suitable measure of violation of object expectation. Using the same paradigm, Experiment 2 revealed an absence of this object expectation effect for 10-month-olds. Results are discussed with regard to paradigmatic aspects and developmental differences. It is suggested that young infants do not automatically represent occluded objects upon perceiving occlusion events, and that occlusion events may initially require relevance in terms of individual activity or social interaction.	[Paetzold, Wiebke; Liszkowski, Ulf] Univ Hamburg, Dept Dev Psychol, Hamburg, Germany	University of Hamburg	Patzold, W (corresponding author), Univ Hamburg, Dept Dev Psychol, Hamburg, Germany.	wiebke.paetzold@uni-hamburg.de						Babinsky E, 2012, EXP BRAIN RES, V217, P237, DOI 10.1007/s00221-011-2984-5; BAILLARGEON R, 1985, COGNITION, V20, P191, DOI 10.1016/0010-0277(85)90008-3; BAILLARGEON R, 1987, DEV PSYCHOL, V23, P655, DOI 10.1037/0012-1649.23.5.655; Bialystok E, 2000, CAN J EXP PSYCHOL, V54, P117, DOI 10.1037/h0087334; Bogartz RS, 1997, DEV PSYCHOL, V33, P408, DOI 10.1037/0012-1649.33.3.408; BRADSHAW JL, 1968, PSYCHON SCI, V13, P69, DOI 10.3758/BF03342414; Bremner JG, 2015, CHILD DEV PERSPECT, V9, P7, DOI 10.1111/cdep.12098; Brisson J, 2013, BEHAV RES METHODS, V45, P1322, DOI 10.3758/s13428-013-0327-0; CLIFTON RK, 1993, CHILD DEV, V64, P1099; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Dunn K, 2017, DEVELOPMENTAL SCI, V20, DOI 10.1111/desc.12452; Fawcett C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08223-3; Geangu E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027132; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Haith M, 1998, INFANT BEHAV DEV, V21, P167, DOI 10.1016/S0163-6383(98)90001-7; Hepach R, 2016, J COGN DEV, V17, P359, DOI 10.1080/15248372.2015.1135801; Hespos S, 2009, COGNITIVE SCI, V33, P1483, DOI 10.1111/j.1551-6709.2009.01051.x; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Hochmann JR, 2014, PSYCHOL SCI, V25, P2038, DOI 10.1177/0956797614547918; HOOD B, 1986, BRIT J DEV PSYCHOL, V4, P57, DOI 10.1111/j.2044-835X.1986.tb00998.x; Hunter M.A., 1988, ADV INFANCY RES, VVol. 5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Kagan J, 2008, CHILD DEV, V79, P1606, DOI 10.1111/j.1467-8624.2008.01211.x; Kaufman J, 2005, P NATL ACAD SCI USA, V102, P15271, DOI 10.1073/pnas.0507626102; Kaufman J, 2003, P ROY SOC B-BIOL SCI, V270, pS140, DOI 10.1098/rsbl.2003.0067; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Meltzoff AN, 1998, INFANT BEHAV DEV, V21, P201, DOI 10.1016/S0163-6383(98)90003-0; MILLER DJ, 1970, J EXP CHILD PSYCHOL, V9, P59, DOI 10.1016/0022-0965(70)90101-3; Munakata Y, 1997, INFANT BEHAV DEV, V20, P405, DOI 10.1016/S0163-6383(97)90011-4; Nieder A, 2016, TRENDS COGN SCI, V20, P830, DOI 10.1016/j.tics.2016.08.008; O'Connor RJ, 2015, DEVELOPMENTAL SCI, V18, P824, DOI 10.1111/desc.12265; Patzold W., 2019, DEVELOPMENTAL SCI, DOI [10.1111/desc, DOI 10.1111/DESC]; Piaget J., 1954, CONSTRUCTION REALITY; Rivera SM, 1999, DEV PSYCHOL, V35, P427, DOI 10.1037/0012-1649.35.2.427; Ruffman T, 2005, COGNITION, V97, pB35, DOI 10.1016/j.cognition.2005.01.007; Schilling TH, 2000, INFANCY, V1, P389, DOI 10.1207/S15327078IN0104_2; Shinskey JL, 2012, INFANCY, V17, P272, DOI 10.1111/j.1532-7078.2011.00078.x; Shinskey JL, 2001, INFANCY, V2, P395, DOI 10.1207/S15327078IN0203_7; Sirois S, 2012, INFANCY, V17, P61, DOI 10.1111/j.1532-7078.2011.00096.x; Tallon-Baudry C, 1998, J NEUROSCI, V18, P4244; Ullwer D., 2010, EYETRACKCONF; Verschoor SA, 2015, COGNITION, V138, P64, DOI 10.1016/j.cognition.2015.01.005; von Hofsten C, 1998, COGNITION, V67, P255, DOI 10.1016/S0010-0277(98)00029-8; Wellman H.M., 1986, MONOGRAPH SOC RES CH, V51; WELLMAN HM, 1986, BRIT J DEV PSYCHOL, V4, P31, DOI 10.1111/j.2044-835X.1986.tb00995.x; WILLATTS P, 1984, DEV PSYCHOL, V20, P389, DOI 10.1037/0012-1649.20.3.389; Wynn K, 1998, PSYCHOL SCI, V9, P448, DOI 10.1111/1467-9280.00084; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0	48	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0230913	10.1371/journal.pone.0230913	http://dx.doi.org/10.1371/journal.pone.0230913			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LS8RF	32330136	Green Published, gold			2022-12-26	WOS:000536647300010
J	Bloch, A; Shaham, M; Vakil, E; Ashkenazi, SS; Zeilig, G				Bloch, Ayala; Shaham, Michal; Vakil, Eli; Ashkenazi, Simone Schwizer; Zeilig, Gabi			Examining implicit procedural learning in tetraplegia using an oculomotor serial reaction time task	PLOS ONE			English	Article							SPINAL-CORD-INJURY; SUPPORTED EMPLOYMENT; IMPAIRMENT; DISSOCIATION; PERFORMANCE; VETERANS; AMNESIA; TRIAL; SKILL; MOTOR	Background and objective Clinical observations indicate that implicit procedural learning, a central component of physical and psychosocial rehabilitation, is impeded following spinal cord injury. In accordance, previous research has revealed a specific deficit in implicit sequence learning among individuals with paraplegia using a standard, manual version of the serial reaction time task. To extend these findings and shed light on the underlying sources of potential spinal cord injury-related deficits in sequence learning, we used an ocular activated serial reaction time task to compare sequence learning performance between individuals with tetraplegia and healthy controls. Participants and measures Twelve participants with spinal cord injury in C5-T1 were compared to 12 matched control participants on measures derived from an ocular activated serial reaction time task. Depression and additional cognitive measures were assessed to explore the source and specificity of potential sequence learning deficits. Results Like controls, and in contrast with previous findings in paraplegia, the spinal cord injury group showed intact implicit sequence learning, evidenced by declining reaction times and improved anticipation over the first six blocks of the serial reaction time task, and an advantage for the initial learning sequence over a novel interference sequence. Conclusions The ocular activated serial reaction time task elicited a performance pattern similar to standard motor versions, such that participants with tetraplegia demonstrated unimpaired sequence learning. This suggests that previously reported implicit sequence learning deficits in spinal cord injury directly involved motor functioning rather than cognitive aspects of the task, and that the ocular activated sequence learning task could be a valid alternative for assessing implicit sequence learning in populations that cannot perform spinal-cord dependent motor tasks. Implications for post-spinal cord injury rehabilitation and adjustment are discussed.	[Bloch, Ayala; Shaham, Michal] Ariel Univ, Dept Behav Sci, Ariel, Israel; [Bloch, Ayala] Natl Inst Rehabil Brain Injured, Tel Aviv, Israel; [Vakil, Eli; Ashkenazi, Simone Schwizer] Bar Ilan Univ, Leslie & Susan Gonda Goldschmied Multidisciplinar, Ramat Gan, Israel; [Vakil, Eli; Ashkenazi, Simone Schwizer] Bar Ilan Univ, Dept Psychol, Ramat Gan, Israel; [Zeilig, Gabi] Sheba Med Ctr, Neurol Rehabil Dept, Ramat Gan, Israel; [Zeilig, Gabi] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel	Ariel University; Bar Ilan University; Bar Ilan University; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine	Bloch, A (corresponding author), Ariel Univ, Dept Behav Sci, Ariel, Israel.; Bloch, A (corresponding author), Natl Inst Rehabil Brain Injured, Tel Aviv, Israel.	ayalabl@shikumil.org.il		Schwizer Ashkenazi, Simone/0000-0002-8211-9624; Bloch, Ayala/0000-0002-1964-7053				Abrahamse EL, 2010, PSYCHON B REV, V17, P603, DOI 10.3758/PBR.17.5.603; Bloch A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158396; Clark GM, 2014, NEUROPSYCHOLOGY, V28, P945, DOI 10.1037/neu0000121; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Conson M, 2010, BRAIN COGNITION, V73, P189, DOI 10.1016/j.bandc.2010.05.001; Craig A, 2017, J NEUROTRAUM, V34, P1156, DOI 10.1089/neu.2016.4632; Craig A, 2015, BRIT J HEALTH PSYCH, V20, P807, DOI 10.1111/bjhp.12143; Fiori F, 2014, J NEUROPSYCHOL, V8, P199, DOI 10.1111/jnp.12020; Gabriel A, 2013, J INT NEUROPSYCH SOC, V19, P264, DOI 10.1017/S1355617712001270; Haider H, 2014, CONSCIOUS COGN, V26, P145, DOI 10.1016/j.concog.2014.03.005; Hill-Briggs F, 2007, ARCH CLIN NEUROPSYCH, V22, P389, DOI 10.1016/j.acn.2007.01.013; Jablonowski J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209590; Jure I, 2017, NEURAL REGEN RES, V12, P1044, DOI 10.4103/1673-5374.211177; Karunakaran KD, 2019, J NEUROTRAUM, V36, P2045, DOI 10.1089/neu.2018.6040; Kinder A, 2008, Q J EXP PSYCHOL, V61, P203, DOI 10.1080/17470210701557555; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; NISSEN MJ, 1987, COGNITIVE PSYCHOL, V19, P1, DOI 10.1016/0010-0285(87)90002-8; Ottomanelli L, 2012, ARCH PHYS MED REHAB, V93, P740, DOI 10.1016/j.apmr.2012.01.002; Ottomanelli L, 2009, J REHABIL RES DEV, V46, P919, DOI 10.1682/JRRD.2008.10.0145; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Ravula, 2018, MICROELECTRONICS ELE, V471, P41, DOI [10.1007/978-981-10-7329-8_5, DOI 10.1007/978-981-10-7329-8_5]; Robertson EM, 2007, J NEUROSCI, V27, P10073, DOI 10.1523/JNEUROSCI.2747-07.2007; Rose M, 2011, J NEUROSCI, V31, P13739, DOI 10.1523/JNEUROSCI.3020-11.2011; Rush AJ, 2005, NEUROPSYCHOPHARMACOL, V30, P405, DOI 10.1038/sj.npp.1300614; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Sachdeva R, 2018, NEUROLOGY, V91, P611, DOI 10.1212/WNL.0000000000006244; Schonherr MC, 1999, CLIN REHABIL, V13, P457, DOI 10.1191/026921599666105472; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; The American Educational Research Association The American Psychological Association & The National Council on Measurement in Education, 1999, STAND ED PSYCH TEST; Vakil E, 2000, NEUROPSYCHOLOGIA, V38, P1, DOI 10.1016/S0028-3932(99)00058-5; Vakil E, 2017, Q J EXP PSYCHOL, V70, P579, DOI 10.1080/17470218.2016.1172095; van Middendorp JJ, 2015, SPINAL CORD, V53, P221, DOI 10.1038/sc.2014.219; Wechsler D., 1997, WECHSLER ADULT INTEL; Ziessler M, 2001, J EXP PSYCHOL LEARN, V27, P595, DOI 10.1037/0278-7393.27.3.595	35	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232124	10.1371/journal.pone.0232124	http://dx.doi.org/10.1371/journal.pone.0232124			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324808	gold, Green Published			2022-12-26	WOS:000536033700080
J	Nguyen, HV; Tiemersma, EW; Nguyen, HB; Cobelens, FGJ; Finlay, A; Glaziou, P; Dao, CH; Mirtskhulava, V; Nguyen, HV; Pham, HTT; Khieu, NTT; de Haas, P; Do, NH; Nguyen, PD; Cung, CV; Nguyen, NV				Hai Viet Nguyen; Tiemersma, Edine W.; Hoa Binh Nguyen; Cobelens, Frank G. J.; Finlay, Alyssa; Glaziou, Philippe; Cu Huy Dao; Mirtskhulava, Veriko; Hung Van Nguyen; Pham, Huyen T. T.; Khieu, Ngoc T. T.; de Haas, Petra; Nam Hoang Do; Phan Do Nguyen; Cong Van Cung; Nhung Viet Nguyen			The second national tuberculosis prevalence survey in Vietnam	PLOS ONE			English	Article								Introduction Tuberculosis (TB) remains a significant cause of morbidity and mortality in Vietnam. The current TB burden is unknown as not all individuals with TB are diagnosed, recorded and notified. The second national TB prevalence survey was conducted in 2017-2018 to assess the current burden of TB disease in the country. Method Eighty-two clusters were selected using a multistage cluster sampling design. Adult (>= 15 years of age) residents having lived for 2 weeks or more in the households of the selected clusters were invited to participate in the survey. The survey participants were screened for TB by a questionnaire and digital chest X-ray after providing written informed consent. Individuals with a positive symptom screen and/or chest X-ray suggestive of TB were asked to provide sputum samples to test for Mycobacterium tuberculosis by Ziehl-Neelsen direct light microscopy, Xpert MTB/RIF G4, BACTEC MGIT960 liquid culture and Lowenstein-Jensen solid culture. Bacteriologically confirmed TB cases were defined by an expert panel following a standard decision tree. Result Of 87,207 eligible residents, 61,763 (70.8%) participated, and 4,738 (7.7%) screened positive for TB. Among these, 221 participants were defined as bacteriologically confirmed TB cases. The estimated prevalence of bacteriologically confirmed adult pulmonary TB was 322 (95% CI: 260-399) per 100,000, and the male-to-female ratio was 4.0 (2.8-5.8, p<0.001). In-depth interviews with the participants with TB disease showed that only 57.9% (95% CI: 51.3-64.3%) reported cough for 2 weeks or more and 32.1% (26.3-38.6%) did not report any symptom consistent with TB, while their chest X-ray results showed that 97.7% (95% CI: 94.6-99.1) had abnormal chest X-ray images suggesting TB. Conclusion With highly sensitive diagnostics applied, this survey showed that the TB burden in Vietnam remains high. Half of the TB cases were not picked up by general symptom-based screening and were identified by chest X-ray only. Our results indicate that improving TB diagnostic capacity and access to care, along with reducing TB stigma, need to be top priorities for TB control and elimination in Vietnam.	[Hai Viet Nguyen; Hoa Binh Nguyen; Cu Huy Dao; Hung Van Nguyen; Pham, Huyen T. T.; Khieu, Ngoc T. T.; Nam Hoang Do; Phan Do Nguyen; Cong Van Cung; Nhung Viet Nguyen] Natl TB Programme, Hanoi, Vietnam; [Hai Viet Nguyen; Tiemersma, Edine W.; Cobelens, Frank G. J.] Univ Amsterdam, Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Hai Viet Nguyen; Tiemersma, Edine W.; Cobelens, Frank G. J.] Univ Amsterdam, Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands; [Tiemersma, Edine W.; Mirtskhulava, Veriko; de Haas, Petra] KNCV TB Fdn, The Hague, Netherlands; [Finlay, Alyssa] Ctr Dis Control Vietnam Off, Hanoi, Vietnam; [Glaziou, Philippe] World Hlth Org, Global TB Programme, Geneva, Switzerland	University of Amsterdam; University of Amsterdam; KNCV Tuberculosis Foundation; World Health Organization	Nguyen, HB (corresponding author), Natl TB Programme, Hanoi, Vietnam.	nguyenbinhhoatb@yahoo.com		dao, cu/0000-0001-5760-4444; Do, Hoang Nam/0000-0001-8246-4674; Mirtskhulava, Veriko/0000-0002-7394-4876; Cobelens, Frank/0000-0002-4367-1133; Glaziou, Philippe/0000-0002-0649-1272; Viet Nguyen, Hai/0000-0002-1547-6541	Vietnam Ministry of Health; US Agency for International Development; US Centers for Disease Control (CDC); KNCV Tuberculosis Foundation; World Health Organization (WHO); Global Fund to Fight AIDS, Tuberculosis and Malaria	Vietnam Ministry of Health; US Agency for International Development(United States Agency for International Development (USAID)); US Centers for Disease Control (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); KNCV Tuberculosis Foundation; World Health Organization (WHO)(World Health Organization); Global Fund to Fight AIDS, Tuberculosis and Malaria	This study was funded by the Vietnam Ministry of Health, the Global Fund to Fight AIDS, Tuberculosis and Malaria, the US Agency for International Development, the US Centers for Disease Control (CDC), the KNCV Tuberculosis Foundation and the World Health Organization (WHO). CDC, KNCV and WHO provided assistance in study design, data collection supervision, data analysis and manuscript preparation.	Alavi-Naini Roya, 2012, Int J High Risk Behav Addict, V1, P71, DOI 10.5812/ijhrba.5215; Anh Nguyen, 2015, 5 C UN AS PAC REG SY; [Anonymous], 2012, GLOB TUB REP 2012; Aung Si Thu, 2019, DISSEMINATION M NATI; Craig GM, 2017, INT J INFECT DIS, V56, P90, DOI 10.1016/j.ijid.2016.10.011; Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Fox GJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-342; Fox GJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049880; General Statistics Office Of Vietnam, 2017, MAIN RES POP FLUCT F, P88; General Statistics Office of Vietnam, 2015, 2009 VIETN POP HOUS; Hertz D, 2019, SEMIN IMMUNOPATHOL, V41, P225, DOI 10.1007/s00281-018-0725-6; Ho J, 2016, INT J MYCOBACT, V5, P374, DOI 10.1016/j.ijmyco.2016.09.023; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; James R, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2670-8; Jann B, 2008, STATA J, V8, P147, DOI 10.1177/1536867X0800800201; Johan Pattiselanno Roberth, 2016, INDONESIA HLTH PROFI, V164; Kancheya N, 2014, INT J TUBERC LUNG D, V18, P1466, DOI 10.5588/ijtld.14.0920; Kulas JT, 2018, HUM RESOUR MANAGE-US, V57, P419, DOI 10.1002/hrm.21796; Kuznetsov VN, 2014, INT J CIRCUMPOL HEAL, V73, DOI 10.3402/ijch.v73.23515; Lansang Mary Ann, 2018, NATL TUBERCULOSIS PR; Ludwig Fahrmeir, 2013, REGRESSION MODELS ME; Martin Andrew, 2019, CONVERSATION FRIENDS; Mor Z., 2015, ISR MED ASS J; Mor Z, 2012, RESP CARE; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Than PQT, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-019-0277-7; Rubin DB, 2004, MULTIPLE IMPUTATION; Sekandi JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117009; Shah N. S., 2008, INT J TUBERC LUNG DI; Stop TB Partnership, 2017, ZERO TB VIETN LAUNCH; Viet Nhung Nguyen, 2015, W PACIFIC SURVEILLAN; Vietnam National Tuberculosis Program, 2017, TUB NOT DAT; Vietnam National Tuberculosis Programme, 2019, ANN REP NAT TUB PROG; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World Health Organization, 2012, ASS TUB UND REP THRO	37	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232142	10.1371/journal.pone.0232142	http://dx.doi.org/10.1371/journal.pone.0232142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324806	Green Published, gold			2022-12-26	WOS:000536033700083
J	Wu, XX; Lee, B; Zhu, LX; Ding, Z; Chen, Y				Wu, Xianxian; Lee, Boram; Zhu, Lingxiang; Ding, Zhi; Chen, Yin			Exposure to mold proteases stimulates mucin production in airway epithelial cells through Ras/Raf1/ERK signal pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE-C; ASPERGILLUS-FUMIGATUS; PULMONARY ASPERGILLOSIS; INVASIVE ASPERGILLOSIS; SEVERE ASTHMA; UP-REGULATION; ACTIVATION; EXPRESSION; GENE	Environmental mold (fungus) exposure poses a significant threat to public health by causing illnesses ranging from invasive fungal diseases in immune compromised individuals to allergic hypertensive diseases such as asthma and asthma exacerbation in otherwise healthy people. However, the molecular pathogenesis has not been completely understood, and treatment options are limited. Due to its thermo-tolerance to the normal human body temperature, Aspergillus. fumigatus (A.fumigatus) is one of the most important human pathogens to cause different lung fungal diseases including fungal asthma. Airway obstruction and hyperresponsiveness caused by mucus overproduction are the hallmarks of many A.fumigatus induced lung diseases. To understand the underlying molecular mechanism, we have utilized a well-established A.fumigatus extracts (AFE) model to elucidate downstream signal pathways that mediate A.fumigatus induced mucin production in airway epithelial cells. AFE was found to stimulate time- and dose-dependent increase of major airway mucin gene expression (MUC5AC and MUC5B) partly via the elevation of their promoter activities. We also demonstrated that EGFR was required but not sufficient for AFE-induced mucin expression, filling the paradoxical gap from a previous study using the same model. Furthermore, we showed that fungal proteases in AFE were responsible for mucin induction by activating a Ras/Raf1/ERK signaling pathway. Ca2+ signaling, but ROS, both of which were stimulated by fungal proteases, was an indispensable determinant for ERK activation and mucin induction. The discovery of this novel pathway likely contributes to our understanding of the pathogenesis of fungal sensitization in allergic diseases such as fungal asthma.	[Wu, Xianxian; Ding, Zhi] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Wu, Xianxian; Lee, Boram; Zhu, Lingxiang; Chen, Yin] Univ Arizona, Dept Pharmacol & Toxicol, Sch Pharm, Tucson, AZ 85721 USA; [Ding, Zhi] Nanjing Univ, Changzhou High Tech Res Inst, Changzhou, Jiangsu, Peoples R China; [Chen, Yin] Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA	Nanjing University; University of Arizona; Nanjing University; University of Arizona	Ding, Z (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.; Chen, Y (corresponding author), Univ Arizona, Dept Pharmacol & Toxicol, Sch Pharm, Tucson, AZ 85721 USA.; Ding, Z (corresponding author), Nanjing Univ, Changzhou High Tech Res Inst, Changzhou, Jiangsu, Peoples R China.; Chen, Y (corresponding author), Univ Arizona, Asthma & Airway Dis Res Ctr, Tucson, AZ 85721 USA.	dingzhi@nju.edu.cn; ychen@pharmacy.arizona.edu			Arizona Biomedical Research Commission innovative award [BIG-3064]; College of Pharmacy at University of Arizona	Arizona Biomedical Research Commission innovative award; College of Pharmacy at University of Arizona	The study was supported by Arizona Biomedical Research Commission innovative award BIG-3064 and the funding from College of Pharmacy at University of Arizona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Abad A, 2010, REV IBEROAM MICOL, V27, P155, DOI 10.1016/j.riam.2010.10.003; Agarwal R, 2011, CURR ALLERGY ASTHM R, V11, P403, DOI 10.1007/s11882-011-0217-4; Ammann H, 2002, J ENVIRON HEALTH, V64, P43; ANDERSON ME, 1985, ARCH BIOCHEM BIOPHYS, V239, P538, DOI 10.1016/0003-9861(85)90723-4; Asokananthan N, 2002, J IMMUNOL, V168, P3577, DOI 10.4049/jimmunol.168.7.3577; Balenga NA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7763; Berkman SJ, 2019, J APPL BEHAV ANAL, V52, P188, DOI 10.1002/jaba.522; Bhabhra R, 2005, MED MYCOL, V43, pS87, DOI 10.1080/13693780400029486; Boitano S, 2011, AM J PHYSIOL-LUNG C, V300, pL605, DOI 10.1152/ajplung.00359.2010; Bonser LR, 2017, J CLIN MED, V6, DOI 10.3390/jcm6120112; Burgel PR, 2004, THORAX, V59, P992, DOI 10.1136/thx.2003.018879; Busse WW, 2007, J ALLERGY CLIN IMMUN, V119, P43, DOI 10.1016/j.jaci.2006.10.021; Chen Y, 2001, AM J RESP CELL MOL, V25, P542, DOI 10.1165/ajrcmb.25.5.4298; Cordasco EM, 1995, ENV RES DIS; Cowley AC, 2017, PEDIATR PULM, V52, P548, DOI 10.1002/ppul.23618; Daines M, 2020, RESPIROLOGY, V25, P502, DOI 10.1111/resp.13675; de Zoete MR, 2011, P NATL ACAD SCI USA, V108, P4968, DOI 10.1073/pnas.1018135108; Denning DW, 2014, CLIN TRANSL ALLERGY, V4, DOI 10.1186/2045-7022-4-14; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; Denning DW, 1998, CLIN INFECT DIS, V26, P781, DOI 10.1086/513943; Dickey BF, 2015, FISHMANS PULMONARY D; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; DOWNWARD J, 1985, J BIOL CHEM, V260, P4538; Eblen ST, 2018, ADV CANCER RES, V138, P99, DOI 10.1016/bs.acr.2018.02.004; Egea J, 1999, CALCIUM INFLUX ACTIV; Evans CM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7281; Evans CM, 2009, CURR OPIN PULM MED, V15, P4, DOI 10.1097/MCP.0b013e32831da8d3; Evans CM, 2009, PHARMACOL THERAPEUT, V121, P332, DOI 10.1016/j.pharmthera.2008.11.001; Fujisawa T, 2011, AM J RESP CELL MOL, V45, P246, DOI 10.1165/rcmb.2009-0313OC; Gao FS, 2012, EXP LUNG RES, V38, P256, DOI 10.3109/01902148.2012.676705; GEFTER WB, 1981, RADIOLOGY, V140, P313, DOI 10.1148/radiology.140.2.7255704; Hansson M, 2013, INFLAMM RES, V62, P561, DOI 10.1007/s00011-013-0608-1; Hauber Hans-Peter, 2006, Can Respir J, V13, P327; Homma T, 2016, AM J RESP CELL MOL, V54, P60, DOI 10.1165/rcmb.2015-0062OC; Kim YH, 2017, TOXICOLOGY, V378, P86, DOI 10.1016/j.tox.2017.01.008; Knight DA, 2001, J ALLERGY CLIN IMMUN, V108, P797, DOI 10.1067/mai.2001.119025; Kogan TV, 2004, J INFECT DIS, V189, P1965, DOI 10.1086/420850; KOTHARY MH, 1984, INFECT IMMUN, V43, P320, DOI 10.1128/IAI.43.1.320-325.1984; Lambrecht BN, 2015, NAT IMMUNOL, V16, P45, DOI 10.1038/ni.3049; Latge JP, 2001, TRENDS MICROBIOL, V9, P382, DOI 10.1016/S0966-842X(01)02104-7; Latge JP, 1999, CLIN MICROBIOL REV, V12, P310, DOI 10.1128/CMR.12.2.310; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Lionakis MS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93156; Lugauskas A, 2004, ANN AGR ENV MED, V11, P19; Masaki K, 2017, ANN ALLERG ASTHMA IM, V119, P253, DOI 10.1016/j.anai.2017.07.008; Matsuwaki Y, 2012, INT ARCH ALLERGY IMM, V158, P19, DOI 10.1159/000337756; Meersseman W, 2004, AM J RESP CRIT CARE, V170, P621, DOI 10.1164/rccm.200401-093OC; MONOD M, 1993, INFECT IMMUN, V61, P4099, DOI 10.1128/IAI.61.10.4099-4104.1993; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nakayama M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02960; Nelson HS, 1999, J ALLERGY CLIN IMMUN, V104, P775, DOI 10.1016/S0091-6749(99)70287-3; Oguma T, 2011, J IMMUNOL, V187, P999, DOI 10.4049/jimmunol.1002257; Page K, 2003, J ALLERGY CLIN IMMUN, V112, P1112, DOI 10.1016/j.jaci.2003.08.050; Roberts HR, 2000, THORAX, V55, P198, DOI 10.1136/thorax.55.3.198; Schmitt JM, 2004, J BIOL CHEM, V279, P24064, DOI 10.1074/jbc.M401501200; Shao MXG, 2005, J IMMUNOL, V175, P4009, DOI 10.4049/jimmunol.175.6.4009; Shao MXG, 2005, P NATL ACAD SCI USA, V102, P767, DOI 10.1073/pnas.0408932102; Sharpe RA, 2015, J ALLERGY CLIN IMMUN, V135, P110, DOI 10.1016/j.jaci.2014.07.002; Skorge TD, 2005, THORAX, V60, P937, DOI 10.1136/thx.2004.025973; Sriwai W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066743; Sunyer J, 1999, EUR RESPIR J, V14, P885, DOI 10.1034/j.1399-3003.1999.14d26.x; Tekaia F, 2005, CURR OPIN MICROBIOL, V8, P385, DOI 10.1016/j.mib.2005.06.017; Templeton SP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02337; Tischer CG, 2011, ALLERGY, V66, P1570, DOI 10.1111/j.1398-9995.2011.02712.x; Verma A, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a019612; Voynow JA, 2006, AM J RESP CELL MOL, V34, P661, DOI 10.1165/rcmb.2006-0035SF; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; YOAKUM GH, 1983, SCIENCE, V222, P385, DOI 10.1126/science.6194563; Zhu L, 2009, AM J RESP CELL MOL, V40, P610, DOI 10.1165/rcmb.2008-0223OC; Zmeili OS, 2007, QJM-INT J MED, V100, P317, DOI 10.1093/qjmed/hcm035	70	6	6	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231990	10.1371/journal.pone.0231990	http://dx.doi.org/10.1371/journal.pone.0231990			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320453	Green Submitted, Green Published, gold			2022-12-26	WOS:000536028800048
J	Hu, JL; Jin, KX; He, ZG; Zhang, H				Hu, Jialing; Jin, Kaixi; He, Zheng-Guo; Zhang, Hua			Citrate lyase CitE in Mycobacterium tuberculosis contributes to mycobacterial survival under hypoxic conditions	PLOS ONE			English	Article							KLEBSIELLA-PNEUMONIAE; METABOLISM; EXPRESSION; GENES; PROTEIN; CLUSTER; ENZYME	Mycobacterium tuberculosis is the causative agent of tuberculosis and has evolved an ability to survive in hostile host environments. M. tuberculosis is thought to utilize the rTCA cycle to sustain its latent growth during infection, but the enzymatic characteristics and physiological function for the key citrate lyase of the rTCA cycle, MtbCitE, in the important pathogen remain unclear. In this study, we investigated the function of MtbCitE based on its structural properties and sequence comparisons with other bacterial citrate lyase subunits. We showed that several amino acid residues were important for the citrate cleavage activity of MtbCitE. Strikingly, the citrate cleavage activity of MtbCitE was inhibited by ATP, indicating that energy metabolism might couple with the regulation of MtbCitE activity, which differed from other CitEs. More interestingly, deletion of citE from Mycobacterium bovis BCG decreased the mycobacterial survival rate under hypoxic conditions, whereas complementation with citE restored the phenotype to wild-type levels. Consistently, three key rTCA cycle enzymes were positively regulated under hypoxic conditions in mycobacteria. Therefore, we characterized a unique citrate lyase MtbCitE from M. tuberculosis and found that the CitE protein significantly contributed to mycobacterial survival under hypoxic conditions.	[Hu, Jialing; Jin, Kaixi; He, Zheng-Guo; Zhang, Hua] Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Zhang, H (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Natl Key Lab Agr Microbiol, Wuhan, Peoples R China.	zhanghua421@126.com			National Key R&D Program of China [2017YFD0500300]; National Natural Science Foundation of China [31470170, 31670075, 81471996]; Fundamental Research Funds for the Central Universities [2662016PY090, 2662017PY096]; Chang Jiang Scholars Program	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by the National Key R&D Program of China (2017YFD0500300), the National Natural Science Foundation of China (31470170, 31670075 and 81471996), the Fundamental Research Funds for the Central Universities (2662016PY090 and 2662017PY096), and Chang Jiang Scholars Program (To He Z-G).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; ANTRANIKIAN G, 1987, FEMS MICROBIOL LETT, V46, P175, DOI 10.1111/j.1574-6968.1987.tb02458.x; Aoshima M, 2004, MOL MICROBIOL, V52, P763, DOI 10.1111/j.1365-2958.2004.04010.x; Arora G, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00385; Bolla JR, 2012, NUCLEIC ACIDS RES, V40, P9340, DOI 10.1093/nar/gks677; BOTT M, 1994, MOL MICROBIOL, V14, P347, DOI 10.1111/j.1365-2958.1994.tb01295.x; Chypre M, 2012, BIOCHEM BIOPH RES CO, V422, P1, DOI 10.1016/j.bbrc.2012.04.144; Dimroth Peter, 2004, EcoSal Plus, V1, DOI 10.1128/ecosalplus.3.4.6; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Fang X, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002688; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Goulding CW, 2007, J MOL BIOL, V365, P275, DOI 10.1016/j.jmb.2006.09.086; Hu JL, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0556-8; Kumari P, 2017, TUBERCULOSIS, V106, P33, DOI 10.1016/j.tube.2017.06.003; Li J, 2015, J IMMUNOL, V194, P3756, DOI 10.4049/jimmunol.1402679; Li WH, 2012, NUCLEIC ACIDS RES, V40, P11292, DOI 10.1093/nar/gks923; Li YQ, 2010, J BIOCHEM, V148, P549, DOI 10.1093/jb/mvq082; Liu Y, 2016, MOL MICROBIOL, V101, P167, DOI 10.1111/mmi.13383; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; Martin M, 1999, FEMS MICROBIOL LETT, V174, P231, DOI 10.1111/j.1574-6968.1999.tb13573.x; MOELLERING H, 1966, ANAL BIOCHEM, V17, P369, DOI 10.1016/0003-2697(66)90172-2; QUENTMEIER A, 1987, BIOCHIM BIOPHYS ACTA, V913, P60, DOI 10.1016/0167-4838(87)90232-9; Rathor N, 2016, INT J MYCOBACT, V5, P328, DOI 10.1016/j.ijmyco.2016.08.004; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Schneider K, 2002, J BACTERIOL, V184, P2439, DOI 10.1128/JB.184.9.2439-2446.2002; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Soderberg C, 2002, ANN NY ACAD SCI, V967, P476; SRERE PA, 1959, J BIOL CHEM, V234, P2544; Srinivasan V, 2006, BIOL BULL-US, V210, P1, DOI 10.2307/4134531; SUBRAMANIAN S, 1984, J BIOSCIENCE, V6, P379, DOI 10.1007/BF02703895; Torres R, 2012, ACTA CRYSTALLOGR F, V68, P2, DOI 10.1107/S1744309111048056; Tsai MC, 2006, CELL MICROBIOL, V8, P218, DOI 10.1111/j.1462-5822.2005.00612.x; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Yang M, 2012, NUCLEIC ACIDS RES, V40, P1009, DOI 10.1093/nar/gkr830; Zhang H, 2008, FEBS J, V275, P753, DOI 10.1111/j.1742-4658.2007.06241.x	35	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0230786	10.1371/journal.pone.0230786	http://dx.doi.org/10.1371/journal.pone.0230786			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302313	Green Published, Green Submitted, gold			2022-12-26	WOS:000536016100011
J	Shivshankar, P; Li, YD; Mueller-Ortiz, SL; Wetsel, RA				Shivshankar, Pooja; Li, Yi-Dong; Mueller-Ortiz, Stacey L.; Wetsel, Rick A.			In response to complement anaphylatoxin peptides C3a and C5a, human vascular endothelial cells migrate and mediate the activation of B-cells and polarization of T-cells	FASEB JOURNAL			English	Article						B-cell and T-cells; C3a and C5a; C3aR and C5aR1; complement; lymphocyte endothelial interaction; vascular endothelial cells	SMOOTH-MUSCLE CELLS; CELLULAR EXPRESSION; CYTOKINE PRODUCTION; GROWTH-FACTOR; STEM-CELLS; RECEPTOR; ADHESION; GENE; MACROPHAGES; PROMOTER	The vascular endothelium has been discovered in the past several years to be important in shaping the cellular immune response. During the immune response the vascular endothelium is constantly perturbed by biologically potent molecules, including the complement activation peptides, C3a and C5a. Despite the importance of C3a and C5a in inflammation and immunity, their role in modulating lymphocyte function via activation of vascular endothelial cells is unknown. Accordingly, we investigated the regulated expression of the C3a and C5a receptors (complement anaphylatoxin C3a receptor [C3aR] and complement anaphylatoxin C5a receptor 1 [C5aR1]) on human umbilical vascular endothelial cells (HUVECs) and examined how C3a or C5a activation of HUVECs affects the activation and polarization of lymphatic cells. Our findings demonstrated that C3a and C5a increase C3aR and C5aR1 expression by HUVECs as well as directing their cellular transmigration and spreading through transwell filters. Moreover, C3a- or C5a-stimulated endothelial cells: (1) caused activation of B-lymphoblasts with significant increase in Fas Ligand (CD95L) (FasL), CD69, and IL-R1 expression, and (2) skewed T-lymphoblast cells toward a Th1 subtype, (CD4(+)/CCR5(+)) that correlated with significant increase of IFN-gamma. Collectively, these data indicate that C3a and C5a signaling is important in the activation and polarization of lymphocytes as they traffic through the vascular endothelium during the immune response.	[Shivshankar, Pooja; Li, Yi-Dong; Mueller-Ortiz, Stacey L.; Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, Brown Fdn Inst Mol Med, Res Ctr Immunol & Autoimmune Dis, McGovern Med Sch, Houston, TX 77030 USA; [Wetsel, Rick A.] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Wetsel, RA (corresponding author), Brown Fdn Inst Mol Med, 1825 Pressler St,Suite 430A, Houston, TX 77030 USA.	Rick.A.Wetsel@uth.tmc.edu			National Institutes of Health Public Service [RO1 AI025011]; Hans J. Muller-Eberhard and Irma Gigli Distinguished Chair in Immunology	National Institutes of Health Public Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hans J. Muller-Eberhard and Irma Gigli Distinguished Chair in Immunology	This work was supported by a National Institutes of Health Public Service Grant RO1 AI025011 (to RAW). Support was also provided by the Hans J. Muller-Eberhard and Irma Gigli Distinguished Chair in Immunology	Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; Bellows-Peterson ML, 2012, J MED CHEM, V55, P4159, DOI 10.1021/jm201609k; Carman CV, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00603; Chen Hong-Chen, 2004, V294, P15; Debefve E, 2011, LASER SURG MED, V43, P696, DOI 10.1002/lsm.21115; Denton MD, 1999, J EXP MED, V190, P555, DOI 10.1084/jem.190.4.555; Dorosz SA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/737310; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Ebert J, 2018, BLOOD, V131, P2161, DOI 10.1182/blood-2017-09-807040; Erbilgin A, 2013, ARTERIOSCL THROM VAS, V33, P2509, DOI 10.1161/ATVBAHA.113.301989; Foreman KE, 1996, INFLAMMATION, V20, P1, DOI 10.1007/BF01487740; FOREMAN KE, 1994, J CLIN INVEST, V94, P1147, DOI 10.1172/JCI117430; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; HAVILAND DL, 1995, J IMMUNOL, V154, P1861; Hunt JR, 2005, MOL IMMUNOL, V42, P1405, DOI 10.1016/j.molimm.2005.01.002; Hwang MS, 2019, J CELL SCI, V132, DOI 10.1242/jcs.219352; Jagels MA, 2000, IMMUNOPHARMACOLOGY, V46, P209, DOI 10.1016/S0162-3109(99)00178-2; Kao WT, 2008, ANTICANCER RES, V28, P2109; Kildsgaard J, 2000, J IMMUNOL, V165, P5406, DOI 10.4049/jimmunol.165.10.5406; Laudes IJ, 2002, J IMMUNOL, V169, P5962, DOI 10.4049/jimmunol.169.10.5962; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liu BY, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-111; Mahajan SD, 2015, IMMUNOLOGY, V146, P130, DOI 10.1111/imm.12489; Martin CB, 2005, J IMMUNOL, V175, P3123, DOI 10.4049/jimmunol.175.5.3123; Michaelis UR, 2014, CELL MOL LIFE SCI, V71, P4131, DOI 10.1007/s00018-014-1678-0; Monsinjon T, 2003, FASEB J, V17, P1003, DOI 10.1096/fj.02-0737com; MURPHY HS, 1992, AM J PHYSIOL, V263, pL51, DOI 10.1152/ajplung.1992.263.1.L51; Nakanishi K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00763; Nilsen EM, 1998, GUT, V42, P635, DOI 10.1136/gut.42.5.635; Noronha AM, 2009, J LEUKOCYTE BIOL, V86, P1007, DOI 10.1189/jlb.0309203; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Oliveira SDS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023547; Orrem HL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02035; Palmer E, 2012, MOL IMMUNOL, V52, P88, DOI 10.1016/j.molimm.2012.04.012; Pober JS, 2012, TRENDS IMMUNOL, V33, P49, DOI 10.1016/j.it.2011.09.006; Reis ES, 2018, NAT REV IMMUNOL, V18, P5, DOI 10.1038/nri.2017.97; Sartain SE, 2018, J BIOL CHEM, V293, P7195, DOI 10.1074/jbc.RA118.002639; Schaefer M, 2005, J BIOL CHEM, V280, P42113, DOI 10.1074/jbc.M508146200; Schraufstatter IU, 2015, WORLD J STEM CELLS, V7, P1090, DOI 10.4252/wjsc.v7.i8.1090; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Shrestha B, 2010, J IMMUNOL, V184, P4819, DOI 10.4049/jimmunol.0903063; Tan JQ, 1997, J IMMUNOL, V158, P475; Treudler R, 1996, ARCH DERMATOL, V132, P1323, DOI 10.1001/archderm.132.11.1323; Trouw LA, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.125; Turner NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121994; Turner NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059372; Urban D, 2011, BIOCHEM BIOPH RES CO, V404, P448, DOI 10.1016/j.bbrc.2010.11.142; Van Beek J, 2000, EXP NEUROL, V161, P373, DOI 10.1006/exnr.1999.7273; Vazquez MI, 2015, CYTOKINE, V74, P318, DOI 10.1016/j.cyto.2015.02.007; Wang JJ, 2015, WORLD J DIABETES, V6, P726, DOI 10.4239/wjd.v6.i5.726; Wetsel RA, 2000, CONT IMMUN, V9, P113; WETSEL RA, 1995, CURR OPIN IMMUNOL, V7, P48, DOI 10.1016/0952-7915(95)80028-X; Whiteside SK, 2018, TRENDS IMMUNOL, V39, P1021, DOI 10.1016/j.it.2018.10.003; Young MR, 2012, CANCER IMMUNOL IMMUN, V61, P1609, DOI 10.1007/s00262-012-1335-0; Yves L, 2017, MOL IMMUNOL, V84, P51, DOI 10.1016/j.molimm.2016.11.013; Zhang T, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/6073961	57	5	7	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7540	7560		10.1096/fj.201902397R	http://dx.doi.org/10.1096/fj.201902397R		APR 2020	21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301538				2022-12-26	WOS:000526643300001
J	Bokharee, N; Khan, YH; Wasim, T; Mallhi, TH; Alotaibi, NH; Iqbal, MS; Rehman, K; Alzarea, AI; Khokhar, A				Bokharee, Nida; Khan, Yusra Habib; Wasim, Tayyiba; Mallhi, Tauqeer Hussain; Alotaibi, Nasser Hadal; Iqbal, Muhammad Shahid; Rehman, Kanwal; Alzarea, Abdulaziz Ibrahim; Khokhar, Aisha			Daily versus stat vitamin D supplementation during pregnancy; A prospective cohort study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; D DEFICIENCY; GLUCOSE-METABOLISM; NEONATAL OUTCOMES; D REQUIREMENTS; DOUBLE-BLIND; OPEN-LABEL; RISK; WOMEN; METAANALYSIS	Background Despite favorable climatic conditions, vitamin D deficiency (VDD) is widespread in Pakistan. Current study was aimed to evaluate the prevalence of VDD in Pakistani pregnant women and effectiveness of various regimen of Vitamin D supplementation. Methodology This hospital-based prospective cohort study included pregnant women at 12th to 24th weeks of gestation attending Gynae clinic from October 2018 to April 2019. Patients were classified into control and treatment groups (Groups: G(1), G(2) and G(3)) according to the dose of vitamin D supplementation. Patients received various regimens of vitamin D including 2000 IU/day (G(1)), 5000 IU/day (G(2)) and stat 200000 IU (G(3)). The levels of vitamin D were measured before and after supplementation. The effectiveness of dosages were compared between and within the groups. Moreover, factors associated with vitamin D sufficiency and insufficiency were ascertained using appropriate statistical methods. Results Among 281 pregnant women (mean age: 28.22 +/- 4.61 years), VDD was prevalent in 47.3% cases. Vitamin D supplementation caused significant rise in the levels 25(OH)D in treatment groups, while there was no significant difference in control group. The highest mean increment in vitamin D (23.14 +/- 11.18 ng/ml) was observed with dose 5000 IU/day followed by doses 200000 IU stat (21.06 +/- 13.73 ng/ml) and 2000 IU/day (10.24 +/- 5.65 ng/ml). Vitamin D toxicity was observed in one patient who received 200000 IU stat of vitamin D. The frequency of VDD following the supplementation was 5.7%. Education status, duration of sun exposure and use of sunblock was substantially associated with vitamin D sufficiency in the current study. Conclusion Our findings underscore the high proportion of VDD among pregnant women in Pakistan. Maternal vitamin D supplementation substantially improved the levels of 25(OH)D. Of three used regimens, the dose of 5000 IU/day is considered safe and equally effective as of 200000 IU stat. Since pregnancy is a time of tremendous growth and physiological changes for mother and her developing fetus with lifelong implications for the child, gestational vitamin D supplementation should be considered to ensure the optimal vitamin D accrual in pregnant women. This study generates the hypothesis that vitamin D supplementation at a dose of 5000 IU/day during pregnancy is superior to the other regimens. However, well-controlled randomized trials are needed to confirm these findings.	[Bokharee, Nida; Khokhar, Aisha] Lahore Coll Women Univ, Inst Pharm, Lahore, Pakistan; [Khan, Yusra Habib; Mallhi, Tauqeer Hussain; Alotaibi, Nasser Hadal; Alzarea, Abdulaziz Ibrahim] Jouf Univ, Dept Clin Pharm, Coll Pharm, Sakaka, Al Jouf, Saudi Arabia; [Wasim, Tayyiba] Serv Hosp, Serv Inst Med Sci, Dept Gynaecol, Lahore, Pakistan; [Iqbal, Muhammad Shahid] Prince Sattam Bin Abdulaziz Univ, Dept Clin Pharm, Coll Pharm, Al Kharj, Saudi Arabia; [Rehman, Kanwal] Univ Agr Faisalabad, Dept Pharm, Faisalabad, Pakistan	Al Jouf University; Prince Sattam Bin Abdulaziz University; University of Agriculture Faisalabad	Khan, YH; Mallhi, TH (corresponding author), Jouf Univ, Dept Clin Pharm, Coll Pharm, Sakaka, Al Jouf, Saudi Arabia.	yusrahabib@ymail.com; tauqeer.hussain.mallhi@hotmail.com	Iqbal, Prof Dr Muhammad Shahid/AIB-1390-2022; Khan, Yusra Habib/AFK-9024-2022; Alzarea, Abdulaziz I./AAE-8140-2019; Mallhi, Tauqeer Hussain/W-5155-2017; Rehman, Kanwal/P-7727-2014	Iqbal, Prof Dr Muhammad Shahid/0000-0003-0245-5976; Khan, Yusra Habib/0000-0002-9479-6147; Alzarea, Abdulaziz I./0000-0003-0604-6299; Mallhi, Tauqeer Hussain/0000-0001-9957-5362; Rehman, Kanwal/0000-0001-7873-6681				Aghajafari F., 2013, BMJ-BRIT MED J, V346, DOI [DOI 10.1136/BMJ.F1169, 10.1136/bmj.f1169]; Akhtar S., 2016, MINI REV PREVALENCE; Akhtar S, 2016, CRIT REV FOOD SCI, V56, P1925, DOI 10.1080/10408398.2013.807419; Andiran N, 2002, NUTRITION, V18, P47, DOI 10.1016/S0899-9007(01)00724-9; Anwar S, 2016, J OBSTET GYNAECOL, V36, P318, DOI 10.3109/01443615.2015.1050647; Asemi Z, 2013, AM J CLIN NUTR, V98, P1425, DOI 10.3945/ajcn.113.072785; Atiq M, 1998, ACTA PAEDIATR, V87, P737, DOI 10.1080/080352598750013806; Babu US, 2010, MOL NUTR FOOD RES; Bandeira Francisco, 2006, Arq Bras Endocrinol Metab, V50, P640, DOI 10.1590/S0004-27302006000400009; Bhutta Z, 2011, NATL NUTR SURVEY PAK; Calvo MS, 2004, AM J CLIN NUTR, V80, p1710S, DOI 10.1093/ajcn/80.6.1710S; Davies-Tuck M, 2015, AUST NZ J OBSTET GYN, V55, P149, DOI 10.1111/ajo.12278; Dawodu A, 2013, J CLIN ENDOCR METAB, V98, P2337, DOI 10.1210/jc.2013-1154; DeLuca HF, 2009, GASTROENTEROLOGY, V137, pS79, DOI 10.1053/j.gastro.2009.07.075; Diogenes MEL, 2013, AM J CLIN NUTR, V98, P82, DOI 10.3945/ajcn.112.056275; Eggemoen AR, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0796-0; Firsova Mazurkevich M, 2013, J PERINATAL MED; Genuis SJ, 2009, INT J ENV RES PUB HE, V6, P151, DOI 10.3390/ijerph6010151; Glerup H, 2000, J INTERN MED, V247, P260, DOI 10.1046/j.1365-2796.2000.00595.x; Grant CC, 2014, PEDIATRICS, V133, pE143, DOI 10.1542/peds.2013-2602; Gulmezoglu MA, 2016, WHO RECOMMENDATIONS; Hathcock JN, 2007, AM J CLIN NUTR, V85, P6, DOI 10.1093/ajcn/85.1.6; Heaney RP, 2003, CALCIUM VITAMIN D200, P181; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Holick MF, 2009, ANN EPIDEMIOL, V19, P73, DOI 10.1016/j.annepidem.2007.12.001; Hollis BW, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.30; Hollis BW, 2013, CALCIFIED TISSUE INT, V92, P128, DOI 10.1007/s00223-012-9607-4; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; Hollis BW, 2006, CAN MED ASSOC J, V174, P1287, DOI 10.1503/cmaj.060149; Hollis BW, 2004, AM J CLIN NUTR, V80, p1752S, DOI 10.1093/ajcn/80.6.1752S; Hollis BW, 2004, AM J CLIN NUTR, V79, P717; Hossain N, 2014, J CLIN ENDOCR METAB, V99, P2448, DOI 10.1210/jc.2013-3491; Hughes R, 2008, ANTENATAL CARE UNCOM; Kaloczi LD, 2014, J MIDWIFERY WOM HEAL, V59, P405, DOI 10.1111/jmwh.12074; Karim SA, 2011, INT J GYNECOL OBSTET, V112, P59, DOI 10.1016/j.ijgo.2010.07.034; Khan FR, 2016, J INT SOC PREV COMMU, V6, P234, DOI 10.4103/2231-0762.183111; Li DK, 2000, PAEDIATR PERINAT EP, V14, P141, DOI 10.1046/j.1365-3016.2000.00245.x; Mahomed K, 2000, COCHRANE DB SYST REV; MALLET E, 1986, OBSTET GYNECOL, V68, P300, DOI 10.1097/00006250-198609000-00002; Mithal A, 2009, OSTEOPOROSIS INT, V20, P1807, DOI 10.1007/s00198-009-0954-6; Nasir JA, 2018, JCPSP-J COLL PHYSICI, V28, P233, DOI 10.29271/jcpsp.2018.03.233; Nimitphong H, 2013, DERM-ENDOCRINOL, V5, DOI 10.4161/derm.24054; Palacios C, 2016, J STEROID BIOCHEM, V164, P148, DOI 10.1016/j.jsbmb.2016.02.008; Pehlivan I, 2003, TURKISH J PEDIATR, V45, P315; Ringe JD, 2012, DERM-ENDOCRINOL, V4, P77, DOI 10.4161/derm.19829; Rodda CP, 2015, CLIN ENDOCRINOL, V83, P363, DOI 10.1111/cen.12762; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Roth DE, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-47; Saadi HF, 2007, AM J CLIN NUTR, V85, P1565, DOI 10.1093/ajcn/85.6.1565; Sharif S, 2013, VITAMIN D LEVELS PRE; Taherian A-A, 2002, PREVENTION PREECLAMP; Talaei Afsaneh, 2012, Indian J Endocrinol Metab, V16, P786, DOI 10.4103/2230-8210.100676; Tonnesen R, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3042-9; Vanlint SJ, 2005, VITAMIN D ADULT BONE; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wagner CL, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.888; Whiting SJ, 2007, J STEROID BIOCHEM, V103, P626, DOI 10.1016/j.jsbmb.2006.12.067; Yap C, 2014, DIABETES CARE, V37, P1837, DOI 10.2337/dc14-0155; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x	61	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231590	10.1371/journal.pone.0231590	http://dx.doi.org/10.1371/journal.pone.0231590			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298329	Green Published, gold			2022-12-26	WOS:000536011400070
J	Li, MM; Chen, L; Zhang, JX; Xiong, CL; Li, XJ				Li, Mengmeng; Chen, Liang; Zhang, Jingxiao; Xiong, Chenglong; Li, Xiangjie			The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study	PLOS ONE			English	Article							ACUTE-RESPIRATORY-SYNDROME; HUMAN-PLACENTA; PREGNANCY	The new type of pneumonia caused by the SARS-CoV-2 (Severe acute respiratory syndrome coronavirus 2) has been declared as a global public health concern by WHO. As of April 3, 2020, more than 1,000,000 human infections have been diagnosed around the world, which exhibited apparent person-to-person transmission characteristics of this virus. The capacity of vertical transmission in SARS-CoV-2 remains controversial recently. Angiotensin-converting enzyme 2 (ACE2) is now confirmed as the receptor of SARS-CoV-2 and plays essential roles in human infection and transmission. In present study, we collected the online available single-cell RNA sequencing (scRNA-seq) data to evaluate the cell specific expression of ACE2 in maternal-fetal interface as well as in multiple fetal organs. Our results revealed that ACE2 was highly expressed in maternal-fetal interface cells including stromal cells and perivascular cells of decidua, and cytotrophoblast and syncytiotrophoblast in placenta. Meanwhile, ACE2 was also expressed in specific cell types of human fetal heart, liver and lung, but not in kidney. And in a study containing series fetal and post-natal mouse lung, we observed ACE2 was dynamically changed over the time, and ACE2 was extremely high in neonatal mice at post-natal day 1 similar to 3. In summary, this study revealed that the SARS-CoV-2 receptor was widely spread in specific cell types of maternal-fetal interface and fetal organs. And thus, both the vertical transmission and the placenta dysfunction/abortion caused by SARS-CoV-2 need to be further carefully investigated in clinical practice.	[Li, Mengmeng] Chinese Acad Med Sci, Dept Obstet & Gynecol, Peking Union Med Coll Hosp, Peking Union Med Coll, Beijing, Peoples R China; [Chen, Liang; Xiong, Chenglong] Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai, Peoples R China; [Zhang, Jingxiao; Li, Xiangjie] Renmin Univ China, Ctr Appl Stat, Sch Stat, Beijing, Peoples R China; [Xiong, Chenglong] Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Fudan University; Renmin University of China; Fudan University	Xiong, CL (corresponding author), Fudan Univ, Dept Epidemiol, Sch Publ Hlth, Shanghai, Peoples R China.; Li, XJ (corresponding author), Renmin Univ China, Ctr Appl Stat, Sch Stat, Beijing, Peoples R China.; Xiong, CL (corresponding author), Fudan Univ, Sch Publ Hlth, Key Lab Publ Hlth Safety, Minist Educ, Shanghai, Peoples R China.	xiongchenlong@fudan.edu.cn; ele717@163.com		Li, Xiangjie/0000-0002-9600-8984	China Postdoctoral Science Foundation; National Natural Science Foundation of China [81872673]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project funded by China Postdoctoral Science Foundation (XL) and was also supported by National Natural Science Foundation of China (81872673) (CX).	Alfaraj SH, 2019, J MICROBIOL IMMUNOL, V52, P501, DOI 10.1016/j.jmii.2018.04.005; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Crackower MA, 2002, NATURE, V417, P822, DOI 10.1038/nature00786; Cui YL, 2019, CELL REP, V26, P1934, DOI 10.1016/j.celrep.2019.01.079; Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Fan C, 2020, MEDRXIV, DOI [10.1101/2020.02.12.20022418, DOI 10.1038/s41591-018-0041-7]; Favre G, 2020, LANCET, V395, pE40, DOI 10.1016/S0140-6736(20)30311-1; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Harmer D, 2002, FEBS LETT, V532, P107, DOI 10.1016/S0014-5793(02)03640-2; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; KOHLER PF, 1966, NATURE, V210, P1070, DOI 10.1038/2101070a0; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Murray IR, 2017, PHARMACOL THERAPEUT, V171, P65, DOI 10.1016/j.pharmthera.2016.09.005; Nelson AC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11414; Ng WF, 2006, PATHOLOGY, V38, P210, DOI 10.1080/00313020600696280; Pavlicev M, 2017, GENOME RES, V27, P349, DOI 10.1101/gr.207597.116; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Pringle KG, 2011, PLACENTA, V32, P956, DOI 10.1016/j.placenta.2011.09.020; Riviere G, 2005, HYPERTENSION, V46, P1169, DOI 10.1161/01.HYP.0000185148.27901.fe; Shek CC, 2003, PEDIATRICS, V112, pE254, DOI 10.1542/peds.112.4.e254; Stuart T., 2019, CELL, V177, P1888, DOI [DOI 10.1016/j.cell.2019.05.031, DOI 10.1016/J.CELL.2019.05.031]; Taylor DM, 2019, DEV CELL, V49, P10, DOI 10.1016/j.devcel.2019.03.001; TEASDALE F, 1985, PLACENTA, V6, P375, DOI 10.1016/S0143-4004(85)80014-X; Turco MY, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.163428; Valdes G, 2006, PLACENTA, V27, P200, DOI 10.1016/j.placenta.2005.02.015; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Wong SF, 2004, AM J OBSTET GYNECOL, V191, P292, DOI 10.1016/j.ajog.2003.11.019; Wong SF, 2003, BJOG-INT J OBSTET GY, V110, P641, DOI 10.1046/j.1471-0528.2003.03008.x; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yajima T, 2011, FUTURE MICROBIOL, V6, P551, DOI [10.2217/FMB.11.40, 10.2217/fmb.11.40]; Zeng H, 2020, JAMA-J AM MED ASSOC, V323, P1848, DOI 10.1001/jama.2020.4861; Zhao Y., 2020, SINGLE CELL RNA EXPR, DOI 10.1101/2020.01.26.919985; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	36	223	229	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230295	10.1371/journal.pone.0230295	http://dx.doi.org/10.1371/journal.pone.0230295			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298273	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400014
J	Rada, S; Strohmaier, S; Drucker, AM; Eliassen, AH; Schernhammer, ES				Rada, Samantha; Strohmaier, Susanne; Drucker, Aaron M.; Eliassen, A. Heather; Schernhammer, Eva S.			Night shift work surrounding pregnancy and offspring risk of atopic disease	PLOS ONE			English	Article							DERMATITIS; ECZEMA; ASTHMA; RHINITIS; ADULT; BIRTH; ASSOCIATION; COMORBIDITY; PREVALENCE; CHILDREN	Background Night shift work surrounding pregnancy may contribute to the risk of developing atopic diseases in offspring due to alterations in the prenatal environment, from stress. Objective To examine the association of maternal night shift work surrounding pregnancy and offspring risk of developing atopic diseases from childhood to adolescence. Methods We examined the association between night shift work before and during pregnancy among 4,044 mothers in the Nurses' Health Study II (NHSII) and atopic dermatitis, asthma and hay fever risk in 4,813 of their offspring enrolled in the Growing Up Today Study (GUTS). Mothers reported whether GUTS participants had ever been diagnosed with atopic dermatitis, asthma or hay fever in the GUTS Mothers' questionnaire. Generalized estimating equation regression models were used to estimate multivariable adjusted odds ratios (OR) and 95% confidence intervals (CIs). Results There were no significant associations between pre-conception maternal night shift work and risk of atopic dermatitis, asthma or hay fever in their offspring. Among 545 mothers with information on night shift work during pregnancy, shift work also was not associated with atopic dermatitis, asthma or hay fever in the offspring. Stratified analyses by history of parental atopy and maternal chronotype showed some statistically significant findings, but they were inconsistent and no significant interaction was seen with increasing duration of night shift work. Conclusion In this study, night shift work before and during pregnancy did not increase offspring risk of developing atopic dermatitis, asthma or hay fever.	[Rada, Samantha; Strohmaier, Susanne; Schernhammer, Eva S.] Med Univ Vienna, Dept Epidemiol, Ctr Publ Hlth, Vienna, Austria; [Strohmaier, Susanne; Eliassen, A. Heather; Schernhammer, Eva S.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Strohmaier, Susanne; Eliassen, A. Heather; Schernhammer, Eva S.] Harvard Med Sch, Boston, MA 02115 USA; [Drucker, Aaron M.] Univ Toronto, Div Dermatol, Dept Med, Toronto, ON, Canada; [Drucker, Aaron M.] Womens Coll Hosp, Dept Med, Womens Coll Res Inst, Toronto, ON, Canada; [Eliassen, A. Heather; Schernhammer, Eva S.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Medical University of Vienna; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Schernhammer, ES (corresponding author), Med Univ Vienna, Dept Epidemiol, Ctr Publ Hlth, Vienna, Austria.; Schernhammer, ES (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Schernhammer, ES (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Schernhammer, ES (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	eva.schernhammer@meduniwien.ac.at		Eliassen, A Heather/0000-0002-3961-6609	Center for Disease Control and Prevention/The National Institute for Occupational Safety and Health [5R01OH009803, UM1 CA176726]; National Institutes of Health	Center for Disease Control and Prevention/The National Institute for Occupational Safety and Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by Center for Disease Control and Prevention/The National Institute for Occupational Safety and Health grant 5R01OH009803 (PI: Schernhammer ES), as well as grant UM1 CA176726 from the National Institutes of Health.	Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Ballardini N, 2016, ALLERGY, V71, P342, DOI 10.1111/all.12798; Ballardini N, 2012, ALLERGY, V67, P537, DOI 10.1111/j.1398-9995.2012.02786.x; BARKER DJP, 1995, P ROY SOC B-BIOL SCI, V262, P37, DOI 10.1098/rspb.1995.0173; Bhatti P, 2017, OCCUP ENVIRON MED, V74, P680, DOI 10.1136/oemed-2017-104414; Bonzini M, 2011, BJOG-INT J OBSTET GY, V118, P1429, DOI 10.1111/j.1471-0528.2011.03066.x; Chan CWH, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030395; Chang HY, 2016, J ALLERGY CLIN IMMUN, V138, P468, DOI 10.1016/j.jaci.2016.01.020; Cookson H, 2009, J ALLERGY CLIN IMMUN, V123, P847, DOI 10.1016/j.jaci.2009.01.042; Drucker AM, 2019, J ALLER CL IMM-PRACT, V7, P96, DOI 10.1016/j.jaip.2018.10.044; Drucker AM, 2017, J INVEST DERMATOL, V137, P26, DOI 10.1016/j.jid.2016.07.012; Dumas O, 2016, ALLERGY, V71, P1295, DOI 10.1111/all.12876; Fogg MI, 2003, J ALLERGY CLIN IMMUN, V112, P796, DOI 10.1016/S0091-6749(03)01715-9; Gaine ME, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00014; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Karimkhani C, 2017, JAMA DERMATOL, V153, P406, DOI 10.1001/jamadermatol.2016.5538; KUSTER W, 1990, ARCH DERMATOL RES, V282, P98, DOI 10.1007/BF00493466; Larsen AD, 2015, DAN MED J, V62; Lin YC, 2004, CLIN EXP ALLERGY, V34, P548, DOI 10.1111/j.1365-2222.2004.1928.x; Luyster FS, 2012, SLEEP, V35, P727, DOI 10.5665/sleep.1846; Margolis JS, 2014, JAMA DERMATOL, V150, P593, DOI 10.1001/jamadermatol.2013.10271; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Megdal SP, 2007, SLEEP MED, V9, P60, DOI 10.1016/j.sleep.2007.01.012; Moberg C, 2006, BRIT J DERMATOL, V155, P557, DOI 10.1111/j.1365-2133.2006.07372.x; Morris CJ, 2017, J BIOL RHYTHM, V32, P154, DOI 10.1177/0748730417697537; Mortz CG, 2015, ACTA DERM-VENEREOL, V95, P968, DOI 10.2340/00015555-2128; Nehme PA, 2019, MED HYPOTHESES, V132, DOI 10.1016/j.mehy.2019.109353; Nehme P. A., 2019, Neurobiology of Sleep and Circadian Rhythms, V6, P70, DOI 10.1016/j.nbscr.2019.04.001; Paganelli Roberto, 2018, Clin Mol Allergy, V16, P1, DOI 10.1186/s12948-018-0080-0; Pan A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001141; Papantoniou K, 2015, INT J CANCER, V137, P1147, DOI 10.1002/ijc.29400; Pinart M, 2014, LANCET RESP MED, V2, P131, DOI 10.1016/S2213-2600(13)70277-7; Puttonen S, SCANDINAVIAN J WORK, V36, P96; Puttonen S, 2011, CHRONOBIOL INT, V28, P528, DOI 10.3109/07420528.2011.580869; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Schernhammer ES, 2001, J NATL CANCER I, V93, P1563, DOI 10.1093/jnci/93.20.1563; Silverberg JI, 2015, BRIT J DERMATOL, V173, P1400, DOI 10.1111/bjd.14031; Silverberg JI, 2013, J ALLERGY CLIN IMMUN, V132, P1132, DOI 10.1016/j.jaci.2013.08.031; Spergel JM, 2010, ANN ALLERG ASTHMA IM, V105, P99, DOI 10.1016/j.anai.2009.10.002; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Strohmaier S, 2019, EUR J EPIDEMIOL, V34, P625, DOI 10.1007/s10654-019-00525-2; Strohmaier S, 2018, OBESITY, V26, P1491, DOI 10.1002/oby.22267; Takita E, 2013, BRIT J DERMATOL, V168, P39, DOI 10.1111/j.1365-2133.2012.11176.x; Tegethoff M, 2011, ENVIRON HEALTH PERSP, V119, P1647, DOI 10.1289/ehp.1003253; Thomsen SF., EPIDEMIOLOGY NATURAL, DOI [http://dx.doi.org/10.3402/ecrj.v2. 24642, DOI 10.3402/ECRJ.V2.24642]; Thomsen SF, 2015, EUR CLIN RESP J, V2; Vaughn AR, 2017, PEDIATR DERMATOL, V34, P240, DOI 10.1111/pde.13149; Vetter C, 2016, JAMA-J AM MED ASSOC, V315, P1726, DOI 10.1001/jama.2016.4454; Vetter C, 2015, DIABETES CARE, V38, P1707, DOI 10.2337/dc15-0302; Wadonda-Kabondo N, 2004, ARCH DIS CHILD, V89, P917, DOI 10.1136/adc.2003.034033; Wang IJ, 2016, PEDIAT ALLERG IMM-UK, V27, P169, DOI 10.1111/pai.12518; Wang IJ, 2013, BRIT J DERMATOL, V168, P794, DOI 10.1111/bjd.12195; Wang XS, 2011, OCCUP MED-OXFORD, V61, P78, DOI 10.1093/occmed/kqr001; Warner JA, 1999, ANN ALLERG ASTHMA IM, V83, P426, DOI 10.1016/S1081-1206(10)62846-3; Wegrzyn LR, 2017, AM J EPIDEMIOL, V186, P532, DOI 10.1093/aje/kwx140; Wen HJ, 2009, BRIT J DERMATOL, V161, P1166, DOI 10.1111/j.1365-2133.2009.09412.x; Williams, 2000, ATOPIC DERMATITIS EP; Williams HC, 2000, CLIN EXP DERMATOL, V25, P522, DOI 10.1046/j.1365-2230.2000.00698.x; Zhu Y, 2011, CHRONOBIOL INT, V28, P852, DOI 10.3109/07420528.2011.618896	59	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231784	10.1371/journal.pone.0231784	http://dx.doi.org/10.1371/journal.pone.0231784			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298373	Green Published, gold			2022-12-26	WOS:000536011400112
J	van de Kreeke, JA; Darma, S; Yin, JMPLCP; Tan, HS; Abramoff, MD; Twisk, JWR; Verbraak, FD				van de Kreeke, Jacoba A.; Darma, Stanley; Yin, Jill M. P. L. Chan Pin; Tan, H. Stevie; Abramoff, Michael D.; Twisk, Jos W. R.; Verbraak, Frank D.			The spatial relation of diabetic retinal neurodegeneration with diabetic retinopathy	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; CELL LAYER THICKNESS; MELLITUS TYPE-1; MACULAR EDEMA; EYES; AGE	Purpose Diabetic retinal neurodegeneration (DRN) has been demonstrated in eyes of patients with diabetes mellitus (DM), even in the absence of diabetic retinopathy (DR). However, no studies have looked at the rate of change in retinal layers and presence/development of DR over time per quadrant of the macula. In this longitudinal study, we aimed to clarify whether the rate of DRN is associated with the development/presence of DR within 4 different quadrants of the retina. Methods 80 eyes of 40 patients with type 1 DM and no/minimal DR were included. At 4 visits over 6 years, SD-OCT and fundus images were acquired. Thickness of the Retinal Nerve Fiber Layer (RNFL), Ganglion Cell Layer (GCL) and Inner Plexiform Layer (IPL) was measured in a 1-6mm circle around the fovea overall and for each quadrant (superior, nasal, inferior, temporal). Fundus images were scored for the presence/absence of DR in these areas. Multilevel analyses were performed to determine the rate of change for each layer overall and per quadrant for eyes/quadrants without and with DR during the follow-up period. Results RNFL and GCL showed significant thinning over time, IPL significant thickening. These changes were more pronounced for GCL and IPL in eyes/quadrants with DR during the follow-up period. Conclusions RNFL and GCL both showed thinning over time, which was more pronounced in eyes with DR for GCL. This holds true even in regional parts of the retina, as quadrant analyses showed similar results, showing that structural DRN is associated with DR per quadrant independently.	[van de Kreeke, Jacoba A.; Yin, Jill M. P. L. Chan Pin; Tan, H. Stevie; Verbraak, Frank D.] Amsterdam UMC, Dept Ophthalmol, Locat VUmc, Amsterdam, Netherlands; [Darma, Stanley; Tan, H. Stevie; Verbraak, Frank D.] Amsterdam UMC, Dept Ophthalmol, Locat AMC, Amsterdam, Netherlands; [Abramoff, Michael D.] Univ Iowa Hosp & Clin, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Abramoff, Michael D.] VA Med Ctr, Iowa City, IA USA; [Abramoff, Michael D.] IDx, Iowa City, IA USA; [Twisk, Jos W. R.] Amsterdam UMC, Dept Epidemiol & Biostat, Locat VUmc, Amsterdam, Netherlands	University of Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System; University of Amsterdam	van de Kreeke, JA (corresponding author), Amsterdam UMC, Dept Ophthalmol, Locat VUmc, Amsterdam, Netherlands.	ja.vandekreeke@amsterdamumc.nl	Abramoff, Michael D/A-5836-2009	Abramoff, Michael D/0000-0002-3490-0037; Verbraak, Frank D/0000-0001-7560-1423; Tan, H. Stevie/0000-0001-8368-1048	NIH [P30 EY025580, R01 EY018853, R01 EY019112]; Research to Prevent Blindness; Edward en Marianne Blaauwfonds; National Institutes of Health/National Eye Institute [R01-EY017066]; Netherlands Organization for Health Research and Development	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Edward en Marianne Blaauwfonds; National Institutes of Health/National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development)	MDA: NIH P30 EY025580, R01 EY018853, R01 EY019112 (https://nei.nih.gov/about/news-and-events/news), Research to Prevent Blindness (https://www.rpbusa.org/rpb/?) FDV: Supported by the Edward en Marianne Blaauwfonds, Netherlands Organization for Health Research and Development (https://www.zonmw.nl/en/), National Institutes of Health/National Eye Institute Grant R01-EY017066 (https://nei.nih.gov/about/news-and-events/news), and Research to Prevent Blindness (https://www.rpbusa.org/rpb/?).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IDx provided support in the form of salaries for author MDA, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the `author contributions' section.	Abramoff MD, 2018, INVEST OPHTH VIS SCI, V59, P519, DOI 10.1167/iovs.17-21873; Bandello F, 2015, OPHTHALMIC RES, V54, P112, DOI 10.1159/000438792; Bearse MA, 2006, PROG RETIN EYE RES, V25, P425, DOI 10.1016/j.preteyeres.2006.07.001; Biallosterski C, 2007, BRIT J OPHTHALMOL, V91, P1135, DOI 10.1136/bjo.2006.111534; Das A, 2016, INVEST OPHTH VIS SCI, V57, P6669, DOI 10.1167/iovs.16-21031; De Clerck EEB, 2018, ACTA OPHTHALMOL, V96, P174, DOI 10.1111/aos.13570; De Clerck EEB, 2015, LANCET DIABETES ENDO, V3, P653, DOI 10.1016/S2213-8587(15)00136-9; Demirkaya N, 2013, INVEST OPHTH VIS SCI, V54, P4934, DOI 10.1167/iovs.13-11913; Fujimoto J, 2016, INVEST OPHTH VIS SCI, V57, pOCT1, DOI 10.1167/iovs.16-19963; Garvin MK, 2008, IEEE T MED IMAGING, V27, P1495, DOI 10.1109/TMI.2008.923966; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Lee R, 2015, EYE VISION, V2, DOI 10.1186/s40662-015-0026-2; Lynch SK, 2019, INVEST OPHTH VIS SCI, V60, P2134, DOI 10.1167/iovs.18-24643; Lynch SK, 2017, VISION RES, V139, P101, DOI 10.1016/j.visres.2017.03.003; Mulder JE, DIABETIC RETINOPATHY; Murthy RK, 2016, BIOMED J, V39, P107, DOI 10.1016/j.bj.2016.04.003; Nieves-Moreno M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194169; Parikh RS, 2007, OPHTHALMOLOGY, V114, P921, DOI 10.1016/j.ophtha.2007.01.023; Santos AR, 2017, DIABETES, V66, P2503, DOI 10.2337/db16-1453; Simo R, 2014, TRENDS ENDOCRIN MET, V25, P23, DOI 10.1016/j.tem.2013.09.005; Sohn EH, 2016, P NATL ACAD SCI USA, V113, pE2655, DOI 10.1073/pnas.1522014113; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; van Dijk HW, 2011, VISION RES, V51, P224, DOI 10.1016/j.visres.2010.08.024; van Dijk HW, 2010, INVEST OPHTH VIS SCI, V51, P3660, DOI 10.1167/iovs.09-5041; van Dijk HW, 2009, INVEST OPHTH VIS SCI, V50, P3404, DOI 10.1167/iovs.08-3143; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5	27	10	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231552	10.1371/journal.pone.0231552	http://dx.doi.org/10.1371/journal.pone.0231552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298369	Green Published, gold			2022-12-26	WOS:000536011400067
J	Verhaegh, R; Becker, KA; Edwards, MJ; Gulbins, E				Verhaegh, Rabea; Becker, Katrin Anne; Edwards, Michael J.; Gulbins, Erich			Sphingosine kills bacteria by binding to cardiolipin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiolipin; Pseudomonas aeruginosa (P; aeruginosa); Staphylococcus aureus (S; aureus); sphingolipid; innate immunity; bactericidal activity; lung pathogen; membrane permeabilization; sphingoid base; sphingosine	PSEUDOMONAS-AERUGINOSA BACTEREMIA; CYSTIC-FIBROSIS GENE; STAPHYLOCOCCUS-AUREUS; HOST-DEFENSE; EPIDEMIOLOGY; INFLAMMATION; INFECTION; SUSCEPTIBILITY; IDENTIFICATION; BASES	Sphingosine is a long-chain sphingoid base that has been shown to have bactericidal activity against many pathogens, including Pseudomonas aeruginosa, Staphylococcus aureus, and Escherichia coli. We have previously demonstrated that sphingosine is present in nasal, tracheal, and bronchial epithelial cells and constitutes a central element of the defense of the airways against bacterial pathogens. Here, using assorted lipid-binding and cell biology assays, we demonstrate that exposing P. aeruginosa and S. aureus cells to sphingosine results in a very rapid, i.e. within minutes, permeabilization of the bacterial plasma membrane, resulting in leakiness of the bacterial cells, loss of ATP, and loss of bacterial metabolic activity. These alterations rapidly induced bacterial death. Mechanistically, we demonstrate that the presence of the protonated NH2 group in sphingosine, which is an amino-alcohol, is required for sphingosine's bactericidal activity. We also show that the protonated NH2 group of sphingosine binds to the highly negatively?charged lipid cardiolipin in bacterial plasma membranes. Of note, this binding was required for bacterial killing by sphingosine, as revealed by genetic experiments indicating that E. coli or P. aeruginosa strains that lack cardiolipin synthase are resistant to sphingosine, both in vitro and in vivo. We propose that binding of sphingosine to cardiolipin clusters cardiolipin molecules in the plasma membrane of bacteria. This clustering results in the formation of gel-like or even crystal-like structures in the bacterial plasma membrane and thereby promotes rapid permeabilization of the plasma membrane and bacterial cell death.	[Verhaegh, Rabea; Becker, Katrin Anne; Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Univ Clin, Essen, Germany; [Edwards, Michael J.; Gulbins, Erich] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA	University of Duisburg Essen; University System of Ohio; University of Cincinnati	Gulbins, E (corresponding author), Univ Duisburg Essen, Dept Mol Biol, Univ Clin, Essen, Germany.; Gulbins, E (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA.	erich.gulbins@uni-due.de			Deutsche Forschungsgemeinschaft [GU 335/35-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant GU 335/35-1.	Azuma MM, 2018, BIOCHEM BIOPH RES CO, V495, P2383, DOI 10.1016/j.bbrc.2017.12.137; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; BIBEL DJ, 1992, J INVEST DERMATOL, V98, P269, DOI 10.1111/1523-1747.ep12497842; Brewer C, 1996, CHEST, V109, P1019; Carstens Henning, 2019, Cell Physiol Biochem, V53, P1015, DOI 10.33594/000000194; Currie AJ, 2003, SEM RESP CRIT CARE M, V24, P671, DOI 10.1055/s-2004-815663; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; El Khoury M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10543-3; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Fischer CL, 2013, SKIN PHARMACOL PHYS, V26, P36, DOI 10.1159/000343175; FORBES AR, 1977, ANESTHESIOLOGY, V46, P319, DOI 10.1097/00000542-197705000-00002; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2017, CELL HOST MICROBE, V21, P707, DOI 10.1016/j.chom.2017.05.001; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; LaBauve AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003889; Martin GE, 2017, BIOCHIMIE, V141, P91, DOI 10.1016/j.biochi.2017.03.014; MCMANUS AT, 1985, EUR J CLIN MICROBIOL, V4, P219, DOI 10.1007/BF02013601; MORRISON AJ, 1984, REV INFECT DIS, V6, pS627; Muraglia KA, 2019, NATURE, V567, P405, DOI 10.1038/s41586-019-1018-5; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Pewzner-Jung Y, 2014, EMBO MOL MED, V6, P1205, DOI 10.15252/emmm.201404075; Rao S, 2006, ARCH DIS CHILD, V91, P786, DOI 10.1136/adc.2004.069419; RIORDAN JR, 1989, SCIENCE, V245, P1066; Schaffer K, 2015, J HOSP INFECT, V89, P309, DOI 10.1016/j.jhin.2015.02.005; Tabazavareh ST, 2016, CELL PHYSIOL BIOCHEM, V38, P2094, DOI 10.1159/000445567; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Vidal F, 1996, ARCH INTERN MED, V156, P2121, DOI 10.1001/archinte.156.18.2121	28	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7686	7696		10.1074/jbc.RA119.012325	http://dx.doi.org/10.1074/jbc.RA119.012325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32327486	Green Published, hybrid			2022-12-26	WOS:000538038900010
J	Yoon, JSJ; Wu, MK; Zhu, TH; Zhao, HL; Cheung, ST; Chamberlain, TC; Mui, ALF				Yoon, Jeff S. J.; Wu, Mike K.; Zhu, Tian Hao; Zhao, Helen; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F.			Interleukin-10 control of pre-miR155 maturation involves CELF2	PLOS ONE			English	Article							RNA-BINDING PROTEINS; MESSENGER-RNA; ANTAGONISTIC ROLE; GENE-EXPRESSION; KSRP; TRISTETRAPROLIN; IDENTIFICATION; MIR-155; PHOSPHORYLATION; MICRORNA-155	The anti-inflammatory cytokine interleukin-10 (IL10) is essential for attenuating inflammatory responses, which includes reducing the expression of pro-inflammatory microRNA-155 (miR155) in lipopolysaccharide (LPS) activated macrophages. miR155 enhances the expression of pro-inflammatory cytokines such as TNF alpha and suppresses expression of anti-inflammatory molecules such as SHIP1 and SOCS1. We previously found that IL10 interfered with the maturation of pre-miR155 to miR155. To understand the mechanism by which IL10 interferes with pre-miR155 maturation we isolated proteins that associate with pre-miR155 in response to IL10 in macrophages. We identified CELF2, a member of the CUGBP, ELAV-Like Family (CELF) family of RNA binding proteins, as protein whose association with pre-miR155 increased in IL10 treated cells. CRISPR-Cas9 mediated knockdown of CELF2 impaired IL10's ability to inhibit both miR155 expression and TNF alpha expression.	[Yoon, Jeff S. J.; Wu, Mike K.; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F.] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada; [Yoon, Jeff S. J.; Wu, Mike K.; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F.] Univ British Columbia, Dept Surg, Vancouver, BC, Canada; [Yoon, Jeff S. J.; Wu, Mike K.; Zhu, Tian Hao; Cheung, Sylvia T.; Chamberlain, Thomas C.; Mui, Alice L-F.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [Zhao, Helen] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC, Canada	Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia; University of British Columbia	Mui, ALF (corresponding author), Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada.; Mui, ALF (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC, Canada.; Mui, ALF (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	alice.mui@ubc.ca		Chamberlain, Thomas/0000-0002-3030-6065; Zhao, Helen/0000-0001-6866-6974	Canadian Institutes of Health Research [MOP-133415]; Natural Science and Engineering Research Council [RGPIN-2014-05662]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	These studies were supported by operating grants from the Canadian Institutes of Health Research (MOP-133415) and the Natural Science and Engineering Research Council (RGPIN-2014-05662) to ALFM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anant S, 2001, J BIOL CHEM, V276, P47338, DOI 10.1074/jbc.M104911200; Barreau C, 2006, BIOCHIMIE, V88, P515, DOI 10.1016/j.biochi.2005.10.011; Bhattacharyya S, 2013, BIOCHEM BIOPH RES CO, V433, P484, DOI 10.1016/j.bbrc.2013.03.025; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Blech-Hermoni Y, 2013, DEV DYNAM, V242, P767, DOI 10.1002/dvdy.23959; Briata P, 2005, MOL CELL, V20, P891, DOI 10.1016/j.molcel.2005.10.021; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Cao J, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw660; Chan CS, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.348599; Cheung ST, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071336; Clark AR, 2016, BIOCHEM SOC T, V44, P1321, DOI 10.1042/BST20160166; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dasgupta T, 2012, WIRES RNA, V3, P104, DOI 10.1002/wrna.107; Eis PS, 2005, P NATL ACAD SCI USA, V102, P3627, DOI 10.1073/pnas.0500613102; El Gazzar M, 2010, J BIOL CHEM, V285, P20940, DOI 10.1074/jbc.M110.115063; El Kasmi KC, 2006, J IMMUNOL, V177, P7880, DOI 10.4049/jimmunol.177.11.7880; Gaba A, 2012, J IMMUNOL, V189, P2089, DOI 10.4049/jimmunol.1201126; Gherzi R, 2010, WIRES RNA, V1, P230, DOI 10.1002/wrna.2; Gibbs MR, 2017, P NATL ACAD SCI USA, V114, P980, DOI 10.1073/pnas.1613665114; Han J, 2005, NUCLEIC ACIDS RES, V33, P2769, DOI 10.1093/nar/gki561; Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4; Kontoyiannis D, 2001, EMBO J, V20, P3760, DOI 10.1093/emboj/20.14.3760; Lang R, 2002, J IMMUNOL, V169, P2253, DOI 10.4049/jimmunol.169.5.2253; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li XL, 2012, GLIA, V60, P1773, DOI 10.1002/glia.22396; Ma WJ, 1997, NUCLEIC ACIDS RES, V25, P3564, DOI 10.1093/nar/25.18.3564; McCoy CE, 2010, J BIOL CHEM, V285, P20492, DOI 10.1074/jbc.M110.102111; Michlewski G, 2010, NAT STRUCT MOL BIOL, V17, P1011, DOI 10.1038/nsmb.1874; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mukhopadhyay D, 2003, MOL CELL, V11, P113, DOI 10.1016/S1097-2765(03)00012-1; Murray PJ, 2006, BIOCHEM SOC T, V34, P1028, DOI 10.1042/BST0341028; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2009, P NATL ACAD SCI USA, V106, P7113, DOI 10.1073/pnas.0902636106; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Schaljo B, 2009, J IMMUNOL, V183, P1197, DOI 10.4049/jimmunol.0803883; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sonkoly E, 2009, J CELL MOL MED, V13, P24, DOI 10.1111/j.1582-4934.2008.00534.x; Subramaniam D, 2008, AM J PHYSIOL-GASTR L, V294, pG1025, DOI 10.1152/ajpgi.00602.2007; Sureban SM, 2007, GASTROENTEROLOGY, V132, P1055, DOI 10.1053/j.gastro.2006.12.031; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Treiber T, 2019, NAT REV MOL CELL BIO, V20, P5, DOI 10.1038/s41580-018-0059-1; Treiber T, 2017, MOL CELL, V66, P270, DOI 10.1016/j.molcel.2017.03.014; Chu VT, 2016, P NATL ACAD SCI USA, V113, P12514, DOI 10.1073/pnas.1613884113; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952	48	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231639	10.1371/journal.pone.0231639	http://dx.doi.org/10.1371/journal.pone.0231639			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324763	Green Published, gold			2022-12-26	WOS:000536033700026
J	Bollaerts, K; Rekkas, A; De Smedt, T; Dodd, C; Andrews, N; Gini, R				Bollaerts, Kaatje; Rekkas, Alexandros; De Smedt, Tom; Dodd, Caitlin; Andrews, Nick; Gini, Rosa			Disease misclassification in electronic healthcare database studies: Deriving validity indices-A contribution from the ADVANCE project	PLOS ONE			English	Article							PREDICTIVE-VALUE; VALIDATION; CODES	There is a strong and continuously growing interest in using large electronic healthcare databases to study health outcomes and the effects of pharmaceutical products. However, concerns regarding disease misclassification (i.e. classification errors of the disease status) and its impact on the study results are legitimate. Validation is therefore increasingly recognized as an essential component of database research. In this work, we elucidate the interrelations between the true prevalence of a disease in a database population (i.e. prevalence assuming no disease misclassification), the observed prevalence subject to disease misclassification, and the most common validity indices: sensitivity, specificity, positive and negative predictive value. Based on this, we obtained analytical expressions to derive all the validity indices and true prevalence from the observed prevalence and any combination of two other parameters. The analytical expressions can be used for various purposes. Most notably, they can be used to obtain an estimate of the observed prevalence adjusted for outcome misclassification from any combination of two validity indices and to derive validity indices from each other which would otherwise be difficult to obtain. To allow researchers to easily use the analytical expressions, we additionally developed a user-friendly and freely available web-application.	[Bollaerts, Kaatje; Rekkas, Alexandros; De Smedt, Tom] P95 Epidemiol & Pharmacovigilance, Leuven, Belgium; [Rekkas, Alexandros; Dodd, Caitlin] Erasmus MC, Rotterdam, Netherlands; [Andrews, Nick] Publ Hlth England, Stat Modelling & Econ Dept, London, England; [Gini, Rosa] Agenzia Reg Sanita Toscana, Florence, Italy	Erasmus University Rotterdam; Erasmus MC; Public Health England	Bollaerts, K (corresponding author), P95 Epidemiol & Pharmacovigilance, Leuven, Belgium.	Kaatje.Bollaerts@p-95.com		Gini, Rosa/0000-0002-6250-877X; Rekkas, Alexandros/0000-0002-5352-943X	Innovative Medicines Initiative (IMI) Joint Undertaking through the ADVANCE project [115557]	Innovative Medicines Initiative (IMI) Joint Undertaking through the ADVANCE project	Finanacial Disclosure: This research was funded by the Innovative Medicines Initiative (IMI) Joint Undertaking through the ADVANCE project [115557]. The IMI is a joint initiative (publicprivate partnership) of the European Commission and the European Federation of Pharmaceutical Industries and Associations (EFPIA) to improve the competitive situation of the European Union in the field of pharmaceutical research. The IMI provided support in the form of salaries for KB, TDS, CD and RG but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. AR and NA did not receive any financial compensation for their contribution to this research. The specific roles of the authors are articulated in the 'author contributions' section.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Aronsky D, 2005, AM J MED QUAL, V20, P319, DOI 10.1177/1062860605280358; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Benchimol EI, 2011, J CLIN EPIDEMIOL, V64, P821, DOI 10.1016/j.jclinepi.2010.10.006; Bowman K. O., 1998, ESTIMATOR METHOD MOM; BRENNER H, 1993, AM J EPIDEMIOL, V138, P1007, DOI 10.1093/oxfordjournals.aje.a116805; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Chan K., 2000, SENSITIVITY ANAL; Chang W, 2016, SHINY WEB APPL FRAME; De Smedt T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199180; Ducharme R, 2013, J PEDIATR-US, V163, P1073, DOI 10.1016/j.jpeds.2013.05.034; Ehrenstein V, 2016, CLIN EPIDEMIOL, V8, P49, DOI 10.2147/CLEP.S104448; Gini R, 2019, VACCINE; Herrett E, 2010, BRIT J CLIN PHARMACO, V69, P4, DOI 10.1111/j.1365-2125.2009.03537.x; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Manuel DG, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4226; Mullooly JP, 2008, METHOD INFORM MED, V47, P328, DOI 10.3414/ME0500; R Development Core Team, 2013, R LANG ENV STAT COMP; ROGAN WJ, 1978, AM J EPIDEMIOL, V107, P71, DOI 10.1093/oxfordjournals.aje.a112510; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; STAQUET M, 1981, J CHRON DIS, V34, P599, DOI 10.1016/0021-9681(81)90059-X; Vose D., 2008, RISK ANAL QUANTITATI	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231333	10.1371/journal.pone.0231333	http://dx.doi.org/10.1371/journal.pone.0231333			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320422	Green Published, gold			2022-12-26	WOS:000536028800017
J	Xian, YJ; Moreno, B; Miranda, V; Vijay, N; Nunez, LC; Choi, J; Quinones, CS; Rios, P; Chauhan, N; Moriel, KV; Ruelas, NJ; Castaneda, AE; Rodriguez, RC; Amezaga, BN; Azzam, SZ; Xiao, C				Xian, Yuejiao; Moreno, Brenda; Miranda, Victoria; Vijay, Neha; Nunez, Luis C.; Choi, Jennie; Quinones, Christian S.; Rios, Paulina; Chauhan, Neha; Moriel, Karla V.; Ruelas, Noah J.; Castaneda, Adan E.; Rodriguez, Ruben Cano; Amezaga, Bianca N.; Azzam, Seham Z.; Xiao, Chuan			Thermal stability analyses of human PERIOD-2 C-terminal domain using dynamic light scattering and circular dichroism	PLOS ONE			English	Article							CIRCADIAN-RHYTHM; SECONDARY STRUCTURE; PER2; PROTEINS; CLOCK; CRY1; PHOSPHORYLATION; VISUALIZATION; RECOGNITION; DISRUPTION	At the molecular level, the circadian clock is regulated by a time delayed transcriptional-translational feedback loop in which the core proteins interact with each other rhythmically to drive daily biological rhythms. The C-terminal domain of a key clock protein PER2 (PER2c) plays a critically important role in the loop, not only for its interaction with the binding partner CRY proteins but also for the CRY/PER complex's translocation from the cytosol to the nucleus. Previous circular dichroism (CD) spectroscopic studies have shown that mouse PER2c (mPER2c) is less structured in solution by itself but folded into stable secondary structures upon interaction with mouse CRYs. To understand the stability and folding of human PER2c (hPER2c), we expressed and purified hPER2c. Three oligomerization forms of recombinant hPER2c were identified and thoroughly characterized through a combination of biochemical and biophysical techniques. Different to mPER2c, both thermal unfolding DLS and CD analyses suggested that all forms of hPER2c have very stable secondary structures in solution by themselves with melting temperatures higher than the physiological body temperature, indicating that hPER2c does not require CRY to fold. Furthermore, we examined the effects of EDTA, salt concentration, and a reducing agent on hPER2c folding and oligomerization. The ability of hPER2c forming oligomers reflects the potential role of hPER2c in the assembly of circadian rhythm core protein complexes.	[Xian, Yuejiao; Moreno, Brenda; Miranda, Victoria; Vijay, Neha; Nunez, Luis C.; Choi, Jennie; Quinones, Christian S.; Rios, Paulina; Chauhan, Neha; Moriel, Karla V.; Ruelas, Noah J.; Castaneda, Adan E.; Rodriguez, Ruben Cano; Amezaga, Bianca N.; Azzam, Seham Z.; Xiao, Chuan] Univ Texas El Paso, Dept Chem & Biochem, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso	Xiao, C (corresponding author), Univ Texas El Paso, Dept Chem & Biochem, El Paso, TX 79968 USA.	cxiao@utep.edu	Xiao, Chuan/B-2130-2010	Xiao, Chuan/0000-0001-6599-8762; Moriel, Karla/0000-0002-0474-0052; Miranda, Victoria/0000-0003-0010-1736	National Research of General Medical Sciences of NIH [SC3GM109870, R01GM129525]; Lawrence and Judi Ellzey Scholarship Fund from the University of Texas at El Paso; NIH RISE fellowship - National Research of General Medical Sciences of NIH [R25GM069621]; BUILDing SCHOLARS consortium - National Institute of General Medical Sciences of NIH [RL5GM118969, TL4GM118971, UL1GM118970]; BUILDing SCHOLARS program; BUILDing SCHOLARS grant [CHEM 1106]; Bridges to the Baccalaureate Program - NIH [R25GM049011]; Campus Office of Undergraduate Research Initiatives (COURI) by Undergraduate Research program MERITUS of the University of Texas at El Paso; National Institute of Minority Health and Health Disparities [U54MD007592]; BBRC grant	National Research of General Medical Sciences of NIH; Lawrence and Judi Ellzey Scholarship Fund from the University of Texas at El Paso; NIH RISE fellowship - National Research of General Medical Sciences of NIH; BUILDing SCHOLARS consortium - National Institute of General Medical Sciences of NIH; BUILDing SCHOLARS program; BUILDing SCHOLARS grant; Bridges to the Baccalaureate Program - NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Campus Office of Undergraduate Research Initiatives (COURI) by Undergraduate Research program MERITUS of the University of Texas at El Paso; National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); BBRC grant	Research reported was supported by the National Research of General Medical Sciences of NIH under Award Number SC3GM109870 and R01GM129525 to author C.X. Authors C.X., N.C. received salary support from the SC3 grant. Authors C.X., Y.X., and B.M. were supported by the R01 grant during the submission and revision of this paper. Author Y.X. was also supported by the Lawrence and Judi Ellzey Scholarship Fund from the University of Texas at El Paso. Author B.M. received support from NIH RISE fellowship funded by National Research of General Medical Sciences of NIH under Award Number R25GM069621. Research instruments used in this study is sponsored by the BUILDing SCHOLARS consortium grant funded by National Institute of General Medical Sciences of NIH under linked Award Numbers RL5GM118969, TL4GM118971, and UL1GM118970 to none of the authors. Author K.V.M. was supported by the BUILDing SCHOLARS program; Authors V.M., N.V., L.C.N., N.J.R., A.E.C., R.C.R., B.N.A., and S.Z.A. were also trained in Research Driven Course (CHEM 1106) supported by the BUILDing SCHOLARS grant. Student P.R. was supported by the Bridges to the Baccalaureate Program funded by the NIH under award number R25GM049011. Student L.C.N. was also supported by the Campus Office of Undergraduate Research Initiatives (COURI) by Undergraduate Research program MERITUS of the University of Texas at El Paso. Research studies have used the core facility at the BBRC (Border Biomedical Research Center) supported by National Institute of Minority Health and Health Disparities under Award Number U54MD007592 to none of the authors. Author C.X. received summer salary support from the BBRC grant during the revision of the paper. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2007, COLD SPRING HARB SYM, V72, P95, DOI 10.1101/sqb.2007.72.001; Aryal RP, 2017, MOL CELL, V67, P770, DOI 10.1016/j.molcel.2017.07.017; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Bhadra U, 2017, SLEEP MED, V35, P49, DOI 10.1016/j.sleep.2017.04.008; CZEISLER CA, 1981, SLEEP, V4, P1; Danaei M, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10020057; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Eide EJ, 2002, J BIOL CHEM, V277, P17248, DOI 10.1074/jbc.M111466200; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Gotoh T, 2016, P NATL ACAD SCI USA, V113, P13516, DOI 10.1073/pnas.1607984113; Gotoh T, 2015, MOL BIOL CELL, V26, P359, DOI 10.1091/mbc.E14-05-0994; Gotoh T, 2014, MOL BIOL CELL, V25, P3081, DOI 10.1091/mbc.E14-05-0993; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Harmer SL, 2001, ANNU REV CELL DEV BI, V17, P215, DOI 10.1146/annurev.cellbio.17.1.215; Hawkins GA, 2008, DNA SEQUENCE, V19, P44, DOI 10.1080/10425170701322197; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu WZ, 2015, BIOINFORMATICS, V31, P3359, DOI 10.1093/bioinformatics/btv362; MAYAUX JF, 1982, EUR J BIOCHEM, V128, P41; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Nangle SN, 2014, ELIFE, V3, DOI 10.7554/eLife.03674; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeffer M, 2018, GEN COMP ENDOCR, V258, P215, DOI 10.1016/j.ygcen.2017.05.013; Potter GDM, 2016, ENDOCR REV, V37, P584, DOI 10.1210/er.2016-1083; Rana Sobia, 2010, J Circadian Rhythms, V8, P3, DOI 10.1186/1740-3391-8-3; Schmalen I, 2014, CELL, V157, P1203, DOI 10.1016/j.cell.2014.03.057; Shearman LP, 2000, MOL CELL BIOL, V20, P6269, DOI 10.1128/MCB.20.17.6269-6275.2000; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stetefeld J., 2016, BIOPHYS REV, V8, P409, DOI [10.1007/s12551-016-0218-6, DOI 10.1007/S12551-016-0218-6]; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Toh KL, 2001, SCIENCE, V291, P1040, DOI 10.1126/science.1057499; Tomita T, 2010, BBA-MOL CELL RES, V1803, P492, DOI 10.1016/j.bbamcr.2010.01.012; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	42	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0221180	10.1371/journal.pone.0221180	http://dx.doi.org/10.1371/journal.pone.0221180			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320392	Green Published, gold			2022-12-26	WOS:000536028800002
J	Jaakkonen, A; Kivisto, R; Aarnio, M; Kalekivi, J; Hakkinen, M				Jaakkonen, Anniina; Kivisto, Rauni; Aarnio, Maria; Kalekivi, Jenni; Hakkinen, Marjaana			Persistent contamination of raw milk by Campylobacter jejuni ST-883	PLOS ONE			English	Article							SURVIVAL; EPIDEMIOLOGY; TRANSMISSION; EXPRESSION; RESISTANCE; STRESS	Campylobacter jejuni has caused several campylobacteriosis outbreaks via raw milk consumption. This study reports follow-up of a milk-borne campylobacteriosis outbreak that revealed persistent C. jejuni contamination of bulk tank milk for seven months or longer. Only the outbreak-causing strain, representing sequence type (ST) 883, was isolated from milk, although other C. jejuni STs were also isolated from the farm. We hypothesized that the outbreak strain harbors features that aid its environmental transmission or survival in milk. To identify such phenotypic features, the outbreak strain was characterized for survival in refrigerated raw milk and in aerobic broth culture by plate counting and for biofilm formation on microplates by crystal violet staining and quantification. Furthermore, whole-genome sequences were studied for such genotypic features. For comparison, we characterized isolates representing other STs from the same farm and an ST-883 isolate that persisted on another dairy farm, but was not isolated from bulk tank milk. With high inocula (10(5) CFU/ml), ST-883 strains survived in refrigerated raw milk longer (4-6 days) than the other strains (<= 3 days), but the outbreak strain showed no outperformance among ST-883 strains. This suggests that ST-883 strains may share features that aid their survival in milk, but other mechanisms are required for persistence in milk. No correlation was observed between survival in refrigerated milk and aerotolerance. The outbreak strain formed a biofilm, offering a potential explanation for persistence in milk. Whether biofilm formation was affected by pTet-like genomic element and phase-variable genes encoding capsular methyltransferase and cytochrome C551 peroxidase warrants further study. This study suggests a phenotypic target candidate for interventions and genetic markers for the phenotype, which should be investigated further with the final aim of developing control strategies against C. jejuni infections.	[Jaakkonen, Anniina; Aarnio, Maria; Kalekivi, Jenni; Hakkinen, Marjaana] Finnish Food Author, Lab & Res Div, Microbiol Unit, Helsinki, Finland; [Jaakkonen, Anniina; Kivisto, Rauni] Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland	Finnish Food Authority; University of Helsinki	Jaakkonen, A; Hakkinen, M (corresponding author), Finnish Food Author, Lab & Res Div, Microbiol Unit, Helsinki, Finland.; Jaakkonen, A (corresponding author), Univ Helsinki, Fac Vet Med, Dept Food Hyg & Environm Hlth, Helsinki, Finland.	anniina.jaakkonen@foodauthority.fi; marjaana.hakkinen@foodauthority.fi		Kivisto, Rauni/0000-0001-9533-2259; Jaakkonen, Anniina/0000-0002-0638-4004	Walter Ehrstrom Foundation; Finnish Foundation of Veterinary Research; Wellcome Trust	Walter Ehrstrom Foundation; Finnish Foundation of Veterinary Research; Wellcome Trust(Wellcome TrustEuropean Commission)	This study received financial support from the Walter Ehrstrom Foundation (AJ, MH; http://www.maitohygienialiitto.fi/walter-ehrstrominsaatio) and the Finnish Foundation of Veterinary Research (AJ; https://www.sels.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the farm for cooperation and all officials who participated in the outbreak investigation or the follow-up investigations on the farm. Furthermore, we thank Animal Health ETT for their expertise in the follow-up investigations. At the Finnish Food Authority and University of Helsinki, we acknowledge especially Kirsi-Maria Eklund, Satu Olkkola, Alejandra Culebro, and Mirko Rossi for their contributions to obtaining sequencing data or during the early stages of the study. Antti Mikkela (Finnish Food Authority) and Saara Salmenlinna (National Institute for Health and Welfare, Helsinki, Finland) are acknowledged, respectively, for providing help in biofilm analyses and for obtaining the human data and critically reviewing the manuscript. The Finnish Institute for Molecular Medicine (Helsinki, Finland) and CSC-IT Center for Science Ltd. (Espoo, Finland) are thanked for providing, respectively, sequencing service and computing resources. Furthermore, we are grateful to institutes that submit genomic data to public repositories. This publication made use of the PubMLST website (https://pubmlst.org/) developed by Keith Jolley, sited at the University of Oxford, and funded by Wellcome Trust.	Alhussien MN, 2018, VET WORLD, V11, P562, DOI 10.14202/vetworld.2018.562-577; [Anonymous], 2000, JEJ; [Anonymous], 2014, JEJ; Atack JM, 2009, FUTURE MICROBIOL, V4, P677, DOI 10.2217/FMB.09.44; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; Bianchini V, 2014, APPL ENVIRON MICROB, V80, P1832, DOI 10.1128/AEM.03784-13; Bronowski C, 2014, FEMS MICROBIOL LETT, V356, P8, DOI 10.1111/1574-6968.12488; Cabrita P, 2015, FOODBORNE PATHOG DIS, V12, P576, DOI 10.1089/fpd.2014.1918; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Centers for Disease Control Prevention, 2013, STANDARD OPERATING P; Crofts AA, 2018, NAT MICROBIOL, V3, P494, DOI 10.1038/s41564-018-0133-7; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Haan CPA, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-200; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; EKSTRAND B, 1989, FOOD BIOTECHNOL, V3, P105, DOI 10.1080/08905438909549703; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Garai P, 2017, VIRULENCE, V8, P297, DOI 10.1080/21505594.2016.1221025; Gonzalez M, 2012, J APPL MICROBIOL, V113, P284, DOI 10.1111/j.1365-2672.2012.05342.x; Hadfield J, 2018, BIOINFORMATICS, V34, P292, DOI 10.1093/bioinformatics/btx610; Hanning I, 2008, J APPL MICROBIOL, V105, P1199, DOI 10.1111/j.1365-2672.2008.03853.x; Hendrixson DR, 2004, MOL MICROBIOL, V52, P471, DOI 10.1111/j.1365-2958.2004.03988.x; International Organization for Standardization, 2006, 1336622006 ISO; International Organization for Standardization, 2013, 72182007AMD12013 ISO; Jaakkonen A, 2019, APPL ENVIRON MICROB, V85, DOI [10.1128/AEM.02910-18, 10.1128/aem.02910-18]; Jolley Keith A, 2018, Wellcome Open Res, V3, P124, DOI 10.12688/wellcomeopenres.14826.1; Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15; Lamarque M, 2011, MICROBIOL-SGM, V157, P1612, DOI 10.1099/mic.0.048173-0; Ma TF, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8030377; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Nascimento M, 2017, BIOINFORMATICS, V33, P128, DOI 10.1093/bioinformatics/btw582; Nordic Committee on Food Analysis. NMKL, 1990, 1191990 NMKL, V119; Nordic Committee on Food Analysis. NMKL, 2007, 1192007 NMKL, V119; Oh E, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2015.01263, 10.3389/fmicb.2015.00126]; Oh E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087312; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pascoe B, 2015, ENVIRON MICROBIOL, V17, P4779, DOI 10.1111/1462-2920.13051; Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588; PIARD JC, 1991, LAIT, V71, P525; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Quigley L, 2013, FEMS MICROBIOL REV, V37, P664, DOI 10.1111/1574-6976.12030; R Core Team, 2021, R LANGUAGE ENV STAT; Sampathkumar B, 2006, MICROBIOL-SGM, V152, P567, DOI 10.1099/mic.0.28405-0; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schildt M, 2006, EPIDEMIOL INFECT, V134, P401, DOI 10.1017/S0950268805005029; Seemann T., SNIPPY; Seemann T, ABRICATE; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sheppard SK, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018119; Sheppard SK, 2011, MOL ECOL, V20, P3484, DOI 10.1111/j.1365-294X.2011.05179.x; Shi HP, 2018, MICROB PATHOGENESIS, V123, P68, DOI 10.1016/j.micpath.2018.06.006; Silva M, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000166; Sullivan MJ, 2011, BIOINFORMATICS, V27, P1009, DOI 10.1093/bioinformatics/btr039; Teh AHT, 2014, APPL ENVIRON MICROB, V80, P5154, DOI 10.1128/AEM.01493-14; van der Graaf-van Bloois L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152832; Vorwerk H, 2014, MOL MICROBIOL, V93, P1224, DOI 10.1111/mmi.12732; Wang HR, 2019, J FOOD PROTECT, V82, P1683, DOI 10.4315/0362-028X.JFP-19-018; Wong EHJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166835; Wood D, 2018, KRAKEN 2 SOFTWARE MI; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yahara K, 2017, ENVIRON MICROBIOL, V19, P361, DOI 10.1111/1462-2920.13628	62	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231810	10.1371/journal.pone.0231810	http://dx.doi.org/10.1371/journal.pone.0231810			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315369	Green Published, Green Submitted, gold			2022-12-26	WOS:000536024800056
J	Liu, PCC; Koblish, H; Wu, LX; Bowman, K; Diamond, S; DiMatteo, D; Zhang, Y; Hansbury, M; Rupar, M; Wen, XM; Collier, P; Feldman, P; Klabe, R; Burke, KA; Soloviev, M; Gardiner, C; He, X; Volgina, A; Covington, M; Ruggeri, B; Wynn, R; Burn, TC; Scherle, P; Yeleswaram, S; Yao, WQ; Huber, R; Hollis, G				Liu, Phillip C. C.; Koblish, Holly; Wu, Liangxing; Bowman, Kevin; Diamond, Sharon; DiMatteo, Darlise; Zhang, Yue; Hansbury, Michael; Rupar, Mark; Wen, Xiaoming; Collier, Paul; Feldman, Patricia; Klabe, Ronald; Burke, Krista A.; Soloviev, Maxim; Gardiner, Christine; He, Xin; Volgina, Alla; Covington, Maryanne; Ruggeri, Bruce; Wynn, Richard; Burn, Timothy C.; Scherle, Peggy; Yeleswaram, Swamy; Yao, Wenqing; Huber, Reid; Hollis, Gregory			INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models	PLOS ONE			English	Article							8P11 MYELOPROLIFERATIVE SYNDROME; THERAPEUTIC TARGET; DOSE-ESCALATION; GENE FUSIONS; PHASE-I; FGFR; CANCER; IDENTIFICATION; OPPORTUNITIES; METABOLISM	Alterations in fibroblast growth factor receptor (FGFR) genes have been identified as potential driver oncogenes. Pharmacological targeting of FGFRs may therefore provide therapeutic benefit to selected cancer patients, and proof-of-concept has been established in early clinical trials of FGFR inhibitors. Here, we present the molecular structure and preclinical characterization of INCB054828 (pemigatinib), a novel, selective inhibitor of FGFR 1, 2, and 3, currently in phase 2 clinical trials. INCB054828 pharmacokinetics and pharmacodynamics were investigated using cell lines and tumor models, and the antitumor effect of oral INCB054828 was investigated using xenograft tumor models with genetic alterations in FGFR1, 2, or 3. Enzymatic assays with recombinant human FGFR kinases showed potent inhibition of FGFR1, 2, and 3 by INCB054828 (half maximal inhibitory concentration [IC50] 0.4, 0.5, and 1.0 nM, respectively) with weaker activity against FGFR4 (IC50 30 nM). INCB054828 selectively inhibited growth of tumor cell lines with activation of FGFR signaling compared with cell lines lacking FGFR aberrations. The preclinical pharmacokinetic profile suggests target inhibition is achievable by INCB054828 in vivo with low oral doses. INCB054828 suppressed the growth of xenografted tumor models with FGFR1, 2, or 3 alterations as monotherapy, and the combination of INCB054828 with cisplatin provided significant benefit over either single agent, with an acceptable tolerability. The preclinical data presented for INCB054828, together with preliminary clinical observations, support continued investigation in patients with FGFR alterations, such as fusions and activating mutations.	[Liu, Phillip C. C.; Koblish, Holly; Bowman, Kevin; Diamond, Sharon; DiMatteo, Darlise; Zhang, Yue; Hansbury, Michael; Rupar, Mark; Wen, Xiaoming; Collier, Paul; Feldman, Patricia; Klabe, Ronald; Burke, Krista A.; Soloviev, Maxim; Gardiner, Christine; He, Xin; Volgina, Alla; Covington, Maryanne; Ruggeri, Bruce; Wynn, Richard; Burn, Timothy C.; Scherle, Peggy; Yeleswaram, Swamy; Huber, Reid; Hollis, Gregory] Incyte Res Inst, Discovery Biol, Wilmington, DE USA; [Wu, Liangxing; Yao, Wenqing] Incyte Res Inst, Discovery Chem, Wilmington, DE 19803 USA		Koblish, H (corresponding author), Incyte Res Inst, Discovery Biol, Wilmington, DE USA.	hkoblish@incyte.com		Burn, Timothy/0000-0001-6648-4333	Incyte Corporation (Wilmington, DE); Incyte Corporation	Incyte Corporation (Wilmington, DE); Incyte Corporation	The study was funded, sponsored and designed by Incyte Corporation (Wilmington, DE) including support in the form of salaries for the authors. Medical writing assistance was provided by Abigail Marmont, PhD, CMPP, and was funded by Incyte Corporation. The lead author (Phillip C.C. Liu, PhD) made the final decision to submit the manuscript for publication.; We thank Alex Margulis, Yanglong Li, Hong Chang, Frank Nedza, Ruth Young-Sciame, and Champions Oncology Inc. (Hackensack, NJ) for expert technical assistance. We also thank Abigail Marmont, PhD, CMPP, of Evidence Scientific Solutions, Inc. (Philadelphia, PA) for medical writing assistance that was funded by Incyte Corporation.	Arai Y, 2014, HEPATOLOGY, V59, P1427, DOI 10.1002/hep.26890; Babina IS, 2017, NAT REV CANCER, V17, P318, DOI 10.1038/nrc.2017.8; Bailey MH, 2018, CELL, V173, P371, DOI [10.1016/j.cell.2018.02.060, 10.1016/j.cell.2018.07.034]; Borad MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004135; Capelletti M, 2014, CLIN CANCER RES, V20, P6551, DOI 10.1158/1078-0432.CCR-14-1337; Dienstmann R, 2014, ANN ONCOL, V25, P552, DOI 10.1093/annonc/mdt419; Drake JM, 2014, MOL CELL BIOL, V34, P1722, DOI 10.1128/MCB.01592-13; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Gavine PR, 2012, CANCER RES, V72, P2045, DOI 10.1158/0008-5472.CAN-11-3034; Greulich H, 2011, TRENDS MOL MED, V17, P283, DOI 10.1016/j.molmed.2011.01.012; Guagnano V, 2012, CANCER DISCOV, V2, P1118, DOI 10.1158/2159-8290.CD-12-0210; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Ho HK, 2014, DRUG DISCOV TODAY, V19, P51, DOI 10.1016/j.drudis.2013.07.021; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jackson CC, 2010, HUM PATHOL, V41, P461, DOI 10.1016/j.humpath.2009.11.003; Knights V, 2010, PHARMACOL THERAPEUT, V125, P105, DOI 10.1016/j.pharmthera.2009.10.001; Knowles MA, 2007, WORLD J UROL, V25, P581, DOI 10.1007/s00345-007-0213-4; Lamont FR, 2011, BRIT J CANCER, V104, P75, DOI 10.1038/sj.bjc.6606016; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Loriot Y, 2019, NEW ENGL J MED, V381, P338, DOI 10.1056/NEJMoa1817323; Macdonald D, 2002, ACTA HAEMATOL-BASEL, V107, P101, DOI 10.1159/000046639; Martin A, 2012, ADV EXP MED BIOL, V728, P65, DOI 10.1007/978-1-4614-0887-1_4; Mellor HR, 2014, LIVER INT, V34, pE1, DOI 10.1111/liv.12462; Nogova L, 2017, J CLIN ONCOL, V35, P157, DOI 10.1200/JCO.2016.67.2048; Paik PK, 2017, CLIN CANCER RES, V23, P5366, DOI 10.1158/1078-0432.CCR-17-0645; Pal SK, 2018, CANCER DISCOV, V8, P812, DOI 10.1158/2159-8290.CD-18-0229; Pardo OE, 2009, CANCER RES, V69, P8645, DOI 10.1158/0008-5472.CAN-09-1576; Reis JS, 2006, CLIN CANCER RES, V12, P6652, DOI 10.1158/1078-0432.CCR-06-1164; Saleh M, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.AM2017-CT111; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Tabernero J, 2015, J CLIN ONCOL, V33, P3401, DOI 10.1200/JCO.2014.60.7341; Tomlinson D, 2007, ONCOGENE, V26, P5889, DOI 10.1038/sj.onc.1210399; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Verstovsek S, 2018, ANN ONCOL, V29, P1880, DOI 10.1093/annonc/mdy173; Weiss J, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001451; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wohrle S, 2013, J BONE MINER RES, V28, P899, DOI 10.1002/jbmr.1810; Wu YM, 2013, CANCER DISCOV, V3, P636, DOI 10.1158/2159-8290.CD-13-0050; Yu CD, 2000, J BIOL CHEM, V275, P15482, DOI 10.1074/jbc.275.20.15482	43	61	62	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231877	10.1371/journal.pone.0231877	http://dx.doi.org/10.1371/journal.pone.0231877			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315352	Green Published, gold			2022-12-26	WOS:000536024800061
J	Xie, HT; Hong, YG; Liu, HM; Jiao, LJ; Wu, JP; Wang, LX				Xie, Haitao; Hong, Yiguo; Liu, Huamin; Jiao, Lijing; Wu, Jiapeng; Wang, Lixin			Spatio-temporal shifts in community structure and activity of nirS-type denitrifiers in the sediment cores of Pearl River Estuary	PLOS ONE			English	Article							SOIL DENITRIFICATION; BACTERIAL ABUNDANCE; SPATIAL VARIATIONS; DIVERSITY; WATER; NITROGEN; CHINA; NITRIFICATION; ANAMMOX; TRANSFORMATION	Denitrification, an important process in microbial mediated nitrogen cycle, plays important roles in nitrogen loss in estuarine sediments. However, the function of denitrifiers in the estuarine subsurface sediments remained poorly understood. In this study, we analyzed the potential activity, abundance and community structure of nirS-type denitrifiers using N-15-labeled incubation quantitative-PCR and high throughput sequencing techniques in sediment cores from Pearl River Estuary (PRE). Results showed that subsurface sediments had nearly same level denitrification potential activity compare to surface sediments, although the abundance of nirS gene decreased sharply from surface to bottom in sediment cores. Meanwhile, nirS gene abundance exhibit significant temporal variations, which is consistent with denitrification potential activity. Moreover, the community structure and diversity of nirS-type denitrifiers in sediment cores exhibited remarkable temporal shift pattern. For spatial variation, no significant difference was observed of denitrifiers community structure in each sediment core from the surface to the subsurface, while there were significant different diversity characteristic among different cores. Redundancy analysis (RDA) showed that multiple environmental factors including salinity, pH, oxidation-reduction potential, nutrient content and organic substances synergistically shaped the diversity and distribution of nirS-type denitrifers in PRE sediments. Our results showed that nirS-type denitrifers played important roles in the nitrogen removal in subsurface sediments of PRE.	[Xie, Haitao; Hong, Yiguo; Jiao, Lijing; Wu, Jiapeng] Guangzhou Univ, Key Lab Water Qual & Conservat Pearl River Delta, Minist Educ, Inst Environm Res Greater Bay, Guangzhou, Guangdong, Peoples R China; [Xie, Haitao; Liu, Huamin; Wang, Lixin] Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China	Guangzhou University; Inner Mongolia University	Hong, YG (corresponding author), Guangzhou Univ, Key Lab Water Qual & Conservat Pearl River Delta, Minist Educ, Inst Environm Res Greater Bay, Guangzhou, Guangdong, Peoples R China.; Liu, HM (corresponding author), Inner Mongolia Univ, Sch Ecol & Environm, Hohhot, Peoples R China.	yghong@gzhu.edu.cn; liuhmimu@aliyun.com	Hong, Yiguo/K-7082-2018	Hong, Yiguo/0000-0002-6255-4100	National Natural Science Foundation of China [31870100, 91851111]; Guangdong basic and applied basic research Foundation [2019B1515120066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong basic and applied basic research Foundation	This work was supported by the National Natural Science Foundation of China (Grant No. 31870100 to YH, 91851111 to YH), and Guangdong basic and applied basic research Foundation (Grant No.2019B1515120066 to YH).	Barta J, 2010, BIOGEOCHEMISTRY, V101, P123, DOI 10.1007/s10533-010-9430-9; Beman JM, 2014, ESTUAR COAST, V37, P1343, DOI 10.1007/s12237-013-9716-y; Braker G, 2001, APPL ENVIRON MICROB, V67, P1893, DOI 10.1128/AEM.67.4.1893-1901.2001; Chen J, 2017, BIOGEOSCIENCES, V14, P2513, DOI 10.5194/bg-14-2513-2017; Cheung KC, 2003, CHEMOSPHERE, V52, P1431, DOI 10.1016/S0045-6535(03)00479-X; Dai M, 2008, BIOGEOSCIENCES, V5, P1227, DOI 10.5194/bg-5-1227-2008; Devol AH, 2015, ANNU REV MAR SCI, V7, P403, DOI 10.1146/annurev-marine-010213-135040; Fan Z, 2016, ENVIRON SCI POLLUT R, V23, P14102, DOI 10.1007/s11356-016-6390-1; Galloway T, 2010, ENVIRON POLLUT, V158, P1748, DOI 10.1016/j.envpol.2009.11.013; Gao J, 2016, APPL MICROBIOL BIOT, V100, P8573, DOI 10.1007/s00253-016-7659-5; Harrison PJ, 2008, CONT SHELF RES, V28, P1405, DOI 10.1016/j.csr.2007.02.011; Hong YG, 2019, MAR POLLUT BULL, V138, P115, DOI 10.1016/j.marpolbul.2018.11.040; Hou LJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15621; Hou LJ, 2012, CONT SHELF RES, V35, P86, DOI 10.1016/j.csr.2012.01.004; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Kuai LP, 1998, APPL ENVIRON MICROB, V64, P4500; Lee JA, 2017, MICROB ECOL, V73, P271, DOI 10.1007/s00248-016-0865-y; Li BX, 2017, INT BIODETERIOR, V126, P143, DOI [10.1016/j.ibiod.2017.10.008, DOI 10.1016/J.IBI0D.2017.10.008]; [梁丽华 LIANG Li-Hua], 2009, [微生物学通报, Microbiology], V36, P627; Moussard H, 2009, ENV MICROBIOL REP, V1, P424, DOI 10.1111/j.1758-2229.2009.00063.x; Najamuddin, 2016, MAR POLLUT BULL, V111, P456, DOI 10.1016/j.marpolbul.2016.06.106; Pan JY, 2014, J GEOPHYS RES-OCEANS, V119, P2480, DOI 10.1002/2013JC009042; Prieme A, 2002, APPL ENVIRON MICROB, V68, P1893, DOI 10.1128/AEM.68.4.1893-1900.2002; Raghoebarsing AA, 2006, NATURE, V440, P918, DOI 10.1038/nature04617; Risgaard-Petersen N, 2004, LIMNOL OCEANOGR-METH, V2, P315, DOI 10.4319/lom.2004.2.315; ROBERTSON LA, 1988, APPL ENVIRON MICROB, V54, P2812, DOI 10.1128/AEM.54.11.2812-2818.1988; Ruiz-Rueda O, 2007, INT MICROBIOL, V10, P253, DOI 10.2436/20.1501.01.34; Seitzinger S, 2006, ECOL APPL, V16, P2064, DOI 10.1890/1051-0761(2006)016[2064:DALAWA]2.0.CO;2; SEITZINGER SP, 1988, LIMNOL OCEANOGR, V33, P702, DOI 10.4319/lo.1988.33.4_part_2.0702; Soltwedel T, 2001, MAR ECOL PROG SER, V219, P291, DOI 10.3354/meps219291; Song KY, 2012, ECOL ENG, V38, P130, DOI 10.1016/j.ecoleng.2011.09.008; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; TOMASZEK JA, 1995, MAR FRESHWATER RES, V46, P27, DOI 10.1071/MF9950027; Wang JX, 2015, CHEM GEOL, V402, P18, DOI 10.1016/j.chemgeo.2015.03.002; Wang SY, 2012, ENVIRON SCI TECHNOL, V46, P8834, DOI 10.1021/es3017446; Wang SJ, 2013, ENVIRON SCI-PROC IMP, V15, P963, DOI 10.1039/c3em30808a; [王兴春 Wang Xingchun], 2012, [中国生物工程杂志, Journal of Chinese Biotechnology], V32, P109; Wu JP, 2019, INT BIODETER BIODEGR, V142, P227, DOI 10.1016/j.ibiod.2019.05.018; Xie W, 2014, APPL MICROBIOL BIOT, V98, P7971, DOI 10.1007/s00253-014-5838-9; Xiong ZQ, 2015, ECOL ENG, V83, P437, DOI 10.1016/j.ecoleng.2015.04.094; Yang Li-biao, 2015, Huanjing Kexue, V36, P905; Yoshie S, 2004, APPL ENVIRON MICROB, V70, P3152, DOI 10.1128/AEM.70.5.3152-3157.2004; Yue WZ, 2005, ENV SCI, V26, DOI [10.13227/j.hjkx.2005.02.040, DOI 10.13227/J.HJKX.2005.02.040]; Zhang L, 2014, J EARTH SCI-CHINA, V25, P197, DOI 10.1007/s12583-014-0413-y; Zhang Y, 2014, BIOGEOSCIENCES, V11, P2131, DOI 10.5194/bg-11-2131-2014; Zheng YL, 2015, MICROB ECOL, V70, P30, DOI 10.1007/s00248-015-0567-x; Zhong S, 2018, ATMOS RES, V213, P163, DOI 10.1016/j.atmosres.2018.05.014; Zhou SL, 2016, RSC ADV, V6, P91517, DOI 10.1039/c6ra18017e; Zumft WG, 1997, MICROBIOL MOL BIOL R, V61, P533, DOI 10.1128/.61.4.533-616.1997	49	8	8	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231271	10.1371/journal.pone.0231271	http://dx.doi.org/10.1371/journal.pone.0231271			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315323	gold, Green Published			2022-12-26	WOS:000536024800020
J	Krzyminska-Siemaszko, R; Tobis, S; Lewandowicz, M; Wieczorowska-Tobis, K				Krzyminska-Siemaszko, Roma; Tobis, Slawomir; Lewandowicz, Marta; Wieczorowska-Tobis, Katarzyna			Comparison of four sarcopenia screening questionnaires in community-dwelling older adults from Poland using six sets of international diagnostic criteria of sarcopenia	PLOS ONE			English	Article							SARC-F; VALIDATION; CONSENSUS; OBESITY; VERSION	Introduction There are four screening sarcopenia questionnaires (SARC-F, SARC-CalF, MSRA-5, MSRA-7). To unambiguously determine which of them is the most effective tool in community-dwelling older adults, we performed a diagnostic accuracy study. The aim of the analysis was to assess the diagnostic values of SARC-F, SARC-CalF, MSRA-5, MSRA-7 and compare their psychometric properties against six criterion standards (EWGSOP1, EWGSOP2, FNIH, AWGS, IWGS, SCWD criteria). Materials and methods We included 100 community-dwelling volunteers aged >= 65yrs. The sensitivity/specificity analyses were performed. Receiver operating characteristic (ROC) curves and area under the ROC curves (AUC) were calculated to compare the overall diagnostic accuracy of the four questionnaires. Ideal screening tools should have reasonably high sensitivity and specificity, and an AUC value above 0.7. Results With respect to the six criterion standards used, the sensitivity of SARC-F, SARC-CalF, MSRA-5, and MSRA-7 ranged 35.0-90.0%, 20.0-75.0%, 64.7-90.0%, 76.5-91.7%, respectively, whereas the specificity ranged 86.9-91.1%, 80.0-90.0%, 45.8-48.8%, 28.9-31.0% respectively. The AUCs of SARC-F, SARC-CalF, MSRA-5, and MSRA-7 ranged from 0.655-0.882, 0.711-0.874, 0.618-0.782 and 0.588-0.711 respectively. Only SARC-CalF had AUC > 0.7 and < 0.9 against the six criterion standards but obesity was a confounding factor, which may affect the diagnostic power of SARC-CalF. MSRA-7 had the smallest AUC of all the questionnaires and MSRA-5 had slightly larger AUC than MSRA-7. Conclusion Based on our analysis, the standard sarcopenia screening questionnaires deliver contradictory results in many practically occurring cases. It appears that SARC-CalF is an optimal choice for screening sarcopenia in community-dwelling older adults.	[Krzyminska-Siemaszko, Roma; Lewandowicz, Marta; Wieczorowska-Tobis, Katarzyna] Poznan Univ Med Sci, Dept Palliat Med, Poznan, Poland; [Tobis, Slawomir] Poznan Univ Med Sci, Dept Geriatr Med & Gerontol, Poznan, Poland	Poznan University of Medical Sciences; Poznan University of Medical Sciences	Krzyminska-Siemaszko, R (corresponding author), Poznan Univ Med Sci, Dept Palliat Med, Poznan, Poland.	krzyminskasiemaszko@ump.edu.pl		Lewandowicz, Marta/0000-0002-9634-5112; Krzyminska-Siemaszko, Roma/0000-0002-6770-7321	Poznan University of Medical Sciences [502-14-11141570-10595]	Poznan University of Medical Sciences	This study was funded by Poznan University of Medical Sciences (grant number 502-14-11141570-10595). Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahat G, 2018, J NUTR HEALTH AGING, V22, P898, DOI 10.1007/s12603-018-1067-8; Bahat G, 2018, J NUTR HEALTH AGING, V22, P1034, DOI 10.1007/s12603-018-1072-y; Bahat G, 2018, EUR GERIATR MED, V9, P23, DOI 10.1007/s41999-017-0003-5; Barbosa-Silva TG, 2016, J AM MED DIR ASSOC, V17, P1136, DOI 10.1016/j.jamda.2016.08.004; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2019, AGE AGEING, V48, P16, DOI 10.1093/ageing/afy169; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Fielding RA, 2011, J AM MED DIR ASSOC, V12, P249, DOI 10.1016/j.jamda.2011.01.003; Graf C, 2008, AM J NURS, V108, P52, DOI 10.1097/01.NAJ.0000314810.46029.74; Hanley JA, 1997, ACAD RADIOL, V4, P49, DOI 10.1016/S1076-6332(97)80161-4; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; JITAPUNKUL S, 1991, AGE AGEING, V20, P332, DOI 10.1093/ageing/20.5.332; Kim S, 2018, J AM MED DIR ASSOC, V19, P40, DOI 10.1016/j.jamda.2017.07.006; Krzyminska-Siemaszko R, 2019, EUR REV MED PHARMACO, V23, P4321, DOI 10.26355/eurrev_201905_17938; Krzyminska-Siemaszko R, 2015, J NUTR HEALTH AGING, V19, P397, DOI 10.1007/s12603-014-0572-7; Lim WS, 2019, J NUTR HEALTH AGING, V23, P393, DOI 10.1007/s12603-019-1177-y; Linden A, 2006, J EVAL CLIN PRACT, V12, P132, DOI 10.1111/j.1365-2753.2005.00598.x; Locquet M, 2018, CLIN EPIDEMIOL, V10, P71, DOI 10.2147/CLEP.S148638; Malmstrom TK, 2013, J AM MED DIR ASSOC, V14, P531, DOI 10.1016/j.jamda.2013.05.018; Mijnarends DM, 2016, EUR GERIATR MED, V7, P276, DOI 10.1016/j.eurger.2015.12.011; Morley JE, 2011, J AM MED DIR ASSOC, V12, P403, DOI 10.1016/j.jamda.2011.04.014; Nawi SNM, 2019, ANN ACAD MED SINGAP, V48, P201; Parra-Rodriguez L, 2016, J AM MED DIR ASSOC, V17, P1142, DOI 10.1016/j.jamda.2016.09.008; Rosenberg IH, 1997, J NUTR, V127, pS990, DOI 10.1093/jn/127.5.990S; Rossi AP, 2017, J NUTR HEALTH AGING, V21, P743, DOI 10.1007/s12603-017-0921-4; Shao A, 2017, J FUNCT FOODS, V33, P244, DOI 10.1016/j.jff.2017.03.048; Shelkey M, 2002, DERMATOL NURS, V14, P192; Siemaszko R, 2014, BIOMED RES INT, V2014, DOI [10.1155/2014/045396, DOI 10.1155/2014/045396]; Studenski SA, 2014, J GERONTOL A-BIOL, V69, P547, DOI 10.1093/gerona/glu010; Tyrovolas S, 2016, J CACHEXIA SARCOPENI, V7, P312, DOI 10.1002/jcsm.12076; Vandewoude Maurits F J, 2012, J Aging Res, V2012, P651570; Woo J, 2014, J AM MED DIR ASSOC, V15, P630, DOI 10.1016/j.jamda.2014.04.021; Yang M, 2019, AGING CLIN EXP RES, V31, P1481, DOI 10.1007/s40520-018-1083-x; Yang M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012426; Yang M, 2019, J AM MED DIR ASSOC, V20, P53, DOI 10.1016/j.jamda.2018.04.012; Yang M, 2018, J AM MED DIR ASSOC, V19, DOI 10.1016/j.jamda.2017.12.016; Yu Solomon C Y, 2016, Curr Gerontol Geriatr Res, V2016, P5978523, DOI 10.1155/2016/5978523	37	11	11	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231847	10.1371/journal.pone.0231847	http://dx.doi.org/10.1371/journal.pone.0231847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310992	gold, Green Published			2022-12-26	WOS:000536019800040
J	Ambrosini, YM; Park, Y; Jergens, AE; Shin, W; Min, S; Atherly, T; Borcherding, DC; Jang, J; Allenspach, K; Mochel, JP; Kim, HJ				Ambrosini, Yoko M.; Park, Yejin; Jergens, Albert E.; Shin, Woojung; Min, Soyoun; Atherly, Todd; Borcherding, Dana C.; Jang, Jinah; Allenspach, Karin; Mochel, Jonathan P.; Kim, Hyun Jung			Recapitulation of the accessible interface of biopsy-derived canine intestinal organoids to study epithelial-luminal interactions	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; GASTROINTESTINAL-TRACT; IN-VITRO; CELLS; MICROBIOME; PLATFORM; MODEL; CLASSIFICATION; DIFFERENTIATE; EXPRESSION	Recent advances in canine intestinal organoids have expanded the option for building a better in vitro model to investigate translational science of intestinal physiology and pathology between humans and animals. However, the three-dimensional geometry and the enclosed lumen of canine intestinal organoids considerably hinder the access to the apical side of epithelium for investigating the nutrient and drug absorption, host-microbiome crosstalk, and pharmaceutical toxicity testing. Thus, the creation of a polarized epithelial interface accessible from apical or basolateral side is critical. Here, we demonstrated the generation of an intestinal epithelial monolayer using canine biopsy-derived colonic organoids (colonoids). We optimized the culture condition to form an intact monolayer of the canine colonic epithelium on a nanoporous membrane insert using the canine colonoids over 14 days. Transmission and scanning electron microscopy revealed a physiological brush border interface covered by the microvilli with glycocalyx, as well as the presence of mucin granules, tight junctions, and desmosomes. The population of stem cells as well as differentiated lineage-dependent epithelial cells were verified by immunofluorescence staining and RNA in situ hybridization. The polarized expression of P-glycoprotein efflux pump was confirmed at the apical membrane. Also, the epithelial monolayer formed tight- and adherence-junctional barrier within 4 days, where the transepithelial electrical resistance and apparent permeability were inversely correlated. Hence, we verified the stable creation, maintenance, differentiation, and physiological function of a canine intestinal epithelial barrier, which can be useful for pharmaceutical and biomedical researches.	[Ambrosini, Yoko M.; Shin, Woojung; Min, Soyoun; Kim, Hyun Jung] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA; [Ambrosini, Yoko M.; Borcherding, Dana C.; Mochel, Jonathan P.] Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA; [Park, Yejin; Jang, Jinah] Pohang Univ Sci & Technol, Dept Creat IT Engn, Pohang, South Korea; [Jergens, Albert E.; Atherly, Todd; Allenspach, Karin] Iowa State Univ, Dept Vet Clin Sci, Ames, IA USA; [Jang, Jinah] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, South Korea; [Jang, Jinah] Pohang Univ Sci & Technol, Dept Mech Engn, Pohang, South Korea; [Kim, Hyun Jung] Univ Texas Austin, Dell Med Sch, Dept Oncol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Iowa State University; Pohang University of Science & Technology (POSTECH); Iowa State University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH); University of Texas System; University of Texas Austin	Kim, HJ (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.; Mochel, JP (corresponding author), Iowa State Univ, Dept Biomed Sci, Ames, IA 50011 USA.; Kim, HJ (corresponding author), Univ Texas Austin, Dell Med Sch, Dept Oncol, Austin, TX 78712 USA.	jmochel@iastate.edu; hyunjung.kim@utexas.edu	Mochel, Jonathan Paul/AAR-3496-2021; Kim, Hyun Jung/GQP-3241-2022; Shin, Woojung/AAE-3651-2022; Shin, Woojung/V-9900-2017	Mochel, Jonathan Paul/0000-0002-0997-3111; Kim, Hyun Jung/0000-0001-5342-2870; Shin, Woojung/0000-0002-1780-0317; Ambrosini, Yoko/0000-0002-9543-2660; Borcherding, Dana/0000-0002-8849-2139	Burroughs Wellcome Fund Collaborative Research Travel Grant [BWF 1019990.01]; American College of Veterinary Internal Medicine Advance Research Fellowships; Ministry of Science and ICT Korea under the ICT Consilience Creative program [IITP-2019-2011-1-00783]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2015R1A6A3A04059015]; Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science and ICT [2018M3A9H3025030]; Technology Impact Award of the Cancer Research Institute [UTA18-000889]; National Cancer Institute of the National Institutes of Health, IMAT program [R21CA236690]; Leona M. & Harry B. Helmsley Charitable Trust [1912-03604]; Asan Foundation Biomedical Science Scholarship; F99/K00 Predoctoral to Postdoctoral Transition Award [F99CA245801]; Iowa State University	Burroughs Wellcome Fund Collaborative Research Travel Grant(Burroughs Wellcome Fund); American College of Veterinary Internal Medicine Advance Research Fellowships; Ministry of Science and ICT Korea under the ICT Consilience Creative program; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education; Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science and ICT; Technology Impact Award of the Cancer Research Institute; National Cancer Institute of the National Institutes of Health, IMAT program; Leona M. & Harry B. Helmsley Charitable Trust; Asan Foundation Biomedical Science Scholarship; F99/K00 Predoctoral to Postdoctoral Transition Award; Iowa State University	This work was supported in part by the Burroughs Wellcome Fund Collaborative Research Travel Grant (BWF 1019990.01 to Y.M.A.), the American College of Veterinary Internal Medicine Advance Research Fellowships (K.A. and Y.M.A.), the Ministry of Science and ICT Korea under the ICT Consilience Creative program supervised by the Institute for Information & communications Technology Planning & Evaluation (IITP) (IITP-2019-2011-1-00783 to Y.P. and J.J.), Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2015R1A6A3A04059015 to Y.P. and J.J.), Iowa State University (Faculty startups, College of Veterinary Medicine Seed Grant and Miller Award), Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science and ICT (2018M3A9H3025030 to H.J.K.), Technology Impact Award of the Cancer Research Institute (UTA18-000889 to H.J.K.), the National Cancer Institute of the National Institutes of Health, IMAT program (R21CA236690 to H.J.K.), the Leona M. & Harry B. Helmsley Charitable Trust (Grant #1912-03604 to H.J.K.), and F99/K00 Predoctoral to Postdoctoral Transition Award (F99CA245801 to W.S.), and Asan Foundation Biomedical Science Scholarship (W.S.). 3D Health Solutions provided support in the form of equity interest for J.P.M., A. E.J., K.A., and H.J.K. and in the form of a salary for T.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ambrosini YM, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00130; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Beck RC, 2003, DIAGN MOL PATHOL, V12, P14, DOI 10.1097/00019606-200303000-00002; Bein A, 2018, CELL MOL GASTROENTER, V5, P659, DOI 10.1016/j.jcmgh.2017.12.010; Cerquetella M, 2010, WORLD J GASTROENTERO, V16, P1050, DOI 10.3748/wjg.v16.i9.1050; Chandra L, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0652-6; Coelho LP, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0450-3; CRISTINA ML, 1978, GASTROENTEROLOGY, V75, P20; Farquhar MJ, 2018, ATLA-ALTERN LAB ANIM, V46, P115, DOI 10.1177/026119291804600304; Galkowska H, 1996, VET IMMUNOL IMMUNOP, V53, P329, DOI 10.1016/S0165-2427(96)05604-8; Gartzke D, 2014, J PHARM SCI-US, V103, P1298, DOI 10.1002/jps.23901; Gunawardene AR, 2011, INT J EXP PATHOL, V92, P219, DOI 10.1111/j.1365-2613.2011.00767.x; Hukkanen RR, 2019, TOXICOL PATHOL, V47, P789, DOI 10.1177/0192623319859261; In J, 2016, CELL MOL GASTROENTER, V2, P48, DOI 10.1016/j.jcmgh.2015.10.001; Jalili-Firoozinezhad S, 2019, NAT BIOMED ENG, V3, P520, DOI 10.1038/s41551-019-0397-0; Kasendra M, 2019, BIORXIV; Kiela PR, 2016, BEST PRACT RES CL GA, V30, P145, DOI 10.1016/j.bpg.2016.02.007; Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112; Kim HJ, 2013, INTEGR BIOL-UK, V5, P1130, DOI 10.1039/c3ib40126j; Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j; Kol A, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9116; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuo JCH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24231; Larregieu CA, 2013, AAPS J, V15, P483, DOI 10.1208/s12248-013-9456-8; Macierzanka A, 2019, SCI REP, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; MARSH MN, 1969, GUT, V10, P940, DOI 10.1136/gut.10.11.940; Mochel JP, 2018, AAPS J, V20, DOI 10.1208/s12248-017-0178-1; Moreira ML, 2015, ACTA VET SCAND, V57, DOI 10.1186/s13028-015-0142-y; MUKHERJEE TM, 1967, J CELL BIOL, V34, P447, DOI 10.1083/jcb.34.2.447; Omori M, 2017, J VET MED SCI, V79, P1840, DOI 10.1292/jvms.17-0045; Park GS, 2017, STEM CELL REV REP, V13, P321, DOI 10.1007/s12015-017-9739-z; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Ramadan Q, 2013, LAB CHIP, V13, P196, DOI 10.1039/c2lc40845g; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider B, 2018, CPT-PHARMACOMET SYST, V7, P65, DOI 10.1002/psp4.12262; Schonhoff SE, 2004, DEV BIOL, V270, P443, DOI 10.1016/j.ydbio.2004.03.013; Shah P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11535; Shin J, 2014, J BIOL CHEM, V289, P25306, DOI 10.1074/jbc.M114.557546; Shin W, 2019, ISCIENCE, V15, P391, DOI 10.1016/j.isci.2019.04.037; Shin W, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00013; Shin W, 2018, P NATL ACAD SCI USA, V115, pE10539, DOI 10.1073/pnas.1810819115; Sontheimer-Phelps A, 2019, CELL MOL GASTROENTER; Srinivasan B, 2015, JALA-J LAB AUTOM, V20, P107, DOI 10.1177/2211068214561025; Tovaglieri A, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0650-5; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van der Hee B, 2018, STEM CELL RES, V28, P165, DOI 10.1016/j.scr.2018.02.013; Van der Heyden S, 2011, J COMP PATHOL, V145, P199, DOI 10.1016/j.jcpa.2011.01.003; Vinaiphat A, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-018-0112-z; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Wang J, 2018, CANCERS, V10, DOI 10.3390/cancers10090330; Wang YL, 2018, CELL MOL GASTROENTER, V5, P113, DOI 10.1016/j.jcmgh.2017.10.007; Weng XH, 2005, AM J PHYSIOL-GASTR L, V288, pG705, DOI 10.1152/ajpgi.00518.2003; Williamson IA, 2018, CELL MOL GASTROENTER, V6, P301, DOI 10.1016/j.jcmgh.2018.05.004; Wilson SS, 2015, MUCOSAL IMMUNOL, V8, P352, DOI 10.1038/mi.2014.72; Zhong XY, 2015, DEV GROWTH DIFFER, V57, P453, DOI 10.1111/dgd.12226	58	11	11	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231423	10.1371/journal.pone.0231423	http://dx.doi.org/10.1371/journal.pone.0231423			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302323	Green Published, gold			2022-12-26	WOS:000536016100026
J	Varela-Castro, L; Alvarez, V; Sevilla, IA; Barral, M				Varela-Castro, Lucia; Alvarez, Vega; Sevilla, Iker A.; Barral, Marta			Risk factors associated to a high Mycobacterium tuberculosis complex seroprevalence in wild boar (Sus scrofa) from a low bovine tuberculosis prevalence area	PLOS ONE			English	Article							ANIMAL TUBERCULOSIS; POPULATION; MAINTENANCE; INFECTION; ABUNDANCE; EPIDEMIOLOGY; RESERVOIR; LESIONS; DEER; PIGS	Animal tuberculosis is a worldwide zoonotic disease caused principally by Mycobacterium bovis, a member of the Mycobacterium tuberculosis complex (MTC). In southern Iberian Peninsula, wild reservoirs such as the wild boar, among other factors, have prevented the eradication of bovine tuberculosis. However, most of the studies have been focused on south-central Spain, where the prevalence of tuberculosis is high among wild ungulates and cattle herds. In northern regions, where wild boar density and bovine tuberculosis prevalence are lower, fewer studies have been carried out and the role of this species is still under debate. The aim of this study was to describe the temporal and spatial distribution of antibodies against MTC in wild boar from the Basque Country, northern Spain. Sera from 1902 animals were collected between 2010 and 2016. The seroprevalence was determined with an in house enzyme-linked immunosorbent assay and the search of risk factors was assessed by Generalized Linear Models. Overall, 17% of wild boars (326/1902; 95%CI, [15.5%-18.9%]) showed antibodies against MTC. Risk factors associated with seropositivity were the year and location of sampling, the number of MTC positive cattle, the distance to positive farms and the percentage of shrub cover. Younger age classes were associated with increased antibody titres among seropositive individuals. The seroprevalence detected was higher than those previously reported in neighbouring regions. Hence, further studies are needed to better understand the role of wild boar in the epidemiology of tuberculosis in low tuberculosis prevalence areas and consequently, its relevance when developing control strategies.	[Varela-Castro, Lucia; Alvarez, Vega; Sevilla, Iker A.; Barral, Marta] NEIKER Inst Vasco Invest & Desarrollo Agr, Anim Hlth Dept, Derio, Bizkaia, Spain		Barral, M (corresponding author), NEIKER Inst Vasco Invest & Desarrollo Agr, Anim Hlth Dept, Derio, Bizkaia, Spain.	mbarral@neiker.eus	Sevilla, Iker A/O-6060-2014; Barral, Marta/F-7174-2015	Sevilla, Iker A/0000-0003-3968-3390; Barral, Marta/0000-0003-3749-1221; ALVAREZ MAIZTEGUI, VEGA/0000-0001-8006-2778; Varela Castro, Lucia/0000-0003-1733-7120	National Institute for Agricultural and Food Research and Technology (INIA) [CPD2016-0006, RTA2014-00002-C02-02]; Gipuzkoa Provincial Council- "Health and environment research" Agreement; "La Caixa"Foundation; Agricultural and Fisheries Department of the Basque Country Government	National Institute for Agricultural and Food Research and Technology (INIA)(Instituto de Investigacion Agropecuaria (INIA)); Gipuzkoa Provincial Council- "Health and environment research" Agreement; "La Caixa"Foundation(La Caixa Foundation); Agricultural and Fisheries Department of the Basque Country Government	This work was funded by the National Institute for Agricultural and Food Research and Technology (INIA) (Research Project RTA2014-00002-C02-02), Gipuzkoa Provincial Council- "Health and environment research" Agreement, "La Caixa"Foundation and Agricultural and Fisheries Department of the Basque Country Government. LV holds a fellowship from the National Institute for Agricultural and Food Research and Technology (INIA) (CPD2016-0006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2006, ACTA THERIOL, V51, P327, DOI 10.1007/BF03192685; Acevedo P, 2014, ECOL INDIC, V36, P594, DOI 10.1016/j.ecolind.2013.09.019; Amat AC, 2015, PREV VET MED, V121, P93, DOI 10.1016/j.prevetmed.2015.05.011; AURTENETXE O, 2008, BMC VET RES, V4, DOI DOI 10.1186/1746-6148-4-1; Balseiro A, 2009, VET REC, V164, P468, DOI 10.1136/vr.164.15.468; Balseiro Ana, 2011, Vet J, V190, pe21, DOI 10.1016/j.tvjl.2011.04.012; Beerli O, 2015, VET J, V203, P131, DOI 10.1016/j.tvjl.2014.10.023; Boadella M, 2011, ECOHEALTH, V8, P478, DOI 10.1007/s10393-011-0713-y; Borowik T, 2013, ACTA THERIOL, V58, P403, DOI 10.1007/s13364-013-0153-x; Chambers MA, 2013, TRANSBOUND EMERG DIS, V60, P14, DOI 10.1111/tbed.12094; CORNER LA, 1981, AUST VET J, V57, P537, DOI 10.1111/j.1751-0813.1981.tb00428.x; Cousins DV, 2001, REV SCI TECH OIE, V20, P71, DOI 10.20506/rst.20.1.1263; Cowie CE, 2016, EUR J WILDLIFE RES, V62, P51, DOI 10.1007/s10344-015-0973-x; Departamento de Desarrollo Economico e Infraestructuras, 1986, INV FOR 1986 COM AUT; Departamento de Desarrollo Economico e Infraestructuras, 2018, INV FOR 2016 2018 CO; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Garrido JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024905; Gortazar C, 2017, PREV VET MED, V146, P150, DOI 10.1016/j.prevetmed.2017.08.009; Gortazar C, 2012, MAMMAL REV, V42, P193, DOI 10.1111/j.1365-2907.2011.00191.x; Gortazar C, 2011, VET MICROBIOL, V151, P170, DOI 10.1016/j.vetmic.2011.02.041; GUTIERREZ M, 1995, J CLIN MICROBIOL, V33, P2953; Keuling O, 2018, EFSA SUPP PUBL, DOI [DOI 10.2903/SP.EFSA.2018.EN-1449, 10.2903/sp.efsa.2018.EN-1449]; Lewis JS, 2017, SCI REP-UK, V7, DOI 10.1038/srep44152; Martin-Hernando MP, 2007, TUBERCULOSIS, V87, P360, DOI 10.1016/j.tube.2007.02.003; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Mentaberre G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088824; Millan J, 2008, J WILDLIFE DIS, V44, P701, DOI 10.7589/0090-3558-44.3.701; Ministerio de Agricultura Pesca Alimentacion y Medio Ambiente, 2019, PROGR NAC ERR ESP AN; Munoz PM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-46; Munoz-Mendoza M, 2016, TRANSBOUND EMERG DIS, V63, P635, DOI 10.1111/tbed.12325; Munoz-Mendoza M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-176; Napp S, 2013, VET REC, V172, DOI 10.1136/vr.101347; Naranjo V, 2008, VET MICROBIOL, V127, P1, DOI 10.1016/j.vetmic.2007.10.002; Nugent G, 2011, VET MICROBIOL, V151, P34, DOI 10.1016/j.vetmic.2011.02.023; Parra A, 2003, VET MICROBIOL, V97, P123, DOI 10.1016/j.vetmic.2003.08.007; Payne A, 2017, FRONT VET SCI, V3, DOI 10.3389/fvets.2016.00122; Pena L, 2006, COMP IMMUNOL MICROB, V29, P114, DOI 10.1016/j.cimid.2006.01.003; de Val BP, 2017, TRANSBOUND EMERG DIS, V64, P275, DOI 10.1111/tbed.12368; Quantum GIS Development Team, 2014, QUANT GIS GEOGR INF; R Core Team, 2013, R LANG ENV STAT COMP; Renwick AR, 2007, EPIDEMIOL INFECT, V135, P529, DOI 10.1017/S0950268806007205; Richomme C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077842; Rodriguez-Campos S, 2012, INFECT GENET EVOL, V12, P877, DOI 10.1016/j.meegid.2011.10.008; SAEZROYUELA C, 1986, MAMMAL REV, V16, P97; Santos N., 2012, EPIDEMIOL INSIGHTS, DOI [10.5772/33781, DOI 10.5772/33781]; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; SROKA CJ, 2018, BMC MED RES METHODOL, V18, DOI DOI 10.1186/S12874-017-0458-6; Tanner E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44148-9; Vicente J, 2007, VET RES, V38, P451, DOI 10.1051/vetres:2007002; Yamamoto D., 2007, NATURAL BOAR WILD BO, P13	50	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231559	10.1371/journal.pone.0231559	http://dx.doi.org/10.1371/journal.pone.0231559			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302328	gold, Green Published			2022-12-26	WOS:000536016100034
J	Zhang, X; Zhan, YT; Lin, WJ; Zhao, F; Guo, CJ; Chen, YJ; Du, MG; Li, DN; Zhang, LQ; An, W; Wang, HR; Xie, P				Zhang, Xin; Zhan, Yutao; Lin, Wenjun; Zhao, Fei; Guo, Chaojing; Chen, Yujiao; Du, Mengge; Li, Dongnian; Zhang, Lingqiang; An, Wei; Wang, Hong-Rui; Xie, Ping			Smurf1 aggravates non-alcoholic fatty liver disease by stabilizing SREBP-1c in an E3 activity-independent manner	FASEB JOURNAL			English	Article						high-fat diet; liver steatosis; ubiquitination	UBIQUITIN LIGASE SMURF1; HEPATIC LIPID-METABOLISM; CELL POLARITY; PHOSPHORYLATION; DEGRADATION; INHIBITION; ACTIVATION; FAMILY	Non-alcoholic fatty liver disease (NAFLD) is one of the most common liver disorders which are characterized by the accumulation of excessive lipid in hepatocytes. The precise pathogenesis of NAFLD is very complicated and remains largely unknown. Smad ubiquitination regulatory factor 1 (Smurf1) is crucial for numerous processes including bone homeostasis, embryogenesis, and pathogenic autophagy. In this study, we found that liver steatosis was alleviated in Smurf1-deficient mice fed with high-fat diet (HFD) for 19 weeks. The deletion of Smurf1 reduced the accumulation of lipid droplets and triglycerides in hepatocytes. The stability of sterol regulatory element-binding protein-1c (SREBP-1c), a key transcription factor that mediates de novo lipogenesis, was markedly reduced in Smurf1-deficient mice. The mechanistic study showed that Smurf1 interacts with SREBP-1c and protects SREBP-1c from ubiquitination and degradation by preventing the binding of SREBP-1c to its ubiquitin E3 ligase Fbw7a. Thus, our study presented an E3 ligase catalytic activity-independent function of Smurf1 in the fatty liver development.	[Zhang, Xin; Wang, Hong-Rui] Xiamen Univ, Innovat Ctr Cell Biol, Sch Life Sci, State Key Lab Cellular Stress Biol, Xiamen, Peoples R China; [Zhan, Yutao; Lin, Wenjun; Chen, Yujiao; Du, Mengge; An, Wei; Xie, Ping] Capital Med Univ, Dept Cell Biol, Municipal Lab Liver Protect & Regulat Regenerat, 10 Xitoutiao, Beijing 100069, Peoples R China; [Zhan, Yutao; Lin, Wenjun; Zhao, Fei; Li, Dongnian] Capital Med Univ, Beijing Tongren Hosp, Dept Gastroenterol, Beijing, Peoples R China; [Guo, Chaojing; Zhang, Lingqiang] Beijing Inst Life, Natl Ctr Prot Sci Beijing, State Key Lab Prote, Beijing, Peoples R China	Xiamen University; Capital Medical University; Capital Medical University	An, W; Xie, P (corresponding author), Capital Med Univ, Dept Cell Biol, Municipal Lab Liver Protect & Regulat Regenerat, 10 Xitoutiao, Beijing 100069, Peoples R China.; Wang, HR (corresponding author), Xiamen Univ, Sch Life Sci, State Key Lab Cellular Stress Biol, D301,Huang Chao Yang Bldg, Xiamen 361102, Fujian, Peoples R China.	anwei@ccmu.edu.cn; wanghr@xmu.edu.cn; xiep@ccmu.edu.cn	An, wei/AGZ-8037-2022		NSFC | National Natural Science Foundation of China [81570515, U1605222]; National Natural Science Foundation of China-Yunnan Joint Fund [31970742]; Beijing Higher Education Young Elite Teacher Project [CITTCD201704097]	NSFC | National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China-Yunnan Joint Fund(National Natural Science Foundation of China (NSFC)); Beijing Higher Education Young Elite Teacher Project	NSFC | National Natural Science Foundation of China, Grant/Award Number: 81570515 and U1605222; National Natural Science Foundation of China-Yunnan Joint Fund, Grant/Award Number: 31970742; Beijing Higher Education Young Elite Teacher Project, Grant/Award Number: CIT&TCD201704097	Arai T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32586-w; Chen H, 2016, BBA-GENE REGUL MECH, V1859, P1459, DOI 10.1016/j.bbagrm.2016.07.010; Chen YH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04815-3; Cohen JC, 2011, SCIENCE, V332, P1519, DOI 10.1126/science.1204265; Dong SX, 2013, CELL METAB, V18, P380, DOI 10.1016/j.cmet.2013.08.012; Frades I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124544; Franco LH, 2017, CELL HOST MICROBE, V21, P59, DOI [10.1016/j.chom.2017.08.005, 10.1016/j.chom.2016.11.002]; Fu L, 2019, SEMIN CANCER BIOL, VS1044-579X, P30423; Giandomenico V, 2003, MOL CELL BIOL, V23, P2587, DOI 10.1128/MCB.23.7.2587-2599.2003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hu F, 2018, FASEB J, V32, P4627, DOI 10.1096/fj.201701480R; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Li S, 2016, ONCOGENE, V35, P642, DOI 10.1038/onc.2015.123; Lin P, 2017, PHARMACOGN MAG, V13, P245, DOI 10.4103/0973-1296.204563; Lu KF, 2008, NAT CELL BIOL, V10, P994, DOI 10.1038/ncb1760; Moon YA, 2017, ENDOCRINOL METAB, V32, P6, DOI 10.3803/EnM.2017.32.1.6; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Nie J, 2010, J BIOL CHEM, V285, P22816, DOI 10.1074/jbc.M110.126920; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Sohn JW, 2015, BMB REP, V48, P229, DOI 10.5483/BMBRep.2015.48.4.272; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Wei JW, 2014, J CLIN INVEST, V124, P1781, DOI 10.1172/JCI72323; Xie P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4733; Xiong P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6330; Xu X, 2013, SEMIN LIVER DIS, V33, P301, DOI 10.1055/s-0033-1358523; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zhan YT, 2017, EXP CELL RES, V355, P40, DOI 10.1016/j.yexcr.2017.03.033; Zhao XP, 2012, J CLIN INVEST, V122, P2417, DOI 10.1172/JCI61462; Zhu HT, 1999, NATURE, V400, P687, DOI 10.1038/23293	34	7	7	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7631	7643		10.1096/fj.201902952RR	http://dx.doi.org/10.1096/fj.201902952RR		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301540				2022-12-26	WOS:000526642700001
J	Gladow, N; Hollmann, C; Ramos, G; Frantz, S; Kerkau, T; Beyersdorf, N; Hofmann, U				Gladow, Nadine; Hollmann, Claudia; Ramos, Gustavo; Frantz, Stefan; Kerkau, Thomas; Beyersdorf, Niklas; Hofmann, Ulrich			Treatment of mice with a ligand binding blocking anti-CD28 monoclonal antibody improves healing after myocardial infarction	PLOS ONE			English	Article							REGULATORY T-CELLS; IN-VIVO; HOMEOSTASIS; LYMPHOCYTES; ACTIVATION; PREVENTS; FIBROSIS	Both conventional and regulatory CD4(+) T-cells rely on costimulatory signals mediated by cell surface receptors including CD28 for full activation. We showed previously that stimulation of CD4(+) Foxp3(+) regulatory T-cells by superagonistic anti-CD28 monoclonal antibodies (mAb) improves myocardial healing after experimental myocardial infarction (MI). However, the effect of ligand binding blocking anti-CD28 monoclonal antibodies has not yet been tested in this context. We hypothesize that ligand blocking anti-CD28 mAb treatment might favorably impact on healing after MI by limiting the activation of conventional CD4(+) T-cells. Therefore, we studied the therapeutic effect of the recently characterized mAb E18 which blocks ligand binding to CD28 in a mouse permanent coronary ligation model. E18 or an irrelevant control mAb was applied once on day two after myocardial infarction to wildtype mice. Echocardiography was performed on day 7 after MI. E18 treatment improved the survival and reduced the incidence of left ventricular ruptures after experimental myocardial infarction. Accordingly, although we found no difference in infarct size, there was significantly less left ventricular dilation after E18 treatment in surviving animals as determined by echocardiography at day 7 after MI. In sham operated control mice neither antibody had an impact on body weight, survival, and echocardiographic parameters. Mechanistically, compared to control immunoglobulin, E18 treatment reduced the number of CD4(+) T-cells and monocytes/macrophages within the infarct and periinfarct zone on day 5. This was accompanied by an upregulation of arginase which is a marker for alternatively differentiated macrophages. The data indicate that CD28-dependent costimulation of CD4(+) T-cells impairs myocardial healing and anti-CD28 antibody treatment constitutes a potentially clinically translatable approach to improve the outcome early after MI.	[Gladow, Nadine; Ramos, Gustavo; Frantz, Stefan; Hofmann, Ulrich] Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany; [Hollmann, Claudia; Ramos, Gustavo; Frantz, Stefan; Hofmann, Ulrich] Univ Hosp Wurzburg, Dept Internal Med 1, Wurzburg, Germany; [Hollmann, Claudia; Kerkau, Thomas; Beyersdorf, Niklas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg	Gladow, N (corresponding author), Univ Hosp Wurzburg, Comprehens Heart Failure Ctr, Wurzburg, Germany.	Gladow_N@ukw.de	Frantz, Stefan/G-1723-2012; Kerkau, Thomas/ABE-8007-2020; Beyersdorf, Niklas/S-3845-2016	Beyersdorf, Niklas/0000-0002-9236-5415	Bundesministerium fur Bildung und Forschung [BMBF01 EO1004]; Deutsche Forschungsgemeinschaft [SFB688 TP A10]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by grants from the Bundesministerium fur Bildung und Forschung (BMBF01 EO1004 to S.F.) and by the Deutsche Forschungsgemeinschaft, SFB688 TP A10 (to S.F., U.H.).	Bansal SS, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.116.003688; Beyersdorf N, 2005, J EXP MED, V202, P445, DOI 10.1084/jem.20051060; Beyersdorf N, 2008, BLOOD, V112, P4328, DOI 10.1182/blood-2008-03-146662; Beyersdorf N, 2015, IMMUNOTARGETS THER, V4, P111, DOI 10.2147/ITT.S61647; Beyersdorf N, 2009, BLOOD, V114, P4575, DOI 10.1182/blood-2009-04-218248; Curtis MJ, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.106; Dillinger B, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01152; Gogishvili T, 2013, EUR J IMMUNOL, V43, P188, DOI 10.1002/eji.201242824; Gogishvili T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004643; Hofmann U, 2016, EUR HEART J, V37, P873, DOI 10.1093/eurheartj/ehv639; Hofmann U, 2015, CIRC RES, V116, P354, DOI 10.1161/CIRCRESAHA.116.304072; Hofmann U, 2012, CIRCULATION, V125, P1652, DOI 10.1161/CIRCULATIONAHA.111.044164; Kitazawa Y, 2009, CELL TRANSPLANT, V18, P627, DOI 10.1177/096368970901805-619; Kubota A, 2016, CIRC J, V80, P1971, DOI 10.1253/circj.CJ-16-0327; Lin CH, 2003, EUR J IMMUNOL, V33, P626, DOI 10.1002/eji.200323570; Mirenda V, 2007, BLOOD, V109, P2968, DOI 10.1182/blood-2006-10-050724; Nevers T, 2017, J EXP MED, V214, P3311, DOI 10.1084/jem.20161791; Poirier N, 2016, J IMMUNOL, V196, P274, DOI 10.4049/jimmunol.1501810; Raes G, 2005, J IMMUNOL, V174, P6561, DOI 10.4049/jimmunol.174.11.6561; Ramos G, 2016, J MOL CELL CARDIOL, V92, P41, DOI 10.1016/j.yjmcc.2016.01.018; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Saxena A, 2014, AM J PHYSIOL-HEART C, V307, pH1233, DOI 10.1152/ajpheart.00328.2014; Tabares P, 2014, EUR J IMMUNOL, V44, P1225, DOI 10.1002/eji.201343967; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; Win SJ, 2016, EUR J IMMUNOL, V46, P1193, DOI 10.1002/eji.201546104; Zhang R, 2013, J CLIN INVEST, V123, P580, DOI 10.1172/JCI65013	28	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0227734	10.1371/journal.pone.0227734	http://dx.doi.org/10.1371/journal.pone.0227734			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298302	Green Published, gold			2022-12-26	WOS:000536011400006
J	Seravalli, V; Maoloni, L; Pasquini, L; Bolzonella, S; Sisti, G; Petraglia, F; Di Tommaso, M				Seravalli, Viola; Maoloni, Lorenzo; Pasquini, Lucia; Bolzonella, Sara; Sisti, Giovanni; Petraglia, Felice; Di Tommaso, Mariarosaria			The impact of assisted reproductive technology on prenatally diagnosed fetal growth restriction in dichorionic twin pregnancies	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; PERINATAL OUTCOMES; NEONATAL OUTCOMES; CONCEPTION; RISK; SINGLETONS; IVF/ICSI; BIRTH	Objective Whether the use of assisted reproductive technologies (ART) affects the outcome of twin pregnancies is still a matter of debate. Previous studies have evaluated the association between birth weight and ART, without a clear distinction between fetal growth restriction (FGR), a condition at higher risk of adverse outcome, and constitutionally small for gestational age (SGA) fetuses. The aim of this study was to determine whether dichorionic (DC) twin pregnancies obtained by ART have a greater risk of developing FGR, defined by accurate ultrasound criteria, than those spontaneously conceived (SC), and to compare the severity of ultrasound features in the growth restricted fetuses. Methods A retrospective study was conducted on DC twin pregnancies delivered between 2010 to 2018 at a tertiary hospital. Twin pregnancies conceived spontaneously were compared with those obtained via in vitro fertilization (IVF) or intracytoplasmic sperm injection (ICSI), after exclusion of cases with major fetal or uterine malformations. The primary outcome was the incidence of FGR. Secondary outcome was the rate of SGA neonates, defined by a birth weight less than the 10th percentile. The ultrasound characteristics of the growth restricted fetuses in the two groups were also compared. The groups were compared using univariate and multivariate analyses. Results Six hundred and seventy-eight DC twin pregnancies were identified. Of these, 367 (54.1%) conceived via IVF/ICSI and 311 (45.9%) conceived spontaneously. The incidence of FGR was not significantly different between the ART and the SC groups (7.9% vs 8.4% respectively, p = 0.76, adjusted OR 0.84, 95% CI 0.53-1.32). Growth restricted fetuses of the two groups showed similar occurrence of an estimated fetal weight less than the 3rd percentile, similar abnormalities in Doppler studies and similar gestational age at diagnosis. There was no difference in the incidence of delivery of an SGA neonate (p = 0.47) or in the rate of maternal complications and preterm delivery between the groups. Conclusions Twin pregnancies conceived by assisted reproductive technologies do not have a higher risk of ultrasound-diagnosed FGR than spontaneously conceived twin pregnancies, and fetuses diagnosed with growth restriction in the two groups show similar severity of the ultrasound findings.	[Seravalli, Viola; Maoloni, Lorenzo; Di Tommaso, Mariarosaria] Univ Florence, Dept Hlth Sci, Florence, Italy; [Pasquini, Lucia] Careggi Univ Hosp, Dept Obstet & Gynecol, Fetal Med Unit, Florence, Italy; [Bolzonella, Sara; Petraglia, Felice] Univ Florence, Dept Clin & Expt Biomed Sci, Florence, Italy; [Sisti, Giovanni] Lincoln Med & Mental Hlth Ctr, Dept Obstet & Gynecol, Bronx, NY 10451 USA	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence	Seravalli, V (corresponding author), Univ Florence, Dept Hlth Sci, Florence, Italy.	viola.seravalli@unifi.it	Sisti, Giovanni/J-1174-2014	Sisti, Giovanni/0000-0003-4152-0603; Seravalli, Viola/0000-0001-8706-3925				Bensdorp AJ, 2016, FERTIL STERIL, V106, P371, DOI 10.1016/j.fertnstert.2016.03.042; Berntsen S, 2019, HUM REPROD UPDATE, V25, P137, DOI 10.1093/humupd/dmz001; Bertino E, 2010, J PEDIATR GASTR NUTR, V51, P353, DOI 10.1097/MPG.0b013e3181da213e; D'Angelo DV, 2011, FERTIL STERIL, V96, P314, DOI 10.1016/j.fertnstert.2011.05.073; DeLuca L M, 2013, J Neonatal Perinatal Med, V6, P217, DOI 10.3233/NPM-1370613; Fan CF, 2013, INT J CLIN EXP PATHO, V6, P2199; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Geisler ME, 2014, EUR J OBSTET GYN R B, V181, P78, DOI 10.1016/j.ejogrb.2014.07.033; Gordijn SJ, 2016, ULTRASOUND OBST GYN, V48, P333, DOI 10.1002/uog.15884; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Khalil A, 2019, ULTRASOUND OBST GYN, V53, P47, DOI 10.1002/uog.19013; Khalil A, 2016, ULTRASOUND OBST GYN, V47, P247, DOI 10.1002/uog.15821; Lewi L, 2010, FETAL DIAGN THER, V27, P121, DOI 10.1159/000313300; McGovern PG, 2004, FERTIL STERIL, V82, P1514, DOI 10.1016/j.fertnstert.2004.06.038; Moini A, 2012, EUR J OBSTET GYN R B, V165, P29, DOI 10.1016/j.ejogrb.2012.07.008; Nassar AH, 2003, AM J OBSTET GYNECOL, V189, P513, DOI 10.1067/S0002-9378(03)00485-X; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Pinborg A, 2004, ACTA OBSTET GYN SCAN, V83, P75, DOI 10.1111/j.1600-0412.2004.00279.x; Qin JB, 2016, FERTIL STERIL, V105, P1180, DOI 10.1016/j.fertnstert.2015.12.131; Seravalli V, 2015, OBSTET GYN CLIN N AM, V42, P275, DOI 10.1016/j.ogc.2015.01.005; Vasario E, 2010, REPROD BIOMED ONLINE, V21, P422, DOI 10.1016/j.rbmo.2010.04.007; Yang H, 2011, TWIN RES HUM GENET, V14, P98, DOI 10.1375/twin.14.1.98	23	2	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231028	10.1371/journal.pone.0231028	http://dx.doi.org/10.1371/journal.pone.0231028			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298277	Green Published, gold			2022-12-26	WOS:000536011400025
J	Fonseca, M; Gasparutto, X; Leboeuf, F; Dumas, R; Armand, S				Fonseca, Mickael; Gasparutto, Xavier; Leboeuf, Fabien; Dumas, Raphael; Armand, Stephane			Impact of knee marker misplacement on gait kinematics of children with cerebral palsy using the Conventional Gait Model-A sensitivity study	PLOS ONE			English	Article							FEMORAL ANTEVERSION; STEREOPHOTOGRAMMETRY; RELIABILITY; AXIS	Clinical gait analysis is widely used in clinical routine to assess the function of patients with motor disorders. The proper assessment of the patient's function relies greatly on the repeatability between the measurements. Marker misplacement has been reported as the largest source of variability between measurements and its impact on kinematics is not fully understood. Thus, the purpose of this study was: 1) to evaluate the impact of the misplacement of the lateral femoral epicondyle marker on lower limb kinematics, and 2) evaluate if such impact can be predicted. The kinematic data of 10 children with cerebral palsy and 10 aged-match typical developing children were included. The lateral femoral epicondyle marker was virtually misplaced around its measured position at different magnitudes and directions. The outcome to represent the impact of each marker misplacement on the lower limb was the root mean square deviations between the resultant kinematics from each simulated misplacement and the originally calculated kinematics. Correlation and regression equations were estimated between the root mean square deviation and the magnitude of the misplacement expressed in percentage of leg length. Results indicated that the lower-limb kinematics is highly sensitive to the lateral femoral epicondyle marker misplacement in the anterior-posterior direction. The joint angles most impacted by the anterior-posterior misplacement were the hip internal-external rotation (5.3 degrees per 10 mm), the ankle internal-external rotation (4.4 degrees per 10 mm) and the knee flexion-extension (4.2 degrees per 10 mm). Finally, it was observed that the lower the leg length, the higher the impact of misplacement on kinematics. This impact was predicted by regression equations using the magnitude of mis-placement expressed in percentage of leg length. An error below 5 degrees on all joints requires a marker placement repeatability under 1.2% of the leg length. In conclusion, the placement of the lateral femoral epicondyle marker in the antero-posterior direction plays a crucial role on the reliability of gait measurements with the Conventional Gait Model.	[Fonseca, Mickael; Gasparutto, Xavier; Armand, Stephane] Geneva Univ Hosp, Lab Kinesiol Willy Taillard, Geneva, Switzerland; [Fonseca, Mickael; Gasparutto, Xavier; Armand, Stephane] Univ Geneva, Geneva, Switzerland; [Fonseca, Mickael; Dumas, Raphael] Univ Claude Bernard Lyon 1, Univ Lyon, IFSTTAR, LBMC,UMR T9406, Lyon, France; [Leboeuf, Fabien] Univ Salford, Sch Hlth & Soc, Salford, Lancs, England; [Leboeuf, Fabien] Nantes Hosp, PHU10, Rehabil Serv, Nantes, France	University of Geneva; University of Geneva; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet; Universite Gustave-Eiffel; University of Salford; Nantes Universite; CHU de Nantes	Fonseca, M (corresponding author), Geneva Univ Hosp, Lab Kinesiol Willy Taillard, Geneva, Switzerland.; Fonseca, M (corresponding author), Univ Geneva, Geneva, Switzerland.; Fonseca, M (corresponding author), Univ Claude Bernard Lyon 1, Univ Lyon, IFSTTAR, LBMC,UMR T9406, Lyon, France.	Mickael.CardosoFonseca@hcuge.ch	Dumas, Raphael/H-2281-2018; ARMAND, Stephane/Q-4395-2016	Dumas, Raphael/0000-0002-0368-8248; ARMAND, Stephane/0000-0001-9144-4982; Gasparutto, Xavier/0000-0001-8617-6522; Fonseca, Mickael/0000-0002-9272-3921; Leboeuf, Fabien/0000-0002-6483-9150	Swiss National Fond [CRSII5_177179]	Swiss National Fond(Swiss National Science Foundation (SNSF))	MF, CRSII5_177179, Swiss National Fond, http://www.snf.ch/en/Pages/default.aspx, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. XG, The author(s) received no specific funding for this work. FL, The author(s) received no specific funding for this work. RD, The author(s) received no specific funding for this work. SA, CRSII5_177179, Swiss National Fond, http://www.snf.ch/en/Pages/default.aspx, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman D.G., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; Armand S, 2016, EFORT OPEN REV, V1, P448, DOI 10.1302/2058-5241.1.000052; Baker R, 1999, HUM MOVEMENT SCI, V18, P655, DOI 10.1016/S0167-9457(99)00027-5; Baker R., 2017, HDB HUM MOTION; Besier TF, 2003, J BIOMECH, V36, P1159, DOI 10.1016/S0021-9290(03)00087-3; Boyer E, 2016, GAIT POSTURE, V50, P223, DOI 10.1016/j.gaitpost.2016.09.004; Camomilla V, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0396-x; Chiari L, 2005, GAIT POSTURE, V21, P197, DOI 10.1016/j.gaitpost.2004.04.004; Davids JR, 2002, J PEDIATR ORTHOPED, V22, P173, DOI 10.1097/00004694-200203000-00007; DAVIS RB, 1991, HUM MOVEMENT SCI, V10, P575, DOI 10.1016/0167-9457(91)90046-Z; Della Croce U, 1999, MED BIOL ENG COMPUT, V37, P155, DOI 10.1007/BF02513282; Della Croce U, 2005, GAIT POSTURE, V21, P226, DOI 10.1016/j.gaitpost.2004.05.003; Gorton GE, 2009, GAIT POSTURE, V29, P398, DOI 10.1016/j.gaitpost.2008.10.060; Groen BE, 2012, GAIT POSTURE, V35, P517, DOI 10.1016/j.gaitpost.2011.11.019; Jan SV, 2005, CLIN BIOMECH, V20, P659, DOI 10.1016/j.clinbiomech.2005.02.002; Jensen E, 2016, J BIOMECH, V49, P1698, DOI 10.1016/j.jbiomech.2016.03.046; KADABA MP, 1990, J ORTHOP RES, V8, P383, DOI 10.1002/jor.1100080310; Leboeuf F, 2019, GAIT POSTURE, V69, P126, DOI 10.1016/j.gaitpost.2019.01.034; Marin F, 2003, HUM MOVEMENT SCI, V22, P285, DOI 10.1016/S0167-9457(03)00036-8; McGinley JL, 2009, GAIT POSTURE, V29, P360, DOI 10.1016/j.gaitpost.2008.09.003; Naaim A, 2019, GAIT POSTURE, V72, P34, DOI 10.1016/j.gaitpost.2019.05.013; Osis ST, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147111; Pohl MB, 2010, GAIT POSTURE, V32, P559, DOI 10.1016/j.gaitpost.2010.07.020; Schache AG, 2006, GAIT POSTURE, V24, P100, DOI 10.1016/j.gaitpost.2005.08.002; Szczerbik E, 2011, ACTA BIOENG BIOMECH, V13, P43; Wilken JM, 2012, GAIT POSTURE, V35, P301, DOI 10.1016/j.gaitpost.2011.09.105; Wren TAL, 2011, GAIT POSTURE, V34, P149, DOI 10.1016/j.gaitpost.2011.03.027	29	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232064	10.1371/journal.pone.0232064	http://dx.doi.org/10.1371/journal.pone.0232064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330162	Green Published, gold, Green Submitted			2022-12-26	WOS:000536647300048
J	So, AR; Si, JM; Lopez, D; Pellegrini, M				So, Alexandra Renee; Si, Jeong Min; Lopez, David; Pellegrini, Matteo			Molecular signatures for inflammation vary across cancer types and correlate significantly with tumor stage, sex and vital status of patients	PLOS ONE			English	Article							BREAST-CANCER; RISK; CLASSIFICATION; SUBTYPES	Cancer affects millions of individuals worldwide. One shortcoming of traditional cancer classification systems is that, even for tumors affecting a single organ, there is significant molecular heterogeneity. Precise molecular classification of tumors could be beneficial in personalizing patients' therapy and predicting prognosis. To this end, here we propose to use molecular signatures to further refine cancer classification. Molecular signatures are collections of genes characterizing particular cell types, tissues or disease. Signatures can be used to interpret expression profiles from heterogeneous samples. Large collections of gene signatures have previously been cataloged in the MSigDB database. We have developed a web-based Signature Visualization Tool (SaVanT) to display signature scores in user-generated expression data. Here we have undertaken a systematic analysis of correlations between inflammatory signatures and cancer samples, to test whether inflammation can differentiate cancer types. Inflammatory response signatures were obtained from MsigDB and SaVanT and a signature score was computed for samples associated with 7 different cancer types. We first identified types of cancers that had high inflammation levels as measured by these signatures. The correlation between signature scores and metadata of these patients (sex, age at initial cancer diagnosis, cancer stage, and vital status) was then computed. We sought to evaluate correlations between inflammation with other clinical parameters and identified four cancer types that had statistically significant association (p-value < 0.05) with at least one clinical characteristic: pancreas adenocarcinoma (PAAD), cholangiocarcinoma (CHOL), kidney chromophobe (KICH), and uveal melanoma (UVM). These results may allow future studies to use these approaches to further refine cancer sub-typing and ultimately treatment.	[So, Alexandra Renee; Si, Jeong Min; Lopez, David; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Lopez, David] Gilead Pharmaceut, Foster City, CA USA	University of California System; University of California Los Angeles	So, AR (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	lexidragon.so@gmail.com		So, Alexandra/0000-0001-6890-8566	Gilead Pharmaceuticals	Gilead Pharmaceuticals(Gilead Sciences)	The author(s) received no specific funding for this work. David Lopez is employed by Gilead Pharmaceuticals. Gilead Pharmaceuticals provided support in the form of salary for author DL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section."	Bierie B, 2008, CANCER RES, V68, P1809, DOI 10.1158/0008-5472.CAN-07-5597; Choi Wook Jin, 2014, Clin Nutr Res, V3, P75, DOI 10.7762/cnr.2014.3.2.75; Fang XX, 2015, EUR J CANCER, V51, P2820, DOI 10.1016/j.ejca.2015.09.010; Ford AC, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3174; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Institute B, 2004, GEN SET HALLMARK INF; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Killock David, 2015, Nat Rev Clin Oncol, V12, P502, DOI 10.1038/nrclinonc.2015.111; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lopez D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4167-7; Malhotra GK, 2010, CANCER BIOL THER, V10, P955, DOI 10.4161/cbt.10.10.13879; Munigala S, 2014, CLIN GASTROENTEROL H, V12, P1143, DOI 10.1016/j.cgh.2013.12.033; Pedraza V, 2010, CANCER-AM CANCER SOC, V116, P486, DOI 10.1002/cncr.24805; Proctor RN, 2001, NAT REV CANCER, V1, P82, DOI 10.1038/35094091; Pusztai L, 2006, ONCOLOGIST, V11, P868, DOI 10.1634/theoncologist.11-8-868; Raimondi S, 2010, BEST PRACT RES CL GA, V24, P349, DOI 10.1016/j.bpg.2010.02.007; Rajput Sandeep, 2010, Front Biosci (Schol Ed), V2, P176; Santos GD, 2011, ANNU REV PATHOL-MECH, V6, P49, DOI 10.1146/annurev-pathol-011110-130206; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shacter E, 2002, ONCOLOGY-NY, V16, P217; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Song QX, 2015, HUM GENOMICS, V9, DOI 10.1186/s40246-015-0049-8; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Triantafillidis JK, 2009, ANTICANCER RES, V29, P2727; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Zellmer VR, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-69	27	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0221545	10.1371/journal.pone.0221545	http://dx.doi.org/10.1371/journal.pone.0221545			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330128	Green Published, Green Submitted, gold			2022-12-26	WOS:000536647300002
J	Nissim, Y; Shloberg, M; Biton, I; Many, Y; Doron-Faigenboim, A; Zemach, H; Hovav, R; Kerem, Z; Avidan, B; Ben-Ari, G				Nissim, Yael; Shloberg, Maya; Biton, Iris; Many, Yair; Doron-Faigenboim, Adi; Zemach, Hanita; Hovav, Ran; Kerem, Zohar; Avidan, Benjamin; Ben-Ari, Giora			High temperature environment reduces olive oil yield and quality	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; FRUIT-GROWTH; HEAT-STRESS; SEASON TEMPERATURES; CELLULAR PROCESSES; IRRIGATION; ACCUMULATION; CULTIVARS; ATTRIBUTES; TOLERANCE	Global warming is predicted to have a negative effect on plant growth due to the damaging effect of high temperatures. In order to address the effect of high temperature environments on olive oil yield and quality, we compared its effect on the fruit development of five olive cultivars placed in a region noted for its high summer temperatures, with trees of the same cultivars placed in a region of relatively mild summers. We found that the effects of a high temperature environment are genotype dependent and in general, high temperatures during fruit development affected three important traits: fruit weight, oil concentration and oil quality. None of the tested cultivars exhibited complete heat stress tolerance. Final dry fruit weight at harvest of the 'Barnea' cultivar was not affected by the high temperature environment, whereas the 'Koroneiki', 'Coratina', 'Souri' and 'Picholine' cultivars exhibited decreased dry fruit weight at harvest in response to higher temperatures by 0.2, 1, 0.4 and 0.2 g respectively. The pattern of final oil concentration was also cultivar dependent, 'Barnea', 'Coratina' and 'Picholine' not being affected by the high temperature environment, whereas the 'Koroneiki' and 'Souri' cultivars showed a decreased dry fruit oil concentration at harvest under the same conditions by 15 and 8% respectively. Regarding the quality of oil produced, the 'Souri' cultivar proved more tolerant to a high temperature environment than any other of the cultivars analyzed in this study. These results suggest that different olive cultivars have developed a variety of mechanisms in dealing with high temperatures. Elucidation of the mechanism of each of these responses may open the way to development of a variety of olives broadly adapted to conditions of high temperatures.	[Nissim, Yael; Shloberg, Maya; Biton, Iris; Many, Yair; Doron-Faigenboim, Adi; Zemach, Hanita; Hovav, Ran; Avidan, Benjamin; Ben-Ari, Giora] ARO, Volcani Ctr, Inst Plant Sci, Rishon Leziyyon, Israel; [Shloberg, Maya; Kerem, Zohar] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Inst Biochem Food Sci & Nutr, Rehovot, Israel	VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH; Hebrew University of Jerusalem	Ben-Ari, G (corresponding author), ARO, Volcani Ctr, Inst Plant Sci, Rishon Leziyyon, Israel.	giora@agri.gov.il			Israeli Ministry of Agriculture and Rural Development [2031170]	Israeli Ministry of Agriculture and Rural Development	This work was supported by a grant (No. 2031170) of the Israeli Ministry of Agriculture and Rural Development to GB.	Alagna F, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-162; Alowaiesh B, 2018, SCI HORTIC-AMSTERDAM, V234, P74, DOI 10.1016/j.scienta.2018.02.017; Atkinson CJ, 1998, SCI HORTIC-AMSTERDAM, V75, P59, DOI 10.1016/S0304-4238(98)00117-4; Austin PT, 1999, ANN BOT-LONDON, V83, P129, DOI 10.1006/anbo.1998.0804; Barnabas B, 2008, PLANT CELL ENVIRON, V31, P11, DOI 10.1111/j.1365-3040.2007.01727.x; Bellincontro A, 2013, J SCI FOOD AGR, V93, P1259, DOI 10.1002/jsfa.5899; Bertin N, 2005, ANN BOT-LONDON, V95, P439, DOI 10.1093/aob/mci042; Bita CE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00273; Breton C, 2009, OCL OILS FAT CROP LI, V16, P58, DOI 10.1051/ocl.2009.0236; Camejo D, 2005, J PLANT PHYSIOL, V162, P281, DOI 10.1016/j.jplph.2004.07.014; Cirilli M, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00717; Conde C, 2008, J PLANT PHYSIOL, V165, P1545, DOI 10.1016/j.jplph.2008.04.018; Dag A, 2008, J SCI FOOD AGR, V88, P1524, DOI 10.1002/jsfa.3243; Dag A, 2015, J SCI FOOD AGR, V95, P2016, DOI 10.1002/jsfa.6913; Fahad S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01147; Fahad S, 2016, PLANT PHYSIOL BIOCH, V103, P191, DOI 10.1016/j.plaphy.2016.03.001; Fanwoua J, 2012, J AM SOC HORTIC SCI, V137, P294, DOI 10.21273/JASHS.137.5.294; Ferris R, 1998, ANN BOT-LONDON, V82, P631, DOI 10.1006/anbo.1998.0740; Galla G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-128; Garcia-Inza GP, 2018, SCI HORTIC-AMSTERDAM, V227, P305, DOI 10.1016/j.scienta.2017.09.030; Garcia-Inza GP, 2014, EUR J AGRON, V54, P107, DOI 10.1016/j.eja.2013.12.005; Goldental-Cohen S, 2019, J HORTIC SCI BIOTECH, V94, P488, DOI 10.1080/14620316.2018.1562313; Gomez-Rico A, 2006, J AGR FOOD CHEM, V54, P7130, DOI 10.1021/jf060798r; Gray SB, 2016, DEV BIOL, V419, P64, DOI 10.1016/j.ydbio.2016.07.023; Gucci R, 2009, TREE PHYSIOL, V29, P1575, DOI 10.1093/treephys/tpp086; Guy Charles, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P231; Hammami SBM, 2011, SCI HORTIC-AMSTERDAM, V130, P445, DOI 10.1016/j.scienta.2011.07.018; Hartmann H, 1949, P AM SOC HORTIC SCI; HARTMANN HT, 1949, P AM SOC HORTIC SCI, V54, P86; Inglese P, 1996, J HORTIC SCI, V71, P257, DOI 10.1080/14620316.1996.11515404; Ismail AM, 1999, CROP SCI, V39, P1762, DOI 10.2135/cropsci1999.3961762x; Jones R., 2000, BIOCH MOL BIOL PLANT, P1158, DOI DOI 10.12691/WJAR-2-2-2; LAVEE S, 1991, J HORTIC SCI, V66, P583, DOI 10.1080/00221589.1991.11516187; Lavee S., 1986, HDB FRUIT SET DEV, P261; Lechaudel M, 2005, TREE PHYSIOL, V25, P583, DOI 10.1093/treephys/25.5.583; Lombardo N., 2008, Advances in Horticultural Science, V22, P49; Hernandez ML, 2011, PHYTOCHEMISTRY, V72, P178, DOI 10.1016/j.phytochem.2010.11.026; Maestri E, 2002, PLANT MOL BIOL, V48, P667, DOI 10.1023/A:1014826730024; Mailer RJ, 2010, J AM OIL CHEM SOC, V87, P877, DOI 10.1007/s11746-010-1608-8; Marsh KB, 1999, J HORTIC SCI BIOTECH, V74, P443, DOI 10.1080/14620316.1999.11511135; Mateos R, 2001, J AGR FOOD CHEM, V49, P2185, DOI 10.1021/jf0013205; Matteucci M, 2011, J EXP BOT, V62, P3403, DOI 10.1093/jxb/err013; Miserere A, 2018, ACTA HORTIC, V1199, P523, DOI 10.17660/ActaHortic.2018.1199.83; Mougiou N, 2018, PLANT PHYSIOL BIOCH, V128, P41, DOI 10.1016/j.plaphy.2018.05.004; Garcia-Inza GP, 2016, EUR J AGRON, V76, P138, DOI 10.1016/j.eja.2016.03.003; Prasad PVV, 1999, ANN BOT-LONDON, V84, P381, DOI 10.1006/anbo.1999.0926; Rainey KM, 2005, GENET RESOUR CROP EV, V52, P117, DOI 10.1007/s10722-004-1811-2; Rallo P, 2001, J HORTIC SCI BIOTECH, V76, P408, DOI 10.1080/14620316.2001.11511385; Rondanini DP, 2014, EUR J AGRON, V52, P237, DOI 10.1016/j.eja.2013.09.002; Schaefer S, 2005, FREEFORM CURVES SPHE; Servili M., 2013, Options Mediterraneennes. Serie A, Seminaires Mediterraneens, P55; Servili M, 2007, J AGR FOOD CHEM, V55, P6609, DOI 10.1021/jf070599n; Tombesi A, 1994, HORTICULTURAL SCI; Tovar MJ, 2002, J SCI FOOD AGR, V82, P892, DOI 10.1002/jsfa.1122; Trentacoste ER, 2012, EUR J AGRON, V38, P83, DOI 10.1016/j.eja.2012.01.001; van der Merwe Rouxlene, 2015, South African Journal of Plant and Soil, V32, P121, DOI 10.1080/02571862.2015.1018354; Vollenweider P, 2005, ENVIRON POLLUT, V137, P455, DOI 10.1016/j.envpol.2005.01.032; WEIS E, 1988, SYM SOC EXP BIOL, V42, P329; Wilhelm EP, 1999, CROP SCI, V39, P1733, DOI 10.2135/cropsci1999.3961733x	59	20	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231956	10.1371/journal.pone.0231956	http://dx.doi.org/10.1371/journal.pone.0231956			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324774	Green Published, gold			2022-12-26	WOS:000536033700049
J	Liao, C; Pang, N; Liu, ZJ; Lei, L				Liao, Chen; Pang, Nan; Liu, Zhaojun; Lei, Lei			Transient inhibition of rDNA transcription in donor cells improves ribosome biogenesis and preimplantation development of embryos derived from somatic cell nuclear transfer	FASEB JOURNAL			English	Article						cx5461; mTOR inhibitor; nucleolar rebuilding; rDNA transcription; SCNT	RNA GENES; SCNT EMBRYOS; NUCLEOLAR; EXPRESSION	Ribosomal DNA (rDNA) transcription is a limiting step in ribosome biogenesis, crucial for protein synthesis and cell growth-especially at the early stages of embryonic development-and is regulated in a mammalian target of rapamycin (mTOR)-dependent manner. Our previous report demonstrated that treatment with mTOR inhibitors during artificial embryonic activation improved the development of embryos derived from somatic cell nuclear transfer (SCNT). We hypothesize that inhibition of ribosome biogenesis in somatic cells facilitates reactivation of embryonic nucleolar establishment and ribosome biogenesis in SCNT embryos. Herein, we show that mTOR inhibitors suppressed ribosome biogenesis in somatic cells, and more importantly, improved development potential of SCNT embryos (blastocyst rate, 34% vs 24%). SCNT embryos derived from drug-treated somatic cells exhibited higher levels of 47S, 18S, and 5S rRNAs, upstream binding factor (UBF) mRNA, ribosomal protein S6; they also improved the rebuilding of the nucleolar ultrastructure. In addition, treatment of donor cells with the RNA polymerase I (Pol I) inhibitor cx5461 caused similar effects on SCNT embryos. These results indicated that transient inhibition of rDNA transcription in donor cells facilitated the establishment of functional nucleoli and improved preimplantation development of SCNT embryos.	[Liao, Chen; Pang, Nan; Liu, Zhaojun; Lei, Lei] Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China	Harbin Medical University	Lei, L (corresponding author), Harbin Med Univ, Dept Histol & Embryol, Harbin 150081, Peoples R China.	leiys2002@yahoo.com	liu, zhao/GXV-6141-2022	Lei, Lei/0000-0001-5372-8749; Liao, Chen/0000-0003-1759-4178	National Natural Science Foundation of China (NSFC) [31671545]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31671545	Bai GY, 2018, ZYGOTE, V26, P24, DOI 10.1017/S0967199417000673; Baran V, 2003, ZYGOTE, V11, P271, DOI 10.1017/S0967199403002326; Baran V, 2002, BIOL REPROD, V66, P534, DOI 10.1095/biolreprod66.2.534; Brombin A, 2015, CURR OPIN GENET DEV, V34, P61, DOI 10.1016/j.gde.2015.07.006; Chauvin C, 2014, ONCOGENE, V33, P474, DOI 10.1038/onc.2012.606; Chung YG, 2015, CELL STEM CELL, V17, P758, DOI 10.1016/j.stem.2015.10.001; Donati G, 2012, CANCER RES, V72, P1602, DOI 10.1158/0008-5472.CAN-11-3992; Drygin D, 2011, CANCER RES, V71, P1418, DOI 10.1158/0008-5472.CAN-10-1728; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Eckardt S, 2004, ANIM REPROD SCI, V82-3, P97, DOI 10.1016/j.anireprosci.2004.04.017; ENGEL W, 1977, HUM GENET, V38, P57, DOI 10.1007/BF00295808; Grummt I, 1999, PROG NUCLEIC ACID RE, V62, P109; Grummt I, HUM MOL GEN, V16, pR21; Hai T, 2011, CELL REPROGRAM, V13, P47, DOI 10.1089/cell.2010.0042; Iadevaia V, 2012, NUCLEIC ACIDS RES, V40, P2527, DOI 10.1093/nar/gkr1040; Kanka J, 1999, MOL REPROD DEV, V52, P253, DOI 10.1002/(SICI)1098-2795(199903)52:3&lt;253::AID-MRD2&gt;3.0.CO;2-N; King WA, 1996, MOL REPROD DEV, V44, P499, DOI 10.1002/(SICI)1098-2795(199608)44:4&lt;499::AID-MRD10&gt;3.0.CO;2-U; Laurincik J, 2007, ADV EXP MED BIOL, V591, P84; Lin CJ, 2014, DEV CELL, V30, P268, DOI 10.1016/j.devcel.2014.06.022; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; Murano K, 2008, MOL CELL BIOL, V28, P3114, DOI 10.1128/MCB.02078-07; Russell J, 2005, TRENDS BIOCHEM SCI, V30, P87, DOI 10.1016/j.tibs.2004.12.008; Sanij E, 2015, GENOME RES, V25, P201, DOI 10.1101/gr.176115.114; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Schlesinger S, 2009, GENE DEV, V23, P2437, DOI 10.1101/gad.544509; Shen XH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17829; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Song YR, 2014, PROTEIN CELL, V5, P382, DOI 10.1007/s13238-014-0034-3; SPECTOR DL, 1984, CHROMOSOMA, V90, P139, DOI 10.1007/BF00292451; Svarcova O, 2009, MOL REPROD DEV, V76, P132, DOI 10.1002/mrd.20936; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Zhai YH, 2018, MOL REPROD DEV, V85, P26, DOI 10.1002/mrd.22935; Zhao QS, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0369-1; Zheng Z, 2012, J BIOL CHEM, V287, P19949, DOI 10.1074/jbc.M112.355099; Zhou C, 2019, FASEB J, V33, P4638, DOI 10.1096/fj.201801887R	37	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8283	8295		10.1096/fj.202000025RR	http://dx.doi.org/10.1096/fj.202000025RR		APR 2020	13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32323360				2022-12-26	WOS:000528405000001
J	Zhao, Y; Louie, KW; Tingle, CF; Sha, C; Heisel, CJ; Unsworth, SP; Kish, PE; Kahana, A				Zhao, Yi; Louie, Ke'ale W.; Tingle, Christina F.; Sha, Cuilee; Heisel, Curtis J.; Unsworth, Shelby P.; Kish, Phillip E.; Kahana, Alon			Twist3 is required for dedifferentiation during extraocular muscle regeneration in adult zebrafish	PLOS ONE			English	Article							RETINOIC ACID; GENE-TRANSFER; EXPRESSION; CELLS; ELECTROPORATION; ROLES; FGF; PROTEIN; TISSUE; MODEL	Severely damaged adult zebrafish extraocular muscles (EOMs) regenerate through dedifferentiation of residual myocytes involving a muscle-to-mesenchyme transition. Members of the Twist family of basic helix-loop-helix transcription factors (TFs) are key regulators of the epithelial-mesenchymal transition (EMT) and are also involved in craniofacial development in humans and animal models. During zebrafish embryogenesis, twist family members (twist1a, twist1b, twist2, and twist3) function to regulate craniofacial skeletal development. Because of their roles as master regulators of stem cell biology, we hypothesized that twist TFs regulate adult EOM repair and regeneration. In this study, utilizing an adult zebrafish EOM regeneration model, we demonstrate that inhibiting twist3 function using translationblocking morpholino oligonucleotides (MOs) impairs muscle regeneration by reducing myocyte dedifferentiation and proliferation in the regenerating muscle. This supports our hypothesis that twist TFs are involved in the early steps of dedifferentiation and highlights the importance of twist3 during EOM regeneration.	[Zhao, Yi; Tingle, Christina F.; Sha, Cuilee; Heisel, Curtis J.; Unsworth, Shelby P.; Kish, Phillip E.; Kahana, Alon] Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Louie, Ke'ale W.] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhao, Y; Kahana, A (corresponding author), Univ Michigan, Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.	zhaoziw@umich.edu; alonk123@gmail.com		Unsworth, Shelby/0000-0003-2719-8187; Kahana, Alon/0000-0002-5667-2274	University of Michigan Forbes Cancer Research Institute; Research to Prevent Blindness, Inc. (RPB); NEI of the NIH [R01 EY022633]; RPB; Cancer Center Research Core [P30 CA046592]; Mrs. William Davidson Emerging Scholar Award from the A. Alfred Taubman Medical Research Institute; NIH NCRR [P40 RR012546]; Vision Research Core [P30 EY007003]	University of Michigan Forbes Cancer Research Institute; Research to Prevent Blindness, Inc. (RPB)(Research to Prevent Blindness (RPB)); NEI of the NIH; RPB; Cancer Center Research Core; Mrs. William Davidson Emerging Scholar Award from the A. Alfred Taubman Medical Research Institute; NIH NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Vision Research Core	This study was supported by: the University of Michigan Forbes Cancer Research Institute, https://www.rogelcancercenter.org/ForbesInstitute a Physician-Scientist Award from Research to Prevent Blindness, Inc. (RPB), https://www.rpbusa.org/rpb/? grant R01 EY022633 from the NEI of the NIH (to AK), https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-eye-institute-nei and an unrestricted grant from RPB to the Department of Ophthalmology and Visual Sciences. This research utilized the Vision Research Core (P30 EY007003), and the Cancer Center Research Core (P30 CA046592). AK is supported by the Mrs. William Davidson Emerging Scholar Award from the A. Alfred Taubman Medical Research Institute. https://www.taubmaninstitute.org/The Zebrafish International Resource Center is supported by grant P40 RR012546 from the NIH NCRR. http://www.ncrr.nih.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara H, 1998, NAT BIOTECHNOL, V16, P867, DOI 10.1038/nbt0998-867; BATE M, 1991, DEVELOPMENT, V113, P79; Bohnsack BL, 2013, DEV BIOL, V373, P300, DOI 10.1016/j.ydbio.2012.11.005; Carlson BM, 2003, DEV DYNAM, V226, P167, DOI 10.1002/dvdy.10223; Castanon I, 2001, DEVELOPMENT, V128, P3145; Cripps RM, 1998, DEV BIOL, V203, P106, DOI 10.1006/dbio.1998.9040; Dahm R., 2002, ZEBRAFISH PRACTICAL; Das A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002710; Eisen JS, 2008, DEVELOPMENT, V135, P1735, DOI 10.1242/dev.001115; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Garg K, 2015, J ORTHOP RES, V33, P40, DOI 10.1002/jor.22730; Gemberling M, 2013, TRENDS GENET, V29, P611, DOI 10.1016/j.tig.2013.07.003; Germanguz I, 2012, J APPL ICHTHYOL, V28, P364, DOI 10.1111/j.1439-0426.2012.02016.x; Germanguz I, 2007, DEV DYNAM, V236, P2615, DOI 10.1002/dvdy.21267; Gitelman I, 2007, MOL BIOL EVOL, V24, P1912, DOI 10.1093/molbev/msm120; Glackin CA, 2018, ENZYMES, P83, DOI 10.1016/bs.enz.2018.08.004; Gong XQ, 2002, J BIOL CHEM, V277, P12310, DOI 10.1074/jbc.M110228200; Gronthos S, 2019, ROADMAP TO NONHEMATOPOIETIC STEM CELL-BASED THERAPEUTICS: FROM THE BENCH TO THE CLINIC, P15, DOI 10.1016/B978-0-12-811920-4.00002-1; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Hyde DR, 2012, JOVE-J VIS EXP, DOI 10.3791/3632; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Jung HY, 2015, CELL STEM CELL, V16, P1, DOI 10.1016/j.stem.2014.12.005; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kim J, 2010, P NATL ACAD SCI USA, V107, P17206, DOI 10.1073/pnas.0915016107; Kim MS, 2019, CELL DEATH DIFFER, V26, P2594, DOI 10.1038/s41418-019-0322-9; Kronenberg HM, 2004, DEV CELL, V6, P317, DOI 10.1016/S1534-5807(04)00069-3; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Laumonier Thomas, 2016, J Exp Orthop, V3, P15, DOI 10.1186/s40634-016-0051-7; Le Douarin NM, 2004, DEVELOPMENT, V131, P4637, DOI 10.1242/dev.01350; Lee Y, 2010, DIS MODEL MECH, V3, P496, DOI 10.1242/dmm.004515; Li JL, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-49; Li N, 2010, DEVELOPMENT, V137, P389, DOI 10.1242/dev.044164; Liu N, 2017, NAT CELL BIOL, V19, P202, DOI 10.1038/ncb3477; Mahmoud MM, 2016, CIRC RES, V119, P450, DOI 10.1161/CIRCRESAHA.116.308870; Mastroyiannopoulos NP, 2013, BIOSCIENCE REP, V33, P903, DOI 10.1042/BSR20130068; McMahon JM, 2004, BIODRUGS, V18, P155, DOI 10.2165/00063030-200418030-00002; Missinato MA, 2015, CARDIOVASC RES, V107, P487, DOI 10.1093/cvr/cvv190; Moyer AL, 2011, CURR OPIN RHEUMATOL, V23, P568, DOI 10.1097/BOR.0b013e32834bac92; MURRE C, 1994, BBA-GENE STRUCT EXPR, V1218, P129, DOI 10.1016/0167-4781(94)90001-9; O'Rourke MP, 2002, DEV BIOL, V248, P143, DOI 10.1006/dbio.2002.0730; Peng BW, 2005, BIOCHEM BIOPH RES CO, V338, P1490, DOI 10.1016/j.bbrc.2005.10.111; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Puisieux A, 2006, BRIT J CANCER, V94, P13, DOI 10.1038/sj.bjc.6602876; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Ramachandran R, 2010, NAT CELL BIOL, V12, P1101, DOI 10.1038/ncb2115; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Saera-Vila A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192214; Saera-Vila A, 2016, AUTOPHAGY, V12, P1864, DOI 10.1080/15548627.2016.1207015; Saera-Vila A, 2016, CELL SIGNAL, V28, P1196, DOI 10.1016/j.cellsig.2016.06.001; Saera-Vila A, 2015, INVEST OPHTH VIS SCI, V56, P4977, DOI 10.1167/iovs.14-16103; Saito S, 2019, CELL MOL LIFE SCI, V76, P45, DOI 10.1007/s00018-018-2924-7; SIMON HG, 1995, DEV DYNAM, V202, P1, DOI 10.1002/aja.1002020102; Singh SP, 2012, DEV CELL, V22, P879, DOI 10.1016/j.devcel.2012.03.006; Skrypek N, 2017, TRENDS GENET, V33, P943, DOI 10.1016/j.tig.2017.08.004; Soo K, 2002, DEV BIOL, V247, P251, DOI 10.1006/dbio.2002.0699; Stainier DYR, 2017, PLOS GENET, V13, DOI [10.1371/journal.pgen.01007000, DOI 10.1371/JOURNAL.PGEN.01007000]; Stewart S, 2012, DEV BIOL, V365, P339, DOI 10.1016/j.ydbio.2012.02.031; Su J, 2016, MOL CARCINOGEN, V55, P1962, DOI 10.1002/mc.22443; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Teng CS, 2018, ELIFE, V7, DOI 10.7554/eLife.37024; Thummel R, 2017, METHODS MOL BIOL, V1565, P79, DOI 10.1007/978-1-4939-6817-6_7; Thummel R, 2011, JOVE-J VIS EXP, DOI 10.3791/3603; Tingle CF, 2019, INVEST OPHTH VIS SCI, V60, P4991, DOI 10.1167/iovs.19-27556; Tuttle AM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001852; Weaver JC, 2000, IEEE T PLASMA SCI, V28, P24, DOI 10.1109/27.842820; Yang DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027324; Yeo GH, 2009, DEV GENES EVOL, V219, P289, DOI 10.1007/s00427-009-0290-z; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457	69	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231963	10.1371/journal.pone.0231963	http://dx.doi.org/10.1371/journal.pone.0231963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320444	Green Published, gold			2022-12-26	WOS:000536028800042
J	Greene-Cramer, B; Summers, A; Lopes-Cardozo, B; Husain, F; Couture, A; Bilukha, O				Greene-Cramer, Blanche; Summers, Aimee; Lopes-Cardozo, Barbara; Husain, Farah; Couture, Alexia; Bilukha, Oleg			Noncommunicable disease burden among conflict-affected adults in Ukraine: A cross-sectional study of prevalence, risk factors, and effect of conflict on severity of disease and access to care	PLOS ONE			English	Article							GENDER-DIFFERENCES; IRAQI REFUGEES; JORDAN; MORTALITY	Background There is limited research on noncommunicable diseases (NCDs) in humanitarian settings despite the overall global burden and disproportionate growth in many conflicts and disaster-prone settings. This study aimed to determine the prevalence of NCDs and assess the perceived effect of conflict on NCD severity and access to treatment among conflict-affected adults (>= 30 years) in Ukraine. Methods and findings We conducted two population-representative, stratified, cross-sectional household surveys: one among adult internally displaced people (IDPs) throughout Ukraine and one among adults living in Donbas in eastern Ukraine. One randomly selected adult per household answered questions about their demographics, height and weight, diagnosed NCDs, access to medications and healthcare since the conflict began, as well as questions assessing psychological distress, trauma exposure, and posttraumatic stress disorder. More than half of participants reported having at least one NCD (55.7% Donbas; 59.8% IDPs) A higher proportion of IDPs compared to adults in Donbas experienced serious psychological distress (29.9% vs. 18.7%), interruptions in care (9.7-14.3% vs. 23.1-51.3%), and interruptions in medication than adults in Donbas (14.9-45.6% vs. 30.2-77.5%). Factors associated with perceived worsening of disease included psychological distress (p: 0.002-0.043), displacement status (IDP vs. Donbas) (p: < 0.001-0.011), interruptions in medication (p: 0.002-0.004), and inability to see a doctor at some point since the start of the conflict (p: < 0.001-0.008). Conclusions Our study found a high burden of NCDs among two conflict-affected populations in Ukraine and identified obstacles to accessing care and medication. Psychological distress, interruptions to care, and interruptions in medication were all reported by a higher proportion of IDPs than adults in Donbas. There is a need for targeted policies and programs to support the unique needs of displaced conflict-affected individuals in Ukraine that address the economic and perceived barriers to NCD treatment and care.	[Greene-Cramer, Blanche; Summers, Aimee; Lopes-Cardozo, Barbara; Husain, Farah; Couture, Alexia; Bilukha, Oleg] Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Div Global Hlth Protect, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Greene-Cramer, B (corresponding author), Ctr Dis Control & Prevent, Emergency Response & Recovery Branch, Div Global Hlth Protect, Atlanta, GA 30333 USA.	bgreenec@gmail.com	Bilukha, Oleg/ABC-5095-2020		Kyiv International Institute of Sociology	Kyiv International Institute of Sociology	The authors would like to acknowledge the support of the Kyiv International Institute of Sociology in completing recruitment, data collection and data entry for this project. The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the Centers for Disease Control and Prevention or the institutions with which the authors are affiliated.	Alleyne G, 2013, LANCET, V381, P566, DOI 10.1016/S0140-6736(12)61806-6; Amara AH, 2014, GLOBALIZATION HEALTH, V10, DOI 10.1186/1744-8603-10-24; [Anonymous], 2007, 2 IPSOS SURVEY IRAQI; Arseven A, 2001, VASC MED, V6, P229, DOI 10.1177/1358836X0100600405; Aryal S, 2013, TRANSL RES, V162, P208, DOI 10.1016/j.trsl.2013.04.003; Blanco PM, 2016, BLANCO, P5, DOI [10.7490/f1000research.1111934.1, DOI 10.7490/F1000RESEARCH.1111934.1]; Doocy S, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2429-3; Doocy S, 2013, INT J HEALTH PLAN M, V28, pe1, DOI 10.1002/hpm.2119; Engedal K, 1996, INT J GERIATR PSYCH, V11, P467, DOI 10.1002/(SICI)1099-1166(199605)11:5<467::AID-GPS338>3.0.CO;2-S; Huijts T, 2017, EUR J PUBLIC HEALTH, V27, P8, DOI 10.1093/eurpub/ckw232; International Organization for Migration (IOM) Mission in Ukraine, 2018, NAT MON SYST REP SIT; Jawad M, 2019, HEART, V105, P1388, DOI 10.1136/heartjnl-2018-314459; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Kehlenbrink S, 2019, LANCET DIABETES ENDO, V7, P638, DOI 10.1016/S2213-8587(19)30082-8; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kim J, 2012, P 72 SCI SESS AM DIA, pA387; Mateen FJ, 2012, J NEUROL, V259, P694, DOI 10.1007/s00415-011-6248-x; Office for the Coordination of Humanitarian Affairs, 2018, HUM B UKR; Oka RK, 2003, VASC MED, V8, P89, DOI 10.1191/1358863x03vm479oa; Penninx BWJH, 1997, AM J EPIDEMIOL, V146, P510, DOI 10.1093/oxfordjournals.aje.a009305; Ramachandran A, 2019, EUR J PUBLIC HEALTH, V29, P1141, DOI 10.1093/eurpub/ckz117; Rehr M, 2018, CONFL HEALTH, V12, DOI 10.1186/s13031-018-0168-7; Roberts B, 2019, EPIDEMIOL PSYCH SCI, V28, P100, DOI 10.1017/S2045796017000385; Rodriguez-Artalejo F, 2006, J CARD FAIL, V12, P621, DOI 10.1016/j.cardfail.2006.06.471; Shoeb M, 2007, INT J SOC PSYCHIATR, V53, P447, DOI 10.1177/0020764007078362; Stringhini S, 2017, LANCET GLOB HEALTH, V5, pE230, DOI 10.1016/S2214-109X(17)30054-2; Summers A, 2019, CONFL HEALTH, V13, DOI 10.1186/s13031-019-0194-0; United Nations, 2011, ANN POL DECL HIGH LE; World Food Programme, 2018, UKR FOOD SEC LIV CLU; World Health Organization, 2018, NON DIS NCD COUNTR P; Yaman H, 2002, SCAND J PRIM HEALTH, V20, P85, DOI 10.1080/02813430215550; Yanni EA, 2013, J IMMIGR MINOR HEALT, V15, P1, DOI 10.1007/s10903-012-9578-6	32	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231899	10.1371/journal.pone.0231899	http://dx.doi.org/10.1371/journal.pone.0231899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315357	Green Published, gold			2022-12-26	WOS:000536024800063
J	Vliegen, G; Kehoe, K; Bracke, A; De Hert, E; Verkerk, R; Fransen, E; Jongers, B; Peters, E; Lambeir, AM; Kumar-Singh, S; Pickkers, P; Jorens, PG; De Meester, I				Vliegen, Gwendolyn; Kehoe, Kaat; Bracke, An; De Hert, Emilie; Verkerk, Robert; Fransen, Erik; Jongers, Bart's; Peters, Esther; Lambeir, Anne-Marie; Kumar-Singh, Samir; Pickkers, Peter; Jorens, Philippe G.; De Meester, Ingrid			Dysregulated activities of proline-specific enzymes in septic shock patients (sepsis-2)	PLOS ONE			English	Article							DIPEPTIDYL-PEPTIDASE-IV; HUMAN PERIPHERAL-TISSUES; PROLYL OLIGOPEPTIDASE; CLEAVING ENZYME; NEUROPEPTIDE-Y; PLASMA; PROLYLCARBOXYPEPTIDASE; PROCALCITONIN; INFLAMMATION; DEFINITIONS	The proline-specific enzymes dipeptidyl peptidase 4 (DPP4), prolylcarboxypeptidase (PRCP), fibroblast activation protein alpha (FAP) and prolyl oligopeptidase (PREP) are known for their involvement in the immune system and blood pressure regulation. Only very limited information is currently available on their enzymatic activity and possible involvement in patients with sepsis and septic-shock. The activity of the enzymes was measured in EDTA-plasma of patients admitted to the intensive care unit (ICU): 40 septic shock patients (sepsis-2) and 22 ICU control patients after major intracranial surgery. These data were used to generate receiver operating characteristic (ROC) curves. A survival analysis (at 90 days) and an association study with other parameters was performed. PRCP (day 1) and PREP (all days) enzymatic activities were higher in septic shock patients compared to controls. In contrast, FAP and DPP4 were lower in these patients on all studied time points. Since large differences were found, ROC curves were generated and these yielded area under the curve (AUC) values for PREP, FAP and DPP4 of 0.88 (CI: 0.80-0.96), 0.94 (CI: 0.89-0.99) and 0.86 (CI: 0.77-0.95), respectively. PRCP had a lower predicting value with an AUC of 0.71 (CI: 0.58-0.83). A nominally significant association was observed between survival and the DPP4 enzymatic activity at day 1 (p<0.05), with a higher DPP4 activity being associated with an increase in survival. All four enzymes were dysregulated in septic shock patients. DPP4, FAP and PREP are good in discriminating between septic shock patients and ICU controls and should be further explored to see whether they are already dysregulated in earlier stages, opening perspectives for their further investigation as biomarkers in sepsis. DPP4 also shows potential as a prognostic biomarker. Additionally, the associations found warrant further research.	[Vliegen, Gwendolyn; Kehoe, Kaat; Bracke, An; De Hert, Emilie; Verkerk, Robert; Lambeir, Anne-Marie; De Meester, Ingrid] Univ Antwerp, Lab Med Biochem, Antwerp, Belgium; [Fransen, Erik] Univ Antwerp, StatUa Ctr Stat, Antwerp, Belgium; [Jongers, Bart's; Kumar-Singh, Samir] Univ Antwerp, Mol Pathol Grp Cell Biol & Histol, Antwerp, Belgium; [Peters, Esther; Pickkers, Peter] Radboud Univ Nijmegen, Med Ctr, Dept Intens Care Med, Nijmegen, Netherlands; [Jorens, Philippe G.] Antwerp Univ Hosp, Dept Crit Care Med, Edegem, Belgium; [Jorens, Philippe G.] Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; Radboud University Nijmegen; University of Antwerp; University of Antwerp	De Meester, I (corresponding author), Univ Antwerp, Lab Med Biochem, Antwerp, Belgium.	ingrid.demeester@uantwerpen.be	Fransen, Erik/C-4102-2015	Fransen, Erik/0000-0001-7785-4790; Verkerk, Robert/0000-0003-3042-3293; Vliegen, Gwendolyn/0000-0002-0915-2444; De Hert, Emilie/0000-0002-6094-4455	Fund for Scientific Research Flanders [1S22417N, SB151525]; GOA BOF 2015 grant of the University of Antwerp [30729]	Fund for Scientific Research Flanders(FWO); GOA BOF 2015 grant of the University of Antwerp	EDH and BSJ are research assistants of the Fund for Scientific Research Flanders (1S22417N and SB151525, respectively; www.fwo.be).This work was supported by a GOA BOF 2015 grant of the University of Antwerp to SKS, AML and IDM (No. 30729; www.uantwerp.be).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baerts L, 2017, TRANSL STROKE RES, V8, P157, DOI 10.1007/s12975-016-0493-3; Becker KL, 2010, BRIT J PHARMACOL, V159, P253, DOI 10.1111/j.1476-5381.2009.00433.x; Bergmann A, 2002, CLIN CHIM ACTA, V321, P123, DOI 10.1016/S0009-8981(02)00042-6; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Bracke A, 2019, CLIN CHIM ACTA, V495, P154, DOI 10.1016/j.cca.2019.04.063; Brakenridge SC, 2019, J AM COLL SURGEONS, V229, P58, DOI 10.1016/j.jamcollsurg.2019.04.014; Brandt I, 2007, CLIN CHIM ACTA, V377, P50, DOI 10.1016/j.cca.2006.09.001; Brennen WN, 2012, MOL CANCER THER, V11, P257, DOI 10.1158/1535-7163.MCT-11-0340; Buljevic S, 2013, RHEUMATOL INT, V33, P2867, DOI 10.1007/s00296-013-2823-z; Dellinger R, 2013, INTENS CARE MED, V41, P580, DOI [10.1097/CCM.0b013e31827e83af, DOI 10.1007/s00134-012-2769-8]; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Durinx C, 2001, CLIN CHEM LAB MED, V39, P155, DOI 10.1515/CCLM.2001.026; Enz N, 2019, PHARMACOL THERAPEUT, V198, P135, DOI 10.1016/j.pharmthera.2019.02.015; Faix JD, 2013, CRIT REV CL LAB SCI, V50, P23, DOI 10.3109/10408363.2013.764490; Felies M, 2004, J PHYSIOL-LONDON, V561, P245, DOI 10.1113/jphysiol.2004.073635; Gariani K, 2013, ENDOCR CONNECT, V2, DOI 10.1530/EC-13-0040; Goossens F, 1996, EUR J CLIN CHEM CLIN, V34, P17; GOOSSENS F, 1992, EUR J CLIN CHEM CLIN, V30, P235; Grootjans J, 2016, WORLD J GASTROENTERO, V22, P2760, DOI 10.3748/wjg.v22.i9.2760; Kager LM, 2013, AM J RESP CRIT CARE, V188, P967, DOI 10.1164/rccm.201307-1344OC; Kehoe K, 2013, ANAL BIOCHEM, V443, P232, DOI 10.1016/j.ab.2013.09.002; Khanna A, 2017, NEW ENGL J MED, V377, P419, DOI 10.1056/NEJMoa1704154; KOIDA M, 1976, J BIOL CHEM, V251, P7593; Lay AJ, 2019, FRONT BIOSCI-LANDMRK, V24, P1, DOI 10.2741/4706; Lebherz C, 2017, AM J MED, V130, P833, DOI 10.1016/j.amjmed.2017.03.010; Lee KN, 2011, J THROMB HAEMOST, V9, P987, DOI 10.1111/j.1538-7836.2011.04195.x; Lee KN, 2006, BLOOD, V107, P1397, DOI 10.1182/blood-2005-08-3452; Levy MM, 2010, CRIT CARE MED, V38, P367, DOI 10.1097/CCM.0b013e3181cb0cdc; Matheeussen V, 2012, CLIN CHIM ACTA, V413, P456, DOI 10.1016/j.cca.2011.10.031; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Mortier A, 2016, J LEUKOCYTE BIOL, V99, P955, DOI 10.1189/jlb.3MR0915-401R; Myohanen TT, 2012, J HISTOCHEM CYTOCHEM, V60, P706, DOI 10.1369/0022155412453051; Nargis T, 2018, IUBMB LIFE, V70, P112, DOI 10.1002/iub.1709; Neviere R., 2019, SEPSIS SYNDROMES ADU; Prucha M, 2015, CLIN CHIM ACTA, V440, P97, DOI 10.1016/j.cca.2014.11.012; Senatore F, 2019, AM J CARDIOVASC DRUG, V19, P11, DOI 10.1007/s40256-018-0297-9; Shariat-Madar Z, 2004, J ENDOTOXIN RES, V10, P3, DOI 10.1179/096805104225003807; Shariat-Madar Z, 2002, J BIOL CHEM, V277, P17962, DOI 10.1074/jbc.M106101200; Shih CJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15260; Singer M, 2004, LANCET, V364, P545, DOI 10.1016/S0140-6736(04)16815-3; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sorrells K, 1971, Adv Exp Med Biol, V23, P393; Steven S, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0465-x; Ulusoy H, 2012, RHEUMATOL INT, V32, P3857, DOI 10.1007/s00296-011-2302-3; Van Elzen R, 2011, CNS NEUROL DISORD-DR, V10, P297, DOI 10.2174/187152711794653814; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wrenger S, 2000, FEBS LETT, V466, P155, DOI 10.1016/S0014-5793(99)01779-2; YANG HYT, 1968, NATURE, V218, P1224, DOI 10.1038/2181224a0; Zhu H, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-58; [No title captured]; [No title captured]; [No title captured], DOI DOI 10.1093/nar/gkr987	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231555	10.1371/journal.pone.0231555	http://dx.doi.org/10.1371/journal.pone.0231555			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315321	Green Published, gold			2022-12-26	WOS:000536024800034
J	Demirkol Canli, S; Dedeoglu, E; Akbar, MW; Kucukkaraduman, B; Isbilen, M; Erdogan, OS; Erciyas, SK; Yazici, H; Vural, B; Gure, AO				Demirkol Canli, Secil; Dedeoglu, Ege; Akbar, Muhammad Waqas; Kucukkaraduman, Baris; Isbilen, Murat; Erdogan, Ozge Sukruoglu; Erciyas, Seda Kilic; Yazici, Hulya; Vural, Burcak; Gure, Ali Osmay			A novel 20-gene prognostic score in pancreatic adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; EXPRESSION SIGNATURE; CELL-PROLIFERATION; GENE-EXPRESSION; CANCER; SURVIVAL; INVASION; COLON; RECURRENCE; ACTIVATION	Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal cancers. Known risk factors for this disease are currently insufficient in predicting mortality. In order to better prognosticate patients with PDAC, we identified 20 genes by utilizing publically available high-throughput transcriptomic data from GEO, TCGA and ICGC which are associated with overall survival and event-free survival. A score generated based on the expression matrix of these genes was validated in two independent cohorts. We find that this "Pancreatic cancer prognostic score 20-PPS20" is independent of the confounding factors in multivariate analyses, is dramatically elevated in metastatic tissue compared to primary tumor, and is higher in primary tumors compared to normal pancreatic tissue. Transcriptomic analyses show that tumors with low PPS20 have overall more immune cell infiltration and a higher CD8 T cell/Treg ratio when compared to those with high PPS20. Analyses of proteomic data from TCGA PAAD indicated higher levels of Cyclin B1, RAD51, EGFR and a lower E-cadherin/Fibronectin ratio in tumors with high PPS20. The PPS20 score defines not only prognostic and biological sub-groups but can predict response to targeted therapy as well. Overall, PPS20 is a stronger and more robust transcriptomic signature when compared to similar, previously published gene lists.	[Demirkol Canli, Secil] Hacettepe Univ, Mol Pathol Applicat & Res Ctr, Ankara, Turkey; [Dedeoglu, Ege; Akbar, Muhammad Waqas; Kucukkaraduman, Baris; Isbilen, Murat; Gure, Ali Osmay] Bilkent Univ, Dept Mol Biol & Genet, Ankara, Turkey; [Erdogan, Ozge Sukruoglu; Erciyas, Seda Kilic; Yazici, Hulya] Istanbul Univ, Inst Oncol, Canc Genet Div, Dept Basic Oncol, Istanbul, Turkey; [Vural, Burcak] Istanbul Univ, Aziz Sancar Inst Expt Med, Dept Genet, Istanbul, Turkey; [Isbilen, Murat] DNAFect Genet Consulting R&D & Biotechnol Inc, Kocaeli, Turkey	Hacettepe University; Ihsan Dogramaci Bilkent University; Istanbul University; Istanbul University	Demirkol Canli, S (corresponding author), Hacettepe Univ, Mol Pathol Applicat & Res Ctr, Ankara, Turkey.	secil.demirkol@hacettepe.edu.tr	vural, burçak/AAC-6553-2020; Canlı, Seçil Demirkol/AAG-8038-2020; YAZICI, HULYA/AAU-9491-2021	Canlı, Seçil Demirkol/0000-0003-0200-7962; YAZICI, HULYA/0000-0002-8919-0482; Gure, Ali Osmay/0000-0002-4064-8608; KILIC ERCIYAS, Seda/0000-0003-4417-4005	Research Fund of Istanbul University [ONAP 46784]	Research Fund of Istanbul University(Istanbul University)	This study was supported by the Research Fund of Istanbul University (Project no: ONAP 46784) to BV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Allen PJ, 2017, ANN SURG, V265, P185, DOI 10.1097/SLA.0000000000001763; Arndt S, 2007, ONCOL REP, V18, P885; Bao ZY, 2017, ONCOTARGET, V8, P39048, DOI 10.18632/oncotarget.16587; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beck L, 2009, J BIOL CHEM, V284, P31363, DOI 10.1074/jbc.M109.053132; Bednarczyk Robert B, 2018, Oncotarget, V9, P24272, DOI 10.18632/oncotarget.24917; Birnbaum DJ, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0936-z; Birnbaum DJ, 2016, CANCER GENOM PROTEOM, V13, P191; Burris HA, 1997, J CLIN ONCOL, V15, P2403, DOI 10.1200/JCO.1997.15.6.2403; Cairns J, 2018, EMBO REP, V19, DOI 10.15252/embr.201744767; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen JH, 2018, J CANCER, V9, P650, DOI 10.7150/jca.21683; Chen Q, 2017, ONCOL REP, V38, P767, DOI 10.3892/or.2017.5724; Chivu-Economescu M, 2017, GASTRIC CANCER, V20, P948, DOI 10.1007/s10120-017-0712-y; Debant A, 1996, P NATL ACAD SCI USA, V93, P5466, DOI 10.1073/pnas.93.11.5466; Demirkol S, 2017, J CANCER, V8, P1113, DOI 10.7150/jca.17872; Fang D, 2017, ONCOGENE, V36, P1546, DOI 10.1038/onc.2016.323; Fukuhisa H, 2019, J HUM GENET, V64, P521, DOI 10.1038/s10038-019-0584-6; Gao HL, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0447-1; Guo M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071090; Guo XL, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-375; Haider S, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0105-3; Handra-Luca A, 2012, PANCREAS, V41, P416, DOI 10.1097/MPA.0b013e318238379d; Hayashi M, 2013, CHANNELS, V7, P432, DOI 10.4161/chan.26100; He D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054181; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Im DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41852-4; Innocenti M, 2003, J CELL BIOL, V160, P17, DOI 10.1083/jcb.200206079; Jiao Y, 2017, ONCOTARGET, V8, P91067, DOI 10.18632/oncotarget.19412; Kakinuma N, 2008, J CELL BIOL, V181, P537, DOI 10.1083/jcb.200707022; Khajah MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193779; Kirby MK, 2016, MOL ONCOL, V10, P1169, DOI 10.1016/j.molonc.2016.05.004; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Kwan WH, 2012, IMMUNOL RES, V54, P247, DOI 10.1007/s12026-012-8327-1; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Le N, 2016, DIGEST LIVER DIS, V48, P223, DOI 10.1016/j.dld.2015.11.001; Lee Kun Yeong, 2019, Medical Bilogical Science and Engineering, V2, P1, DOI 10.30579/mbse.2019.2.1.1; Liu KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143008; Ma JM, 2013, JNCI-J NATL CANCER I, V105, P1694, DOI 10.1093/jnci/djt292; MacDonald PE, 2003, DIABETOLOGIA, V46, P1046, DOI 10.1007/s00125-003-1159-8; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mazzoccoli G, 2012, J CANCER RES CLIN, V138, P501, DOI 10.1007/s00432-011-1126-6; Merkin RD, 2017, HUM PATHOL, V62, P23, DOI 10.1016/j.humpath.2016.10.006; Nabeshima K, 2002, PATHOL INT, V52, P255, DOI 10.1046/j.1440-1827.2002.01343.x; Nawaz Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep27753; Newhook TE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105631; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; O'Connell MJ, 2010, J CLIN ONCOL, V28, P3937, DOI 10.1200/JCO.2010.28.9538; Ohshima K, 2019, ONCOL REP, V41, P1019, DOI 10.3892/or.2018.6869; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pallante P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098295; Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peng XG, 2018, ONCOTARGETS THER, V11, P8865, DOI 10.2147/OTT.S181433; Pirsko V, 2018, MEDICINA-LITHUANIA, V54, DOI 10.3390/medicina54020011; R Core Team, 2019, R LANG ENV STAT COMP; Rahib L, 2014, CANCER RES, V74, P4006, DOI 10.1158/0008-5472.CAN-14-1642; Raman P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201751; Saung MT, 2017, CLIN THER, V39, P2125, DOI 10.1016/j.clinthera.2017.08.015; Schnittger A, 2018, TRENDS PLANT SCI, V23, P475, DOI 10.1016/j.tplants.2018.03.015; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Spanknebel K, 2001, CANCER J, V7, P312; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Therneau T.M., 2000, MODELING SURVIVAL DA; Tian J, 2009, J BIOL CHEM, V284, P14921, DOI 10.1074/jbc.M808355200; Uhlen M, 2017, SCIENCE, V357, P660, DOI 10.1126/science.aan2507; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang LS, 2016, ONCOTARGET, V7, P38539, DOI 10.18632/oncotarget.9533; Watanabe S, 2009, AM J PATHOL, V174, P854, DOI 10.2353/ajpath.2009.080523; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Winter JM, 2013, J SURG ONCOL, V107, P15, DOI 10.1002/jso.23192; Wu IC, 2016, ONCOTARGET, V7, P85244, DOI 10.18632/oncotarget.13267; Wu LF, 2017, FEBS J, V284, P3000, DOI 10.1111/febs.14162; Yan XK, 2019, CANCER MANAG RES, V11, P273, DOI 10.2147/CMAR.S185205; Yang L, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01294; Yeh JY, 2001, J UROLOGY, V166, P1937, DOI 10.1016/S0022-5347(05)65724-2; Yu KD, 2013, CLIN CANCER RES, V19, P2723, DOI 10.1158/1078-0432.CCR-12-2986; Yu TF, 2017, ONCOTARGET, V8, P26637, DOI 10.18632/oncotarget.15789; Zhao G, 2013, MOL CANCER THER, V12, P2569, DOI 10.1158/1535-7163.MCT-13-0296	84	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231835	10.1371/journal.pone.0231835	http://dx.doi.org/10.1371/journal.pone.0231835			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310997	Green Published, Green Submitted			2022-12-26	WOS:000536019800037
J	Howarth, T; Brunette, R; Davies, T; Andrews, RM; Patel, BK; Tong, S; Barzi, F; Kearns, TM				Howarth, Timothy; Brunette, Raelene; Davies, Tanya; Andrews, Ross M.; Patel, Bhavini K.; Tong, Steven; Barzi, Federica; Kearns, Therese M.			Antibiotic use for Australian Aboriginal children in three remote Northern Territory communities	PLOS ONE			English	Article							LIFE	Objective To describe antibiotic prescription rates for Australian Aboriginal children aged < 2 years living in three remote Northern Territory communities. Design A retrospective cohort study using electronic health records. Setting Three primary health care centres located in the Katherine East region. Participants Consent was obtained from 149 mothers to extract data from 196 child records. There were 124 children born between January 2010 and July 2014 who resided in one of the three chosen communities and had electronic health records for their first two years of life. Main outcome measures Antibiotic prescription rates, factors associated with antibiotic prescription and factors associated with appropriate antibiotic prescription. Results There were 5,675 Primary Health Care (PHC) encounters for 124 children (median 41, IQR 25.5, 64). Of the 5,675 PHC encounters, 1,542 (27%) recorded at least one infection (total 1,777) and 1,330 (23%) had at least one antibiotic prescription recorded (total 1,468). Children had a median five (IQR 2, 9) prescriptions in both their first and second year of life, with a prescription rate of 5.99/person year (95% CI 5.35, 6.63). Acute otitis media was the most common infection (683 records, 38%) and Amoxycillin was the most commonly prescribed antibiotic (797 prescriptions, 54%). Of the 1,468 recorded prescriptions, 398 (27%) had no infection recorded and 116 (8%) with an infection recorded were not aligned with local treatment guidelines. Conclusion Prescription rates for Australian Aboriginal children in these communities are significantly higher than that reported nationally for non-Aboriginal Australians. Prescriptions predominantly aligned with treatment guidelines in this setting where there is a high burden of infectious disease.	[Howarth, Timothy; Kearns, Therese M.] Menzies Sch Hlth Res, Child Hlth, Darwin, NT, Australia; [Brunette, Raelene] Sunrise Hlth Serv Aboriginal Corp, Child Hlth, Katherine, NT, Australia; [Davies, Tanya] Sunrise Hlth Serv Aboriginal Corp, Publ Hlth & Planning, Katherine, NT, Australia; [Andrews, Ross M.] Menzies Sch Hlth Res, Trop Hlth, Brisbane, Qld, Australia; [Patel, Bhavini K.] Top End Hlth Serv, Med Management Res Transformat & Change, Darwin, NT, Australia; [Tong, Steven] Univ Melbourne, Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Barzi, Federica] Menzies Sch Hlth Res, Wellbeing & Preventable Chron Dis, Darwin, NT, Australia	Charles Darwin University; Menzies School of Health Research; Charles Darwin University; Menzies School of Health Research; University of Melbourne; Charles Darwin University; Menzies School of Health Research	Howarth, T (corresponding author), Menzies Sch Hlth Res, Child Hlth, Darwin, NT, Australia.	timothy.howarth@menzies.edu.au	Barzi, Federica/AAI-7465-2021; Tong, Steven/N-2353-2013; Kearns, Therese/N-2308-2013	Barzi, Federica/0000-0001-7427-0167; Tong, Steven/0000-0002-1368-8356; Kearns, Therese/0000-0003-0862-7572; Howarth, Timothy/0000-0003-3028-0376	Lowitja Institute	Lowitja Institute	TK received funding from the Lowitja Institute (https://www.lowitja.org.au/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Yaman F., 2011, PUBLIC HLTH RES PRAC, V2017, P27, DOI DOI 10.17061/PHRP2741732]; Aminov RI, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00134; Anderson H, 2017, J PAEDIAT CHILD HLTH; [Anonymous], 2019, STAT STAT SOFTW REL; Australian Bureau of Statistics, 2011, CENS 2011, DOI [10.5694/mja2.50216, DOI 10.5694/MJA2.50216]; Australian Commission on Safety and Quality in Health Care, 2017, AURA 2017 2 AUSTR RE; Australian Commission on Safety and Quality in Health Care (ACSQHC), 2016, AURA 2016 1 AUSTR RE; Australian Government Department of Health, 2019, S100 REM AR AB HLTH; Australian Institute of Health and Welfare, 2015, NAT PARTN AGR IND EA; Bowen AC, 2019, MED J AUSTRALIA, V211, P9, DOI 10.5694/mja2.50216; Cecchini M, 2015, ANTIMICROBIAL RESIST; Central Australian Rural Practitioners Association, 2017, CENTR AUSTR RUR PRAC; Collignon PJ, 2002, MED J AUSTRALIA, V177, P325, DOI 10.5694/j.1326-5377.2002.tb04794.x; Cuningham W, 2019, AUST NZ J PUBL HEAL, V43, P149, DOI 10.1111/1753-6405.12876; Drug Utilisation Sub Committee (DUSC), 2014, ANT PBS RPBS UT; Farooqui HH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204805; Fink G, 2019, LANCET INFECT DIS; Gadzhanova S, 2016, AUST FAM PHYSICIAN, V45, P134; Greer RC, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022250; Kearns T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058231; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; McAuley K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154171; McMeniman E, 2011, AUSTRALAS J DERMATOL, V52, P270, DOI 10.1111/j.1440-0960.2011.00806.x; Morris Peter S, 2005, BMC Pediatr, V5, P27, DOI 10.1186/1471-2431-5-27; Murray R., 2003, AUST PRESCR, V26, P55, DOI 10.18773/austprescr.2003.080; Northern Territory Government Department of Health, 2019, ENV HLTH PUBL HLTH M; ONeill J., 2014, REV ANTIMICROB RESIS; READ AW, 1994, ARCH DIS CHILD, V70, P205, DOI 10.1136/adc.70.3.205; Rogawski ET, 2017, B WORLD HEALTH ORGAN, V95, P49, DOI 10.2471/BLT.16.176123; Shah Mohammad, 2016, Trop Med Health, V44, P39, DOI 10.1186/s41182-016-0038-1; Stam J, 2012, ACTA PAEDIATR, V101, P929, DOI 10.1111/j.1651-2227.2012.02728.x; Sunrise Health, 2016, SUNR SIT; Therapeutic Guidelines Limited, 2005, ETG COMPL NTH MELB; United Nations Children's Fund and World Health Organization, 2004, LOW BIRTHW COUNTR RE	34	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231798	10.1371/journal.pone.0231798	http://dx.doi.org/10.1371/journal.pone.0231798			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302359	Green Published, gold			2022-12-26	WOS:000536016100053
J	Cao, HJ; Li, X; Li, XL; Ward, L; Xie, ZG; Hu, H; Zhang, YJ; Liu, JP				Cao, Hui-Juan; Li, Xun; Li, Xin-Lin; Ward, Lesley; Xie, Zhan-Guo; Hu, Hui; Zhang, Ya-Jing; Liu, Jian-Ping			Factors influencing participant compliance in acupuncture trials: An in-depth interview study	PLOS ONE			English	Article								Introduction Little is known of acupuncture patients' experiences and opinions of clinical trials, and what may influence their compliance when participating in an acupuncture trial. Objectives To explore the potential factors that influence patients' choice and determinants to participate in acupuncture clinical trials. Methods Ten qualitative, in-depth interviews were conducted with patients from acupuncture clinics in Beijing, who had previously participated in acupuncture clinical trials. Results Four main themes emerged from the interview data: effectiveness of the treatment, convenience of participating in a trial, doctor-participant communication, and participant acceptance of the treatment (or the trial). Effectiveness of acupuncture in treating the health condition was the most important factor for participant adherence. Pragmatics of treatment schedules, travel and attendance burden, together with confidence in the doctor's ability additionally influenced trial and treatment compliance. Conclusions In-depth interviews suggest that treatment effectiveness, the pragmatics of attending treatment sessions, and the expertise and attitudes of acupuncturists are determining factors of participation and compliance in acupuncture clinical trials. Participants' confidence in, and expectation of, acupuncture may facilitate compliance, while their fear of acupuncture and negative perceptions of the trial's purpose may reduce treatment compliance. Compliance may be facilitated by enhanced doctor-patient communication, personalized treatment programs, and feedback on treatment outcomes.	[Cao, Hui-Juan; Li, Xun; Liu, Jian-Ping] Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China; [Li, Xin-Lin] China Press Tradit Chinese Med, Beijing, Peoples R China; [Ward, Lesley] Northumbria Univ, Dept Sport Exercise & Rehabil, Newcastle Upon Tyne, Tyne & Wear, England; [Ward, Lesley] Univ Technol Sydney, Australian Res Ctr Complementary & Integrat Med, Ultimo, Australia; [Xie, Zhan-Guo] First Peoples Hosp Dongcheng Dist, Dept Acupuncture & Moxibust, Beijing, Peoples R China; [Hu, Hui] Beijing Univ Chinese Med, Dept Acupuncture & Metab Dis, Dongfang Hosp, Beijing, Peoples R China; [Zhang, Ya-Jing] Jiangxi Inst Tradit Chinese Med, Inst Informat & Literature, Nanchang, Jiangxi, Peoples R China	Beijing University of Chinese Medicine; Northumbria University; University of Technology Sydney; Beijing University of Chinese Medicine; Jiangxi University of Traditional Chinese Medicine	Cao, HJ; Liu, JP (corresponding author), Beijing Univ Chinese Med, Ctr Evidence Based Chinese Med, Beijing, Peoples R China.	huijuancao327@hotmail.com; jianping_l@hotmail.com		Cao, Huijuan/0000-0003-3244-6288; Ward, Lesley/0000-0001-7285-2032; Li, Xun/0000-0002-3513-5904	National Natural Science Foundation of China [81804000]; Beijing Municipal Organization Department [2017000020124G292]; Key project of the National Natural Science Foundation of China [81830115]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Organization Department; Key project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Hui-Juan Cao is supported by the National Natural Science Foundation of China (81804000) and the Beijing Municipal Organization Department (2017000020124G292). Jian-Ping Liu is supported by the Key project of the National Natural Science Foundation of China (No.81830115). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anneken C, 2001, EUR J MED RES, V6, P75; Cao HJ, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/362831; Dziura James D., 2013, Yale Journal of Biology and Medicine, V86, P343; Gf L, 2012, J NURS TRAIN, V27, P926; Goh YL, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/871217; Hopton AK, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000456; Li XL, 2019, PATIENT PREFER ADHER, V13, P53, DOI 10.2147/PPA.S173202; [李欣霖 Li Xinlin], 2018, [中医杂志, Journal of Traditional Chinese Medicine], V59, P577; Liu Mai-Lan, 2012, Zhongguo Zhen Jiu, V32, P452; McDonald AM, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-9; Sully BGO, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-166; Sun Junjun, 2017, Zhongguo Zhen Jiu, V37, P1015, DOI 10.13703/j.0255-2930.2017.09.029; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wang L, 2015, LIAONING J TRADITION, V42, P2399; Wang P, 2018, J TRADITIONAL CHINES, V59, P254; Wei J, 2014, BEIJING J TRADITIONA, V33, P97; Yin CS, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/635089	17	8	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231780	10.1371/journal.pone.0231780	http://dx.doi.org/10.1371/journal.pone.0231780			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298368	Green Published, gold, Green Accepted			2022-12-26	WOS:000536011400111
J	Gandjour, A; Armsen, W; Wehmeyer, W; Multmeier, J; Tschulena, U				Gandjour, Afschin; Armsen, Wencke; Wehmeyer, Wolfgang; Multmeier, Jan; Tschulena, Ulrich			Costs of patients with chronic kidney disease in Germany	PLOS ONE			English	Article							HEALTH-CARE COSTS; ECONOMIC BURDEN; STAGE	Background This study aimed to determine the costs and distribution of healthcare spending of patients with chronic kidney disease (CKD) at stages 3 and 4 and on dialysis both at the individual and population level in Germany. Methods The study took the perspective of the German statutory health insurance (SHI) system and analyzed claims data on 3,687,015 insurees from the year 2014. To extrapolate costs to the whole SHI population, a literature search on the prevalence of CKD was conducted. Results Average costs per person per year in an age- and gender-matched control group of the normal population were (sic)2,876 (95% confidence interval [CI], (sic)2,798 to (sic)2,955) and >= 2.8-fold higher in CKD patients ((sic)8,030 [95% CI, (sic)7,848 to (sic)8,212] at CKD stage 3, (sic)9,760 [95% CI, (sic)9,266 to (sic)10,255] at CKD stage 4, and (sic)44,374 [95% CI, (sic)43,608 to (sic)45,139] on dialysis). At CKD stages 3 and 4 the major cost driver was hospitalizations, contributing to more than 50% of total expenditures. Among dialysis patients, hospitalizations and dialysis-treatment costs contributed to 23% and 53% of total healthcare spending, respectively. At CKD stages 3 and 4, patients with the highest 20% of healthcare spending showed a considerable increase in per-patient costs over the reference population, while the bottom 80% of patients generated only moderately higher per-patient costs (p < 0.001). Comparing total CKD costs to total SHI expenditures yields that 10.2% of SHI expenditures was driven by patients at CKD stages 3 and 4 and 1.6% by dialysis patients. Conclusions Healthcare spending of patients with CKD at stages 3 and 4 and on dialysis is concentrated among a small number of high-need patients. As hospitalizations and dialysis treatment are key drivers of total expenditures, strategies that lead to a reduction in hospitalizations, delay in dialysis onset, or increase in the availability of kidney donors should become important considerations by policymakers.	[Gandjour, Afschin] Frankfurt Sch Finance & Management, Frankfurt, Germany; [Armsen, Wencke; Wehmeyer, Wolfgang; Tschulena, Ulrich] Fresenius Med Care, Bad Homburg, Germany; [Multmeier, Jan] Elsevier Hlth Analyt, Berlin, Germany	Frankfurt School Finance & Management; Reed Elsevier; Elsevier	Gandjour, A (corresponding author), Frankfurt Sch Finance & Management, Frankfurt, Germany.	a.gandjour@fs.de		Multmeier, Jan/0000-0002-2825-6716	Fresenius Medical Care	Fresenius Medical Care	Fresenius Medical Care supported this study in the form of salaries to WA, WW, and UT and consulting fees to AG. Elsevier Health Analytics also provided support in the form of salary to JM. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aumann N, 2015, KIDNEY BLOOD PRESS R, V40, P231, DOI 10.1159/000368499; Baumeister SE, 2010, AM J NEPHROL, V31, P222, DOI 10.1159/000272937; Blumel M, GERMAN HLTH CARE SYS; Busse R, 2017, LANCET, V390, P882, DOI 10.1016/S0140-6736(17)31280-1; Eriksson JK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012062; Eurotransplant International Foundation, 2018, ANN REP 2018; Gandjour A, 2015, EXPERT REV PHARM OUT, V15, P341, DOI 10.1586/14737167.2015.972375; Gemeinsamer Bundesausschuss, 2017, BESCHL GEM BUND VERF; Golestaneh L, 2017, AM J MANAG CARE, V23, pS163; Hill NR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158765; Howdon D, 2018, J HEALTH ECON, V57, P60, DOI 10.1016/j.jhealeco.2017.11.001; Icks A, 2010, NEPHROL DIAL TRANSPL, V25, P1647, DOI 10.1093/ndt/gfp672; Kent S, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0054-0; Kerr M, 2012, NEPHROL DIAL TRANSPL, V27, P73, DOI 10.1093/ndt/gfs269; Kim SH, 2017, J NEPHROL, V30, P787, DOI 10.1007/s40620-017-0380-3; Kleophas Werner, 2007, Int J Health Care Finance Econ, V7, P185, DOI 10.1007/s10754-007-9020-0; Kraus D, 2017, DEUT MED WOCHENSCHR, V142, P1276, DOI 10.1055/s-0043-113464; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mafham M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025920; Roggeri A, 2017, J NEPHROL, V30, P263, DOI 10.1007/s40620-016-0291-8; Statistisches Bundesamt, 2019, GES MIL EUR 2017; Statistisches Bundesamt, 2017, PRESS, V13; Statistisches Bundesamt, 2018, GENESIS ONL DAT; Trocchi P, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0749-5; Turchetti G, 2017, EUR J HEALTH ECON, V18, P847, DOI 10.1007/s10198-016-0830-1; United States Renal Data System, 2018, 2018 USRDS ANN DAT R; Vanholder R, 2017, NAT REV NEPHROL, V13, P393, DOI 10.1038/nrneph.2017.63; Wan S, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.182173; Wang V, 2016, SEMIN NEPHROL, V36, P319, DOI 10.1016/j.semnephrol.2016.05.008; Zhang QL, 2009, PREV MED, V48, P122, DOI 10.1016/j.ypmed.2008.10.026	30	15	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231375	10.1371/journal.pone.0231375	http://dx.doi.org/10.1371/journal.pone.0231375			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330140	Green Published, gold			2022-12-26	WOS:000536647300011
J	Dietrich, JJ; Hornschuh, S; Khunwane, M; Makhale, LM; Otwombe, K; Morgan, C; Huang, YD; Lemos, M; Lazarus, E; Kublin, JG; Gray, GE; Laher, F; Andrasik, M				Dietrich, Janan J.; Hornschuh, Stefanie; Khunwane, Mamakiri; Makhale, Lerato M.; Otwombe, Kennedy; Morgan, Cecilia; Huang, Yunda; Lemos, Maria; Lazarus, Erica; Kublin, James G.; Gray, Glenda E.; Laher, Fatima; Andrasik, Michele		HVTN 915 Team	A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; PREEXPOSURE PROPHYLAXIS; HIV PREVENTION; BEHAVIOR; BIAS; PARTICIPATION; VALIDITY; HEALTH; TRIAL; ACCEPTABILITY	Background The HIV epidemiology in South Africa reveals stark age and gender disparities, with young women being the most vulnerable to HIV acquisition in 2017. Evaluation of HIV exposure is a challenge in HIV prevention research. Intermittent in-clinic interviewer-administered risk behaviour assessments are utilised but may be limited by social desirability and recall biases. We piloted a mobile phone application for daily self-report of sexual risk behaviour in fifty 18-25 year old women at risk of HIV infection enrolled in HIV Vaccine Trials Network 915 (HVTN 915) in Soweto, South Africa. Through a mixed-methods investigation, we explored barriers and facilitators to completing daily mobile phone surveys among HVTN 915 study participants and staff. Methods We analysed quantitative data on barriers and facilitators to mobile phone study completion collected during the larger HVTN 915 study as well as two post-study focus group discussions (FGDs) with fifteen former participants with a median age of 24 years (IQR 23-25) and six individual in-depth interviews (IDIs) with HVTN 915 staff. FGDs and IDIs utilised semi-structured interview guides, were audio-recorded, transcribed verbatim and translated to English. After coding, thematic analysis was performed. Results The main facilitator for daily mobile phone survey completion assessed across 336 follow-up visits for 49 participants was the daily short message system (SMS) reminders (93%, 312/336). Across 336 visits, 31/49 (63%) retained participants reported barriers to completion of daily mobile phone surveys: forgetting (20%, 12/49), being too busy (19%, 11/49) and the survey being an inconvenience (15%, 9/49). Five main themes were identified during the coding of IDIs and FGDs: (1) facilitators of mobile phone survey completion, such as daily SMS reminders and follow up calls for non-completers; (2) barriers to mobile phone survey completion, including partner, time-related and technical barriers; (3) power of incentives; (4) response bias in providing sensitive information, and (5) recommendations for future mobile phone based interventions. Conclusion Despite our enthusiasm to use innovation to optimise sexual risk assessments, technical and practical solutions are required to improve implementation. We recommend further engagement with participants to optimise this approach and to further understand social desirability bias and study incentives in sexual risk reporting.	[Dietrich, Janan J.; Hornschuh, Stefanie; Khunwane, Mamakiri; Makhale, Lerato M.; Otwombe, Kennedy; Lazarus, Erica; Gray, Glenda E.; Laher, Fatima] Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit PHRU, Johannesburg, Gauteng, South Africa; [Dietrich, Janan J.] South African Med Res Council, Hlth Syst Res Unit, Cape Town, Western Cape, South Africa; [Morgan, Cecilia; Huang, Yunda; Lemos, Maria; Kublin, James G.; Andrasik, Michele] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div VIDD, 1124 Columbia St, Seattle, WA 98104 USA; [Gray, Glenda E.] South African Med Res Council, Off President, Cape Town, Western Cape, South Africa	University of Witwatersrand; South African Medical Research Council; Fred Hutchinson Cancer Center; South African Medical Research Council	Dietrich, JJ (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Perinatal HIV Res Unit PHRU, Johannesburg, Gauteng, South Africa.; Dietrich, JJ (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Cape Town, Western Cape, South Africa.	dietrichj@phru.co.za		Dietrich, Janan/0000-0002-1949-3138; Makhale, Lerato/0000-0003-0952-6757	South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the SAMRC Postdoctoral Programme from the South African National Treasury; National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service [UM1 AI068614, UM1 AI068635, UM1 AI068618, UM1 AI069453]; South African National Research Foundation (NRF); South African NRF; NIH/NIAID [2UM1AI068614-08]; NIH/NIAID via Public Health Service [UM1 AI068635]	South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the SAMRC Postdoctoral Programme from the South African National Treasury; National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service; South African National Research Foundation (NRF)(National Research Foundation - South Africa); South African NRF(National Research Foundation - South Africa); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIAID via Public Health Service	The work reported herein for JJD was also made possible through funding by the South African Medical Research Council (SAMRC) through its Division of Research Capacity Development under the SAMRC Postdoctoral Programme from funding received from the South African National Treasury. The HVTN 915 study was supported by the National Institute of Allergy and Infectious Diseases (NIAID) U.S. Public Health Service Grants UM1 AI068614 [LOC: HIV Vaccine Trials Network], UM1 AI068635 [SDMC: HIV Vaccine Trials Network], UM1 AI068618 [LC: HIV Vaccine Trials Network] and UM1 AI069453 [Soweto-Bara Clinical Research Site]. JJD received a Thuthuka post PhD funding award from the South African National Research Foundation (NRF). MK received a Thuthuka PhD award from the South African NRF. MA was supported through NIH/NIAID 2UM1AI068614-08. YH was supported by NIH/NIAID via Public Health Service Grant UM1 AI068635 [HVTN SDMC]. Any opinion, finding, conclusion or recommendation expressed in this material is solely the responsibility of the authors, and does not necessarily represent the official views of the SAMRC, NIAID, NIH, the SA NRF or their funders.	Ainsworth J, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2328; Alam M, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2361-6; Andriesen J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7513; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; CATANIA JA, 1990, PSYCHOL BULL, V108, P339, DOI 10.1037/0033-2909.108.3.339; Chillag Kata, 2006, Afr J AIDS Res, V5, P123, DOI 10.2989/16085900609490372; Collins M, 2005, WESTERN J NURS RES, V27, P188, DOI 10.1177/0193945904268068; Curran K, 2013, AIDS BEHAV, V17, P2977, DOI 10.1007/s10461-013-0510-4; Davis CG, 2010, ADDICT BEHAV, V35, P302, DOI 10.1016/j.addbeh.2009.11.001; De Tolly K., 2009, INNOVATIVE USE CELLP; DiClemente RJ, 2013, SEX TRANSM DIS, V40, P111, DOI 10.1097/OLQ.0b013e3182838474; Dietrich J., 2016, PROSPECTIVE COHORT S; Dietrich JJ, 2018, AIDS BEHAV, V22, P2312, DOI 10.1007/s10461-018-2080-y; Doyle AM, 2012, TROP MED INT HEALTH, V17, P796, DOI 10.1111/j.1365-3156.2012.03005.x; Farmer S, 2017, J ASSOC NURSE AIDS C, V28, P737, DOI 10.1016/j.jana.2017.04.001; Goldenberg T, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.3745; Graham CA, 2003, J SEX RES, V40, P325, DOI 10.1080/00224490209552198; Gurzawska A, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9101759; Haberer JE, 2016, AIDS, V30, P1294, DOI 10.1097/QAD.0000000000001021; Harrison A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-102; Human Sciences Research Council (HSRC), 2017, HIV IMP ASS SUMM REP; Independent Communications Authority of South Africa (ICASA), 2019, STAT OCT SECT REP S; Jackson T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187478; Johnson LF, 2015, AIDS, V29, P1401, DOI 10.1097/QAD.0000000000000721; Kahn JG, 2010, HEALTH AFFAIR, V29, P254, DOI 10.1377/hlthaff.2009.0965; Kelly CA, 2013, INT PERSPECT SEX R H, V39, P14, DOI 10.1363/3901413; Kerrigan D, 2017, HEALTH RES POLICY SY, V15, DOI 10.1186/s12961-017-0206-8; Labrique A, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7329; Langhaug LF, 2010, TROP MED INT HEALTH, V15, P362, DOI 10.1111/j.1365-3156.2009.02464.x; Latkin CA, 2016, AIDS EDUC PREV, V28, P417, DOI 10.1521/aeap.2016.28.5.417; Lebreton M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq0668; Leidich A, 2018, INT J MED INFORM, V114, P108, DOI 10.1016/j.ijmedinf.2017.10.017; Lemos M, DAILY VAGINAL SWABS; Lemos M, 2015, HIGH ADHERENCE DAILY; Linek SB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183216; LOPRESTI MA, 2015, PHARM MED, V29, P17, DOI DOI 10.1007/s40290-015-0085-7; Montgomery ET, 2015, AIDS BEHAV, V19, P784, DOI 10.1007/s10461-014-0950-5; Muessig KE, 2013, J MED INTERNET RES, V15, P19, DOI 10.2196/jmir.2301; Napper LE, 2010, AIDS BEHAV, V14, P152, DOI 10.1007/s10461-009-9575-5; Nkala B, 2015, AIDS CARE, V27, P697, DOI 10.1080/09540121.2014.993352; O'Reilly-Shah VN, 2017, PEERJ, V5, DOI 10.7717/peerj.3785; Orrell C, 2015, JAIDS-J ACQ IMM DEF, V70, P495, DOI 10.1097/QAI.0000000000000770; Pariyo GW, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7302; Ramjee G, 2011, BIOMEDICAL ENG THEOR; Roth AM, 2014, AIDS BEHAV, V18, P2314, DOI 10.1007/s10461-014-0718-y; Sabin LL, 2015, JAIDS-J ACQ IMM DEF, V69, P551, DOI 10.1097/QAI.0000000000000651; Scott-Sheldon LAJ, 2014, CURR HIV RES, V11, P549, DOI 10.2174/1570162X12666140129105726; Stalgaitis C, 2014, SEX TRANSM INFECT, V90, P374, DOI 10.1136/sextrans-2013-051472; Statistics South Africa, 2019, MID YEAR POP EST PRE; Succop SM, 2014, AIDS CARE, V26, P1521, DOI 10.1080/09540121.2014.938014; Tomlinson M, 2009, BMC MED INFORM DECIS, V9, DOI 10.1186/1472-6947-9-51; Vu A., 2013, WORLD J AIDS, V3, P345, DOI [10.4236/wja.2013.34044, DOI 10.4236/WJA.2013.34044]; Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519; Wray TB, 2016, AIDS BEHAV, V20, P2231, DOI 10.1007/s10461-015-1272-y	54	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231086	10.1371/journal.pone.0231086	http://dx.doi.org/10.1371/journal.pone.0231086			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324753	gold, Green Published			2022-12-26	WOS:000536033700010
J	Lee, SA; Kang, HT; Lee, YJ; Lee, JD; Kimid, BG				Lee, Se A.; Kang, Hyun Tag; Lee, Yun Ji; Lee, Jong Dae; Kimid, Bo Gyung			National representative analysis of unilateral hearing loss and hearing aid usage in South Korea	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; PREVALENCE; CHILDREN; HEALTH; ADULTS	A definitive study on the prevalence of adult unilateral hearing loss and hearing aid rehabilitation is lacking in Korea. The purpose of our study was to investigate the prevalence of adult unilateral hearing loss and the factors associated with hearing aid use in patients with unilateral hearing loss in South Korea. We obtained data from 2009 to 2012 from the Korea National Health and Nutrition Examination Surveys (KNHANES), a cross-sectional, nationwide and population-based survey in the Republic of Korea. We analyzed the prevalence and associated factors of unilateral hearing loss and hearing aid adoption by univariable and multivariable analysis. Unilateral hearing loss was defined as pure tone average. 41 dB in the worse hearing ear, and < 41 dB in the other ear assessed at 0.5, 1.0, 2.0, and 3.0 kHz. From 2009 to 2012, 33,252 individuals participated in the KNHANES. Among them, the number of patients with unilateral hearing loss was 1632 (5.55%) and the prevalence of hearing aid adoption in unilateral hearing loss was 1.56%. We also compared the factors between hearing aid users and non-users. Occupational status (OR 3.759, 95% CI 1.4439.804), the hearing threshold in the better ear (OR 1.088, 95% CI 1.029-1.151), and hearing threshold in the worse ear (OR 1.031, 1.005-1.058) were found to affect the adoption of hearing aids. The prevalence of noise exposure at work in hearing aid users was significantly lower than the prevalence of noise exposure at work in those with no hearing aid. The prevalence of hearing aid use in patients with unilateral hearing loss in Korea is very low compared to other countries. Public health education is needed to increase public awareness of unilateral hearing loss, hearing aid adoption and its continued usage. Auditory rehabilitation should be actively recommended to patients with unilateral hearing loss.	[Lee, Se A.] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Kang, Hyun Tag; Lee, Yun Ji; Lee, Jong Dae; Kimid, Bo Gyung] Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bucheon, South Korea	Yonsei University; Yonsei University Health System; Soonchunhyang University	Kimid, BG (corresponding author), Soonchunhyang Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Bucheon, South Korea.	bgkim@schmc.ac.kr			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2016R1D1A1B03934946]; Soonchunhyang University Research Fund	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Soonchunhyang University Research Fund	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology (2016R1D1A1B03934946), and the Soonchunhyang University Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal Y, 2008, ARCH INTERN MED, V168, P1522, DOI 10.1001/archinte.168.14.1522; [Anonymous], 2015, 5 KOR NAT HLTH NUTR; Arlinger S, 1996, EAR HEARING, V17, pS87, DOI 10.1097/00003446-199617031-00009; Baudonck N, 2011, INT J AUDIOL, V50, P912, DOI 10.3109/14992027.2011.605803; Bess FH, 1998, EAR HEARING, V19, P339, DOI 10.1097/00003446-199810000-00001; Chia EM, 2007, EAR HEARING, V28, P187, DOI 10.1097/AUD.0b013e31803126b6; Chien W, 2012, ARCH INTERN MED, V172, P292, DOI 10.1001/archinternmed.2011.1408; COLLETTI V, 1988, British Journal of Audiology, V22, P113, DOI 10.3109/03005368809077805; COZAD R L, 1977, Journal of Auditory Research, V17, P25; Dawes P, 2014, EAR HEARING, V35, pE44, DOI 10.1097/AUD.0000000000000010; Fischer ME, 2011, AM J PUBLIC HEALTH, V101, P1449, DOI 10.2105/AJPH.2010.300078; Golub JS, 2018, LARYNGOSCOPE, V128, P1681, DOI 10.1002/lary.27017; Gordon K, 2019, HEARING RES, V380, P60, DOI 10.1016/j.heares.2019.05.011; Hearing S. K., 2005, HEARING REV, V12, P16; Hosford-Dunn H, 2001, J Am Acad Audiol, V12, P15; Jiam NTL, 2016, LARYNGOSCOPE, V126, P2587, DOI 10.1002/lary.25927; Kelly-Campbell R., 2012, ASIA PACIFIC J SPEEC, V15, P145, DOI DOI 10.1179/JSLH.2012.15.2.145; Kochkin S, 2011, HEAR J, V64, P25, DOI DOI 10.1097/01.HJ.0000399150.30374.45; Korver AMH, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2016.94; Kral A, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00093; Kral A, 2013, BRAIN, V136, P180, DOI 10.1093/brain/aws305; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Lin FR, 2011, ARCH NEUROL-CHICAGO, V68, P214, DOI 10.1001/archneurol.2010.362; MONSELL EM, 1995, OTOLARYNG HEAD NECK, V113, P186, DOI 10.1016/S0194-5998(95)70103-6; Moon IJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001580; Palmer CV, 2009, J AM ACAD AUDIOL, V20, P341, DOI 10.3766/jaaa.20.6.2; Park KH, 2014, J EPIDEMIOL, V24, P417, DOI 10.2188/jea.JE20140024; Purcell PL, 2016, LARYNGOSCOPE, V126, P746, DOI 10.1002/lary.25524; Van der Horst H, 2014, DISABIL SOC, V29, P821, DOI 10.1080/09687599.2013.844102	29	5	5	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232112	10.1371/journal.pone.0232112	http://dx.doi.org/10.1371/journal.pone.0232112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324804	gold, Green Published			2022-12-26	WOS:000536033700077
J	van Dijk, DM; van Rhenen, W; Murre, JMJ; Verwijk, E				van Dijk, Dela M.; van Rhenen, Willem; Murre, Jaap M. J.; Verwijk, Esmee			Cognitive functioning, sleep quality, and work performance in non-clinical burnout: The role of working memory	PLOS ONE			English	Article							NEUROPSYCHOLOGICAL TEST-PERFORMANCE; EXECUTIVE CONTROL; DISTURBED SLEEP; INSOMNIA; STRESS; POPULATION; ASSOCIATIONS; IMPAIRMENTS; DISORDERS; SYMPTOMS	We investigated the relationship between cognitive functioning, work performance, and sleep in non-clinical burnout. In a working population, an online survey was conducted with additional online neuropsychological tests of varying complexity, measuring attention and different components of working memory, of which the coordinating subcomponent the 'Central Executive' is thought to be the most vulnerable to stress. Results indicate that nonclinical burnout is associated with more-though not severe-sleep problems, more depressive complaints, impaired work performance, and with both subjective and objective cognitive impairments. Compared with healthy respondents (N = 107), people with non-clinical burnout (N = 17) had a significantly poorer performance on the tests of the visuospatial sketchpad and the Central Executive of the working memory. Our study also indicates that more complex tests may be more sensitive in detecting cognitive dysfunction in non-clinical burnout. Furthermore, a relationship was found between dual-task performance and work performance. Regarding to sleep quality, in our sample of people with non-clinical burnout, there were no severe sleep problems. In the entire sample, however, insomnia was significantly related to subjective, but not objective, cognitive functioning, and also not to work performance.	[van Dijk, Dela M.; Murre, Jaap M. J.; Verwijk, Esmee] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [van Dijk, Dela M.; van Rhenen, Willem] Occupat Hlth & Safety Serv, Arbo Unie, Utrecht, Netherlands; [Verwijk, Esmee] Univ Amsterdam, Med Ctr, Dept Med Psychol, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	van Dijk, DM (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.; van Dijk, DM (corresponding author), Occupat Hlth & Safety Serv, Arbo Unie, Utrecht, Netherlands.	dela@delavandijk.com	van Rhenen, Willem/AAS-9406-2021					Altena E, 2008, SLEEP, V31, P1271; Armon G, 2008, J PSYCHOSOM RES, V65, P5, DOI 10.1016/j.jpsychores.2008.01.012; Baddeley A, 1997, NEUROPSYCHOLOGY, V11, P187, DOI 10.1037/0894-4105.11.2.187; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baddeley A, 1996, PHILOS T ROY SOC B, V351, P1397, DOI 10.1098/rstb.1996.0123; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Beaman CP, 2002, Q J EXP PSYCHOL-A, V55, P371, DOI 10.1080/02724980143000307; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berch DB, 1998, BRAIN COGNITION, V38, P317, DOI 10.1006/brcg.1998.1039; Bouma A, 2012, HDB NEUROPSYCHOLOGIS; Boykoff N, 2009, J CANCER SURVIV, V3, P223, DOI 10.1007/s11764-009-0098-x; Calvio L, 2010, J OCCUP ENVIRON MED, V52, P219, DOI 10.1097/JOM.0b013e3181d0bef7; Castaneda AE, 2011, NORD J PSYCHIAT, V65, P32, DOI 10.3109/08039488.2010.485328; Chow Y, 2018, ADV MED SCI-POLAND, V63, P192, DOI 10.1016/j.advms.2017.11.004; Corsi P., 1972, THESIS; Deligkaris P, 2014, WORK STRESS, V28, P107, DOI 10.1080/02678373.2014.909545; Desart S., 2018, NEW MEASUREMENT BURN; Desart S., 2017, TIJDSCH STEUNPUNT WE; Diestel S, 2013, WORK STRESS, V27, P164, DOI 10.1080/02678373.2013.790243; Dorland HF, 2016, J CANCER SURVIV, V10, P545, DOI 10.1007/s11764-015-0500-9; Ekstedt M, 2006, SCAND J WORK ENV HEA, V32, P121, DOI 10.5271/sjweh.987; Ellbin S, 2018, J CLIN EXP NEUROPSYC, V40, P567, DOI 10.1080/13803395.2017.1388359; Eskildsen A, 2017, STRESS, V20, P371, DOI 10.1080/10253890.2017.1341484; Eskildsen A, 2015, STRESS, V18, P198, DOI 10.3109/10253890.2015.1004629; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Fortier-Brochu E, 2012, SLEEP MED REV, V16, P83, DOI 10.1016/j.smrv.2011.03.008; Gajewski PD, 2017, PSYCHONEUROENDOCRINO, V86, P176, DOI 10.1016/j.psyneuen.2017.09.017; Gavelin HM, 2015, STRESS, V18, P578, DOI 10.3109/10253890.2015.1064892; Goldman-Mellor S, 2015, SLEEP, V38, P623, DOI 10.5665/sleep.4584; Golonka K, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00676; Grossi G, 2015, SCAND J PSYCHOL, V56, P626, DOI 10.1111/sjop.12251; Grossi G, 2015, NORD J PSYCHIAT, V69, P292, DOI 10.3109/08039488.2014.973442; He SC, 2017, PSYCHONEUROENDOCRINO, V77, P236, DOI 10.1016/j.psyneuen.2017.01.002; Hill AP, 2016, PERS SOC PSYCHOL REV, V20, P269, DOI [10.1177/1088868315596286, 10.1109/EPE.2015.7309385]; Hooftman W, 2018, NATL ARBEIDSOMSTANDI; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; Jonsdottir IH, 2017, SCAND J PSYCHOL, V58, P504, DOI 10.1111/sjop.12394; Kessels R P, 2000, Appl Neuropsychol, V7, P252, DOI 10.1207/S15324826AN0704_8; Kessler RC, 2011, SLEEP, V34, P1161, DOI 10.5665/SLEEP.1230; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Kleinsorge T, 2014, APPL COGNITIVE PSYCH, V28, P274, DOI 10.1002/acp.2999; Klingner J, 2011, PSYCHOPHYSIOLOGY, V48, P323, DOI 10.1111/j.1469-8986.2010.01069.x; Koopmans L, 2012, INT J PRODUCT PERFOR, V62, P6, DOI 10.1108/17410401311285273; Kyle SD, 2017, SLEEP MED, V38, P85, DOI 10.1016/j.sleep.2017.07.001; Kyle SD, 2013, SLEEP MED, V14, P493, DOI 10.1016/j.sleep.2012.10.023; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lindblom KM, 2006, INT J BEHAV MED, V13, P51, DOI 10.1207/s15327558ijbm1301_7; Ling A, 2016, SLEEP MED, V17, P7, DOI 10.1016/j.sleep.2015.07.037; Linton SJ, 2000, J OCCUP REHABIL, V10, P169, DOI 10.1023/A:1009408204694; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; McGann JP, 2017, SCIENCE, V356, DOI 10.1126/science.aam7263; McInerney S, 2012, IRISH J PSYCHOL MED, V29, P176, DOI 10.1017/S0790966700017213; Melby-Lervag M, 2013, DEV PSYCHOL, V49, P270, DOI 10.1037/a0028228; Millan MJ, 2012, NAT REV DRUG DISCOV, V11, P141, DOI 10.1038/nrd3628; MILNER B, 1971, BRIT MED BULL, V27, P272, DOI 10.1093/oxfordjournals.bmb.a070866; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Morgan CA, 2011, J INT NEUROPSYCH SOC, V17, P494, DOI 10.1017/S1355617711000221; Morin C., 2003, INSOMNIA A CLIN GUID; Murre, 2016, GETTING STARTED NEUR; Murre JMJ, 2013, ACTA PSYCHOL, V142, P96, DOI 10.1016/j.actpsy.2012.10.005; Oberauer K, 2004, J MEM LANG, V51, P80, DOI 10.1016/j.jml.2004.03.003; Oosterholt BG, 2016, BIOL PSYCHOL, V117, P89, DOI 10.1016/j.biopsycho.2016.02.009; Oosterholt BG, 2014, STRESS, V17, P400, DOI 10.3109/10253890.2014.949668; Orena Eleonora Francesca, 2013, Saudi J Anaesth, V7, P277, DOI 10.4103/1658-354X.115351; Ottati A, 2013, J CANCER SURVIV, V7, P262, DOI 10.1007/s11764-013-0275-9; PENNEY CG, 1989, MEM COGNITION, V17, P398, DOI 10.3758/BF03202613; Plaisier I, 2010, J AFFECT DISORDERS, V125, P198, DOI 10.1016/j.jad.2010.01.072; Savic I, 2018, CEREB CORTEX, V28, P894, DOI 10.1093/cercor/bhw413; Schaufeli W.B., 2018, BURNOUT EUROPE RELAT; Sokka L, 2017, INT J PSYCHOPHYSIOL, V112, P70, DOI 10.1016/j.ijpsycho.2016.12.004; Strobach T, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00108; Swanson LM, 2011, J SLEEP RES, V20, P487, DOI 10.1111/j.1365-2869.2010.00890.x; Taris TW, 2006, WORK STRESS, V20, P316, DOI 10.1080/02678370601065893; Taris TW, 2005, WORK STRESS, V19, P238, DOI 10.1080/02678370500270453; TAUB HA, 1972, DEV PSYCHOL, V6, P60, DOI 10.1037/h0032215; Terluin B, 2004, WORK STRESS, V18, P187, DOI 10.1080/0267837042000297535; Terluin B, 1996, HUISARTS WET, V39, P538; Terluin B, 2006, BMC PSYCHIATRY, V6, DOI 10.1186/1471-244X-6-34; Towse JN, 2001, BRIT J DEV PSYCHOL, V19, P319, DOI 10.1348/026151001166100; Van der Linden D, 2005, WORK STRESS, V19, P23, DOI 10.1080/02678370500065275; van Mill JG, 2010, J CLIN PSYCHIAT, V71, P239, DOI 10.4088/JCP.09m05218gry; Verhage F., 1964, INTELLIGENTIE LEEFTI; Wechsler D., 2012, WAIS 4 NL WECHSLER A; Wekenborg MK, 2018, STRESS, V21, P511, DOI 10.1080/10253890.2018.1479393	84	15	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231906	10.1371/journal.pone.0231906	http://dx.doi.org/10.1371/journal.pone.0231906			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32325479	Green Published, gold			2022-12-26	WOS:000536033700044
J	Wickramasuriya, DS; Faghih, RT				Wickramasuriya, Dilranjan S.; Faghih, Rose T.			A mixed filter algorithm for sympathetic arousal tracking from skin conductance and heart rate measurements in Pavlovian fear conditioning	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; RATE-VARIABILITY; DYNAMIC-ANALYSIS; ANXIETY; MODELS; RESPONSES; EMOTION; CORTEX; DECOMPOSITION; EXTINCTION	Pathological fear and anxiety disorders can have debilitating impacts on individual patients and society. The neural circuitry underlying fear learning and extinction has been known to play a crucial role in the development and maintenance of anxiety disorders. Pavlovian conditioning, where a subject learns an association between a biologically-relevant stimulus and a neutral cue, has been instrumental in guiding the development of therapies for treating anxiety disorders. To date, a number of physiological signal responses such as skin conductance, heart rate, electroencephalography and cerebral blood flow have been analyzed in Pavlovian fear conditioning experiments. However, physiological markers are often examined separately to gain insight into the neural processes underlying fear acquisition. We propose a method to track a single brain-related sympathetic arousal state from physiological signal features during fear conditioning. We develop a state-space formulation that probabilistically relates features from skin conductance and heart rate to the unobserved sympathetic arousal state. We use an expectation-maximization framework for state estimation and model parameter recovery. State estimation is performed via Bayesian filtering. We evaluate our model on simulated and experimental data acquired in a trace fear conditioning experiment. Results on simulated data show the ability of our proposed method to estimate an unobserved arousal state and recover model parameters. Results on experimental data are consistent with skin conductance measurements and provide good fits to heartbeats modeled as a binary point process. The ability to track arousal from skin conductance and heart rate within a state-space model is an important precursor to the development of wearable monitors that could aid in patient care. Anxiety and trauma-related disorders are often accompanied by a heightened sympathetic tone and the methods described herein could find clinical applications in remote monitoring for therapeutic purposes.	[Wickramasuriya, Dilranjan S.; Faghih, Rose T.] Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA	University of Houston System; University of Houston	Faghih, RT (corresponding author), Univ Houston, Dept Elect & Comp Engn, Houston, TX 77004 USA.	rtfaghih@uh.edu			National Science Foundation [1755780 CRII: CPS]	National Science Foundation(National Science Foundation (NSF))	The work was supported in part by the National Science Foundation grant 1755780 CRII: CPS: Wearable Machine Interface Architectures to RTF. URL: https://www.nsf.gov/awardsearch/showAward?AWD_ID=1755780 The funder did not play any role in the study design, data collection Iand analysis, decision to publish, or preparation of the manuscript.	Aikins DE, 2009, BEHAV RES THER, V47, P744, DOI 10.1016/j.brat.2009.06.006; Alpers GW, 2005, INT J PSYCHOPHYSIOL, V57, P25, DOI 10.1016/j.ijpsycho.2005.01.008; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Amin MR, 2018, CONF REC ASILOMAR C, P655, DOI 10.1109/ACSSC.2018.8645408; Amin MR, 2019, IEEE T BIO-MED ENG, V66, P2585, DOI 10.1109/TBME.2019.2892352; Azgomi HF, 2019, IEEE ENG MED BIO, P6327, DOI 10.1109/EMBC.2019.8857904; Bach DR, 2010, INT J PSYCHOPHYSIOL, V75, P349, DOI 10.1016/j.ijpsycho.2010.01.005; Baczkowski BM, 2017, NEUROIMAGE, V153, P168, DOI 10.1016/j.neuroimage.2017.03.022; Barbieri R, 2005, AM J PHYSIOL-HEART C, V288, pH424, DOI 10.1152/ajpheart.00482.2003; Barbieri R, 2006, IEEE T BIO-MED ENG, V53, P4, DOI 10.1109/TBME.2005.859779; Barbieri R, 2001, J NEUROSCI METH, V105, P25, DOI 10.1016/S0165-0270(00)00344-7; Barbieri R, 2008, BIOSYSTEMS, V93, P120, DOI 10.1016/j.biosystems.2008.03.011; BARRY RJ, 1993, INT J PSYCHOPHYSIOL, V15, P39, DOI 10.1016/0167-8760(93)90093-5; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; Benedek M, 2010, PSYCHOPHYSIOLOGY, V47, P647, DOI 10.1111/j.1469-8986.2009.00972.x; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BERNTSON GG, 1995, PSYCHOPHYSIOLOGY, V32, P162, DOI 10.1111/j.1469-8986.1995.tb03308.x; Boardman A, 2002, PHYSIOL MEAS, V23, P325, DOI 10.1088/0967-3334/23/2/308; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Braithwaite J. J., 2013, PSYCHOPHYSIOLOGY, V49, P1017, DOI DOI 10.1111/J.1469-8986.2012.01384.X; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Castegnetti G, 2017, PSYCHOPHYSIOLOGY, V54, P215, DOI 10.1111/psyp.12778; Castegnetti G, 2016, PSYCHOPHYSIOLOGY, V53, P930, DOI 10.1111/psyp.12637; Chen Z, 2009, IEEE T BIO-MED ENG, V56, P1791, DOI 10.1109/TBME.2009.2016349; Coleman T. P., 2011, DYNAMIC BRAIN EXPLOR, P1; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; DEJONG P, 1988, BIOMETRIKA, V75, P601, DOI 10.1093/biomet/75.3.601; Deng XY, 2015, IEEE ENG MED BIO, P7808, DOI 10.1109/EMBC.2015.7320203; Drew R. C., 2012, PRIMER AUTONOMIC NER, P177, DOI [DOI 10.1016/B978-0-12-386525-0.00036-6, 10.1016/B978-0-12-386525-0.00036-6]; Dunsmoor JE, 2009, LEARN MEMORY, V16, P460, DOI 10.1101/lm.1431609; Dvir M, 2019, BEHAV RES THER, V120, DOI 10.1016/j.brat.2019.103431; Eden UT, 2004, NEURAL COMPUT, V16, P971, DOI 10.1162/089976604773135069; Eden UT, 2008, NEURAL SIGNAL PROCES, P79; FUREDY JJ, 1976, BIOL PSYCHOL, V4, P93, DOI 10.1016/0301-0511(76)90010-7; Garcia-Cabezas MA, 2017, CEREB CORTEX, V27, P4891, DOI 10.1093/cercor/bhw284; Gatzke-Kopp LM, 2002, J ABNORM CHILD PSYCH, V30, P477, DOI 10.1023/A:1019816930615; GLINER JA, 1977, PSYCHOPHYSIOLOGY, V14, P281, DOI 10.1111/j.1469-8986.1977.tb01176.x; Greco A, 2016, IEEE T BIO-MED ENG, V63, P797, DOI 10.1109/TBME.2015.2474131; Hall J.E., 2016, GUYTON HALL TXB MED, Vthirteenth; Jain S, 2017, IEEE T BIO-MED ENG, V64, P2142, DOI 10.1109/TBME.2016.2632523; Jovanovic T, 2005, BIOL PSYCHIAT, V57, P1559, DOI 10.1016/j.biopsych.2005.02.025; Kallinen K, 2004, PERS INDIV DIFFER, V37, P275, DOI 10.1016/j.paid.2003.09.002; Kang HK, 2003, AM J EPIDEMIOL, V157, P141, DOI 10.1093/aje/kwf187; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KLORMAN R, 1980, PSYCHOPHYSIOLOGY, V17, P513, DOI 10.1111/j.1469-8986.1980.tb02290.x; Koyama S, 2008, NEURAL COMPUT, V20, P1776, DOI 10.1162/neco.2008.06-07-540; Kreibig SD, 2010, BIOL PSYCHOL, V84, P394, DOI 10.1016/j.biopsycho.2010.03.010; LABERG JC, 1987, BRIT J ADDICT, V82, P1341; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; LEON AC, 1995, BRIT J PSYCHIAT, V166, P19, DOI 10.1192/S0007125000293355; Linnman C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-8; Lipp O.V., 2006, FEAR LEARNING BASIC, pS. 48; Lithari C, 2010, BRAIN TOPOGR, V23, P27, DOI 10.1007/s10548-009-0130-5; Low P. A, 2012, PRIMER AUTONOMIC NER, P249, DOI DOI 10.1016/B978-0-12-386525-0.00051-2; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; Malem-Shinitski N, 2018, J NEUROSCI METH, V307, P175, DOI 10.1016/j.jneumeth.2018.04.006; Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897; McCullagh P, 1989, GEN LINEAR MODELS; Mella N, 2011, BRAIN COGNITION, V75, P182, DOI 10.1016/j.bandc.2010.11.012; Mendel JM, 1995, PEARSON ED; Milad MR, 2011, NEUROMETHODS, V50, P111, DOI 10.1007/978-1-60761-883-6_5; Milad MR, 2009, BIOL PSYCHIAT, V66, P1075, DOI 10.1016/j.biopsych.2009.06.026; Moratti S, 2008, ARCH GEN PSYCHIAT, V65, P532, DOI 10.1001/archpsyc.65.5.532; Mueller EM, 2019, PSYCHOL SCI; Nagai Y, 2004, NEUROIMAGE, V22, P243, DOI 10.1016/j.neuroimage.2004.01.019; Norrholm SD, 2006, LEARN MEMORY, V13, P681, DOI 10.1101/lm.393906; Nutt D, 2008, HBK BEHAV NEUROSCI, V17, P365, DOI 10.1016/S1569-7339(07)00017-3; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; Pervanidou P, 2008, J NEUROENDOCRINOL, V20, P632, DOI 10.1111/j.1365-2826.2008.01701.x; Pichon A, 2006, J ELECTROCARDIOL, V39, P31, DOI 10.1016/j.jelectrocard.2005.08.001; Pitman RK, 2012, NAT REV NEUROSCI, V13, P769, DOI 10.1038/nrn3339; Pohjavaara P, 2003, NORD J PSYCHIAT, V57, P55, DOI 10.1080/08039480310000266; Prechelt L, 1998, LECT NOTES COMPUT SC, V1524, P55; Prerau MJ, 2009, J NEUROPHYSIOL, V102, P3060, DOI 10.1152/jn.91251.2008; Prerau MJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003866; Rahman F, 2011, CLIN AUTON RES, V21, P133, DOI 10.1007/s10286-010-0098-y; REGAN M, 1995, PSYCHOPHYSIOLOGY, V32, P208, DOI 10.1111/j.1469-8986.1995.tb02950.x; Rolls ET, 2000, BEHAV BRAIN SCI, V23, P177, DOI 10.1017/S0140525X00002429; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Sano Akane, 2015, Int Conf Wearable Implant Body Sens Netw, V2015, DOI 10.1109/BSN.2015.7299420; Schneider F, 1999, BIOL PSYCHIAT, V45, P863, DOI 10.1016/S0006-3223(98)00269-8; Sevenster D, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00032; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smith AC, 2004, J NEUROSCI, V24, P447, DOI 10.1523/JNEUROSCI.2908-03.2004; Smith AC, 2003, NEURAL COMPUT, V15, P965, DOI 10.1162/089976603765202622; Staib M, 2018, NEUROIMAGE, V166, P276, DOI 10.1016/j.neuroimage.2017.11.009; Stanley GB, 2000, IEEE T BIO-MED ENG, V47, P1147, DOI 10.1109/10.867918; Tanielian TL., 2008, INVISIBLE WOUNDS WAR, V1; Tzovara Athina, 2018, PLoS Comput Biol, V14, pe1006243, DOI 10.1371/journal.pcbi.1006243; VanElzakker MB, 2014, NEUROBIOL LEARN MEM, V113, P3, DOI 10.1016/j.nlm.2013.11.014; Wallentin M, 2011, NEUROIMAGE, V58, P963, DOI 10.1016/j.neuroimage.2011.06.077; Wickramasuriya DS, 2019, IEEE ENG MED BIO, P599, DOI 10.1109/EMBC.2019.8857917; Wickramasuriya DS, 2020, IEEE T BIO-MED ENG, V67, P1749, DOI 10.1109/TBME.2019.2945579; Wickramasuriya DS, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00780; YEHUDA R, 1992, J NERV MENT DIS, V180, P321, DOI 10.1097/00005053-199205000-00006; Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006; Yousefi A, 2019, IEEE T BIO-MED ENG, V66, P3486, DOI 10.1109/TBME.2019.2906640	100	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231659	10.1371/journal.pone.0231659	http://dx.doi.org/10.1371/journal.pone.0231659			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324756	Green Published, Green Submitted, gold			2022-12-26	WOS:000536033700028
J	Zhuang, QY; Lau, ZY; Ong, WS; Yang, GM; Tan, KB; Ong, MEH; Wong, TH				Zhuang, Qingyuan; Lau, Zheng Yi; Ong, Whee Sze; Yang, Grace Meijuan; Tan, Kelvin Bryan; Ong, Marcus Eng Hock; Wong, Ting Hway			Sociodemographic and clinical factors for non-hospital deaths among cancer patients: A nationwide population-based cohort study	PLOS ONE			English	Article							OF-LIFE CARE; PALLIATIVE CARE; END; HOME; PLACE; AGGRESSIVENESS; PREFERENCES; PREDICTORS; INDICATORS; SINGAPORE	Background Factors associated with place of death inform policies with respect to allocating end-of-life care resources and tailoring supportive measures. Objective To determine factors associated with non-hospital deaths among cancer patients. Design Retrospective cohort study of cancer decedents, examining factors associated with non-hospital deaths using multinomial logistic regression with hospital deaths as the reference category. Setting/subjects Cancer patients (n = 15254) in Singapore who died during the study period from January 1, 2012 till December 31, 2105 at home, acute hospital, long-term care (LTC) or hospice were included. Results Increasing age (categories >= 65 years: RRR 1.25-2.61), female (RRR 1.40; 95% CI 1.28-1.52), Malays (RRR 1.67; 95% CI 1.47-1.89), Brain malignancy (RRR 1.92; 95% CI 1.15-3.23), metastatic disease (RRR 1.33-2.01) and home palliative care (RRR 2.11; 95% CI 1.95-2.29) were associated with higher risk of home deaths. Patients with low socioeconomic status were more likely to have hospice or LTC deaths: those living in smaller housing types had higher risk of dying in hospice (1-4 rooms apartment: RRR 1.13-3.17) or LTC (15 rooms apartment: RRR 1.36-4.11); and those with Medifund usage had higher risk of dying in LTC (RRR 1.74; 95% CI 1.36-2.21). Patients with haematological malignancies had increased risk of dying in hospital (categories of haematological subtypes: RRR 0.06-0.87). Conclusions We found key sociodemographic and clinical factors associated with non-hospital deaths in cancer patients. More can be done to enable patients to die in the community and with dignity rather than in a hospital.	[Zhuang, Qingyuan; Yang, Grace Meijuan] Natl Canc Ctr Singapore, Dept Support & Palliat Care, Singapore, Singapore; [Lau, Zheng Yi; Tan, Kelvin Bryan] Minist Hlth, Policy Res & Evaluat Div, Singapore, Singapore; [Ong, Whee Sze] Natl Canc Ctr Singapore, Singapore, Singapore; [Yang, Grace Meijuan] Duke Natl Univ Singapore, Med Sch, Lien Ctr Palliat Care, Singapore, Singapore; [Tan, Kelvin Bryan] Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Ong, Marcus Eng Hock; Wong, Ting Hway] Singapore Gen Hosp, Singapore, Singapore; [Ong, Marcus Eng Hock; Wong, Ting Hway] Duke Natl Univ Singapore, Med Sch, Singapore, Singapore	National Cancer Centre Singapore (NCCS); Ministry of Health-Singapore; National Cancer Centre Singapore (NCCS); National University of Singapore; Singapore General Hospital; National University of Singapore	Zhuang, QY (corresponding author), Natl Canc Ctr Singapore, Dept Support & Palliat Care, Singapore, Singapore.	zhuang.qingyuan@singhealth.com.sg	Yang, Grace/AFS-0236-2022	Yang, Grace/0000-0002-0915-6007				[Anonymous], M810361 KEY IND HOUS; [Anonymous], TOP COD ICD O 2 ICD; [Anonymous], PLAC DEATH DIFF PAT; Barclay JS, 2013, JAMA INTERN MED, V173, P450, DOI 10.1001/jamainternmed.2013.2773; Bekelman JE, 2016, JAMA-J AM MED ASSOC, V315, P272, DOI 10.1001/jama.2015.18603; Blackbox Research, 2014, LIEN FDN SURV DEATH; Bremner KE, 2015, PALLIATIVE MED, V29, P918, DOI 10.1177/0269216315596505; Chastek B, 2012, J ONCOL PRACT, V8, p75S, DOI 10.1200/JOP.2011.000469; Cheung MC, 2015, CANCER-AM CANCER SOC, V121, P3307, DOI 10.1002/cncr.29485; Cohen J, 2015, BRIT J CANCER, V113, P1397, DOI 10.1038/bjc.2015.312; Cohen J, 2010, J CLIN ONCOL, V28, P2267, DOI 10.1200/JCO.2009.23.2850; Davies E, 2004, SOLID FACTS PALLIATI; Davies JM, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002782; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Finkelstein EA, 2015, HEALTH POLICY, V119, P1482, DOI 10.1016/j.healthpol.2015.09.001; Fukui S, 2004, CANCER-AM CANCER SOC, V101, P421, DOI 10.1002/cncr.20383; Fukui S, 2011, ANN ONCOL, V22, P2113, DOI 10.1093/annonc/mdq719; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-7; Gomes B, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0466-5; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Gubhaju B, 2018, ROUTL CONT SE ASIA S, P112; Harrell FE, 2001, REGRESSION MODELING; Higginson IJ, 2013, PALLIATIVE MED, V27, P918, DOI 10.1177/0269216313487940; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Hong CY, 2011, J PALLIAT MED, V14, P1128, DOI 10.1089/jpm.2011.0092; Howell DA, 2013, BMC PALLIAT CARE, V12, DOI 10.1186/1472-684X-12-42; Howell Debra A, 2010, BMC Palliat Care, V9, P9, DOI 10.1186/1472-684X-9-9; Klabunde CN, 2000, J CLIN EPIDEMIOL, V53, P1258, DOI 10.1016/S0895-4356(00)00256-0; Lee A., 1998, SMJ, V39, P447; Lee YS, 2017, J PAIN SYMPTOM MANAG, V53, P1035, DOI 10.1016/j.jpainsymman.2017.01.008; Lim J, 2017, GLOB POLICY, V8, P103, DOI 10.1111/1758-5899.12247; Low LL, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00109; Malhotra C, 2015, PALLIATIVE MED, V29, P842, DOI 10.1177/0269216315578803; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; McCaughan D, 2018, BMJ SUPPORT PALLIAT, V8, P78, DOI 10.1136/bmjspcare-2016-001289; Ministry of Health, COSTS FIN; Moreno-Alonso D, 2018, PALLIATIVE MED, V32, P79, DOI 10.1177/0269216317735246; Nakamura S, 2010, GERIATR GERONTOL INT, V10, P154, DOI 10.1111/j.1447-0594.2009.00570.x; Ng CWL, 2016, PALLIATIVE MED, V30, P843, DOI 10.1177/0269216316634242; Peppercorn JM, 2011, J CLIN ONCOL, V29, P755, DOI 10.1200/JCO.2010.33.1744; Sharon Siddique, 1990, SOJOURN, V5, P35, DOI [10.1355/SJ5-1B, DOI 10.1355/SJ5-1B]; Sussman T, 2017, CAN J AGING, V36, P306, DOI 10.1017/S0714980817000253; Tan WS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215566; Tan WS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024662; Tang ST, 2010, J PAIN SYMPTOM MANAG, V40, P566, DOI 10.1016/j.jpainsymman.2010.01.020; Tanuseputro P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121759; Teo WSK, 2014, PALLIATIVE MED, V28, P430, DOI 10.1177/0269216314526270; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO Media centre, 2018, CANC FACT SHEET; Wong TH, 2017, CANCER-AM CANCER SOC, V123, P1998, DOI 10.1002/cncr.30557; Yan S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10878; Yvonne A, 2019, LEAVING WELL END OF	56	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232219	10.1371/journal.pone.0232219	http://dx.doi.org/10.1371/journal.pone.0232219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324837	gold, Green Published			2022-12-26	WOS:000536033700089
J	Abitew, DB; Yalew, AW; Bezabih, AM; Bazzano, AN				Abitew, Dereje Birhanu; Yalew, Alemayehu Worku; Bezabih, Afework Mulugeta; Bazzano, Alessandra N.			Predictors of relapse of acute malnutrition following exit from community-based management program in Amhara region, Northwest Ethiopia: An unmatched case-control study	PLOS ONE			English	Article							RISK-FACTORS; CHILDREN; UNDERNUTRITION; WATER	Background Community-based management of acute malnutrition (CMAM) is an effective program to manage children with acute malnutrition, including both severe and moderate acute malnutrition. However, little is known about continued child nutritional status after discharge from community based management of acute malnutrition programs in Ethiopia. Objective The study aimed to identify factors associated with relapse of acute malnutrition among children 6-59 months after been discharged recovered from community based management program in South Gondar Zone, Northwest Ethiopia. Methods A case-control study was conducted in three districts of South Gondar Zone by tracing children age 6-59 months who were reported as recovered from the community based management program. Sample size calculated for the first objective of assessing prevalence of severe acute malnutrition among children following discharge as recovery using Epi-Info version 7.1.3.3 StatCalc taking 95% CL, 17.8% post discharge relapse (Ashraf H, et al. (2012), 3% margin of error, design effect of 2 and adding 5% non-response rate was the largest sample size and used to this study. Children with Mid Upper Arm Circumference (MUAC) < 12.5cm constituted cases and children with > = 12.5cm served as controls. Data were collected from 10 November 2017 to 30 January 2018 using a survey questionnaire and families were asked to bring children to a health facility for anthropometric measurements, following which data were entered and analyzed. Bivariate and multivariable logistic regression models were utilized to measure association between the risk factors and acute malnutrition. Results Overall, 1,273 participants were interviewed. The mean age in months of children was 23.1 (+/- 9.1 SD) for cases and 23.1 (+/- 8.9 SD) for controls. About 40% of the cases and 50% of the controls were female children. The factors associated with acute malnutrition were: male children (AOR = 1.84, 95% CI: 1.42-2.39), living in a food insecure household (AOR = 1.67, 95% CI:1.15-2.44), non-receipt of Vitamin A supplement (AOR = 1.76, 95% CI: 1.28-2.41), prelacteal feeding (AOR = 2.81 (95%CI, 1.57-5.05), distance to water source more than 15 walk (AOR = 1.88, 95% CI:1.32-2.71), less frequent self-reported hand washing (AOR = 1.35, 95% CI:1.05-1.75), mother not having consumed extra food during this pregnancy/lactation (AOR = 1.36, 95% CI: 1.03-1.78), and respondent age above 30 years (AOR = 1.43, 95% CI:1.10-1.87). Conclusion The key factors contributing to relapse of acute malnutrition were related to childcare and feeding practices. Social and behavior change communication strategies targeting families at risk of undernutrition, along with improved food security and integrated programming are recommended to prevent relapse of acute malnutrition.	[Abitew, Dereje Birhanu; Yalew, Alemayehu Worku] Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia; [Bezabih, Afework Mulugeta] Mekelle Univ, Sch Publ Hlth, Mekele, Ethiopia; [Bazzano, Alessandra N.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Global Community Hlth & Behav Sci, New Orleans, LA USA	Addis Ababa University; Mekelle University; Tulane University	Abitew, DB (corresponding author), Addis Ababa Univ, Sch Publ Hlth, Addis Ababa, Ethiopia.	derejefrae2014@gmail.com		Birhanu, Dereje/0000-0001-6373-0826; Mulugeta, Afework/0000-0003-0707-4363; Bazzano, Alessandra N./0000-0002-8299-2626	Addis Ababa University, School of Public Health	Addis Ababa University, School of Public Health	This study was funded by Addis Ababa University, School of Public Health who provide money for data collection but the funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuka T., 2017, PEDIAT THER, V7; Ajao KO, 2010, AFRICAN J REPROD HLT, V14; Ambadekar NN, 2017, PUBLIC HEALTH, V142, P136, DOI 10.1016/j.puhe.2016.07.018; [Anonymous], PROGR NUTR SPEC INT; [Anonymous], 2017, S GONDAR ZONE HLTH D; [Anonymous], 2018, SPHERE HDB HUMANITAR; Ayana AB., 2015, BMC NUTR, V1, P34, DOI [10.1186/s40795-015-0031-9, DOI 10.1186/S40795-015-0031-9]; Banerjee C., 2016, FOLLOW STATUS CHILDR; Bhutta ZA, 2013, LANCET, V382, P452, DOI 10.1016/S0140-6736(13)60996-4; Bisrat G., 2017, GLOBAL J MED RES; Brown J, 2013, ARCH DIS CHILD, V98, P629, DOI 10.1136/archdischild-2011-301528; Burza S, 2016, EUR J CLIN NUTR, V70, P437, DOI 10.1038/ejcn.2015.140; Chang CY, 2013, J NUTR, V143, P215, DOI 10.3945/jn.112.168047; Chowdhury MRK, 2016, J PEDIATR-US, V172, P194, DOI 10.1016/j.jpeds.2016.01.023; Ciliberto MA, 2005, AM J CLIN NUTR, V81, P864, DOI 10.1093/ajcn/81.4.864; Coates J., 2007, FOOD NUTR TECHNICAL; Collins S, 2002, LANCET, V360, P1824, DOI 10.1016/S0140-6736(02)11770-3; Collins S., 2003, LETTER, V362; Collins S, 2007, ARCH DIS CHILD, V92, P453, DOI 10.1136/adc.2006.098327; Concern-Worldwide, 2010, EV NAT COMM MAN AC M; CSA, 2013, POPULATION PROJECTIO; Dale NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055404; Das S, 2011, ANTHROPOLOGIST, V13, P227, DOI 10.1080/09720073.2011.11891201; Demissie S., 2013, SCI J PUBLIC HLTH, V1, P175, DOI [10.11648/j.sjph.20130104.12, DOI 10.11648/J.SJPH.20130104.12]; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Dodos J, 2018, ARCH PUBLIC HEALTH, V76, DOI 10.1186/s13690-018-0281-5; EDHS, 2011, ETH DEM HLTH SURV AD; EDHS central statistics agency, 2016, ETH DEM HLTH SURV AD; Eshetu A., 2016, QUAL PRIM CARE, V24, P181; Federal Ministry of Health, 2007, PROT MAN SEV AC MALN; FMOH, 2013, TRAN COURS MAN SEV A; Forsen E, 2015, MATERN CHILD NUTR, V11, P962, DOI 10.1111/mcn.12076; Frozanfar MK, 2016, NAGOYA J MED SCI, V78, P41; Fuchs C, 2014, INT J PEDIAT, V2014, DOI 10.1155/2014/267806; Gewa CA, 2012, PUBLIC HEALTH NUTR, V15, P1029, DOI 10.1017/S136898001100245X; Gone T, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0221-y; Huang ZY, 2018, J CLIN MED, V7, DOI 10.3390/jcm7090258; Hug L., 2020, LEVELS TRENDS CHILD; James P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153530; Kumi-Kyereme A, 2016, J EPIDEMIOL GLOB HEA, V6, P131, DOI 10.1016/j.jegh.2015.05.001; Lama N, 2018, INT J COMMUNITY MED, V5, P5045; Legesse M, 2014, INT BREASTFEED J, V9, DOI 10.1186/s13006-014-0025-2; Maust A., 2015, J NUTR; Mekuria G, 2015, INT BREASTFEED J, V10, DOI 10.1186/s13006-014-0027-0; Mishra K, 2014, INDIAN J PEDIATR, V81, P762, DOI 10.1007/s12098-013-1127-3; Miskir A., 2017, QUALITY PRIMARY CARE, V25, P242; Musa M.K., 2017, J MED SCI HLTH, P13; Nzala S. H., 2011, Journal of Public Health and Epidemiology, V3, P362; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Prashanth M., 2017, INT J CONT PEDIAT, V4, P1721, DOI [10.18203/2349, DOI 10.18203/2349-3291.IJCP20173773]; Pravana NK, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017084; Rayhan MI, 2006, PAK J NUTR, V5, P558, DOI [DOI 10.3923/PJN.2006.558.562, 10.3923/pjn.2006.558.562]; Sanghvi J., 2014, PREDICATORS WEIGHT G, P1; Seid A, 2017, J NUTR METAB, V2017, DOI 10.1155/2017/7265972; Somasse Yassinme Elysee, 2015, MATERNAL CHILD NUTRT, P1; Tadesse E, 2018, MATERN CHILD NUTR, V14, DOI 10.1111/mcn.12519; Talati Kandarp N, 2016, BMJ GLOB HLTH, V1; Talukder A, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4100088; Teferi E, 2010, ETHIOP J HEALTH DEV, V24, P234; Tekeste Asayehegn, 2012, Cost Eff Resour Alloc, V10, P4, DOI 10.1186/1478-7547-10-4; Tewabe T, 2017, INT BREASTFEED J, V12, DOI 10.1186/s13006-017-0103-3; Todd B, 2005, ASSESSMENT CAUSES MA; Tongun JB, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1523304; Trehan I, 2015, J PEDIATR GASTR NUTR, V60, P544, DOI 10.1097/MPG.0000000000000639; Tsedeke W., 2016, J NUTR FOOD SCI, V6, P2; UNICEF, 2019, MIN QUAL STAND IND C; United Nations Children's Fund (UNICEF), 2010, FACTS LIF, VFourth; Valid-International and Concern-Worldwide, 2006, FIELD MANUAL; van Cooten MH, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12631; WHO, 2011, GUID VIT SUPPL INF C; WHO-WORLD HEALTH ORGANIZATION, 2009, INF YOUNG CHILD FEED; World Health Organization , 2007, COMM BAS MAN SEV AC; World Health Organization, 2007, CHILD GROWTH STAND; World Health Organization, 1999, MAN SEV MALN MAN PHY; World Health Organization, 2013, GUID UPD MAN SEV AC; World Health Organization, 2015, IMPR NUTR OUTC BETT; World Health Organization, 2013, ESS NUTR ACT IMPR MA	77	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231524	10.1371/journal.pone.0231524	http://dx.doi.org/10.1371/journal.pone.0231524			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320426	Green Published, gold			2022-12-26	WOS:000536028800025
J	Fabre, MS; Stanton, NM; Slatter, TL; Lee, S; Senanayake, D; Gordon, RMA; Castro, ML; Rowe, MR; Taha, A; Royds, JA; Hung, N; Melnick, AM; McConnell, MJ				Fabre, Marie-Sophie; Stanton, Nicole M.; Slatter, Tania L.; Lee, Samuel; Senanayake, Dinindu; Gordon, Rosemary M. A.; Castro, M. Leticia; Rowe, Matthew R.; Taha, Ahmad; Royds, Janice A.; Hung, Noelyn; Melnick, Ari M.; McConnell, Melanie J.			The oncogene BCL6 is up-regulated in glioblastoma in response to DNA damage, and drives survival after therapy	PLOS ONE			English	Article							EXPRESSION PREDICTS; STEM-CELLS; OVEREXPRESSION; TRANSLOCATION; INHIBITOR; MUTATIONS; ADJUVANT; INCREASE; TARGET	The prognosis for people with the high-grade brain tumor glioblastoma is very poor, due largely to low cell death in response to genotoxic therapy. The transcription factor BCL6, a protein that normally suppresses the DNA damage response during immune cell maturation, and a known driver of B-cell lymphoma, was shown to mediate the survival of glioblastoma cells. Expression was observed in glioblastoma tumor specimens and cell lines. When BCL6 expression or activity was reduced in these lines, increased apoptosis and a profound loss of proliferation was observed, consistent with gene expression signatures suggestive of anti-apoptotic and pro-survival signaling role for BCL6 in glioblastoma. Further, treatment with the standard therapies for glioblastoma-ionizing radiation and temozolomide-both induced BCL6 expression in vitro, and an in vivo orthotopic animal model of glioblastoma. Importantly, inhibition of BCL6 in combination with genotoxic therapies enhanced the therapeutic effect. Together these data demonstrate that BCL6 is an active transcription factor in glioblastoma, that it drives survival of cells, and that it increased with DNA damage, which increased the survival rate of therapy-treated cells. This makes BCL6 an excellent therapeutic target in glioblastoma-by increasing sensitivity to standard DNA damaging therapy, BCL6 inhibitors have real potential to improve the outcome for people with this disease.	[Fabre, Marie-Sophie; Stanton, Nicole M.; Lee, Samuel; Senanayake, Dinindu; Gordon, Rosemary M. A.; Castro, M. Leticia; Rowe, Matthew R.; McConnell, Melanie J.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand; [Fabre, Marie-Sophie; Stanton, Nicole M.; Lee, Samuel; Senanayake, Dinindu; Gordon, Rosemary M. A.; Castro, M. Leticia; Rowe, Matthew R.; McConnell, Melanie J.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Fabre, Marie-Sophie; Stanton, Nicole M.; Rowe, Matthew R.; McConnell, Melanie J.] Malaghan Inst Med Res, Wellington, New Zealand; [Slatter, Tania L.; Royds, Janice A.; Hung, Noelyn] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Taha, Ahmad] Southern Dist Hlth Board, Neurosurg, Dunedin, New Zealand; [Melnick, Ari M.] Weill Cornell Med Coll, New York, NY USA	Victoria University Wellington; Victoria University Wellington; Malaghan Institute; Victoria University Wellington; University of Otago; Dunedin Public Hospital; Cornell University	McConnell, MJ (corresponding author), Victoria Univ Wellington, Ctr Biodiscovery, Wellington, New Zealand.; McConnell, MJ (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.; McConnell, MJ (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	Melanie.mcconnell@vuw.ac.nz		Stanton, Nicole/0000-0001-5058-6060; Gordon, Rose/0000-0002-2970-4971; Lee, Samuel/0000-0002-6805-4051	Cancer Society of New Zealand [CSNZ13/25]; Genesis Oncology Trust [1155RPG, 1457-RPG]; Victoria University of Wellington [211159]; Cancer Society of New Zealand, Wellington Division, CT Collins PhD scholarship 2014-2017	Cancer Society of New Zealand; Genesis Oncology Trust; Victoria University of Wellington; Cancer Society of New Zealand, Wellington Division, CT Collins PhD scholarship 2014-2017	Financial support came from the following funders: Cancer Society of New Zealand CSNZ13/25 (MJM); Genesis Oncology Trust 1155RPG (MJM) and 1457-RPG (MJM); Victoria University of Wellington 211159 (MJM). Cancer Society of New Zealand, Wellington Division, CT Collins PhD scholarship 2014-2017 (NMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Authier A, 2015, INT J CANCER, V136, P2566, DOI 10.1002/ijc.29309; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Broadley KWR, 2011, STEM CELLS, V29, P452, DOI 10.1002/stem.582; Cardenas MG, 2016, J CLIN INVEST, V126, P3351, DOI 10.1172/JCI85795; Cerchietti LC, 2010, J CLIN INVEST, V120, P4569, DOI 10.1172/JCI42869; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Chamdin A, 2009, TRANSL ONCOL, V2, P128, DOI 10.1593/tlo.08220; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen YW, 2006, BLOOD, V108, P2373, DOI 10.1182/blood-2006-05-022517; DEWEINDT C, 1995, CELL GROWTH DIFFER, V6, P1495; Duy C, 2011, NATURE, V473, P384, DOI 10.1038/nature09883; Feldman LA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184250; Fernando TM, 2019, CANCER DISCOV, V9, P662, DOI 10.1158/2159-8290.CD-17-1444; Grasso C, 2014, FRONT ONCOL, V4, DOI [10.3389/fonc.2014.003560, 10.3389/fonc.2014.00356]; Hsu CY, 2013, AM J SURG PATHOL, V37, P264, DOI 10.1097/PAS.0b013e318267b061; Hunn MK, 2012, CLIN CANCER RES, V18, P6446, DOI 10.1158/1078-0432.CCR-12-0704; Infanger DW, 2013, CANCER RES, V73, P7079, DOI 10.1158/0008-5472.CAN-13-1355; Jones NM, 2016, INT J ONCOL, V49, P207, DOI 10.3892/ijo.2016.3510; Kepp O, 2009, APOPTOSIS, V14, P364, DOI 10.1007/s10495-008-0303-9; Kurosu T, 2003, ONCOGENE, V22, P4459, DOI 10.1038/sj.onc.1206755; Lathia JD, 2015, GENE DEV, V29, P1203, DOI 10.1101/gad.261982.115; Liang PI, 2014, TUMOR BIOL, V35, P1417, DOI 10.1007/s13277-013-1195-z; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lossos C, 2014, BRIT J HAEMATOL, V165, P640, DOI 10.1111/bjh.12801; Parekh S, 2008, LEUKEMIA LYMPHOMA, V49, P874, DOI 10.1080/10428190801895345; Patel VN, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003237; Perez-Rosado A, 2008, J PATHOL, V214, P498, DOI 10.1002/path.2279; Pietras A, 2014, CELL STEM CELL, V14, P357, DOI 10.1016/j.stem.2014.01.005; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Ribeiro IP, 2014, CELL ONCOL, V37, P29, DOI 10.1007/s13402-013-0161-5; Ruggieri S, 2014, CANCER LETT, V353, P41, DOI 10.1016/j.canlet.2014.06.017; Sena P, 2014, ONCOL REP, V31, P103, DOI 10.3892/or.2013.2846; Stegh AH, 2008, CELL CYCLE, V7, P2833, DOI 10.4161/cc.7.18.6759; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takeda N, 2003, J IMMUNOL, V171, P426, DOI 10.4049/jimmunol.171.1.426; Tiberi L, 2014, CANCER CELL, V26, P797, DOI 10.1016/j.ccell.2014.10.021; Valls E, 2017, CANCER DISCOV, V7, P506, DOI 10.1158/2159-8290.CD-16-1189; Walker SR, 2015, ONCOGENE, V34, P1073, DOI 10.1038/onc.2014.61; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013; Xu L, 2017, P NATL ACAD SCI USA, V114, P3981, DOI 10.1073/pnas.1609758114; Xu YY, 2015, CANCER BIOL MED, V12, P223, DOI 10.7497/j.issn.2095-3941.2015.0020; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	42	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231470	10.1371/journal.pone.0231470	http://dx.doi.org/10.1371/journal.pone.0231470			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LL9BH	32320427	gold, Green Published			2022-12-26	WOS:000531847200001
J	Desai, AN; Seshasayee, SM; Majumder, MS; Lassmann, B; Madoff, LC; Cohn, EL; Brownstein, JS				Desai, Angel N.; Seshasayee, Shravanthi M.; Majumder, Maimuna S.; Lassmann, Britta; Madoff, Lawrence C.; Cohn, Emily L.; Brownstein, John S.			Tuberculosis and foreign-born populations in the United States: A mixed methods pilot study of media reporting and political identification	PLOS ONE			English	Article							NEWSPAPER COVERAGE	Background Media reporting on communicable diseases has been demonstrated to affect the perception of the public. Communicable disease reporting related to foreign-born persons has not yet been evaluated. Objective Examine how political leaning in the media affects reporting on tuberculosis (TB) in foreign-born persons. Methods HealthMap, a digital surveillance platform that aggregates news sources on global infectious diseases, was used. Data was queried for media reports from the U.S. between 2011-2019, containing the term "TB" or "tuberculosis" and "foreign born", "refugee (s)," or "im (migrants)." Reports were reviewed to exclude duplicates and non-human cases. Each media source was rated using two independent media bias indicators to assess political leaning. Forty-six non-tuberculosis reports were randomly sampled and evaluated as a control. Two independent reviewers performed sentiment analysis on each report. Results Of 891 TB-associated reports in the US, 46 referenced foreign-born individuals, and were included in this analysis. 60.9% (28) of reports were published in right-leaning news media and 6.5% (3) of reports in left-leaning media, while 39.1% (18) of the control group reports were published in left- leaning media and 10.9% (5) in right-leaning media (p <.001). 43% (20) of all study reports were posted in 2016. Sentiment analysis revealed that right-leaning reports often portrayed foreign-born persons negatively. Conclusion Preliminary data from this pilot suggest that political leaning may affect reporting on TB in US foreign-born populations. Right-leaning news organizations produced the most reports on TB, and the majority of these reports portrayed foreign-born persons negatively. In addition, the control group comprised of non-TB, non-foreign born reports on communicable diseases featured a higher percentage of left-leaning news outlets, suggesting that reporting on TB in foreign-born individuals may be of greater interest to right-leaning outlets. Further investigation both in the U.S. and globally is needed.	[Desai, Angel N.] Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA; [Desai, Angel N.; Lassmann, Britta; Madoff, Lawrence C.] Int Soc Infect Dis, Boston, MA 02115 USA; [Seshasayee, Shravanthi M.] Maine Med Ctr, Res Inst, Ctr Outcomes Res & Evaluat, Portland, ME 04102 USA; [Majumder, Maimuna S.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA; [Majumder, Maimuna S.; Cohn, Emily L.; Brownstein, John S.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Madoff, Lawrence C.] Boston Childrens Hosp, Computat Epidemiol Lab, Boston, MA USA; [Cohn, Emily L.; Brownstein, John S.] Univ Massachusetts, Div Infect Dis, Worcester, MA 01605 USA	Harvard University; Brigham & Women's Hospital; Maine Medical Center; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Desai, AN (corresponding author), Brigham & Womens Hosp, Div Infect Dis, 75 Francis St, Boston, MA 02115 USA.; Desai, AN (corresponding author), Int Soc Infect Dis, Boston, MA 02115 USA.	angel.n.desai@gmail.com		Lassmann, Britta/0000-0003-0807-9297; Majumder, Maimuna/0000-0002-3986-4303; Desai, Angel/0000-0001-8962-9427	National Institute of Allergy and Infectious Diseases [T32 AI007433]; International Society for Infectious Diseases	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); International Society for Infectious Diseases	AND reported receiving support from Grant Number T32 AI007433 from the National Institute of Allergy and Infectious Diseases, and its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. AND, BL, and LCM reported receiving support from the International Society for Infectious Diseases (https://www.isid.org/).The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akdenizli B, DEMOCRACY AGE NEW ME; [Anonymous], TUB DAT STAT; [Anonymous], 2018, US POL GOV; Baker BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147353; BENHABIB B, 1987, IEEE T ROBOTIC AUTOM, V3, P317, DOI 10.1109/JRA.1987.1087112; Berry M, 2015, PRESS COVERAGE REFUG; Breban R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028300; CDC, 1953, TB INC US; Collinson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141423; Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544; Frost K, 1997, AM J PUBLIC HEALTH, V87, P842, DOI 10.2105/AJPH.87.5.842; Hilton S, 2011, J EPIDEMIOL COMMUN H, V65, P941, DOI 10.1136/jech.2010.119875; Kostkova P, 2013, J MED INTERNET RES, V15, P167, DOI 10.2196/jmir.2146; KRISTIANSEN CM, 1983, EUR J SOC PSYCHOL, V13, P193, DOI 10.1002/ejsp.2420130208; Leahy MP, 2016, BREITBART NEWS  0609; Leahy MP, 2016, BREITBART NEWS  0714; MCCOMBS ME, 1972, PUBLIC OPIN QUART, V36, P176, DOI 10.1086/267990; Menjivar C, 2016, AM BEHAV SCI, V60, P597, DOI 10.1177/0002764216632836; Pew Research Center, 2014, POLITICAL POLARIZATI; Smith KC, 2013, INFLUENZA OTHER RESP, V7, P847, DOI 10.1111/irv.12073; Sun CJ, 2011, MATH BIOSCI, V230, P87, DOI 10.1016/j.mbs.2011.01.005; Tsang CA, 2017, MMWR-MORBID MORTAL W, V66, P295, DOI 10.15585/mmwr.mm6611a3; Walsh S, 2015, EPIDEMIOL INFECT, V143, P550, DOI 10.1017/S0950268814000752; World Health Organization, 2015, GLOB TUB REP 2015; Young, 2008, PLOS ONE	25	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230967	10.1371/journal.pone.0230967	http://dx.doi.org/10.1371/journal.pone.0230967			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315312	Green Published, gold			2022-12-26	WOS:000536024800015
J	Efa, BW; Berhanie, E; Desta, KW; Hinkosa, L; Fetensa, G; Etafa, W; Tsegaye, R				Efa, Bizuneh Wakuma; Berhanie, Emebet; Desta, Kalkidan Wondwossen; Hinkosa, Leta; Fetensa, Getahun; Etafa, Werku; Tsegaye, Reta			Essential new-born care practices and associated factors among post natal mothers in Nekemte City, Western Ethiopia	PLOS ONE			English	Article								Background New-born survival is a prominent goal on the global health agenda and an important area of focus for programs seeking to ensure child survival. Geographically, neonatal deaths are most prevalent in Sub-Saharan Africa and southern Asia, accounting for 39% and 38% of all neonatal deaths respectively while Ethiopia in particular has 28% neonatal death. Promotion of essential new-born care practice is one of a cheap approach to improve health outcomes of new-born babies. Thus, this study was aimed to assess the magnitude of essential newborn care practices and associated factors among postnatal mothers in Nekemte city, Western Ethiopia. Methods An institution-based cross-sectional study was conducted from February to March, 2017, in Nekemte city, East Wollega Zone. Data was collected from 417 randomly selected mothers who have less than six months infants by face to face interview in three public health institutions of Nekemte City, Ethiopia. Women who were not biological mother to the new-born were excluded from the study. The collected data were coded, cleaned and entered using Epi-Data version 3.1 and analysed using Statistical Package for Social Science (SPSS) version 21.0. Both bivariable and multivariable logistic regression analysis were computed to identify associated factors. The strength of association was measured by odds ratios with 95% confidence interval (CI) at a p-value of < 0.05 and finally obtained results were presented by using simple frequency tables, graphs, and charts. Results The study revealed that the level of essential new-born care practice was 184(44.1%). The overall safe cord care practice of the respondents was 285 (68.3%) while the optimal thermal care practices and good neonatal feeding were 328 (78.7%) and 322 (77.2%) respectively. Having visit to Antenatal Care (ANC) [Adjusted Odds Ratio (AOR) = 4.38, 95% CI = (1.38, 13.94)], knowledge of essential new-born care [AOR = 4.58, 95% CI = (2.93, 7.16)], and counselled about essential new-born care [AOR = 2.32, 95% CI = (1.38, 3.91)] were factors significantly associated with good practices of essential new-born care. Conclusion This study indicated that the level of essential new-born care practice was unsatisfactory in the study area. Promotion of essential new-born care through the provision of community awareness and provision of counselling on essential new-born care and neonatal danger signs to all pregnant women should be given emphasis.	[Efa, Bizuneh Wakuma; Hinkosa, Leta; Fetensa, Getahun; Etafa, Werku; Tsegaye, Reta] Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia; [Berhanie, Emebet; Desta, Kalkidan Wondwossen] Addis Ababa Univ, Sch Allied Hlth Sci, Dept Nursing & Midwifery, Addis Ababa, Ethiopia	Addis Ababa University	Tsegaye, R (corresponding author), Wollega Univ, Inst Hlth Sci, Sch Nursing & Midwifery, Nekemte, Ethiopia.	retatg@gmail.com	Hirko, Getahun Fetensa/ABY-0109-2022; Ebi, Werku Etafa/Q-2742-2019	Ebi, Werku Etafa/0000-0001-9576-8888; Desta, Kalkidan Wondwossen/0000-0002-3508-1272; Tsegaye, Reta/0000-0003-4721-3647	Addis Ababa University	Addis Ababa University	BW received funding for this study from Addis Ababa University. The funder has no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Ababor S, 2019, ETHIOP J HEALTH SCI, V29, P343, DOI 10.4314/ejhs.v29i3.6; [Anonymous], 2004, WHAT WORKS CHILDREN; [Anonymous], 2014, MANAGEMENT PROTOCOL; [Anonymous], 2015, NATL NEWB CHILD SURV; Berhe M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175902; Berhea TA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202542; Callaghan-Koru JA, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-198; Carvajal-Aguirre L, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020508; Central statistical agency (CSA) [Ethiopia] and ICF, 2016, ETH DEM HLTH SURV 20; Chaudhary J., 2013, J CHITWAN MED COLL, V3, P42, DOI [DOI 10.3126/jcmc.v3i1.8465, 10.3126/jcmc.v3i1.8465, DOI 10.3126/JCMC.V3I1.8465]; Chichiabellu TY, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0609-1; Costello A, 2000, CURRENT STATE HLTH N; Federal Democratic Republic of Ethiopia Ministry of Health, 2010, MAN PROT SEL OBST TO; Gebretsadik A, 2018, DOVE PRESS J PEDIAT; Hug L, 2017, LEVELS TRENDS CHILD; Kokebie T., 2015, INT J ADV SCI RES, V1, P17, DOI [DOI 10.7439/ijasr.v1i1.1637, 10.7439/ijasr.v1i1.1637, DOI 10.7439/IJASR.V1I1.1637]; Mersha A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208984; Monebenimp F., 2013, HLTH SCI DIS, V14; Rahman M, 2011, JOGNN-J OBST GYN NEO, V40, P262, DOI 10.1111/j.1552-6909.2011.01240.x; Reshma, 2014, NITTE UNIV J HEALTH, V4, P21; Saaka M, 2014, INT J POPUL RES, V2014, P10, DOI DOI 10.1155/2014/404387; Semanew Y, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4133-3; Setegn T, 2011, BMC PUBLIC HEALTH, V11, P1; Shrestha T, 2013, J NEPAL MED ASS, V52; Sinha LN, 2014, WEST PAC SURVEILL RE, V5, P22, DOI [10.5365/wpsar.2014.5.1.006, 10.5365/WPSAR.2014.5.1.006]; Tafere TE, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0544-3; Tinker A, 2010, GLOB PUBLIC HEALTH, V5, P28, DOI 10.1080/17441690903286572; Waiswa P, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-9; World Health Organization, 1996, REP TECHN WORK GROUP; You DZ, 2015, LANCET, V386, P2275, DOI 10.1016/S0140-6736(15)00120-8	30	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231354	10.1371/journal.pone.0231354	http://dx.doi.org/10.1371/journal.pone.0231354			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315342	Green Published, gold			2022-12-26	WOS:000536024800025
J	Hanitsch, LG; Kruger, R; Hoppe, PA; Humme, D; Pokrywka, A; Niebank, M; Stegemann, M; Kola, A; Leistner, R				Hanitsch, Leif G.; Krueger, Renate; Hoppe, Pia-Alice; Humme, Daniel; Pokrywka, Anna; Niebank, Michaela; Stegemann, Miriam; Kola, Axel; Leistner, Rasmus			Outpatient decolonization after recurrent skin infection with Panton-Valentine leukocidin (PVL)-producing S. aureus-The importance of treatment repetition	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; TRANSMISSION; PREVENTION; MANAGEMENT; SOCIETY; DISEASE; SPREAD; UPDATE	Background Recurrent skin abscesses are often associated with Panton-Valentine leukocidin-producing strains of S. aureus (PVL-SA). Decolonization measures are required along with treatment of active infections to prevent re-infection and spreading. Even though most PVL-SA patients are treated as outpatients, there are few studies that assess the effectiveness of outpatient topical decolonization in PVL-SA patients. Methods We assessed the results of topical decolonization of PVL-SA in a retrospective review of patient files and personal interviews. Successful decolonization was defined as the absence of any skin abscesses for at least 6 months after completion of the final decolonization treatment. Clinical and demographic data was assessed. An intention-to-treat protocol was used. Results Our cohort consisted of 115 symptomatic patients, 66% from PVL-positive MSSA and 19% from PVL-positive MRSA. The remaining 16% consisted of symptomatic patients with close contact to PVL-SA positive index patients but without detection of PVL-SA. The majority of patients were female (66%). The median age was 29.87% of the patients lived in multiple person households. Our results showed a 48% reduction in symptomatic PVL-SA cases after the first decolonization treatment. The results also showed that the decrease continued with each repeated decolonization treatment and reached 89% following the 5th treatment. A built multivariable Cox proportional-hazards model showed that the absence of PVL-SA detection (OR 2.0) and living in single person households (OR 2.4) were associated with an independently increased chance of successful decolonization. Conclusion In our cohort, topical decolonization was a successful preventive measure for reducing the risk of PVL-SA skin abscesses in the outpatient setting. Special attention should be given to patients living in multiple person households because these settings could confer a risk that decolonization will not be successful.	[Hanitsch, Leif G.] Charite Univ Med Berlin, Inst Med Immunol, Berlin, Germany; [Hanitsch, Leif G.; Krueger, Renate; Hoppe, Pia-Alice; Humme, Daniel; Pokrywka, Anna; Niebank, Michaela; Stegemann, Miriam; Leistner, Rasmus] Charite Univ Med Berlin, Interdisciplinary Workgrp PVL Posit S Aureus, Berlin, Germany; [Krueger, Renate; Hoppe, Pia-Alice] Charite Univ Med Berlin, Dept Pediat Pulmonol & Immunol, Berlin, Germany; [Humme, Daniel; Pokrywka, Anna] Charite Univ Med Berlin, Dept Dermatol & Allergy, Berlin, Germany; [Niebank, Michaela; Stegemann, Miriam] Charite Univ Med Berlin, Dept Internal Med Infect Dis & Pulm Med, Berlin, Germany; [Kola, Axel; Leistner, Rasmus] Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Leistner, R (corresponding author), Charite Univ Med Berlin, Interdisciplinary Workgrp PVL Posit S Aureus, Berlin, Germany.; Leistner, R (corresponding author), Charite Univ Med Berlin, Inst Hyg & Environm Med, Berlin, Germany.	rasmus.leistner@charite.de		Stegemann, Miriam Songa/0000-0002-7968-0429; Leistner, Rasmus/0000-0002-1225-9023; Hanitsch, Leif G./0000-0002-8181-0093				Bagge K, 2019, EUR J CLIN MICROBIOL, V38, P683, DOI 10.1007/s10096-019-03474-6; Buehlmann M, 2008, INFECT CONT HOSP EP, V29, P510, DOI 10.1086/588201; Calfee DP, 2003, INFECT CONT HOSP EP, V24, P422, DOI 10.1086/502225; Cespedes C, 2005, J INFECT DIS, V191, P444, DOI 10.1086/427240; Coll F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9745; Daum RS, 2017, NEW ENGL J MED, V376, P2545, DOI 10.1056/NEJMoa1607033; Davis MF, 2012, LANCET INFECT DIS, V12, P703, DOI 10.1016/S1473-3099(12)70156-1; Edelstein Michael, 2011, J Infect Public Health, V4, P145, DOI 10.1016/j.jiph.2011.04.001; Ellington MJ, 2009, EUR J CLIN MICROBIOL, V28, P1113, DOI 10.1007/s10096-009-0757-x; Fogo A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5343; Gillet Y, 2011, INT J ANTIMICROB AG, V38, P457, DOI 10.1016/j.ijantimicag.2011.05.003; Hoppe PA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3281-8; Jaton L, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2016.05.026; Kapadia S, 2018, J HOSP INFECT; Knox J, 2015, TRENDS MICROBIOL, V23, P437, DOI 10.1016/j.tim.2015.03.007; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Mollema FPN, 2010, J CLIN MICROBIOL, V48, P202, DOI 10.1128/JCM.01499-09; Petersen IS, 2019, J HOSP INFECT; Planet PJ, 2017, J INFECT DIS, V215, pS71, DOI 10.1093/infdis/jiw444; Rasigade JP, 2010, J INFECT DIS, V201, P1589, DOI 10.1086/652008; Saeed K, 2018, INT J ANTIMICROB AG, V51, P16, DOI 10.1016/j.ijantimicag.2017.11.002; Septimus EJ, 2016, CLIN MICROBIOL REV, V29, P201, DOI 10.1128/CMR.00049-15; Shallcross LJ, 2010, CLIN MICROBIOL INFEC, V16, P1644, DOI 10.1111/j.1469-0691.2010.03153.x; Shallcross LJ, 2013, LANCET INFECT DIS, V13, P43, DOI 10.1016/S1473-3099(12)70238-4; Skov R, 2012, INT J ANTIMICROB AG, V39, P193, DOI 10.1016/j.ijantimicag.2011.09.029; Stevens DL, 2014, CLIN INFECT DIS, V59, P147, DOI [10.1093/cid/ciu444, 10.1093/cid/ciu296]; Uhlemann AC, 2014, P NATL ACAD SCI USA, V111, P6738, DOI 10.1073/pnas.1401006111; Votintseva AA, 2014, J CLIN MICROBIOL, V52, P1192, DOI 10.1128/JCM.03254-13; Warren DK, 2004, J CLIN MICROBIOL, V42, P5578, DOI 10.1128/JCM.42.12.5578-5581.2004; Wiese-Posselt M, 2007, CLIN INFECT DIS, V44, pE88, DOI 10.1086/517503; Zanger P, 2012, CLIN INFECT DIS, V54, P483, DOI 10.1093/cid/cir822	31	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231772	10.1371/journal.pone.0231772	http://dx.doi.org/10.1371/journal.pone.0231772			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315364	Green Published, gold			2022-12-26	WOS:000536024800054
J	Munhoz, MDES; Pomini, KT; Plepis, AMD; Martins, VDA; Machado, EG; de Moraes, R; Cunha, FB; Santos, AR; Cardoso, GBC; Duarte, MAH; Alcalde, MP; Buchaim, DV; Buchaim, RL; da Cunha, MR				de Azevedo e Sousa Munhoz, Marcelo; Pomini, Karina Torres; de Guzzi Plepis, Ana Maria; Amaro Martins, Virginia da Conceicao; Machado, Eduardo Gomes; de Moraes, Renato; Cunha, Fernando Bento; Santos Junior, Arnaldo Rodrigues; Camargo Cardoso, Guinea Brasil; Hungaro Duarte, Marco Antonio; Alcalde, Murilo Priori; Buchaim, Daniela Vieira; Buchaim, Rogerio Leone; da Cunha, Marcelo Rodrigues			Elastin-derived scaffolding associated or not with bone morphogenetic protein (BMP) or hydroxyapatite (HA) in the repair process of metaphyseal bone defects	PLOS ONE			English	Article							IN-VIVO; REGENERATION; MATRIX; BIOMATERIALS; MICROPARTICLES; IMPLANTS; DELIVERY; RATS	Tissue engineering represents a promising alternative for reconstructive surgical procedures especially for the repair of bone defects that do not regenerate spontaneously. The present study aimed to evaluate the effects of the elastin matrix (E24/50 and E96/37) incorporated with hydroxyapatite (HA) or morphogenetic protein (BMP) on the bone repair process in the distal metaphysis of rat femur. The groups were: control group (CG), hydrolyzed elastin matrix at 50 degrees C/24h (E24/50), E24/50 + HA (E24/50/HA), E24/50 + BMP (E24/50/BMP), hydrolyzed elastin matrix at 37 degrees C/96h (E96/37), E96/37 + HA (E96/37/HA), E96/37 + BMP (E96/37/BMP). Macroscopic and radiographic analyses showed longitudinal integrity of the femur in all groups without fractures or bone deformities. Microtomographically, all groups demonstrated partial closure by mineralized tissue except for the E96/37/HA group with hyperdense thin bridge formation interconnecting the edges of the ruptured cortical. Histologically, there was no complete cortical recovery in any group, but partial closure with trabecular bone. In defects filled with biomaterials, no chronic inflammatory response or foreign body type was observed. The mean volume of new bone formed was statistically significant higher in the E96/37/HA and E24/50 groups (71.28 +/- 4.26 and 66.40 +/- 3.69, respectively) than all the others. In the confocal analysis, it was observed that all groups presented new bone markings formed during the experimental period, being less evident in the CG group. Von Kossa staining revealed intense calcium deposits distributed in all groups. Qualitative analysis of collagen fibers under polarized light showed a predominance of red-orange birefringence in the newly regenerated bone with no difference between groups. It was concluded that the E24/50 and E96/37/HA groups promoted, with greater speed, the bone repair process in the distal metaphysis of rat femur.	[de Azevedo e Sousa Munhoz, Marcelo; Machado, Eduardo Gomes; de Moraes, Renato; Cunha, Fernando Bento; da Cunha, Marcelo Rodrigues] Med Coll Jundiai, Dept Morphol & Pathol, Jundiai, SP, Brazil; [de Azevedo e Sousa Munhoz, Marcelo; de Guzzi Plepis, Ana Maria; Machado, Eduardo Gomes; de Moraes, Renato; Cunha, Fernando Bento; da Cunha, Marcelo Rodrigues] Univ Sao Paulo, Interunit Postgrad Program Bioengn EESC FMRP IQSC, Sao Carlos, SP, Brazil; [Pomini, Karina Torres; Buchaim, Rogerio Leone] Univ Sao Paulo FOB USP, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil; [de Guzzi Plepis, Ana Maria; Amaro Martins, Virginia da Conceicao] Univ Sao Paulo, Sao Carlos Inst Chem, Sao Carlos, SP, Brazil; [Santos Junior, Arnaldo Rodrigues] Fed Univ ABC UFABC, Ctr Nat & Human Sci, Sao Bernardo Do Campo, SP, Brazil; [Camargo Cardoso, Guinea Brasil] Univ Estadual Campinas, Fac Mech Engn, Mat Engn Dept, Campinas, SP, Brazil; [Camargo Cardoso, Guinea Brasil; da Cunha, Marcelo Rodrigues] Cruzeiro do Sul Univ UNICSUL, Univ Ctr Nossa Senhora do Patrocinio CEUNSP, Itu, SP, Brazil; [Hungaro Duarte, Marco Antonio; Alcalde, Murilo Priori] Univ Sao Paulo FOB USP, Bauru Sch Dent, Dept Dent Endodont & Dent Mat, Bauru, SP, Brazil; [Alcalde, Murilo Priori] Sacred Heart Univ Ctr UNISAGRADO, Hlth Sci Ctr, Bauru, SP, Brazil; [Buchaim, Daniela Vieira; Buchaim, Rogerio Leone] Univ Marilia UNIMAR, Postgrad Program Struct & Funct Interact Rehabil, Marilia, SP, Brazil; [Buchaim, Daniela Vieira] Univ Ctr Adamantina UniFAI, Med Sch, Adamantina, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Marilia	Buchaim, RL (corresponding author), Univ Sao Paulo FOB USP, Bauru Sch Dent, Dept Biol Sci, Bauru, SP, Brazil.; Buchaim, RL (corresponding author), Univ Marilia UNIMAR, Postgrad Program Struct & Funct Interact Rehabil, Marilia, SP, Brazil.	rogerio@fob.usp.br	Buchaim, Rogerio L/D-1666-2012; Martins, Virginia C. A./H-5832-2012; Buchaim, Rogerio/AAO-9206-2020; Pomini, Karina Torres/AAX-1419-2020; Santos, Arnaldo R./I-4813-2012; Buchaim, Daniela Vieira/AAO-6013-2020; Buchaim, Rogerio/GQA-8890-2022; Alcalde, Murilo Priori/U-9452-2018; Santos, Arnaldo R./AAV-8966-2021; Buchaim, Daniela Vieira/G-8675-2013	Buchaim, Rogerio L/0000-0002-5881-2218; Martins, Virginia C. A./0000-0001-7565-9641; Pomini, Karina Torres/0000-0003-2858-4717; Santos, Arnaldo R./0000-0003-0535-0088; Buchaim, Daniela Vieira/0000-0002-9914-1262; Buchaim, Rogerio/0000-0002-5881-2218; Alcalde, Murilo Priori/0000-0001-8735-065X; Santos, Arnaldo R./0000-0003-0535-0088; Buchaim, Daniela Vieira/0000-0002-9914-1262; Plepis, Ana/0000-0002-4360-8433	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [001]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The present study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) - Finance Code 001 to KTP in the form of a doctoral scholarship. There was no additional external funding received for this study.	Allen T., 1997, PARTICLE SIZE MEASUR, P525; Alt V, 2016, INJURY, V47, pS58, DOI 10.1016/S0020-1383(16)47010-5; Amini Ami R., 2012, Critical Reviews in Biomedical Engineering, V40, P363; Escudero JSB, 2019, INJURY, V50, P1853, DOI 10.1016/j.injury.2019.09.031; Bessa PC, 2010, TISSUE ENG PART C-ME, V16, P937, DOI [10.1089/ten.tec.2009.0486, 10.1089/ten.TEC.2009.0486]; Blair HC, 2017, TISSUE ENG PART B-RE, V23, P268, DOI [10.1089/ten.TEB.2016.0454, 10.1089/ten.teb.2016.0454]; Chen FM, 2016, PROG POLYM SCI, V53, P86, DOI 10.1016/j.progpolymsci.2015.02.004; Cheng LM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053202, 10.1371/journal.pone.0062100]; Cunha MR, 2008, J MATER SCI-MATER M, V19, P1341, DOI 10.1007/s10856-006-0105-y; Daamen WF, 2007, BIOMATERIALS, V28, P4378, DOI 10.1016/j.biomaterials.2007.06.025; de Grado GF, 2018, J TISSUE ENG, V9, DOI 10.1177/2041731418776819; de Moraes R, 2019, AM J TRANSL RES, V11, P5261; Goncalves JBD, 2016, J PHOTOCH PHOTOBIO B, V162, P663, DOI 10.1016/j.jphotobiol.2016.07.023; Echave MC, 2017, CURR PHARM DESIGN, V23, P3567, DOI 10.2174/0929867324666170511123101; Edgerton BC, 2004, J ORTHOP RES, V8, P1; Horn MM, 2009, CARBOHYD POLYM, V77, P239, DOI 10.1016/j.carbpol.2008.12.039; Kim S, 2018, ADV EXP MED BIOL, V1078, P233, DOI 10.1007/978-981-13-0950-2_12; Koolen M, 2019, EUR CELLS MATER, V38, P94, DOI 10.22203/eCM.v038a08; Langdon SE, 1999, BIOMATERIALS, V20, P137, DOI 10.1016/S0142-9612(98)00142-2; Le Guehennec L, 2004, Eur Cell Mater, V8, P1; Lourenco AH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04866-4; Machado EG, 2015, ACTA HISTOCHEM, V117, P288, DOI 10.1016/j.acthis.2015.03.006; Mantripragada VP, 2016, MAT SCI ENG C-MATER, V63, P596, DOI 10.1016/j.msec.2016.02.080; Matta C, 2019, DIFFERENTIATION, V107, P24, DOI 10.1016/j.diff.2019.05.002; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; Munhoz MAS, 2018, INJURY, V49, P2154, DOI 10.1016/j.injury.2018.09.018; Naddeo P, 2015, DENT MATER, V31, P235, DOI 10.1016/j.dental.2014.12.015; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; POBLOTH AM, 2016, BMC MUSCULOSKEL DIS, V17, DOI DOI 10.1186/S12891-015-0856-Z; Pomini KT, 2014, J ULTRAS MED, V33, P713, DOI 10.7863/ultra.33.4.713; Pomini KT, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071761; Pomini KT, 2019, DRUG ALCOHOL DEPEN, V197, P315, DOI 10.1016/j.drugalcdep.2018.12.031; Pomini KT, 2019, IJAERS, V6, P16, DOI [10.22161/ijaers.673, DOI 10.22161/IJAERS.673]; Schindeler A, 2018, J ORTHOP RES, V36, P832, DOI 10.1002/jor.23824; Sivaraman B, 2012, DRUG DELIV TRANSL RE, V2, P323, DOI 10.1007/s13346-012-0070-6; Sohn HS, 2019, BIOMATER RES, V23, DOI 10.1186/s40824-019-0157-y; Tampieri A, 2011, TRENDS BIOTECHNOL, V29, P526, DOI 10.1016/j.tibtech.2011.04.011; Tao ZS, 2015, INJURY, V46, P2134, DOI 10.1016/j.injury.2015.07.042; Thrivikraman G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11455-8; Uusitalo H, 2001, BONE, V28, P423, DOI 10.1016/S8756-3282(01)00406-9; Velasco MA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/729076; Wang WH, 2017, BIOACT MATER, V2, P224, DOI 10.1016/j.bioactmat.2017.05.007; Winkler T, 2018, BONE JOINT RES, V7, P232, DOI 10.1302/2046-3758.73.BJR-2017-0270.R1; Zhao F, 2015, J NANOMATER, V2015, DOI 10.1155/2015/893545; Zhu BT, 2019, ACS BIOMATER SCI ENG, V5, P986, DOI 10.1021/acsbiomaterials.8b01371	45	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231112	10.1371/journal.pone.0231112	http://dx.doi.org/10.1371/journal.pone.0231112			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310975	Green Published, gold			2022-12-26	WOS:000536019800010
J	Tutzauer, J; Sjostrom, M; Bendahl, PO; Ryden, L; Ferno, M; Leeb-Lundberg, LMF; Alkner, S				Tutzauer, Julia; Sjostrom, Martin; Bendahl, Par-Ola; Ryden, Lisa; Ferno, Marten; Leeb-Lundberg, L. M. Fredrik; Alkner, Sara			Plasma membrane expression of G protein-coupled estrogen receptor (GPER)/G protein-coupled receptor 30 (GPR30) is associated with worse outcome in metachronous contralateral breast cancer	PLOS ONE			English	Article							COMPREHENSIVE MOLECULAR PORTRAITS; GROWTH-FACTOR RECEPTOR; TUMOR; GPER; TRANSACTIVATION; PROGNOSIS; SURVIVAL; REQUIRES; COMPLEX	Background G protein-coupled estrogen receptor (GPER), or G protein-coupled receptor 30 (GPR30), is reported to mediate non-genomic estrogen signaling. GPR30 associates with breast cancer (BC) outcome and may contribute to tamoxifen resistance. We investigated the expression and prognostic significance of GPR30 in metachronous contralateral breast cancer (CBC) as a model of tamoxifen resistance. Methods Total GPR30 expression (GPR30(TOT)) and plasma membrane-localized GPR30 expression (GPR30(PM)) were analyzed by immunohistochemistry in primary (BC1; n(BC1) = 559) and contralateral BC (BC2; n(BC2) = 595), and in lymph node metastases (LGL; n(LGL1) = 213; n(LGL2) = 196). Death from BC (BCD), including BC death or death after documented distant metastasis, was used as primary end-point. Results GPR30(PM) in BC2 and LGL2 were associated with increased risk of BCD (HRBC2 = 1.7, p = 0.03; HRLGL2 = 2.0; p = 0.02). In BC1 and BC2, GPR30(PM) associated with estrogen receptor (ER)-negativity (p(BC1)<0.0001; p(BC2)<0.0001) and progesterone receptor (PR)-negativity (p(BC1) = 0.0007; p(BC2)<0.0001). The highest GPR30(TOT) and GPR30(PM) were observed in triple-negative BC. GPR30(PM) associated with high Ki67 staining in BC1 (p<0.0001) and BC2 (p<0.0001). GPR30(TOT) in BC2 did not associate with tamoxifen treatment for BC1. However, BC2 that were diagnosed during tamoxifen treatment were more likely to express GPR30(PM) than BC2 diagnosed after treatment completion (p = 0.01). Furthermore, a trend was observed that patients with GPR30(PM) in an ER-positive BC2 had greater benefit from tamoxifen treatment. Conclusion PM-localized GPR30 staining is associated with increased risk of BC death when expressed in BC2 and LGL2. Additionally, PM-localized GPR30 correlates with prognostic markers of worse outcome, such as high Ki67 and a triple-negative subtype. Therefore, PM-localized GPR30 may be an interesting new target for therapeutic exploitation. We found no clear evidence that total GPR30 expression is affected by tamoxifen exposure during development of metachronous CBC, or that GPR30 contributes to tamoxifen resistance.	[Tutzauer, Julia; Leeb-Lundberg, L. M. Fredrik] Lund Univ, Dept Expt Med Sci, Lund, Sweden; [Sjostrom, Martin; Bendahl, Par-Ola; Ferno, Marten; Alkner, Sara] Lund Univ, Div Oncol & Pathol, Dept Clin Sci Lund, Lund, Sweden; [Ryden, Lisa] Lund Univ, Div Surg, Dept Clin Sci Lund, Lund, Sweden; [Ryden, Lisa] Skane Univ Hosp, Dept Surg, Lund, Sweden; [Alkner, Sara] Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Sjostrom, Martin] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA	Lund University; Lund University; Lund University; Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of California System; University of California San Francisco	Leeb-Lundberg, LMF (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Fredrik.Leeb-Lundberg@med.lu.se	Tutzauer, Julia/GQR-0460-2022; Sjöström, Martin/AAO-5204-2020; Tutzauer, Julia/GQY-5247-2022	Tutzauer, Julia/0000-0001-8267-8445; Sjöström, Martin/0000-0002-2629-9966; Leeb-Lundberg, Fredrik/0000-0002-8583-2329	Swedish Cancer Foundation [CAN 2016/423]; Swedish Research Council [2016-02427]; Swedish Breast Cancer Association (BRO); Skane University Hospital foundation; Percy Falks Stiftelse for Forskning Betraffande Prostata-och Brostcancer; Skane County Council's Research and Development Foundation; Swedish Governmental Funding of Clinical Research within the National Health Service	Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Breast Cancer Association (BRO); Skane University Hospital foundation; Percy Falks Stiftelse for Forskning Betraffande Prostata-och Brostcancer; Skane County Council's Research and Development Foundation; Swedish Governmental Funding of Clinical Research within the National Health Service	LMFLL: Swedish Cancer Foundation, CAN 2016/423, https://www.cancerfonden.se/; Swedish Research Council, 2016-02427, https://www.vr.se/SA: Swedish Breast Cancer Association (BRO); Skane University Hospital foundation; Percy Falks Stiftelse for Forskning Betraffande Prostata-och Brostcancer; Skane County Council's Research and Development Foundation; Swedish Governmental Funding of Clinical Research within the National Health Service The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; ADAMI HO, 1985, CANCER, V55, P643, DOI 10.1002/1097-0142(19850201)55:3<643::AID-CNCR2820550328>3.0.CO;2-L; Akama KT, 2013, J BIOL CHEM, V288, P6438, DOI 10.1074/jbc.M112.412478; Alkner S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150977; Alkner S, 2015, EUR J CANCER, V51, P2304, DOI 10.1016/j.ejca.2015.07.016; Alkner S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0608-x; Alkner S, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-114; [Anonymous], 2018, R LANG ENV STAT COMP, DOI DOI 10.18637/JSS.V028.I05; Ariazi EA, 2010, CANCER RES, V70, P1184, DOI 10.1158/0008-5472.CAN-09-3068; Broselid S, 2014, J BIOL CHEM, V289, P22117, DOI 10.1074/jbc.M114.566893; Broselid S, 2013, CLIN CANCER RES, V19, P1681, DOI 10.1158/1078-0432.CCR-12-2376; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Y, 1999, CANCER EPIDEM BIOMAR, V8, P855; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; de Valdivia EG, 2017, J BIOL CHEM, V292, P9932, DOI 10.1074/jbc.M116.765875; Ding QM, 2009, AM J PHYSIOL-CELL PH, V297, pC1178, DOI 10.1152/ajpcell.00185.2009; Duffy MJ, 2017, EUR J CANCER, V75, P284, DOI 10.1016/j.ejca.2017.01.017; Filardo EJ, 2006, CLIN CANCER RES, V12, P6359, DOI 10.1158/1078-0432.CCR-06-0860; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, J STEROID BIOCHEM, V80, P231, DOI 10.1016/S0960-0760(01)00190-X; Fribbens C, 2016, J CLIN ONCOL, V34, P2961, DOI 10.1200/JCO.2016.67.3061; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gray B, 2009, CMPRSK SUBDISTRIBUTI; Ignatov A, 2011, BREAST CANCER RES TR, V128, P457, DOI 10.1007/s10549-011-1584-1; Ignatov A, 2010, BREAST CANCER RES TR, V123, P87, DOI 10.1007/s10549-009-0624-6; Ignatov T, 2019, BREAST CANCER RES TR, V174, P121, DOI 10.1007/s10549-018-5064-8; Ignatov T, 2013, CANCER INVEST, V31, P309, DOI 10.3109/07357907.2013.789901; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kotarsky K, 2001, ANAL BIOCHEM, V288, P209, DOI 10.1006/abio.2000.4898; Kuo Wen-Hung, 2007, Taiwan J Obstet Gynecol, V46, P135, DOI 10.1016/S1028-4559(07)60007-2; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Malone KE, 2010, J CLIN ONCOL, V28, P2404, DOI 10.1200/JCO.2009.24.2495; Martin M, 2017, NAT COMMUN, V8, DOI [10.1038/ncomms15127, 10.1038/s41467-017-01864-y]; Martin Stewart G, 2018, Oncotarget, V9, P25946, DOI 10.18632/oncotarget.25408; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mo ZQ, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3581; O'Hayre M, 2013, NAT REV CANCER, V13, P412, DOI 10.1038/nrc3521; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pupo M, 2017, ONCOTARGET, V8, P46728, DOI 10.18632/oncotarget.18156; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Ring A, 2004, ENDOCR-RELAT CANCER, V11, P643, DOI 10.1677/erc.1.00776; Sanden C, 2011, MOL PHARMACOL, V79, P400, DOI 10.1124/mol.110.069500; Sjostrom M, 2014, BREAST CANCER RES TR, V145, P61, DOI 10.1007/s10549-014-2936-4; Therneau T., 2015, PACKAGE SURVIVAL ANA; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Tran QK, 2015, J BIOL CHEM, V290, P13293, DOI 10.1074/jbc.M114.628743; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Weissenborn C, 2017, CANCER INVEST, V35, P100, DOI 10.1080/07357907.2016.1271886; Weissenborn C, 2014, J CANCER RES CLIN, V140, P713, DOI 10.1007/s00432-014-1620-8	51	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231786	10.1371/journal.pone.0231786	http://dx.doi.org/10.1371/journal.pone.0231786			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302351	gold, Green Submitted, Green Published			2022-12-26	WOS:000536016100050
J	Gledovic, A; Lezaic, AJ; Krstonosic, V; Djokovic, J; Nikolic, I; Bajuk-Bogdanovic, D; Stankovic, JA; Randjelovic, D; Savic, SM; Filipovic, M; Tamburic, S; Savic, SD				Gledovic, Ana; Lezaic, Aleksandra Janosevic; Krstonosic, Veljko; Djokovic, Jelena; Nikolic, Ines; Bajuk-Bogdanovic, Danica; Stankovic, Jelena Antic; Randjelovic, Danijela; Savic, Sanela M.; Filipovic, Mila; Tamburic, Slobodanka; Savic, Snezana D.			Low-energy nanoemulsions as carriers for red raspberry seed oil: Formulation approach based on Raman spectroscopy and textural analysis, physicochemical properties, stability and in vitro antioxidant/biological activity	PLOS ONE			English	Article							E-ENRICHED NANOEMULSIONS; VITAMIN-E; CUBIC PHASE; EMULSION; RHEOLOGY; MICROEMULSIONS; ANTIOXIDANTS; INGREDIENTS; CAROTENOIDS; MICROSCOPY	Considering a growing demand for medicinal/cosmetic products with natural actives, this study focuses on the low-energy nanoemulsions (LE-NEs) prepared via the Phase inversion composition (PIC) method at room temperature as potential carriers for natural oil. Four different red raspberry seed oils (ROs) were tested, as follows: cold-pressed vs. CO2-extracted, organic vs. non-organic, refined vs. unrefined. The oil phase was optimized with Tocopheryl acetate and Isostearyl isostearate, while water phase was adjusted with either glycerol or an antioxidant hydro-glycolic extract. This study has used a combined approach to formulation development, employing both conventional methods (pseudo-ternary phase diagram - PTPD, electrical conductivity, particle size measurements, microscopical analysis, and rheological measurements) and the methods novel to this area, such as textural analysis and Raman spectroscopy. Raman spectroscopy has detected fine differences in chemical composition among ROs, and it detected the interactions within nanoemulsions. It was shown that the cold-pressed, unrefined, organic grade oil (RO2) with 6.62% saturated fatty acids and 92.25% unsaturated fatty acids, was optimal for the LE-NEs. Textural analysis confirmed the existence of cubic gel-like phase as a crucial step in the formation of stable RO2-loaded LE-NEs, with droplets in the narrow nano-range (125 to 135 nm; PDI <= 0.1). The DPPH test in methanol and ABTS in aqueous medium have revealed a synergistic free radical scavenging effect between lipophilic and hydrophilic antioxidants in LE-NEs. The nanoemulsion carrier has improved the biological effect of raw materials on HeLa cervical adenocarcinoma cells, while exhibiting good safety profile, as confirmed on MRC-5 normal human lung fibroblasts. Overall, this study has shown that low-energy nanoemulsions present very promising carriers for topical delivery of natural bioactives. Raman spectroscopy and textural analysis have proven to be a useful addition to the arsenal of methods used in the formulation and characterization of nanoemulsion systems.	[Gledovic, Ana; Djokovic, Jelena; Nikolic, Ines; Savic, Snezana D.] Univ Belgrade, Dept Pharmaceut Technol & Cosmetol, Fac Pharm, Belgrade, Serbia; [Lezaic, Aleksandra Janosevic] Univ Belgrade, Dept Phys Chem & Instrumental Methods, Fac Pharm, Belgrade, Serbia; [Krstonosic, Veljko] Univ Novi Sad, Dept Pharm, Fac Med, Novi Sad, Serbia; [Bajuk-Bogdanovic, Danica] Univ Belgrade, Fac Phys Chem, Belgrade, Serbia; [Stankovic, Jelena Antic] Univ Belgrade, Dept Microbiol & Immunol, Fac Pharm, Belgrade, Serbia; [Randjelovic, Danijela] Univ Belgrade, Inst Chem Technol & Met, Dept Microelect Technol, Belgrade, Serbia; [Savic, Sanela M.] DCP Hemigal, Leskovac, Serbia; [Filipovic, Mila] Higher Educ Sch Profess Hlth Studies, Belgrade, Serbia; [Tamburic, Slobodanka] Univ Arts London, London Coll Fash, London, England	University of Belgrade; University of Belgrade; University of Novi Sad; University of Belgrade; University of Belgrade; University of Belgrade; University of Arts London	Gledovic, A (corresponding author), Univ Belgrade, Dept Pharmaceut Technol & Cosmetol, Fac Pharm, Belgrade, Serbia.	ana.gledovic@pharmacy.bg.ac.rs	Filipovic, Mila/GWR-1646-2022; Bajuk-Bogdanovic, Danica/AAP-5266-2020; Krstonošić, Veljko/AFV-2396-2022; Nikolic, Ines/AFL-7590-2022; Nikolic, Ruzica/AAV-3440-2021; Nikolic, Ines/AAG-7535-2022; Ležaić, Aleksandra Janošević/ABD-3904-2020	Bajuk-Bogdanovic, Danica/0000-0003-2443-376X; Krstonošić, Veljko/0000-0003-4685-483X; Nikolic, Ines/0000-0001-6534-0418; Nikolic, Ruzica/0000-0003-3042-8916; Nikolic, Ines/0000-0001-6534-0418; Ležaić, Aleksandra Janošević/0000-0003-4343-0572; Dokovic, Jelena/0000-0003-0936-4276; Savic, Snezana/0000-0002-6236-9730; Gledovic, Ana/0000-0003-2697-8800	Ministry of Education, Science and Technological Development, Republic of Serbia [TR34031]; Ministry of Education, Science and Technological Development of Serbia [OI172043]; London College of Fashion, University of the Arts London (	Ministry of Education, Science and Technological Development, Republic of Serbia; Ministry of Education, Science and Technological Development of Serbia(Ministry of Education, Science & Technological Development, Serbia); London College of Fashion, University of the Arts London (	This research was funded by the Ministry of Education, Science and Technological Development, Republic of Serbia, through the research project TR34031 Development of Micro- and Nanosystems as Carriers for Drugs with Anti-inflammatory Effects and Methods for Their Characterization. This funder provided support in the form of salaries, materials, equipment, and facilities for authors [AG, JD, IN and SDS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also part of the project for which financial support was provided by the Ministry of Education, Science and Technological Development of Serbia (project OI172043 A.J.L, D.B.-B.). This funder provided Raman spectroscopy analysis but it did not play a role in study design, or preparation of the manuscript. Publication funding was provided by the London College of Fashion, University of the Arts London (S.T). DCP Hemigal [S.N.S] did not play a role in funding, study design, or preparation of the manuscript. The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.	Alam MM, 2009, J OLEO SCI, V58, P361, DOI 10.5650/jos.58.361; Alam MM, 2009, J COLLOID INTERF SCI, V329, P366, DOI 10.1016/j.jcis.2008.09.074; Beattie JR, 2007, FASEB J, V21, P766, DOI 10.1096/fj.06-7028com; Bernardi DS, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-44; Bowen-Forbes CS, 2010, J FOOD COMPOS ANAL, V23, P554, DOI 10.1016/j.jfca.2009.08.012; Carvalho E, 2013, FOOD CHEM, V139, P744, DOI 10.1016/j.foodchem.2012.12.047; Chen L, 2012, J AM ACAD DERMATOL, V67, P1013, DOI 10.1016/j.jaad.2012.02.009; Chong WT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202771; da Silva PB, 2017, POLYMERS-BASEL, V9, DOI 10.3390/polym9010030; de Souza VR, 2014, FOOD CHEM, V156, P362, DOI 10.1016/j.foodchem.2014.01.125; Dederen JC, 2012, INT J COSMETIC SCI, V34, P502, DOI 10.1111/j.1468-2494.2012.00744.x; Duraipandian S, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9122433; Fasolin LH, 2012, COLLOID SURFACE A, V415, P31, DOI 10.1016/j.colsurfa.2012.10.021; Feng SL, 2013, J AGR FOOD CHEM, V61, P10467, DOI 10.1021/jf4038858; Fernandez P, 2004, COLLOID SURFACE A, V251, P53, DOI 10.1016/j.colsurfa.2004.09.029; Ferreira BS, 2013, SPECTROSC LETT, V46, P122, DOI 10.1080/00387010.2012.693569; Fonseca-Santos B, 2017, INT J NANOMED, V12, P6883, DOI 10.2147/IJN.S138629; Garti N, 2012, FOOD FUNCT, V3, P700, DOI 10.1039/c2fo00005a; Gupta A, 2016, SOFT MATTER, V12, P2826, DOI 10.1039/c5sm02958a; Jeong JH, 2010, FOOD CHEM, V123, P338, DOI 10.1016/j.foodchem.2010.04.040; Jimenez-Sanchidrian C, 2016, APPL SPECTROSC REV, V51, P417, DOI 10.1080/05704928.2016.1141292; Klang V, 2012, MICRON, V43, P85, DOI 10.1016/j.micron.2011.07.014; Kolanowski W, 2004, J SCI FOOD AGR, V84, P2135, DOI 10.1002/jsfa.1770; Krasodomska O, 2015, COLLOID SURFACE A, V481, P468, DOI 10.1016/j.colsurfa.2015.06.022; Lee J, 2012, FOOD CHEM, V130, P785, DOI 10.1016/j.foodchem.2011.08.022; Lukic M, 2013, J TEXTURE STUD, V44, P34, DOI 10.1111/j.1745-4603.2012.00363.x; Masaki H, 2010, J DERMATOL SCI, V58, P85, DOI 10.1016/j.jdermsci.2010.03.003; Mayer S, 2013, J COLLOID INTERF SCI, V402, P122, DOI 10.1016/j.jcis.2013.04.016; McClements DJ, 2012, SOFT MATTER, V8, P1719, DOI 10.1039/c2sm06903b; Moghaddasi F, 2018, LWT-FOOD SCI TECHNOL, V92, P92, DOI 10.1016/j.lwt.2018.02.023; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Mudalige A, 2007, VIB SPECTROSC, V45, P27, DOI 10.1016/j.vibspec.2007.04.002; Nastiti CMRR, 2017, PHARMACEUTICS, V9, DOI 10.3390/pharmaceutics9040037; Nikolic I, 2020, J MOL LIQ, V301, DOI 10.1016/j.molliq.2020.112479; Nikolic I, 2018, INT J PHARMACEUT, V550, P333, DOI 10.1016/j.ijpharm.2018.08.060; Oomah BD, 2000, FOOD CHEM, V69, P187, DOI 10.1016/S0308-8146(99)00260-5; Pennick G., 2010, International Journal of Cosmetic Science, V32, P304, DOI 10.1111/j.1468-2494.2010.00604.x; Popovic BM, 2013, SCI WORLD J, DOI 10.1155/2013/134656; Rachmawati H, 2015, DRUG DEV IND PHARM, V41, P560, DOI 10.3109/03639045.2014.884127; Rebolleda S, 2015, FOOD CHEM, V167, P16, DOI 10.1016/j.foodchem.2014.06.097; Rodriguez-Abreu C, 2004, LANGMUIR, V20, P5235, DOI 10.1021/la0498962; Saberi AH, 2013, FOOD RES INT, V54, P812, DOI 10.1016/j.foodres.2013.08.028; Teo Brian Sheng Xian, 2010, Journal of Nanobiotechnology, V8, P4, DOI 10.1186/1477-3155-8-4; Van Hoed V, 2011, FOOD CHEM, V127, P1848, DOI 10.1016/j.foodchem.2011.01.134; Van Hoed V, 2009, J FOOD LIPIDS, V16, P33, DOI 10.1111/j.1745-4522.2009.01130.x; Vinha AF, 2016, IND CROP PROD, V94, P143, DOI 10.1016/j.indcrop.2016.08.027; Walker R, 2015, FOOD FUNCT, V6, P42, DOI 10.1039/c4fo00723a; Yang BR, 2011, FOOD RES INT, V44, P2009, DOI 10.1016/j.foodres.2011.02.025; Yim TK, 2002, PHARM BIOL, V40, P329, DOI 10.1076/phbi.40.5.329.8457; Yukuyama MN, 2016, INT J COSMETIC SCI, V38, P13, DOI 10.1111/ics.12260; Zhu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43439-5; Zillich OV, 2015, INT J COSMETIC SCI, V37, P455, DOI 10.1111/ics.12218	52	13	13	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230993	10.1371/journal.pone.0230993	http://dx.doi.org/10.1371/journal.pone.0230993			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298275	Green Published, Green Accepted, gold			2022-12-26	WOS:000536011400023
J	Korolkova, OY; Widatalla, SE; Whalen, DS; Nangami, GN; Abimbola, A; Williams, SD; Beasley, HK; Reisenbichler, E; Washington, MK; Ochieng, J; Mayer, IA; Lehmann, BD; Sakwe, AM				Korolkova, Olga Y.; Widatalla, Sarrah E.; Whalen, Diva S.; Nangami, Gladys N.; Abimbola, Adeniyi; Williams, Stephen D.; Beasley, Heather K.; Reisenbichler, Emily; Washington, Mary Kay; Ochieng, Josiah; Mayer, Ingrid A.; Lehmann, Brian D.; Sakwe, Amos M.			Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets	PLOS ONE			English	Article							SURVIVAL; SUBTYPES; IDENTIFICATION; PATTERNS; GENES; CELLS; CARCINOMA; FEATURES; MARKERS; MODELS	Actively growing tumors are often histologically associated with Ki67 positivity, while the detection of invasiveness relies on non-quantitative pathologic evaluation of mostly advanced tumors. We recently reported that reduced expression of the Ca2+- dependent membrane-binding annexin A6 (AnxA6) is associated with increased expression of the Ca2+ activated RasGRF2 (GRF2), and that the expression status of these proteins inversely influence the growth and motility of triple negative breast cancer (TNBC) cells. Here, we establish that the reciprocal expression of AnxA6 and GRF2 is at least in part, dependent on inhibition of non-selective Ca2+ channels in AnxA6-low but not AnxA6-high TNBC cells. Immunohistochemical staining of breast cancer tissues revealed that compared to non-TNBC tumors, TNBC tumors express lower levels of AnxA6 and higher Ki67 expression. GRF2 expression levels strongly correlated with high Ki67 in pretreatment biopsies from patients with residual disease and with residual tumor size following chemotherapy. Elevated AnxA6 expression more reliably identified patients who responded to chemotherapy, while low AnxA6 levels were significantly associated with shorter distant relapse-free survival. Finally, the reciprocal expression of AnxA6 and GRF2 can delineate GRF2-low/AnxA6-high invasive from GRF2-high/AnxA6-low rapidly growing TNBCs. These data suggest that AnxA6 may be a reliable biomarker for distant relapse-free survival and response of TNBC patients to chemotherapy, and that the reciprocal expression of AnxA6 and GRF2 can reliably delineate TNBCs into rapidly growing and invasive subsets which may be more relevant for subset-specific therapeutic interventions.	[Korolkova, Olga Y.; Widatalla, Sarrah E.; Whalen, Diva S.; Nangami, Gladys N.; Abimbola, Adeniyi; Williams, Stephen D.; Beasley, Heather K.; Ochieng, Josiah; Sakwe, Amos M.] Meharry Med Coll, Sch Grad Studies & Res, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA; [Reisenbichler, Emily] Yale Med Sch, Dept Pathol, New Haven, CT USA; [Washington, Mary Kay] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Mayer, Ingrid A.; Lehmann, Brian D.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA	Meharry Medical College; Yale University; Vanderbilt University; Vanderbilt University	Sakwe, AM (corresponding author), Meharry Med Coll, Sch Grad Studies & Res, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA.	asakwe@mmc.edu	Lehmann, Brian D./H-8464-2019; Korolkova, Olga/ABH-9870-2020	Lehmann, Brian D./0000-0003-0407-5248; Williams, Stephen/0000-0003-1960-8158; Beasley, Heather/0000-0002-4636-2889; Reisenbichler, Emily/0000-0002-1570-6538	NIH [1SC1CA211030, P50CA098131, 8U54MD007593, 5U54MD007586, 5U54CA163069, 5R25GM059994]; Vanderbilt CTSA grant from NIH/NCATS [ULTR000445]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt CTSA grant from NIH/NCATS	Supported by NIH grants 1SC1CA211030 (AMS), P50CA098131 (Vanderbilt-Ingram Cancer Center SPORE in Breast Cancer), 8U54MD007593 (Meharry Translational Research Center), 5U54MD007586 (RCMI Program in Health Disparities Research at Meharry Medical College), 5U54CA163069 (MMC, VICC, TSU Cancer Partnership), 5R25GM059994 (Meharry Rise Initiative) and Vanderbilt CTSA grant ULTR000445 from NIH/NCATS.	Anderson H, 2011, ANN ONCOL, V22, P1770, DOI 10.1093/annonc/mdq700; Badve S, 2011, MODERN PATHOL, V24, P157, DOI 10.1038/modpathol.2010.200; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Burstein MD, 2015, CLIN CANCER RES, V21, P1688, DOI 10.1158/1078-0432.CCR-14-0432; Calvo F, 2011, NAT CELL BIOL, V13, P819, DOI 10.1038/ncb2271; Carey LA, 2006, JAMA-J AM MED ASSOC, V295, P2492, DOI 10.1001/jama.295.21.2492; Chen JS, 2001, BLOOD, V97, P2115, DOI 10.1182/blood.V97.7.2115; de Hoog CL, 2001, MOL CELL BIOL, V21, P2107, DOI 10.1128/MCB.21.6.2107-2117.2001; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Emeriau Noemie, 2018, Oncotarget, V9, P16059, DOI 10.18632/oncotarget.24685; Fekete JT, 2019, INT J CANC; Francia G, 1996, CANCER RES, V56, P3855; Gonzalez-Noriega A, 2016, MOL GENET METAB, V119, P338, DOI 10.1016/j.ymgme.2016.10.002; Griffin KA, 2001, HYPERTENSION, V37, P1268, DOI 10.1161/01.HYP.37.5.1268; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hashimoto K, 2014, ANN ONCOL, V25, P1973, DOI 10.1093/annonc/mdu247; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Jacinto FV, 2007, CANCER RES, V67, P11481, DOI 10.1158/0008-5472.CAN-07-2687; Koumangoye RB, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-167; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Lehmann BD, 2011, J CLIN INVEST, V121, P2750, DOI 10.1172/JCI45014; Lindner R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071915; Lipsanen A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060235; Liu SL, 2014, STEM CELL REP, V2, P78, DOI 10.1016/j.stemcr.2013.11.009; Liu YR, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0690-8; Lotshaw DP, 1999, J PHYSIOL-LONDON, V514, P397, DOI 10.1111/j.1469-7793.1999.397ae.x; Ma XJ, 2014, J BIOL CHEM, V289, P13638, DOI 10.1074/jbc.M113.511360; Nakai K, 2016, AM J CANCER RES, V6, P1609; Omarini C, 2018, CANCER MANAG RES, V10, P91, DOI 10.2147/CMAR.S146658; Prasad S, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2444-6; Qi HB, 2015, ONCOL LETT, V10, P1947, DOI 10.3892/ol.2015.3498; Rakha E, 2009, ARCH PATHOL LAB MED, V133, P860, DOI 10.1043/1543-2165-133.6.860; Raynal NJM, 2016, CANCER RES, V76, P1494, DOI 10.1158/0008-5472.CAN-14-2391; Sakwe AM, 2011, EXP CELL RES, V317, P823, DOI 10.1016/j.yexcr.2010.12.008; Soliman NA, 2016, CANCER BIOL MED, V13, P496, DOI 10.20892/j.issn.2095-3941.2016.0066; Wang X, 2013, AM J TRANSL RES, V5, P555; Wei W, 2014, STEM CELLS, V32, P2571, DOI 10.1002/stem.1752; Weinstein B, 2008, ADV EXP MED BIOL, V617, P3, DOI 10.1007/978-0-387-69080-3_1; Whalen Diva S, 2019, Oncotarget, V10, P133, DOI 10.18632/oncotarget.26512; Widatalla SE, 2019, CARCINOGENESIS, V40, P998, DOI 10.1093/carcin/bgy192; Yu YS, 2017, MOL PHARMACEUT, V14, P1548, DOI 10.1021/acs.molpharmaceut.6b00952; Zaidi AH, 2014, CANCER-AM CANCER SOC, V120, P3902, DOI 10.1002/cncr.28963	44	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231711	10.1371/journal.pone.0231711	http://dx.doi.org/10.1371/journal.pone.0231711			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298357	Green Published, Green Submitted, gold			2022-12-26	WOS:000536011400093
J	Mboya, IB; Mahande, MJ; Obure, J; Mwambi, HG				Mboya, Innocent B.; Mahande, Michael J.; Obure, Joseph; Mwambi, Henry G.			Predictors of perinatal death in the presence of missing data: A birth registry-based study in northern Tanzania	PLOS ONE			English	Article							MULTIPLE IMPUTATION; CHAINED EQUATIONS; MORTALITY; OUTCOMES	Background More than five million perinatal deaths occur each year globally. Despite efforts put forward during the millennium development goals era, perinatal deaths continue to increase relative to under-five deaths, especially in low- and middle-income countries. This study aimed to determine predictors of perinatal death in the presence of missing data using birth registry data from Kilimanjaro Christian Medical Center (KCMC), between 2000-2015. Methods This was a retrospective cohort study from the medical birth registry at KCMC referral hospital located in Moshi Municipality, Kilimanjaro region, northern Tanzania. Data were analyzed using Stata version 15.1. Multiple imputation by fully conditional specification (FCS) was used to impute missing values. Generalized estimating equations (GEE) were used to determine the marginal effects of covariates on perinatal death using a log link mean model with robust standard errors. An exchangeable correlation structure was used to account for the dependence of observations within mothers. Results Among 50,487 deliveries recorded in the KCMC medical birth registry between 2000-2015, 4.2% (95%CI 4.0%, 4.3%) ended in perinatal death (equivalent to a perinatal mortality rate (PMR) of 41.6 (95%CI 39.9, 43.3) deaths per 1,000 births). After the imputation of missing values, the proportion of perinatal death remained relatively the same. The risk of perinatal death was significantly higher among deliveries from mothers who resided in rural compared to urban areas (RR = 1.241, 95%CI 1.137, 1.355), with primary education level (RR = 1.201, 95%CI 1.083, 1.332) compared to higher education level, with <4 compared to >= 4 antenatal care (ANC) visits (RR = 1.250, 95%CI 1.146, 1.365), with postpartum hemorrhage (PPH) (RR = 2.638, 95%CI 1.997, 3.486), abruption placenta (RR = 4.218, 95%CI 3.438, 5.175), delivered a low birth weight baby (LBW) (RR = 4.210, 95%CI 3.788, 4.679), male child (RR = 1.090, 95%CI 1.007, 1.181), and were referred for delivery (RR = 2.108, 95%CI 1.919, 2.317). On the other hand, deliveries from mothers who experienced premature rupture of the membranes (PROM) (RR = 0.411, 95%CI 0.283, 0.598) and delivered through cesarean section (CS) (RR = 0.662, 95%CI 0.604, 0.724) had a lower risk of perinatal death. Conclusions Perinatal mortality in this cohort is higher than the national estimate. Higher risk of perinatal death was associated with low maternal education level, rural residence, <4 ANC visits, PPH, abruption placenta, LBW delivery, child's sex, and being referred for delivery. Ignoring missing values in the analysis of adverse pregnancy outcomes produces biased covariate coefficients and standard errors. Close clinical follow-up of women at high risk of experiencing perinatal death, particularly during ANC visits and delivery, is of high importance to increase perinatal survival.	[Mboya, Innocent B.; Mwambi, Henry G.] Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa; [Mboya, Innocent B.; Mahande, Michael J.] Kilimanjaro Christian Med Univ Coll KCMUCo, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi Tanzania, Tanzania; [Obure, Joseph] Kilimanjaro Christian Med Ctr KCMC, Dept Obstet & Gynecol, Moshi Tanzania, Tanzania	University of Kwazulu Natal; Kilimanjaro Christian Medical Centre	Mboya, IB (corresponding author), Univ KwaZulu Natal, Sch Math Stat & Comp Sci, Pietermaritzburg, South Africa.; Mboya, IB (corresponding author), Kilimanjaro Christian Med Univ Coll KCMUCo, Inst Publ Hlth, Dept Epidemiol & Biostat, Moshi Tanzania, Tanzania.	ib.mboya@gmail.com	Mboya, Innocent/AAE-6488-2020	Mboya, Innocent/0000-0001-9861-5879	DELTAS Africa Initiative Grant [107754/Z/15/ZDELTAS]; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust [107754/Z/15/Z]; UK government; Norwegian Council for Higher Education's Program for Development Research (NUFU); Kilimanjaro Christian Medical Center (KCMC)	DELTAS Africa Initiative Grant; African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency); Wellcome Trust(Wellcome TrustEuropean Commission); UK government; Norwegian Council for Higher Education's Program for Development Research (NUFU); Kilimanjaro Christian Medical Center (KCMC)	This work was supported through the DELTAS Africa Initiative Grant No. 107754/Z/15/ZDELTAS Africa SSACAB. The DELTAS Africa Initiative is an independent funding scheme of the African Academy of Sciences (AAS)'s Alliance for Accelerating Excellence in Science in Africa (AESA) and supported by the New Partnership for Africa's Development Planning and Coordinating Agency (NEPAD Agency) with funding from the Wellcome Trust (Grant No. 107754/Z/15/Z) and the UK government. The views expressed in this publication are those of the author(s) and not necessarily those of AAS, NEPAD Agency, Wellcome Trust or the UK government. The Norwegian Council for Higher Education's Program for Development Research (NUFU) funded the establishment of the birth registry at the Kilimanjaro Christian Medical Center (KCMC). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ali AAA, 2014, J TROP PEDIATRICS, V60, P79, DOI 10.1093/tropej/fmt075; Aloisio KM, 2014, STATA J, V14, P863, DOI 10.1177/1536867X1401400410; Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bailey PE, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1479-1; Baptista Flavia Hashizume, 2017, Rev. Bras. Saude Mater. Infant., V17, P271, DOI 10.1590/1806-93042017000200004; Bayou G, 2012, ETHIOPIAN J HLTH SCI, V22; Bellad MB, 2010, S ASIAN FED OBSTET G, V2, P49; Benova L, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000779; Bergsjo Per, 2007, East Afr J Public Health, V4, P1; Bergsjo P, 2010, ACTA OBSTET GYN SCAN, V89, P789, DOI 10.3109/00016341003801664; Blumenshine P, 2010, AM J PREV MED, V39, P263, DOI 10.1016/j.amepre.2010.05.012; Chuwa FS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182250; Fitzmaurice G, 2009, CH CRC HANDB MOD STA, P1; Getiye Y, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1420-7; Gregory E, 2018, LACK CHANGE PERINATA; Hinderaker SG, 2003, J HEALTH POPUL NUTR, V21, P8; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Ibrahim JG, 2009, TEST-SPAIN, V18, P1, DOI 10.1007/s11749-009-0138-x; Isaksen AB, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0630-0; Jakobsen JC, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0442-1; Kayiga H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190388; Kombo AY, 2017, J APPL STAT, V44, P270, DOI 10.1080/02664763.2016.1168370; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; Liu Yang, 2015, Int J Stat Med Res, V4, P287; Mahande MJ, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-166; Mahande MJ, 2015, RECURRENCE PERINATAL; Ministry of Health Community Development Gender Elderly and Children (MoHCDGEC) Ministry of Health (MoH) National Bureau of Statistics (NBS) Office of the Chief Government Statistician (OCGS) and ICF, 2016, TANZ DEM HLTH SURV M; Miranda MH, 2017, REV ENFERM UFPE ONLI, V11, P1171; Mitao M., 2016, Asian Pacific Journal of Reproduction, V5, P72; Mmbaga BT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-139; Mmbaga BT, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-68; Mmbaga BT, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-116; Mpembeni R., 2014, J PEDIAT NEONATAL CA, V1, P0022, DOI [10.15406/jpnc.2014.01.00022, DOI 10.15406/JPNC.2014.01.00022]; Nankabirwa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019674; Nijkamp JW, 2017, SEMIN FETAL NEONAT M, V22, P167, DOI 10.1016/j.siny.2017.02.005; Ouyang FX, 2013, B WORLD HEALTH ORGAN, V91, P357, DOI 10.2471/BLT.12.111021; Oyira EJ, 2017, INT J SCI RES METHOD, V6, P1; Pedersen AB, 2017, CLIN EPIDEMIOL, V9, P157, DOI 10.2147/CLEP.S129785; Quinn JA, 2016, VACCINE, V34, P6047, DOI 10.1016/j.vaccine.2016.03.045; Royston P, 2011, J STAT SOFTW, V45, P1, DOI 10.18637/jss.v045.i04; rural Tanzania, 2003, J HLTH POPULATION NU, P8; Salihu HM, 2011, EUR J OBSTET GYN R B, V154, P31, DOI 10.1016/j.ejogrb.2010.08.006; StataCorp, 2017, STATA STAT SOFTWARE; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; United Nations Inter-Agency Group for Child Mortality Estimation (UN IGME), 2019, LEV TRENDS CHILD MOR; Unterscheider J, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-63; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; WHO, 2022, WHO RECOMMENDATIONS; World Health Organization, 2019, MAT PER HLTH; World Health Organization, 2016, WHO APPL ICD 10 DEAT	52	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231636	10.1371/journal.pone.0231636	http://dx.doi.org/10.1371/journal.pone.0231636			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298332	gold, Green Published			2022-12-26	WOS:000536011400080
J	Sheikholeslami, B; Shukla, M; Turi, C; Harpur, C; Saxena, PK				Sheikholeslami, Bita; Shukla, Mukund; Turi, Christina; Harpur, Cavan; Saxena, Praveen K.			Saving threatened plant species: Reintroduction of Hill's thistle (Cirsium hillii. (Canby) Fernald) to its natural habitat	PLOS ONE			English	Article							IN-VITRO PROPAGATION; MICROPROPAGATION; CONSERVATION; CYTOKININ; HERBIVORY; GROWTH	Hill's thistle (Cirsium hillii (Canby) Fernald) is a perennial plant endemic to the Great Lakes region of North America. Hill's thistle is listed as threatened in Ontario and Canada where it is found in globally rare alvar habitats. The main objective of this study was ex-situ conservation of Hill's thistle using in vitro culture techniques and reintroduction of micropropagated plants back to their natural habitat in Bruce Peninsula National Park, Ontario, Canada. Two out of twenty-nine available seeds were successfully germinated under in vitro condition. An efficient micropropagation protocol was optimized with 100% survival during acclimatization of plantlets in the greenhouse. Three hundred micropropagated plants were reintroduced to twelve different sites within Bruce Peninsula National Park in June and July 2017. Plants were monitored for survival, rosette growth, and flowering on all sites from 2017-2019. After four months of planting, 67 to 99% of the plants were alive in different sites and 90 to 99% of them survived over winter. In the following years, shoot regeneration and flowering were observed on most sites. This study further confirms the benefit of plant tissue culture techniques to ensure revival of Hill's thistle ecological biodiversity through the reintroduction of micropropagated plants. This approach consisting of the components of conservation, propagation, and reintroduction (CPR) may potentially serve as a model for saving and enriching other species at risk.	[Sheikholeslami, Bita; Shukla, Mukund; Turi, Christina; Saxena, Praveen K.] Univ Guelph, Gosling Res Inst Plant Preservat, Dept Plant Agr, Guelph, ON, Canada; [Harpur, Cavan] Bruce Peninsula Natl Pk, Tobermory, ON, Canada	University of Guelph	Saxena, PK (corresponding author), Univ Guelph, Gosling Res Inst Plant Preservat, Dept Plant Agr, Guelph, ON, Canada.	psaxena@uoguelph.ca			Gosling Foundation, Guelph, Ontario	Gosling Foundation, Guelph, Ontario	This research was supported by a grant from the Gosling Foundation, Guelph, Ontario to the Gosling Research Institute for Plant Preservation (GRIPP).	Arrebola ML, 2003, J HERBS SPICES MED P, V10, P89, DOI DOI 10.1300/; Barton KE, 2013, ANN BOT-LONDON, V112, P643, DOI 10.1093/aob/mct139; Bell TJ, 2003, ECOL STU AN, V165, P313; Catlin P, 2009, CAN FIELD NAT, V123, P240, DOI 10.22621/cfn.v123i3.971; Chickarmane VS, 2012, P NATL ACAD SCI USA, V109, P4002, DOI 10.1073/pnas.1200636109; COSEWIC, 2004, COSEWIC ASS STAT REP; COSEWIC [Committee on the Status of Endangered Wildlife in Canada], 2017, CAN WILDL SPEC RISK; Daws MI, 2015, PLANT ECOL, V216, P565, DOI 10.1007/s11258-015-0459-7; Dooley FD, 2013, AQUAT BOT, V111, P130; Eckberg J, 2017, NATIVE THISTLES CONS; Endres D, 2018, ACTA BOT BRAS, V32, P555, DOI 10.1590/0102-33062018abb0009; Erland LAE, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223878; Freeland JR, 2010, BOTANY, V88, P1073, DOI 10.1139/B10-080; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Garcia-Rubio O, 2010, HORTSCIENCE, V45, P934, DOI 10.21273/HORTSCI.45.6.934; Godefroid S, 2011, BIOL CONSERV, V144, P672, DOI 10.1016/j.biocon.2010.10.003; Hayta S, 2017, PLANT BIOSYST, V151, P20, DOI 10.1080/11263504.2015.1057267; Higman PJ, 1996, MICHIGAN NATURAL FEA, P2; HUNTER JH, 1985, BOT GAZ, V146, P483, DOI 10.1086/337552; International Union for Conservation of Nature (IUCN), 2013, GUID REINTR OTH CONS; Juliani HR, 2011, IND CROP PROD, V34, P1353, DOI 10.1016/j.indcrop.2010.12.009; Lee H.T., 1998, ECOLOGICAL LAND CLAS; Loyola-Vargas Victor M, 2012, Methods Mol Biol, V877, P1, DOI 10.1007/978-1-61779-818-4_1; MAUNDER M, 1992, BIODIVERS CONSERV, V1, P51, DOI 10.1007/BF00700250; MOORE RJ, 1966, CAN J BOTANY, V44, P581, DOI 10.1139/b66-070; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OMNR, 2013, REC STRAT HILLS THIS; PARSONS DJ, 1979, FOREST ECOL MANAG, V2, P21, DOI 10.1016/0378-1127(79)90034-3; PENCE V., 2011, J KY ACAD SCI, V72, P91, DOI DOI 10.3101/1098-7096-72.2.91; Penfield S, 2017, CURR BIOL, V27, pR874, DOI 10.1016/j.cub.2017.05.050; Perez-Tornero O, 1999, IN VITRO CELL DEV-PL, V35, P249, DOI 10.1007/s11627-999-0087-9; Rady M. R., 2018, Journal of Genetic Engineering and Biotechnology, V16, P563, DOI 10.1016/j.jgeb.2018.02.007; Rathwell R, 2016, CAN J PLANT SCI, V96, P571, DOI 10.1139/cjps-2015-0331; Robinson J, 2015, J ENVIRON MANAGE, V150, P157, DOI 10.1016/j.jenvman.2014.10.033; Salama A, CAN J PLANT SCI; Salama A, 2018, CAN J PLANT SCI, V98, P762, DOI 10.1139/cjps-2017-0207; Schaller GE, 2015, PLANT CELL, V27, P44, DOI 10.1105/tpc.114.133595; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shahcheraghi S. T., 2016, Advances in Horticultural Science, V30, P129, DOI 10.13128/ahs-20248; Sharaf ARN, 2011, HORTIC ENVIRON BIOTE, V52, P298, DOI 10.1007/s13580-011-0129-1; Shukla MR, 2012, CAN J FOREST RES, V42, P686, DOI [10.1139/X2012-022, 10.1139/x2012-022]; Silva AL, 2003, CROP BREED APPL BIOT, V3, P149; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Staden J. van, 2008, Plant propagation by tissue culture. Volume 1: the background, P205; Stanforth LM, 1997, ECOSCIENCE, V4, P57, DOI 10.1080/11956860.1997.11682377; Uchendu EE, 2011, IN VITRO CELL DEV-PL, V47, P710, DOI 10.1007/s11627-011-9379-y	46	8	8	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231741	10.1371/journal.pone.0231741	http://dx.doi.org/10.1371/journal.pone.0231741			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298393	gold, Green Published			2022-12-26	WOS:000536011400099
J	Huang, M; Feng, X; Su, D; Wang, G; Wang, C; Tang, MF; Paulucci-Holthauzen, A; Hart, T; Chen, JJ				Huang, Min; Feng, Xu; Su, Dan; Wang, Gang; Wang, Chao; Tang, Mengfan; Paulucci-Holthauzen, Adriana; Hart, Traver; Chen, Junjie			Genome-wide CRISPR screen uncovers a synergistic effect of combining Haspin and Aurora kinase B inhibition	ONCOGENE			English	Article							SMALL-MOLECULE INHIBITOR; PHOSPHORYLATED HISTONE H3; THR-3 PHOSPHORYLATION; STRUCTURAL BASIS; FEEDBACK LOOP; OVEREXPRESSION; RECOGNITION; CARCINOMA; MLN8054; POTENT	Aurora kinases are a family of serine/threonine kinases vital for cell division. Because of the overexpression of Aurora kinases in a broad range of cancers and their important roles in mitosis, inhibitors targeting Aurora kinases have attracted attention in cancer therapy. VX-680 is an effective pan-Aurora kinase inhibitor; however, its clinical efficacy was not satisfying. In this study, we performed CRISPR/Cas9 screens to identify genes whose depletion shows synthetic lethality with VX-680. The top hit from these screens was GSG2 (also known as Haspin), a serine/threonine kinase that phosphorylates histone H3 at Thr-3 during mitosis. Moreover, both Haspin knockout and Haspin inhibitor-treated HCT116 cells were hypersensitive to VX-680. Furthermore, we showed that the synthetic lethal interaction between Haspin depletion and VX-680 was mediated by the inhibition of Haspin with Aurora kinase B (AURKB), but not with Aurora kinase A (AURKA). Strikingly, combined inhibition of Haspin and AURKB had a better efficacy than single-agent treatment in both head and neck squamous cell carcinoma and non-small cell lung cancer. Taken together, our findings have uncovered a synthetic lethal interaction between AURKB and Haspin, which provides a strong rationale for this combination therapy for cancer patients.	[Huang, Min; Feng, Xu; Su, Dan; Wang, Chao; Tang, Mengfan; Chen, Junjie] Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA; [Wang, Gang; Hart, Traver] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Paulucci-Holthauzen, Adriana] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Chen, JJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Radiat Oncol, Houston, TX 77030 USA.	jchen8@mdanderson.org		Wang, Andy/0000-0001-6798-1032; Feng, Xu/0000-0003-1603-7070	NCI NIH HHS [P30 CA016672, R01 CA210929] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amoussou NG, 2018, DRUG DISCOV TODAY, V23, P409, DOI 10.1016/j.drudis.2017.10.005; Araki K, 2004, J NEURO-ONCOL, V67, P53, DOI 10.1023/B:NEON.0000021784.33421.05; Balzano D, 2011, CHEM BIOL, V18, P966, DOI 10.1016/j.chembiol.2011.04.013; Bavetsias V, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00278; Bebbington D, 2009, BIOORG MED CHEM LETT, V19, P3586, DOI 10.1016/j.bmcl.2009.04.136; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Borisa AC, 2017, EUR J MED CHEM, V140, P1, DOI 10.1016/j.ejmech.2017.08.045; Boss DS, 2009, ONCOLOGIST, V14, P780, DOI 10.1634/theoncologist.2009-0019; Burdova K, 2019, EMBO J, V38, DOI 10.15252/embj.2018101443; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chieffi P, 2004, J ENDOCRINOL, V181, P263, DOI 10.1677/joe.0.1810263; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; dos Santos EO, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0494-6; Du JM, 2012, STRUCTURE, V20, P185, DOI 10.1016/j.str.2011.12.001; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Ghenoiu C, 2013, MOL CELL, V52, P734, DOI 10.1016/j.molcel.2013.10.002; Gritsko TM, 2003, CLIN CANCER RES, V9, P1420; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Helfrich BA, 2016, MOL CANCER THER, V15, P2314, DOI 10.1158/1535-7163.MCT-16-0298; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hoar K, 2007, MOL CELL BIOL, V27, P4513, DOI 10.1128/MCB.02364-06; Jeyaprakash AA, 2011, STRUCTURE, V19, P1625, DOI 10.1016/j.str.2011.09.002; Katayama H, 2010, BBA-GENE REGUL MECH, V1799, P829, DOI 10.1016/j.bbagrm.2010.09.004; Kelly AE, 2010, SCIENCE, V330, P235, DOI 10.1126/science.1189505; Kestav K, 2017, CURR MED CHEM, V24, P2276, DOI 10.2174/0929867324666170414155520; Li Y, 2010, AM J TRANSL RES, V2, P296; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Marur S, 2016, MAYO CLIN PROC, V91, P386, DOI 10.1016/j.mayocp.2015.12.017; Mehra R, 2013, LANCET ONCOL, V14, pE425, DOI 10.1016/S1470-2045(13)70128-1; Niedzialkowska E, 2012, MOL BIOL CELL, V23, P1457, DOI 10.1091/mbc.E11-11-0904; Potting C, 2018, P NATL ACAD SCI USA, V115, pE180, DOI 10.1073/pnas.1711023115; Reichardt W, 2003, ONCOL REP, V10, P1275; Sells TB, 2015, ACS MED CHEM LETT, V6, P630, DOI 10.1021/ml500409n; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shimada M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12059; Sorrentino R, 2005, J CLIN ENDOCR METAB, V90, P928, DOI 10.1210/jc.2004-1518; Takeshita M, 2013, LUNG CANCER, V80, P85, DOI 10.1016/j.lungcan.2012.12.018; Tanaka T, 1999, CANCER RES, V59, P2041; Tang AQ, 2017, ONCOTARGET, V8, P23937, DOI 10.18632/oncotarget.14893; Wang C, 2019, ONCOGENE, V38, P2451, DOI 10.1038/s41388-018-0606-4; Wang FW, 2012, J CELL BIOL, V199, P251, DOI 10.1083/jcb.201205106; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Willems E, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0040-6; Yamagishi Y, 2010, SCIENCE, V330, P239, DOI 10.1126/science.1194498; Yu FZ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2016.49; Zappa C, 2016, TRANSL LUNG CANCER R, V5, P288, DOI 10.21037/tlcr.2016.06.07; Zhou HY, 1998, NAT GENET, V20, P189, DOI 10.1038/2496; Zhou LL, 2014, EMBO REP, V15, P273, DOI 10.1002/embr.201338080	51	9	9	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2020	39	21					4312	4322		10.1038/s41388-020-1296-2	http://dx.doi.org/10.1038/s41388-020-1296-2			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	LQ2DH	32300176	Green Accepted			2022-12-26	WOS:000534819000012
J	Akhtar, N; Kamran, S; Elkhider, H; Al-Makki, S; Mhjob, N; ElShiekh, L; AlHussain, H; Ali, M; Khodair, R; Wadiwala, F; Salam, A; Deleu, D; Francis, R; Shuaib, A				Akhtar, Naveed; Kamran, Saadat; Elkhider, Hisham; Al-Makki, Soha; Mhjob, Noha; ElShiekh, Lubna; AlHussain, Hassan; Ali, Musab; Khodair, Rola; Wadiwala, Faisal; Salam, Abdul; Deleu, Dirk; Francis, Reny; Shuaib, Ashfaq			Progression of stroke deficits in patients presenting with mild symptoms: The underlying etiology determines outcome	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; TRANSIENT ISCHEMIC ATTACK; RAPIDLY IMPROVING STROKE; MINOR STROKE; TOO GOOD; THROMBOLYSIS; THERAPY; EVENTS; TREAT; MRI	Background and purpose Patients with acute stroke and mild or rapidly improving symptoms frequently show progression. The role of reperfusion treatment in such patients is not clear. We hypothesized that progression was most likely in patients with cortical localization and such patients may benefit from thrombolysis. Material and methods We interrogated Hamad Stroke Database to evaluate 90-days outcome in patients with acute ischemic stroke admitted within 4 hours and a NIHSS score of <= 6. Evaluation was based on localization (lacunar or cortical), multi-model imaging abnormalities and whether they received rt-PA. The 90-day mRS was used to determine outcome. Results During study period 6381 patients were admitted with acute stroke. Mild stroke within 4 hours was diagnosed in 506 [no thrombolysis: 381(lacunar: 213; cortical: 168), thrombolysis: 125 (lacunar: 45; cortical: 80)]. The rt-PA treated patients had significantly higher NIHSS (2.94 +/- 3.9 versus 1.28 +/- 2.46, p<0.0001), increased rates of complications (16.0% versus 3.9%, p<0.0001) and longer hospital stay (6.05 +/- 8.1 versus 3.78 +/- 3.6 days; p<0.001). In patients with cortical stroke, intracranial arterial occlusions (11.6% vs 3.9%, p<0.0001) and CTP mismatch (22.2% vs 4.4%, p<0.0001) were more frequent in rt-PA treated patients. Discharge mRS (33.6% versus 13.9%, p<0.001) and 90-days mRS (23.2% versus 11.8%, p = 0.002) was significantly worse in patients with cortical stroke (rt-PA-treated and untreated patients). Conclusions The outcome in patients with mild stroke depends on lesion location (lacunar versus cortical) and severity of symptoms. Patients who receive rt-PA have significantly larger deficits, increased imaging abnormalities and higher rates of hospital complication, explaining the poor outcome in such subjects.	[Akhtar, Naveed; Kamran, Saadat; Elkhider, Hisham; Al-Makki, Soha; Mhjob, Noha; ElShiekh, Lubna; AlHussain, Hassan; Ali, Musab; Khodair, Rola; Wadiwala, Faisal; Salam, Abdul; Deleu, Dirk; Francis, Reny; Shuaib, Ashfaq] Hamad Med Corp, Neurosci Inst, Doha, Qatar; [Shuaib, Ashfaq] Univ Alberta, Dept Med, Stroke Program, Edmonton, AB, Canada	Hamad Medical Corporation; University of Alberta	Shuaib, A (corresponding author), Hamad Med Corp, Neurosci Inst, Doha, Qatar.; Shuaib, A (corresponding author), Univ Alberta, Dept Med, Stroke Program, Edmonton, AB, Canada.	ashuaib@hamad.qa	Salam, Abdul/GWC-1029-2022	Alhussein, Hassan/0000-0002-9165-7846; Kamran, Saadat/0000-0002-0260-2086; Elkhider, Hisham/0000-0003-3266-6483				Akhtar N, 2016, EUR STROKE J, V1, P231, DOI 10.1177/2396987316663776; Ali SF, 2016, STROKE, V47, P2986, DOI 10.1161/STROKEAHA.116.014871; Balucani C, 2011, STROKE, V42, P3005, DOI 10.1161/STROKEAHA.111.628701; Barber PA, 2001, NEUROLOGY, V56, P1015, DOI 10.1212/WNL.56.8.1015; Choi JC, 2015, J AM HEART ASSOC, V4, DOI [10.1161/JAHA.114.001306, 10.1161/JAHA.114.000596]; Cocho D, 2005, NEUROLOGY, V64, P719, DOI 10.1212/01.WNL.0000152041.20486.2F; Coutts SB, 2008, STROKE, V39, P2461, DOI 10.1161/STROKEAHA.107.513234; Coutts SB, 2012, STROKE, V43, P3018, DOI 10.1161/STROKEAHA.112.665141; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fischer U, 2010, STROKE, V41, P661, DOI 10.1161/STROKEAHA.109.572883; Greisenegger S, 2014, STROKE, V45, P765, DOI 10.1161/STROKEAHA.113.003827; Hassan AE, 2010, SOUTH MED J, V103, P398, DOI 10.1097/SMJ.0b013e3181d7814a; Horton M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065752; Ibrahim F, 2016, J STROKE CEREBROVASC, V25, P2043, DOI 10.1016/j.jstrokecerebrovasdis.2016.03.047; Khatri P, 2018, JAMA-J AM MED ASSOC, V320, P156, DOI 10.1001/jama.2018.8496; Khatri P, 2015, STROKE, V46, P2325, DOI 10.1161/STROKEAHA.115.009951; Khatri P, 2012, STROKE, V43, P560, DOI 10.1161/STROKEAHA.110.593897; Khatri P, 2010, STROKE, V41, P2581, DOI 10.1161/STROKEAHA.110.593632; Kim JT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070996; Messe SR, 2016, NEUROLOGY, V87, P1565, DOI 10.1212/WNL.0000000000003198; Mokin M, 2014, J NEUROINTERV SURG, V6, P413, DOI 10.1136/neurintsurg-2013-010720; Nagel S, 2018, STROKE, V49, P2391, DOI 10.1161/STROKEAHA.118.021106; Nedeltchev K, 2007, STROKE, V38, P2531, DOI 10.1161/STROKEAHA.107.482554; Ng FC, 2016, STROKE; Park TH, 2013, J STROKE CEREBROVASC, V22, P482, DOI 10.1016/j.jstrokecerebrovasdis.2013.03.006; Poisson SN, 2011, STROKE, V42, P44, DOI 10.1161/STROKEAHA.110.591099; Rajajee V, 2006, NEUROLOGY, V67, P980, DOI 10.1212/01.wnl.0000237520.88777.71; Romano JG, 2016, STROKE, V47, P1278, DOI 10.1161/STROKEAHA.115.011528; Rostanski SK, 2017, STROKE; Shi L, 2014, MED SCI MONITOR, V20, P2117, DOI 10.12659/MSM.892259; Smith EE, 2005, STROKE, V36, P2497, DOI 10.1161/01.STR.0000185798.78817.f3; Smith EE, 2011, STROKE, V42, P3110, DOI 10.1161/STROKEAHA.111.613208; van den Berg JSP, 2009, ACTA NEUROL SCAND, V120, P157, DOI 10.1111/j.1600-0404.2008.01140.x; Willey JZ, 2012, INT J STROKE, V7, P202, DOI 10.1111/j.1747-4949.2011.00696.x; Yeo LLL, 2014, J STROKE CEREBROVASC, V23, P2156, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.008; You SJ, 2018, STROKE VASC NEUROL, V3, P22, DOI 10.1136/svn-2017-000106; Yu AYX, 2015, INT J STROKE, V10, P292, DOI 10.1111/ijs.12426	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231448	10.1371/journal.pone.0231448	http://dx.doi.org/10.1371/journal.pone.0231448			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330144	gold, Green Published			2022-12-26	WOS:000536647300013
J	Nishikiori, T; Kubota, T; Miyazu, S; Harada, N; Yoshikawa, N; Fujiwara, H; Saito, T				Nishikiori, Tatsuhiro; Kubota, Tomijiro; Miyazu, Susumu; Harada, Naoki; Yoshikawa, Natsuki; Fujiwara, Hideshi; Saito, Takashi			Input and output pathways determining potassium budgets in two paddy fields subjected to countermeasures against radiocesium in Fukushima, Japan	PLOS ONE			English	Article							NUTRIENT-UPTAKE; RICE; SOIL; BALANCES; YIELD; DISCHARGE	Countermeasures to reduce radiocesium (Cs-134 and Cs-137) uptake by crops have been implemented in farmlands affected by the Fukushima nuclear accident in 2011. A widely practiced countermeasure is the application of potassium (K). Long-term soil K maintenance is a key issue due to the long physical half-life of Cs-137 (30 years). Information on input and output pathways determining plant-available K budgets can provide a base for the development of maintenance strategies. Therefore, in this study we evaluated these pathways in paddy fields subjected to K fertilization as a countermeasure. We selected two fields with different soil textures and drainage conditions and quantified input and output via fertilization, irrigation, precipitation, straw return to soil, plant harvesting, surface runoff, and percolation during the cropping period in 2018. The major input pathways were fertilization, straw return, and irrigation due to a large inflow volume with spill-over irrigation. The major output pathways consisted of plant harvesting, surface runoff, and percolation. However, 85% of K in harvested plants was brought back by straw return; in practice, harvesting was a minor pathway. The K budgets during the study period were negative (-20 and -289 kg ha(-1)) and especially severe in clay loam soil with high output via percolation. This could probably be attributed to the low cation exchange capacity and high permeability from the low total C and clay contents. Losses via surface runoff stemmed from excessive irrigation volumes in both fields. Around 70% of the total K output via surface runoff and percolation was discharged before mid-summer drainage. Accordingly, controlling the irrigation volume during this period in addition to increasing cation exchange capacity and decreasing permeability may improve the negative budgets.	[Nishikiori, Tatsuhiro] Natl Agr & Food Res Org, Agr Radiat Res Ctr, Tohoku Agr Res Ctr, Fukushima, Fukushima, Japan; [Kubota, Tomijiro; Miyazu, Susumu] Natl Agr & Food Res Org, Inst Rural Engn, Tsukuba, Ibaraki, Japan; [Miyazu, Susumu; Harada, Naoki; Yoshikawa, Natsuki] Niigata Univ, Fac Agr, Nishi Ku, Niigata, Niigata, Japan; [Fujiwara, Hideshi] Natl Agr & Food Res Org, Inst Agroenvironm Sci, Tsukuba, Ibaraki, Japan; [Saito, Takashi] Fukushima Agr Technol Ctr, Hama Agr Regenerat Res Ctr, Fukushima, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; Niigata University; National Agriculture & Food Research Organization - Japan	Nishikiori, T (corresponding author), Natl Agr & Food Res Org, Agr Radiat Res Ctr, Tohoku Agr Res Ctr, Fukushima, Fukushima, Japan.	nishikiorit110@affrc.go.jp			Ministry of Agriculture, Forestry and Fisheries, Government of Japan	Ministry of Agriculture, Forestry and Fisheries, Government of Japan(Ministry of Agriculture Forestry & Fisheries - Japan)	This work received support from the Ministry of Agriculture, Forestry and Fisheries, Government of Japan to TN, https://www.maff.go.jp/e/.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; Bijay-Singh Y-S, 2004, ADV AGRONOMY, V81, P203; Bouman BAM, 2007, ADV AGRON, V92, P187, DOI 10.1016/S0065-2113(04)92004-4; Buresh RJ, 2010, PLANT SOIL, V335, P35, DOI 10.1007/s11104-010-0441-z; Carey PL, 2011, PLANT SOIL, V341, P461, DOI 10.1007/s11104-010-0658-x; Eguchi S., 2017, J JPN SOC SOIL PHYS, V135, P9; Fukushima Prefectural Government, 2014, GUID DEC TECHN MEAS; Fukushima Prefecture, 2019, FERT STAND FUK PREF; Hoa NM, 2006, AGR ECOSYST ENVIRON, V116, P121, DOI 10.1016/j.agee.2006.03.020; Islam A, 2016, ARCH AGRON SOIL SCI, V62, P1530, DOI 10.1080/03650340.2016.1157259; Japan Meteorological Agency, 2019, DAT DOC; Japanese Society of Soil Science and Plant Nutrition, 1997, METH SOIL ENV AN; Kubo K, 2017, PLANT PROD SCI, V20, P396, DOI 10.1080/1343943X.2017.1355737; Liu XJ, 2003, FIELD CROP RES, V83, P297, DOI 10.1016/S0378-4290(03)00079-0; Mendes WD, 2016, REV BRAS ENG AGR AMB, V20, P972, DOI 10.1590/1807-1929/agriambi.v20n11p972-977; Ministry of Agriculture Forestry and Fisheries of Japan, 2013, TECHN BOOK FARML DEC; Ministry of the Environment, 2013, DEC GUID; Miyazu S, 2016, J ENVIRON RADIOACTIV, V155, P23, DOI 10.1016/j.jenvrad.2016.01.013; Nuclear Regulation Authority, 2019, EXT SIT DISTR MAP RA; Okubo T., 2014, Journal of Japan Society on Water Environment, V37, P229, DOI 10.2965/jswe.37.229; Osawa K, 2018, ANTHROPOCENE, V22, P40, DOI 10.1016/j.ancene.2018.04.003; Panaullah GM, 2006, J PLANT NUTR, V29, P173, DOI 10.1080/01904160500416554; Regmi AP, 2002, SOIL SCI SOC AM J, V66, P857, DOI 10.2136/sssaj2002.0857; SAWHNEY BL, 1972, CLAY CLAY MINER, V20, P93, DOI 10.1346/CCMN.1972.0200208; Shin M, 2019, PADDY WATER ENVIRON, V17, P703, DOI 10.1007/s10333-019-00694-6; Singh VK, 2018, FIELD CROP RES, V224, P1, DOI 10.1016/j.fcr.2018.04.012; Takahashi J, 2018, J ENVIRON RADIOACTIV, V182, P157, DOI 10.1016/j.jenvrad.2017.11.034; Taniguchi K, 2019, ENVIRON SCI TECHNOL, V53, P12339, DOI 10.1021/acs.est.9b02890; Ueda S, 2013, J ENVIRON RADIOACTIV, V118, P96, DOI 10.1016/j.jenvrad.2012.11.009; Wakahara T, 2014, ENVIRON SCI-PROC IMP, V16, P2580, DOI [10.1039/c4em00262h, 10.1039/C4EM00262H]; Wihardjaka A, 1999, FIELD CROP RES, V64, P237, DOI 10.1016/S0378-4290(99)00045-3; Yamanaka K, 1955, AGR HORTIC, V30, P1409; Yamashiki Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03714	33	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232139	10.1371/journal.pone.0232139	http://dx.doi.org/10.1371/journal.pone.0232139			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330181	Green Published, gold			2022-12-26	WOS:000536647300054
J	Safdari, H; Kalirad, A; Picioreanu, C; Tusserkani, R; Goliaei, B; Sadeghi, M				Safdari, Hadiseh; Kalirad, Ata; Picioreanu, Cristian; Tusserkani, Rouzbeh; Goliaei, Bahram; Sadeghi, Mehdi			Noise-driven cell differentiation and the emergence of spatiotemporal patterns	PLOS ONE			English	Article							STOCHASTIC GENE-EXPRESSION; EVOLUTION; NETWORK; DYNAMICS; ORDER; FATE	The emergence of phenotypic diversity in a population of cells and their arrangement in space and time is one of the most fascinating features of living systems. In fact, understanding multicellularity is unthinkable without explaining the proximate and the ultimate causes of cell differentiation in time and space. Simpler forms of cell differentiation can be found in unicellular organisms, such as bacterial biofilm, where reversible cell differentiation results in phenotypically diverse populations. In this manuscript, we attempt to start with the simple case of reversible nongenetic phenotypic to construct a model of differentiation and pattern formation. Our model, which we refer to as noise-driven differentiation (NDD) model, is an attempt to consider the prevalence of noise in biological systems, alongside what is known about genetic switches and signaling, to create a simple model which generates spatiotemporal patterns from bottom-up. Our simulations indicate that the presence of noise in cells can lead to reversible differentiation and the addition of signaling can create spatiotemporal pattern.	[Safdari, Hadiseh; Kalirad, Ata] Inst Res Fundamental Sci IPM, Sch Biol Sci, Tehran, Iran; [Picioreanu, Cristian] Delft Univ Technol, Fac Appl Sci, Dept Biotechnol, Delft, Netherlands; [Tusserkani, Rouzbeh] Inst Res Fundamental Sci IPM, Sch Comp Sci, Tehran, Iran; [Goliaei, Bahram] Univ Tehran, Inst Biochem & Biophys, Tehran, Iran; [Sadeghi, Mehdi] Natl Inst Genet Engn & Biotechnol NIGEB, Tehran, Iran	Delft University of Technology; University of Tehran	Sadeghi, M (corresponding author), Natl Inst Genet Engn & Biotechnol NIGEB, Tehran, Iran.	sadeghi@nigeb.ac.ir	Safdari, Hadi/ABA-8610-2020	Safdari, Hadi/0000-0002-0917-7609				Balazsi G, 2011, CELL, V144, P910, DOI 10.1016/j.cell.2011.01.030; Betschinger J., 2017, CURR BIOL, V14, pR674, DOI DOI 10.1016/J.CUB.2004.08.017; Bradshaw N, 2015, ELIFE, V4, DOI 10.7554/eLife.08145; Carson E, 2000, MODELLING METHODOLOG; Chalancon G, 2012, TRENDS GENET, V28, P221, DOI 10.1016/j.tig.2012.01.006; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Clevers H, 2005, NAT GENET, V37, P1027, DOI 10.1038/ng1005-1027; Cortes MG, 2017, BIOPHYS J, V113, P2110, DOI 10.1016/j.bpj.2017.09.012; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ghaffarizadeh A, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S7; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Hooshangi S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002172; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; Huh D, 2011, P NATL ACAD SCI USA, V108, P15004, DOI 10.1073/pnas.1013171108; Jan YN, 1998, NATURE, V392, P775, DOI 10.1038/33854; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Khorasani N, 2020, BIORXIV; KIMURA M, 1967, GENET RES, V9, P23, DOI 10.1017/S0016672300010284; Kittisopikul M, 2010, P NATL ACAD SCI USA, V107, P13300, DOI 10.1073/pnas.1003975107; Kreft JU, 2001, MICROBIOL-SGM, V147, P2897, DOI 10.1099/00221287-147-11-2897; Kupiec J, 1997, MOL GEN GENET, V255, P201, DOI 10.1007/s004380050490; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Margolin W., 2000, FEMS MICROBIOL REV; Maynard Smith John., 1995, MAJOR TRANSITION EVO; Monahan LG, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00019; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Moussy A, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001867; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; NOVICK A, 1957, P NATL ACAD SCI USA, V43, P553, DOI 10.1073/pnas.43.7.553; Olimpio EP, 2018, ISCIENCE, V2, P27, DOI 10.1016/j.isci.2018.03.013; Ostrowski EA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-218; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Paldi A, 2003, CELL MOL LIFE SCI, V60, P1775, DOI 10.1007/s00018-003-23147-z; Paliwal S, 2007, NATURE, V446, P46, DOI 10.1038/nature05561; Perez-Carrasco R, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005154; Pickett-Heaps JD, 1999, AM J BOT, V86, P153, DOI 10.2307/2656933; Ptashne M, 2004, GENETIC SWITCH PHAGE; Queller DC, 2009, PHILOS T R SOC B, V364, P3143, DOI 10.1098/rstb.2009.0095; Rudel D, 2003, DEV BIOL, V264, P15, DOI 10.1016/S0012-1606(03)00353-1; Sanchez A, 2013, SCIENCE, V342, P1188, DOI 10.1126/science.1242975; Schluter J, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004848; Sharifi-Zarchi A, 2015, BMC SYST BIOL, V9, DOI 10.1186/s12918-015-0169-8; Suzuki N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027232; Vogt G, 2015, J BIOSCIENCES, V40, P159, DOI 10.1007/s12038-015-9506-8; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wolk CP, 1996, ANNU REV GENET, V30, P59, DOI 10.1146/annurev.genet.30.1.59; Wolpert L, 2011, J THEOR BIOL, V269, P359, DOI 10.1016/j.jtbi.2010.10.034; Wu JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050715; Yamagishi JF, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005042	53	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0232060	10.1371/journal.pone.0232060	http://dx.doi.org/10.1371/journal.pone.0232060			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330159	gold, Green Published, Green Submitted			2022-12-26	WOS:000536647300046
J	Freuer, D; Linseisen, J; Waterboer, T; Pessler, F; Guzman, CA; Wawro, N; Peters, A; Meisinger, C				Freuer, Dennis; Linseisen, Jakob; Waterboer, Tim; Pessler, Frank; Guzman, Carlos Alberto; Wawro, Nina; Peters, Annette; Meisinger, Christa			Seropositivity of selected chronic infections and different measures of obesity	PLOS ONE			English	Article							BODY-MASS INDEX; HELICOBACTER-PYLORI INFECTION; PREVALENCE; RISK; HEALTH; BMI	The impact of sex-specific body fat distribution on the susceptibility to five chronic infections, helicobacter pylori and human herpesviruses 3 to 6 (i.e. varicella-zoster, Epstein-Barr, cytomegalo- and human herpesvirus 6), has not previously been examined. In the present study, seropositivity was determined via multiplex serology in serum samples of study participants collected in 2006/08 and 2013/14 during the follow-up examinations F4 (n = 3080) and FF4 (n = 2279) of the German population-based baseline KORA S4 survey. We quantified the severity of overall and abdominal obesity by body mass index, body adiposity index, waist circumference, waist-to-hip ratio, and waist-to-height ratio. Using sex-specific logistic spline-models, cross-sectional and longitudinal associations between obesity measures and seropositivity of the previously mentioned infections were investigated. Overall and abdominal fat content were significantly associated with seropositivity of varicella-zoster virus in both cross-sectional and longitudinal analyses among women. In addition, a non-significant inverse relationship with Epstein-Barr virus seroprevalence in both sexes and a trend towards a positive association with human herpesvirus 6 seropositivity in women were observed. Therefore, in women total body fat may be associated with VZV-seropositivity and may influence the reactivation of the varicella-zoster virus, independent of adipose tissue distribution.	[Freuer, Dennis; Linseisen, Jakob; Wawro, Nina; Meisinger, Christa] Ludwig Maximilians Univ Munchen, Chair Epidemiol UNIKA T Augsburg, Augsburg, Germany; [Freuer, Dennis; Linseisen, Jakob; Wawro, Nina; Meisinger, Christa] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Independent Res Grp Clin Epidemiol, Neuherberg, Germany; [Waterboer, Tim] German Canc Res Ctr, Infect & Canc Epidemiol, Heidelberg, Germany; [Pessler, Frank] TWINCORE, Ctr Expt & Clin Infect Res, Res Grp Biomarkers for Infect Dis, Hannover, Germany; [Pessler, Frank; Guzman, Carlos Alberto] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Pessler, Frank] Ctr Individualised Infect Med, Hannover, Germany; [Peters, Annette] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany	University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Freuer, D (corresponding author), Ludwig Maximilians Univ Munchen, Chair Epidemiol UNIKA T Augsburg, Augsburg, Germany.; Freuer, D (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Independent Res Grp Clin Epidemiol, Neuherberg, Germany.	d.freuer@unika-t.de	Peters, Annette/A-6117-2011; Linseisen, Jakob/B-5353-2014	Peters, Annette/0000-0001-6645-0985; Linseisen, Jakob/0000-0002-9386-382X; Freuer, Dennis/0000-0001-7188-9087; Wawro, Nina/0000-0001-8144-0291	iMed - the Helmholtz Association's Cross Programme Initiative on Personalized Medicine; Helmholtz Association's Portfolio Topic "Metabolic Dysfunction and Chronic Diseases"; Helmholtz Zentrum Munchen - German Research Centre for Environmental Health - German Federal Ministry of Education and Research (BMBF); State of Bavaria	iMed - the Helmholtz Association's Cross Programme Initiative on Personalized Medicine; Helmholtz Association's Portfolio Topic "Metabolic Dysfunction and Chronic Diseases"; Helmholtz Zentrum Munchen - German Research Centre for Environmental Health - German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); State of Bavaria	This work was supported by iMed - the Helmholtz Association's Cross Programme Initiative on Personalized Medicine and the Helmholtz Association's Portfolio Topic "Metabolic Dysfunction and Chronic Diseases". The KORA study was initiated and financed by the Helmholtz Zentrum Munchen - German Research Centre for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibek K, 2014, INFECT AGENTS CANCER, V9, DOI 10.1186/1750-9378-9-3; Arslan E, 2009, EUR J INTERN MED, V20, P695, DOI 10.1016/j.ejim.2009.07.013; Bassig BA, 2018, INT J CANCER, V143, P570, DOI 10.1002/ijc.31385; Beisel C, 2015, DEUT MED WOCHENSCHR, V140, P1385, DOI 10.1055/s-0041-104246; Bennett JM, 2012, BRAIN BEHAV IMMUN, V26, P739, DOI 10.1016/j.bbi.2011.11.007; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Brenner N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209379; Dobner J, 2018, CLIN MICROBIOL INFEC, V24, P24, DOI 10.1016/j.cmi.2017.02.013; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; FerroLuzzi A, 1995, WHO TECH REP SER, V854, P1; Hamer M, 2016, J CLIN ENDOCR METAB, V101, P1680, DOI 10.1210/jc.2015-4208; Harpsoe MC, 2016, AM J EPIDEMIOL, V183, P1008, DOI 10.1093/aje/kwv300; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Karastergiou K, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-13; Karjala Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019092; Karlsson EA, 2010, EXP BIOL MED, V235, P1412, DOI 10.1258/ebm.2010.010227; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Klein SL, 2015, T ROY SOC TROP MED H, V109, P9, DOI 10.1093/trstmh/tru167; Kok P, 2004, Ned Tijdschr Geneeskd, V148, P2379; Liu SH, 2016, ADV METEOROL, V2016, DOI 10.1155/2016/9159532; Markle JG, 2014, TRENDS IMMUNOL, V35, P97, DOI 10.1016/j.it.2013.10.006; Marti A, 2001, Obes Rev, V2, P131, DOI 10.1046/j.1467-789x.2001.00025.x; Michel A, 2009, HELICOBACTER, V14, P525, DOI 10.1111/j.1523-5378.2009.00723.x; Ozdemir SH, 2017, INDIAN J PATHOL MICR, V60, P451, DOI 10.4103/IJPM.IJPM_374_16; Rathmann W, 2003, DIABETOLOGIA, V46, P182, DOI 10.1007/s00125-002-1025-0; Ruggieri Anna, 2016, Ann Ist Super Sanita, V52, P198, DOI 10.4415/ANN_16_02_11; Suki M, 2018, EUR J GASTROEN HEPAT, V30, P143, DOI 10.1097/MEG.0000000000001014; Thjodleifsson B, 2008, SCAND J INFECT DIS, V40, P381, DOI 10.1080/00365540701708293; VanderWeele TJ, 2011, BIOMETRICS, V67, P1406, DOI 10.1111/j.1541-0420.2011.01619.x; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Xu CF, 2014, HELICOBACTER, V19, P437, DOI 10.1111/hel.12153	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231974	10.1371/journal.pone.0231974	http://dx.doi.org/10.1371/journal.pone.0231974			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320435	Green Published, gold			2022-12-26	WOS:000536028800045
J	Paschoalini, M; Almeida, RM; Trujillo, F; Melo-Santos, G; Marmontel, M; Pavanato, HJ; Guerra, FM; Ristau, N; Zerbini, AN				Paschoalini, Mariana; Almeida, Rafael Marques; Trujillo, Fernando; Melo-Santos, Gabriel; Marmontel, Miriam; Pavanato, Heloise Juliao; Guerra, Federico Mosquera; Ristau, Nathali; Zerbini, Alexandre Novaes			On the brink of isolation: Population estimates of the Araguaian river dolphin in a human-impacted region in Brazil	PLOS ONE			English	Article							BOTOS INIA-GEOFFRENSIS; SOTALIA-FLUVIATILIS; PLATANISTA-GANGETICA; TUCURUI DAM; HABITAT USE; AMAZON; CONSERVATION; HYDROPOWER; ABUNDANCE; CETACEAN	Populations of freshwater dolphins are declining in response to increased human pressure, including habitat degradation, overfishing, bycatch, poaching and obstruction of free-flowing river corridors by dams. At least three river dolphin species occur in South America: the Amazonian river dolphin, or boto (Inia geoffrensis), the Bolivian river dolphin (Inia boliviensis) and the tucuxi (Sotalia fluviatilis). A fourth species, the Araguaian boto (Inia araguaiaensis), been proposed for the Tocantins-Araguaia, a large river basin in northern Brazil. Here we show that the Araguaian boto population in the Tocantins River is relatively small (N = 1083, CV = 0.52). During a survey to estimate density and abundance, 138 groups (198 individuals) of botos were observed along a similar to 600 km stretch of the Tocantins River in five different habitats (river margin, river channel, channel, island margin, and a dam reservoir). Overall, lower densities of the Araguaian boto were registered downstream of the Tucurui ' dam, the world's fifth largest hydropower dam. Density was 68% lower in the river margin habitat downstream (0.23 ind./km(2), CV = 0.92) than upstream (0.72 ind./km(2), CV = 0.53). In addition, density within the Tucurui ' reservoir decreases from upstream areas towards the dam. Geographic post-stratification of data into sub-regions (downstream, reservoir, upstream) in relation to the Tucurui ' dam helped to reduce CV by similar to 70%, which illustrates the high variability in the encounter rate in these areas. Our findings suggest that the Araguaian boto population has been impacted by the construction of the Tucurui ' dam. The construction of other dams proposed for the Tocantins-Araguaia basin should be planned strategically to minimize overlapping with the Araguaian boto distribution. Coordinated conservation actions are imperative to prevent the Araguaian boto from reaching extinction or nearextinction as some of their Asian counterparts such as the Yangtze, Ganges, and Indus river dolphins.	[Paschoalini, Mariana] Univ Fed Juiz De Fora, Lab Ecol Comportamental & Bioacust, Programa Posgrad Ecol, Juiz De Fora, MG, Brazil; [Paschoalini, Mariana; Zerbini, Alexandre Novaes] Inst Aqualie, Juiz De Fora, MG, Brazil; [Paschoalini, Mariana; Marmontel, Miriam; Pavanato, Heloise Juliao] Inst Desenvolvimento Sustentavel Mamiraua, Grp Pesquisa Mamiferos Aquat Amazonicos, Tefe, Brazil; [Almeida, Rafael Marques] Cornell Univ, Dept Ecol & Evolutionary Biol, Atkinson Ctr Sustainable Future, Sustainabil, New York, NY 10021 USA; [Trujillo, Fernando; Guerra, Federico Mosquera] Fdn Omacha, Bogota, Colombia; [Melo-Santos, Gabriel] Univ St Andrews, Scottish Oceans Inst, Sch Biol, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Melo-Santos, Gabriel] BioMA Biol & Conservac Mamiferos Aquat Amazonicos, Belem, Para, Brazil; [Pavanato, Heloise Juliao] Univ Otago, Dept Math & Stat, Dunedim, New Zealand; [Ristau, Nathali] Univ Fed Maranhao, Dept Ciencias Biol, Cidade Univ, Sao Luis, Maranhao, Brazil; [Zerbini, Alexandre Novaes] Univ Washington, Joint Inst Study Atmosphere & Ocean JISAO, Sand Point Way NE, Seattle, WA 98195 USA; [Zerbini, Alexandre Novaes] NOAA Fisheries, Alaska Fisheries Sci Ctr, Marine Mammal Lab, Sand Point Way NE, Seattle, WA USA; [Zerbini, Alexandre Novaes] Cascadia Res Collect, Olympia, WA USA; [Zerbini, Alexandre Novaes] Marine Ecol & Telemetry Res, Seabeck, WA USA	Universidade Federal de Juiz de Fora; Cornell University; University of St Andrews; Universidade Federal do Maranhao; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA	Paschoalini, M (corresponding author), Univ Fed Juiz De Fora, Lab Ecol Comportamental & Bioacust, Programa Posgrad Ecol, Juiz De Fora, MG, Brazil.; Paschoalini, M (corresponding author), Inst Aqualie, Juiz De Fora, MG, Brazil.; Paschoalini, M (corresponding author), Inst Desenvolvimento Sustentavel Mamiraua, Grp Pesquisa Mamiferos Aquat Amazonicos, Tefe, Brazil.	pf.mariana@yahoo.com.br	Marmontel, Miriam/AGF-7653-2022; Zerbini, Alexandre/ABH-3916-2020	Zerbini, Alexandre/0000-0002-9776-6605; Paschoalini, Mariana/0000-0002-4748-3236	Whitley Fund for Nature; Petrobras Ambiental; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Swarovski Foundation; Cornell Atkinson Center for Sustainability; Universidade Federal de Juiz de Fora; Fundacion Omacha; Mamiraua Sustainable Development Institute; Cetacean Society International (CSI)	Whitley Fund for Nature; Petrobras Ambiental(Petrobras); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Swarovski Foundation; Cornell Atkinson Center for Sustainability; Universidade Federal de Juiz de Fora; Fundacion Omacha; Mamiraua Sustainable Development Institute; Cetacean Society International (CSI)	This study "On the brink of isolation: Population estimates of the Araguaian river dolphin in a human-impacted region in Brazil" submitted for publication as a Research Article to Plos One's Biodiversity Conservation Collection, was supported by Whitley Fund for Nature (https://whitleyaward.org/) and Petrobras Ambiental (http:// www.petrobras.com.br/pt/).Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; https://www.capes.gov.br/) provided MP with a scholarship during her Phd' studies. Cetacean Society International (CSI; https://www.csiwhalesalive.org/) awarded MP during the development of this work. GMS was funded by Swarovski Foundation. RMA was funded by Cornell Atkinson Center for Sustainability. We also want to thank Universidade Federal de Juiz de Fora for financial support MP in publishing this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Fundacion Omacha and Mamiraua Sustainable Development Institute for supporting the research and fieldwork. Catalina Gomez-Salazar, Joice Farias, Nayara S. Tartari, and Sa ' via Moreira helped with data collection. Raquel Fernandes Mendonca and Franciele Rezende Castro provided valuable advices regarding the presentation and conceptualization of the maps. We are also thankful to Sam F. Walmsley for providing a friendly review. Gabriel Melo-Santos was funded by the Swarovski Foundation. Rafael M. Almeida is funded by the Cornell Atkinson Center for Sustainability.	Almeida RM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12179-5; ANGANUZZI AA, 1993, J WILDLIFE MANAGE, V57, P827, DOI 10.2307/3809085; [Anonymous], STAT WORLDS RIV; Araujo CC, 2015, ORYX, V49, P17, DOI 10.1017/S0030605314000362; Araujo CC, 2012, AQUAT MAMM, V38, P435, DOI 10.1578/AM.38.4.2012.435; Barrow C.J., 1987, REGUL RIVERS RES MAN, V1, P49, DOI DOI 10.1002/RRR.3450010106; Best R. C., 1989, HDB MARINE MAMMALS; Best RC, 1989, BIOL CONSERVATION RI, P23; Braulik GT, 2015, BIOL CONSERV, V192, P30, DOI 10.1016/j.biocon.2015.09.008; Braulik GT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101657; Braulik GT, 2012, AQUAT CONSERV, V22, P533, DOI 10.1002/aqc.2246; Braulik Gillian T., 2012, Endangered Species Research, V17, P201, DOI 10.3354/esr00425; Buckland S.T., 2001, pi; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Committee on Taxonomy, 2019, LIST MAR MAMM SPEC S; da Silva V., 2018, INIA GEOFFRENSIS ASS, V2018, P1, DOI [10.2305/IUCN.UK.2018-2.RLTS.T10831A50358152.en, DOI 10.2305/IUCN.UK.2018-2.RLTS.T10831A50358152.EN]; da Silva V. M. F., 2010, ACTION PLAN S AM RIV; da Silva VMF, 2011, MAGAZINE SPECIES SUR; de Merona B, 2001, ENVIRON BIOL FISH, V60, P375, DOI 10.1023/A:1011033025706; DUDGEON D, 1992, HYDROBIOLOGIA, V248, P167, DOI 10.1007/BF00006146; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Espindola E. L. G., 2000, Revista Brasileira de Biologia, V60, P179; FAO (Food and Agriculture Organization of the United Nations), 2001, 419 FAO; Fearnside Peter M., 1990, FUTURE AMAZONIA DEST, P179; Fearnside PM, 2001, ENVIRON MANAGE, V27, P377, DOI 10.1007/s002670010156; Fearnside PM, 2015, HIDRELETRICAS AMAZON, P53; Fewster RM, 2009, BIOMETRICS, V65, P225, DOI 10.1111/j.1541-0420.2008.01018.x; Fletcher RJ, 2006, AUK, V123, P695, DOI 10.1642/0004-8038(2006)123[695:EDPORB]2.0.CO;2; Gomez-Salazar C, 2012, ECOL INDIC, V23, P19, DOI 10.1016/j.ecolind.2012.02.034; Gomez-Salazar C, 2012, MAR MAMMAL SCI, V28, P124, DOI 10.1111/j.1748-7692.2011.00468.x; Goulding M, 2003, SMITHSONIAN ATLAS AM; Gravena W, 2015, BIOL J LINN SOC, V114, P764, DOI 10.1111/bij.12463; Gravena W, 2014, CONSERV GENET, V15, P619, DOI 10.1007/s10592-014-0565-4; Hammond Philip S., 2010, P42; Hrbek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083623; Huang SL, 2012, FRESHWATER BIOL, V57, P1266, DOI 10.1111/j.1365-2427.2012.02772.x; HUGGINS RM, 1991, BIOMETRICS, V47, P725, DOI 10.2307/2532158; Jager HI, 2015, RENEW SUST ENERG REV, V45, P808, DOI 10.1016/j.rser.2015.01.067; Junk W.J., 1993, WETL ECOL MANAG, V2, P231, DOI [10.1007/BF00188157, DOI 10.1007/BF00188157]; Kahn JR, 2014, ENERGIES, V7, P6063, DOI 10.3390/en7096063; Kreb D., 2010, ESTABLISHING PROTECT; Laake JL, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P108; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; Luz-Agostinho KDG, 2008, HYDROBIOLOGIA, V607, P187, DOI 10.1007/s10750-008-9390-4; Lytle DA, 2004, TRENDS ECOL EVOL, V19, P94, DOI 10.1016/j.tree.2003.10.002; Manyari WV, 2007, ENERG POLICY, V35, P6526, DOI 10.1016/j.enpol.2007.07.031; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Martin AR, 2004, J ZOOL, V263, P295, DOI 10.1017/S095283690400528X; Martin AR, 2004, MAR MAMMAL SCI, V20, P189, DOI 10.1111/j.1748-7692.2004.tb01150.x; Nilsson C, 2000, BIOSCIENCE, V50, P783, DOI 10.1641/0006-3568(2000)050[0783:AORECB]2.0.CO;2; OTIS DL, 1978, WILDLIFE MONOGR, P1; Paudel S, 2015, MAR MAMMAL SCI, V31, P707, DOI 10.1111/mms.12192; Pavanato H. J., 2019, Journal of Cetacean Research and Management, V20, P93; Pavanato HJ, 2016, ENDANGER SPECIES RES, V31, P47, DOI 10.3354/esr00751; Pilleri G, 1977, INVESTIGATIONS CETAC, P11; Poff NL, 2007, P NATL ACAD SCI USA, V104, P5732, DOI 10.1073/pnas.0609812104; Pringle CM, 2000, BIOSCIENCE, V50, P807, DOI 10.1641/0006-3568(2000)050[0807:REOHAO]2.0.CO;2; Provete DB, 2013, BIOMES ECOSYSTEMS, P1237; QGIS.org, 2020, OP SOURC GEOSP FDN P, DOI [10.26131/IRSA525, DOI 10.26131/IRSA525]; R Core Team, 2013, R LANG ENV STAT COMP; Reeves RR, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P976; Reeves RR, 1994, DOLPHINS PORPOISES W; Reeves RR, IUCN RED LIST THREAT; Ribeiro MCLD, 1995, REGUL RIVER, V11, P325, DOI 10.1002/rrr.3450110308; Rice D. W., 1998, SPECIAL PUBLICATION, V4; Richter BD, 1998, REGUL RIVER, V14, P329; Rossetti DF, 2007, CATENA, V70, P253, DOI 10.1016/j.catena.2006.08.009; Siciliano S, 2016, HYDROBIOLOGIA, V777, P255, DOI 10.1007/s10750-016-2794-7; Sioli H., 1984, AMAZON LIMNOLOGY LAN, DOI [10.1007/978-94-009-6542-3_5, DOI 10.1007/978-94-009-6542-3_5]; Smith BD, 2001, ORYX, V35, P61, DOI 10.1046/j.1365-3008.2001.00153.x; Smith BD, 2006, MAR MAMMAL SCI, V22, P527, DOI 10.1111/j.1748-7692.2006.00041.x; Smith Brian D., 2012, Journal of Marine Biology, P1; Taylor BL, 1999, MAR MAMMAL SCI, V15, P1004, DOI 10.1111/j.1748-7692.1999.tb00875.x; Thomas Len, 2007, Journal of Cetacean Research and Management, V9, P1; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Timpe K, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700611; Trujillo F., 2010, ACTION PLAN S AM RIV, P145; Turvey ST, 2007, BIOL LETTERS, V3, P537, DOI 10.1098/rsbl.2007.0292; Turvey ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037902; Vidal O, 1997, MAR MAMMAL SCI, V13, P427, DOI 10.1111/j.1748-7692.1997.tb00650.x; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2011, EOS, V85, P509; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0	85	10	10	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231224	10.1371/journal.pone.0231224	http://dx.doi.org/10.1371/journal.pone.0231224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320415	gold, Green Published			2022-12-26	WOS:000536028800016
J	Maran, S; Ee, R; Faten, SA; Bing, CS; Khaw, KY; Lim, SHE; Lai, KS; Ibrahim, WPW; Zain, MRM; Chan, KG; Gan, SH; Tan, HL				Maran, Sathiya; Ee, Robson; Faten, Siti Aisyah; Bing, Choi Sy; Khaw, Kooi Yeong; Lim, Swee-Hua Erin; Lai, Kok-Song; Ibrahim, Wan Pauzi Wan; Zain, Mohd Rizal Mohd; Chan, Kok Gan; Gan, Siew Hua; Tan, Huay Lin			Mutations in the tail domain of MYH3 contributes to atrial septal defect	PLOS ONE			English	Article							CONGENITAL HEART-DISEASE; MYOSIN STORAGE MYOPATHY; HEAVY; PREVALENCE	Atrial septal defect (ASD) is one of the most common congenital heart defects diagnosed in children. Sarcomeric genes has been attributed to ASD and knockdown of MYH3 functionally homologues gene in chick models indicated abnormal atrial septal development. Here, we report for the first time, a case-control study investigating the role of MYH3 among nonsyndromic ASD patients in contributing to septal development. Four amplicons which will amplifies the 40 kb MYH3 were designed and amplified using long range-PCR. The amplicons were then sequenced using indexed paired-end libraries on the MiSeq platform. The STREGA guidelines were applied for planning and reporting. The non-synonymous c. 3574G>A (p.Ala1192Thr) [p = 0.001, OR = 2.30 (1.36-3.87)] located within the tail domain indicated a highly conserved protein region. The mutant model of c. 3574G>A (p. Ala1192Thr) showed high root mean square deviation (RMSD) values compared to the wild model. To our knowledge, this is the first study to provide compelling evidence on the pathogenesis of MYH3 variants towards ASD hence, suggesting the crucial role of non-synonymous variants in the tail domain of MYH3 towards atrial septal development. It is hoped that this gene can be used as panel for diagnosis of ASD in future.	[Maran, Sathiya; Khaw, Kooi Yeong; Gan, Siew Hua] Monash Univ, Sch Pharm, Sunway, Selangor, Malaysia; [Maran, Sathiya; Faten, Siti Aisyah; Tan, Huay Lin] Univ Sains Malaysia, Human Genome Ctr, Kubang Kerian, Kelantan, Malaysia; [Ee, Robson; Chan, Kok Gan] Univ Malaya, Div Genet & Mol Biol, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Bing, Choi Sy] Perdana Univ, Sch Data Sci, Perdana University, Selangor, Malaysia; [Lim, Swee-Hua Erin; Lai, Kok-Song] Higher Coll Technol, Abu Dhabi Womens Coll, Hlth Sci Div, Abu Dhabi, U Arab Emirates; [Ibrahim, Wan Pauzi Wan] Univ Sultan Zainal Abidin, Fac Med & Hlth Sci, Terengganu, Malaysia; [Zain, Mohd Rizal Mohd] Univ Sains Malaysia, Sch Med Sci, Dept Paediat, Kubang Kerian, Kelantan, Malaysia; [Chan, Kok Gan] Jiangsu Univ, Int Genome Ctr, Zhenjiang, Jiangsu, Peoples R China	Monash University; Monash University Sunway; Universiti Sains Malaysia; Universiti Malaya; Perdana University; Higher Colleges of Technology - United Arab Emirates; Universiti Sultan Zainal Abidin; Universiti Sains Malaysia; Jiangsu University	Maran, S (corresponding author), Monash Univ, Sch Pharm, Sunway, Selangor, Malaysia.; Maran, S (corresponding author), Univ Sains Malaysia, Human Genome Ctr, Kubang Kerian, Kelantan, Malaysia.	sathiyamaran@gmail.com	Lai, Kok Song/AAR-8772-2020; Yeong, Khaw Kooi/B-6475-2016; Lim, Erin/AAR-9060-2020; Song, Lai Kok/ABA-2585-2020; gan, siew hua/A-6266-2011; Chan, Kok Gan/B-8347-2010	Yeong, Khaw Kooi/0000-0003-2360-6235; Lim, Erin/0000-0001-5177-0257; gan, siew hua/0000-0001-6470-3651; Chan, Kok Gan/0000-0002-1883-1115; Maran, Sathiya/0000-0001-5617-901X; MOHD ZAIN, MOHD RIZAL/0000-0003-0919-4609	Research University Grant (RU), Universiti Sains Malaysia [1001/PPSP/813066]; Fundamental Research Grant Scheme, Ministry of Education Malaysia [FRGS/1/2018/SKK11/PERDANA/02/1]	Research University Grant (RU), Universiti Sains Malaysia(Universiti Sains Malaysia); Fundamental Research Grant Scheme, Ministry of Education Malaysia	This work was funded by the Research University Grant (RU), Universiti Sains Malaysia [1001/PPSP/813066] and Fundamental Research Grant Scheme, Ministry of Education Malaysia [FRGS/1/2018/SKK11/PERDANA/02/1]. THL and SHEL were the respective Principle investigators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado DM, 2011, J BONE JOINT SURG AM, V93A, P1045, DOI 10.2106/JBJS.J.02004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Celermajer DS, 2018, EUR HEART J, V39, P999, DOI 10.1093/eurheartj/ehx633; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; Chong JX, 2015, AM J HUM GENET, V96, P841, DOI 10.1016/j.ajhg.2015.04.004; Cory N, 2012, TXB CLIN PEDIAT, V1; Darin N, 1998, ANN NEUROL, V44, P242, DOI 10.1002/ana.410440215; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; England J, 2013, CELL MOL LIFE SCI, V70, P1221, DOI 10.1007/s00018-012-1131-1; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Geva T, 2014, LANCET, V383, P1921, DOI 10.1016/S0140-6736(13)62145-5; Granados-Riveron JT, 2010, HUM MOL GENET, V19, P4007, DOI 10.1093/hmg/ddq315; Hung L C, 2000, Med J Malaysia, V55, P424; Knowles RL, 2017, ARCH DIS CHILD, V102, P496, DOI 10.1136/archdischild-2016-311143; Knowles RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106806; Korn ED, 2000, P NATL ACAD SCI USA, V97, P12559, DOI 10.1073/pnas.230441597; Laing NG, 2005, NEUROLOGY, V64, P527, DOI 10.1212/01.WNL.0000150581.37514.30; Lamichhane DK, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0841-z; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Liu YJ, 2019, INT J EPIDEMIOL, V48, P455, DOI 10.1093/ije/dyz009; Meredith C, 2004, AM J HUM GENET, V75, P703, DOI 10.1086/424760; Poehls UG, 2018, EUR J MED RES, V23, DOI 10.1186/s40001-018-0318-9; Ratanasit Nithima, 2015, Journal of the Medical Association of Thailand, V98, P7; Reller MD, 2008, J PEDIATR-US, V153, P807, DOI 10.1016/j.jpeds.2008.05.059; Rutland CS, 2011, DEVELOPMENT, V138, P3955, DOI 10.1242/dev.059063; Schwedler G, 2011, CLIN RES CARDIOL, V100, P1111, DOI 10.1007/s00392-011-0355-7; Tajsharghi H, 2003, ANN NEUROL, V54, P494, DOI 10.1002/ana.10693; Tajsharghi H, 2002, NEUROLOGY, V58, P780, DOI 10.1212/WNL.58.5.780; Tajsharghi H, 2008, ARCH NEUROL-CHICAGO, V65, P1083, DOI 10.1001/archneur.65.8.1083; Tajsharghi H, 2013, ACTA NEUROPATHOL, V125, P3, DOI 10.1007/s00401-012-1024-2; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; van der Linde D, 2011, J AM COLL CARDIOL, V58, P2241, DOI 10.1016/j.jacc.2011.08.025; Wang HS, 2019, MED SCI MONITOR, V25, P2756, DOI 10.12659/MSM.916052; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Wessels MW, 2010, CLIN GENET, V78, P103, DOI 10.1111/j.1399-0004.2010.01435.x; Wu MH, 2010, J PEDIATR-US, V156, P782, DOI 10.1016/j.jpeds.2009.11.062; Zaidi S, 2017, CIRC RES, V120, P923, DOI 10.1161/CIRCRESAHA.116.309140	38	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230982	10.1371/journal.pone.0230982	http://dx.doi.org/10.1371/journal.pone.0230982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315303	Green Published, gold, Green Submitted			2022-12-26	WOS:000536024800016
J	Jama-Rodzenska, A; Walczak, A; Adamczewska-Sowinska, K; Janik, G; Klosowicz, I; Glab, L; Sowinski, J; Chen, XH; Peczkowski, G				Jama-Rodzenska, Anna; Walczak, Amadeusz; Adamczewska-Sowinska, Katarzyna; Janik, Grzegorz; Klosowicz, Izabela; Glab, Lilianna; Sowinski, Jozef; Chen, Xinhao; Peczkowski, Grzegorz			Influence of variation in the volumetric moisture content of the substrate on irrigation efficiency in early potato varieties	PLOS ONE			English	Article							SOLANUM-TUBEROSUM L.; DRIP IRRIGATION; SOIL-MOISTURE; RESPONSES; CLIMATE; YIELD; CROP; PHOTOSYNTHESIS; MANAGEMENT; FREQUENCY	Potato is a plant with high water requirements. This factor affects not only the weight of potato tubers but also their quality parameters. In order to achieve quantity and quality goal, it is helpful if we apply the principles of precision agriculture, which also contributes to sustainable management of environmental resources. Accurate identification of the water requirements of crops is the basis for determining optimal irrigation doses and dates. After their application, it is possible to assess the effectiveness of irrigation treatments and their impact on the air-water conditions in soil with a root system. The aim of the presented study was to analyse the influence of volumetric soil moisture diversity on the vegetation of early potato varieties. Two potato varieties were subject to investigation: Denar and Julinka. Pot experiments were carried out at the Department of Horticulture of Wroclaw University of Environmental and Life Sciences. Three variants were analysed: one with a low water content in the soil (pF 2.7), one with the optimal water content (pF 2.5) and one with a high water content (pF 2.2). The basis for the selection of the frequency and application rate of water doses was soil moisture measured with an SM150-Kit set. Volumetric moisture was measured with a TDR apparatus. It was found that the water requirements of both potato varieties differ and increase along with the development of the aboveground and underground parts. Moreover, it was shown that the irrigation requirements of cv. Julinka are higher than those of Denar (31.4-33.0% higher), depending on the adopted variant. The research also showed that the most effective method of potato cultivation is to maintain soil moisture at a lower level. This should be taken into account in regions where the cultivation of this species uses supplementation of the water requirements by irrigation.	[Jama-Rodzenska, Anna; Glab, Lilianna; Sowinski, Jozef] Wroclaw Univ Environm & Life Sci, Inst Agroecol & Plant Prod, Div Plant Prod, Wroclaw, Poland; [Walczak, Amadeusz; Janik, Grzegorz; Peczkowski, Grzegorz] Wroclaw Univ Environm & Life Sci, Inst Environm Protect & Dev, Wroclaw, Poland; [Adamczewska-Sowinska, Katarzyna] Wroclaw Univ Environm & Life Sci, Dept Hort, Wroclaw, Poland; [Klosowicz, Izabela] Hunan Agr Univ, Students Sci Assoc Meliorat, Changscha, Peoples R China; [Chen, Xinhao] Hunan Agr Univ, Changscha, Peoples R China	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Hunan Agricultural University; Hunan Agricultural University	Jama-Rodzenska, A (corresponding author), Wroclaw Univ Environm & Life Sci, Inst Agroecol & Plant Prod, Div Plant Prod, Wroclaw, Poland.	anna.jama@upwr.edu.pl	Kłosowicz, Izabela/AAN-8236-2021; Jama-Rodzeńska, Anna/AAF-2085-2021; Sowinski, Jozef/AAQ-9721-2021	Kłosowicz, Izabela/0000-0003-0092-4492; Jama-Rodzeńska, Anna/0000-0003-4864-7367; Sowinski, Jozef/0000-0002-4611-9897; Walczak, Amadeusz/0000-0002-4231-9066; Adamczewska-Sowinska, Katarzyna/0000-0001-6020-3975; Janik, Grzegorz/0000-0002-7095-602X	National Centre for Research and Development [BIOSTRATEG3/343547/8/NCBR/2017]	National Centre for Research and Development(National Centre for Research & Development, Poland)	Financed by the National Centre for Research and Development as part of the project "A mobile system for precision injection irrigation and fertilization meeting the individual requirements of plants". MSINiN - Polish acronym for the project title. Grant number: BIOSTRATEG3/343547/8/NCBR/2017	Agrawal YC, 2010, PRINCIPLES METHODS A, P119, DOI [10.1016/0278-4343(94)90030-2, DOI 10.1016/0278-4343(94)90030-2]; [Anonymous], 2010, INT J ENG SCI TECHNO; Bethke PC, 2009, AM J POTATO RES, V86, P519, DOI 10.1007/s12230-009-9109-8; Bianchi A, 2017, ITAL J AGROMETEOROL, V22, P25, DOI 10.19199/2017.2.2038-5625.025; Boguszewska D, 2010, POTATO RES, V53, P373, DOI 10.1007/s11540-010-9178-6; Boguszewska-Mankowska D, 2018, J AGRON CROP SCI, V204, P13, DOI 10.1111/jac.12245; Dabrowska J, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5470-5; Denis DM, 2007, INT AGR ENG J; Ekelof J, 2015, POTATO RES, V58, P15, DOI 10.1007/s11540-014-9261-5; El-Abedin TKZ, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9040172; Elsen H. G. M. van den, 1995, International Agrophysics, V9, P235; Erdem T, 2006, SCI AGR, V63, P226, DOI 10.1590/S0103-90162006000300003; Fandika I. R., 2010, Agronomy New Zealand, V40, P159; FAO, 2015, 2016 GLOB FOR PROD F; Ferreira TC, 2002, FIELD CROP RES, V78, P51, DOI 10.1016/S0378-4290(02)00089-8; Hewelke P, 2015, POL J ENVIRON STUD, V24, P1013; Janik G., 2011, ACTA AGROPHYSICA, V18, P269; Kandelous MM, 2011, SOIL SCI SOC AM J, V75, P488, DOI 10.2136/sssaj2010.0181; Kowalik P., 2007, ZARYS FIZYKI GRUNTOW; Kusnierz M, 2015, HYDROBIOLOGIA, V758, P243, DOI 10.1007/s10750-015-2294-1; Liao XL, 2016, AGR WATER MANAGE, V165, P230, DOI 10.1016/j.agwat.2015.10.023; Liu F, 2006, SCI HORTIC, V792, P413; Liu FL, 2006, J EXP BOT, V57, P3727, DOI 10.1093/jxb/erl131; Miyashita K, 2005, ENVIRON EXP BOT, V53, P205, DOI 10.1016/j.envexpbot.2004.03.015; Mondal Mousumi, 2007, Journal of the Entomological Research Society, V9, P15; Montoya F, 2016, AGR WATER MANAGE, V164, P267, DOI 10.1016/j.agwat.2015.10.019; Nolz R., 2016, BODENKULTUR J LAND M, V67, P133, DOI DOI 10.1515/BOKU-2016-0012; Nowacki W., 2018, INZYNIERIA EKOL, V19, P14, DOI DOI 10.12912/23920629/95273; OJALA JC, 1990, AM POTATO J, V67, P29, DOI 10.1007/BF02986910; Olszewska B, 2015, J ECOL ENG, V16, P44, DOI 10.12911/22998993/59346; Onder S, 2005, AGR WATER MANAGE, V73, P73, DOI 10.1016/j.agwat.2004.09.023; Pandit NR, 2020, ARCH AGRON SOIL SCI, V66, P250, DOI 10.1080/03650340.2019.1610168; Pandit NR, 2018, SCI TOTAL ENVIRON, V625, P1380, DOI 10.1016/j.scitotenv.2018.01.022; Pohankova E, 2018, J AGR SCI-CAMBRIDGE, V156, P628, DOI 10.1017/S0021859618000060; Pulatov B, 2016, AGR ECOSYST ENVIRON, V224, P39, DOI 10.1016/j.agee.2016.03.027; Radzka E., 2015, NAUKA PRZYR TECHNOL, V9, P25, DOI [10.17306/J.NPT.2015.2.25, DOI 10.17306/J.NPT.2015.2.25]; Raymundo R, 2018, EUR J AGRON, V100, P87, DOI 10.1016/j.eja.2017.11.008; Reddy AR, 2004, J PLANT PHYSIOL, V161, P1189, DOI 10.1016/j.jplph.2004.01.013; Reyes-Cabrera J, 2016, AGR WATER MANAGE, V169, P183, DOI 10.1016/j.agwat.2016.03.001; Rolbiecki S, 2015, FRESEN ENVIRON BULL, V24, P3895; Rykaczewska K, 2015, AM J POTATO RES, V92, P339, DOI 10.1007/s12230-015-9436-x; Rymuza K., 2015, Communications in Biometry and Crop Science, V10, P65; Sarec P., OPIS BUDOWY NOWEGO T; Shock CC, 1998, HORTSCIENCE, V33, P655, DOI 10.21273/HORTSCI.33.4.655; Skierucha W, 2012, SENSORS-BASEL, V12, P13545, DOI 10.3390/s121013545; Skierucha W, 2010, SENSORS-BASEL, V10, P3314, DOI 10.3390/s100403314; Sreekantha DK, 2017, PROCEEDINGS OF 2017 11TH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS AND CONTROL (ISCO 2017), P134, DOI 10.1109/ISCO.2017.7855968; Suchorab Z, 2015, METHODOLOGY MOISTURE, V19, P97, DOI [10.1515/CDEM-2014-0009, DOI 10.1515/CDEM-2014-0009]; Szewranski S, 2018, WATER-SUI, V10, DOI 10.3390/w10060746; Takac J, 2011, BIOCLIMATE SOURCE LI; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Verstraeten WW, 2008, SENSORS-BASEL, V8, P70, DOI 10.3390/s8010070; Wang FX, 2006, AGR WATER MANAGE, V79, P248, DOI 10.1016/j.agwat.2005.02.016; Wang H, 2009, IRRIG SCI; Yao WW, 2011, IRRIGATION SCI, V29, P331, DOI 10.1007/s00271-010-0236-2; Zhang DJ, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16081308	56	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231831	10.1371/journal.pone.0231831	http://dx.doi.org/10.1371/journal.pone.0231831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310986	Green Published, gold			2022-12-26	WOS:000536019800036
J	Beckmann, KM; Wang-Leandro, A; Dennler, M; Carrera, I; Richter, H; Bektas, RN; Steiner, A; Haller, S				Beckmann, Katrin M.; Wang-Leandro, Adriano; Dennler, Matthias; Carrera, Ines; Richter, Henning; Bektas, Rima N.; Steiner, Aline; Haller, Sven			Resting state networks of the canine brain under sevoflurane anaesthesia	PLOS ONE			English	Article							DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; EPILEPSY; CORTEX; ROBUST; DOGS; OPTIMIZATION; REGISTRATION; ARCHITECTURE; DISORDERS	Resting-state functional Magnetic Resonance Imaging (rs-fMRI) has become an established technique in humans and reliably determines several resting state networks (RSNs) simultaneously. Limited data exist about RSN in dogs. The aim of this study was to investigate the RSNs in 10 healthy beagle dogs using a 3 tesla MRI scanner and subsequently perform group-level independent component analysis (ICA) to identify functionally connected brain networks. Rs-fMRI sequences were performed under steady state sevoflurane inhalation anaesthesia. Anaesthetic depth was titrated to the minimum level needed for immobilisation and mechanical ventilation of the patient. This required a sevoflurane MAC between 0.8 to 1.2. Group-level ICA dimensionality of 20 components revealed distributed sensory, motor and higher-order networks in the dogs' brain. We identified in total 7 RSNs (default mode, primary and higher order visual, auditory, two putative motor-somatosensory and one putative somatosensory), which are common to other mammals including humans. Identified RSN are remarkably similar to those identified in awake dogs. This study proves the feasibility of rs-fMRI in anesthetized dogs and describes several RSNs, which may set the basis for investigating pathophysiological characteristics of various canine brain diseases.	[Beckmann, Katrin M.] Vetsuisse Fac Zurich, Clin Small Anim Surg, Neurol Dept, Zurich, Switzerland; [Wang-Leandro, Adriano; Dennler, Matthias; Richter, Henning] Vetsuisse Fac Zurich, Clin Diagnost Imaging, Dept Diagnost & Clin Serv, Zurich, Switzerland; [Carrera, Ines] Willows Vet Ctr & Referral Serv, Shirley, England; [Bektas, Rima N.; Steiner, Aline] Univ Zurich, Vetsuisse Fac, Sect Anaesthesiol, Dept Diagnost & Clin Serv, Zurich, Switzerland; [Haller, Sven] Uppsala Univ, Dept Surg Sci, Radiol, Uppsala, Sweden; [Haller, Sven] Univ Geneva, Fac Med, Geneva, Switzerland	University of Zurich; Uppsala University; University of Geneva	Beckmann, KM (corresponding author), Vetsuisse Fac Zurich, Clin Small Anim Surg, Neurol Dept, Zurich, Switzerland.	kbeckmann@vetclinics.uzh.ch	Haller, Sven/AAY-2564-2020	Haller, Sven/0000-0001-7433-0203; Beckmann, Katrin/0000-0002-1823-7845; Richter, Henning/0000-0003-3696-6993; Steiner, Aline Rebecca/0000-0001-5584-6722	Albert-Heim-Stiftung; Stiftung fur Kleintiere der Vetsuisse-Fakultat Universitat Zurich	Albert-Heim-Stiftung; Stiftung fur Kleintiere der Vetsuisse-Fakultat Universitat Zurich	The study was partly supported by the "Albert-Heim-Stiftung" and the "Stiftung fur Kleintiere der Vetsuisse-Fakultat Universitat Zurich" to KMB. The funders had no	Aguirre GK, 2007, PLOS MED, V4, P1117, DOI 10.1371/journal.pmed.0040230; Andics A, 2014, CURR BIOL, V24, P574, DOI 10.1016/j.cub.2014.01.058; Bach JP, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-210; Barkhof F, 2014, RADIOLOGY, V272, P28, DOI 10.1148/radiol.14132388; Beckmann C., 2009, NEUROIMAGE, V47, pS148, DOI [10.1016/S1053-8119(09)71511-3, DOI 10.1016/S1053-8119(09)71511-3, 10.1016/s1053-8119(09)71511-3]; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Beitz AJFT, 2012, MILLERS ANATOMY DOG; Belcher AM, 2013, J NEUROSCI, V33, P16796, DOI 10.1523/JNEUROSCI.3146-13.2013; Brett M, 2002, NAT REV NEUROSCI, V3, P243, DOI 10.1038/nrn756; Brown GG, 2007, NEUROPSYCHOL REV, V17, P107, DOI 10.1007/s11065-007-9028-8; Brown TA, 2013, NEUROIMAGE, V64, P458, DOI 10.1016/j.neuroimage.2012.09.034; Bunford N, 2017, TRENDS NEUROSCI, V40, P438, DOI 10.1016/j.tins.2017.05.003; Cheung MM, 2012, NEUROIMAGE, V60, P1205, DOI 10.1016/j.neuroimage.2012.01.087; Chuang KH, 2017, NEUROIMAGE, V163, P419, DOI 10.1016/j.neuroimage.2017.09.038; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Danek M, 2017, PSYCHIATR POL, V51, P1009, DOI 10.12740/PP/74304; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Dilks DD, 2015, PEERJ, V3, DOI 10.7717/peerj.1115; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Heske L, 2014, VET J, V202, P471, DOI 10.1016/j.tvjl.2014.09.023; Huneau C, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00467; Jann K, 2009, NEUROIMAGE, V45, P903, DOI 10.1016/j.neuroimage.2009.01.001; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kearsley-Fleet L, 2013, VET REC, V172, DOI 10.1136/vr.101133; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Kyathanahally SP, 2015, BRAIN STRUCT FUNCT, V220, P1063, DOI 10.1007/s00429-013-0700-x; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Lu HB, 2012, P NATL ACAD SCI USA, V109, P3979, DOI [10.1073/pnas.1101934108, 10.1073/pnas.1200506109]; Mantini D, 2011, J NEUROSCI, V31, P12954, DOI 10.1523/JNEUROSCI.2318-11.2011; Mazzatenta A, 2017, SEMIN CELL DEV BIOL, V70, P141, DOI 10.1016/j.semcdb.2017.08.024; Mechling AE, 2014, NEUROIMAGE, V96, P203, DOI 10.1016/j.neuroimage.2014.03.078; Moeller S, 2009, J NEUROSCI, V29, P5897, DOI 10.1523/JNEUROSCI.0220-09.2009; Mohan Akansha, 2016, Yale Journal of Biology and Medicine, V89, P49; Murta T, 2015, HUM BRAIN MAPP, V36, P391, DOI 10.1002/hbm.22623; Nickel RS A, 2004, NERVENSYTSEM SINNESO; Nickerson LD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00115; Nitzsche B., 2018, NEUROIMAGE; Paasonen J, 2018, NEUROIMAGE, V172, P9, DOI 10.1016/j.neuroimage.2018.01.014; Palanca BA, 2015, ANESTHESIOLOGY, V123, P346, DOI 10.1097/ALN.0000000000000731; Patterson EE, 2014, ILAR J, V55, P182, DOI 10.1093/ilar/ilu021; Potschka H, 2013, EPILEPSIA, V54, P571, DOI 10.1111/epi.12138; Prichard A, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00737; Ramani R, 2015, CURR OPIN ANESTHESIO, V28, P498, DOI 10.1097/ACO.0000000000000237; Rioja E, 2010, AM J VET RES, V71, P24, DOI 10.2460/ajvr.71.1.24; Robinson JL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36851; Roland JL, 2017, J NEUROSURG-PEDIATR, V20, P583, DOI 10.3171/2017.6.PEDS1711; Rosazza C, 2011, NEUROL SCI, V32, P773, DOI 10.1007/s10072-011-0636-y; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Smitha KA, 2017, NEURORADIOL J, V30, DOI 10.1177/1971400917697342; Stafford JM, 2014, P NATL ACAD SCI USA, V111, P18745, DOI 10.1073/pnas.1404346111; Szabo D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51752-2; Thompkins AM, 2016, COMP COGN BEHAV REV, V11, P63, DOI 10.3819/ccbr.2016.110004; Venkatraghavan L, 2017, BRAIN CONNECT, V7, P250, DOI 10.1089/brain.2016.0448; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Wang R, 2006, NEUROIMAGE, V31, P1, DOI 10.1016/j.neuroimage.2005.12.004; Willis CKR, 2001, VET OPHTHALMOL, V4, P243, DOI 10.1046/j.1463-5216.2001.00183.x; Willis CKR, 2001, CAN J VET RES, V65, P188; Yamamoto AK, 2019, NEUROIMAGE-CLIN, V23, DOI 10.1016/j.nicl.2019.101923; Zhou ZC, 2016, NEUROIMAGE, V143, P70, DOI 10.1016/j.neuroimage.2016.09.003	62	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231955	10.1371/journal.pone.0231955	http://dx.doi.org/10.1371/journal.pone.0231955			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302373	Green Published, gold, Green Accepted			2022-12-26	WOS:000536016100063
J	Kiyoi, T; Liu, S; Takemasa, E; Nakaoka, H; Hato, N; Mogi, M				Kiyoi, Takeshi; Liu, Shuang; Takemasa, Erika; Nakaoka, Hirotomo; Hato, Naohito; Mogi, Masaki			Constitutive hydrogen inhalation prevents vascular remodeling via reduction of oxidative stress	PLOS ONE			English	Article							MOLECULAR-HYDROGEN; DNA-DAMAGE; PROTEIN-KINASE; S-GUANYLATION; RICH SALINE; ORAL INTAKE; ANTIOXIDANT; WATER; MIGRATION; INJURY	Molecular hydrogen is thought to have an inhibitory effect on oxidative stress, thereby attenuating the onset and progression of various diseases including cardiovascular disease; however, few reports have assessed the preventive effect of constitutive inhalation of hydrogen gas on of vascular remodeling. Here, we investigated the effect of constitutive inhalation of hydrogen gas on vascular neointima formation using a cuff-induced vascular injury mouse model. After constitutive inhalation of compressed hydrogen gas (O-2 21%, N2 77.7%, hydrogen 1.3%) or compressed air only (O-2 21%, N2 79%) by C57BL/6 mice for 2 weeks from 8 weeks of age in a closed chamber, inflammatory cuff injury was induced by polyethylene cuff placement around the femoral artery under anesthesia, and hydrogen gas administration was continued until sampling of the femoral artery. Neointima formation, accompanied by an increase in cell proliferation, was significantly attenuated in the hydrogen group compared with the control group. NADPH oxidase NOX1 downregulation in response to cuff injury was shown in the hydrogen group, but the expression levels of NADPH oxidase subunits, p40phox and p47phox, did not differ significantly between the hydrogen and control groups. Although the increase in superoxide anion production did not significantly differ between the hydrogen and control groups, DNA damage was decreased as a result of reduction of reactive oxygen species such as hydroxyl radical (center dot OH) and peroxynitrite (ONOO-) in the hydrogen group. These results demonstrate that constitutive inhalation of hydrogen gas attenuates vascular remodeling partly via reduction of oxidative stress, suggesting that constitutive inhalation of hydrogen gas at a safe concentration in the living environment could be an effective strategy for prevention of vascular diseases such as atherosclerosis.	[Kiyoi, Takeshi; Liu, Shuang; Takemasa, Erika; Mogi, Masaki] Ehime Univ, Grad Sch Med, Dept Pharmacol, Tohon, Ehime, Japan; [Kiyoi, Takeshi] Ehime Univ, Adv Res Support Ctr, Div Analyt Biomed, Toon, Ehime, Japan; [Nakaoka, Hirotomo] Ehime Univ, Adv Res Support Ctr, Div Lab Anim Res, Toon, Ehime, Japan; [Hato, Naohito] Ehime Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Tohon, Ehime, Japan	Ehime University; Ehime University; Ehime University; Ehime University	Mogi, M (corresponding author), Ehime Univ, Grad Sch Med, Dept Pharmacol, Tohon, Ehime, Japan.	mmogi@m.ehime-u.ac.jp	Shuang, Liu/AAW-2695-2020; Mogi, Masaki/ABH-2011-2020	Shuang, Liu/0000-0002-6401-7317; Mogi, Masaki/0000-0002-0275-9198	JSPS KAKENHI [18K08389, 25462220]; Panasonic Corporation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Panasonic Corporation	This study was supported by JSPS KAKENHI Grant Numbers 18K08389 (S.L.) and 25462220 (M.M.), and research grants from Panasonic Corporation (https://www.panasonic.com/jp/home.html).The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed KA, 2011, AMINO ACIDS, V41, P123, DOI 10.1007/s00726-010-0535-1; Bruder-Nascimento T, 2014, J MOL CELL CARDIOL, V66, P18, DOI 10.1016/j.yjmcc.2013.10.013; Cai H, 2005, CARDIOVASC RES, V68, P26, DOI 10.1016/j.cardiores.2005.06.021; Cardinal JS, 2010, KIDNEY INT, V77, P101, DOI 10.1038/ki.2009.421; Chisaka T, 2016, AM J HYPERTENS, V29, P54, DOI 10.1093/ajh/hpv072; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Ge L, 2017, ONCOTARGET, V8, P102653, DOI 10.18632/oncotarget.21130; Hayashida K, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003459; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hong Y, 2012, J NEUROSCI RES, V90, P1670, DOI 10.1002/jnr.22739; Igarashi T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31190; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kasai H, 1997, MUTAT RES-REV MUTAT, V387, P147, DOI 10.1016/S1383-5742(97)00035-5; Koyama Y, 2014, HEPATOL RES, V44, P663, DOI 10.1111/hepr.12165; Kuribayashi F, 2002, EMBO J, V21, P6312, DOI 10.1093/emboj/cdf642; Lipinski B, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/809696; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Mahmoudi M, 2006, CARDIOVASC RES, V71, P259, DOI 10.1016/j.cardiores.2006.03.002; Martinet W, 2002, CIRCULATION, V106, P927, DOI 10.1161/01.CIR.0000026393.47805.21; Moris D, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2017.06.27; Nakaoka H, 2016, J AM SOC HYPERTENS, V10, P811, DOI 10.1016/j.jash.2016.07.005; Ohnishi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117616; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2015, METHOD ENZYMOL, V555, P289, DOI 10.1016/bs.mie.2014.11.038; Ohta S, 2014, PHARMACOL THERAPEUT, V144, P1, DOI 10.1016/j.pharmthera.2014.04.006; Ohta S, 2012, BBA-GEN SUBJECTS, V1820, P586, DOI 10.1016/j.bbagen.2011.05.006; Ohta S, 2011, CURR PHARM DESIGN, V17, P2241, DOI 10.2174/138161211797052664; Oltmanns U, 2003, BRIT J PHARMACOL, V139, P1228, DOI 10.1038/sj.bjp.0705345; Qin ZX, 2012, ATHEROSCLEROSIS, V220, P343, DOI 10.1016/j.atherosclerosis.2011.11.002; Roth GA, 2017, J AM COLL CARDIOL, V70, P1, DOI 10.1016/j.jacc.2017.04.052; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sun Q, 2012, CARDIOVASC RES, V94, P144, DOI 10.1093/cvr/cvs024; Tsuda M, 2005, HYPERTENSION, V45, P545, DOI 10.1161/01.HYP.0000157409.88971.fc; Zhang YX, 2016, CHINESE J PHYSIOL, V59, P46, DOI 10.4077/CJP.2016.BAE365; Zhang YX, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00392	36	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0227582	10.1371/journal.pone.0227582	http://dx.doi.org/10.1371/journal.pone.0227582			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302306	Green Published, gold, Green Submitted			2022-12-26	WOS:000536016100005
J	Pestrak, MJ; Gupta, TT; Dusane, DH; Guzior, DV; Staats, A; Harro, J; Horswill, AR; Stoodley, P				Pestrak, Matthew J.; Gupta, Tripti Thapa; Dusane, Devendra H.; Guzior, Doug V.; Staats, Amelia; Harro, Jan; Horswill, Alexander R.; Stoodley, Paul			Investigation of synovial fluid induced Staphylococcus aureus aggregate development and its impact on surface attachment and biofilm formation	PLOS ONE			English	Article							BACTERIAL BIOFILMS; JOINT INFECTION; FIBRONECTIN; MODULATION; ADHESION; TISSUE; AGENTS	Periprosthetic joint infections (PJIs) are a devastating complication that occurs in 2% of patients following joint replacement. These infections are costly and difficult to treat, often requiring multiple corrective surgeries and prolonged antimicrobial treatments. The Gram-positive bacterium Staphylococcus aureus is one of the most common causes of PJIs, and it is often resistant to a number of commonly used antimicrobials. This tolerance can be partially attributed to the ability of S. aureus to form biofilms. Biofilms associated with the surface of indwelling medical devices have been observed on components removed during chronic infection, however, the development and localization of biofilms during PJIs remains unclear. Prior studies have demonstrated that synovial fluid, in the joint cavity, promotes the development of bacterial aggregates with many biofilm-like properties, including antibiotic resistance. We anticipate these aggregates have an important role in biofilm formation and antibiotic tolerance during PJIs. Therefore, we sought to determine specifically how synovial fluid promotes aggregate formation and the impact of this process on surface attachment. Using flow cytometry and microscopy, we quantified the aggregation of various clinical S. aureus strains following exposure to purified synovial fluid components. We determined that fibrinogen and fibronectin promoted bacterial aggregation, while cell free DNA, serum albumin, and hyaluronic acid had minimal effect. To determine how synovial fluid mediated aggregation affects surface attachment, we utilized microscopy to measure bacterial attachment. Surprisingly, we found that synovial fluid significantly impeded bacterial surface attachment to a variety of materials. We conclude from this study that fibrinogen and fibronectin in synovial fluid have a crucial role in promoting bacterial aggregation and inhibiting surface adhesion during PJI. Collectively, we propose that synovial fluid may have conflicting protective roles for the host by preventing adhesion to surfaces, but by promoting bacterial aggregation is also contributing to the development of antibiotic tolerance.	[Pestrak, Matthew J.; Gupta, Tripti Thapa; Dusane, Devendra H.; Guzior, Doug V.; Staats, Amelia; Stoodley, Paul] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Harro, Jan] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Horswill, Alexander R.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Stoodley, Paul] Ohio State Univ, Dept Orthoped, Columbus, OH 43210 USA; [Stoodley, Paul] Univ Southampton, Natl Ctr Adv Tribol Southampton nCATS, Southampton, Hants, England; [Stoodley, Paul] Univ Southampton, Natl Biofilm Innovat Ctr NBIC, Mech Engn, Southampton, Hants, England	University System of Ohio; Ohio State University; University System of Maryland; University of Maryland Baltimore; University of Colorado System; University of Colorado Anschutz Medical Campus; University System of Ohio; Ohio State University; University of Southampton; University of Southampton	Stoodley, P (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.; Stoodley, P (corresponding author), Ohio State Univ, Dept Orthoped, Columbus, OH 43210 USA.; Stoodley, P (corresponding author), Univ Southampton, Natl Ctr Adv Tribol Southampton nCATS, Southampton, Hants, England.; Stoodley, P (corresponding author), Univ Southampton, Natl Biofilm Innovat Ctr NBIC, Mech Engn, Southampton, Hants, England.	Paul.Stoodley@osumc.edu	Dusane, PhD, Devendra/AAZ-9820-2021; Dusane, Devendra/P-9829-2018; Stoodley, Paul/E-5079-2013	Dusane, Devendra/0000-0003-4340-6214; Staats, Amelia/0000-0001-5503-9402; Guzior, Douglas/0000-0002-7019-3261; Stoodley, Paul/0000-0001-6069-273X	National Institutes of Health [R01GM124436]; BBSRC [BB/R012415/1] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the National Institutes of Health grant R01GM124436 (PS).	Alhede M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027943; Ambriz-Avina V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/461941; Bay L, 2018, ADV WOUND CARE, V7, P105, DOI 10.1089/wound.2017.0770; Bhattacharya M, 2015, EXPERT REV ANTI-INFE, V13, P1499, DOI 10.1586/14787210.2015.1100533; Bjarnsholt T, 2009, PEDIATR PULM, V44, P547, DOI 10.1002/ppul.21011; Boles BR, 2011, TRENDS MICROBIOL, V19, P449, DOI 10.1016/j.tim.2011.06.004; Bronner S, 2004, FEMS MICROBIOL REV, V28, P183, DOI 10.1016/j.femsre.2003.09.003; Cheng AG, 2011, TRENDS MICROBIOL, V19, P225, DOI 10.1016/j.tim.2011.01.007; Cheng AG, 2009, FASEB J, V23, P3393, DOI 10.1096/fj.09-135467; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Crosby HA, 2016, ADV APPL MICROBIOL, V96, P1, DOI 10.1016/bs.aambs.2016.07.018; Dastgheyb S, 2015, J INFECT DIS, V211, P641, DOI 10.1093/infdis/jiu514; Dastgheyb SS, 2015, ANTIMICROB AGENTS CH, V59, P2122, DOI 10.1128/AAC.04579-14; DECKER B, 1959, CLIN CHEM, V5, P465; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Doriot P-A, 2000, CORON ARTERY DIS, V11; Fazli M, 2009, J CLIN MICROBIOL, V47, P4084, DOI 10.1128/JCM.01395-09; Fleming D, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.01998-16; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010; Gawande PV, 2014, CURR MICROBIOL, V68, P635, DOI 10.1007/s00284-014-0519-6; Gilbertie J, 2019, PLOS ONE, P1; GORMSEN J, 1971, ARTHRITIS RHEUM-US, V14, P503, DOI 10.1002/art.1780140410; GRISTINA AG, 1987, SCIENCE, V237, P1588, DOI 10.1126/science.3629258; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harris LG, 2004, BIOMATERIALS, V25, P4135, DOI 10.1016/j.biomaterials.2003.11.033; Hashimoto T, 2017, INT J RHEUM DIS, V20, P722, DOI 10.1111/1756-185X.12959; HAWIGER J, 1982, BIOCHEMISTRY-US, V21, P1407, DOI 10.1021/bi00535a047; Hogan S, 2017, J HOSP INFECT, V96, P177, DOI 10.1016/j.jhin.2017.02.008; Ibberson CB, 2016, INFECT IMMUN, V84, P1917, DOI 10.1128/IAI.01418-15; Inabathula A, 2018, JBJS, V100; Kaplan SL, 2014, J INFECTION, V68, pS51, DOI 10.1016/j.jinf.2013.09.014; Kiedrowski MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095574; Kirketerp-Moller K, 2008, J CLIN MICROBIOL, V46, P2717, DOI 10.1128/JCM.00501-08; Kragh KN, 2016, MBIO, V7, DOI 10.1128/mBio.00237-16; Kucharikova S, 2016, J ANTIMICROB CHEMOTH, V71, P936, DOI 10.1093/jac/dkv437; Mann EE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005822; Peel TN, 2012, ANTIMICROB AGENTS CH, V56, P2386, DOI 10.1128/AAC.06246-11; Perez K, 2015, J INFECT DIS, V212, P335, DOI 10.1093/infdis/jiv096; Pestrak MJ, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00234-19, 10.1128/aac.00234-19]; Pestrak MJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006842; Petrova OE, 2012, J BACTERIOL, V194, P2413, DOI 10.1128/JB.00003-12; Pulido L, 2008, CLIN ORTHOP RELAT R, V466, P1710, DOI 10.1007/s11999-008-0209-4; Ricciardi BF, 2018, CURR REV MUSCULOSKE, V11, P389, DOI 10.1007/s12178-018-9501-4; Saeed K, 2019, J ORTHOP RES, V37, P1007, DOI 10.1002/jor.24229; Schwarz EM, 2021, J ORTHOP RES, V39, P227, DOI 10.1002/jor.24616; Schwarz EM, 2019, J ORTHOP RES, V37, P997, DOI 10.1002/jor.24293; Schwarz-Linek U, 2004, MOL MICROBIOL, V52, P631, DOI 10.1111/j.1365-2958.2004.04027.x; SIMON GL, 1983, INFECT IMMUN, V40, P1004, DOI 10.1128/IAI.40.3.1004-1010.1983; Stoodley P, 2001, APPL ENVIRON MICROB, V67, P5608, DOI 10.1128/AEM.67.12.5608-5613.2001; Stoodley P, 2012, FEMS IMMUNOL MED MIC, V65, P283, DOI 10.1111/j.1574-695X.2012.00948.x; Stoodley P, 2011, FEMS IMMUNOL MED MIC, V62, P66, DOI 10.1111/j.1574-695X.2011.00793.x; VARTIO T, 1981, EUR J CLIN INVEST, V11, P207, DOI 10.1111/j.1365-2362.1981.tb01842.x; WEINBERGER A, 1989, SEMIN ARTHRITIS RHEU, V19, P66, DOI 10.1016/0049-0172(89)90087-5; Zhao LZ, 2009, J BIOMED MATER RES B, V91B, P470, DOI 10.1002/jbm.b.31463; Zimmerli W, 2014, J INTERN MED, V276, P111, DOI 10.1111/joim.12233; Zmistowski B, 2013, JBJS, V95	59	27	27	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231791	10.1371/journal.pone.0231791	http://dx.doi.org/10.1371/journal.pone.0231791			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302361	gold, Green Published, Green Accepted			2022-12-26	WOS:000536016100051
J	Conant, GC				Conant, Gavin C.			The lasting after-effects of an ancient polyploidy on the genomes of teleosts	PLOS ONE			English	Article							GENE BALANCE HYPOTHESIS; WHOLE-GENOME; DUPLICATE GENES; DOSAGE-SENSITIVITY; PROVIDES EVIDENCE; EVOLUTION; FISH; YEAST; ZEBRAFISH; MODEL	The ancestor of most teleost fishes underwent a whole-genome duplication event three hundred million years ago. Despite its antiquity, the effects of this event are evident both in the structure of teleost genomes and in how the surviving duplicated genes still operate to drive form and function. I inferred a set of shared syntenic regions that survive from the teleost genome duplication (TGD) using eight teleost genomes and the outgroup gar genome (which lacks the TGD). I then phylogenetically modeled the TGD's resolution via shared and independent gene losses and applied a new simulation-based statistical test for the presence of bias toward the preservation of genes from one parental subgenome. On the basis of that test, I argue that the TGD was likely an allopolyploidy. I find that duplicate genes surviving from this duplication in zebrafish are less likely to function in early embryo development than are genes that have returned to single copy at some point in this species' history. The tissues these ohnologs are expressed in, as well as their biological functions, lend support to recent suggestions that the TGD was the source of a morphological innovation in the structure of the teleost retina. Surviving duplicates also appear less likely to be essential than singletons, despite the fact that their single-copy orthologs in mouse are no less essential than other genes.	[Conant, Gavin C.] North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA; [Conant, Gavin C.] North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA; [Conant, Gavin C.] North Carolina State Univ, Program Genet, Raleigh, NC 27695 USA; [Conant, Gavin C.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of Missouri System; University of Missouri Columbia	Conant, GC (corresponding author), North Carolina State Univ, Dept Biol Sci, Raleigh, NC 27695 USA.; Conant, GC (corresponding author), North Carolina State Univ, Bioinformat Res Ctr, Raleigh, NC 27695 USA.; Conant, GC (corresponding author), North Carolina State Univ, Program Genet, Raleigh, NC 27695 USA.; Conant, GC (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	gconant@ncsu.edu		Conant, Gavin/0000-0002-8677-4933	United States National Science Foundation [NSF-IOS-1339156, NSF-CCF1421765]	United States National Science Foundation(National Science Foundation (NSF))	GCC was supported by the United States National Science Foundation (www.nsf.gov; grant numbers NSF-IOS-1339156 and NSF-CCF1421765). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanes H, 2011, GENOME RES, V21, P1328, DOI 10.1101/gr.116012.110; Aken BL, 2017, NUCLEIC ACIDS RES, V45, pD635, DOI 10.1093/nar/gkw1104; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alves MJ, 2001, GENETICA, V111, P375, DOI 10.1023/A:1013783029921; Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Bekaert M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049903; Bekaert M, 2011, PLANT CELL, V23, P1719, DOI 10.1105/tpc.110.081281; Bekaert M, 2011, MOL BIOL EVOL, V28, P1111, DOI 10.1093/molbev/msq296; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Birchler JA, 2007, PLANT CELL, V19, P395, DOI 10.1105/tpc.106.049338; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bird KA, 2018, NEW PHYTOLOGIST; Blanc-Mathieu R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006777; Braasch I., 2012, POLYPLOIDY GENOME EV, P341, DOI DOI 10.1007/978-3-642-31442-1_17; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; Chenuil A, 1999, HEREDITY, V82, P373, DOI 10.1038/sj.hdy.6884890; Christensen KA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173053; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Clausen RE, 1925, GENETICS, V10, P278; Conant GC, 2008, GENETICS, V179, P1681, DOI 10.1534/genetics.107.074450; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; Conant GC, 2014, MOL BIOL EVOL, V31, P3184, DOI 10.1093/molbev/msu250; Conant GC, 2014, CURR OPIN PLANT BIOL, V19, P91, DOI 10.1016/j.pbi.2014.05.008; Conant GC, 2006, PLOS BIOL, V4, P545, DOI 10.1371/journal.pbio.0040109; Conant GC, 2004, P ROY SOC B-BIOL SCI, V271, P89, DOI 10.1098/rspb.2003.2560; Conant GC, 2002, NUCLEIC ACIDS RES, V30, P3378, DOI 10.1093/nar/gkf449; Crow KD, 2006, MOL BIOL EVOL, V23, P121, DOI 10.1093/molbev/msj020; De Smet R, 2013, P NATL ACAD SCI USA, V110, P2898, DOI 10.1073/pnas.1300127110; DeLuna A, 2008, NAT GENET, V40, P676, DOI 10.1038/ng.123; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Edger PP, 2015, P NATL ACAD SCI USA, V112, P8362, DOI 10.1073/pnas.1503926112; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Emery M, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007267; ENGSTROM KJELL, 1960, ACTA ZOOL [STOCKHOLM], V41, P277; Evangelisti AM, 2010, GENOME BIOL EVOL, V2, P826, DOI 10.1093/gbe/evq067; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Force A, 1999, GENETICS, V151, P1531; Freeling M, 2006, GENOME RES, V16, P805, DOI 10.1101/gr.3681406; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Garsmeur O, 2014, MOL BIOL EVOL, V31, P448, DOI 10.1093/molbev/mst230; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo BC, 2012, MOL BIOL EVOL, V29, P3005, DOI 10.1093/molbev/mss108; Guschanski K, 2017, GENOME RES, V27, P1461, DOI 10.1101/gr.215566.116; Hahn MW, 2005, MOL BIOL EVOL, V22, P803, DOI 10.1093/molbev/msi072; Hao Y, 2020, GENOME BIOL EVOL; Hoegg S, 2004, J MOL EVOL, V59, P190, DOI 10.1007/s00239-004-2613-z; Hoegg S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-317; HOLLAND PWH, 1994, DEVELOPMENT, P125; Howe DG, 2013, NUCLEIC ACIDS RES, V41, pD854, DOI 10.1093/nar/gks938; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Inoue J, 2015, P NATL ACAD SCI USA, V112, P14918, DOI 10.1073/pnas.1507669112; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Jensen LJ, 2008, NUCLEIC ACIDS RES, V36, pD250, DOI 10.1093/nar/gkm796; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kasahara M, 2007, CURR OPIN IMMUNOL, V19, P547, DOI 10.1016/j.coi.2007.07.009; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kollitz EM, 2014, ENDOCRINOLOGY, V155, P4641, DOI 10.1210/en.2014-1505; Koscielny G, 2014, NUCLEIC ACIDS RES, V42, pD802, DOI 10.1093/nar/gkt977; Kuwada Y., 1911, BOT MAGAZINE, V25, P163; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; LYALL AH, 1957, Q J MICROSC SCI, V98, P189; Makino T, 2012, GENOME RES, V22, P2427, DOI 10.1101/gr.131953.111; Makino T, 2010, P NATL ACAD SCI USA, V107, P9270, DOI 10.1073/pnas.0914697107; Makino T, 2009, TRENDS GENET, V25, P152, DOI 10.1016/j.tig.2009.03.001; Marcet-Houben M, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002220; Masanobu S, 2012, DNA RES, V19, P305, DOI 10.1093/dnares/dss012; McGaugh SE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6307; McGrath CL, 2014, GENOME RES, V24, P1665, DOI 10.1101/gr.173740.114; McLysaght A, 2002, NAT GENET, V31, P200, DOI 10.1038/ng884; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Meyer A, 1999, CURR OPIN CELL BIOL, V11, P699, DOI 10.1016/S0955-0674(99)00039-3; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Mi HY, 2013, NAT PROTOC, V8, P1551, DOI 10.1038/nprot.2013.092; Moriyama Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10397; Nakatani Y, 2019, P NATL ACAD SCI USA, V116, P1816, DOI 10.1073/pnas.1817937116; Nakatani Y, 2017, BIOINFORMATICS, V33, pI369, DOI 10.1093/bioinformatics/btx259; Naruse K, 2004, GENOME RES, V14, P820, DOI 10.1101/gr.2004004; Near TJ, 2012, P NATL ACAD SCI USA, V109, P13698, DOI 10.1073/pnas.1206625109; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Ohno S., 1970, EVOLUTION GENE DUPLI; Papp B, 2003, NATURE, V424, P194, DOI 10.1038/nature01771; Parey E, 2020, SYNTENY GUIDED RESOL; Pires JC, 2016, ANNU REV GENET, V50, P113, DOI 10.1146/annurev-genet-120215-035400; Postlethwait JH, 1998, NAT GENET, V18, P345, DOI 10.1038/ng0498-345; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Raymond PA, 2004, INT J DEV BIOL, V48, P935, DOI 10.1387/ijdb.041873pr; Rohlfs RV, 2015, SYST BIOL, V64, P695, DOI 10.1093/sysbio/syv042; Roux J, 2017, MOL BIOL EVOL, V34, P2773, DOI 10.1093/molbev/msx199; Roux J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000311; Sankoff D, 1998, J COMPUT BIOL, V5, P555, DOI 10.1089/cmb.1998.5.555; Sankoff D, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-313; Scannell DR, 2007, P NATL ACAD SCI USA, V104, P8397, DOI 10.1073/pnas.0608218104; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Schartl M, 2013, NAT GENET, V45, P567, DOI 10.1038/ng.2604; Schnable JC, 2011, P NATL ACAD SCI USA, V108, P4069, DOI 10.1073/pnas.1101368108; Schoonmaker A, 2020, G3-GENES GENOM GENET, V10, P225, DOI 10.1534/g3.119.400650; Schwager EE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0399-x; Scienski K, 2015, GENOME BIOL EVOL, V7, P3249, DOI 10.1093/gbe/evv216; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; Semon M, 2007, TRENDS GENET, V23, P108, DOI 10.1016/j.tig.2007.01.003; Singh PP, 2020, NUCLEIC ACIDS RES, V48, pD724, DOI 10.1093/nar/gkz909; Singh PP, 2012, CELL REP, V2, P1387, DOI 10.1016/j.celrep.2012.09.034; Sokal RR, 1995, BIOMETRY; Soltis DE, 2009, AM J BOT, V96, P336, DOI 10.3732/ajb.0800079; STEBBINS GL, 1947, ADV GENET, V1, P403, DOI 10.1016/S0065-2660(08)60490-3; Steinke D, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-16; Stenkamp DL, 2002, MOL VIS, V8, P280; Sukeena JM, 2016, J EXP ZOOL PART B, V326, P403, DOI 10.1002/jez.b.22710; Tang HB, 2012, GENETICS, V190, P1563, DOI 10.1534/genetics.111.137349; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Taylor JS, 2001, PHILOS T R SOC B, V356, P1661, DOI 10.1098/rstb.2001.0975; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Van de Peer Y, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-250; Van De Peer Y, 2017, NAT REV GENET, V18, P411, DOI 10.1038/nrg.2017.26; van Hoek MJA, 2009, MOL BIOL EVOL, V26, P2441, DOI 10.1093/molbev/msp160; Vandepoele K, 2004, P NATL ACAD SCI USA, V101, P1638, DOI 10.1073/pnas.0307968100; Varadharajan S, 2018, GENOME BIOL EVOL, V10, P2785, DOI 10.1093/gbe/evy201; Veitia RA, 2015, TRENDS BIOCHEM SCI, V40, P309, DOI 10.1016/j.tibs.2015.03.011; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wendel JF, 2018, CURR OPIN GENET DEV, V49, P1, DOI 10.1016/j.gde.2018.01.004; WERTH CR, 1991, AM NAT, V137, P515, DOI 10.1086/285180; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Woods S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003330; Xie T, 2016, MOL BIOL EVOL, V33, P2368, DOI 10.1093/molbev/msw108; Yang L, 2015, MOL PHYLOGENET EVOL, V85, P97, DOI 10.1016/j.ympev.2015.01.014; Zwaenepoel A, 2019, MOL PLANT, V12, P133, DOI 10.1016/j.molp.2018.12.019	136	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231356	10.1371/journal.pone.0231356	http://dx.doi.org/10.1371/journal.pone.0231356			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298330	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400037
J	Laffan, SB; Thomson, AS; Mai, S; Fishman, C; Kambara, T; Nistala, K; Raymond, JT; Chen, SG; Ramani, T; Pageon, L; Polsky, R; Watkins, M; Ottolangui, G; White, JR; Maier, C; Herdman, M; Bouma, G				Laffan, Susan B.; Thomson, Andrew S.; Mai, Shing; Fishman, Cindy; Kambara, Takahito; Nistala, Kiran; Raymond, James T.; Chen, Shugui; Ramani, Thulasi; Pageon, Laura; Polsky, Rodd; Watkins, Mark; Ottolangui, Gemma; White, John R.; Maier, Curtis; Herdman, Michael; Bouma, Gerben			Immune complex disease in a chronic monkey study with a humanised, therapeutic antibody against CCL20 is associated with complement-containing drug aggregates	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; CHEMOKINE CCL20; CCR6; CELLS; RESPONSIVENESS; NEUTRALIZATION; EXPRESSION; PROTEIN	Despite the potential for the chemokine class as therapeutic targets in immune mediated disease, success has been limited. Many chemokines can bind to multiple receptors and many receptors have multiple ligands, with few exceptions. One of those exceptions is CCL20, which exclusively pairs to CCR6 and is associated with several immunologic conditions, thus providing a promising therapeutic target. Following successful evaluation in a single dose, first time in human clinical study, GSK3050002-a humanized IgG1 monoclonal antibody against human CCL20-was evaluated in a 26-week cynomolgus monkey toxicology study. A high incidence of unexpected vascular and organ inflammation was observed microscopically, leading to the decision to halt clinical development. Here we report a doseresponsive increase in the incidence and severity of inflammation in multiple organs from monkeys receiving 30 and 300 mg/kg/week by either subcutaneous or intravenous injection. Histomorphological changes resembled an immune complex-mediated pathology, which is often due to formation of anti-drug antibodies in monkeys receiving a human protein therapeutic and thus not predictive of clinical outcome. However, the presentation was atypical in that there was a clear dose response with a very high incidence of inflammation with a low incidence of ADA that did not correlate well individually. Additionally, the immunohistologic presentation was atypical in that the severity and distribution of tissue inflammation was greater than the numbers of associated immune complexes (i.e., granular deposits). An extensive ex vivo analysis of large molecular weight protein complexes in monkey serum from this study and in human serum samples demonstrated a time-dependent aggregation of GSK3050002, that was not predicted by in vitro assays. The aggregates also contained complement components. These findings support the hypothesis that immune complexes of drug aggregates, not necessarily including anti-drug antibodies, can fix complement, accumulate over time, and trigger immune complex disease. A situation which may have increased clinical relevance than typical anti-drug antibody-associated immune complex disease in monkeys administered human antibody proteins.	[Laffan, Susan B.; Fishman, Cindy; Watkins, Mark; Maier, Curtis] GlaxoSmithKline, R&D, In Vitro In Vivo Translat IVIVT, Collegeville, PA USA; [Thomson, Andrew S.; Mai, Shing; Chen, Shugui; Polsky, Rodd; White, John R.] GlaxoSmithKline, R&D Platform Technol & Sci, Biopharm Analyt Sci, King Of Prussia, PA USA; [Kambara, Takahito] GlaxoSmithKline, R&D, IVIVT, Pathol, Collegeville, PA USA; [Nistala, Kiran; Bouma, Gerben] GlaxoSmithKline, Adapt Immun Res Unit, Stevenage, Herts, England; [Raymond, James T.] Charles River Labs Inc, Frederick, MD USA; [Ramani, Thulasi; Pageon, Laura] Envigo CRS Inc, Princeton, NJ USA; [Ottolangui, Gemma] GlaxoSmithKline, Biopharm Mol Discovery, R&D Platform Technol & Sci, Stevenage, Herts, England; [Herdman, Michael; Bouma, Gerben] GlaxoSmithKline, Clin Pharmacol & Expt Med, Stevenage, Herts, England; [Kambara, Takahito] Preclin Safety AbbVie, Pathol, N Chicago, IL USA; [Ramani, Thulasi] Covance CRS LLC, Global Early Dev, Somerset, NJ USA; [Pageon, Laura] Confluence Pathol LLC, Oakland, NJ USA	GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline	Bouma, G (corresponding author), GlaxoSmithKline, Adapt Immun Res Unit, Stevenage, Herts, England.; Bouma, G (corresponding author), GlaxoSmithKline, Clin Pharmacol & Expt Med, Stevenage, Herts, England.	gerben.x.bouma@gsk.com		White, John R/0000-0003-2998-1626	GlaxoSmithKline; Morphotek, Inc. [NCT01984047]	GlaxoSmithKline(GlaxoSmithKline); Morphotek, Inc.	Funding for this study was provided by GlaxoSmithKline and Morphotek, Inc. (NCT01984047). JR is an employee of Charles River Laboratories and principal investigator of the immunohistochemistry analysis. TR is an employee of Covance CRS, LLC (formerly Envigo CRS) and study director of the 26-week monkey toxicity study. LP was an employee of Envigo CRS for the duration of the study. All other listed authors were employees of GlaxoSmithKline (GSK) during the conduct of the study, hold GSK stock or stock options, and meet the criteria for authorship set forth by the International Committee for Medical Journal Editors. Listed authors from GlaxoSmithKline designed the studies and were involved in data collection and analysis, decision to publish and preparation of the manuscript.; The authors would like to acknowledge the support from the GSK Immunotoxicology Safety Board members (including Daniel Rubio, Maggie Dempster, Eric Lewis) and Antal Rot and Mohamed Daha for assistance with incorporating the toxicology findings, Christopher Carroll, William Bowen and Nadia Tournier for assistance and interpretation of affinity measurements of GSK3050002, Manish Burman for assistance with evaluation of dimeric CCL20 and Steve Castellino for MALDI examination.	Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bonvin P, 2017, J BIOL CHEM, V292, P4185, DOI 10.1074/jbc.M116.745877; Bouma G, 2017, BRIT J CLIN PHARMACO, V83, P1976, DOI 10.1111/bcp.13286; BURTON DR, 1985, MOL IMMUNOL, V22, P161, DOI 10.1016/0161-5890(85)90151-8; CARTER PM, 1973, ANN RHEUM DIS, V32, P265, DOI 10.1136/ard.32.3.265; Chan DI, 2008, ANTIMICROB AGENTS CH, V52, P883, DOI 10.1128/AAC.00805-07; Cochrane C G, 1973, Adv Immunol, V16, P185, DOI 10.1016/S0065-2776(08)60298-9; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; Fernandez N, 2004, TRENDS PHARMACOL SCI, V25, P512, DOI 10.1016/j.tips.2004.08.005; Frazier KS, 2018, TOXICOL PATHOL, V46, P904, DOI 10.1177/0192623318789399; Frazier KS, 2015, TOXICOL PATHOL, V43, P915, DOI 10.1177/0192623315570340; Genentech, 2013, GAZ TM OB PHARM TOX; Ghadjar P, 2009, INT J CANCER, V125, P741, DOI 10.1002/ijc.24468; Haringman JJ, 2006, ARTHRITIS RHEUM, V54, P2387, DOI 10.1002/art.21975; Hedrick MN, 2010, EXPERT OPIN THER TAR, V14, P911, DOI 10.1517/14728222.2010.504716; Heyen JR, 2014, TOXICOL PATHOL, V42, P765, DOI 10.1177/0192623314522559; Kleinewietfeld M, 2005, BLOOD, V105, P2877, DOI 10.1182/blood-2004-07-2505; Krzysiek R, 2000, BLOOD, V96, P2338, DOI 10.1182/blood.V96.7.2338.h8002338_2338_2345; Leach MW, 2014, TOXICOL PATHOL, V42, P293, DOI 10.1177/0192623313510987; Liao F, 1999, J IMMUNOL, V162, P186; Nishimura M, 2009, ANN NY ACAD SCI, V1173, P350, DOI 10.1111/j.1749-6632.2009.04738.x; Proudfoot AEI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030070; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Rojko JL, 2014, TOXICOL PATHOL, V42, P725, DOI 10.1177/0192623314526475; Sandhu SK, 2013, CANCER CHEMOTH PHARM, V71, P1041, DOI 10.1007/s00280-013-2099-8; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Williams IR, 2004, IMMUNOL RES, V29, P283, DOI 10.1385/IR:29:1-3:283; Zimmermann A., 2017, LOCALIZED GEN CRYSTA, P1823	28	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231655	10.1371/journal.pone.0231655	http://dx.doi.org/10.1371/journal.pone.0231655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32325480	Green Published, gold			2022-12-26	WOS:000536033700027
J	Lu, Y; Yang, DL; Niu, Y; Zhang, HG; Du, BL; Jiang, XL				Lu, Ying; Yang, Dongliang; Niu, Ying; Zhang, Huaguo; Du, Bingli; Jiang, Xiaolian			Factors associated with the resilience of Tibetan adolescent survivors five years after the 2010 Yushu earthquake	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; SOCIAL SUPPORT; EFFORTFUL CONTROL; CHILDREN; TRAUMA; SCHOOL; DEPRESSION; DISASTER; SCALE; RISK	Resilience contributes to the recovery of disaster victims. The resilience of Tibetan adolescents after the Yushu earthquake has not been properly studied. This study aimed to examine the current resilience and associated factors in Tibetan adolescent survivors in the hardest-hit area 5 years after the Yushu earthquake. This cross-sectional survey was conducted in the area hit the hardest by the Yushu earthquake. Data were collected from 4681 respondents in October and November 2015. Measurements included the participant characteristics, traumatic earthquake experience, the Connor-Davidson resilience scale (CD-RISC), and the social support appraisals (SS-A) scale. The individual datasets were randomized as 80% for the training set and 20% for the validation set. The mean resilience score of the Tibetan adolescent survivors was 55.0 +/- 12.3. Thirteen variables were entered into the regression equation. The three dimensions of social support (from family, from friends, from others than family/friends) were positively associated with resilience (all P<0.05), among which support from others than family/friends was the strongest (r = 0.388, P<0.001). Academic performance, activeness of participation in school activities, harmonious relationship with teachers/classmates, health over the last year, and regular physical exercise were positively associated with resilience (all P<0.05). Being female and being extremely worried about their own lives were negatively associated with resilience (both P<0.05). In conclusion, among Tibetan adolescent survivors to the Yushu earthquake of 2010, support from others than family/friends was the strongest positive factor associated with resilience, while being female and extreme worry about their own lives were negative factors. These results expand our knowledge regarding resilience in Tibetan adolescent disaster survivors.	[Lu, Ying; Niu, Ying; Du, Bingli] Hong Kong Polytech Univ, Sichuan Univ, Inst Disaster Management & Reconstruct, Chengdu, Sichuan, Peoples R China; [Yang, Dongliang] Cangzhou Med Coll, Cangzhou, Hebei, Peoples R China; [Zhang, Huaguo; Jiang, Xiaolian] Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu, Sichuan, Peoples R China	Hong Kong Polytechnic University; Sichuan University; Sichuan University	Jiang, XL (corresponding author), Sichuan Univ, West China Hosp, West China Sch Nursing, Chengdu, Sichuan, Peoples R China.	jiangxiaolian2019@163.com						Ahn HW, 2016, AM J SPORT MED, V44, P3158, DOI 10.1177/0363546516660069; Alim TN, 2008, AM J PSYCHIAT, V165, P1566, DOI 10.1176/appi.ajp.2008.07121939; Benzies K, 2009, CHILD FAM SOC WORK, V14, P103, DOI 10.1111/j.1365-2206.2008.00586.x; Brennan PA, 2003, J AM ACAD CHILD PSY, V42, P1469, DOI 10.1097/00004583-200312000-00014; Brooks JE, 2006, CHILD SCH, V28, P69, DOI 10.1093/cs/28.2.69; Chen Z, 2012, CHIN J SCH HLTH, V33, P470; Connor KM, 2006, J CLIN PSYCHIAT, V67, P46; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Danielsen AG, 2009, J EDUC RES, V102, P303, DOI 10.3200/JOER.102.4.303-320; Davidson J, 2008, INT CLIN PSYCHOPHARM, V23, P299, DOI 10.1097/YIC.0b013e32830c202d; de la Fuente J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01039; Deuster Patricia A, 2013, US Army Med Dep J, P24; Eisenberg N, 2009, DEV PSYCHOPATHOL, V21, P455, DOI 10.1017/S095457940900025X; Fu C, 2014, J AFFECT DISORDERS, V155, P149, DOI 10.1016/j.jad.2013.10.041; GARMEZY N, 1984, CHILD DEV, V55, P97, DOI 10.1111/j.1467-8624.1984.tb00276.x; Grabenwarter C, 2018, VERFBLOG        0612, DOI [10.17176/20190211-225554-0, DOI 10.17176/20190211-225554-0]; Graber R, 2016, BRIT J PSYCHOL, V107, P338, DOI 10.1111/bjop.12135; GUERRA NG, 1989, J ABNORM CHILD PSYCH, V17, P277, DOI 10.1007/BF00917399; Hamm JV, 2005, NEW DIR CHILD ADOLES, V107, P61, DOI 10.1002/cd.121; Hofler M, 2014, INT J DISAST RISK SC, V5, P33, DOI 10.1007/s13753-014-0009-2; Jaworska N, 2015, J PSYCHIATR NEUROSCI, V40, P291, DOI 10.1503/jpn.150268; Jiang R, 2012, J HUZHOU TEACHERS CO, V34, P101; Jin YC, 2015, J NERV MENT DIS, V203, P679, DOI 10.1097/NMD.0000000000000351; Kaye-Tzadok A, 2017, VIOLENCE AGAINST WOM, V23, P993, DOI 10.1177/1077801216652506; Kidd AC, 2018, BMJ OPEN RESPIR RES, V5, DOI 10.1136/bmjresp-2017-000240; Kimerling R, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0981-0; Kukihara H, 2014, PSYCHIAT CLIN NEUROS, V68, P524, DOI 10.1111/pcn.12159; Lavoie J, 2016, J PEDIATR NURS, V31, P701, DOI 10.1016/j.pedn.2016.07.011; Li J, 2006, J TIBET NATL I PHILO, P40; Liu Qiaolan, 2013, Wei Sheng Yan Jiu, V42, P950; Loukas A, 2010, J RES ADOLESCENCE, V20, P13, DOI 10.1111/j.1532-7795.2009.00632.x; Luo M., 2012, J CHIFENG U NAT SCI, V28, P107; Luthar A, 2003, RESILIENCE VULNERABI; Marshall AD, 2016, J AM ACAD CHILD PSY, V55, P25, DOI 10.1016/j.jaac.2015.10.004; Martinez-Torteya C, 2009, CHILD DEV, V80, P562, DOI 10.1111/j.1467-8624.2009.01279.x; Masten AS, 2014, CHILD DEV, V85, P6, DOI 10.1111/cdev.12205; Masten AS, 2012, ANNU REV PSYCHOL, V63, P227, DOI 10.1146/annurev-psych-120710-100356; Masten AS, 2001, AM PSYCHOL, V56, P227, DOI 10.1037/0003-066X.56.3.227; Migerode F, 2012, J DEV PHYS DISABIL, V24, P487, DOI 10.1007/s10882-012-9285-1; Mo PKH, 2014, AIDS CARE, V26, P1526, DOI 10.1080/09540121.2014.923810; Najarian LM, 2011, J AFFECT DISORDERS, V135, P51, DOI 10.1016/j.jad.2011.06.038; Olsson CA, 2003, J ADOLESCENCE, V26, P1, DOI 10.1016/S0140-1971(02)00118-5; Osofsky JD, 2015, J CHILD PSYCHOL PSYC, V56, P1347, DOI 10.1111/jcpp.12420; Partido BB, 2018, J DENT EDUC, V82, P974, DOI 10.21815/JDE.018.094; Quan LJ, 2017, ARCH PSYCHIAT NURS, V31, P507, DOI 10.1016/j.apnu.2017.06.003; Ronan KevinR., 2005, PROMOTING COMMUNITY, DOI 10.1007/b102725; Sahin Baltaci H, 2015, EURASIAN J EDUC RES, P111, DOI 10.14689/ejer.2015.60.7; Scali J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039879; Seery MD, 2010, J PERS SOC PSYCHOL, V99, P1025, DOI 10.1037/a0021344; Shaikh A, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0311-6; Silverman MN, 2014, INTERFACE FOCUS, V4, DOI 10.1098/rsfs.2014.0040; Skinner E, 2008, J EDUC PSYCHOL, V100, P765, DOI 10.1037/a0012840; Stratta P, 2013, PERS INDIV DIFFER, V54, P327, DOI 10.1016/j.paid.2012.09.016; Trucchia Silvina M, 2013, Rev Fac Cien Med Univ Nac Cordoba, V70, P144; Ungar M, 2013, TRAUMA VIOLENCE ABUS, V14, P255, DOI 10.1177/1524838013487805; Vanderbilt-Adriance E, 2008, J ABNORM CHILD PSYCH, V36, P887, DOI 10.1007/s10802-008-9220-1; VAUX A, 1986, AM J COMMUN PSYCHOL, V14, P195, DOI 10.1007/BF00911821; Wang JN, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-114; Wang TY, 2011, J XINZANG U, V2011, P133; Xiao H, 2010, CLIN CARDIOL, V33, P149, DOI 10.1002/clc.20713; [辛自强 XIN ZiQiang], 2007, [中国心理卫生杂志, Chinese Mental Health Journal], V21, P379; Ying LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089401; Yoshikawa E, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3251-2; Yu S., 2011, J SICHUAN NORMAL U S, V38, P45; Yu XN, 2011, COMPR PSYCHIAT, V52, P218, DOI 10.1016/j.comppsych.2010.05.010; Yuen WWY, 2019, J ADOLESCENT HEALTH, V64, pS73, DOI 10.1016/j.jadohealth.2018.10.005; Zhang JG, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5483-9; Ziaian T, 2012, INT J POPULATION RES, V2012, P1, DOI [10.1155/2012/485956, DOI 10.1155/2012/485956]; Zimmer-Gembeck MJ, 2006, J ADOLESCENCE, V29, P911, DOI 10.1016/j.adolescence.2006.04.008; Zolkoski SM, 2012, CHILD YOUTH SERV REV, V34, P2295, DOI 10.1016/j.childyouth.2012.08.009	70	4	4	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231736	10.1371/journal.pone.0231736	http://dx.doi.org/10.1371/journal.pone.0231736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324755	Green Published, gold			2022-12-26	WOS:000536033700033
J	Petrelli, A; Di Napoli, A; Demuru, E; Ventura, M; Gnavi, R; Di Minco, L; Tamburini, C; Mirisola, C; Sebastiani, G				Petrelli, Alessio; Di Napoli, Anteo; Demuru, Elena; Ventura, Martina; Gnavi, Roberto; Di Minco, Lidia; Tamburini, Cristina; Mirisola, Concetta; Sebastiani, Gabriella			Socioeconomic and citizenship inequalities in hospitalisation of the adult population in Italy	PLOS ONE			English	Article							HEALTH-CARE; SERVICES UTILIZATION; BRAIN-TUMOR; IMMIGRANTS; EDUCATION; EUROPE	Background Higher levels of hospital admissions among people with lower socioeconomic level, including immigrants, have been observed in developed countries. In Europe, immigrants present a more frequent use of emergency services compared to the native population. The aim of our study was to evaluate the socioeconomic and citizenship differences in the hospitalisation of the adult population in Italy. Methods The study was conducted using the database created by the record linkage between the National Health Interview Survey (2005) with the National Hospital Discharge Database (2005-2014). 79,341 individuals aged 18-64 years were included. The outcomes were acute hospital admissions, urgent admissions and length of stay (1-7 days, > = 8 days). Education level, occupational status, self-perceived economic resources and migratory status were considered as socioeconomic determinants. A multivariate proportional hazards model for recurrent events was used to estimate the risk of total hospital admissions. Logistic models were used to estimate the risk of urgent hospitalisation as well as of length of stay. Results Low education level, the lack of employment and negative self-perceived economic resources were conditions associated with the risk of hospitalisation, a longer hospital stay and greater recourse to urgent hospitalisation. Foreigners had a lower risk of hospitalisation (HR = 0.75; 95% CI:0.68-0.83) but a higher risk of urgent hospitalisation (OR = 1.36; 95% CI:1.18-1.55) and more frequent hospitalisations with a length of stay of at least eight days (OR = 1.19; 95% CI:1.02-1.40). Conclusions To improve equity in access, effective primary, secondary and tertiary prevention strategies must be strengthened, as should access to appropriate levels of care.	[Petrelli, Alessio; Di Napoli, Anteo; Demuru, Elena; Ventura, Martina; Mirisola, Concetta] Natl Inst Hlth Migrat & Poverty INMP, Rome, Italy; [Gnavi, Roberto] ASL TO3, Epidemiol Unit, Turin, Italy; [Di Minco, Lidia; Tamburini, Cristina] Minist Hlth, Rome, Italy; [Sebastiani, Gabriella] Italian Natl Inst Stat Istat, Rome, Italy		Petrelli, A (corresponding author), Natl Inst Hlth Migrat & Poverty INMP, Rome, Italy.	alessio.petrelli@inmp.it	Demuru, Elena/AAE-9183-2019; Di Napoli, Anteo/AAN-1659-2020; Gnavi, Roberto/J-9263-2016	Di Napoli, Anteo/0000-0003-3207-8761; Gnavi, Roberto/0000-0003-1919-2199; Demuru, Elena/0000-0003-2979-4169; Petrelli, Alessio/0000-0002-7533-7260				Afilalo J, 2009, AM J CARDIOL, V103, P1616, DOI 10.1016/j.amjcard.2009.01.375; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bonvicini L, 2011, EPIDEMIOL PREV, V35, P259; Brameld KJ, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-61; Dalla Zuanna T, 2017, EUR J PUBLIC HLTH, V27; de Waure C, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-014-0032-9; Di Napoli A, 2017, EPIDEMIOL PREV, V41, P3, DOI [10.19191/EP17.1.P003.002, DOI 10.19191/EP17.1.P003.002]; Di Napoli A, 2017, EPIDEMIOL PREV, V41, P41, DOI 10.19191/EP17.3-4S1.P041.064; Fedeli U, 2015, PEERJ, V3, DOI 10.7717/peerj.975; Glazier RH, 2000, CAN J PUBLIC HEALTH, V91, P268, DOI 10.1007/BF03404286; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; Hernandez-Quevedo C, 2009, SOC SCI MED, V69, P370, DOI 10.1016/j.socscimed.2009.05.005; Huang ME, 1998, ARCH PHYS MED REHAB, V79, P1386, DOI 10.1016/S0003-9993(98)90232-5; ISTAT, 2017, IND DEC CAUS MORT IN; ISTAT, 2008, COND SAL RIC SERV SA; ISTAT, 2016, DIS NELL SPER VIT LI; Luben R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009461; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mccartney G., 2013, BMJ OPEN, V3; Ministero della Salute, 2017, RAPP ANN ATT RIC OSP; Norredam M, 2010, EUR J PUBLIC HEALTH, V20, P555, DOI 10.1093/eurpub/ckp195; Pace A, 2016, SUPPORT CARE CANCER, V24, P4801, DOI 10.1007/s00520-016-3333-9; Pappas G, 1997, AM J PUBLIC HEALTH, V87, P811, DOI 10.2105/AJPH.87.5.811; Peeters A, 2015, LANCET DIABETES ENDO, V3, P838, DOI 10.1016/S2213-8587(15)00373-3; Petrelli A, 2019, EPIDEMIOL PREV, V43, P1, DOI 10.19191/EP19.1.S1.002; Petrelli A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021653; Petrelli A, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-017-0596-9; Schifano P, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-33; Stevens A, 1998, BRIT MED J, V316, P1448, DOI 10.1136/bmj.316.7142.1448; Stirbu I, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-288; Takahashi PY, 2016, J EPIDEMIOL COMMUN H, V70, P286, DOI 10.1136/jech-2015-205925; Tamayo-Fonseca N, 2015, SELF RATED HLTH HOSP; Taylor CB, 2006, AM J PREV MED, V31, P127, DOI 10.1016/j.amepre.2006.03.025; Torssander J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152369; van Doorslaer E, 2000, J HEALTH ECON, V19, P553, DOI 10.1016/S0167-6296(00)00050-3; VanKampen IG, 2014, PLOS ONE, V9; WEI LJ, 1989, J AM STAT ASSOC, V84, P1065, DOI 10.2307/2290084; Wiking E, 2004, J EPIDEMIOL COMMUN H, V58, P574, DOI 10.1136/jech.2003.011387	39	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231564	10.1371/journal.pone.0231564	http://dx.doi.org/10.1371/journal.pone.0231564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324771	Green Published, gold			2022-12-26	WOS:000536033700019
J	Zhong, LS; Lin, LJ; Yang, L; Liao, MA; Wang, X; Wang, J; Lv, XL; Deng, HH; Liang, D; Xia, H; Tang, Y				Zhong, Lisha; Lin, Lijin; Yang, Liu; Liao, Ming'an; Wang, Xun; Wang, Jin; Lv, Xiulan; Deng, Honghong; Liang, Dong; Xia, Hui; Tang, Yi			Exogenous melatonin promotes growth and sucrose metabolism of grape seedlings	PLOS ONE			English	Article							STRESS TOLERANCE; STIMULATING COMPOUND; ENZYME-ACTIVITIES; SENESCENCE; ANTIOXIDANT; ROOT; OVEREXPRESSION; BIOSYNTHESIS; HYPOCOTYLS; INCREASE	Melatonin (MT) has many important functions in plants. In this study, different concentrations of MT (0, 50, 100, 150, and 200 mu mol/L) were sprayed on grape seedlings, and its effects on plant growth and sucrose metabolism were determined. The results show that there was a mutual influence and promotional relationship between growth and sugar metabolism in grape seedlings. The MT treatments promoted the development and growth of grape seedlings by increasing their biomass and promoting the photosynthetic performance of leaves. This resulted in increased nutrient absorption and a greater ability to compete for resources. The increase in photosynthesis resulted in greater sucrose production. The MT treatments increased the activities of enzymes related to sucrose metabolism, so that a large amount of sucrose was hydrolysed into glucose and fructose to meet the rapid growth requirements of grape seedlings. The increased total soluble sugars contents and increased activities of antioxidant enzymes resulted in greater resistance of grape seedlings, and greater adaptability to environmental changes. In general, MT treatments had beneficial effects on grape seedling growth, glucose metabolism, and resistance. Under these conditions, foliar spraying with MT at 150 mu mol/L had the best effects.	[Zhong, Lisha; Yang, Liu; Liao, Ming'an] Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China; [Lin, Lijin; Wang, Xun; Wang, Jin; Lv, Xiulan; Deng, Honghong; Liang, Dong; Xia, Hui; Tang, Yi] Sichuan Agr Univ, Inst Pomol & Olericulture, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Sichuan Agricultural University	Liao, MA (corresponding author), Sichuan Agr Univ, Coll Hort, Chengdu, Sichuan, Peoples R China.	lman@sicau.edu.cn						ARAI M, 1991, PLANT CELL PHYSIOL, V32, P1291; Arnao MB, 2009, J PINEAL RES, V46, P58, DOI 10.1111/j.1600-079X.2008.00625.x; Arnao MB, 2007, J PINEAL RES, V42, P147, DOI 10.1111/j.1600-079X.2006.00396.x; Arnao MB, 2014, ADV IN BOT; Byeon Y, 2014, J PINEAL RES, V56, P408, DOI 10.1111/jpi.12129; Chen Q, 2009, J PLANT PHYSIOL, V166, P324, DOI 10.1016/j.jplph.2008.06.002; DUBBELS R, 1995, J PINEAL RES, V18, P28, DOI 10.1111/j.1600-079X.1995.tb00136.x; Galano A, 2011, J PINEAL RES, V51, P1, DOI 10.1111/j.1600-079X.2011.00916.x; Gao H, 2016, POSTHARVEST BIOL TEC, V118, P103, DOI 10.1016/j.postharvbio.2016.03.006; Gao Qing-hai, 2016, Yingyong Shengtai Xuebao, V27, P519; Gao ZF, 1999, PHYSIOL PLANTARUM, V106, P1, DOI 10.1034/j.1399-3054.1999.106101.x; Gong RongGao, 2004, Acta Horticulturae Sinica, V31, P719; Hao Z.B., 2004, PLANT PHYSL EXPT; Hernandez-Ruiz J, 2005, J PINEAL RES, V39, P137, DOI 10.1111/j.1600-079X.2005.00226.x; Hernandez-Ruiz J, 2004, PLANTA, V220, P140, DOI 10.1007/s00425-004-1317-3; Hirano K, 1996, AM SOC HORT SCI, V121, P466; [黄佳璟 Huang Jiajing], 2017, [四川农业大学学报, Journal of Sichuan Agricultural University], V35, P375; Kang K, 2010, J PINEAL RES, V49, P176, DOI 10.1111/j.1600-079X.2010.00783.x; KLIEWER W. M., 1965, AMER J ENOL VITICULT, V16, P101; Kolar J, 2003, PHYSIOL PLANTARUM, V118, P605, DOI 10.1034/j.1399-3054.2003.00114.x; Kubo T, 2001, SCI HORTIC-AMSTERDAM, V91, P215, DOI 10.1016/S0304-4238(01)00262-X; LERNER AB, 1958, J AM CHEM SOC, V80, P2587, DOI 10.1021/ja01543a060; Li HY, 2019, ENVIRON SCI POLLUT R, V26, P33228, DOI 10.1007/s11356-019-06498-9; Li X., 2009, PLANT PHYSL EXPT GUI, V4th; Li ZY, 2022, INT J ENVIRON AN CH, V102, P771, DOI 10.1080/03067319.2020.1726336; Liang CZ, 2015, J PINEAL RES, V59, P91, DOI 10.1111/jpi.12243; Lin LJ, 2020, ENVIRON SCI POLLUT R, V27, P7120, DOI 10.1007/s11356-019-07446-3; Liu N, 2015, SCI HORTIC-AMSTERDAM, V181, P18, DOI 10.1016/j.scienta.2014.10.049; [刘自力 Liu Zili], 2018, [植物生理学报, Plant Physiology Journal], V54, P660; LOWELL CA, 1989, PLANT PHYSIOL, V90, P1394, DOI 10.1104/pp.90.4.1394; Lu CaiYu, 2011, Acta Horticulturae Sinica, V38, P825; Lu H.Q., 2005, CHIN AGR SCI B, V21, P34; Lu QH, 2005, CHIN AGR SCI B, V21, P57; Meng JF, 2015, FOOD CHEM, V185, P127, DOI 10.1016/j.foodchem.2015.03.140; Meng JF, 2014, J PINEAL RES, V57, P200, DOI 10.1111/jpi.12159; Murch SJ, 2000, PLANT CELL REP, V19, P698, DOI 10.1007/s002990000206; Nawaz MA, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01230; Nawaz MA, 2018, J PLANT PHYSIOL, V220, P115, DOI 10.1016/j.jplph.2017.11.003; [潘红艳 Pan Hongyan], 2013, [西北大学学报. 自然科学版, Journal of Northwest University. Natural Science Edition], V43, P238; Patrick JW, 2013, PLANT BIOTECHNOL J, V11, P142, DOI 10.1111/pbi.12002; Pelagio-Flores R, 2012, J PINEAL RES, V53, P279, DOI 10.1111/j.1600-079X.2012.00996.x; Ramakrishna A, 2009, PLANT SIGNAL BEHAV, V4, P1136; Reiter RJ, 1997, ANN NY ACAD SCI, V825, P70, DOI 10.1111/j.1749-6632.1997.tb48415.x; Reiter RJ, 2002, ANN NY ACAD SCI, V957, P341, DOI 10.1111/j.1749-6632.2002.tb02938.x; Reiter RJ, 2007, ACTA BIOCHIM POL, V54, P1; Shi HT, 2015, J PINEAL RES, V58, P335, DOI 10.1111/jpi.12219; Shi HT, 2015, J PINEAL RES, V58, P26, DOI 10.1111/jpi.12188; Swarup R, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00225; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tan DX, 2000, FREE RADICAL BIO MED, V29, P1177, DOI 10.1016/S0891-5849(00)00435-4; Wang P, 2012, J PINEAL RES, V53, P11, DOI 10.1111/j.1600-079X.2011.00966.x; Wang QN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01882; Weeda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093462; Wei W, 2015, J EXP BOT, V66, P695, DOI 10.1093/jxb/eru392; Wen D, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00718; Xi LJ, 2019, NO HORTIC, V43, P7; Xia H, 2020, INT J PHYTOREMEDIAT, V22, P62, DOI 10.1080/15226514.2019.1644287; [许丽丽 Xu Lili], 2017, [植物生理学报, Plant Physiology Journal], V53, P2181; [徐利伟 Xu Liwei], 2017, [核农学报, Journal of Nuclear Agricultural Sciences], V31, P1963; [徐向东 Xu Xiangdong], 2011, [核农学报, Acta Agriculturae Nucleatae Sinica], V25, P179; Zhang Y., 2011, PHYS CHEM ANAL TUTOR; [张懿 Zhang Yi], 2015, [植物学报, Chinese Bulletin of Botany], V50, P107; Zhao SF, 2003, THESIS; Zhao ZhiZhong, 2001, Acta Horticulturae Sinica, V28, P112; Zhu SM, 2017, J SCI FOOD AGR, V97, P4094, DOI 10.1002/jsfa.8276; Zuo BX, 2014, J PINEAL RES, V57, P408, DOI 10.1111/jpi.12180	66	15	15	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232033	10.1371/journal.pone.0232033	http://dx.doi.org/10.1371/journal.pone.0232033			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324780	gold, Green Published			2022-12-26	WOS:000536033700063
J	Manenzhe, RI; Dube, FS; Wright, M; Lennard, K; Zar, HJ; Mounaud, S; Nierman, WC; Nicol, MP; Moodley, C				Manenzhe, Rendani I.; Dube, Felix S.; Wright, Meredith; Lennard, Katie; Zar, Heather J.; Mounaud, Stephanie; Nierman, William C.; Nicol, Mark P.; Moodley, Clinton			Longitudinal changes in the nasopharyngeal resistome of South African infants using shotgun metagenomic sequencing	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE GENES; D BETA-LACTAMASE; ANTIMICROBIAL RESISTANCE; CHILDREN; COLONIZATION; DETERMINANTS; FLORA	Introduction Nasopharyngeal (NP) colonization with antimicrobial-resistant bacteria is a global public health concern. Antimicrobial-resistance (AMR) genes carried by the resident NP microbiota may serve as a reservoir for transfer of resistance elements to opportunistic pathogens. Little is known about the NP antibiotic resistome. This study longitudinally investigated the composition of the NP antibiotic resistome in Streptococcus-enriched samples in a South African birth cohort. Methods As a proof of concept study, 196 longitudinal NP samples were retrieved from a subset of 23 infants enrolled as part of broader birth cohort study. These were selected on the basis of changes in serotype and antibiogram over time. NP samples underwent short-term enrichment for streptococci prior to total nucleic acid extraction and whole metagenome shotgun sequencing (WMGS). Reads were assembled and aligned to pneumococcal reference genomes for the extraction of streptococcal and non-streptococcal bacterial reads. Contigs were aligned to the Antibiotic Resistance Gene-ANNOTation database of acquired AMR genes. Results AMR genes were detected in 64% (125/196) of the samples. A total of 329 AMR genes were detected, including 36 non-redundant genes, ranging from 1 to 14 genes per sample. The predominant AMR genes detected encoded resistance mechanisms to beta-lactam (52%, 172/329), macrolide-lincosamide-streptogramin (17%, 56/329), and tetracycline antibiotics 12%, 38/329). MsrD, ermB, and mefA genes were only detected from streptococcal reads. The predominant genes detected from non-streptococcal reads included bla(OXA-60), bla(OXA-22), and bla(BRO-1). Different patterns of carriage of AMR genes were observed, with only one infant having a stable carriage of mefA, msrD and tetM over a long period. Conclusion This study demonstrates that WMGS can provide a broad snapshot of the NP resistome and has the potential to provide a comprehensive assessment of resistance elements present in this niche.	[Manenzhe, Rendani I.; Dube, Felix S.; Nicol, Mark P.; Moodley, Clinton] Univ Cape Town, Div Med Microbiol, Fac Hlth Sci, Cape Town, South Africa; [Dube, Felix S.] Univ Cape Town, Dept Mol & Cell Biol, Fac Sci, Cape Town, South Africa; [Wright, Meredith; Mounaud, Stephanie; Nierman, William C.] J Craig Venter Inst, Rockville, MD USA; [Lennard, Katie] Univ Cape Town, Div Computat Biol, Fac Hlth Sci, Cape Town, South Africa; [Zar, Heather J.] Univ Cape Town, Red Cross War Mem Childrens Hosp, Dept Paediat & Child Hlth, Cape Town, South Africa; [Zar, Heather J.] Univ Cape Town, MRC Unit Child & Adolescent Hlth, Cape Town, South Africa; [Nicol, Mark P.] Univ Western Australia, Div Infect & Immun, Perth, WA, Australia; [Moodley, Clinton] Groote Schuur Hosp, Natl Hlth Lab Serv, Cape Town, South Africa	University of Cape Town; University of Cape Town; J. Craig Venter Institute; University of Cape Town; University of Cape Town; University of Cape Town; University of Western Australia; University of Cape Town	Manenzhe, RI (corresponding author), Univ Cape Town, Div Med Microbiol, Fac Hlth Sci, Cape Town, South Africa.	manenzhe.r.i@gmail.com	Zar, Heather/GZL-5350-2022; Mashiya, Nombeko Monica/AET-3950-2022; Nicol, Mark/J-4987-2014	Zar, Heather/0000-0002-9046-759X; Mounaud, Stephanie/0000-0003-3618-1539; Moodley, Clinton/0000-0001-7547-9026; Manenzhe, Rendani Innocent/0000-0003-1384-4336; Mashiya, Nombeko Monica/0000-0003-0124-9118; Nicol, Mark/0000-0002-1366-4805	Bill and Melinda Gates Foundation Global Health Grant [OPP1017641]; H3Africa through the Office of Strategic Coordination/Office of the NIH Director, National Institute of Environmental Health Sciences; National Research Foundation of South Africa Thuthuka Grant [UID107410]; Pfizer Investigator Initiated Award [WI208622]; National Research Foundation of South Africa [UID95257, UID111570, UID99696]; FIDSSA-GlaxoSmithKline Research Fellowships; University of Cape Town Faculty Research Committee (FRC) Postgraduate Publication Incentive; SAMRC; National Human Genome Institute of Health of the National Institutes of Health [U54HG009824, 1U01HG006961]	Bill and Melinda Gates Foundation Global Health Grant; H3Africa through the Office of Strategic Coordination/Office of the NIH Director, National Institute of Environmental Health Sciences; National Research Foundation of South Africa Thuthuka Grant; Pfizer Investigator Initiated Award; National Research Foundation of South Africa(National Research Foundation - South Africa); FIDSSA-GlaxoSmithKline Research Fellowships; University of Cape Town Faculty Research Committee (FRC) Postgraduate Publication Incentive; SAMRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Human Genome Institute of Health of the National Institutes of Health	This work was funded by grants from the Bill and Melinda Gates Foundation Global Health Grant (OPP1017641), H3Africa funded through the Office of Strategic Coordination/Office of the NIH Director, National Institute of Environmental Health Sciences and National Human Genome Institute of Health of the National Institutes of Health under Award Number U54HG009824 and 1U01HG006961, National Research Foundation of South Africa Thuthuka Grant (UID107410), and by a Pfizer Investigator Initiated Award (WI208622). RIM is supported by the National Research Foundation of South Africa (UID95257 and UID111570). F.S.D (UID99696) is supported by the National Research Foundation of South Africa, FIDSSA-GlaxoSmithKline Research Fellowships and received funding from the University of Cape Town Faculty Research Committee (FRC) Postgraduate Publication Incentive; HJZ is supported by the SAMRC.	Aminov RI, 2007, FEMS MICROBIOL LETT, V271, P147, DOI 10.1111/j.1574-6968.2007.00757.x; BERMAN S, 1991, REV INFECT DIS, V13, pS454; Brook I, 2004, J ANTIMICROB CHEMOTH, V53, P399, DOI 10.1093/jac/dkh061; Buelow E, 2014, J ANTIMICROB CHEMOTH, V69, P2215, DOI 10.1093/jac/dku092; Carlet J, 2012, ANTIMICROB RESIST IN, V1, DOI 10.1186/2047-2994-1-11; CLEWELL DB, 1995, TRENDS MICROBIOL, V3, P229, DOI 10.1016/S0966-842X(00)88930-1; Daxboeck F, 2005, J MED MICROBIOL, V54, P55, DOI 10.1099/jmm.0.45656-0; de Lencastre H, 2002, J ANTIMICROB CHEMOTH, V50, P75, DOI 10.1093/jac/dkf511; Dube FS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30345-5; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; FADEN H, 1990, PEDIATR INFECT DIS J, V9, P623; Forslund K, 2014, BIOESSAYS, V36, P316, DOI 10.1002/bies.201300143; Garcia-Rodriguez JA, 2002, J ANTIMICROB CHEMOTH, V50, P59, DOI 10.1093/jac/dkf506; Girlich D, 2004, ANTIMICROB AGENTS CH, V48, P4217, DOI 10.1128/AAC.48.11.4217-4225.2004; Girlich D, 2006, MICROBIOL-SGM, V152, P2661, DOI 10.1099/mic.0.29027-0; Girlich D, 2009, FEMS MICROBIOL LETT, V301, P50, DOI 10.1111/j.1574-6968.2009.01796.x; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Hu YF, 2014, GUT MICROBES, V5, P245, DOI 10.4161/gmic.27916; Jalali S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128711; Khan MA, 2010, J ANTIMICROB CHEMOTH, V65, P91, DOI 10.1093/jac/dkp401; Kristiansson E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017038; Leiberman A, 1999, INT J PEDIATR OTORHI, V49, pS151; Levy SB, 2002, J ANTIMICROB CHEMOTH, V49, P25, DOI 10.1093/jac/49.1.25; Li GL, 2016, INFECT IMMUN, V84, P1887, DOI 10.1128/IAI.00097-16; Lima ABM, 2010, BRAZ J MICROBIOL, V41, P24, DOI 10.1590/S1517-83822010000100005; Lingling Wang ZY, 2012, ANTIBIOTIC RESISTANT, P369; Manenzhe RI, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00610; McDougal LK, 1998, ANTIMICROB AGENTS CH, V42, P2312, DOI 10.1128/AAC.42.9.2312; NEYFAKH AA, 1993, ANTIMICROB AGENTS CH, V37, P128, DOI 10.1128/AAC.37.1.128; Nordmann P, 2000, ANTIMICROB AGENTS CH, V44, P2201, DOI 10.1128/AAC.44.8.2201-2204.2000; Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Poyart C, 2003, ANTIMICROB AGENTS CH, V47, P794, DOI 10.1128/AAC.47.2.794-797.2003; Reinert RR, 2009, CLIN MICROBIOL INFEC, V15, P7, DOI 10.1111/j.1469-0691.2009.02724.x; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; SAZAWAL S, 1992, LANCET, V340, P528, DOI 10.1016/0140-6736(92)91720-S; Schmitz Franz-Josef, 1999, Clin Microbiol Infect, V5, P287, DOI 10.1111/j.1469-0691.1999.tb00143.x; Suzuki M, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00405-15; Tantivitayakul P, 2016, INDIAN J MICROBIOL, V56, P417, DOI 10.1007/s12088-016-0607-3; van Schaik W, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0087; Wolf B, 2001, Int J Infect Dis, V5, P155, DOI 10.1016/S1201-9712(01)90091-8; Wright MS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01661; Xu XP, 2010, ANTIMICROB AGENTS CH, V54, P1152, DOI 10.1128/AAC.01268-09; Yang Y, 2013, ENVIRON SCI TECHNOL, V47, P10197, DOI 10.1021/es4017365; Zar HJ, 2015, THORAX, V70, P592, DOI 10.1136/thoraxjnl-2014-206242	45	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231887	10.1371/journal.pone.0231887	http://dx.doi.org/10.1371/journal.pone.0231887			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320455	Green Published, gold			2022-12-26	WOS:000536028800038
J	Fan, XL; Xu, ZB; Wang, F; Feng, B; Zhou, Q; Cao, J; Ji, GS; Yu, Q; Liu, XF; Liao, SM; Wang, T				Fan, Xiaoli; Xu, Zhibin; Wang, Fang; Feng, Bo; Zhou, Qiang; Cao, Jun; Ji, Guangsi; Yu, Qin; Liu, Xiaofeng; Liao, Simin; Wang, Tao			Identification of colored wheat genotypes with suitable quality and yield traits in response to low nitrogen input	PLOS ONE			English	Article							ANTHOCYANIN SYNTHESIS; ANTIOXIDANT ACTIVITY; PIGMENTED WHEAT; WINTER-WHEAT; KERNEL SIZE; PURPLE; BIOSYNTHESIS; ARABIDOPSIS; EXPRESSION; MANAGEMENT	Colored wheat is a valuable resource that is rich in anthocyanins and minerals and thus contributes additional nutritional value to a healthy human diet. However, the effects of nitrogen fertilization on anthocyanin content (AC) and the balance between quality and yield still merit discussion. In this study, blue, purple, and common-colored wheat genotypes were used to investigate three nutrient quality traits, seven processing quality traits, three yield traits and seven grain morphology traits at three nitrogen levels in two years to excavate their possible plasticity under low-nitrogen stress and the tradeoffs among these traits. The highest AC was found in the blue genotypes followed by the purple genotypes. Analysis of variance (ANOVA) showed that AC could be significantly increased by reducing N application, especially in the purple genotypes. Therefore, growing colored wheat with low nitrogen input could allow efficient harvesting of grain with higher AC. However, the other nutrient quality traits and most processing quality traits were observed to decrease under low-nitrogen (LN) stress. Additionally, a correlation analysis indicated that the nutrient quality traits had stable tradeoffs with thousand kernel weight at all N levels because of the significantly negative correlations among them. Therefore, the additive main effect and multiplicative interaction (AMMI) model was used to further identify the most suitable colored genotypes with the best yield potential and also nutrient quality relative characteristics under LN stress. The blue lines Lanmai2999 and purple varieties Zhongkezinuomai 168 were found to be specifically adapted to LN stress with the highest AC values and showed stable performance in the other nutrient quality-and yield-related features. To further investigate the possible mechanism of anthocyanin accumulation in response to reduced N application, the expression of four genes (TaCHS, TaFDR, TaCHI and TaANS) involved in the anthocyanin synthesis pathway was evaluated. All four genes were downregulated under high nitrogen fertilizer application, indicating that anthocyanin synthesis in colored wheat might be inhibited by nitrogen fertilizer. Therefore, this research provided information for optimizing nitrogen fertilizer management in producing colored wheat and also demonstrated that it is efficient and economical to plant colored wheat genotypes in nitrogen-poor areas for use in a healthy human diet, improving the benefits of wheat planting and facilitating nitrogen pollution control.	[Fan, Xiaoli; Xu, Zhibin; Feng, Bo; Zhou, Qiang; Cao, Jun; Ji, Guangsi; Yu, Qin; Liu, Xiaofeng; Liao, Simin; Wang, Tao] Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China; [Wang, Fang] Chinese Acad Agr Sci, Inst Urban Agr, Chengdu, Peoples R China; [Cao, Jun; Ji, Guangsi; Yu, Qin; Liu, Xiaofeng; Liao, Simin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Tao] Chinese Acad Sci, Innovat Acad Seed Design, Beijing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Chinese Academy of Agricultural Sciences; Institute of Urban Agriculture, CAAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Xu, ZB; Wang, T (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Chengdu, Peoples R China.; Wang, T (corresponding author), Chinese Acad Sci, Innovat Acad Seed Design, Beijing, Peoples R China.	xuzb@cib.ac.cn; wangtao@cib.ac.cn		Fan, Xiaoli/0000-0003-1095-8805	National Natural Science Foundation of China [31971934]; Agricultural Science and Technology Achievements Transformation Funds Project of Sichuan Province [2018NZZJ005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Agricultural Science and Technology Achievements Transformation Funds Project of Sichuan Province	This work is supported by the National Natural Science Foundation of China (31971934) and the Agricultural Science and Technology Achievements Transformation Funds Project of Sichuan Province (2018NZZJ005).	Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Abdel-Aal ESM, 2018, FOOD CHEM, V254, P13, DOI 10.1016/j.foodchem.2018.01.170; Abdel-Aal EM, 2013, J CEREAL SCI, V57, P312, DOI 10.1016/j.jcs.2012.12.001; Battenfield SD, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2016.01.0005; Boehm DJ, 2004, CEREAL CHEM, V81, P51, DOI 10.1094/CCHEM.2004.81.1.51; Cui F, 2016, THEOR APPL GENET, V129, P469, DOI 10.1007/s00122-015-2641-7; Dholakia BB, 2003, PLANT BREEDING, V122, P392, DOI 10.1046/j.1439-0523.2003.00896.x; Diacono M, 2013, AGRON SUSTAIN DEV, V33, P219, DOI 10.1007/s13593-012-0111-z; Giordano D, 2017, FOOD CHEM, V233, P483, DOI 10.1016/j.foodchem.2017.04.065; Guzman C, 2016, APPL TRANSL GENOM, V11, P3, DOI 10.1016/j.atg.2016.10.004; Hawkesford MJ, 2014, J CEREAL SCI, V59, P276, DOI 10.1016/j.jcs.2013.12.001; Hosseinian FS, 2008, FOOD CHEM, V109, P916, DOI 10.1016/j.foodchem.2007.12.083; Hurkman WJ, 2007, J CHROMATOGR B, V849, P344, DOI 10.1016/j.jchromb.2006.11.047; Jezek M, 2018, J AGR FOOD CHEM, V66, P753, DOI 10.1021/acs.jafc.7b03813; Kahkonen MP, 2003, J AGR FOOD CHEM, V51, P628, DOI 10.1021/jf025551i; Kim MJ, 2007, J AGR FOOD CHEM, V55, P4802, DOI 10.1021/jf0701943; Knievel DC, 2009, J CEREAL SCI, V50, P113, DOI 10.1016/j.jcs.2009.03.007; Kong LA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43363; Kunert A, 2007, THEOR APPL GENET, V115, P683, DOI 10.1007/s00122-007-0600-7; Landi M, 2015, ENVIRON EXP BOT, V119, P4, DOI 10.1016/j.envexpbot.2015.05.012; Li XL, 2018, PLANT PHYSIOL BIOCH, V130, P235, DOI 10.1016/j.plaphy.2018.07.011; Liu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155428; Liu MS, 2005, J INTEGR PLANT BIOL, V47, P1107, DOI 10.1111/j.1744-7909.2005.00148.x; Mahjourimajd S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159374; Paznocht L, 2018, FOOD CHEM, V240, P670, DOI 10.1016/j.foodchem.2017.07.151; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Petroni K, 2014, PLANTA, V240, P901, DOI 10.1007/s00425-014-2131-1; Petroni K, 2011, PLANT SCI, V181, P219, DOI 10.1016/j.plantsci.2011.05.009; Putta S, 2018, CURR MED CHEM, V25, P5347, DOI 10.2174/0929867325666171206101945; Rubin G, 2009, PLANT CELL, V21, P3567, DOI 10.1105/tpc.109.067041; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Sharma S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194367; Shewry PR, 2015, FOOD ENERGY SECUR, V4, P178, DOI 10.1002/fes3.64; Souza EJ, 2004, CROP SCI, V44, P425, DOI 10.2135/cropsci2004.0425; Springob K, 2003, NAT PROD REP, V20, P288, DOI 10.1039/b109542k; Suprayogi Y, 2009, THEOR APPL GENET, V119, P437, DOI 10.1007/s00122-009-1050-1; Trojan V, 2014, J CEREAL SCI, V59, P48, DOI 10.1016/j.jcs.2013.10.008; Tsuda T, 2012, MOL NUTR FOOD RES, V56, P159, DOI 10.1002/mnfr.201100526; Wang F, 2019, J AGR FOOD CHEM, V67, P563, DOI 10.1021/acs.jafc.8b05104; Wang HC, 2011, HORTSCIENCE, V46, P1116, DOI 10.21273/HORTSCI.46.8.1116; Welch CR, 2008, CURR ANAL CHEM, V4, P75, DOI 10.2174/157341108784587795; Zanetti S, 2001, PLANT BREEDING, V120, P13, DOI 10.1046/j.1439-0523.2001.00552.x; Zecevic V, 2010, CEREAL RES COMMUN, V38, P243, DOI 10.1556/CRC.38.2010.2.10	43	5	6	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0229535	10.1371/journal.pone.0229535	http://dx.doi.org/10.1371/journal.pone.0229535			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315299	Green Published, gold			2022-12-26	WOS:000536024800003
J	Swathy, R; Vinayagasundaram, B; Rajesh, G; Nayyar, A; Abouhawwash, M; Abu Elsoud, M				Swathy, R.; Vinayagasundaram, B.; Rajesh, G.; Nayyar, Anand; Abouhawwash, Mohamed; Abu Elsoud, Mohamed			Game theoretical approach for load balancing using SGMLB model in cloud environment	PLOS ONE			English	Article								On-demand cloud computing is one of the rapidly evolving technologies that is being widely used in the industries now. With the increase in IoT devices and real-time business analytics requirements, enterprises that ought to scale up and scale down their services have started coming towards on-demand cloud computing service providers. In a cloud data center, a high volume of continuous incoming task requests to physical hosts makes an imbalance in the cloud data center load. Most existing works balance the load by optimizing the algorithm in selecting the optimal host and achieves instantaneous load balancing but with execution inefficiency for tasks when carried out in the long run. Considering the long-term perspective of load balancing, the research paper proposes Stackelberg (leader-follower) game-theoretical model reinforced with the satisfaction factor for selecting the optimal physical host for deploying the tasks arriving at the data center in a balanced way. Stackelberg Game Theoretical Model for Load Balancing (SGMLB) algorithm deploys the tasks on the host in the data center by considering the utilization factor of every individual host, which helps in achieving high resource utilization on an average of 60%. Experimental results show that the Stackelberg equilibrium incorporated with a satisfaction index has been very useful in balancing the loading across the cluster by choosing the optimal hosts. The results show better execution efficiency in terms of the reduced number of task failures by 47%, decreased 'makespan' value by 17%, increased throughput by 6%, and a decreased front-end error rate as compared to the traditional random allocation algorithms and flow-shop scheduling algorithm.	[Swathy, R.; Vinayagasundaram, B.] Anna Univ, Comp Ctr, MIT Campus, Chennai, Tamil Nadu, India; [Rajesh, G.] Anna Univ, Dept Informat Technol, MIT Campus, Chennai, Tamil Nadu, India; [Nayyar, Anand] Duy Tan Univ, Grad Sch, Da Nang, Vietnam; [Abouhawwash, Mohamed] Mansoura Univ, Dept Math, Fac Sci, Mansoura, Egypt; [Abouhawwash, Mohamed] Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA; [Abu Elsoud, Mohamed] Mansoura Univ, Fac Comp & Informat, Comp Sci Dept, Mansoura, Egypt; [Abu Elsoud, Mohamed] Univ Tabuk, Comp Sci Dept, Tabuk, Saudi Arabia	Anna University; Anna University Chennai; Anna University; Anna University Chennai; Duy Tan University; Egyptian Knowledge Bank (EKB); Mansoura University; Michigan State University; Egyptian Knowledge Bank (EKB); Mansoura University; University of Tabuk	Abouhawwash, M (corresponding author), Mansoura Univ, Dept Math, Fac Sci, Mansoura, Egypt.; Abouhawwash, M (corresponding author), Michigan State Univ, Dept Elect & Comp Engn, E Lansing, MI 48824 USA.	abouhaww@msu.edu	Nayyar, Anand/F-3732-2015; Ganesan, Rajesh/W-9696-2019; Abouhawwash, Mohamed/O-7122-2018	Nayyar, Anand/0000-0002-9821-6146; Ganesan, Rajesh/0000-0002-6927-9578; Abouhawwash, Mohamed/0000-0003-2846-4707				Aslam S, 2015, 2015 NATIONAL SOFTWARE ENGINEERING CONFERENCE (NSEC), P30, DOI 10.1109/NSEC.2015.7396341; Calheiros RN, 2011, SOFTWARE PRACT EXPER, V41, P23, DOI 10.1002/spe.995; DASPREMONT C, 1980, J ECON THEORY, V23, P201, DOI 10.1016/0022-0531(80)90006-X; Deep G, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19204444; Farrag AAS, 2015, 2015 IEEE SEVENTH INTERNATIONAL CONFERENCE ON INTELLIGENT COMPUTING AND INFORMATION SYSTEMS (ICICIS), P210, DOI 10.1109/IntelCIS.2015.7397223; Fernandez-Cerero D, 2018, 32ND EUROPEAN CONFERENCE ON MODELLING AND SIMULATION (ECMS 2018), P460; Garg SK, 2013, FUTURE GENER COMP SY, V29, P1012, DOI 10.1016/j.future.2012.06.006; Kaur A, 2019, SCALABLE COMPUT-PRAC, V20, P377, DOI 10.12694/scpe.v20i2.1530; Kuo IH, 2009, EXPERT SYST APPL, V36, P7027, DOI 10.1016/j.eswa.2008.08.054; Linlin Wu, 2011, 2011 Proceedings of 11th IEEE/ACM International Symposium on Cluster, Cloud and Grid Computing (CCGrid 2011), P195, DOI 10.1109/CCGrid.2011.51; Mazrekaj A, 2016, INT J ADV COMPUT SC, V7, P80; Nan G., 2013, IEEE SYSTEMS J, V8, P256; Nayyar A., 2019, HDB CLOUD COMPUTING; Duong ND, 2016, IEEE T VEH TECHNOL, V65, P2341, DOI 10.1109/TVT.2015.2418297; Patel S, 2017, INT J RAPID RES ENG, V3; Rastogi G, 2015, 2015 INTERNATIONAL CONFERENCE ON GREEN COMPUTING AND INTERNET OF THINGS (ICGCIOT), P1506, DOI 10.1109/ICGCIoT.2015.7380705; Remesh Babu K. R., 2016, INNOVATIONS BIOINSPI, P67; Roughgarden T, 2004, SIAM J COMPUT, V33, P332, DOI 10.1137/S0097539701397059; Santra S., 2015, P 2015 INT C COMP CO, P1; Shah S. C., 2010, Journal of Applied Sciences, V10, P174, DOI 10.3923/jas.2010.174.181; Somula R, 2018, SCALABLE COMPUT-PRAC, V19, P39, DOI 10.12694/scpe.v19i1.1392; Song S., 2014, J APPL MATH, V2014; Sun Z., 2008, ARXIV08093285; Tang F., 2016, IEEE T CLOUD COMPUT, V6, P915; Tran NH, 2016, IEEE T SMART GRID, V7, P937, DOI 10.1109/TSG.2015.2421286; Tripathi R, 2017, J PARALLEL DISTR COM, V107, P76, DOI 10.1016/j.jpdc.2017.04.006; Wang H, 2016, IEEE T SMART GRID, V7, P1584, DOI 10.1109/TSG.2015.2501808; Wang X., 2015, IEEE COMMUNICATIONS, V20, P946; Wang Y, 2016, CHINA COMMUN, V13, P130, DOI 10.1109/CC.2016.7405731; Wooldridge M, 2012, IEEE INTELL SYST, V27, P76, DOI 10.1109/MIS.2012.108; Xiao Z, 2017, APPL SOFT COMPUT, V52, P376, DOI 10.1016/j.asoc.2016.10.028; Yu M, 2016, IEEE T SMART GRID, V7, P879, DOI 10.1109/TSG.2015.2413813; Zhang WZ, 2017, FUTURE GENER COMP SY, V76, P428, DOI 10.1016/j.future.2016.03.009; Zhao J, 2016, IEEE T PARALL DISTR, V27, P305, DOI 10.1109/TPDS.2015.2402655	34	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231708	10.1371/journal.pone.0231708	http://dx.doi.org/10.1371/journal.pone.0231708			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310989	Green Published, gold			2022-12-26	WOS:000536019800026
J	dos Santos, FAA; Monteiro, M; Pinto, A; Carvalho, CL; Peleteiro, MC; Carvalho, P; Mendonca, P; Carvalho, T; Duarte, MD				Abade dos Santos, F. A.; Monteiro, M.; Pinto, A.; Carvalho, C. L.; Peleteiro, M. C.; Carvalho, P.; Mendonca, P.; Carvalho, T.; Duarte, M. D.			First description of a herpesvirus infection in genus Lepus	PLOS ONE			English	Article							VIRUS; PCR	During the necropsies of Iberian hares obtained in 2018/2019, along with signs of the nodular form of myxomatosis, other unexpected external lesions were also observed. Histopathology revealed nuclear inclusion bodies in stromal cells suggesting the additional presence of a nuclear replicating virus. Transmission electron microscopy further demonstrated the presence of herpesvirus particles in the tissues of affected hares. We confirmed the presence of herpesvirus in 13 MYXV-positive hares by PCR and sequencing analysis. Herpesvirus-DNA was also detected in seven healthy hares, suggesting its asymptomatic circulation. Phylogenetic analysis based on concatenated partial sequences of DNA polymerase gene and glycoprotein B gene enabled greater resolution than analysing the sequences individually. The hare' virus was classified close to herpesviruses from rodents within the Rhadinovirus genus of the gammaherpesvirus subfamily. We propose to name this new virus Leporid gammaherpesvirus 5 (LeHV-5), according to the International Committee on Taxonomy of Viruses standards. The impact of herpesvirus infection on the reproduction and mortality of the Iberian hare is yet unknown but may aggravate the decline of wild populations caused by the recently emerged natural recombinant myxoma virus.	[Abade dos Santos, F. A.; Monteiro, M.; Carvalho, C. L.; Carvalho, P.; Mendonca, P.; Duarte, M. D.] Inst Nacl Invest Agr & Vet, Oeiras, Portugal; [Abade dos Santos, F. A.; Peleteiro, M. C.; Duarte, M. D.] Univ Lisbon, Fac Med Vet, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal; [Pinto, A.; Carvalho, T.] Univ Lisbon, Fac Med, Inst Med Mol Joao Lobo Antunes, Ave Prof Egas Moniz, Lisbon, Portugal; [Pinto, A.] Royal Brompton Hosp & Harefield NHS Fdn Trust, EM Suite, Lisbon, Portugal	Universidade de Lisboa; Instituto Superior de Ciencias da Saude Egas Moniz; Universidade de Lisboa	dos Santos, FAA (corresponding author), Inst Nacl Invest Agr & Vet, Oeiras, Portugal.; dos Santos, FAA (corresponding author), Univ Lisbon, Fac Med Vet, Ctr Interdisciplinary Res Anim Hlth CIISA, Lisbon, Portugal.	faas@fmv.ulisboa.pt	dos Santos, F.A. Abade/ADL-4092-2022; Carvalho, Tânia/GNM-6203-2022; Duarte, Margarida/J-2640-2013	dos Santos, F.A. Abade/0000-0002-0696-7322; Carvalho, Carina/0000-0002-6648-9254; D N Pinto, Andreia L/0000-0002-0840-6844; Duarte, Margarida/0000-0003-1488-9659	Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BD/137067/2018]; Fundo Florestal Permanente (Government of Portugal) [4757/2017]; Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon (CIISA, FMV-UL) (Portugal) [UID/CVT/00276/2013]	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Florestal Permanente (Government of Portugal); Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon (CIISA, FMV-UL) (Portugal)	Most of the field and laboratory work referred to in this manuscript was supported by the Fundacao para a Ciencia e Tecnologia (FCT) (Grant SFRH/BD/137067/2018), Fundo Florestal Permanente (Government of Portugal) in the scope of the Action Plan for the Control of Rabbit Viral Haemorrhagic Disease (+COELHO, Dispatch no. 4757/2017 of 31 May) and by the Centre for Interdisciplinary Research in Animal Health, Faculty of Veterinary Medicine, University of Lisbon (CIISA, FMV-UL) (Portugal) (Project UID/CVT/00276/2013). Funding bodies played no direct role in the design or conclusion of the study.	AKATSUKA K, 1986, MICROBIOL IMMUNOL, V30, P289, DOI 10.1111/j.1348-0421.1986.tb00945.x; Barlow A, 2014, VET REC, V175, DOI 10.1136/vr.g4621; Barthold SW, 2016, PATHOLOGY LAB RODENT, P258; Bocanegra IG, 2019, 1 OUTBREAK MYXOMATOS, P1, DOI [10.1111/tbed.13289, DOI 10.1111/TBED.13289]; Brash ML, 2010, CAN VET J, V51, P1383; Brown JC, 2011, CURR OPIN VIROL, V1, P142, DOI 10.1016/j.coviro.2011.06.003; COLLINS J. J., 1955, Irish Veterinary Journal, V9, P268; David M., 2013, FIELDS VIROLOGY; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; Devanter DRVAN, 1996, DETECTION ANAL DIVER, V34, P1666; Duarte MD, 2015, J VIROL METHODS, V219, P90, DOI 10.1016/j.jviromet.2015.03.017; Duarte MD, 2014, J VIROL METHODS, V196, P219, DOI 10.1016/j.jviromet.2013.11.014; Ehlers B, 2008, J VIROL, V82, P3509, DOI 10.1128/JVI.02646-07; FENNER F, 1965, MYXOMATOSIS; Fenner F., 1999, BIOL CONTROL VERTEBR; Graham L, 2007, NAT PROTOC, V2, P2439, DOI 10.1038/nprot.2007.304; Grinde B, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.22766; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HESSELTON RM, 1988, AM J PATHOL, V133, P639; HINZE HC, 1971, INFECT IMMUN, V3, P350, DOI 10.1128/IAI.3.2.350-354.1971; Hricova M, 2007, ACTA VIROL, V51, P283; Huff JL, 2003, EMERG INFECT DIS, V9, P246; Izumi Y, 2006, J VET MED SCI, V68, P189, DOI 10.1292/jvms.68.189; Jin L, 2008, VIROLOGY, V378, P13, DOI 10.1016/j.virol.2008.05.003; Kumar S, 2018, MOL BIOL EVOLUTION; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Marenzoni ML, 2015, VET MED-RES REP, V6, P91, DOI 10.2147/VMRR.S39473; Oie, 2018, MYXOMATOSIS; Palacios F., 1983, Acta Zoologica Fennica, P27; Roizman B, 2001, FIELDS VIROL, P2381; Saliki JT, 2006, J WILDLIFE DIS, V42, P142, DOI 10.7589/0090-3558-42.1.142; Soriguer R, 2019, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK, DOI 10.2305/IUCN.UK]; Spiesschaert B, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-76; Sunohara-Neilson JR, 2013, COMPARATIVE MED, V63, P422; Wibbelt G., 2014, INFECT DIS EUROPEAN, DOI [10.2461/wbp.2005.1.11, DOI 10.2461/WBP.2005.1.11]; Williams KJ, 2013, PLOS ONE, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0077754; Zygraich N, 1972, EXPT INFECT RABBITS, V13, P241	37	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231795	10.1371/journal.pone.0231795	http://dx.doi.org/10.1371/journal.pone.0231795			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302375	Green Submitted, Green Published, gold			2022-12-26	WOS:000536016100052
J	Benz, F; Bogen, A; Praktiknjo, M; Jansen, C; Meyer, C; Wree, A; Demir, M; Loosen, S; Vucur, M; Schierwagen, R; Tacke, F; Trebicka, J; Roderburg, C				Benz, Fabian; Bogen, Andreas; Praktiknjo, Michael; Jansen, Christian; Meyer, Carsten; Wree, Alexander; Demir, Muenevver; Loosen, Sven; Vucur, Mihael; Schierwagen, Robert; Tacke, Frank; Trebicka, Jonel; Roderburg, Christoph			Serum levels of bone sialoprotein correlate with portal pressure in patients with liver cirrhosis	PLOS ONE			English	Article							PLASMA OSTEOPONTIN LEVELS; PROGNOSTIC MARKER; DISEASE-ACTIVITY; METASTASIS; PROTEINS	Liver cirrhosis represents the common end-stage of chronic liver diseases regardless of its etiology. Patients with compensated disease are mostly asymptomatic, however, progression to a decompensated disease stage is common. The available stratification strategies are often unsuitable to identify patients with a higher risk for disease progression and a limited prognosis. SIBLINGs, soluble glycophosphoproteins, are secreted into the blood by immune-cells. While osteopontin, the most prominent member of the SIBLINGs family, has been repeatedly associated with liver cirrhosis, data on the diagnostic and/or prognostic value of bone sialoprotein (BSP) are scarce and partly inconclusive. In this study, we analyzed the diagnostic and prognostic potential of circulating BSP in comparison to other standard laboratory markers in a large cohort of patients with liver cirrhosis receiving transjugular intrahepatic portosystemic shunt (TIPS). Serum levels of BSP were similar in patients with different disease stages and were not indicative for prognosis. Interestingly, BSP serum levels did correlate inversely with portal pressure, as well as its surrogates such as platelet count, the portal vein cross-sectional area and correlated positively with the portal venous velocity. In summary, our data highlight that BSP might represent a previously unrecognized marker for portal hypertension in patients with liver cirrhosis.	[Benz, Fabian; Wree, Alexander; Demir, Muenevver; Tacke, Frank; Roderburg, Christoph] Charite Univ Med Berlin, Dept Gastroenterol Hepatol, Berlin, Germany; [Bogen, Andreas; Praktiknjo, Michael; Jansen, Christian] Univ Clin Bonn, Dept Internal Med 1, Bonn, Germany; [Meyer, Carsten] Univ Clin Bonn, Dept Radiol, Bonn, Germany; [Loosen, Sven; Vucur, Mihael] Univ Hosp RWTH Aachen, Dept Med 3, Aachen, Germany; [Schierwagen, Robert; Trebicka, Jonel] Univ Clin Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Trebicka, Jonel] European Fdn Study Chron Liver Failure EF CLIF, Barcelona, Spain; [Trebicka, Jonel] Inst Bioengn Catalonia, Barcelona, Spain; [Trebicka, Jonel] Odense Univ Hosp, Dept Gastroenterol & Hepatol, Odense, Denmark	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Bonn; University of Bonn; RWTH Aachen University; RWTH Aachen University Hospital; Barcelona Institute of Science & Technology; Institut de Bioenginyeria de Catalunya; University of Barcelona; University of Southern Denmark; Odense University Hospital	Benz, F (corresponding author), Charite Univ Med Berlin, Dept Gastroenterol Hepatol, Berlin, Germany.	fabian.benz@charite.de	Loosen, Sven/AHC-5236-2022; Roderburg, Christoph/AAR-3051-2021; Tacke, Frank/ABF-2212-2020; Schierwagen, Robert/AAE-6305-2019; Roderburg, Christoph/AHC-8101-2022	Loosen, Sven/0000-0002-2799-2287; Schierwagen, Robert/0000-0002-2195-3666; Roderburg, Christoph/0000-0002-1409-7697; Demir, Munevver/0000-0002-7050-797X; Wree, Alexander/0000-0002-2968-1335	Deutsche Forschungsgemeinschaft [SFB TRR57, CRC 1382]; European Union [668031, 825694]; Societal Challenges - Health, Demographic Change and Wellbeing [731875]; Cellex Foundation (PREDICT)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); Societal Challenges - Health, Demographic Change and Wellbeing; Cellex Foundation (PREDICT)(Foundation CELLEX)	JT is supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57 to P18; CRC 1382, A09), European Union's Horizon 2020 Research and Innovation Programme (Galaxy, No. 668031 and MICROB-PREDICT, No. 825694) and Societal Challenges - Health, Demographic Change and Wellbeing (No. 731875), and Cellex Foundation (PREDICT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; Berres ML, 2016, LIVER INT, V36, P386, DOI 10.1111/liv.12922; Berres ML, 2015, J HEPATOL, V62, P332, DOI 10.1016/j.jhep.2014.09.032; Bruha R, 2016, WORLD J GASTROENTERO, V22, P3441, DOI 10.3748/wjg.v22.i12.3441; Demirkan B, 2013, J CLIN MED, V2, P264, DOI 10.3390/jcm2040264; Dirchwolf M, 2016, CYTOKINE, V77, P14, DOI 10.1016/j.cyto.2015.10.006; European Assoc Study Liver, 2018, J HEPATOL, V69, P406, DOI 10.1016/j.jhep.2018.03.024; Kruger TE, 2014, CRIT REV ONCOL HEMAT, V89, P330, DOI 10.1016/j.critrevonc.2013.08.013; Lamort AS, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080815; Lamour V, 2013, M S-MED SCI, V29, P1018, DOI 10.1051/medsci/20132911019; Lehmann JM, 2018, LIVER INT, V38, P875, DOI 10.1111/liv.13610; Loosen SH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38352-2; Loosen SH, 2017, J HEPATOL, V67, P749, DOI 10.1016/j.jhep.2017.06.020; Luedde M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28201-7; Meersseman P, 2018, J HEPATOL, V69, P803, DOI 10.1016/j.jhep.2018.04.025; Mishima R, 2007, J CLIN GASTROENTEROL, V41, P167, DOI 10.1097/MCG.0b013e31802d6268; Pombeiro I, 2018, J CLIN MED, V7, DOI 10.3390/jcm7070175; Rittling SR, 2015, J DENT RES, V94, P1638, DOI 10.1177/0022034515605270; Roderburg C, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0988-4; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Saha B., 2019, HEPATOLOGY; Shimizu Y, 2013, J NEUROIMMUNOL, V263, P148, DOI 10.1016/j.jneuroim.2013.07.005; Wang K, 2014, HEPAT MON, V14, DOI 10.5812/hepatmon.19370; Wong CK, 2005, RHEUMATOLOGY, V44, P602, DOI 10.1093/rheumatology/keh558	24	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231701	10.1371/journal.pone.0231701	http://dx.doi.org/10.1371/journal.pone.0231701			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302330	Green Published, Green Submitted, gold			2022-12-26	WOS:000536016100044
J	Bustos, AS; Hakansson, A; Linares-Pasten, JA; Penarrieta, JM; Nilsson, L				Bustos, Atma-Sol; Hakansson, Andreas; Linares-Pasten, Javier A.; Penarrieta, J. Mauricio.; Nilsson, Lars			Interaction of quercetin and epigallocatechin gallate (EGCG) aggregates with pancreatic lipase under simplified intestinal conditions	PLOS ONE			English	Article							PHARMACOKINETICS; FLAVONOIDS; METABOLISM; INHIBITORS; MECHANISM; FOOD; TEA	Diets rich in flavonoids have been related with low obesity rates, which could be related with their potential to inhibit pancreatic lipase, the main enzyme of fat assimilation. Some flavonoids can aggregate in aqueous medium suggesting that the inhibition mechanism could occur on both molecular and colloidal levels. This study investigates the interaction of two flavonoid aggregates, quercetin and epigallocatechin gallate (EGCG), with pancreatic lipase under simplified intestinal conditions. The stability and the morphology of these flavonoid aggregates were studied in four different solutions: Control (water), salt, low lipase concentration and high lipase concentration. Particles were found by optical microscopy in almost all the solutions tested, except EGCG-control. The results show that the precipitation rate decreases for quercetin and increases for EGCG in salt solution and that lipase stabilize quercetin aggregates. In addition, both flavonoids were shown to precipitate together with pancreatic lipase resulting in a sequestering of the enzyme.	[Bustos, Atma-Sol; Hakansson, Andreas; Nilsson, Lars] Lund Univ, Fac Engn LTH, Food Technol, Lund, Sweden; [Bustos, Atma-Sol; Penarrieta, J. Mauricio.] Univ Mayor San Andres, Sch Chem, Fac Pure & Nat Sci, La Paz, Bolivia; [Linares-Pasten, Javier A.] Lund Univ, Fac Engn LTH, Biotechnol, Lund, Sweden	Lund University; Universidad Mayor de San Andres; Lund University	Bustos, AS (corresponding author), Lund Univ, Fac Engn LTH, Food Technol, Lund, Sweden.; Bustos, AS (corresponding author), Univ Mayor San Andres, Sch Chem, Fac Pure & Nat Sci, La Paz, Bolivia.	atma-sol.bustos@food.lth.se	Linares-Pastén, Javier/N-8450-2018; Peñarrieta, J. Mauricio/AAZ-1216-2020; Peñarrieta, Mauricio/ABB-4331-2021	Linares-Pastén, Javier/0000-0001-6999-6334; Peñarrieta, J. Mauricio/0000-0002-0958-3092; 	Swedish International Development Agency (SIDA) [75000553-02]	Swedish International Development Agency (SIDA)	A.B, M.P and L.N have received funding from Swedish International Development Agency (SIDA) [grant numbers 75000553-02] https://www.sida.se/English/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biosolutions L., 2018, LIP MO; Bustos AS, 2018, J FOOD SCI, V83, P2071, DOI 10.1111/1750-3841.14217; Chen X, 2005, PHARM RES-DORDR, V22, P892, DOI 10.1007/s11095-005-4584-1; de Castilho TS, 2018, FOOD SCI HUM WELL, V7, P215, DOI 10.1016/j.fshw.2018.08.001; Graefe EU, 2001, J CLIN PHARMACOL, V41, P492, DOI 10.1177/00912700122010366; Griffiths D W, 1986, Adv Exp Med Biol, V199, P509; Guerciolini R, 1997, INT J OBESITY, V21, pS12; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; Kasprzak MM, 2015, RSC ADV, V5, P45853, DOI 10.1039/c5ra05069c; Kourti T., 2006, ENCY ANAL CHEM; Le Nest G, 2004, INORG CHIM ACTA, V357, P775, DOI 10.1016/j.ica.2003.09.014; Lof D, 2011, J FOOD SCI, V76, pN35, DOI 10.1111/j.1750-3841.2011.02103.x; Lunagariya NA, 2014, EXCLI J, V13, P897; Martinez-Gonzalez AI, 2017, FOOD TECHNOL BIOTECH, V55, P519, DOI 10.17113/ftb.55.04.17.5138; MARTINEZGONZALEZ A, 2017, MOL BASEL SWITZERLAN, V22, DOI DOI 10.3390/MOLECULES22040669; McGovern SL, 2003, J MED CHEM, V46, P4265, DOI 10.1021/jm030266r; McGovern SL, 2002, J MED CHEM, V45, P1712, DOI 10.1021/jm010533y; Medina-Remon A, 2013, DATABASE, V2013; Minekus M, 2014, FOOD FUNCT, V5, P1113, DOI 10.1039/c3fo60702j; Nijveldt RJ, 2001, AM J CLIN NUTR, V74, P418; OLEFSKY J, 1974, J CLIN INVEST, V53, P64, DOI 10.1172/JCI107560; Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41; Pohjala L, 2012, MOLECULES, V17, P10774, DOI 10.3390/molecules170910774; Theisen A., 2000, REFRACTIVE INCREMENT; Vernarelli JA, 2017, NUTR DIABETES, V7, DOI 10.1038/nutd.2017.22; Wahlund K.-G., 2012, FIELD FLOW FRACTIONA, P1; Walle T, 2004, FREE RADICAL BIO MED, V36, P829, DOI 10.1016/j.freeradbiomed.2004.01.002; WHO, 2018, OBESITY OVERWEIGHT W; Wu XL, 2013, J AGR FOOD CHEM, V61, P8829, DOI 10.1021/jf401779z; Yao LH, 2004, PLANT FOOD HUM NUTR, V59, P113, DOI 10.1007/s11130-004-0049-7; Yuda N, 2012, J FOOD SCI, V77, pH254, DOI 10.1111/j.1750-3841.2012.02967.x; ZIMM BH, 1948, J CHEM PHYS, V16, P1093, DOI 10.1063/1.1746738	32	6	6	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0224853	10.1371/journal.pone.0224853	http://dx.doi.org/10.1371/journal.pone.0224853			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298262	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400001
J	Choi, JW; Park, JS; Lee, CH				Choi, Jong Wook; Park, Joon-Sung; Lee, Chang Hwa			Interactive effect of high sodium intake with increased serum triglycerides on hypertension	PLOS ONE			English	Article							URINARY SODIUM; BLOOD-PRESSURE; DIETARY-SODIUM; SALT; EXCRETION; ADULTS; RISK; HYPERTRIGLYCERIDEMIA; CONSEQUENCES; REDUCTION	Background A high salt diet is associated with the development of hypertension, one of the most important cardiovascular risk factors. A reduction in sodium intake seems to have an effect on increasing serum triglycerides (TGs). Elevated TGs are independently linked to cardiovascular risk. However, there is limited evidence of a possible interactive effect of sodium intake and serum TGs on high blood pressure (BP). Methods We conducted a nationwide, population-based interaction analysis using the Kawasaki method for estimating 24-h urinary sodium excretion (e24hUNaE(Kawasaki)) as a candidate indicator of dietary sodium intake. All native Koreans aged 20 years or older without significant medical illness were eligible for inclusion. Results A total of 16936 participants were divided into quintiles according to their e24hUNaE(Kawasaki) results. Participants in the highest quintile were more obese and hypertensive and had higher white blood cell count, lower hemoglobin, greater glycemic exposure, and poor lipid profiles compared to the same parameters of individuals in other quintiles. Linear regression revealed that e24UNaE(Kawasaki) was related to systolic BP, diastolic BP, and TGs. Multiple logistic regression, adjusted for dietary sodium intake and various conventional risk factors for chronic vascular diseases, showed that both e24UNaE(Kawasaki) and TGs were significant predictors of hypertension. Our interaction analysis demonstrated that increased sodium intake was associated with higher risk of hypertension in participants with elevated TGs than in those without (adjusted RERI = 0.022, 95% CI = 0.017-0.027; adjusted AP = 0.017, 95% CI = 0.006-0.028; adjusted SI = 1.010, 95% CI = 1.007-1.014). Conclusion Our findings suggest that the interaction between a high salt diet and elevated TGs may exert synergistic biological effects on the risk of hypertension.	[Choi, Jong Wook] Konkuk Univ, Sch Med, Res Inst Med Sci, Chungju, South Korea; [Park, Joon-Sung; Lee, Chang Hwa] Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Konkuk University; Konkuk University Medical Center; Hanyang University	Park, JS; Lee, CH (corresponding author), Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea.	sjpjoon@hanyang.ac.kr; changhwa@hanyang.ac.kr		Park, Joon-Sung/0000-0003-4740-3061				Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Boegehold MA, 2013, J VASC RES, V50, P458, DOI 10.1159/000355270; CAMPESE VM, 1982, KIDNEY INT, V21, P371, DOI 10.1038/ki.1982.32; Campino C, 2018, AM J HYPERTENS, V31, P1127, DOI 10.1093/ajh/hpy097; Cogswell ME, 2013, AM J CLIN NUTR, V98, P1502, DOI 10.3945/ajcn.113.059436; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Fan L, 2014, KIDNEY INT, V86, P582, DOI 10.1038/ki.2014.59; Farquhar WB, 2015, J AM COLL CARDIOL, V65, P1042, DOI 10.1016/j.jacc.2014.12.039; FERRARA LA, 1984, HYPERTENSION, V6, P755, DOI 10.1161/01.HYP.6.5.755; Flint AC, 2019, NEW ENGL J MED, V381, P243, DOI 10.1056/NEJMoa1803180; Gilbert K, 2013, J HYPERTENS, V31, P820, DOI 10.1097/HJH.0b013e32835e8227; Graudal NA, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004022.pub4; He F. J., 2013, BMJ, V346; He J, 2015, J ENG-JOE, P1, DOI [10.1681/ASN.2015010022, 10.1049/joe.2015.0102]; HIRANO T, 1994, METABOLISM, V43, P248, DOI 10.1016/0026-0495(94)90253-4; Hoffmann IS, 2009, NUTR METAB CARDIOVAS, V19, P123, DOI 10.1016/j.numecd.2008.02.011; Jablonski KL, 2013, J AM COLL CARDIOL, V61, P335, DOI 10.1016/j.jacc.2012.09.010; Kanbay M, 2011, CURR OPIN NEPHROL HY, V20, P37, DOI 10.1097/MNH.0b013e32834122f1; Kang Yoon Jung, 2016, Clin Nutr Res, V5, P290, DOI 10.7762/cnr.2016.5.4.290; Kim TJ, 2018, YONSEI MED J, V59, P356, DOI 10.3349/ymj.2018.59.3.356; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Knol MJ, 2011, EUR J EPIDEMIOL, V26, P433, DOI 10.1007/s10654-011-9554-9; Kunes J, 2009, PHYSIOL RES, V58, pS33, DOI 10.33549/physiolres.931913; Lee HY, 2019, CLIN HYPERTENS, V25, DOI 10.1186/s40885-019-0124-x; Lenda DM, 2000, AM J PHYSIOL-HEART C, V279, pH7, DOI 10.1152/ajpheart.2000.279.1.H7; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Mente A, 2016, LANCET, V388, P465, DOI 10.1016/S0140-6736(16)30467-6; Mills KT, 2016, JAMA-J AM MED ASSOC, V315, P2200, DOI 10.1001/jama.2016.4447; Nagata T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152306; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Oberleithner H, 2007, P NATL ACAD SCI USA, V104, P16281, DOI 10.1073/pnas.0707791104; Ogihara T, 2002, HYPERTENSION, V40, P83, DOI 10.1161/01.HYP.0000022880.45113.C9; Oh J, 2014, J KOREAN MED SCI, V29, pS109, DOI 10.3346/jkms.2014.29.S2.S109; Oh SW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188770; Peng YG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149655; Pfister R, 2014, EUR J HEART FAIL, V16, P394, DOI 10.1002/ejhf.56; Rossier BC, 2002, ANNU REV PHYSIOL, V64, P877, DOI 10.1146/annurev.physiol.64.082101.143243; Sanders PW, 2009, AM J PHYSIOL-RENAL, V297, pF237, DOI 10.1152/ajprenal.00027.2009; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Shin J, 2015, TRKO201600016020; Teng F, 2011, J HUM HYPERTENS, V25, P686, DOI 10.1038/jhh.2010.112; Tohidi M, 2012, J HUM HYPERTENS, V26, P525, DOI 10.1038/jhh.2011.70; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P937, DOI 10.1097/EDE.0000000000000186; Vidal-Petiot E, 2016, LANCET, V388, P2142, DOI 10.1016/S0140-6736(16)31326-5; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; WON JY, 2016, MEDICINE, V95, DOI DOI 10.1097/MD; Yu J, 2016, BMC CARDIOVASC DISOR, V16, DOI 10.1186/s12872-016-0358-4; Zheng RJ, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0562-y; Zhou L, 2017, AM J CLIN NUTR, V105, P1291, DOI 10.3945/ajcn.116.147553	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231707	10.1371/journal.pone.0231707	http://dx.doi.org/10.1371/journal.pone.0231707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298354	gold, Green Published			2022-12-26	WOS:000536011400092
J	Ding, YQ; Ding, KJ; Qian, HD; Yu, XF; Zou, DH; Yang, HJ; Mo, WJ; He, XM; Zhang, FR; Qin, CD; Zheng, YR; Ding, XW				Ding, Yuqin; Ding, Kaijing; Qian, Hongdan; Yu, Xingfei; Zou, Dehong; Yang, Hongjian; Mo, Wenju; He, Xiangming; Zhang, Fanrong; Qin, Chengdong; Zheng, Yurong; Ding, Xiaowen			Impact on survival of estrogen receptor, progesterone receptor and Ki-67 expression discordance pre- and post-neoadjuvant chemotherapy in breast cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; GUIDELINE RECOMMENDATIONS; HORMONE-RECEPTORS; PROGNOSTIC VALUE; PRIMARY THERAPY; HIGHLIGHTS; EFFICACY; SUBTYPES; COLLEGE; SOCIETY	Purpose To investigate whether estrogen receptor (ER), progesterone receptor (PR) and Ki-67 expression discordance before and after neoadjuvant chemotherapy (NAC) correlates with prognosis and treatment of breast cancer patients. Methods The study cohort included 482 breast cancer patients at the Zhejiang Cancer Hospital from January 1, 2008, to December 31, 2018. Core needle biopsies and excised tissue biopsies pre- and post-NAC were obtained. Immunohistochemistry was used to determine ER, PR and Ki-67 status. The relationship between biomarker discordance before and after NAC and clinicopathological features was compared retrospectively. Results ER (n = 482), PR (n = 482) and Ki-67 (n = 448) expression was assessed in the same lesion pre- and post-NAC. Discordance in the three markers pre- and post-NAC was observed in 50 (10.4%), 82 (17.0%) and 373 (77.4%) cases, respectively. Positive-to-negative PR expression changes were the most common type of discordance observed. The risk of death in patients with a PR positive-to-negative conversion was 6.58 times greater than for patients with stable PR expression. The risk of death in patients with increased Ki-67 expression following NAC treatment was 2.05 times greater than for patients with stable Ki-67 expression. Conclusion Breast cancer patients showed changes in ER, PR and/or Ki-67 status throughout NAC, and these changes possibly influenced disease-free survival and overall survival. A switch to negative hormone receptor expression with increased Ki-67 expression following NAC could be indicators of a worse prognosis. Biomarker expression investigations following NAC may potentially improve patient management and survival.	[Ding, Yuqin; Yu, Xingfei; Zou, Dehong; Yang, Hongjian; Mo, Wenju; He, Xiangming; Zhang, Fanrong; Qin, Chengdong; Zheng, Yurong; Ding, Xiaowen] Univ Chinese Acad Sci, Chinese Acad Sci, Canc Hosp,Zhejiang Canc Hosp, Dept Breast Surg,Inst Canc Res & Basic Med Sci, Hangzhou, Zhejiang, Peoples R China; [Ding, Kaijing] Zhejiang Univ, Affiliated Mental Hlth Ctr, Hangzhou Peoples Hosp 7, Dept Child Psychol, Hangzhou, Zhejiang, Peoples R China; [Qian, Hongdan] Deqing Cty Hosp Tradit Chinese Med, Dept Gen Surg, Huzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Zhejiang Cancer Hospital; Zhejiang University	Ding, XW (corresponding author), Univ Chinese Acad Sci, Chinese Acad Sci, Canc Hosp,Zhejiang Canc Hosp, Dept Breast Surg,Inst Canc Res & Basic Med Sci, Hangzhou, Zhejiang, Peoples R China.	dingxw@zjcc.org.cn		yuqin, ding/0000-0002-9562-7943; Zheng, Yurong/0000-0002-1224-4796	Hangzhou Health Commission [2015A32]	Hangzhou Health Commission	This study was funded by the general project supported by Hangzhou Health Commission (Grant number: 2015A32) to Kaijing Ding.	Arens N, 2005, VIRCHOWS ARCH, V446, P489, DOI 10.1007/s00428-005-1244-0; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Chen R, 2018, BREAST CANCER RES TR, V170, P35, DOI 10.1007/s10549-018-4730-1; Curigliano G, 2011, ANN ONCOL, V22, P2227, DOI 10.1093/annonc/mdq751; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Giuliano AE, 2018, ANN SURG ONCOL, V25, P1783, DOI 10.1245/s10434-018-6486-6; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Hirata T, 2009, BRIT J CANCER, V101, P1529, DOI 10.1038/sj.bjc.6605360; Huang JB, 2013, MED HYPOTHESES, V80, P441, DOI 10.1016/j.mehy.2012.12.037; Kasami M, 2008, BREAST, V17, P523, DOI 10.1016/j.breast.2008.04.002; Lindstrom LS, 2012, J CLIN ONCOL, V30, P2601, DOI 10.1200/JCO.2011.37.2482; Marcom PK, 2007, BREAST CANCER RES TR, V102, P43, DOI 10.1007/s10549-006-9307-8; Matsubara N, 2013, BREAST CANCER RES TR, V137, P203, DOI 10.1007/s10549-012-2344-6; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Singh K, 2017, HUM PATHOL, V65, P123, DOI 10.1016/j.humpath.2017.04.016; Singh K, 2016, BREAST CANCER RES TR, V157, P405, DOI 10.1007/s10549-016-3824-x; Spring LM, 2016, JAMA ONCOL, V2, P1477, DOI 10.1001/jamaoncol.2016.1897; Tacca O, 2007, ONCOLOGIST, V12, P636, DOI 10.1634/theoncologist.12-6-636; Tan QX, 2014, INT J CLIN EXP PATHO, V7, P6862; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; van de Ven S, 2011, CANCER TREAT REV, V37, P422, DOI 10.1016/j.ctrv.2010.11.006; von Minckwitz G, 2013, CLIN CANCER RES, V19, P4521, DOI 10.1158/1078-0432.CCR-12-3628; Wolff AC, 2007, ARCH PATHOL LAB MED, V131, P18, DOI 10.1043/1543-2165(2007)131[18:ASOCCO]2.0.CO;2; Wu YT, 2018, J BIOMED RES, V32, P191, DOI 10.7555/JBR.32.20170059; Yamazaki N, 2015, EJSO-EUR J SURG ONC, V41, P617, DOI 10.1016/j.ejso.2015.01.036; Yoshioka T, 2015, BREAST CANCER-TOKYO, V22, P185, DOI 10.1007/s12282-013-0474-2	28	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231895	10.1371/journal.pone.0231895	http://dx.doi.org/10.1371/journal.pone.0231895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298374	gold, Green Published			2022-12-26	WOS:000536011400121
J	Jo, Y; Bartholomew, TS; Doblecki-Lewis, S; Rodriguez, A; Forrest, DW; Tomita-Barber, J; Oves, J; Tookes, HE				Jo, Young; Bartholomew, Tyler S.; Doblecki-Lewis, Susanne; Rodriguez, Allan; Forrest, David W.; Tomita-Barber, Jasmine; Oves, Juan; Tookes, Hansel E.			Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida	PLOS ONE			English	Article							HIV PREEXPOSURE PROPHYLAXIS; SEX WORK; US CITIES; INFECTION; RISK; OUTBREAK; USERS; WILLINGNESS; WASHINGTON; PREVENTION	Background People who inject drugs (PWID) are at an increased risk for HIV infection due to injection and sexual risk behaviors. This study aims to examine PrEP knowledge, awareness, and willingness to be linked to PrEP services at a syringe services program (SSP), and examine the relationship between substance use and interest in PrEP linkage. Methods Data were collected using a cross-sectional survey of IDEA SSP clients in Miami, FL (N = 157). Based on reported substance injected, participants were classified into opioid-only injection or polysubstance injection. Socio-demographics and HIV risk were examined using Pearson's Chi-Squared analysis. Bivariate and multivariable logistic regression models were used to test for significant correlates of interest in PrEP linkage. Results Only 28.3% of PWID surveyed had previously heard of PrEP. However, 57.2% were interested in receiving more information about PrEP. In the adjusted model, people with opioid-only use were significantly less likely to report interest in being linked to PrEP. Conclusion Knowledge, awareness, and interest in being linked to PrEP were low among PWID surveyed. No participants of the study were successfully linked to PrEP services through direct referrals. Further research is needed to examine low threshold service delivery of PrEP to PWID at SSPs.	[Jo, Young; Bartholomew, Tyler S.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA; [Doblecki-Lewis, Susanne; Rodriguez, Allan; Tomita-Barber, Jasmine; Tookes, Hansel E.] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA; [Forrest, David W.] Univ Miami, Dept Anthropol, Coll Arts & Sci, Miami, FL USA; [Oves, Juan] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA	University of Miami; University of Miami; University of Miami; State University System of Florida; Florida International University	Tookes, HE (corresponding author), Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA.	hetookes@med.miami.edu		Jo, Young/0000-0003-3711-555X; Tookes, Hansel/0000-0002-2369-360X; Bartholomew, Tyler/0000-0002-9384-0812	Center for AIDS Research [P30AI073961]; National Cancer Institute of the National Institutes of Health [P30CA240139]	Center for AIDS Research; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was funded by the Center for AIDS Research P30AI073961 to HET. Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under Award Number P30CA240139. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson PL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004006; [Anonymous], 2015, HIV SO US; Biello KB, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0263-5; Blouin K, 2016, SEX TRANSM DIS, V43, P648, DOI 10.1097/OLQ.0000000000000504; Bluthenthal RN, 2000, AIDS, V14, P605, DOI 10.1097/00002030-200003310-00015; Broz D, 2018, INT J DRUG POLICY, V52, P97, DOI 10.1016/j.drugpo.2017.12.003; Broz D, 2014, MMWR SURVEILL SUMM, V63, P1; Campbell EM, 2017, J INFECT DIS, V216, P1053, DOI 10.1093/infdis/jix307; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen SE, 2015, JAIDS-J ACQ IMM DEF, V70, pE33, DOI 10.1097/QAI.0000000000000716; Croxford S, 2015, INT J DRUG POLICY, V26, P429, DOI 10.1016/j.drugpo.2014.09.014; DeBeck K, 2007, DRUG ALCOHOL DEPEN, V91, P50, DOI 10.1016/j.drugalcdep.2007.05.003; Doblecki-Lewis S, 2017, JAIDS-J ACQ IMM DEF, V74, P531, DOI 10.1097/QAI.0000000000001236; Eisingerich AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028238; Escudero DJ, 2015, AIDS BEHAV, V19, P752, DOI 10.1007/s10461-014-0867-z; Golden MR, 2019, MMWR-MORBID MORTAL W, V68, P344, DOI 10.15585/mmwr.mm6815a2; Hagan H, 2000, J SUBST ABUSE TREAT, V19, P247, DOI 10.1016/S0740-5472(00)00104-5; Hess, 2018, DIAGNOSES HIV INFECT; HIV/AIDS JUNPo, 2018, MIL GO CLOS GAPS BRE; Hurley SF, 1997, LANCET, V349, P1797, DOI 10.1016/S0140-6736(96)11380-5; Kerr T, 2016, AIDS, V30, P627, DOI 10.1097/QAD.0000000000000948; Ksobiech K, 2003, AIDS EDUC PREV, V15, P257, DOI 10.1521/aeap.15.4.257.23828; Kuo I, 2016, DRUG ALCOHOL DEPEN, V164, P8, DOI 10.1016/j.drugalcdep.2016.02.044; Martin M, 2017, LANCET HIV, V4, pE59, DOI 10.1016/S2352-3018(16)30207-7; McCormack S, 2016, LANCET, V387, P53, DOI 10.1016/S0140-6736(15)00056-2; Nerlander LM, 2017, JAIDS-J ACQ IMM DEF, V75, pS333, DOI [10.1097/QAI.0000000000001408, 10.1097/qai.0000000000001408]; Peters PJ, 2016, NEW ENGL J MED, V375, P229, DOI 10.1056/NEJMoa1515195; Roth AM, 2018, SEX TRANSM DIS, V45, P217, DOI 10.1097/OLQ.0000000000000728; Sherman SG, DRUG ALCOHOL DEPENDE; Spillane J, 2003, DRUG ALCOHOL DEPEN, V70, pS5, DOI 10.1016/S0376-8716(03)00096-6; Stein M, 2014, AIDS BEHAV, V18, P1694, DOI 10.1007/s10461-014-0778-z; Sudano JJ, 2003, AM J PUBLIC HEALTH, V93, P130, DOI 10.2105/AJPH.93.1.130; Tookes H., 2018, AIDS BEHAV, V2019, P1; Tookes H, 2019, INT J STD AIDS, V30, P978, DOI 10.1177/0956462419855178; Walters SM, 2017, HARM REDUCT J, V14, DOI 10.1186/s12954-017-0166-x; Walters SM, 2017, JAIDS-J ACQ IMM DEF, V75, pS383, DOI [10.1097/QAI.0000000000001415, 10.1097/qai.0000000000001415]; Williams JE, 2019, J URBAN HEALTH, V96, P469, DOI 10.1007/s11524-018-0238-6	37	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231424	10.1371/journal.pone.0231424	http://dx.doi.org/10.1371/journal.pone.0231424			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298320	Green Published, gold			2022-12-26	WOS:000536011400042
J	Rajavel, S; Raghav, P; Gupta, MK; Muralidhar, V				Rajavel, Saranya; Raghav, Pankaja; Gupta, Manoj Kumar; Muralidhar, Venkiteswaran			Silico-tuberculosis, silicosis and other respiratory morbidities among sandstone mine workers in Rajasthan- a cross-sectional study	PLOS ONE			English	Article								Background Exposures to respirable crystalline silica causes silicosis, pulmonary tuberculosis, chronic obstructive pulmonary disease, lung cancer, autoimmune disorders and chronic renal disease. The aim of this study was to find out the prevalence of silico-tuberculosis, silicosis and other respiratory morbidities in sandstone mine workers in Jodhpur district of Rajasthan. Methods It was a cross-sectional study done in sandstone mines in Jodhpur. A total of 15 mines were selected. The sample size was calculated and fixed to 174 mine workers. Chi-square and t-test were applied to draw inferences. Results The mean age of the mine workers was 39.13 +/- 11.09 years. Three fourth (75.3%) of the workers were working for more than ten years in mines. Around 30.0% had a history of tuberculosis. Abnormal spirometry was found in 89.2% of workers. Around 42% of mine workers were found with abnormal chest x-rays. Prevalence of silicosis was 37.3%, silicotuberculosis was 7.4%, tuberculosis was 10.0%, and other respiratory diseases like emphysema and pleural effusion were diagnosed among 4.3% workers. Conclusion Prevalence of silico-tuberculosis, silicosis and other respiratory morbidities are high among sandstone mine workers.	[Rajavel, Saranya; Raghav, Pankaja; Gupta, Manoj Kumar] All India Inst Med Sci AIIMS Jodhpur, Dept Community Med & Family Med, Jodhpur, Rajasthan, India; [Muralidhar, Venkiteswaran] Chettinad Med Coll & Hosp, Dept Gen Surg, Chennai, Tamil Nadu, India	All India Institute of Medical Sciences (AIIMS) Jodhpur	Rajavel, S (corresponding author), All India Inst Med Sci AIIMS Jodhpur, Dept Community Med & Family Med, Jodhpur, Rajasthan, India.	saranyar6789@gmail.com	Gupta, Manoj Kumar/H-2379-2019	Gupta, Manoj Kumar/0000-0002-5367-5795; Rajavel, Saranya/0000-0002-5183-1061; Muralidhar, Venkiteswaran/0000-0003-4739-1056; RAGHAV, PANKAJA/0000-0002-4209-3829	Indian Council of Medical Research, New Delhi [3/2/June-2017/PG-Thesis-HRD(53)]	Indian Council of Medical Research, New Delhi(Indian Council of Medical Research (ICMR))	This study was a post-graduate thesis in Community Medicine from All India Institute of Medical Sciences, Jodhpur. This study was funded by Indian Council of Medical Research, New Delhi. This was awarded to Dr. Saranya Rajavel (Grant number: No.3/2/June-2017/PG-Thesis-HRD(53) dated on 13.03.2018) The URL for funder website is https://icmr.nic.in/content/mdmsdmmchmds-support. The funder has no role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Ahmad A, 2015, J THORAC ONCOL; Ahmad A, 2015, INT J DEV STUD RES, V3; Ahmad A, 2015, EHS J; [Anonymous], 2011, DET SIL STON MIN WOR; [Anonymous], 2015, INT J RES MED SCI; [Anonymous], 2016, NATL FAMILY HLTH SUR; Athavale Amita, 2011, Indian J Occup Environ Med, V15, P104, DOI 10.4103/0019-5278.93199; Bairagya TD, 2012, ANN TROP MED PUBLIC, V5, P528, DOI 10.4103/1755-6783.105154; CDC-Silica, GEN PUBL NIOSH WORKP; Chaudhury N, 2012, LUNG INDIA, V29, P6, DOI 10.4103/0970-2113.92348; D'Arco S., 2006, IECON 2006. 32nd Annual Conference on IEEE Industrial Electronics (IEEE Cat. No. 06CH37763), P1149, DOI 10.1109/IECON.2006.347617; Dixit R, 2015, INT J OCCUP MED ENV, V28, P635, DOI 10.13075/ijomeh.1896.00399; Evelyn Kortum E, 2007, GLOBAL OCCUPATIONAL; Farazi A, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.333.4993; Fotedar S, 2010, LUNG INDIA, V27, P173, DOI 10.4103/0970-2113.68325; Gupta KB, CASE REPORT BILATERA; Kulkarni G K, 2007, Indian J Occup Environ Med, V11, P95, DOI 10.4103/0019-5278.38456; Mathur M. L., 2005, Indian Journal of Occupational and Environmental Medicine, V9, P80; Mishra P, 2014, CASE REP PATHOL, V2014, DOI 10.1155/2014/561861; SAIYED HN, 1985, AM J IND MED, V8, P127, DOI 10.1002/ajim.4700080207; Sharma DC, 2015, LANCET RESP MED, V3, P181, DOI 10.1016/S2213-2600(15)00052-1; Sharma RK, INT J ADV MED, V4, P1547; Singh Suresh Kumar, 2007, Int J Environ Res Public Health, V4, P296, DOI 10.3390/ijerph200704040005; Sishodiya DPK, REPORT DETECTION SIL; Sishodiya PK, NATL PROGRAMME ELIMI; Sivanmani Keerthivasan, 2013, Indian J Occup Environ Med, V17, P25, DOI 10.4103/0019-5278.116370; Srivastava GN, 2014, ACUTE SILICOSIS BILA; Tiwari Rajnarayan R, 2007, Indian J Occup Environ Med, V11, P61, DOI 10.4103/0019-5278.34530; Tiwari Rajnarayan R, 2010, Indian J Occup Environ Med, V14, P87, DOI 10.4103/0019-5278.75695; Tiwari RR, 2008, INT J OCCUP ENV HEAL, V14, P280, DOI 10.1179/oeh.2008.14.4.280; Tiwari RR, 2005, ARCH MED RES, V36, P171, DOI 10.1016/j.arcmed.2004.12.014; Tyagi P, 2013, J INTEGR HEAL SCI, V1, P86; Whig J, 2004, LUNG INDIA, V21, P1; WHO, 2007, TRAIN MAN WHO PACK E, P1; Yadav S. P., 2011, Journal of Human Ecology, V33, P191	35	7	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230574	10.1371/journal.pone.0230574	http://dx.doi.org/10.1371/journal.pone.0230574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298271	Green Published, gold			2022-12-26	WOS:000536011400017
J	Shoemaker, ES; Kendall, CE; Mathew, C; Crispo, S; Welch, V; Andermann, A; Mott, S; Lalonde, C; Bloch, G; Mayhew, A; Aubry, T; Tugwell, P; Stergiopoulos, V; Pottie, K				Shoemaker, Esther S.; Kendall, Claire E.; Mathew, Christine; Crispo, Sarah; Welch, Vivian; Andermann, Anne; Mott, Sebastian; Lalonde, Christine; Bloch, Gary; Mayhew, Alain; Aubry, Tim; Tugwell, Peter; Stergiopoulos, Vicky; Pottie, Kevin			Establishing need and population priorities to improve the health of homeless and vulnerably housed women, youth, and men: A Delphi consensus study	PLOS ONE			English	Article							ASSERTIVE COMMUNITY TREATMENT; INTENSIVE CASE-MANAGEMENT; HOUSING 1ST; INTERVENTIONS; CARE; INDIVIDUALS; PREVALENCE; SUPPORT; ILLNESS; ADULTS	Background Homelessness is one of the most disabling and precarious living conditions. The objective of this Delphi consensus study was to identify priority needs and at-risk population subgroups among homeless and vulnerably housed people to guide the development of a more responsive and person-centred clinical practice guideline. Methods We used a literature review and expert working group to produce an initial list of needs and at-risk subgroups of homeless and vulnerably housed populations. We then followed a modified Delphi consensus method, asking expert health professionals, using electronic surveys, and persons with lived experience of homelessness, using oral surveys, to prioritize needs and at-risk sub-populations across Canada. Criteria for ranking included potential for impact, extent of inequities and burden of illness. We set ratings of. 60% to determine consensus over three rounds of surveys. Findings Eighty four health professionals and 76 persons with lived experience of homelessness participated from across Canada, achieving an overall 73% response rate. The participants identified priority needs including mental health and addiction care, facilitating access to permanent housing, facilitating access to income support and case management/care coordination. Participants also ranked specific homeless sub-populations in need of additional research including: Indigenous Peoples (First Nations, Metis, and Inuit); youth, women and families; people with acquired brain injury, intellectual or physical disabilities; and refugees and other migrants. Interpretation The inclusion of the perspectives of both expert health professionals and people with lived experience of homelessness provided validity in identifying real-world needs to guide systematic reviews in four key areas according to priority needs, as well as launch a number of working groups to explore how to adapt interventions for specific at-risk populations, to create evidence-based guidelines.	[Shoemaker, Esther S.; Kendall, Claire E.; Mathew, Christine; Crispo, Sarah; Welch, Vivian; Lalonde, Christine; Mayhew, Alain; Tugwell, Peter; Pottie, Kevin] Bruyere Res Inst, Ottawa, ON, Canada; [Shoemaker, Esther S.; Kendall, Claire E.; Tugwell, Peter; Pottie, Kevin] Univ Ottawa, Dept Family Med, Ottawa, ON, Canada; [Shoemaker, Esther S.; Kendall, Claire E.] Inst Clin & Evaluat Sci, Toronto, ON, Canada; [Shoemaker, Esther S.; Kendall, Claire E.; Tugwell, Peter] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Kendall, Claire E.] Inst Savoir Montfort, Ottawa, ON, Canada; [Welch, Vivian] Univ Ottawa, Sch Epidemiol & Publ Hlth, Fac Med, Ottawa, ON, Canada; [Andermann, Anne; Mott, Sebastian] McGill Univ, Dept Family Med, Montreal, PQ, Canada; [Andermann, Anne] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Andermann, Anne] St Marys Hosp, St Marys Res Ctr, Montreal, PQ, Canada; [Bloch, Gary] St Michaels Hosp, Dept Family & Community Med, Toronto, ON, Canada; [Bloch, Gary; Stergiopoulos, Vicky] Univ Toronto, Fac Med, Toronto, ON, Canada; [Bloch, Gary] Inner City Hlth Associates, Toronto, ON, Canada; [Aubry, Tim] Univ Ottawa, Sch Psychol, Ottawa, ON, Canada; [Aubry, Tim] Univ Ottawa, Ctr Res Educ & Community Serv, Ottawa, ON, Canada; [Stergiopoulos, Vicky] Ctr Addict & Mental Hlth, Toronto, ON, Canada	University of Ottawa; University of Ottawa; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; McGill University; McGill University; McGill University; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University of Ottawa; University of Ottawa; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada	Pottie, K (corresponding author), Bruyere Res Inst, Ottawa, ON, Canada.; Pottie, K (corresponding author), Univ Ottawa, Dept Family Med, Ottawa, ON, Canada.	kpottie@uottawa.ca	Tugwell, Peter/AFD-8076-2022; Aubry, Tim/ABB-9932-2021; Pottie, Kevin/ABC-4385-2020; Welch, Vivian Andrea/AAD-9338-2020	Tugwell, Peter/0000-0001-5062-0556; Aubry, Tim/0000-0002-6204-3773; Welch, Vivian Andrea/0000-0002-5238-7097	Inner City Health Associated (ICHA), Toronto, Canada	Inner City Health Associated (ICHA), Toronto, Canada	This manuscript was funded by Inner City Health Associated (ICHA), Toronto, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-81; Anderson JT, 2014, HOUSING STUD, V29, P959, DOI 10.1080/02673037.2014.923091; [Anonymous], 2010, DELPHI TECHNIQUE NUR; Aubry T, 2016, PSYCHIAT SERV, V67, P275, DOI 10.1176/appi.ps.201400587; Briss PA, 2000, AM J PREV MED, V18, P35, DOI 10.1016/S0749-3797(99)00119-1; Buckland L., 2001, STRUCTURAL SYSTEMIC; Canada PHA of, 2007, CAN STREET YOUTH SUB; Canada PHA of, 2013, WHAT MAK CAN HLTH UN; Canada TC of FP of, 2018, BEST ADV GUID SOC DE; Canadian Medical Association, 2012, PHYS HLTH EQ OPP PRA; Chambers DA, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-117; Collins SE, 2013, AM J PUBLIC HEALTH, V103, pS269, DOI 10.2105/AJPH.2013.301312; Dieterich M, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007906.pub3; Evans J, 2015, HEALTH PLACE, V33, P118, DOI 10.1016/j.healthplace.2015.02.011; Farrell B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122246; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Frank L, 2014, JAMA-J AM MED ASSOC, V312, P1513, DOI 10.1001/jama.2014.11100; Gaetz S, 2012, CANADIAN DEFINITION; Gaetz S, 2016, STATE HOMELESSNESS C; Gaudet S., 2007, EMERGING ADULTHOOD N; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Greenwood RM, 2005, AM J COMMUNITY PSYCH; Habibis D, 2013, HOUSING STUD, V28, P764, DOI 10.1080/02673037.2013.759545; Herman DB, 2010, RES SOCIAL WORK PRAC, V20, P502, DOI 10.1177/1049731509360667; Hwang SW, 2008, CAN MED ASSOC J, V179, P779, DOI 10.1503/cmaj.080341; Hwang SW, 2014, LANCET, V384, P1541, DOI 10.1016/S0140-6736(14)61133-8; Hwang SW, 2009, J URBAN HEALTH, V86, P791, DOI 10.1007/s11524-009-9388-x; Hwang SW, 2005, AM J PREV MED, V29, P311, DOI 10.1016/j.amepre.2005.06.017; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Kerr T, 2006, BRIT MED J, V332, P220, DOI 10.1136/bmj.332.7535.220; Kerr T, INJECTION DRUG USE S; Leads Health, 2018, BETT HLTH ON CONN TI; McFarlane W R, 1992, New Dir Ment Health Serv, P43; Murdoch DM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-9; National Institute for Health and Care Excellence, 2020, FIND GUID; Nelson G, 2007, AM J ORTHOPSYCHIAT, V77, P350, DOI 10.1037/0002-9432.77.3.350; Palepu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075133; Petkovic J, 2020, SYST REV-LONDON, V9, DOI 10.1186/s13643-020-1272-5; Pottie K, 2014, CAN FAM PHYSICIAN, V60, pE32; Public Health Agency of Canada, 2007, CAN STREET YOUTH SUB; Ringwalt CL, 1998, J ADOLESCENCE, V21, P241, DOI 10.1006/jado.1998.0150; Rodrigue S, 2016, INSIGHTS CANADIAN SO; Rog DJ, 2014, PSYCHIAT SERV, V65, P287, DOI 10.1176/appi.ps.201300261; Roy E, 1999, CAN MED ASSOC J, V161, P689; Schmidt RC, 1997, DECISION SCI, V28, P763, DOI 10.1111/j.1540-5915.1997.tb01330.x; Segaert Aaron., 2012, NATL SHELTER STUDY E; Stefancic A, 2013, AM J PUBLIC HLTH; Stefancic A, 2013, AM J PUBLIC HEALTH, V103, pS206, DOI 10.2105/AJPH.2013.301606; Stergiopoulos V, 2003, CAN J PSYCHIAT, V48, P374, DOI 10.1177/070674370304800603; STERGIOPOULOS V, 2015, JAMA J AM MED ASSOC, V313, P905, DOI DOI 10.1001/; Stergiopoulos V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-167; Stergiopoulos V, 2010, J HEALTH CARE POOR U, V21, P1031, DOI 10.1353/hpu.0.0334; Stock M., 2016, ENDING HOMELESSNESS; Swinkels H, 2011, CMAJ; Tessler R, 2001, J SOC DISTRESS HOMEL, V10, P243, DOI 10.1023/A:1016688707698; The College of Family Physicians of Canada, 2018, BEST ADV GUID SOC DE; Thistle J, 2019, CAN ALL END HOM C ED; Tsemberis S, 2004, AM J PUBLIC HEALTH, V94, P651, DOI 10.2105/AJPH.94.4.651; Walker R., 2003, CANADIAN J URBAN RES, V12, P99; Wenzel SL, 2006, J INTERPERS VIOLENCE, V21, P820, DOI 10.1177/0886260506288662; White Newman, 2015, ACCESS PRIMARY CARE; Wild C, 2011, DIMENSIONS PROMISING; Woolley E., 2015, MANY HOMELESS PEOPLE	64	8	8	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231758	10.1371/journal.pone.0231758	http://dx.doi.org/10.1371/journal.pone.0231758			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298388	Green Published, gold			2022-12-26	WOS:000536011400105
J	Laharnar, N; Uibel, S; Hild, C; Glos, M; Penzel, T; Fietze, I				Laharnar, Naima; Uibel, Stefanie; Hild, Corin; Glos, Martin; Penzel, Thomas; Fietze, Ingo			Overnight polysomnography and the recording of sleep and sleep-related respiration in orchestra musicians - possible protective effects of wind instruments on respiration	PLOS ONE			English	Article							GENERAL-POPULATION; APNEA; RISK; STIMULATION; QUALITY	Our study is the first to objectively assess sleep and sleep-related respiration in orchestra musicians. We hypothesized low sleep quality due to high work demands and irregular work-sleep schedules, and a better respiration for wind instrument (WI) players than string instrument (SI) players due to habitual upper airway muscles training. We recorded overnight polysomnography with 29 professional orchestra musicians (21 men, 14 WI/15 SI). The musicians presented a sleep efficiency of 88% (IQR 82-92%) with WI having a significant higher sleep efficiency than SI (89%, 85-93% vs. 85%, 74-89%; p = 0.029). The group had a total sleep time around 6 hours (377min, 340-421min) with signs of increased NREM 1 (light sleep) and decreased REM (dream sleep). The musicians displayed an apneahypopnea-index of 2.1events/hour (0.7-5.5) and an oxygen saturation of 98% (97-100%). While SI player exhibited declining sleep-related respiration with age (breathing events: r = 0.774, p = 0.001, oxygen: r = -0.647, p = 0.009), WI player showed improved respiration with age (breathing events: r = -0.548, p = 0.043; oxygen: r = 0.610, p = 0.020). Our study is the first objective investigation of sleep pattern and respiration during sleep with overnight polysomnography in professional orchestra musicians. While sleep and respiration were unexpectedly good, our results revealed possible signs of sleep deprivation and an interesting age-related pattern on respiration depending on instrument. While sample size was small and results modest, these findings present first objective evidence towards the assumption that habitual playing of a WI-and training of the upper airway muscles-may have a protective effect on respiration.	[Laharnar, Naima; Hild, Corin; Glos, Martin; Penzel, Thomas; Fietze, Ingo] Charite Univ Med Berlin, Interdisciplinary Sleep Ctr, Berlin, Germany; [Uibel, Stefanie] Univ Hosp Frankfurt, Med Clin Cardiol 3, Frankfurt, Germany; [Penzel, Thomas] Saratov NG Chernyshevskii State Univ, Saratov, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Saratov State University	Laharnar, N (corresponding author), Charite Univ Med Berlin, Interdisciplinary Sleep Ctr, Berlin, Germany.	naima.laharnar@charite.de	Penzel, Thomas/M-2344-2014	Penzel, Thomas/0000-0002-4304-0112; Fietze, Ingo/0000-0001-5567-5206; Laharnar, Naima/0000-0001-7484-7747	Berlin Staatskapelle	Berlin Staatskapelle	The authors would like to thank the Berlin Staatskapelle for their participation and support.	Acosta-Castro P, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.02484-2017; Alberts C, 2012, PNEUMOLOGIE, VS1, pP37, DOI [10.1055/s-0032-1302789, DOI 10.1055/S-0032-1302789]; Assefa SZ, 2015, AIMS NEUROSCI, V2, P155, DOI 10.3934/Neuroscience.2015.3.155; Banks S, 2007, J CLIN SLEEP MED, V3, P519; Banks S, 2010, SLEEP, V33, P1013, DOI 10.1093/sleep/33.8.1013; Banzhoff S, 2017, MED PROBL PERFORM AR, V32, P235, DOI 10.21091/mppa.2017.4040; Bliwise DL., 2017, PRINCIPLES PRACTICE, P25, DOI DOI 10.1016/B978-0-323-24288-2.00003-9; Brown DL, 2009, SLEEP MED, V10, P657, DOI 10.1016/j.sleep.2008.05.013; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Camerino D, 2008, CHRONOBIOL INT, V25, P425, DOI 10.1080/07420520802118236; Carskadon MA, 2012, PRINCIPLES PRACTICE; Ferrara M, 2001, SLEEP MED REV, V5, P155, DOI 10.1053/smrv.2000.0138; Fietze I, 2003, NEUROPSYCHOPHARMACOL, V28, P558, DOI 10.1038/sj.npp.1300082; Fietze I, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12770; Fietze I, 2009, CHRONOBIOL INT, V26, P1249, DOI [10.3109/07420520903221319, 10.1080/07420520903221319]; Heinzer R, 2015, LANCET RESP MED, V3, P310, DOI 10.1016/S2213-2600(15)00043-0; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P40, DOI 10.1016/j.sleh.2014.12.010; Hoffmann RM, 1996, FRAGEBOGEN ERFASSUNG; Iber C., 2007, AASM MANUAL SCORING; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kato M, 2000, HYPERTENSION, V35, P1173, DOI 10.1161/01.HYP.35.5.1173; Knauth P, 2007, IND HEALTH, V45, P125, DOI 10.2486/indhealth.45.125; Mann EA, 2002, LARYNGOSCOPE, V112, P351, DOI 10.1097/00005537-200202000-00027; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Nedelcut Sebastian, 2018, Clujul Med, V91, P312, DOI 10.15386/cjmed-959; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Ostberg O., 1996, INT J CHRONOBIOL, V4, P97; Pilcher JJ, 2000, SLEEP, V23, P155; Piperek M., 1981, STRESS MUSIC MED PSY; Puhan MA, 2006, BMJ-BRIT MED J, V332, P266, DOI 10.1136/bmj.38705.470590.55; QUADE D, 1967, J AM STAT ASSOC, V62, P1187, DOI 10.2307/2283769; Randerath WJ, 2004, SLEEP, V27, P254, DOI 10.1093/sleep/27.2.254; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Spahn C, 2011, MUSIKER MED DIAGNOST; Steinberg R, 2010, SCHLAFMEDIZIN GRUNDL; Vaag J, 2016, BEHAV SLEEP MED, V14, P325, DOI 10.1080/15402002.2015.1007991; Vranish JR, 2016, SLEEP, V39, P1179, DOI 10.5665/sleep.5826; Walch OJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501705; Ward CP, 2012, J CLIN SLEEP MED, V8, P251, DOI 10.5664/jcsm.1906; Wessolleck E, 2018, SOMNOLOGIE, V22, P117, DOI 10.1007/s11818-018-0161-9; WINGARD DL, 1983, SLEEP, V6, P102, DOI 10.1093/sleep/6.2.102; Young T, 2002, AM J RESP CRIT CARE, V165, P1217, DOI 10.1164/rccm.2109080	42	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231549	10.1371/journal.pone.0231549	http://dx.doi.org/10.1371/journal.pone.0231549			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294119	gold, Green Published, Green Submitted			2022-12-26	WOS:000536003500039
J	Lvovschi, VE; Maignan, M; Tazarourte, K; Diallo, ML; Hadjadj-Baillot, C; Pons-Kerjean, N; Lapostolle, F; Dussart, C				Lvovschi, Virginie Eve; Maignan, Maxime; Tazarourte, Karim; Diallo, Mohamed Lamine; Hadjadj-Baillot, Caroline; Pons-Kerjean, Nathalie; Lapostolle, Frederic; Dussart, Claude			Multiple criteria decision analysis approach to consider therapeutic innovations in the emergency department: The methoxyflurane organizational impact in acute trauma pain	PLOS ONE			English	Article							HOSPITAL MANAGERS NEED; DOUBLE-BLIND; CARE; INFORMATION; PREVALENCE	Background Acute trauma pain is poorly managed in the emergency department (ED). The reasons are partly organizational: ED crowding and rare trauma care pathways contribute to oligoanalgesia. Anticipating the organizational impact of an innovative care procedure might facilitate the decision-making process and help to optimize pain management. Methods We used a multiple criteria decision analysis (MCDA) approach to consider the organizational impact of methoxyflurane (self-administered) in the ED, introduced alone or supported by a trauma care pathway. A MCDA experiment was designed for this specific context, 8 experts in emergency trauma care pathways (leading physicians and pharmacists working in French urban tertiary hospitals) were recruited. The study involved four steps: (i) Selection of organizational criteria for evaluating the innovation's impact; (ii) assessment of the relative weight of each criterion; (iii) choice of appropriate scenarios for exploring the organizational impact of MEOX under various contexts; and (iv) software-assisted simulation based on pairwise comparisons of the scenarios. The final outcome measure was the expected overall organizational impact of methoxyflurane on a 0-to-100 scale (score > 50: positive impact). Results Nine organizational criteria were selected. "Mean length of stay in the ED" was the most weighted. Methoxyflurane alone obtained 59 as a total score, with a putative positive impact for eight criteria, and a neutral effect on one. When a trauma care pathway was introduced concomitantly, the impact of methoxyflurane was greater overall (score: 75) and for each individual criterion. Conclusions Our model highlighted the putative positive organizational impact of methoxyflurane in the ED-particularly when supported by a trauma care pathway-and the relevance of expert consensus in this particular pharmacoeconomic context. The MCDA approach could be extended to other research fields and healthcare challenges in emergency medicine.	[Lvovschi, Virginie Eve] Normandie Univ, Rouen Univ Hosp, Emergency Dept, INSERM U1073,UNIROUEN, Rouen, France; [Maignan, Maxime] Univ Grenoble Alpes, Grenoble Alps Univ, Grenoble Univ Hosp, Emergency Dept,INSERM U1042,CHU Grenoble Alpes,HP, Grenoble, France; [Tazarourte, Karim] Hop Edouard Herriot, Lyon Publ Hosp, Emergency Dept, Lyon, France; [Tazarourte, Karim] Claude Bernard Univ, Hlth Serv & Performance Res, EA, HESPER, Lyon, France; [Diallo, Mohamed Lamine] Grand Hop Est Francilien, Pharm Dept, Meaux, Seine & Marne, France; [Hadjadj-Baillot, Caroline] CHU Bordeaux, Pharm Dept, Bordeaux, France; [Pons-Kerjean, Nathalie] Beaujon Hosp, AP HP, Pharm Dept, Clichy, France; [Lapostolle, Frederic] Avicenne Hosp, AP HP, SAMU 93, Bobigny, France; [Lapostolle, Frederic] Paris 13 Univ, INSERM U942, Paris, France; [Dussart, Claude] Lyon Publ Hosp, Cent Pharm, Lyon, France; [Dussart, Claude] Univ Claude Bernard, Syst Hlth Pathway Lab, EA, Lyon, France	CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Dussart, C (corresponding author), Lyon Publ Hosp, Cent Pharm, Lyon, France.; Dussart, C (corresponding author), Univ Claude Bernard, Syst Hlth Pathway Lab, EA, Lyon, France.	claude.dussart@univ-lyon1.fr	Tazarourte, karim/GQZ-6054-2022	LVOVSCHI, VIRGINIE/0000-0003-2903-1911	Mundipharma SAS (Paris, France)	Mundipharma SAS (Paris, France)	This work was funded by Mundipharma SAS (Paris, France; www.mundipharma.fr).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badia X, 2019, INT J TECHNOL ASSESS, V35, P56, DOI 10.1017/S0266462318003641; Blair HA, 2016, CLIN DRUG INVEST, V36, P1067, DOI 10.1007/s40261-016-0473-0; Borobia AM, 2020, ANN EMERG MED, V75, P315, DOI 10.1016/j.annemergmed.2019.07.028; Chang HY, 2014, AM J EMERG MED, V32, P421, DOI 10.1016/j.ajem.2014.01.015; Christensen M., 1997, INNOVATORS DILEMMA N; Coffey F, 2016, ADV THER, V33, P2012, DOI 10.1007/s12325-016-0405-7; Coffey F, 2014, EMERG MED J, V31, P613, DOI 10.1136/emermed-2013-202909; Cordell WH, 2002, AM J EMERG MED, V20, P165, DOI 10.1053/ajem.2002.32643; Decosterd I, 2007, ANN EMERG MED, V50, P462, DOI 10.1016/j.annemergmed.2007.01.019; Dissmann PD, 2018, PAIN THER, V7, P179, DOI 10.1007/s40122-018-0101-1; Dubromel Amelie, 2018, J Mark Access Health Policy, V6, P1458575, DOI 10.1080/20016689.2018.1458575; Hansen P, 2008, J MULTI-CRITERIA DEC, V15, P87, DOI 10.1002/mcda.428; Haugland H, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0362-4; Josephson SA, 2018, JAMA-J AM MED ASSOC, V320, P1239, DOI 10.1001/jama.2018.11122; Kidholm K, 2015, HEALTH POLICY, V119, P1424, DOI 10.1016/j.healthpol.2015.08.011; Kristensen FB, 2007, HLTH TECHNOLOGY ASSE; Lvovschi V, 2008, AM J EMERG MED, V26, P676, DOI 10.1016/j.ajem.2007.10.025; Marsh K, 2016, VALUE HEALTH, V19, P125, DOI 10.1016/j.jval.2015.12.016; Marsh K, 2014, PHARMACOECONOMICS, V32, P345, DOI 10.1007/s40273-014-0135-0; Morley C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203316; Motov Sergey M, 2008, J Pain Res, V2, P5; Olholm AM, 2015, INT J TECHNOL ASSESS, V31, P414, DOI 10.1017/S0266462315000665; Pasiorowski A, 2021, CLIN NURS RES, V30, P23, DOI 10.1177/1054773818820175; Pines JM, 2008, ANN EMERG MED, V51, P1, DOI 10.1016/j.annemergmed.2007.07.008; Pines JM, 2011, ACAD EMERG MED, V18, P1358, DOI 10.1111/j.1553-2712.2011.01235.x; Porter KM, 2018, OPEN ACCESS EMERG M, V10, P149, DOI 10.2147/OAEM.S181222; Strayer RJ, 2017, AM J EMERG MED, V35, P337, DOI 10.1016/j.ajem.2016.10.043; Tanios N, 2013, INT J TECHNOL ASSESS, V29, P456, DOI 10.1017/S0266462313000573; Thokala P, 2012, VALUE HEALTH, V15, P1172, DOI 10.1016/j.jval.2012.06.015; Thokala P, 2016, VALUE HEALTH, V19, P1, DOI 10.1016/j.jval.2015.12.003; Vivien B, 2010, ANN FR ANESTH, V29, P934	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231571	10.1371/journal.pone.0231571	http://dx.doi.org/10.1371/journal.pone.0231571			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294125	Green Published, gold			2022-12-26	WOS:000536003500040
J	Bowen, JM; Cormican, P; Lister, SJ; McCabe, MS; Duthie, CA; Roehe, R; Dewhurst, RJ				Bowen, Jenna M.; Cormican, Paul; Lister, Susan J.; McCabe, Matthew S.; Duthie, Carol-Anne; Roehe, Rainer; Dewhurst, Richard J.			Links between the rumen microbiota, methane emissions and feed efficiency of finishing steers offered dietary lipid and nitrate supplementation	PLOS ONE			English	Article							BACTERIAL COMMUNITY COMPOSITION; PERFORMANCE; CAPACITY; ECOLOGY; STARCH; CATTLE; CORN; COWS; OIL	Ruminant methane production is a significant energy loss to the animal and major contributor to global greenhouse gas emissions. However, it also seems necessary for effective rumen function, so studies of anti-methanogenic treatments must also consider implications for feed efficiency. Between-animal variation in feed efficiency represents an alternative approach to reducing overall methane emissions intensity. Here we assess the effects of dietary additives designed to reduce methane emissions on the rumen microbiota, and explore relationships with feed efficiency within dietary treatment groups. Seventy-nine finishing steers were offered one of four diets (a forage/concentrate mixture supplemented with nitrate (NIT), lipid (MDDG) or a combination (COMB) compared to the control (CTL)). Rumen fluid samples were collected at the end of a 56 d feed efficiency measurement period. DNA was extracted, multiplexed 16s rRNA libraries sequenced (Illumina MiSeq) and taxonomic profiles were generated. The effect of dietary treatments and feed efficiency (within treatment groups) was conducted both overall (using non-metric multidimensional scaling (NMDS) and diversity indexes) and for individual taxa. Diet affected overall microbial populations but no overall difference in beta-diversity was observed. The relative abundance of Methanobacteriales (Methanobrevibacter and Methanosphaera) increased in MDDG relative to CTL, whilst VadinCA11 (Methanomassiliicoccales) was decreased. Trimethylamine precursors from rapeseed meal (only present in CTL) probably explain the differences in relative abundance of Methanomassiliicoccales. There were no differences in Shannon indexes between nominal low or high feed efficiency groups (expressed as feed conversion ratio or residual feed intake) within treatment groups. Relationships between the relative abundance of individual taxa and feed efficiency measures were observed, but were not consistent across dietary treatments.	[Bowen, Jenna M.; Cormican, Paul; McCabe, Matthew S.] TEAGASC, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland; [Bowen, Jenna M.; Lister, Susan J.] Aberystwyth Univ, IBERS, Aberystwyth, Dyfed, Wales; [Duthie, Carol-Anne; Roehe, Rainer; Dewhurst, Richard J.] SRUC, Edinburgh, Midlothian, Scotland	Teagasc; Aberystwyth University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Institute of Biological, Environmental, Rural & Sciences (IBERS)	Bowen, JM (corresponding author), TEAGASC, Anim & Grassland Res & Innovat Ctr, Dunsany, Meath, Ireland.; Bowen, JM (corresponding author), Aberystwyth Univ, IBERS, Aberystwyth, Dyfed, Wales.	jenna.bowen@sruc.ac.uk	Bowen, Jenna/AAW-2787-2021; Dewhurst, Richard/D-2384-2010	Bowen, Jenna/0000-0001-7398-8353; Dewhurst, Richard/0000-0002-9357-7372; Roehe, Rainer/0000-0002-4880-3756; Duthie, Carol-Anne/0000-0003-3020-9078	Teagasc Walsh Fellowship Scheme [2012026]; AHDB Beef and Lamb; Scottish Government; DEFRA; UK Agricultural Greenhouse Gas Inventory Research Platform [66714]; BBSRC [BB/N01720X/1, BB/S006567/1] Funding Source: UKRI	Teagasc Walsh Fellowship Scheme; AHDB Beef and Lamb; Scottish Government; DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); UK Agricultural Greenhouse Gas Inventory Research Platform; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was carried out with funding from the Teagasc Walsh Fellowship Scheme (awarded to RJD; https://www.teagasc.ie/about/research-innovation/postgraduate-fellowships/; Project number 2012026). The SRUC animal study was funded by AHDB Beef and Lamb, the Scottish Government and by DEFRA and the devolved administrations through the UK Agricultural Greenhouse Gas Inventory Research Platform (awarded to RR; Project Number 66714). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma N., 2002, Animal Science Journal, V73, P199, DOI 10.1046/j.1344-3941.2002.00028.x; Attwood G, 2008, AUST J EXP AGR, V48, P28, DOI 10.1071/EA07203; Ben Shabat SK, 2016, ISME J, V10, P2958, DOI 10.1038/ismej.2016.62; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carberry CA, 2012, APPL ENVIRON MICROB, V78, P4949, DOI 10.1128/AEM.07759-11; Crowley JJ, 2010, J ANIM SCI, V88, P885, DOI 10.2527/jas.2009-1852; Danielsson R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00226; Duthie CA, 2018, ANIMAL, V12, P280, DOI 10.1017/S175173111700146X; Eger M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02094; Granja-Salcedo YT, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00614; Hegarty RS, 2007, J ANIM SCI, V85, P1479, DOI 10.2527/jas.2006-236; Henderson G, 2015, SCI REP-UK, V5, DOI 10.1038/srep14567; Hristov AN, 2015, P NATL ACAD SCI USA, V112, pE5218, DOI 10.1073/pnas.1515515112; *IPCC, 2014, WORK GROUP 3 MIT CLI, pCH11; Iwamoto M, 2002, ANAEROBE, V8, P209, DOI 10.1006/anae.2002.0428; Jami E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085423; Jami E, 2013, ISME J, V7, P1069, DOI 10.1038/ismej.2013.2; Jewell KA, 2015, APPL ENVIRON MICROB, V81, P4697, DOI 10.1128/AEM.00720-15; Kretzschmar K, 2013, ARCH GEFLUGELKD, V77, P145; Lee HJ, 2012, APPL ENVIRON MICROB, V78, P5983, DOI 10.1128/AEM.00104-12; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lin M, 2013, APPL MICROBIOL BIOT, V97, P8719, DOI 10.1007/s00253-013-5143-z; McAllister TA, 1996, CAN J ANIM SCI, V76, P231, DOI 10.4141/cjas96-035; McCann JC, 2014, BIOINFORM BIOL INSIG, V8, P109, DOI 10.4137/BBI.S15389; McCann JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091864; McGovern E, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01842; Myer PR, 2016, J ANIM SCI, V94, P327, DOI 10.2527/jas.2015-9839; Myer PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129174; Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494; Popova M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00937; POULSEN M, 2013, NATURE COMMUNICATION, V4, DOI DOI 10.1038/NCOMMS2497; Poulsen M, 2012, ANAEROBE, V18, P83, DOI 10.1016/j.anaerobe.2011.12.009; Ramirez HAR, 2012, CAN J ANIM SCI, V92, P365, DOI 10.4141/CJAS2011-133; Rius AG, 2012, J DAIRY SCI, V95, P5024, DOI 10.3168/jds.2012-5392; Roehe R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005846; Ross EM, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-53; Seedorf H, 2014, PEERJ, V2, DOI 10.7717/peerj.494; Singh KM, 2014, META GENE, V2, P191, DOI 10.1016/j.mgene.2014.01.001; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Veneman JB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140282; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zened A, 2013, FEMS MICROBIOL ECOL, V83, P504, DOI 10.1111/1574-6941.12011	44	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231759	10.1371/journal.pone.0231759	http://dx.doi.org/10.1371/journal.pone.0231759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330150	Green Published, gold			2022-12-26	WOS:000536647300022
J	Han, TZ; Mignatti, P; Abramson, SB; Attur, M				Han, Tianzhen; Mignatti, Paolo; Abramson, Steven B.; Attur, Mukundan			Periostin interaction with discoidin domain receptor-1 (DDR1) promotes cartilage degeneration	PLOS ONE			English	Article							GENE-EXPRESSION; ARTICULAR-CARTILAGE; BETA-CATENIN; OSTEOARTHRITIS; REVEALS; PATHWAY; IDENTIFICATION; DEGRADATION; INHIBITION; DISCOVERY	Osteoarthritis (OA) is characterized by progressive loss of articular cartilage accompanied by the new bone formation and, often, a synovial proliferation that culminates in pain, loss of joint function, and disability. However, the cellular and molecular mechanisms of OA progression and the relative contributions of cartilage, bone, and synovium remain unclear. We recently found that the extracellular matrix (ECM) protein periostin (Postn, or osteoblast-specific factor, OSF-2) is expressed at high levels in human OA cartilage. Multiple groups have also reported elevated expression of Postn in several rodent models of OA. We have previously reported that in vitro Postn promotes collagen and proteoglycan degradation in human chondrocytes through AKT/beta-catenin signaling and downstream activation of MMP-13 and ADAMTS4 expression. Here we show that Postn induces collagen and proteoglycan degradation in cartilage by signaling through discoidin domain receptor-1 (DDR1), a receptor tyrosine kinase. The genetic deficiency or pharmacological inhibition of DDR1 in mouse chondrocytes blocks Postn-induced MMP-13 expression. These data show that Postn is signaling though DDR1 is mechanistically involved in OA pathophysiology. Specific inhibitors of DDR1 may provide therapeutic opportunities to treat OA.	[Han, Tianzhen; Mignatti, Paolo; Abramson, Steven B.; Attur, Mukundan] NYU Langone Orthoped Hosp, NYU Grossman Sch Med, Div Rheumatol, Dept Med, New York, NY 10003 USA		Attur, M (corresponding author), NYU Langone Orthoped Hosp, NYU Grossman Sch Med, Div Rheumatol, Dept Med, New York, NY 10003 USA.	mukundan.attur@nyulangone.org	Attur, Mukundan/O-1578-2019	Attur, Mukundan/0000-0001-7080-8118; Mignatti, Paolo/0000-0002-8157-457X; Abramson, Steven/0000-0002-0668-6344	National Institute of Health [AR054817, AR068341, AR070934]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding for this project provided by the National Institute of Health grant AR054817, AR068341, and AR070934. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript	Alfieri C, 2015, NEPHROL DIAL TRANSPL, V30, P1965, DOI 10.1093/ndt/gfv074; Attur M, 2015, FASEB J, V29, P4107, DOI 10.1096/fj.15-272427; Balakrishnan L, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-6; Bonnet N, 2012, P NATL ACAD SCI USA, V109, P15048, DOI 10.1073/pnas.1203085109; Brophy RH, 2019, OSTEOARTHR CARTILAGE, V27, P1778, DOI 10.1016/j.joca.2019.08.002; Brophy RH, 2016, AM J SPORT MED, V44, P2064, DOI 10.1177/0363546516643810; Cai L, 2019, FASEB J, V33, P8386, DOI 10.1096/fj.201802281R; Chijimatsu R, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0682-3; Chinzei N, 2018, OSTEOARTHR CARTILAGE, V26, P588, DOI 10.1016/j.joca.2018.01.017; Chinzei N, 2019, ARTHRITIS RHEUMATOL, V71, P370, DOI 10.1002/art.40730; Chou CH, 2015, OSTEOARTHR CARTILAGE, V23, P571, DOI 10.1016/j.joca.2014.12.020; Chou CH, 2013, OSTEOARTHR CARTILAGE, V21, P450, DOI 10.1016/j.joca.2012.11.016; Chou CH, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4380; Coelho NM, 2018, CELL ADHES MIGR, V12, P348, DOI 10.1080/19336918.2018.1448353; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fu HL, 2013, J BIOL CHEM, V288, P7430, DOI 10.1074/jbc.R112.444158; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Hakuno D, 2010, J CLIN INVEST, V120, P2292, DOI 10.1172/JCI40973; Honsawek S, 2015, JOINT BONE SPINE, V82, P352, DOI 10.1016/j.jbspin.2015.01.023; Jia Y, 2019, LIFE SCI, V226, P91, DOI 10.1016/j.lfs.2019.04.021; Jonason JH, 2015, METHODS MOL BIOL, V1226, P11, DOI 10.1007/978-1-4939-1619-1_2; Karimaian A, 2017, DNA REPAIR, V51, P14, DOI 10.1016/j.dnarep.2017.01.003; Karlsson C, 2010, OSTEOARTHR CARTILAGE, V18, P581, DOI 10.1016/j.joca.2009.12.002; Katsara O, 2017, ARTHRITIS RHEUMATOL, V69, P586, DOI 10.1002/art.39947; Kerroch M, 2016, SCI REP-UK, V6, DOI 10.1038/srep21262; Kim BJ, 2015, BONE, V81, P435, DOI 10.1016/j.bone.2015.08.014; Kim HG, 2013, ACS CHEM BIOL, V8, P2145, DOI 10.1021/cb400430t; Kormann R, 2019, J AM SOC NEPHROL; Kumar P, 2018, J BIOL CHEM, V293, P12781, DOI 10.1074/jbc.RA117.001601; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Leitinger B, 2014, INT REV CEL MOL BIO, V310, P39, DOI 10.1016/B978-0-12-800180-6.00002-5; Li GH, 2010, ATHEROSCLEROSIS, V208, P358, DOI 10.1016/j.atherosclerosis.2009.07.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P705, DOI 10.1002/art.33388; Lourido L, 2014, J PROTEOME RES, V13, P6096, DOI 10.1021/pr501024p; MATSUZAWA M, 2015, J PERIODONTAL RES, V50, P855, DOI DOI 10.1111/JRE.12277; Nakazeki F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27009-9; Neuhaus B, 2011, CELL MOL LIFE SCI, V68, P3757, DOI 10.1007/s00018-011-0676-8; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Orecchia P, 2011, EUR J CANCER, V47, P2221, DOI 10.1016/j.ejca.2011.04.026; Rammal H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00055; Schminke B, 2014, CELL MOL LIFE SCI, V71, P1081, DOI 10.1007/s00018-013-1436-8; Soomro I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211670; Watanabe T, 2012, ARCH ORAL BIOL, V57, P52, DOI 10.1016/j.archoralbio.2011.07.010; Xu HF, 2011, MATRIX BIOL, V30, P16, DOI 10.1016/j.matbio.2010.10.004; Zhang R, 2012, PLOS ONE, V7, P10	49	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231501	10.1371/journal.pone.0231501	http://dx.doi.org/10.1371/journal.pone.0231501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330138	Green Published, gold			2022-12-26	WOS:000536647300015
J	Tassew, SG; Woldu, MA; Degu, WA; Shibeshi, W				Tassew, Segen Gebremeskel; Woldu, Minyahil Alebachew; Degu, Wondwossen Amogne; Shibeshi, Workineh			Management of hospital-acquired infections among patients hospitalized at Zewditu memorial hospital, Addis Ababa, Ethiopia: A prospective cross-sectional study	PLOS ONE			English	Article							CLINICAL-PRACTICE GUIDELINES; BLOOD-STREAM INFECTIONS; RISK-FACTORS; POINT PREVALENCE; DISEASES SOCIETY; NOSOCOMIAL INFECTIONS; SURVEILLANCE; AMERICA; PROPHYLAXIS; MORTALITY	Background Hospital-Acquired Infections (HAIs) are acquired when the patient is hospitalized for more than 48 hours. In Ethiopia data are scarce in management appropriateness of HAIs. Hence, this study was aimed to assess the prevalence and management of HAIs among patients admitted at Zewditu Memorial Hospital. Method A facility based prospective cross sectional study was conducted from March 1, 2017 to August 30, 2017. The sample was proportionally allocated among (medical, pediatrics, gynecology and obstetrics and surgical) wards, based on patient flow. Data were collected using data abstraction format and supplemented by key informant interview. Interview was made on eight physicians and four microbiologists who have been working in the wards during study period. Management appropriateness was assessed using Infectious Disease Society of America guideline and experts opinion (Infectious disease specialist). A multivariate logistic regression was used to identify factors associated with HAIs. Result The prevalence of HAIs was 19.8%. Surgical Site Infection (SSI) and pneumonia accounted for 20 (24.7%) of the infections. Culture and sensitivity was done for 24 (29.6%) patients. Of the 81 patients who developed HAIs, 54 (66.67%) of them were treated inappropriately. Physicians' response for this variation was information gap, forgetfulness, affordability and availability issue of first line medications. Younger age (AOR (Adjusted odds ratio) = 8.53, 95% CI: 2.67-27.30); male gender (AOR = 2.06, 95% CI: 1.01-4.22); longer hospital stay (AOR = 0.17, 95% CI: 0.06-0.51); and previous hospital admission (AOR = 3.22, 95% CI: 1.76-5.89); were independent predictors of HAIs. Conclusion Prevalence of HAIs and inappropriate management were substantially high in this study. Pneumonia and SSI were the common types of HAIs. Locally conformable guidelines could help to correct such problems.	[Tassew, Segen Gebremeskel] Mekelle Univ, Sch Pharm, Dept Clin Pharm, Coll Hlth Sci, Mekelle, Ethiopia; [Woldu, Minyahil Alebachew; Shibeshi, Workineh] Addis Ababa Univ, Sch Pharm, Dept Pharmacol & Clin Pharm, Coll Hlth Sci, Addis Ababa, Ethiopia; [Degu, Wondwossen Amogne] Addis Ababa Univ, Sch Med, Dept Internal Med, Coll Hlth Sci, Addis Ababa, Ethiopia	Mekelle University; Addis Ababa University; Addis Ababa University	Tassew, SG (corresponding author), Mekelle Univ, Sch Pharm, Dept Clin Pharm, Coll Hlth Sci, Mekelle, Ethiopia.	segengm@gmail.com	Degu, Wondwossen Amogne/GON-3590-2022; Woldu, Minyahil/ABD-9452-2020	Woldu, Minyahil/0000-0002-3163-0326; Gebremeskel, Segen/0000-0002-9308-6944				Abdulah R., 2012, PHARM REGUL AFF, V1, P2, DOI [10.4172/2167-7689.1000e106, DOI 10.4172/2167-7689.1000E106]; Ahoyo TA, 2014, ANTIMICROB RESIST IN, V3, DOI 10.1186/2047-2994-3-17; Amenu D, 2011, ETHIOP J HEALTH SCI, V21, P91; Amoran O, 2013, RATES RISK FACTORS A; [Anonymous], 2013, HLTH CAR ASS INF FAC; Asl HM, 2011, NATL NOSOCOMIAL INFE, P1; Assar S, 2012, SURVEY NOSOCOMIAL IN; Balkhy HH, 2006, INT J INFECT DIS, V10, P326, DOI 10.1016/j.ijid.2005.06.013; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Colpan A, 2005, AM J INFECT CONTROL, V33, P42, DOI 10.1016/j.ajic.2004.09.005; Dayanand M., 2004, MED J ARMED FORCES I, V60, P312, DOI [10.1016/S0377-1237(04)80079-0, DOI 10.1016/S0377-1237(04)80079-0]; Durando P, 2009, J HOSP INFECT, V71, P81, DOI 10.1016/j.jhin.2008.10.012; Elbur AI, 2012, INT J INFECT CONTROL, V8; Gailiene G, 2012, MED LITH, V48, P399; Garey KW, 2006, J ANTIMICROB CHEMOTH, V58, P645, DOI 10.1093/jac/dkl279; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Ginawi I, 2014, J CLIN DIAGN RES, V8, P81, DOI 10.7860/JCDR/2014/6673.4014; Gradel KO, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2233-z; Hajdu A, 2007, J HOSP INFECT, V66, P378, DOI 10.1016/j.jhin.2007.04.018; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Kallel H, 2005, J HOSP INFECT, V59, P343, DOI 10.1016/j.jhin.2004.09.015; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; King C, 2012, J HOSP INFECT, V82, P219, DOI 10.1016/j.jhin.2012.05.004; Laloto TL, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2167-x; Masterton R, 2003, J HOSP INFECT, V55, P1, DOI 10.1016/S0195-6701(03)00294-9; Mengesha Reiye Esayas, 2014, BMC Res Notes, V7, P575, DOI 10.1186/1756-0500-7-575; Messele G, 2009, ETHIOP J HLTH BIOMED, V2, P3; Miliani K, 2009, J ANTIMICROB CHEMOTH, V64, P1307, DOI 10.1093/jac/dkp367; Moyo S, 2010, SAMJ S AFR MED J, V100, P835, DOI 10.7196/SAMJ.4186; Mulu Andargachew, 2006, Ethiop Med J, V44, P125; Mulu W., 2013, CLIN MED RES, V2, P140, DOI DOI 10.11648/J.CMR.20130206.1514; Nair V, 2017, INDIAN J MED RES, V145, P824, DOI [10.4103/ijmr.IJMR_1167_15, 10.4103/ijmr.ijmr_1167_15]; Nejad Sepideh Bagheri, 2011, B WHO, V89; Nigatu Endalafer, 2011, Journal of Infection Prevention, V12, P38, DOI 10.1177/1757177410376680; Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14; Raveh D, 2001, QJM-INT J MED, V94, P141, DOI 10.1093/qjmed/94.3.141; Razine Rachid, 2012, Int Arch Med, V5, P26, DOI 10.1186/1755-7682-5-26; Singh Shivinder, 2013, Med J Armed Forces India, V69, P124, DOI 10.1016/j.mjafi.2012.08.028; Tabatabaei S.M., 2015, INT J INFECT, V2; Tadesse ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1221; Tunkel AR, 2017, CLIN INFECT DIS, V64, pE34, DOI 10.1093/cid/ciw861; Wassef MA, 2012, AFR J MICROBIOL RES, V6, P3072, DOI 10.5897/AJMR12.377; Yallew WW, 2016, DRUG HEALTHC PATIENT, V8, P71, DOI 10.2147/DHPS.S107344; Zaman M, 2014, BANGLADESH J DENT RE, V4, P49; Zarb P, 2012, EUROSURVEILLANCE, V17, P4; Zilberberg M, 2012, SURG INFECT, V13, P377, DOI 10.1089/sur.2011.101	46	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231949	10.1371/journal.pone.0231949	http://dx.doi.org/10.1371/journal.pone.0231949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330164	Green Published, gold			2022-12-26	WOS:000536647300033
J	Ghosh, R; Wood-Kaczmar, A; Dobson, L; Smith, EJ; Sirinathsinghji, EC; Kriston-Vizi, J; Hargreaves, IP; Heaton, R; Herrmann, F; Abramov, AY; Lam, AJ; Heales, SJ; Ketteler, R; Bates, GP; Andre, R; Tabrizi, SJ				Ghosh, Rhia; Wood-Kaczmar, Alison; Dobson, Lucianne; Smith, Edward J.; Sirinathsinghji, Eva C.; Kriston-Vizi, Janos; Hargreaves, Iain P.; Heaton, Robert; Herrmann, Frank; Abramov, Andrey Y.; Lam, Amanda J.; Heales, Simon J.; Ketteler, Robin; Bates, Gillian P.; Andre, Ralph; Tabrizi, Sarah J.			Expression of mutant exon 1 huntingtin fragments in human neural stem cells and neurons causes inclusion formation and mitochondrial dysfunction	FASEB JOURNAL			English	Article						aggregation; Huntington's; mitochondria; model; respiration	CELLULAR TOXICITY; SKELETAL-MUSCLE; CAG REPEAT; DISEASE; PROTEIN; AGGREGATION; METABOLISM; NUCLEAR; MODEL; DEATH	Robust cellular models are key in determining pathological mechanisms that lead to neurotoxicity in Huntington's disease (HD) and for high throughput pre-clinical screening of potential therapeutic compounds. Such models exist but mostly comprise non-human or non-neuronal cells that may not recapitulate the correct biochemical milieu involved in pathology. We have developed a new human neuronal cell model of HD, using neural stem cells (ReNcell VM NSCs) stably transduced to express exon 1 huntingtin (HTT) fragments with variable length polyglutamine (polyQ) tracts. Using a system with matched expression levels of exon 1 HTT fragments, we investigated the effect of increasing polyQ repeat length on HTT inclusion formation, location, neuronal survival, and mitochondrial function with a view to creating an in vitro screening platform for therapeutic screening. We found that expression of exon 1 HTT fragments with longer polyQ tracts led to the formation of intra-nuclear inclusions in a polyQ length-dependent manner during neurogenesis. There was no overt effect on neuronal viability, but defects of mitochondrial function were found in the pathogenic lines. Thus, we have a human neuronal cell model of HD that may recapitulate some of the earliest stages of HD pathogenesis, namely inclusion formation and mitochondrial dysfunction.	[Ghosh, Rhia; Wood-Kaczmar, Alison; Dobson, Lucianne; Smith, Edward J.; Sirinathsinghji, Eva C.; Bates, Gillian P.; Andre, Ralph; Tabrizi, Sarah J.] UCL, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, UCL Queen Sq Inst Neurol, London WC1N 3BG, England; [Kriston-Vizi, Janos; Ketteler, Robin] UCL, MRC Lab Mol Cell Biol, London, England; [Hargreaves, Iain P.; Heaton, Robert] Liverpool John Moores Univ, Sch Pharm, Liverpool, Merseyside, England; [Herrmann, Frank] Evotec AG, Hamburg, Germany; [Abramov, Andrey Y.] Univ Coll London, Dept Clin & Movement Neurosci, UCL Queen Sq Inst Neurol, London, Germany; [Lam, Amanda J.; Heales, Simon J.] Natl Hosp Neurol & Neurosurg, Neurometab Unit, London, Germany	University of London; University College London; MRC Laboratory Molecular Biology; University of London; University College London; Liverpool John Moores University; Evotec	Tabrizi, SJ (corresponding author), UCL, Huntingtons Dis Ctr, Dept Neurodegenerat Dis, UCL Queen Sq Inst Neurol, London WC1N 3BG, England.	s.tabrizi@ucl.ac.uk	Abramov, Andrey Y/H-9053-2012; Kriston-Vizi, Janos/L-6021-2013; Bates, Gillian/E-1146-2012	Abramov, Andrey Y/0000-0002-7646-7235; Kriston-Vizi, Janos/0000-0002-0149-145X; Bates, Gillian/0000-0002-4041-6305; Tabrizi, Sarah/0000-0003-2716-2045	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.); RCUK \ Medical Research Council (MRC) [MR/L02053X/1, MR/M02492X/1, MC_U12266B]; MRC [UKDRI-1008/1, UKDRI-1008/2, MR/L02053X/1, MR/M02492X/1, MR/K023268/1] Funding Source: UKRI	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.); RCUK \ Medical Research Council (MRC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Takeda Pharmaceutical Company (Takeda Pharmaceutical Co., Ltd.); RCUK vertical bar Medical Research Council (MRC), Grant/Award Number: MR/L02053X/1, MR/M02492X/1 and LMCB; MC_U12266B	An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026; ANDREW SE, 1993, NAT GENET, V4, P398, DOI 10.1038/ng0893-398; [Anonymous], 2018, R LANG ENV STAT COMP; Antoniou M, 2003, GENOMICS, V82, P269, DOI 10.1016/S0888-7543(03)00107-1; Apostol BL, 2003, P NATL ACAD SCI USA, V100, P5950, DOI 10.1073/pnas.2628045100; Barbaro BA, 2015, HUM MOL GENET, V24, P913, DOI 10.1093/hmg/ddu504; Bayram-Weston Z, 2012, BRAIN RES BULL, V88, P104, DOI 10.1016/j.brainresbull.2011.07.009; Clemens LE, 2015, BRAIN, V138, P3632, DOI 10.1093/brain/awv290; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Donato R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-36; Duncan AJ, 2005, CLIN CHEM, V51, P2380, DOI 10.1373/clinchem.2005.054643; Gandhi S, 2009, MOL CELL, V33, P627, DOI 10.1016/j.molcel.2009.02.013; Germain PL, 2017, STEM CELL REP, V8, P1784, DOI 10.1016/j.stemcr.2017.05.012; Gouarne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081528; Grima JC, 2017, NEURON, V94, P93, DOI 10.1016/j.neuron.2017.03.023; Guedes-Dias P, 2016, NEUROBIOL DIS, V90, P51, DOI 10.1016/j.nbd.2015.09.008; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hamilton J, 2015, HUM MOL GENET, V24, P4862, DOI 10.1093/hmg/ddv209; Hargreaves IP, 1999, J INHERIT METAB DIS, V22, P925, DOI 10.1023/A:1005643508075; Hatefi Y, 1978, Methods Enzymol, V53, P21; HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Hughes A., 2014, HUNTINGTONS DIS; Ismailoglu I, 2014, DEV BIOL, V391, P230, DOI 10.1016/j.ydbio.2014.04.005; Jacquard C, 2006, FASEB J, V20, P1021, DOI 10.1096/fj.05-5085fje; Kim YH, 2015, NAT PROTOC, V10, P985, DOI 10.1038/nprot.2015.065; Kim YE, 2016, MOL CELL, V63, P951, DOI 10.1016/j.molcel.2016.07.022; King T.E., 1967, METHODS ENZYMOL, P216, DOI DOI 10.1016/0076-6879(67)10043-8; Kirby DM, 2007, METHOD CELL BIOL, V80, P93, DOI 10.1016/S0091-679X(06)80004-X; Ko J, 2018, HUM MOL GENET, V27, P2330, DOI 10.1093/hmg/ddy141; Labbadia J, 2012, BRAIN, V135, P1180, DOI 10.1093/brain/aws022; Labbadia J, 2011, J CLIN INVEST, V121, P3306, DOI 10.1172/JCI57413; Li H, 2003, HUM MOL GENET, V12, P2021, DOI 10.1093/hmg/ddg218; Lopez LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011897; Lou S, 2016, HUM MOL GENET, V25, P2813, DOI 10.1093/hmg/ddw138; Lu BX, 2013, FASEB J, V27, P1820, DOI 10.1096/fj.12-219220; Macdonald D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096854; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Mejia EM, 2016, LIPIDS, V51, P561, DOI 10.1007/s11745-015-4110-0; Miller J, 2010, J NEUROSCI, V30, P10541, DOI 10.1523/JNEUROSCI.0146-10.2010; Nekooki-Machida Y, 2009, P NATL ACAD SCI USA, V106, P9679, DOI 10.1073/pnas.0812083106; Neueder A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01510-z; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Polyzos AA, 2017, MECH AGEING DEV, V161, P181, DOI 10.1016/j.mad.2016.09.003; Rahman S, 2001, J PEDIATR-US, V139, P456, DOI 10.1067/mpd.2001.117575; Ramdzan YM, 2017, CELL REP, V19, P919, DOI 10.1016/j.celrep.2017.04.029; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Sahoo B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155747; Sathasivam K, 2013, P NATL ACAD SCI USA, V110, P2366, DOI 10.1073/pnas.1221891110; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1999, P NATL ACAD SCI USA, V96, P4604, DOI 10.1073/pnas.96.8.4604; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selak MA, 2000, PEDIATR NEUROL, V23, P54, DOI 10.1016/S0887-8994(00)00145-4; SIMPSON JR, 1993, EXP NEUROL, V121, P57, DOI 10.1006/exnr.1993.1071; Woerner AC, 2016, SCIENCE, V351, P173, DOI 10.1126/science.aad2033; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yang SH, 2008, NATURE, V453, P921, DOI 10.1038/nature06975; Ye CF, 2008, NEUROSCI LETT, V442, P63, DOI 10.1016/j.neulet.2008.05.119	58	12	12	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8139	8154		10.1096/fj.201902277RR	http://dx.doi.org/10.1096/fj.201902277RR		APR 2020	16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329133	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000529446100001
J	Macaulay, AD; Allais, A; FitzHarris, G				Macaulay, Angus D.; Allais, Adelaide; FitzHarris, Greg			Chromosome dynamics and spindle microtubule establishment in mouse embryos	FASEB JOURNAL			English	Article						embryo; error correction; mitosis; spindle	AURORA C; SEGREGATION; CENTROSOME; MECHANISMS; MOSAICISM; MTOCS; CONSEQUENCES; ORGANIZATION; INHERITANCE; ANEUPLOIDY	Chromosome segregation errors in mammalian embryos are common and jeopardize embryo health. Here, we perform for the first time 4-Dimensional imaging and tracking of chromosomes and centromeres through each preimplantation mitotic cell division in mouse embryos to define the normal dynamics of chromosome segregation. We show that a microtubule (MT)-dependent inward movement of chromosomes occurs at the time of nuclear envelope breakdown (NEBD), particularly in the earliest cell divisions, to position chromosomes prior to spindle assembly. Establishment of a rudimentary metaphase plate occurs immediately after NEBD, and is followed by a progressive alignment and biorientation of mitotic chromosomes. Stable end-on kinetochore-MT attachments form rapidly and attachment errors are uncommon. Altogether our data describe a rapid and efficient spindle assembly pathway that apparently minimizes the need for canonical MT attachment error correction in normally dividing embryos.	[Macaulay, Angus D.; Allais, Adelaide; FitzHarris, Greg] Ctr Rech Ctr Hosp Univ Montreal, 900 St Denis St, Montreal, PQ H2X 3H8, Canada; [FitzHarris, Greg] Univ Montreal, Dept OBGYN, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal	FitzHarris, G (corresponding author), Ctr Rech Ctr Hosp Univ Montreal, 900 St Denis St, Montreal, PQ H2X 3H8, Canada.	greg.fitzharris@umontreal.ca		Macaulay, Angus/0000-0001-8638-5068	Gouvernement du Canada \ CIHR \ Institute of Human Development, Child and Youth Health (IHDCYH); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Fondation Jean-Louis Levesque (Fondation J Louis Levesque)	Gouvernement du Canada \ CIHR \ Institute of Human Development, Child and Youth Health (IHDCYH); Gouvernement du Canada \ Natural Sciences and Engineering Research Council of Canada (NSERC); Fondation Jean-Louis Levesque (Fondation J Louis Levesque)	Gouvernement du Canada vertical bar CIHR vertical bar Institute of Human Development, Child and Youth Health (IHDCYH); Gouvernement du Canada vertical bar Natural Sciences and Engineering Research Council of Canada (NSERC); Fondation Jean-Louis Levesque (Fondation J Louis Levesque)	Ajduk A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09526-1; Beaudouin J, 2002, CELL, V108, P83, DOI 10.1016/S0092-8674(01)00627-4; Bennabi I, 2016, J CELL BIOL, V215, P611, DOI 10.1083/jcb.201607062; Bolton H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11165; Booth AJR, 2019, ELIFE, V8, DOI 10.7554/eLife.46902; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Courtois A, 2012, J CELL BIOL, V198, P357, DOI 10.1083/jcb.201202135; Davydenko O, 2013, J CELL BIOL, V202, P221, DOI 10.1083/jcb.201303019; Delattre M, 2004, J CELL SCI, V117, P1619, DOI 10.1242/jcs.01128; DELHANTY JDA, 1993, HUM MOL GENET, V2, P1183, DOI 10.1093/hmg/2.8.1183; Fernandez-Miranda G, 2011, DEVELOPMENT, V138, P2661, DOI 10.1242/dev.066381; Gregan J, 2011, TRENDS CELL BIOL, V21, P374, DOI 10.1016/j.tcb.2011.01.003; GUETHHALLONET C, 1993, J CELL SCI, V105, P157; Heald R, 2015, J CELL BIOL, V211, P1103, DOI 10.1083/jcb.201510015; Howe K, 2013, CELL CYCLE, V12, P1616, DOI 10.4161/cc.24755; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lampson MA, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6010001; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Luksza M, 2013, DEV BIOL, V382, P48, DOI 10.1016/j.ydbio.2013.07.029; Magidson V, 2011, CELL, V146, P555, DOI 10.1016/j.cell.2011.07.012; Michel L, 2004, P NATL ACAD SCI USA, V101, P4459, DOI 10.1073/pnas.0306069101; Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094; Mihajlovic AI, 2018, CURR BIOL, V28, pR895, DOI 10.1016/j.cub.2018.06.057; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Mogessie B, 2017, SCIENCE, V357, DOI 10.1126/science.aal1647; MUNNE S, 1994, BIOL REPROD, V51, P373, DOI 10.1095/biolreprod51.3.373; Munne S, 2017, FERTIL STERIL, V108, P62, DOI 10.1016/j.fertnstert.2017.05.002; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nakagawa S, 2017, CURR BIOL, V27, P1040, DOI 10.1016/j.cub.2017.02.025; Nakagawa S, 2016, METHODS MOL BIOL, V1457, P217, DOI 10.1007/978-1-4939-3795-0_16; Paim LMG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12772-8; Reichmann J, 2018, SCIENCE, V361, P189, DOI 10.1126/science.aar7462; Salmon ED, 2005, PHILOS T R SOC B, V360, P553, DOI 10.1098/rstb.2004.1610; SCHATTEN G, 1994, DEV BIOL, V165, P299, DOI 10.1006/dbio.1994.1256; Schindler K, 2012, P NATL ACAD SCI USA, V109, pE2215, DOI 10.1073/pnas.1120517109; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Sikora-Polaczek M, 2006, BIOL REPROD, V74, P734, DOI 10.1095/biolreprod.105.047092; Taylor TH, 2014, HUM REPROD UPDATE, V20, P571, DOI 10.1093/humupd/dmu016; Thompson SL, 2011, P NATL ACAD SCI USA, V108, P17974, DOI 10.1073/pnas.1109720108; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Tsichlaki E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28040; Vazquez-Diez C, 2019, CURR BIOL, V29, P865, DOI 10.1016/j.cub.2018.12.042; Vazquez-Diez C, 2018, REPRODUCTION, V155, pR63, DOI 10.1530/REP-17-0569; Vazquez-Diez C, 2016, P NATL ACAD SCI USA, V113, P626, DOI 10.1073/pnas.1517628112; Yamagata K, 2013, CELL CYCLE, V12, P157, DOI 10.4161/cc.23052	47	2	2	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8057	8067		10.1096/fj.201902947R	http://dx.doi.org/10.1096/fj.201902947R		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329130				2022-12-26	WOS:000529446900001
J	Peng, C; Xu, ZW; Mei, M				Peng, Cong; Xu, Zhongwei; Mei, Meng			Applying aspiration in local search for satisfiability	PLOS ONE			English	Article							CONFIGURATION CHECKING; ROUTABILITY; HEURISTICS; ALGORITHM	The Boolean Satisfiability problem (SAT) is a prototypical NP-complete problem, which has been widely studied due to its significant importance in both theory and applications. Stochastic local search (SLS) algorithms are among the most efficient approximate methods available for solving certain types of SAT instances. The quantitative configuration checking (QCC) heuristic is an effective approach for improving SLS algorithms on solving the SAT problem, resulting in an efficient SLS solver for SAT named Swqcc. In this paper, we focus on combining the QCC heuristic with an aspiration mechanism, and then design a new heuristic called QCCA. On the top of Swqcc, we utilize the QCCA heuristic to develop a new SLS solver dubbed AspiSAT. Through extensive experiments, the results illustrate that, on random 3-SAT instances, the performance of AspiSAT is much better than that of Swqcc and Sparrow, which is an influential and efficient SLS solver for SAT. In addition, we further enhance the original clause weighting schemes employed in Swqcc and AspiSAT, and thus obtain two new SLS solvers called Ptwqcc and AspiPT, respectively. The eperimental results present that both Ptwqcc and AspiPT outperform Swqcc and AspiSAT on random 5-SAT instances, indicating that both QCC and QCCA heuristics are able to cooperate effectively with different clause weighting schemes.	[Peng, Cong; Xu, Zhongwei; Mei, Meng] Tongji Univ, Sch Elect Informat Engn, Shanghai, Peoples R China; [Peng, Cong] Leiden Univ, LIACS, Leiden, Netherlands	Tongji University; Leiden University; Leiden University - Excl LUMC	Peng, C (corresponding author), Tongji Univ, Sch Elect Informat Engn, Shanghai, Peoples R China.; Peng, C (corresponding author), Leiden Univ, LIACS, Leiden, Netherlands.	ppcc1988@outlook.com		Peng, Cong/0000-0001-8070-9092	National Science and Technology Key Plan of China [2017YFB120110508]; National Natural Science Foundation of China [U1734211]; national CSC Scholarship	National Science and Technology Key Plan of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); national CSC Scholarship	This work was supported in part by the National Science and Technology Key Plan of China under Grant 2017YFB120110508 to ZX, in part by the National Natural Science Foundation of China under Grant U1734211 to ZX, and in part by the national CSC Scholarship to CP.	Achlioptas D, 2009, FRONT ARTIF INTEL AP, V185, P245, DOI 10.3233/978-1-58603-929-5-245; Aurell E., 2004, ADV NEURAL INFORM PR, V17, P49; Balint A, 2010, LECT NOTES COMPUT SC, V6175, P10, DOI 10.1007/978-3-642-14186-7_3; Biere A., 1999, Proceedings 1999 Design Automation Conference (Cat. No. 99CH36361), P317, DOI 10.1109/DAC.1999.781333; Cai S., 2012, P 26 AAAI C ART INT; Cai SW, 2017, PROCEEDINGS OF THE TWENTY-SIXTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P571; Cai SW, 2015, PROCEEDINGS OF THE TWENTY-FOURTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE (IJCAI), P747; Cai SW, 2013, ARTIF INTELL, V204, P75, DOI 10.1016/j.artint.2013.09.001; Cai SW, 2013, J ARTIF INTELL RES, V46, P687, DOI 10.1613/jair.3907; Cai SW, 2011, PROC INT C TOOLS ART, P59, DOI 10.1109/ICTAI.2011.18; Cai SW, 2011, ARTIF INTELL, V175, P1672, DOI 10.1016/j.artint.2011.03.003; Chu Y, 2019, FRONT COMPUT SCI-CHI, V13, P86, DOI 10.1007/s11704-018-7107-z; DAVIS M, 1962, COMMUN ACM, V5, P394, DOI 10.1145/368273.368557; Duong TN, 2013, IJCAI 2013 P 23 INT, P524; Gableske O, 2011, LECT NOTES COMPUT SC, V6695, P367; GENT IP, 1993, PROCEEDINGS OF THE ELEVENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P28; GU J, 1993, IEEE T SYST MAN CYB, V23, P1108, DOI 10.1109/21.247892; Hoos H. H., 2004, STOCHASTIC LOCAL SEA; Hoos HH, 2002, EIGHTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-02)/FOURTEENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE CONFERENCE (IAAI-02), PROCEEDINGS, P655; Hoos HH, 1999, SIXTEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE (AAAI-99)/ELEVENTH INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE (IAAI-99), P661; Hung WNN, 2006, IEEE T COMPUT AID D, V25, P1652, DOI 10.1109/TCAD.2005.858352; Hung WNN, 2004, ACM T DES AUTOMAT EL, V9, P517, DOI 10.1145/1027084.1027090; Hung WNN, 2004, IEEE T VLSI SYST, V12, P1371, DOI 10.1109/TVLSI.2004.837999; Hung WNN, 2004, INT HIGH LEVEL DESIG, P9, DOI 10.1109/HLDVT.2004.1431221; Hung WNN, 2007, ABS07054320 CORR; Hutter F., 2002, Principles and Practice of Constraint Programming - CP 2002. 8th International Conference, CP 2002. Proceedings (Lecture Notes in Computer Science Vol.2470), P233; Kautz H, 2009, FRONT ARTIF INTEL AP, V185, P185, DOI 10.3233/978-1-58603-929-5-185; LARRABEE T, 1992, IEEE T COMPUT AID D, V11, P4, DOI 10.1109/43.108614; Lei ZD, 2018, PROCEEDINGS OF THE TWENTY-SEVENTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P1346; Li C.M., 2012, LNCS, V7317, P477, DOI [10.1007/978-3-642-31612-843, DOI 10.1007/978-3-642-31612-843]; Li CM, 2007, LECT NOTES COMPUT SC, V4501, P121; Li CM, 2005, LECT NOTES COMPUT SC, V3569, P158; LI QL, 2012, THEOR APPL SAT TEST, P475; Li WQ, 2002, IEEE T SYST MAN CY A, V32, P173, DOI 10.1109/TSMCA.2002.1021106; Luo C, 2017, ARTIF INTELL, V243, P26, DOI 10.1016/j.artint.2016.11.001; Luo C, 2015, IEEE T COMPUT, V64, P1830, DOI 10.1109/TC.2014.2346196; Luo C, 2015, IEEE T CYBERNETICS, V45, P1014, DOI 10.1109/TCYB.2014.2343242; Luo C, 2012, FRONT ARTIF INTEL AP, V242, P570, DOI 10.3233/978-1-61499-098-7-570; Luo C, 2014, AAAI CONF ARTIF INTE, P2703; McAllester D., 1997, P 14 NAT C ART INT A, P321; Michiels W, 2007, AN EATCS SERIES; Pham DN, 2008, J SATISFIABILITY BOO, V4, P149; Salhi S, 2002, COMPUT OPER RES, V29, P67, DOI 10.1016/S0305-0548(00)00062-9; SELMAN B, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P440; SELMAN B, 1994, PROCEEDINGS OF THE TWELFTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS 1 AND 2, P337; Song XY, 2003, IEEE T VLSI SYST, V11, P511, DOI 10.1109/TVLSI.2003.812322; Thornton J, 2004, PROCEEDING OF THE NINETEENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE AND THE SIXTEENTH CONFERENCE ON INNOVATIVE APPLICATIONS OF ARTIFICIAL INTELLIGENCE, P191; Tompkins DAD, 2011, LECT NOTES COMPUT SC, V6695, P302; Wood R, 1997, FPGA, P119, DOI DOI 10.1145/258305.258322; Yin LZ, 2012, IEEE T COMPUT, V61, P420, DOI 10.1109/TC.2010.270	50	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231702	10.1371/journal.pone.0231702	http://dx.doi.org/10.1371/journal.pone.0231702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324765	Green Published, gold			2022-12-26	WOS:000536033700030
J	Koch, CW; Cooper, LW; Lalande, C; Brown, TA; Frey, KE; Grebmeier, JM				Koch, Chelsea Wegner; Cooper, Lee W.; Lalande, Catherine; Brown, Thomas A.; Frey, Karen E.; Grebmeier, Jacqueline M.			Seasonal and latitudinal variations in sea ice algae deposition in the Northern Bering and Chukchi Seas determined by algal biomarkers	PLOS ONE			English	Article							BRANCHED ISOPRENOID ALKENES; MACKENZIE SHELF; CHLOROPHYLL-A; H-PRINT; PHYTOPLANKTON; SEDIMENTS; COVER; PROXY; IP25; IDENTIFICATION	An assessment of the production, distribution and fate of highly branched isoprenoid (HBI) biomarkers produced by sea ice and pelagic diatoms is necessary to interpret their detection and proportions in the northern Bering and Chukchi Seas. HBIs measured in surface sediments collected from 2012 to 2017 were used to determine the distribution and seasonality of the biomarkers relative to sea ice patterns. A northward gradient of increasing ice algae deposition was observed with localized occurrences of elevated IP25 (sympagic HBI) concentrations from 68-70 degrees N and consistently strong sympagic signatures from 71-72.5 degrees N. A declining sympagic signature was observed from 2012 to 2017 in the northeast Chukchi Sea, coincident with declining sea ice concentrations. HBI fluxes were investigated on the northeast Chukchi shelf with a moored sediment trap deployed from August 2015 to July 2016. Fluxes of sea ice exclusive diatoms (Nitzschia frigida and Melosira arctica) and HBI-producing taxa (Pleurosigma, Haslea and Rhizosolenia spp.) were measured to confirm HBI sources and ice associations. IP25 was detected year-round, increasing in March 2016 (10 ng m(-2) d(-1)) and reaching a maximum in July 2016 (1331 ng m(-2) d(-1)). Snowmelt triggered the release of sea ice algae into the water column in May 2016, while under-ice pelagic production contributed to the diatom export in June and July 2016. Sea ice diatom fluxes were strongly correlated with the IP25 flux, however associations between pelagic diatoms and HBI fluxes were inconclusive. Bioturbation likely facilitates sustained burial of sympagic organic matter on the shelf despite the occurrence of pelagic diatom blooms. These results suggest that sympagic diatoms may sustain the food web through winter on the northeast Chukchi shelf. The reduced relative proportions of sympagic HBIs in the northern Bering Sea are likely driven by sea ice persistence in the region.	[Koch, Chelsea Wegner; Cooper, Lee W.] Univ Maryland, Ctr Environm Sci, Solomons, MD 20688 USA; [Lalande, Catherine] Univ Laval, Amundsen Sci, Quebec City, PQ, Canada; [Brown, Thomas A.] Scottish Assoc Marine Sci, Oban, Argyll, Scotland; [Frey, Karen E.; Grebmeier, Jacqueline M.] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA	University System of Maryland; University of Maryland Center for Environmental Science; Laval University; UHI Millennium Institute; Clark University	Koch, CW (corresponding author), Univ Maryland, Ctr Environm Sci, Solomons, MD 20688 USA.	cwegner@umces.edu	Cooper, Lee W./E-5251-2012; Grebmeier, Jacqueline/L-9805-2013; Koch, Chelsea Wegner/O-6580-2018	Cooper, Lee W./0000-0001-7734-8388; Grebmeier, Jacqueline/0000-0001-7624-3568; Koch, Chelsea Wegner/0000-0003-0684-9657	NSF Arctic Observing Network program [1204082, 1702456, 1917469, 1204044, 1702137, 1917434]; NOAA Arctic Research Program [CINAR 22309.07]; U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Alaska Outer Continental Shelf Region [M11AC00007]; University of Texas at Austin as part of the Chukchi Sea Offshore Monitoring in Drilling Area (COMIDA); BOEM Alaska Environmental Studies Program; North Pacific Research Board Graduate Research Award; Cove Point Natural Heritage Trust; Chesapeake Biological Laboratory Graduate Education Committee	NSF Arctic Observing Network program; NOAA Arctic Research Program; U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Alaska Outer Continental Shelf Region; University of Texas at Austin as part of the Chukchi Sea Offshore Monitoring in Drilling Area (COMIDA); BOEM Alaska Environmental Studies Program; North Pacific Research Board Graduate Research Award; Cove Point Natural Heritage Trust; Chesapeake Biological Laboratory Graduate Education Committee	Financial support was provided by grants from the NSF Arctic Observing Network program (1204082,1702456 and 1917469 to J. Grebmeier and L. Cooper; 1204044,1702137 and 1917434 to K. Frey, https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=503222) and NOAA Arctic Research Program (CINAR 22309.07_UMCES_Grebmeier, https://arctic.noaa.gov/) to J. Grebmeier and L. Cooper. Research cruises in 2012 and 2013 were part of the Hanna Shoal Ecosystem Study for the COMIDA project funded by the U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Alaska Outer Continental Shelf Region, Anchorage, Alaska (https://www.boem.gov/regions/alaska-ocs-region/alaska-ocs-region) under BOEM Cooperative Agreement No. M11AC00007 with The University of Texas at Austin as part of the Chukchi Sea Offshore Monitoring in Drilling Area (COMIDA) and the BOEM Alaska Environmental Studies Program (https://www.boem.gov/about-boem/alaskaenvironmental-studies), to PIs J. Grebmeier and L. Cooper. Additional funding support was provided to C. Wegner (Koch) by the North Pacific Research Board Graduate Research Award (https://www.nprb.org/), the Cove Point Natural Heritage Trust (http://www.covepoint-trust.org/) and the Chesapeake Biological Laboratory Graduate Education Committee (https://www.umces.edu/cbl).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiraux R, 2019, TEMPORAL EVOLUTION I; Amiraux R, 2017, MAR CHEM, V194, P89, DOI 10.1016/j.marchem.2017.05.006; Arrigo KR, 2014, DEEP-SEA RES PT II, V105, P1, DOI 10.1016/j.dsr2.2014.03.018; Arrigo KR, 2014, ANNU REV MAR SCI, V6, P439, DOI 10.1146/annurev-marine-010213-135103; Bai YC, 2019, PROG OCEANOGR, V171, P22, DOI 10.1016/j.pocean.2018.12.002; BASKARAN M, 1995, GEOCHIM COSMOCHIM AC, V59, P4435, DOI 10.1016/0016-7037(95)00248-X; Belt ST, 2007, ORG GEOCHEM, V38, P16, DOI 10.1016/j.orggeochem.2006.09.013; Belt ST, 2018, ORG GEOCHEM, V125, P277, DOI 10.1016/j.orggeochem.2018.10.002; Belt ST, 2018, ORG GEOCHEM, V118, P1, DOI 10.1016/j.orggeochem.2018.01.008; Belt ST, 2017, ORG GEOCHEM, V110, P65, DOI 10.1016/j.orggeochem.2017.05.007; Belt ST, 2013, ORG GEOCHEM, V62, P33, DOI 10.1016/j.orggeochem.2013.07.002; Belt ST, 2013, QUATERNARY SCI REV, V79, P9, DOI 10.1016/j.quascirev.2012.12.001; Belt ST, 2012, ANAL METHODS-UK, V4, P705, DOI 10.1039/c2ay05728j; Belt ST, 2000, CHEM COMMUN, P501, DOI 10.1039/a909670a; Brown T, 2011, PRODUCTION PRESERVAT; Brown T, ORGANIC GEOCHEMISTRY, V2020, P103977; Brown TA, 2014, ENVIRON CHEM LETT, V12, P455, DOI 10.1007/s10311-014-0472-4; Brown TA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5197; Brown TA, 2018, POLAR BIOL, V41, P1901, DOI 10.1007/s00300-018-2317-2; Brown TA, 2011, POLAR BIOL, V34, P1857, DOI 10.1007/s00300-010-0942-5; Collins LG, 2013, QUATERNARY SCI REV, V79, P87, DOI 10.1016/j.quascirev.2013.02.004; Cooper L.W., 1998, CHEM ECOL, V15, P27; Cooper LW, 2018, DEEP-SEA RES PT II, V152, P48, DOI 10.1016/j.dsr2.2018.01.009; Dezutter T, 2019, PROG OCEANOGR, V173, P66, DOI 10.1016/j.pocean.2019.02.008; Ellegaard M, 2018, BIOL REV, V93, P166, DOI 10.1111/brv.12338; Fetterer F., 2017, SEA ICE INDEX VERSIO, DOI [DOI 10.7265/N5K072F8(2022, 10.7265/N5K072F8(2022]; Fortier M, 2002, MAR ECOL PROG SER, V225, P1, DOI 10.3354/meps225001; Frey K.E., 2018, NOAA ARCTIC REPORT C, V2018; Frey KE, 2015, PROG OCEANOGR, V136, P32, DOI 10.1016/j.pocean.2015.05.009; Gong DL, 2015, DEEP-SEA RES PT II, V118, P18, DOI 10.1016/j.dsr2.2015.02.006; Gosselin M, 1997, DEEP-SEA RES PT II, V44, P1623, DOI 10.1016/S0967-0645(97)00054-4; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; Grebmeier JM, 2006, PROG OCEANOGR, V71, P331, DOI 10.1016/j.pocean.2006.10.001; Grebmeier JM, 2018, OCEANOGRAPHY, V31, P136, DOI 10.5670/oceanog.2018.224; Grebmeier JM, 2015, PROG OCEANOGR, V136, P92, DOI 10.1016/j.pocean.2015.05.006; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; Grebmeier JM, 2019, SURFACE SEDIMENT SAM, DOI [10.18739/A2HH6C58X, DOI 10.18739/A2HH6C58X]; GREBMEIER JM, 2010, EOS, V91, P161, DOI DOI 10.1029/2010EO180001; Grebmeier JM, 2019, OCEAN SEDIMENT GRAIN, DOI [10.18739/A2BR8MG32, DOI 10.18739/A2BR8MG32]; Grebmeier JM, 2019, SURFACE SEDIMENT SAM, DOI [10.18739/A2WH2DF2X, DOI 10.18739/A2WH2DF2X]; Grebmeier JM, 2019, SURFACE SEDIMENT SAM, DOI 10.18739/A2XD0QX8B; Grebmeier JM, 2017, SURFACE SEDIMENT SAM, DOI [10.18739/A2804XK1F, DOI 10.18739/A2804XK1F]; Hauri C., 2018, OCEAN SCI DISCUSSION, P1, DOI [10.5194/os-2018-82, DOI 10.5194/OS-2018-82]; Hill V, 2018, DEEP-SEA RES PT II, V152, P82, DOI 10.1016/j.dsr2.2016.12.015; Horner R.A., 1989, P123; Jay CV, 2017, J MAMMAL, V98, P386, DOI 10.1093/jmammal/gyw195; Jay CV, 2012, MAR ECOL PROG SER, V468, P1, DOI 10.3354/meps10057; Juul-Pedersen T, 2008, MAR ECOL PROG SER, V353, P13, DOI 10.3354/meps07165; Lalande C, 2007, CONT SHELF RES, V27, P2051, DOI 10.1016/j.csr.2007.05.005; Lalande C, 2020, DEEP-SEA RES PT II, V177, DOI 10.1016/j.dsr2.2020.104730; Lalande C, 2019, GEOPHYS RES LETT, V46, P5959, DOI 10.1029/2019GL083167; LEGENDRE L, 1992, POLAR BIOL, V12, P429; Limoges A, 2018, FRONT EARTH SC-SWITZ, V6, DOI 10.3389/feart.2018.00226; LITZ BT, 1992, CLIN PSYCHOL REV, V12, P417, DOI 10.1016/0272-7358(92)90125-R; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Moore SE, 2018, ARCTIC, V71, DOI 10.14430/arctic4606; Muller J, 2011, EARTH PLANET SC LETT, V306, P137, DOI 10.1016/j.epsl.2011.04.011; North CA, 2014, ECOL APPL, V24, P1525, DOI 10.1890/13-0486.1; Pirtle-Levy R, 2009, DEEP-SEA RES PT II, V56, P1326, DOI 10.1016/j.dsr2.2008.10.022; Poulin Michel, 2011, Marine Biodiversity, V41, P13, DOI 10.1007/s12526-010-0058-8; R Core Team, 2021, R LANGUAGE ENV STAT; RIEBESELL U, 1991, POLAR BIOL, V11, P239; Riedel A, 2006, AQUAT MICROB ECOL, V45, P195, DOI 10.3354/ame045195; ROACH AT, 1995, J GEOPHYS RES-OCEANS, V100, P18443, DOI 10.1029/95JC01673; Rontani JF, 2019, ORG GEOCHEM, V129, P63, DOI 10.1016/j.orggeochem.2019.02.002; Rontani JF, 2018, ORG GEOCHEM, V118, P73, DOI 10.1016/j.orggeochem.2018.01.003; Schlitzer R., 2016, OCEAN DATA VIEW; Selz V, 2018, LIMNOL OCEANOGR, V63, P1109, DOI 10.1002/lno.10757; Serreze MC, 2019, ANN NY ACAD SCI, V1436, P36, DOI 10.1111/nyas.13856; Smik L, 2016, ORG GEOCHEM, V92, P63, DOI 10.1016/j.orggeochem.2015.12.007; Stabeno PJ, 2019, DEEP-SEA RES PT II, V162, P8, DOI 10.1016/j.dsr2.2018.11.006; Steward GF, 1996, MAR ECOL PROG SER, V131, P287, DOI 10.3354/meps131287; Szymanski A, 2016, POLAR BIOL, V39, P309, DOI 10.1007/s00300-015-1783-z; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; VOLKMAN JK, 1994, ORG GEOCHEM, V21, P407, DOI 10.1016/0146-6380(94)90202-X; Wang MY, 2018, DEEP-SEA RES PT II, V152, P22, DOI 10.1016/j.dsr2.2017.11.017; Weingartner T, 2005, DEEP-SEA RES PT II, V52, P3150, DOI 10.1016/j.dsr2.2005.10.015; Weingartner T, 2017, DEEP-SEA RES PT II, V144, P6, DOI 10.1016/j.dsr2.2017.08.006; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Woodgate RA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021747; Woodgate RA, 2005, DEEP-SEA RES PT II, V52, P3116, DOI 10.1016/j.dsr2.2005.10.016; Woodgate RA, 2018, PROG OCEANOGR, V160, P124, DOI 10.1016/j.pocean.2017.12.007; Xiaotong XT, 2015, GEOCHIM COSMOCHIM AC, V155, P16, DOI 10.1016/j.gca.2015.01.029	84	18	18	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231178	10.1371/journal.pone.0231178	http://dx.doi.org/10.1371/journal.pone.0231178			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LL8ZL	32320403	gold, Green Published			2022-12-26	WOS:000531842400001
J	Kojima, Y; Fukusaki, C; Ishii, N				Kojima, Yuta; Fukusaki, Chiho; Ishii, Naokata			Effects of hyperoxia on dynamic muscular endurance are associated with individual whole-body endurance capacity	PLOS ONE			English	Article							ARTERIAL OXYGEN-CONTENT; O-2 UPTAKE; EXERCISE TOLERANCE; PERCEIVED EXERTION; MUSCLE; PERFORMANCE; DESATURATION; METABOLISM; MIXTURES; STRENGTH	Low-intensity training involving high repetitions is recommended to enhance muscular endurance. Hyperoxic conditions could increase the number of repetitions until exhaustion and thereby improve the results of muscular endurance training. This study aimed to investigate the acute effects of hyperoxia on dynamic muscular endurance, and determine individual factors that may be related to these effects. A single-blinded, counterbalanced crossover design was used. Twenty-five young men performed repetitions of the one-arm preacher curl at 30% of their 1-repetition maximum until exhaustion under hyperoxic and normoxic conditions. The maximum number of repetitions was recorded as an index of muscular endurance. Electromyogram (EMG) and near-infrared spectroscopy parameters were measured in the biceps brachii. The maximum number of repetitions was greater (P < 0.001) under hyperoxic conditions (132 +/- 59 repetitions) than under normoxic conditions (114 +/- 40 repetitions). The root mean square amplitude of EMG and oxygenated hemoglobin concentration for the last five repetitions under normoxic conditions were greater than those under hyperoxic conditions (P = 0.015 and P = 0.003, respectively). The percent change in the maximum number of repetitions between hyperoxic and normoxic conditions had significant positive correlations with individual maximal oxygen uptake measured using an incremental cycle ergometer test (r = 0.562, 95% confidence intervals [CI] = 0.213-0.783, P = 0.003), but not with muscle strength (tau = -0.124, 95% CI = -0.424-0.170, P = 0.387). The 95% CI for the correlation coefficient between the percent change in the maximum number of repetitions and muscular endurance included 0 (tau = 0.284, 95% CI = -0.003-0.565, P = 0.047); this indicated no significant correlation between the two parameters. The results suggest that hyperoxia can acutely enhance dynamic muscular endurance, with delayed elevation of EMG amplitude due to fatigue, and the effects are associated with individual whole-body endurance capacity.	[Kojima, Yuta] Univ Tokyo, Grad Sch Frontier Sci, Dept Human & Engn Environm Studies, Kashiwa, Chiba, Japan; [Fukusaki, Chiho; Ishii, Naokata] Univ Tokyo, Grad Sch Frontier Sci, Res Ctr Total Life Hlth & Sports Sci, Kashiwa, Chiba, Japan; [Ishii, Naokata] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Fukusaki, C (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Res Ctr Total Life Hlth & Sports Sci, Kashiwa, Chiba, Japan.	fukusaki@edu.k.u-tokyo.ac.jp		Kojima, Yuta/0000-0002-4755-1833				ADAMS RP, 1980, J APPL PHYSIOL, V49, P863, DOI 10.1152/jappl.1980.49.5.863; ADAMS RP, 1986, J APPL PHYSIOL, V61, P523, DOI 10.1152/jappl.1986.61.2.523; ALLEN PD, 1977, MED SCI SPORT EXER, V9, P122; Amann M, 2006, J APPL PHYSIOL, V101, P119, DOI 10.1152/japplphysiol.01596.2005; ANDERSON T, 1982, RES Q EXERCISE SPORT, V53, P1; Astrand PO, 1986, TXB WORK PHYSL PHYSL, P116; Ball N, 2010, J ELECTROMYOGR KINES, V20, P81, DOI 10.1016/j.jelekin.2008.09.004; Bassett DR, 2000, MED SCI SPORT EXER, V32, P70, DOI 10.1097/00005768-200001000-00012; Bemben MG, 1998, SPORTS MED, V25, P259, DOI 10.2165/00007256-199825040-00004; BORG GAV, 1973, MED SCI SPORT EXER, V5, P90; Charles LD, 2018, ACSMS GUIDE LINES EX, P101; DeLorey DS, 2003, J APPL PHYSIOL, V95, P113, DOI 10.1152/japplphysiol.00956.2002; EIKEN O, 1987, J APPL PHYSIOL, V63, P571, DOI 10.1152/jappl.1987.63.2.571; EIKEN O, 1984, ACTA PHYSIOL SCAND, V122, P629, DOI 10.1111/j.1748-1716.1984.tb07553.x; EKBLOM B, 1975, J APPL PHYSIOL, V39, P71, DOI 10.1152/jappl.1975.39.1.71; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Grassi B, 2003, J APPL PHYSIOL, V95, P149, DOI 10.1152/japplphysiol.00695.2002; Grataloup O, 2005, EUR J APPL PHYSIOL, V94, P641, DOI 10.1007/s00421-005-1361-0; Harms CA, 2000, MED SCI SPORT EXER, V32, P1101, DOI 10.1097/00005768-200006000-00010; Heraud N, 2008, RESP MED, V102, P1276, DOI 10.1016/j.rmed.2008.04.005; Dinh HC, 2019, J GERONTOL A-BIOL, V74, P1870, DOI 10.1093/gerona/gly229; Kondo S, 2019, MED SCI SPORT EXER, V51, P168, DOI 10.1249/MSS.0000000000001773; LINNARSSON D, 1974, J APPL PHYSIOL, V36, P399, DOI 10.1152/jappl.1974.36.4.399; Linossier MT, 2000, ACTA PHYSIOL SCAND, V168, P403; LIPPOLD OCJ, 1960, ERGONOMICS, V3, P121, DOI 10.1080/00140136008930474; Mallette MM, 2018, SPORTS MED, V48, P153, DOI 10.1007/s40279-017-0791-2; MORITANI T, 1986, J APPL PHYSIOL, V60, P1179, DOI 10.1152/jappl.1986.60.4.1179; Mourtzakis M, 2004, J APPL PHYSIOL, V97, P1796, DOI 10.1152/japplphysiol.00169.2004; Nielsen HB, 1999, AM J PHYSIOL-HEART C, V277, pH1045, DOI 10.1152/ajpheart.1999.277.3.H1045; POWERS SK, 1988, EUR J APPL PHYSIOL O, V58, P298, DOI 10.1007/BF00417266; SALTIN B, 1985, AM J CARDIOL, V55, pD42, DOI 10.1016/0002-9149(85)91054-9; Shaw DM, 2019, MED SCI SPORT EXER, V51, P2135, DOI 10.1249/MSS.0000000000002008; Stellingwerff T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1180, DOI 10.1152/ajpendo.00499.2005; Stone WJ, 1994, J STRENGTH COND RES, V8, P231; Veale JF, 2014, LATERALITY, V19, P164, DOI 10.1080/1357650X.2013.783045; WELCH HG, 1982, MED SCI SPORT EXER, V14, P253, DOI 10.1249/00005768-198204000-00001; WILSON GD, 1975, MED SCI SPORT EXER, V7, P48	37	0	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231643	10.1371/journal.pone.0231643	http://dx.doi.org/10.1371/journal.pone.0231643			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315330	Green Published, gold			2022-12-26	WOS:000536024800038
J	Mishra, B; McDonald, LM; Roy, M; Lanzirotti, A; Myneni, SCB				Mishra, Bhoopesh; McDonald, Louis M.; Roy, Mimi; Lanzirotti, Antonio; Myneni, Satish C. B.			Uptake and speciation of zinc in edible plants grown in smelter contaminated soils	PLOS ONE			English	Article							RAY-ABSORPTION SPECTROSCOPY; CRYSTAL-STRUCTURE; METAL TOLERANCE; BRASSICA-JUNCEA; HEAVY-METALS; CADMIUM; LEAD; ACCUMULATION; PB	Heavy metal accumulation in edible plants grown in contaminated soils poses a major environmental risk to humans and grazing animals. This study focused on the concentration and speciation of Zn in different edible plants grown in soils contaminated with smelter wastes (Spelter, WV, USA) containing high levels of the metals Zn, Cu, Pb, Cd. Their accumulation was examined in different parts (roots, stem, and leaves) of plants and as a function of growth stage (dry seed, sprouting seed, cotyledon, and leaves) in the root vegetables radish, the leafy vegetable spinach and the legume clover. Although the accumulation of metals varied significantly with plant species, the average metal concentrations were [Zn] > [Pb] > [Cu] > [Cd]. Metal uptake studies were complemented with bulk and micro X-ray absorption spectroscopy (XAS) at Zn K-edge and micro X-ray fluorescence (mu XRF) measurements to evaluate the speciation and distribution of Zn in these plant species. Dynamic interplay between the histidine and malate complexation of Zn was observed in all plant species. XRF mapping of spinach leaves at micron spatial resolution demonstrated the accumulation of Zn in vacuoles and leaf tips. Radish root showed accumulation of Zn in root hairs, likely as ZnS nanoparticles. At locations of high Zn concentration in spinach leaves, mu XANES suggests Zn complexation with histidine, as opposed to malate in the bulk leaf. These findings shed new light on the dynamic nature of Zn speciation in plants.	[Mishra, Bhoopesh] Univ Leeds, Sch Chem & Proc Engn, Leeds, W Yorkshire, England; [Mishra, Bhoopesh] IIT, Dept Phys, Chicago, IL 60616 USA; [McDonald, Louis M.] West Virginia Univ, Div Plant & Soil Sci, Morgantown, WV 26506 USA; [Roy, Mimi] OP Jindal Global Univ, Jindal Sch Liberal Arts & Humanities, Sonipat, Haryana, India; [Lanzirotti, Antonio] Univ Chicago, GeoSoil CARS, Chicago, IL 60637 USA; [Myneni, Satish C. B.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	University of Leeds; Illinois Institute of Technology; West Virginia University; O.P. Jindal Global University; University of Chicago; Princeton University	Mishra, B (corresponding author), Univ Leeds, Sch Chem & Proc Engn, Leeds, W Yorkshire, England.; Mishra, B (corresponding author), IIT, Dept Phys, Chicago, IL 60616 USA.	b.mishra@leeds.ac.uk			National Science Foundation; Department of Energy (DOE) - Geosciences [DE-FG02-92ER14244]; DOE - Office of Biological and Environmental Research, Environmental Remediation Sciences Div [DE-FC09-96-SR18546]; DOE [DE-AC02-98CH10886]	National Science Foundation(National Science Foundation (NSF)); Department of Energy (DOE) - Geosciences(United States Department of Energy (DOE)); DOE - Office of Biological and Environmental Research, Environmental Remediation Sciences Div(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	This work was funded by National Science Foundation through grant to BM and SM. X26A was supported by the Department of Energy (DOE) - Geosciences (DE-FG02-92ER14244 to The University of Chicago - CARS) and DOE -Office of Biological and Environmental Research, Environmental Remediation Sciences Div. (DEFC09-96-SR18546 to the University of Kentucky). Use of the NSLS was supported by DOE under Contract No. DE-AC02-98CH10886.	Adediran GA, 2016, NEW PHYTOL, V209, P280, DOI 10.1111/nph.13588; Adele NC, 2018, ENVIRON SCI TECHNOL, V52, P3412, DOI 10.1021/acs.est.7b05094; Ankudinov AL, 1998, PHYS REV B, V58, P7565, DOI 10.1103/PhysRevB.58.7565; Bench G, 2001, ENVIRON SCI TECHNOL, V35, P270, DOI 10.1021/es0014180; BOON DY, 1992, J ENVIRON QUAL, V21, P82, DOI 10.2134/jeq1992.00472425002100010012x; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Brown RW, 2008, ENVIRON GEOCHEM HLTH, V30, P541, DOI 10.1007/s10653-008-9180-y; Clemens S, 2001, PLANTA, V212, P475, DOI 10.1007/s004250000458; Cobb GP, 2000, ENVIRON TOXICOL CHEM, V19, P600, DOI [10.1002/etc.5620190311, 10.1897/1551-5028(2000)019&lt;0600:AOHMBV&gt;2.3.CO;2]; David M.O., 2000, PHYSL PLANTS STRESS; De D. N., 2000, PLANT CELL VACUOLES; ERNST WHO, 1992, ACTA BOT NEERL, V41, P229, DOI 10.1111/j.1438-8677.1992.tb01332.x; Gardea-Torresdey JL, 2005, COORDIN CHEM REV, V249, P1797, DOI 10.1016/j.ccr.2005.01.001; Geraldine Sarret, 2009, NEW PHYTOL, V184, P584; Gustafsson J. P., VISUAL MINTEQ VERSIO; Hall GEM, 2002, ANALYST, V127, P674, DOI 10.1039/b110491h; HARDING MM, 1963, ACTA CRYSTALLOGR, V16, P643, DOI 10.1107/S0365110X63001699; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Kabata-Pendias A., 1992, TRACE ELEMENTS SOILS; Kelly RA, 2002, MICROCHEM J, V71, P231, DOI 10.1016/S0026-265X(02)00015-2; Kupper H, 2004, PLANT PHYSIOL, V134, P748, DOI 10.1104/pp.103.032953; Liu DH, 2000, BIORESOURCE TECHNOL, V71, P273, DOI 10.1016/S0960-8524(99)00082-6; Marschner H., 2002, MARSCHNERS MINERAL N; Mateos-Naranjo E, 2008, PLANT BIOLOGY, V10, P754, DOI 10.1111/j.1438-8677.2008.00098.x; MATHYS W, 1977, PHYSIOL PLANTARUM, V40, P130, DOI 10.1111/j.1399-3054.1977.tb01509.x; Merrington G, 1997, ENVIRON POLLUT, V96, P111, DOI 10.1016/S0269-7491(96)00149-2; Mishra B, 2009, GEOCHIM COSMOCHIM AC, V73, P4311, DOI 10.1016/j.gca.2008.11.032; Mishra T, 2019, PHYTOMANAGEMENT OF POLLUTED SITES: MARKET OPPORTUNITIES IN SUSTAINABLE PHYTOREMEDIATION, P409, DOI 10.1016/B978-0-12-813912-7.00016-8; NEWVILLE M, 1995, PHYSICA B, V208, P154, DOI 10.1016/0921-4526(94)00655-F; NEWVILLE M, 1993, PHYS REV B, V47, P14126, DOI 10.1103/PhysRevB.47.14126; Palmer CM, 2009, NAT CHEM BIOL, V5, P333, DOI 10.1038/nchembio.166; Peralta-Videa JR, 2009, INT J BIOCHEM CELL B, V41, P1665, DOI 10.1016/j.biocel.2009.03.005; Pierzynski GM, 2004, SOILS ENV QUALITY; Rabitsch WB, 1996, B ENVIRON CONTAM TOX, V56, P734, DOI 10.1007/s001289900108; Rauser WE, 1999, CELL BIOCHEM BIOPHYS, V31, P19, DOI 10.1007/BF02738153; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Ravel B., 2004, J SYNCHROTRON RADIAT, V8, P314; Raven KP, 1997, J ENVIRON QUAL, V26, P551, DOI 10.2134/jeq1997.00472425002600020028x; Rawat M, 2009, J HAZARD MATER, V172, P1145, DOI 10.1016/j.jhazmat.2009.07.115; REED AT, 1976, ACTA CRYSTALLOGR B, V32, P2085, DOI 10.1107/S0567740876007152; Robinson GR, 2007, J ENVIRON QUAL, V36, P654, DOI 10.2134/jeq2006.0413; Roy M, 2015, LAND DEGRAD DEV, V26, P785, DOI 10.1002/ldr.2237; Salt DE, 1999, ENVIRONMENTAL, P713; Sarret G, 2002, PLANT PHYSIOL, V130, P1815, DOI 10.1104/pp.007799; SAS Institute Inc, 2006, STAT AN SOFTW; Slagle A., 2004, Soil Survey Horizons, V45, P73; STERN EA, 1995, PHYSICA B, V208, P117, DOI 10.1016/0921-4526(94)00826-H; Sukkariyah BF, 2005, J ENVIRON QUAL, V34, P2255, DOI 10.2134/jeq2004.0369; Terzano R, 2008, J AGR FOOD CHEM, V56, P3222, DOI 10.1021/jf073304e; TESSIER A, 1979, ANAL CHEM, V51, P844, DOI 10.1021/ac50043a017; Thomas SA, 2019, J PHYS CHEM LETT, V10, P2585, DOI 10.1021/acs.jpclett.9b01186; Verkleij JAC, 1998, J PLANT PHYSIOL, V153, P188, DOI 10.1016/S0176-1617(98)80064-3; Yasutake A, 2002, HDB TOXICOLOGY	53	6	6	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0226180	10.1371/journal.pone.0226180	http://dx.doi.org/10.1371/journal.pone.0226180			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302305	Green Published, gold			2022-12-26	WOS:000536016100003
J	Chuang, CC; Chou, YH; Peng, SL; Tai, JE; Lee, SC; Tyan, YS; Shih, CT				Chuang, Chun-Chao; Chou, Ying-Hsiang; Peng, Shin-Lei; Tai, Jou-Erh; Lee, Shan-Chih; Tyan, Yeu-Sheng; Shih, Cheng-Ting			Calculating air volume fractions from computed tomography images for chronic obstructive pulmonary disease diagnosis	PLOS ONE			English	Article							QUANTITATIVE CT; LUNG ATTENUATION; EMPHYSEMA; DENSITY; COPD; QUANTIFICATION; MORPHOMETRY; MANAGEMENT; PHENOTYPES	Quantitative evaluation using image biomarkers calculated from threshold-segmented low-attenuation areas on chest computed tomography (CT) images for diagnosing chronic obstructive pulmonary diseases (COPD) has been widely investigated. However, the segmentation results depend on the applied threshold and slice thickness of the CT images because of the partial volume effect (PVE). In this study, the air volume fraction (AV/TV) of lungs was calculated from CT images using a two-compartment model (TCM) for COPD diagnosis. A relative air volume histogram (RAVH) was constructed using the AV/TV values to describe the air content characteristics of lungs. In phantom studies, the TCM accurately calculated total cavity volumes and foam masses with percent errors of less than 8% and +/- 4%, respectively. In patient studies, the relative volumes of normal and damaged lung tissues and the damaged-to-normal RV ratio were defined and calculated from the RAVHs as image biomarkers, which correctly differentiated COPD patients from controls in 2.5- and 5-mm-thick images with areas under receiver operating characteristic curves of >0.94. The AV/TV calculated using the TCM can prevent the effect of slice thickness, and the image biomarkers calculated from the RAVH are reliable for diagnosing COPD.	[Chuang, Chun-Chao; Chou, Ying-Hsiang; Tai, Jou-Erh; Lee, Shan-Chih; Tyan, Yeu-Sheng; Shih, Cheng-Ting] Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan; [Chuang, Chun-Chao; Lee, Shan-Chih; Tyan, Yeu-Sheng; Shih, Cheng-Ting] Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan; [Chou, Ying-Hsiang] Chung Shan Med Univ Hosp, Dept Radiat Oncol, Taichung, Taiwan; [Peng, Shin-Lei] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan	Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan	Tyan, YS; Shih, CT (corresponding author), Chung Shan Med Univ, Dept Med Imaging & Radiol Sci, Taichung, Taiwan.; Tyan, YS; Shih, CT (corresponding author), Chung Shan Med Univ Hosp, Dept Med Imaging, Taichung, Taiwan.	ystyan08@gmail.com; ctshih21@gmail.com		Lee, Shan-Chih/0000-0001-6583-1575; Shih, Cheng-Ting/0000-0002-8554-9136	Chung Shan Medical University Hospital, Taiwan [CSH-2019C-012]; Ministry of Science and Technology of Taiwan [MOST 108-2314-B-040 -005 -]	Chung Shan Medical University Hospital, Taiwan; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	YST was funded by the Chung Shan Medical University Hospital, Taiwan (http://www.csh.org.tw/index.html) under Contract CSH-2019C-012. CTS was funded by the Ministry of Science and Technology of Taiwan (https://www.most.gov.tw/en/) under Contract MOST 108-2314-B-040 -005 -. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr RG, 2010, NEW ENGL J MED, V362, P217, DOI 10.1056/NEJMoa0808836; Camiciottoli G, 2006, CHEST, V129, P558, DOI 10.1378/chest.129.3.558; Capaldi DPI, 2016, RADIOLOGY, V279, P597, DOI 10.1148/radiol.2015151484; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Galban CJ, 2012, NAT MED, V18, P1711, DOI 10.1038/nm.2971; Gevenois PA, 1996, AM J RESP CRIT CARE, V154, P187, DOI 10.1164/ajrccm.154.1.8680679; Gevenois PA, 1996, RADIOLOGY, V199, P825, DOI 10.1148/radiology.199.3.8638012; GEVENOIS PA, 1995, AM J RESP CRIT CARE, V152, P653, DOI 10.1164/ajrccm.152.2.7633722; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hoffman EA, 2003, ACAD RADIOL, V10, P1104, DOI 10.1016/S1076-6332(03)00330-1; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; ICRU, 1992, J INT COMM RAD UN ME, P1; Jeffery PK, 2001, AM J RESP CRIT CARE, V164, pS28, DOI 10.1164/ajrccm.164.supplement_2.2106061; Karayama M, 2019, INT J CHRONIC OBSTR, V14, P1333, DOI 10.2147/COPD.S207267; Koo HJ, 2019, KOREAN J RADIOL, V20, P683, DOI 10.3348/kjr.2018.0391; Lin HH, 2017, IEEE T MED IMAGING, V36, P1094, DOI 10.1109/TMI.2016.2646698; Madani A, 2010, RADIOLOGY, V257, P260, DOI 10.1148/radiol.10091446; Marin JM, 2001, AM J RESP CRIT CARE, V163, P1395, DOI 10.1164/ajrccm.163.6.2003172; Matsuoka S, 2010, RADIOGRAPHICS, V30, P55, DOI 10.1148/rg.301095110; Nathell L, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-89; Ochs M, 2004, AM J RESP CRIT CARE, V169, P120, DOI 10.1164/rccm.200308-1107OC; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Paoletti M, 2015, RADIOLOGY, V276, P571, DOI 10.1148/radiol.2015141769; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Sharifi H, 2019, J MED IMAG RADIAT ON, V63, P370, DOI 10.1111/1754-9485.12881; Sluimer I, 2006, IEEE T MED IMAGING, V25, P385, DOI 10.1109/TMI.2005.862753; Torres M, 2007, CLIN GERIATR MED, V23, P307, DOI 10.1016/j.cger.2007.01.007; Vogelmeier CF, 2017, RESPIROLOGY, V22, P575, DOI 10.1111/resp.13012; Wang ZM, 2013, EUR RADIOL, V23, P975, DOI 10.1007/s00330-012-2683-z; WHITE DR, 1991, BRIT J RADIOL, V64, P149, DOI 10.1259/0007-1285-64-758-149; WHO, 2018, TOP 10 CAUS DEATH	31	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231730	10.1371/journal.pone.0231730	http://dx.doi.org/10.1371/journal.pone.0231730			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298358	Green Published, gold			2022-12-26	WOS:000536011400097
J	Fanchon, LM; Russell, J; Pillarsetty, N; O'Donoghue, I; Gangangari, K; Yu, KH; Humm, JL				Fanchon, Louise M.; Russell, James; Pillarsetty, Nagavarakishore; O'Donoghue, Isabella; Gangangari, Kishore; Yu, Kenneth H.; Humm, John L.			Comparing the intra-tumoral distribution of Gemcitabine, 5-Fluorouracil, and Capecitabine in a murine model of pancreatic ductal adenocarcinoma	PLOS ONE			English	Article							CANCER; INHIBITION; HYPOXIA	Purpose To develop a technique to compare the intra-tumoral distribution of the drug gemcitabine, its surrogate [F-18]-fluoroarabinocytosine ([F-18]-FAC) and related chemotherapeutics 5-FU and capecitabine in a pre-clinical model of pancreatic ductal adenocarcinoma (PDAC). Experimental design Using a KPC-organoid derived model of PDAC, we obtained autoradiographic images of the tumor distribution of, [C-14]-gemcitabine, [C-14]-5-FU, [H-3]-capecitabine. These were compared indirectly by co-administering [F-18]-FAC, a close analog of gemcitabine with a proven equivalent intra-tumor distribution. The short half-life of F-18 allows for clean separation of H-3/C-14 labeled drugs in specimens by dual isotope digital autoradiography. Autoradiographic images of [C-14]-gemcitabine, [H-3]-capecitabine and [C-14]-5-FU were each correlated to [F-18]-FAC on a pixel-by-pixel basis. The tumor drug penetration was compared using cumulative histograms. Results Gemcitabine distribution correlated strongly with FAC as expected. 5-FU also gave a similar microdistribution to that of FAC, whereas no correlation was found between capecitabine or its metabolic products and FAC distribution. Accumulation of Gemcitabine and 5-FU was lower in hypoxic regions of the tumor, whereas no such correlation was observed for capecitabine and its metabolites. Conclusions Gemcitabine and 5-FU target the same regions of the tumor, leaving hypoxic cells untreated. Capecitabine metabolites penetrate further into the tumor but it is yet to be determined whether these metabolites are the active form of the drug.	[Fanchon, Louise M.; Russell, James; O'Donoghue, Isabella; Humm, John L.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Pillarsetty, Nagavarakishore; Gangangari, Kishore] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Gangangari, Kishore] CUNY Hunter Coll, Dept Chem, New York, NY 10021 USA; [Yu, Kenneth H.] Mem Sloan Kettering Canc Ctr, Gastrointestinal Oncol Serv, 1275 York Ave, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; City University of New York (CUNY) System; Hunter College (CUNY); Memorial Sloan Kettering Cancer Center	Humm, JL (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA.	hummj@mskcc.org		Fanchon, Louise/0000-0001-7600-1155; Pillarsetty, Naga Vara Kishore/0000-0002-1750-7436	National Institute of Health [R01CA194321]; NIH/NCI cancer Center Support grant [P30 CA008748]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI cancer Center Support grant	LF, JR, NP, IOD, JLH were supported by the National Institute of Health under grant number R01CA194321 (Principal Investigator: John Humm). The research was supported in part through the NIH/NCI cancer Center Support grant P30 CA008748 (Principal Investigator: Craig B. Thompson). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nih.gov/.	Alvarellos ML, 2014, PHARMACOGENET GENOM, V24, P564, DOI 10.1097/FPC.0000000000000086; Axente M, 2011, J NUCL MED, V52, P1621, DOI 10.2967/jnumed.111.091595; Baker LA, 2019, METHODS MOL BIOL, V1882, P117, DOI 10.1007/978-1-4939-8879-2_10; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Courtin A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067330; Cunningham D, 2009, J CLIN ONCOL, V27, P5513, DOI 10.1200/JCO.2009.24.2446; Gangangari KK, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.019678, 10.1371/journal.pone.0196784]; Hruban RH, 2001, CANCER J, V7, P251; Huxham LA, 2004, CANCER RES, V64, P6537, DOI 10.1158/0008-5472.CAN-04-0986; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Kleeff J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.22; Koong AC, 2000, INT J RADIAT ONCOL, V48, P919, DOI 10.1016/S0360-3016(00)00803-8; Malka D, 2018, LANCET GASTROENTEROL, V3, P659, DOI 10.1016/S2468-1253(18)30235-8; Metran-Nascente C, 2016, J NUCL MED, V57, P361, DOI 10.2967/jnumed.115.167650; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; Neoptolemos JP, 2017, LANCET, V389, P1011, DOI 10.1016/S0140-6736(16)32409-6; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Palmer AC, 2017, CELL, V171, P1678, DOI 10.1016/j.cell.2017.11.009; Quinney SK, 2005, J PHARMACOL EXP THER, V313, P1011, DOI 10.1124/jpet.104.081265; Russell J, 2017, MOL IMAGING BIOL, V19, P885, DOI 10.1007/s11307-017-1078-6; Salnikov AV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046391; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wisinski KB, 2007, ONCOLOGY-NY, V21, P1558; Wisinski KB, 2007, ONCOLOGY, P70; Wisinski KB, 2007, ONCOLOGY, P65; Yuen A, 2014, HYPOXIA, V2, P91, DOI 10.2147/HP.S52636	27	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231745	10.1371/journal.pone.0231745	http://dx.doi.org/10.1371/journal.pone.0231745			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298392	gold, Green Published			2022-12-26	WOS:000536011400101
J	Ramos-Maqueda, J; Bermudez-Jimenez, F; Ruiz, RM; Ramos, MC; Lerma, MM; Millan, PS; Lopez, MA; Sanchez, LT; Jimenez-Jalmez, J				Ramos-Maqueda, Javier; Bermudez-Jimenez, Francisco; Macias Ruiz, Rosa; Cabrera Ramos, Mercedes; Molina Lerma, Manuel; Sanchez Millan, Pablo; Alvarez Lopez, Miguel; Tercedor Sanchez, Luis; Jimenez-Jalmez, Juan			Prognostic impact of misdiagnosis of cardiac channelopathies as epilepsy	PLOS ONE			English	Article							SUDDEN UNEXPECTED DEATH; LONG QT SYNDROME; HEART; DEFINITIONS; ASSOCIATION; GUIDELINES; MUTATION; GENETICS; HISTORY; ARREST	Introduction Cardiac channelopathies are a frequent cause of sudden cardiac death (SCD) and often manifest with convulsive syncope, leading to a misdiagnosis of epilepsy. We aim to evaluate the clinical impact of epilepsy misdiagnosis in a cohort of patients with cardiac channelopathies. Methods Fifty probands/families with a cardiac channelopathy were included. We retrospectively collected information from medical records to identify all patients who presented with convulsive syncope and were diagnosed with epilepsy after neurological evaluation. Clinical data and outcome were compared with those of patients without a previous epilepsy diagnosis. Results Eight patients had a previous diagnosis of epilepsy. At first episode, 3 of them presented a positive family history of SCD and 5 showed a pathological electrocardiogram; half presented with sudden cardiac arrest (SCA) and the rest with recurrent syncope despite treatment with 1 or more anti-epileptic drugs. Five patients had long QT syndrome, 2 had catecholaminergic polymorphic ventricular tachycardia, and 1 had Brugada syndrome. Epilepsy misdiagnosis was associated with an increased risk of SCA/SCD (OR 6.92, P=.04), a delay of 12 years (P=.047) in correct diagnosis, and a delay from first symptom to channelopathy diagnosis of 18.45 years (P<.0001). Conclusion Cardiac channelopathy patients can be misdiagnosed with epilepsy. This involves a delayed diagnosis, a delay from the first symptom to a correct diagnosis, and an increased risk of SCA/SCD.	[Ramos-Maqueda, Javier; Bermudez-Jimenez, Francisco; Macias Ruiz, Rosa; Cabrera Ramos, Mercedes; Molina Lerma, Manuel; Sanchez Millan, Pablo; Alvarez Lopez, Miguel; Tercedor Sanchez, Luis; Jimenez-Jalmez, Juan] Hosp Univ Virgen Nieves, Cardiol Dept, Granada, Spain; [Bermudez-Jimenez, Francisco; Macias Ruiz, Rosa; Molina Lerma, Manuel; Sanchez Millan, Pablo; Alvarez Lopez, Miguel; Tercedor Sanchez, Luis; Jimenez-Jalmez, Juan] Inst Invest Biosanitaria Granada, Granada, Spain	Hospital Universitario Virgen de las Nieves; Instituto de Investigacion Biosanitaria IBS Granada	Jimenez-Jalmez, J (corresponding author), Hosp Univ Virgen Nieves, Cardiol Dept, Granada, Spain.; Jimenez-Jalmez, J (corresponding author), Inst Invest Biosanitaria Granada, Granada, Spain.	Jimenez.jaimez@gmail.com	Molina-Lerma, Manuel/AAO-3365-2021; Ramos Maqueda, Javier/GZM-7501-2022	Bermudez Jimenez, Francisco Jose/0000-0003-0325-7349; Macias-Ruiz, Rosa/0000-0003-4686-5678				Ackerman MJ, 2011, EUROPACE, V13, P1077, DOI 10.1093/europace/eur245; Annegers JF, 1999, SEIZURE-EUR J EPILEP, V8, P347, DOI 10.1053/seiz.1999.0306; Aurlien D, 2009, SEIZURE-EUR J EPILEP, V18, P158, DOI 10.1016/j.seizure.2008.07.008; Bagnall RD, 2016, ANN NEUROL, V79, P522, DOI 10.1002/ana.24596; Bezzina CR, 2015, CIRC RES, V116, P1919, DOI 10.1161/CIRCRESAHA.116.304030; Coll M, 2016, INT J LEGAL MED, V130, P331, DOI 10.1007/s00414-015-1269-0; Drezner JA, 2012, J AM BOARD FAM MED, V25, P408, DOI 10.3122/jabfm.2012.04.110225; Gaita F, 2003, CIRCULATION, V108, P965, DOI 10.1161/01.CIR.0000085071.28695.C4; Hazle MA, 2013, PEDIATR NEUROL, V49, P134, DOI 10.1016/j.pediatrneurol.2013.03.017; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Iannetti P, 2017, EUR REV MED PHARMACO, V21, P5523, DOI 10.26355/eurrev_201712_13949; Jimenez-Jaimez J, 2015, AM J CARDIOL, V116, P894, DOI 10.1016/j.amjcard.2015.06.030; Lamberts RJ, 2015, J NEUROL NEUROSUR PS, V86, P309, DOI 10.1136/jnnp-2014-307772; Lamberts RJ, 2012, EPILEPSIA, V53, P253, DOI 10.1111/j.1528-1167.2011.03360.x; Li MCH, 2019, EPILEPSIA, V60, P1753, DOI 10.1111/epi.16301; MacCormick JM, 2009, ANN EMERG MED, V54, P26, DOI 10.1016/j.annemergmed.2009.01.031; Manolis TA, 2019, SEIZURE-EUR J EPILEP, V64, P65, DOI 10.1016/j.seizure.2018.12.007; Migdalovich D, 2011, HEART RHYTHM, V8, P1537, DOI 10.1016/j.hrthm.2011.03.049; Nashef L, 2012, EPILEPSIA, V53, P227, DOI 10.1111/j.1528-1167.2011.03358.x; Omichi C, 2010, EPILEPSIA, V51, P289, DOI 10.1111/j.1528-1167.2009.02267.x; Pedley TA, 2002, LANCET, V359, P1790, DOI 10.1016/S0140-6736(02)08726-3; Priori SG, 2015, EUR HEART J, V36, P2793, DOI 10.1093/eurheartj/ehv316; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rodrigues TD, 2010, PACE, V33, P804, DOI 10.1111/j.1540-8159.2009.02685.x; Ryvlin P, 2013, LANCET NEUROL, V12, P966, DOI 10.1016/S1474-4422(13)70214-X; Scheepers B, 1998, SEIZURE-EUR J EPILEP, V7, P403, DOI 10.1016/S1059-1311(05)80010-X; Taggart NW, 2007, CIRCULATION, V115, P2613, DOI 10.1161/CIRCULATIONAHA.106.661082; Wever EFD, 2004, J AM COLL CARDIOL, V43, P1137, DOI 10.1016/j.jacc.2003.10.053; Zaidi A, 2000, J AM COLL CARDIOL, V36, P181, DOI 10.1016/S0735-1097(00)00700-2	29	2	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231442	10.1371/journal.pone.0231442	http://dx.doi.org/10.1371/journal.pone.0231442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298319	gold, Green Published			2022-12-26	WOS:000536011400046
J	Feldman, M; Smoum, R; Mechoulam, R; Steinberg, D				Feldman, Mark; Smoum, Reem; Mechoulam, Raphael; Steinberg, Doron			Potential combinations of endocannabinoid/endocannabinoid-like compounds and antibiotics against methicillin-resistant Staphylococcus aureus	PLOS ONE			English	Article							ARACHIDONOYL-L-SERINE; ENDOCANNABINOID ANANDAMIDE; BRAIN CONSTITUENT; INFECTIONS	Infections caused by antibiotic-resistant strains of Staphylococcus aureus have reached epidemic proportions globally. Our previous study showed antimicrobial effects of anandamide (AEA) and arachidonoyl serine (AraS) against methicillin (MET)-resistant S. aureus (MRSA) strains, proposing the therapeutic potential of these endocannabinoid/endocannabinoid-like (EC/EC-like) agents for the treatment of MRSA. Here, we investigated the potential synergism of combinations of AEA and AraS with different types of antibiotics against MRSA grown under planktonic growth or biofilm formation. The most effective combinations under planktonic conditions were mixtures of AEA and ampicillin (AMP), and of AraS and gentamicin (GEN). The combination with the highest synergy in the biofilm formation against all tested bacterial strains was AEA and MET. Moreover, the combination of AraS and MET synergistically caused default of biofilm formation. Slime production of MRSA was also dramatically impaired by AEA or AraS combined with MET. Our data suggest the novel potential activity of combinations of EC/EC-like agents and antibiotics in the prevention of MRSA biofilm formation.	[Feldman, Mark; Steinberg, Doron] Hebrew Univ Jerusalem, Fac Dent Med, Biofilm Res Lab, Jerusalem, Israel; [Smoum, Reem; Mechoulam, Raphael] Hebrew Univ Jerusalem, Sch Pharm, Inst Drug Res, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Feldman, M (corresponding author), Hebrew Univ Jerusalem, Fac Dent Med, Biofilm Res Lab, Jerusalem, Israel.	markfel15@yahoo.com			chief scientist office of the ministry of agriculture	chief scientist office of the ministry of agriculture	MF, RS, RM, DS; Partially supported by the chief scientist office of the ministry of agriculture; https://www.moag.gov.il/en/Ministrys %20Units/Ministers_Bureau/Pages/default.aspx; funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appendino G, 2008, J NAT PROD, V71, P1427, DOI 10.1021/np8002673; Bae S, 2016, ANTIMICROBIAL AGENTS; Bajaksouzian S, 1997, ANTIMICROB AGENTS CH, V41, P1073, DOI 10.1128/AAC.41.5.1073; Brackman G, 2011, ANTIMICROBIAL AGENTS; Chan BCL, 2015, J PHARM PHARMACOL, V67, P107, DOI 10.1111/jphp.12315; Cohen-Yeshurun A, 2011, J CEREBR BLOOD F MET, V31, P1768, DOI 10.1038/jcbfm.2011.53; Corey GR, 2009, CLIN INFECT DIS, V48, pS254, DOI 10.1086/598186; Dainese E, 2012, ACS CHEM NEUROSCI, V3, P386, DOI 10.1021/cn300016c; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Pasquale E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004989; Dou Y, 2017, MOL MED REP, V15, P4061, DOI 10.3892/mmr.2017.6528; Feldman M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35793-7; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; FREEMAN DJ, 1989, J CLIN PATHOL, V42, P872, DOI 10.1136/jcp.42.8.872; Friedman L, 2019, CANNABIS CANNABINOID; Gould IM, 2010, CLIN MICROBIOL INFEC, V16, P1721, DOI 10.1111/j.1469-0691.2010.03365.x; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Hernandez-Cervantes R, 2017, NEUROIMMUNOMODULAT, V24, P183, DOI 10.1159/000481824; Hersh AL, 2008, ARCH INTERN MED, V168, P1585, DOI 10.1001/archinte.168.14.1585; Hess DJ, 2014, ANTIMICROBIAL AGENTS; Hill KP, 2017, CANNABIS CANNABINOID, V2, P96, DOI 10.1089/can.2017.0017; Hiramatsu K, 2014, J INFECT CHEMOTHER, V20, P593, DOI 10.1016/j.jiac.2014.08.001; Joshi-Navare K, 2013, BIOCHEM RES INT, V2013, DOI 10.1155/2013/169797; Kalan L, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399410001766; Kaplan SL, 2005, CLIN INFECT DIS, V40, P1785, DOI 10.1086/430312; Klevens RM, 2007, JAMA-J AM MED ASSOC, V298, P1763, DOI 10.1001/jama.298.15.1763; Medeiros D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41362; Milman G, 2006, P NATL ACAD SCI USA, V103, P2428, DOI 10.1073/pnas.0510676103; Naber CK, 2009, CLIN INFECT DIS, V48, pS231, DOI 10.1086/598189; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Pisanti S, 2007, J CELL PHYSIOL, V211, P495, DOI 10.1002/jcp.20954; Rani A, 2009, WORLD APPL SCI J, P59; Rettori E, 2012, NEUROIMMUNOMODULAT, V19, P293, DOI 10.1159/000339113; Ryder VJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047695; Savage VJ, 2013, ANTIMICROB AGENTS CH, V57, P1968, DOI 10.1128/AAC.02008-12; Shibata H, 2005, ANTIMICROB AGENTS CH, V49, P549, DOI 10.1128/AAC.49.2.549-555.2005; Takahashi A, 1997, J MED, V28, P87; Thiyagarajan D, 2017, CHEMMEDCHEM, V12, P1125, DOI 10.1002/cmdc.201700260; Wasim K, 1995, Pak J Pharm Sci, V8, P29; Wu H, 2004, J ANTIMICROB CHEMOTH, V53, P1054, DOI 10.1093/jac/dkh223; Yarwood JM, 2003, J CLIN INVEST, V112, P1620, DOI 10.1172/JCI200320442; Zhang X, 2010, BRIT J PHARMACOL, V160, P1583, DOI 10.1111/j.1476-5381.2010.00841.x; Zhou YL, 2013, EXP THER MED, V6, P1000, DOI 10.3892/etm.2013.1231	43	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231583	10.1371/journal.pone.0231583	http://dx.doi.org/10.1371/journal.pone.0231583			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294120	Green Published, gold			2022-12-26	WOS:000536003500041
J	Ujcikova, H; Cechova, K; Jagr, M; Roubalova, L; Vosahlikova, M; Svoboda, P				Ujcikova, Hana; Cechova, Kristina; Jagr, Michal; Roubalova, Lenka; Vosahlikova, Miroslava; Svoboda, Petr			Proteomic analysis of protein composition of rat hippocampus exposed to morphine for 10 days; comparison with animals after 20 days of morphine withdrawal	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ALPHA-SYNUCLEIN; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; OXIDATIVE STRESS; OPIOID-RECEPTOR; NEUROGENESIS; EXPRESSION; CORTEX; BRAIN; STIMULATION	Opioid addiction is recognized as a chronic relapsing brain disease resulting from repeated exposure to opioid drugs. Cellular and molecular mechanisms underlying the ability of organism to return back to the physiological norm after cessation of drug supply are not fully understood. The aim of this work was to extend our previous studies of morphine-induced alteration of rat forebrain cortex protein composition to the hippocampus. Rats were exposed to morphine for 10 days and sacrificed 24 h (groups +M10 and -M10) or 20 days after the last dose of morphine (groups +M10/-M20 and -M10/-M20). The six altered proteins (>= 2-fold) were identified in group (+M10) when compared with group (-M10) by two-dimensional fluorescence difference gel electrophoresis (2D-DIGE). The number of differentially expressed proteins was increased to thirteen after 20 days of the drug withdrawal. Noticeably, the altered level of alpha-synuclein, beta-synuclein, alpha-enolase and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was also determined in both (+/- M10) and (+/- M10/-M20) samples of hippocampus. Immunoblot analysis of 2D gels by specific antibodies oriented against alpha/beta-synucleins and GAPDH confirmed the data obtained by 2D-DIGE analysis. Label-free quantification identified nineteen differentially expressed proteins in group (+M10) when compared with group (-M10). After 20 days of morphine withdrawal (+/- M10/-M20), the number of altered proteins was increased to twenty. We conclude that the morphine-induced alteration of protein composition in rat hippocampus after cessation of drug supply proceeds in a different manner when compared with the forebrain cortex. In forebrain cortex, the total number of altered proteins was decreased after 20 days without morphine, whilst in hippocampus, it was increased.	[Ujcikova, Hana; Cechova, Kristina; Roubalova, Lenka; Vosahlikova, Miroslava; Svoboda, Petr] Czech Acad Sci, Inst Physiol, Dept Biomath, Lab Membrane Receptors, Prague 4, Czech Republic; [Cechova, Kristina] Charles Univ Prague, Dept Biochem, Fac Sci, Prague 2, Czech Republic; [Jagr, Michal] Czech Acad Sci, Inst Physiol, Lab Anal Biol Important Cpds, Prague 4, Czech Republic	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences	Ujcikova, H (corresponding author), Czech Acad Sci, Inst Physiol, Dept Biomath, Lab Membrane Receptors, Prague 4, Czech Republic.	Hana.Ujcikova@fgu.cas.cz	Svoboda, Petr/C-2619-2012; Ujcikova, Hana/G-8230-2015; Roubalova, Lenka/C-2628-2012; Vosahlikova, Miroslava/G-3022-2014	Svoboda, Petr/0000-0002-3076-4672; Ujcikova, Hana/0000-0003-2588-5784; Roubalova, Lenka/0000-0002-0603-7184; Vosahlikova, Miroslava/0000-0003-4832-7953	Czech Science Foundation GA CR [17-05903S, 1903295S]; Institute of Physiology of the Czech Academy of Sciences [RVO:67985823]	Czech Science Foundation GA CR(Grant Agency of the Czech Republic); Institute of Physiology of the Czech Academy of Sciences(Czech Academy of Sciences)	This work was supported by the Czech Science Foundation GA CR (17-05903S and 1903295S) and by the institutional project of the Institute of Physiology of the Czech Academy of Sciences (RVO:67985823).	Antolak A, 2017, J CELL BIOCHEM, V118, P4323, DOI 10.1002/jcb.26085; Bell RAV, 2014, PEERJ, V2, DOI 10.7717/peerj.634; Bendor JT, 2013, NEURON, V79, P1044, DOI 10.1016/j.neuron.2013.09.004; Berger AC, 2010, ANN NEUROL, V67, P559, DOI 10.1002/ana.22002; Bierczynska-Krzysik A, 2006, INT J MOL MED, V18, P775; Bodzon-Kulakowska A, 2009, J SEP SCI, V32, P1200, DOI 10.1002/jssc.200800464; Boldrini M, 2018, CELL STEM CELL, V22, P589, DOI 10.1016/j.stem.2018.03.015; Bourova L, 2010, MED SCI MONITOR, V16, pBR260; Cai Y, 2016, J CELL BIOL, V215, P245, DOI 10.1083/jcb.201605065; Chen XL, 2007, CELL RES, V17, P689, DOI 10.1038/cr.2007.63; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Diaz-Ramos A, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/156795; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Ernst A, 2014, CELL, V156, P1072, DOI 10.1016/j.cell.2014.01.044; Fountoulakis M, 1999, ELECTROPHORESIS, V20, P2181, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2181::AID-ELPS2181>3.0.CO;2-Q; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Jagr M, 2016, J PROTEOMICS, V145, P127, DOI 10.1016/j.jprot.2016.04.022; Jiang X, 2007, CELL RES, V17, P741, DOI 10.1038/cr.2007.75; Kim SY, 2005, MOL BRAIN RES, V133, P58, DOI 10.1016/j.molbrainres.2004.09.018; Kosten TR, 2019, AM J ADDICTION, V28, P55, DOI 10.1111/ajad.12862; Kosten Thomas R, 2002, Sci Pract Perspect, V1, P13; Kunjithapatham R, 2015, J PROTEOME RES, V14, P1645, DOI 10.1021/acs.jproteome.5b00089; Kutlu MG, 2016, LEARN MEMORY, V23, P515, DOI 10.1101/lm.042192.116; Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640; Liao D, 2005, P NATL ACAD SCI USA, V102, P1725, DOI 10.1073/pnas.0406797102; Ma J, 2015, LIFE SCI, V124, P128, DOI 10.1016/j.lfs.2015.01.003; Maher CE, 2005, LIFE SCI, V77, P1140, DOI 10.1016/j.lfs.2005.03.004; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mansouri FA, 1999, BRAIN RES, V815, P419, DOI 10.1016/S0006-8993(98)01148-2; Mansouri FA, 1997, BRAIN RES, V769, P119, DOI 10.1016/S0006-8993(97)00608-2; Marie-Claire C, 2004, NEUROPSYCHOPHARMACOL, V29, P2208, DOI 10.1038/sj.npp.1300513; Maries E, 2003, NAT REV NEUROSCI, V4, P727, DOI 10.1038/nrn1199; Mattel V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169571; Monti B, 2007, J NEUROCHEM, V103, P518, DOI 10.1111/j.1471-4159.2007.04778.x; Moravcova Z, 2004, BBA-MOL CELL RES, V1691, P51, DOI 10.1016/j.bbamcr.2003.12.004; Moron JA, 2007, MOL CELL PROTEOMICS, V6, P29, DOI 10.1074/mcp.M600184-MCP200; Payabvash S, 2006, LIFE SCI, V79, P972, DOI 10.1016/j.lfs.2006.05.008; Person Maria D, 2006, J Biomol Tech, V17, P145; Ponti G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002366; Popa-Wagner A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/963520; Pu L, 2002, J NEUROSCI, V22, P1914, DOI 10.1523/JNEUROSCI.22-05-01914.2002; Rudajev V, 2005, J BIOCHEM, V138, P111, DOI 10.1093/jb/mvi114; Sim LJ, 1996, J NEUROSCI, V16, P2684; Sim-Selley LJ, 2000, J NEUROSCI, V20, P4555, DOI 10.1523/JNEUROSCI.20-12-04555.2000; Skrabalova J, 2013, MINI-REV ORG CHEM, V10, P367, DOI 10.2174/1570193X113106660031; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Taguchi K, 2016, J COMP NEUROL, V524, P1236, DOI 10.1002/cne.23901; Taguchi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089327; Tannu NS, 2006, NAT PROTOC, V1, P1732, DOI 10.1038/nprot.2006.256; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Ujcikova H, 2014, PHYSIOL RES, V63, pS165, DOI 10.33549/physiolres.932638; Ujcikova H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186797; Ujcikova H, 2016, J PROTEOMICS, V145, P11, DOI 10.1016/j.jprot.2016.02.019; Ujcikova H, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-11; Ujcikova H, 2011, BBA-GEN SUBJECTS, V1810, P1220, DOI 10.1016/j.bbagen.2011.09.017; Xu B, 2006, BASIC CLIN PHARMACOL, V99, P153, DOI 10.1111/j.1742-7843.2006.pto_461.x; Xu NJ, 2003, J NEUROSCI, V23, P4775; Zhou JF, 2000, BIOMED ENVIRON SCI, V13, P131; Ziolkowska B, 2005, J NEUROSCI, V25, P4996, DOI 10.1523/JNEUROSCI.4376-04.2005	63	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231721	10.1371/journal.pone.0231721	http://dx.doi.org/10.1371/journal.pone.0231721			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ1US	32294144	gold, Green Published			2022-12-26	WOS:000529957800001
J	Holt, C; Hamborg, L; Lau, K; Brohus, M; Sorensen, AB; Larsen, KT; Sommer, C; Van Petegem, F; Overgaard, MT; Wimmer, R				Holt, Christian; Hamborg, Louise; Lau, Kelvin; Brohus, Malene; Sorensen, Anders Bundgaard; Larsen, Kamilla Taunsig; Sommer, Cordula; Van Petegem, Filip; Overgaard, Michael Toft; Wimmer, Reinhard			The arrhythmogenic N53I variant subtly changes the structure and dynamics in the calmodulin N-terminal domain, altering its interaction with the cardiac ryanodine receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calmodulin (CaM); calcium-binding protein; ryanodine receptor; protein structure; protein-protein interaction; structure-function; CaM-N53I; cardiac arrhythmia; CPVT; NMR; X-ray crystallography	LONG QT SYNDROME; VENTRICULAR-TACHYCARDIA; MUTATIONS; BINDING; PROTEIN; INACTIVATION; INHIBITION; CALM1; GENE	Mutations in the genes encoding the highly conserved Ca2+-sensing protein calmodulin (CaM) cause severe cardiac arrhythmias, including catecholaminergic polymorphic ventricular tachycardia or long QT syndrome and sudden cardiac death. Most of the identified arrhythmogenic mutations reside in the C-terminal domain of CaM and mostly affect Ca2+-coordinating residues. One exception is the catecholaminergic polymorphic ventricular tachycardia?causing N53I substitution, which resides in the N-terminal domain (N-domain). It does not affect Ca2+ coordination and has only a minor impact on binding affinity toward Ca2+ and on other biophysical properties. Nevertheless, the N53I substitution dramatically affects CaM's ability to reduce the open probability of the cardiac ryanodine receptor (RyR2) while having no effect on the regulation of the plasmalemmal voltage-gated Ca2+ channel, Ca(v)1.2. To gain more insight into the molecular disease mechanism of this mutant, we used NMR to investigate the structures and dynamics of both apo- and Ca2+-bound CaM-N53I in solution. We also solved the crystal structures of WT and N53I CaM in complex with the primary calmodulin-binding domain (CaMBD2) from RyR2 at 1.84?2.13 ? resolutions. We found that all structures of the arrhythmogenic CaM-N53I variant are highly similar to those of WT CaM. However, we noted that the N53I substitution exposes an additional hydrophobic surface and that the intramolecular dynamics of the protein are significantly altered such that they destabilize the CaM N-domain. We conclude that the N53I-induced changes alter the interaction of the CaM N-domain with RyR2 and thereby likely cause the arrhythmogenic phenotype of this mutation.	[Holt, Christian; Hamborg, Louise; Brohus, Malene; Sorensen, Anders Bundgaard; Larsen, Kamilla Taunsig; Sommer, Cordula; Overgaard, Michael Toft; Wimmer, Reinhard] Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark; [Lau, Kelvin; Van Petegem, Filip] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada	Aalborg University; University of British Columbia	Overgaard, MT; Wimmer, R (corresponding author), Aalborg Univ, Dept Chem & Biosci, DK-9220 Aalborg, Denmark.; Van Petegem, F (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	petegem@mail.ubc.ca; mto@bio.aau.dk; rw@bio.aau.dk	Wimmer, Reinhard/A-7901-2012; Wimmer, Reinhard/M-2346-2019	Wimmer, Reinhard/0000-0001-6942-5056; Lau, Kelvin/0000-0002-9040-7597; Holt, Christian/0000-0003-2604-0695; Overgaard, Michael Toft/0000-0002-1423-2481; Hamborg Nielsen, Louise/0000-0002-8580-9751	Danish Council for Independent Research Grant [DFF-1323-00344]; Novo Nordisk Foundation [NNF18OC0053032, NNF16OC0023344]; Obel Family Foundation; SparNord Foundation; Carlsberg Foundation; Canadian Institutes of Health Research [PJT-148632]	Danish Council for Independent Research Grant; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Obel Family Foundation; SparNord Foundation; Carlsberg Foundation(Carlsberg Foundation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Danish Council for Independent Research Grant DFF-1323-00344 and Novo Nordisk Foundation Grants NNF18OC0053032 and NNF16OC0023344. The medical biotechnology group at Aalborg University is supported by the Obel Family Foundation, the SparNord Foundation, and the Carlsberg Foundation. This work is also supported by Operating Grant PJT-148632 from the Canadian Institutes of Health Research (to F. V. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Balshaw DM, 2001, J BIOL CHEM, V276, P20144, DOI 10.1074/jbc.M010771200; Ben-Johny M, 2014, J GEN PHYSIOL, V143, P679, DOI 10.1085/jgp.201311153; Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Boczek NJ, 2016, CIRC-CARDIOVASC GENE, V9, P136, DOI 10.1161/CIRCGENETICS.115.001323; Brohus M, 2019, BIOCHEM J, V476, P193, DOI 10.1042/BCJ20180545; Burnley BT, 2012, ELIFE, V1, DOI 10.7554/eLife.00311; Burnley BT., 2013, COMPUT CRYSTALLOGR N, V4, P51; CHATTOPADHYAYA R, 1992, J MOL BIOL, V228, P1177, DOI 10.1016/0022-2836(92)90324-D; Coumel P., 1978, BRIT HEART J, V40, P28; Crotti L, 2019, EUR HEART J, V40, P2964, DOI 10.1093/eurheartj/ehz311; Crotti L, 2013, CIRCULATION, V127, P1009, DOI 10.1161/CIRCULATIONAHA.112.001216; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Friedberg F, 2001, IUBMB LIFE, V51, P215; Gomez-Hurtado N, 2016, CIRC-ARRHYTHMIA ELEC, V9, DOI 10.1161/CIRCEP.116.004161; Gong DS, 2019, NATURE, V572, P347, DOI 10.1038/s41586-019-1377-y; Guntert P, 2015, J BIOMOL NMR, V62, P453, DOI 10.1007/s10858-015-9924-9; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Guntert P, 1997, Methods Mol Biol, V60, P157; Gyorke I, 2004, BIOPHYS J, V86, P2121, DOI 10.1016/S0006-3495(04)74271-X; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Hwang HS, 2014, CIRC RES, V114, P1114, DOI 10.1161/CIRCRESAHA.114.303391; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525; Keller R., 2004, COMPUTER AIDED RESON, V1; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Laitinen PJ, 2001, CIRCULATION, V103, P485, DOI 10.1161/01.CIR.103.4.485; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Lau K, 2014, BIOCHEMISTRY-US, V53, P932, DOI 10.1021/bi401502x; Limpitikul WB, 2014, J MOL CELL CARDIOL, V74, P115, DOI 10.1016/j.yjmcc.2014.04.022; Liu B, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008155; Makita N, 2014, CIRC-CARDIOVASC GENE, V7, P466, DOI 10.1161/CIRCGENETICS.113.000459; Marsman RF, 2014, J AM COLL CARDIOL, V63, P259, DOI 10.1016/j.jacc.2013.07.091; Maximciuc AA, 2006, STRUCTURE, V14, P1547, DOI 10.1016/j.str.2006.08.011; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Nyegaard M, 2012, AM J HUM GENET, V91, P703, DOI 10.1016/j.ajhg.2012.08.015; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Rezacova P, 2008, PROTEINS, V70, P311, DOI 10.1002/prot.21511; Sarhan MF, 2012, P NATL ACAD SCI USA, V109, P3558, DOI 10.1073/pnas.1114748109; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sondergaard MT, 2020, FEBS J, V287, P2256, DOI 10.1111/febs.15147; Sondergaard MT, 2015, J BIOL CHEM, V290, P26151, DOI 10.1074/jbc.M115.676627; Sondergaard MT, 2015, FEBS J, V282, P803, DOI 10.1111/febs.13184; Sondergaard MT, 2017, J BIOL CHEM, V292, P1385, DOI 10.1074/jbc.M116.766253; Sorensen AB, 2013, FEBS J, V280, P5511, DOI 10.1111/febs.12337; Sorensen BR, 1998, BIOCHEMISTRY-US, V37, P4244, DOI 10.1021/bi9718200; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; Tidow H, 2013, FEBS J, V280, P5551, DOI 10.1111/febs.12296; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; TSALKOVA TN, 1985, J MOL BIOL, V181, P533, DOI 10.1016/0022-2836(85)90425-5; Vassilakopoulou V, 2015, BBA-GEN SUBJECTS, V1850, P2168, DOI 10.1016/j.bbagen.2015.07.001; Wang KQ, 2020, J PHYSIOL-LONDON, V598, P1169, DOI 10.1113/JP279307; Wang KQ, 2018, P NATL ACAD SCI USA, V115, pE10556, DOI 10.1073/pnas.1808733115; Yamaguchi N, 2003, J BIOL CHEM, V278, P23480, DOI 10.1074/jbc.M301125200; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Yin G, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000996; Yuchi ZG, 2012, STRUCTURE, V20, P1201, DOI 10.1016/j.str.2012.04.015; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	68	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7620	7634		10.1074/jbc.RA120.013430	http://dx.doi.org/10.1074/jbc.RA120.013430			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32317284	hybrid, Green Published			2022-12-26	WOS:000538038900006
J	Curioni, A; Knoblich, GK; Sebanz, N; Sacheli, LM				Curioni, Arianna; Knoblich, Gunther Klaus; Sebanz, Natalie; Sacheli, Lucia Maria			The engaging nature of interactive gestures	PLOS ONE			English	Article							DORSAL PREMOTOR CORTEX; SHARED GOALS; MOTOR; SELECTION; COMMUNICATION; OBJECTS; SYSTEM	The social interactions that we experience from early infancy often involve actions that are not strictly instrumental but engage the recipient by eliciting a (complementary) response. Interactive gestures may have privileged access to our perceptual and motor systems either because of their intrinsically engaging nature or as a result of extensive social learning. We compared these two hypotheses in a series of behavioral experiments by presenting individuals with interactive gestures that call for motor responses to complement the interaction ('hand shaking', 'requesting', ;high-five') and with communicative gestures that are equally socially relevant and salient, but do not strictly require a response from the recipient ('Ok', 'Thumbs up', 'Peace'). By means of a spatial compatibility task, we measured the interfering power of these task-irrelevant stimuli on the behavioral responses of individuals asked to respond to a target. Across three experiments, our results showed that the interactive gestures impact on response selection and reduce spatial compatibility effects as compared to the communicative (non-interactive) gestures. Importantly, this effect was independent of the activation of specific social scripts that may interfere with response selection. Overall, our results show that interactive gestures have privileged access to our perceptual and motor systems, possibly because they entail an automatic preparation to respond that involuntary engages the motor system of the observers. We discuss the implications from a developmental and neurophysiological point of view.	[Curioni, Arianna; Knoblich, Gunther Klaus; Sebanz, Natalie] Cent European Univ, Dept Cognit Sci, Budapest, Hungary; [Sacheli, Lucia Maria] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Sacheli, Lucia Maria] Univ Milano Bicocca, Milan Ctr Neurosci NeuroMi, Milan, Italy	Central European University; University of Milano-Bicocca; University of Milano-Bicocca	Curioni, A (corresponding author), Cent European Univ, Dept Cognit Sci, Budapest, Hungary.	curionia@ceu.edu		Knoblich, Gunther/0000-0003-4463-5318; CURIONI, ARIANNA/0000-0003-4874-9320; Sebanz, Natalie/0000-0003-1280-8974	European Research Council under the European Union [609819]; ERC [616072]	European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission)	European Research Council under the European Union's Seventh Framework Program (FP7/2007-2013)/ERC grant agreement no 609819, SOMICS, and by ERC grant agreement no 616072, JAXPERTISE.	Albertini D, 2019, PROG NEUROBIOL; Arbib MA, 2008, CURR ANTHROPOL, V49, P1052, DOI 10.1086/593015; Azaad S, 2019, Q J EXP PSYCHOL; Baayen R. H., 2008, ANAL LINGUISTIC DATA, DOI [10.1017/CBO9780511801686, DOI 10.1017/CBO9780511801686]; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Borghi AM, 2018, ANN NY ACAD SCI, P1, DOI [DOI 10.1007/S11229-018-1842-4, 10.1007/s11229-018-1842-4]; Bub DN, 2018, J EXP PSYCHOL HUMAN, V44, P53, DOI 10.1037/xhp0000431; Bub DN, 2010, J EXP PSYCHOL HUMAN, V36, P341, DOI 10.1037/a0017606; Buccino G, 2009, NEUROPSYCHOLOGIA, V47, P3074, DOI 10.1016/j.neuropsychologia.2009.07.003; Caiani SZ, 2014, PHENOMENOL COGN SCI, V13, P275, DOI 10.1007/s11097-013-9295-1; Candidi M, 2015, PHYS LIFE REV, V12, P126, DOI 10.1016/j.plrev.2015.01.023; Chemero A, 2003, ECOL PSYCHOL, V15, P181, DOI 10.1207/S15326969ECO1502_5; Cisek P, 2003, J NEUROPHYSIOL, V89, P922, DOI 10.1152/jn.00607.2002; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; Cisek P, 2007, PHILOS T R SOC B, V362, P1585, DOI 10.1098/rstb.2007.2054; Corballis MC, 2010, BRAIN LANG, V112, P25, DOI 10.1016/j.bandl.2009.02.002; Cunnington R, 2005, HUM MOVEMENT SCI, V24, P644, DOI 10.1016/j.humov.2005.10.001; di Pellegrino G, 2005, CURR BIOL, V15, P1469, DOI 10.1016/j.cub.2005.06.068; Elsner C, 2014, J EXP CHILD PSYCHOL, V126, P280, DOI 10.1016/j.jecp.2014.05.007; Faber TW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154457; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flach R, 2010, BRIT J PSYCHOL, V101, P739, DOI 10.1348/000712609X484595; Gelman A., 2007, DATA ANAL USING REGR, DOI 10.1017/CBO9780511790942; Gibson J.J., 1977, PERCEIVING ACTING KN, V1, P67, DOI [DOI 10.2307/1421838, 10.4324/9781315740218]; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Grezes J, 2003, EUR J NEUROSCI, V17, P2735, DOI 10.1046/j.1460-9568.2003.02695.x; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Iverson JM, 2005, PSYCHOL SCI, V16, P367, DOI 10.1111/j.0956-7976.2005.01542.x; Jaeger TF, 2008, J MEM LANG, V59, P434, DOI 10.1016/j.jml.2007.11.007; Knoblich G, 2011, PSYCHOL LEARN MOTIV, V54, P59, DOI 10.1016/B978-0-12-385527-5.00003-6; Kokal I, 2009, NEUROIMAGE, V47, P2046, DOI 10.1016/j.neuroimage.2009.06.010; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lanzilotto M, 2016, CEREB CORTEX, V26, P4435, DOI 10.1093/cercor/bhw315; Liepelt R, 2010, EXP PSYCHOL; Lindenberg R, 2012, HUM BRAIN MAPP, V33, P812, DOI 10.1002/hbm.21258; Livi A, 2019, P NATL ACAD SCI USA, V116, P2691, DOI 10.1073/pnas.1810890116; Makris S, 2013, BEHAV NEUROSCI, V127, P797, DOI 10.1037/a0033946; Newman-Norlund RD, 2007, NAT NEUROSCI, V10, P817, DOI 10.1038/nn1911; Pappas Z, 2014, COGNITION, V133, P716, DOI 10.1016/j.cognition.2014.08.018; PETITTO LA, 1991, SCIENCE, V251, P1493, DOI 10.1126/science.2006424; Pollick AS, 2007, P NATL ACAD SCI USA, V104, P8184, DOI 10.1073/pnas.0702624104; Proctor R.W., 2006, STIMULUS RESPONSE CO; Reddy V, 2003, TRENDS COGN SCI, V7, P397, DOI 10.1016/S1364-6613(03)00191-8; Sacheli LM, 2018, J COGNITIVE NEUROSCI, V30, P737, DOI 10.1162/jocn_a_01227; Sacheli LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8544; Sacheli LM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23275-9; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Tomasello M., 2010, ORIGINS HUMAN COMMUN; Vainiger D, 2014, PSYCHOL RES-PSYCH FO, V78, P55, DOI 10.1007/s00426-012-0475-3; van Schie HT, 2008, J EXP PSYCHOL HUMAN, V34, P1493, DOI 10.1037/a0011750; Xu J, 2009, P NATL ACAD SCI USA, V106, P20664, DOI 10.1073/pnas.0909197106; Yoshida K, 2011, CURR BIOL, V21, P249, DOI 10.1016/j.cub.2011.01.004	56	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232128	10.1371/journal.pone.0232128	http://dx.doi.org/10.1371/journal.pone.0232128			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324834	Green Published, gold			2022-12-26	WOS:000536033700082
J	Girgis, G; Powell, M; Youssef, M; Graugnard, DE; King, WD; Dawson, KA				Girgis, G.; Powell, M.; Youssef, M.; Graugnard, D. E.; King, W. D.; Dawson, K. A.			Effects of a mannan-rich yeast cell wall-derived preparation on cecal concentrations and tissue prevalence of Salmonella Enteritidis in layer chickens	PLOS ONE			English	Article							TYPHIMURIUM COLONIZATION; BROILER; CONTAMINATION; FRACTIONS; SPP.; FOOD	Salmonella Enteritidis (SE) has been the most common Salmonella serotype associated with foodborne infections in the last several years. Dietary applications of yeast-based preparations in feed have shown to reduce Salmonella colonization in chickens augmenting SE control strategies. This study was conducted to evaluate the effects of a mannan-rich yeast cell wall-derived preparation (Actigen (R)) administered in feed at a rate of 400 g/ton on SE colonization in the cecum and internal organs of commercial layer chickens. Sixteen week-old layer pullets were orally challenged with a selected nalidixic acid resistant SE strain at a dose of 1.7x10<^>9 colony forming units (CFU) per bird. SE colonization was assessed by evaluating isolation rates from ovary and pooled liver/spleen samples as well as enumeration of SE in cecal pouches one week post-challenge. Recovery rates of SE from the ovaries of directly challenged birds receiving Actigen (R) were significantly lower (P < 0.02) than those in directly challenged birds fed an unsupplemented control diet. Recovery rates of SE from pooled liver/spleen samples were not significantly different between Actigen (R)-treated pullets and controls (P = 0.22). Using direct plate count methods, cecal SE concentrations were 1 log(10) lower (P < 0.001) in challenged pullets in the Actigen (R)-supplemented group than in the challenged controls. The SE concentration distributions in the ceca were similar in groups testing positive and groups testing negative for SE in the ovaries and liver/spleens tissues. As a result, SE concentrations in the ceca could not be directly related to the occurrence or prevalence of SE in these tissues. In conclusion, Actigen (R) supplementation appears to decrease the prevalence of SE in ovarian tissue and concentrations of SE in cecal contents and may be useful as a tool for reducing the risk of eggshell contamination and transovarian transmission of SE in eggs.	[Girgis, G.; Powell, M.; Youssef, M.] Iowa State Univ, Nevysta Lab, Res Pk, Ames, IA 50010 USA; [Graugnard, D. E.; King, W. D.; Dawson, K. A.] Alltech Ctr Anim Nutrigen & Appl Anim Nutr, Nicholasville, KY USA	Iowa State University	Girgis, G (corresponding author), Iowa State Univ, Nevysta Lab, Res Pk, Ames, IA 50010 USA.	george@nevysta.com			Alltech Center for Animal Nutrigenomics and Applied Animal Nutrition	Alltech Center for Animal Nutrigenomics and Applied Animal Nutrition	This project was supported by the Alltech Center for Animal Nutrigenomics and Applied Animal Nutrition through a direct research contract awarded to Nevysta Laboratory. Data from the challenge studies were collected independently by Nevysta. Authors from the funding institution participated in the design of the study, data analysis, decision to publish and preparation of the manuscript.	Association of Official Analytical Chemists, 1990, OFFICIAL METHODS ANA; Berghaus RD, 2013, APPL ENVIRON MICROB, V79, P4106, DOI 10.1128/AEM.00836-13; Centers for Disease Control and Prevention, 2019, MMWR-MORBID MORTAL W; Corrigan A, 2017, J APPL POULTRY RES, V26, P350, DOI 10.3382/japr/pfx002; Dorea FC, 2010, APPL ENVIRON MICROB, V76, P7820, DOI 10.1128/AEM.01320-10; Fernandez F, 2002, AVIAN PATHOL, V31, P49, DOI 10.1080/03079450120106000; Gast RK, 2016, POULTRY SCI, V95, P1363, DOI 10.3382/ps/pew037; Gast RK, 2011, AVIAN DIS, V55, P243, DOI 10.1637/9540-092810-Reg.1; Gast RK, 2003, AVIAN DIS, V47, P633, DOI 10.1637/6098; GAST RK, 1994, INT J FOOD MICROBIOL, V21, P107, DOI 10.1016/0168-1605(94)90204-6; Gast RK, 1998, POULTRY SCI, V77, P1759, DOI 10.1093/ps/77.12.1759; Gu W, 2015, EPIDEMIOL INFECT, V143, P2786, DOI 10.1017/S095026881500014X; Hofacre CL, 2018, J APPL POULTRY RES, V27, P453, DOI 10.3382/japr/pfy030; Line JE, 1997, POULTRY SCI, V76, P1227, DOI 10.1093/ps/76.9.1227; McWhorter AR, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00012; Micciche AC, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00191; National Research Council, 1994, NUTR REQ POULTR; National Research Council, 2011, GUIDE CARE USE LAB A; O'Brien SJ, 2013, CLIN INFECT DIS, V56, P705, DOI 10.1093/cid/cis967; OYOFO BA, 1989, AVIAN DIS, V33, P531, DOI 10.2307/1591117; OYOFO BA, 1989, POULTRY SCI, V68, P1357, DOI 10.3382/ps.0681357; Ricke SC, 2018, YALE J BIOL MED, V91, P151; Sheng KC, 2006, IMMUNOLOGY, V118, P372, DOI 10.1111/j.1365-2567.2006.02384.x; Spellberg B, 2013, NEW ENGL J MED, V368, P299, DOI 10.1056/NEJMp1215093; Spring P, 2000, POULTRY SCI, V79, P205, DOI 10.1093/ps/79.2.205; Tack DM, 2019, MMWR-MORBID MORTAL W, V68, P369, DOI 10.15585/mmwr.mm6816a2; USDA, 2007, QDFMICRO000407 USDA; Walker GK, 2017, POULTRY SCI, V96, P2684, DOI 10.3382/ps/pex054; Wang YY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02111	29	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232088	10.1371/journal.pone.0232088	http://dx.doi.org/10.1371/journal.pone.0232088			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324793	Green Published, gold			2022-12-26	WOS:000536033700071
J	Mueller, KD; Norton, D; Koscik, RL; Morris, MC; Jonaitis, EM; Clark, LR; Fields, T; Allison, S; Berman, S; Kraning, S; Zuelsdorff, M; Okonkwo, O; Chin, N; Carlsson, CM; Bendlin, BB; Hermann, BP; Johnson, SC				Mueller, Kimberly D.; Norton, Derek; Koscik, Rebecca L.; Morris, Martha C.; Jonaitis, Erin M.; Clark, Lindsay R.; Fields, Taylor; Allison, Samantha; Berman, Sara; Kraning, Sarah; Zuelsdorff, Megan; Okonkwo, Ozioma; Chin, Nathaniel; Carlsson, Cynthia M.; Bendlin, Barbara B.; Hermann, Bruce P.; Johnson, Sterling C.			Self-reported health behaviors and longitudinal cognitive performance in late middle age: Results from the Wisconsin Registry for Alzheimer's Prevention	PLOS ONE			English	Article							CARDIORESPIRATORY FITNESS; LIFE-STYLE; DECLINE; RISK	Background Studies have suggested associations between self-reported engagement in health behaviors and reduced risk of cognitive decline. Most studies explore these relationships using one health behavior, often cross-sectionally or with dementia as the outcome. In this study, we explored whether several individual self-reported health behaviors were associated with cognitive decline when considered simultaneously, using data from the Wisconsin Registry for Alzheimer's Prevention (WRAP), an Alzheimer's disease risk-enriched cohort who were non-demented and in late midlife at baseline. Method We analyzed longitudinal cognitive data from 828 participants in WRAP, with a mean age at baseline cognitive assessment of 57 (range = 36-78, sd = 6.8) and an average of 6.3 years (standard deviation = 1.9, range = 2-10) of follow-up. The primary outcome was a multidomain cognitive composite, and secondary outcomes were immediate/delayed memory and executive function composites. Predictors of interest were self-reported measures of physical activity, cognitive activity, adherence to a Mediterranean-style diet (MIND), and interactions with each other and age. We conducted linear mixed effects analyses within an Information-theoretic (IT) model averaging (MA) approach on a set of models including covariates and combinations of these 2- and 3-way interactions. The IT approach was selected due to the large number of interactions of interest and to avoid pitfalls of traditional model selection approaches. Results Model-averaged results identified no significant self-reported health behavior* age interactions in relationship to the primary composite outcome. In secondary outcomes, higher MIND diet scores associated with slower decline in executive function. Men showed faster decline than women on delayed memory, independent of health behaviors. There were no other significant interactions among any other health behaviors and cognitive trajectories. Conclusions When multiple covariates and health behaviors were considered simultaneously, there were limited weak associations with cognitive decline in this age range. These results may be explained alone or in combination by three alternative explanations: 1) the range of cognitive decline is in middle age is too small to observe relationships with health behaviors, 2) the putative associations of these health behaviors on cognition may not be robust in this age range, or 3) the self-reported measures of the health behaviors may not be optimal for predicting cognitive decline. More study may be needed that incorporates sensitive measures of health behaviors, AD biomarker profiles, and/or other disease comorbidities.	[Mueller, Kimberly D.; Koscik, Rebecca L.; Jonaitis, Erin M.; Chin, Nathaniel; Carlsson, Cynthia M.; Hermann, Bruce P.; Johnson, Sterling C.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Inst, Madison, WI 53706 USA; [Mueller, Kimberly D.; Norton, Derek; Clark, Lindsay R.; Fields, Taylor; Allison, Samantha; Berman, Sara; Zuelsdorff, Megan; Okonkwo, Ozioma; Chin, Nathaniel; Carlsson, Cynthia M.; Bendlin, Barbara B.; Johnson, Sterling C.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Madison, WI 53706 USA; [Mueller, Kimberly D.; Kraning, Sarah] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Norton, Derek] Univ Wisconsin, Dept Biostat & Med Informat, Madison, WI USA; [Morris, Martha C.] Rush Univ, Med Ctr, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Clark, Lindsay R.; Hermann, Bruce P.] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA; [Clark, Lindsay R.; Allison, Samantha; Carlsson, Cynthia M.; Johnson, Sterling C.] William S Middleton Mem Vet Adm Med Ctr, Geriatr Res & Educ Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Rush University; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital	Mueller, KD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Inst, Madison, WI 53706 USA.; Mueller, KD (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin Alzheimers Dis Res Ctr, Madison, WI 53706 USA.; Mueller, KD (corresponding author), Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA.	kdmueller@wisc.edu	Hermann, Bruce/ACM-4355-2022	Zuelsdorff, Megan/0000-0002-9632-475X; Mueller, Kimberly/0000-0001-8691-9517	National Institutes of Health [R01 AG027161, R01 AG054059, UL1 TR000427]; Wisconsin Alzheimer's Institute Lou Holland Fund; Wisconsin Alzheimer's Disease Research Center; Geriatric Research Education and Clinical Center of the William S. Middleton Memorial Veterans Hospital, Madison, WI; Wisconsin Alzheimer's Institute	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wisconsin Alzheimer's Institute Lou Holland Fund; Wisconsin Alzheimer's Disease Research Center; Geriatric Research Education and Clinical Center of the William S. Middleton Memorial Veterans Hospital, Madison, WI; Wisconsin Alzheimer's Institute	This research was supported by the National Institutes of Health awards R01 AG027161, R01 AG054059, UL1 TR000427 and by donor funds including the Wisconsin Alzheimer's Institute Lou Holland Fund. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Portions of this research were supported by resources at the Wisconsin Alzheimer's Institute, the Wisconsin Alzheimer's Disease Research Center, and the Geriatric Research Education and Clinical Center of the William S. Middleton Memorial Veterans Hospital, Madison, WI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61; [Anonymous], 2018, J INT NEUROPSYCH SOC, P1, DOI [10.1017/S1355617718000954, DOI 10.1017/S1355617718000954]; Baker LD, 2017, ALZHEIMERS DEMENT, V13, pP613, DOI [10.1016/j, DOI 10.1016/J]; Boots EA, 2015, BRAIN IMAGING BEHAV, V9, P639, DOI 10.1007/s11682-014-9325-9; Brenner PS, 2014, SOC INDIC RES, V117, P489, DOI 10.1007/s11205-013-0359-y; Clark LR, 2019, ALZHEIMERS DEMENT, V15, P418, DOI 10.1016/j.jalz.2018.09.008; Clark LR, 2016, ALZHEIMERS DEMENT, V12, P805, DOI 10.1016/j.jalz.2015.12.009; Darst BF, 2017, J ALZHEIMERS DIS, V55, P473, DOI 10.3233/JAD-160195; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fratiglioni L, 2004, LANCET NEUROL, V3, P343, DOI 10.1016/S1474-4422(04)00767-7; Head D, 2012, ARCH NEUROL-CHICAGO, V69, P636, DOI 10.1001/archneurol.2011.845; Howieson DB, 2003, NEUROLOGY, V60, P1489, DOI 10.1212/01.WNL.0000063317.44167.5C; Jack CRJ, 2017, NIA AA RES FRAMEOWOR; Johnson Sterling C, 2018, Alzheimers Dement (Amst), V10, P130, DOI 10.1016/j.dadm.2017.11.007; Koscik RL, 2019, J INT NEUROPSYCH SOC, V25, P1, DOI 10.1017/S1355617718000929; Lehtisalo J, 2019, ALZHEIMERS DEMENT, V15, P410, DOI 10.1016/j.jalz.2018.10.001; Lourida I, 2019, JAMA-J AM MED ASSOC, V322, P430, DOI 10.1001/jama.2019.9879; Manly JJ, 2006, MED CARE, V44, pS10, DOI 10.1097/01.mlr.0000245427.22788.be; Manly JJ, 2004, APPL NEUROPSYCHOL, V11, P37, DOI 10.1207/s15324826an1101_5; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1015, DOI 10.1016/j.jalz.2015.04.011; Morris MC, 2015, ALZHEIMERS DEMENT, V11, P1007, DOI 10.1016/j.jalz.2014.11.009; Morris MC, 2014, ALZHEIMERS DEMENT, V10, pP166; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Paillard-Borg S, 2012, J ALZHEIMERS DIS, V31, P835, DOI 10.3233/JAD-2012-120724; Scarmeas N, 2003, J CLIN EXP NEUROPSYC, V25, P625, DOI 10.1076/jcen.25.5.625.14576; Schinka JA, 2005, J INT NEUROPSYCH SOC, V11, P108, DOI 10.1017/S1355617705050125; Schmidt M., 1996, W PSYCHOL SERVICES; Schultz SA, 2015, J INT NEUROPSYCH SOC, V21, P841, DOI 10.1017/S1355617715000843; Sisco S, 2015, J GERONTOL B-PSYCHOL, V70, P557, DOI 10.1093/geronb/gbt133; Solfrizzi V, 2017, J ALZHEIMERS DIS, V59, P815, DOI [10.3233/jad-170248, 10.3233/JAD-170248]; Spring B, 2012, J PUBLIC HEALTH-UK, V34, pI3, DOI 10.1093/pubmed/fdr111; Sturman MT, 2005, ARCH NEUROL-CHICAGO, V62, P1750, DOI 10.1001/archneur.62.11.1750; Vellas B, 2014, J Prev Alzheimers Dis, V1, P13; Wechsler D., 1981, WAIS R WECHSLER ADUL; Wechsler D., 1984, WMS R WECHSLER MEMOR; Wilkinson G, 1993, WRAT 3 WIDE RANGE AC; Wilson RS, 2002, JAMA-J AM MED ASSOC, V287, P742, DOI 10.1001/jama.287.6.742	39	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0221985	10.1371/journal.pone.0221985	http://dx.doi.org/10.1371/journal.pone.0221985			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324741	Green Published, gold			2022-12-26	WOS:000536033700001
J	Sinson, E; Ocampo, C; Liao, CD; Nguyen, S; Dinh, L; Rodems, K; Whitters, E; Hamilton, RG				Sinson, Edsel; Ocampo, Camille; Liao, Cindy; Nguyen, Steven; Dinh, Lauren; Rodems, Kelline; Whitters, Eric; Hamilton, Robert G.			Cross-reactive carbohydrate determinant interference in cellulose-based IgE allergy tests utilizing recombinant allergen components	PLOS ONE			English	Article							IMMUNOGLOBULIN-E-BINDING; N-GLYCANS; DOUBLE POSITIVITY; VENOM; DIAGNOSIS; EPITOPES; HONEYBEE; POLLEN; RELEVANCE; CELERY	Background Cross-reactive carbohydrate determinant (CCD) structures found in plant and insect glycoproteins are commonly recognized by IgE antibodies as epitopes that can lead to extensive cross-reactivity and obscure in vitro diagnostic (IVD) serology results. With the introduction of component resolved diagnosis (CRD), recombinant non-glycosylated components have been utilized to mitigate the risk of CCD-specific IgE (sIgE) detection. However, a recent study has shown that CCD-sIgE may bind directly to the cellulose solid phase matrix used in certain in vitro diagnostic assays, eliminating the advantage of CRD over traditional extract-based testing. The aim of this study is to further investigate the prevalence of CCD-sIgE interference on a commonly-used in vitro sIgE automated platform which employs a cellulose-based matrix to immobilize CCD-free recombinant components. Methods Sera from patients sensitized to peanut, silver birch, and/or timothy grass were analyzed for CCD-sIgE reactivity on ImmunoCAP/Phadia and NOVEOS autoanalyzers against the MUXF3 carbohydrate component. Positive CCD-sIgE sera were further analyzed against non-glycosylated recombinant components bound to the ImmunoCAP solid phase in the absence and presence of a soluble CCD inhibitor. For comparison, sera were then analyzed on NOVEOS, a non-cellulose based automated sIgE assay. Results Sera from 35% of the sensitized population tested in this study were positive (>= 0.35 kU/L) for CCD-sIgE. Of those positives, 17% resulted in CCD-sIgE-positive (false positive) results on ImmunoCAP using non-glycosylated allergosorbents that were negative on NOVEOS. Sera producing false-positive results on ImmunoCAP had varying levels of CCD-sIgE from 0.67 kU/L to 36.52 kU/L. The incidence of CCD interference was predominantly delimited to low-positive IgE results (0.35 kU(A)/L-3.00 kU(A)/L). Conclusion Falsely elevated diagnostic allergen-sIgE results can commonly occur due to the presence of CCD-sIgE using assays that employ a carbohydrate matrix-based allergosorbent. Even the use of non-glycosylated recombinant allergenic components coupled to cellulose matrices do not reduce their risk of detection. The risk of CCD interference that compromises quantitative IgE results can be mitigated by the addition of a soluble CCD inhibitor to positive CCD-sIgE containing sera or by alternatively using a non-cellulose based sIgE assay, such as the NOVEOS assay.	[Sinson, Edsel; Ocampo, Camille; Liao, Cindy; Nguyen, Steven; Dinh, Lauren; Rodems, Kelline; Whitters, Eric] HYCOR Biomed LLC, Garden Grove, CA 92841 USA; [Hamilton, Robert G.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University	Sinson, E (corresponding author), HYCOR Biomed LLC, Garden Grove, CA 92841 USA.	esinson@hycorbiomedical.com						Ahrazem O, 2006, INT ARCH ALLERGY IMM, V139, P96, DOI 10.1159/000090384; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Altmann F, 2016, ALLERGO J, V25, P18, DOI 10.1007/s40629-016-0112-6; Bardor M, 2003, GLYCOBIOLOGY, V13, P427, DOI 10.1093/glycob/cwg024; Batanero E, 1999, J ALLERGY CLIN IMMUN, V103, P147, DOI 10.1016/S0091-6749(99)70538-5; Bublin M, 2003, FASEB J, V17, P1697, DOI 10.1096/fj.02-0872fje; De Knop KJ, 2010, ADV CLIN CHEM, V50, P87, DOI 10.1016/S0065-2423(10)50005-2; Foetisch K, 2003, J ALLERGY CLIN IMMUN, V111, P889, DOI 10.1067/mai.2003.173; Fotisch K, 1999, INT ARCH ALLERGY IMM, V120, P30, DOI 10.1159/000024217; Hemmer W, 2004, CLIN EXP ALLERGY, V34, P460, DOI 10.1111/j.1365-2222.2004.01897.x; Hemmer W, 2001, J ALLERGY CLIN IMMUN, V108, P1045, DOI 10.1067/mai.2001.120013; Hemmer W., 2012, ANTICARBOHYDRATE ANT, P181; Hemmer W, 2018, J ALLERGY CLIN IMMUN, V141, P372, DOI 10.1016/j.jaci.2017.04.028; Holzweber F, 2013, ALLERGY, V68, P1269, DOI 10.1111/all.12229; Iacovacci P., 2002, Clinical and Experimental Allergy, V32, P1620, DOI 10.1046/j.1365-2222.2002.01516.x; Jappe U, 2006, ALLERGY, V61, P1220, DOI 10.1111/j.1398-9995.2006.01232.x; Jin C, 2008, J ALLERGY CLIN IMMUN, V121, P185, DOI 10.1016/j.jaci.2007.07.047; Kleine-Tebbe J, 2016, IMMUNOL ALLERGY CLIN, V36, P191, DOI 10.1016/j.iac.2015.08.012; Kochuyt AM, 2005, CLIN EXP ALLERGY, V35, P441, DOI 10.1111/j.1365-2222.2005.02217.x; KUBELKA V, 1993, EUR J BIOCHEM, V213, P1193, DOI 10.1111/j.1432-1033.1993.tb17870.x; KUROSAKA A, 1991, J BIOL CHEM, V266, P4168; Malandain H, 2007, Eur Ann Allergy Clin Immunol, V39, P216; Mari A, 1999, J ALLERGY CLIN IMMUN, V103, P1005, DOI 10.1016/S0091-6749(99)70171-5; Mari A, 2002, INT ARCH ALLERGY IMM, V129, P286, DOI 10.1159/000067591; Mittermann I, 2010, J ALLERGY CLIN IMMUN, V125, P1300, DOI 10.1016/j.jaci.2010.03.017; Muller UR, 2009, ALLERGY, V64, P543, DOI 10.1111/j.1398-9995.2008.01794.x; Petersen A, 1996, J ALLERGY CLIN IMMUN, V98, P805, DOI 10.1016/S0091-6749(96)70130-6; TRETTER V, 1993, INT ARCH ALLERGY IMM, V102, P259, DOI 10.1159/000236534; Treudler R, 2013, CURR ALLERGY ASTHM R, V13, P110, DOI 10.1007/s11882-012-0318-8; Valenta R, 2007, J INVEST ALLERG CLIN, V17, P36; van Ree R, 2002, INT ARCH ALLERGY IMM, V129, P189, DOI 10.1159/000066770; van Ree R, 1999, J ALLERGY CLIN IMMUN, V103, P1000, DOI 10.1016/S0091-6749(99)70169-7; Vieths S., 1994, Food and Agricultural Immunology, V6, P453, DOI 10.1080/09540109409354857	33	5	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231344	10.1371/journal.pone.0231344	http://dx.doi.org/10.1371/journal.pone.0231344			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324770	Green Published, gold			2022-12-26	WOS:000536033700012
J	Zhang, Y; Tian, PY; Duan, GH; Gao, FL; Schnabel, G; Zhan, J; Chen, FP				Zhang, Yue; Tian, Peiyu; Duan, Guohua; Gao, Fangluan; Schnabel, Guido; Zhan, Jiasui; Chen, Fengping			Histone H3 gene is not a suitable marker to distinguish Alternaria tenuissima from A. alternata affecting potato	PLOS ONE			English	Article							1ST REPORT; SENSITIVITY; BLIGHT; IDENTIFICATION; RESISTANCE; EVOLUTION; PROTENTA; BENOMYL; PEACH	Potato Alternaria leaf blight is one of the economically most important disease in potato production worldwide. A recent study reported a quick method to distinguish main Alternaria pathogens A. tenuissima, A. alternata, and A. solani using partial histone H3 gene sequences. Using this method, our collection of 79 isolates from 8 provinces in China were presumably separated into A. tenussima and A. alternata. But in depth morphological and genetic analysis casted doubt on this identification. Culture morphologies of six presumed A. alternata isolates (PresA_alt) and six presumed A. tenuissima isolates (PresA_ten) were not significantly different. PresA_ten isolates also produced conidia in branched chains which supposed to be A. aternata. Phylogenetic analyses were conducted using internal transcribed spacer region (ITS) and five genes commonly used for species identification including glyceraldehyde-3-phosphate dehydrogenase (GPDH), translation elongation factor 1-alpha (TEF1), beta-tubulin, plasma membrane ATPase (ATPase), and calmodulin genes. The results showed that GPDH and TEF1 sequences of PresA_alt and PresA_ten isolates were identical. The 12 isolates did not cluster by presumed species neither by individual or concatenated sequence comparisons. The phylogeny-trait association analysis confirmed that the two group isolates were undistinguishable by those molecular markers. Analysis of histone H3 gene sequences revealed variable intron sequences between PresA_ten and PresA_alt isolates, but the amino acid sequences were identical. Our results indicate that the previously published method to distinguish Alternaria species based on histone H3 gene sequence variation is inaccurate and that the prevalence of A. tenuissima isolates in China was likely overestimated.	[Zhang, Yue; Tian, Peiyu; Duan, Guohua; Gao, Fangluan; Zhan, Jiasui; Chen, Fengping] Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Key Lab Plant Virol, Fuzhou, Peoples R China; [Schnabel, Guido] Clemson Univ, Dept Plant & Environm Sci, Clemson, SC USA; [Zhan, Jiasui] Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Peoples R China	Fujian Agriculture & Forestry University; Clemson University; Fujian Agriculture & Forestry University	Zhan, J; Chen, FP (corresponding author), Fujian Agr & Forestry Univ, Inst Plant Virol, Fujian Key Lab Plant Virol, Fuzhou, Peoples R China.; Zhan, J (corresponding author), Fujian Agr & Forestry Univ, State Key Lab Ecol Pest Control Fujian & Taiwan C, Fuzhou, Peoples R China.	jiasui.zhan@fafu.edu.cn; chenfengping@fafu.edu.cn		Gao, Fangluan/0000-0001-9031-9944	National Key Research and Development (R & D) Plan of China [2018YFD0200802]; Agriculture Research System of China [CARS-9-P20]; Natural Science Foundation of Fujian [2015J01086]	National Key Research and Development (R & D) Plan of China; Agriculture Research System of China; Natural Science Foundation of Fujian(Natural Science Foundation of Fujian Province)	This work was supported by National Key Research and Development (R & D) Plan of China (No. 2018YFD0200802), Agriculture Research System of China (CARS-9-P20) and Natural Science Foundation of Fujian (2015J01086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIS CD, 1979, P NATL ACAD SCI USA, V76, P4857, DOI 10.1073/pnas.76.10.4857; Amaradasa BS, 2014, PLANT DIS, V98, P279, DOI 10.1094/PDIS-05-13-0487-PDN; Ardestani S. Tahery, 2010, Iranian Journal of Plant Pathology, V45, P83; Ayad D, 2017, PLANT DIS, V101, P836, DOI 10.1094/PDIS-10-16-1420-PDN; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Binyam Tsedaley, 2014, Journal of Biology, Agriculture and Healthcare, V4, P191; Chen FP, 2012, PLANT DIS, V96, P416, DOI 10.1094/PDIS-06-11-0495; Chen SN, 2016, PLANT DIS, V100, P2434, DOI 10.1094/PDIS-04-16-0574-RE; Croll D, 2012, GENOME BIOL EVOL, V4, P1148, DOI 10.1093/gbe/evs091; Dang HX, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1430-7; de Hoog G S, 2007, Stud Mycol, V58, P219, DOI 10.3114/sim.2007.58.08; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gannibal PB, 2014, EUR J PLANT PATHOL, V139, P609, DOI 10.1007/s10658-014-0417-6; GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995; Heidari K, 2018, MYCOSPHERE, V9, P635, DOI 10.5943/mycosphere/9/4/2; Hu MJ, 2015, PLANT DIS, V99, P806, DOI 10.1094/PDIS-10-14-1077-RE; Hyde KD, 2016, FUNGAL DIVERS, V80, P1, DOI 10.1007/s13225-016-0373-x; Ishii H, 2016, PEST MANAG SCI, V72, P1844, DOI 10.1002/ps.4216; Jaouani A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/439197; Jones LR, 1997, J TORREY BOT SOC, V24, P254; Kawai H, 2020, EUR J PHYCOL, V55, P234, DOI 10.1080/09670262.2019.1692911; Kirk W, 2012, MICH EXT B E; Kiss N, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9010009; Koonin EV, 2009, J HERED, V100, P618, DOI 10.1093/jhered/esp056; Landschoot S, 2017, FUNGAL BIOL-UK, V121, P172, DOI 10.1016/j.funbio.2016.11.005; Lee HR, 2005, P NATL ACAD SCI USA, V102, P11793, DOI 10.1073/pnas.0503863102; Milia G, 2015, PLANT J, V82, P915, DOI 10.1111/tpj.12860; Nirenberg Helgard I., 1997, Mycoscience, V38, P329, DOI 10.1007/BF02464091; Nylander J.A.A, 2008, MRMODELTEST V2 3 PRO MRMODELTEST V2 3 PRO; Parker J, 2008, INFECT GENET EVOL, V8, P239, DOI 10.1016/j.meegid.2007.08.001; Pem D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217982; Peres NAR, 2002, PLANT DIS, V86, P620, DOI 10.1094/PDIS.2002.86.6.620; Rueda-Hernandez KR, 2013, J PHYTOPATHOL, V161, P246, DOI 10.1111/jph.12040; Roy SW, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-192; Roy SW, 2009, TRENDS GENET, V25, P67, DOI 10.1016/j.tig.2008.11.004; Shoaib A, 2014, PLANT DIS, V98, DOI 10.1094/PDIS-05-14-0539-PDN; Simmons E.G., 2007, CBS BIODIVERSITY SER, V6, P775; Sousa ES, 2017, PLANT DIS, V101, P1551, DOI 10.1094/PDIS-11-16-1661-PDN; Stevenson WR, 2007, PLANT DIS, V91, P1327, DOI 10.1094/PDIS-91-10-1327; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang MCW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004964; Thomma BPHJ, 2003, MOL PLANT PATHOL, V4, P225, DOI 10.1046/J.1364-3703.2003.00173.X; Tymon L, 2014, PLANT DIS, V98, P1648, DOI 10.1094/PDIS-12-13-1199-RE; Tymon LS, 2016, PLANT DIS, V100, P465, DOI 10.1094/PDIS-03-15-0263-RE; Xia XH, 2017, J HERED, V108, P431, DOI 10.1093/jhered/esx033; Zhang LY, 2010, J MOL EVOL, V71, P364, DOI 10.1007/s00239-010-9391-6; Zheng HH, 2015, PLANT PATHOL, V64, P425, DOI 10.1111/ppa.12274	47	1	1	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231961	10.1371/journal.pone.0231961	http://dx.doi.org/10.1371/journal.pone.0231961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324785	gold, Green Published			2022-12-26	WOS:000536033700050
J	dos Santos, VM; Dallago, BSL; Racanicci, AMC; Santana, AP; Cue, RI; Bernal, FEM				dos Santos, Viniclus M.; Dallago, Bruno S. L.; Racanicci, Aline M. C.; Santana, Angela P.; Cue, Roger I.; Bernal, Francisco E. M.			Effect of transportation distances, seasons and crate microclimate on broiler chicken production losses	PLOS ONE			English	Article							FEED WITHDRAWAL; PSE PALE; PHYSIOLOGICAL STRESS; EXUDATIVE MEAT; DEATH RATES; SLAUGHTER; WELFARE; MORTALITY; QUALITY; SOFT	The goal of this research was to evaluate the microclimate (temperature, relative humidity and ECI-enthalpy comfort index) of commercial loads of broiler chickens at different transport distances: Dist15 (15 km on average) and Dist90 (90 km on average) in the summer and winter seasons and their effects on the production parameters body weight difference (BWD), mortality (%) and bruising prevalence (%). Twelve broiler loads were monitored using dataloggers to record temperature and humidity, with a total of 24 target crates per load. The experiment followed a factorial design [2 seasons (rainy and dry) x 2 distances (Dist15 and Dist90)] with a randomized complete block arrangement, 3 sexes (all males, all females, or mixed shipments) and one shipment per combination. BWD had a heterogeneous distribution throughout the load, and this distribution was not significantly correlated with the mean ECI measured during transport at 12 positions along the load. In terms of comfort, summer is the most critical period for broiler transport. In the interaction between rainy season and Dist90, the highest ECI was scored in the lethal zone (where physiological mechanisms are not enough to control body temperature). Mortality during the rainy season was not significantly different between distances. However, during the dry season, mortality was twice as high as broilers that travelled for 15 km. The prevalence of bruising on carcasses was not affected by the interaction between season and distance. As we know, broiler chicken performance, during transport, can be also related to road conditions, being hard to evaluate the real impact of seasons and distances on animal welfare. Load microclimate can compromise broiler chicken welfare during transport and it does not necessary reflect significant losses pre and post-slaughter.	[dos Santos, Viniclus M.] Fed Inst Brasilia, Brasilia, DF, Brazil; [Dallago, Bruno S. L.; Racanicci, Aline M. C.; Santana, Angela P.; Bernal, Francisco E. M.] Univ Brasilia, Fac Agron & Vet Med, Brasilia, DF, Brazil; [Cue, Roger I.] McGill Univ, Dept Anim Sci, Montreal, PQ, Canada	Instituto Federal de Brasilia; Universidade de Brasilia; McGill University	dos Santos, VM (corresponding author), Fed Inst Brasilia, Brasilia, DF, Brazil.	vinicius.santos@ifb.edu.br	dos Santos, Vinícius Machado/R-4365-2019	dos Santos, Vinícius Machado/0000-0003-1249-0230; Dallago, Bruno/0000-0003-4883-1076				[Anonymous], 2019, R LANG ENV STAT COMP; Aral Y, 2014, ANKARA UNIV VET FAK, V61, P205, DOI 10.1501/Vetfak_0000002630; Arikan MS, 2017, BRAZ J POULTRY SCI, V19, P421, DOI 10.1590/1806-9061-2016-0429; Assayag Junior M. S., 2005, Brazilian Journal of Veterinary Research and Animal Science, V42, P188; Barbosa JAD, 2014, ENG AGR-JABOTICABAL, V34, P405, DOI 10.1590/S0100-69162014000300003; Bejaei M, 2014, POULTRY SCI, V93, P296, DOI 10.3382/ps.2013-03417; Byrd JA, 1998, AVIAN DIS, V42, P802, DOI 10.2307/1592719; Caffrey NP, 2017, PREV VET MED, V147, P199, DOI 10.1016/j.prevetmed.2017.09.011; Campos FS, 2019, INT J BIOMETEOROL, V63, P1525, DOI 10.1007/s00484-019-01675-4; Cobb-Vantress, 2012, MAN MAN FRANG CORT B; Vieira FMC, 2010, REV BRAS ZOOTECN, V39, P2471, DOI 10.1590/S1516-35982010001100021; Costa F, 2007, REV VET ZOOTECNIA, V14, P234; Dadgar S, 2010, POULTRY SCI, V89, P1033, DOI 10.3382/ps.2009-00248; Langer ROD, 2010, BRAZ ARCH BIOL TECHN, V53, P1161, DOI 10.1590/S1516-89132010000500021; Barbosa JAD, 2009, REV BRAS ZOOTECN, V38, P2442, DOI 10.1590/S1516-35982009001200021; Denadai JC, 2002, Rev. Bras. Cienc. Avic., V4, P101, DOI 10.1590/S1516-635X2002000200002; Department for Environment Food and Rural Affairs, 2002, COD REC WELF MEAT CH; dos Santos VM, 2017, POULTRY SCI, V96, P4270, DOI 10.3382/ps/pex282; Fitzgerald, 2017, POULTRY HANDLING TRA; Furlan R.L., 2002, FISIOLOGIA AVIARIA A, P209; Girardin P, 1999, J SUSTAIN AGR, V13, P5, DOI 10.1300/J064v13n04_03; Grandin T., 2010, IMPROVING ANIMAL WEL; Grandin T., 2009, POULTRY SLAUGHTER PL; Grandin T, 2010, MEAT SCI, V86, P56, DOI 10.1016/j.meatsci.2010.04.022; HARGIS BM, 1995, POULTRY SCI, V74, P1548, DOI 10.3382/ps.0741548; Huertas SM, 2018, ANIMALS, V8, P3; INMET National Institute of Meteorology, 2018, MET DAT TEACH RES; Jacobs L, 2017, POULTRY SCI, V96, P266, DOI 10.3382/ps/pew361; Kettlewell P, 1993, INT S AM SOC AGR ENG, P345; Knezacek TD, 2010, CAN J ANIM SCI, V90, P321, DOI 10.4141/CJAS09083; Li XF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197028; Ludtke C.B., 2010, ABATE HUMANITARIO AV, V1st; Lund VP, 2013, BRIT POULTRY SCI, V54, P430, DOI 10.1080/00071668.2013.804173; LYON CE, 1991, POULTRY SCI, V70, P1020, DOI 10.3382/ps.0701020; Mendes A. A., 2011, BRAZILIAN J ANIMAL S, V40, P352, DOI DOI 10.1590/S1516-35982011000200017; Mendes AA, 2001, BRAZ J POULTRY SCI, P199; de Oliveira RFM, 2006, REV BRAS ZOOTECN, V35, P797, DOI 10.1590/S1516-35982006000300023; Mitchell M. A., 2009, World Poultry Science Association (WPSA), Proceedings of the 8th European Symposium on Poultry Welfare, Cervia, Italy, 18-22 May, 2009, P76; Mitchell MA, 1992, ANIM WELFARE, V1, P91; Mitchell MA, 1998, POULTRY SCI, V77, P1803, DOI 10.1093/ps/77.12.1803; MITCHELL MA, 1994, WORLD POULTRY SCI J, V50, P57, DOI 10.1079/WPS19940006; Mitchell MA, 2009, AVIAN BIOL RES, V2, P99, DOI 10.3184/175815509X431894; da Silva MAN, 2007, REV BRAS ZOOTECN, V36, P1126, DOI 10.1590/S1516-35982007000500020; NICOL CJ, 1990, APPL ANIM BEHAV SCI, V28, P57, DOI 10.1016/0168-1591(90)90046-G; Northcutt JK, 1997, POULTRY SCI, V76, P410, DOI 10.1093/ps/76.2.410; da Silva IJO, 2006, REV BRAS ZOOTECN, V35, P1439, DOI 10.1590/S1516-35982006000500025; Silva JAO, 2011, SEMIN-CIENC AGRAR, V32, P795, DOI 10.5433/1679-0359.2011v32n2p795; Olivo R, 2001, CARNES CAMINHO PESQU; Pereira REP, 2013, BRAZ J POULTRY SCI, V15, P119, DOI 10.1590/S1516-635X2013000200007; Queiroz M, 2012, PRODUCAO ANIM AVIC, V66, P21; RICHARDS SA, 1970, ANN BIOL ANIM BIOCH, V10, P151, DOI 10.1051/rnd:19700614; Rodrigues VC, 2011, INT J BIOMETEOROL, V55, P455, DOI 10.1007/s00484-010-0344-y; Schettino DN, 2006, ARQ BRAS MED VET ZOO, V58, P918, DOI 10.1590/S0102-09352006000500030; Sevegnani KB, 2016, ENG AGR-JABOTICABAL, V36, P1, DOI 10.1590/1809-4430-Eng.Agric.v36n1p1-12/2016; Simoes GS, 2009, BRAZ ARCH BIOL TECHN, V52, P195, DOI 10.1590/S1516-89132009000700025; Sowinska J, 2013, MED WETER, V69, P420; Spurio RS, 2016, ANIM SCI J, V87, P277, DOI 10.1111/asj.12407; Ulupi N, 2018, INT J POULT SCI, V17, P197, DOI [10.3923/ijps.2018.197.204, DOI 10.3923/IJPS.2018.197.204]; Vecerek V, 2006, POULTRY SCI, V85, P1881, DOI 10.1093/ps/85.11.1881; Vecerek V, 2016, ASIAN AUSTRAL J ANIM, V29, P1796, DOI 10.5713/ajas.15.0996; Voslarova E, 2007, VET MED-CZECH, V52, P262, DOI 10.17221/1881-VETMED; Vosmerova P, 2010, POULTRY SCI, V89, P2719, DOI 10.3382/ps.2010-00709; Weeks CA, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P378, DOI 10.1079/9781780643212.0378; Wei T, 2017, R PACKAGE CORRPLOT V	64	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0232004	10.1371/journal.pone.0232004	http://dx.doi.org/10.1371/journal.pone.0232004			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320452	gold, Green Published			2022-12-26	WOS:000536028800049
J	Qiu, MS; Zhu, YP				Qiu, Mingshan; Zhu, Yuanpeng			C-1 triangular Coons surface construction and image interpolation based on new Side-Side and Side-Vertex interpolation operators	PLOS ONE			English	Article							CURVES	In this paper, a new class of rational quadratic/linear trigonometric Hermite functions with two shape parameters is proposed. Based on these Hermite functions, new improved first class of Side-Side (FCSS), second class of Side-Side (SCSS), first class of Side-Vertex (FCSV) and second class of Side-Vertex (SCSV) interpolation operators are proposed respectively, which can be used to construct C-1 Coons surfaces over triangular domain. By altering the values of two shape parameters, the shape of the Coons surface patch can be adjusted flexibly, but without affecting the function values and partial derivatives of the boundaries. For constructing the triangular surface patches with the center of mass passing through a fixed point, we also give a center of mass function value control method, by which we can solve the corresponding shape parameter values. Moreover, we also apply these four improved interpolation operators to image interpolation. Compared with some widely used image interpolation methods, our methods achieve competitive performance.	[Qiu, Mingshan; Zhu, Yuanpeng] South China Univ Technol, Sch Math, Guangzhou, Peoples R China	South China University of Technology	Zhu, YP (corresponding author), South China Univ Technol, Sch Math, Guangzhou, Peoples R China.	ypzhu@scut.edu.cn		Zhu, Yuanpeng/0000-0001-8682-6089	National Natural Science Foundation of China [61802129]; Natural Science Foundation Guangdong Province, China [2018A030310381]; National Training Program of Innovation and Entrepreneurship for Undergraduates [201910561129]; Hundred steps climbing plan of South China University of Technology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Guangdong Province, China; National Training Program of Innovation and Entrepreneurship for Undergraduates; Hundred steps climbing plan of South China University of Technology	The research is supported by the National Natural Science Foundation of China (No. 61802129) and the Natural Science Foundation Guangdong Province, China (No. 2018A030310381), and the National Training Program of Innovation and Entrepreneurship for Undergraduates (No. 201910561129) and the Hundred steps climbing plan of South China University of Technology (No. j2tw202004019).	Abbas S, 2018, ALEX ENG J, V57, P931, DOI 10.1016/j.aej.2017.01.004; Abbas S, 2018, IET IMAGE PROCESS, V12, P769, DOI 10.1049/iet-ipr.2016.0393; [Anonymous], USC SIPI DAT; Barnhill R. E., 1973, Journal of Approximation Theory, V8, P114, DOI 10.1016/0021-9045(73)90020-8; BARNHILL RE, 1975, J APPROX THEORY, V15, P214, DOI 10.1016/0021-9045(75)90104-5; BARNHILL RE, 1975, MATH COMPUT, V29, P726, DOI 10.1090/S0025-5718-1975-0375735-3; Coons, 1967, SURFACES COMPUTER AI; Fan QL, 2016, 2016 IEEE 14TH INTL CONF ON DEPENDABLE, AUTONOMIC AND SECURE COMPUTING, 14TH INTL CONF ON PERVASIVE INTELLIGENCE AND COMPUTING, 2ND INTL CONF ON BIG DATA INTELLIGENCE AND COMPUTING AND CYBER SCIENCE AND TECHNOLOGY CONGRESS (DASC/PICOM/DATACOM/CYBERSC, P217, DOI 10.1109/DASC-PICom-DataCom-CyberSciTec.2016.56; Hagen H., 1989, Mathematical Methods in Computer Aided Geometric Design, P373; Hagen H., 1986, Computer-Aided Geometric Design, V3, P179, DOI 10.1016/0167-8396(86)90035-X; Han XL, 2002, COMPUT AIDED GEOM D, V19, P503, DOI 10.1016/S0167-8396(02)00126-7; HOU HS, 1978, IEEE T ACOUST SPEECH, V26, P508; Hussain MZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179721; Ibraheem F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120658; KEYS RG, 1981, IEEE T ACOUST SPEECH, V29, P1153, DOI 10.1109/TASSP.1981.1163711; Li X, 2001, IEEE T IMAGE PROCESS, V10, P1521, DOI 10.1109/83.951537; Nielson G, 1987, SIAM GEOM MOD, P235; NIELSON GM, 1979, J APPROX THEORY, V25, P318, DOI 10.1016/0021-9045(79)90020-0; Takeda H, 2007, IEEE T IMAGE PROCESS, V16, P349, DOI 10.1109/TIP.2006.888330; Wang CC, 2012, WORLD J GASTROENTERO, V18, P25, DOI 10.3748/wjg.v18.i1.25; Wang J, 2013, FETAL DIAGN THER, V34, P110, DOI 10.1159/000350272; Wang Z, 2003, CONF REC ASILOMAR C, P1398; Wu Xiao-qin, 2010, Computer Engineering and Applications, V46, P173, DOI 10.3778/j.issn.1002-8331.2010.01.051; Yang Zhao-Xia, 2001, Journal of Computer Aided Design & Computer Graphics, V13, P824; Zhang CM, 2002, COMPUT AIDED GEOM D, V19, P645, DOI 10.1016/S0167-8396(02)00148-6; Zhang JW, 1996, COMPUT AIDED GEOM D, V13, P199, DOI 10.1016/0167-8396(95)00022-4; Zhang L, 2011, IEEE T IMAGE PROCESS, V20, P2378, DOI 10.1109/TIP.2011.2109730; Zhang YF, 2018, IEEE T IMAGE PROCESS, V27, P3782, DOI 10.1109/TIP.2018.2826139; [邹倩 Zou Qian], 2019, [图学学报, Journal of Graphics], V40, P388	29	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231617	10.1371/journal.pone.0231617	http://dx.doi.org/10.1371/journal.pone.0231617			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320432	Green Published, gold			2022-12-26	WOS:000536028800028
J	Nigro, LM; Elling, FJ; Hinrichs, KU; Joye, SB; Teske, A				Nigro, Lisa M.; Elling, Felix J.; Hinrichs, Kai-Uwe; Joye, Samantha B.; Teske, Andreas			Microbial ecology and biogeochemistry of hypersaline sediments in Orca Basin	PLOS ONE			English	Article							SULFATE-REDUCING BACTERIUM; COLD-SEEP HABITATS; NORTHERN GULF; ANOXIC BRINE; GEN. NOV.; PHYLOGENETIC DIVERSITY; ANAEROBIC OXIDATION; HYDROGEN-ISOTOPE; ATLANTIS-II; RED-SEA	In deep ocean hypersaline basins, the combination of high salinity, unusual ionic composition and anoxic conditions represents significant challenges for microbial life. We used geo-chemical porewater characterization and DNA sequencing based taxonomic surveys to enable environmental and microbial characterization of anoxic hypersaline sediments and brines in the Orca Basin, the largest brine basin in the Gulf of Mexico. Full-length bacterial 16S rRNA gene clone libraries from hypersaline sediments and the overlying brine were dominated by the uncultured halophilic KB1 lineage, Deltaproteobacteria related to cultured sulfate-reducing halophilic genera, and specific lineages of heterotrophic Bacteroidetes. Archaeal clones were dominated by members of the halophilic methanogen genus Methanohalophilus, and the ammonia-oxidizing Marine Group I (MG-I) within the Thaumarchaeota. Illumina sequencing revealed higher phylum- and subphylum-level complexity, especially in lower-salinity sediments from the Orca Basin slope. Illumina and clone library surveys consistently detected MG-I Thaumarchaeota and halotolerant Deltaproteobacteria in the hypersaline anoxic sediments, but relative abundances of the KB1 lineage differed between the two sequencing methods. The stable isotopic composition of dissolved inorganic carbon and methane in porewater, and sulfate concentrations decreasing downcore indicated methanogenesis and sulfate reduction in the anoxic sediments. While anaerobic microbial processes likely occur at low rates near their maximal salinity thresholds in Orca Basin, long-term accumulation of reaction products leads to high methane concentrations and reducing conditions within the Orca Basin brine and sediments.	[Nigro, Lisa M.; Teske, Andreas] Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA; [Elling, Felix J.; Hinrichs, Kai-Uwe] Univ Bremen, Ctr Marine Environm Sci MARUM, Bremen, Germany; [Joye, Samantha B.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Nigro, Lisa M.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Elling, Felix J.] Harvard Univ, Dept Earth & Planetary Sci, 20 Oxford St, Cambridge, MA 02138 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Bremen; University System of Georgia; University of Georgia; University of Connecticut; Harvard University	Nigro, LM (corresponding author), Univ N Carolina, Dept Marine Sci, Chapel Hill, NC 27515 USA.; Nigro, LM (corresponding author), Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA.	lmnigro@alumni.unc.edu	Elling, Felix J/B-2149-2015; Teske, Andreas/AAQ-9577-2021	Elling, Felix J/0000-0003-0405-4033; 	National Science Foundation [0801742, 0801741]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (www.nsf.gov) Microbial Observatories program award numbers 0801742 to APT and 0801741 to SBJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	ADDY SK, 1980, MAR GEOL, V37, P241, DOI 10.1016/0025-3227(80)90104-8; Antunes A, 2011, ENV MICROBIOL REP, V3, P416, DOI 10.1111/j.1758-2229.2011.00264.x; Aronesty E., 2011, EA UTILS COMMAND LIN; Belyakova EV, 2006, MICROBIOLOGY+, V75, P161, DOI 10.1134/S0026261706020093; Ben Hania W, 2011, SYST APPL MICROBIOL, V34, P581, DOI 10.1016/j.syapm.2011.04.001; Borin Sara, 2008, Saline Syst, V4, P10, DOI 10.1186/1746-1448-4-10; Borin S, 2009, P NATL ACAD SCI USA, V106, P9151, DOI 10.1073/pnas.0811984106; Bowles M, 2016, DEEP-SEA RES PT II, V129, P31, DOI 10.1016/j.dsr2.2016.02.011; Brandt KK, 1999, INT J SYST BACTERIOL, V49, P193, DOI 10.1099/00207713-49-1-193; BURKE RA, 1986, INITIAL REP DEEP SEA, V96, P777; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Crespo-Medina M, 2016, GEOBIOLOGY, V14, P483, DOI 10.1111/gbi.12185; CROZIER TE, 1974, J CHEM ENG DATA, V19, P242, DOI 10.1021/je60062a007; Danovaro R, 2005, ENVIRON MICROBIOL, V7, P586, DOI 10.1111/j.1462-2920.2005.00727.x; DICKINS HD, 1992, DEEP-SEA RES, V39, P521, DOI 10.1016/0198-0149(92)90086-9; Diercks A, 2019, ELEMENTA-SCI ANTHROP, V7, DOI 10.1525/elementa.348; Durbin AM, 2010, ENV MICROBIOL REP, V2, P693, DOI 10.1111/j.1758-2229.2010.00163.x; Eder W, 1999, ARCH MICROBIOL, V172, P213, DOI 10.1007/s002030050762; Eder W, 2002, ENVIRON MICROBIOL, V4, P758, DOI 10.1046/j.1462-2920.2002.00351.x; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Edgcomb VP, 2016, ISME J, V10, P2643, DOI 10.1038/ismej.2016.58; Ertefai TF, 2010, GEOCHIM COSMOCHIM AC, V74, P6033, DOI 10.1016/j.gca.2010.08.006; Faith DP, 2006, EVOL BIOINFORM, V2, P277; Farag IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092139; Guan Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00839; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Harris JK, 2013, ISME J, V7, P50, DOI 10.1038/ismej.2012.79; HARTMANN M, 1985, MAR GEOL, V64, P157, DOI 10.1016/0025-3227(85)90166-5; HARVEY HR, 1992, ORG GEOCHEM, V18, P181, DOI 10.1016/0146-6380(92)90128-K; HOEHLER TM, 1994, GLOBAL BIOGEOCHEM CY, V8, P451, DOI 10.1029/94GB01800; Hurtgen MT, 1999, AM J SCI, V299, P556, DOI 10.2475/ajs.299.7-9.556; Isenbarger TA, 2008, APPL ENVIRON MICROB, V74, P840, DOI 10.1128/AEM.01933-07; ISHIZUKA T, 1986, INITIAL REP DEEP SEA, V96, P711; Jakobsen TF, 2006, INT J SYST EVOL MICR, V56, P2063, DOI 10.1099/ijs.0.64323-0; Joye SB, 2010, DEEP-SEA RES PT II, V57, P1990, DOI 10.1016/j.dsr2.2010.06.001; Joye SB, 2009, NAT GEOSCI, V2, P349, DOI 10.1038/NGEO475; Joye SB, 2004, CHEM GEOL, V205, P219, DOI 10.1016/j.chemgeo.2003.12.019; Kjeldsen KU, 2010, INT J SYST EVOL MICR, V60, P1060, DOI 10.1099/ijs.0.014746-0; Kleindienst S, 2012, ENVIRON MICROBIOL, V14, P2689, DOI 10.1111/j.1462-2920.2012.02832.x; Knittel K, 2003, GEOMICROBIOL J, V20, P269, DOI 10.1080/01490450303896; Knittel K, 2009, ANNU REV MICROBIOL, V63, P311, DOI 10.1146/annurev.micro.61.080706.093130; Kormas KA, 2015, EXTREMOPHILES, V19, P949, DOI 10.1007/s00792-015-0770-1; La Cono V, 2011, ENVIRON MICROBIOL, V13, P2250, DOI 10.1111/j.1462-2920.2011.02478.x; LAROCK PA, 1979, APPL ENVIRON MICROB, V37, P466, DOI 10.1128/AEM.37.3.466-470.1979; Li M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9933; Lin YS, 2012, GEOCHIM COSMOCHIM AC, V77, P186, DOI 10.1016/j.gca.2011.11.008; Lloyd KG, 2006, APPL ENVIRON MICROB, V72, P7218, DOI 10.1128/AEM.00886-06; Losekann T, 2007, APPL ENVIRON MICROB, V73, P3348, DOI 10.1128/AEM.00016-07; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; Lucker S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00027; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Merlino G, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy085; Mwirichia R, 2016, SCI REP-UK, V6, DOI 10.1038/srep19181; Ngugi DK, 2015, ISME J, V9, P396, DOI 10.1038/ismej.2014.137; Nigro LM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01266; Nobu MK, 2016, ISME J, V10, P273, DOI 10.1038/ismej.2015.97; OLLIVIER B, 1991, INT J SYST BACTERIOL, V41, P74, DOI 10.1099/00207713-41-1-74; Pachiadaki MG, 2014, ISME J, V8, P2478, DOI 10.1038/ismej.2014.100; Parada AE, 2016, ENVIRON MICROBIOL, V18, P1403, DOI 10.1111/1462-2920.13023; Pester M, 2011, CURR OPIN MICROBIOL, V14, P300, DOI 10.1016/j.mib.2011.04.007; Pilcher RS, 2007, AAPG BULL, V91, P823, DOI 10.1306/12180606049; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252; SACKETT WM, 1979, EARTH PLANET SC LETT, V44, P73, DOI 10.1016/0012-821X(79)90009-8; Schijf J, 2007, CHEM GEOL, V243, P255, DOI 10.1016/j.chemgeo.2007.06.011; Schreiber L, 2010, ENVIRON MICROBIOL, V12, P2327, DOI 10.1111/j.1462-2920.2010.02275.x; Shah SR, 2013, BIOGEOSCIENCES, V10, P3175, DOI 10.5194/bg-10-3175-2013; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; SHEU DD, 1986, MAR GEOL, V69, P309, DOI 10.1016/0025-3227(86)90045-9; SHEU DD, 1990, REV AQUAT SCI, V2, P491; SHOKES RF, 1977, SCIENCE, V196, P1443, DOI 10.1126/science.196.4297.1443; Siam R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042872; SOLORZANO L, 1969, LIMNOL OCEANOGR, V14, P799, DOI 10.4319/lo.1969.14.5.0799; Sorensen KB, 2005, APPL ENVIRON MICROB, V71, P7352, DOI 10.1128/AEM.71.11.7352-7365.2005; Steinle L, 2018, ISME J, V12, P1414, DOI [10.1038/S41396-018-0107-z, 10.1038/s41396-018-0107-z]; Swift SA, 2012, DEEP-SEA RES PT I, V64, P118, DOI 10.1016/j.dsr.2012.02.006; Teske A, 2002, APPL ENVIRON MICROB, V68, P1994, DOI 10.1128/AEM.68.4.1994-2007.2002; Trefry J.H., 1984, GEO-MAR LETT, V4, P125, DOI [10.1007/BF02277083, DOI 10.1007/BF02277083]; Tribovillard N, 2008, MAR GEOL, V254, P62, DOI 10.1016/j.margeo.2008.04.016; Tribovillard N, 2009, CR GEOSCI, V341, P1, DOI 10.1016/j.crte.2008.10.002; Van Cappellen P, 1998, ENVIRON SCI TECHNOL, V32, P2931, DOI 10.1021/es980307m; van der Wielen PWJJ, 2005, SCIENCE, V307, P121, DOI 10.1126/science.1103569; Wang Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140766; WHELAN JK, 1986, INITIAL REP DEEP SEA, V96, P767; Whiticar MJ, 1999, CHEM GEOL, V161, P291, DOI 10.1016/S0009-2541(99)00092-3; Widderich N, 2016, ENVIRON MICROBIOL, V18, P1227, DOI 10.1111/1462-2920.13156; WIESENBURG DA, 1985, GEOCHIM COSMOCHIM AC, V49, P2069, DOI 10.1016/0016-7037(85)90064-X; Yakimov MM, 2013, SCI REP-UK, V3, DOI 10.1038/srep03554; Zhuang GC, 2016, GEOCHIM COSMOCHIM AC, V187, P1, DOI 10.1016/j.gca.2016.05.005	93	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231676	10.1371/journal.pone.0231676	http://dx.doi.org/10.1371/journal.pone.0231676			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315331	Green Published, gold, Green Submitted			2022-12-26	WOS:000536024800044
J	Yadav, VK; Lee, TY; Hsu, JBK; Huang, HD; Yang, WCV; Chang, TH				Yadav, Vijesh Kumar; Lee, Tzong-Yi; Hsu, Justin Bo-Kai; Huang, Hsien-Da; Yang, Wei-Chung Vivian; Chang, Tzu-Hao			Computational analysis for identification of the extracellular matrix molecules involved in endometrial cancer progression	PLOS ONE			English	Article							INTEGRIN-LINKED KINASE; MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; MESSENGER-RNA; UP-REGULATION; BREAST; EXPRESSION; COLLAGEN; MIGRATION; RECEPTOR	Recurrence and poorly differentiated (grade 3 and above) and atypical cell type endometrial cancer (EC) have poor prognosis outcome. The mechanisms and characteristics of recurrence and distal metastasis of EC remain unclear. The extracellular matrix (ECM) of the reproductive tract in women undergoes extensive structural remodelling changes every month. Altered ECMs surrounding cells were believed to play crucial roles in a cancer progression. To decipher the associations between ECM and EC development, we generated a PAN-ECM Data list of 1516 genes including ECM molecules (ECMs), synthetic and degradation enzymes for ECMs, ECM receptors, and soluble molecules that regulate ECM and used RNA-Seq data from The Cancer Genome Atlas (TCGA) for the studies. The alterations of PAN-ECM genes by comparing the RNA-Seq expressions profiles of EC samples which have been grouped as tumorigenesis and metastasis group based on their pathological grading were identified. Differential analyses including functional enrichment, co-expression network, and molecular network analysis were carried out to identify the specific PAN-ECM genes that may involve in the progression of EC. Eight hundred and thirty-one and 241 PAN-ECM genes were significantly involved in tumorigenesis (p-value <1.571e-15) and metastasis (p-value <2.2e-16), respectively, whereas 140 genes were in the intersection of tumorigenesis and metastasis. Interestingly, 92 of the 140 intersecting PAN-ECM genes showed contrasting fold changes between the tumorigenesis and metastasis datasets. Enrichment analysis for the contrast PAN-ECM genes indicated pathways such as GP6 signaling, ILK signaling, and interleukin (IL)-8 signaling pathways were activated in metastasis but inhibited in tumorigenesis. The significantly activated ECM and ECM associated genes in GP6 signaling, ILK signaling, and interleukin (IL)-8 signaling pathways may play crucial roles in metastasis of EC. Our study provides a better understanding of the etiology and the progression of EC.	[Yadav, Vijesh Kumar; Yang, Wei-Chung Vivian] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Program Translat Med, Taipei, Taiwan; [Lee, Tzong-Yi; Huang, Hsien-Da] Chinese Univ Hong Kong, Warshel Inst Computat Biol, Shenzhen, Guangdong, Peoples R China; [Lee, Tzong-Yi; Huang, Hsien-Da] Chinese Univ Hong Kong, Sch Life & Hlth Sci, Shenzhen, Guangdong, Peoples R China; [Hsu, Justin Bo-Kai] Taipei Med Univ Hosp, Dept Med Res, Taipei, Taiwan; [Yang, Wei-Chung Vivian] Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ Hosp, Clin Big Data Res Ctr, Taipei, Taiwan	Taipei Medical University; Chinese University of Hong Kong, Shenzhen; Chinese University of Hong Kong, Shenzhen; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital	Yang, WCV (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Program Translat Med, Taipei, Taiwan.; Yang, WCV (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, PhD Program Translat Med, Taipei, Taiwan.; Chang, TH (corresponding author), Taipei Med Univ, Grad Inst Biomed Informat, Coll Med Sci & Technol, Taipei, Taiwan.; Chang, TH (corresponding author), Taipei Med Univ Hosp, Clin Big Data Res Ctr, Taipei, Taiwan.	vyang@tmu.edu.tw; kevinchang@tmu.edu.tw	YADAV, VIJESH KUMAR/AAQ-6047-2021; Huang, Hsien-Da/AAA-7376-2019; Hsu, Justin BoKai/ABB-4597-2021	YADAV, VIJESH KUMAR/0000-0002-2679-1205; Hsu, Justin BoKai/0000-0002-4563-2672				Aaboe M, 2003, BBA-MOL BASIS DIS, V1638, P72, DOI 10.1016/S0925-4439(03)00059-0; Abdel-Fatah TMA, 2015, ONCOTARGET, V6, P21964, DOI 10.18632/oncotarget.4157; Abdel-Fatah TMA, 2014, MOL ONCOL, V8, P1326, DOI 10.1016/j.molonc.2014.04.009; ABECASSIS J, 1987, INT J CANCER, V40, P525, DOI 10.1002/ijc.2910400416; Adhikary A, 2014, J BIOL CHEM, V289, P25431, DOI 10.1074/jbc.M113.527267; Alexopoulos LG, 2009, ARTHRITIS RHEUM-US, V60, P771, DOI 10.1002/art.24293; Ali MY, 2014, SOFT MATTER, V10, P8829, DOI 10.1039/c4sm01602e; Amant F, 2005, LANCET, V366, P491, DOI 10.1016/S0140-6736(05)67063-8; Amin MB, 2017, AJCC CANC STAGING MA; [Anonymous], 2011, Oncology (Williston Park), V25, P1091; [Anonymous], 2011, Oncology (Williston Park), V25, P849; [Anonymous], 2011, ONCOLOGY WILLISTON P, V25, P91; Barcus CE, 2013, J BIOL CHEM, V288, P12722, DOI 10.1074/jbc.M112.447631; Bellucci S, 2005, THROMB HAEMOSTASIS, V93, P130, DOI 10.1160/TH04-05-0312; Boll D, 2013, EUR J OBSTET GYN R B, V166, P209, DOI 10.1016/j.ejogrb.2012.10.028; Byron A, 2013, INT J EXP PATHOL, V94, P75, DOI 10.1111/iep.12011; Cox TR, 2011, DIS MODEL MECH, V4, P165, DOI 10.1242/dmm.004077; Cuellar K, 2007, J BIOL CHEM, V282, P5195, DOI 10.1074/jbc.M611048200; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Du J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20395; Du XL, 2008, INT J MOL MED, V22, P619, DOI 10.3892/ijmm_00000064; Dziobek K, 2019, CURR PHARM BIOTECHNO, V20, P727, DOI 10.2174/1389201020666190619145655; Ezumi Y, 2000, BIOCHEM BIOPH RES CO, V277, P27, DOI 10.1006/bbrc.2000.3624; Fini MA, 2008, J CELL BIOCHEM, V105, P1008, DOI 10.1002/jcb.21901; Freeman SJ, 2012, RADIOGRAPHICS, V32, P1805, DOI 10.1148/rg.326125519; Georgiou GK, 2013, WORLD J SURG ONCOL, V11, DOI 10.1186/1477-7819-11-213; Gimenez A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112431; Gordon A, 2007, ANN APPL STAT, V1, P179, DOI 10.1214/07-AOAS102; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Grabarek B, 2018, CURR PHARM BIOTECHNO, V19, P556, DOI 10.2174/1389201019666180730094046; Herishanu Y, 2011, LEUKEMIA LYMPHOMA, V52, P1758, DOI 10.3109/10428194.2011.569962; Hsu NC, 2013, BIOCHEM BIOPH RES CO, V441, P514, DOI 10.1016/j.bbrc.2013.10.093; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jain S, 2009, J THROMB HAEMOST, V7, P1713, DOI 10.1111/j.1538-7836.2009.03559.x; Karamichos D, 2007, J BIOMED MATER RES A, V83A, P887, DOI 10.1002/jbm.a.31423; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kopp HG, 2009, CANCER RES, V69, P7775, DOI 10.1158/0008-5472.CAN-09-2123; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kuo YC, 2009, INT J CANCER, V124, P2568, DOI 10.1002/ijc.24263; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lax S F, 1997, Verh Dtsch Ges Pathol, V81, P228; Lei YL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005397; Lim SB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01430-6; Lin TH, 2013, BBA-GEN SUBJECTS, V1830, P4917, DOI 10.1016/j.bbagen.2013.06.033; Liu LN, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2966; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Matias-Guiu X, 2001, HUM PATHOL, V32, P569, DOI 10.1053/hupa.2001.25929; Matsubara T, 2015, DIABETES, V64, P2978, DOI 10.2337/db14-0893; Milovanovic J, 2018, CYTOKINE; Moiseeva EP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085980; Moriarity JL, 2002, J BIOL CHEM, V277, P16968, DOI 10.1074/jbc.M109316200; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Nicolaije KAH, 2013, GYNECOL ONCOL, V129, P324, DOI 10.1016/j.ygyno.2013.02.018; Onstad MA, 2016, J CLIN ONCOL, V34, P4225, DOI 10.1200/JCO.2016.69.4638; Owens GL, 2017, CANCER MED-US, V6, P408, DOI 10.1002/cam4.967; Owens P, 2012, P NATL ACAD SCI USA, V109, P2814, DOI 10.1073/pnas.1101139108; Page JM, 2015, BIOMATERIALS, V64, P33, DOI 10.1016/j.biomaterials.2015.06.026; Parikh D, 2018, BIOPHYS J, V114, p651A, DOI 10.1016/j.bpj.2017.11.3519; Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515; Pedrola N, 2015, CLIN EXP METASTAS, V32, P467, DOI 10.1007/s10585-015-9720-7; Reid SE, 2017, EMBO J, V36, P2373, DOI 10.15252/embj.201694912; Seewaldt V, 2014, NAT MED, V20, P332, DOI 10.1038/nm.3523; Seki N, 2001, INT J ONCOL, V19, P305; Selvamurugan N, 2004, J BIOL CHEM, V279, P27764, DOI 10.1074/jbc.M312870200; Shen YF, 2012, INT J GYNECOL CANCER, V22, P1316, DOI 10.1097/IGC.0b013e318263ef34; Staff N, 2017, ENDOMETRIAL CANC INC; Su Y, 2012, MOL VIS, V18, P1881; Sun HZ, 2016, ARCH GYNECOL OBSTET, V293, P429, DOI 10.1007/s00404-015-3844-5; Sutton G, 2005, GYNECOL ONCOL, V97, P755, DOI 10.1016/j.ygyno.2005.03.011; Tan C, 2004, CANCER CELL, V5, P79, DOI 10.1016/S1535-6108(03)00281-2; Torres PB, 2009, REPROD SCI, V16, P727, DOI 10.1177/1933719109334967; Vlad C, 2016, J BUON, V21, P973; Wei SC, 2015, NAT CELL BIOL, V17, P678, DOI 10.1038/ncb3157; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Win AK, 2015, OBSTET GYNECOL, V125, P89, DOI 10.1097/AOG.0000000000000563; Xiong SY, 2015, ONCOTARGET, V6, P31659, DOI 10.18632/oncotarget.5229; Yen CF, 2014, GYNECOL MINIM INVASI, V3, P67, DOI 10.1016/j.gmit.2014.06.002; Yusuf N, 2014, GYNECOL ONCOL, V134, P356, DOI 10.1016/j.ygyno.2014.04.009	81	11	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231594	10.1371/journal.pone.0231594	http://dx.doi.org/10.1371/journal.pone.0231594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315343	Green Published, gold			2022-12-26	WOS:000536024800036
J	Colborn, JM; Zulliger, R; Da Silva, M; Mathe, G; Chico, AR; Castel-Branco, AC; Brito, F; Andela, M; de Leon, GP; Saifodine, A; Candrinho, B; Plucinski, MM				Colborn, James M.; Zulliger, Rose; Da Silva, Mariana; Mathe, Guidion; Chico, Ana Rita; Castel-Branco, Ana Christina; Brito, Frederico; Andela, Marcel; de Leon, Gabriel Ponce; Saifodine, Abuchahama; Candrinho, Baltazar; Plucinski, Mateusz M.			Quality of malaria data in public health facilities in three provinces of Mozambique	PLOS ONE			English	Article								Background Malaria data reported through Mozambique's routine health information system are used to guide the implementation of prevention and control activities. Although previous studies have identified issues with the quality of aggregated data reported from public health facilities in the country, no studies have evaluated the quality of routine indicators recorded in health facility registries. This study addresses this issue by comparing indicators calculated from data from exit interviews and re-examinations of patients with data based on registry records from health facilities in order to measure the quality of registry data and data reporting in three provinces in Mozambique. Methods Data were collected from 1,840 outpatients from 117 health facilities in Maputo, Zambezia, and Cabo Delgado Provinces interviewed and examined as part of a malaria-specific health facility survey. Key indicators based on exit interview / re-examination data were compared to the same indicators based on records from health facility registries. Multivariable regression was performed to identify factors associated with indicators matching in re-examination / exit interview data and health facility registries. Aggregated indicators abstracted from facility registries were compared to those reported through the routine health management information system (HMIS) for the same time period. Results Sensitivity of exit interview / re-examination data compared with those recorded in facility registries was low for all indicators in all facilities. The lowest sensitivities were in Maputo, where the sensitivity for recording negative RDT results was 9.7%. The highest sensitivity was for recording positive RDT results in Cabo Delgado, at 75%. Multivariable analysis of factors associated with agreement between gold standard and registry data showed patients were less likely to be asked about having a fever in the triage ward in Maputo and Cabo Delgado (adjusted Odds Ratio 0.75 and 0.39 respectively), and in the outpatient ward in Cabo Delgado (aOR = 0.37), compared with the emergency department. Patients with positive RDT were also more likely to have RDT results recorded in all three provinces when patients had been managed according to national treatment guidelines during initial examination. Comparison of retrospective data abstracted from facility registries to HMIS data showed discrepancies in all three provinces. The proportion of outpatient cases with suspected and confirmed malaria were similar in registry and HMIS data across all provinces (a relatively low difference between registry and HMIS data of 3% in Maputo and Zambe ' zia), though the total number of all-cause outpatient cases was consistently higher in the HMIS. The largest difference was in Maputo, where a total of 87,992 all-cause outpatient cases were reported in HMIS, compared with a total of 42,431 abstracted from facility registries. Conclusion This study shows that care should be taken in interpreting trends based solely on routine data due to data quality issues, though the discrepancy in all-cause outpatient cases may be indicative that register availability and storage are important factors. As such, simple steps such as providing consistent access and storage of registers that include reporting of patient fever symptoms might improve the quality of routine data recorded at health facilities.	[Colborn, James M.; Chico, Ana Rita; Andela, Marcel] Clinton Hlth Access Initiat, Maputo, Mozambique; [Zulliger, Rose] US Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Maputo, Mozambique; [Da Silva, Mariana; Mathe, Guidion; Candrinho, Baltazar] Minist Hlth, Natl Malaria Control Program, Maputo, Mozambique; [Brito, Frederico] UNICEF, Maputo, Mozambique; [de Leon, Gabriel Ponce; Plucinski, Mateusz M.] US Ctr Dis Control & Prevent, Malaria Branch, Atlanta, GA USA; [de Leon, Gabriel Ponce; Plucinski, Mateusz M.] US Ctr Dis Control & Prevent, US Presidents Malaria Initiat, Atlanta, GA USA; [Saifodine, Abuchahama] US Agcy Int Dev, US Presidents Malaria Initiat, Maputo, Mozambique	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; United States Agency for International Development (USAID)	Colborn, JM (corresponding author), Clinton Hlth Access Initiat, Maputo, Mozambique.	jcolborn.IC@clintonhealthaccess.org		, James/0000-0002-2214-8984; Plucinski, Mateusz/0000-0002-7322-4625				Candrinho B, 2019, MALAR J; Chilundo B, 2004, MALAR J; Davis LM, 2019, J GLOB HLTH; Davlantes E, 2018, AM J TROP MED HYG; Gimbel S, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-12; Instituto Nacional de Estatistica, 2017, CENS 2017 BROCH RES; Instituto Nacional de Saude (INS), 2015, MOC INQ IND MAL HIV; Instituto Nacional de Saude (INS), 2018, MOC INQ IND MAL IIM; Plucinski MM, 2017, MALAR J; Pulford J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0628-8; Rowe AK, 2009, MALAR J; Steinhardt LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089050; WHO, 2015, MOZ COUNTR PROF; Yourkavitch J, 2019, J GLOB HLTH; Zurovac D, 2004, INT J EPIDEMIOL; Zurovac D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092782	16	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231358	10.1371/journal.pone.0231358	http://dx.doi.org/10.1371/journal.pone.0231358			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310983	gold, Green Published			2022-12-26	WOS:000536019800012
J	Van Praag, DLG; Fardzadeh, HE; Covic, A; Maas, AIR; von Steinbuchel, N				Van Praag, Dominique L. G.; Fardzadeh, Haghish Ebad; Covic, Amra; Maas, Andrew I. R.; von Steinbuechel, Nicole			Preliminary validation of the Dutch version of the Posttraumatic stress disorder checklist for DSM-5 (PCL-5) after traumatic brain injury in a civilian population	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; QUALITY-OF-LIFE; PTSD CHECKLIST; SOCIAL SUPPORT; RISK-FACTORS; HEART-RATE; FOLLOW-UP; PRIME-MD; 1ST YEAR; SYMPTOMS	The Posttraumatic stress disorder checklist (PCL) is the most widely used questionnaire to screen for symptoms of posttraumatic stress disorder (PTSD), based on the Diagnostic and Statistical manual of Mental disorders (DSM-IV) criteria. In the latest edition of the DSM (DSM-5), the criteria for PTSD were revised leading to the development of the PCL-5. So far, there is no validated Dutch version of the PCL-5. The aim of this study is to determine psychometric characteristics of the Dutch translation and linguistic validation of the PCL-5 and to evaluate internal consistency, criterion and structural validity. In a population of 495 civilian, traumatic brain injury patients, the PCL-5, the Generalized anxiety disorder questionnaire and the Depression scale of the Patient health questionnaire were administered. The PCL-5 was translated in Dutch following a strict procedure of linguistic validation and cognitive debriefing. Results show an excellent internal consistency and high criterion validity. Confirmatory factor analysis demonstrated a good fit for the four-factor DSM-5 model, but a superior fit for the six-factor Anhedonia model and the seven-factor Hybrid model, similar to the English version of the PCL-5. Preliminary validation of the Dutch translation of the PCL-5 was proven to be psychometrically sound and can be used for clinical and academic purposes, specifically for TBI patients. Future research should examine concurrent and discriminant validity for the Dutch translation in broader populations at risk for PTSD, and include a structured interview to evaluate diagnostic utility.	[Van Praag, Dominique L. G.; Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Van Praag, Dominique L. G.; Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Fardzadeh, Haghish Ebad; Covic, Amra; von Steinbuechel, Nicole] Georg August Univ, Univ Med Ctr Gottingen UMG, Inst Med Psychol & Med Sociol, Gottingen, Germany	University of Antwerp; University of Antwerp; University of Gottingen	Van Praag, DLG (corresponding author), Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium.; Van Praag, DLG (corresponding author), Univ Antwerp, Edegem, Belgium.	Dominique.vanpraag@uza.be	; Maas, Andrew I.R./C-5584-2013	Van Praag, Dominique/0000-0002-4279-6532; Maas, Andrew I.R./0000-0003-1612-1264	European Union [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	European Union(European Commission); Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	This study was supported by the Framework 7 program of the European Union in the context of CENTER-TBI (grant number 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). The funders did not play a role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ahman S, 2013, J REHABIL MED, V45, P758, DOI 10.2340/16501977-1182; Alexander M. P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; Alway Y, 2016, J NEUROTRAUM, V33, P825, DOI 10.1089/neu.2015.3992; Alway Y, 2016, DEPRESS ANXIETY, V33, P19, DOI 10.1002/da.22396; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Armour C, 2015, J PSYCHIATR RES, V61, P106, DOI 10.1016/j.jpsychires.2014.10.012; Ashbaugh AR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161645; Ashman TA, 2004, ARCH PHYS MED REHAB, V85, pS36, DOI 10.1016/j.apmr.2003.08.117; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Baranyi A, 2010, PSYCHOSOMATICS, V51, P237, DOI 10.1176/appi.psy.51.3.237; Beck A.T., 1979, COGNITIVE THERAPY EM; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Blevins CA, 2015, J TRAUMA STRESS, V28, P489, DOI 10.1002/jts.22059; Bombardier CH, 2006, J NEUROPSYCH CLIN N, V18, P501, DOI 10.1176/appi.neuropsych.18.4.501; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Boysan M, 2017, PSYCHIAT CLIN PSYCH, V27, P306, DOI 10.1080/24750573.2017.1342769; Bryant RA, 2004, PSYCHOSOM MED, V66, P760, DOI 10.1097/01.psy.0000138121.13198.84; Bryant RA, 1999, J NERV MENT DIS, V187, P302, DOI 10.1097/00005053-199905000-00006; Bryant RA, 1999, BRAIN INJURY, V13, P15, DOI 10.1080/026990599121836; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Bryant RA, 2009, J INT NEUROPSYCH SOC, V15, P862, DOI 10.1017/S1355617709990671; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chalmers RP, 2012, J STAT SOFTW, V48, P1; Choi MS, 2014, J KOREAN NEUROSURG S, V55, P190, DOI 10.3340/jkns.2014.55.4.190; COCHRAN WG, 1952, ANN MATH STAT, V23, P315, DOI 10.1214/aoms/1177729380; Creamer M, 2005, BEHAV RES THER, V43, P1383, DOI 10.1016/j.brat.2004.11.001; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Dischinger P, 2003, Annu Proc Assoc Adv Automot Med, V47, P577; Donker T, 2011, PSYCHIAT RES, V188, P58, DOI 10.1016/j.psychres.2011.01.016; Gfeller JD, 2013, BEHAV SCI LAW, V31, P833, DOI 10.1002/bsl.2084; Gil S, 2005, AM J PSYCHIAT, V162, P963, DOI 10.1176/appi.ajp.162.5.963; Gould KR, 2011, PSYCHOL MED, V41, P2099, DOI 10.1017/S003329171100033X; Haagsma JA, 2015, J NEUROTRAUM, V32, P853, DOI 10.1089/neu.2013.3283; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hall BJ, 2019, EUR J OSYCHOTRAUMATO, V10, P23, DOI [10.1016/s0163-8343(03)00072-0, DOI 10.1016/S0163-8343(03)00072-0]; Harvey AG, 2000, AM J PSYCHIAT, V157, P626, DOI 10.1176/appi.ajp.157.4.626; HESBACHER PT, 1980, J CLIN PSYCHIAT, V41, P6; HICKLING EJ, 1992, J ANXIETY DISORD, V6, P285, DOI 10.1016/0887-6185(92)90040-E; Hoffman JM, 2012, ARCH PHYS MED REHAB, V93, P287, DOI 10.1016/j.apmr.2011.08.041; Hoofien D, 2001, BRAIN INJURY, V15, P189; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Ibrahim H, 2018, BMC PSYCHIATRY, V18, DOI 10.1186/s12888-018-1839-z; Kjeldgaard D, 2014, CEPHALALGIA, V34, P191, DOI 10.1177/0333102413505236; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kruger-Gottschalk A, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1541-6; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lamers F, 2008, J CLIN EPIDEMIOL, V61, P679, DOI 10.1016/j.jclinepi.2007.07.018; Levin HS, 2001, J CLIN EXP NEUROPSYC, V23, P754, DOI 10.1076/jcen.23.6.754.1021; Lima Eduardo de Paula, 2016, Trends Psychiatry Psychother., V38, P207, DOI 10.1590/2237-6089-2015-0074; Liu P, 2014, J ANXIETY DISORD, V28, P345, DOI 10.1016/j.janxdis.2014.03.008; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; McCauley SR, 2001, J CLIN EXP NEUROPSYC, V23, P792, DOI 10.1076/jcen.23.6.792.1016; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Mittal VA, 2011, PSYCHIAT RES, V189, P158, DOI 10.1016/j.psychres.2011.06.006; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Ommaya AK, 1996, J TRAUMA, V41, P972, DOI 10.1097/00005373-199612000-00005; Persoons P, 2003, GEN HOSP PSYCHIAT, V25, P316, DOI 10.1016/S0163-8343(03)00072-0; Phelps LF, 2008, REHABIL PSYCHOL, V53, P28, DOI 10.1037/0090-5550.53.1.28; Pietrzak RH, 2009, J NERV MENT DIS, V197, P748, DOI 10.1097/NMD.0b013e3181b97a75; Polinder S, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-783; Powell TJ, 1996, DISABIL REHABIL, V18, P231, DOI 10.3109/09638289609166306; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reid LM, 2011, J NEUROPSYCH CLIN N, V23, P454, DOI 10.1176/jnp.23.4.jnp454; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Schinka JA, 2007, J TRAUMA STRESS, V20, P281, DOI 10.1002/jts.20202; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Sumpter RE, 2005, BRIT J PSYCHIAT, V186, P423, DOI 10.1192/bjp.186.5.423; Sveen J, 2016, EUR J PSYCHOTRAUMATO, V7, DOI 10.3402/ejpt.v7.30165; Van Praag DLG, 2019, J NEUROTRAUM, V36, P3220, DOI 10.1089/neu.2018.5759; Wang L, 2015, J ANXIETY DISORD, V31, P90, DOI 10.1016/j.janxdis.2015.02.006; Weathers F.W., 1993, PTSD CHECKLIST PCL R; Weathers F.W., 2013, PTSD CHECKLIST DSM 5, DOI DOI 10.1037/T02622-000; Williams WH, 2002, BRAIN INJURY, V16, P673, DOI 10.1080/02699050210128861; Zatzick DF, 2010, ARCH GEN PSYCHIAT, V67, P1291, DOI 10.1001/archgenpsychiatry.2010.158; Zhong QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125096; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	85	16	16	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231857	10.1371/journal.pone.0231857	http://dx.doi.org/10.1371/journal.pone.0231857			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9MR	32310970	Green Published, Green Submitted, gold			2022-12-26	WOS:000536019800042
J	Cheng, WS; Lin, IH; Feng, KM; Chang, ZY; Huang, YC; Lu, DW				Cheng, Wen-Sheng; Lin, I-Hung; Feng, Kathy Ming; Chang, Zhi-Yang; Huang, Yu Chuan; Lu, Da-Wen			Neuroprotective effects of exogenous erythropoietin in Wistar rats by downregulating apoptotic factors to attenuate N-methyl-D-aspartate-mediated retinal ganglion cells death	PLOS ONE			English	Article							AXONAL-TRANSPORT; GLUTAMATE LEVELS; MOUSE MODEL; ACTIVATION; ISCHEMIA; PROTECTS; NEURONS; NEUROTOXICITY; ELEVATION; BCL-X(L)	The aim of this study was to investigate whether exogenous erythropoietin (EPO) administration attenuates N-methyl-D-aspartate (NMDA)-mediated excitotoxic retinal damage in Wistar rats. The survival rate of retinal ganglion cells (RGCs) were investigated by flat mount analysis and flow cytometry. A total of 125 male Wistar rats were randomly assigned to five groups: negative control, NMDA80 (i.e., 80 nmoles NMDA intravitreally injected), NMDA80 + 10ng EPO, NMDA80 + 50ng EPO, and NMDA80 + 250ng EPO. The NMDA80 + 50ng EPO treatment group was used to evaluate various administrated points (pre-/co-/post- administration of NMDA80). Meanwhile, the transferase dUTP Nick-End Labeling (TUNEL) assay of RGCs, the inner plexiform layer (IPL) thickness and the apoptotic signal transduction pathways of mu-calpain, Bax, and caspase 9 were assessed simultaneously using an immunohistochemical method (IHC). When EPO was co-administered with NMDA80, attenuated cell death occurred through the downregulation of the apoptotic indicators: mu-calpain was activated first (peak at similar to 18hrs), followed by Bax and caspase 9 (peak at similar to 40hrs). Furthermore, the images of retinal cross sections have clearly demonstrated that thickness of the inner plexiform layer (IPL) was significantly recovered at 40 hours after receiving intravitreal injection with NMDA80 and 50ng EPO. Exogenous EPO may protect RGCs and bipolar cell axon terminals in IPL by downregulating apoptotic factors to attenuate NMDA-mediated excitotoxic retinal damage.	[Cheng, Wen-Sheng; Lu, Da-Wen] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Cheng, Wen-Sheng; Huang, Yu Chuan] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan; [Cheng, Wen-Sheng; Huang, Yu Chuan] Natl Def Med Ctr, Dept Res & Dev, Taipei, Taiwan; [Lin, I-Hung; Feng, Kathy Ming; Lu, Da-Wen] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan; [Chang, Zhi-Yang] BASF Taiwan Ltd, Pharma Solut, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; BASF	Lu, DW (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.; Huang, YC (corresponding author), Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.; Huang, YC (corresponding author), Natl Def Med Ctr, Dept Res & Dev, Taipei, Taiwan.; Lu, DW (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan.	yuh@mail.ndmctsgh.edu.tw; p310849@ms23.hinet.net	鄭, 文勝/AAU-8543-2021	Lin, I-Hung/0000-0003-4268-2540	Tri-Service General Hospital [TSGH-C108-120, TSGH-C109-122]; Ministry National DefenseMedical Affairs Bureau [MAB-109-032, MAB-109086]	Tri-Service General Hospital; Ministry National DefenseMedical Affairs Bureau	This work was supported by grants from Tri-Service General Hospital (TSGH-C108-120; TSGH-C109-122) and Ministry National DefenseMedical Affairs Bureau (MAB-109-032; MAB-109086). Yu Chuan Huang and Da-Wen Lu, both corresponding authors contributed equally to this manuscript.	Aghdam KA, 2016, J CURR OPHTHALMOL, V28, P5, DOI 10.1016/j.joco.2016.01.008; Andrews DA, 2014, TOXICOL PATHOL, V42, P524, DOI 10.1177/0192623313486319; Bocker-Meffert S, 2002, INVEST OPHTH VIS SCI, V43, P2021; Bourne RRA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162229; Broker LE, 2005, CLIN CANCER RES, V11, P3155, DOI 10.1158/1078-0432.CCR-04-2223; Casson RJ, 2006, CLIN EXP OPHTHALMOL, V34, P54, DOI 10.1111/j.1442-9071.2006.01146.x; Celik M, 2002, P NATL ACAD SCI USA, V99, P2258, DOI 10.1073/pnas.042693799; Chang ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055291; Chidlow G, 2007, DRUGS, V67, P725, DOI 10.2165/00003495-200767050-00006; Chiu Kin, 2008, J Vis Exp, DOI 10.3791/819; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; Chong ZZ, 2003, J CEREBR BLOOD F MET, V23, P320, DOI 10.1097/01.WCB.0000050061.57184.AE; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Dreyer EB, 1996, ARCH OPHTHALMOL-CHIC, V114, P299, DOI 10.1001/archopht.1996.01100130295012; Ehrenreich H, 2002, MOL MED, V8, P495, DOI 10.1007/BF03402029; Fuchs C, 2005, INVEST OPHTH VIS SCI, V46, P2983, DOI 10.1167/iovs.04-1177; GLOVINSKY Y, 1991, INVEST OPHTH VIS SCI, V32, P484; Grimm C, 2002, NAT MED, V8, P718, DOI 10.1038/nm723; Hartwick ATE, 2008, J PHYSIOL-LONDON, V586, P3425, DOI 10.1113/jphysiol.2008.154609; Hartwick ATE, 2001, OPTOMETRY VISION SCI, V78, P85, DOI 10.1097/00006324-200102000-00008; Hirooka K, 2006, INVEST OPHTH VIS SCI, V47, P1653, DOI 10.1167/iovs.05-1018; Ihle J N, 1993, Semin Immunol, V5, P375, DOI 10.1006/smim.1993.1043; Junk AK, 2002, P NATL ACAD SCI USA, V99, P10659, DOI 10.1073/pnas.152321399; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; Kashiwagi F, 2000, INVEST OPHTH VIS SCI, V41, P2373; KOURY MJ, 1990, SCIENCE, V248, P378, DOI 10.1126/science.2326648; LUCAS DR, 1957, ARCH OPHTHALMOL-CHIC, V58, P193; Marti HH, 1996, EUR J NEUROSCI, V8, P666, DOI 10.1111/j.1460-9568.1996.tb01252.x; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; McKinnon SJ, 2009, EXP EYE RES, V88, P816, DOI 10.1016/j.exer.2008.12.002; MEY J, 1993, BRAIN RES, V602, P304, DOI 10.1016/0006-8993(93)90695-J; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Nivison-Smith L, 2014, NEUROCHEM INT, V66, P1, DOI 10.1016/j.neuint.2014.01.003; Park KJ, 2017, J DIGIT FORENSICS SE, V12, P31, DOI 10.15394/jdfsl.2017.1421; Pease ME, 2000, INVEST OPHTH VIS SCI, V41, P764; Quigley HA, 2000, INVEST OPHTH VIS SCI, V41, P3460; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1987, INVEST OPHTH VIS SCI, V28, P913; QUIGLEY HA, 1988, OPHTHALMOLOGY, V95, P357; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Schuettauf F, 2011, CLIN EXP OPHTHALMOL, V39, P545, DOI 10.1111/j.1442-9071.2010.02486.x; SILIPRANDI R, 1992, VISUAL NEUROSCI, V8, P567, DOI 10.1017/S0952523800005666; Silva M, 1996, BLOOD, V88, P1576, DOI 10.1182/blood.V88.5.1576.1576; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Tan YF, 2006, J BIOL CHEM, V281, P16016, DOI 10.1074/jbc.M601299200; Uddin S, 2000, BIOCHEM BIOPH RES CO, V275, P16, DOI 10.1006/bbrc.2000.3266; Wax MB, 2009, EXP EYE RES, V88, P825, DOI 10.1016/j.exer.2009.02.005; Yamazaki M, 2017, CLIN EXP OPHTHALMOL, V45, P310, DOI 10.1111/ceo.12852; Yoles E, 1998, ARCH OPHTHALMOL-CHIC, V116, P906, DOI 10.1001/archopht.116.7.906; Zhou X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.82; Zhou XH, 2005, J BIOL CHEM, V280, P31240, DOI 10.1074/jbc.M502641200; Zivkovic M, 2018, OPHTHALMIC RES, V59, P148, DOI 10.1159/000478052	52	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0223208	10.1371/journal.pone.0223208	http://dx.doi.org/10.1371/journal.pone.0223208			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302311	Green Published, Green Submitted, gold			2022-12-26	WOS:000536016100001
J	Marchena, M; Echebarria, B				Marchena, Miquel; Echebarria, Blas			Influence of the tubular network on the characteristics of calcium transients in cardiac myocytes	PLOS ONE			English	Article							VENTRICULAR MYOCYTES; T-TUBULES; TRANSVERSE TUBULES; CA2+ RELEASE; SARCOPLASMIC-RETICULUM; HEART-FAILURE; ALTERNANS; SYSTEM; ORGANIZATION; HYPERTROPHY	Transverse and axial tubules (TATS) are an essential ingredient of the excitation-contraction machinery that allow the effective coupling of L-type Calcium Channels (LCC) and ryanodine receptors (RyR2). They form a regular network in ventricular cells, while their presence in atrial myocytes is variable regionally and among animal species We have studied the effect of variations in the TAT network using a bidomain computational model of an atrial myocyte with variable density of tubules. At each z-line the t-tubule length is obtained from an exponential distribution, with a given mean penetration length. This gives rise to a distribution of t-tubules in the cell that is characterized by the fractional area (F.A.) occupied by the t-tubules. To obtain consistent results, we average over different realizations of the same mean penetration length. To this, in some simulations we add the effect of a network of axial tubules. Then we study global properties of calcium signaling, as well as regional heterogeneities and local properties of sparks and RyR2 openings. In agreement with recent experiments in detubulated ventricular and atrial cells, we find that detubulation reduces the calcium transient and synchronization in release. However, it does not affect sarcoplasmic reticulum (SR) load, so the decrease in SR calcium release is due to regional differences in Ca2+ release, that is restricted to the cell periphery in detubulated cells. Despite the decrease in release, the release gain is larger in detubulated cells, due to recruitment of orphaned RyR2s, i.e, those that are not confronting a cluster of LCCs. This probably provides a safeguard mechanism, allowing physiological values to be maintained upon small changes in the t-tubule density. Finally, we do not find any relevant change in spark properties between tubulated and detubulated cells, suggesting that the differences found in experiments could be due to differential properties of the RyR2s in the membrane and in the t-tubules, not incorporated in the present model. This work will help understand the effect of detubulation, that has been shown to occur in disease conditions such as heart failure (HF) in ventricular cells, or atrial fibrillation (AF) in atrial cells.	[Marchena, Miquel; Echebarria, Blas] Univ Politecn Cataluna, Dept Fis, Barcelona, Spain	Universitat Politecnica de Catalunya	Echebarria, B (corresponding author), Univ Politecn Cataluna, Dept Fis, Barcelona, Spain.	blas.echebarria@upc.edu	Echebarria, Blas/K-5247-2014; Echebarria, Blas/AAE-4135-2021; echebarria, blas/ABD-6811-2020	Echebarria, Blas/0000-0003-0503-1781; 	Spanish Ministry of Science Innovation and Universities [SAF2017-88019-C3-3R]; Fundacio Marato-TV3 [20151110]	Spanish Ministry of Science Innovation and Universities(Spanish Government); Fundacio Marato-TV3	BE thanks support from the Spanish Ministry of Science Innovation and Universities, http://www.ciencia.gob.es/portal/site/MICINN (SAF2017-88019-C3-3R). BE and MM thank support from Fundacio Marato-TV3, https://www.ccma.cat/tv3/marato/fundacio (20151110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Lacalle E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055042; Arora R, 2017, HEART RHYTHM, V14, P273, DOI 10.1016/j.hrthm.2016.09.022; Bootman MD, 2011, BBA-MOL CELL RES, V1813, P922, DOI 10.1016/j.bbamcr.2011.01.030; Brandenburg S, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01227; Brandenburg S, 2016, J CLIN INVEST, V126, P3999, DOI 10.1172/JCI88241; Brette F, 2005, J MOL CELL CARDIOL, V39, P804, DOI 10.1016/j.yjmcc.2005.08.005; Brette F, 2002, AM J PHYSIOL-HEART C, V283, pH1720, DOI 10.1152/ajpheart.00347.2002; Caldwell JL, 2014, CIRC RES, V115, P986, DOI 10.1161/CIRCRESAHA.116.303448; CANNELL MB, 1984, BIOPHYS J, V45, P913, DOI 10.1016/S0006-3495(84)84238-1; Colman MA, 2016, COMPUT CARDIOL CONF, V43, P221; Crocini C, 2014, P NATL ACAD SCI USA, V111, P15196, DOI 10.1073/pnas.1411557111; Dibb KM, 2013, J MOL CELL CARDIOL, V58, P84, DOI 10.1016/j.yjmcc.2012.11.001; Dibb KM, 2009, CIRC-HEART FAIL, V2, P482, DOI 10.1161/CIRCHEARTFAILURE.109.852228; Frank KF, 2002, BASIC RES CARDIOL S1, V97, pI72, DOI DOI 10.1007/S003950200033; Frisk M, 2014, AM J PHYSIOL-HEART C, V307, pH609, DOI 10.1152/ajpheart.00295.2014; Gadeberg HC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156862; Gianni D, 2005, J BIOENERG BIOMEMBR, V37, P375, DOI 10.1007/s10863-005-9474-z; Gomez AM, 2001, CIRCULATION, V104, P688, DOI 10.1161/hc3201.092285; Gomez AM, 1997, SCIENCE, V276, P800, DOI 10.1126/science.276.5313.800; Greiser M, 2011, CARDIOVASC RES, V89, P722, DOI 10.1093/cvr/cvq389; Guo A, 2014, BIOPHYS J, V106, P2729, DOI 10.1016/j.bpj.2014.05.013; Guo A, 2013, CARDIOVASC RES, V98, P204, DOI 10.1093/cvr/cvt020; Hayashi T, 2009, J CELL SCI, V122, P1005, DOI 10.1242/jcs.028175; Heinzel FR, 2011, J MOL CELL CARDIOL, V50, P390, DOI 10.1016/j.yjmcc.2010.11.008; HIBBS RG, 1969, AM J ANAT, V124, P251, DOI 10.1002/aja.1001240302; Huser J, 1996, J PHYSIOL-LONDON, V494, P641; Ibrahim M, 2012, EUR J HEART FAIL, V14, P571, DOI 10.1093/eurjhf/hfs038; Ibrahim M, 2011, P ROY SOC B-BIOL SCI, V278, P2714, DOI 10.1098/rspb.2011.0624; Kawai M, 1999, AM J PHYSIOL-HEART C, V277, pH603, DOI 10.1152/ajpheart.1999.277.2.H603; Kirk MM, 2003, J PHYSIOL-LONDON, V547, P441, DOI 10.1113/jphysiol.2002.034355; Lee YS, 2008, J THEOR BIOL, V253, P668, DOI 10.1016/j.jtbi.2008.04.027; Lenaerts I, 2009, CIRC RES, V105, P876, DOI 10.1161/CIRCRESAHA.109.206276; Lipp P, 1996, J PHYSIOL-LONDON, V497, P589, DOI 10.1113/jphysiol.1996.sp021792; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; Mackenzie L, 2001, J PHYSIOL-LONDON, V530, P417, DOI 10.1111/j.1469-7793.2001.0417k.x; Marchena M, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01760; McNary TG, 2012, PROG BIOPHYS MOL BIO, V110, P218, DOI 10.1016/j.pbiomolbio.2012.07.010; Meethal SV, 2007, CELL CALCIUM, V41, P123, DOI 10.1016/j.ceca.2006.05.006; Nival M, 2015, J MOL CELL CARDIOL, V79, P32, DOI 10.1016/j.yjmcc.2014.10.018; Orchard CH, 2009, EXP PHYSIOL, V94, P509, DOI 10.1113/expphysiol.2008.043984; Oyehaug L, 2013, BIOPHYS J, V104, P1685, DOI 10.1016/j.bpj.2013.03.022; Pasqualin C, 2015, AM J PHYSIOL-CELL PH, V308, pC237, DOI 10.1152/ajpcell.00259.2014; Richards MA, 2011, AM J PHYSIOL-HEART C, V301, pH1996, DOI 10.1152/ajpheart.00284.2011; ROBERTSON SP, 1981, BIOPHYS J, V34, P559, DOI 10.1016/S0006-3495(81)84868-0; Scardigli M, 2017, P NATL ACAD SCI USA, V114, P5737, DOI 10.1073/pnas.1702188114; Shkryl VM, 2012, AM J PHYSIOL-HEART C, V302, pH2310, DOI 10.1152/ajpheart.00079.2012; Smyrnias I, 2010, CELL CALCIUM, V47, P210, DOI 10.1016/j.ceca.2009.10.001; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Song Z, 2018, J MOL CELL CARDIOL, V114, P288, DOI 10.1016/j.yjmcc.2017.12.003; TRAFFORD AW, 1995, J PHYSIOL-LONDON, V488, P577, DOI 10.1113/jphysiol.1995.sp020991; Wei S, 2010, CIRC RES, V107, P520, DOI 10.1161/CIRCRESAHA.109.212324	51	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231056	10.1371/journal.pone.0231056	http://dx.doi.org/10.1371/journal.pone.0231056			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302318	Green Published, Green Submitted, gold			2022-12-26	WOS:000536016100014
J	Minamikawa-Tachino, R; Ogura, K; Ito, A; Nagayama, K				Minamikawa-Tachino, Reiko; Ogura, Kiyoshi; Ito, Ayane; Nagayama, Katsuya			Time-lapse imaging of HeLa spheroids in soft agar culture provides virtual inner proliferative activity	PLOS ONE			English	Article							CELL; GROWTH; MODELS	Cancer is a complex disease caused by multiple types of interactions. To simplify and normalize the assessment of drug effects, spheroid microenvironments have been utilized. Research models that involve agent measurement with the examination of clonogenic survival by monitoring culture process with image analysis have been developed for spheroid-based screening. Meanwhile, computer simulations using various models have enabled better predictions for phenomena in cancer. However, user-based parameters that are specific to a researcher's own experimental conditions must be inputted. In order to bridge the gap between experimental and simulated conditions, we have developed an in silico analysis method with virtual three-dimensional embodiment computed using the researcher's own samples. The present work focused on HeLa spheroid growth in soft agar culture, with spheroids being modeled in silico based on time-lapse images capturing spheroid growth. The spheroids in silico were optimized by adjusting the growth curves to those obtained from time-lapse images of spheroids and were then assigned virtual inner proliferative activity by using generations assigned to each cellular particle. The ratio and distribution of the virtual inner proliferative activities were confirmed to be similar to the proliferation zone ratio and histochemical profiles of HeLa spheroids, which were also consistent with those identified in an earlier study. We validated that time-lapse images of HeLa spheroids provided virtual inner proliferative activity for spheroids in vitro. The present work has achieved the first step toward an in silico analysis method using computational simulation based on a researcher's own samples, helping to bridge the gap between experiment and simulation.	[Minamikawa-Tachino, Reiko; Ogura, Kiyoshi] Tokyo Metropolitan Inst Med Sci, Translat Med Res Ctr, Setagaya Ku, Tokyo, Japan; [Ito, Ayane] Kyushu Inst Technol, Grad Sch Comp Sci & Syst Engn, Dept Interdisciplinary Informat, Iizuka, Fukuoka, Japan; [Nagayama, Katsuya] Kyushu Inst Technol, Dept Mech Informat Sci & Technol, Fac Comp Sci & Syst Engn, Iizuka, Fukuoka, Japan; [Minamikawa-Tachino, Reiko] Kanto Gakuin Univ, Inst Sci & Technol, Yokohama, Kanagawa, Japan; [Ogura, Kiyoshi] Tokyo Metropolitan Inst Med Sci, Dept Basic Med Sci, Setagaya Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Medical Science; Kyushu Institute of Technology; Kyushu Institute of Technology; Kanto Gakuin University; Tokyo Metropolitan Institute of Medical Science	Minamikawa-Tachino, R (corresponding author), Tokyo Metropolitan Inst Med Sci, Translat Med Res Ctr, Setagaya Ku, Tokyo, Japan.; Minamikawa-Tachino, R (corresponding author), Kanto Gakuin Univ, Inst Sci & Technol, Yokohama, Kanagawa, Japan.	r041259@kanto-gakuin.ac.jp		Tachino, Reiko/0000-0001-8337-6115	JSPS KAKENHI [JP24650156]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP24650156.	Achilli TM, 2012, EXPERT OPIN BIOL TH, V12, P1347, DOI 10.1517/14712598.2012.707181; Arai K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162394; Castillo LRC, 2016, SCI REP-UK, V6, DOI 10.1038/srep35099; Dahlmann J, 2013, BIOMATERIALS, V34, P2463, DOI 10.1016/j.biomaterials.2012.12.024; Deckers T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199092; Edelman LB, 2010, WIRES SYST BIOL MED, V2, P438, DOI 10.1002/wsbm.75; Edmondson R, 2014, ASSAY DRUG DEV TECHN, V12, P207, DOI 10.1089/adt.2014.573; Eke I, 2016, INT J ONCOL, V48, P313, DOI 10.3892/ijo.2015.3230; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Ghaffarizadeh A, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1005991; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoehme S, 2010, BIOINFORMATICS, V26, P2641, DOI 10.1093/bioinformatics/btq437; Ivascu A, 2007, INT J ONCOL, V31, P1403; LaBarbera DV, 2012, EXPERT OPIN DRUG DIS, V7, P819, DOI 10.1517/17460441.2012.708334; Lal-Nag M, 2017, SLAS DISCOV, V22, P494, DOI 10.1177/2472555216687082; Lu N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103173; Maioli V, 2016, SCI REP-UK, V6, DOI 10.1038/srep37777; Martin I, 1997, CYTOMETRY, V28, P141, DOI 10.1002/(SICI)1097-0320(19970601)28:2<141::AID-CYTO7>3.0.CO;2-I; Mehta G, 2012, J CONTROL RELEASE, V164, P192, DOI 10.1016/j.jconrel.2012.04.045; Milotti E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013942; Mittler F, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00293; MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103; Musin OR, 2006, DISCRETE COMPUT GEOM, V35, P375, DOI 10.1007/s00454-005-1201-3; O'Connor C. M., 2010, ESSENTIALS CELL BIOL; Oja E., 1983, SUBSPACE METHODPAT; Pereira PMR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177737; RICHARDS FJ, 1959, J EXP BOT, V10, P290, DOI 10.1093/jxb/10.2.290; Robinson EE, 2003, J CELL SCI, V116, P377, DOI 10.1242/jcs.00231; Salmenpera P, 2008, EXP CELL RES, V314, P3444, DOI 10.1016/j.yexcr.2008.09.004; Turgeon M.L., 2005, CLIN HEMATOLOGY THEO; Ulman V, 2016, CYTOM PART A, V89A, P1057, DOI 10.1002/cyto.a.23031; Van Liedekerke P, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006273; Weinberg RA, 2007, BIOL CANC; Yoshii Y, 2011, BIOMATERIALS, V32, P6052, DOI 10.1016/j.biomaterials.2011.04.076; Yoshioka S, 1997, J BIOCHEM, V122, P691	36	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231774	10.1371/journal.pone.0231774	http://dx.doi.org/10.1371/journal.pone.0231774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302356	Green Published, gold			2022-12-26	WOS:000536016100048
J	Pineau, F; Caimmi, D; Magalhaes, M; Fremy, E; Mohamed, A; Mely, L; Leroy, S; Murris, M; Claustres, M; Chiron, R; De Sario, A				Pineau, Fanny; Caimmi, Davide; Magalhaes, Milena; Fremy, Enora; Mohamed, Abdillah; Mely, Laurent; Leroy, Sylvie; Murris, Marlene; Claustres, Mireille; Chiron, Raphael; De Sario, Albertina			Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis	PLOS ONE			English	Article							EXPRESSION; FILAMIN; CELLS; MODEL	Cystic fibrosis (CF) is a rare genetic disease that affects the respiratory and digestive systems. Lung disease is variable among CF patients and associated with the development of comorbidities and chronic infections. The rate of lung function deterioration depends not only on the type of mutations in CFTR, the disease-causing gene, but also on modifier genes. In the present study, we aimed to identify genes and pathways that (i) contribute to the pathogenesis of cystic fibrosis and (ii) modulate the associated comorbidities. We profiled blood samples in CF patients and healthy controls and analyzed RNA-seq data with Weighted Gene Correlation Network Analysis (WGCNA). Interestingly, lung function, body mass index, the presence of diabetes, and chronic P. aeruginosa infections correlated with four modules of co-expressed genes. Detailed inspection of networks and hub genes pointed to cell adhesion, leukocyte trafficking and production of reactive oxygen species as central mechanisms in lung function decline and cystic fibrosis-related diabetes. Of note, we showed that blood is an informative surrogate tissue to study the contribution of inflammation to lung disease and diabetes in CF patients. Finally, we provided evidence that WGCNA is useful to analyze-omic datasets in rare genetic diseases as patient cohorts are inevitably small.	[Pineau, Fanny; Magalhaes, Milena; Fremy, Enora; Mohamed, Abdillah; Claustres, Mireille; De Sario, Albertina] Univ Montpellier, Lab Genet Malad Rares LGMR, EA7402, Montpellier, France; [Caimmi, Davide; Chiron, Raphael] Arnaud Villeneuve Hosp, CRCM, Montpellier, France; [Mely, Laurent] Renee Sabran Hosp, CRCM, Hyeres, France; [Leroy, Sylvie] Pasteur Hosp, CRCM, Nice, France; [Murris, Marlene] Larrey Hosp, CRCM, Toulouse, France; [Claustres, Mireille] CHU Montpellier, Lab Genet Mol, Montpellier, France	Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; CHU Nice; CHU de Toulouse; Universite de Montpellier; CHU de Montpellier	De Sario, A (corresponding author), Univ Montpellier, Lab Genet Malad Rares LGMR, EA7402, Montpellier, France.	albertina.de-sario@inserm.fr		DE SARIO, Albertina/0000-0002-9997-1645; Magalhaes, Milena/0000-0002-1695-7515; MOHAMED, Abdillah/0000-0002-6042-7714	Vaincre La Mucoviscidose [RC20130500857, RC20140501072, RC20150501383, RC20170501949]; Fondation Maladies Rares; Montpellier University; Montpellier Hospital; Ciencia Sem Fronteiras program (CNPq Brazil); Vaincre La Mucoviscidose	Vaincre La Mucoviscidose; Fondation Maladies Rares; Montpellier University; Montpellier Hospital; Ciencia Sem Fronteiras program (CNPq Brazil); Vaincre La Mucoviscidose	This study was supported by Vaincre La Mucoviscidose (RC20130500857, RC20140501072, RC20150501383, RC20170501949), Fondation Maladies Rares, and Montpellier Hospital to AD. FP was supported by Montpellier University and Montpellier Hospital, MMa by the Ciencia Sem Fronteiras program (CNPq Brazil), and EF by Vaincre La Mucoviscidose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bridges N, 2018, DIABETIC MED, V35, P1181, DOI 10.1111/dme.13652; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Debey-Pascher S, 2011, J MOL DIAGN, V13, P452, DOI 10.1016/j.jmoldx.2011.03.006; Delaspre F, 2015, DIABETES, V64, P3499, DOI 10.2337/db15-0153; DIMARIO U, 1986, CLIN EXP IMMUNOL, V65, P57; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; GUAN SS, 2015, SCI REP, V5, DOI DOI 10.1038/SRE914561; Hart NJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98240; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kormann MSD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183526; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee HZ, 2004, LIFE SCI, V74, P2085, DOI 10.1016/j.lfs.2003.06.046; Magalhaes M, 2018, EPIGENOMICS-UK, V10, P1131, DOI 10.2217/epi-2018-0005; Magalhaes M, 2017, CLIN EPIGENETICS, V9, DOI 10.1186/s13148-016-0300-8; Malhotra S, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00138-18; Minandri F, 2016, INFECT IMMUN, V84, P2324, DOI 10.1128/IAI.00098-16; Muhlebach MS, 2016, J CYST FIBROS, V15, P714, DOI 10.1016/j.jcf.2016.10.009; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Osborne DG, 2015, J IMMUNOL, V194, P4555, DOI 10.4049/jimmunol.1402734; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Playford MP, 2010, J BIOL CHEM, V285, P17156, DOI 10.1074/jbc.M109.080523; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Sajuthi SP, 2016, HUM GENET, V135, P869, DOI 10.1007/s00439-016-1680-8; Savinko T, 2018, J IMMUNOL, V200, P3109, DOI 10.4049/jimmunol.1700913; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Shelmerdine SC, 2017, PEDIATR PULM, V52, P1306, DOI 10.1002/ppul.23695; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Stephenson AL, 2013, AM J CLIN NUTR, V97, P872, DOI 10.3945/ajcn.112.051409; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Uotila LM, 2017, J IMMUNOL, V199, P3644, DOI 10.4049/jimmunol.1700087; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wright JM, 2006, AM J RESP CELL MOL, V35, P327, DOI 10.1165/rcmb.2005-0359OC	38	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231285	10.1371/journal.pone.0231285	http://dx.doi.org/10.1371/journal.pone.0231285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302349	Green Published, gold			2022-12-26	WOS:000536016100021
J	Amodeo, AL; Esposito, C; Bacchini, D				Amodeo, Anna Lisa; Esposito, Concetta; Bacchini, Dario			Heterosexist microaggressions, student academic experience and perception of campus climate: Findings from an Italian higher education context	PLOS ONE			English	Article							SEXUAL ORIENTATION MICROAGGRESSIONS; MENTAL-HEALTH; RACIAL MICROAGGRESSIONS; COLLEGE-STUDENTS; GAY; THATS; MINORITY; HEARING; STRESS; IMPACT	While overt instances of harassment and violence towards LGBQ+ individuals have decreased in recent years, subtler forms of heterosexism still shape the social and academic experience of students in higher education contexts. Such forms, defined as microaggressions, frequently include environmental slights that communicate hostile and derogatory messages about one's sexual-minority status. However, there is some evidence suggesting that environmental microaggressions have deleterious effects on all students, regardless of their sexual orientation. The aim of the current study was to examine how heterosexist environmental microaggressions on campus contributed to heterosexual and non-heterosexual students' negative perceptions of campus climate. We also analyzed whether the effect of microaggressions on campus climate was mediated by student social integration on campus. Data were collected in 2018 through an anonymous web-based survey that involved students from a large university of Southern Italy. The sample consisted of 471 students from 18 to 33 years old. Thirty-eight (8.1%) students self-identified as non-heterosexual. Measures included self-reported experiences of environmental microaggressions on campus, student degree of satisfaction with peer-group and student-faculty interactions, perceptions of faculty concern for student development, and of the overall campus climate. The structural equation model showed that heterosexist environmental microaggressions on campus were associated with negative perceptions of campus climate through lowered satisfaction with peer-group interactions and perceptions of faculty concern for student development, for both heterosexual and non-heterosexual students. Overall, the findings of this study suggest that heterosexist microaggressions within campus environments are negatively associated with students' perceptions of campus climate, regardless of their sexual orientation. Both faculty and peers play an important role in creating an environment that supports the inclusivity of diversity and fosters a greater sense of belonging to the campus community.	[Amodeo, Anna Lisa; Esposito, Concetta; Bacchini, Dario] Univ Naples Federico II, Dept Humanist Studies, Naples, Italy; [Amodeo, Anna Lisa; Esposito, Concetta] Univ Naples Federico II, SInAPSi Ctr, Serv Act & Participated Inclus Students, Naples, Italy	University of Naples Federico II; University of Naples Federico II	Esposito, C (corresponding author), Univ Naples Federico II, Dept Humanist Studies, Naples, Italy.; Esposito, C (corresponding author), Univ Naples Federico II, SInAPSi Ctr, Serv Act & Participated Inclus Students, Naples, Italy.	concetta.esposito3@unina.it	Amodeo, Anna Lisa/ABG-8580-2020; Esposito, Concetta/AHC-7473-2022	AMODEO, Anna Lisa/0000-0001-9551-1281				Amodeo AL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102318; Chonody JM, 2012, J GAY LESBIAN SOC SE, V24, P241, DOI 10.1080/10538720.2012.697036; Dodge B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164430; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hurtado S., 2012, HIGHER ED HDB THEORY, V27, P41, DOI [DOI 10.1007/978-94-007-2950-6_2, 10.1007/978-94-007-2950-6_2]; ILGA World, 2019, MAPS SEX OR LAWS; Kosciw J.G., 2018, 2017 NATL SCH CLIMAT; Lingiardi V, 2005, ARCH SEX BEHAV, V34, P81, DOI 10.1007/s10508-005-1002-z; Lingiardi V, 2016, SEX RES SOC POLICY, V13, P95, DOI 10.1007/s13178-015-0197-6; Little R.J.A., 2002, STAT ANAL MISSING DA; Mathies N, 2019, J LGBT YOUTH, V16, P255, DOI 10.1080/19361653.2019.1571981; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Muthen L.K., 2017, MPLUS USERS GUIDE; Nadal KL, 2011, J LGBT YOUTH, V8, P234, DOI 10.1080/19361653.2011.584204; Norris AL, 2018, APPL DEV SCI, V22, P154, DOI 10.1080/10888691.2016.1245101; Oswalt SB, 2011, J HOMOSEXUAL, V58, P1255, DOI 10.1080/00918369.2011.605738; Pascarella ET, 2006, J COLL STUDENT DEV, V47, P508, DOI 10.1353/csd.2006.0060; PASCARELLA ET, 1980, J EDUC RES, V73, P344, DOI 10.1080/00220671.1980.10885264; Platt LF, 2013, J HOMOSEXUAL, V60, P1011, DOI 10.1080/00918369.2013.774878; Poteat VP, 2014, ADV CHILD DEV BEHAV, V47, P261, DOI 10.1016/bs.acdb.2014.04.005; Rankin S., 2010, STATE HIGHER ED LGBT; Rankin S, 2008, J DIVERS HIGH EDUC, V1, P262, DOI 10.1037/a0014018; Renn KA, 2010, EDUC RESEARCHER, V39, P132, DOI 10.3102/0013189X10362579; Russell ST, 2010, SOCIAL POLICY REPORT; Salvati M, 2018, SEX RES SOC POLICY, V15, P312, DOI 10.1007/s13178-017-0296-7; Seelman KL, 2017, J ETHN CULT DIVERSIT, V26, P112, DOI 10.1080/15313204.2016.1263816; Shelton K, 2011, J COUNS PSYCHOL, V58, P210, DOI 10.1037/a0022251; Silverschanz P, 2008, SEX ROLES, V58, P179, DOI 10.1007/s11199-007-9329-7; Stoffel M, 2010, ADV GLOB CHANGE RES, V41, P3, DOI 10.1007/978-90-481-8736-2_1; Sue DW, 2008, PROF PSYCHOL-RES PR, V39, P329, DOI 10.1037/0735-7028.39.3.329; Sue DW, 2007, AM PSYCHOL, V62, P271, DOI 10.1037/0003-066X.62.4.271; Tager D., 2005, PSYCHOL MEN MASCULIN, V6, P264, DOI [10.1037/1524-9220.6.4.264, DOI 10.1037/1524-9220.6.4.264]; Tetreault PA, 2013, J HOMOSEXUAL, V60, P947, DOI 10.1080/00918369.2013.774874; Vaccaro A, 2012, J STUD AFF RES PRACT, V49, P429, DOI 10.1515/jsarp-2012-6473; Woodford MR, 2015, J HOMOSEXUAL, V62, P1660, DOI 10.1080/00918369.2015.1078205; Woodford MR, 2015, J DIVERS HIGH EDUC, V8, P73, DOI 10.1037/a0038552; Woodford MR, 2015, AM J COMMUN PSYCHOL, V55, P13, DOI 10.1007/s10464-014-9683-x; Woodford MR, 2014, J GAY LESBIAN MENT H, V18, P142, DOI 10.1080/19359705.2013.833882; Woodford MR, 2014, AM J ORTHOPSYCHIAT, V84, P519, DOI 10.1037/ort0000015; Woodford MR, 2013, J INTERPERS VIOLENCE, V28, P416, DOI 10.1177/0886260512454719; Woodford MR, 2012, J AM COLL HEALTH, V60, P429, DOI 10.1080/07448481.2012.673519	42	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231580	10.1371/journal.pone.0231580	http://dx.doi.org/10.1371/journal.pone.0231580			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298367	gold, Green Published			2022-12-26	WOS:000536011400069
J	Gao, JL; Zheng, PP; Jia, YN; Chen, H; Mao, YM; Chen, SH; Wang, Y; Fu, H; Dai, JM				Gao, Junling; Zheng, Pinpin; Jia, Yingnan; Chen, Hao; Mao, Yimeng; Chen, Suhong; Wang, Yi; Fu, Hua; Dai, Junming			Mental health problems and social media exposure during COVID-19 outbreak	PLOS ONE			English	Article								Huge citizens expose to social media during a novel coronavirus disease (COVID-19) outbroke in Wuhan, China. We assess the prevalence of mental health problems and examine their association with social media exposure. A cross-sectional study among Chinese citizens aged >= 18 years old was conducted during Jan 31 to Feb 2, 2020. Online survey was used to do rapid assessment. Total of 4872 participants from 31 provinces and autonomous regions were involved in the current study. Besides demographics and social media exposure (SME), depression was assessed by The Chinese version of WHO-Five Well-Being Index (WHO-5) and anxiety was assessed by Chinese version of generalized anxiety disorder scale (GAD-7). multivariable logistic regressions were used to identify associations between social media exposure with mental health problems after controlling for covariates. The prevalence of depression, anxiety and combination of depression and anxiety (CDA) was 48.3% (95%CI: 46.9%-49.7%), 22.6% (95%CI: 21.4%-23.8%) and 19.4% (95%CI: 18.3%-20.6%) during COVID-19 outbroke in Wuhan, China. More than 80% (95%CI:80.9%-83.1%) of participants reported frequently exposed to social media. After controlling for covariates, frequently SME was positively associated with high odds of anxiety (OR = 1.72, 95%CI: 1.31-2.26) and CDA (OR = 1.91, 95%CI: 1.52-2.41) compared with less SME. Our findings show there are high prevalence of mental health problems, which positively associated with frequently SME during the COVID-19 outbreak. These findings implicated the government need pay more attention to mental health problems, especially depression and anxiety among general population and combating with "infodemic" while combating during public health emergency.	[Gao, Junling; Zheng, Pinpin; Jia, Yingnan; Chen, Hao; Mao, Yimeng; Chen, Suhong; Wang, Yi; Fu, Hua; Dai, Junming] Fudan Univ, Fudan Inst Hlth Commun, Sch Publ Hlth, Shanghai, Peoples R China	Fudan University	Dai, JM (corresponding author), Fudan Univ, Fudan Inst Hlth Commun, Sch Publ Hlth, Shanghai, Peoples R China.	jmdai@fudan.edu.cn	gao, junling/L-7465-2019; Gao, Junling/GLS-4118-2022	Gao, Junling/0000-0002-0694-2010	National key R&D Program of China [2018YFC2002000, 2018YFC2002001]; National Natural Science Foundation of China [71573048]	National key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Junling Gao was funded by National key R&D Program of China (grant no. 2018YFC2002000 & 2018YFC2002001) and National Natural Science Foundation of China (grant no. 71573048). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], XINHUA; Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3; Bontcheva K., 2013, SOCIAL MEDIA INFORM; Choi DH, 2017, COMPUT HUM BEHAV, V72, P422, DOI 10.1016/j.chb.2017.03.004; Huang YQ, 2019, LANCET PSYCHIAT, V6, P211, DOI 10.1016/S2215-0366(18)30511-X; Ji D, 2017, ONCOTARGET, V8, P12784, DOI 10.18632/oncotarget.14498; Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X; Mak IWC, 2009, GEN HOSP PSYCHIAT, V31, P318, DOI 10.1016/j.genhosppsych.2009.03.001; National Health Commission of the People's Republic of China, GUID PSYCH CRIS INT; Neria Y, 2011, JAMA-J AM MED ASSOC, V306, P1374, DOI 10.1001/jama.2011.1358; Niederkrotenthaler T, 2019, JAMA PSYCHIAT, V76, P933, DOI 10.1001/jamapsychiatry.2019.0922; Shigemura J, 2020, PSYCHIAT CLIN NEUROS, V74, P281, DOI 10.1111/pcn.12988; Shultz JM, 2015, JAMA-J AM MED ASSOC, V313, P567, DOI 10.1001/jama.2014.17934; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; WHO, COVID 2019 PHEIC GLO; WHO, EM COR EC M; World Health Organization, NOV COR 2019 NCOV SI; World Health Organization, WHO DIR GEN STAT IHR; World Health Organization Collaborating Center for Mental Health, WHO 5 WELL BEING IND; Xie ZT, 2017, J MENT HEALTH, V26, P43, DOI 10.1080/09638237.2016.1276525; Xu W.F., 2018, WORLD LATEST MED INF, V18, P12, DOI 10.19613/j.cnki.1671-3141.2018.16.006; Zjablovskaja P, 2020, CANCERS, V12, DOI 10.3390/cancers12010103	23	855	861	84	339	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231924	10.1371/journal.pone.0231924	http://dx.doi.org/10.1371/journal.pone.0231924			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298385	Green Published, gold			2022-12-26	WOS:000536011400122
J	Pondorfer, SG; Heinemann, M; Wintergerst, MWM; Pfau, M; Stromer, AL; Holz, FG; Finger, RP				Pondorfer, Susanne G.; Heinemann, Manuel; Wintergerst, Maximilian W. M.; Pfau, Maximilian; Stroemer, Annika L.; Holz, Frank G.; Finger, Robert P.			Detecting vision loss in intermediate age-related macular degeneration: A comparison of visual function tests	PLOS ONE			English	Article							ROBSON CONTRAST SENSITIVITY; MEDIATED DARK-ADAPTATION; OPTIMAL CUT-POINT; LOW-LUMINANCE; YOUDEN INDEX; GEOGRAPHIC ATROPHY; ACUITY LOSS; MICROPERIMETRY; MACULOPATHY; ASSOCIATIONS	The purpose of the study was to evaluate the diagnostic accuracy of visual function tests in intermediate age-related macular degeneration (iAMD). A total of 62 subjects (38 patients with iAMD and 24 controls) were included and underwent several functional assessments: Best-corrected visual acuity (BCVA), low luminance visual acuity (LLVA), visual acuity (VA) measured with the Moorfields Vanishing Optotypes Acuity Charts (MAC), contrast sensitivity with the Pelli-Robson test, reading speed using the International Reading Speed texts (IReST) and mesopic and dark-adapted microperimetry (S-MAIA, CenterVue, Padova, Italy). Groups were compared using non-parametric Wilcoxon rank sum tests and ROC analyses. Linear regression was used to control for confounding. Results showed that all visual function test performances except the IReST were significantly reduced in iAMD patients compared to controls (p < 0.05). These effects did not alter after controlling for age and sex. Best discrimination between iAMD and controls yield the combination of LLVA and contrast sensitivity as well as MAC-VA and contrast sensitivity (ROC area under the curve 0.95 and 0.93, respectively). Our results suggest that LLVA, MAC-VA, contrast sensitivity and mesopic and dark-adapted microperimetry can capture visual impairment characteristic for iAMD. Best discrimination against iAMD is achieved with a combination of two tests.	[Pondorfer, Susanne G.; Heinemann, Manuel; Wintergerst, Maximilian W. M.; Pfau, Maximilian; Stroemer, Annika L.; Holz, Frank G.; Finger, Robert P.] Univ Bonn, Dept Ophthalmol, Bonn, Germany	University of Bonn	Finger, RP (corresponding author), Univ Bonn, Dept Ophthalmol, Bonn, Germany.	robert.finger@ukbonn.de	Wintergerst, Maximilian/E-5523-2019; Wintergerst, Maximilian/AAW-2972-2021	Wintergerst, Maximilian/0000-0002-2766-7038; Finger, Robert P/0000-0003-4253-7597; Pfau, Maximilian/0000-0001-9761-9640	Else Krohner Fresenius Stiftung/German Scholars Organization [GSO/EKFS 16]	Else Krohner Fresenius Stiftung/German Scholars Organization	R.P.F.: Else Krohner Fresenius Stiftung/German Scholars Organization (GSO/EKFS 16) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], PREV INC HEALTHC NEE; Barteselli G, 2014, EYE, V28, P1231, DOI 10.1038/eye.2014.189; CAMPBELL FW, 1966, J PHYSIOL-LONDON, V186, P558, DOI 10.1113/jphysiol.1966.sp008056; Cassels NK, 2018, USE MICROPERIMETRY A; Chandramohan A, 2016, RETINA-J RET VIT DIS, V36, P1021, DOI 10.1097/IAE.0000000000001002; Choi BCK, 1998, AM J EPIDEMIOL, V148, P1127; Cleves Mario A, 2002, STATA J, P301; Cocce KJ, 2018, AM J OPHTHALMOL, V189, P127, DOI 10.1016/j.ajo.2018.02.012; Colijn JM, 2017, OPHTHALMOLOGY, V124, P1753, DOI 10.1016/j.ophtha.2017.05.035; Dimitrov PN, 2011, INVEST OPHTH VIS SCI, V52, P9457, DOI 10.1167/iovs.10-7043; Dinc UA, 2008, EUR J OPHTHALMOL, V18, P595, DOI 10.1177/112067210801800416; Faria BM, 2015, RETINA-J RET VIT DIS, V35, P1465, DOI 10.1097/IAE.0000000000000474; Feigl B, 2005, EYE, V19, P1169, DOI 10.1038/sj.eye.6701711; Feigl B, 2004, CURR EYE RES, V29, P327, DOI 10.1080/02713680490516198; Feigl B, 2007, CLIN OPHTHALMOL, V1, P167; FERRIS FL, 1982, AM J OPHTHALMOL, V94, P91, DOI 10.1016/0002-9394(82)90197-0; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Finger RP, 2019, OPHTHALMOLOGICA, V241, P61, DOI 10.1159/000491402; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; KLEINER RC, 1988, ARCH OPHTHALMOL-CHIC, V106, P55; Mantyjarvi M, 2001, J CATARACT REFR SURG, V27, P261, DOI 10.1016/S0886-3350(00)00562-9; Maynard ML, 2016, ACTA OPHTHALMOL, V94, pE772, DOI 10.1111/aos.13112; McKeague C, 2014, OPTOMETRY VISION SCI, V91, P916, DOI 10.1097/OPX.0000000000000318; METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2; Nebbioso M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/671529; Owsley C, 2006, INVEST OPHTH VIS SCI, V47, P528, DOI 10.1167/iovs.05-1222; Owsley C, 2016, OPHTHALMOLOGY, V123, P344, DOI 10.1016/j.ophtha.2015.09.041; Owsley C, 2014, INVEST OPHTH VIS SCI, V55, P4776, DOI 10.1167/iovs.14-14502; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Puell MC, 2012, INVEST OPHTH VIS SCI, V53, P7310, DOI 10.1167/iovs.11-8649; Ruopp MD, 2008, BIOMETRICAL J, V50, P419, DOI 10.1002/bimj.200710415; Sato T, 2015, RETINA-J RET VIT DIS, V35, P1292, DOI 10.1097/IAE.0000000000000505; Sauer L, 2018, INVEST OPHTH VIS SCI, V59, pAMD65, DOI 10.1167/iovs.17-23764; Schisterman EF, 2005, EPIDEMIOLOGY, V16, P73, DOI 10.1097/01.ede.0000147512.81966.ba; Scilley K, 2002, OPHTHALMOLOGY, V109, P1235, DOI 10.1016/S0161-6420(02)01060-6; Shah N, 2016, BRIT J OPHTHALMOL, V100, P1346, DOI 10.1136/bjophthalmol-2015-307375; StataCorp, 2017, STATA STAT SOFTWARE; Steinberg JS, 2015, JAMA OPHTHALMOL, V133, P690, DOI 10.1001/jamaophthalmol.2015.0477; Sunness JS, 2008, OPHTHALMOLOGY, V115, P1480, DOI 10.1016/j.ophtha.2008.03.009; Tran BK, 2015, KLIN MONATSBL AUGENH, V232, P529, DOI 10.1055/s-0035-1545779; Trauzettel-Klosinski S, 2012, INVEST OPHTH VIS SCI, V53, P5452, DOI 10.1167/iovs.11-8284; Varadaraj V, 2018, AM J OPHTHALMOL, V186, P138, DOI 10.1016/j.ajo.2017.11.026; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Vujosevic S, 2011, Z AUGENHEILKD, V225, P155, DOI [10.1159/000320340, DOI 10.1159/000320340]; Vujosevic S, 2016, A VONGRAEFES ARCH KL; Welker Susanne G, 2018, Invest Ophthalmol Vis Sci, V59, pAMD152, DOI 10.1167/iovs.18-23878; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Wu ZC, 2016, INVEST OPHTH VIS SCI, V57, P3714, DOI 10.1167/iovs.15-18294; Wu ZC, 2016, BRIT J OPHTHALMOL, V100, P395, DOI 10.1136/bjophthalmol-2015-306621; Wu ZC, 2015, JAMA OPHTHALMOL, V133, P442, DOI 10.1001/jamaophthalmol.2014.5963; Wu ZC, 2015, INVEST OPHTH VIS SCI, V56, P1546, DOI 10.1167/iovs.14-16211; Wu ZC, 2014, OPHTHALMOLOGY, V121, P1612, DOI 10.1016/j.ophtha.2014.02.005; Wu ZC, 2013, INVEST OPHTH VIS SCI, V54, P7378, DOI 10.1167/iovs.13-12617	54	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231748	10.1371/journal.pone.0231748	http://dx.doi.org/10.1371/journal.pone.0231748			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298375	gold, Green Published			2022-12-26	WOS:000536011400104
J	Turek, EM; Fairley, CK; Bradshaw, CS; Chen, MY; Vodstrcil, LA; Snow, A; Fortune, R; Chow, EPF				Turek, Evelyn M.; Fairley, Christopher K.; Bradshaw, Catriona S.; Chen, Marcus Y.; Vodstrcil, Lenka A.; Snow, Anthony; Fortune, Ria; Chow, Eric P. F.			Are genital examinations necessary for STI screening for female sex workers? An audit of decriminalized and regulated sex workers in Melbourne, Australia	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS	Background The Victorian legislation prohibits sex workers from working when they have visible anogenital herpes or warts. The aim of this study was to determine the proportion of asymptomatic female sex workers (FSW) diagnosed with anogenital herpes or warts by genital examination. Methods We analysed all computerised medical records of consultations with FSW at the Melbourne Sexual Health Centre (MSHC) in 2018. All asymptomatic sex workers were offered screening sexually transmitted infections (STIs) and a genital examination to identify visible anogenital herpes or warts at MSHC. FSW consultations were categorised into either 'asymptomatic' or 'symptomatic' based on the presence of symptoms reported by the FSW to the triage nurse. The proportion of asymptomatic FSW diagnosed with visible anogenital herpes or warts during a routine screening examination was calculated. Results In 2018, 4055 consultations were provided to 1979 FSW. 3406 of these consultations were asymptomatic and all were examined by an experienced clinician for signs of STIs. Of these 3406 asymptomatic consultations, seven FSW (0.21%, 95% CI: 0.08% to 0.42%) were diagnosed with visible anogenital herpes and/or warts following a genital examination. Four were diagnosed with warts (0.12%, 95% CI: 0.03% to 0.30%), two with herpes (0.06%, 95% CI: 0.01% to 0.21%) and one with both herpes and warts (0.03%, 95% CI: 0.001% to 0.16%). Conclusion Based on these data, approximately 500 asymptomatic FSW would need to be examined to identify one case of anogenital herpes or warts. Genital examinations consume considerable clinical resources, increase the duration of consultations and provide essentially no significant benefit to the mandated testing for gonorrhoea, chlamydia, HIV and syphilis. Our clinic will use self-collected samples and no longer examine FSW who are asymptomatic.	[Turek, Evelyn M.; Fairley, Christopher K.; Bradshaw, Catriona S.; Chen, Marcus Y.; Vodstrcil, Lenka A.; Snow, Anthony; Fortune, Ria; Chow, Eric P. F.] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia; [Turek, Evelyn M.; Fairley, Christopher K.; Bradshaw, Catriona S.; Chen, Marcus Y.; Vodstrcil, Lenka A.; Chow, Eric P. F.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia; [Chow, Eric P. F.] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia	Monash University; University of Melbourne	Turek, EM; Chow, EPF (corresponding author), Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.; Turek, EM; Chow, EPF (corresponding author), Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.; Chow, EPF (corresponding author), Univ Melbourne, Melbourne Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Vic, Australia.	etur12@student.monash.edu; eric.chow@monash.edu	Chow, Eric P.F./W-6684-2019	Chow, Eric P.F./0000-0003-1766-0657				Ali H, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2032; Chow EPF, 2019, SEX TRANSM INFECT, V95, P398, DOI 10.1136/sextrans-2018-053957; Chow EPF, 2019, LANCET HIV, V6, pE396, DOI 10.1016/S2352-3018(19)30043-8; Chow EPF, 2018, SEX HEALTH, V15, P350, DOI 10.1071/SH18024; Chow EPF, 2017, LANCET INFECT DIS, V17, P68, DOI 10.1016/S1473-3099(16)30116-5; Chow EPF, 2015, SEX TRANSM INFECT, V91, P214, DOI 10.1136/sextrans-2014-051813; Chow EPF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103081; Donovan B, 2011, LANCET INFECT DIS, V11, P39, DOI 10.1016/S1473-3099(10)70225-5; Dunne EF, 2006, CLIN INFECT DIS, V43, P624, DOI 10.1086/505982; Golden MR, 2015, SEX TRANSM DIS, V42, P294, DOI 10.1097/OLQ.0000000000000271; Golden MR, 2010, SEX TRANSM DIS, V37, P264, DOI 10.1097/OLQ.0b013e3181d5e01e; Green P, 2007, INT J STD AIDS, V18, P85, DOI 10.1258/095646207779949646; Harcourt Christine, 2005, Sex Health, V2, P121, DOI 10.1071/SH04042; Jasek E, 2017, COMMUN DIS INTELL, V41, pE212; Kirby Institute, 2018, HIV VIR HEP SEX TRAN; Lee DM, 2006, INT J STD AIDS, V17, P631, DOI 10.1258/095646206778113069; Lee DM, 2005, SEX TRANSM INFECT, V81, P434, DOI 10.1136/sti.2004.014431; Ma JY, 2011, SEX HEALTH, V8, P90, DOI 10.1071/SH10024; Machalek DA, 2017, J INFECT DIS, V215, P202, DOI 10.1093/infdis/jiw530; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Unemo M, 2017, LANCET INFECT DIS, V17, pE235, DOI [10.1016/s1473-3099(17)30310-9, 10.1016/S1473-3099(17)30310-9]; Zappulla A, 2020, SEX HEALTH, V17, P53, DOI 10.1071/SH19037	22	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231547	10.1371/journal.pone.0231547	http://dx.doi.org/10.1371/journal.pone.0231547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298328	Green Published, gold			2022-12-26	WOS:000536011400065
J	Van Bourg, J; Patterson, JE; Wynne, CDL				Van Bourg, Joshua; Patterson, Jordan Elizabeth; Wynne, Clive D. L.			Pet dogs (Canis lupus familiaris) release their trapped and distressed owners: Individual variation and evidence of emotional contagion	PLOS ONE			English	Article							DOMESTIC DOGS; BEHAVIOR; EMPATHY; HUMANS; ANIMALS; HELP; FOOD	Domestic dogs have assisted humans for millennia. However, the extent to which these helpful behaviors are prosocially motivated remains unclear. To assess the propensity of pet dogs to actively rescue distressed humans without explicit training, this study tested whether sixty pet dogs would release their seemingly trapped owners from a large box. To examine the causal mechanisms that shaped this behavior, the readiness of each dog to open the box was tested in three conditions: 1) the owner sat in the box and called for help (distress test), 2) an experimenter placed high-value food rewards in the box (food test), and 3) the owner sat in the box and calmly read aloud (reading test). Dogs were as likely to release their distressed owner as to retrieve treats from inside the box, indicating that rescuing an owner may be a highly rewarding action for dogs. After accounting for opening ability, dogs released the owner more often when the owner called for help than when the owner read aloud calmly. In addition, opening latencies decreased with test number in the distress test but not the reading test. Thus, rescuing the owner could not be attributed solely to social facilitation, stimulus enhancement, or social contact-seeking behavior. Dogs displayed more stress behaviors in the distress test than in the reading test, and stress scores decreased with test number in the reading test but not in the distress test. This evidence of emotional contagion supports the hypothesis that rescuing the distressed owner was an empathetically-motivated prosocial behavior. Success in the food task and previous (in-home) experience opening objects were both strong predictors of releasing the owner. Thus, prosocial behavior tests for dogs should control for physical ability and previous experience.	[Van Bourg, Joshua; Patterson, Jordan Elizabeth; Wynne, Clive D. L.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Patterson, Jordan Elizabeth] Duke Univ, Mech Engn & Mat Sci, Durham, NC USA	Arizona State University; Arizona State University-Tempe; Duke University	Van Bourg, J (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	jvanbour@asu.edu		Van Bourg, Joshua/0000-0003-0599-9602				Albuquerque N, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0883; Bartal IB, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00850; Bartal IBA, 2011, SCIENCE, V334, P1427, DOI 10.1126/science.1210789; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Batson C. D., 1998, HDB SOCIAL PSYCHOL, V2, P282, DOI DOI 10.1002/0471264385.WEI0519; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; BATSON CD, 1981, J PERS SOC PSYCHOL, V40, P290, DOI 10.1037/0022-3514.40.2.290; Blystad MH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223039; Brauer J, 2015, INTERACT STUD, V16, P341, DOI 10.1075/is.16.3.01bra; Brauer J, 2013, APPL ANIM BEHAV SCI, V148, P138, DOI 10.1016/j.applanim.2013.07.009; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Carballo F, 2020, ANIM COGN, V23, P389, DOI 10.1007/s10071-019-01343-5; CIALDINI RB, 1987, J PERS SOC PSYCHOL, V52, P749, DOI 10.1037/0022-3514.52.4.749; Coppinger Roger, 2002, DOGS NEW UNDERSTANDI; Cronin KA, 2012, ANIM BEHAV, V84, P1085, DOI 10.1016/j.anbehav.2012.08.009; Custance D, 2012, ANIM COGN, V15, P851, DOI 10.1007/s10071-012-0510-1; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Decety J, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0077; Drayton LA, 2014, ANIM COGN, V17, P689, DOI 10.1007/s10071-013-0700-5; Dugatkin L.A., 1997, COOPERATION ANIMALS; Feuerbacher EN, 2014, J EXP ANAL BEHAV, V101, P385, DOI 10.1002/jeab.81; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Hollis KL, 2013, EVOL PSYCHOL-US, V11, P647; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Kaminski J, 2011, ANIM BEHAV, V82, P651, DOI 10.1016/j.anbehav.2011.06.015; Kaminski M, 2002, CHILD HEALTH CARE, V31, P321, DOI 10.1207/S15326888CHC3104_5; Kujala MV., 2017, ANIM SENTIENCE, V2, P1, DOI [10.51291/2377-7478.1114, DOI 10.51291/2377-7478.1114]; Macpherson K, 2006, J COMP PSYCHOL, V120, P113, DOI 10.1037/0735-7036.120.2.113; Marshall-Pescini S, 2016, ANIM COGN, V19, P679, DOI 10.1007/s10071-016-0973-6; Miklosi A, 2007, NEUROREPORT, V18, P467; Moehlman P.D., 1986, P64; Moehlman P.D., 1989, P143; Moen OM, 2016, J VALUE INQUIRY, V50, P267, DOI 10.1007/s10790-015-9506-9; Nowbahari E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006573; Panksepp J, 2013, TRENDS NEUROSCI, V36, P489, DOI 10.1016/j.tins.2013.04.009; Petter M, 2009, BEHAV PROCESS, V82, P109, DOI 10.1016/j.beproc.2009.07.002; Quervel-Chaumette M, 2016, FRONT PSYCHOL, V7, P1, DOI [10.3389/fpsyg.2016.00001, DOI 10.3389/FPSYG.2016.00001]; Quervel-Chaumette M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18102; Romero T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071365; Sanford EM, 2018, LEARN BEHAV, V46, P374, DOI 10.3758/s13420-018-0332-3; Sapolsky RM, 2016, NAT NEUROSCI, V19, P1387, DOI 10.1038/nn.4397; Silberberg A, 2014, ANIM COGN, V17, P609, DOI [10.1007/s10071-013-0623-1, 10.1007/s10071-013-0692-1]; Silk JB, 2009, NEUROECONOMICS: DECISION MAKING AND THE BRAIN, P269, DOI 10.1016/B978-0-12-374176-9.00018-X; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Tomek SE, 2019, ADDICT BIOL, V24, P676, DOI 10.1111/adb.12633; Topal J, 2005, ANIM BEHAV, V70, P1367, DOI 10.1016/j.anbehav.2005.03.025; Udell MAR, 2008, J EXP ANAL BEHAV, V89, P247, DOI 10.1901/jeab.2008.89-247; Udell MAR, 2011, LEARN BEHAV, V39, P289, DOI 10.3758/s13420-011-0034-6; Vasconcelos M, 2012, BIOL LETTERS, V8, P910, DOI 10.1098/rsbl.2012.0554; vonHoldt BM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700398; Warneken F, 2009, TRENDS COGN SCI, V13, P397, DOI 10.1016/j.tics.2009.06.008; West SA, 2006, CURR BIOL, V16, pR482, DOI 10.1016/j.cub.2006.06.014	53	14	14	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231742	10.1371/journal.pone.0231742	http://dx.doi.org/10.1371/journal.pone.0231742			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298391	gold, Green Published			2022-12-26	WOS:000536011400100
J	Herdendorf, TJ; Stapels, DAC; Rooijakkers, SHM; Geisbrecht, BV				Herdendorf, Timothy J.; Stapels, Daphne A. C.; Rooijakkers, Suzan H. M.; Geisbrecht, Brian V.			Local structural plasticity of the Staphylococcus aureus evasion protein EapH1 enables engagement with multiple neutrophil serine proteases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						neutrophil; protease; protease inhibitor; protein?protein interaction; Staphylococcus aureus (S; aureus)	IMMUNE EVASION; CRYSTAL-STRUCTURE; CATHEPSIN-G; ELASTASE; MECHANISMS; MYELOPEROXIDASE; RECOGNITION; INHIBITOR; COMPLEX; REVEAL	Members of the EAP family of Staphylococcus aureus immune evasion proteins potently inhibit the neutrophil serine proteases (NSPs) neutrophil elastase, cathepsin-G, and proteinase-3. Previously, we determined a 1.8 ? resolution crystal structure of the EAP family member EapH1 bound to neutrophil elastase. This structure revealed that EapH1 blocks access to the enzyme's active site by forming a noncovalent complex with this host protease. To determine how EapH1 inhibits other NSPs, we studied here the effects of EapH1 on cathepsin-G. We found that EapH1 inhibits cathepsin-G with a K-i of 9.8 ? 4.7 nm. Although this K-i value is ?466-fold weaker than the K-i for EapH1 inhibition of neutrophil elastase, the time dependence of inhibition was maintained. To define the physical basis for EapH1's inhibition of cathepsin-G, we crystallized EapH1 bound to this protease, solved the structure at 1.6 ? resolution, and refined the model to R-work and R-free values of 17.4% and 20.9%, respectively. This structure revealed a protease-binding mode for EapH1 with cathepsin-G that was globally similar to that seen in the previously determined EapH1?neutrophil elastase structure. The nature of the intermolecular interactions formed by EapH1 with cathepsin-G differed considerably from that with neutrophil elastase, however, with far greater contributions from the inhibitor backbone in the cathepsin-G?bound form. Together, these results reveal that EapH1's ability to form high-affinity interactions with multiple NSP targets is due to its remarkable level of local structural plasticity.	[Herdendorf, Timothy J.; Geisbrecht, Brian V.] Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall,1711 Claflin Rd, Manhattan, KS 66506 USA; [Stapels, Daphne A. C.; Rooijakkers, Suzan H. M.] Univ Med Ctr Utrecht, Dept Med Microbiol, NL-3584 CX Utrecht, Netherlands	Kansas State University; Utrecht University; Utrecht University Medical Center	Geisbrecht, BV (corresponding author), Kansas State Univ, Dept Biochem & Mol Biophys, 141 Chalmers Hall,1711 Claflin Rd, Manhattan, KS 66506 USA.	GeisbrechtB@ksu.edu		Stapels, Daphne/0000-0001-7058-541X	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	X-ray diffraction data were collected at Southeast Regional Collaborative Access Team 22-ID Beamline at the Advanced Photon Source, Argonne National Laboratory. A list of supporting institutions will be provided upon request. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract W-31-109-Eng-38.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; de Jong NWM, 2017, P NATL ACAD SCI USA, V114, P9439, DOI 10.1073/pnas.1707032114; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; Fujinaga M, 1996, J MOL BIOL, V261, P267, DOI 10.1006/jmbi.1996.0458; Garcia BL, 2016, J IMMUNOL, V197, P2051, DOI 10.4049/jimmunol.1600863; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Geisbrecht BV, 2005, J BIOL CHEM, V280, P17243, DOI 10.1074/jbc.M412311200; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Herdendorf TJ, 2019, ARCH BIOCHEM BIOPHYS, V676, DOI 10.1016/j.abb.2019.108140; Herdendorf TJ, 2018, BIOCHEMISTRY-US, V57, P6888, DOI 10.1021/acs.biochem.8b01134; Hof P, 1996, EMBO J, V15, P5481, DOI 10.1002/j.1460-2075.1996.tb00933.x; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; JONSSON K, 1995, J BIOL CHEM, V270, P21457, DOI 10.1074/jbc.270.37.21457; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lambris JD, 2008, NAT REV MICROBIOL, V6, P132, DOI 10.1038/nrmicro1824; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lin SJ, 2014, STRUCTURE, V22, P1333, DOI 10.1016/j.str.2014.07.008; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nauseef WM, 2007, IMMUNOL REV, V219, P88, DOI 10.1111/j.1600-065X.2007.00550.x; Nauseef WM, 2014, CELL MICROBIOL, V16, P1146, DOI 10.1111/cmi.12312; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; ODEBERG H, 1976, INFECT IMMUN, V14, P1276; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Spaan AN, 2013, ANNU REV MICROBIOL, V67, P629, DOI 10.1146/annurev-micro-092412-155746; Stapels DAC, 2018, PROTEIN SCI, V27, P509, DOI 10.1002/pro.3342; Stapels DAC, 2015, CURR OPIN MICROBIOL, V23, P42, DOI 10.1016/j.mib.2014.11.002; Stapels DAC, 2014, P NATL ACAD SCI USA, V111, P13187, DOI 10.1073/pnas.1407616111; Thwaites GE, 2011, NAT REV MICROBIOL, V9, P215, DOI 10.1038/nrmicro2508; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wright CD, 1999, BIOCHEM BIOPH RES CO, V254, P614, DOI 10.1006/bbrc.1998.0108	37	3	3	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7753	7762		10.1074/jbc.RA120.013601	http://dx.doi.org/10.1074/jbc.RA120.013601			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32303641	Green Published, hybrid			2022-12-26	WOS:000538038900015
J	Lucini, FA; Morone, F; Tomassone, MS; Makse, HA				Lucini, Francesca Arese; Morone, Flaviano; Tomassone, Maria Silvina; Makse, Hernan A.			Diversity increases the stability of ecosystems	PLOS ONE			English	Article							BIODIVERSITY; NETWORKS; ARCHITECTURE; COMPETITION; MUTUALISM; ECOLOGY; SYSTEM; BIRDS	In 1972, Robert May showed that diversity is detrimental to an ecosystem since, as the number of species increases, the ecosystem is less stable. This is the so-called diversity-stability paradox, which has been derived by considering a mathematical model with linear interactions between the species. Despite being in contradiction with empirical evidence, the diversity-stability paradox has survived the test of time for over 40+ years. In this paper we first show that this paradox is a conclusion driven solely by the linearity of the model employed in its derivation which allows for the neglection of the fixed point solution in the stability analysis. The linear model leads to an ill-posed solution and along with it, its paradoxical stability predictions. We then consider a model ecosystem with nonlinear interactions between species, which leads to a stable ecosystem when the number of species is increased. The saturating non linear term in the species interaction is analogous to a Hill function appearing in systems like gene regulation, neurons, diffusion of information and ecosystems The exact fixed point solution of this model is based on k-core percolation and shows that the paradox disappears. This theoretical result, which is exact and non-perturbative, shows that diversity is beneficial to the ecosystem in agreement with analyzed experimental evidence.	[Lucini, Francesca Arese; Morone, Flaviano; Makse, Hernan A.] CUNY City Coll, Levich Inst, New York, NY 10031 USA; [Lucini, Francesca Arese; Morone, Flaviano; Makse, Hernan A.] CUNY City Coll, Phys Dept, New York, NY 10031 USA; [Tomassone, Maria Silvina] Rutgers State Univ, Dept Chem & Biochem Engn, Piscataway, NJ USA	City University of New York (CUNY) System; City College of New York (CUNY); City University of New York (CUNY) System; City College of New York (CUNY); Rutgers State University New Brunswick	Makse, HA (corresponding author), CUNY City Coll, Levich Inst, New York, NY 10031 USA.; Makse, HA (corresponding author), CUNY City Coll, Phys Dept, New York, NY 10031 USA.	hmakse@lev.ccny.cuny.edu			NSF-IIS [1515022]; NIH-NIBIB [R01EB022720]	NSF-IIS(National Science Foundation (NSF)); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Research was sponsored by NSF-IIS 1515022 and NIH-NIBIB R01EB022720.	Allesina S, 2012, NATURE, V483, P205, DOI 10.1038/nature10832; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bascompte J, 2006, SCIENCE, V312, P431, DOI 10.1126/science.1123412; Bascompte J, 2006, SCIENCE, V313, P1887, DOI 10.1126/science.1129628; Bastolla U, 2009, NATURE, V458, P1018, DOI 10.1038/nature07950; BEEHLER B, 1983, AUK, V100, P1; Biroli G, 2018, NEW J PHYS, V20, DOI 10.1088/1367-2630/aada58; Bunin G, 2017, PHYS REV E, V95, DOI 10.1103/PhysRevE.95.042414; Cleland E, 2018, NATURE ED KNOWLEDGE, V3, P10; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; Elberling H, 1999, ECOGRAPHY, V22, P314, DOI 10.1111/j.1600-0587.1999.tb00507.x; Hector A, 2010, ECOLOGY, V91, P2213, DOI 10.1890/09-1162.1; HOCKING B, 1968, OIKOS, V19, P359, DOI 10.2307/3565022; Holland JN, 2002, AM NAT, V159, P231, DOI 10.1086/338510; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; HURD LE, 1971, SCIENCE, V173, P1134, DOI 10.1126/science.173.4002.1134; INOUYE DW, 1988, AUST J ECOL, V13, P191, DOI 10.1111/j.1442-9993.1988.tb00968.x; Ives AR, 2007, SCIENCE, V317, P58, DOI 10.1126/science.1133258; Kato M, 1990, INSECT FLOWER RELATI; Loreau M, 2013, ECOL LETT, V16, P106, DOI 10.1111/ele.12073; MAY RM, 1972, NATURE, V238, P413, DOI 10.1038/238413a0; MAY RM, 1982, NATURE, V296, P803, DOI 10.1038/296803a0; Morone F, 2019, NAT PHYS, V15, P95, DOI 10.1038/s41567-018-0304-8; MOSQUIN THEODORE, 1967, CAN FIELD NATUR, V81, P201; Olesen JM, 2002, DIVERS DISTRIB, V8, P181, DOI 10.1046/j.1472-4642.2002.00148.x; Pachepsky E, 2002, ARTIF LIFE, V8, P5, DOI 10.1162/106454602753694747; Pfisterer AB, 2002, NATURE, V416, P84, DOI 10.1038/416084a; Proulx R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013382; Roy F, 2019, J PHYS A; SCHEMSKE DW, 1978, ECOLOGY, V59, P351, DOI 10.2307/1936379; SORENSEN AE, 1981, OECOLOGIA, V50, P242, DOI 10.1007/BF00348046; Thebault E, 2010, SCIENCE, V329, P853, DOI 10.1126/science.1188321; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742	33	7	9	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0228692	10.1371/journal.pone.0228692	http://dx.doi.org/10.1371/journal.pone.0228692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330134	Green Published, Green Submitted, gold			2022-12-26	WOS:000536647300006
J	Sow, D; Ndiaye, M; Sarr, L; Kante, MD; Ly, F; Diousse, P; Faye, BT; Gaye, AM; Sokhna, C; Ranque, S; Faye, B				Sow, Doudou; Ndiaye, Maodo; Sarr, Lamine; Kante, Mamadou D.; Ly, Fatoumata; Diousse, Pauline; Faye, Babacar T.; Gaye, Abdou Magip; Sokhna, Cheikh; Ranque, Stephane; Faye, Babacar			Mycetoma epidemiology, diagnosis management, and outcome in three hospital centres in Senegal from 2008 to 2018	PLOS ONE			English	Article							MADURELLA; EUMYCETOMA; UPDATE; AGENTS	Mycetoma is a neglected tropical disease caused by various actinomycetes or fungi. The disease is characterized by the formation of tumor like-swellings and grains. Senegal is an endemic country where mycetoma cases are under-or misdiagnosed due to the lack of capacities and knowledge among health workers and the community; and where the management of eumycetoma, burdened by a high amputation rate, is currently inadequate. This study aimed to update data on the epidemiology of mycetoma cases diagnosed in three hospital centres in Senegal over a 10 years-period. A total of 193 patients, diagnosed from 2008 to 2018, were included in the study. The most frequent presentation was eumycetoma (47.2%); followed by actinomycetoma (36.8%); it remained undetermined in 16.1% of the patients. The mean age was 38.3 years (68.4% of the patients were between 15 and 45 years-old); the male: female ratio was a 2.94; and most were farmers. One hundred fifty-six (80.8%) patients had used phytotherapy before attending the hospital. Mycetoma was mainly located to the lower limbs (91.2%). Grains were observed in 85% of the patients; including white (25.6%) and yellow (4.3%) grains. The etiological diagnosis was complex, resulting in negative direct microscopy, culture and/or histopathology findings, which explains that 16.1% remained uncharacterized. In most of cases, actinomycetoma were treated with a combination of cotrimoxazole, amoxicillin/clavulanic acid, and streptomycin; whereas eumycetoma cases were treated with terbinafine. The surgery was done in 100 (51.8%) of the patients including 9 in actinomycetoma, 78 in eumycetoma and 13 in undetermined form. The high number of uncharacterized mycetoma in this study, the delay in attending a qualified health-care facility, and the lack of available adequate antifungal drug, point out the need to strengthen mycetoma management capacities in Senegal.	[Sow, Doudou] Univ Gasbon Berger St Louis, UFR Sci Sante, Serv Parasitol Mycol, St Louis, Senegal; [Sow, Doudou; Faye, Babacar T.; Faye, Babacar] Univ Cheikh Anta Diop Dakar, Fac Med, Serv Parasitol Mycol, Dakar, Senegal; [Sow, Doudou; Sokhna, Cheikh] Campus Int IRD UCAD IRD, UMR VITROME, Dakar, Senegal; [Ndiaye, Maodo; Kante, Mamadou D.] Hop Aristide Dantec, Serv Dermatol, Dakar, Senegal; [Sarr, Lamine] Hop Aristide Le Dantec, Serv Orthopedie, Dakar, Senegal; [Ly, Fatoumata] Inst Hyg Sociale, Serv Dermatol, Dakar, Senegal; [Diousse, Pauline] Ctr Hosp Reg Thies, Serv Dermatol, Thies, Senegal; [Gaye, Abdou Magip] Hop Aristide Le Dantec, Serv Anat Pathol, Dakar, Senegal; [Ranque, Stephane] Aix Marseille Univ, IHU Mediterranee Infect, VITROME, IRD,APHM,SSA, Marseille, France	University Cheikh Anta Diop Dakar; Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Sow, D (corresponding author), Univ Gasbon Berger St Louis, UFR Sci Sante, Serv Parasitol Mycol, St Louis, Senegal.; Sow, D (corresponding author), Univ Cheikh Anta Diop Dakar, Fac Med, Serv Parasitol Mycol, Dakar, Senegal.; Sow, D (corresponding author), Campus Int IRD UCAD IRD, UMR VITROME, Dakar, Senegal.	doudou.sow@ugb.edu.sn	Ranque, Stéphane/K-2317-2015	Ranque, Stéphane/0000-0003-3293-5276				Adoubryn KD, 2010, J MYCOL MED, V20, P26, DOI 10.1016/j.mycmed.2009.11.007; Adoubryn KD, 2009, J MYCOL MED, V19, P71, DOI 10.1016/j.mycmed.2008.11.004; Ahmed AAO, 2007, CURR OPIN INFECT DIS, V20, P146, DOI 10.1097/QCO.0b013e32803d38fe; Ahmed AOA, 1999, J CLIN MICROBIOL, V37, P3175, DOI 10.1128/JCM.37.10.3175-3178.1999; Ahmed SA, 2014, PERSOONIA, V33, P141, DOI 10.3767/003158514X684744; Bakshi R, 2008, INDIAN J PATHOL MICR, V51, P154; Bonifaz A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003102; Castro LGM, 2008, INT J DERMATOL, V47, P160, DOI 10.1111/j.1365-4632.2008.03447.x; de Hoog GS, 2012, J CLIN MICROBIOL, V50, P988, DOI 10.1128/JCM.05477-11; Develoux M, 2003, Bull Soc Pathol Exot, V96, P376; Dieng MT, 2003, ANN DERMATOL VENER, V130, P16; Dieng MT, 1990, B SOC PATHOL EXOT, V98, P18; Diongue K, 2019, J MYCOL MED, V29, P185, DOI 10.1016/j.mycmed.2019.03.001; ELHASSAN AM, 1972, T ROY SOC TROP MED H, V66, P165, DOI 10.1016/0035-9203(72)90065-X; Estrada R, 2012, CLIN DERMATOL, V30, P389, DOI 10.1016/j.clindermatol.2011.09.009; Ezaldeen EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002400; Fahal AH, 2004, T ROY SOC TROP MED H, V98, P3, DOI 10.1016/S0035-9203(03)00009-9; Fahal AH, 2011, KHARTOUM MED J, Vthird, P565; Fahal A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003679; Fahal A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003587; Fahal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003271; Gismalla MDA, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-018-0129-2; Lopez-Martinez R, 2013, GAC MED MEX, V149, P586; Mathur, 1989, Indian J Pathol Microbiol, V32, P75; Mendes RP, 2000, MED MYCOL, V38, P237, DOI 10.1080/mmy.38.s1.237.241; Mhmoud NA, 2012, J CLIN MICROBIOL, V50, P2987, DOI 10.1128/JCM.01470-12; N'Diaye B, 2006, INT J DERMATOL, V45, P154, DOI 10.1111/j.1365-4632.2004.02392.x; Ndiaye D, 2011, J MYCOL MED, V21, P173, DOI 10.1016/j.mycmed.2011.07.003; Ndiaye M, 2014, J MYCOL MED, V24, P44, DOI 10.1016/j.mycmed.2013.10.002; Sharma NL, 2008, INDIAN J DERMATOL VE, V74, P635, DOI 10.4103/0378-6323.45110; STEINGRUBE VA, 1995, J CLIN MICROBIOL, V33, P3096, DOI 10.1128/JCM.33.12.3096-3101.1995; Suleiman SH, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004690; van de Sande WWJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002667; van de Sande WWJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002550; van de Sande WWJ, 2010, MED MYCOL, V48, P959, DOI 10.3109/13693781003636680; Vera-Cabrera L, 2012, CLIN DERMATOL, V30, P382, DOI 10.1016/j.clindermatol.2011.09.008; VERGHESE A, 1966, INDIAN J MED RES, V54, P524; Welsh O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003218; Zhi XY, 2009, INT J SYST EVOL MICR, V59, P589, DOI 10.1099/ijs.0.65780-0	39	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231871	10.1371/journal.pone.0231871	http://dx.doi.org/10.1371/journal.pone.0231871			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330155	Green Published, gold			2022-12-26	WOS:000536647300026
J	Krebs, EE; Clothier, B; Nugent, S; Jensen, AC; Martinson, BC; Goldsmith, ES; Donaldson, MT; Frank, JW; Rutks, I; Noorbaloochi, S				Krebs, Erin E.; Clothier, Barbara; Nugent, Sean; Jensen, Agnes C.; Martinson, Brian C.; Goldsmith, Elizabeth S.; Donaldson, Melvin T.; Frank, Joseph W.; Rutks, Indulis; Noorbaloochi, Siamak			The evaluating prescription opioid changes in veterans (EPOCH) study: Design, survey response, and baseline characteristics	PLOS ONE			English	Article							CHRONIC NONCANCER PAIN; LONG-TERM USE; UNITED-STATES; OVERDOSE; OUTCOMES; COHORT; RISK; ASSOCIATION; INVENTORY; PATTERNS	In the United States (US), long-term opioid therapy has been commonly prescribed for chronic pain. Since recognition of the opioid overdose epidemic, clinical practice guidelines have recommended tapering long-term opioids to reduced doses or discontinuation. The Effects of Prescription Opioid Changes for veterans (EPOCH) study is a national population-based prospective observational study of US Veterans Health Administration primary care patients designed to assess effects of evolving opioid prescribing practice on patients treated with long-term opioids for chronic pain. A stratified random sampling design was used to identify a survey sample from the target population of patients treated with opioid analgesics for. 6 months. Demographic, diagnostic, visit, and pharmacy dispensing data were extracted from existing datasets. A 2016 mixed-mode mail and telephone survey collected patient-reported data, including the main patient-reported outcomes of pain-related function (Brief Pain Inventory interference; BPI-I scores 0-10, higher scores = worse) and health-related quality of life. Data on survey participants and non-participants were analyzed to assess potential nonresponse bias. Weights were used to account for design. Linear regression models were used to assess cross-sectional associations of opioid treatment with patient-reported measures. Of 14,160 patients contacted, 9253 (65.4%) completed the survey. Participants were older than non-participants (63.9 +/- 10.6 vs. 59.6 +/- 13.0 years). The mean number of bothersome pain locations was 6.8 (SE 0.04). Effectiveness of pain treatment and quality of pain care were rated fair or poor by 56.1% and 45.3%, respectively. The opioid daily dosage range was 1.6 to 1038.2 mg, with mean = 50.6 mg (SE 1.1) and median = 30.9 mg (IQR 40.7). Among the 73.2% of patients who did not receive long-acting opioids, the mean daily dosage was 30.4 mg (SE 0.6) and mean BPI-I was 6.4 (SE 00.4). Among patients who received long-acting opioids, the mean daily dosage was 106.2 mg (SE 2.8) and mean BPI-I was 6.8 (SE 0.07). Higher daily dosage was associated with worse pain-related function and quality of life among patients without long-acting opioids, but not among patients with long-acting opioids. Future analyses will use follow-up data to examine effects of opioid dose reduction and discontinuation on patient outcomes.	[Krebs, Erin E.; Clothier, Barbara; Nugent, Sean; Jensen, Agnes C.; Martinson, Brian C.; Goldsmith, Elizabeth S.; Rutks, Indulis; Noorbaloochi, Siamak] Minneapolis VA Hlth Care Syst, Ctr Care Delivery & Outcomes Res, Minneapolis, MN 55417 USA; [Krebs, Erin E.; Martinson, Brian C.; Noorbaloochi, Siamak] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Martinson, Brian C.] HealthPartners Inst, Bloomington, MN USA; [Goldsmith, Elizabeth S.; Donaldson, Melvin T.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Donaldson, Melvin T.] Univ Minnesota, Sch Med, Med Scientist Training Program, Minneapolis, MN 55455 USA; [Frank, Joseph W.] VA Eastern Colorado Hlth Care Syst, Ctr Innovat Veteran Cent & Value Driven Care, Aurora, CO USA; [Frank, Joseph W.] Univ Colorado, Sch Med, Div Gen Internal Med, Aurora, CO USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; University of Minnesota System; University of Minnesota Twin Cities; HealthPartners Institute for Education & Research; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus	Krebs, EE (corresponding author), Minneapolis VA Hlth Care Syst, Ctr Care Delivery & Outcomes Res, Minneapolis, MN 55417 USA.; Krebs, EE (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.	erin.krebs@va.gov	Martinson, Brian C/AAX-2860-2020; Noorbaloochi, Siamak/ABB-5817-2020	Martinson, Brian C/0000-0002-4255-5595; Krebs, Erin/0000-0003-0843-7410	United States Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development [IIR 14-295, CDA 15059]; National Institutes of Health [F30AT009162]	United States Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was supported by the United States Department of Veterans Affairs, Veterans Health Administration, Health Services Research and Development (IIR 14-295 to EEK and CDA 15059 to JWF) and National Institutes of Health (F30AT009162 to MTD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banta-Green CJ, 2010, CLIN J PAIN, V26, P489, DOI 10.1097/AJP.0b013e3181e103d9; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Busse JW, 2018, JAMA-J AM MED ASSOC, V320, P2448, DOI 10.1001/jama.2018.18472; Campbell G, 2015, PAIN MED, V16, P1745, DOI 10.1111/pme.12773; Campbell G, 2015, PAIN, V156, P231, DOI 10.1097/01.j.pain.0000460303.63948.8e; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Dillman D. A., 2009, INTERNET PHONE MAIL, V3rd; Dowell D, 2016, MMWR RECOMM REP, V65, P1, DOI [10.15585/mmwr.rr6501e1, 10.1001/jama.2016.1464, 10.15585/mmwr.rr7103a1]; Edlund MJ, 2014, PAIN, V155, P2337, DOI 10.1016/j.pain.2014.08.033; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Frank JW, 2016, PAIN MED, V17, P1838, DOI 10.1093/pm/pnw078; Hadlandsmyth K, 2018, J GEN INTERN MED, V33, P818, DOI 10.1007/s11606-017-4283-8; Henry SG, 2019, J PAIN, V20, P181, DOI 10.1016/j.jpain.2018.09.001; Kazis LE, 1998, ARCH INTERN MED, V158, P626, DOI 10.1001/archinte.158.6.626; Keller S, 2004, CLIN J PAIN, V20, P309, DOI 10.1097/00002508-200409000-00005; Kolenikov S., 2016, SURV PRACT, V9, DOI [10.29115/SP-2016-0014, DOI 10.29115/SP-2016-0014]; Kotz S., 2006, STRATIFIED MULTISTAG; Liang YY, 2015, J PAIN, V16, P318, DOI 10.1016/j.jpain.2014.11.007; Lin MF, 2013, INFORM SYST RES, V24, P906, DOI 10.1287/isre.2013.0480; Lumley T, SURVEY ANAL R ANAL C; Malaysia Health Technology Assessment Section, 2017, CLIN PRACT GUID MAN; Matthias MS, 2018, J PAIN, V19, P1082, DOI 10.1016/j.jpain.2018.04.008; Matthias MS, 2017, J PAIN, V18, P1365, DOI 10.1016/j.jpain.2017.06.008; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Mojtabai R, 2018, PHARMACOEPIDEM DR S, V27, P526, DOI 10.1002/pds.4278; Mokdad AH, 2018, JAMA-J AM MED ASSOC, V319, P1444, DOI 10.1001/jama.2018.0158; Morasco BJ, 2017, J PAIN, V18, P437, DOI 10.1016/j.jpain.2016.12.004; National Center for Injury Prevention and Control, 2018, CDC COMP BENZ MUSCL; Paulozzi LJ, 2014, J AM BOARD FAM MED, V27, P329, DOI 10.3122/jabfm.2014.03.130290; Pitcher MH, 2019, J PAIN, V20, P146, DOI 10.1016/j.jpain.2018.07.006; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rogers KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080095; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Sjogren P, 2010, CLIN J PAIN, V26, P763, DOI 10.1097/AJP.0b013e3181f15daf; Sullivan M, 2014, PAIN, V155, P843, DOI 10.1016/j.pain.2014.01.032; Tan G, 2004, J PAIN, V5, P133, DOI 10.1016/j.jpain.2003.12.005; Toblin RL, 2011, PAIN, V152, P1249, DOI 10.1016/j.pain.2010.12.036; Turner JA, 2016, PAIN, V157, P849, DOI 10.1097/j.pain.0000000000000452; Von Korff M, 2016, J PAIN, V17, P1068, DOI 10.1016/j.jpain.2016.06.009; Von Korff M, 2011, PAIN, V152, P1256, DOI 10.1016/j.pain.2011.01.005; Ziliak ST, 2008, CULT STAT SIGNIFICAN	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0230751	10.1371/journal.pone.0230751	http://dx.doi.org/10.1371/journal.pone.0230751			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320421	Green Published, gold			2022-12-26	WOS:000536028800011
J	Markwart, H; Bomba, F; Menrath, I; Brenk-Franz, K; Ernst, G; Thyen, U; Hildebrandt, A; Schmidt, S				Markwart, Henriette; Bomba, Franziska; Menrath, Ingo; Brenk-Franz, Katja; Ernst, Gundula; Thyen, Ute; Hildebrandt, Andrea; Schmidt, Silke			Assessing empowerment as multidimensional outcome of a patient education program for adolescents with chronic conditions: A latent difference score model	PLOS ONE			English	Article							ADULT CARE; PSYCHOLOGICAL EMPOWERMENT; TRANSITIONAL CARE; DISEASE; IMPACT; LIFE	Objectives The current study aims to examine the construct of empowerment in the context of a transition education program. Patient education programs strive to empower adolescents with chronic conditions to take responsibility for their own health care to manage their transition from pediatric to adult medicine. Our study aimed to identify the core components of patient empowerment and examined whether its components are responsive to a patient education program. Methods Data was collected in two longitudinal studies involving N = 723 adolescents with chronic conditions. We used Latent Difference Score models (LDSm) of: 1) self-efficacy (GSE), 2) transition competence (TCS), and 3) patient activation (PAM) to quantify the latent variable of patient empowerment (PE). Additionally, the LDSm were extended to analyze the effects of group affiliation (intervention vs. control) and participants' age on empowerment. Results PE was identifiable by the three components. The intervention group developed significantly higher scores of PE compared to the control group. Age (13-21 years) did not moderate the relation between group affiliation and PE. Conclusions We quantified PE successfully using a psychometric modeling of change. Patient empowerment is measureable and utilizable in the specific context of transition of adolescents with chronic conditions.	[Markwart, Henriette; Schmidt, Silke] Ernst Moritz Arndt Univ Greifswald, Dept Hlth & Prevent, Greifswald, Germany; [Bomba, Franziska; Menrath, Ingo; Brenk-Franz, Katja; Thyen, Ute] Univ Lubeck, Dept Pediat & Adolescent Med, Lubeck, Germany; [Brenk-Franz, Katja] Jena Univ Hosp, Dept Psychosocial Med & Psychotherapy, Jena, Germany; [Ernst, Gundula] Hannover Med Sch, Dept Med Psychol, Hannover, Germany; [Hildebrandt, Andrea] Carl von Ossietzky Univ Oldenburg, Dept Psychol Methods & Stat, Oldenburg, Germany	Ernst Moritz Arndt Universitat Greifswald; University of Lubeck; Friedrich Schiller University of Jena; Hannover Medical School; Carl von Ossietzky Universitat Oldenburg	Markwart, H (corresponding author), Ernst Moritz Arndt Univ Greifswald, Dept Hlth & Prevent, Greifswald, Germany.	henriette.markwart@uni-greifswald.de		Schmidt, Silke/0000-0002-4194-1937; Markwart, Henriette/0000-0002-1775-6053	Federal Ministry of Education and Research (BMBF) [01 GX1005]; Federal Ministry of Health (BMG) [IA5-2512FSB121//314-123006/21]; DFG (German Research Foundation) [393148499]; Open Access Publication Fund of the University of Greifswald	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Federal Ministry of Health (BMG); DFG (German Research Foundation)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Greifswald	The study was funded by the Federal Ministry of Education and Research (BMBF, Grant No. 01 GX1005) and the Federal Ministry of Health (BMG, Grant No. IA5-2512FSB121//314-123006/21). Further, we acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 393148499) and the Open Access Publication Fund of the University of Greifswald.	Aujoulat I, 2007, PATIENT EDUC COUNS, V66, P13, DOI 10.1016/j.pec.2006.09.008; Bal MI, 2016, PATIENT EDUC COUNS, V99, P1293, DOI 10.1016/j.pec.2016.02.012; Berg CA, 2013, HEALTH PSYCHOL, V32, P719, DOI 10.1037/a0029427; Bollen K. A., 1993, TESTING STRUCTURAL E; Bomba F, 2018, RES NURS HEALTH, V41, P78, DOI 10.1002/nur.21831; Bomba F, 2017, HEALTH SOC CARE COMM, V25, P652, DOI 10.1111/hsc.12356; Cattell R. B., 1988, HDB MULTIVARIATE EXP, V2, P561, DOI DOI 10.1007/978-1-4613-0893-5_17; Christens BD, 2012, J YOUTH ADOLESCENCE, V41, P623, DOI 10.1007/s10964-011-9724-9; de Beaufort C, 2010, PEDIATR DIABETES, V11, P24, DOI 10.1111/j.1399-5448.2009.00524.x; de Silva PSA, 2014, INFLAMM BOWEL DIS, V20, P1458, DOI 10.1097/MIB.0000000000000045; Ernst G, 2017, PATIENT EDUC COUNS, P1, DOI [10.1016/j.pec.2016.11.012, DOI 10.1016/J.PEC.2016.11.012]; Fumagalli LP, 2015, HEALTH POLICY, V119, P384, DOI 10.1016/j.healthpol.2014.10.017; Geerlings RPJ, 2016, SEIZURE-EUR J EPILEP, V38, P46, DOI 10.1016/j.seizure.2016.04.004; Gilliam PP, 2011, J ASSOC NURSE AIDS C, V22, P283, DOI 10.1016/j.jana.2010.04.003; Herrmann-Garitz C., 2015, GESUNDHEITSWESEN, V79, P491, DOI DOI 10.1055/S-0035-1549986; Hibbard JH, 2005, HEALTH SERV RES, V40, P1918, DOI 10.1111/j.1475-6773.2005.00438.x; Holden DJ, 2005, HEALTH EDUC BEHAV, V32, P264, DOI 10.1177/1090198104272336; Jaccard J, 1996, LISREL APPROACHES IN; Julian Rappaport, 2000, PSYCHIAT SERV, V52, DOI [10.1176/appi.ps.52.11.1538-a, DOI 10.1176/APPI.PS.52.11.1538-A]; Matsunaga M, 2008, COMMUN METHODS MEAS, V2, P260, DOI 10.1080/19312450802458935; McAllister M, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-157; Menrath I., 2019, J TRANSITION MED, V1, P2018001, DOI [10.1515/jtm-2018-0001, DOI 10.1515/JTM-2018-0001]; Miguel MC, 2015, J COMMUNITY PSYCHOL, V43, P900, DOI 10.1002/jcop.21721; Mora MA, 2020, TRANSITION PEDIAT AD, DOI [10.1007/978-3-030-23384-6, DOI 10.1007/978-3-030-23384-6]; Muthen L. K., 2014, MPLUS USERS GUIDE; Peterson NA, 2014, AM J COMMUN PSYCHOL, V53, P96, DOI 10.1007/s10464-013-9624-0; Schmidt S, 2016, PATIENT EDUC COUNS, V99, P421, DOI 10.1016/j.pec.2015.10.024; Schwarzer R., 1995, MEASURES HLTH PSYCHO, P35, DOI DOI 10.1037/T00393-000; Stam H, 2006, J ADOLESCENT HEALTH, V39, P4, DOI 10.1016/j.jadohealth.2005.03.011; Sullivan-oliveira JO, 2014, TRANSITION PEDIAT PA, V2014, P40; Tomarken AJ, 2005, ANNU REV CLIN PSYCHO, V1, P31, DOI 10.1146/annurev.clinpsy.1.102803.144239; While A, 2004, CHILD CARE HLTH DEV, V30, P439, DOI 10.1111/j.1365-2214.2004.00440.x; Wisk LE, 2015, JAMA PEDIATR, V169, DOI 10.1001/jamapediatrics.2015.0951; Worthington RL, 2006, COUNS PSYCHOL, V34, P806, DOI 10.1177/0011000006288127; Yassaee A, 2019, J ADOLESCENT HEALTH, V64, P709, DOI 10.1016/j.jadohealth.2018.11.023; Zhou HQ, 2016, J CLIN NURS, V25, P3113, DOI 10.1111/jocn.13326; Zimmerman MA, 1995, AM J COMMUN PSYCHOL, V23, P581, DOI 10.1007/BF02506983	37	5	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230659	10.1371/journal.pone.0230659	http://dx.doi.org/10.1371/journal.pone.0230659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315371	Green Published, gold			2022-12-26	WOS:000536024800009
J	Michel, L; Shevlyakova, M; Cleirigh, EN; Eckhardt, E; Holvoet, S; Nutten, S; Sprenger, N; Korner, A; Vogel, M; Nembrini, C; Kiess, W; Blanchard, C				Michel, Loris; Shevlyakova, Maya; Cleirigh, Ellen Ni; Eckhardt, Erik; Holvoet, Sebastien; Nutten, Sophie; Sprenger, Norbert; Koerner, Antje; Vogel, Mandy; Nembrini, Chiara; Kiess, Wieland; Blanchard, Carine			Novel approach to visualize the interdependencies between maternal sensitization, breast milk immune components and human milk oligosaccharides in the LIFE Child cohort	PLOS ONE			English	Article							ALLERGIC DISEASE; FATTY-ACIDS; ASSOCIATION	Background Numerous studies have shown that specific components of breast milk, considered separately, are associated with disease status in the mother or the child using univariate analyses. However, very few studies have considered multivariate analysis approaches to evaluate the relationship between multiple breast milk components simultaneously. Aim Here we aimed at visualizing breast milk component complex interactions in the context of the allergy status of the mother or the child. Methods Milk samples were collected from lactating mothers participating in the Leipziger Forschungszentrum fur Zivilisationskrankheiten (LIFE) Child cohort in Leipzig, Germany. A total of 156 breast milk samples, collected at 3 months after birth from mother/infant pairs, were analyzed for 51 breast milk components. Correlation, principal component analysis (PCA) and graphical discovery analysis were used. Result Correlations ranging from 0.40 to 0.96 were observed between breast milk fatty acid and breast milk phospholipids levels and correlations ranging from 0 to 0.76 between specific human milk oligosaccharides (HMO) were observed. No separation of the data based on the risk of allergy in the infants was identified using PCA. When graphical discovery analysis was used, dependencies between maternal plasma immunoglobulin E (IgE) level and the breast milk immune marker transforming growth factor-beta 2 (TGF-beta 2), between TGF-beta 2, breast milk immunoglobulin A (IgA) and TGF-beta 1 as well as between breast milk total protein and birth weight were observed. Graphical discovery analysis also exemplifies a possible competition for the fucosyl group between 2'FL, LNFP-I and 3'FL in the HMO group. Additionally, dependencies between immune component IgA and specific HMO (6'SL and blood group A antigen tetraose type 5 or PI-HMO) were identified. Conclusion Graphical discovery analysis applied to complex matrices such as breast milk composition can aid in understanding the complexity of interactions between breast milk components and possible relations to health parameters in the mother or the infant. This approach can lead to novel discoveries in the context of health and diseases such as allergy. Our study thus represents the first attempt to visualize the complexity and the inter-dependency of breast milk components.	[Michel, Loris; Shevlyakova, Maya; Eckhardt, Erik; Holvoet, Sebastien; Nutten, Sophie; Sprenger, Norbert; Nembrini, Chiara; Blanchard, Carine] Nestle Res, Lausanne, Switzerland; [Cleirigh, Ellen Ni] Nestle Dev Ctr Nutr, Askeaton, Ireland; [Koerner, Antje; Vogel, Mandy; Kiess, Wieland] Univ Leipzig, LIFE Leipzig Res Ctr Civilizat Dis, Fac Med, Leipzig, Germany	Nestle SA; Leipzig University	Blanchard, C (corresponding author), Nestle Res, Lausanne, Switzerland.	Carine.Blanchard@rdls.nestle.com	Körner, Antje/B-3988-2015	Körner, Antje/0000-0001-6001-0356; Vogel, Mandy/0000-0003-2051-1249; Eckhardt, Erik/0000-0002-3015-5180	LIFE -Leipzig Research Centre for Civilization Diseases, Universitat Leipzig; European Union; European Regional Development Fund (ERDF); Free State of Saxony; Societe des Produits Nestle S.A.; Societe' des Produits Nestle' S.A.	LIFE -Leipzig Research Centre for Civilization Diseases, Universitat Leipzig; European Union(European Commission); European Regional Development Fund (ERDF)(European Commission); Free State of Saxony; Societe des Produits Nestle S.A.; Societe' des Produits Nestle' S.A.	This work is supported by LIFE -Leipzig Research Centre for Civilization Diseases, Universitat Leipzig. LIFE is funded through the European Union, by the European Regional Development Fund (ERDF) and by the Free State of Saxony within the framework of the excellence initiative. In addition, this work was supported by the Societe des Produits Nestle S.A. The Societe ' des Produits Nestle ' S.A. provided support in the form of salaries for authors MS, ENC, EE, SH, SN, NS, CN, and CB. The specific roles of these authors are articulated in the `author contributions' section. The funders had a role in study statistical design, data collection, analysis, decision to publish, and preparation of the manuscript.	Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; Austin S, 2018, ANAL CHIM ACTA, V1010, P86, DOI 10.1016/j.aca.2017.12.036; Azad MB, 2018, J NUTR, V148, P1733, DOI 10.1093/jn/nxy175; Ballard O, 2013, PEDIATR CLIN N AM, V60, P49, DOI 10.1016/j.pcl.2012.10.002; Carter A H, 1898, Br Med J, V1, P199; Cruz-Hernandez C, 2013, J CHROMATOGR A, V1284, P174, DOI 10.1016/j.chroma.2013.01.094; Fleischer DM, 2013, J ALLER CL IMM-PRACT, V1, P29, DOI 10.1016/j.jaip.2012.09.003; Ismail IH, 2013, PEDIAT ALLERG IMM-UK, V24, P352, DOI 10.1111/pai.12075; Joseph CLM, 2014, PEDIAT ALLERG IMM-UK, V25, P257, DOI 10.1111/pai.12205; Khaleva E, 2019, CLIN EXP ALLERGY, V49, P1201, DOI 10.1111/cea.13409; Kramer MS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000133.pub3; Logan CA, 2017, ALLERGY, V72, P1374, DOI 10.1111/all.13161; Martins TB, 2014, J ALLERGY CLIN IMMUN, V133, P589, DOI 10.1016/j.jaci.2013.08.037; Miliku K, 2018, ALLERGY, V73, P2070, DOI 10.1111/all.13476; Moore MM, 2004, PEDIATRICS, V113, P468, DOI 10.1542/peds.113.3.468; Morita Y, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00162; Munblit D, 2015, CLIN EXP ALLERGY, V45, P583, DOI 10.1111/cea.12381; Munro B. H., 2005, STAT METHODS HLTH CA, DOI DOI 10.1093/annonc/mdx645; Poulain T, 2017, EUR J EPIDEMIOL, V32, P145, DOI 10.1007/s10654-016-0216-9; Quante M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1021; Rajani PS, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00218; RCore Team, 2020, R LANG ENV STAT COMP; Saadeh M Randa, 2003, Forum Nutr, V56, P236; Salvador AM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071659; Seppo AE, 2017, J ALLERGY CLIN IMMUN, V139, P708, DOI 10.1016/j.jaci.2016.08.031; Sprenger N, 2017, EUR J NUTR, V56, P1293, DOI 10.1007/s00394-016-1180-6; Thakkar SK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010112; Waidyatillake NT, 2018, ALLERGY, V73, P295, DOI 10.1111/all.13300; Worcester A, 1900, BOSTON MED SURG J, V143, P361, DOI 10.1056/NEJM190010111431502; Zou H., J AM STAT ASS, V101, P1418	30	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230472	10.1371/journal.pone.0230472	http://dx.doi.org/10.1371/journal.pone.0230472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315306	Green Published, gold			2022-12-26	WOS:000536024800006
J	Rao, A; Joseph, T; Saipradeep, VG; Kotte, S; Sivadasan, N; Srinivasan, R				Rao, Aditya; Joseph, Thomas; Saipradeep, Vangala G.; Kotte, Sujatha; Sivadasan, Naveen; Srinivasan, Rajgopal			PRIORI-T: A tool for rare disease gene prioritization using MEDLINE	PLOS ONE			English	Article							IDENTIFICATION	Introduction Phenotype-driven rare disease gene prioritization relies on high quality curated resources containing disease, gene and phenotype annotations. However, the effectiveness of gene prioritization tools is constrained by the incomplete coverage of rare disease, phenotype and gene annotations in such curated resources. Methods We extracted rare disease correlation pairs involving diseases, phenotypes and genes from MEDLINE abstracts and used the information propagation algorithm GCAS to build an association network. We built a tool called PRIORI-T for rare disease gene prioritization that uses this network for phenotype-driven rare disease gene prioritization. The quality of disease-gene associations in PRIORI-T was compared with resources such as DisGeNET and Open Targets in the context of rare diseases. The gene prioritization performance of PRIORI-T was evaluated using phenotype descriptions of 230 real-world rare disease clinical cases collated from recent publications, as well as compared to other gene prioritization tools such as HANRD and Orphamizer. Results PRIORI-T contains qualitatively better associations than DisGeNET and Open Targets. Furthermore, the causal genes were captured within Top-50 for more than 40% of the realworld clinical cases and within Top-300 for more than 72% of the cases when PRIORI-T was used for gene prioritization. It outperformed other gene prioritization tools such as HANRD and Orphamizer that primarily rely on curated resources. Conclusions PRIORI-T exhibited improved gene prioritization performance without requiring high quality curated data. Thus, it holds great promise in phenotype-driven gene prioritization for rare disease studies.	[Rao, Aditya; Joseph, Thomas; Saipradeep, Vangala G.; Kotte, Sujatha; Sivadasan, Naveen; Srinivasan, Rajgopal] Tata Consultancy Serv Ltd, TCS Res & Innovat, Hyderabad, India	Tata Sons; Tata Consultancy Services Limited (TCS)	Rao, A (corresponding author), Tata Consultancy Serv Ltd, TCS Res & Innovat, Hyderabad, India.	adityar.rao@tcs.com		Joseph, Thomas/0000-0001-7808-0301	Tata Consultancy Services Ltd.	Tata Consultancy Services Ltd.	The funder Tata Consultancy Services Ltd. provided support in the form of salaries for all the authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 1997, ORPH ONL RAT DIS ORP; Bone WP, 2016, GENET MED, V18, P608, DOI 10.1038/gim.2015.137; Bravo A, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0472-9; Dragusin R, 2013, RARE DIS, V1, DOI 10.4161/rdis.25001; ElShal S, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv905; Fujiwara T, 2018, AM J HUM GENET, V103, P389, DOI 10.1016/j.ajhg.2018.08.003; Gray KA, 2015, NUCLEIC ACIDS RES, V43, pD1079, DOI 10.1093/nar/gku1071; Griffon N, 2016, BMC MED INFORM DECIS, V16, DOI 10.1186/s12911-016-0333-0; Hammond DK, 2011, APPL COMPUT HARMON A, V30, P129, DOI 10.1016/j.acha.2010.04.005; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Howe D, 2008, NATURE, V455, P47, DOI 10.1038/455047a; Joseph T, 2012, BIOINFORMATION, V8, P578, DOI 10.6026/97320630008578; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kohler S, 2009, AM J HUM GENET, V85, P457, DOI 10.1016/j.ajhg.2009.09.003; Koscielny G, 2017, NUCLEIC ACIDS RES, V45, pD985, DOI 10.1093/nar/gkw1055; Lee H, 2014, JAMA-J AM MED ASSOC, V312, P1880, DOI 10.1001/jama.2014.14604; MCKUSICK VA, 2000, ONLINE MENDELIAN INH; Ramoni RB, 2017, AM J HUM GENET, V100, P185, DOI 10.1016/j.ajhg.2017.01.006; Rao A, 2017, C P BIOCURATION; Rao A, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0372-8; Smedley D, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0199-2; Stavropoulos DJ, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.12; Stelzer G., 2016, BMC GENOMICS, V17, P195; Svenstrup D, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1083145; Zhiheng Huang, ABS150801991 CORR	25	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231728	10.1371/journal.pone.0231728	http://dx.doi.org/10.1371/journal.pone.0231728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315351	Green Published, gold, Green Submitted			2022-12-26	WOS:000536024800052
J	Claus, J; Brietzke, A; Lehnert, C; Oschatz, S; Grabow, N; Kragl, U				Claus, Johanna; Brietzke, Andreas; Lehnert, Celina; Oschatz, Stefan; Grabow, Niels; Kragl, Udo			Swelling characteristics and biocompatibility of ionic liquid based hydrogels for biomedical applications	PLOS ONE			English	Article							NANOPARTICLES; DEGRADATION	Polymers are commonly used in medical device manufacturing, e.g. for drug delivery systems, bone substitutes and stent coatings. Especially hydrogels exhibit very promising properties in this field. Hence, the development of new hydrogel systems for customized application is of great interest, especially regarding the swelling behavior and mechanical properties as well as the biocompatibility. The aim of this work was the preparation and investigation of various polyelectrolyte and poly-ionic liquid based hydrogels accessible by radical polymerization. The obtained polymers were covalently crosslinked with N,N'-methylenebisacrylamide (MBAA) or different lengths of poly(ethyleneglycol)diacrylate (PEGDA). The effect of different crosslinker-to-monomer ratios has been examined. In addition to the compression curves and the maximum degree of swelling, the biocompatibility with L929 mouse fibroblasts of these materials was determined in direct cell seeding experiments and the outcome for the different hydrogels was compared.	[Claus, Johanna; Lehnert, Celina; Kragl, Udo] Univ Rostock, Dept Chem Ind & Appl Chem, Rostock, Germany; [Claus, Johanna; Lehnert, Celina; Grabow, Niels; Kragl, Udo] Univ Rostock, Dept Life Light & Matter, Rostock, Germany; [Brietzke, Andreas; Oschatz, Stefan; Grabow, Niels] Rostock Univ, Med Ctr, Inst Biomed Engn, Rostock, Germany	University of Rostock; University of Rostock; University of Rostock	Kragl, U (corresponding author), Univ Rostock, Dept Chem Ind & Appl Chem, Rostock, Germany.; Kragl, U (corresponding author), Univ Rostock, Dept Life Light & Matter, Rostock, Germany.	udo.kragl@uni-rostock.de	Kragl, Udo/A-3691-2015	Kragl, Udo/0000-0002-2507-7472; Meyer, Johanna/0000-0003-2557-4425; Oschatz, Stefan Thomas/0000-0003-2339-456X	Deutsche Forschungsgemeinschaft; University of Rostock; Federal Ministry of Education and Research within RESPONSE "Partnership for Innovation in Implant Technology" [FKZ 03ZZ0910B]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Rostock; Federal Ministry of Education and Research within RESPONSE "Partnership for Innovation in Implant Technology"	We acknowledge financial support by Deutsche Forschungsgemeinschaft and University of Rostock within the funding programme Open Access Publishing. Funding by the Federal Ministry of Education and Research within RESPONSE "Partnership for Innovation in Implant Technology" (FKZ 03ZZ0910B) is gratefully acknowledged.	ALTANKOV G, 1994, J MATER SCI-MATER M, V5, P732, DOI 10.1007/BF00120366; Amer LD, 2019, ACTA BIOMATER, V100, P105, DOI 10.1016/j.actbio.2019.09.043; Bandomir J, 2014, MACROMOL CHEM PHYS, V215, P716, DOI 10.1002/macp.201400009; Behl G, 2016, PHARM RES-DORDR, V33, P1638, DOI 10.1007/s11095-016-1903-7; de Queiroz AAB, 2018, KNEE SURG SPORT TR A, V26, P2934, DOI 10.1007/s00167-018-4834-5; Bingol B, 2019, ACS APPL POLYM MATER, V1, P1724, DOI 10.1021/acsapm.9b00287; BONGRAND P, 1982, PROG SURF SCI, V12, P217, DOI 10.1016/0079-6816(82)90007-7; Brietzke A, 2017, CURR DIR BIOMED ENG, V3, P695, DOI [10.1515/cdbme-2017-0147, DOI 10.1515/CDBME-2017-0147]; Calvert P, 2009, ADV MATER, V21, P743, DOI 10.1002/adma.200800534; Chang S, 2000, J MED BIOL ENG, V20, P6; Chen YF, 2001, RADIAT PHYS CHEM, V61, P65; Claus J, 2018, SOLID STATE IONICS, V314, P119, DOI 10.1016/j.ssi.2017.11.012; Colter J, 2018, ANN BIOMED ENG, V46, P211, DOI 10.1007/s10439-017-1962-x; Cui ZW, 2011, J BIOMED MATER RES A, V98A, P159, DOI 10.1002/jbm.a.33093; Darwis D, 2002, RADIAT PHYS CHEM, V63, P539, DOI 10.1016/S0969-806X(01)00636-3; de Feng X, 1988, MAKROMOL CHEM, V189, P77; Deguchi Y, 2015, CHEM COMMUN, V51, P9287, DOI 10.1039/c5cc02189h; Fairbanks BD, 2014, BIOMACROMOLECULES, V15, P3259, DOI 10.1021/bm500654q; Highley CB, 2016, CURR OPIN BIOTECH, V40, P35, DOI 10.1016/j.copbio.2016.02.008; Hu XY, 2014, CARBOHYD POLYM, V105, P135, DOI 10.1016/j.carbpol.2014.01.051; Jamadi M, 2017, MACROMOL BIOSCI, V17, DOI 10.1002/mabi.201600479; Kamaly N, 2016, CHEM REV, V116, P2602, DOI 10.1021/acs.chemrev.5b00346; Kaufman JD, 2008, J MATER RES, V23, P1472, DOI 10.1557/JMR.2008.0185; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; Lu JM, 2009, PROG POLYM SCI, V34, P431, DOI 10.1016/j.progpolymsci.2008.12.001; Ma ZW, 2010, BIOMACROMOLECULES, V11, P1873, DOI 10.1021/bm1004299; Marcilla R, 2004, J POLYM SCI POL CHEM, V42, P208, DOI 10.1002/pola.11015; Mazzoli Robert A, 2004, Curr Opin Ophthalmol, V15, P426, DOI 10.1097/01.icu.0000138618.61059.4c; Moghadam MN, 2016, J BIOMED MATER RES B, V104, P1161, DOI 10.1002/jbm.b.33469; Motta A, 2004, J BIOMAT SCI-POLYM E, V15, P851, DOI 10.1163/1568562041271075; Mrksich M, 2000, CHEM SOC REV, V29, P267, DOI 10.1039/a705397e; Okafuji A, 2016, MACROMOL RAPID COMM, V37, P1130, DOI 10.1002/marc.201500752; Okay O, 2009, SPRINGER SER CHEM SE, V6, P1, DOI 10.1007/978-3-540-75645-3_1; Rayahin JE, 2017, RESULTS PROBL CELL D, V62, P317, DOI 10.1007/978-3-319-54090-0_13; Sigler M, 2005, Z KARDIOL, V94, P383, DOI 10.1007/s00392-005-0231-4; Smit TJ, 1991, ORBIT, V10, P63, DOI [10.3109/01676839109023086, DOI 10.3109/01676839109023086]; Strachota B, 2015, SOFT MATTER, V11, P9291, DOI 10.1039/c5sm01996f; Su E, 2019, MACROMOLECULES, V52, P3257, DOI 10.1021/acs.macromol.9b00032; Sun HF, 2015, J COLLOID INTERF SCI, V450, P353, DOI 10.1016/j.jcis.2015.03.037; Taksali Sudeep, 2004, Spine J, V4, p231S, DOI 10.1016/j.spinee.2004.07.012; TANAKA T, 1973, J CHEM PHYS, V59, P5151, DOI 10.1063/1.1680734; Tognetto D, 2005, EXPERT REV MED DEVIC, V2, P57, DOI 10.1586/17434440.2.1.57; Trindade R, 2016, CLIN IMPLANT DENT R, V18, P192, DOI 10.1111/cid.12274; Trindade R, 2015, ORAL MAXIL SURG CLIN, V27, P175, DOI 10.1016/j.coms.2015.01.004; Tummala GK, 2019, J FUNCT BIOMATER, V10, DOI 10.3390/jfb10030035; Verma AS, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-47	46	18	18	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231421	10.1371/journal.pone.0231421	http://dx.doi.org/10.1371/journal.pone.0231421			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310981	Green Published, gold			2022-12-26	WOS:000536019800015
J	Higazi, M; Abdeen, S; Abu-Fanne, R; Heyman, SN; Masarwy, A; Bdeir, K; Maraga, E; Cines, DB; Higazi, A				Higazi, Mohamed; Abdeen, Suhair; Abu-Fanne, Rami; Heyman, Samuel N.; Masarwy, Aseel; Bdeir, Khalil; Maraga, Emad; Cines, Douglas B.; Higazi, Abd Al-Roof			Opposing effects of HNP1 (alpha-defensin-1) on plasma cholesterol and atherogenesis	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; HUMAN NEUTROPHIL PEPTIDE-1; ALPHA-DEFENSINS; ATHEROSCLEROSIS; APOLIPOPROTEIN; INFLAMMATION; PROMOTES; BINDING; LDL	Atherosclerosis, the predominant cause of death in well-resourced countries, may develop in the presence of plasma lipid levels within the normal range. Inflammation may contribute to lesion development in these individuals, but the underlying mechanisms are not well understood. Transgenic mice expressing alpha-def-1 released from activated neutrophils develop larger lipid and macrophage-rich lesions in the proximal aortae notwithstanding hypocholesterolemia caused by accelerated clearance of alpha-def-1/low-density lipoprotein (LDL) complexes from the plasma. The phenotype does not develop when the release of alpha-def-1 is prevented with colchicine. However, ApoE(-/-) mice crossed with alpha-def-1 mice or given exogenous alpha-def-1 develop smaller aortic lesions associated with reduced plasma cholesterol, suggesting a protective effect of accelerated LDL clearance. Experiments were performed to address this seeming paradox and to determine if alpha-def-1 might provide a means to lower cholesterol and thereby attenuate atherogenesis. We confirmed that exposing ApoE(-/-) mice to alpha-def-1 lowers total plasma cholesterol and decreases lesion size. However, lesion size was larger than in mice with total plasma cholesterol lowered to the same extent by inhibiting its adsorption or by ingesting a low-fat diet. Furthermore, alpha-def-1 levels correlated independently with lesion size in ApoE(-/-) mice. These studies show that alpha-def-1 has competing effects on atherogenesis. Although alpha-def-1 accelerates LDL clearance from plasma, it also stimulates deposition and retention of LDL in the vasculature, which may contribute to development of atherosclerosis in individuals with normal or even low plasma levels of cholesterol. Inhibiting alpha-def-1 may attenuate the impact of chronic inflammation on atherosclerotic vascular disease.	[Higazi, Mohamed; Abdeen, Suhair; Abu-Fanne, Rami; Masarwy, Aseel; Maraga, Emad; Higazi, Abd Al-Roof] Hadassah Hebrew Univ, Dept Clin Biochem, Jerusalem, Israel; [Heyman, Samuel N.] Hadassah Univ Hosp, Dept Med, Jerusalem, Israel; [Bdeir, Khalil; Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Pathol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Bdeir, Khalil; Cines, Douglas B.; Higazi, Abd Al-Roof] Univ Penn, Dept Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA	Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Higazi, A (corresponding author), Hadassah Hebrew Univ, Dept Clin Biochem, Jerusalem, Israel.; Higazi, A (corresponding author), Univ Penn, Dept Pathol, Perelman Sch Med, Philadelphia, PA 19104 USA.; Higazi, A (corresponding author), Univ Penn, Dept Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.	abdh@ekmd.huji.ac.il		Abd Al-Roof, Higazi/0000-0002-2247-0121	Israeli Science Foundation;  [HL123912];  [HL139448]	Israeli Science Foundation(Israel Science Foundation); ; 	This work was supported by HL123912 (AAH), HL139448 (DBC) and a grant from the Israeli Science Foundation (AAH).	Abu-Fanne R, 2016, J BIOL CHEM, V291, P2777, DOI 10.1074/jbc.M115.669812; Barnathan ES, 1997, AM J PATHOL, V150, P1009; Bdeir K, 1999, BLOOD, V94, P2007; Chen Y, 2015, BBA-MOL CELL RES, V1853, P396, DOI 10.1016/j.bbamcr.2014.11.012; Christensen HM, 2012, EUR J HEART FAIL, V14, P387, DOI 10.1093/eurjhf/hfs021; Demidowich AP, 2019, J CLIN LIPIDOL, V13, P1016, DOI 10.1016/j.jacl.2019.10.011; Fanne Rami Abu, 2011, J Neurosurg, V114, P85, DOI 10.3171/2010.4.JNS10263; Higazi AA, 2000, BLOOD, V96, P1393; Higazi AAR, 1997, BLOOD, V89, P4290, DOI 10.1182/blood.V89.12.4290; Karatasakis A, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006910; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Masuda Y, 2016, J PHARMACOL SCI, V132, P271, DOI 10.1016/j.jphs.2016.11.001; Nassar H, 2007, ATHEROSCLEROSIS, V194, P452, DOI 10.1016/j.atherosclerosis.2006.08.046; Nassar T, 2002, BLOOD, V100, P4026, DOI 10.1182/blood-2002-04-1080; Paulin N, 2017, EBIOMEDICINE, V16, P204, DOI 10.1016/j.ebiom.2017.01.006; Quinn KL, 2011, ARTERIOSCL THROM VAS, V31, P2070, DOI 10.1161/ATVBAHA.111.227116; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Tardif JC, 2019, NEW ENGL J MED, V381, P2497, DOI 10.1056/NEJMoa1912388; Urbonaviciene G, 2012, INT J CARDIOL, V160, P89, DOI 10.1016/j.ijcard.2011.03.030; Zhao HJ, 2012, J ATHEROSCLER THROMB, V19, P357, DOI 10.5551/jat.10108	22	7	7	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231582	10.1371/journal.pone.0231582	http://dx.doi.org/10.1371/journal.pone.0231582			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302327	Green Published, gold			2022-12-26	WOS:000536016100036
J	Talal, AH; Ding, YX; Venuto, CS; Chakan, LM; McLeod, A; Dharia, A; Morse, GD; Brown, LS; Markatou, M; Kharasch, ED				Talal, Andrew H.; Ding, Yuxin; Venuto, Charles S.; Chakan, Lindsay M.; McLeod, Anthony; Dharia, Arpan; Morse, Gene D.; Brown, Lawrence S.; Markatou, Marianthi; Kharasch, Evan D.			Toward precision prescribing for methadone: Determinants of methadone deposition	PLOS ONE			English	Article							CONTROLLED ATTENUATION PARAMETER; HEPATITIS-C VIRUS; GENETIC POLYMORPHISMS; CYTOCHROME P4502B6; STEREOSELECTIVE METABOLISM; N-DEMETHYLATION; PLASMA-LEVELS; CYP2B6; PHARMACOKINETICS; STEATOSIS	Background Despite the World Health Organization listing methadone as an essential medication, effective dose selection is challenging, especially in racial and ethnic minority populations. Subtherapeutic doses can result in withdrawal symptoms while supratherapeutic doses can result in overdose and death. Although CYP3A4 was conventionally considered the principal methadone metabolizing enzyme, more recent data have identified CYP2B6 as the principal enzyme. CYP2B6 has ethnically-associated polymorphisms that affect the metabolic rate. Our objective was to investigate the effects of genetic and nongenetic factors on methadone metabolism. Methods We measured trough plasma methadone levels in 100 participants with opioid use disorder. We assessed methadone metabolism by calculating the metabolite ratio (major metabolite: 2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine [EDDP] divided by methadone concentration). We assessed hepatic fibrosis and steatosis by transient elastography and CYP2B6 alleles, principally responsible for methadone metabolism. Mixed effects models modeled the data in 97 participants. Results Participants were largely male (58%), minority (61% African American) and non-Hispanic (68%). Forty percent were HCV mono-infected, 40% were uninfected, and 20% were HCV/HIV co-infected. Female sex had significant effects on (R)- and (S)-methadone metabolism (p = 0.016 and p = 0.044, respectively). CYP2B6 loss of function (LOF) alleles significantly affected (S)-methadone metabolism (p = 0.012). Body mass index (BMI) significantly affected (R)-methadone metabolism (p = 0.034). Methadone metabolism appeared to be lower in males, in individuals with LOF alleles, and elevated BMI. Conclusions Genetic analysis, especially in minority populations, is essential to delivering individualized treatments. Although the principal methadone metabolizing enzyme remains controversial, our results suggest that sex, CYP2B6 genotype, and BMI should be incorporated into multivariate models to create methadone dosing algorithms. Methadone dosing algorithms should facilitate medication delivery, improve patient satisfaction, and diminish overdose potential.	[Talal, Andrew H.; Chakan, Lindsay M.; Dharia, Arpan] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Gastroenterol Hepatol & Nutr, Buffalo, NY USA; [Ding, Yuxin; Markatou, Marianthi] SUNY Buffalo, Sch Publ Hlth & Hlth Profess, Dept Biostat, Buffalo, NY USA; [Venuto, Charles S.] Univ Rochester, Dept Neurol, Rochester, NY USA; [McLeod, Anthony; Brown, Lawrence S.] START Treatment & Recovery Ctr, Brooklyn, NY USA; [Morse, Gene D.] SUNY Buffalo, NYS Ctr Excellence Bioinformat & Life Sci, Buffalo, NY USA; [Kharasch, Evan D.] Duke Univ, Sch Med, Dept Anesthesiol, Durham, NC USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Duke University	Talal, AH (corresponding author), SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Div Gastroenterol Hepatol & Nutr, Buffalo, NY USA.	ahtalal@buffalo.edu		Venuto, Charles/0000-0002-2394-9513	University of Rochester Center for AIDS Research [4P30AI078498-09]; National Institute of Allergies and Infectious Diseases [K23 AI108355]; National Institute of Drug Abuse [DA14211, DA42985]; Kaleida Health Foundation Troup Fund	University of Rochester Center for AIDS Research; National Institute of Allergies and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Kaleida Health Foundation Troup Fund	This study was supported by the University of Rochester Center for AIDS Research (https://www.urmc.rochester.edu/center-for-aids-research.aspx) (4P30AI078498-09) to CSV and AHT; the National Institute of Allergies and Infectious Diseases (https://www.niaid.nih.gov/) (K23 AI108355) to CSV; the National Institute of Drug Abuse (https://www.drugabuse.gov/) (DA14211 and DA42985) to EDK; and the Kaleida Health Foundation Troup Fund (https://foundation.kaleidahealth.org/) to AHT. We also acknowledge Echosens (Paris, France https://www.echosens.com/en/) for providing FibroScan (R) for assessment of hepatic steatosis and fibrosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderks CE., 2013, TRENDS USE METHADONE, P1; [Anonymous], 2015, J HEPATOL, V63, P237, DOI 10.1016/j.jhep.2015.04.006; Baxter LE, 2013, J ADDICT MED, V7, P377, DOI 10.1097/01.ADM.0000435321.39251.d7; Bonder Alan, 2014, Curr Gastroenterol Rep, V16, P372, DOI 10.1007/s11894-014-0372-6; Bruce RD, 2010, JAIDS-J ACQ IMM DEF, V54, P511, DOI 10.1097/QAI.0b013e3181d3cad3; Chang Y, 2011, BASIC CLIN PHARMACOL, V108, P55, DOI 10.1111/j.1742-7843.2010.00628.x; Chou R, 2014, J PAIN, V15, P321, DOI 10.1016/j.jpain.2014.01.494; Clarke SM, 2001, BRIT J CLIN PHARMACO, V51, P213, DOI 10.1046/j.1365-2125.2001.00342.x; Crettol S, 2005, CLIN PHARMACOL THER, V78, P593, DOI 10.1016/j.clpt.2005.08.011; Crettol S, 2006, CLIN PHARMACOL THER, V80, P668, DOI 10.1016/j.clpt.2006.09.012; CURETON EE, 1956, PSYCHOMETRIKA, V21, P287, DOI 10.1007/BF02289138; Dennis BB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086114; Desta Z, 2019, CLIN PHARMACOL THER, V106, P726, DOI 10.1002/cpt.1477; DEVOS JW, 1995, EUR J CLIN PHARMACOL, V48, P361, DOI 10.1007/BF00194951; Dole V P, 1966, Trans Assoc Am Physicians, V79, P122; DOLE VP, 1965, J AMER MED ASSOC, V193, P646, DOI 10.1001/jama.1965.03090080008002; El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013; Fabrellas N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200656; Faucette SR, 2004, DRUG METAB DISPOS, V32, P348, DOI 10.1124/dmd.32.3.348; Ferrari A, 2004, PHARMACOL RES, V50, P551, DOI 10.1016/j.phrs.2004.05.002; Fonseca F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019527; Foster DJR, 2000, BRIT J CLIN PHARMACO, V50, P427, DOI 10.1046/j.1365-2125.2000.00272.x; Gadel S, 2015, DRUG METAB DISPOS, V43, P994, DOI 10.1124/dmd.115.064352; Gadel S, 2013, DRUG METAB DISPOS, V41, P709, DOI 10.1124/dmd.112.050625; Gerber JG, 2004, CHIRALITY, V16, P36, DOI 10.1002/chir.10303; Gibbons JD, 2011, NONPARAMETRIC STAT I, V1, P977, DOI 10.1007/978-3-642-04898-2_420; GLASS GV, 1966, EDUC PSYCHOL MEAS, V26, P623, DOI 10.1177/001316446602600307; Gorman AL, 1997, NEUROSCI LETT, V223, P5; Guan S, 2006, EUR J PHARM SCI, V29, P14, DOI 10.1016/j.ejps.2006.04.004; Huber P. H., 1981, ROBUST STAT; Kanda T, 2019, INT J MOL SCI, P20; Karlas T, 2017, J HEPATOL, V66, P1022, DOI 10.1016/j.jhep.2016.12.022; Kharasch ED, 2012, CLIN PHARMACOL THER, V91, P673, DOI 10.1038/clpt.2011.276; Kharasch ED, 2019, J CLIN PHARMACOL, V59, P1044, DOI 10.1002/jcph.1427; Kharasch ED, 2015, ANESTHESIOLOGY, V123, P1142, DOI 10.1097/ALN.0000000000000867; Kharasch ED, 2013, J CLIN PHARMACOL, V53, P305, DOI 10.1002/jcph.1; Kharasch ED, 2009, DRUG ALCOHOL DEPEN, V101, P158, DOI 10.1016/j.drugalcdep.2008.12.009; Kirchheiner J, 2003, PHARMACOGENETICS, V13, P619, DOI 10.1097/00008571-200310000-00005; Kljucevic Z, 2018, CROAT MED J, V59, P298, DOI 10.3325/cmj.2018.59.298; KRISTENSEN K, 1994, LIFE SCI, V56, pPL45; Kumar M, 2013, J GASTROEN HEPATOL, V28, P1194, DOI 10.1111/jgh.12134; Levran O, 2013, ADDICT BIOL, V18, P709, DOI 10.1111/j.1369-1600.2011.00349.x; Li J, 2012, PHARMACOGENOMICS, V13, P555, DOI [10.2217/PGS.11.160, 10.2217/pgs.11.160]; Lin BH, 2019, ANN INTERN MED, V170, P796, DOI 10.7326/M18-2357; Lonardo A, 2004, GASTROENTEROLOGY, V126, P586, DOI 10.1053/j.gastro.2003.11.020; Mohr R, 2018, MEDICINE, V97, DOI [10.1097/MD.0000000000010462, 10.1097/md.0000000000010462]; MOOLCHAN ET, 1994, INT J ADDICT, V29, P135, DOI 10.3109/10826089409047374; Mouly S, 2015, BRIT J CLIN PHARMACO, V79, P967, DOI 10.1111/bcp.12576; National Academies of Sciences Engineering and Medicine, 2017, PAIN MAN OP EP BAL S; Noureddin M, 2018, WORLD J GASTROENTERO, V24, P1269, DOI 10.3748/wjg.v24.i11.1269; Preston KL, 2003, J ANAL TOXICOL, V27, P332, DOI 10.1093/jat/27.6.332; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Schlienz NJ, 2018, INT REV PSYCHIATR, V30, P147, DOI 10.1080/09540261.2018.1509843; Song AX, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00212; Talal AH, 2017, CLIN PHARM DRUG DEV, V6, P206, DOI 10.1002/cpdd.336; Totah RA, 2008, ANESTHESIOLOGY, V108, P363, DOI 10.1097/ALN.0b013e3181642938; Turpeinen Miia, 2012, Drug Metabolism and Drug Interactions, V27, P185, DOI 10.1515/dmdi-2012-0027; US Food and Drug Administration, 2018, DOLOPHINE METH HYDR; Wang J, 2006, PHARMACOGENET GENOM, V16, P191; Wang SC, 2011, J CLIN PSYCHOPHARM, V31, P463, DOI 10.1097/JCP.0b013e318222b5dd; Wang YE, 2015, INT J CLIN EXP MED, V8, P17654; Wesson DR, 2003, J PSYCHOACTIVE DRUGS, V35, P253, DOI 10.1080/02791072.2003.10400007; Wojcik GL, 2019, NATURE, V570, P514, DOI 10.1038/s41586-019-1310-4; Wu SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069310; Younis IR, 2019, J CLIN PHARMACOL, V59, P1035, DOI 10.1002/jcph.1405; Zanger Ulrich M., 2013, Frontiers in Genetics, V4, P24, DOI 10.3389/fgene.2013.00024; Zhou Y, 2017, CLIN PHARMACOL THER, V102, P688, DOI 10.1002/cpt.690; Zibbell JE, 2018, AM J PUBLIC HEALTH, V108, P175, DOI 10.2105/AJPH.2017.304132	68	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231467	10.1371/journal.pone.0231467	http://dx.doi.org/10.1371/journal.pone.0231467			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9LH	32302325	gold, Green Published			2022-12-26	WOS:000536016100030
J	McIntyre, MH; Kless, A; Hein, P; Field, M; Tung, JY				McIntyre, Matthew H.; Kless, Achim; Hein, Peter; Field, Mark; Tung, Joyce Y.		23andMe Res Team	Validity of the cold pressor test and pain sensitivity questionnaire via online self-administration	PLOS ONE			English	Article							VALIDATION; ADAPTATION; DEPRESSION; VERSION; MODELS	To determine the feasibility of complex home-based phenotyping, 1,876 research participants from the customer base of 23 and Me completed an online version of a Pain Sensitivity Questionnaire (PSQ) as well as a cold pressor test (CPT) which is used in clinical assessments of pain. Overall our online version of the PSQ performed similarly to the original pen-and-paper version. Construct validity of the PSQ total was demonstrated by internal consistency and consistent discrimination between more and less painful items. Criterion validity was demonstrated by correlation with pain sensitivity as measured by the CPT. Within the same cohort we performed a cold pressor test using a layperson description and household equipment. Comparison with published reports from controlled studies revealed similar distributions of cold pain tolerance times (i.e., time elapsed before removing the hand from the water). Of those who elected to participate in the CPT, a large majority of participants did not report issues with the test procedure or noncompliance with the instructions (97%). We confirmed a large sex difference in CPT thresholds in line with published data, such that women removed their hands from the water at a median of 54.2 seconds, with men lasting for a median time of 82.7 seconds (Kruskal-Wallis statistic, p < 0.0001), but other factors like age or current pain treatment were at most weakly associated, and inconsistently between men and women. We introduce a new paradigm for performing pain testing, called testing@ home, that, in the case of cold nociception, showed comparable results to studies conducted under controlled conditions and supervision of a health care professional.	[McIntyre, Matthew H.; Tung, Joyce Y.; 23andMe Res Team] 23andMe Inc, Mountain View, CA USA; [Kless, Achim; Hein, Peter; Field, Mark] Grunenthal GmbH, Grunenthal Innovat, Aachen, Germany	Grunenthal Group	Tung, JY (corresponding author), 23andMe Inc, Mountain View, CA USA.; Kless, A (corresponding author), Grunenthal GmbH, Grunenthal Innovat, Aachen, Germany.	Kless@gmx.net; Joyce@23andme.com	Kless, Achim/B-8341-2014; Field, Mark/AAD-6455-2021	Kless, Achim/0000-0001-8301-5934; field, mark/0000-0003-0391-5452; Hein, Peter/0000-0002-5899-3979				Coghill RC, 2003, P NATL ACAD SCI USA, V100, P8538, DOI 10.1073/pnas.1430684100; Coronado RA, 2018, MUSCULOSKEL SCI PRAC, V36, P61, DOI 10.1016/j.msksp.2018.04.009; Duale C, 2019, CAN J ANESTH, V66, P1202, DOI 10.1007/s12630-019-01377-w; Edwards RR, 2016, PAIN, V157, P1851, DOI 10.1097/j.pain.0000000000000602; Felt JM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00863; Fillingim Roger B, 2005, Curr Rheumatol Rep, V7, P342, DOI 10.1007/s11926-005-0018-7; Grundstrom H, 2019, EUR J PAIN, V23, P1631, DOI 10.1002/ejp.1439; Hermesdorf M, 2016, J PAIN, V17, P606, DOI 10.1016/j.jpain.2016.01.474; Hines EA, 1932, P STAFF M MAYO CLIN, P332; Ji QB, 2019, ANN RHEUM DIS, V78, P100, DOI 10.1136/annrheumdis-2017-212863; Johansen A, 2014, PAIN, V155, P341, DOI 10.1016/j.pain.2013.10.013; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Krebs EE, 2007, J GEN INTERN MED, V22, P1453, DOI 10.1007/s11606-007-0321-2; Latka D, 2019, J PAIN RES, V12, P969, DOI 10.2147/JPR.S189427; Mayer TG, 2012, PAIN PRACT, V12, P276, DOI 10.1111/j.1533-2500.2011.00493.x; Melotti R, 2018, J PAIN, V19, P1424, DOI 10.1016/j.jpain.2018.06.007; Meng WH, 2020, EUR J HUM GENET, V28, P358, DOI 10.1038/s41431-019-0530-2; Mitchell LA, 2004, J PAIN, V5, P233, DOI 10.1016/j.jpain.2004.03.004; Modir JG, 2010, METHODS MOL BIOL, V617, P165, DOI 10.1007/978-1-60327-323-7_13; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Perry BG, 2016, EXP PHYSIOL, V101, P135, DOI 10.1113/EP085449; Pud D, 2004, EUR J PAIN, V8, P31, DOI 10.1016/S1090-3801(03)00065-X; Pud D, 2009, NEUROSCI LETT, V467, P237, DOI 10.1016/j.neulet.2009.10.048; Quan XL, 2018, PAIN PRACT, V18, P180, DOI 10.1111/papr.12587; Robinson PN, 2015, CSH MOL CASE STUD, V1, DOI 10.1101/mcs.a000372; Ruscheweyh R, 2012, PAIN, V153, P1210, DOI 10.1016/j.pain.2012.02.025; Ruscheweyh R, 2009, PAIN, V146, P65, DOI 10.1016/j.pain.2009.06.020; Sellers AB, 2013, REGION ANESTH PAIN M, V38, P508, DOI 10.1097/AAP.0000000000000007; Staahl C, 2009, BRIT J CLIN PHARMACO, V68, P149, DOI 10.1111/j.1365-2125.2009.03456.x; Treister R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197844; Treister R, 2017, J PAIN RES, V10, P319, DOI 10.2147/JPR.S121455; Treister R, 2015, J PAIN, V16, P537, DOI 10.1016/j.jpain.2015.03.001; Treister R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063808; Tung JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023473; Valeberg BT, 2017, J PAIN RES, V10, P1137, DOI 10.2147/JPR.S129540; Visscher PM, 2017, AM J HUM GENET, V101, P5, DOI 10.1016/j.ajhg.2017.06.005; von Baeyer CL, 2005, J PAIN, V6, P218, DOI 10.1016/j.jpain.2005.01.349	37	5	5	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231697	10.1371/journal.pone.0231697	http://dx.doi.org/10.1371/journal.pone.0231697			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298348	Green Published, Green Submitted, gold			2022-12-26	WOS:000536011400090
J	Montegut, L; Martinez-Basilio, PC; Moreira, JD; Schwartz, L; Jolicoeur, M				Montegut, Lea; Martinez-Basilio, Pablo Cesar; Moreira, Jorgelindo da Veiga; Schwartz, Laurent; Jolicoeur, Mario			Combining lipoic acid to methylene blue reduces the Warburg effect in CHO cells: From TCA cycle activation to enhancing monoclonal antibody production	PLOS ONE			English	Article							LACTATE METABOLISM SHIFT; HAMSTER OVARY CELLS; DICHLOROACETATE DCA; OXIDATIVE STRESS; CULTURE; CANCER; GLUCOSE; EXPRESSION; REDUCTION; COPPER	The Warburg effect, a hallmark of cancer, has recently been identified as a metabolic limitation of Chinese Hamster Ovary (CHO) cells, the primary platform for the production of monoclonal antibodies (mAb). Metabolic engineering approaches, including genetic modifications and feeding strategies, have been attempted to impose the metabolic prevalence of respiration over aerobic glycolysis. Their main objective lies in decreasing lactate production while improving energy efficiency. Although yielding promising increases in productivity, such strategies require long development phases and alter entangled metabolic pathways which singular roles remain unclear. We propose to apply drugs used for the metabolic therapy of cancer to target the Warburg effect at different levels, on CHO cells. The use of alpha-lipoic acid, a pyruvate dehydrogenase activator, replenished the Krebs cycle through increased anaplerosis but resulted in mitochondrial saturation. The electron shuttle function of a second drug, methylene blue, enhanced the mitochondrial capacity. It pulled on anaplerotic pathways while reducing stress signals and resulted in a 24% increase of the maximum mAb production. Finally, the combination of both drugs proved to be promising for stimulating Krebs cycle activity and mitochondrial respiration. Therefore, drugs used in metabolic therapy are valuable candidates to understand and improve the metabolic limitations of CHO-based bioproduction.	[Montegut, Lea; Martinez-Basilio, Pablo Cesar; Moreira, Jorgelindo da Veiga; Jolicoeur, Mario] Ecole Polytech Montreal, Dept Chem Engn, Res Lab Appl Metab Engn, Montreal, PQ, Canada; [Schwartz, Laurent] AP HP, Paris, France	Universite de Montreal; Polytechnique Montreal; Assistance Publique Hopitaux Paris (APHP)	Jolicoeur, M (corresponding author), Ecole Polytech Montreal, Dept Chem Engn, Res Lab Appl Metab Engn, Montreal, PQ, Canada.	mario.jolicoeur@polymtl.ca		da Veiga Moreira, Jorgelindo/0000-0002-8020-9562	NSERC [RGPIN-2019-05050]	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	MJ received the NSERC (https://www.nserc-crsng.gc.ca/) Discovery Grant #RGPIN-2019-05050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn WS, 2011, METAB ENG, V13, P598, DOI 10.1016/j.ymben.2011.07.002; Altamirano C, 2000, BIOTECHNOL PROGR, V16, P69, DOI 10.1021/bp990124j; Atamna H, 2008, FASEB J, V22, P703, DOI 10.1096/fj.07-9610com; Barron E S, 1930, J Exp Med, V52, P447, DOI 10.1084/jem.52.3.447; Bingham PM, 2014, EXPERT REV CLIN PHAR, V7, P837, DOI 10.1586/17512433.2014.966816; Brookes PS, 2005, FREE RADICAL BIO MED, V38, P12, DOI 10.1016/j.freeradbiomed.2004.10.016; Buchsteiner M, 2018, BIOTECHNOL BIOENG, V115, P2315, DOI 10.1002/bit.26724; Chong WPK, 2010, J BIOTECHNOL, V147, P116, DOI 10.1016/j.jbiotec.2010.03.018; Deshmukh A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0555-x; Duicu DM, 2017, CAN J PHYSIOL PHARM, V95, P1376, DOI 10.1139/cjpp-2017-0074; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Fan Y, 2015, BIOTECHNOL BIOENG, V112, P521, DOI 10.1002/bit.25450; Fogolin MB, 2004, J BIOTECHNOL, V109, P179, DOI 10.1016/j.jbiotec.2003.10.035; Gagnon M, 2011, BIOTECHNOL BIOENG, V108, P1328, DOI 10.1002/bit.23072; Ghorbaniaghdam A, 2014, J THEOR BIOL, V357, P112, DOI 10.1016/j.jtbi.2014.04.035; GLACKEN MW, 1986, BIOTECHNOL BIOENG, V28, P1376, DOI 10.1002/bit.260280912; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gupta SK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181455; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartley F, 2018, BIOTECHNOL BIOENG, V115, P1890, DOI 10.1002/bit.26603; HAYTER PM, 1993, BIOTECHNOL BIOENG, V42, P1077, DOI 10.1002/bit.260420909; Ishida S, 2013, P NATL ACAD SCI USA, V110, P19507, DOI 10.1073/pnas.1318431110; Kafara P, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0165-z; Kelley B, 2009, MABS-AUSTIN, V1, P443, DOI 10.4161/mabs.1.5.9448; Kim DY, 2013, BIOTECHNOL PROGR, V29, P165, DOI 10.1002/btpr.1658; Kim SH, 2007, APPL MICROBIOL BIOT, V74, P152, DOI 10.1007/s00253-006-0654-5; Kleinkauf-Rocha J, 2013, INT J DEV NEUROSCI, V31, P165, DOI 10.1016/j.ijdevneu.2012.12.006; Korotchkina LG, 2004, FREE RADICAL RES, V38, P1083, DOI 10.1080/10715760400004168; Kuwae S, 2005, J BIOSCI BIOENG, V99, P264, DOI 10.1263/jbb.99.264; Lamboursain L, 2002, BIOTECHNOL PROGR, V18, P1377, DOI 10.1021/bp015511j; Le H, 2013, METAB ENG, V20, P212, DOI 10.1016/j.ymben.2013.09.004; Luo J, 2012, BIOTECHNOL BIOENG, V109, P2306, DOI 10.1002/bit.24510; Luo J, 2012, BIOTECHNOL BIOENG, V109, P146, DOI 10.1002/bit.23291; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; Michelakis ED, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000677; Moreira JD, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39109-1; Niewisch MR, 2012, CELL PHYSIOL BIOCHEM, V29, P373, DOI 10.1159/000338492; Oz M, 2011, MED RES REV, V31, P93, DOI 10.1002/med.20177; Popp O, 2016, BIOTECHNOL BIOENG, V113, P2005, DOI 10.1002/bit.25958; Poteet E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048279; Qian YM, 2011, BIOTECHNOL PROGR, V27, P1190, DOI 10.1002/btpr.630; Robitaille J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136815; Rochette L, 2013, MOL NUTR FOOD RES, V57, P114, DOI 10.1002/mnfr.201200608; Schwartz L, 2014, ANTICANCER RES, V34, P973; Schwartz L, 2010, ONCOL REP, V23, P1407, DOI 10.3892/or_00000778; Solmonson A, 2018, J BIOL CHEM, V293, P7522, DOI 10.1074/jbc.TM117.000259; Stolfa G, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700227; Toussaint C, 2016, J BIOTECHNOL, V217, P122, DOI 10.1016/j.jbiotec.2015.11.010; Villacres C, 2015, BIOTECHNOL J, V10, P1051, DOI 10.1002/biot.201400662; Walsh G, 2018, NAT BIOTECHNOL, V36, P1136, DOI 10.1038/nbt.4305; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wen Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.208447; Wilkens CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119053; Wlaschin KF, 2007, J BIOTECHNOL, V131, P168, DOI 10.1016/j.jbiotec.2007.06.006; Yang SH, 2017, PROG NEUROBIOL, V157, P273, DOI 10.1016/j.pneurobio.2015.10.005; Young JD, 2013, CURR OPIN BIOTECH, V24, P1108, DOI 10.1016/j.copbio.2013.04.016; Yuk IH, 2015, BIOTECHNOL PROGR, V31, P226, DOI 10.1002/btpr.2004; Zagari F, 2013, NEW BIOTECHNOL, V30, P238, DOI 10.1016/j.nbt.2012.05.021; Zielke HR, 1984, FEDERATION P	59	4	5	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231770	10.1371/journal.pone.0231770	http://dx.doi.org/10.1371/journal.pone.0231770			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298377	gold, Green Published			2022-12-26	WOS:000536011400108
J	Wang, C; Dang, YL; Shah, P; Esfandiari, H; Hong, Y; Loewen, RT; Waxman, S; Atta, S; Xia, XB; Loewen, NA				Wang, Chao; Dang, Yalong; Shah, Priyal; Esfandiari, Hamed; Hong, Ying; Loewen, Ralitsa T.; Waxman, Susannah; Atta, Sarah; Xia, Xiaobo; Loewen, Nils A.			Intraocular pressure reduction in a pigmentary glaucoma model by Goniotome Ab interno trabeculectomy	PLOS ONE			English	Article							SELECTIVE LASER TRABECULOPLASTY; DISPERSION SYNDROME; OUTFLOW TRACT; GENETIC-MODIFICATION; ANTERIOR SEGMENTS; AQUEOUS OUTFLOW; BYPASS STENTS; LONG-TERM; EXPRESSION; PERFUSION	Purpose To investigate whether microsurgical excision of trabecular meshwork (TM) in an ex vivo pigmentary glaucoma model can normalize the hypertensive phenotype. Methods Eight eyes of a porcine pigmentary glaucoma model underwent 90 degrees of microsurgical TM excision with an aspirating dual-blade (Goniotome (G)). 24 hours later, additional 90 degrees of TM were removed. Anterior segments with sham surgeries served as the control (C). Outflow facility and intraocular pressure (IOP) were analyzed. Histology with hematoxylin and eosin (H&E) was obtained. Results After the first 90 degrees TM excision, IOP was significantly lower in G (10.2 +/- 2.4 mmHg, n = 7) than C (20.0 +/- 2.0mmHg, n = 8, P<0.01). Outflow facility in G (0.38 +/- 0.07 mu l/min/mmHg) was higher than C (0.16 +/- 0.02 mu l/min/mmHg, P<0.01). After the second 90 degrees TM excision, IOP in G (6.46 +/- 0.81 mmHg, n = 7) was significantly lower than C (20.3 +/- 1.7 mmHg, n = 8, P<0.001), while the outflow facility in G (0.50 +/- 0.05 mu l/min/mmHg, n = 7) was higher than C (0.16 +/- 0.01 mu l/min/mmHg, n = 8, P<0.001). Compared to the first excision, excision of an additional 90 degrees did not change of IOP (P = 0.20) or outflow facility (P = 0.17) further. Conclusions Excision of 90 degrees of TM in a pigmentary glaucoma model using an aspirating dual-blade decreased IOP and increased outflow facility.	[Wang, Chao; Loewen, Ralitsa T.; Loewen, Nils A.] Univ Wurzburg, Dept Ophthalmol, Wurzburg, Germany; [Wang, Chao; Xia, Xiaobo] Cent South Univ, Xiangya Hosp, Dept Ophthalmol, Changsha, Hunan, Peoples R China; [Wang, Chao; Dang, Yalong; Shah, Priyal; Esfandiari, Hamed; Hong, Ying; Loewen, Ralitsa T.; Waxman, Susannah; Atta, Sarah] Univ Pittsburgh, Med Ctr, Dept Ophthalmol, Pittsburgh, PA USA; [Hong, Ying] Peking Univ, Dept Ophthalmol, Hosp 3, Beijing, Peoples R China	University of Wurzburg; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Peking University	Loewen, NA (corresponding author), Univ Wurzburg, Dept Ophthalmol, Wurzburg, Germany.	loewen.nils@gmail.com		Waxman, Susannah/0000-0001-6708-3187	NIH [K08-EY022737]; NIH CORE Grant [P30 EY08098]; Initiative to Cure Glaucoma of the Eye and Ear Foundation of Pittsburgh; Wiegand Fellowship; Research to Prevent Blindness, New York, NY; Third Xiangya Hospital of Central South University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CORE Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Initiative to Cure Glaucoma of the Eye and Ear Foundation of Pittsburgh; Wiegand Fellowship; Research to Prevent Blindness, New York, NY(Research to Prevent Blindness (RPB)); Third Xiangya Hospital of Central South University	This work was supported by NIH grant K08-EY022737 (NAL), NIH CORE Grant P30 EY08098 to the Department of Ophthalmology, the Initiative to Cure Glaucoma of the Eye and Ear Foundation of Pittsburgh (NAL), the Wiegand Fellowship (YD), an unrestricted grant from Research to Prevent Blindness, New York, NY and an unrestricted fellowship grant from the Third Xiangya Hospital of Central South University (CW)	ALVARADO JA, 1992, ARCH OPHTHALMOL-CHIC, V110, P1769, DOI 10.1001/archopht.1992.01080240109042; Andersen JS, 1997, ARCH OPHTHALMOL-CHIC, V115, P384, DOI 10.1001/archopht.1997.01100150386012; Bussel II, 2015, BRIT J OPHTHALMOL, V99, P258, DOI 10.1136/bjophthalmol-2013-304717; Damji KF, 2006, BRIT J OPHTHALMOL, V90, P1490, DOI 10.1136/bjo.2006.098855; Dang Y, 2016, EXP EYE RES; Dang Y, 2018, F1000RES, V7, P174, DOI DOI 10.12688/f1000research.13797.1; Dang Yalong, 2016, F1000Res, V5, P762, DOI 10.12688/f1000research.8448.2; Dang YL, 2018, GRAEF ARCH CLIN EXP, V256, P1305, DOI 10.1007/s00417-018-3990-0; Dang YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23861-x; Dang YL, 2017, PEERJ, V5, DOI 10.7717/peerj.3629; Dang YL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01815-z; Dang YL, 2016, CLIN EXP OPHTHALMOL, V44, P783, DOI 10.1111/ceo.12796; De Moraes CG, 2016, PEARLS GLAUCOMA MANA, P419; Duker JS, 2013, OPHTHALMOLOGY EXPERT, P1133; EPSTEIN DL, 1986, INVEST OPHTH VIS SCI, V27, P387; Fallano Katherine, 2017, F1000Res, V6, P67, DOI 10.12688/f1000research.10236.1; Fautsch MP, 2006, INVEST OPHTH VIS SCI, V47, P213, DOI 10.1167/iovs.05-0334; Gottanka JY, 2006, J GLAUCOMA, V15, P142, DOI 10.1097/00061198-200604000-00011; Harasymowycz PJ, 2005, AM J OPHTHALMOL, V139, P1110, DOI 10.1016/j.ajo.2004.11.038; Hunter KS, 2014, CLIN OPHTHALMOL, V8, P499, DOI 10.2147/OPTH.S56245; Jacobi PC, 2000, OPHTHALMOLOGY, V107, P417, DOI 10.1016/S0161-6420(99)00091-3; Kaplowitz K, 2016, BRIT J OPHTHALMOL, V100, P594, DOI 10.1136/bjophthalmol-2015-307131; Kaplowitz K, 2015, ESSENT OPHTHALMOL, P15, DOI 10.1007/978-3-319-18060-1_3; Kaplowitz K, 2014, BRIT J OPHTHALMOL, V98, P579, DOI 10.1136/bjophthalmol-2013-304256; Khaja HA, 2008, INVEST OPHTH VIS SCI, V49, P4191; Khare PD, 2008, MOL THER, V16, P97, DOI 10.1038/sj.mt.6300318; Koucheki B, 2012, J GLAUCOMA, V21, P65, DOI 10.1097/IJG.0b013e3182027596; LEHTO I, 1992, OPHTHALMIC SURG LAS, V23, P614; Loewen N, 2004, INVEST OPHTH VIS SCI, V45, P3091, DOI 10.1167/iovs.04-0366; Loewen N, 2002, INVEST OPHTH VIS SCI, V43, P3686; Loewen N, 2001, HUM GENE THER, V12, P2109, DOI 10.1089/10430340152677449; Loewen RT, 2016, INVEST OPHTH VIS SCI, V57, P2831, DOI 10.1167/iovs.16-19541; Loewen RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151926; Loewen RT, 2016, INVEST OPHTH VIS SCI, V57, P1338, DOI 10.1167/iovs.15-18125; Loewen RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151754; McDonnell F, 2018, AM J PHYSIOL-CELL PH, V315, pC44, DOI 10.1152/ajpcell.00024.2018; Neiweem AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153585; Ngai P, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005383; Niyadurupola N, 2008, CLIN EXP OPHTHALMOL, V36, P868, DOI 10.1111/j.1442-9071.2009.01920.x; Oatts JT, 2013, INVEST OPHTH VIS SCI, V54, P5416, DOI 10.1167/iovs.13-11853; Parikh HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep34705; Parikh HA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149384; RITCH R, 1993, AM J OPHTHALMOL, V115, P707, DOI 10.1016/S0002-9394(14)73635-9; Ritch R, 1993, J Glaucoma, V2, P44; Roy P, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0421-7; Siddiqui Y, 2003, AM J OPHTHALMOL, V135, P794, DOI 10.1016/S0002-9394(02)02289-4; SUGAR HS, 1966, AM J OPHTHALMOL, V62, P499; Tamm ER, 2009, EXP EYE RES, V88, P618, DOI 10.1016/j.exer.2009.02.012; Ting JLM, 2012, J CATARACT REFR SURG, V38, P315, DOI 10.1016/j.jcrs.2011.08.043; Dang T, 2018, VIETNAM SERIES, P1; Wang C., 2018, GLOBAL ENERGY INTERC, P1; Wang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177238; Waxman S, 2018, INVEST OPHTH VIS SCI, V59, P4886, DOI 10.1167/iovs.18-24943; Zhang Z, 2014, INVEST OPHTH VIS SCI, V55, P935, DOI 10.1167/iovs.13-12890	54	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231360	10.1371/journal.pone.0231360	http://dx.doi.org/10.1371/journal.pone.0231360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298335	Green Published, Green Submitted, gold			2022-12-26	WOS:000536011400038
J	Bosman, SH; Schwing, PT; Larson, RA; Wildermann, NE; Brooks, GR; Romero, IC; Sanchez-Cabeza, JA; Ruiz-Fernandez, AC; Machain-Castillo, ML; Gracia, A; Escobar-Briones, E; Murawski, SA; Hollander, DJ; Chanton, JP				Bosman, Samantha H.; Schwing, Patrick T.; Larson, Rebekka A.; Wildermann, Natalie E.; Brooks, Gregg R.; Romero, Isabel C.; Sanchez-Cabeza, Joan-Albert; Carolina Ruiz-Fernandez, Ana; Luisa Machain-Castillo, Maria; Gracia, Adolfo; Escobar-Briones, Elva; Murawski, Steven A.; Hollander, David J.; Chanton, Jeffrey P.			The southern Gulf of Mexico: A baseline radiocarbon isoscape of surface sediments and isotopic excursions at depth	PLOS ONE			English	Article							STABLE CARBON; GROWTH-RATE; OIL-SPILL; IXTOC-I; FISH POPULATIONS; ORGANIC-MATTER; FOSSIL CARBON; FRACTIONATION; PB-210; C-13	The southern Gulf of Mexico (sGoM) is home to an extensive oil recovery and development infrastructure. In addition, the basin harbors sites of submarine hydrocarbon seepage and receives terrestrial inputs from bordering rivers. We used stable carbon, nitrogen, and radiocarbon analyses of bulk sediment organic matter to define the current baseline isoscapes of surface sediments in the sGoM and determined which factors might influence them. These baseline surface isoscapes will be useful for accessing future environmental impacts. We also examined the region for influence of hydrocarbon deposition in the sedimentary record that might be associated with hydrocarbon recovery, spillage and seepage, as was found in the northern Gulf of Mexico (nGoM) following the Deepwater Horizon (DWH) oil spill in 2010. In 1979, the sGoM experienced a major oil spill, Ixtoc 1. Surface sediment delta C-13 values ranged from -22.4% to -19.9%, while Delta C-14 values ranged from -337.1% to -69.2%. Sediment delta N-15 values ranged from 2.8% to 7.2%, while the %C on a carbonate-free basis ranged in value of 0.65% to 3.89% and %N ranged in value of 0.09% to 0.49%. Spatial trends for delta C-13 and Delta C-14 were driven by water depth and distance from the coastline, while spatial trends for delta N-15 were driven by location (latitude and longitude). Location and distance from the coastline were significantly correlated with %C and %N. At depth in two of twenty (10%) core profiles, we found negative delta C-13 and Delta C-14 excursions from baseline values in bulk sedimentary organic material, consistent with either oil-residue deposition or terrestrial inputs, but likely the latter. We then used Pb-210 dating on those two profiles to determine the time in which the excursion-containing horizons were deposited. Despite the large spill in 1979, no evidence of hydrocarbon residue remained in the sediments from this specific time period.	[Bosman, Samantha H.; Wildermann, Natalie E.; Chanton, Jeffrey P.] Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA; [Schwing, Patrick T.; Romero, Isabel C.; Murawski, Steven A.; Hollander, David J.] Univ S Florida, Coll Marine Sci, St Petersburg, FL USA; [Schwing, Patrick T.; Larson, Rebekka A.; Brooks, Gregg R.] Eckerd Coll, St Petersburg, FL 33733 USA; [Sanchez-Cabeza, Joan-Albert; Carolina Ruiz-Fernandez, Ana; Luisa Machain-Castillo, Maria; Gracia, Adolfo; Escobar-Briones, Elva] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Ciudad De Mexico, Mexico	State University System of Florida; Florida State University; State University System of Florida; University of South Florida; Universidad Nacional Autonoma de Mexico	Bosman, SH; Chanton, JP (corresponding author), Florida State Univ, Dept Earth Ocean & Atmospher Sci, Tallahassee, FL 32306 USA.	sbosman@fsu.edu; jchanton@fsu.edu	Ruiz-Fernández, Ana Carolina/ABG-6985-2020; Sanchez-Cabeza, Joan-Albert/Q-2394-2016	Ruiz-Fernández, Ana Carolina/0000-0002-2515-1249; Sanchez-Cabeza, Joan-Albert/0000-0002-3540-1168; Bosman, Samantha/0000-0003-1697-4080; Escobar Briones, Elva/0000-0002-8485-7495; Romero, Isabel C./0000-0002-8590-5989	Gulf of Mexico Research Initiative/C-IMAGE II [SA 12-10]; Gulf of Mexico Research Initiative/C-IMAGE III [SA 12-10]	Gulf of Mexico Research Initiative/C-IMAGE II; Gulf of Mexico Research Initiative/C-IMAGE III	This research was made possible by a grant from The Gulf of Mexico Research Initiative/C-IMAGE II and C-IMAGE III, No. SA 12-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeppli C, 2012, ENVIRON SCI TECHNOL, V46, P8799, DOI 10.1021/es3015138; Ainsworth C, 2020, DEEP OIL SPILLS FACT, P374; Appleby P.C., 2002, TRACKING ENV CHANGE, P171, DOI [DOI 10.1007/0-306-47669-X_9, 10.1007/0-306-47669-X_9]; APPLEBY PG, 1983, HYDROBIOLOGIA, V103, P29, DOI 10.1007/BF00028424; Arana HAH, 2005, MAR ECOL PROG SER, V289, P89; Arreguin-Sanchez F, 2004, ECOL MODEL, V172, P421, DOI 10.1016/j.ecolmodel.2003.09.016; Baelum J, 2012, ENVIRON MICROBIOL, V14, P2405, DOI 10.1111/j.1462-2920.2012.02780.x; Bagby SC, 2017, P NATL ACAD SCI USA, V114, pE9, DOI 10.1073/pnas.1610110114; Baskaran M, 2014, J ENVIRON RADIOACTIV, V138, P355, DOI 10.1016/j.jenvrad.2014.07.006; Bidigare RR, 1997, GLOBAL BIOGEOCHEM CY, V11, P279, DOI 10.1029/96GB03939; Binford, 1990, J PALEOLIMNOL, V3, P253, DOI DOI 10.1007/BF00219461; BOEHM PD, 1982, ENVIRON SCI TECHNOL, V16, P67, DOI 10.1021/es00096a003; Bosman SH, 2018, OIL SPILL ENV FORENS, P639; Brooks GR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132341; Burkhardt S, 1999, MAR ECOL PROG SER, V184, P31, DOI 10.3354/meps184031; Chanton J., 1997, DRAFT REPORT ACF ACT; Chanton JP, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/4/045303; Chanton J, 2015, ENVIRON SCI TECHNOL, V49, P847, DOI 10.1021/es5046524; Chanton JP, 2018, ELEMENTA-SCI ANTHROP, V6, DOI 10.1525/elementa.298; Cherrier J, 2014, ENVIRON SCI TECH LET, V1, P108, DOI 10.1021/ez400149c; CIFUENTES LA, 1988, LIMNOL OCEANOGR, V33, P1102, DOI 10.4319/lo.1988.33.5.1102; Crespo-Medina M, 2014, NAT GEOSCI, V7, P423, DOI [10.1038/ngeo2156, 10.1038/NGEO2156]; Daly KL, 2016, ANTHROPOCENE, V13, P18, DOI 10.1016/j.ancene.2016.01.006; Dubinsky EA, 2013, ENVIRON SCI TECHNOL, V47, P10860, DOI 10.1021/es401676y; Ellwood BB, 2006, MAR GEOL, V230, P237, DOI 10.1016/j.margeo.2006.05.008; Escobar-Briones Elva, 2009, Bol. Soc. Geol. Mex, V61, P73; Gundlach ER, 1981, IXTOC I OIL SPILL FE, P41; Harper A, 2018, ESTUAR COAST, V41, P1486, DOI 10.1007/s12237-017-0355-6; Hazen TC, 2010, SCIENCE, V330, P204, DOI 10.1126/science.1195979; Holguin-Quinones N., 2005, B ASOC MEX GEOL PET, V52, P20; Jernelov A, 2010, AMBIO, V39, P353, DOI 10.1007/s13280-010-0085-5; JERNELOV A, 1981, AMBIO, V10, P299; Kessler JD, 2011, SCIENCE, V331, P312, DOI 10.1126/science.1199697; Kinner N. E., 2014, EOS, V95, P176; Larson R.A., 2020, DEEP OIL SPILLS FACT, P221, DOI DOI 10.1007/978-3-030-11605-7_13; Larson RA, 2018, ANTHROPOCENE, V24, P40, DOI 10.1016/j.ancene.2018.11.002; LAWS EA, 1995, GEOCHIM COSMOCHIM AC, V59, P1131, DOI 10.1016/0016-7037(95)00030-4; Lincoln S.A., 2020, DEEP OIL SPILLS FACT, P312, DOI [10.1007/978-3-030-11605-7_19, DOI 10.1007/978-3-030-11605-7_19]; MacDonald IR, 2015, J GEOPHYS RES-OCEANS, V120, P8364, DOI 10.1002/2015JC011062; MacDonald IR, 2020, SCENARIOS RESPONSES, P132, DOI 10.1007/978-3-030-12963-7_8; Mason OU, 2012, ISME J, V6, P1715, DOI 10.1038/ismej.2012.59; Middelburg JJ, 1998, MAR CHEM, V60, P217, DOI 10.1016/S0304-4203(97)00104-7; Overholt WA, 2019, ENVIRON MICROBIOL, V21, P4316, DOI 10.1111/1462-2920.14794; Passow U, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/035301; PATTON JS, 1981, NATURE, V290, P235, DOI 10.1038/290235a0; Peebles EB, 2020, SCENARIOS RESPONSES, P203, DOI DOI 10.1007/978-3-030-12963-7_12; Pendergraft MA, 2014, ENVIRON SCI TECHNOL, V48, P10966, DOI 10.1021/es501354c; Programa Coordinado de Estudios Ecologicos en la Sonda de Campeche, 1980, INF TRAB REAL CONTR; Radabaugh KR, 2014, CONT SHELF RES, V84, P158, DOI 10.1016/j.csr.2014.05.002; Radabaugh KR, 2013, CONT SHELF RES, V68, P112, DOI 10.1016/j.csr.2013.08.010; Rau GH, 1997, GLOBAL BIOGEOCHEM CY, V11, P267, DOI 10.1029/97GB00328; Reddy CM, 2002, ENVIRON SCI TECHNOL, V36, P1774, DOI 10.1021/es011343f; Redmond MC, 2012, P NATL ACAD SCI USA, V109, P20292, DOI 10.1073/pnas.1108756108; Rogers KL, 2019, ELEMENTA-SCI ANTHROP, V7, DOI 10.1525/elementa.389; Rogers KL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212433; Rosenheim BE, 2016, DEEP-SEA RES PT II, V129, P249, DOI 10.1016/j.dsr2.2014.03.020; Ruiz-Fernandez AC, 2019, SCI TOTAL ENVIRON, V651, P3174, DOI 10.1016/j.scitotenv.2018.10.109; Ryerson TB, 2012, P NATL ACAD SCI USA, V109, P20246, DOI 10.1073/pnas.1110564109; Sanchez-Cabeza JA, 2012, GEOCHIM COSMOCHIM AC, V82, P183, DOI 10.1016/j.gca.2010.12.024; SANTIAGO J, 1992, AAPG MEMOIR, V54, P73; Schifter I, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4944-1; Schroeder W.W., 1999, BIOGEOCHEMISTRY GULF, P3; Schrope M, 2010, NATURE, V466, P304, DOI 10.1038/466304a; Schwing P.T., 2020, SCENARIOS RESPONSES, P96; Schwing PT, 2018, ENVIRON POLLUT, V237, P424, DOI 10.1016/j.envpol.2018.02.066; Schwing PT, 2016, JOVE-J VIS EXP, DOI 10.3791/54363; Soto LA, 1995, OLSEN INT S, P233; Soto LA, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00057; Stout SA, 2017, MAR POLLUT BULL, V114, P327, DOI 10.1016/j.marpolbul.2016.09.046; Sun SJ, 2015, MAR POLLUT BULL, V101, P632, DOI 10.1016/j.marpolbul.2015.10.036; Tunnell JW, 2011, EXPERT OPINION GULF, P1; V?zquez-Bader, 2020, DEEP OIL SPILLS FACT, P414; VOGEL JS, 1984, NUCL INSTRUM METH B, V5, P289, DOI 10.1016/0168-583X(84)90529-9; Vonk SM, 2015, MAR POLLUT BULL, V100, P5, DOI 10.1016/j.marpolbul.2015.08.023; Wang XC, 2001, GEOPHYS RES LETT, V28, P3313, DOI 10.1029/2001GL013430; White HK, 2008, ENVIRON SCI TECHNOL, V42, P5428, DOI 10.1021/es800478x; White HK, 2005, ENVIRON SCI TECHNOL, V39, P2545, DOI 10.1021/es048675f; Wilson RM, 2016, DEEP-SEA RES PT II, V129, P89, DOI 10.1016/j.dsr2.2015.05.014; Wilson RM, 2010, ESTUAR COAST, V33, P1406, DOI 10.1007/s12237-010-9304-3; Yanez-Arancibia A, 2004, OCEAN COAST MANAGE, V47, P727, DOI 10.1016/j.ocecoaman.2004.12.010	80	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231678	10.1371/journal.pone.0231678	http://dx.doi.org/10.1371/journal.pone.0231678			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294128	Green Published, Green Submitted, gold			2022-12-26	WOS:000536003500050
J	Richter, K; Rufer, AC; Muller, M; Burger, D; Casagrande, F; Grossenbacher, T; Huber, S; Hug, MN; Koldewey, P; D'Osualdo, A; Schlatter, D; Stoll, T; Rudolph, MG				Richter, Kirsten; Rufer, Arne C.; Muller, Magali; Burger, Dominique; Casagrande, Fabio; Grossenbacher, Tabea; Huber, Sylwia; Hug, Melanie N.; Koldewey, Philipp; D'Osualdo, Andrea; Schlatter, Daniel; Stoll, Theodor; Rudolph, Markus G.			Small molecule AX-024 reduces T cell proliferation independently of CD3?/Nck1 interaction, which is governed by a domain swap in the Nck1-SH3.1 domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						adaptor protein; crystal structure; T-cell receptor (TCR); protein drug interaction; cell proliferation; structure-function; protein structure; nuclear magnetic resonance (NMR); analytical ultracentrifugation; surface plasmon resonance (SPR)	TERMINAL SH3 DOMAIN; CRYSTAL-STRUCTURE; PROTEIN INTERACTIONS; BINDING; ACTIVATION; PHOSPHORYLATION; CD3-EPSILON; MECHANISM; ADAPTERS; DIMER	Activation of the T cell receptor (TCR) results in binding of the adapter protein Nck (noncatalytic region of tyrosine kinase) to the CD3? subunit of the TCR. The interaction was suggested to be important for the amplification of TCR signals and is governed by a proline-rich sequence (PRS) in CD3? that binds to the first Src homology 3 (SH3) domain of Nck (Nck-SH3.1). Inhibition of this protein/protein interaction ameliorated inflammatory symptoms in mouse models of multiple sclerosis, psoriasis, and asthma. A small molecule, AX-024, was reported to inhibit the Nck/CD3? interaction by physically binding to the Nck1-SH3.1 domain, suggesting a route to develop an inhibitor of the Nck1/CD3? interaction for modulating TCR activity in autoimmune and inflammatory diseases. We show here that AX-024 reduces T cell proliferation upon weak TCR stimulation but does not significantly affect phosphorylation of Zap70 (? chain of T cell receptor?associated protein kinase 70). We also find that AX-024 is likely not involved in modulating the Nck/TCR interaction but probably has other targets in T cells. An array of biophysical techniques did not detect a direct interaction between AX-024 and Nck-SH3.1 in vitro. Crystal structures of the Nck-SH3.1 domain revealed its binding mode to the PRS in CD3?. The SH3 domain tends to generate homodimers through a domain swap. Domain swaps observed previously in other SH3 domains indicate a general propensity of this protein fold to exchange structural elements. The swapped form of Nck-SH3.1 is unable to bind CD3?, possibly representing an inactive form of Nck in cells.	[Richter, Kirsten; Muller, Magali; D'Osualdo, Andrea] F Hoffmann La Roche Ltd, I2O Dis Translat Area, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Rufer, Arne C.; Burger, Dominique; Casagrande, Fabio; Grossenbacher, Tabea; Huber, Sylwia; Hug, Melanie N.; Koldewey, Philipp; Schlatter, Daniel; Stoll, Theodor; Rudolph, Markus G.] F Hoffmann La Roche Ltd, PRED Pharma Res & Early Dev, Roche Innovat Ctr Basel, Therapeut Modal,Discovery & Med Chem, Grenzacherstr 124, CH-4070 Basel, Switzerland; [Hug, Melanie N.] Univ Appl Sci Northwestern Switzerland FHNW, Sch Life Sci, Inst Chem & Bioanalyt, Hofackerstr 30, CH-4132 Muttenz, Switzerland	Roche Holding; Roche Holding; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Rudolph, MG (corresponding author), F Hoffmann La Roche Ltd, PRED Pharma Res & Early Dev, Therapeut Modal, CH-4070 Basel, Switzerland.	markus.rudolph@roche.com						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bacarizo J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113224; Baker MAB, 2016, NAT STRUCT MOL BIOL, V23, P197, DOI 10.1038/nsmb.3172; Banjade S, 2015, P NATL ACAD SCI USA, V112, pE6426, DOI 10.1073/pnas.1508778112; Baxter EL, 2012, P NATL ACAD SCI USA, V109, P1955, DOI 10.1073/pnas.1116369109; Benfield AP, 2007, ARCH BIOCHEM BIOPHYS, V462, P47, DOI 10.1016/j.abb.2007.03.010; Bennett MJ, 2006, STRUCTURE, V14, P811, DOI 10.1016/j.str.2006.03.011; BENNETT MJ, 1995, PROTEIN SCI, V4, P2455, DOI 10.1002/pro.5560041202; Bladt F, 2003, MOL CELL BIOL, V23, P4586, DOI 10.1128/MCB.23.13.4586-4597.2003; Borroto A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2140; Borroto A, 2014, IMMUNOL LETT, V161, P113, DOI 10.1016/j.imlet.2014.05.007; Borroto A, 2014, J IMMUNOL, V192, P2042, DOI 10.4049/jimmunol.1203414; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Camara-Artigas A, 2016, ARCH BIOCHEM BIOPHYS, V602, P116, DOI 10.1016/j.abb.2016.02.024; Camara-Artigas A, 2009, FEBS LETT, V583, P749, DOI 10.1016/j.febslet.2009.01.036; Concordet JP, 2018, NUCLEIC ACIDS RES, V46, pW242, DOI 10.1093/nar/gky354; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Ding F, 2002, J MOL BIOL, V324, P851, DOI 10.1016/S0022-2836(02)01112-9; Ehler A, 2014, ACTA CRYSTALLOGR D, V70, P2163, DOI 10.1107/S1399004714012917; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frank MK, 2002, NAT STRUCT BIOL, V9, P877, DOI 10.1038/nsb854; Frese S, 2006, J BIOL CHEM, V281, P18236, DOI 10.1074/jbc.M512917200; GREEN SM, 1995, NAT STRUCT BIOL, V2, P746, DOI 10.1038/nsb0995-746; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Harkiolaki M, 2006, STRUCTURE, V14, P1741, DOI 10.1016/j.str.2006.09.013; Hosoe Y, 2019, BIOPHYS PHYSICOBIOL, V16, P80, DOI 10.2142/biophysico.16.0_80; Huculeci R, 2017, METHODS MOL BIOL, V1555, P257, DOI 10.1007/978-1-4939-6762-9_14; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Kishan KVR, 1997, NAT STRUCT BIOL, V4, P739; Lettau M, 2010, PROTEIN SCI, V19, P658, DOI 10.1002/pro.334; Lettau M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-1; Liu Y, 2002, PROTEIN SCI, V11, P1285, DOI 10.1110/ps.0201402; Love PE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002485; Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094; Matsumura Y, 2013, BIOPHYS CHEM, V175, P39, DOI 10.1016/j.bpc.2013.02.005; MAZZARELLA L, 1993, ACTA CRYSTALLOGR D, V49, P389, DOI 10.1107/S0907444993003403; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ngoenkam J, 2018, IMMUNOLOGY, V153, P42, DOI 10.1111/imm.12809; Ngoenkam J, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-21; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Paensuwan P, 2016, J IMMUNOL, V196, P448, DOI 10.4049/jimmunol.1500958; Pei XY, 1997, P NATL ACAD SCI USA, V94, P9637, DOI 10.1073/pnas.94.18.9637; PERISIC O, 1994, STRUCTURE, V2, P1217, DOI 10.1016/S0969-2126(94)00123-5; Rousseau F, 2012, ADV EXP MED BIOL, V747, P137, DOI 10.1007/978-1-4614-3229-6_9; Roy E, 2010, P NATL ACAD SCI USA, V107, P15529, DOI 10.1073/pnas.1009743107; Rufer AC, 2018, ACTA CRYSTALLOGR D, V74, P450, DOI 10.1107/S2059798318004813; Saint-Jean AP, 1998, BIOCHEMISTRY-US, V37, P10345, DOI 10.1021/bi980868q; Santiveri CM, 2009, BBA-PROTEINS PROTEOM, V1794, P110, DOI 10.1016/j.bbapap.2008.09.016; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schymkowitz JWH, 2001, NAT STRUCT BIOL, V8, P888, DOI 10.1038/nsb1001-888; Spinelli S, 2004, FEBS LETT, V564, P35, DOI 10.1016/S0014-5793(04)00304-7; Tailor P, 2008, J IMMUNOL, V181, P243, DOI 10.4049/jimmunol.181.1.243; Takeuchi K, 2008, J MOL BIOL, V380, P704, DOI 10.1016/j.jmb.2008.05.037; Teyra J, 2017, STRUCTURE, V25, P1598, DOI 10.1016/j.str.2017.07.017; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yiemwattana I, 2012, CLIN EXP IMMUNOL, V167, P99, DOI 10.1111/j.1365-2249.2011.04494.x; Yuzawa S, 2004, GENES CELLS, V9, P443, DOI 10.1111/j.1356-9597.2004.00733.x	61	9	9	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					7849	7864		10.1074/jbc.RA120.012788	http://dx.doi.org/10.1074/jbc.RA120.012788			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32317279	Green Published, hybrid			2022-12-26	WOS:000540935400004
J	Singh, G; Fritz, SE; Seufzer, B; Boris-Lawrie, K				Singh, Gatikrushna; Fritz, Sarah E.; Seufzer, Bradley; Boris-Lawrie, Kathleen			The mRNA encoding the JUND tumor suppressor detains nuclear RNA-binding proteins to assemble polysomes that are unaffected by mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammalian target of rapamycin (mTOR); tumor suppressor gene; eukaryotic translation initiation factor 4E (eIF4E); RNA helicase; RNA binding protein; complex 5'-UTR; mTOR; non-canonical cap-binding complex; polyribosome; post-transcriptional control element (PCE)	NONSENSE-MEDIATED DECAY; TRANSLATION INITIATION; FXR1A-ASSOCIATED MICRORNP; HELICASE-A; CAP; GENE; CANCER; HIV-1; EIF4E; CELLS	One long-standing knowledge gap is the role of nuclear proteins in mRNA translation. Nuclear RNA helicase A (DHX9/RHA) is necessary for the translation of the mRNAs of JUND (JunD proto-oncogene AP-1 transcription factor subunit) and HIV-1 genes, and nuclear cap-binding protein 1 (NCBP1)/CBP80 is a component of HIV-1 polysomes. The protein kinase mTOR activates canonical messenger ribonucleoproteins by post-translationally down-regulating the eIF4E inhibitory protein 4E-BP1. We posited here that NCBP1 and DHX9/RHA (RHA) support a translation pathway of JUND RNA that is independent of mTOR. We present evidence from reciprocal immunoprecipitation experiments indicating that NCBP1 and RHA both are components of messenger ribonucleoproteins in several cell types. Moreover, tandem affinity and RT?quantitative PCR results revealed that JUND mRNA is a component of a previously unknown ribonucleoprotein complex. Results from the tandem IP indicated that another component of the JUND-containing ribonucleoprotein complex is NCBP3, a recently identified ortholog of NCBP2/CBP20. We also found that NCBP1, NCBP3, and RHA, but not NCBP2, are components of JUND-containing polysomes. Mutational analysis uncovered two dsRNA-binding domains of RHA that are necessary to tether JUND?NCBP1/NCBP3 to polysomes. We also found that JUND translation is unaffected by inhibition of mTOR, unless RHA was down-regulated by siRNA. These findings uncover a noncanonical cap-binding complex consisting of NCBP1/NCBP3 and RHA substitutes for the eukaryotic translation initiation factors 4E and 4G and activates mTOR-independent translation of the mRNA encoding the tumor suppressor JUND.	[Singh, Gatikrushna; Seufzer, Bradley; Boris-Lawrie, Kathleen] Univ Minnesota, Dept Vet & Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA; [Fritz, Sarah E.; Boris-Lawrie, Kathleen] Ohio State Univ, Integrated Biomed Sci Grad Program, Columbus, OH 43210 USA; [Fritz, Sarah E.] NIH, Biochem & Biophys Ctr, Bldg 10, Bethesda, MD 20892 USA	University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; Ohio State University; National Institutes of Health (NIH) - USA	Boris-Lawrie, K (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, 1971 Commonwealth Ave, St Paul, MN 55108 USA.	kbl@umn.edu	Fritz, Sarah/AAR-9924-2021	Fritz, Sarah/0000-0001-6318-4319; Boris-Lawrie, Kathleen/0000-0001-6366-6270	National Institutes of Health [P50 NIGMS0103297, T32GM068412, U54AI50470]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants P50 NIGMS0103297, T32GM068412, and U54AI50470. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atsaves V, 2019, CANCERS, V11, DOI 10.3390/cancers11071037; Boeras I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06883-9; Boeras I, 2016, J MOL BIOL, V428, P2418, DOI 10.1016/j.jmb.2016.04.011; Bolinger C, 2007, NUCLEIC ACIDS RES, V35, P2629, DOI 10.1093/nar/gkm124; Bolinger C, 2010, NUCLEIC ACIDS RES, V38, P1686, DOI 10.1093/nar/gkp1075; BRADDOCK M, 1994, NUCLEIC ACIDS RES, V22, P5255, DOI 10.1093/nar/22.24.5255; Brady S, 2019, J BIOL CHEM, V294, P11473, DOI 10.1074/jbc.RA119.007679; Bukhari SIA, 2017, RNA BIOL, V14, P137, DOI 10.1080/15476286.2016.1265197; Bukhari SIA, 2016, MOL CELL, V61, P760, DOI 10.1016/j.molcel.2016.02.013; Cao SG, 2017, AM J TRANSL RES, V9, P674; Cheng DD, 2017, ONCOTARGET, V8, P26380, DOI 10.18632/oncotarget.15474; Childs-Disney JL, 2018, CHEM-US, V4, P2384, DOI 10.1016/j.chempr.2018.08.003; Choe J, 2014, P NATL ACAD SCI USA, V111, pE4577, DOI 10.1073/pnas.1409695111; Choe J, 2013, NUCLEIC ACIDS RES, V41, P1307, DOI 10.1093/nar/gks1196; Gebhardt A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008155; Gebhardt A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9192; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Henis-Korenblit S, 2000, MOL CELL BIOL, V20, P496, DOI 10.1128/MCB.20.2.496-506.2000; Hernandez JM, 2008, ONCOGENE, V27, P4757, DOI 10.1038/onc.2008.120; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Ishigaki Y, 2001, CELL, V106, P607, DOI 10.1016/S0092-8674(01)00475-5; Isken O, 2008, NAT REV GENET, V9, P699, DOI 10.1038/nrg2402; IZAURRALDE E, 1994, CELL, V78, P657, DOI 10.1016/0092-8674(94)90530-4; Jeong SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09086-0; Kim KM, 2009, GENE DEV, V23, P2033, DOI 10.1101/gad.1823409; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Le Hir H, 2003, TRENDS BIOCHEM SCI, V28, P215, DOI 10.1016/S0968-0004(03)00052-5; Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954; Lee CG, 1999, SOMAT CELL MOLEC GEN, V25, P33, DOI 10.1023/B:SCAM.0000007138.44216.3a; Lee T, 2016, ONCOGENE, V35, P5093, DOI 10.1038/onc.2016.52; Lee T, 2016, ONCOTARGET, V7, P42716, DOI 10.18632/oncotarget.8446; Lewis SM, 2008, NUCLEIC ACIDS RES, V36, P168, DOI 10.1093/nar/gkm1007; Lu SH, 2003, RNA, V9, P618, DOI 10.1261/rna.5260303; Matsumoto K, 1998, EMBO J, V17, P2107, DOI 10.1093/emboj/17.7.2107; Mazza C, 2002, EMBO J, V21, P5548, DOI 10.1093/emboj/cdf538; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Nevins TA, 2003, J BIOL CHEM, V278, P3572, DOI 10.1074/jbc.M206781200; Ng YC, 2018, NUCLEIC ACIDS RES, V46, P9011, DOI 10.1093/nar/gky742; Nott A, 2003, RNA, V9, P607, DOI 10.1261/rna.5250403; Nousch M, 2007, RNA, V13, P374, DOI 10.1261/rna.372307; Ranji A, 2011, J BIOL CHEM, V286, P5328, DOI 10.1074/jbc.M110.176339; Roberts TM, 2000, J VIROL, V74, P8111, DOI 10.1128/JVI.74.17.8111-8118.2000; Roberts TM, 2003, J VIROL, V77, P11973, DOI 10.1128/JVI.77.22.11973-11984.2003; Ryu I, 2017, BMB REP, V50, P186, DOI 10.5483/BMBRep.2017.50.4.007; Santulli G, 2013, PHARMACOGENOMICS, V14, P1517, DOI 10.2217/pgs.13.143; Sharma A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002612; Shen BC, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13148; Shih JW, 2008, ONCOGENE, V27, P700, DOI 10.1038/sj.onc.1210687; Short JD, 2002, J BIOL CHEM, V277, P32697, DOI 10.1074/jbc.M204553200; Singh G, 2018, NUCLEIC ACIDS RES, V46, P7366, DOI 10.1093/nar/gky369; Singh G, 2017, JOVE-J VIS EXP, DOI 10.3791/54391; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Toro-Ascuy D, 2018, NUCLEIC ACIDS RES, V46, P11539, DOI 10.1093/nar/gky851; Yoffe Y, 2016, GENE DEV, V30, P1991, DOI 10.1101/gad.285239.116	58	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7763	7773		10.1074/jbc.RA119.012005	http://dx.doi.org/10.1074/jbc.RA119.012005			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32312751	Green Published, hybrid			2022-12-26	WOS:000538038900016
J	Falero-Perez, J; Sorenson, CM; Sheibani, N				Falero-Perez, Juliana; Sorenson, Christine M.; Sheibani, Nader			Retinal astrocytes transcriptome reveals Cyp1b1 regulates the expression of genes involved in cell adhesion and migration	PLOS ONE			English	Article							PRIMARY CONGENITAL GLAUCOMA; OXIDATIVE STRESS; CYTOCHROME-P450 2E1; GLIAL SCAR; RNA-SEQ; WEBGESTALT; CANCER; ANNOTATION; METABOLISM; ACTIVATION	Astrocytes (AC) are the most abundant cells in the central nervous system. In the retina, astrocytes play important roles in the development and integrity of the retinal neurovasculature. Astrocytes dysfunction contributes to pathogenesis of a variety of neurovascular diseases including diabetic retinopathy. Recent studies have demonstrated the expression of Cyp1b1 in the neurovascular cells of the central nervous system including AC. We recently showed retinal AC constitutively express Cyp1b1, and global Cyp1b1-deficiency (Cyp1b1-/-) attenuates retinal ischemia-mediated neovascularization in vivo and the pro-angiogenic activity of retinal vascular cells in vitro. We also demonstrated that Cyp1b1 expression is a key regulator of retinal AC function. However, the underlying mechanisms involved need further investigation. Here we determined changes in the transcriptome profiles of Cyp1b1+/+ and Cyp1b1-/- retinal AC by RNA sequencing. We identified 585 differentially expressed genes, whose pathway enrichment analysis revealed the most significant pathways impacted in Cyp1b1-/- AC. These genes included those of axon guidance, extracellular matrix proteins and their receptors, cancer, cell adhesion molecules, TGF-beta signaling, and the focal adhesion modulation. The expression of a selected set of differentially expressed genes was confirmed by RT-qPCR analysis. To our knowledge, this is the first report of RNAseq investigation of the retinal AC transcriptome and the molecular pathways impacted by Cyp1b1 expression. These results demonstrated an important role for Cyp1b1 expression in the regulation of various retinal AC functions, which are important in neurovascular development and integrity.	[Falero-Perez, Juliana; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Sorenson, Christine M.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA; [Sorenson, Christine M.; Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI 53706 USA; [Sheibani, Nader] Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, McPherson Eye Res Inst, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomed Engn, Madison, WI 53706 USA.; Sheibani, N (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Cell & Regenerat Biol, Madison, WI 53706 USA.	nsheibanikar@wisc.edu		Sheibani, Nader/0000-0003-2723-9217	Research to Prevent Blindness; Retina Research Foundation [P30 EY016665, P30 CA014520, R01 EY026078]; RRF/Daniel M. Albert Chair; RPB Stein Innovation Award [F31 EY027987]	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Retina Research Foundation; RRF/Daniel M. Albert Chair; RPB Stein Innovation Award	The work in NS lab is supported by an unrestricted award from Research to Prevent Blindness to the Department of Ophthalmology and Visual Sciences, Retina Research Foundation, P30 EY016665, P30 CA014520, and R01 EY026078. CMS is supported by the RRF/Daniel M. Albert Chair. NS is a recipient of RPB Stein Innovation Award. JFP is supported by F31 EY027987 training grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki-Kinoshita Kiyoko F., 2007, V396, P71; Atala A, 2017, J UROLOGY, V197, P154, DOI 10.1016/j.juro.2016.10.010; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Barnett JA, 2007, CLIN CANCER RES, V13, P3559, DOI 10.1158/1078-0432.CCR-06-2430; Bolton JL, 2008, CHEM RES TOXICOL, V21, P93, DOI 10.1021/tx700191p; Deng WJ, 2018, J CELL MOL MED, V22, P3108, DOI 10.1111/jcmm.13588; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorrell MI, 2002, INVEST OPHTH VIS SCI, V43, P3500; Falero-Perez Juliana, 2018, Trends Cell Mol Biol, V13, P27; Falero-Perez J, 2019, AM J PHYSIOL-CELL PH, V316, pC767, DOI 10.1152/ajpcell.00021.2019; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fruttiger M, 1996, NEURON, V17, P1117, DOI 10.1016/S0896-6273(00)80244-5; Fruttiger Marcus, 2007, Angiogenesis, V10, P77, DOI 10.1007/s10456-007-9065-1; Gajjar K, 2012, CANCER LETT, V324, P13, DOI 10.1016/j.canlet.2012.04.021; Gao DK, 2019, INT J BIOL MACROMOL, V124, P460, DOI 10.1016/j.ijbiomac.2018.10.212; Givant-Horwitz V, 2005, CANCER LETT, V223, P1, DOI 10.1016/j.canlet.2004.08.030; Hassan HM, 2016, ANTIMICROB AGENTS CH, V60, P5285, DOI 10.1128/AAC.00854-16; Hillen AEJ, 2018, PROG NEUROBIOL, V165, P66, DOI 10.1016/j.pneurobio.2018.02.002; Hrycay Eugene G, 2015, Adv Pharmacol, V74, P35, DOI 10.1016/bs.apha.2015.03.003; Huang XQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-145; Hur JH, 2000, J KOREAN MED SCI, V15, P309, DOI 10.3346/jkms.2000.15.3.309; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kanehisa M, 2002, NOVART FDN SYMP, V247, P91; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kirov S, 2014, METHODS MOL BIOL, V1101, P31, DOI 10.1007/978-1-62703-721-1_3; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lu D, 2012, HYPERTENSION, V60, P81, DOI 10.1161/HYPERTENSIONAHA.112.191478; Ma Yingxin, 2014, Int J Physiol Pathophysiol Pharmacol, V6, P102; Mao WF, 2020, CYTOKINE, V125, DOI 10.1016/j.cyto.2019.154771; Mittal B, 2015, ADV CLIN CHEM, V71, P77, DOI 10.1016/bs.acc.2015.06.003; Muskhelishvili L, 2001, J HISTOCHEM CYTOCHEM, V49, P229, DOI 10.1177/002215540104900210; Palenski TL, 2013, LAB INVEST, V93, P646, DOI 10.1038/labinvest.2013.55; Piromkraipak P, 2018, CELL MOL NEUROBIOL, V38, P559, DOI 10.1007/s10571-017-0507-z; Ramachandran RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172234; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rich JN, 1999, J BIOL CHEM, V274, P35053, DOI 10.1074/jbc.274.49.35053; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; RUNGGERBRANDLE E, 1989, J CELL BIOL, V109, P705, DOI 10.1083/jcb.109.2.705; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Scheef E, 2005, MOL VIS, V11, P613; Shan WS, 2000, J CELL BIOL, V148, P579, DOI 10.1083/jcb.148.3.579; Stoilov I, 1998, AM J HUM GENET, V62, P573, DOI 10.1086/301764; Stoilov I, 1997, HUM MOL GENET, V6, P641, DOI 10.1093/hmg/6.4.641; STONE J, 1995, VISUAL NEUROSCI, V12, P273, DOI 10.1017/S0952523800007951; Sun H, 2018, J CANCER, V9, P4642, DOI 10.7150/jca.27686; Tang YX, 2010, AM J PHYSIOL-CELL PH, V298, pC665, DOI 10.1152/ajpcell.00153.2009; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; Tian XX, 2018, ONCOTARGETS THER, V11, P7795, DOI 10.2147/OTT.S178152; Trettel F, 2020, NEUROSCIENCE, V439, P230, DOI 10.1016/j.neuroscience.2019.07.035; Veith Alex, 2018, Current Opinion in Toxicology, V7, P44, DOI 10.1016/j.cotox.2017.10.003; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Xu XP, 2005, CANCER RES, V65, P130; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhang YX, 2016, GENE DEV, V30, P1636, DOI 10.1101/gad.281972.116; Zhao TY, 2014, DEVELOPMENT, V141, P148, DOI 10.1242/dev.101550; Zhao Yun, 2015, J Ophthalmic Vis Res, V10, P60, DOI 10.4103/2008-322X.156116; Zhao Y, 2013, MOL CELL BIOL, V33, P4225, DOI 10.1128/MCB.00856-13	62	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231752	10.1371/journal.pone.0231752	http://dx.doi.org/10.1371/journal.pone.0231752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330152	Green Published, gold			2022-12-26	WOS:000536647300020
J	Applegate, JA; Ahmed, S; Harrison, M; Callaghan-Koru, J; Mousumi, M; Begum, N; Moin, MI; Joarder, T; Ahmed, S; George, J; Mitra, DK; Ahmed, ANU; Shahidullah, M; Baqui, AH				Applegate, Jennifer A.; Ahmed, Salahuddin; Harrison, Meagan; Callaghan-Koru, Jennifer; Mousumi, Mahfuza; Begum, Nazma; Moin, Mamun Ibne; Joarder, Taufique; Ahmed, Sabbir; George, Joby; Mitra, Dipak K.; Ahmed, Asm Nawshad Uddin; Shahidullah, Mohammod; Baqui, Abdullah H.			Provider performance and facility readiness for managing infections in young infants in primary care facilities in rural Bangladesh	PLOS ONE			English	Article							SIMPLIFIED ANTIBIOTIC REGIMENS; PREDICT SEVERE ILLNESS; QUALITY-OF-CARE; CLINICAL SIGNS; HEALTH-WORKERS; RATIONAL USE; OPEN-LABEL; CHILDREN; STRATEGIES; MANAGEMENT	Background Neonatal infections remain a leading cause of newborn deaths globally. In 2015, WHO issued guidelines for managing possible serious bacterial infection (PSBI) in young infants (0-59 days) using simplified antibiotic regimens when compliance with hospital referral is not feasible. Bangladesh was one of the first countries to adopt WHO's guidelines for implementation. We report results of an implementation research study that assessed facility readiness and provider performance in three rural sub-districts of Bangladesh during August 2015-August 2016. Methods This study took place in 19 primary health centers. Facility readiness was assessed using checklists completed by study staff at three time points. To assess provider performance, we extracted data for all infection cases from facility registers and compared providers' diagnosis and treatment against the guidelines. We plotted classification and dosage errors across the study period and superimposed a locally weighted smoothed (LOWESS) curve to analyze changes in performance over time. Focus group discussions (N = 2) and in-depth interviews (N = 28) with providers were conducted to identify barriers and facilitators for facility readiness and provider performance. Results At baseline, none of the facilities had adequate supply of antibiotics. During the 10-month period, 606 sick infants with signs of infection presented at the study facilities. Classification errors were identified in 14.9% (N = 90/606) of records. For infants receiving the first dose(s) of antibiotic treatment (N = 551), dosage errors were identified in 22.9% (N = 126/551) of the records. Distribution of errors varied by facility (35.7% [IQR: 24.7-57.4%]) and infection severity. Errors were highest at the beginning of the study period and decreased over time. Qualitative data suggest errors in early implementation were due to changes in providers' assessment and treatment practices, including confusion about classifying an infant with multiple signs of infection, and some providers' concerns about the efficacy of simplified antibiotic regimens. Conclusions Strategies to monitor early performance and targeted supports are important for enhancing implementation fidelity when introducing complex guidelines in new settings. Future research should examine providers' assessment of effectiveness of simplified treatment and address misconceptions about superiority of broader spectrum antibiotics for treating community-acquired neonatal infections in this context.	[Applegate, Jennifer A.; Harrison, Meagan; Joarder, Taufique; Baqui, Abdullah H.] Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Ahmed, Salahuddin; Begum, Nazma; Moin, Mamun Ibne] Johns Hopkins Univ Bangladesh, Dhaka, Bangladesh; [Callaghan-Koru, Jennifer] Univ Maryland Baltimore Cty, Dept Sociol Anthropol & Hlth Adm & Policy, Baltimore, MD 21228 USA; [Mousumi, Mahfuza] Jhpiego Bangladesh, Dhaka, Bangladesh; [Ahmed, Sabbir; George, Joby] Save Children, USAIDs MaMoni Hlth Syst Strengthening Project, Washington, DC USA; [Mitra, Dipak K.] North South Univ, Sch Hlth & Life Sci, Dept Publ Hlth, Dhaka, Bangladesh; [Ahmed, Asm Nawshad Uddin] Child Hlth Res Fdn CHRF, Dept Pediat, Dhaka, Bangladesh; [Shahidullah, Mohammod] Bangabandhu Sheikh Mujib Med Univ BSMMU, Neonatal Dept, Dhaka, Bangladesh	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University System of Maryland; University of Maryland Baltimore County; Save the Children; North South University (NSU); Bangabandhu Sheikh Mujib Medical University (BSMMU)	Baqui, AH (corresponding author), Johns Hopkins Univ, Dept Int Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	abaqui@jhu.edu	Ahmed, Salahuddin/ABC-3497-2021; Ahmed, Salahuddin/AAH-7005-2020; George, Joby/AAW-1365-2021; Mitra, Dipak/W-9569-2018	Ahmed, Salahuddin/0000-0001-6771-0638; George, Joby/0000-0002-4791-901X; Mitra, Dipak/0000-0001-8680-4146; Applegate, Jennifer/0000-0002-9472-299X	United States Agency for International Development (USAID) through JHU's Health Research Challenge for Impact [GHS-A00-0900004-00]	United States Agency for International Development (USAID) through JHU's Health Research Challenge for Impact(United States Agency for International Development (USAID))	AB received support for this study from the United States Agency for International Development (USAID) through JHU's Health Research Challenge for Impact (grant number GHS-A00-0900004-00). The contents are the responsibilities of the authors and do not necessarily reflect the views of USAID, the United States Government and/or the decisions, policy, or views of their respective organizations.	Ahmed I, 2019, INT J INFECT DIS; Ahmed S, 2019, J HEALTH POPUL NUTR, V38, DOI 10.1186/s41043-019-0200-6; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Ahmed SM, 2012, J HEALTH POPUL NUTR, V30, P99; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Alonge O, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001257; [Anonymous], 2018, DED VERS 8 0 35; [Anonymous], MAMONI HLTH SYST STR; [Anonymous], IMPLEMENTATION RES H; Arifeen SE, 2005, B WORLD HEALTH ORGAN, V83, P260; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Asia Pacific Observatory on Health Systems and Policies, 2015, HLTH SYSTEMS TRANSIT, V5; Bangladesh Ministry of Health and Family Welfare, 2017, NAT NEWB HLTH PROGR; Baqui AH, 2016, J PERINATOL, V36, P71, DOI 10.1038/jp.2015.139; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Baqui AH, 2015, LANCET GLOB HEALTH, V3, pE279, DOI 10.1016/S2214-109X(14)70347-X; Bishwajit Sutradhar K., 2014, ANN RES REV BIOL, V4, P1421, DOI [10.9734/ARRB/2014/8184, DOI 10.9734/ARRB/2014/8184]; Biswas M, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-15; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Brassard M, THEMEMORY JOGGER 2 P; Cardemil CV, 2012, AM J TROP MED HYG, V87, P127, DOI 10.4269/ajtmh.2012.12-0389; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; Chowdhury EK, 2008, LANCET, V372, P822, DOI 10.1016/S0140-6736(08)61166-6; Chowdhury Sameena, 2009, Bangladesh Med Res Counc Bull, V35, P53; Coghill JE, 2011, J TROP PEDIATRICS, V57, P3, DOI 10.1093/tropej/fmr001; Creswell J.W., 2007, DESIGNING CONDUCTING; Creswell JW, 2016, QUALITATIVE INQUIRY; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Das SK, 2013, AM J TROP MED HYG, V89, P62, DOI 10.4269/ajtmh.13-0107; Edmond K, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000213; Engl E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214922; Esamai Fabian, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS46, DOI 10.1097/INF.0b013e31829ff941; Fahad B, 2010, AUSTRALASIAN MED J, V3; Faiz MA, 2011, ANTIMICROBIAL RESIST; Gera T, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010123.pub2; Hoque DME, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-197; Horwood C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005937; Hsia Y, 2019, LANCET INFECT DIS, V19, P67, DOI 10.1016/S1473-3099(18)30547-4; Joarder T, 2019, ADV PUBLIC HLTH, V2019; Khan M, 2010, BANGLADESH HLTH FACI; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Liu L, 2016, LANCET, V388, P3027, DOI 10.1016/S0140-6736(16)31593-8; McMahon SA, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000837; Mir F, 2017, LANCET GLOB HEALTH, V5, pE177, DOI [10.1016/s2214-109x(16)30335-7, 10.1016/S2214-109X(16)30335-7]; Mohiuddin M, 2015, BMC MED ETHICS, V16, DOI 10.1186/s12910-015-0075-z; Murni IK, 2015, ARCH DIS CHILD, V100, P454, DOI 10.1136/archdischild-2014-307297; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV; National technical Working Committee on Newborn Health, 2015, BANGL NAT GUID MAN I; Opiyo N, 2011, ARCH DIS CHILD, V96, P1052, DOI 10.1136/adc.2010.186049; Pinnock H, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6795; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Qazi Shamim Ahmad, 2013, Pediatr Infect Dis J, V32 Suppl 1, pS3, DOI 10.1097/INF.0b013e31829ff5e5; Rahman AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170267; Rowe AK, 2018, LANCET GLOB HEALTH, V6, pE1163, DOI 10.1016/S2214-109X(18)30398-X; Rowe SY, 2019, PLOS ONE, V14; Saha SK, 2018, LANCET, V392, P145, DOI 10.1016/S0140-6736(18)31127-9; Sankar MJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5314; Shah BA, 2014, VIRULENCE, V5, P170, DOI 10.4161/viru.26906; Simen-Kapeu A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/1471-2393-15-S2-S6; Tashakkori A., 2009, FDN MIXED METHODS RE; Theobald S, 2018, LANCET, V392, P2214, DOI [10.1016/S0140-6736(18)32205-0, 10.1016/s0140-6736(18)32205-0]; Tshefu A, 2015, LANCET, V385, P1767, DOI 10.1016/S0140-6736(14)62284-4; World Health Organization, 2017, SEL US ESS MED REP W; World Health Organization, 2015, GUID MAN POSS SER BA; World Health Organization, 2015, SERV AV READ ASS SAR; World Health Organization unicef Save the Children, 2017, OPERATIONALIZING MAN; You D, 2015, LEVELS TRENDS CHILD	70	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0229988	10.1371/journal.pone.0229988	http://dx.doi.org/10.1371/journal.pone.0229988			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320993	Green Published, Green Submitted, gold			2022-12-26	WOS:000536028800008
J	Dortey, BA; Anaba, EA; Lassey, AT; Damale, NKR; Maya, ET				Dortey, Benjamin Ansah; Anaba, Emmanuel Anongeba; Lassey, A. T.; Damale, N. K. R.; Maya, Ernest T.			Seroprevalence of Hepatitis B virus infection and associated factors among pregnant women at Korle-Bu Teaching Hospital, Ghana	PLOS ONE			English	Article								Introduction Hepatitis B virus infection is a global public health problem. Though, the disease is endemic in sub-Saharan Africa, little is known about its epidemiology among pregnant women in Ghana. This study sought to determine the seroprevalence of Hepatitis B virus infection and associated factors among pregnant women attending antenatal care at Korle-Bu Teaching Hospital; Ghana's largest hospital. Methods We conducted a facility-based cross-sectional survey among 232 antenatal attendants. Participants were recruited using systematic random sampling technique and screened with HBsAg Rapid Test. Data was analyzed with the aid of Statistical Package for Social Sciences (SPSS), version 23.0. Results were presented using descriptive statistics, Fisher's Exact test and Logistic Regression analysis. Results Two hundred and twenty-one (221) of the total sample (n = 232) agreed to participate in this study; representing a response rate of 95%. The mean age of the participants was 31 years and standard deviation of 5.3. The mean gestational period at recruitment was 28 weeks and standard deviation of 6.8. Majority of the participants were married (83.3%), parous (69.6%), educated (91.4%) and employed (90.5%). The prevalence of HBsAg was 7.7%. We found no significant association between socio-demographic characteristics of the participants and HBV infection. Conclusion Seroprevalence of 7.7% indicates moderate endemicity. Socio-demographic characteristics did not influence HBV infection among pregnant women attending antenatal care at Korle-Bu Teaching Hospital. The findings provide empirical evidence that will contribute to knowledge of HBV epidemiology in Ghana.	[Dortey, Benjamin Ansah] Trauma & Specialist Hosp, Winneba, Ghana; [Anaba, Emmanuel Anongeba; Maya, Ernest T.] Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana; [Lassey, A. T.; Damale, N. K. R.] Univ Ghana, Sch Med & Dent, Accra, Ghana	University of Ghana; University of Ghana	Anaba, EA (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana.	emmaanaba24@gmail.com		Anaba, Emmanuel Anongeba/0000-0002-8942-0460				Anabire NG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210365; Anaedobe CG, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.406.6206; [Anonymous], 2018, GHAN MAT HLTH SURV 2; Bayo P, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005889; Bittaye M, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3883-9; Chung PW, 2012, CHINESE MED J-PEKING, V125, P422, DOI 10.3760/cma.j.issn.0366-6999.2012.03.004; Cui AM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0884-1; Dabsu R, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4792584; Day SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059346; Eke AC, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-12; Ephraim R, 2015, AFR HEALTH SCI, V15, P709, DOI 10.4314/ahs.v15i3.2; Esan A., 2014, AM J BIOMEDICAL RES, V2, P11, DOI [10.12691/ajbr-2-1-3, DOI 10.12691/AJBR-2-1-3]; Eyong EM, 2019, PAN AFR MED J, V32, DOI 10.11604/pamj.2019.32.122.16055; Frambo Andreas A Besong, 2014, BMC Res Notes, V7, P394, DOI 10.1186/1756-0500-7-394; Gedefaw G, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4561-0; Helegbe GK, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/5610981; Hussein A. A., 2018, J PHARM SCI RES, V10, P3157; International Alliance of Patients' Organizations, 2017, HEP GHAN SIT REV; Kapinga D.R., 2017, SEROPREVALENCE FACTO; Kebede KM, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3234-2; Maddrey WC, 2000, J MED VIROL, V61, P362, DOI 10.1002/1096-9071(200007)61:3&lt;362::AID-JMV14&gt;3.0.CO;2-I; Mezgebo TA, 2018, J MED VIROL, V90, P503, DOI 10.1002/jmv.24987; Ministry of Health, NAT POL VIR HEP 2014; Nyamusi MM., 2016, INT J COMMUNITY MED, V3, P3096, DOI [10.18203/2394-6040.ijcmph20163918, DOI 10.18203/2394-6040.IJCMPH20163918]; Ofori-Asenso R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1467-5; Slowik May K, 2005, Semin Pediatr Infect Dis, V16, P296, DOI 10.1053/j.spid.2005.06.009; Tanga AT, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4220-z; Volker F, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1351-3	28	1	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0232208	10.1371/journal.pone.0232208	http://dx.doi.org/10.1371/journal.pone.0232208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320459	Green Published, gold			2022-12-26	WOS:000536028800059
J	Davidson, CQ; Tharmalingam, S; Niccoli, S; Nemec-Bakk, A; Khurana, S; Murray, A; Tai, TC; Boreham, DR; Khaper, N; Lees, SJ				Davidson, Caitlund Q.; Tharmalingam, Sujeenthar; Niccoli, Sarah; Nemec-Bakk, Ashley; Khurana, Sandhya; Murray, Alyssa; Tai, T. C.; Boreham, Douglas R.; Khaper, Neelam; Lees, Simon J.			Dose threshold for radiation induced fetal programming in a mouse model at 4 months of age: Hepatic expression of genes and proteins involved in glucose metabolism and glucose uptake in brown adipose tissue	PLOS ONE			English	Article							INSULIN-RESISTANCE; PHOSPHOENOLPYRUVATE CARBOXYKINASE; GLUCOCORTICOID EXPOSURE; LATE-GESTATION; GROWTH; MICE; SENSITIVITY; BEHAVIOR; OBESITY; SOCS-1	Exposure to ionizing radiation contributing to negative health outcomes is a widespread concern. However, the impact of low dose and sub-lethal dose radiation (SLDR) exposures remain contentious, particularly in pregnant women who represent a vulnerable group. The fetal programming hypothesis states that an adverse in utero environment or stress during development of an embryo or fetus can result in permanent physiologic changes often resulting in progressive metabolic dysfunction with age. To assess changes in gene expression profiles of glucose/insulin signaling and lipid metabolism caused by radiation exposure in utero, pregnant C57Bl/6J mice were irradiated using a dose response ranging from low dose to SLDR and compared to a Sham-irradiated group. mRNA expression analysis in 16 week old offspring (n = 84) revealed that genes involved in metabolic function including glucose metabolism, insulin signaling and lipid metabolism were unaffected by prenatal radiation exposures up to 300 mGy. However, female offspring of dams exposed to 1000 mGy had upregulated expression of genes contributing to insulin resistance and gluconeogenesis. In a second cohort of mice, the effects of SLDR on fetal programming of hepatic SOCS3 and PEPCK protein expression were assessed. 4 month old female offspring of dams irradiated at 1000 mGy had: 1) increased liver weights, 2) increased hepatic expression of proteins involved in glucose metabolism and 3) increased F-18-fluorodeoxyglucose (FDG) uptake in interscapular brown adipose tissue (IBAT) measured by positron emission tomography (PET) (n = 25). The results of this study indicate that prenatal radiation exposure does not affect metabolic function up to 300 mGy and 1000 mGy may be a threshold dose for sex-specific alterations in glucose uptake and hepatic gene and protein expression of SOCS3, PEPCK, PPARGC1A and PPARGC1B. These findings suggest that SLDR doses alter glucose uptake in IBAT and hepatic gene and protein expression of offspring and these changes may progress with age.	[Davidson, Caitlund Q.; Niccoli, Sarah; Nemec-Bakk, Ashley; Khaper, Neelam; Lees, Simon J.] Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada; [Tharmalingam, Sujeenthar; Khurana, Sandhya; Murray, Alyssa; Tai, T. C.; Boreham, Douglas R.] Laurentian Univ, Northern Ontario Sch Med, Div Med Sci, Sudbury, ON, Canada; [Boreham, Douglas R.] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON, Canada; [Khaper, Neelam; Lees, Simon J.] Lakehead Univ, Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada	Lakehead University; Laurentian University; Northern Ontario School of Medicine; McMaster University; Lakehead University; Northern Ontario School of Medicine	Lees, SJ (corresponding author), Lakehead Univ, Dept Biol, Thunder Bay, ON, Canada.; Lees, SJ (corresponding author), Lakehead Univ, Northern Ontario Sch Med, Div Med Sci, Thunder Bay, ON, Canada.	simon.lees@nosm.ca			Natural Sciences and Engineering Research Council CRD; Bruce Power	Natural Sciences and Engineering Research Council CRD; Bruce Power	This work was supported by the Natural Sciences and Engineering Research Council CRD and Bruce Power.	Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Andrews RC, 1999, CLIN SCI, V96, P513, DOI 10.1042/cs0960513; Ayala JE, 2006, DIABETES, V55, P390, DOI 10.2337/diabetes.55.02.06.db05-0686; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Barjaktarovic Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027811; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Benekou A, 2001, INT J RADIAT BIOL, V77, P83, DOI 10.1080/095530001453140; Booth C, 2012, HEALTH PHYS, V103, P383, DOI 10.1097/HP.0b013e318266ee13; Boucher J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1905; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chang E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52583-x; Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196; De Santis Marco, 2007, Birth Defects Research, V81, P177, DOI 10.1002/bdrc.20099; Dube S, 2015, J CLIN ENDOCR METAB, V100, P4155, DOI 10.1210/jc.2015-2673; Dumortier O, 2017, DIABETES, V66, P627, DOI 10.2337/db16-0956; EZEKWE MO, 1984, J ANIM SCI, V59, P974, DOI 10.2527/jas1984.594974x; Falch J A, 1992, Tidsskr Nor Laegeforen, V112, P260; Fernandez-Perez Leandro, 2013, Front Endocrinol (Lausanne), V4, P66, DOI 10.3389/fendo.2013.00066; Franko KL, 2010, J ENDOCRINOL, V204, P319, DOI 10.1677/JOE-09-0390; Garofano A, 1999, DIABETOLOGIA, V42, P711, DOI 10.1007/s001250051219; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; GRAHN D, 1957, GENETICS, V42, P189; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Gruchot M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-18; Harlow E, 2006, CSH PROTOC; Harris K, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0115-9; Heerwagen MJR, 2010, AM J PHYSIOL-REG I, V299, pR711, DOI 10.1152/ajpregu.00310.2010; Heijboer AC, 2005, J LIPID RES, V46, P582, DOI 10.1194/jlr.M400440-JLR200; Herring CM, 2018, EXP BIOL MED, V243, P525, DOI 10.1177/1535370218758275; Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166; Hutter D, 2010, INT J PEDIAT, V2010, DOI 10.1155/2010/401323; Intapad S, 2016, PEDIATR RES, V79, P962, DOI 10.1038/pr.2016.14; Jackson AA, 2000, ADV EXP MED BIOL, V478, P41; Jakus PB, 2008, J LIPID RES, V49, P332, DOI 10.1194/jlr.M700316-JLR200; Jaquet D, 2005, DIABETOLOGIA, V48, P849, DOI 10.1007/s00125-005-1724-4; Jaquet D, 2000, J CLIN ENDOCR METAB, V85, P1401, DOI 10.1210/jc.85.4.1401; Kokosova N, 2015, CELL MOL NEUROBIOL, V35, P45, DOI 10.1007/s10571-014-0144-8; Kooijman S, 2015, TRENDS ENDOCRIN MET, V26, P657, DOI 10.1016/j.tem.2015.09.008; Labbe SM, 2015, FASEB J, V29, P2046, DOI 10.1096/fj.14-266247; Lee P, 2014, DIABETES, V63, P3686, DOI 10.2337/db14-0513; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowe XR, 2009, RADIAT RES, V171, P53, DOI 10.1667/RR1389.1; Lu LL, 2009, BEHAV BRAIN RES, V198, P172, DOI 10.1016/j.bbr.2008.10.031; Luchetti A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00093; Mirbolooki MR, 2014, NUCL MED BIOL, V41, P10, DOI 10.1016/j.nucmedbio.2013.08.009; MOLE RH, 1984, BRIT J RADIOL, V57, P355, DOI 10.1259/0007-1285-57-677-355; Mortiz CP, 2017, PROTEOMICS, V20; Muhlhausler B, 2009, TRENDS ENDOCRIN MET, V20, P51, DOI 10.1016/j.tem.2008.10.006; Nguyen P, 2015, J ENDOCRINOL, V227, P117, DOI 10.1530/JOE-15-0244; Nyirenda MJ, 1998, J CLIN INVEST, V101, P2174, DOI 10.1172/JCI1567; O'Regan D, 2004, AM J PHYSIOL-ENDOC M, V287, pE863, DOI 10.1152/ajpendo.00137.2004; OTAKE M, 1993, INT J RADIAT BIOL, V63, P255, DOI 10.1080/09553009314550341; Paigen B, 2014, LAB ANIM-UK, V48, P207, DOI 10.1177/0023677214521606; Rui LY, 2002, J BIOL CHEM, V277, P42394, DOI 10.1074/jbc.C200444200; Ryu Seung-Hyun, 2016, Lab Anim Res, V32, P116, DOI 10.5625/lar.2016.32.2.116; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sarvas JL, 2013, J DIABETES METAB S13, pS13; Shaw P, 2011, J VASC SURG, V53, p28S, DOI 10.1016/j.jvs.2010.05.140; Shen MQ, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/294278; Sreetharan S, 2017, RADIAT RES, V187, P647, DOI 10.1667/RR14657.1; Sun Y, 2002, J BIOL CHEM, V277, P23301, DOI 10.1074/jbc.M200964200; Suvorov A, 2016, ENDOCRINOLOGY, V157, P2586, DOI 10.1210/en.2016-1145; Tomasova L, 2012, ACTA PHYSIOL HUNG, V99, P126, DOI 10.1556/APhysiol.99.2012.2.5; Ueki K, 2005, HEPATOL RES, V33, P185, DOI 10.1016/j.hepres.2005.09.032; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; United Nations Scientific Committee on the Sources effects and risks of ionizing radiation, 2014, ANN LEV EFF RAD EXP; VALERA A, 1994, P NATL ACAD SCI USA, V91, P9151, DOI 10.1073/pnas.91.19.9151; Verreet T, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00083; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wang XF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099772; Westermeier F, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/917672; Williams PM, 2010, AM FAM PHYSICIAN, V82, P488; Wu CX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113742; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Young L E, 2001, Twin Res, V4, P307, DOI 10.1375/twin.4.5.307; Zhou XL, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0346-7	76	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231650	10.1371/journal.pone.0231650	http://dx.doi.org/10.1371/journal.pone.0231650			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315370	Green Published, gold, Green Submitted			2022-12-26	WOS:000536024800041
J	Neufcourt, L; Deguen, S; Bayat, S; Zins, M; Grimaud, O				Neufcourt, Lola; Deguen, Severine; Bayat, Sahar; Zins, Marie; Grimaud, Olivier			Gender differences in the association between socioeconomic status and hypertension in France: A cross-sectional analysis of the CONSTANCES cohort	PLOS ONE			English	Article							HEALTH INEQUALITIES; BLOOD-PRESSURE; PREVALENCE; POPULATION; INDICATORS; SES; AGE	Background Hypertension prevalence increases when socioeconomic status decreases but gender differences in the relationship between socioeconomic status and hypertension have been less studied. This work aimed to explore the pattern of associations between three indicators of socioeconomic status at individual, household, and municipal levels with hypertension across genders in a large sample of French adults from the CONSTANCES cohort. Methods Using data at inclusion from 59 805 participants (52% women) aged 25-69 years and recruited between 2012 and 2015, multilevel log-Poisson regressions with robust variance estimates were used to assess the associations of Relative Index of Inequality in education, monthly income per consumption unit and residential deprivation with hypertension. Modifying effects of gender and age in those associations were tested. Results Hypertension prevalence was higher in men than in women. Steep socioeconomic gradients of hypertension were observed for the three socioeconomic indicators in both genders and from the youngest to the oldest age class. Socioeconomic inequalities, especially educational inequalities, were larger among women than men: Relative Index of Inequality for highest versus lowest education among the 25-34 years were 0.43 [95%-confidence interval = 0.28-0.67] in women and 0.70 [95%-confidence interval = 0.53-0.92] in men. With increasing age, socioeconomic gradients of hypertension eased in men and even more in women so that gender differences decreased. Conclusions In this cross-sectional analysis of a large sample of adults, prevalence of hypertension was higher in men than in women. Moreover, socioeconomic status and especially education displayed a stronger association with hypertension prevalence in women compared to men. Reducing inequalities in hypertension may require gender-specific approaches.	[Neufcourt, Lola; Bayat, Sahar; Grimaud, Olivier] Univ Rennes, EHESP, REPERES Rech Pharmacoepidemiol & Recours Soins, EA, Rennes, France; [Deguen, Severine] IPLESP Inst PierreLouis Epidemiol & Sante Publ, EHESP, UMR S 1136, Rennes, France; [Zins, Marie] INSERM, Populat Based Epidemiol Cohorts Unit, UMS 011, Villejuif, France; [Zins, Marie] Paris Descartes Univ, Paris, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Universite de Rennes; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Neufcourt, L (corresponding author), Univ Rennes, EHESP, REPERES Rech Pharmacoepidemiol & Recours Soins, EA, Rennes, France.	lola.neufcourt@ehesp.fr	Neufcourt, Lola/AAA-2047-2022; Zins, Marie/AAX-6551-2021		French ministry of health; Region Bretagne; Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Council of the Ile de France Region; Cohorts TGIR IReSP-ISP INSERM (Ministere de la sante et des sports); Cohorts TGIR IReSP-ISP INSERM (Ministere delegue a la recherche); Cohorts TGIR IReSP-ISP INSERM (Institut national de la sante et de la recherche me dicale); Cohorts TGIR IReSP-ISP INSERM (Institut national du cancer et Caisse nationale de solidarite pour l'autonomie); French National Research Agency [ANR-11-INBS-0002]; MSD; AstraZeneca; Lundbeck	French ministry of health; Region Bretagne(Region Bretagne); Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS); Council of the Ile de France Region(Region Ile-de-France); Cohorts TGIR IReSP-ISP INSERM (Ministere de la sante et des sports); Cohorts TGIR IReSP-ISP INSERM (Ministere delegue a la recherche); Cohorts TGIR IReSP-ISP INSERM (Institut national de la sante et de la recherche me dicale); Cohorts TGIR IReSP-ISP INSERM (Institut national du cancer et Caisse nationale de solidarite pour l'autonomie); French National Research Agency(French National Research Agency (ANR)); MSD; AstraZeneca(AstraZeneca); Lundbeck(Lundbeck Corporation)	This work was supported by the French ministry of health and the Region Bretagne (research grant to LN). The CONSTANCES Cohort Study is supported by the Caisse Nationale d'Assurance Maladie des Travailleurs Salaries (CNAMTS), the french Ministry of Health, the Council of the Ile de France Region, and by the Cohorts TGIR IReSP-ISP INSERM (Ministere de la sante et des sports, Ministere delegue a la recherche, Institut national de la sante et de la recherche me dicale, Institut national du cancer et Caisse nationale de solidarite pour l'autonomie). CONSTANCES benefits from a grant from the French National Research Agency [grant number ANR-11-INBS-0002] and is also partly funded by MSD, AstraZeneca and Lundbeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Baek TH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2175-6; Beckfield J, 2013, AM BEHAV SCI, V57, P1014, DOI 10.1177/0002764213487343; Benzeval M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-947; Brown TH, 2016, J HEALTH SOC BEHAV, V57, P200, DOI 10.1177/0022146516645165; Clougherty JE, 2011, OCCUP ENVIRON MED, V68, P16, DOI 10.1136/oem.2009.049908; Cois A, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-414; Colhoun HM, 1998, J HUM HYPERTENS, V12, P91, DOI 10.1038/sj.jhh.1000558; Dalstra JAA, 2005, INT J EPIDEMIOL, V34, P316, DOI 10.1093/ije/dyh386; de Gaudemaris R, 2002, HYPERTENSION, V39, P1119, DOI 10.1161/01.HYP.0000018912.05345.55; de Saint Pol T, 2009, ECON HUM BIOL, V7, P398, DOI 10.1016/j.ehb.2009.06.002; Di Giosia P, 2018, CURR ATHEROSCLER REP, V20, DOI 10.1007/s11883-018-0716-z; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Godet-Thobie H., 2008, Bulletin Epidemiologique Hebdomadaire, P478; GREENLAND S, 1987, AM J EPIDEMIOL, V125, P761, DOI 10.1093/oxfordjournals.aje.a114593; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Leng B, 2015, J HYPERTENS, V33, P221, DOI 10.1097/HJH.0000000000000428; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mosquera PA, 2016, SOC SCI MED, V149, P135, DOI 10.1016/j.socscimed.2015.12.017; Murphy M., JOINT PROGRAMMING IN; National Institute of Statistics and Economic Studies, CONS UN DEF; National Institute of Statistics and Economic Studies (INSEE), 2017, FEMM HOMM LEG QUEST; Neufcourt L, 2019, EUR J PREV CARDIOL, V26, P1242, DOI 10.1177/2047487319842229; Perrine A. L., 2018, Bulletin Epidemiologique Hebdomadaire, P170; Pickett KE, 2015, SOC SCI MED, V128, P316, DOI 10.1016/j.socscimed.2014.12.031; Prus SG, 2007, SOCIOL HEALTH ILL, V29, P275, DOI 10.1111/j.1467-9566.2007.00547.x; Reckelhoff JF, 2018, CURR OPIN NEPHROL HY, V27, P176, DOI 10.1097/MNH.0000000000000404; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Ruiz F, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3439-5; Santin G., 2016, Bulletin Epidemiologique Hebdomadaire, P622; Alves RFS, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0441-6; Tuppin P, 2013, ARCH CARDIOVASC DIS, V106, P274, DOI 10.1016/j.acvd.2013.02.005; United Nations, SUST DEV GOALS; Van Minh H, 2006, J HUM HYPERTENS, V20, P109, DOI 10.1038/sj.jhh.1001942; Wagner A, 2011, J HYPERTENS, V29, P43, DOI 10.1097/HJH.0b013e32833f9c4d; WHELTON PK, 1994, LANCET, V344, P101, DOI 10.1016/S0140-6736(94)91285-8; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; Yelland LN, 2011, INT J BIOSTAT, V7, DOI 10.2202/1557-4679.1278; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zins M, 2015, EUR J EPIDEMIOL, V30, P1317, DOI 10.1007/s10654-015-0096-4	45	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231878	10.1371/journal.pone.0231878	http://dx.doi.org/10.1371/journal.pone.0231878			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9MR	32311000	gold, Green Published			2022-12-26	WOS:000536019800044
J	Shilova, IN; Magasin, JD; Mills, MM; Robidart, JC; Turk-Kubo, KA; Zehr, JP				Shilova, Irina N.; Magasin, Jonathan D.; Mills, Matthew M.; Robidart, Julie C.; Turk-Kubo, Kendra A.; Zehr, Jonathan P.			Phytoplankton transcriptomic and physiological responses to fixed nitrogen in the California current system	PLOS ONE			English	Article							CYANOBACTERIUM SYNECHOCOCCUS; PROCHLOROCOCCUS ECOTYPES; NITRATE ASSIMILATION; MARINE SYNECHOCOCCUS; MONTEREY BAY; NORTHERN CALIFORNIA; TEMPORAL DYNAMICS; TRANSITION ZONE; IRON; UREA	Marine phytoplankton are responsible for approximately half of photosynthesis on Earth. However, their ability to drive ocean productivity depends on critical nutrients, especially bioavailable nitrogen (N) which is scarce over vast areas of the ocean. Phytoplankton differ in their preferences for N substrates as well as uptake efficiencies and minimal N requirements relative to other critical nutrients, including iron (Fe) and phosphorus. In this study, we used the MicroTOOLs high-resolution environmental microarray to examine transcriptomic responses of phytoplankton communities in the California Current System (CCS) transition zone to added urea, ammonium, nitrate, and also Fe in the late summer when N depletion is common. Transcript level changes of photosynthetic, carbon fixation, and nutrient stress genes indicated relief of N limitation in many strains of Prochlorococcus, Synechococcus, and eukaryotic phytoplankton. The transcriptomic responses helped explain shifts in physiological and growth responses observed later. All three phytoplankton groups had increased transcript levels of photosynthesis and/or carbon fixation genes in response to all N substrates. However, only Prochlorococcus had decreased transcript levels of N stress genes and grew substantially, specifically after urea and ammonium additions, suggesting that Prochlorococcus outcompeted other community members in these treatments. Diatom transcript levels of carbon fixation genes increased in response to Fe but not to Fe with N which might have favored phytoplankton that were co-limited by N and Fe. Moreover, transcription patterns of closely related strains indicated variability in N utilization, including nitrate utilization by some high-light adapted Prochlorococcus. Finally, up-regulation of urea transporter genes by both Prochlorococcus and Synechococcus in response to filtered deep water suggested a regulatory mechanism other than classic control via the global N regulator NtcA. This study indicated that co-existing phytoplankton strains experience distinct nutrient stresses in the transition zone of the CCS, an understudied region where oligotrophic and coastal communities naturally mix.	[Shilova, Irina N.; Magasin, Jonathan D.; Turk-Kubo, Kendra A.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [Mills, Matthew M.] Stanford Univ, Dept Earth Syst Sci, Stanford, CA 94305 USA; [Robidart, Julie C.] Natl Oceanog Ctr, Ocean Technol & Engn, Southampton, England; [Shilova, Irina N.] Second Genome, San Francisco, CA USA	University of California System; University of California Santa Cruz; Stanford University; NERC National Oceanography Centre	Shilova, IN; Zehr, JP (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA.	irinanshi@gmail.com; jpzehr@ucsc.edu	Shilova, Irina/ABF-9218-2020	Shilova, Irina/0000-0002-6216-5842; mills, matthew/0000-0002-9738-5589; , Jonathan/0000-0003-4187-4778; Turk-Kubo, Kendra/0000-0002-9847-7514	National Science Foundation [OCE 1241221]; Center for Microbial Oceanography: Research and Education [NSF EF0424599]; Simons Foundation [329108, 426570SP]; NERC [noc010013] Funding Source: UKRI	National Science Foundation(National Science Foundation (NSF)); Center for Microbial Oceanography: Research and Education; Simons Foundation; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Financial Disclosure: This work was supported by awards from National Science Foundation (https://www.nsf.gov/) Dimensions of Biodiversity Program (OCE 1241221 to J.P.Z) and Center for Microbial Oceanography: Research and Education (http://cmore.soest.hawaii.edu/, NSF EF0424599 to J.P.Z). Additional support was provided by the Simons Foundation (https://www.simonsfoundation.org/) SCOPE (Award ID 329108 to J.P.Z) and Gradients (Award ID 426570SP: V. Armbrust, U. Washington, with subcontract to J.P. Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the captain, crew and technicians of the R/V New Horizon for their assistance and support during the NH1417 research cruise and experiments. We gratefully acknowledge M. Hogan (UCSC) for helping in preparations for the cruise, J.P. Baro and I. Rapp (GEOMAR) for providing support for the trace-metal clean work, and G. Hehman at the Roy J. Carver Center for Genomics (The University of Iowa, USA) for microarray consultation and hybridization. In addition, we thank T. Fredrickson and M. Linney for their help in experiment set-up and sampling. The authors also appreciate the efforts of the anonymous reviewers who critically read and helped to clarify the manuscript.	Ahlgren NA, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00213; Alhamdoosh M, 2017, BIOINFORMATICS, V33, P414, DOI 10.1093/bioinformatics/btw623; Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berges JA, 1997, EUR J PHYCOL, V32, P3; BERNSTEIN RL, 1977, SCIENCE, V195, P353, DOI 10.1126/science.195.4276.353; Berthelot H, 2019, ISME J, V13, P651, DOI 10.1038/s41396-018-0285-8; Berube PM, 2019, ELIFE, V8, DOI 10.7554/eLife.41043; Berube PM, 2016, LIMNOL OCEANOGR, V61, P482, DOI 10.1002/lno.10226; Berube PM, 2015, ISME J, V9, P1195, DOI 10.1038/ismej.2014.211; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Biller DV, 2014, PROG OCEANOGR, V120, P370, DOI 10.1016/j.pocean.2013.11.002; Biller DV, 2013, MAR CHEM, V155, P50, DOI 10.1016/j.marchem.2013.06.003; Biller DV, 2013, CONT SHELF RES, V66, P58, DOI 10.1016/j.csr.2013.07.003; Bird C, 2003, APPL ENVIRON MICROB, V69, P7009, DOI 10.1128/AEM.69.12.7009-7018.2003; BRAND LE, 1991, LIMNOL OCEANOGR, V36, P1756, DOI 10.4319/lo.1991.36.8.1756; Bronk DA, 1998, AQUAT MICROB ECOL, V15, P177, DOI 10.3354/ame015177; BRONK DA, 2002, BIOGEOCHEMISTRY MARI, P153, DOI DOI 10.1016/B978-012323841-2/50007-5; Bruhn A, 2010, J PHYCOL, V46, P266, DOI 10.1111/j.1529-8817.2010.00809.x; Bruland KW, 2001, LIMNOL OCEANOGR, V46, P1661, DOI 10.4319/lo.2001.46.7.1661; CAMPBELL L, 1994, LIMNOL OCEANOGR, V39, P954, DOI 10.4319/lo.1994.39.4.0954; CHAVEZ FP, 1991, J GEOPHYS RES-OCEANS, V96, P14833, DOI 10.1029/91JC01163; Cho BC, 1996, MAR ECOL PROG SER, V142, P19, DOI 10.3354/meps142019; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Collier JL, 1999, MICROBIOL-SGM, V145, P447, DOI 10.1099/13500872-145-2-447; Collins CA, 2003, DEEP-SEA RES PT II, V50, P2389, DOI 10.1016/S0967-0645(03)00134-6; DeSantis TZ, 2007, MICROB ECOL, V53, P371, DOI 10.1007/s00248-006-9134-9; Dufresne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r90; Durazo R, 2015, J GEOPHYS RES-OCEANS, V120, P1173, DOI 10.1002/2014JC010405; Endo H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29039-9; EPPLEY RW, 1977, MAR BIOL, V39, P111, DOI 10.1007/BF00386996; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flores E, 2005, BIOCHEM SOC T, V33, P164, DOI 10.1042/BST0330164; Glibert PM, 2016, LIMNOL OCEANOGR, V61, P165, DOI 10.1002/lno.10203; Gorl M, 1998, MICROBIOL-SGM, V144, P2449, DOI 10.1099/00221287-144-9-2449; HANSELL DA, 1989, CAN J FISH AQUAT SCI, V46, P198, DOI 10.1139/f89-027; Herrero A, 2001, J BACTERIOL, V183, P411, DOI 10.1128/JB.183.2.411-425.2001; Hewson I, 2009, ISME J, V3, P1286, DOI 10.1038/ismej.2009.75; Huang SJ, 2012, ISME J, V6, P285, DOI 10.1038/ismej.2011.106; Jacox MG, 2015, GEOPHYS RES LETT, V42, P5950, DOI 10.1002/2015GL065147; Kashtan N, 2014, SCIENCE, V344, P416, DOI 10.1126/science.1248575; Kettler GC, 2007, PLOS GENET, V3, P2515, DOI 10.1371/journal.pgen.0030231; Koch AL, 1996, ANNU REV MICROBIOL, V50, P317, DOI 10.1146/annurev.micro.50.1.317; Kolody BC, 2019, ISME J, V13, P2817, DOI 10.1038/s41396-019-0472-2; KRUSKAL JB, 1964, PSYCHOMETRIKA, V29, P1, DOI 10.1007/BF02289565; Kudela RM, 2008, OCEANOGRAPHY, V21, P46, DOI 10.5670/oceanog.2008.04; Kudela RM, 2000, DEEP-SEA RES PT II, V47, P1023, DOI 10.1016/S0967-0645(99)00135-6; Landry MR, 2012, J PLANKTON RES, V34, P739, DOI 10.1093/plankt/fbs025; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li QP, 2012, J PLANKTON RES, V34, P790, DOI 10.1093/plankt/fbs006; Lindehoff E, 2011, HARMFUL ALGAE, V12, P70, DOI 10.1016/j.hal.2011.09.001; Lindell D, 1998, J BACTERIOL, V180, P1878, DOI 10.1128/JB.180.7.1878-1886.1998; Lindell D, 2001, APPL ENVIRON MICROB, V67, P3340, DOI 10.1128/AEM.67.8.3340-3349.2001; Lomas MW, 1999, LIMNOL OCEANOGR, V44, P556, DOI 10.4319/lo.1999.44.3.0556; Ludwig M, 2012, FRONT MICROBIOL, V3, DOI [10.3389/fmicb.2012.00145, 10.3389/fmicb.2012.00354]; LYNN RJ, 1987, J GEOPHYS RES-OCEANS, V92, P12947, DOI 10.1029/JC092iC12p12947; Malmstrom RR, 2010, ISME J, V4, P1252, DOI 10.1038/ismej.2010.60; Mann EL, 2000, LIMNOL OCEANOGR, V45, P1067, DOI 10.4319/lo.2000.45.5.1067; Martiny AC, 2006, P NATL ACAD SCI USA, V103, P12552, DOI 10.1073/pnas.0601301103; Martiny AC, 2009, P NATL ACAD SCI USA, V106, P10787, DOI 10.1073/pnas.0902532106; Mazard S, 2012, ENVIRON MICROBIOL, V14, P372, DOI 10.1111/j.1462-2920.2011.02514.x; McCarren J, 2010, P NATL ACAD SCI USA, V107, P16420, DOI 10.1073/pnas.1010732107; McCarthy JK, 2017, PLANT CELL, V29, P2047, DOI 10.1105/tpc.16.00910; Mills MM, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00362; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore LR, 2002, LIMNOL OCEANOGR, V47, P989, DOI 10.4319/lo.2002.47.4.0989; Morando M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01932; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Nagai T, 2015, J GEOPHYS RES-OCEANS, V120, P5318, DOI 10.1002/2015JC010889; Ottesen EA, 2011, ISME J, V5, P1881, DOI 10.1038/ismej.2011.70; Paerl RW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00059; Painter SC, 2008, MAR ECOL PROG SER, V368, P53, DOI 10.3354/meps07586; Palenik B, 2006, P NATL ACAD SCI USA, V103, P13555, DOI 10.1073/pnas.0602963103; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Read RW, 2017, ISME J, V11, P2267, DOI 10.1038/ismej.2017.88; Rii YM, 2016, LIMNOL OCEANOGR, V61, P806, DOI 10.1002/lno.10255; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivers AR, 2009, ENVIRON MICROBIOL, V11, P382, DOI 10.1111/j.1462-2920.2008.01778.x; Robidart JC, 2019, ISME J, V13, P374, DOI 10.1038/s41396-018-0280-0; Rocap G, 2002, APPL ENVIRON MICROB, V68, P1180, DOI 10.1128/AEM.68.3.1180-1191.2002; Rocap G, 2003, NATURE, V424, P1042, DOI 10.1038/nature01947; Scanlan DJ, 2009, MICROBIOL MOL BIOL R, V73, P249, DOI 10.1128/MMBR.00035-08; Schulien JA, 2017, MAR ECOL PROG SER, V572, P43, DOI 10.3354/meps12142; Shi YM, 2012, ENVIRON MICROBIOL, V14, P191, DOI 10.1111/j.1462-2920.2011.02598.x; Shilova IN, 2017, LIMNOL OCEANOGR, V62, P2550, DOI 10.1002/lno.10590; Shilova IN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146706; Shilova IN, 2014, ISME J, V8, P1476, DOI 10.1038/ismej.2014.1; Simmons MP, 2016, APPL ENVIRON MICROB, V82, P1693, DOI 10.1128/AEM.02730-15; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sohm JA, 2016, ISME J, V10, P333, DOI 10.1038/ismej.2015.115; Su ZC, 2006, NUCLEIC ACIDS RES, V34, P1050, DOI 10.1093/nar/gkj496; Su ZC, 2005, NUCLEIC ACIDS RES, V33, P5156, DOI 10.1093/nar/gki817; Sudek S, 2015, ENVIRON MICROBIOL, V17, P3692, DOI 10.1111/1462-2920.12742; Toledo G, 1997, APPL ENVIRON MICROB, V63, P4298, DOI 10.1128/AEM.63.11.4298-4303.1997; Tolonen AC, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100087; VEGAPALAS MA, 1992, MOL MICROBIOL, V6, P1853, DOI 10.1111/j.1365-2958.1992.tb01357.x; Waterbury JB, 1986, CAN B FISH AQUAT SCI, V214, P71; Wilkerson FP, 2000, DEEP-SEA RES PT II, V47, P1003, DOI 10.1016/S0967-0645(99)00134-4; WILKINSON B, 1951, PSYCHOL BULL, V48, P156, DOI 10.1037/h0059111; Williams E., 1999, THESIS; Wyman M, 2007, APPL ENVIRON MICROB, V73, P3028, DOI 10.1128/AEM.02606-06; Zinser ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005135; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	105	2	2	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231771	10.1371/journal.pone.0231771	http://dx.doi.org/10.1371/journal.pone.0231771			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32310982	Green Accepted, gold, Green Published			2022-12-26	WOS:000536019800029
J	Perli, E; Pisano, A; Pignataro, MG; Campese, AF; Pelullo, M; Genovese, I; de Turris, V; Ghelli, AM; Cerbelli, B; Giordano, C; Colotti, G; Morea, V; d'Amati, G				Perli, Elena; Pisano, Annalinda; Pignataro, Maria Gemma; Campese, Antonio Francesco; Pelullo, Maria; Genovese, Ilaria; de Turris, Valeria; Ghelli, Anna Maria; Cerbelli, Bruna; Giordano, Carla; Colotti, Gianni; Morea, Veronica; d'Amati, Giulia			Exogenous peptides are able to penetrate human cell and mitochondrial membranes, stabilize mitochondrial tRNA structures, and rescue severe mitochondrial defects	FASEB JOURNAL			English	Article						mitochondrial (mt) diseases; mitochondrial targeting; rescuing peptides; transfer RNA (tRNA) point mutations	SYNTHETASE; MUTATIONS; GENOMES; MODEL	Mutations in mitochondrial transfer RNA (mt-tRNA) genes are responsible for a wide range of syndromes, for which no effective treatment is available. We previously reported that transfection of the nucleotide sequence encoding for the 16-residue beta 32_33 peptide from mitochondrial leucyl-tRNA synthetase ameliorates the cell phenotype caused by the mitochondrial tRNA mutations. In this work, we demonstrated that both the beta 32_33 peptide linked with the known (L)-Phe-(D)-Arg-(L)-Phe-(L)-Lys (FrFK) mitochondrial penetrating sequence and, strikingly, the beta 32_33 peptide per se, are able to penetrate both the plasma and mitochondrial membranes and exert the rescuing activity when exogenously administered to cells bearing the mutations m.3243A > G and m.8344A > G. These mutations are responsible for the most common and severe mt-tRNA-related diseases. In addition, we dissected the molecular determinants of constructs activity by showing that both the order of amino acids along the sequence and presence of positive charges are essential determinants of the peptide activity in cells and mt-tRNA structures stabilization in vitro. In view of future in vivo studies, this information may be required to design of beta 32_33 peptide-mimetic derivatives. The beta 32_33 and FrFK-beta 32_33 peptides are, therefore, promising molecules for the development of therapeutic agents against diseases caused by the mt-tRNA point mutations.	[Perli, Elena; Pisano, Annalinda; Pignataro, Maria Gemma; Giordano, Carla] Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Rome, Italy; [Campese, Antonio Francesco] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Pelullo, Maria; de Turris, Valeria] Ist Italiano Tecnol, Ctr Life Nano Sci Sapienza, Rome, Italy; [Genovese, Ilaria] Sapienza Univ Rome, Dept Biochem Sci A Rossi Fanelli, Rome, Italy; [Ghelli, Anna Maria] Univ Bologna, Dept Pharm & Biotechnol FABIT, Bologna, Italy; [Cerbelli, Bruna] Sapienza Univ, Dept Med Surg Sci & Biotechnol, Latina, Italy; [Colotti, Gianni; Morea, Veronica] Natl Res Council Italy, Inst Mol Biol & Pathol, Rome, Italy; [d'Amati, Giulia] Sapienza Univ Rome, Ist Pasteur Italia Fdn Cenci Bolognetti, Dept Radiol Oncol & Pathol Sci, Rome, Italy	Sapienza University Rome; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; Sapienza University Rome; University of Bologna; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	d'Amati, G (corresponding author), Sapienza Univ Rome, Dept Radiol Oncol & Pathol Sci, Policlin Umberto I, Viale Regina Elena 324, I-00161 Rome, Italy.; Morea, V (corresponding author), Sapienza Univ Rome, Natl Res Council Italy, Inst Mol Biol & Pathol, Dept Biochem Sci A Rossi Fanelli, Piazzale Aldo Moro 5, I-00161 Rome, Italy.	veronica.morea@cnr.it; giulia.damati@uniroma1.it	Genovese, Ilaria/AAK-3403-2021; Pelullo, Maria/AFE-7902-2022; Morea, Veronica/AAS-6881-2020; GIORDANO, Carla/L-5657-2015; Colotti, Gianni/D-2015-2010	Morea, Veronica/0000-0003-2566-3049; GENOVESE, Ilaria/0000-0002-1981-750X; GIORDANO, Carla/0000-0002-3716-4303; Colotti, Gianni/0000-0002-9913-0635	AFM-Telethon (French Muscular Dystrophy Association) [20607]; Istituto Pasteur-Fondazione Cenci Bolognetti (Cenci Bolognetti Foundation); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2017483NH8_005]; Mitocon Italy [2018-02]	AFM-Telethon (French Muscular Dystrophy Association); Istituto Pasteur-Fondazione Cenci Bolognetti (Cenci Bolognetti Foundation); Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Mitocon Italy	AFM-Telethon (French Muscular Dystrophy Association), Grant/Award Number: 20607; Istituto Pasteur-Fondazione Cenci Bolognetti (Cenci Bolognetti Foundation), Grant/Award Number: Anna Tramontano; Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR), Grant/Award Number: 2017483NH8_005 to Veronica Morea; Mitocon Italy, Grant/Award Number: 2018-02 to Annalinda Pisano	Bacman SR, 2018, NAT MED, V24, P1696, DOI 10.1038/s41591-018-0166-8; Bacman SR, 2013, NAT MED, V19, P1111, DOI 10.1038/nm.3261; Bredenoord AL, 2017, SCIENCE, V355, DOI 10.1126/science.aaf9414; Campese AF, 2009, INT IMMUNOL, V21, P727, DOI 10.1093/intimm/dxp042; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; Craven L, 2017, ANNU REV GENOM HUM G, V18, P257, DOI 10.1146/annurev-genom-091416-035426; Di Micco P, 2014, BBA-MOL CELL RES, V1843, P3065, DOI 10.1016/j.bbamcr.2014.09.011; Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007; Gammage PA, 2018, NAT MED, V24, P1691, DOI 10.1038/s41591-018-0165-9; Gammage PA, 2014, EMBO MOL MED, V6, P458, DOI 10.1002/emmm.201303672; Hirano M, 2018, ESSAYS BIOCHEM, V62, P467, DOI 10.1042/EBC20170114; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Hue THD, 2014, EMBO MOL MED, V6, P183, DOI 10.1002/emmm.201303202; Inak G, 2017, STEM CELLS, V35, P1655, DOI 10.1002/stem.2637; Jean SR, 2016, ACCOUNTS CHEM RES, V49, P1893, DOI 10.1021/acs.accounts.6b00277; KING MP, 1992, MOL CELL BIOL, V12, P480, DOI 10.1128/MCB.12.2.480; Kirino Y, 2004, P NATL ACAD SCI USA, V101, P15070, DOI 10.1073/pnas.0405173101; Ma H, 2015, NATURE, V524, P234, DOI 10.1038/nature14546; Mahon KP, 2007, CHEM BIOL, V14, P923, DOI 10.1016/j.chembiol.2007.07.011; McDonnell MT, 2004, EUR J HUM GENET, V12, P778, DOI 10.1038/sj.ejhg.5201216; Meseguer S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06553-w; Nightingale H, 2016, BRAIN, V139, P1633, DOI 10.1093/brain/aww081; Pello R, 2008, HUM MOL GENET, V17, P4001, DOI 10.1093/hmg/ddn303; Perli E, 2016, HUM MOL GENET, V25, P903, DOI 10.1093/hmg/ddv619; Perli E, 2014, EMBO MOL MED, V6, P169, DOI 10.1002/emmm.201303198; Rasband WS, 2018, IMAGEJ; Rorbach J, 2008, NUCLEIC ACIDS RES, V36, P3065, DOI 10.1093/nar/gkn147; Rossmanith W, 1998, FEBS LETT, V433, P269, DOI 10.1016/S0014-5793(98)00928-4; Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245; Tomcin S, 2014, INT J NANOMED, V9, P5471, DOI 10.2147/IJN.S70908; Yarham JW, 2010, WIRES RNA, V1, P304, DOI 10.1002/wrna.27; Yasukawa T, 2001, EMBO J, V20, P4794, DOI 10.1093/emboj/20.17.4794	32	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7675	7686		10.1096/fj.201903270R	http://dx.doi.org/10.1096/fj.201903270R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32304340				2022-12-26	WOS:000527389300001
J	Boukhris, I; Smaoui, S; Ennouri, K; Morjene, N; Farhat-Khemakhem, A; Blibech, M; Alghamdi, OA; Chouayekh, H				Boukhris, Ines; Smaoui, Slim; Ennouri, Karim; Morjene, Nawres; Farhat-Khemakhem, Ameny; Blibech, Monia; Alghamdi, Othman A.; Chouayekh, Hichem			Towards understanding the antagonistic activity of phytic acid against common foodborne bacterial pathogens using a general linear model	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; STAPHYLOCOCCUS-AUREUS; CITRIC-ACID; SALMONELLA; PHYTATE; CALCIFICATIONS; TYPHIMURIUM; COMBINATION; EFFICACY; FUTURE	The increasing challenge of antibiotic resistance requires not only the discovery of new antibiotics, but also the development of new alternative approaches. Therefore, in the present study, we investigated for the first time the antibacterial potential of phytic acid (myo-inositol hexakisphosphate, IP6), a natural molecule that is 'generally recognized as safe' (FDA classification), against the proliferation of common foodborne bacterial pathogens such as Listeria monocytogenes, Staphylococcus aureus and Salmonella Typhimurium. Interestingly, compared to citric acid, IP6 was found to exhibit significantly greater inhibitory activity (P< 0.05) against these pathogenic bacteria. The minimum inhibitory concentration of IP6 varied from 0.488 to 0.97 mg/ml for the Gram-positive bacteria that were tested, and was 0.244 mg/ml for the Gram-negative bacteria. Linear and general models were used to further explore the antibacterial effects of IP6. The developed models were validated using experimental growth data for L. monocytogenes, S. aureus and S. Typhimurium. Overall, the models were able to accurately predict the growth of L. monocytogenes, S. aureus, and S. Typhimuriumin Polymyxin acriflavine lithium chloride ceftazidime aesculin mannitol (PAL-CAM), Chapman broth, and xylose lysine xeoxycholate (XLD) broth, respectively. Remarkably, the early logarithmic growth phase of S. Typhimurium showed a rapid and severe decrease in a period of less than one hour, illustrating the bactericidal effect of IP6. These results suggest that IP6 is an efficient antibacterial agent and can be used to control the proliferation of foodborne pathogens. It has promising potential for environmentally friendly applications in the food industry, such as for food preservation, food safety, and for prolonging shelf life.	[Boukhris, Ines; Smaoui, Slim; Morjene, Nawres; Farhat-Khemakhem, Ameny; Blibech, Monia; Chouayekh, Hichem] Univ Sfax, Ctr Biotechnol Sfax, Lab Microorganismes & Biomol, Sfax, Tunisia; [Ennouri, Karim] Univ Sfax, Olive Tree Inst, Lab Ameliorat & Protect Olive Genet Resources, Sfax, Tunisia; [Alghamdi, Othman A.; Chouayekh, Hichem] Univ Jeddah, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia	Centre de Biotechnologie de Sfax; Universite de Sfax; Institut de l'Olivier; Universite de Sfax; University of Jeddah	Chouayekh, H (corresponding author), Univ Sfax, Ctr Biotechnol Sfax, Lab Microorganismes & Biomol, Sfax, Tunisia.; Chouayekh, H (corresponding author), Univ Jeddah, Dept Biol Sci, Fac Sci, Jeddah, Saudi Arabia.	hschouayekh@uj.edu.sa		FARHAT - KHEMAKHEM, Ameny/0000-0002-9422-7091; SMAOUI, Slim/0000-0002-8839-7377; Chouayekh, Hichem/0000-0003-3894-1116; Alghamdi, Othman/0000-0001-5673-284X	Tunisian Government; University of Jeddah; International Cooperation Grant Research Project [UJ-02-009-ICGR]; University of Jeddah (Saudi Arabia) through the International Cooperation Grant Research [UJ-02-009-ICGR]	Tunisian Government; University of Jeddah; International Cooperation Grant Research Project; University of Jeddah (Saudi Arabia) through the International Cooperation Grant Research	The Tunisian Government provided support via the Contract Program LMB-CBS (2015-2018) which includes several research projects, including this work. Funding was also received from the recently accepted International Cooperation Grant Research Project No UJ-02-009-ICGR, funded by the University of Jeddah, though the grant is not specific to this study, but rather focusing on bio-composites for active packaging. These provided funds were used to support the editing by a commercial and professional editing service as well as the publication fees of this manuscript in PLOS ONE.; This work was supported by the Tunisian Government (Contract Program LMB-CBS, 2015-2018) and by the University of Jeddah (Saudi Arabia) through the International Cooperation Grant Research Project No UJ-02-009-ICGR.	Anekonda TS, 2011, J ALZHEIMERS DIS, V23, P21, DOI 10.3233/JAD-2010-101287; Axmann S, 2017, FOOD ADDIT CONTAM A, V34, P1915, DOI 10.1080/19440049.2017.1363415; Bari ML, 2005, J FOOD PROTECT, V68, P1381, DOI 10.4315/0362-028X-68.7.1381; Ben Braiek O, 2019, LWT-FOOD SCI TECHNOL, V99, P244, DOI 10.1016/j.lwt.2018.09.053; Ben Braiek O, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5827986; Bhaskar SV, 2017, FOOD SAFETY IN THE 21ST CENTURY: PUBLIC HEALTH PERSPECTIVE, P3, DOI 10.1016/B978-0-12-801773-9.00001-7; Bhowmik A, 2017, BIOMED PHARMACOTHER, V87, P443, DOI 10.1016/j.biopha.2016.12.125; Brunet J, 2010, FOOD TECHNOL BIOTECH, V48, P524; Canan C, 2012, ACTA SCI-TECHNOL, V34, P457, DOI 10.4025/actascitechnol.v34i4.16358; Carocho M, 2015, TRENDS FOOD SCI TECH, V45, P284, DOI 10.1016/j.tifs.2015.06.007; Chen JH, 2012, COMPR REV FOOD SCI F, V11, P119, DOI 10.1111/j.1541-4337.2011.00177.x; Chen Y, 2016, J FOOD PROTECT, V79, P1828, DOI 10.4315/0362-028X.JFP-16-208; Choi MJ, 2013, INT J FOOD MICROBIOL, V166, P499, DOI 10.1016/j.ijfoodmicro.2013.08.016; Colagiorgi A, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030041; Doulgeraki AI, 2017, RES MICROBIOL, V168, P1, DOI 10.1016/j.resmic.2016.08.001; EVANS WJ, 1982, J AM OIL CHEM SOC, V59, P189, DOI 10.1007/BF02680274; Ferreira S, 2016, J SCI FOOD AGR, V96, P4531, DOI 10.1002/jsfa.7669; Gossner S, 2019, J AGR FOOD CHEM, V67, P247, DOI 10.1021/acs.jafc.8b06117; Grases F, 2006, FRONT BIOSCI-LANDMRK, V11, P136, DOI 10.2741/1786; Grases F, 2000, BIOFACTORS, V11, P171, DOI 10.1002/biof.5520110303; Gulluce M, 2007, FOOD CHEM, V103, P1449, DOI 10.1016/j.foodchem.2006.10.061; Gutierrez D, 2012, APPL ENVIRON MICROB, V78, P8547, DOI 10.1128/AEM.02045-12; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Hu WD, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15016084; Vu HTK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214641; Jariwalla RJ, 1999, ANTICANCER RES, V19, P3699; Jiang HY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/2035851; Joshi K, 2013, TRENDS FOOD SCI TECH, V34, P54, DOI 10.1016/j.tifs.2013.08.008; Kalani BS, 2018, MICROB PATHOGENESIS, V122, P19, DOI 10.1016/j.micpath.2018.06.003; Khabbaz RF, 2014, LANCET, V384, P53, DOI 10.1016/S0140-6736(14)60890-4; Kwon SA, 2019, FOOD MICROBIOL, V82, P342, DOI 10.1016/j.fm.2019.03.012; Lee C, 2019, PLOS ONE, V14; Lin CM, 2010, FOOD CONTROL, V21, P1710, DOI 10.1016/j.foodcont.2010.06.008; Mathipa MG, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220321; Meyers L. S., 2006, APPL MULTIVARIATE RE; Morach M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222036; Nilsson OR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215190; Norazalina S, 2010, EXP TOXICOL PATHOL, V62, P259, DOI 10.1016/j.etp.2009.04.002; Norhaizan M E, 2011, Malays J Nutr, V17, P367; Parish M. E., 2003, COMPR REV FOOD SCI F, V2, P161, DOI DOI 10.1111/J.1541-4337.2003.TB00033.X; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Rutherford A., 2001, INTRO ANOVA ANCOVA G; Schlemmer U, 2009, MOL NUTR FOOD RES, V53, pS330, DOI 10.1002/mnfr.200900099; Schubert J, 2017, FOODBORNE PATHOG DIS, V14, P223, DOI 10.1089/fpd.2016.2210; Shamsuddin AM, 1997, LIFE SCI, V61, P343, DOI 10.1016/S0024-3205(97)00092-1; Smaoui S, 2014, FOOD ADDIT CONTAM A, V31, P218, DOI 10.1080/19440049.2013.873144; Valgas C, 2007, BRAZ J MICROBIOL, V38, P369, DOI 10.1590/S1517-83822007000200034; Vazquez-Sanchez D, 2018, FOOD SCI TECHNOL INT, V24, P209, DOI 10.1177/1082013217742753; Vazquez-Sanchez D, 2014, FOOD CONTROL, V39, P8, DOI 10.1016/j.foodcont.2013.09.029; World Health Organization (WHO), 2013, 1 M GEN SEPT 19 20; Xu Q, 2008, TOXICOLOGY, V245, P101, DOI 10.1016/j.tox.2007.12.017	51	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231397	10.1371/journal.pone.0231397	http://dx.doi.org/10.1371/journal.pone.0231397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302332	Green Submitted, Green Published, gold			2022-12-26	WOS:000536016100025
J	Cisse, YM; Russart, K; Nelson, RJ				Cisse, Yasmine M.; Russart, Kathryn; Nelson, Randy J.			Exposure to dim light at night prior to conception attenuates offspring innate immune responses	PLOS ONE			English	Article							INFLAMMATORY RESPONSES; ALTERS; CLOCK; RHYTHMS; ALPHA	Functional circadian timekeeping is necessary for homeostatic control of the immune system and appropriate immune responsiveness. Disruption of natural light-dark cycles, through light at night (LAN), impairs innate and adaptive immune responses in nocturnal rodents. These altered immune responses are associated with disrupted endogenous gene transcriptional and endocrine cycles. However, few studies have addressed the multigenerational consequences of systemic circadian rhythm disruption. We hypothesized that parental exposure to dim LAN (dLAN) would alter innate immune and sickness responses to an endotoxin challenge in adult offspring gestated and reared in dark nights. Adult male and female Siberian hamsters were exposed to either dark nights (DARK) or dLAN (similar to 5 lux) for 8 weeks, then paired, mated, and thereafter housed under dark nights. Maternal exposure to dLAN prior to conception impaired febrile responses and increased splenic il-1 production in response to LPS in male offspring. Paternal pre-conception dLAN dampened offspring tnf-alpha expression in the hypothalamus, reduced serum bactericidal capacity, and dark phase locomotor activity. These changes occurred despite offspring being conceived, gestated, and reared under standard dark night conditions. Overall, these data suggest that dLAN has intergenerational effects on innate immunity and sickness responses.	[Cisse, Yasmine M.] Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA; [Russart, Kathryn] Ohio State Univ, Wexner Med Ctr, Columbus, OH 43210 USA; [Nelson, Randy J.] West Virginia Univ, Rockefeller Neurosci Inst, Dept Neurosci, Morgantown, WV 26506 USA	University System of Maryland; University of Maryland Baltimore; Ohio State University; West Virginia University	Cisse, YM (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol, Baltimore, MD 21201 USA.	ycisse@som.umaryland.edu			National Science Foundation [IOS 11-18792]; National Institute of Environmental Health Sciences [ES026890-02]	National Science Foundation(National Science Foundation (NSF)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by grant from National Science Foundation IOS 11-18792 to Dr. Randy J. Nelson and National Institute of Environmental Health Sciences ES026890-02 to Dr. Yasmine M Cisse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; BAUMANN H, 1993, J IMMUNOL, V151, P4248; Baumann H., 2008, ANN NY ACAD SCI, V557, P280; Bedrosian TA, 2013, J NEUROENDOCRINOL, V25, P590, DOI 10.1111/jne.12036; Bedrosian TA, 2013, MOL PSYCHIATR, V18, P930, DOI 10.1038/mp.2012.96; Bedrosian TA, 2013, BRAIN BEHAV IMMUN, V34, P39, DOI 10.1016/j.bbi.2013.05.009; Bedrosian TA, 2011, BIOL LETTERS, V7, P468, DOI 10.1098/rsbl.2010.1108; Cable EJ, 2017, PHYSIOL BEHAV, V171, P165, DOI 10.1016/j.physbeh.2016.12.019; Cain DW, 2017, NAT REV IMMUNOL, V17, P233, DOI 10.1038/nri.2017.1; Cisse YM, 2017, SCI REP-UK, V7, P1, DOI 10.1038/srep45497; Commission Internationale de l'Eclairage, 2018, S026E2018 CIE, DOI [10.25039/S026.2018, DOI 10.25039/S026.2018]; Fonken LK, 2013, BRAIN BEHAV IMMUN, V34, P159, DOI 10.1016/j.bbi.2013.08.011; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; JUAN TSC, 1993, P NATL ACAD SCI USA, V90, P2584, DOI 10.1073/pnas.90.7.2584; Konsman JP, 2002, TRENDS NEUROSCI, V25, P154, DOI 10.1016/S0166-2236(00)02088-9; Martin LB, 2007, ECOLOGY, V88, P2516, DOI 10.1890/07-0060.1; Millet S, 2007, DEV COMP IMMUNOL, V31, P188, DOI 10.1016/j.dci.2006.05.013; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Prendergast BJ, 2015, J BIOL RHYTHM, V30, P543, DOI 10.1177/0748730415609450; Prendergast BJ, 2013, BRAIN BEHAV IMMUN, V32, P94, DOI 10.1016/j.bbi.2013.02.007; Shuboni D, 2010, NEUROSCIENCE, V170, P1172, DOI 10.1016/j.neuroscience.2010.08.009; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Weinrauch Y, 1998, J CLIN INVEST, V102, P633, DOI 10.1172/JCI3121	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231140	10.1371/journal.pone.0231140	http://dx.doi.org/10.1371/journal.pone.0231140			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302341	gold, Green Published, Green Submitted			2022-12-26	WOS:000536016100018
J	Cerchione, D; Loveluck, K; Tillotson, EL; Harbinski, F; DaSilva, J; Kelley, CP; Keston-Smith, E; Fernandez, CA; Myer, VE; Jayaram, H; Steinberg, BE				Cerchione, Derek; Loveluck, Katherine; Tillotson, Eric L.; Harbinski, Fred; DaSilva, Jen; Kelley, Chase P.; Keston-Smith, Elise; Fernandez, Cecilia A.; Myer, Vic E.; Jayaram, Hariharan; Steinberg, Barrett E.			SMOOT libraries and phage-induced directed evolution of Cas9 to engineer reduced off-target activity	PLOS ONE			English	Article							CRISPR-CAS9 NUCLEASES; GENOME; CLEAVAGE; MODEL	RNA-guided endonucleases such as Cas9 provide efficient on-target genome editing in cells but may also cleave at off-target loci throughout the genome. Engineered variants of Streptococcus pyogenes Cas9 (SpCas9) have been developed to globally reduce off-target activity, but individual off-targets may remain, or on-target activity may be compromised. In order to evolve against activity at specific off-targets while maintaining strong on-target editing, we developed a novel M13 bacteriophage-mediated selection method. Using this method, sequential rounds of positive and negative selection are used to identify mutations to Cas9 that enhance or diminish editing activity at particular genomic sequences. We also introduce scanning mutagenesis of oligo-directed targets (SMOOT), a comprehensive mutagenesis method to create highly diverse libraries of Cas9 variants that can be challenged with phage-based selection. Our platform identifies novel SpCas9 mutants which mitigate cleavage against off-targets both in biochemical assays and in T-cells while maintaining higher on-target activity than previously described variants. We describe an evolved variant, S. pyogenes Adapted to Reduce Target Ambiguity Cas9 (SpartaCas), composed of the most enriched mutations, each of unknown function. This evolved Cas9 mutant reduces off-target cleavage while preserving efficient editing at multiple therapeutically relevant targets. Directed evolution of Cas9 using our system demonstrates an improved structure-independent methodology to effectively engineer nuclease activity.	[Cerchione, Derek; Loveluck, Katherine; Tillotson, Eric L.; Harbinski, Fred; DaSilva, Jen; Kelley, Chase P.; Keston-Smith, Elise; Fernandez, Cecilia A.; Myer, Vic E.; Jayaram, Hariharan; Steinberg, Barrett E.] Editas Med, Cambridge, MA 02141 USA		Steinberg, BE (corresponding author), Editas Med, Cambridge, MA 02141 USA.	barrett.steinberg@gmail.com	Steinberg, Barrett/AAL-6832-2020	Steinberg, Barrett/0000-0003-2036-1164; Kelley, Chase/0000-0001-5383-4701	Editas Medicine	Editas Medicine	All authors are currently or formerly shareholders and salaried employees of Editas Medicine. Editas Medicine funded related research materials and assisted in the preparation of this manuscript and the decision to publish.	[Anonymous], 2018, FORENSIC SCI INT-GEN, V34, pe18; Araya CL, 2011, TRENDS BIOTECHNOL, V29, P435, DOI 10.1016/j.tibtech.2011.04.003; Casini A, 2018, NAT BIOTECHNOL, V533, P103; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Constantinescu A, 2015, SPRINGER INDAM SER, V12, P203, DOI 10.1007/978-3-319-20155-9_29; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Ikeda A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0627-8; Kim D, 2015, NATURE; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Lee JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05477-x; Long CZ, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9004; Pattanayak V, 2013, NAT BIOTECHNOL, V31, P839, DOI 10.1038/nbt.2673; Pritchard L, 2005, J THEOR BIOL, V234, P497, DOI 10.1016/j.jtbi.2004.12.005; Siloto RMP, 2012, BIOCATAL AGRIC BIOTE, V1, P181, DOI 10.1016/j.bcab.2012.03.010; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stella S, 2017, NAT STRUCT MOL BIOL, V24, P882, DOI 10.1038/nsmb.3486; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Vakulskas CA, 2018, NAT MED, V24, P1216, DOI 10.1038/s41591-018-0137-0; Wrenbeck EE, 2016, NAT METHODS, V13, P928, DOI 10.1038/nmeth.4029	22	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231716	10.1371/journal.pone.0231716	http://dx.doi.org/10.1371/journal.pone.0231716			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LJ6KU	32298334	gold, Green Published			2022-12-26	WOS:000530272700001
J	Goralczyk-Binkowska, A; Jasinska, A; Dlugonski, A; Plocinski, P; Dlugonski, J				Goralczyk-Binkowska, Aleksandra; Jasinska, Anna; Dlugonski, Andrzej; Plocinski, Przemyslaw; Dlugonski, Jerzy			Laccase activity of the ascomycete fungus Nectriella pironii and innovative strategies for its production on leaf litter of an urban park	PLOS ONE			English	Article							ROT FUNGUS; INDUCTION; ENZYMES; COPPER; DECOLORIZATION; LIGNIN; IDENTIFICATION; OPTIMIZATION; DEGRADATION; PEROXIDASE	A laccase-producing ascomycete fungus was isolated from soil collected around the premises of a textile dye factory and identified as Nectriella pironii. Efficient laccase production was achieved via the synergistic action of 1 mM copper sulfate and ferulic acid. Extracts of rapeseed oil cake, grass hay, and leaf litter collected in a pocket urban park were used for enzyme production. The highest laccase activity (3,330 U/L) was observed in the culture grown on the leaf litter extract. This is the first report on biosynthesis of laccase by N. pironii. This is also the first study on utilization of naturally fallen park leaves as a substrate for fungal laccase production. The extracellular enzyme possessing laccase activity was purified to homogeneity by ion-exchange and gel filtration chromatographic techniques. The amino acid sequence of the protein revealed highest similarity to the laccase enzyme produced by Stachybotrys chartarum-and considerable homology to those produced by other fungal species. The purified laccase possessed a molecular mass of 50 kDa. The enzyme had an optimum pH of 2.0 or 6.0 and retained more than 50% of residual activity after 3 hours of incubation at pH 3.0-10.6 or 4.0-9.0 when 2,20-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid or 2,6-dimethoxyphenol, respectively, were used. Dithiothreitol, beta-mercaptoethanol, and sodium azide at 1 mM concentration strongly inhibited the laccase activity, while in the presence of 50 mM urea, the enzyme was found to retain 25% of its activity. The laccase was able to decolorize more than 80% of Indigo Carmine, Remazol Brilliant Blue R, Reactive Orange 16, and Acid Red 27 dyes within 1 h. The possibility of leaf litter use for the production of the laccase enzyme from N. pironii (IM 6443), exhibiting high pH stability and degradative potential, makes it a promising tool for use in different environmental and industrial operations.	[Goralczyk-Binkowska, Aleksandra; Jasinska, Anna; Dlugonski, Jerzy] Univ Lodz, Fac Biol & Environm Protect, Dept Ind Microbiol & Biotechnol, Lodz, Poland; [Dlugonski, Andrzej] Cardinal Stefan Wyszynski Univ Warsaw, Fac Biol & Environm Sci, Dept Environm Engn, Warsaw, Poland; [Plocinski, Przemyslaw] Polish Acad Sci, Inst Med Biol, Lodz, Poland	University of Lodz; Cardinal Stefan Wyszynski University in Warsaw; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences	Dlugonski, J (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Ind Microbiol & Biotechnol, Lodz, Poland.	jerzy.dlugonski@biol.uni.lodz.pl	Góralczyk-Bińkowska, Aleksandra/AAS-9607-2021; Plocinski, Przemyslaw/S-5587-2017	Góralczyk-Bińkowska, Aleksandra/0000-0002-3391-4621; Dlugonski, Andrzej/0000-0001-9978-4981; Plocinski, Przemyslaw/0000-0002-6623-3494; Dlugonski, Jerzy/0000-0002-2075-5967; Jasinska, Anna/0000-0003-3354-0102	National Science Centre, Poland [UMO-2017/27/N/NZ9/02160]; Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland	National Science Centre, Poland(National Science Centre, Poland); Centre for Preclinical Research and Technology (CePT); European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland	The study was supported by the National Science Centre, Poland (Project No. UMO-2017/27/N/NZ9/02160), grant recipient - Aleksandra Goralczyk-Binkowska. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are thankful to the City of Lo ' dz Office, especially "Zarzad Zieleni Miejskiej" (Management of City Greenery), for providing permission to conduct the study in the area of Plac Komuny Paryskiej pocket park (Lodz, Poland) and for access to the documentation related to the park. We are also thankful to the RDLS Heritage Ltd for help in genetic analysis. The authors thank the mass spectrometry service at the Institute of Biochemistry and Biophysics PAS in Warsaw for MS analysis. The MS analysis equipment used for the analysis was sponsored in part by the Centre for Preclinical Research and Technology (CePT), a project co-sponsored by European Regional Development Fund and Innovative Economy, The National Cohesion Strategy of Poland.	Anjaneyulu Y., 2005, Reviews in Environmental Science and Bio/Technology, V4, P245, DOI 10.1007/s11157-005-1246-z; Ashrafi SD, 2013, INT BIODETER BIODEGR, V85, P173, DOI 10.1016/j.ibiod.2013.07.006; Atlas RM, 2010, HDB MICROBIOLOGICAL; Baldrian P, 2006, FEMS MICROBIOL REV, V30, P215, DOI 10.1111/j.1574-4976.2005.00010.x; Birhanli E, 2017, TURK J BIOL, V41, P587, DOI 10.3906/biy-1608-44; Chairin T, 2014, J BASIC MICROB, V54, P35, DOI 10.1002/jobm.201200456; Chaurasia P.K., 2013, RES PLANT SCI, V1, P32, DOI [DOI 10.1007/S12010-011-9289-9, 10.12691/plant-1-2-5, DOI 10.12691/PLANT-1-2-5]; Chua LS, 2017, PLANT BIOSYST, V151, P74, DOI 10.1080/11263504.2015.1076085; Dlugonski A, 2016, ECOURBAN ATLAS GREEN, V1; Dlugonski A, 2016, ECOL CHEM ENG A, V23, P265, DOI 10.2428/ecea.2016.23(3)20; Dlugonski A, 2015, J URBAN PLAN DEV, V141, DOI 10.1061/(ASCE)UP.1943-5444.0000242; Dudek-Makuch M, 2011, ACTA POL PHARM, V68, P403; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eggert C, 1996, FEBS LETT, V391, P144, DOI 10.1016/0014-5793(96)00719-3; Elisashvili V, 2009, J BIOTECHNOL, V144, P37, DOI 10.1016/j.jbiotec.2009.06.020; Feltynowski M, 2018, URBAN FOR URBAN GREE, V31, P56, DOI 10.1016/j.ufug.2017.12.003; Fonseca MI, 2010, ENZYME MICROB TECH, V46, P534, DOI 10.1016/j.enzmictec.2009.12.017; Fu K, 2013, BIORESOURCES, V8, P1385; Gasecka M, 2017, CHEM ECOL, V33, P196, DOI 10.1080/02757540.2017.1289186; Gomaa OM, 2015, BRAZ J MICROBIOL, V46, P285, DOI 10.1590/S1517-838246120120118; Goralczyk-Binkowska A, 2019, ADV MICROBIOL-NY, V58, P7, DOI 10.21307/PM-2019.58.1.007; Gygli G, 2015, CURR BIOTECHNOL, V4, P100, DOI [10.2174/2211550104666150423202036, DOI 10.2174/2211550104666150423202036]; HAARS A, 1983, ARCH MICROBIOL, V134, P309, DOI 10.1007/BF00407808; Haase D, 2019, LANDSCAPE URBAN PLAN, V182, P44, DOI 10.1016/j.landurbplan.2018.10.010; Herezniak J., 2012, POMNIKOWE DRZEWA SWI; Hoegger PJ, 2006, FEBS J, V273, P2308, DOI 10.1111/j.1742-4658.2006.05247.x; Janusz G, 2017, FEMS MICROBIOL REV, V41, P941, DOI 10.1093/femsre/fux049; Jasinska A, 2019, INT J ENVIRON SCI TE, V16, P4811, DOI 10.1007/s13762-019-02290-x; Jasinska A, 2018, ACTA BIOCHIM POL, V65, P287, DOI 10.18388/abp.2017_2546; Jasinska A, 2016, MICROBIAL BIODEGRADATION: FROM OMICS TO FUNCTION AND APPLICATION, P119; Jasinska A, 2012, INT BIODETER BIODEGR, V73, P33, DOI 10.1016/j.ibiod.2012.06.025; Jeon SJ, 2017, J MICROBIOL BIOTECHN, V27, P1120, DOI 10.4014/jmb.1701.01004; Kaczmarek M.B., 2017, BIOTECHNOL FOOD SCI, V81, P41; Kaczmarek Piotr, 2016, Polish Journal of Natural Sciences, V31, P545; Kuhar F, 2014, REV ARGENT MICROBIOL, V46, P144, DOI 10.1016/S0325-7541(14)70063-X; LEONOWICZ A, 1981, ENZYME MICROB TECH, V3, P55, DOI 10.1016/0141-0229(81)90036-3; Lesage-Meessen L, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1218-5; Liimatainen J, 2012, J CHEM ECOL, V38, P1410, DOI 10.1007/s10886-012-0199-2; Mukhopadhyay M, 2015, 3 BIOTECH, V5, P227, DOI 10.1007/s13205-014-0219-8; Nykiel-Szymanska J, 2018, ECOTOX ENVIRON SAFE, V162, P1, DOI 10.1016/j.ecoenv.2018.06.060; Osma Johann F, 2010, Enzyme Res, V2010, P918761, DOI 10.4061/2010/918761; Oszmianski J, 2014, MOLECULES, V19, P14625, DOI 10.3390/molecules190914625; Panda SK, 2016, ENVIRON RES, V146, P161, DOI 10.1016/j.envres.2015.12.035; Paraszkiewicz K, 2009, INT BIODETER BIODEGR, V63, P100, DOI 10.1016/j.ibiod.2008.03.015; Piscitelli A, 2011, CURR GENOMICS, V12, P104, DOI 10.2174/138920211795564331; Postemsky PD, 2017, BIORESOURCE TECHNOL, V231, P85, DOI 10.1016/j.biortech.2017.01.064; Purahong W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093700; Radhika R., 2013, International Journal of Current Science, P7; Ravindran Rajeev, 2018, Bioengineering (Basel), V5, DOI 10.3390/bioengineering5040093; Saparrat MCN, 2000, WORLD J MICROB BIOT, V16, P799, DOI 10.1023/A:1008923804859; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shobana S, 2012, J BIOREMED BIODEG, V3, P6; Singh G, 2015, APPL MICROBIOL BIOT, V99, P155, DOI 10.1007/s00253-014-6219-0; Sondhi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096951; Strong PJ, 2011, CRIT REV ENV SCI TEC, V41, P373, DOI 10.1080/10643380902945706; Vats A, 2018, J HAZARD MATER, V344, P466, DOI 10.1016/j.jhazmat.2017.10.043; Viswanath B., 2014, ENZYME RES, V2014, P1, DOI [DOI 10.1155/2014/163242, 10.1155/2014/163242]; Vrsanska M, 2016, MOLECULES, V21, DOI 10.3390/molecules21111553; Xu YY, 2016, ACTA BIOCHIM POL, V63, P273, DOI 10.18388/abp.2015_1091; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079307; Zhao D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038817; Zhu CW, 2016, BIOTECHNOL BIOTEC EQ, V30, P270, DOI 10.1080/13102818.2015.1135081	62	18	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231453	10.1371/journal.pone.0231453	http://dx.doi.org/10.1371/journal.pone.0231453			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298310	gold, Green Published			2022-12-26	WOS:000536011400049
J	Grimaldi, M; Palisi, A; Marino, C; Montoro, P; Capasso, A; Novi, S; Tecce, MF; D'Ursi, AM				Grimaldi, Manuela; Palisi, Angelica; Marino, Carmen; Montoro, Paola; Capasso, Anna; Novi, Sara; Tecce, Mario Felice; D'Ursi, Anna Maria			NMR-based metabolomic profile of hypercholesterolemic human sera: Relationship with in vitro gene expression?	PLOS ONE			English	Article							FATTY-ACIDS; SPECTROSCOPY; CHOLESTEROL; PLASMA; TRANSCRIPTION; METABONOMICS; RELEASE; TISSUE; URINE; ALPHA	Hypercholesterolaemia is considered an important cause of atherosclerotic cardiovascular disease. In a previous investigation, we demonstrated that cultured hepatoma cells treated with hypercholesterolaemic sera compared with cells treated with normocholesterolaemic sera show overexpression of mRNAs related to mitochondrial 3-hydroxy-3-methylglutaryl-coenzyme A synthase (HMGCS2). In the present work, using an NMR metabolomic analysis, we demonstrate that the hypercholesterolaemic blood sera previously used to treat cultured hepatoma cells are characterized by a metabolomic profile that is significantly different from the normocholesterolaemic sera. Acetate, acetone, 2-hydroxybutyrate, cysteine, valine, and glutamine are the metabolites distinguishing the two groups. Abnormalities in the concentrations of these metabolites reflect alterations in energy-related pathways, such as pantothenate and CoA biosynthesis, pyruvate, glycolysis/gluconeogenesis, the citrate cycle, and ketone bodies. Regarding ketone bodies, the pathway is regulated by HMGCS2; therefore, serum samples previously found to be able to increase HMGCS2 mRNA levels in cultured cells also contain higher amounts of the metabolites of its encoded enzyme protein product.	[Grimaldi, Manuela; Palisi, Angelica; Marino, Carmen; Montoro, Paola; Capasso, Anna; Novi, Sara; Tecce, Mario Felice; D'Ursi, Anna Maria] Univ Salerno, Dept Pharm, Fisciano, Italy	University of Salerno	D'Ursi, AM (corresponding author), Univ Salerno, Dept Pharm, Fisciano, Italy.	dursi@unisa.it	Grimaldi, Manuela/AAQ-2981-2020; Montoro, Paola/F-7609-2010; D'Ursi, Anna Maria/E-8557-2016	Montoro, Paola/0000-0001-9445-6006; D'Ursi, Anna Maria/0000-0001-6814-8472				Aranibar N, 2011, J BIOMOL NMR, V49, P195, DOI 10.1007/s10858-011-9490-8; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Boren J, 2016, CURR OPIN LIPIDOL, V27, P473, DOI 10.1097/MOL.0000000000000330; Chen HH, 2015, INT J OBESITY, V39, P1241, DOI 10.1038/ijo.2015.65; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Conboy E, 2017, JIMD REP, P63; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; De Rosa MC, 2015, J CELL PHYSIOL, V230, P2059, DOI 10.1002/jcp.24932; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; Hall WL, 2017, P NUTR SOC, V76, P408, DOI 10.1017/S0029665117000428; HARVEY PW, 1981, J NUTR, V111, P639, DOI 10.1093/jn/111.4.639; Haug K, 2013, NUCLEIC ACIDS RES, V41, pD781, DOI 10.1093/nar/gks1004; Jacob N, 1999, ATHEROSCLEROSIS, V146, P53, DOI 10.1016/S0021-9150(99)00128-8; Jupin M, 2014, J MAGN RESON, V239, P34, DOI 10.1016/j.jmr.2013.11.019; Kanehisa M, 1997, PAC S BIOCOMPUT; Kim Y, 2010, NUTR RES, V30, P455, DOI 10.1016/j.nutres.2010.06.014; Kostiuk MA, 2010, FASEB J, V24, P1914, DOI 10.1096/fj.09-149765; Liu MH, 2008, MOL ENDOCRINOL, V22, P1078, DOI 10.1210/me.2007-0547; McKay RT, 2011, CONCEPT MAGN RESON A, V38A, P197, DOI 10.1002/cmr.a.20223; Meertens LM, 1998, EMBO J, V17, P6972, DOI 10.1093/emboj/17.23.6972; Mo HP, 2008, J MAGN RESON, V190, P1, DOI 10.1016/j.jmr.2007.09.016; Navarese EP, 2019, EUR HEART J-CARD PHA, V5, P47, DOI 10.1093/ehjcvp/pvy038; NICHOLSON JK, 1995, ANAL CHEM, V67, P793, DOI 10.1021/ac00101a004; Palisi A, 2017, J PHARMACEUT BIOMED, V133, P90, DOI 10.1016/j.jpba.2016.11.002; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rakhshandehroo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006796; Rescigno T, 2018, J CELL PHYSIOL, V233, P3306, DOI 10.1002/jcp.26177; Shukla SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04469-z; Simons LA, 2019, MED J AUSTRALIA, V211, P87, DOI 10.5694/mja2.50142; SMITH SA, 1978, BIOCHEM J, V176, P817, DOI 10.1042/bj1760817; Vila-Brau A, 2011, J BIOL CHEM, V286, P20423, DOI 10.1074/jbc.M111.235044; Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD608, DOI 10.1093/nar/gkx1089; YEH YY, 1984, ARCH BIOCHEM BIOPHYS, V233, P10, DOI 10.1016/0003-9861(84)90596-4; Zhang Z, 2019, ENDOCRINE, V63, P615, DOI 10.1007/s12020-018-1810-2; Zirpoli H, 2012, J CELL BIOCHEM, V113, P815, DOI 10.1002/jcb.23409	35	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231506	10.1371/journal.pone.0231506	http://dx.doi.org/10.1371/journal.pone.0231506			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298312	Green Published, gold			2022-12-26	WOS:000536011400055
J	Guo, H; Wang, YQ; Cai, W; He, CQ				Guo, Hua; Wang, Yuqing; Cai, Wei; He, Chengqi			Evaluation of ultra-early and dose-dependent edema and ultrastructural changes in the myocyte during anti-hypertensive drug delivery in the spontaneously hypertensive rat model	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKER; T-TYPE; MIBEFRADIL	Background Quantifying dose-dependent ultra-early edema and ultrastructural changes in the myocyte after drug delivery is important for the development of new mixed calcium channel blockers (CCBs). Materials and methods Arterial cannulation was used to measure mean arterial pressure in real time; simultaneously, magnetic resonance imaging proton density mapping was used to quantify edema 5-55 min after the delivery of L-type CCBs, T- and L-type CCBs, and solvent to a spontaneously hypertensive rat model. Transmission electron microscopy was used to show ultrastructural changes in the myocyte. Results Analysis of variance showed significant differences among the three groups in mean arterial pressure reduction (F = 246.36, P = 5.75E(-25)), ultra-early level of edema (ULE) (F = 175.49, P = 5.62E(-22)), and dose-dependent level of edema (DLE) (F = 199.48, P = 4.28E(-23)). Compared with the solvent's mean arterial pressure reduction (2.65 +/- 6.56 +/- 1.64), ULE (1.16 +/- 0.09 +/- 0.02), and DLE (0.0010 +/- 0.0001 +/- 0.0000), post hoc tests showed that T- and L-type CCBs had better mean arterial pressure reduction (90.67 +/- 11.58 +/- 2.90, P = 1.06E(-24) vs. 68.34 +/- 15.19 +/- 3.80, P = 1.76E(-12)), lower ULE (1.53 +/- 0.14 +/- 0.04, P = 4.74E(-9) vs. 2.08 +/- 0.18 +/- 0.04, P = 2.68E(-22)), and lower DLE (0.0025 +/- 0.0004 +/- 0.0001, P = 1.14E(-11) vs. 0.0047 +/- 0.0008 +/- 0.0002, P = 2.10E(-11)) than L-type CCBs. Transmission electron microscopy showed that T- and L-type CCBs caused fewer ultrastructural changes in the myocytes after drug delivery than L-type CCBs. Conclusion T- and L-type CCBs produced less ultra-early and dose-dependent edema, fewer ultrastructural changes in the myocyte, and a greater antihypertensive effect. Proton density mapping combined with arterial cannulation and transmission electron microscopy allowed for quantification of ultra-early and dose-dependent edema, antihypertensive efficacy, and ultrastructural changes in the myocyte. This is important for the evaluation of induced vasodilatory edema.	[Guo, Hua; He, Chengqi] Sichuan Univ, West China Hosp, Dept Rehabil Med, Prov Key Lab Rehabil Med, Chengdu, Peoples R China; [Wang, Yuqing] Natl Ctr Nanosci & Technol China, Nanotechnol Dev Dept, Beijing, Peoples R China; [Cai, Wei] Peking Univ, Beijing Jishuitan Hosp, Clin Med Coll 4, Dept Radiol, Beijing, Peoples R China	Sichuan University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China; Peking University	He, CQ (corresponding author), Sichuan Univ, West China Hosp, Dept Rehabil Med, Prov Key Lab Rehabil Med, Chengdu, Peoples R China.	chengqihe1998@sina.com	Wang, yuqing/HIR-1604-2022					Brogden RN, 1998, DRUGS, V55, P517, DOI 10.1007/BF03259985; Esposito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059308; Feng MG, 2004, AM J NEPHROL, V24, P641, DOI 10.1159/000082946; Gonzalez-Beltran A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127612; Gupta AK, 2010, AM J HYPERTENS, V23, P1023, DOI 10.1038/ajh.2010.105; Huber I, 2000, BIOCHEM J, V347, P829, DOI 10.1042/0264-6021:3470829; Karpov Y, 2012, ADV THER, V29, P134, DOI 10.1007/s12325-011-0095-0; Klengel A, 2017, RADIOLOGY, V283, P469, DOI 10.1148/radiol.2016160306; Kobrin I, 1997, MED CLIN N AM, V81, P1359, DOI 10.1016/S0025-7125(05)70588-5; Levine TB, 2000, CIRCULATION, V101, P758, DOI 10.1161/01.CIR.101.7.758; Major TC, 2008, J PHARMACOL EXP THER, V325, P723, DOI 10.1124/jpet.107.133892; Messerli FH, 2001, AM J HYPERTENS, V14, P978, DOI 10.1016/S0895-7061(01)02178-1; Messerli Franz H, 2002, Curr Cardiol Rep, V4, P479, DOI 10.1007/s11886-002-0110-9; Ozawa Y, 2001, HYPERTENSION, V38, P343, DOI 10.1161/01.HYP.38.3.343; Patten Carolynn, 2003, Semin Musculoskelet Radiol, V7, P297; Safak C, 2006, MINI-REV MED CHEM, V6, P747, DOI 10.2174/138955706777698606; Tawara N, 2011, MAGN RESON MED SCI, V10, P85, DOI 10.2463/mrms.10.85; Weir MR, 2001, AM J HYPERTENS, V14, P963, DOI 10.1016/S0895-7061(01)02167-7; Zhang LY, 2011, J SURG RES, V167, pE357, DOI 10.1016/j.jss.2010.09.014	19	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231244	10.1371/journal.pone.0231244	http://dx.doi.org/10.1371/journal.pone.0231244			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298274	Green Published, gold			2022-12-26	WOS:000536011400033
J	He, N; Su, R; Wang, ZY; Zhang, YJ; Li, JQ				He, Nimantana; Su, Rui; Wang, Zhiying; Zhang, Yanjun; Li, Jinquan			Exploring differentially expressed genes between anagen and telogen secondary hair follicle stem cells from the Cashmere goat (Capra hircus) by RNA-Seq	PLOS ONE			English	Article							WOUND REPAIR; SOX9; LHX2; MORPHOGENESIS; REGENERATION; HOMEOSTASIS; NICHE	Hair follicle stem cells (HFSCs) have been shown to be essential in the development and regeneration of hair follicles (HFs). The Inner Mongolia Cashmere goat (Capra hircus) has two types of HFs, primary and secondary, with cashmere being produced from the secondary hair follicle. To identify the genes associated with cashmere growth, transcriptome profiling of anagen and telogen secondary HFSCs was performed by RNA-Seq. The RNA-Seq analysis generated over 58 million clean reads from each group, with 2717 differentially expressed genes (DEGs) detected between anagen and telogen, including 1500 upregulated and 1217 downregulated DEGs. A large number of DEGs were predominantly associated with cell part, cellular process, binding, biological regulation and organelle. In addition, the PI3K-Akt, MAPK, Ras and Rap1 signaling pathways may be involved in the growth of HFSCs cultured in vitro. The RNA-Seq results showed that the well-defined HFSC signature genes and cell cycle-associated genes showed no significant differences between anagen and telogen HFSCs, indicating a relatively quiescent cellular state of the HFSCs cultured in vitro. These results are useful for future studies of complex molecular mechanisms of hair follicle cycling in cashmere goats.	[He, Nimantana; Su, Rui; Wang, Zhiying; Zhang, Yanjun; Li, Jinquan] Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China; [He, Nimantana] Chifeng Univ, Agr Res Ctr, Chifeng, Inner Mongolia, Peoples R China; [Su, Rui; Li, Jinquan] Key Lab Anim Genet Breeding & Reprod, Hohhot, Inner Mongolia, Peoples R China; [Su, Rui; Li, Jinquan] Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China; [Su, Rui; Wang, Zhiying; Zhang, Yanjun; Li, Jinquan] Engn Res Ctr Goat Genet & Breeding, Hohhot, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Chifeng University; Ministry of Agriculture & Rural Affairs	Li, JQ (corresponding author), Inner Mongolia Agr Univ, Coll Anim Sci, Hohhot, Inner Mongolia, Peoples R China.; Li, JQ (corresponding author), Key Lab Anim Genet Breeding & Reprod, Hohhot, Inner Mongolia, Peoples R China.; Li, JQ (corresponding author), Minist Agr, Key Lab Mutton Sheep Genet & Breeding, Hohhot, Peoples R China.; Li, JQ (corresponding author), Engn Res Ctr Goat Genet & Breeding, Hohhot, Inner Mongolia, Peoples R China.	lijinquan_nd@126.com			China Postdoctoral Science Foundation [2017M613263XB]; Natural Science Foundation of Inner Mongolia [2019BS03012]; Inner Mongolia Agricultural University [DC1900004124]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Inner Mongolia; Inner Mongolia Agricultural University	Nimantana He, 2017M613263XB, project funded by China Postdoctoral Science Foundation; Nimantana He, 2019BS03012, project funded by Natural Science Foundation of Inner Mongolia; Jinquan Li, DC1900004124, project funded by Inner Mongolia Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Blanpain C, 2014, SCIENCE, V344, P1243, DOI 10.1126/science.1242281; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chacon-Martinez CA, 2017, EMBO J, V36, P151, DOI 10.15252/embj.201694902; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dong Y, 2013, NAT BIOTECHNOL, V31, P135, DOI 10.1038/nbt.2478; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Fuchs E, 2018, STEM CELL REP, V10, P1432, DOI 10.1016/j.stemcr.2018.04.008; Ge YJ, 2017, CELL, V169, P636, DOI 10.1016/j.cell.2017.03.042; Geng RQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062704; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; He N, 2018, CYTOTECHNOLOGY, V70, P1155, DOI 10.1007/s10616-018-0206-8; He N, 2016, CYTOTECHNOLOGY, V68, P2579, DOI 10.1007/s10616-016-9981-2; He N, 2016, IN VITRO CELL DEV-AN, V52, P782, DOI 10.1007/s11626-016-0023-3; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Kadaja M, 2014, GENE DEV, V28, P328, DOI 10.1101/gad.233247.113; Kenneth Lay, 2016, FOXC1 MAINTAINS HAIR, V113, pE1506, DOI [10.1073/pnas.1601569113, DOI 10.1073/PNAS.1601569113]; Langbein L, 2005, INT REV CYTOL, V243, P1, DOI 10.1016/S0074-7696(05)43001-6; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; [李长青 Li Changqing], 2005, [畜牧兽医学报, Acta Veterinaria et Zootechnica Sinica], V36, P674; Li YuRong, 2008, Scientia Agricultura Sinica, V41, P3920; Liu B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147124; Liu S, 2013, INT J MOL SCI, V14, P10869, DOI 10.3390/ijms140610869; Mardaryev AN, 2011, DEVELOPMENT, V138, P4843, DOI 10.1242/dev.070284; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nikolova Oristian Daniel S., 2015, NATURE, V521, P366, DOI [10.1038/nature14289, DOI 10.1038/NATURE14289]; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Purba TS, 2014, BIOESSAYS, V36, P513, DOI 10.1002/bies.201300166; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; Sennett R, 2012, SEMIN CELL DEV BIOL, V23, P917, DOI 10.1016/j.semcdb.2012.08.011; Tiede S, 2006, BIOESSAYS, V28, P1157, DOI 10.1002/bies.20506; Toyoshima K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1784; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Wang DM, 2013, NAT CELL BIOL, V15, P1153, DOI 10.1038/ncb2827; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu JH, 2012, J INTEGR AGR, V11, P1159, DOI 10.1016/S2095-3119(12)60110-5; Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13986-w; Yi R, 2017, STEM CELLS, V35, P2323, DOI 10.1002/stem.2696	41	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231376	10.1371/journal.pone.0231376	http://dx.doi.org/10.1371/journal.pone.0231376			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298297	gold, Green Published			2022-12-26	WOS:000536011400039
J	Olstad, BH; Zinner, C				Olstad, Bjorn Harald; Zinner, Christoph			Validation of the Polar OH1 and M600 optical heart rate sensors during front crawl swim training	PLOS ONE			English	Article							RATE MONITOR; ACCURACY; REST	Purpose The Polar OH1 is an optical heart rate (HR) sensor which can be used on different parts of the body. The purpose of the study was to evaluate the validity of the OH1 as well as a wrist worn heart rate device (Polar M600) during swimming. Methods Twenty-six well-trained competitive swimmers performed a regular training session including different swimming intensities. During the training the swimmers wore a H10 HR sensor with Polar Pro strap (H10) underneath the swim suit, a Polar OH1 optical HR sensor (OH1) underneath the swimming cap at the temple, and a sports watch with optical HR sensor, Polar M600 smart watch (M600) on the wrist. Results No difference in HRmax, HRmean and HRmin between H10 and OH1 were evident. The HRmax and HRmean obtained by the M600 was significantly lower than the obtained by H10 and OH1 (p < 0.05). The ICC showed mostly excellent agreements between H10 and OH1 and poor to good agreements between H10 and M600. Bland-Altmann plot for M600 vs. H10 indicates upper and lower limits of agreement of -53.0 to 33.9 beats per minute. For OH1 vs. H10 the upper and lower limits of agreement were -26.9 to 24.7 beats per minute. Conclusion The Polar OH1 optical HR sensor is a valid tool to monitor HR of different intensities during swimming whereas the Polar M600 smart watch as a wrist worn device is less accurate.	[Olstad, Bjorn Harald; Zinner, Christoph] Norwegian Sch Sport Sci, Inst Phys Performance, Oslo, Norway; [Zinner, Christoph] Univ Appl Sci Police & Adm Hesse, Dept Sport, Wiesbaden, Germany	Norwegian School of Sport Sciences	Olstad, BH (corresponding author), Norwegian Sch Sport Sci, Inst Phys Performance, Oslo, Norway.	b.h.olstad@nih.no	Olstad, Bjørn Harald/AAL-4756-2020	Olstad, Bjorn Harald/0000-0002-5670-2269				BARTKO JJ, 1966, PSYCHOL REP, V19, P3, DOI 10.2466/pr0.1966.19.1.3; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Borresen J, 2008, INTJ SPORT PHYSIOL, V3, P16, DOI 10.1123/ijspp.3.1.16; Delgado-Gonzalo R, 2015, IEEE ENG MED BIO, P430, DOI 10.1109/EMBC.2015.7318391; Engstrom E, 2012, EUR J PHYSIOTHER, V14, P115, DOI 10.3109/14038196.2012.694118; Giggins OM, 2019, HEART, V105, pA5, DOI 10.1136/heartjnl-2019-SCF.9; Gilgen-Ammann R, 2019, EUR J APPL PHYSIOL, V119, P1525, DOI 10.1007/s00421-019-04142-5; Gillinov S, 2017, MED SCI SPORT EXER, V49, P1697, DOI 10.1249/MSS.0000000000001284; Halson SL, 2014, SPORTS MED, V44, P13, DOI 10.1007/s40279-014-0147-0; Hellard P, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00363; Hermand E, 2019, INT J SPORTS MED, V40, P462, DOI 10.1055/a-0875-4033; Hettiarachchi IT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217288; Horton JF, 2017, MED SCI SPORT EXER, V49, P2600, DOI 10.1249/MSS.0000000000001388; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Olstad BH, 2019, SPORTS BASEL, V7; Schafer A, 2013, INT J CARDIOL, V166, P15, DOI 10.1016/j.ijcard.2012.03.119; Seiler KS, 2006, SCAND J MED SCI SPOR, V16, P49, DOI 10.1111/j.1600-0838.2004.00418.x; Spierer David K., 2015, Journal of Medical Engineering & Technology, V39, P264, DOI 10.3109/03091902.2015.1047536; Temko A, 2017, IEEE T BIO-MED ENG, V64, P2016, DOI 10.1109/TBME.2017.2676243; Terbizan D., 2002, MEAS PHYS EDUC EXERC, V6, P243, DOI DOI 10.1207/S15327841MPEE0604_3; Wallace LK, 2009, J STRENGTH COND RES, V23, P33, DOI 10.1519/JSC.0b013e3181874512	21	7	7	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231522	10.1371/journal.pone.0231522	http://dx.doi.org/10.1371/journal.pone.0231522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298322	Green Published, gold			2022-12-26	WOS:000536011400059
J	Roch, LM; Haase, F; Kreisbeck, C; Tamayo-Mendoza, T; Yunker, LPE; Hein, JE; Aspuru-Guzik, A				Roch, Loic M.; Hase, Florian; Kreisbeck, Christoph; Tamayo-Mendoza, Teresa; Yunker, Lars P. E.; Hein, Jason E.; Aspuru-Guzik, Alan			ChemOS: An orchestration software to democratize autonomous discovery	PLOS ONE			English	Article							HIGH-THROUGHPUT EXPERIMENTATION; AUTOMATION; OPTIMIZATION; CHEMISTRY; SEARCH; LAB; WORKSTATION; FLOW	The current Edisonian approach to discovery requires up to two decades of fundamental and applied research for materials technologies to reach the market. Such a slow and capital-intensive turnaround calls for disruptive strategies to expedite innovation. Self-driving laboratories have the potential to provide the means to revolutionize experimentation by empowering automation with artificial intelligence to enable autonomous discovery. However, the lack of adequate software solutions significantly impedes the development of self-driving laboratories. In this paper, we make progress towards addressing this challenge, and we propose and develop an implementation of ChemOS; a portable, modular and versatile software package which supplies the structured layers necessary for the deployment and operation of self-driving laboratories. ChemOS facilitates the integration of automated equipment, and it enables remote control of automated laboratories. ChemOS can operate at various degrees of autonomy; from fully unsupervised experimentation to actively including inputs and feedbacks from researchers into the experimentation loop. The flexibility of ChemOS provides a broad range of functionality as demonstrated on five applications, which were executed on different automated equipment, highlighting various aspects of the software package.	[Roch, Loic M.; Hase, Florian; Kreisbeck, Christoph; Tamayo-Mendoza, Teresa; Aspuru-Guzik, Alan] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Yunker, Lars P. E.; Hein, Jason E.] Univ British Columbia, Dept Chem, Vancouver, BC, Canada; [Aspuru-Guzik, Alan] Univ Toronto, Dept Chem & Comp Sci, Toronto, ON, Canada; [Aspuru-Guzik, Alan] Vector Inst Artificial Intelligence, Toronto, ON, Canada; [Aspuru-Guzik, Alan] Canadian Inst Adv Res, Toronto, ON, Canada	Harvard University; University of British Columbia; University of Toronto; Canadian Institute for Advanced Research (CIFAR)	Roch, LM (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	loic.m.roch@gmail.com		Yunker, Lars/0000-0002-8899-2926	Tata Sons Limited - Alliance Agreement [A32391]; Herchel Smith Graduate Fellowship; CONACyT scholarship [433469]; National Science Foundation [CHE-1464862]; University of British Columbia, North Robotics; Natural Sciences and Engineering Research Council of Canada [2016-RGPIN-04613]; Canada Foundation for Innovation [35833]	Tata Sons Limited - Alliance Agreement; Herchel Smith Graduate Fellowship; CONACyT scholarship(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation(National Science Foundation (NSF)); University of British Columbia, North Robotics; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	L.M.R. and A.A.-G. were supported by the Tata Sons Limited - Alliance Agreement (A32391). F.H. was supported by the Herchel Smith Graduate Fellowship. T.T.-M. was supported by the CONACyT scholarship No. 433469. C.K. and A.A.-G. were supported by the National Science Foundation under award number CHE-1464862. L. M.R., F.H., C.K., T.T.-M., and A.A.-G. acknowledge Financial support from Anders Froseth. L.P.E.Y. and J.E.H. acknowledge Financial support provided by the University of British Columbia, North Robotics, the Natural Sciences and Engineering Research Council of Canada (Engage, 2016-RGPIN-04613), and the Canada Foundation for Innovation (grant 35833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author A.A.G is affiliated with Vector Institute for Artificial Intelligence, which did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Author A.A.G is affiliated with Vector Institute for Artificial Intelligence. Vector Institute for Artificial Intelligence provided support in the form of salary for authors A.A.G but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adamo A, 2016, SCIENCE, V352, P61, DOI 10.1126/science.aaf1337; Anderson M. J., 2016, DOE SIMPLIFIED PRATI; Aspuru-Guzik A, 2018, ACS CENTRAL SCI, V4, P144, DOI 10.1021/acscentsci.7b00550; Bates M, 2017, ACS SYNTH BIOL, V6, P167, DOI 10.1021/acssynbio.6b00108; Bergstra J. S., 2011, P 24 INT C NEUR INF, P2546, DOI DOI 10.1145/3065386; Bergstra J, 2012, J MACH LEARN RES, V13, P281; BOX G.E.P., 2005, STAT EXPT DESIGN INN; Chan EM, 2010, NANO LETT, V10, P1874, DOI 10.1021/nl100669s; Chapman T, 2003, NATURE, V421, P661, DOI 10.1038/421661a; Chen S, 2018, ADV ENERGY MATER, V8, DOI 10.1002/aenm.201701543; CORKAN LA, 1992, CHEMOMETR INTELL LAB, V17, P47; Dar YL, 2004, MACROMOL RAPID COMM, V25, P34, DOI 10.1002/marc.200300166; Dixon JM, 2014, SLAS TECHNOLOGY TRAN, V9, P364; Dragone V, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15733; Duros V, 2017, ANGEW CHEM INT EDIT, V56, P10815, DOI 10.1002/anie.201705721; Fisher R.A., 1937, DESIGN EXPT; Godfrey AG, 2013, DRUG DISCOV TODAY, V18, P795, DOI 10.1016/j.drudis.2013.03.001; Gronle M, 2014, APPL OPTICS, V53, P2974, DOI 10.1364/AO.53.002974; Hase F, 2019, TRENDS CHEM, V1, P282, DOI 10.1016/j.trechm.2019.02.007; Hase F, 2018, CHEM SCI, V9, P7642, DOI 10.1039/c8sc02239a; Hase F, 2018, ACS CENTRAL SCI, V4, P1134, DOI 10.1021/acscentsci.8b00307; Hoogenboom R, 2005, J COMB CHEM, V7, P10, DOI 10.1021/cc049846f; Houben C, 2015, CURR OPIN CHEM ENG, V9, P1, DOI 10.1016/j.coche.2015.07.001; Hutter F., 2012, LEARNING INTELLIGENT; Hutter F, 2011, LION; Johnson TH, 2014, EPJ QUANTUM TECHNOL, V1, DOI 10.1140/epjqt10; King RD, 2009, SCIENCE, V324, P85, DOI 10.1126/science.1165620; Kitson PJ, 2018, SCIENCE, V359, P314, DOI 10.1126/science.aao3466; Krenn M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.090405; Lehman J., 2018, ARXIV180303453; Li JQ, 2015, SCIENCE, V347, P1221, DOI 10.1126/science.aaa5414; Lindauer M., 2017, SMAC V3 ALGORITHM CO; LINDSEY JS, 1992, CHEMOMETR INTELL LAB, V17, P15, DOI 10.1016/0169-7439(92)90025-B; Malig TC, 2017, REACT CHEM ENG, V2, P309, DOI 10.1039/c7re00026j; MATSUDA R, 1988, CHEM PHARM BULL, V36, P3512; McMullen JP, 2010, ANNU REV ANAL CHEM, V3, P19, DOI 10.1146/annurev.anchem.111808.073718; Meier MAR, 2004, J AM CHEM SOC, V126, P11517, DOI 10.1021/ja0488481; Mijalis AJ, 2017, NAT CHEM BIOL, V13, P464, DOI [10.1038/NCHEMBIO.2318, 10.1038/nchembio.2318]; Nicolaou CA, 2016, J CHEM INF MODEL, V56, P1253, DOI 10.1021/acs.jcim.6b00173; Nikolaev P, 2016, NPJ COMPUT MATER, V2, DOI 10.1038/npjcompumats.2016.31; Okamoto H, 2000, LAB ROBOTICS AUTOMAT, V12, P2, DOI 10.1002/(SICI)1098-2728(2000)12:1<2::AID-LRA2>3.0.CO;2-K; Patel DC, 2018, ANAL CHIM ACTA, V1004, P32, DOI 10.1016/j.aca.2017.11.070; Persson K., 2018, MISSION INNO VATION; Porte C, 1996, PROCESS CONTR QUAL, V8, P111; Quigley M, 2009, IEEE INT CONF ROBOT, P3604; Reizman BJ, 2016, ACCOUNTS CHEM RES, V49, P1786, DOI 10.1021/acs.accounts.6b00261; Roch LM, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat5559; Schneider G, 2018, NAT REV DRUG DISCOV, V17, P97, DOI 10.1038/nrd.2017.232; Service RF, 2015, SCIENCE, V347, P1190, DOI 10.1126/science.347.6227.1190; Simms C, 2000, ORG PROCESS RES DEV, V4, P554, DOI 10.1021/op000049p; Snoek J., 2012, ADV NEURAL INFORM PR, V2, P2951, DOI DOI 10.48550/ARXIV.1206.2944; Snoek J, 2014, PR MACH LEARN RES, V32, P1674; Sugawara T, 1996, LAB ROBOTICS AUTOMAT, V8, P221, DOI 10.1002/(SICI)1098-2728(1996)8:4<221::AID-LRA4>3.0.CO;2-2; Tabor DP, 2018, NAT REV MATER, V3, P5, DOI 10.1038/s41578-018-0005-z; Thomas PH, 2004, AM GENESIS CENTURY I; Whitehead E, 2018, ACS SYNTH BIOL, V7, P922, DOI 10.1021/acssynbio.8b00021; WINICOV H, 1978, ANAL CHIM ACTA-COMP, V2, P469; Woerly EM, 2014, NAT CHEM, V6, P484, DOI 10.1038/NCHEM.1947; Xue DZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11241; Yang GZ, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aar7650; Zhang L, 2017, SCI ROBOT, V2, DOI 10.1126/scirobotics.aar1868; Zhou ZP, 2017, ACS CENTRAL SCI, V3, P1337, DOI 10.1021/acscentsci.7b00492	63	39	38	10	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0229862	10.1371/journal.pone.0229862	http://dx.doi.org/10.1371/journal.pone.0229862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298284	Green Submitted, Green Published, gold			2022-12-26	WOS:000536011400008
J	Vaughn, CM; Selby, CP; Yang, YY; Hsu, DS; Sancar, A				Vaughn, Courtney M.; Selby, Christopher P.; Yang, Yanyan; Hsu, David S.; Sancar, Aziz			Genome-wide single-nucleotide resolution of oxaliplatin?DNA adduct repair in drug-sensitive and -resistant colorectal cancer cell lines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nucleotide excision repair; DNA damage; chemoresistance; colorectal cancer; DNA repair; genomics; drug resistance; chemotherapy; cytotoxicity; excision repair sequencing (XR-seq); oxaliplatin resistance	EXCISION-REPAIR; DNA-REPAIR; COLON-CANCER; ACQUIRED-RESISTANCE; GENE-EXPRESSION; POOR-PROGNOSIS; CISPLATIN; RNA; CYTOTOXICITY; ASSOCIATION	Platinum-based chemotherapies, including oxaliplatin, are a mainstay in the management of solid tumors and induce cell death by forming intrastrand dinucleotide DNA adducts. Despite their common use, they are highly toxic, and approximately half of cancer patients have tumors that are either intrinsically resistant or develop resistance. Previous studies suggest that this resistance is mediated by variations in DNA repair levels or net drug influx. Here, we aimed to better define the roles of nucleotide excision repair and DNA damage in platinum chemotherapy resistance by profiling DNA damage and repair efficiency in seven oxaliplatin-sensitive and three oxaliplatin-resistant colorectal cancer cell lines. We assayed DNA repair indirectly as toxicity and directly measured bulky adduct formation and removal from the genome by slot blot and repair capacity in an excision assay, and used excision repair sequencing (XR-seq) to map repair events genome-wide at single-nucleotide resolution. Using this combinatorial approach and proxies for oxaliplatin?DNA damage, we observed no significant differences in repair efficiency that could explain the relative sensitivities and chemotherapy resistances of these cell lines. In contrast, the levels of oxaliplatin-induced DNA damage were significantly lower in the resistant cells, indicating that decreased damage formation, rather than increased damage repair, is a major determinant of oxaliplatin resistance in these cell lines. XR-seq?based analysis of gene expression revealed up-regulation of membrane transport pathways in the resistant cells, and these pathways may contribute to resistance. In conclusion, additional research is needed to characterize the factors mitigating cellular DNA damage formation by platinum compounds.	[Vaughn, Courtney M.; Selby, Christopher P.; Yang, Yanyan; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Hsu, David S.] Duke Univ, Med Ctr, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Sancar, A (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	aziz_sancar@med.unc.edu			National Institutes of Health [GM118102, ES027255]; National Institute of General Medical Sciences [5T32 GM007092]; National Cancer Institute [F30CA225060]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants GM118102 and ES027255 (to A. S.) and National Institute of General Medical Sciences award 5T32 GM007092 and National Cancer Institute fellowship F30CA225060 (to C. M. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Barckhausen C, 2014, ONCOGENE, V33, P1964, DOI 10.1038/onc.2013.141; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Bowden NA, 2014, CANCER LETT, V346, P163, DOI 10.1016/j.canlet.2014.01.005; Chen SF, 2016, BIOMED PHARMACOTHER, V82, P583, DOI 10.1016/j.biopha.2016.05.017; de Gramont A, 2003, Colorectal Dis, V5 Suppl 3, P10, DOI 10.1046/j.1463-1318.5.s3.3.x; Deger N, 2019, J BIOL CHEM, V294, P18092, DOI 10.1074/jbc.AC119.011448; Di Francia R, 2015, EUR REV MED PHARMACO, V19, P4443; Fang C, 2017, SCI REP-UK, V7, DOI 10.1038/srep40384; Fang YN, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170609; Gong WJ, 2016, TUMOR BIOL, V37, P8349, DOI 10.1007/s13277-015-4497-5; Guffanti Federica, 2018, Oncotarget, V9, P24707, DOI 10.18632/oncotarget.25185; Hahne JC, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00226; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Ho GY, 2016, CRIT REV ONCOL HEMAT, V102, P37, DOI 10.1016/j.critrevonc.2016.03.014; Howell SB, 2010, MOL PHARMACOL, V77, P887, DOI 10.1124/mol.109.063172; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Huang YX, 2017, MOL CARCINOGEN, V56, P447, DOI 10.1002/mc.22507; JOHNSON SW, 1994, BIOCHEM PHARMACOL, V47, P689, DOI 10.1016/0006-2952(94)90132-5; Katano K, 2002, CANCER RES, V62, P6559; Kemp MG, 2012, J BIOL CHEM, V287, P22889, DOI 10.1074/jbc.M112.374447; Kim ES, 2012, J CLIN ONCOL, V30, P3345, DOI 10.1200/JCO.2011.40.8120; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Ling H, 2013, GENOME RES, V23, P1446, DOI 10.1101/gr.152942.112; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Massari F, 2015, CRIT REV ONCOL HEMAT, V96, P81, DOI 10.1016/j.critrevonc.2015.05.005; MASUDA H, 1988, CANCER RES, V48, P5713; Meynard D, 2007, ONCOL REP, V17, P1213; Mezencev R, 2016, CANCER GENE THER, V23, P446, DOI 10.1038/cgt.2016.71; Modi S, 2016, J GASTROINTEST SURG, V20, P13, DOI 10.1007/s11605-015-3000-3; Novakovic P, 2006, CARCINOGENESIS, V27, P916, DOI 10.1093/carcin/bgi312; Ozawa T, 2017, ANN ONCOL, V28, P1882, DOI 10.1093/annonc/mdx248; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Preston TJ, 2009, MOL CANCER THER, V8, P2015, DOI 10.1158/1535-7163.MCT-08-0929; Riou L, 2004, CANCER RES, V64, P889, DOI 10.1158/0008-5472.CAN-03-2070; Saintas E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172140; Samimi G, 2004, CLIN CANCER RES, V10, P4661, DOI 10.1158/1078-0432.CCR-04-0137; Sancar A, 1996, ANNU REV BIOCHEM, V65, P43, DOI 10.1146/annurev.bi.65.070196.000355; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Unger FT, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-359; Veal GJ, 2001, CLIN CANCER RES, V7, P2205; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang SS, 2018, CHEM RES TOXICOL, V31, P1293, DOI 10.1021/acs.chemrestox.8b00170; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wu XM, 2003, CLIN CANCER RES, V9, P5874; Yang YY, 2019, J BIOL CHEM, V294, P11960, DOI 10.1074/jbc.RA119.009579; Yu WK, 2017, BRIT J PHARMACOL, V174, P302, DOI 10.1111/bph.13690; Zhang JL, 2017, ONCOL LETT, V14, P6907, DOI 10.3892/ol.2017.7049	53	7	7	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7584	7594		10.1074/jbc.RA120.013347	http://dx.doi.org/10.1074/jbc.RA120.013347			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32299912	Green Published, hybrid			2022-12-26	WOS:000538038900003
J	Charpentier, V; Meggers, F; Adriaenssens, S; Baverel, O				Charpentier, Victor; Meggers, Forrest; Adriaenssens, Sigrid; Baverel, Olivier			Occupant-centered optimization framework to evaluate and design new dynamic shading typologies	PLOS ONE			English	Article							MULTIOBJECTIVE OPTIMIZATION; DAYLIGHT; SYSTEMS; PERFORMANCE; OPERATION; COMFORT; IMPACT	Dynamic solar shading has the potential to dramatically reduce the energy consumption in buildings while at the same time improving the thermal and visual comfort of its occupants. Many new typologies of shading systems that have appeared recently, but it is difficult to compare those new systems to existing typologies due to control algorithm being rule-based as opposed to performance driven. Since solar shading is a design problem, there is no single right answer. What is the metric to determine if a system has reached its optimal kinematic design? Shading solutions should come from a thorough iterative and comparative process. This paper provides an original and flexible framework for the design and performance optimization of dynamic shading systems based on interpolation of simulations and global minimization. The methodology departs from existing rule-based strategies and applies to existing and to complex shading systems with multiple degree-of-freedom mobility. The strategy for control is centered on meeting comfort targets for work plane illuminance while minimizing the energy needed to operate space. The energy demand for thermal comfort and work plane daylight quantity (illuminance) are evaluated with Radiance and EnergyPlus based on local weather data. Applied to a case study of three typologies of dynamic shading, the results of the methodology inform the usefulness and quality of each degree-of-freedom of the kinematic systems. The case study exemplifies the iterative benefits of the methodology by providing detailed analytics on the behavior of the shades. Designers of shading systems can use this framework to evaluate their design and compare them to existing shading systems. This allows creativity to be guided so that eventually building occupants benefit from the innovation in the field.	[Charpentier, Victor; Adriaenssens, Sigrid] Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA; [Meggers, Forrest] Princeton Univ, Sch Architecture, Princeton, NJ 08544 USA; [Meggers, Forrest] Princeton Univ, Andlinger Ctr Energy & Environm, Princeton, NJ 08544 USA; [Baverel, Olivier] UPE, CNRS, IFSTTAR, Lab Navier,UMR 8205,Eole Ponts, Champs Sur Marne, France	Princeton University; Princeton University; Princeton University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Ecole des Ponts ParisTech; Universite Gustave-Eiffel	Charpentier, V (corresponding author), Princeton Univ, Dept Civil & Environm Engn, Princeton, NJ 08544 USA.	viccharp@gmail.com		Charpentier, Victor/0000-0001-8975-1465	National Science Foundation [1538330]	National Science Foundation(National Science Foundation (NSF))	Funded study: VC, FM, SA, National Science Foundation,, Grant No 1538330	Adriaenssens S, 2014, ENERGIES, V7, P5201, DOI 10.3390/en7085201; Al-Masrani SM, 2018, SOL ENERGY, V170, P849, DOI 10.1016/j.solener.2018.04.047; Al-Obaidi KM, 2017, SOL ENERGY, V149, P85, DOI 10.1016/j.solener.2017.04.001; Carlucci S, 2015, RENEW SUST ENERG REV, V47, P1016, DOI 10.1016/j.rser.2015.03.062; Chan YC, 2015, ENERG BUILDINGS, V92, P81, DOI 10.1016/j.enbuild.2015.01.057; Charpentier V, 2017, SMART MATER STRUCT, V26, DOI 10.1088/1361-665X/aa640f; Chinazzo G, 2019, SCI REPORTS, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-018-37186-2]; Crawley DB, 2001, ENERG BUILDINGS, V33, P319, DOI 10.1016/S0378-7788(00)00114-6; Cziker A, 2008, PROCEEDINGS OF THE 11TH INTERNATIONAL CONFERENCE ON OPTIMIZATION OF ELECTRICAL AND ELECTRONIC EQUIPMENT, VOL IV, P203; da Silva PC, 2012, ENERG BUILDINGS, V50, P35, DOI 10.1016/j.enbuild.2012.03.019; Delgarm N, 2016, APPL ENERG, V170, P293, DOI 10.1016/j.apenergy.2016.02.141; Dubois M.-C., 2003, Lighting Research & Technology, V35, P61, DOI 10.1191/1477153503li062oa; Dubois M-C, 2001, SIMULATIONS RADIANCE; Elkhayat Y, 2014, J ENG SCI, V42; Fiorito F, 2016, RENEW SUST ENERG REV, V55, P863, DOI 10.1016/j.rser.2015.10.086; Futrell BJ, 2015, BUILD ENVIRON, V92, P591, DOI 10.1016/j.buildenv.2015.03.039; Galasiu AD, 2006, ENERG BUILDINGS, V38, P728, DOI 10.1016/j.enbuild.2006.03.001; Grynning S, 2014, SOL ENERGY, V107, P182, DOI 10.1016/j.solener.2014.06.007; Guo HS, 2020, RENEW SUST ENERG REV, V117, DOI 10.1016/j.rser.2019.06.014; Hviid CA, 2008, SOL ENERGY, V82, P787, DOI 10.1016/j.solener.2008.03.001; Jakubiec JA, 2011, P BUILDING SIMULATIO; Katsifaraki A, 2017, BUILD ENVIRON, V126, P207, DOI 10.1016/j.buildenv.2017.10.003; Khoroshiltseva M, 2016, APPL ENERG, V184, P1400, DOI 10.1016/j.apenergy.2016.05.015; Kirimtat A., 2016, 2016 IEEE C EV COMP; Korner A, 2018, SMART MATER STRUCT, V27, DOI 10.1088/1361-665X/aa9c2f; Konstantoglou M, 2016, RENEW SUST ENERG REV, V60, P268, DOI 10.1016/j.rser.2015.12.246; Langevin J, 2013, BUILD ENVIRON, V69, P206, DOI 10.1016/j.buildenv.2013.07.017; Lee E, 1998, ENERG BUILDINGS, V29, P47, DOI 10.1016/S0378-7788(98)00035-8; Lienhard J, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/045001; Luo YQ, 2019, APPL ENERG, V255, DOI 10.1016/j.apenergy.2019.113896; Mangkuto RA, 2018, J BUILD ENG, V18, P195, DOI 10.1016/j.jobe.2018.03.007; Manzan M, 2017, BUILD ENVIRON, V113, P175, DOI 10.1016/j.buildenv.2016.09.035; Mardaljevic J, 2012, P BUILD SIM OPT C BS; McNeel R., 2012, GRASSHOPPER RHINO3D; Mills E, 1999, J ILLUM ENG SOC, V28, P155, DOI 10.1080/00994480.1999.10748262; Nabil A, 2006, ENERG BUILDINGS, V38, P905, DOI 10.1016/j.enbuild.2006.03.013; Nagy Z, 2016, FRONT ARCHIT RES, V5, P143, DOI 10.1016/j.foar.2016.03.002; Nielsen MV, 2011, SOL ENERGY, V85, P757, DOI 10.1016/j.solener.2011.01.010; Pesenti M, 2015, ENRGY PROCED, V70, P661, DOI 10.1016/j.egypro.2015.02.174; Reference EE, 2014, REF EN PLUS CALC; Santos L, 2018, SOL ENERGY, V161, P47, DOI 10.1016/j.solener.2017.12.020; Sghiouri H, 2018, J BUILD ENG, V18, P292, DOI 10.1016/j.jobe.2018.03.018; Shen H, 2017, ENERG BUILDINGS, V145, P200, DOI 10.1016/j.enbuild.2017.04.021; SUTHERLAND IE, 1974, COMMUN ACM, V17, P32, DOI 10.1145/360767.360802; Tzempelikos A, 2007, SOL ENERGY, V81, P369, DOI 10.1016/j.solener.2006.06.015; Ward G.J., 1994, COMPUTER GRAPHICS P; Wienold J, 2007, BUILDING SIMULATION 2007, VOLS 1-3, PROCEEDINGS, P1197; Wilcox S, 2008, USERS MANUAL TMY3 DA; Xiong J, 2016, SOL ENERGY, V134, P416, DOI 10.1016/j.solener.2016.04.026	49	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231554	10.1371/journal.pone.0231554	http://dx.doi.org/10.1371/journal.pone.0231554			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330135	Green Published, gold			2022-12-26	WOS:000536647300016
J	Kamiyama, MT; Bradford, BZ; Groves, RL; Guedot, C				Kamiyama, Matthew T.; Bradford, Benjamin Z.; Groves, Russell L.; Guedot, Christelle			Degree day models to forecast the seasonal phenology of Drosophila suzukii in tart cherry orchards in the Midwest US	PLOS ONE			English	Article							SPOTTED-WING DROSOPHILA; DIPTERA DROSOPHILIDAE; MAGGOT DIPTERA; PEST; SUSCEPTIBILITY; INSECTICIDES; INFESTATION; TEMPERATURE; WISCONSIN; EMERGENCE	Spotted-wing drosophila, Drosophila suzukii (Matsumura) (Diptera: Drosophilidae), is an invasive economic pest of soft-skinned and stone fruit across the globe. Our study establishes both a predictive generalized linear mixed model (GLMM), and a generalized additive mixed model (GAMM) of the dynamic seasonal phenology of D. suzukii based on four years of adult monitoring trap data in Wisconsin tart cherry orchards collected throughout the growing season. The models incorporate year, field site, relative humidity, and degree days (DD); and relate these factors to trap catch. The GLMM estimated a coefficient of 2.21 for DD/1000, meaning for every increment of 1000 DD, trap catch increases by roughly 9 flies. The GAMM generated a curve based on a cubic regression smoothing function of DD which approximates critical DD points of first adult D. suzukii detection at 1276 DD, above average field populations beginning at 2019 DD, and peak activity at 3180 DD. By incorporating four years of comprehensive seasonal phenology data from the same locations, we introduce robust models capable of using DD to forecast changing adult D. suzukii populations in the field leading to the application of more timely and effective management strategies.	[Kamiyama, Matthew T.] Kyoto Univ, Res Inst Sustainable Humanosphere, Div Appl Biosci, Kyoto, Japan; [Kamiyama, Matthew T.; Bradford, Benjamin Z.; Groves, Russell L.; Guedot, Christelle] Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA	Kyoto University; University of Wisconsin System; University of Wisconsin Madison	Guedot, C (corresponding author), Univ Wisconsin, Dept Entomol, Madison, WI 53706 USA.	guedot@wisc.edu		Kamiyama, Matthew/0000-0002-8309-4537	Wisconsin Department of Agriculture, Trade, and Consumer Protection Specialty Crop Block Grant [16-01]	Wisconsin Department of Agriculture, Trade, and Consumer Protection Specialty Crop Block Grant	CG received funding for the project from the Wisconsin Department of Agriculture, Trade, and Consumer Protection Specialty Crop Block Grant #16-01. https://datcp.wi.gov/Pages/Homepage.aspx The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; Beers EH, 2011, PEST MANAG SCI, V67, P1386, DOI 10.1002/ps.2279; Bolda MP, 2016, AGR RESOURCE EC UPDA, V13, P5; Bridges CM, 2000, ARCH ENVIRON CON TOX, V39, P91, DOI 10.1007/s002440010084; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Daane KM, 2010, ANNU REV ENTOMOL, V55, P151, DOI 10.1146/annurev.ento.54.110807.090553; Depra M, 2014, J PEST SCI, V87, P379, DOI 10.1007/s10340-014-0591-5; Diepenbrock LM, 2016, CROP PROT, V81, P76, DOI 10.1016/j.cropro.2015.12.012; DiGiacomo G, 2019, J INTEGR PEST MANAG, V10, DOI 10.1093/jipm/pmz006; Doi H, 2008, BIOL LETTERS, V4, P388, DOI 10.1098/rsbl.2008.0234; Enviroweather, 2019, WEATH BAS PEST NAT R; Epstein DL, 2000, ENVIRON ENTOMOL, V29, P340, DOI 10.1603/0046-225X(2000)029[0340:EOBSIO]2.0.CO;2; Evans RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171718; Frost KE, 2013, ENVIRON ENTOMOL, V42, P477, DOI 10.1603/EN12239; Goodhue RE, 2011, PEST MANAG SCI, V67, P1396, DOI 10.1002/ps.2259; Guedot C, 2018, ENVIRON ENTOMOL, V47, P1365, DOI 10.1093/ee/nvy159; Hamby KA, 2016, J PEST SCI, V89, P605, DOI 10.1007/s10340-016-0756-5; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Jaffe BD, 2019, PEST MANAG SCI, V75, P2188, DOI 10.1002/ps.5343; Kamiyama MT, 2019, BIOCONTROL, V64, P665, DOI 10.1007/s10526-019-09966-w; Kamiyama MT, 2019, J ECON ENTOMOL, V112, P1789, DOI 10.1093/jee/toz102; Leach H, 2016, INTEGRATED STRATEGIE; Leach H, 2019, ENVIRON ENTOMOL, V48, P1223, DOI 10.1093/ee/nvz101; Lee JC, 2015, ANN ENTOMOL SOC AM, V108, P117, DOI 10.1093/aesa/sau014; Pelton E, 2017, J APPL ENTOMOL, V141, P644, DOI 10.1111/jen.12384; PRISM Climate Group, 2019, 2019 NW ALL COMP SCI; R Core Team, 2018, R LANG ENV STAT COMP; REISSIG WH, 1979, CAN ENTOMOL, V111, P621, DOI 10.4039/Ent111621-5; Teixeira LAF, 2001, ENVIRON ENTOMOL, V30, P925, DOI 10.1603/0046-225X-30.5.925; Tochen S, 2016, J APPL ENTOMOL, V140, P47, DOI 10.1111/jen.12247; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; Van Timmeren S, 2013, CROP PROT, V54, P126, DOI 10.1016/j.cropro.2013.08.003; Walsh DB, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10010; Wang XG, 2016, J PEST SCI, V89, P701, DOI 10.1007/s10340-016-0747-6; Wiman NG, 2016, J PEST SCI, V89, P653, DOI 10.1007/s10340-016-0757-4; Wiman NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106909; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	37	6	6	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0227726	10.1371/journal.pone.0227726	http://dx.doi.org/10.1371/journal.pone.0227726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330137	gold, Green Published			2022-12-26	WOS:000536647300005
J	Nomoto, H; Ishikane, M; Nakamoto, T; Ohta, M; Morioka, S; Yamamoto, K; Kutsuna, S; Tezuka, S; Kunimatsu, J; Ohmagari, N				Nomoto, Hidetoshi; Ishikane, Masahiro; Nakamoto, Takato; Ohta, Masayuki; Morioka, Shinichiro; Yamamoto, Kei; Kutsuna, Satoshi; Tezuka, Shunsuke; Kunimatsu, Junwa; Ohmagari, Norio			Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012-2013 and 2018-2019	PLOS ONE			English	Article							VIRUS; PERSISTENCE	Background Rubella virus infection mainly causes illness with mild fever, rash, and lymphadenopathy in children; however, the clinical characteristics of adult rubella are not well-known. Methods An observational study was conducted to compare the characteristics between adult rubella and adult non-rubella among participants aged >= 18 years, with suspected symptomatic rubella. Participants were screened for rubella-specific IgM expression using an enzyme immune assay kit, at a tertiary care hospital in Japan during two outbreaks (January 2012-December 2013 and January 2018-March 2019). Adult rubella diagnosis followed strong positive or paired rubella-specific IgM expression or positive rubella-specific reverse-transcription-polymerase chain reaction. Patients aged <18 years or with clinically suspected rubella with weak or negative IgM expression were excluded. Results Overall, 82 adult rubella and 139 adult non-rubella, with a median age (interquartile range) of 31 (25-41) years and 34 (27-42) years, respectively, were included. Multivariate analysis showed that conjunctivitis (odds ratio 80.6; 95% confidence interval 13.4-486.3; P < 0.001) and male sex (odds ratio 7.1; 95% confidence interval 1.8-28.1; P = 0.005) were significantly associated with adult rubella. Among men born from 1962 to 1979 (high-risk population, n = 68), conjunctivitis also showed a significant association with adult rubella in the multivariate analysis (odds ratio 24.2; 95% confidence interval 1.1-553.7; P = 0.046) as these patients were not included in the national vaccination program. There was no difference in the clinical characteristics between one-time vaccination (n = 11) and no vaccination (n = 8) patient in the adult rubella group. Conclusions Conjunctivitis was the key clinical symptom associated with adult rubella. For the early diagnosis of adult rubella, clinicians should focus on assessing conjunctivitis in patients.	[Nomoto, Hidetoshi; Ishikane, Masahiro; Nakamoto, Takato; Ohta, Masayuki; Morioka, Shinichiro; Yamamoto, Kei; Kutsuna, Satoshi; Ohmagari, Norio] Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo, Japan; [Nomoto, Hidetoshi; Ohmagari, Norio] Tohoku Univ, Natl Ctr Global Hlth & Med, Grad Sch Med, Collaborat Chairs Emerging & Reemerging Infect Di, Sendai, Miyagi, Japan; [Ishikane, Masahiro; Ohmagari, Norio] Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Shinjuku Ku, Tokyo, Japan; [Tezuka, Shunsuke] Natl Ctr Global Hlth & Med, Lab Testing Dept, Shinjuku Ku, Tokyo, Japan; [Kunimatsu, Junwa] Natl Ctr Global Hlth & Med, Dept Gen Internal Med, Shinjuku Ku, Tokyo, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; Tohoku University; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan	Ishikane, M (corresponding author), Natl Ctr Global Hlth & Med, Dis Control & Prevent Ctr, Shinjuku Ku, Tokyo, Japan.; Ishikane, M (corresponding author), Natl Ctr Global Hlth & Med, AMR Clin Reference Ctr, Shinjuku Ku, Tokyo, Japan.	ishikanemasahiro@gmail.com	Ishikane, Masahiro/ABA-9878-2020; Ohmagari, Norio/GLN-5290-2022	Ohmagari, Norio/0000-0002-4622-8970; Nomoto, Hidetoshi/0000-0002-9323-3924; Ishikane, Masahirio/0000-0002-4719-651X				[Anonymous], 2005, Wkly Epidemiol Rec, V80, P126; Best JM, 2007, SEMIN FETAL NEONAT M, V12, P182, DOI 10.1016/j.siny.2007.01.017; Centers for Disease Control and Prevention, THE PINK BOOK; Centers for Disease Control and Prevention USA, MEASL RUB 2013 CAS D; Centers for Disease Control and Prevention USA, RUB JAP; HORSTMANN DM, 1985, REV INFECT DIS, V7, pS80; HOSHINO M, 1982, J BIOL STAND, V10, P213, DOI 10.1016/S0092-1157(82)80022-X; Jindai K, 2018, LANCET INFECT DIS, V18, P713, DOI 10.1016/S1473-3099(18)30356-6; Kato Hirofumi, 2013, Kansenshogaku Zasshi, V87, P603; Kumar DM, 2019, MANDELL DOUGLAS BENN, P1502; Kunimatsu J, 2013, ADULT RUBELLA RETROS; Kurata T, 2019, MICROBIOL IMMUNOL, V63, P32, DOI 10.1111/1348-0421.12664; KURTZ JB, 1985, LANCET, V2, P1356; Ministry of Health Labor and Welfare in Japan, ADD MEAS RUB; National Institute of Infectious Disease in Japan, INF DIS SURV SYST JA; National Institute of Infectious Diseases in Japan, 2018, NAT EP SURV VACC PRE; National Institute of Infectious Diseases in Japan, 2019, INF DIS WEEKL REP 20; National Institute of Infectious Diseases in Japan, REP CONG RUB SYNDR; National Institute of Infectious diseases Japan, PATH DET MAN; Okamoto K, 2016, J CLIN VIROL, V80, P98, DOI 10.1016/j.jcv.2016.05.005; Tago S, 2019, INT J INFECT DIS, V82, P7, DOI 10.1016/j.ijid.2019.02.034; Thomas HIJ, 1999, J CLIN VIROL, V14, P107, DOI 10.1016/S1386-6532(99)00051-7; Tipples GA, 2004, J CLIN VIROL, V30, P233, DOI 10.1016/j.jcv.2003.11.006; Tucker JD, 2014, LANCET, V383, P1460, DOI 10.1016/S0140-6736(14)60712-1; Ujiie M., 2019, J TRAVEL MED, V1; who, FACT SHEETS; World Health Organization, GLOB MEASL RUB MONTH	27	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0231966	10.1371/journal.pone.0231966	http://dx.doi.org/10.1371/journal.pone.0231966			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330153	Green Published, gold			2022-12-26	WOS:000536647300034
J	Lachaud, J; Mejia-Lancheros, C; Wang, R; Wiens, K; Nisenbaum, R; Stergiopoulos, V; Hwang, SW; O'Campo, P				Lachaud, James; Mejia-Lancheros, Cilia; Wang, Ri; Wiens, Kathryn; Nisenbaum, Rosane; Stergiopoulos, Vicky; Hwang, Stephen W.; O'Campo, Patricia			Mental and substance use disorders and food insecurity among homeless adults participating in the At Home/Chez Soi study	PLOS ONE			English	Article							DEPRESSIVE SYMPTOMS; HEALTH CONDITIONS; INDIVIDUALS; ILLNESS; SECURITY; PREVALENCE; CONTEXT; STIGMA	Background Few studies have examined how food insecurity changes over time when living with severe mental disorders or substance use disorders. This study identifies food insecurity trajectories of homeless adults participating in a trial of a housing intervention and examines whether receiving the intervention and having specific mental and substance disorders predict food insecurity trajectories. Materials and methods We studied 520 participants in the Toronto site of the At Home/Chez-Soi project. Food insecurity data were collected at seven times during a follow-up period of up to 5.5 years. Mental and substance use disorders were assessed at baseline. Food insecurity trajectories were identified using group based-trajectory modeling. Multinomial logistic regression was used to examine the effects of the intervention and mental and substance use disorders on food insecurity trajectories. Results Four food insecurity trajectories were identified: persistently high food insecurity, increasing food insecurity, decreasing food insecurity, and consistently low food insecurity. Receiving the intervention was not a predictor of membership in any specific food insecurity trajectory group. Individuals with major depressive episode, mood disorder with psychotic features, substance disorder, and co-occurring disorder (defined as having at least one alcohol or other substance use disorder and at least one non-substance related mental disorder] were more likely to remain in the persistently high food insecurity group than the consistently low food insecurity group. Conclusion A persistently high level of food insecurity is common among individuals with mental illness who have experienced homelessness, and the presence of certain mental health disorders increases this risk. Mental health services combined with access to resources for basic needs, and re-adaptation training are required to enhance the health and well-being of this population.	[Lachaud, James; Mejia-Lancheros, Cilia; Wang, Ri; Wiens, Kathryn; Nisenbaum, Rosane; Stergiopoulos, Vicky; Hwang, Stephen W.; O'Campo, Patricia] St Michaels Hosp, Unity Hlth Toronto, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada; [Nisenbaum, Rosane] St Michaels Hosp, Li Ka Shing Knowledge Inst, Appl Hlth Res Ctr, Toronto, ON, Canada; [Stergiopoulos, Vicky] Ctr Addict & Mental Hlth, Toronto, ON, Canada; [Stergiopoulos, Vicky] Univ Toronto, Dept Psychiat, Toronto, ON, Canada; [Hwang, Stephen W.] Univ Toronto, Dept Med, Div Gen Internal Med, Toronto, ON, Canada; [O'Campo, Patricia] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto	Lachaud, J (corresponding author), St Michaels Hosp, Unity Hlth Toronto, Li Ka Shing Knowledge Inst, MAP Ctr Urban Hlth Solut, Toronto, ON, Canada.	james.lachaud@unityhealth.to	Mejia-Lancheros, Cilia/ABG-6716-2020; Hwang, Stephen W./GVR-7773-2022	Lachaud, James/0000-0001-8498-8922	Health Canada; Ontario Ministry of Health and LongTerm Care (HSRF) [259]; Canadian Institute of Health Research [CIHR MOP-130405]; HSRF [259]; CIHR [MOP-130405]	Health Canada; Ontario Ministry of Health and LongTerm Care (HSRF); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); HSRF; CIHR(Canadian Institutes of Health Research (CIHR))	The At Home/Chez Soi research demonstration project was made possible through a financial contribution from Health Canada provided to Mental Health Commission of Canada. This study was financially supported from research grants from Ontario Ministry of Health and LongTerm Care (HSRF #259), and the Canadian Institute of Health Research (CIHR MOP-130405). Initials of authors who received Grants: HSRF #259: VS and SWH CIHR operating grant: MOP-130405: VS, PO and SWH URLs to sponsors' websites: Canadian Institute of Health Research: http://www.cihr-irsc.gc.ca/e/193.html Ontario Ministry of Health and Long-Term Care: http://www.health.gov.on.ca/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair CE, 2017, CAN J PSYCHIAT, V62, P30, DOI 10.1177/0706743716645302; Baer TE, 2015, J ADOLESCENT HEALTH, V57, P601, DOI 10.1016/j.jadohealth.2015.08.013; Baggett TP, 2011, J GEN INTERN MED, V26, P627, DOI 10.1007/s11606-011-1638-4; Belcher JR, 2012, J HUM BEHAV SOC ENVI, V22, P929, DOI 10.1080/10911359.2012.707941; Belsky DW, 2010, AM J EPIDEMIOL, V172, P809, DOI 10.1093/aje/kwq201; Bickel G., 2000, MEASURING FOOD SECUR; Carod-Artal FJ., 2017, GLOBAL MENTAL HLTH P; Crisp AH, 2000, BR J PSYCHIAT; D'Andreamatteo C, 2018, CAN J DIET PRACT RES, V79, P42, DOI 10.3148/cjdpr-2017-026; Davison KM, 2015, ANN GEN PSYCHIATR, V14, DOI 10.1186/s12991-015-0059-x; Dee R., 2010, VOICES EXPERIENCE NA, P76; Dewing S, 2013, J AFFECT DISORDERS, V150, P460, DOI 10.1016/j.jad.2013.04.040; Draine J., 2013, AM J PSYCHIATRIC REH, V16, P87, DOI [10.1080/15487768.2013.789684, DOI 10.1080/15487768.2013.789684]; Fazel S, LANCET, V384; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Ferreira RL, 2018, ECOL STUD-ANAL SYNTH, V235, P435, DOI 10.1007/978-3-319-98852-8_21; Gaebel W, 2015, DIALOGUES CLIN NEURO, V17, P9; Goering PN, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000323; Gundersen C, 2017, PUBLIC HEALTH NUTR, V20, P1367, DOI 10.1017/S1368980017000180; Gundersen C, 2015, HEALTH AFFAIR, V34, P1830, DOI 10.1377/hlthaff.2015.0645; Hamelin A.-M., 2009, CANADIAN J URBAN RES, V18, P1; Hanson KL, 2012, J HEALTH CARE POOR U, V23, P1174, DOI 10.1353/hpu.2012.0116; Holland AC, 2011, PUBLIC HEALTH NUTR, V14, P2254, DOI 10.1017/S1368980011001327; Howard LL, 2011, ECON EDUC REV, V30, P157, DOI 10.1016/j.econedurev.2010.08.003; Hwang SW, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-787; Jessiman-Perreault G, 2017, SSM-POPUL HLTH, V3, P464, DOI 10.1016/j.ssmph.2017.05.013; Jones B, 2012, THIS WORK WAS GENERO; Kemp AH, 2013, INT J PSYCHOPHYSIOL, V89, P288, DOI 10.1016/j.ijpsycho.2013.06.018; Kirkpatrick SI, 2011, J URBAN HEALTH, V88, P284, DOI 10.1007/s11524-010-9535-4; Lennon MC, 2005, AM J PUBLIC HEALTH, V95, P1760, DOI 10.2105/AJPH.2005.064402; Leung CW, 2015, J NUTR, V145, P622, DOI 10.3945/jn.114.199414; Li X, 2014, CHINA COMMUN, V11, P90, DOI 10.1109/CC.2014.6821741; Martin MS, 2016, PUBLIC HEALTH, V132, P86, DOI 10.1016/j.puhe.2015.11.014; McLaughlin KA, 2012, J AM ACAD CHILD PSY, V51, P1293, DOI 10.1016/j.jaac.2012.09.009; Meyer F, 2009, HARVARD REV PSYCHIAT, V17, P353, DOI 10.3109/10673220903463325; Mojtabai R, 2015, SOC PSYCH PSYCH EPID, V50, P1657, DOI 10.1007/s00127-015-1097-z; Muldoon KA, 2013, SOC PSYCH PSYCH EPID, V48, P795, DOI 10.1007/s00127-012-0597-3; Nagin D, 2010, GROUP BASED TRAJECTO; Newson R, 2003, STATA J, V3, P109, DOI 10.1177/1536867X0300300202; O'Campo P, 2017, PUBLIC HEALTH NUTR, V20, P2023, DOI 10.1017/S1368980017000489; Palar K, 2015, AIDS BEHAV, V19, P1527, DOI 10.1007/s10461-014-0922-9; Parcesepe AM, 2013, ADM POLICY MENT HLTH, V40, P384, DOI 10.1007/s10488-012-0430-z; Parpouchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159334; Pienkos E, 2019, SCHIZOPHRENIA BULL, V45, pS67, DOI 10.1093/schbul/sby057; Rush B, 2008, CAN J PSYCHIAT, V53, P810, DOI 10.1177/070674370805301207; Scheepers FE, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00237; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; StataCorp, 2017, STATA STAT SOFTWARE; Stergiopoulos V, 2012, BMC HEALTH SERV RES, V12, P1; STERGIOPOULOS V, 2016, BMC PUBLIC HEALTH, V16, P1; Stergiopoulos V, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-167; Tarasuk V, 2016, HOUSEHOLD FOOD INSEC; Tarasuk V, 2013, J NUTR, V143, P1785, DOI 10.3945/jn.113.178483; Thornicroft G., 2010, ADV PSYCHIAT TREAT, V16, P53, DOI DOI 10.1192/APT.BP.107.004481; United States Department of Agriculture Economic Research Security, 2018, DEF FOOD SEC; US Department of Agriculture, 2012, US AD FOOD SEC SURV; Wang J, 2017, SOCIAL PSYCHIAT PSYC; Weiser SD, 2009, AIDS BEHAV, V13, P841, DOI 10.1007/s10461-009-9597-z	58	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232001	10.1371/journal.pone.0232001	http://dx.doi.org/10.1371/journal.pone.0232001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324795	Green Published, gold			2022-12-26	WOS:000536033700057
J	Adam, A; Fusheini, A				Adam, Awolu; Fusheini, Adam			Knowledge, risk of infection, and vaccination status of hepatitis B virus among rural high school students in Nanumba North and South Districts of Ghana	PLOS ONE			English	Article							PREGNANT-WOMEN; PREVALENCE; REGION	Background Hepatitis B (HB) is a viral infection that affects the liver and can lead to life-threatening conditions including cirrhosis and liver cancer. Over a billion people are estimated to be infected globally with the hepatitis B virus, with over 240 million chronically infected. Sub-Saharan Africa including Ghana is an HBV endemic area and an estimated 5%-10% of the population in the region is infected. Research on the knowledge and vaccination status of hepatitis B in rural communities in Ghana is lacking. Objectives The objectives of this study proposed were to assess the HBV knowledge, risk of HBV infection, and vaccination status of high school students in two rural districts of the Northern region on Ghana. Methods A cross-sectional study of a random sample of 426 students from two senior high schools in the Nanumba North and South districts of the Northern region of Ghana on hepatitis B knowledge and vaccination status was conducted. Descriptive statistics were used to analyze and present data on demographic and knowledge variables. A Mann Whitney U test was used to compare the differences in HBV knowledge between male and female students and between students of the two high schools that were involved in the study. Pearson correlation coefficient was used to compute the association between HBV knowledge and age of students. Logistic regression was used to develop a model to predict variables that influenced vaccination against HB. Results The results of the study showed basic but not a good knowledge of HBV among the rural high school students, with a mean score of 11.8 (SD = 1.98) out of a maximum score of 16. Descriptive statistics also revealed that only 20% of 426 students ever tested for HBV and 96 (22.5%) were vaccinated against HBV. A Mann-Whitney U test results revealed no statistically significant difference in HBV knowledge between male and female students (p = 0.688, two-tailed) and between the two high schools (p = 0.24, two-tailed). A Pearson correlation showed no relationship between age and HBV knowledge (p = 0.486). Regression analysis showed that only taking the HBV test (p < 0.05) and attending Bimbilla Senior High (p = 0.032) significantly predicted vaccination against HBV infection. Conclusion The results of this study has re-echoed the high prevalence of HBV in Ghana. The poor state of knowledge and a high risk of HBV infection among young adults in rural communities have also been highlighted in the findings of this study. Vaccination against the HBV infection was found to be low and consistent with other findings. Finally, HBV screening is shown to be significantly associated with vaccination against the virus, hence the need for national screening and vaccination programs.	[Adam, Awolu] Univ Hlth & Allied Sci, Sch Publ Hlth, Ho, Ghana; [Adam, Awolu; Fusheini, Adam] Ctr Hlth Literacy & Rural Hlth Promot, Accra, Ghana; [Fusheini, Adam] Univ Otago, Dunedin Sch Med, Dept Prevent & Social Med, Dunedin, New Zealand	University of Otago	Adam, A (corresponding author), Univ Hlth & Allied Sci, Sch Publ Hlth, Ho, Ghana.; Adam, A (corresponding author), Ctr Hlth Literacy & Rural Hlth Promot, Accra, Ghana.	aawolu@uhas.edu.gh	ADAM, AWOLU/AGG-2856-2022; Fusheini, Adam/H-2400-2016	Fusheini, Adam/0000-0001-7896-3841				Abbasi IN, 2014, INT J OCCUP MED ENV, V27, P757, DOI 10.2478/s13382-014-0299-z; Abeje G, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0756-8; Adekanle O, 2015, HEPATITIS RES TREATM, V2015; Adeyemi AB, 2013, J OBSTET GYNAECOL, V33, P155, DOI 10.3109/01443615.2012.711389; Adjei CA, 2018, AM J TROP MED HYG, V99, P1469, DOI 10.4269/ajtmh.17-0752; Adoba P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2389-7; Afihene MY, 2015, INT J COMMUNITY MED, V2, P244; Agyeman AA, 2016, AIDS RES THER, V13, DOI 10.1186/s12981-016-0107-x; [Anonymous], 2017, 2016 ANN REP; Brouard C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-576; Carabez RM, 2014, J CANCER EDUC, V29, P522, DOI 10.1007/s13187-013-0585-7; CDC, 2015, VIR HEP B INF PER TR; Cho Y, 2012, GUT LIVER, V6, P235, DOI 10.5009/gnl.2012.6.2.235; DEMENDOZA C, 2019, THER ADV INFECT DIS, V6, DOI DOI 10.1177/204993611985146; Dongdem Julius Tieroyaare, 2012, BMC Res Notes, V5, P115, DOI 10.1186/1756-0500-5-115; Fink A., 2003, SAMPLE SURVEYS; Geretti AM, 2010, J CLIN MICROBIOL, V48, P3223, DOI 10.1128/JCM.02231-09; Hagan OC, 2018, J PUBLIC HLTH AFRICA, V9; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; Kothari CR, 2004, RES METHODOLOGY METH, P174; Mkandawire P, 2013, HEALTH PLACE, V23, P89, DOI 10.1016/j.healthplace.2013.06.001; Owusu M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203699; Pham DA, 2009, ASIAN PAC J ALLERGY, V27, P153; UN-DESA, 2017, SUSTAINABLE DEV GOAL, V3; Wilton J., 2017, PUBLIC HLTH, V33, P5	25	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231930	10.1371/journal.pone.0231930	http://dx.doi.org/10.1371/journal.pone.0231930			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320446	gold, Green Published			2022-12-26	WOS:000536028800040
J	Hope, S; Naerland, T; Hoiland, AL; Torske, T; Malt, E; Abrahamsen, T; Nerhus, M; Wedervang-Resell, K; Lonning, V; Johannessen, J; Steen, NE; Agartz, I; Stenberg, N; Hundhausen, T; Morkrid, L; Andreassen, OA				Hope, Sigrun; Naerland, Terje; Hoiland, Anne Lise; Torske, Tonje; Malt, Eva; Abrahamsen, Tore; Nerhus, Mari; Wedervang-Resell, Kirsten; Lonning, Vera; Johannessen, Jade; Steen, Nils Eiel; Agartz, Ingrid; Stenberg, Nina; Hundhausen, Thomas; Morkrid, Lars; Andreassen, Ole A.			Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia A comparison among participants between 2 and 53 years	FASEB JOURNAL			English	Article						autism; cobalamin; hypercobalaminemia; intellectual disability; TCN1	FOLATE RECEPTOR AUTOANTIBODIES; AUTISM SPECTRUM DISORDER; COGNITIVE IMPAIRMENT; EUROPEAN ADOLESCENTS; REFERENCE INTERVALS; SERUM VITAMIN-B12; DEFICIENCY; CHILDREN; MARKERS; ASSOCIATION	Recent studies suggest that both high and low levels of vitamin B12 (vitB12) may have negative health impacts. We measured VitB12 in patients with the Neurodevelopmental disorders (ND) (n = 222), comprised of Autism Spectrum Disorders, specific Developmental disorders, and Intellectual Disability (aged 2-53 years), schizophrenia (n = 401), and healthy controls (HC) (n = 483). Age-and gender-adjusted vitB12 z-scores were calculated by comparisons with a reference population (n = 76 148). We found higher vitB12 in ND (median 420 pmol/L, mean z-score: 0.30) than in HC (316 pmol/L, z-score: 0.06, P < .01) and schizophrenia (306 pmol/L, z-score: -0.02, P < .001), which was significant after adjusting for age, gender, vitB12 supplement, folate, hemoglobin, leukocytes, liver, and kidney function (P < .02). In ND, 20% (n = 44) had vitB12 above 650 pmol/L, and 1% (n = 3) had below 150 pmol/L (common reference limits). In 6.3% (n = 14) of ND, vitB12 was above 2SD of mean in the age-and gender-adjusted reference population, which was more frequent than in HC (n = 8, 1.6%), OR: 4.0, P = .001. Low vitB12 was equally frequent as in HC, and vitB12 z-scores were equal across the age groups. To conclude, vitB12 was higher in ND than in HC and schizophrenia, suggesting a specific feature of ND, which warrants further studies to investigate the underlying mechanisms.	[Hope, Sigrun; Naerland, Terje; Nerhus, Mari; Wedervang-Resell, Kirsten; Lonning, Vera; Steen, Nils Eiel; Agartz, Ingrid; Andreassen, Ole A.] Oslo Univ Hosp Ulleval, Dept Neuro Habilitat, Oslo, Norway; [Hope, Sigrun] Univ Oslo, Norwegian Ctr Mental Disorders Res, Inst Clin Med, NORMENT, Oslo, Norway; [Naerland, Terje] Oslo Univ Hosp, Natl Competence Ctr Neurodev Disorders & Hypersom, Oslo, Norway; [Hoiland, Anne Lise] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Pediat, Trondheim, Norway; [Hoiland, Anne Lise] Norwegian Univ Sci & Technol, Fac Med & Hlth Sci, Reg Ctr Child & Youth Mental Hlth & Child Welf, Dept Mental Hlth, Trondheim, Norway; [Torske, Tonje] Vestre Viken Hosp Trust, Div Mental Hlth & Addict, Drammen, Norway; [Malt, Eva; Nerhus, Mari; Lonning, Vera] Akershus Univ Hosp, Div Mental Hlth, Lorenskog, Norway; [Malt, Eva; Abrahamsen, Tore] Univ Oslo, Inst Clin Med, Oslo, Norway; [Abrahamsen, Tore] Oslo Univ Hosp, Dept Pediat, Oslo, Norway; [Wedervang-Resell, Kirsten; Steen, Nils Eiel; Stenberg, Nina; Andreassen, Ole A.] Oslo Univ Hosp Ulleval, Div Mental Hlth & Addict, Oslo, Norway; [Johannessen, Jade] Autism Soc Norway, Oslo, Norway; [Agartz, Ingrid] Diakonhjemmet Hosp, Dept Psychiat Res, Oslo, Norway; [Hundhausen, Thomas] Univ Agder, Dept Nat Sci, Kristiansand, Norway; [Hundhausen, Thomas] Sorlandet Hosp Trust, Dept Lab Med, Kristiansand, Norway; [Morkrid, Lars] Oslo Univ Hosp, Dept Med Biochem, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; University of Oslo; University of Oslo; University of Oslo; Diakonhjemmet Hospital; University of Agder; University of Oslo	Hope, S (corresponding author), Univ Oslo, Ctr Psychosis Res, Inst Clin Med, NORMENT, Oslo, Norway.	sigrun.hope@ous-hf.no	Steen, Nils Eiel/GRO-6284-2022; Andreassen, Ole A./AAY-7531-2020	Steen, Nils Eiel/0000-0001-6442-1179; Naerland, Terje/0000-0001-9175-4286; Wedervang-Resell, Kirsten/0000-0002-2856-5412; Hope, Sigrun/0000-0003-0115-5285	Norges Forskningsrad (Forskningsradet) [223273]; KG Jebsen stiftelsen	Norges Forskningsrad (Forskningsradet); KG Jebsen stiftelsen	Norges Forskningsrad (Forskningsradet) Grant number 213694, Norges Forskningsrad (Forskningsradet) Grant number 223273, KG Jebsen stiftelsen.	Adams JB, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-34; Akkouh IA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30898-5; Al-Farsi YM, 2013, NUTRITION, V29, P537, DOI 10.1016/j.nut.2012.09.014; Allen LH, 2009, AM J CLIN NUTR, V89, p693S, DOI 10.3945/ajcn.2008.26947A; Andres E, 2013, QJM-INT J MED, V106, P505, DOI 10.1093/qjmed/hct051; Andrew T, 2013, BRIT J NUTR, V110, P1672, DOI 10.1017/S0007114513000974; Aparicio-Ugarriza R, 2015, CLIN CHEM LAB MED, V53, P1149, DOI 10.1515/cclm-2014-0784; Arendt JFB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045979; Bailey D, 2013, CLIN CHEM, V59, P1393, DOI 10.1373/clinchem.2013.204222; Bala KA, 2016, EUR REV MED PHARMACO, V20, P923; Bellerose J, 2016, JIMD REP, V29, P19, DOI 10.1007/8904_2015_517; Cao B, 2016, SCHIZOPHR RES, V172, P216, DOI 10.1016/j.schres.2016.01.050; Christensen EI, 2013, NEPHROL DIAL TRANSPL, V28, P274, DOI 10.1093/ndt/gfs565; Dror DK, 2008, NUTR REV, V66, P250, DOI 10.1111/j.1753-4887.2008.00031.x; Frye RE, 2013, MOL PSYCHIATR, V18, P369, DOI 10.1038/mp.2011.175; Frye RE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00080; Gonzalez-Gross M, 2012, NUTR RES, V32, P817, DOI 10.1016/j.nutres.2012.09.016; Grove J, 2019, NAT GENET, V51, P431, DOI 10.1038/s41588-019-0344-8; Guest J, 2015, NUTR NEUROSCI, V18, P355, DOI 10.1179/1476830515Y.0000000041; GUNDUZ M, 2017, J NEUROL EXP NEUROSC, V2, P4; HUNDHAUSEN T, 2016, NORD C CLIN BIOCH; Iglesia I, 2014, NUTR RES, V34, P199, DOI 10.1016/j.nutres.2014.01.006; James SJ, 2009, AM J CLIN NUTR, V89, P425, DOI 10.3945/ajcn.2008.26615; Keene KL, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00112; MARKS PW, 2009, HEMATOLOGY BASIC PRI, P439; Masalha R, 2001, ISRAEL MED ASSOC J, V3, P701; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Misra UK, 2017, MOL NEUROBIOL, V54, P1278, DOI 10.1007/s12035-016-9736-2; Modabbernia A, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0121-4; Mollehave LT, 2017, EUR J CLIN NUTR, V71, P1054, DOI 10.1038/ejcn.2017.97; Moore E, 2012, INT PSYCHOGERIATR, V24, P541, DOI 10.1017/S1041610211002511; Morkrid L, 2015, CLIN CHEM, V61, P760, DOI 10.1373/clinchem.2014.235564; Nielsen MJ, 2012, NAT REV GASTRO HEPAT, V9, P345, DOI 10.1038/nrgastro.2012.76; Nongmaithem SS, 2017, HUM MOL GENET, V26, P2551, DOI [10.1093/hmg/ddx071, 10.1093/hmg/ddx156]; Pisula W, 2014, MED HYPOTHESES, V83, P488, DOI 10.1016/j.mehy.2014.08.007; Raghavan R, 2018, PAEDIATR PERINAT EP, V32, P100, DOI 10.1111/ppe.12414; Ramaekers VT, 2007, NEUROPEDIATRICS, V38, P276, DOI 10.1055/s-2008-1065354; Ramaekers VT, 2013, MOL PSYCHIATR, V18, P270, DOI 10.1038/mp.2012.22; Remacha AF, 2014, INT J LAB HEMATOL, V36, P92, DOI 10.1111/ijlh.12131; Reynolds A, 2012, PEDIATRICS, V130, pS154, DOI 10.1542/peds.2012-0900M; Rietsema WJ, 2014, J AM GERIATR SOC, V62, P1611, DOI 10.1111/jgs.12966; Riglin L, 2017, LANCET PSYCHIAT, V4, P57, DOI 10.1016/S2215-0366(16)30406-0; Sandin S, 2017, JAMA-J AM MED ASSOC, V318, P1182, DOI 10.1001/jama.2017.12141; SAVORY DJ, 1990, ANN CLIN BIOCHEM, V27, P99, DOI 10.1177/000456329002700201; Schendel DE, 2016, JAMA PEDIATR, V170, P243, DOI 10.1001/jamapediatrics.2015.3935; Schmidt-Kastner R, 2012, MOL PSYCHIATR, V17, P1194, DOI 10.1038/mp.2011.183; Schork AJ, 2019, NAT NEUROSCI, V22, P353, DOI 10.1038/s41593-018-0320-0; Schwettmann L, 2015, CLIN LAB, V61, P1095, DOI 10.7754/Clin.Lab.2015.150112; Sequeira JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152249; Sequeira JM, 2013, CLIN CHEM LAB MED, V51, P545, DOI 10.1515/cclm-2012-0577; Shibata K, 2014, NUTR METAB INSIGHTS, V7, P61, DOI 10.4137/NMI.S17245; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; Steward-Scott E, 2014, J PEDIATR NURS, V29, P107, DOI 10.1016/j.pedn.2013.12.009; Veasey SC, 2013, SLEEP, V36, P1471, DOI 10.5665/sleep.3038; Zinck JWR, 2015, AM J CLIN NUTR, V101, P1295, DOI 10.3945/ajcn.115.107219	55	4	4	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8114	8124		10.1096/fj.201900855RRR	http://dx.doi.org/10.1096/fj.201900855RRR		APR 2020	11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32323402	Bronze			2022-12-26	WOS:000528405100001
J	Whitman, J; Jayaprakash, C				Whitman, John; Jayaprakash, Ciriyam			Stochastic modeling of influenza spread dynamics with recurrences	PLOS ONE			English	Article							SOCIAL NETWORK; PERIODICITY; MULTISCALE; INFECTION; SYSTEMS; DISEASE; SCALE	We present results of a study of a simple, stochastic, agent-based model of influenza A infection, simulating its dynamics over the course of one flu season. Building on an early work of Bartlett, we define a model with a limited number of parameters and rates that have clear epidemiological interpretation and can be constrained by data. We demonstrate the occurrence of recurrent behavior in the infected number [more than one peak in a season], which is observed in data, in our simulations for populations consisting of cohorts with strong intra- and weak inter-cohort transmissibility. We examine the dependence of the results on epidemiological and population characteristics by investigating their dependence on a range of parameter values. Finally, we study infection with two strains of influenza, inspired by observations, and show a counter-intuitive result for the effect of inoculation against the strain that leads to the first wave of infection.	[Whitman, John; Jayaprakash, Ciriyam] Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA; [Whitman, John] Ohio State Univ, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Whitman, J (corresponding author), Ohio State Univ, Dept Phys, 174 W 18th Ave, Columbus, OH 43210 USA.; Whitman, J (corresponding author), Ohio State Univ, Columbus, OH 43210 USA.	whitman.103@osu.edu		Whitman, John/0000-0001-5848-0164	PRIME (Program for Research on Immune Modeling and 532 Experimentation), an NIAID [533 U19 AI117873]	PRIME (Program for Research on Immune Modeling and 532 Experimentation), an NIAID	J.W. and C.J. were supported by PRIME (Program for Research on Immune Modeling and 532 Experimentation), an NIAID-funded Modeling Immunity for Biodefense Center (Grant 533 U19 AI117873). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, INFL INF; [Anonymous], 2019, CDC SORT STATS CDC P; [Anonymous], 2019, OH FLU SEAS DAT; [Anonymous], 2019, COL FLU REP INFL SUR; Bailey NTJ, 1977, MATH THEORY EPIDEMIC; Bartlett M.S., 1956, P 3 BERK S MATH STAT, P81, DOI DOI 10.2307/2342553; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; Bartlett MS, 1970, STOCHASTIC POPULATIO; Bernstein SL, 2009, ACAD EMERG MED, V16, P1, DOI 10.1111/j.1553-2712.2008.00295.x; Brachman PS, 2003, INT J EPIDEMIOL, V32, P684, DOI 10.1093/ije/dyg282; Caini S, 2018, INFLUENZA OTHER RESP, V12, P780, DOI 10.1111/irv.12575; Caravagna G, 2010, J THEOR BIOL, V265, P336, DOI 10.1016/j.jtbi.2010.05.013; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Centers for Disease Control and Prevention, 2019, WEEKL US INFL SURV R; Chao DL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000656; Fonkwo PN, 2008, EMBO REP, V9, pS13, DOI 10.1038/embor.2008.110; Fox SJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005749; Gomez S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38722-4; Guo DM, 2015, SCI REP-UK, V5, DOI 10.1038/srep08980; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Lande R, 1998, OIKOS, V83, P353, DOI 10.2307/3546849; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Lukens S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1019; Murillo LN, 2013, J THEOR BIOL, V332, P267, DOI 10.1016/j.jtbi.2013.03.024; Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Ramos I, 2019, J VIROL, V93, DOI 10.1128/JVI.00559-19; Research W., 2019, FINDPEAKS DOC FINDPE; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Roche B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-87; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; RVACHEV LA, 1968, DOKL AKAD NAUK SSSR+, V180, P294; Sanjuan R, 2010, J VIROL, V84, P9733, DOI [10.1128/JVI.00694-10, DOI 10.1128/JVI.00694-10]; SEGEL LA, 1989, SIAM REV, V31, P446, DOI 10.1137/1031091; Smith H, 2010, INTRO DELAY DIFFEREN; Soper HE, 1929, J R STAT SOC, V92, P34, DOI 10.2307/2341437; Tanaka G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05522; Teukolsky SA, 1992, NUMERICAL RECIPES C; Tokars JI, 2018, CLIN INFECT DIS, V66, P1511, DOI 10.1093/cid/cix1060; Uyeki TM, 2019, CLIN INFECT DIS, V68, pE1, DOI [10.1093/cid/ciy866, 10.1093/cid/ciy874]; Venkatramanan S, 2018, EPIDEMICS-NETH, V22, P43, DOI 10.1016/j.epidem.2017.02.010; Watts DJ, 2005, P NATL ACAD SCI USA, V102, P11157, DOI 10.1073/pnas.0501226102; WolframResearch Inc., 2019, MATH VERS 12 0; WOODHOUSE DE, 1994, AIDS, V8, P1331, DOI 10.1097/00002030-199409000-00018; Wylie JL, 2001, SEX TRANSM DIS, V28, P14, DOI 10.1097/00007435-200101000-00005	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231521	10.1371/journal.pone.0231521	http://dx.doi.org/10.1371/journal.pone.0231521			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315318	Green Published, gold			2022-12-26	WOS:000536024800032
J	Bukosza, EN; Kratochwill, K; Kornauth, C; Schachner, H; Aufricht, C; Gebeshuber, CA				Bukosza, Eva Nora; Kratochwill, Klaus; Kornauth, Christoph; Schachner, Helga; Aufricht, Christoph; Gebeshuber, Christoph A.			Podocyte RNA sequencing reveals Wnt- and ECM-associated genes as central in FSGS	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BETA-CATENIN; EXPRESSION; CLAUDIN-1; TARGET; RHOA; PROTEINURIA; JUNCTIONS; PATHWAYS	Loss of podocyte differentiation can cause nephrotic-range proteinuria and Focal and Segmental Glomerulosclerosis (FSGS). As specific therapy is still lacking, FSGS frequently progresses to end-stage renal disease. The exact molecular mechanisms of FSGS and gene expression changes in podocytes are complex and widely unknown as marker changes have mostly been assessed on the glomerular level. To gain a better insight, we isolated podocytes of miR-193a overexpressing mice, which suffer from FSGS due to suppression of the podocyte master regulator Wt1. We characterised the podocytic gene expression changes by RNAseq and identified many novel candidate genes not linked to FSGS so far. This included strong upregulation of the receptor tyrosine kinase EphA6 and a massive dysregulation of circadian genes including the loss of the transcriptional activator Arntl. By comparison with podocyte-specific changes in other FSGS models we found a shared dysregulation of genes associated with the Wnt signaling cascade, while classical podocyte-specific genes appeared widely unaltered. An overlap with gene expression screens from human FSGS patients revealed a strong enrichment in genes associated with extracellular matrix (ECM) and metabolism. Our data suggest that FSGS progression might frequently depend on pathways that are often overlooked when considering podocyte homeostasis.	[Bukosza, Eva Nora] Semmelweis Univ Budapest, Translat Med Inst, Budapest, Hungary; [Bukosza, Eva Nora; Kratochwill, Klaus; Aufricht, Christoph; Gebeshuber, Christoph A.] Med Univ Vienna, Dept Pediat & Adolescent Med, Div Pediat Nephrol & Gastroenterol, Vienna, Austria; [Kratochwill, Klaus] Med Univ Vienna, Dept Pediat & Adolescent Med, Christian Doppler Lab Mol Stress Res Peritoneal D, Vienna, Austria; [Kornauth, Christoph] Med Univ Vienna, Dept Internal Med 1, Clin Div Hematol & Hemostaseol, Vienna, Austria; [Kornauth, Christoph; Schachner, Helga; Gebeshuber, Christoph A.] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	Semmelweis University; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Gebeshuber, CA (corresponding author), Med Univ Vienna, Dept Pediat & Adolescent Med, Div Pediat Nephrol & Gastroenterol, Vienna, Austria.; Gebeshuber, CA (corresponding author), Med Univ Vienna, Clin Inst Pathol, Vienna, Austria.	christoph.gebeshuber@meduniwien.ac.at	Kornauth, Christoph/AAA-3935-2022	Kornauth, Christoph/0000-0003-0443-3498; Gebeshuber, Christoph A/0000-0003-3293-4572; Kratochwill, Klaus/0000-0003-0803-614X				Bennett MR, 2007, NEPHRON EXP NEPHROL, V107, pE30, DOI 10.1159/000106775; Blanchard O, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051498; Boerries M, 2013, KIDNEY INT, V83, P1052, DOI 10.1038/ki.2012.487; Brunskill EW, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0063-z; Chen X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121319; Condello S, 2015, ONCOGENE, V34, P2297, DOI 10.1038/onc.2014.178; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; Dhawan P, 2005, J CLIN INVEST, V115, P1765, DOI 10.1172/JCI24543; Firsov D, 2018, NAT REV NEPHROL, V14, P626, DOI 10.1038/s41581-018-0048-9; Ford-Speelman DL, 2009, MOL BIOL CELL, V20, P3905, DOI 10.1091/mbc.E08-10-1029; Fukuda A, 2012, J AM SOC NEPHROL, V23, P1351, DOI 10.1681/ASN.2012030271; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Gong YF, 2017, J AM SOC NEPHROL, V28, P106, DOI 10.1681/ASN.2015121324; Grgic I, 2014, KIDNEY INT, V86, P1116, DOI 10.1038/ki.2014.204; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Hergenhan S, 2020, J MOL BIOL, DOI [10.1038/s41581-018-0048-9, DOI 10.1038/S41581-018-0048-9]; Hodgin JB, 2010, AM J PATHOL, V177, P1674, DOI 10.2353/ajpath.2010.090746; Hu TJ, 2009, BIOCHEMISTRY-US, V48, P6369, DOI 10.1021/bi900831k; Jiang XL, 2010, J BIOL CHEM, V285, P8472, DOI 10.1074/jbc.M109.069450; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Kilanczyk E, 2012, CELL CALCIUM, V51, P470, DOI 10.1016/j.ceca.2012.04.005; Laurin Louis-Philippe, 2017, Can J Kidney Health Dis, V4, p2054358117692559, DOI 10.1177/2054358117692559; Lovric S, 2016, NEPHROL DIAL TRANSPL, V31, P1802, DOI 10.1093/ndt/gfv355; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Ohashi N, 2019, HYPERTENS RES, V42, P761, DOI 10.1038/s41440-018-0186-2; Pappa KI, 2013, DIABETES RES CLIN PR, V99, P151, DOI 10.1016/j.diabres.2012.10.015; Perry NA, 2014, ONCOTARGET, V5, P8558, DOI 10.18632/oncotarget.2338; Potter AS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216261; Puelles VG, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.99271; Richards J, 2014, BLOOD PRESS MONIT, V19, P249, DOI 10.1097/MBP.0000000000000060; Rieger ME, 2010, MOL CELL BIOL, V30, P4267, DOI 10.1128/MCB.01418-09; Rosenberg AZ, 2017, CLIN J AM SOC NEPHRO, V12, P502, DOI 10.2215/CJN.05960616; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Suzuki A, 2003, J AM SOC NEPHROL, V14, P981, DOI 10.1097/01.ASN.0000057857.66268.8F; Tong J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140453; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Yan D, 2001, P NATL ACAD SCI USA, V98, P3802, DOI 10.1073/pnas.071041898; Yang D, 2011, ONCOGENE, V30, P4590, DOI [10.1038/onc.2011.541, 10.1038/onc.2011.166]; Yang L, 2009, FREE RADICAL RES, V43, P174, DOI 10.1080/10715760802657308; Zheng SR, 2008, J AM SOC NEPHROL, V19, P2077, DOI 10.1681/ASN.2007080967; Zhou LL, 2015, J AM SOC NEPHROL, V26, P677, DOI 10.1681/ASN.2013101067; Zhou X, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12470; Zhu L, 2011, J AM SOC NEPHROL, V22, P1621, DOI 10.1681/ASN.2010111146	46	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231898	10.1371/journal.pone.0231898	http://dx.doi.org/10.1371/journal.pone.0231898			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302353	gold, Green Published			2022-12-26	WOS:000536016100061
J	Hou, XL; Yang, DD; Li, DJ; Liu, MJ; Zhou, Y; Shi, M				Hou, Xiaolin; Yang, Dongdong; Li, Dingjun; Liu, Meijun; Zhou, Yuan; Shi, Min			A new simple brain segmentation method for extracerebral intracranial tumors	PLOS ONE			English	Article							SUPRATENTORIAL LESIONS; SLICER	Normal brain segmentation is available via FreeSurfer, Vbm, and Ibaspm software. However, these software packages cannot perform segmentation of the brain for patients with brain tumors. As we know, damage from extracerebral tumors to the brain occurs mainly by way of pushing and compressing while leaving the structure of the brain intact. Three-dimensional (3D) imaging, augmented reality (AR), and virtual reality (VR) technology have begun to be applied in clinical practice. The free medical open-source software 3D Slicer allows us to perform 3D simulations on a computer and requires little user interaction. Moreover, 3D Slicer can integrate with the third-party software mentioned above. The relationship between the tumor and surrounding brain tissue can be judged, but accurate brain segmentation cannot be performed using 3D Slicer. In this study, we combine 3D Slicer and FreeSurfer to provide a novel brain segmentation method for extracerebral tumors. This method can help surgeons identify the "real" relationship between the lesion and adjacent brain tissue before surgery and improve preoperative planning.	[Hou, Xiaolin; Yang, Dongdong; Li, Dingjun; Liu, Meijun; Zhou, Yuan; Shi, Min] Chengdu Univ TCM, Hosp Chengdu Univ Tradit Chinese Med, Sch Clin Med, Chengdu, Peoples R China	Chengdu University of Traditional Chinese Medicine	Yang, DD (corresponding author), Chengdu Univ TCM, Hosp Chengdu Univ Tradit Chinese Med, Sch Clin Med, Chengdu, Peoples R China.	hxlhxf@126.com	xiaolin, hou/AAN-8441-2021	xiaolin, hou/0000-0001-8394-1866				Bernardo A, 2017, WORLD NEUROSURG, V106, P1015, DOI 10.1016/j.wneu.2017.06.140; Chang K, 2019, NEURO-ONCOLOGY, V21, P1412, DOI 10.1093/neuonc/noz106; Chen JG, 2017, WORLD NEUROSURG, V106, P193, DOI [10.1016/j.WNEU.2017.06.146, 10.1016/j.wneu.2017.06.146]; Chen LW, 2018, DEPRESS ANXIETY, V35, P1018, DOI 10.1002/da.22833; Chen T, 2012, J VOICE, V26, P555, DOI 10.1016/j.jvoice.2011.03.012; Costabile JD, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00426; Dwarakanath S, 2007, NEUROL INDIA, V55, P111; Eftekhar B, 2016, WORLD NEUROSURG, V85, P359, DOI 10.1016/j.wneu.2015.09.091; Egger J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01364; Egger J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051788; Fedorov A, 2012, MAGN RESON IMAGING, V30, P1323, DOI 10.1016/j.mri.2012.05.001; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Hanganu A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172374; Hervey-Jumper SL, 2015, J NEUROSURG, V123, P325, DOI 10.3171/2014.10.JNS141520; Leclercq D, 2011, NEUROSURG CLIN N AM, V22, P253, DOI 10.1016/j.nec.2010.11.004; Li XR, 2016, J NEUROSCI METH, V264, P47, DOI 10.1016/j.jneumeth.2016.03.001; Lu CY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011702; McCutcheon Ian E, 2013, Acta Neurochir Suppl, V116, P71, DOI 10.1007/978-3-7091-1376-9_12; Perez DL, 2018, HUM BRAIN MAPP, V39, P428, DOI 10.1002/hbm.23853; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Scanlon C, 2013, J NEUROIMAGING, V23, P64, DOI 10.1111/j.1552-6569.2012.00736.x; Sefcik RK, 2017, INTERDISCIP NEUROSUR, V8, P17, DOI 10.1016/j.inat.2017.01.003; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Tack P, 2016, BIOMED ENG ONLINE, V15, DOI 10.1186/s12938-016-0236-4; Yushkevich PA, 2016, IEEE ENG MED BIO, P3342, DOI 10.1109/EMBC.2016.7591443	25	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0230754	10.1371/journal.pone.0230754	http://dx.doi.org/10.1371/journal.pone.0230754			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302315	gold, Green Published			2022-12-26	WOS:000536016100010
J	Shim, JW; Kim, KR; Jung, Y; Park, J; Lee, HM; Kim, YS; Moon, YE; Hong, SH; Chae, MS				Shim, Jung-Woo; Kim, Kyoung Rim; Jung, Yoonju; Park, Jaesik; Lee, Hyung Mook; Kim, Yong-Suk; Moon, Young Eun; Hong, Sang Hyun; Chae, Min Suk			Role of intraoperative oliguria in risk stratification for postoperative acute kidney injury in patients undergoing colorectal surgery with an enhanced recovery protocol: A propensity score matching analysis	PLOS ONE			English	Article							CLASICC TRIAL; GUIDELINES; COLON; MANAGEMENT; OUTCOMES; SOCIETY; CARE	Background The enhanced recovery after surgery (ERAS) protocol for colorectal cancer resection recommends balanced perioperative fluid therapy. According to recent guidelines, zero-balance fluid therapy is recommended in low-risk patients, and immediate correction of low urine output during surgery is discouraged. However, several reports have indicated an association of intraoperative oliguria with postoperative acute kidney injury (AKI). We investigated the impact of intraoperative oliguria in the colorectal ERAS setting on the incidence of postoperative AKI. Patients and methods From January 2017 to August 2019, a total of 453 patients underwent laparoscopic colorectal cancer resection with the ERAS protocol. Among them, 125 patients met the criteria for oliguria and were propensity score (PS) matched to 328 patients without intraoperative oliguria. After PS matching had been performed, 125 patients from each group were selected and the incidences of AKI were compared between the two groups. Postoperative kidney function and surgical outcomes were also evaluated. Results The incidence of AKI was significantly higher in the intraoperative oliguria group than in the non-intraoperative oliguria group (26.4% vs. 11.2%, respectively, P = 0.002). Also, the eGFR reduction on postoperative day 0 was significantly greater in the intraoperative oliguria than non-intraoperative oliguria group (-9.02 vs. -1.24 mL/min/1.73 m(2) respectively, P < 0.001). In addition, the surgical complication rate was higher in the intraoperative oliguria group than in the non-intraoperative oliguria group (18.4% vs. 9.6%, respectively, P = 0.045). Conclusions Despite the proven benefits of perioperative care with the ERAS protocol, caution is required in patients with intraoperative oliguria to prevent postoperative AKI. Further studies regarding appropriate management of intraoperative oliguria in association with long-term prognosis are needed in the colorectal ERAS setting.	[Shim, Jung-Woo; Park, Jaesik; Lee, Hyung Mook; Kim, Yong-Suk; Moon, Young Eun; Hong, Sang Hyun; Chae, Min Suk] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Kim, Kyoung Rim] Catholic Univ Korea, Bucheon St Marys Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea; [Jung, Yoonju] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Chae, MS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Anesthesiol & Pain Med, Seoul, South Korea.	shscms@gmail.com		Lee, Hyungmook/0000-0002-5178-7240; Chae, Min Suk/0000-0002-1426-4651				Asklid D, 2017, EJSO-EUR J SURG ONC, V43, P1433, DOI 10.1016/j.ejso.2017.04.003; Bihorac A, 2013, CRIT CARE MED, V41, P2570, DOI 10.1097/CCM.0b013e31829860fc; Bonjer HJ, 2015, NEW ENGL J MED, V372, P1324, DOI 10.1056/NEJMoa1414882; Brandstrup B, EFFECTS INTRAVENOUS; Cannesson M, HEMODYNAMIC MONITORI; Carmichael JC, 2017, DIS COLON RECTUM, V60, P761, DOI 10.1097/DCR.0000000000000883; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Cortes DO, 2015, ANESTH ANALG, V120, P389, DOI 10.1213/ANE.0000000000000564; Demyttenaere S, EFFECT PNEUMOPERITON; Egal M, TARGETING OLIGURIA R; Eng OS, RELATIONSHIP PERIOPE; Fearon KCH, 2005, CLIN NUTR, V24, P466, DOI 10.1016/j.clnu.2005.02.002; Go J, 2019, J CLIN MED, V8, DOI 10.3390/jcm8070955; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Gupta R, 2016, ANAESTHESIA, V71, P40, DOI 10.1111/anae.13309; Gustafsson UO, 2019, WORLD J SURG, V43, P659, DOI 10.1007/s00268-018-4844-y; Gustafsson UO, 2013, WORLD J SURG, V37, P259, DOI 10.1007/s00268-012-1772-0; Ho KM, METAANALYSIS FRUSEMI; Hur M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37432-7; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kim MK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48526-1; Koerner CP, 2019, AM SURGEON, V85, P156; Kreimeier U, 2000, CRIT CARE, V4, pS3, DOI 10.1186/cc968; Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Longo WE, 2000, DIS COLON RECTUM, V43, P83, DOI 10.1007/BF02237249; Marcotte JH, 2018, INT J COLORECTAL DIS, V33, P1259, DOI 10.1007/s00384-018-3084-9; Matot I, EFFECT VOLUME FLUIDS; Mizota T, 2017, BRIT J ANAESTH, V119, P1127, DOI 10.1093/bja/aex255; Myles PS, IMPORTANCE INTRAOPER; Mythen MG, 2012, PERIOPER MED, V1, DOI 10.1186/2047-0525-1-2; Nisanevich V, EFFECT INTRAOPERATIV; Nygren J, GUIDELINES PERIOPERA, P1532; Puckett JR, LOW VERSUS STANDARD; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Sear JW, KIDNEY DYSFUNCTION P; Shiba A, ASS INTRAOPERATIVE O; Thacker JKM, 2016, ANN SURG, V263, P502, DOI 10.1097/SLA.0000000000001402; Thakar CV, 2003, KIDNEY INT, V64, P239, DOI 10.1046/j.1523-1755.2003.00040.x; Wiesenthal JD, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2011.02.022	42	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231447	10.1371/journal.pone.0231447	http://dx.doi.org/10.1371/journal.pone.0231447			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302336	Green Published, gold			2022-12-26	WOS:000536016100027
J	Arfer, KB; O'Connor, MJ; Tomlinson, M; Rotheram-Borus, MJ				Arfer, Kodi B.; O'Connor, Mary J.; Tomlinson, Mark; Rotheram-Borus, Mary Jane			South African mothers' immediate and 5-year retrospective reports of drinking alcohol during pregnancy	PLOS ONE			English	Article							CAPE-TOWN; PRENATAL ALCOHOL; WOMEN; VALIDITY	Prenatal alcohol-drinking is often measured with self-report, but it is unclear whether mothers give more accurate answers when asked while pregnant or some time after their pregnancy. There is also the question of whether to measure drinking in a dichotomous or continuous fashion. We sought to examine how the timing and scale of self-reports affected the content of reports. From a sample of 576 black mothers around Cape Town, South Africa, we compared prenatal reports of prenatal drinking with 5-year retrospective reports, and dichotomous metrics (drinking or abstinent) with continuous metrics (fluid ounces of absolute alcohol drunk per day). Amounts increased over the 5-year period, whereas dichotomous measures found mothers less likely to report drinking later. All four measures were weakly associated with birth weight, birth height, child head circumference soon after birth, and child intelligence at age 5. Furthermore, neither reporting time nor the scale of measurement were consistently related to the strengths of these associations. Our results point to problems with self-report, particularly with this population, but we recommend post-birth continuous measures as the best of the group for their flexibility and their consistency with previous research.	[Arfer, Kodi B.] Mt Sinai Hlth Syst, Icahn Sch Med, New York, NY 10029 USA; [O'Connor, Mary J.] Univ Calif Los Angeles, Semel Inst, Los Angeles, CA USA; [Tomlinson, Mark] Stellenbosch Univ, Dept Psychol, Stellenbosch, South Africa; [Rotheram-Borus, Mary Jane] Univ Calif Los Angeles, Global Ctr Children & Families, Los Angeles, CA USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; Stellenbosch University; University of California System; University of California Los Angeles	Arfer, KB (corresponding author), Mt Sinai Hlth Syst, Icahn Sch Med, New York, NY 10029 USA.	research@arfer.net			National Institute on Alcohol Abuse and Alcoholism [1R01AA017104]; National Institute of Mental Health [T32MH109205]; UCLA Center for HIV Identification, Prevention and Treatment Services [P30MH58107]; UCLA Clinical and Translational Science Institute [UL1TR000124]; UCLA Center for AIDS Research [P30AI028697]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); UCLA Center for HIV Identification, Prevention and Treatment Services; UCLA Clinical and Translational Science Institute; UCLA Center for AIDS Research	This study was funded by the National Institute on Alcohol Abuse and Alcoholism (1R01AA017104), the National Institute of Mental Health (T32MH109205), the UCLA Center for HIV Identification, Prevention and Treatment Services (P30MH58107), the UCLA Clinical and Translational Science Institute (UL1TR000124), and the UCLA Center for AIDS Research (P30AI028697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2001, J MIDWIFERY WOM HEAL, V46, P240, DOI 10.1016/S1526-9523(01)00138-6; Arfer KB, 2018, INT J MENT HEALTH AD, V16, P45, DOI 10.1007/s11469-017-9769-4; Brittain K, 2017, DRUG ALCOHOL DEPEN, V173, P69, DOI 10.1016/j.drugalcdep.2016.12.017; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Centers for Disease Control and Prevention, 2004, FETAL ALCOHOL SYNDRO; del Campo M, 2017, EUR J MED GENET, V60, P55, DOI 10.1016/j.ejmg.2016.10.004; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; ERNHART CB, 1988, ALCOHOL CLIN EXP RES, V12, P506, DOI 10.1111/j.1530-0277.1988.tb00233.x; Gelman A, 2008, STAT MED, V27, P2865, DOI 10.1002/sim.3107; Hannigan JH, 2010, ALCOHOL, V44, P583, DOI 10.1016/j.alcohol.2009.03.003; Jacobson SW, 2002, PEDIATRICS, V109, P815, DOI 10.1542/peds.109.5.815; Jessor R., 1968, SOC PERSONALITY DEVI; JONES EE, 1971, PSYCHOL BULL, V76, P349, DOI 10.1037/h0031617; le Roux IM, 2013, AIDS, V27, P1461, DOI 10.1097/QAD.0b013e3283601b53; Lichtenberger EO, 2010, ENCY CROSS CULTURAL, P557, DOI DOI 10.1007/978-0-387-71799-9_218; May PA, 2018, REPROD TOXICOL, V77, P25, DOI 10.1016/j.reprotox.2018.02.002; O'Connor MJ, 2006, J PEDIATR PSYCHOL, V31, P50, DOI 10.1093/jpepsy/jsj021; OCONNOR MJ, 1986, PEDIATRICS, V78, P444; Roozen S, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022578; Rottenstreich Y, 2001, PSYCHOL SCI, V12, P185, DOI 10.1111/1467-9280.00334; Sorsdahl K, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-101; Watt MH, 2016, MATERN CHILD HLTH J, V20, P48, DOI 10.1007/s10995-015-1800-4; Watt MH, 2014, SOC SCI MED, V116, P119, DOI 10.1016/j.socscimed.2014.06.048; Williams JF, 2015, PEDIATRICS, V136, pE1395, DOI 10.1542/peds.2015-3113	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231518	10.1371/journal.pone.0231518	http://dx.doi.org/10.1371/journal.pone.0231518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298313	Green Published, gold			2022-12-26	WOS:000536011400058
J	Chowdhury, UR; Kudgus, RA; Rinkoski, TA; Holman, BH; Bahler, CK; Hann, CR; Reid, JM; Dosa, PI; Fautsch, MP				Chowdhury, Uttio Roy; Kudgus, Rachel A.; Rinkoski, Tommy A.; Holman, Bradley H.; Bahler, Cindy K.; Hann, Cheryl R.; Reid, Joel M.; Dosa, Peter I.; Fautsch, Michael P.			Pharmacological and pharmacokinetic profile of the novel ocular hypotensive prodrug CKLP1 in Dutch-belted pigmented rabbits	PLOS ONE			English	Article							INTRAOCULAR-PRESSURE; CHANNEL OPENERS; CROMAKALIM; GLAUCOMA	Elevated intraocular pressure is the only treatable risk factor for glaucoma, an eye disease that is the leading cause of irreversible blindness worldwide. We have identified cromakalim prodrug 1 (CKLP1), a novel water-soluble ATP-sensitive potassium channel opener, as a new ocular hypotensive agent. To evaluate the pharmacokinetic and safety profile of CKLP1 and its parent compound levcromakalim, Dutch-belted pigmented rabbits were treated intravenously (0.25 mg/kg) or topically (10 mM; 4.1 mg/ml) with CKLP1. Body fluids (blood, aqueous and vitreous humor) were collected at multiple time points and evaluated for the presence of CKLP1 and levcromakalim using a liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) based assay. Histology of tissues isolated from Dutch-belted pigmented rabbits treated once daily for 90 days was evaluated in a masked manner by a certified veterinary pathologist. The estimated plasma parameters following intravenous administration of 0.25 mg/kg of CKLP1 showed CKLP1 had a terminal half-life of 61.8 +/- 55.2 min, T-max of 19.8 +/- 23.0 min and C-max of 1968.5 +/- 831.0 ng/ml. Levcromakalim had a plasma terminal half-life of 85.0 +/- 37.0 min, T-max of 61.0 +/- 32.0 min and C-max of 10.6 +/- 1.2 ng/ml. Topical CKLP1 treatment in the eye showed low levels (< 0.3 ng/mL) of levcromakalim in aqueous and vitreous humor, and trace amounts of CKLP1 and levcromakalim in the plasma. No observable histological changes were noted in selected tissues that were examined following topical application of CKLP1 for 90 consecutive days. These results suggest that CKPL1 is converted to levcromakalim in the eye and likely to some extent in the systemic circulation.	[Chowdhury, Uttio Roy; Rinkoski, Tommy A.; Holman, Bradley H.; Bahler, Cindy K.; Hann, Cheryl R.; Fautsch, Michael P.] Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA; [Kudgus, Rachel A.; Reid, Joel M.] Mayo Clin, Dept Oncol Res, Rochester, MN USA; [Dosa, Peter I.] Univ Minnesota, Dept Med Chem, Inst Therapeut Discovery & Dev, Minneapolis, MN 55455 USA	Mayo Clinic; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Fautsch, MP (corresponding author), Mayo Clin, Dept Ophthalmol, Rochester, MN 55905 USA.	Fautsch@mayo.edu		Fautsch, Michael/0000-0002-9115-2485	NIH [EY21727, EY26490]; Minnesota Partnership for Biotechnology and Medical Genomics [12.06]; Minnesota Partnership for Biotechnology and Medical Genomics TPDF [15.01]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1TR000114]; Mayo Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; Minnesota Partnership for Biotechnology and Medical Genomics TPDF; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Mayo Foundation	NIH grants EY21727 (MPF), EY26490 (MPF); Minnesota Partnership for Biotechnology and Medical Genomics #12.06 (MPF, PID); Minnesota Partnership for Biotechnology and Medical Genomics TPDF #15.01 (MPF, PID); National Center for Advancing Translational Sciences of the National Institutes of Health Award Number UL1TR000114 (PID); Mayo Foundation (MPF).	Boland MV, 2013, ANN INTERN MED, V158, P271, DOI 10.7326/0003-4819-158-4-201302190-00008; Boland MV, TREATMENT GLAUCOMA C; Chowdhury UR, 2017, INVEST OPHTH VIS SCI, V58, P5723, DOI 10.1167/iovs.17-22538; Chowdhury UR, 2017, EXP EYE RES, V158, P85, DOI 10.1016/j.exer.2016.04.020; Chowdhury UR, 2016, J MED CHEM, V59, P6221, DOI 10.1021/acs.jmedchem.6b00406; Chowdhury UR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141783; Chowdhury UR, 2015, INVEST OPHTH VIS SCI, V56, P2993, DOI 10.1167/iovs.15-16744; Chowdhury UR, 2013, INVEST OPHTH VIS SCI, V54, P4892, DOI 10.1167/iovs.13-11872; Chowdhury UR, 2011, INVEST OPHTH VIS SCI, V52, P6435, DOI 10.1167/iovs.11-7523; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Roy Chowdhury U, 2018, GLAUCOMA RES CLIN AD, P201; Scherer WJ, 2002, J OCUL PHARMACOL TH, V18, P287, DOI 10.1089/108076802760116205; Schmidl D, 2015, J OCUL PHARMACOL TH, V31, P63, DOI 10.1089/jop.2014.0067; Shen J, 2014, INVEST OPHTH VIS SCI, V55, P1056, DOI 10.1167/iovs.13-13650; Sjoquist B, 1998, DRUG METAB DISPOS, V26, P745; SUGRUE MF, 1989, PHARMACOL THERAPEUT, V43, P91, DOI 10.1016/0163-7258(89)90049-1	16	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231841	10.1371/journal.pone.0231841	http://dx.doi.org/10.1371/journal.pone.0231841			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298376	Green Published, gold			2022-12-26	WOS:000536011400118
J	Park, YJ; Kim, TS; Kim, EH; Kim, HD; Kim, J				Park, Yong Jun; Kim, Tae-Sung; Kim, Eun-Ho; Kim, Hag Dong; Kim, Joon			Ribosomal protein S3 is a novel negative regulator of non-homologous end joining repair of DNA double-strand breaks	FASEB JOURNAL			English	Article						DNA-PK; extra-ribosomal function; Ku; NHEJ; rpS3	HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; CELL-DEATH; RPS3; PHOSPHORYLATION; APOPTOSIS; ENDONUCLEASE; NUCLEOLUS; INTERACTS; COMPLEX	DNA double-strand breaks (DSBs) are one of the most serious types of DNA damage. However, multiple repair pathways are present in cells to ensure rapid and appropriate repair of DSBs. Pathway selection depends on several factors including cell type, cell cycle phase, and damage severity. Ribosomal protein S3 (rpS3), a component of the 40S small ribosomal subunit, is a multi-functional protein primarily involved in protein synthesis. rpS3 is also involved in the mediation of various extra-ribosomal pathways, including DNA damage processing and the stress response. Here, we report that rpS3 is a novel negative regulator of non-homologous end joining (NHEJ)-mediated repair of DSBs. We found that rpS3 interacts with the Ku heterodimers of the DNA-dependent protein kinase (DNA-PK) complex and slows down NHEJ ligation reactions, ultimately triggering p53-dependent cell death following treatment with high-dose ionizing radiation. After DSB formation, DNA-PK phosphorylates rpS3, which consequently reduces the binding of rpS3 to the Ku complex. We hypothesized that rpS3 may play a role in DSB repair by repressing NHEJ, while inducing other repair pathways, and by initiating DSB-induced cell death in response to severe DNA damage.	[Park, Yong Jun; Kim, Tae-Sung; Kim, Eun-Ho; Kim, Joon] Korea Univ, Div Life Sci, Lab Biochem, Seoul 02841, South Korea; [Kim, Hag Dong; Kim, Joon] Korea Univ, HAEL Lab, Seoul, South Korea	Korea University; Korea University	Kim, J (corresponding author), Korea Univ, Div Life Sci, Lab Biochem, Seoul 02841, South Korea.	joonkim@korea.ac.kr			National Research Foundation of Korea (NRF) [2017R1E1A1A01074101]; Korea University (KU) [2019S1A5A2A03050121]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea University (KU)	National Research Foundation of Korea (NRF), Grant/Award Number: 2017R1E1A1A01074101; Korea University (KU), Grant/Award Number: 2019S1A5A2A03050121	Ahn JY, 2000, CANCER RES, V60, P5934; Boulon S, 2010, MOL CELL, V40, P216, DOI 10.1016/j.molcel.2010.09.024; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Chen JJ, 1999, CANCER RES, V59, p1752S; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Costantini S, 2007, DNA REPAIR, V6, P712, DOI 10.1016/j.dnarep.2006.12.007; Fell VL, 2015, MUTAT RES-REV MUTAT, V763, P15, DOI 10.1016/j.mrrev.2014.06.002; Gao XF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000708; Golomb L, 2014, FEBS LETT, V588, P2571, DOI 10.1016/j.febslet.2014.04.014; Han SH, 2017, ONCOL LETT, V13, P3681, DOI 10.3892/ol.2017.5906; Hara S, 2004, CELL DEATH DIFFER, V11, P853, DOI 10.1038/sj.cdd.4401428; Hegde V, 2004, BIOCHEMISTRY-US, V43, P14211, DOI 10.1021/bi049234b; Hegde V, 2009, MUTAT RES-FUND MOL M, V666, P16, DOI 10.1016/j.mrfmmm.2009.03.005; Howard SM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004943; Jang CY, 2012, BIOCHEM BIOPH RES CO, V421, P474, DOI 10.1016/j.bbrc.2012.04.020; Jang CY, 2004, FEBS LETT, V560, P81, DOI 10.1016/S0014-5793(04)00074-2; Jeggo P, 2007, ONCOGENE, V26, P7717, DOI 10.1038/sj.onc.1210868; Kass EM, 2010, FEBS LETT, V584, P3703, DOI 10.1016/j.febslet.2010.07.057; Kelley MR, 2000, DNA CELL BIOL, V19, P149, DOI 10.1089/104454900314537; Kim HD, 2011, ONCOGENE, V30, P3317, DOI 10.1038/onc.2011.47; KIM J, 1995, J BIOL CHEM, V270, P13620, DOI 10.1074/jbc.270.23.13620; Kim SH, 2005, BIOCHEM BIOPH RES CO, V328, P962, DOI 10.1016/j.bbrc.2005.01.045; Kim Y, 2013, BBA-MOL CELL RES, V1833, P2943, DOI 10.1016/j.bbamcr.2013.07.015; Kysela B, 2003, J BIOL CHEM, V278, P22466, DOI 10.1074/jbc.M303273200; Lees-Miller SP, 2003, BIOCHIMIE, V85, P1161, DOI 10.1016/j.biochi.2003.10.011; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lindstrom MS, 2018, ONCOGENE, V37, P2351, DOI 10.1038/s41388-017-0121-z; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mao ZY, 2008, DNA REPAIR, V7, P1765, DOI 10.1016/j.dnarep.2008.06.018; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; Ohnishi T, 2009, MUTAT RES-FUND MOL M, V669, P8, DOI 10.1016/j.mrfmmm.2009.06.010; Patil AV, 2017, J BIOL CHEM, V292, P4313, DOI 10.1074/jbc.M116.764324; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Radyuk SN, 2006, FREE RADICAL BIO MED, V41, P757, DOI 10.1016/j.freeradbiomed.2006.05.021; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Seong KM, 2012, FEBS LETT, V586, P356, DOI 10.1016/j.febslet.2011.12.030; Smeaton MB, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm974; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Suzuki A, 2012, CANCER SCI, V103, P632, DOI 10.1111/j.1349-7006.2012.02219.x; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wan FY, 2011, NAT IMMUNOL, V12, P335, DOI 10.1038/ni.2007; Wang B, 2001, J RADIAT RES, V42, P1, DOI 10.1269/jrr.42.1; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003	48	6	6	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8102	8113		10.1096/fj.201903245R	http://dx.doi.org/10.1096/fj.201903245R		APR 2020	12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32297663				2022-12-26	WOS:000526651100001
J	Yeung, R; Zhu, XB; Gee, T; Gheen, B; Jassby, D; Rodgers, VGJ				Yeung, Raymond; Zhu, Xiaobo; Gee, Terence; Gheen, Ben; Jassby, David; Rodgers, Victor G. J.			Single and binary protein electroultrafiltration using poly(vinyl-alcohol)-carbon nanotube (PVA-CNT) composite membranes	PLOS ONE			English	Article							BOVINE SERUM-ALBUMIN; POLYSULFONE ULTRAFILTRATION MEMBRANE; ALPHA-LACTALBUMIN; CARBON NANOTUBES; ADSORPTION-KINETICS; ELECTRIC-FIELD; LYSOZYME; SEPARATION; TRANSPORT; MICROFILTRATION	Electrically conductive composite ultrafiltration membranes composed of carbon nanotubes have exhibited efficient fouling inhibition in wastewater treatment applications. In the current study, poly(vinyl-alcohol)-carbon nanotube membranes were applied to fed batch crossflow electroultrafiltration of dilute (0.1 g/L of each species) single and binary protein solutions of alpha-lactalbumin and hen egg-white lysozyme at pH 7.4, 4 mM ionic strength, and 1 psi. Electroultrafiltration using the poly(vinyl-alcohol)-carbon nanotube composite membranes yielded temporary enhancements in sieving for single protein filtration and in selectivity for binary protein separation compared to ultrafiltration using the unmodified PS-35 membranes. Assessment of membrane fouling based on permeate flux, zeta potential measurements, and scanning electron microscopy visualization of the conditioned membranes indicated significant resulting protein adsorption and aggregation which limited the duration of improvement during electroultrafiltration with an applied cathodic potential of -4.6 V (vs. Ag/AgCl). These results imply that appropriate optimization of electroultrafiltration using carbon nanotube-deposited polymeric membranes may provide substantial short-term improvements in binary protein separations.	[Yeung, Raymond; Gee, Terence; Gheen, Ben; Rodgers, Victor G. J.] Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA; [Zhu, Xiaobo; Jassby, David] Univ Calif Los Angeles, Dept Civil & Environm Engn, Los Angeles, CA USA	University of California System; University of California Riverside; University of California System; University of California Los Angeles	Rodgers, VGJ (corresponding author), Univ Calif Riverside, Dept Bioengn, Riverside, CA 92521 USA.	victor.rodgers@ucr.edu	Rodgers, Victor G. J./AAF-3838-2021	Rodgers, Victor G. J./0000-0002-1857-8025	Jacques S. Yeager, Sr. Professorship	Jacques S. Yeager, Sr. Professorship	This research was funded by an endowment from Jacques S. Yeager, Sr. Professorship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALAKRISHNAN M, 1993, J MEMBRANE SCI, V85, P111, DOI 10.1016/0376-7388(93)85161-O; Brusatori MA, 2003, LANGMUIR, V19, P5089, DOI 10.1021/la0269558; Burns DB, 2001, AICHE J, V47, P1101, DOI 10.1002/aic.690470517; Calonder C, 2001, LANGMUIR, V17, P4392, DOI 10.1021/la001734s; CAUSSERAND C, 1994, J MEMBRANE SCI, V88, P211, DOI 10.1016/0376-7388(94)87007-1; Cayot P., 1997, FOOD SCI TECHNOLOGY, V11, P225; Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b; Daly SM, 2005, LANGMUIR, V21, P1328, DOI 10.1021/la048316y; de Lannoy CF, 2012, J MEMBRANE SCI, V415, P718, DOI 10.1016/j.memsci.2012.05.061; de Lannoy CF, 2013, J MEMBRANE SCI, V447, P395, DOI 10.1016/j.memsci.2013.07.023; Du P, 2014, J PHYS CHEM C, V118, P22249, DOI 10.1021/jp5044943; Duan WY, 2017, J MEMBRANE SCI, V531, P160, DOI 10.1016/j.memsci.2017.02.050; Duan WY, 2016, ACS APPL MATER INTER, V8, P22574, DOI 10.1021/acsami.6b07196; Dudchenko AV, 2014, J MEMBRANE SCI, V468, P1, DOI 10.1016/j.memsci.2014.05.041; EBERSTEIN W, 1994, J CRYST GROWTH, V143, P71, DOI 10.1016/0022-0248(94)90369-7; Fievet P, 2005, J MEMBRANE SCI, V264, P1, DOI 10.1016/j.memsci.2005.04.011; Hamborg M, 2014, BBA-BIOMEMBRANES, V1838, P2001, DOI 10.1016/j.bbamem.2014.04.013; Huisman IH, 1998, J MEMBRANE SCI, V147, P187, DOI 10.1016/S0376-7388(98)00135-5; HUXLEY VH, 1987, AM J PHYSIOL, V252, pH188, DOI 10.1152/ajpheart.1987.252.1.H188; Ihsanullah, 2019, SEP PURIF TECHNOL, V209, P307, DOI 10.1016/j.seppur.2018.07.043; Kang TJ, 2011, CARBON, V49, P1087, DOI 10.1016/j.carbon.2010.11.012; KESHAVARZ E, 1979, BIOCHIM BIOPHYS ACTA, V576, P269, DOI 10.1016/0005-2795(79)90402-1; Kim KS, 2002, J MEMBRANE SCI, V199, P135, DOI 10.1016/S0376-7388(01)00686-X; KRISDHASIMA V, 1993, J COLLOID INTERF SCI, V161, P325, DOI 10.1006/jcis.1993.1474; Labbez C, 2001, J MEMBRANE SCI, V184, P79, DOI 10.1016/S0376-7388(00)00611-6; Lee J, 2017, SEP PURIF TECHNOL, V176, P323, DOI 10.1016/j.seppur.2016.10.061; Ma LN, 2017, MEMBRANES-BASEL, V7, DOI 10.3390/membranes7010016; Mayani M, 2010, J MEMBRANE SCI, V347, P150, DOI 10.1016/j.memsci.2009.10.016; Mehta A, 2006, BIOTECHNOL PROGR, V22, P484, DOI 10.1021/bp050324x; Molek JR, 2007, BIOTECHNOL PROGR, V23, P1417, DOI 10.1021/bp070243w; Mu QX, 2008, J PHYS CHEM C, V112, P3300, DOI 10.1021/jp710541j; Muller CH, 2003, J MEMBRANE SCI, V227, P51, DOI 10.1016/j.memsci.2003.07.020; MunozAguado MJ, 1996, J MEMBRANE SCI, V117, P175, DOI 10.1016/0376-7388(96)00066-X; NAKAO S, 1988, DESALINATION, V70, P191, DOI 10.1016/0011-9164(88)85054-9; NEL RG, 1994, BIOTECHNOL PROGR, V10, P539, DOI 10.1021/bp00029a013; NYSTROM M, 1989, COLLOID SURFACE, V36, P297, DOI 10.1016/0166-6622(89)80245-8; Ohmori S, 2012, CARBON, V50, P4932, DOI 10.1016/j.carbon.2012.06.023; Palacio L, 2003, J MEMBRANE SCI, V222, P41, DOI 10.1016/S0376-7388(03)00143-1; PUJAR NS, 1994, IND ENG CHEM RES, V33, P2473, DOI 10.1021/ie00034a032; Rabe M, 2011, ADV COLLOID INTERFAC, V162, P87, DOI 10.1016/j.cis.2010.12.007; ROBBINS FM, 1967, BIOCHIM BIOPHYS ACTA, V133, P33, DOI 10.1016/0005-2795(67)90036-0; Ronen A, 2015, ENVIRON SCI TECHNOL, V49, P12741, DOI 10.1021/acs.est.5b01281; Sakintuna B, 2005, IND ENG CHEM RES, V44, P2893, DOI 10.1021/ie049080w; Santore MM, 2005, LANGMUIR, V21, P10172, DOI 10.1021/la051059s; Sarkar B, 2010, SEP PURIF TECHNOL, V74, P73, DOI 10.1016/j.seppur.2010.05.009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Szymczyk A, 2001, AICHE J, V47, P2349, DOI 10.1002/aic.690471019; Tominaga M, 2014, RSC ADV, V4, P27224, DOI 10.1039/c4ra02875a; Vandrangi P, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4737140; Weng YH, 2005, J HAZARD MATER, V122, P171, DOI 10.1016/j.jhazmat.2005.04.001; Zhu XB, 2017, J MEMBRANE SCI, V529, P159, DOI 10.1016/j.memsci.2017.02.004; Zorbas V, 2005, J AM CHEM SOC, V127, P12323, DOI 10.1021/ja050747v	53	3	4	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0228973	10.1371/journal.pone.0228973	http://dx.doi.org/10.1371/journal.pone.0228973			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298267	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400007
J	Okal, J; Lango, D; Matheka, J; Obare, F; Ngunu-Gituathi, C; Mugambi, M; Sarna, A				Okal, Jerry; Lango, Daniel; Matheka, James; Obare, Francis; Ngunu-Gituathi, Carol; Mugambi, Mary; Sarna, Avina			"It is always better for a man to know his HIV status" - A qualitative study exploring the context, barriers and facilitators of HIV testing among men in Nairobi, Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; FEMALE SEX WORKERS; HIGH-RISK; POPULATION; GENDER; HIV/AIDS; STIGMA; WOMEN; DISCRIMINATION; BEHAVIORS	HIV testing services are an important component of HIV program and provide an entry point for clinical care for persons newly diagnosed with HIV. Although uptake of HIV testing has increased in Kenya, men are still less likely than women to get tested and access services. There is, however, limited understanding of the context, barriers and facilitators of HIV testing among men in the country. Data are from in-depth interviews with 30 men living with HIV and 8 HIV testing counsellors that were conducted to gain insights on motivations and drivers for HIV testing among men in the city of Nairobi. Men were identified retroactively by examining clinical CD4 registers on early and late diagnosis (e.g. CD4 of >= 500 cells/mm, early diagnosis and < 500 cells/mm, late diagnosis). Analysis involved identifying broad themes and generating descriptive codes and categories. Timing for early testing is linked with strong social support systems and agency to test, while cost of testing, choice of facility to test and weak social support systems (especially poor inter-partner relations) resulted in late testing. Minimal discussions occurred prior to testing and whenever there was dialogue it happened with partners or other close relatives. Interrelated barriers at individual, healthcare system, and interpersonal levels hindered access to testing services. Specifically, barriers to testing included perceived providers attitudes, facility location and set up, wait time/inconvenient clinic times, low perception of risk, limited HIV knowledge, stigma, discrimination and fear of having a test. High risk perception, severe illness, awareness of partner's status, confidentiality, quality of services and supplies, flexible/extended opening hours, and pre-and post-test counselling were facilitators. Experiences between early and late testers overlapped though there were minor differences. In order to achieve the desired impact nationally and to attain the 90-90-90 targets, multiple interventions addressing both barriers and facilitators to testing are needed to increase uptake of testing and to link the positive to care.	[Okal, Jerry; Lango, Daniel; Matheka, James; Obare, Francis] Populat Council, Nairobi, Kenya; [Ngunu-Gituathi, Carol] Cty Hlth Serv, Nairobi City Cty, Nairobi, Kenya; [Mugambi, Mary] Natl HIV & STI Control Programme NASCOP, Nairobi, Kenya; [Sarna, Avina] Populat Council, New Delhi, India		Okal, J (corresponding author), Populat Council, Nairobi, Kenya.	jokal@popcouncil.org			United States President's Emergency Plan for AIDS Relief (PEPFAR) [AID-OAA-A-1400060]; United States Agency for International Development (USAID) [AID-OAA-A-1400060]	United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR)	This work was supported by Project SOAR (Cooperative agreement AID-OAA-A-1400060), made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEPFAR) and United States Agency for International Development (USAID). The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, or the United States Government.	Aliyu M, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l1965; Avert.org, HIV AIDS KEN 2019; Bailey RC, 2002, AIDS CARE, V14, P27, DOI 10.1080/09540120220097919; Barros Claudia Renata dos Santos, 2017, Rev. bras. epidemiol., V20, P394, DOI 10.1590/1980-5497201700030004; Bhatia DS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00188; Brashers D E, 1998, J Assoc Nurses AIDS Care, V9, P66, DOI 10.1016/S1055-3290(98)80078-2; Bwambale FM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-263; Camlin CS, 2016, AIDS CARE, V28, P67, DOI 10.1080/09540121.2016.1164806; Chamie G, 2016, LANCET HIV, V3, pE111, DOI 10.1016/S2352-3018(15)00251-9; Chanda MM, 2017, AIDS PATIENT CARE ST, V31, P290, DOI 10.1089/apc.2017.0016; Chow EPF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/607261; Conserve DF, 2018, AM J MENS HEALTH, V12, P1185, DOI 10.1177/1557988318777674; Cremin I, 2012, TROP MED INT HEALTH, V17, pe26, DOI 10.1111/j.1365-3156.2011.02937.x; Dave S, 2019, PLOS ONE, V14; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Genberg Becky, 2019, J Int Assoc Provid AIDS Care, V18, p2325958218823285, DOI 10.1177/2325958218823285; Genberg BL, 2008, AIDS BEHAV, V12, P772, DOI 10.1007/s10461-007-9340-6; Gokengin D, 2016, INT J INFECT DIS, V44, P66, DOI 10.1016/j.ijid.2015.11.008; Gottert A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200920; Gottert A, 2018, AIDS BEHAV, V22, P1858, DOI 10.1007/s10461-017-1706-9; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Guiguet M, 2017, J IMMIGR MINOR HEALT, V19, P991, DOI 10.1007/s10903-016-0385-3; Hampanda K, 2019, AIDS BEHAV, P1; Hensen B, 2015, AIDS BEHAV, V19, P492, DOI 10.1007/s10461-014-0866-0; Indravudh PP, 2018, CURR OPIN INFECT DIS, V31, P14, DOI 10.1097/QCO.0000000000000426; Jamieson D, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20917; Johnson LF, 2015, AIDS, V29, P1401, DOI 10.1097/QAD.0000000000000721; Kenya NACCo, 2016, KEN AIDS RESP PROGR; KNBS, 2014, HLTH SURV 2014 KEY I; Kojima N, 2018, CLIN INFECT DIS, V67, P1468, DOI 10.1093/cid/ciy344; Kujawski S, 2017, AIDS CARE, V29, P1062, DOI 10.1080/09540121.2016.1274367; Kuteesa MO, 2019, AIDS BEHAV, V23, P3199, DOI 10.1007/s10461-019-02483-y; Liu Y, 2015, AIDS PATIENT CARE ST, V29, P481, DOI 10.1089/apc.2015.0083; Mabachi NM, 2020, AIDS BEHAV, V24, P18, DOI 10.1007/s10461-019-02451-6; Meremo A, 2016, PAN AFR MED J, V23, DOI 10.11604/pamj.2016.23.189.5683; Micheni M, 2017, AIDS PATIENT CARE ST, V31, P113, DOI 10.1089/apc.2016.0213; Mikkelsen E, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002240; Minet T, 2016, J AIDS CLIN RES, V7, P2; [Ministry of Health NASCP NASCOP], 2018, GUID US ANT DRUGS DR; Mitchell S, 2010, BMC INT HEALTH HUM R, V10, DOI 10.1186/1472-698X-10-23; Moth I A, 2005, SAHARA J, V2, P244; Musheke M, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-220, 10.1186/1472-6963-13-97]; Nachega JB, 2018, CLIN INFECT DIS; NASCOP, 2012, IND SURV KAIS 2012; National AIDS Control Council, 2014, KEN AIDS STRAT FRAM; Njau B, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-838; Obermeyer CM, 2009, SOC SCI MED, V69, P877, DOI 10.1016/j.socscimed.2009.07.003; Ochieng-Ooko V, 2010, B WORLD HEALTH ORGAN, V88, P681, DOI 10.2471/BLT.09.064329; Okal J, 2020, IMPROVING UPTAKE HIV; Ongaki D, 2019, J INT ASS PROVIDERS, V18, DOI [10.1177/, DOI 10.1177/]; Pintye J, 2019, AIDS, V33, P1369, DOI 10.1097/QAD.0000000000002211; Reece M, 2010, AIDS CARE, V22, P743, DOI 10.1080/09540120903431330; Reynolds Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203208; Rhead R, 2019, AIDS, V33, P537, DOI 10.1097/QAD.0000000000002041; Rotheram-Borus MJ, 2006, AIDS EDUC PREV, V18, P273, DOI 10.1521/aeap.2006.18.3.273; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Shattuck D, 2013, MEN MASC, V16, P540, DOI 10.1177/1097184X13502730; Sileo KM, 2018, AIDS BEHAV, V22, P2468, DOI 10.1007/s10461-018-2160-z; Simbayi LC, 2007, SOC SCI MED, V64, P1823, DOI 10.1016/j.socscimed.2007.01.006; Siu GE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-33; Skinner D, 2004, SAHARA J, V1, P157; Staveteig S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186316; Stevens DR, 2018, AIDS BEHAV, V22, P497, DOI 10.1007/s10461-017-1707-8; Sylvester K, 2010, INFLUENCE GENDER LOS; Takahashi R, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1344-9; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; Treves-Kagan S, 2017, AIDS BEHAV, V21, P2579, DOI 10.1007/s10461-016-1671-8; UNAIDS, 2017, FACT SHEET LAT GLOB; UNAIDS, 2015, AIDS BY THE NUMB; Varga C A, 2001, Afr J Reprod Health, V5, P175, DOI 10.2307/3583334; Velloza J, 2020, AIDS BEHAV, V24, P1727, DOI 10.1007/s10461-019-02716-0; Vrana-Diaz CJ, 2019, SEX TRANSM DIS, V46, P588, DOI [10.1097/OLQ.0000000000001037, 10.1097/OL]; Walensky RP, 2016, ANN INTERN MED, V165, P325, DOI 10.7326/M16-0799; Woodford MR, 2016, GLOB PUBLIC HEALTH, V11, P363, DOI 10.1080/17441692.2015.1057757; Yamanis T, 2017, AIDS BEHAV, V21, P1171, DOI 10.1007/s10461-016-1513-8; Ziraba AK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-663	76	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231645	10.1371/journal.pone.0231645	http://dx.doi.org/10.1371/journal.pone.0231645			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9GL	32294124	Green Published, gold			2022-12-26	WOS:000536003500046
J	Melick, CH; Meng, DL; Jewell, JL				Melick, Chase H.; Meng, Delong; Jewell, Jenna L.			A-kinase anchoring protein 8L interacts with mTORC1 and promotes cell growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mTOR complex (mTORC); mTORC1; protein synthesis; cell biology; cell proliferation; protein kinase A (PKA); A-kinase anchoring protein (AKAP); cell size; mRNA translation; nutrient sensing; scaffolding protein; AKAP8L; anabolic pathway; cAMP signaling	MESSENGER-RNA TRANSLATION; AKAP SIGNALING COMPLEXES; REGULATORY SUBUNIT; PHOSPHOPROTEOMIC ANALYSIS; CATALYTIC SUBUNIT; NUCLEAR-PROTEIN; HELICASE-A; INITIATION; PATHWAY; HA95	mTOR complex 1 (mTORC1) senses nutrients to mediate anabolic processes within the cell. Exactly how mTORC1 promotes cell growth remains unclear. Here, we identified a novel mTORC1-interacting protein called protein kinase A anchoring protein 8L (AKAP8L). Using biochemical assays, we found that the N-terminal region of AKAP8L binds to mTORC1 in the cytoplasm. Importantly, loss of AKAP8L decreased mTORC1-mediated processes such as translation, cell growth, and cell proliferation. AKAPs anchor protein kinase A (PKA) through PKA regulatory subunits, and we show that AKAP8L can anchor PKA through regulatory subunit I?. Reintroducing full-length AKAP8L into cells restored mTORC1-regulated processes, whereas reintroduction of AKAP8L missing the N-terminal region that confers the interaction with mTORC1 did not. Our results suggest a multifaceted role for AKAPs in the cell. We conclude that mTORC1 appears to regulate cell growth, perhaps in part through AKAP8L.	[Melick, Chase H.; Meng, Delong; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA; [Melick, Chase H.; Meng, Delong; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Melick, Chase H.; Meng, Delong; Jewell, Jenna L.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Jewell, JL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, 6000 Harry Hines Blvd,Rm NA5-508A, Dallas, TX 75390 USA.	Jenna.Jewell@UTSouthwestern.edu		Meng, Delong/0000-0001-5183-4564; Melick, Chase/0000-0003-3977-9886; Jewell, Jenna/0000-0002-8021-9453	Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant [RR150032]; Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award [RP160713]; Welch Foundation [I-1927-20170325]; 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society Institutional Research Grant [ACS-IRG-17-174-13]; National Institutes of Health [R01GM129097-01, T32GM008203]	Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant; Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award; Welch Foundation(The Welch Foundation); 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society Institutional Research Grant(American Cancer Society); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Cancer Prevention Research Institute of Texas (CPRIT) Scholar Recruitment of First-Time, Tenure-Track Faculty Member Grant RR150032; Cancer Prevention Research Institute of Texas (CPRIT) High-Impact/High-Risk Research Award RP160713; Welch Foundation Grant I-1927-20170325; the 2017 UT Southwestern President's Research Council Distinguished Researcher Award; American Cancer Society Institutional Research Grant ACS-IRG-17-174-13; and National Institutes of Health Grants R01GM129097-01 (to J. L. J.) and T32GM008203 (to C. H. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avni D, 1997, NUCLEIC ACIDS RES, V25, P995, DOI 10.1093/nar/25.5.995; Barbet NC, 1996, MOL BIOL CELL, V7, P25, DOI 10.1091/mbc.7.1.25; BARONI MD, 1989, MOL CELL BIOL, V9, P2715, DOI 10.1128/MCB.9.6.2715; Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x; CADD G, 1989, NEURON, V3, P71, DOI 10.1016/0896-6273(89)90116-5; CHUNG J, 1992, CELL, V69, P1227, DOI 10.1016/0092-8674(92)90643-Q; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; DOSKELAND SO, 1993, BIOCHIM BIOPHYS ACTA, V1178, P249, DOI 10.1016/0167-4889(93)90201-Y; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Egan DF, 2011, AUTOPHAGY, V7, P645, DOI 10.4161/auto.7.6.15123; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; Esseltine JL, 2013, TRENDS PHARMACOL SCI, V34, P648, DOI 10.1016/j.tips.2013.10.005; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fonseca BD, 2015, J BIOL CHEM, V290, P15996, DOI 10.1074/jbc.M114.621730; Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Gutzkow KB, 2003, CELL SIGNAL, V15, P871, DOI 10.1016/S0898-6568(03)00038-X; Han I, 2002, MOL CELL BIOL, V22, P2136, DOI 10.1128/MCB.22.7.2136-2146.2002; Hanlon CD, 2015, J CELL SCI, V128, P3533, DOI 10.1242/jcs.175158; Hartman TR, 2006, NAT STRUCT MOL BIOL, V13, P509, DOI 10.1038/nsmb1092; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hong S, 2017, ELIFE, V6, DOI 10.7554/eLife.25237; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; JAHNSEN T, 1986, J BIOL CHEM, V261, P6637; Jefferies HBJ, 1997, EMBO J, V16, P3693, DOI 10.1093/emboj/16.12.3693; JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441; Jewell JL, 2019, ELIFE, V8, DOI 10.7554/eLife.43038; Jewell JL, 2013, TRENDS BIOCHEM SCI, V38, P233, DOI 10.1016/j.tibs.2013.01.004; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; JOACHIM S, 1990, EUR J CELL BIOL, V51, P76; Kapiloff MS, 2014, J GEN PHYSIOL, V143, P9, DOI 10.1085/jgp.201311020; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KOYAMA S, 1993, CELL, V72, P945, DOI 10.1016/0092-8674(93)90582-B; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; Lopez IP, 2013, MOL CELL BIOL, V33, P2903, DOI 10.1128/MCB.00031-13; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Malbon CC, 2004, BIOCHEM J, V379, P1, DOI 10.1042/BJ20031648; Martins S, 2003, J CELL BIOL, V160, P177, DOI 10.1083/jcb.200210026; Martins SB, 2000, J CELL SCI, V113, P3703; Mavrakis M, 2006, HUM MOL GENET, V15, P2962, DOI 10.1093/hmg/ddl239; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Menon S, 2008, Oncogene, V27 Suppl 2, pS43, DOI 10.1038/onc.2009.352; Nandagopal N, 2015, TRANSLATION, V3, DOI 10.4161/21690731.2014.983402; NIGG EA, 1985, CELL, V41, P1039, DOI 10.1016/S0092-8674(85)80084-2; Orstavik S, 2000, BIOL CELL, V92, P27, DOI 10.1016/S0248-4900(00)88761-4; Parsyan A, 2011, NAT REV MOL CELL BIO, V12, P235, DOI 10.1038/nrm3083; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pavlos NJ, 2017, TRENDS ENDOCRIN MET, V28, P213, DOI 10.1016/j.tem.2016.10.007; Philippe L, 2018, NUCLEIC ACIDS RES, V46, P1457, DOI 10.1093/nar/gkx1237; Richardson CJ, 2004, CURR BIOL, V14, P1540, DOI 10.1016/j.cub.2004.08.061; Rinaldi L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.241; Roux PP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012252; RUBIN CS, 1972, J BIOL CHEM, V247, P6135; Ryan KJ, 2000, CURR OPIN CELL BIOL, V12, P361, DOI 10.1016/S0955-0674(00)00101-0; SALVATORI S, 1990, BIOCHEM J, V267, P679, DOI 10.1042/bj2670679; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; SARKAR D, 1984, J BIOL CHEM, V259, P9840; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; SCOTT JD, 1991, PHARMACOL THERAPEUT, V50, P123, DOI 10.1016/0163-7258(91)90075-W; Tcherkezian J, 2014, GENE DEV, V28, P357, DOI 10.1101/gad.231407.113; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; TOKIWA G, 1994, NATURE, V371, P342, DOI 10.1038/371342a0; Westberg C, 2000, J BIOL CHEM, V275, P21396, DOI 10.1074/jbc.M909887199; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Yang JP, 2001, J BIOL CHEM, V276, P30694, DOI 10.1074/jbc.M102809200; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang YY, 2017, J PROTEOME RES, V16, P2825, DOI 10.1021/acs.jproteome.7b00140; Zhu XZ, 2017, JOVE-J VIS EXP, DOI 10.3791/55218	74	9	9	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2020	295	23					8096	8105		10.1074/jbc.AC120.012595	http://dx.doi.org/10.1074/jbc.AC120.012595			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LZ0QD	32312749	Green Published, hybrid			2022-12-26	WOS:000540935400021
J	Radka, CD; Frank, MW; Yao, JW; Seetharaman, J; Miller, DJ; Rock, CO				Radka, Christopher D.; Frank, Matthew W.; Yao, Jiangwei; Seetharaman, Jayaraman; Miller, Darcie J.; Rock, Charles O.			The genome of a Bacteroidetes inhabitant of the human gut encodes a structurally distinct enoyl-acyl carrier protein reductase (FabI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteria; fatty acid synthase (FAS); microbiome; acyl carrier protein (ACP); crystal structure; Bacteroidetes; FabI; enoyl-acyl carrier protein reductase; fatty acid biosynthesis; Alistipes finegoldii; structural biology; gut microbiome; water channel; NADH binding	FATTY-ACID SYNTHESIS; IN-VITRO ACTIVITY; ACP-REDUCTASE; CRYSTAL-STRUCTURE; SUBSTRATE RECOGNITION; ANTIBACTERIAL AGENT; ISONIAZID TARGET; BINDING MODE; TRICLOSAN; INHIBITION	Enoyl-acyl carrier protein reductase (FabI) catalyzes a rate-controlling step in bacterial fatty-acid synthesis and is a target for antibacterial drug development. A phylogenetic analysis shows that FabIs fall into four divergent clades. Members of clades 1?3 have been structurally and biochemically characterized, but the fourth clade, found in members of phylum Bacteroidetes, is uncharacterized. Here, we identified the unique structure and conformational changes that distinguish clade 4 FabIs. Alistipes finegoldii is a prototypical Bacteroidetes inhabitant of the gut microbiome. We found that A. finegoldii FabI (AfFabI) displays cooperative kinetics and uses NADH as a cofactor, and its crystal structure at 1.72 ? resolution showed that it adopts a Rossmann fold as do other characterized FabIs. It also disclosed a carboxyl-terminal extension that forms a helix?helix interaction that links the protomers as a unique feature of AfFabI. An AfFabI?NADH crystal structure at 1.86 ? resolution revealed that this feature undergoes a large conformational change to participate in covering the NADH-binding pocket and establishing the water channels that connect the active site to the central water well. Progressive deletion of these interactions led to catalytically compromised proteins that fail to bind NADH. This unique conformational change imparted a distinct shape to the AfFabI active site that renders it refractory to a FabI drug that targets clade 1 and 3 pathogens. We conclude that the clade 4 FabI, found in the Bacteroidetes inhabitants of the gut, have several structural features and conformational transitions that distinguish them from other bacterial FabIs.	[Radka, Christopher D.; Frank, Matthew W.; Yao, Jiangwei; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA; [Seetharaman, Jayaraman; Miller, Darcie J.] St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA; [Yao, Jiangwei] Gen Dynam Informat Technol, 2 Corp Blvd NE, Atlanta, GA 30329 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rock, CO (corresponding author), 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org	Radka, Christopher D./AGX-1090-2022; Rock, Charles/N-2256-2018	Radka, Christopher D./0000-0002-6037-7710; Frank, Matthew/0000-0002-4914-1440; Yao, Jiangwei/0000-0001-7088-3468; JAYARAMAN, SEETHARAMAN/0000-0003-3942-9640; Rock, Charles/0000-0001-8648-4189	NIGMS, National Institutes of Health [GM034496]; Cancer Center Support Grant [CA21765]; American Lebanese Syrian Associated Charities	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Cancer Center Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by NIGMS, National Institutes of Health Grant GM034496 (to C. O. R.), Cancer Center Support Grant CA21765, and the American Lebanese Syrian Associated Charities. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BAKER ME, 1995, BIOCHEM J, V309, P1029, DOI 10.1042/bj3091029; Belluti F, 2013, J MED CHEM, V56, P7516, DOI 10.1021/jm400637m; BERGLER H, 1992, J GEN MICROBIOL, V138, P2093, DOI 10.1099/00221287-138-10-2093; Chen L., 2007, SE COLLABORATORY STR, p2P91; Croswell A, 2009, INFECT IMMUN, V77, P2741, DOI 10.1128/IAI.00006-09; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DESSEN A, 1995, SCIENCE, V267, P1638, DOI 10.1126/science.7886450; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLOCCO MM, 1994, J MOL BIOL, V235, P709, DOI 10.1006/jmbi.1994.1022; Francino MP, 2016, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01543; GHOSH D, 1994, STRUCTURE, V2, P629, DOI 10.1016/S0969-2126(00)00064-2; Hafkin B, 2016, ANTIMICROB AGENTS CH, V60, P1695, DOI 10.1128/AAC.01741-15; Hartkoorn RC, 2012, EMBO MOL MED, V4, P1032, DOI 10.1002/emmm.201201689; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; HEATH RJ, 1995, J BIOL CHEM, V270, P26538, DOI 10.1074/jbc.270.44.26538; Heath RJ, 2000, J BIOL CHEM, V275, P40128, DOI 10.1074/jbc.M005611200; Heath RJ, 2000, J BIOL CHEM, V275, P4654, DOI 10.1074/jbc.275.7.4654; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; Hevener KE, 2018, ACTA CRYSTALLOGR F, V74, P105, DOI 10.1107/S2053230X18000262; Hirschbeck MW, 2012, STRUCTURE, V20, P89, DOI 10.1016/j.str.2011.07.019; HOL WGJ, 1978, NATURE, V273, P443, DOI 10.1038/273443a0; Jackowski S, 2002, ANTIMICROB AGENTS CH, V46, P1246, DOI 10.1128/AAC.46.5.1246-1252.2002; Johnson EL, 2017, J MOL MED, V95, P1, DOI 10.1007/s00109-016-1492-2; Jordan C. A., 2015, CRYSTAL STRUCTURE E, p5CFZ; Jordan CA, 2015, ACTA CRYSTALLOGR F, V71, P1521, DOI 10.1107/S2053230X15022098; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaplan N, 2013, J CHEMOTHERAPY, V25, P18, DOI 10.1179/1973947812Y.0000000063; Kaplan N, 2012, ANTIMICROB AGENTS CH, V56, P5865, DOI 10.1128/AAC.01411-12; Karlowsky JA, 2009, ANTIMICROB AGENTS CH, V53, P3544, DOI 10.1128/AAC.00400-09; Keeney KM, 2014, ANNU REV MICROBIOL, V68, P217, DOI 10.1146/annurev-micro-091313-103456; Kim HT, 2017, BIOCHEM BIOPH RES CO, V493, P28, DOI 10.1016/j.bbrc.2017.09.084; Kim KH, 2011, J MOL BIOL, V406, P403, DOI 10.1016/j.jmb.2010.12.003; Kim SJ, 2010, BIOCHEM BIOPH RES CO, V400, P517, DOI 10.1016/j.bbrc.2010.08.083; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Luckner SR, 2010, J BIOL CHEM, V285, P14330, DOI 10.1074/jbc.M109.090373; Marrakchi H, 2003, BIOCHEM J, V370, P1055, DOI 10.1042/BJ20021699; Marrakchi H, 2002, J BIOL CHEM, V277, P44809, DOI 10.1074/jbc.M208920200; Massengo-Tiasse RP, 2008, J BIOL CHEM, V283, P1308, DOI 10.1074/jbc.M708171200; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Mehboob S, 2012, J MED CHEM, V55, P5933, DOI 10.1021/jm300489v; Menetrey A, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01669-18; Muench SP, 2007, ACTA CRYSTALLOGR D, V63, P328, DOI 10.1107/S0907444906053625; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parikh S, 1999, BIOCHEMISTRY-US, V38, P13623, DOI 10.1021/bi990529c; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Parsons JB, 2011, P NATL ACAD SCI USA, V108, P15378, DOI 10.1073/pnas.1109208108; Perozzo R, 2002, J BIOL CHEM, V277, P13106, DOI 10.1074/jbc.M112000200; Pidugu LS, 2004, J MOL BIOL, V343, P147, DOI 10.1016/j.jmb.2004.08.033; Pojer F., 2012, MYCOBACTERIUM TUBERC, p4DRE; Priyadarshi A, 2010, PROTEINS, V78, P480, DOI 10.1002/prot.22581; Qiu XY, 1999, PROTEIN SCI, V8, P2529, DOI 10.1110/ps.8.11.2529; Radka CD, 2020, MOL MICROBIOL, V113, P807, DOI 10.1111/mmi.14445; Radka CD, 2017, ACTA CRYSTALLOGR D, V73, P921, DOI 10.1107/S2059798317015236; RAFFERTY JB, 1995, STRUCTURE, V3, P927, DOI 10.1016/S0969-2126(01)00227-1; Rinninella E, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010014; Rozwarski DA, 1999, J BIOL CHEM, V274, P15582, DOI 10.1074/jbc.274.22.15582; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saito J, 2008, PROTEIN SCI, V17, P691, DOI 10.1110/ps.073288808; Schiebel J, 2015, BIOCHEMISTRY-US, V54, P1943, DOI 10.1021/bi5014358; Schiebel J, 2012, STRUCTURE, V20, P802, DOI 10.1016/j.str.2012.03.013; Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P., 2015, BASIC PRINCIPLES ANA; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Subramanya H., 2013, CRYSTAL STRUCTURE CO, p4JQC; Tanaka N, 1996, BIOCHEMISTRY-US, V35, P7715, DOI 10.1021/bi951904d; Ward WHJ, 1999, BIOCHEMISTRY-US, V38, P12514, DOI 10.1021/bi9907779; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wright ES, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0749-z; Yao J., 2014, CRYSTAL STRUCTURE CH, p4Q9N; Yao JW, 2017, BBA-MOL CELL BIOL L, V1862, P1300, DOI 10.1016/j.bbalip.2016.09.014; Yao JW, 2016, ANTIMICROB AGENTS CH, V60, P4264, DOI 10.1128/AAC.00535-16; Yao JW, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a027045; Yao JW, 2016, J BIOL CHEM, V291, P171, DOI 10.1074/jbc.M115.699462; Yao JW, 2014, J BIOL CHEM, V289, P22365, DOI 10.1074/jbc.M114.584185; Yao JW, 2013, J BIOL CHEM, V288, P36261, DOI 10.1074/jbc.M113.512905; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zhao HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126420; Zhao Huaying, 2013, Curr Protoc Protein Sci, VChapter 20, DOI 10.1002/0471140864.ps2012s71; Zhu L, 2010, ANTIMICROB AGENTS CH, V54, P689, DOI 10.1128/AAC.01152-09	83	4	4	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7635	7652		10.1074/jbc.RA120.013336	http://dx.doi.org/10.1074/jbc.RA120.013336			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32317282	hybrid, Green Published			2022-12-26	WOS:000538038900007
J	Maver, M; Miras-Moreno, B; Lucini, L; Trevisan, M; Pii, Y; Cesco, S; Mimmo, T				Maver, Mauro; Miras-Moreno, Begona; Lucini, Luigi; Trevisan, Marco; Pii, Youry; Cesco, Stefano; Mimmo, Tanja			New insights in the allelopathic traits of different barley genotypes: Middle Eastern and Tibetan wild-relative accessions vs. cultivated modern barley	PLOS ONE			English	Article							ACTIVE SECONDARY METABOLITES; HERBICIDE-TOLERANT CROPS; DOMESTICATION HISTORY; WEED-CONTROL; GRAMINE; ALLELOCHEMICALS; RESISTANCE; SEEDLINGS; PERSISTENCE; SORGOLEONE	The two alkaloids gramine and hordenine have been known for playing a role in the allelopathic ability in barley (Hordeum vulgare L.). These allelochemicals can be both found in leaves and roots in some barley cultivars whereas in others one seems to exclude the other. In this study eighteen accessions of barley from the Middle-East area, one accession from Tibet and the modern spring cultivar Barke, already used as parental donor in a nested associated mapping (NAM) population, were screened for their gramine, hordenine and N-methyltyramine (the direct precursor of hordenine) content in leaves, roots and exudates. Moreover, the toxicity of the three allelochemicals on root growth inhibition on lettuce (Lactuca sativa L.) was evaluated. Results of this study showed the preferential production of gramine and hordenine in leaves and roots, respectively, in the nineteen barley accessions. On the other hand, in the modern barley cultivar Barke, the highest content of hordenine in roots and the general lack of gramine suggests a favored biosynthesis of the former. Gramine was not detected in the root exudates. In additions, different metabolomic profiles were observed in wild relatives compared to modern barley genotypes. The results also showed the phytotoxic effects of the three compounds on root growth of lettuce seedlings, with a reduction in root length and an increase of root surface area and diameter. In conclusion, this study highlighted the impact of the domestication effects on the production and distribution of the two allelopathic alkaloids gramine and hordenine in barley.	[Maver, Mauro; Pii, Youry; Cesco, Stefano; Mimmo, Tanja] Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy; [Miras-Moreno, Begona; Lucini, Luigi; Trevisan, Marco] Univ Cattolica Sacro Cuore, Dept Sustainable Food Proc, Piacenza, Italy	Free University of Bozen-Bolzano; Catholic University of the Sacred Heart	Maver, M (corresponding author), Free Univ Bozen Bolzano, Fac Sci & Technol, Bolzano, Italy.	mauro.maver@unibz.it	Lucini, Luigi/L-1503-2013; Maver, Mauro/GLT-8406-2022; CESCO, Stefano/F-3088-2011	Lucini, Luigi/0000-0002-5133-9464; Maver, Mauro/0000-0002-8162-3618; Mimmo, Tanja/0000-0002-2375-8370; CESCO, Stefano/0000-0001-5191-0520				Ahman I, 2000, J CHEM ECOL, V26, P233, DOI 10.1023/A:1005405915031; ALBUQUERQUE MBD, 2011, AGRON SUSTAIN DEV, V31, P379, DOI DOI 10.1051/AGR0/2010031; Badr A, 2000, MOL BIOL EVOL, V17, P499, DOI 10.1093/oxfordjournals.molbev.a026330; Belz RG, 2007, PEST MANAG SCI, V63, P308, DOI 10.1002/ps.1320; Bertholdsson NO, 2004, WEED RES, V44, P78, DOI 10.1111/j.1365-3180.2003.00375.x; Bolger ME, 2014, CURR OPIN BIOTECH, V26, P31, DOI 10.1016/j.copbio.2013.08.019; Bravo H. R., 2010, Revista Latinoamericana de Quimica, V38, P123; Burgos NR, 2004, J CHEM ECOL, V30, P671, DOI 10.1023/B:JOEC.0000018637.94002.ba; Chon SU, 2002, CROP PROT, V21, P1077, DOI 10.1016/S0261-2194(02)00092-3; Czarnota MA, 2001, WEED TECHNOL, V15, P813, DOI 10.1614/0890-037X(2001)015[0813:MOALOP]2.0.CO;2; Davis AS, 2017, PEST MANAG SCI, V73, P2209, DOI 10.1002/ps.4643; de Andrea MM, 2003, PESQUI AGROPECU BRAS, V38, P1329, DOI 10.1590/S0100-204X2003001100012; de Mendiburu M.F., 2019, R PACKAGE; Favaretto A, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-018-0495-5; Gianessi LP, 2013, PEST MANAG SCI, V69, P1099, DOI 10.1002/ps.3598; Green JM, 2014, PEST MANAG SCI, V70, P1351, DOI 10.1002/ps.3727; Guo T, 2018, PLANTS, V7, P1; HANSON AD, 1981, CROP SCI, V21, P726, DOI 10.2135/cropsci1981.0011183X002100050024x; HANSON AD, 1983, PLANT PHYSIOL, V71, P896, DOI 10.1104/pp.71.4.896; HARLAN JR, 1966, SCIENCE, V153, P1074, DOI 10.1126/science.153.3740.1074; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Ishiai S, 2016, PHYSIOL MOL PLANT P, V96, P94, DOI 10.1016/j.pmpp.2016.10.003; Jabran K, 2017, SPRINGERBR PLANT SCI, P77, DOI 10.1007/978-3-319-53186-1_9; Jabran K, 2015, CROP PROT, V72, P57, DOI 10.1016/j.cropro.2015.03.004; KANEHISA K, 1990, APPL ENTOMOL ZOOL, V25, P251, DOI 10.1303/aez.25.251; KIRKWOOD S, 1950, J AM CHEM SOC, V72, P2522, DOI 10.1021/ja01162a050; Kohli R, 2008, J CROP PROT, V4, P287, DOI [10.1300/J144v04n02, DOI 10.1300/J144V04N02]; Kong CH, 2011, PEST MANAG SCI, V67, P1100, DOI 10.1002/ps.2154; Kremer RJ, 2009, ALLELOPATHY J, V24, P225; Lamichhane JR, 2017, CRIT REV BIOTECHNOL, V37, P459, DOI 10.1080/07388551.2016.1180588; Larsson KAE, 2006, PHYTOCHEMISTRY, V67, P2002, DOI 10.1016/j.phytochem.2006.06.036; Larsson KAE, 2011, PLANT PHYSIOL BIOCH, V49, P96, DOI 10.1016/j.plaphy.2010.10.005; Latif S, 2017, ADV BOT RES, V82, P19, DOI 10.1016/bs.abr.2016.12.001; Lebecque S, 2018, SCI REP, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; LELAND TJ, 1985, PLANT SCI, V42, P77, DOI 10.1016/0168-9452(85)90145-1; LIU DL, 1993, J CHEM ECOL, V19, P2231, DOI 10.1007/BF00979660; LIU DL, 1993, J CHEM ECOL, V19, P2217, DOI 10.1007/BF00979659; LOVETT JV, 1995, ACS SYM SER, V582, P170; LOVETT JV, 1994, J CHEM ECOL, V20, P1945, DOI 10.1007/BF02066235; Lucini L, 2019, PHYTOCHEMISTRY, V157, P158, DOI 10.1016/j.phytochem.2018.10.033; Mangino MM, 1982, FORMATION N NITROSOD, V244; Maqbool N, 2013, ALLELOPATHY, P451, DOI DOI 10.1007/978-3-642-30595-5_19; Mascher M, 2016, NAT GENET, V48, P1089, DOI 10.1038/ng.3611; Matsuo H, 2001, PLANT CELL PHYSIOL, V42, P1103, DOI 10.1093/pcp/pce139; Maurer A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1459-7; Mercurio P, 2014, MAR POLLUT BULL, V85, P385, DOI 10.1016/j.marpolbul.2014.01.021; Molish H., 1937, J FOOD CHEM, V1, P99; NEVO E, 1986, BIOL J LINN SOC, V27, P355, DOI 10.1111/j.1095-8312.1986.tb01742.x; Nevo Eviatar, 2006, Plant Genetic Resources Characterization and Utilization, V4, P36, DOI 10.1079/PGR2006108; Newton AC, 2011, FOOD SECUR, V3, P141, DOI 10.1007/s12571-011-0126-3; Oveisi M, 2008, WEED BIOL MANAG, V8, P225, DOI 10.1111/j.1445-6664.2008.00301.x; OVERLAND L, 1966, AM J BOT, V53, P423, DOI 10.2307/2440341; Owen MDK, 2011, J VERBRAUCH LEBENSM, V6, P85, DOI 10.1007/s00003-011-0679-2; Paul K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00047; Peterson MA, 2018, PEST MANAG SCI, V74, P2246, DOI 10.1002/ps.4821; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Radhakrishnan R, 2018, ECOTOX ENVIRON SAFE, V158, P131, DOI 10.1016/j.ecoenv.2018.04.018; Reigosa M, 2013, ACTA BOT BRAS, V27, P629, DOI 10.1590/S0102-33062013000400001; Sanchez-Moreiras AM, 2005, J CHEM ECOL, V31, P2689, DOI 10.1007/s10886-005-7620-z; Scagliola M, 2016, PLANT PHYSIOL BIOCH, V107, P187, DOI 10.1016/j.plaphy.2016.06.002; Servillo L, 2012, N METHYLATED TRYPTAM; Soltys D., 2013, HERBICIDES CURRENT R, P517, DOI [10.5772/56185, DOI 10.5772/56185]; Tenhaken R, 2015, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00771; Valentinuzzi F, 2015, BIOL FERT SOILS, V51, P757, DOI 10.1007/s00374-015-1015-2; Vasilakoglou I, 2009, ALLELOPATHY J, V24, P309; Velozo JA, 1999, PHYTOCHEMISTRY, V52, P1059, DOI 10.1016/S0031-9422(99)00358-1; Weston LA, 2012, J EXP BOT, V63, P3445, DOI 10.1093/jxb/ers054; Wickham H., 2016, GGPLOT2 ELEGANT GRAP, DOI 10.1007/978-3-319-24277-4; Yang GQ, 2011, WEED BIOL MANAG, V11, P152, DOI 10.1111/j.1445-6664.2011.00413.x; Yang XH, 2004, J CHEM ECOL, V30, P199, DOI 10.1023/B:JOEC.0000013191.35181.03; YOSHIDA H, 1993, PHYTOCHEMISTRY, V34, P1011, DOI 10.1016/S0031-9422(00)90704-0; Zhang JF, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00018; Zhou LL, 2006, J AGR FOOD CHEM, V54, P9287, DOI 10.1021/jf061819k; ZUNIGA GE, 1986, ENTOMOL EXP APPL, V40, P259, DOI 10.1007/BF00293708	74	9	9	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231976	10.1371/journal.pone.0231976	http://dx.doi.org/10.1371/journal.pone.0231976			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324789	Green Submitted, Green Published, gold			2022-12-26	WOS:000536033700055
J	Olmos, AA; Stratton, MT; Ha, PL; Dalton, BE; VanDusseldorp, TA; Mangine, GT; Feito, Y; Poisal, MJ; Jones, JA; Smith, TM; Hester, GM				Olmos, Alex A.; Stratton, Matthew T.; Ha, Phuong L.; Dalton, Benjamin E.; VanDusseldorp, Trisha A.; Mangine, Gerald T.; Feito, Yuri; Poisal, Micah J.; Jones, Joshua A.; Smith, Tyler M.; Hester, Garrett M.			Early and late rapid torque characteristics and select physiological correlates in middle-aged and older males	PLOS ONE			English	Article							SURAE MUSCLE ARCHITECTURE; CONTRACTILE PROPERTIES; FORCE DEVELOPMENT; STRENGTH; YOUNG; ACTIVATION; SIZE; ENDURANCE; DECLINE; POWER	Purpose The purpose of this study was to compare early and late rapid torque parameters of the plantar flexors (PFs) in middle-aged (MM) and older (OM) males, and determine the effect of normalization to peak torque (PT) and muscle cross-sectional area (CSA). Methods Twenty-nine healthy, MM (n = 14; 45 +/- 2 yrs) and OM (n = 15; 65 +/- 3 yrs) performed rapid, maximal isometric contractions of the PFs. PT, as well as rate of torque development and impulse during the early (0-50 ms; RTD0-50, IMP0-50) and late (100-200 ms; RTD100-200, IMP100-200) contraction phases were calculated. Torque at 50 (TQ(50)), 100 (TQ(100)), and 200 (TQ(200)) ms was also obtained. CSA and echo-intensity (EI) of the gastrocnemii were acquired via ultrasonography. Torque variables were normalized to PT and CSA. Rate of EMG rise (RER) for the medial gastrocnemius was calculated at 30, 50 and 75 ms. Results TQ(100) (MM = 69.71 +/- 16.85 vs. OM = 55.99 +/- 18.54 Nm; p = 0.046), TQ(200) (MM = 114.76 +/- 26.79 vs. OM = 91.56 +/- 28.10 Nm; p = 0.031), and IMP100-200 (MM = 4.79 +/- 1.11 vs. OM = 3.83 +/- 1.17 Nm.s; p = 0.032) were lower in OM. PT, TQ(50), RTD0-50, IMP0-50, RTD100-200, RER, CSA, and EI were similar between groups (p > 0.05). No differences were found for normalized torque variables (p > 0.05). EI was moderately associated with normalized torque parameters only (r = -0.38 -0.45). RER, at 75 ms, was moderately correlated with early, absolute torque measures and rapid torque variables made relative to PT and CSA (r = 0.41 -0.64). Conclusion Late rapid torque parameters of the PFs were preferentially impaired in OM compared to MM, and PT as well as CSA appeared to mediate this result.	[Olmos, Alex A.; Ha, Phuong L.; Dalton, Benjamin E.; VanDusseldorp, Trisha A.; Mangine, Gerald T.; Feito, Yuri; Poisal, Micah J.; Jones, Joshua A.; Smith, Tyler M.; Hester, Garrett M.] Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA; [Stratton, Matthew T.] Texas Tech Univ, Dept Kinesiol & Sport Management, Lubbock, TX 79409 USA	University System of Georgia; Kennesaw State University; Texas Tech University System; Texas Tech University	Hester, GM (corresponding author), Kennesaw State Univ, Dept Exercise Sci & Sport Management, Kennesaw, GA 30144 USA.	ghester4@kennesaw.edu			Creative Activities and Research Experiences for Teams program, Kennesaw State University	Creative Activities and Research Experiences for Teams program, Kennesaw State University	This study was supported by the Creative Activities and Research Experiences for Teams program, Kennesaw State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Alway SE, 1996, J GERONTOL A-BIOL, V51, pB195, DOI 10.1093/gerona/51A.3.B195; Andersen LL, 2006, EUR J APPL PHYSIOL, V96, P46, DOI 10.1007/s00421-005-0070-z; Barry BK, 2005, EXP BRAIN RES, V162, P122, DOI 10.1007/s00221-004-2127-3; BEMBEN M G, 1991, Medicine and Science in Sports and Exercise, V23, P1302; Cohen J., 1988, STAT POWER ANAL SOCI, V2; de Ruiter CJ, 2004, J APPL PHYSIOL, V97, P1693, DOI 10.1152/japplphysiol.00230.2004; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Folland JP, 2014, SCAND J MED SCI SPOR, V24, P894, DOI 10.1111/sms.12131; Frank-Wilson AW, 2018, J GERONTOL A-BIOL, V73, P931, DOI 10.1093/gerona/glx262; Gerstner GR, 2017, EXP GERONTOL, V99, P27, DOI 10.1016/j.exger.2017.09.009; Gerstner GR, 2017, MED SCI SPORT EXER, V49, P1327, DOI 10.1249/MSS.0000000000001231; Harbo T, 2012, EUR J APPL PHYSIOL, V112, P267, DOI 10.1007/s00421-011-1975-3; Harridge SDR, 1996, PFLUG ARCH EUR J PHY, V432, P913, DOI 10.1007/s004240050215; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; Hester GM, 2019, EUR J APPL PHYSIOL, V119, P1313, DOI 10.1007/s00421-019-04123-8; Hester GM, J GERIATR PHYS THER; KALLMAN DA, 1990, J GERONTOL, V45, pM82, DOI 10.1093/geronj/45.3.M82; Klass M, 2008, J APPL PHYSIOL, V104, P739, DOI 10.1152/japplphysiol.00550.2007; LEXELL J, 1988, J NEUROL SCI, V84, P275, DOI 10.1016/0022-510X(88)90132-3; Lindle RS, 1997, J APPL PHYSIOL, V83, P1581, DOI 10.1152/jappl.1997.83.5.1581; Maffiuletti NA, 2016, EUR J APPL PHYSIOL, V116, P1091, DOI 10.1007/s00421-016-3346-6; Mau-Moeller A, 2013, J ELECTROMYOGR KINES, V23, P640, DOI 10.1016/j.jelekin.2013.01.009; Morse CI, 2005, ACTA PHYSIOL SCAND, V183, P291, DOI 10.1111/j.1365-201X.2004.01404.x; Mota JA, 2017, ULTRASOUND MED BIOL, V43, P1651, DOI 10.1016/j.ultrasmedbio.2017.04.010; Olmos AA, 2019, EXP GERONTOL, V125, DOI 10.1016/j.exger.2019.110677; Osawa Y, 2018, J CACHEXIA SARCOPENI; Palmer TB, 2017, AGING CLIN EXP RES, V29, P1231, DOI 10.1007/s40520-017-0734-7; Pijnappels M, 2005, EXP BRAIN RES, V160, P326, DOI 10.1007/s00221-004-2014-y; Quinlan JI, 2018, J GERONTOL A-BIOL, V73, P539, DOI 10.1093/gerona/glx149; Rahemi H, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0365; Rech A, 2014, AGE, V36, DOI 10.1007/s11357-014-9708-2; Reid KF, 2012, EXERC SPORT SCI REV, V40, P4, DOI 10.1097/JES.0b013e31823b5f13; Stenroth L, 2012, J APPL PHYSIOL, V113, P1537, DOI 10.1152/japplphysiol.00782.2012; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; Thompson BJ, 2019, J BIOMECH, V83, P235, DOI 10.1016/j.jbiomech.2018.12.006; Thompson BJ, 2014, AGE, V36, P839, DOI 10.1007/s11357-013-9605-0; Thompson BJ, 2013, EXP GERONTOL, V48, P277, DOI 10.1016/j.exger.2012.10.009; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; van der Krogt MM, 2012, GAIT POSTURE, V36, P113, DOI 10.1016/j.gaitpost.2012.01.017; van Melick N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189876; YOUNG A, 1985, CLIN PHYSIOL, V5, P145; Young HJ, 2015, MUSCLE NERVE, V52, P963, DOI 10.1002/mus.24656	46	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231907	10.1371/journal.pone.0231907	http://dx.doi.org/10.1371/journal.pone.0231907			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9SA	32324776	Green Published, gold			2022-12-26	WOS:000536033700045
J	Schonherz, AA; Bodker, JS; Schmitz, A; Brondum, RF; Jakobsen, LH; Roug, AS; Severinsen, MT; El-Galaly, TC; Jensen, P; Johnsen, HE; Bogsted, M; Dybkaer, K				Schonherz, Anna A.; Bodker, Julie Stove; Schmitz, Alexander; Brondum, Rasmus Froberg; Jakobsen, Lasse Hjort; Roug, Anne Stidsholt; Severinsen, Marianne T.; El-Galaly, Tarec C.; Jensen, Paw; Johnsen, Hans Erik; Bogsted, Martin; Dybkaer, Karen			Normal myeloid progenitor cell subset-associated gene signatures for acute myeloid leukaemia subtyping with prognostic impact	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; STEM-CELLS; EPIGENETIC REGULATORS; EXPRESSION PROFILES; CLASSIFICATION; MUTATIONS; CRITERIA; AML; RECOMMENDATIONS; HETEROGENEITY	Acute myeloid leukaemia (AML) is characterised by phenotypic heterogeneity, which we hypothesise is a consequence of deregulated differentiation with transcriptional reminiscence of the normal compartment or cell-of-origin. Here, we propose a classification system based on normal myeloid progenitor cell subset-associated gene signatures (MAGS) for individual assignments of AML subtypes. We generated a MAGS classifier including the progenitor compartments CD34(+)/CD38(-) for haematopoietic stem cells (HSCs), CD34(+)/ CD38(+)/CD45RA(-) for megakaryocyte-erythroid progenitors (MEPs), and CD34(+)/CD38(+)/CD45RA(+) for granulocytic-monocytic progenitors (GMPs) using regularised multinomial regression with three discrete outcomes and an elastic net penalty. The regularisation parameters were chosen by cross-validation, and MAGS assignment accuracy was validated in an independent data set (N = 38; accuracy = 0.79) of sorted normal myeloid subpopulations. The prognostic value of MAGS assignment was studied in two clinical cohorts (TCGA: N = 171; GSE6891: N = 520) and had a significant prognostic impact. Furthermore, multivariate Cox regression analysis using the MAGS subtype, FAB subtype, cytogenetics, molecular genetics, and age as explanatory variables showed independent prognostic value. Molecular characterisation of subtypes by differential gene expression analysis, gene set enrichment analysis, and mutation patterns indicated reduced proliferation and overrepresentation of RUNX1 and IDH2 mutations in the HSC subtype; increased proliferation and overrepresentation of CEBPA mutations in the MEP subtype; and innate immune activation and overrepresentation of WT1 mutations in the GMP subtype. We present a differentiationdependent classification system for AML subtypes with distinct pathogenetic and prognostic importance that can help identify candidates poorly responding to combination chemotherapy and potentially guide alternative treatments.	[Schonherz, Anna A.; Jakobsen, Lasse Hjort; Roug, Anne Stidsholt; Severinsen, Marianne T.; El-Galaly, Tarec C.; Johnsen, Hans Erik; Bogsted, Martin; Dybkaer, Karen] Aalborg Univ, Dept Clin Med, Fac Med, Aalborg, Denmark; [Schonherz, Anna A.; Bodker, Julie Stove; Schmitz, Alexander; Brondum, Rasmus Froberg; Jakobsen, Lasse Hjort; Roug, Anne Stidsholt; Severinsen, Marianne T.; El-Galaly, Tarec C.; Jensen, Paw; Johnsen, Hans Erik; Bogsted, Martin; Dybkaer, Karen] Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Haematol, Aalborg, Denmark; [Schonherz, Anna A.] Aarhus Univ, Ctr Quantitat Genet & Genom, Dept Mol Biol & Genet, Aarhus, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital; Aarhus University	Dybkaer, K (corresponding author), Aalborg Univ, Dept Clin Med, Fac Med, Aalborg, Denmark.; Dybkaer, K (corresponding author), Aalborg Univ Hosp, Clin Canc Res Ctr, Dept Haematol, Aalborg, Denmark.	k.dybkaer@rn.dk	; Schonherz, Anna/V-3713-2018	Jensen, Paw/0000-0002-5248-0523; Dybkaer, Karen/0000-0003-2488-435X; Schonherz, Anna/0000-0002-5057-9351; Bogsted, Martin/0000-0001-9192-1814; Brondum, Rasmus/0000-0001-5537-6767; Severinsen, Marianne Tang/0000-0003-0996-1812	Innovationsfonden [153-2014-10]; Karen Elise Jensen Fonden; Det Obelske Familefond [27251]	Innovationsfonden; Karen Elise Jensen Fonden; Det Obelske Familefond	HEJ, 30-06-2015, Karen Elise Jensen Fonden, http://www.kejfond.dk/.JSB, 27251, Det Obelske Familefond, http://obel.com/.MB, 153-2014-10, Innovationsfonden, https://innovationsfonden.dk The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Roel Verhaak from the Department of Bioinformatics and Computational Biology, the University of Texas MD Anderson Cancer Center Houston, Texas, USA and Peter Valk from the Department of Haematology, Erasmus University Medical Center, Rotterdam, Netherlands for kindly providing survival data for the GSE6891 cohort.	Andersson A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-6; Bacher U, 2010, CURR OPIN ONCOL, V22, P646, DOI 10.1097/CCO.0b013e32833ed806; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BENNETT JM, 1985, ANN INTERN MED, V103, P460, DOI 10.7326/0003-4819-103-3-460; BENNETT JM, 1976, BRIT J HAEMATOL, V33, P451, DOI 10.1111/j.1365-2141.1976.tb03563.x; BENNETT JM, 1991, BRIT J HAEMATOL, V78, P325, DOI 10.1111/j.1365-2141.1991.tb04444.x; BENNETT JM, 1985, ANN INTERN MED, V103, P620, DOI 10.7326/0003-4819-103-4-620; Bergkvist KS, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-3; Bodker JS, 2018, BLOOD ADV, V2, P2400, DOI 10.1182/bloodadvances.2018018564; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; Corces-Zimmerman MR, 2014, P NATL ACAD SCI USA, V111, P2548, DOI 10.1073/pnas.1324297111; de Jonge HJM, 2010, BLOOD, V116, P1747, DOI 10.1182/blood-2010-03-270991; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dohner H, 2017, BLOOD, V129, P424, DOI 10.1182/blood-2016-08-733196; Drolle H, 2015, LEUKEMIA RES, V39, P779, DOI 10.1016/j.leukres.2015.04.019; Dybkaer K, 2015, J CLIN ONCOL, V33, P1379, DOI 10.1200/JCO.2014.57.7080; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Essers MAG, 2010, MOL ONCOL, V4, P443, DOI 10.1016/j.molonc.2010.06.001; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gaidzik VI, 2016, LEUKEMIA, V30, P2160, DOI 10.1038/leu.2016.126; Gentles AJ, 2010, JAMA-J AM MED ASSOC, V304, P2706, DOI 10.1001/jama.2010.1862; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Hasemann MS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004079; Ignatz-Hoover JJ, 2015, LEUKEMIA, V29, P918, DOI 10.1038/leu.2014.293; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Johnsen HE, 2014, LEUKEMIA LYMPHOMA, V55, P1251, DOI 10.3109/10428194.2013.839785; Johnson WE, 2007, BIOSTATISTICS, DOI [10.1093/biostatisfics/kM037, DOI 10.1093/BI0STATISFICS/KM037]; Jung N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9489; Kohlmann A, 2010, LEUKEMIA, V24, P1216, DOI 10.1038/leu.2010.73; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; Mancini E, 2012, EMBO J, V31, P351, DOI 10.1038/emboj.2011.390; McShane LM, 2013, NATURE, V502, P317, DOI 10.1038/nature12564; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Metzeler KH, 2016, BLOOD, V128, P686, DOI 10.1182/blood-2016-01-693879; Monlish DA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00390; Mrozek K, 2012, J CLIN ONCOL, V30, P4515, DOI 10.1200/JCO.2012.43.4738; Muzio M, 2009, BRIT J HAEMATOL, V144, P507, DOI 10.1111/j.1365-2141.2008.07475.x; Okamoto M, 2009, BRIT J HAEMATOL, V147, P585, DOI 10.1111/j.1365-2141.2009.07858.x; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pastore F, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/s13045-014-0055-7; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Phipson B, 2016, ANN APPL STAT, V10, P946, DOI 10.1214/16-AOAS920; R Development Core Team, 2016, R LANG ENV STAT COMP; Rapin N, 2014, BLOOD, V123, P894, DOI 10.1182/blood-2013-02-485771; Raponi M, 2008, BLOOD, V111, P2589, DOI 10.1182/blood-2007-09-112730; Rasmussen T, 1999, BRIT J HAEMATOL, V107, P818, DOI 10.1046/j.1365-2141.1999.01770.x; Rasmussen T, 1998, MED ONCOL; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rolf N, 2015, EUR J IMMUNOL, V45, P1980, DOI 10.1002/eji.201444874; Rybka J, 2015, LEUKEMIA RES, V39, P318, DOI 10.1016/j.leukres.2015.01.002; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Shlush LI, 2014, NATURE, V506, P328, DOI 10.1038/nature13038; Shlush LI, 2012, BLOOD, V120, P603, DOI 10.1182/blood-2011-10-388629; Sood R, 2017, BLOOD, V129, P2070, DOI 10.1182/blood-2016-10-687830; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swerdlow SH, 2008, WHO CLASSIFICATION T; Theilgaard-Monch K, 2011, LEUKEMIA, DOI 10.1038/leu.2011.48; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Wei Y, 2013, LEUKEMIA, V27, P1832, DOI 10.1038/leu.2013.180; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhang P, 2004, IMMUNITY, DOI 10.10168/j.immuni.2004.11.006; 2014, LIP LIP BIL MOD, P1	76	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0229593	10.1371/journal.pone.0229593	http://dx.doi.org/10.1371/journal.pone.0229593			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324791	Green Published, gold			2022-12-26	WOS:000536033700005
J	Futami, M; Suzuki, K; Kato, S; Ohmae, S; Tahara, Y; Nojima, M; Imai, Y; Mimura, T; Watanabe, Y; Tojo, A				Futami, Muneyoshi; Suzuki, Keisuke; Kato, Satomi; Ohmae, Saori; Tahara, Yoshio; Nojima, Masanori; Imai, Yoichi; Mimura, Takayuki; Watanabe, Yoshihiro; Tojo, Arinobu			The novel multi-cytokine inhibitor TO-207 specifically inhibits pro-inflammatory cytokine secretion in monocytes without affecting the killing ability of CAR T cells	PLOS ONE			English	Article							IMMATURE MYELOID CELLS; SUPPRESSOR-CELLS; JTE-607; THERAPY; DIFFERENTIATION; EXPRESSION; MANAGEMENT; ENDOTOXIN; INJURY; SHOCK	Cancer immunotherapy using chimeric antigen receptor-armed T (CAR T) cells have been shown to improve outcomes significantly in patients with hematological malignancies. However, cytokine release syndrome (CRS) remains a risk. CRS is characterized by the excessive activation of CAR T cells and macrophages. Signs and symptoms of CRS are usually resolved after steroid administration, but steroids abrogate the expansion and persistence of CAR T cell populations. Tocilizumab is a humanized monoclonal antibody (mAb) that attenuates CRS without significant loss of CAR T cell activity. However, interleukin-6 (IL-6)/IL-6 receptor (IL-6R) blockade alone cannot relieve CRS symptoms fully, and novel treatments are needed to prevent or cure CRS. TO-207 is an N-benzoyl-L-phenylalanine derivative that significantly inhibits inflammatory cytokine production in human monocyte and macrophage-specific manner. We investigated whether TO-207 could inhibit cytokine production without impairing CAR T cell function in a CRS-simulating co-culture system.	[Futami, Muneyoshi; Kato, Satomi; Tojo, Arinobu] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Mol Therapy, Tokyo, Japan; [Suzuki, Keisuke; Ohmae, Saori; Tahara, Yoshio; Mimura, Takayuki; Watanabe, Yoshihiro] Torii Pharmaceut, Res Labs, Sakura, Japan; [Nojima, Masanori] Univ Tokyo, Inst Med Sci Hosp, Ctr Translat Res, Tokyo, Japan; [Imai, Yoichi] Univ Tokyo, Inst Med Sci, Dept Hematol Oncol, Tokyo, Japan; [Watanabe, Yoshihiro] Kanazawa Univ, Innovat Clin Res Ctr, Kanazawa, Ishikawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Kanazawa University	Futami, M (corresponding author), Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Mol Therapy, Tokyo, Japan.	m-futami@umin.ac.jp	Nojima, Masanori/ABE-2237-2020	Nojima, Masanori/0000-0002-8788-2522; Imai, Yoichi/0000-0002-2938-6133; Futami, Muneyoshi/0000-0003-1425-6261	Torii Pharmaceutical	Torii Pharmaceutical	M.F., S.K., and A.T. received a research grant from Torii Pharmaceutical. K.S., S.O., Y.T., T. M., and Y.W. are employed by Torii Pharmaceutical. The funder provided support in the form of salaries for authors K.S., S.O., Y.T., T.M., and Y.W., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Acharya UH, 2019, EXPERT REV HEMATOL, V12, P195, DOI 10.1080/17474086.2019.1585238; Borozdenkova S, 2011, INT IMMUNOPHARMACOL, V11, P1837, DOI 10.1016/j.intimp.2011.07.013; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Garfall AL, 2015, NEW ENGL J MED, V373, P1040, DOI 10.1056/NEJMoa1504542; GARSON D, 1985, EXP HEMATOL, V13, P885; Giavridis T, 2018, NAT MED, V24, P731, DOI 10.1038/s41591-018-0041-7; Gruber AJ, 2019, NAT REV GENET, V20, P599, DOI 10.1038/s41576-019-0145-z; Grupp SA, 2013, NEW ENGL J MED, V368, P1509, DOI 10.1056/NEJMoa1215134; Hollerer I, 2014, EMBO MOL MED, V6, P16, DOI 10.1002/emmm.201303300; Iwamura H, 2004, J PHARMACOL EXP THER, V311, P1256, DOI 10.1124/jpet.104.072421; Iwamura H, 2002, INFLAMM RES, V51, P160, DOI 10.1007/PL00000288; June CH, 2018, SCIENCE, V359, P1361, DOI 10.1126/science.aar6711; Kakegawa J, 2019, BIOCHEM BIOPH RES CO, V518, P32, DOI 10.1016/j.bbrc.2019.08.004; Kakutani M, 1999, INFLAMM RES, V48, P461, DOI 10.1007/s000110050487; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Kochenderfer JN, 2009, J IMMUNOTHER, V32, P689, DOI 10.1097/CJI.0b013e3181ac6138; Lechner MG, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-90; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Neelapu SS, 2018, NAT REV CLIN ONCOL, V15, P47, DOI 10.1038/nrclinonc.2017.148; Norelli M, 2018, NAT MED, V24, P739, DOI 10.1038/s41591-018-0036-4; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Ross NT, 2020, NAT CHEM BIOL, V16, P50, DOI 10.1038/s41589-019-0424-1; Ryugo M, 2004, J THORAC CARDIOV SUR, V127, P1723, DOI 10.1016/j.jtcvs.2003.08.015; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Santomasso BD, 2018, CANCER DISCOV, V8, P958, DOI 10.1158/2159-8290.CD-17-1319; Shell SA, 2005, J BIOL CHEM, V280, P39950, DOI 10.1074/jbc.M508848200; Song XP, 2005, J IMMUNOL, V175, P8200, DOI 10.4049/jimmunol.175.12.8200; Tajima N, 2010, CANCER SCI, V101, P774, DOI 10.1111/j.1349-7006.2009.01446.x; Teachey DT, 2016, CANCER DISCOV, V6, P664, DOI 10.1158/2159-8290.CD-16-0040; The Lancet Global Health, 2016, LANCET GLOB HLTH, V4, pe427; Uesato N, 2006, EXP HEMATOL, V34, P1385, DOI 10.1016/j.exphem.2006.05.016; Veglia F, 2018, NAT IMMUNOL, V19, P108, DOI 10.1038/s41590-017-0022-x	37	10	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231896	10.1371/journal.pone.0231896	http://dx.doi.org/10.1371/journal.pone.0231896			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LL9AF	32320454	Green Submitted, Green Published, gold			2022-12-26	WOS:000531844400001
J	Wodas, L; Mackowski, M; Borowska, A; Puppel, K; Kuczynska, B; Cieslak, J				Wodas, Lukasz; Mackowski, Mariusz; Borowska, Alicja; Puppel, Kamila; Kuczynska, Beata; Cieslak, Jakub			Genes encoding equine beta-lactoglobulin (LGB1 and LGB2): Polymorphism, expression, and impact on milk composition	PLOS ONE			English	Article							MARES MILK; COAGULATION PROPERTIES; PROTEIN GENES; ASSOCIATION; VARIANTS; VARIABILITY; TRAITS; PARAMETERS; QUALITY; CASEIN	beta-lactoglobulin is one of the most abundant milk whey proteins in many mammal species, including the domestic horse. The aim of this study was to screen for polymorphism in the equine LGB1 and LGB2 gene sequences (all exons, introns, and 5'-flanking region) and to assess potential relationship of particular genotypes with gene expression levels (measured in milk somatic cells) and milk composition traits (protein, fat, lactose, and total beta-lactoglobulin content). Direct DNA sequencing analysis was performed for twelve horse breeds: Polish Primitive Horse (PPH), Polish Coldblood Horse (PCH), Polish Warmblood Horse (PWH), Silesian, Hucul, Fjording, Haflinger, Shetland Pony, Welsh Pony, Arabian, Thoroughbred, and Percheron-and revealed the presence of 83 polymorphic sites (47 and 36 for LGB1 and LGB2 genes, respectively), including eight that were previously unknown. Association analysis of the selected polymorphisms, gene expression, and milk composition traits (conducted for the PPH, PCH, and PWH breeds) showed several statistically significant relationships; for example, the two linked LGB1 SNPs (rs1143515669 and rs1144647991) were associated with total milk protein content (p < 0.01). Our study also confirmed that horse breed had significant impact on both gene transcript levels (p < 0.01) and on milk LGB content (p < 0.05), whereas an influence of lactation period was seen only for gene relative mRNA abundances (p < 0.01).	[Wodas, Lukasz; Mackowski, Mariusz; Borowska, Alicja; Cieslak, Jakub] Poznan Univ Life Sci, Dept Horse Breeding, Poznan, Poland; [Mackowski, Mariusz] Poznan Univ Life Sci, Horse Genet Markers Lab, Poznan, Poland; [Puppel, Kamila; Kuczynska, Beata] Warsaw Univ Life Sci, Cattle Breeding Div, Dept Anim Sci, Warsaw, Poland	Poznan University of Life Sciences; Poznan University of Life Sciences; Warsaw University of Life Sciences	Cieslak, J (corresponding author), Poznan Univ Life Sci, Dept Horse Breeding, Poznan, Poland.	jakub.cieslak@up.poznan.pl	Beata, Kuczyńska/ABB-3267-2020; Kuczyńska, Beata/AAC-7166-2022	Beata, Kuczyńska/0000-0002-9093-9905; Mackowski, Mariusz/0000-0003-2214-7284; Cieslak, Jakub/0000-0001-6936-2550; Borowska, Alicja/0000-0003-2366-4531; Puppel, Kamila/0000-0003-2909-2087	Polish National Science Centre [2016/21/N/NZ9/01350]	Polish National Science Centre	This study was funded by the Polish National Science Centre, through grant 2016/21/N/NZ9/01350	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Braunschweig MH, 2006, J DAIRY SCI, V89, P4414, DOI 10.3168/jds.S0022-0302(06)72488-2; Brinkmann J, 2016, LIVEST SCI, V187, P181, DOI 10.1016/j.livsci.2016.03.014; Canovas A, 2014, SCI REP-UK, V4, DOI 10.1038/srep05297; Caroli AM, 2009, J DAIRY SCI, V92, P5335, DOI 10.3168/jds.2009-2461; Cecchinato A, 2012, J DAIRY SCI, V95, P450, DOI 10.3168/jds.2011-4581; Cieslak J, 2019, J APPL GENET, V60, P71, DOI 10.1007/s13353-018-0473-2; Cieslak J, 2017, J SCI FOOD AGR, V97, P2174, DOI 10.1002/jsfa.8026; Cieslak J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139688; CORBEIL RR, 1976, TECHNOMETRICS, V18, P31, DOI 10.2307/1267913; Dettori ML, 2015, J DAIRY RES, V82, P434, DOI 10.1017/S0022029915000461; Docena G, 2002, ALLERGY, V57, P83, DOI 10.1034/j.1398-9995.2002.1o3219.x; Foekel C, 2009, INT J FOOD SCI NUTR, V60, P41, DOI 10.1080/09637480802249082; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Ganai NA, 2009, ANIM GENET, V40, P127, DOI 10.1111/j.1365-2052.2008.01806.x; Jastrzebska E, 2017, CZECH J ANIM SCI, V62, P511, DOI 10.17221/61/2016-CJAS; Jawasreh K, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9060382; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Lemay DG, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-872; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Zepeda-Batista JL, 2017, ASIAN AUSTRAL J ANIM, V30, P1684, DOI 10.5713/ajas.16.0481; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Markiewicz-Keszycka M, 2013, INT DAIRY J, V31, P62, DOI 10.1016/j.idairyj.2013.02.006; Martin CR, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050279; Molee A, 2015, GENET MOL RES, V14, P2561, DOI 10.4238/2015.March.30.15; Mroczkowski S., 2004, Archiv fur Tierzucht, V47, P114; Neamt RI, 2017, ACTA BIOCHIM POL, V64, P493, DOI 10.18388/abp.2016_1454; Noce A, 2016, ANIM GENET, V47, P717, DOI 10.1111/age.12474; Pieszka M, 2016, ANN ANIM SCI, V16, P33, DOI 10.1515/aoas-2015-0041; Potocnik K, 2011, MLJEKARSTVO, V61, P107; Puppel K, 2016, J SCI FOOD AGR, V96, P2240, DOI 10.1002/jsfa.7341; Rad JS, 2013, BRIT BIOMEDICAL B; Salimei E, 2012, INT DAIRY J, V24, P130, DOI 10.1016/j.idairyj.2011.11.008; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Schopen GCB, 2009, J DAIRY SCI, V92, P1182, DOI 10.3168/jds.2008-1281; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Selvaggi M., 2015, Advances in Animal and Veterinary Sciences, V3, P478; Summer A, 2005, CAN J ANIM SCI, V85, P93, DOI 10.4141/A04-008; THREADGILL DW, 1990, NUCLEIC ACIDS RES, V18, P6935, DOI 10.1093/nar/18.23.6935; Uniacke-Lowe T, 2010, INT DAIRY J, V20, P609, DOI 10.1016/j.idairyj.2010.02.007; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Varshney N, 2012, J DAIRY SCI, V95, P2935, DOI 10.3168/jds.2011-4442; Vidovic V, 2014, ANIM SCI PAP REP, V32, P179; Wodas L, 2018, J ANIM FEED SCI, V27, P317, DOI 10.22358/jafs/97175/2018; Xiang L.W., 2019, ENCY FOOD CHEM, P560, DOI DOI 10.1016/B978-0-08-100596-5.21488-1; Zaglool AW., 2016, WORLD VET J, V6, P117, DOI [10.5455/wvj.20160876, DOI 10.5455/WVJ.20160876]; Zhou JP, 2013, GENET MOL RES, V12, P3375, DOI 10.4238/2013.September.4.3	48	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0232066	10.1371/journal.pone.0232066	http://dx.doi.org/10.1371/journal.pone.0232066			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320437	gold, Green Published			2022-12-26	WOS:000536028800054
J	Pua, K; Yuhara, D; Ayuba, S; Yasuoka, K				Pua, Kai; Yuhara, Daisuke; Ayuba, Sho; Yasuoka, Kenji			Dataflow programming for the analysis of molecular dynamics with AViS, an analysis and visualization software application	PLOS ONE			English	Article								The study of molecular dynamics simulations is largely facilitated by analysis and visualization toolsets. However, these toolsets are often designed for specific use cases and those only, while scripting extensions to such toolsets is often exceedingly complicated. To overcome this problem, we designed a software application called AViS which focuses on the extensibility of analysis. By utilizing the dataflow programming (DFP) paradigm, algorithms can be defined by execution graphs, and arbitrary data can be transferred between nodes using visual connectors. Extension nodes can be implemented in either Python, C++, and Fortran, and combined in the same algorithm. AViS offers a comprehensive collection of nodes for sophisticated visualization state modifications, thus greatly simplifying the rules for writing extensions. Input files can also be read from the server automatically, and data is fetched automatically to improve memory usage. In addition, the visualization system of AViS uses physically-based rendering techniques, improving the 3D perception of molecular structures for interactive visualization. By performing two case studies on complex molecular systems, we show that the DFP workflow offers a much higher level of flexibility and extensibility when compared to legacy workflows. The software source code and binaries for Windows, MacOS, and Linux are freely available at https://avis-md.github.io/.	[Pua, Kai; Yuhara, Daisuke; Ayuba, Sho; Yasuoka, Kenji] Keio Univ, Dept Mech Engn, Yokohama, Kanagawa, Japan; [Pua, Kai] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Comp Sci, Tokyo, Japan	Keio University; University of Tokyo	Yasuoka, K (corresponding author), Keio Univ, Dept Mech Engn, Yokohama, Kanagawa, Japan.	yasuoka@mech.keio.ac.jp		kai, pua/0000-0002-1856-5259				Ayuba S, 2018, J CHEM PHYS, V149, DOI 10.1063/1.5037647; Barnes BC, 2014, J PHYS CHEM B, V118, P13236, DOI 10.1021/jp507959q; Barnes BC, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4871898; Berman H. M., 2006, INT TABLES CRYSTALLO, P675, DOI DOI 10.1107/97809553602060000722; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Gowers R. J., 2016, 15 PYTH SCI C SCIPY, P98, DOI [10.25080/majora-629-541a-00e, DOI 10.25080/MAJORA-629-541A-00E, DOI 10.25080/MAJORA-629E541A-00E]; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Iwasawa M, 2016, PUBL ASTRON SOC JPN, V68, DOI 10.1093/pasj/psw053; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Plimpton S., 2007, SANDIA NATL LAB, V18, P43; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; SCHLICK C, 1994, COMPUT GRAPH FORUM, V13, pC233, DOI 10.1111/1467-8659.1330233; Stukowski A, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/1/015012; Travis E., 2006, A GUIDE TO NUMPY	18	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231714	10.1371/journal.pone.0231714	http://dx.doi.org/10.1371/journal.pone.0231714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315327	Green Published, gold, Green Submitted			2022-12-26	WOS:000536024800048
J	Kovalchik, SA				Kovalchik, Stephanie A.			'In search of lost time': Identifying the causative role of cumulative competition load and competition time-loss in professional tennis using a structural nested mean model	PLOS ONE			English	Article							INJURY; PREVENTION; SPORT; INFERENCE	Injury prevention is critical to the achievement of peak performance in elite sport. For professional tennis players, the topic of injury prevention has gained even greater importance in recent years as multiple of the best male players have been sidelined owing to injury. Identifying potential causative factors of injury is essential for the development of effective prevention strategies, yet such research is hampered by incomplete data, the complexity of injury etiology, and observational study biases. The present study attempts to address these challenges by focusing on competition load and time-loss to competition-a completely observable risk factor and outcome-and using a structural nested mean model (SNMM) to identify the potential causal role of cumulative competition load on the risk of time-loss. Using inverse probability of treatment weights to balance exposure histories with respect to player ability, past injury, and consecutive competition weeks at each time point; the SNMM analysis of 389 professional male players and 55,773 weeks of competition found that total load significantly increases the risk of time-loss (HR = 1.05 per 1,000 games of additional load 95% CI 1.01-1.10) and this effect becomes magnified with age. Standard regression showed a protective effect of load, highlighting the value of more robust causal methods in the study of dynamic exposures and injury in sport and the need for further applications of these methods for understanding how time-loss and injuries of elite athletes might be prevented in the future.	[Kovalchik, Stephanie A.] Zelus Analyt, Austin, TX 78731 USA		Kovalchik, SA (corresponding author), Zelus Analyt, Austin, TX 78731 USA.	skovalchik@zelusanalytics.com			Tennis Australia	Tennis Australia	The author received no specific funding for this work. Tennis Australia provided support in the form of a salary for author SAK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Almirall D, 2010, BIOMETRICS, V66, P131, DOI 10.1111/j.1541-0420.2009.01238.x; [Anonymous], HLTH ELITE SPORT IS; Bang H, 2005, BIOMETRICS, V61, P962, DOI 10.1111/j.1541-0420.2005.00377.x; Banister E W, 1980, Can J Appl Sport Sci, V5, P170; Barker D, 2014, REFLECT PRACT, V15, P1, DOI 10.1080/14623943.2013.868799; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bengtsson H., 2017, MATCH RELATED RISK F; BenKibler W, 1996, AM J SPORT MED, V24, P279, DOI 10.1177/036354659602400306; Bornn L., 2019, SLOANSPORTSCONFERENC; Breznik K, 2012, J SPORT SCI MED, V11, P270; Bromley Sally, 2018, JMIR Hum Factors, V5, pe27, DOI 10.2196/humanfactors.9541; Carayol T., 2019, THE RINGER      0121; Drew MK, 2016, SPORTS MED, V46, P861, DOI 10.1007/s40279-015-0459-8; Ekegren CL, 2016, SPORTS MED, V46, P49, DOI 10.1007/s40279-015-0410-z; Elo A. E., 1978, RATING CHESSPLAYERS; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Fu MC, 2018, CURR REV MUSCULOSKE, V11, P1, DOI 10.1007/s12178-018-9452-9; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2018, BRIT J SPORT MED; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Kovalchik SA, 2020, INT J FORECASTING, V1, P1; Okholm Kryger K, 2015, AM J SPORT MED, V43, P34, DOI 10.1177/0363546514552996; Meeuwisse WH, 2007, CLIN J SPORT MED, V17, P205, DOI 10.1097/JSM.0b013e318057518f; Pearl J, 2014, PSYCHOL METHODS, V19, P459, DOI 10.1037/a0036434; Pluim BM, 2016, BRIT J SPORT MED, V50, P641, DOI 10.1136/bjsports-2016-095997; Pluim BM, 2006, BRIT J SPORT MED, V40, P415, DOI 10.1136/bjsm.2005.023184; R Core Team, 2021, R LANGUAGE ENV STAT; Robins J.M., 2000, STAT MODELS EPIDEMIO, P95, DOI DOI 10.1007/978-1-4612-1284-3_2; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROBINS JM, 1994, COMMUN STAT THEORY, V23, P2379, DOI 10.1080/03610929408831393; Soligard T, 2016, BRIT J SPORT MED, V50, P1030, DOI 10.1136/bjsports-2016-096581; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tignor S., 2018, TENNIS          0105; Weinberg CR, 2007, EPIDEMIOLOGY, V18, P569, DOI 10.1097/EDE.0b013e318126c11d	36	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0231568	10.1371/journal.pone.0231568	http://dx.doi.org/10.1371/journal.pone.0231568			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302343	Green Submitted, Green Published, gold			2022-12-26	WOS:000536016100035
J	Rivas, J; Diaz, N; Silva, I; Morales, D; Lavanderos, B; Alvarez, A; Saldias, MP; Pulgar, E; Cruz, P; Maureira, D; Flores, G; Colombo, A; Blanco, C; Contreras, HR; Jana, F; Gallegos, I; Concha, ML; Vergara-Jaque, A; Poblete, H; Gonzalez, W; Varela, D; Trimmer, JS; Caceres, M; Cerda, O				Rivas, Jose; Diaz, Nicolas; Silva, Ian; Morales, Danna; Lavanderos, Boris; Alvarez, Alhejandra; Paz Saldias, Maria; Pulgar, Eduardo; Cruz, Pablo; Maureira, Diego; Flores, Guillermo; Colombo, Alicia; Blanco, Constanza; Contreras, Hector R.; Jana, Fabian; Gallegos, Ivan; Concha, Miguel L.; Vergara-Jaque, Ariela; Poblete, Horacio; Gonzalez, Wendy; Varela, Diego; Trimmer, James S.; Caceres, Monica; Cerda, Oscar			KCTD5, a novel TRPM4-regulatory protein required for cell migration as a new predictor for breast cancer prognosis	FASEB JOURNAL			English	Article						cell migration; KCTD proteins; TRP channels	CATION CHANNEL TRPM4; PROSTATE-CANCER; MICROARRAY ANALYSIS; SURFACE EXPRESSION; IDENTIFICATION; FAMILY; DOMAIN; BIOMARKERS; DOCKING; SIGNAL	Transient receptor potential melastatin 4 (TRPM4) is a Ca2+-activated nonselective cationic channel that regulates cell migration and contractility. Increased TRPM4 expression has been related to pathologies, in which cytoskeletal rearrangement and cell migration are altered, such as metastatic cancer. Here, we identify the K+ channel tetramerization domain 5 (KCTD5) protein, a putative adaptor of cullin3 E3 ubiquitin ligase, as a novel TRPM4-interacting protein. We demonstrate that KCTD5 is a positive regulator of TRPM4 activity by enhancing its Ca2+ sensitivity. We show that through its effects on TRPM4 that KCTD5 promotes cell migration and contractility. Finally, we observed that both TRPM4 and KCTD5 expression are increased in distinct patterns in different classes of breast cancer tumor samples. Together, these data support that TRPM4 activity can be regulated through expression levels of either TRPM4 or KCTD5, not only contributing to increased understanding of the molecular mechanisms involved on the regulation of these important ion channels, but also providing information that could inform treatments based on targeting these distinct molecules that define TRPM4 activity.	[Rivas, Jose; Diaz, Nicolas; Silva, Ian; Lavanderos, Boris; Alvarez, Alhejandra; Paz Saldias, Maria; Cruz, Pablo; Maureira, Diego; Flores, Guillermo; Blanco, Constanza; Caceres, Monica; Cerda, Oscar] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Cellular & Mol Biol, Santiago, Chile; [Rivas, Jose; Diaz, Nicolas; Silva, Ian; Morales, Danna; Lavanderos, Boris; Alvarez, Alhejandra; Paz Saldias, Maria; Cruz, Pablo; Maureira, Diego; Blanco, Constanza; Vergara-Jaque, Ariela; Poblete, Horacio; Gonzalez, Wendy; Varela, Diego; Caceres, Monica; Cerda, Oscar] Millennium Nucleus Ion Channel Associated Dis MiN, Santiago, Chile; [Rivas, Jose; Jana, Fabian] Univ Aysen, Dept Ciencias Salud, Coyhaique, Chile; [Morales, Danna; Varela, Diego] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Physiol & Biophys, Santiago, Chile; [Pulgar, Eduardo; Concha, Miguel L.] Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Anat & Dev Biol, Santiago, Chile; [Colombo, Alicia; Contreras, Hector R.; Gallegos, Ivan] Univ Chile, Fac Med, Dept Oncol Bas Clin, Santiago, Chile; [Colombo, Alicia; Gallegos, Ivan] Univ Chile, Hosp Clin Univ Chile, Dept Anat Patol, Santiago, Chile; [Jana, Fabian; Caceres, Monica; Cerda, Oscar] Wound Repair Treatment & Hlth WoRTH Initiat, Santiago, Chile; [Concha, Miguel L.] Biomed Neurosci Inst, Santiago, Chile; [Concha, Miguel L.] Ctr Gerosci Brain Hlth & Metab, Santiago, Chile; [Concha, Miguel L.] Millennium Nucleus Phys Act Matter, Santiago, Chile; [Vergara-Jaque, Ariela; Poblete, Horacio] Univ Talca, Multidisciplinary Sci Nucleus, Talca, Chile; [Vergara-Jaque, Ariela; Poblete, Horacio; Gonzalez, Wendy] Univ Talca, Fac Engn, Ctr Bioinformat & Mol Simulat CBSM, Talca, Chile; [Trimmer, James S.] Univ Calif Davis, Dept Physiol & Membrane Biol, Sch Med, Davis, CA 95616 USA	Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Chile; Universidad de Talca; Universidad de Talca; University of California System; University of California Davis	Cerda, O (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci ICBM, Program Cellular & Mol Biol, Santiago, Chile.	oscarcerda@uchile.cl	Contreras, Hector/CAE-9087-2022; Poblete, Horacio N/E-4974-2012; Colombo, Alicia/AAD-5178-2021; Jaña, Fabián/D-9364-2017; Poblete, Horacio/J-9781-2012; Concha, Miguel/I-2551-2013	Poblete, Horacio N/0000-0003-2650-3565; Jaña, Fabián/0000-0001-7786-4569; Contreras, Hector/0000-0003-4012-2662; Cerda, Oscar/0000-0003-2873-5722; Cruz, Pablo/0000-0002-1389-2162; Concha, Miguel/0000-0003-3353-9398; Pulgar, Eduardo/0000-0001-9569-062X	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1160518, 11170291, 11170223, 1171155, 1190806, 1160900, 1181263]; Iniciativa Cientifica Milenio	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifica Milenio	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Grant/Award Number: 1160518, 11170291, 11170223, 1171155, 1190806, 1160900 and 1181263; Iniciativa Cientifica Milenio	Albarran L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24452; Alvarez A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00450; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Barbet G, 2008, NAT IMMUNOL, V9, P1148, DOI 10.1038/ni.1648; Bayon Y, 2008, FEBS J, V275, P3900, DOI 10.1111/j.1742-4658.2008.06537.x; Berg KD, 2016, VIRCHOWS ARCH, V468, P345, DOI 10.1007/s00428-015-1880-y; Blanco C, 2019, FASEB J, V33, P9434, DOI 10.1096/fj.201900136R; Brockmann M, 2017, NATURE, V546, P307, DOI 10.1038/nature22376; Caceres M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130540; Cerda O, 2015, PFLUG ARCH EUR J PHY, V467, P1723, DOI 10.1007/s00424-014-1610-3; Cheng H, 2007, CELL CALCIUM, V41, P51, DOI 10.1016/j.ceca.2006.04.032; Colombo A, 2013, DEVELOPMENT, V140, P3997, DOI 10.1242/dev.091934; Corey DR, 2001, GENOME BIOL, V2; Dementieva IS, 2009, J MOL BIOL, V387, P175, DOI 10.1016/j.jmb.2009.01.030; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Duffy MJ, 2017, EUR J CANCER, V75, P284, DOI 10.1016/j.ejca.2017.01.017; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Fotia AB, 2004, J BIOL CHEM, V279, P28930, DOI 10.1074/jbc.M402820200; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Fritzius T, 2017, J NEUROSCI, V37, P1162, DOI 10.1523/JNEUROSCI.2181-16.2016; Garcia-Sanz N, 2007, J NEUROSCI, V27, P11641, DOI 10.1523/JNEUROSCI.2457-07.2007; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; Hasegawa T, 2013, HUM PATHOL, V44, P1271, DOI 10.1016/j.humpath.2012.10.013; Haydaroglu A, 2013, PRINCIPLES PRACTICE; He HB, 2018, FEBS LETT, V592, P2334, DOI 10.1002/1873-3468.13104; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Kim SY, 2017, RADIOLOGY, V284, P354, DOI 10.1148/radiol.2017162348; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519; Kruse M, 2014, CURR OPIN PHARMACOL, V15, P68, DOI 10.1016/j.coph.2013.12.003; Kruse M, 2009, J CLIN INVEST, V119, P2737, DOI 10.1172/JCI38292; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Lehmann BD, 2014, J PATHOL, V232, P142, DOI 10.1002/path.4280; Li LP, 2016, SCI REP-UK, V6, DOI 10.1038/srep20460; Liu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054131; Liu H, 2010, CIRC-CARDIOVASC GENE, V3, P374, DOI 10.1161/CIRCGENETICS.109.930867; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Liu ZP, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-45; Mizoguchi T, 2008, DEVELOPMENT, V135, P2521, DOI 10.1242/dev.020107; Mizuno H, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-18; Narayan G, 2007, GENE CHROMOSOME CANC, V46, P373, DOI 10.1002/gcc.20418; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pfeiffenberger C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003003; Rajalu M, 2015, NEUROPHARMACOLOGY, V88, P145, DOI 10.1016/j.neuropharm.2014.08.020; Rakha EA, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2607; Rohacs T, 2005, NAT NEUROSCI, V8, P626, DOI 10.1038/nn1451; Ross-Adams H, 2015, EBIOMEDICINE, V2, P1133, DOI 10.1016/j.ebiom.2015.07.017; Roulot A, 2016, ANN BIOL CLIN-PARIS, V74, P653, DOI 10.1684/abc.2016.1192; Rutz N, 2015, BIOCHEM BIOPH RES CO, V464, P922, DOI 10.1016/j.bbrc.2015.07.069; Sagredo AI, 2019, J CELL PHYSIOL, V234, P2037, DOI 10.1002/jcp.27371; Sagredo AI, 2018, MOL ONCOL, V12, P151, DOI 10.1002/1878-0261.12100; Sakaguchi T, 2006, DEVELOPMENT, V133, P4063, DOI 10.1242/dev.02581; Schattling B, 2012, NAT MED, V18, P1805, DOI 10.1038/nm.3015; Schinke EN, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-120; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Schwenk J, 2010, NATURE, V465, P231, DOI 10.1038/nature08964; Shimizu T, 2009, CELL CALCIUM, V45, P226, DOI 10.1016/j.ceca.2008.10.005; Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036; Singh J, 2006, CANCER LETT, V237, P298, DOI 10.1016/j.canlet.2005.06.008; Sozucan Y., 2015, Experimental Oncology, V37, P208; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; Stavropoulos N, 2011, NEURON, V72, P964, DOI 10.1016/j.neuron.2011.12.003; Suguro M, 2006, CANCER SCI, V97, P868, DOI 10.1111/j.1349-7006.2006.00267.x; Syam N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00052; Turashvili G, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00227; van Bemmelen MX, 2004, CIRC RES, V95, P284, DOI 10.1161/01.RES.0000136816.05109.89; Wagner SA, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.013284; Wang HJ, 2019, J INVEST DERMATOL, V139, P1089, DOI 10.1016/j.jid.2018.10.044; Weber KS, 2010, J IMMUNOL, V185, P2836, DOI 10.4049/jimmunol.1000880; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Woo SK, 2013, J BIOL CHEM, V288, P36409, DOI 10.1074/jbc.M113.530584; Woo S, 2012, J CELL BIOL, V198, P941, DOI 10.1083/jcb.201203012; Young JA, 2011, J BIOL CHEM, V286, P6521, DOI 10.1074/jbc.M110.172288; Zurek N, 2011, TRAFFIC, V12, P28, DOI 10.1111/j.1600-0854.2010.01134.x	81	20	20	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					7847	7865		10.1096/fj.201901195RRR	http://dx.doi.org/10.1096/fj.201901195RRR		APR 2020	19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301552				2022-12-26	WOS:000526644900001
J	Derakhshani, B; Jafary, H; Zanjani, BM; Hasanpur, K; Mishina, K; Tanaka, T; Kawahara, Y; Oono, Y				Derakhshani, Behnam; Jafary, Hossein; Zanjani, Bahram Maleki; Hasanpur, Karim; Mishina, Kohei; Tanaka, Tsuyoshi; Kawahara, Yoshihiro; Oono, Youko			Combined QTL mapping and RNA-Seq profiling reveals candidate genes associated with cadmium tolerance in barley	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; MOLECULAR CHARACTERIZATION; STRESS-RESPONSE; METAL; PLANTS; WHEAT; BIOSYNTHESIS; ACCUMULATION; CHLOROPHYLL	The high toxicity of cadmium (Cd) and its ready uptake by plants has become a major agricultural problem. To investigate the genetic architecture and genetic regulation of Cd tolerance in barley, we conducted quantitative trait loci (QTL) analysis in the phenotypically polymorphic Oregon Wolfe Barley (OWB) mapping population, derived from a cross between Rec and Dom parental genotypes. Through evaluating the Cd tolerance of 87 available doubled haploid lines of the OWB mapping population at the seedling stage, one minor and one major QTL were detected on chromosomes 2H and 6H, respectively. For chlorosis and necrosis traits, the major QTL explained 47.24% and 38.59% of the phenotypic variance, respectively. RNA-Seq analysis of the parental seedlings under Cd treatment revealed 542 differentially expressed genes between Cd-tolerant Rec and Cd-susceptible Dom genotypes. By analyzing sequence variations in transcribed sequences of the parental genotypes, 155,654 SNPs and 1,525 InDels were identified between the two contrasting genotypes and may contribute to Cd tolerance. Finally, by integrating the data from the identified QTLs and RNA-Seq analysis, 16 Cd tolerance-related candidate genes were detected, nine of which were metal ion transporters. These results provide promising candidate genes for further gene cloning and improving Cd tolerance in barley.	[Derakhshani, Behnam; Zanjani, Bahram Maleki] Univ Zanjan, Dept Agron & Plant Breeding, Fac Agr, Zanjan, Iran; [Derakhshani, Behnam; Oono, Youko] Natl Agr & Food Res Org NARO, Breeding Mat Dev Unit, Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Jafary, Hossein] Agr Res Educ & Extens Org AREEO, Iranian Res Inst Plant Protect, Tehran, Iran; [Hasanpur, Karim] Univ Tabriz, Dept Anim Sci, Fac Agr, Tabriz, Iran; [Mishina, Kohei] NARO, Plant Genome Res Unit, Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Tanaka, Tsuyoshi; Kawahara, Yoshihiro] NARO, Breeding Informat Res Unit, Inst Crop Sci, Tsukuba, Ibaraki, Japan; [Tanaka, Tsuyoshi; Kawahara, Yoshihiro] NARO, Bioinformat Team, Adv Anal Ctr, Tsukuba, Ibaraki, Japan	University Zanjan; National Agriculture & Food Research Organization - Japan; University of Tabriz; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Oono, Y (corresponding author), Natl Agr & Food Res Org NARO, Breeding Mat Dev Unit, Inst Crop Sci, Tsukuba, Ibaraki, Japan.; Jafary, H (corresponding author), Agr Res Educ & Extens Org AREEO, Iranian Res Inst Plant Protect, Tehran, Iran.	h.jafary@areeo.ac.ir; yoono@affrc.go.jp	derakhshani, behnam/AAV-8384-2020	derakhshani, behnam/0000-0002-8171-4093; Tanaka, Tsuyoshi/0000-0003-3740-6832; Jafary, Hossein/0000-0002-2053-6932				Adams ML, 2004, J ENVIRON QUAL, V33, P532, DOI 10.2134/jeq2004.0532; Amirbakhtiar N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213305; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chmielowska-Bak J, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00245; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Costa JM, 2001, THEOR APPL GENET, V103, P415, DOI 10.1007/s001220100622; Das P, 1997, ENVIRON POLLUT, V98, P29, DOI 10.1016/S0269-7491(97)00110-3; Neto JBDA, 2017, J EXP BOT, V68, P687, DOI 10.1093/jxb/erw423; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Hall JL, 2002, J EXP BOT, V53, P1, DOI 10.1093/jexbot/53.366.1; Han MG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061479; Hiraga S, 2001, PLANT CELL PHYSIOL, V42, P462, DOI 10.1093/pcp/pce061; HOAGLAND D. R., 1950, Circular. California Agricultural Experiment Station, V347; Huang X, 2018, MOL BREEDING, V38, DOI 10.1007/s11032-017-0767-9; Jain M, 2014, PLANT BIOTECHNOL J, V12, P253, DOI 10.1111/pbi.12133; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim DY, 2007, PLANT J, V50, P207, DOI 10.1111/j.1365-313X.2007.03044.x; Kobae Y, 2004, PLANT CELL PHYSIOL, V45, P1749, DOI 10.1093/pcp/pci015; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee M, 2005, PLANT PHYSIOL, V138, P827, DOI 10.1104/pp.104.058107; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marino R, 2009, MOL GENET GENOMICS, V281, P163, DOI 10.1007/s00438-008-0401-y; Milla MAR, 2003, PLANT J, V36, P602, DOI 10.1046/j.1365-313X.2003.01901.x; Mithofer A, 2004, FEBS LETT, V566, P1, DOI 10.1016/j.febslet.2004.04.011; Moustafa K, 2008, SYREXE BIOL, V2008, DOI [10.3814/2008/143656, DOI 10.3814/2008/143656]; Navakode S, 2009, CEREAL RES COMMUN, V37, P531, DOI 10.1556/CRC.37.2009.4.6; Neto JB, 2016, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01260; Oono Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096946; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Reid RJ, 2009, PLANT SIGNAL BEHAV, V4, P1091, DOI 10.4161/psb.4.11.9798; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Schmidt F, 2010, MOL BIOL REP, V37, P839, DOI 10.1007/s11033-009-9636-x; Shukla UC, 2003, BIOL TRACE ELEM RES, V92, P257, DOI 10.1385/BTER:92:3:257; SIEDLECKA A, 1993, PHYSIOL PLANTARUM, V87, P199, DOI 10.1111/j.1399-3054.1993.tb00142.x; Smeets K, 2009, J PLANT PHYSIOL, V166, P1982, DOI 10.1016/j.jplph.2009.06.014; STOBART AK, 1985, PHYSIOL PLANTARUM, V63, P293, DOI 10.1111/j.1399-3054.1985.tb04268.x; Ueno D, 2011, J EXP BOT, V62, P2265, DOI 10.1093/jxb/erq383; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Vassilev Andon, 1997, Bulgarian Journal of Plant Physiology, V23, P114; Wang MY, 2010, PLANT MOL BIOL, V73, P467, DOI 10.1007/s11103-010-9633-4; Wang S., 2007, WINDOWS QTL CARTOGRA; Wang SS, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01427; Wang XK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071732; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Weidner A, 2006, QTLS SALT TOLERANCE; Welch RM, 1999, PLANT SOIL, V208, P243, DOI 10.1023/A:1004598228978; Witzel K, 2010, PLANT CELL ENVIRON, V33, P211, DOI 10.1111/j.1365-3040.2009.02071.x; Wolfe R. I., 1990, Barley Genetics Newsletter, V20, P117; Wu DZ, 2015, NEW PHYTOL, V208, P817, DOI 10.1111/nph.13512; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xiong HC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03024-0; Yuan LY, 2012, PLANT CELL REP, V31, P67, DOI 10.1007/s00299-011-1140-9; Zeng XQ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2685-3; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhou ZQ, 2018, J GEOCHEM EXPLOR, V192, P72, DOI 10.1016/j.gexplo.2018.06.003	59	14	14	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230820	10.1371/journal.pone.0230820	http://dx.doi.org/10.1371/journal.pone.0230820			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298285	gold, Green Published			2022-12-26	WOS:000536011400022
J	Polsky, S; Garcetti, R; Pyle, L; Joshee, P; Demmitt, JK; Snell-Bergeon, JK				Polsky, Sarit; Garcetti, Rachel; Pyle, Laura; Joshee, Prakriti; Demmitt, Jamie K.; Snell-Bergeon, Janet K.			Continuous glucose monitor use with and without remote monitoring in pregnant women with type 1 diabetes: A pilot study	PLOS ONE			English	Article							VALIDATION; MELLITUS; OUTCOMES; CARE	Background To examine whether continuous glucose monitoring (CGM) with remote monitoring by followers (family/friends) changes glucose management, follower interventions, and health outcomes compared to CGM alone in pregnant women with diabetes. Methods We prospectively stratified first trimester pregnant women with Type 1 Diabetes to CGM Share (remote monitoring) or CGM Alone. We enrolled a main follower per woman. We retrospectively acquired data for pregnant women who did not use CGM (no CGM). We compared hemoglobin A1c (HbA1c) between groups. We compared sensor glucose, follower interventions, and gestational outcomes between CGM Alone and CGM Share. Longitudinal mixed effects models were used for analyses of changes in outcomes over time. Results HbA1c decreased in all groups throughout pregnancy and was significantly lower over time in women using CGM Share (n = 15) compared to CGM Alone (n = 13) or no CGM (n = 8) (p = 0.0042). CGM Share users had lower median sensor glucose levels (p = 0.0331) and percent time spent > 180 mg/dL (p = 0.0228) across pregnancy. There were no significant differences in maternal and fetal outcomes between groups. CGM Share followers had more alerts for hypoglycemia, but did fewer interventions. Conclusions In this small pilot study, use of CGM with remote monitoring improved some glycemic metrics in pregnant women with diabetes.	[Polsky, Sarit; Garcetti, Rachel; Joshee, Prakriti; Demmitt, Jamie K.; Snell-Bergeon, Janet K.] Univ Colorado Anschutz Med Campus, Barbara Davis Ctr, Aurora, CO 80045 USA; [Pyle, Laura] Univ Colorado Anschutz Med Campus, Dept Pediat, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Polsky, S (corresponding author), Univ Colorado Anschutz Med Campus, Barbara Davis Ctr, Aurora, CO 80045 USA.	Sarit.Polsky@cuanschutz.edu	Polsky, Sarit/AAT-3067-2020	Polsky, Sarit/0000-0002-7602-0396; Snell-Bergeon, Janet/0000-0002-9337-3740	Dexcom, Inc. through the Board of Regents at the University of Colorado Denver; NIH/NCRR Colorado CTSI Grant [UL1 RR025780]	Dexcom, Inc. through the Board of Regents at the University of Colorado Denver; NIH/NCRR Colorado CTSI Grant	This was an investigator-initiated study in part supported by Dexcom, Inc. through the Board of Regents at the University of Colorado Denver. Dexcom, Inc is the manufacturer of the continuous glucose monitoring device and the Share software assessed here. This study was supported by NIH/NCRR Colorado CTSI Grant Number UL1 RR025780. Its contents are the authors' sole responsibility and do not necessarily represent Dexcom, Inc. or official NIH views. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funders suggested including in the study design use of CGM Share, which we opted to include as a separate study arm.	Battelino T, 2019, DIABETES CARE; Cordua S, 2013, DIABETIC MED, V30, P1374, DOI 10.1111/dme.12246; COX DJ, 1987, DIABETES CARE, V10, P617, DOI 10.2337/diacare.10.5.617; DeSalvo DJ, 2014, DIABETES TECHNOL THE, V16, P1, DOI 10.1089/dia.2013.0139; El-Laboudi AH, 2016, DIABETES TECHNOL THE, V18, P806, DOI 10.1089/dia.2016.0146; Feig DS, 2017, LANCET; Gardosi J, 2018, AM J OBSTET GYNECOL, V218, pS609, DOI 10.1016/j.ajog.2017.12.011; Garg SK, 2017, LANCET; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hirst Jane E, 2015, J Diabetes Sci Technol, V9, P111, DOI 10.1177/1932296814556506; Homko CJ, 2007, DIABETES TECHNOL THE, V9, P297, DOI 10.1089/dia.2006.0034; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Kitzmiller JL, 2008, DIABETES CARE, V31, P1060, DOI 10.2337/dc08-9020; Litchman ML, 2018, DIABETES TECHNOL THE, V20, P25, DOI 10.1089/dia.2017.0285; Murphy HR, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1680; Pearson DWM, 2007, BJOG-INT J OBSTET GY, V114, P104, DOI 10.1111/j.1471-0528.2006.01145.x; Perez-Ferre N, 2010, INT J ENDOCRINOL, V2010, DOI 10.1155/2010/386941; Petrovski G, 2011, DIABETES TECHNOL THE, V13, P1109, DOI 10.1089/dia.2011.0081; Polsky S, 2019, J DIABETES SCI TECHN; Polsky S, 2017, DIABETES TECHNOL THE, V19, pS49, DOI 10.1089/dia.2017.0023; Ray JG, 2001, QJM-INT J MED, V94, P435, DOI 10.1093/qjmed/94.8.435; Rodbard D, 2017, DIABETES TECHNOL THE, V19, pS25, DOI 10.1089/dia.2017.0035; */* S  99, 2016, DIABETES CARE S1, V39, pS9, DOI DOI 10.2337/DC16-S016; Wahabi HA, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-63; Wojcicki J M, 2001, Diabetes Technol Ther, V3, P581, DOI 10.1089/15209150152811207; Yu F, 2014, J CLIN ENDOCR METAB, V99, P4674, DOI 10.1210/jc.2013-4332	26	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0230476	10.1371/journal.pone.0230476	http://dx.doi.org/10.1371/journal.pone.0230476			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298269	Green Published, gold, Green Submitted			2022-12-26	WOS:000536011400016
J	Andriantsoa, R; Jones, JPG; Achimescu, V; Randrianarison, H; Raselimanana, M; Andriatsitohaina, M; Rasamy, J; Lyko, F				Andriantsoa, Ranja; Jones, Julia P. G.; Achimescu, Vlad; Randrianarison, Heriniaina; Raselimanana, Miary; Andriatsitohaina, Manjary; Rasamy, Jeanne; Lyko, Frank			Perceived socio-economic impacts of the marbled crayfish invasion in Madagascar	PLOS ONE			English	Article							PROCAMBARUS-FALLAX HAGEN; DECAPODA; CAMBARIDAE; PLANTS; PARASTACIDAE; MARMORKREBS; ECOLOGY; CLARKII; RISE	The negative environmental and economic impacts of many invasive species are well known. However, given the increased homogenization of global biota, and the difficulty of eradicating species once established, a balanced approach to considering the impacts of invasive species is needed. The marbled crayfish (Procambarus virginalis) is a parthenogenetic freshwater crayfish that was first observed in Madagascar around 2005 and has spread rapidly. We present the results of a socio-economic survey (n = 385) in three regions of Madagascar that vary in terms of when the marbled crayfish first arrived. Respondents generally considered marbled crayfish to have a negative impact on rice agriculture and fishing, however the animals were seen as making a positive contribution to household economy and food security. Regression modeling showed that respondents in regions with longer experience of marbled crayfish have more positive perceptions. Unsurprisingly, considering the perception that crayfish negatively impact rice agriculture, those not involved in crayfish harvesting and trading had more negative views towards the crayfish than those involved in crayfish-related activities. Food preference ranking and market surveys revealed the acceptance of marbled crayfish as a cheap source of animal protein; a clear positive in a country with widespread malnutrition. While data on biodiversity impacts of the marbled crayfish invasion in Madagascar are still completely lacking, this study provides insight into the socio-economic impacts of the dramatic spread of this unique invasive species. "Biby kely tsy fantampiaviana, mahavelona fianakaviana" (a small animal coming from who knows where which supports the needs of the family). Government worker Analamanga, Madagascar.	[Andriantsoa, Ranja; Lyko, Frank] DKFZ ZMBH Alliance German Canc Res Ctr DKFZ, Div Epigenet, Heidelberg, Germany; [Jones, Julia P. G.] Bangor Univ, Sch Nat Sci, Bangor, Gwynedd, Wales; [Achimescu, Vlad] Mannheim Univ, Sch Social Sci, Mannheim, Germany; [Randrianarison, Heriniaina; Raselimanana, Miary; Andriatsitohaina, Manjary; Rasamy, Jeanne] Univ Antananarivo, Ment Zool & Biodiversite Anim, Antananarivo, Madagascar	Bangor University; University of Mannheim; University Antananarivo	Lyko, F (corresponding author), DKFZ ZMBH Alliance German Canc Res Ctr DKFZ, Div Epigenet, Heidelberg, Germany.	f.lyko@dkfz.de	RASELIMANANA, Miary/AAX-2972-2020; Jones, Julia P G/ABD-5629-2021	RASELIMANANA, Miary/0000-0002-2312-2516; Jones, Julia P G/0000-0002-5199-3335; Lyko, Frank/0000-0002-4873-5431				Anastacio PM, 2005, INT VER THEOR ANGEW, V29, P849; Anastacio PM, 1997, FRESHWATER CRAYFISH 11: A JOURNAL OF ASTACOLOGY, P608; Andriamanoro T., 2018, LEXPRESS MADAGASCAR; Andriantsoa R, 2019, BMC ECOL, V19, DOI 10.1186/s12898-019-0224-1; [Anonymous], 2007, MIDI MADAGASIKARA; Bellard C, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2454; Benstead JP, 2009, SCI YORK, V53, P1101; Bobeldyk AM, 2008, J GREAT LAKES RES, V34, P265, DOI 10.3394/0380-1330(2008)34[265:ADAIET]2.0.CO;2; Bonanno G, 2016, ENVIRON SCI POLICY, V59, P67, DOI 10.1016/j.envsci.2016.02.011; Boyko CB, 2005, ZOOTAXA, P41, DOI 10.11646/zootaxa.1091.1.3; Carroll SP, 2011, EVOL APPL, V4, P184, DOI 10.1111/j.1752-4571.2010.00180.x; Clavero M, 2005, TRENDS ECOL EVOL, V20, P110, DOI 10.1016/j.tree.2005.01.003; Deidun A, 2018, J CRUSTACEAN BIOL, V38, P748, DOI 10.1093/jcbiol/ruy076; FAO, 2005, MAD LIV SECT BRIEF, P20; FAO, 2009, CULT AQ FACT SHEETS; Feria TP, 2011, AQUAT INVASIONS, V6, P55, DOI 10.3391/ai.2011.6.1.07; Ferrari PA, 2011, COMPUT STAT DATA AN, V55, P2410, DOI 10.1016/j.csda.2011.02.007; Giuseppe M, 2018, ETHOL ECOL EVOL; Gutekunst J, 2018, NAT ECOL EVOL, V2, P567, DOI 10.1038/s41559-018-0467-9; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; HOFFMANN BD, 2016, NEOBIOTA, P1, DOI DOI 10.3897/NE0BI0TA.31.6960; Hulme PE, 2015, J APPL ECOL, V52, P1418, DOI 10.1111/1365-2664.12470; Jenkins RKB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027570; Jernelov A, 2017, LONG-TERM FATE OF INVASIVE SPECIES: ALIENS FOREVER OR INTEGRATED IMMIGRANTS WITH TIME?, P91, DOI 10.1007/978-3-319-55396-2_7; Jones JPG, 2007, FRESHWATER BIOL, V52, P1820, DOI 10.1111/j.1365-2427.2007.01766.x; Jones JPG, 2009, BIOL INVASIONS, V11, P1475, DOI 10.1007/s10530-008-9334-y; Kawai T, 2009, J CRUSTACEAN BIOL, V29, P562, DOI 10.1651/08-3125.1; Kurien J, 2013, SMART FISH PUBL, V173; Lewis SL, 2015, NATURE, V519, P171, DOI 10.1038/nature14258; Liptak B, 2016, J LIMNOL, V75, P305, DOI 10.4081/jlimnol.2016.1313; Lokkos A, 2016, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2016003; Lyko F, 2017, ZOOTAXA, V4363, P544, DOI 10.11646/zootaxa.4363.4.6; Martin P, 2010, CONTRIB ZOOL, V79, P107, DOI 10.1163/18759866-07903003; McNeely JA, 2001, GLOBAL STRATEGY INVA; Mkoji GM, 1999, AM J TROP MED HYG, V61, P751; Ngorima A, 2019, J ENVIRON MANAGE, V229, P158, DOI 10.1016/j.jenvman.2018.05.077; Parvulescu L, 2017, BIOINVASIONS REC, V6, P357, DOI 10.3391/bir.2017.6.4.09; Patoka J, 2016, BIOLOGIA, V71, P1380, DOI 10.1515/biolog-2016-0164; Patti, 2012, ZAVA MISY MIRONGATRA; Pienkowski T, 2015, ECOL ECON, V112, P68, DOI 10.1016/j.ecolecon.2015.02.012; Pysek P, 2010, ANNU REV ENV RESOUR, V35, P25, DOI 10.1146/annurev-environ-033009-095548; Rogers P, 2017, PASTORALISM, V7, DOI 10.1186/s13570-017-0094-0; Russell JC, 2017, TRENDS ECOL EVOL, V32, P3, DOI 10.1016/j.tree.2016.10.012; Scholtz G, 2003, NATURE, V421, P806, DOI 10.1038/421806a; Seeney A, 2019, BIOL INVASIONS, V21, P1933, DOI 10.1007/s10530-019-01947-5; Semba RD, 2016, ANN NUTR METAB, V69, P79, DOI 10.1159/000449175; Shackleton RT, 2019, J ENVIRON MANAGE, V229, P145, DOI 10.1016/j.jenvman.2018.05.007; Stoebenau Kirsten, 2011, Global Health, V7, P34, DOI 10.1186/1744-8603-7-34; Tabak MA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1844; Wang Q, 2018, 2018 26TH INTERNATIONAL CONFERENCE ON SOFTWARE, TELECOMMUNICATIONS AND COMPUTER NETWORKS (SOFTCOM), P367; World Bank, 2016, MACR POV OUTL; World Bank, 2019, MAD COUNTR OV	52	12	12	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231773	10.1371/journal.pone.0231773	http://dx.doi.org/10.1371/journal.pone.0231773			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294134	Green Published, gold			2022-12-26	WOS:000536003500055
J	Witt, RG; Blair, L; Frascoli, M; Rosen, MJ; Nguyen, QH; Bercovici, S; Zompi, S; Romero, R; Mackenzie, TC				Witt, Russell G.; Blair, Lily; Frascoli, Michela; Rosen, Michael J.; Quoc-Hung Nguyen; Bercovici, Sivan; Zompi, Simone; Romero, Roberto; Mackenzie, Tippi C.			Detection of microbial cell-free DNA in maternal and umbilical cord plasma in patients with chorioamnionitis using next generation sequencing	PLOS ONE			English	Article							PRETERM PRELABOR RUPTURE; FETAL DNA; AMNIOTIC-FLUID; INFECTION; AMNIOCENTESIS; MECHANISMS; MUTATIONS; LENGTH	Background Chorioamnionitis has been linked to spontaneous preterm labor and complications such as neonatal sepsis. We hypothesized that microbial cell-free (cf) DNA would be detectable in maternal plasma in patients with chorioamnionitis and could be the basis for a non-invasive method to detect fetal exposure to microorganisms. Objective The purpose of this study was to determine whether next generation sequencing could detect microbial cfDNA in maternal plasma in patients with chorioamnionitis. Study design Maternal plasma (n = 94) and umbilical cord plasma (n = 120) were collected during delivery at gestational age 28-41 weeks. cfDNA was extracted and sequenced. Umbilical cord plasma samples with evidence of contamination were excluded. The prevalence of microorganisms previously implicated in choriomanionitis, neonatal sepsis and intra-amniotic infections, as described in the literature, were examined to determine if there was enrichment of these microorganisms in this cohort. Specific microbial cfDNA associated with chorioamnionitis was first detected in umbilical cord plasma and confirmed in the matched maternal plasma samples (n = 77 matched pairs) among 14 cases of histologically confirmed chorioamnionitis and one case of clinical chorioamnionitis; 63 paired samples were used as controls. A correlation of rank of a given microorganism across maternal plasma and matched umbilical cord plasma was used to assess whether signals found in umbilical cord plasma were also present in maternal plasma. Results Microbial DNA sequences associated with clinical and/or histological chorioamnionitis were enriched in maternal plasma in cases with suspected chorioamnionitis when compared to controls (12/14 microorganisms, p = 0.02). Analysis of the microbial cfDNA in umbilical cord plasma among the 1,251 microorganisms detectable with this assay identified Streptococcus mitis, Ureaplasma spp., and Mycoplasma spp. in cases of suspected chorioamnionitis. This assay also detected cfDNA from Lactobacillus spp. in controls. Comparison between maternal plasma and umbilical cord plasma confirmed these signatures were also present in maternal plasma. Unbiased analysis of microorganisms with significantly correlated signal between matched maternal plasma and umbilical cord plasma identified the above listed 3 microorganisms, all of which have previously been implicated in patients with chorioamnionitis (Mycoplasma hominis p = 0.0001; Ureaplasma parvum p = 0.002; Streptococcus mitis p = 0.007). These data show that the pathogen signal relevant for chorioamnionitis can be identified in both maternal and umbilical cord plasma. Conclusion This is the first report showing the detection of relevant microbial cell-free cfDNA in maternal plasma and umbilical cord plasma in patients with clinical and/or histological chorioamnionitis. These results may lead to the development of a specific assay to detect perinatal infections for targeted therapy to reduce early neonatal sepsis complications.	[Witt, Russell G.; Frascoli, Michela; Quoc-Hung Nguyen; Mackenzie, Tippi C.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med, San Francisco, CA 94143 USA; [Witt, Russell G.; Frascoli, Michela; Quoc-Hung Nguyen; Mackenzie, Tippi C.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Blair, Lily; Rosen, Michael J.; Bercovici, Sivan; Zompi, Simone] Karius Inc, Redwood City, CA USA; [Rosen, Michael J.] D2G Oncol Inc, Mountain View, CA USA; [Zompi, Simone] Univ Calif San Francisco, Sch Med, Dept Expt Med, San Francisco, CA USA; [Romero, Roberto] Wayne State Univ, Detroit, MI USA; [Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Romero, Roberto] NICHHD, Perinatol Res Branch, NIH, Dept Hlth & Human Serv, Detroit, MI USA; [Mackenzie, Tippi C.] Univ Calif San Francisco, Ctr Maternal Fetal Precis Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of California System; University of California San Francisco	Mackenzie, TC (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med, San Francisco, CA 94143 USA.; Mackenzie, TC (corresponding author), Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA.; Mackenzie, TC (corresponding author), Univ Calif San Francisco, Ctr Maternal Fetal Precis Med, San Francisco, CA 94143 USA.	Tippi.Mackenzie@ucsf.edu	; Romero, Roberto/A-5268-2019	Witt, Russell/0000-0003-3747-8633; Romero, Roberto/0000-0002-4448-5121	NIH [R01AI116880-05]; Burroughs Wellcome Fund	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We have the following interests: The study was funded by NIH R01AI116880-05 and Burroughs Wellcome Fund grants to TCM. LB, MJR, SB and SZ are or were employees of Karius, Inc. Karius Inc. provided support in the form of salaries for authors LB, MJR, SB and SZ, and their next generation sequencing process was performed to generate the microbial profiles, but the company did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. MJR is employed by D2G Oncology. D2G Oncology provided support in the form of salary for author MJR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the `author contributions' section.	Blauwkamp TA, 2019, NAT MICROBIOL, V4, P663, DOI 10.1038/s41564-018-0349-6; De Vlaminck I, 2015, P NATL ACAD SCI USA, V112, P13336, DOI 10.1073/pnas.1517494112; Devaney SA, 2011, JAMA-J AM MED ASSOC, V306, P627, DOI 10.1001/jama.2011.1114; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Farnaes L, 2019, DIAGNOSTIC MICROBIOL; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Hamoda H, 2002, PRENATAL DIAG, V22, P783, DOI 10.1002/pd.409; Hong DK, 2018, DIAGN MICR INFEC DIS, V92, P210, DOI 10.1016/j.diagmicrobio.2018.06.009; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P423, DOI 10.1034/j.1600-0412.2003.00157.x; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kiser C, 2014, PEDIATRICS, V133, P992, DOI 10.1542/peds.2013-2927; Leung TN, 1998, LANCET, V352, P1904, DOI 10.1016/S0140-6736(05)60395-9; Li Y, 2005, JAMA-J AM MED ASSOC, V293, P843, DOI 10.1001/jama.293.7.843; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Mark SP, 2000, OBSTET GYNECOL, V95, P909, DOI 10.1016/S0029-7844(00)00816-4; Mendz GL, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00058; Mukherjee A, 2015, ARCH DIS CHILD-FETAL, V100, pF248, DOI 10.1136/archdischild-2014-306349; Ogilvie C, 2014, J CLIN MED, V3, P741, DOI 10.3390/jcm3030741; Oh KJ, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.02.035; Pantel K, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002205; Pappas A, 2014, JAMA PEDIATR, V168, P137, DOI 10.1001/jamapediatrics.2013.4248; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1382, DOI 10.1016/0002-9378(92)91609-E; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1343, DOI 10.3109/14767058.2014.954243; Romero R, 2015, J PERINAT MED, V43, P19, DOI 10.1515/jpm-2014-0249; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Rouse DJ, 2004, AM J OBSTET GYNECOL, V191, P211, DOI 10.1016/j.ajog.2004.03.003; Schwaederle M, 2016, ONCOTARGET, V7, P9707, DOI 10.18632/oncotarget.7110; Sung JH, 2017, BJOG-INT J OBSTET GY, V124, P775, DOI 10.1111/1471-0528.14176; Sweeney EL, 2017, CLIN MICROBIOL REV, V30, P349, DOI 10.1128/CMR.00091-16; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; Urushiyama D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11699-8; Vander Haar EL, 2018, ANAEROBE, DOI [10.1038/s41598-017-11699-8, DOI 10.1038/S41598-017-11699-8]; Wagner J, 2012, BIOCHEM MEDICA, V22, P24; WALLMARK G, 1978, J INFECT DIS, V138, P791, DOI 10.1093/infdis/138.6.791; Zhong XY, 2000, PRENATAL DIAG, V20, P795	40	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231239	10.1371/journal.pone.0231239	http://dx.doi.org/10.1371/journal.pone.0231239			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294121	Green Published, gold			2022-12-26	WOS:000536003500023
J	Harbig, A; Mernberger, M; Bittel, L; Pleschka, S; Schughart, K; Steinmetzer, T; Stiewe, T; Nist, A; Bottcher-Friebertshauser, E				Harbig, Anne; Mernberger, Marco; Bittel, Linda; Pleschka, Stephan; Schughart, Klaus; Steinmetzer, Torsten; Stiewe, Thorsten; Nist, Andrea; Boettcher-Friebertshaeuser, Eva			Transcriptome profiling and protease inhibition experiments identify proteases that activate H3N2 influenza A and influenza B viruses in murine airways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						infectious disease; serine protease; trypsin; virus; mouse; airway proteases; hemagglutinin; influenza virus; cleavage; protease gene expression; TMPRSS2; TMPRSS4; hepsin; prostasin; trypsin-like protease; host-pathogen interactions; mouse lung proteases	TRANSMEMBRANE SERINE-PROTEASE; PROTEOLYTIC ACTIVATION; CLEAVAGE ACTIVATION; HEMAGGLUTININ; TMPRSS2; MATRIPTASE; HAT; IDENTIFICATION; PATHOGENICITY; REPLICATION	Cleavage of influenza virus hemagglutinin (HA) by host proteases is essential for virus infectivity. HA of most influenza A and B (IAV/IBV) viruses is cleaved at a monobasic motif by trypsin-like proteases. Previous studies have reported that transmembrane serine protease 2 (TMPRSS2) is essential for activation of H7N9 and H1N1pdm IAV in mice but that H3N2 IAV and IBV activation is independent of TMPRSS2 and carried out by as-yet-undetermined protease(s). Here, to identify additional H3 IAV- and IBV-activating proteases, we used RNA-Seq to investigate the protease repertoire of murine lower airway tissues, primary type II alveolar epithelial cells (AECIIs), and the mouse lung cell line MLE-15. Among 13 candidates identified, TMPRSS4, TMPRSS13, hepsin, and prostasin activated H3 and IBV HAin vitro. IBV activation and replication was reduced in AECIIs fromTmprss2/Tmprss4-deficient mice compared with WT or Tmprss2-deficient mice, indicating that murine TMPRSS4 is involved in IBV activation. Multicycle replication of H3N2 IAV and IBV in AECIIs ofTmprss2/Tmprss4-deficient mice varied in sensitivity to protease inhibitors, indicating that different, but overlapping, sets of murine proteases facilitate H3 and IBV HA cleavages. Interestingly, human hepsin and prostasin orthologs did not activate H3, but they did activate IBV HAin vitro. Our results indicate that TMPRSS4 is an IBV-activating protease in murine AECIIs and suggest that TMPRSS13, hepsin, and prostasin cleave H3 and IBV HA in mice. They further show that hepsin and prostasin orthologs might contribute to the differences observed in TMPRSS2-independent activation of H3 in murine and human airways.	[Harbig, Anne; Bittel, Linda; Boettcher-Friebertshaeuser, Eva] Philipps Univ, Inst Virol, D-35043 Marburg, Germany; [Mernberger, Marco; Stiewe, Thorsten] Philipps Univ, Inst Mol Oncol, German Ctr Lung Res, D-35043 Marburg, Germany; [Steinmetzer, Torsten] Philipps Univ, Inst Pharmaceut Chem, D-35043 Marburg, Germany; [Stiewe, Thorsten; Nist, Andrea] Philipps Univ, Genom Core Facil, D-35043 Marburg, Germany; [Pleschka, Stephan] Justus Liebig Univ, Inst Med Virol, D-35390 Giessen, Germany; [Schughart, Klaus] Helmholtz Ctr Infect Res, Dept Infect Genet, D-38124 Braunschweig, Germany; [Schughart, Klaus] Univ Vet Med Hannover, D-30559 Hannover, Germany; [Schughart, Klaus] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN 38163 USA	Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Center for Infection Research; University of Veterinary Medicine Hannover, Foundation; University of Tennessee System; University of Tennessee Health Science Center	Bottcher-Friebertshauser, E (corresponding author), Philipps Univ Marburg, Inst Virol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	friebertshaeuser@staff.uni-marburg.de	Pleschka, Stephan/HGU-9354-2022; Böttcher-Friebertshäuser, Eva/D-6266-2012	Stiewe, Thorsten/0000-0003-0134-7826; Pleschka, Stephan/0000-0002-7372-7089	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the collaborative research center [SFB 1021]; Von-Behring Rontgen Stiftung; LOEWE Center DRUID; Helmholtz-Association (Program Infection and Immunity); German Ministry for Education and Research (BMBF)	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the collaborative research center(German Research Foundation (DFG)); Von-Behring Rontgen Stiftung; LOEWE Center DRUID; Helmholtz-Association (Program Infection and Immunity)(Helmholtz Association); German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through the collaborative research center SFB 1021 (to E. B.-F. and S. P.), by the Von-Behring Rontgen Stiftung (to E. B.-F.), by the LOEWE Center DRUID (to E. B.-F. and T. S.), by intramural grants from the Helmholtz-Association (Program Infection and Immunity) (to K. S.), and by the German Ministry for Education and Research (BMBF)funded German Center for Infectious Diseases (DZIF) partner site Giessen (to S. P.). The authors declare that they have no conflicts of interest with the contents of this article.	Andreasen D, 2006, J AM SOC NEPHROL, V17, P968, DOI 10.1681/ASN.2005060637; Baron J, 2013, J VIROL, V87, P1811, DOI 10.1128/JVI.02320-12; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Beaulieu A, 2013, J VIROL, V87, P4237, DOI 10.1128/JVI.03005-12; Bottcher E, 2009, VACCINE, V27, P6324, DOI 10.1016/j.vaccine.2009.03.029; Bottcher-Friebertshauser E, 2014, CURR TOP MICROBIOL, V385, P3, DOI 10.1007/82_2014_384; Bottcher-Friebertshauser E, 2012, VACCINE, V30, P7374, DOI 10.1016/j.vaccine.2012.10.001; Bottcher-Friebertshauser E, 2010, J VIROL, V84, P5605, DOI 10.1128/JVI.00140-10; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Bottcher-Friebertshauser E., 2018, ACTIVATION VIRUSES H, P153; Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; Guenet JL, 2005, GENOME RES, V15, P1729, DOI 10.1101/gr.3728305; Guipponi M, 2007, AM J PATHOL, V171, P608, DOI 10.2353/ajpath.2007.070068; Hamilton BS, 2013, J BIOL CHEM, V288, P17399, DOI 10.1074/jbc.M112.440362; Hamilton BS, 2012, J VIROL, V86, P10579, DOI 10.1128/JVI.00306-12; Hammami M, 2012, MEDCHEMCOMM, V3, P807, DOI 10.1039/c2md20074k; Hatesuer B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003774; Keppner A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135224; Kido Hiroshi, 2008, J Mol Genet Med, V3, P167; Kim TS, 2006, MOL CELL BIOL, V26, P965, DOI 10.1128/MCB.26.3.965-975.2006; Koutsakos M, 2016, FUTURE MICROBIOL, V11, P119, DOI 10.2217/fmb.15.120; Kuhn N, 2016, J VIROL, V90, P4298, DOI 10.1128/JVI.02693-15; Lambertz RLO, 2019, J GEN VIROL, V100, P1073, DOI 10.1099/jgv.0.001274; Laporte M, 2020, J VIROL, V94, DOI 10.1128/JVI.01430-19; Leu CH, 2015, ANTIMICROB AGENTS CH, V59, P5619, DOI 10.1128/AAC.00065-15; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Limburg H, 2019, J VIROL, V93, DOI 10.1128/JVI.00649-19; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu YH, 2015, ANTIVIR RES, V120, P89, DOI 10.1016/j.antiviral.2015.05.006; Madsen DH, 2014, BIOCHEM J, V461, P487, DOI 10.1042/BJ20140337; Magnen M, 2018, BIOL CHEM, V399, P1053, DOI 10.1515/hsz-2017-0340; Massucci MT, 2004, BIOMETALS, V17, P249, DOI 10.1023/B:BIOM.0000027700.90780.45; Meyer D, 2013, BIOCHEM J, V452, P331, DOI 10.1042/BJ20130101; Netzel-Arnett S, 2006, J BIOL CHEM, V281, P32941, DOI 10.1074/jbc.C600208200; OVCHARENKO AV, 1994, ANTIVIR RES, V23, P107, DOI 10.1016/0166-3542(94)90038-8; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Peters DE, 2014, J BIOL CHEM, V289, P14740, DOI 10.1074/jbc.M113.541318; Rawlings ND, 2018, NUCLEIC ACIDS RES, V46, pD624, DOI 10.1093/nar/gkx1134; Sakai K, 2016, SCI REP-UK, V6, DOI 10.1038/srep29430; Sakai K, 2014, J VIROL, V88, P5608, DOI 10.1128/JVI.03677-13; SCHEIBLAUER H, 1992, J INFECT DIS, V166, P783, DOI 10.1093/infdis/166.4.783; Sisay MT, 2010, J MED CHEM, V53, P5523, DOI 10.1021/jm100183e; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Steinhauer DA, 1999, VIROLOGY, V258, P1, DOI 10.1006/viro.1999.9716; Szabo R, 2008, INT J BIOCHEM CELL B, V40, P1297, DOI 10.1016/j.biocel.2007.11.013; Szabo R, 2016, DEVELOPMENT, V143, P2818, DOI 10.1242/dev.137968; Tanabe LM, 2017, FEBS J, V284, P1421, DOI 10.1111/febs.13971; Tarnow C, 2014, J VIROL, V88, P4744, DOI 10.1128/JVI.03799-13; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Wong GW, 2001, J BIOL CHEM, V276, P49169, DOI 10.1074/jbc.M108677200; Yoon SW, 2014, CURR TOP MICROBIOL, V385, P359, DOI 10.1007/82_2014_396; Zhirnov OP, 2011, ANTIVIR RES, V92, P27, DOI 10.1016/j.antiviral.2011.07.014; Zmora P, 2014, J VIROL, V88, P12087, DOI 10.1128/JVI.01427-14	55	13	15	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2020	295	33					11388	11407		10.1074/jbc.RA120.012635	http://dx.doi.org/10.1074/jbc.RA120.012635			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	NG3YV	32303635	Green Published, hybrid			2022-12-26	WOS:000563922500002
J	Shi, D; Zhao, SJ; Zuo, MQ; Zhang, JJ; Hou, WY; Dong, MQ; Cao, QH; Lou, HQ				Shi, Di; Zhao, Shuaijun; Zuo, Mei-Qing; Zhang, Jingjing; Hou, Wenya; Dong, Meng-Qiu; Cao, Qinhong; Lou, Huiqiang			The acetyltransferase Eco1 elicits cohesin dimerization during S phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; acetylation; DNA replication; dimerization; acetyltransferase; chromatid cohesion; cohesin; double ring model; Eco1; self-interaction; protein acetylation	SISTER-CHROMATID COHESION; CHROMOSOME STRUCTURE; DNA-REPLICATION; ESTABLISHMENT; COMPLEX; PROTEINS; ACETYLATION; DEPENDS; ROLES; ARMS	Cohesin is a DNA-associated protein complex that forms a tripartite ring controlling sister chromatid cohesion, chromosome segregation and organization, DNA replication, and gene expression. Sister chromatid cohesion is established by the protein acetyltransferase Eco1, which acetylates two conserved lysine residues on the cohesin subunit Smc3 and thereby ensures correct chromatid separation in yeast (Saccharomyces cerevisiae) and other eukaryotes. However, the consequence of Eco1-catalyzed cohesin acetylation is unknown, and the exact nature of the cohesive state of chromatids remains controversial. Here, we show that self-interactions of the cohesin subunits Scc1/Rad21 and Scc3 occur in a DNA replication?coupled manner in both yeast and human cells. Using cross-linking MS-based and in vivo disulfide cross-linking analyses of purified cohesin, we show that a subpopulation of cohesin may exist as dimers. Importantly, upon temperature-sensitive and auxin-induced degron-mediated Eco1 depletion, the cohesin-cohesin interactions became significantly compromised, whereas deleting either the deacetylase Hos1 or the Eco1 antagonist Wpl1/Rad61 increased cohesin dimer levels by ?20%. These results indicate that cohesin dimerizes in the S phase and monomerizes in mitosis, processes that are controlled by Eco1, Wpl1, and Hos1 in the sister chromatid cohesion-dissolution cycle. These findings suggest that cohesin dimerization is controlled by the cohesion cycle and support the notion that a double-ring cohesin model operates in sister chromatid cohesion.	[Shi, Di; Zhao, Shuaijun; Zhang, Jingjing; Hou, Wenya; Cao, Qinhong; Lou, Huiqiang] China Agr Univ, State Key Lab Agrobiotechnol, Coll Biol Sci, 2 Yuan Ming Yuan West Rd, Beijing 100193, Peoples R China; [Shi, Di; Zhao, Shuaijun; Zhang, Jingjing; Hou, Wenya; Cao, Qinhong; Lou, Huiqiang] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Biol Sci, 2 Yuan Ming Yuan West Rd, Beijing 100193, Peoples R China; [Zuo, Mei-Qing; Dong, Meng-Qiu] Natl Inst Biol Sci, Beijing 102206, Peoples R China	China Agricultural University; China Agricultural University; National Institute of Biological Sciences, Beijing	Lou, HQ (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China.; Lou, HQ (corresponding author), China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing 100193, Peoples R China.	lou@cau.edu.cn	Lou, Huiqiang/B-6287-2012	Lou, Huiqiang/0000-0003-4465-6186; Dong, Meng-Qiu/0000-0002-6094-1182	National Natural Science Foundation of China [31630005, 31770084, 31771382]; National Basic Research Program (973 Program) of China [2014CB849801]; Program for Extramural Scientists of the State Key Laboratory of Agrobiotechnology Grant [2018SKLAB6-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973 Program) of China(National Basic Research Program of China); Program for Extramural Scientists of the State Key Laboratory of Agrobiotechnology Grant	This work was supported by the National Natural Science Foundation of China Grants 31630005, 31770084, and 31771382; National Basic Research Program (973 Program) of China Grant 2014CB849801; and Program for Extramural Scientists of the State Key Laboratory of Agrobiotechnology Grant 2018SKLAB6-5. The authors declare that they have no conflicts of interest with the contents of this article.	Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Cattoglio C, 2019, ELIFE, V8, DOI 10.7554/eLife.40164; Chan KL, 2012, CELL, V150, P961, DOI 10.1016/j.cell.2012.07.028; Ciosk R, 2000, MOL CELL, V5, P243, DOI 10.1016/S1097-2765(00)80420-7; Eng T, 2015, MOL BIOL CELL, V26, P4224, DOI 10.1091/mbc.E15-06-0331; Feytout A, 2011, MOL CELL BIOL, V31, P1771, DOI 10.1128/MCB.01284-10; Gligoris T, 2016, TRENDS CELL BIOL, V26, P680, DOI 10.1016/j.tcb.2016.04.002; Gruber S, 2003, CELL, V112, P765, DOI 10.1016/S0092-8674(03)00162-4; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hansen AS, 2017, ELIFE, V6, DOI 10.7554/eLife.25776; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Hirano T, 2017, GENES CELLS, V22, P934, DOI 10.1111/gtc.12539; Holzmann J, 2019, ELIFE, V8, DOI 10.7554/eLife.46269; Holzmann J, 2011, J PROTEOME RES, V10, P780, DOI 10.1021/pr100927x; in 't Veld PJH, 2014, SCIENCE, V346, P968, DOI 10.1126/science.1256904; Ivanov D, 2005, CELL, V122, P849, DOI 10.1016/j.cell.2005.07.018; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kim Y, 2019, SCIENCE, V366, P1345, DOI 10.1126/science.aaz4475; Kulemzina I, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002856; Li Y, 2018, ELIFE, V7, DOI 10.7554/eLife.38356; Liu L, 2020, CELL MOL LIFE SCI, V77, P3041, DOI 10.1007/s00018-019-03333-9; Makrantoni V, 2018, CURR BIOL, V28, pR688, DOI 10.1016/j.cub.2018.05.019; Maradeo ME, 2010, FEBS LETT, V584, P4037, DOI 10.1016/j.febslet.2010.08.020; Mohan C, 2018, ELIFE, V7, DOI 10.7554/eLife.36654; Morales C, 2018, CURR OPIN CELL BIOL, V52, P51, DOI 10.1016/j.ceb.2018.01.010; Murayama Y, 2018, CELL, V172, P465, DOI 10.1016/j.cell.2017.12.021; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Onn I, 2008, ANNU REV CELL DEV BI, V24, P105, DOI 10.1146/annurev.cellbio.24.110707.175350; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Quan Y, 2015, CELL REP, V13, P2576, DOI 10.1016/j.celrep.2015.11.018; Sherwood R, 2010, GENE DEV, V24, P2723, DOI 10.1101/gad.1976710; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Skibbens RV, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006337; Skibbens RV, 2009, CURR BIOL, V19, pR1126, DOI 10.1016/j.cub.2009.10.067; Skibbens RV, 1999, GENE DEV, V13, P307, DOI 10.1101/gad.13.3.307; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Srinivasan M, 2018, CELL, V173, P1508, DOI 10.1016/j.cell.2018.04.015; Sutani T, 2009, CURR BIOL, V19, P492, DOI 10.1016/j.cub.2009.01.062; Tanaka K, 2000, MOL CELL BIOL, V20, P3459, DOI 10.1128/MCB.20.10.3459-3469.2000; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Uhlmann F, 2009, EMBO REP, V10, P1095, DOI 10.1038/embor.2009.207; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Zhang JL, 2008, MOL CELL, V31, P143, DOI 10.1016/j.molcel.2008.06.006; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	51	10	10	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7554	7565		10.1074/jbc.RA120.013102	http://dx.doi.org/10.1074/jbc.RA120.013102			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32312753	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000538038900001
J	Ramirez, LMN; Ferro, BE; Diaz, G; Anthony, RM; de Beer, J; van Soolingen, D				Nieto Ramirez, Luisa Maria; Ferro, Beatriz E.; Diaz, Gustavo; Anthony, Richard M.; de Beer, Jessica; van Soolingen, Dick			Genetic profiling of Mycobacterium tuberculosis revealed "modern" Beijing strains linked to MDR-TB from Southwestern Colombia	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; MODERN SUBLINEAGE; VARIABLE-NUMBER; GENOTYPE; FAMILY; IDENTIFICATION; LINEAGE	Beijing strains of Mycobacterium tuberculosis (lineage 2) have been associated with drug-resistance and transmission of tuberculosis worldwide. Most of the Beijing strains identified in the Colombian Pacific coast have exhibited a multidrug resistant (MDR) phenotype. We sought to evaluate the clonality and sublineage of Beijing strains circulating in Southwestern Colombia. Thirty-seven Beijing strains were identified through spoligotyping out of 311 clinical isolates collected in 9 years from 2002-2010. Further analysis by MIRU-VNTR 24 loci was conducted for the Beijing strains. For sublineage classification, deletions of RD105, RD207, and RD131 and point mutations at fbpB, mutT2, and acs were evaluated. Drug-resistance associated mutations to first-and second-line anti-TB drugs were also evaluated. Additionally, two Beijing strains were Illumina-whole genome sequenced (one MDR and one drug-susceptible). Among the 37 Beijing strains characterized, 36 belonged to the SIT190 type from which 28 were MDR, four pre-extensively drug resistant (XDR) TB, and four XDR-TB. The remaining strain was SIT1 and drug susceptible. MIRU-VNTR analysis allowed the identification of three Beijing clusters and two unique strains. Beijing strains were confirmed as "modern" sublineage. The mutations rpoB S531L and katG S315T were the most common among MDR strains. Moreover, the two strains evaluated by whole genome sequencing (WGS) shared most of the genetic features with the sublineage 2.2.1 "modern" Beijing previously characterized from Asian strains. WGS analysis of the MDR strain revealed the presence of eight SNPs previously reported in other MDR "Beijing-like" strains from Colombia. The presence of "modern" Beijing strains in Southwestern Colombia, most of them with MDR phenotype, suggests a different origin of this M. tuberculosis sublineage compared to other Beijing strains found in neighboring South American countries. This work may serve as a genetic baseline to study the evolution and spread of M. tuberculosis Beijing strains in Colombia, which play an important role in the propagation of MDR-TB.	[Nieto Ramirez, Luisa Maria] Univ Santiago Cali, Cali, Colombia; [Ferro, Beatriz E.] Univ Icesi, Dept Salud Publ & Med Comunitaria, Cali, Colombia; [Diaz, Gustavo] Ctr Int Entrenamiento & Invest Med CIDEIM, Cali, Colombia; [Diaz, Gustavo] Univ Icesi, Cali, Colombia; [Anthony, Richard M.; van Soolingen, Dick] Natl Inst Publ Hlth & Environm RIVM, Ctr Infect Dis Res Diagnost & Perinatal Screening, Mycobacteria Diagnost Lab Bacteriol & Parasitol B, Bilthoven, Netherlands; [de Beer, Jessica] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands; [van Soolingen, Dick] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands	Universidad Santiago de Cali; Universidad ICESI; Universidad ICESI; Netherlands National Institute for Public Health & the Environment; University of Groningen; Radboud University Nijmegen	Ferro, BE (corresponding author), Univ Icesi, Dept Salud Publ & Med Comunitaria, Cali, Colombia.	beferro@gmail.com	; Anthony, Richard/G-5654-2010; Ferro, Beatriz/F-7144-2016	Nieto Ramirez, Luisa Maria/0000-0003-1566-5876; Anthony, Richard/0000-0002-0550-5273; DIAZ, GUSTAVO/0000-0002-9313-1936; Ferro, Beatriz/0000-0001-6045-1610	Valle del Cauca State; NIH FIC grant [D43TW01540]; NHLBI; Direccion General de Investigaciones (DGI) from Universidad Santiago de Cali; Santiago de Cali; Colciencias [512, 529]	Valle del Cauca State; NIH FIC grant; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direccion General de Investigaciones (DGI) from Universidad Santiago de Cali; Santiago de Cali; Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was supported by local health authorities from Valle del Cauca State and Santiago de Cali. We thank the funding provided by NIH FIC grant D43TW01540 and NHLBI awarded to GD. We also thank Colciencias grants 512 that was awarded to LMN, and 529 awarded to GD and BEF. Additionally, we would like to thank Direccion General de Investigaciones (DGI) from Universidad Santiago de Cali that supported LMN. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-122; Ajawatanawong P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50078-3; Banerjee R, 2008, CLIN INFECT DIS, V47, P450, DOI 10.1086/590009; Barletta F, 2015, J CLIN MICROBIOL, V53, P1854, DOI 10.1128/JCM.03585-14; Bergval I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043240; Bifani PJ, 2002, TRENDS MICROBIOL, V10, P45, DOI 10.1016/S0966-842X(01)02277-6; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Candia N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-75; Chen J, 2013, REV CUERPO MED; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; David Felipe G, 2019, BIOMEDICA, V39; de Beer JL, 2014, INT J TUBERC LUNG D, V18, P594, DOI 10.5588/ijtld.13.0531; de Keijzer J, 2014, MOL CELL PROTEOMICS, V13, P2632, DOI 10.1074/mcp.M114.038380; Engstrom A, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4480-7; Ferro BE, 2011, EMERG INFECT DIS, V17, P1259, DOI 10.3201/eid1707.101797; Garzon-Chavez D, 2019, MICROB DRUG RESIST, V25, P931, DOI 10.1089/mdr.2018.0429; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Glynn JR, 2006, EMERG INFECT DIS, V12, P736, DOI 10.3201/eid1205.050400; Glynn JR, 2005, EMERG INFECT DIS, V11, P150, DOI 10.3201/eid1101.040869; Holt KE, 2018, NAT GENET, V50, P849, DOI 10.1038/s41588-018-0117-9; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; HUNTER PR, 1988, J CLIN MICROBIOL, V26, P2465, DOI 10.1128/JCM.26.11.2465-2466.1988; Iwamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049651; Jimenez P, 2017, BIOMEDICA, V37, P233, DOI 10.7705/biomedica.v37i3.3450; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kent PT, 1985, PUBLIC HLTH MYCOBACT; Laserson KF, 2000, INT J TUBERC LUNG D, V4, P673; Liu QY, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.14; Liu Y, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3578-7; Lomtadze N, 2009, INT J TUBERC LUNG D, V13, P68; Marais BJ, 2013, J CLIN MICROBIOL, V51, P1818, DOI 10.1128/JCM.00200-13; Nieto LM, 2012, J CLIN MICROBIOL, V50, P4185, DOI 10.1128/JCM.01946-12; Meehan CJ, 2018, EBIOMEDICINE, V37, P410, DOI 10.1016/j.ebiom.2018.10.013; Mokrousov I, 2005, GENOME RES, V15, P1357, DOI 10.1101/gr.3840605; Parwati I, 2010, LANCET INFECT DIS, V10, P103, DOI 10.1016/S1473-3099(09)70330-5; Puerto D, 2019, BIOMEDICA, V39, P78, DOI 10.7705/biomedica.v39i3.4318; Repossi A., 2011, EUR RESPIR J, V38, P3299; Ribeiro SCM, 2014, J CLIN MICROBIOL, V52, P2615, DOI 10.1128/JCM.00498-14; Ritacco V, 2008, MEM I OSWALDO CRUZ, V103, P489, DOI 10.1590/S0074-02762008000500014; Rodriguez-Castillo JG, 2017, INFECT GENET EVOL, V54, P314, DOI 10.1016/j.meegid.2017.07.022; Saelens JW, 2015, TUBERCULOSIS, V95, P810, DOI 10.1016/j.tube.2015.09.001; Schurch AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028365; Sengstake S, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-572; Shitikov E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10018-5; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Walker BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112963; Weniger T, 2010, NUCLEIC ACIDS RES, V38, pW326, DOI 10.1093/nar/gkq351; World Health Organization, 2021, 10 THREATS GLOB HLTH	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 24	2020	15	4							e0224908	10.1371/journal.pone.0224908	http://dx.doi.org/10.1371/journal.pone.0224908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LS8RF	32330146	Green Submitted, Green Published, gold			2022-12-26	WOS:000536647300003
J	Agustina, R; Nadiya, K; Andini, E; Setianingsih, AA; Sadariskar, AA; Prafiantini, E; Wirawan, F; Karyadi, E; Raut, MK				Agustina, Rina; Nadiya, Khairun; Andini, El A.; Setianingsih, Ainanur A.; Sadariskar, Arini A.; Prafiantini, Erfi; Wirawan, Fadila; Karyadi, Elvina; Raut, Manoj K.			Y Associations of meal patterning, dietary quality and diversity with anemia and overweight-obesity among Indonesian school-going adolescent girls in West Java	PLOS ONE			English	Article							IRON-ABSORPTION; PREVALENCE; KNOWLEDGE; NUTRIENT; CHILD; TIME; RISK	Background Poor diet is a risk factor for anemia, overweight, and obesity among adolescent girls. However, comprehensive assessment on dietary quality and habits in this population is limited. We assessed the association of meal patterning, dietary quality, and dietary diversity with both anemia and overweight-obesity. Methods We conducted a cross-sectional survey in 335 school-going adolescent girls aged 12-19 years from three districts in West Java using multi-stage cluster sampling. Meal patterning, Dietary Quality Index for Adolescents (DQI-A), and Dietary Diversity Score (DDS) were determined using 2-day 24-h recall. Results Of the girls, 45% were anemic and 17% overweight or obese. Eating occasions of 3-4 times (AOR 2.68, 95% CI 1.21-5.98) and > 4 times (AOR 2.43, 95% CI 1.01-5.83) were associated with greater odds of developing anemia compared to eating occasions of < 3 times. Adolescent girls who skipped dinner had greater odds of being overweight or obese (AOR 2.13, 95% CI 1.10-4.10) and were less likely to be anemic (AOR 0.56, 95%CI 0.33-0.95) compared to those who did not skip dinner. Difference in energy intake was found between girls who had dinner and skipped dinner (p = 0.05). Mean total DQI-A score was 44.4% +/- 7.71% and DDS was 4.0 out of 9.0. DQI-A score was significantly higher in non-anemic compared to anemic girls. Moreover, each unit increment of 1% of total DQI-A score was associated with a 3.967 g/dL increases of hemoglobin after adjustment for confounders. We found differences in total DQI-A score between normal-weight and overweight or obese girls. DDS score was not significantly different between groups, although lower meat, chicken, and fish consumption were correlated with anemia (p<0.01). Conclusions Overall, the girls had poor dietary quality and diversity. The findings therefore indicated the importance of improving dietary quality and diversity in a regular meal pattern, especially meal frequency and meal skipping, to reduce the risk of anemia and overweight-obesity among adolescent girls.	[Agustina, Rina; Prafiantini, Erfi] Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Nutr, Jakarta, Indonesia; [Agustina, Rina; Nadiya, Khairun; Prafiantini, Erfi; Wirawan, Fadila] Univ Indonesia, Indonesian Med Educ & Res Inst HNRC IMERI, Human Nutr Res Ctr, Fac Med, Jakarta, Indonesia; [Andini, El A.; Setianingsih, Ainanur A.; Sadariskar, Arini A.] Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Med Study Program, Fac Med, Jakarta, Indonesia; [Karyadi, Elvina] Nutr Int, Country Off Jakarta, Jakarta, Indonesia; [Raut, Manoj K.] Nutr Int, Asia Reg Off, New Delhi, India	University of Indonesia; University of Indonesia; University of Indonesia	Agustina, R (corresponding author), Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Dept Nutr, Jakarta, Indonesia.; Agustina, R (corresponding author), Univ Indonesia, Indonesian Med Educ & Res Inst HNRC IMERI, Human Nutr Res Ctr, Fac Med, Jakarta, Indonesia.	r.agustina@ui.ac.id	Agustina, Rina/ACB-0823-2022; Wirawan, Fadila/GZB-2266-2022; Agustina, Rina/GLU-2061-2022	Wirawan, Fadila/0000-0003-1621-1470; Agustina, Rina/0000-0002-8464-1037; Raut, Manoj/0000-0003-1322-3863	Nutrition International through Government of Canada through Global Affairs Canada (GAC); Directorate of Research and Community Services Universitas Indonesia [NKB-0233/UN2.R3.1/HKP.05.00/2019S]	Nutrition International through Government of Canada through Global Affairs Canada (GAC); Directorate of Research and Community Services Universitas Indonesia	This work had been commissioned with a grant from Nutrition International (formerly Micronutrient Initiative) through the financial assistance of the Government of Canada through Global Affairs Canada (GAC). Dietary intake data analyses, paper writing process, and publication of this study were supported by grants from the Directorate of Research and Community Services Universitas Indonesia through the Q1Q2 Publication grant no. NKB-0233/UN2.R3.1/HKP.05.00/2019S.	Abriha Abrehet, 2014, BMC Res Notes, V7, P888, DOI 10.1186/1756-0500-7-888; American College of Obstetricians and Gynecologists, 2017, OBSTET GYNECOL; Aparicio A, 2017, PUBLIC HEALTH NUTR, V20, P2364, DOI [10.1017/S1368980017000635, 10.1017/s1368980017000635]; Barkley JS, 2015, ASIA PAC J CLIN NUTR, V24, P452, DOI 10.6133/apjcn.2015.24.3.22; Cheung LTF, 2018, NUTR J, V17, DOI 10.1186/s12937-018-0374-6; Dixit S., 2011, INDIAN J PREV SOC ME, V42, P393; Fahmida U, 2013, SMILING D3 5 FOOD CO; FAO, 2011, GUID MEAS HOUS IND D; FHI 360/LINKAGES, 2016, MINIMUM DIETARY DIVE; Food and Agriculture Organization of the United Nations, INT FOOD COMP TABL D; Group TIW, 2014, IMPR NUTR AD GIRLS A; Howarth NC, 2007, INT J OBESITY, V31, P675, DOI 10.1038/sj.ijo.0803456; HURRELL RF, 1992, AM J CLIN NUTR, V56, P573, DOI 10.1093/ajcn/56.3.573; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Kubuga C, 2016, FASEB J, V30; Larocque R, 2005, AM J TROP MED HYG, V73, P783, DOI 10.4269/ajtmh.2005.73.783; Leech RM, 2015, NUTR RES REV, V28, P1, DOI 10.1017/S0954422414000262; MILLS A F, 1989, Archives of Disease in Childhood, V64, P1468; Ministry of Health Republic of Indonesia, 2013, IND HLTH PROF; National Institute of Health Research and Development, 2008, BAS HLTH RES 2007; National Institute of Health Research and Development, 2013, NAT BAS HLTH RES 201 NAT BAS HLTH RES 201; National Institute of Health Research and Development, 2018, NAT BAS HLTH RES 201 NAT BAS HLTH RES 201; Onyiriuka AN, 2013, S AFR J CHILD HEALTH, V7, P108, DOI 10.7196/SAJCH.529; PAHO, 2008, AN AD YOUNG AD YOUNG; Patimah S, 2016, BIOMED RES-INDIA, V27, P165; Popkin BM, 2010, AM J CLIN NUTR, V91, P1342, DOI 10.3945/ajcn.2009.28962; Rachmalina R., 2015, DIETARY DIVERSITY AD; Rati SA., 2014, INT J SCI RES, V3, P1237; Roba K. T., 2016, Journal of Nutrition and Food Sciences, V6, P493; Sanchis-Gomar F, 2013, JALA-J LAB AUTOM, V18, P198, DOI 10.1177/2211068212457560; Sarkar M, 2015, IOSR J DENT MED SCI, V14, P54; Savige G, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-36; Siva PM, 2016, J CLIN DIAGN RES, V10, pLC19, DOI 10.7860/JCDR/2016/20939.8938; Souganidis ES, 2012, MATERN CHILD HLTH J, V16, P1913, DOI 10.1007/s10995-011-0938-y; THOMAS FB, 1976, GASTROENTEROLOGY, V71, P1028; Verawati R., 2017, HUBUNGAN ANTARA BODY; Viana Marcos Borato, 2011, Rev. Bras. Hematol. Hemoter., V33, P90, DOI 10.5581/1516-8484.20110024; Viana MB, 2011, J PEDIAT-BRAZIL, V87, P180, DOI [10.2223/JPED.2081, 10.1590/S0021-75572011000200016]; Vyncke K, 2013, BRIT J NUTR, V109, P2067, DOI 10.1017/S000711451200414X; Wang JB, 2014, J HUM NUTR DIET, V27, P255, DOI 10.1111/jhn.12141; Watts AW, 2017, CAN J DIET PRACT RES, V78, P166, DOI 10.3148/cjdpr-2017-010; WHO, 2011, WHONMHNHDMNM111; WHO, 2006, ADOLESCENT NUTR REV; Widjaja I, 2014, PAEDIAT INDONESIANA, V54; Worku M., 2017, WORLD J NUTR HEAL, V5, P41, DOI DOI 10.12691/JNH-5-2-3; World Health Organization, 2008, WHO GLOBAL DATABASE; World Health Organization, 2017, NUTR AN TOOLS EFF PR; World Health Organization, 2005, NUTR AD ISS CHALL HL; Yosaee Somaye, 2016, Med J Islam Repub Iran, V30, P376; Zhao WZ, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4381-x	50	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231519	10.1371/journal.pone.0231519	http://dx.doi.org/10.1371/journal.pone.0231519			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324775	Green Published, gold			2022-12-26	WOS:000536033700017
J	Chen, XJ; Hu, QY; Zhang, K; Teng, HJ; Li, MZ; Li, D; Wang, JS; Du, QS; Zhao, M				Chen, Xiaojuan; Hu, Qianying; Zhang, Ke; Teng, Huajing; Li, Mingzhen; Li, Dan; Wang, Jiesi; Du, Quansheng; Zhao, Mei			The clock-controlled chemokine contributes to neuroinflammation-induced depression	FASEB JOURNAL			English	Article						clock gene; cytokine; depression-like behavior; inflammation; Per2	CIRCADIAN-CLOCK; GENE; ABNORMALITIES; IMMUNOLOGY; EXPRESSION; MICROGLIA; ANXIETY	The circadian rhythm plays a central role in immune function, and its disruption has been closely linked to the etiology of depression. However, the mechanisms underlying the association between depression and circadian rhythm remain unclear. We found that mice deficient of Per2, a central clock component of circadian output, were resilient to neuroinflammation-induced depressive behavior. After repeated central lipopolysaccharide (LPS) injections, MCP-1, MIP-1 beta, and RANTES increased in wild type (WT) but not in Per2-deficient mice. In addition, intracerebroventricular injection of RANTES resulted in depression-like behavior, and Met-RANTES, a CCR5 antagonist, could reverse depression-like behavior induced by LPS treatments. These results indicated that the Per2 gene contributes to depression via chemokines, especially RANTES. Furthermore, BMAL1 expression decreased in LPS-treated Per2-deficient mice and BMAL1 could bind to the promoter of Rantes, indicating clock gene can act as a regulator for neuroinflammation. In conclusion, Rantes, a clock-controlled gene (CCG), is involved in clock-immunological mechanisms underlying the effects of Per2 on neuroinflammation-induced depression-like behavior.	[Chen, Xiaojuan; Hu, Qianying; Zhang, Ke; Li, Mingzhen; Li, Dan; Wang, Jiesi; Zhao, Mei] Inst Psychol, CAS Key Lab Mental Hlth, 16 Lincui Rd, Beijing 100101, Peoples R China; [Chen, Xiaojuan; Hu, Qianying; Zhang, Ke; Li, Dan; Wang, Jiesi; Zhao, Mei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Teng, Huajing] Chinese Acad Sci, Beijing Inst Life Sci, Beijing, Peoples R China; [Du, Quansheng] Natl Nat Sci Fdn China, Dept Life Sci, Beijing, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; National Natural Science Foundation of China (NSFC)	Zhao, M (corresponding author), Inst Psychol, CAS Key Lab Mental Hlth, 16 Lincui Rd, Beijing 100101, Peoples R China.	zhaomei@psych.ac.cn	Wang, Jiesi/AAB-3815-2020	Wang, Jiesi/0000-0002-2425-4262; Teng, Huajing/0000-0001-9952-3618	National Natural Science Foundation of China [91132728, 31741062]; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the National Natural Science Foundation of China (No. 91132728, 31741062); and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences.	Albrecht Urs, 2013, Handb Exp Pharmacol, P227, DOI 10.1007/978-3-642-25950-0_9; Arjona A, 2006, BRAIN BEHAV IMMUN, V20, P469, DOI 10.1016/j.bbi.2005.10.002; Fonken LK, 2016, NEUROBIOL AGING, V47, P102, DOI 10.1016/j.neurobiolaging.2016.07.019; Fonken LK, 2015, BRAIN BEHAV IMMUN, V45, P171, DOI 10.1016/j.bbi.2014.11.009; Franklin TC, 2018, BIOL PSYCHIAT, V83, P50, DOI 10.1016/j.biopsych.2017.06.034; Geiger SS, 2015, IMMUNOLOGY, V146, P349, DOI 10.1111/imm.12525; Griesauer I, 2014, ANN MED, V46, P148, DOI 10.3109/07853890.2013.866440; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Jiang WG, 2013, PSYCHOPHARMACOLOGY, V227, P79, DOI 10.1007/s00213-012-2941-4; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kim M, 2018, BIOMOL THER, V26, P358, DOI 10.4062/biomolther.2017.131; Kinoshita C, 2012, NEUROREPORT, V23, P98, DOI 10.1097/WNR.0b013e32834e7ec2; Landgraf D, 2014, BEHAV NEUROSCI, V128, P344, DOI 10.1037/a0036029; Lavebratt C, 2010, AM J MED GENET B, V153B, P570, DOI 10.1002/ajmg.b.31021; Leighton SP, 2018, MOL PSYCHIATR, V23, P48, DOI 10.1038/mp.2017.205; Leistedt SJ, 2013, EUR NEUROPSYCHOPHARM, V23, P55, DOI 10.1016/j.euroneuro.2012.10.011; Li NY, 2015, INT J MOL SCI, V16, P6831, DOI 10.3390/ijms16046831; Liu JG, 2006, INFECT IMMUN, V74, P4750, DOI 10.1128/IAI.00287-06; Muller N, 2014, NEUROIMMUNOMODULAT, V21, P123, DOI 10.1159/000356540; Munhoz CD, 2006, J NEUROSCI, V26, P3813, DOI 10.1523/JNEUROSCI.4398-05.2006; Oglodek EA, 2014, PHARMACOL REP, V66, P920, DOI 10.1016/j.pharep.2014.06.001; Satyanarayanan SK, 2020, BRAIN BEHAV IMMUN, V85, P142, DOI 10.1016/j.bbi.2019.03.003; Silver AC, 2012, IMMUNITY, V36, P251, DOI 10.1016/j.immuni.2011.12.017; Simon NM, 2008, EUR NEUROPSYCHOPHARM, V18, P230, DOI 10.1016/j.euroneuro.2007.06.004; Spencer S, 2013, EUR J NEUROSCI, V37, P242, DOI 10.1111/ejn.12010; Stuart MJ, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00357; Suarez EC, 2004, PSYCHONEUROENDOCRINO, V29, P1119, DOI 10.1016/j.psyneuen.2004.01.002; Tang MM, 2017, BRAIN BEHAV IMMUN, V66, P322, DOI 10.1016/j.bbi.2017.05.013; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504	29	4	4	4	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8357	8366		10.1096/fj.201900581RRR	http://dx.doi.org/10.1096/fj.201900581RRR		APR 2020	10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32329129	hybrid			2022-12-26	WOS:000529406900001
J	Endo, C; Watanabe, K				Endo, Chiharu; Watanabe, Katsutoshi			Morphological variation associated with trophic niche expansion within a lake population of a benthic fish	PLOS ONE			English	Article							FRESH-WATER FISHES; RESOURCE POLYMORPHISMS; ECOLOGY; DIVERSIFICATION; DISPLACEMENT; INDIVIDUALS; MECHANISMS; SPECIATION; SELECTION; EVOLUTION	Ecological theory suggests that generalist species should have traits with multiple adaptive peaks. Consequently, in heterogeneous environments such adaptive landscapes may lead to phenotypic divergence that becomes fixed in populations via reproductive isolation, thus driving speciation. However, contrary to this expectation, the process of ecological diversification in wild populations is not always associated with obvious trait divergence and reproductive isolation due to some ecological and geographic constrains. To examine the ecological conditions that promote (or inhibit) divergence is quite important to improve our understanding of the underlying mechanisms. Here we examine how the patterns of trait variation (divergence/non-divergence) are determined in relation to ecological niche expansion and gene flow using a benthic fish, Pseudogobio esocinus, in the Lake Biwa system, Japan. The fish exhibited various patterns of morphological variation in mouth parts among populations. Lake fish tended to have a smaller mouth compared with river fish and also showed remarkable individual variations within some local samples. Lake fish utilized chironomid larvae as the primary prey, as in riverine fish. But, fish with smaller and narrower mouths utilized significantly higher proportions of amphipods (a novel prey unique to the lake) as their secondary prey. Microsatellite analysis detected no genetic structuring in the Lake Biwa catchment, suggesting no reproductive separation among eco-morphologically divergent individuals. Our results exemplify population niche expansion associated with continuous eco-morphological variation without divergence, and provide insights into the role of non-discrete diversification for thriving in heterogeneous environments.	[Endo, Chiharu; Watanabe, Katsutoshi] Kyoto Univ, Grad Sch Sci, Lab Anim Ecol, Kyoto, Japan	Kyoto University	Endo, C; Watanabe, K (corresponding author), Kyoto Univ, Grad Sch Sci, Lab Anim Ecol, Kyoto, Japan.	chiharupn1622@gmail.com; watanak@terra.zool.kyoto-u.ac.jp			JSPS [26291079, 26250044, 17H03720,18H01330]; Kyoto University Core Stage Backup Research Grant	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Kyoto University Core Stage Backup Research Grant	This work was partly supported by JSPS (Nos. 26291079, 26250044, 17H03720,18H01330) and Kyoto University Core Stage Backup Research Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata K, 2014, SPRINGERBRIEF BIOL, P1, DOI 10.1007/978-4-431-54150-9_1; ALEXANDER RM, 1966, J ZOOL, V149, P288; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; DeWitt T.J., 2004, PHENOTYPIC PLASTICIT, P98; Dickman CR, 1996, WILDLIFE BIOL, V2, P185, DOI 10.2981/wlb.1996.018; Elmer KR, 2009, EVOLUTION, V63, P2750, DOI 10.1111/j.1558-5646.2009.00736.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; HINDAR K, 1993, BIOL J LINN SOC, V48, P63, DOI 10.1111/j.1095-8312.1993.tb00877.x; Hosoya K., 1989, FRESHWATER FISHES JA, P314; HYNES HBN, 1950, J ANIM ECOL, V19, P36, DOI 10.2307/1570; Jackman S., 2008, PSCL POLITICAL SCI C; Kawamura K., 1991, B NATL RES I AQUACUL, V20, P11; Kawanabe H, 1996, ENVIRON BIOL FISH, V47, P219, DOI 10.1007/BF00000495; Langella O., 1999, POPULATIONS 1 2 32; Langerhans RB, 2004, AM NAT, V164, P335, DOI 10.1086/422857; Maan ME, 2013, SEMIN CELL DEV BIOL, V24, P516, DOI 10.1016/j.semcdb.2013.05.003; Maan ME, 2004, P ROY SOC B-BIOL SCI, V271, P2445, DOI 10.1098/rspb.2004.2911; Nagel L, 1998, EVOLUTION, V52, P209, DOI 10.1111/j.1558-5646.1998.tb05154.x; Nakajima T., 1994, NATURAL HIST LAKE BI; Nakamura M., 1969, CYPRINID FISHES JAPA; Nishino M., 1991, 90A05 LAK BIW ENV RE, P47; Nishino M., 1993, BENTHOS LAKE BIWA RI; Nishino M., 1996, SHIGA NATURAL OBSERV, V5; Nishino M., 2000, KAIYO MONTHLY, V32, P694; Nishino M., 1992, BENTHOS LAKE BIWA RI; Nishino M., 2007, INVASION ALIEN SPECI, V7, P3; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nosil P, 2004, EVOLUTION, V58, P102, DOI 10.1111/j.0014-3820.2004.tb01577.x; Pritchard JK, 2000, GENETICS, V155, P945; Robinson BW, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P65; Robinson BW, 2002, CAN J FISH AQUAT SCI, V59, P1819, DOI 10.1139/F02-144; ROBINSON BW, 1994, AM NAT, V144, P596, DOI 10.1086/285696; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; SCHLUTER D, 1993, TRENDS ECOL EVOL, V8, P197, DOI 10.1016/0169-5347(93)90098-A; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 1998, ENDLESS FORMS, P114; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; SKULASON S, 1995, TRENDS ECOL EVOL, V10, P366, DOI 10.1016/S0169-5347(00)89135-1; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Snowberg LK, 2008, AM NAT, V172, P733, DOI 10.1086/591692; Tabata R, 2016, ECOL EVOL, V6, P2601, DOI 10.1002/ece3.2070; Takahashi S, 1989, J PALEOLIMNOL, V1, P279, DOI DOI 10.1007/BF00184002; Takeshima H, 2017, CONSERV GENET RESOUR, V9, P479, DOI 10.1007/s12686-017-0699-z; Tominaga K, 2019, ICHTHYOL RES, V32, P1; Tominaga K, 2016, ICHTHYOL RES, V63, P79, DOI 10.1007/s10228-015-0478-3; Tomoda Y., 1978, LAKE BIWA CATFISH; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Van Wassenbergh S, 2006, PHYSIOL BIOCHEM ZOOL, V79, P43, DOI 10.1086/498188; Wainwright P, 2007, INTEGR COMP BIOL, V47, P96, DOI 10.1093/icb/icm032; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	55	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0232114	10.1371/journal.pone.0232114	http://dx.doi.org/10.1371/journal.pone.0232114			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324829	Green Published, gold			2022-12-26	WOS:000536033700078
J	Kundu, S; Kumar, V; Tyagi, K; Chandra, K				Kundu, Shantanu; Kumar, Vikas; Tyagi, Kaomud; Chandra, Kailash			The complete mitochondrial genome of the endangered Assam Roofed Turtle, Pangshura sylhetensis (Testudines: Geoemydidae): Genomic features and phylogeny	PLOS ONE			English	Article							GENE ORDER; MOLECULAR PHYLOGENY; BOX TURTLE; EVOLUTION; TREE; DNA; REARRANGEMENTS; TOOL; ORGANIZATION; SEQUENCES	The Assam Roofed Turtle, Pangshura sylhetensis is an endangered and least studied species endemic to India and Bangladesh. The present study decodes the first complete mitochondrial genome of P. sylhetensis (16,568 bp) by using next-generation sequencing. The assembly encodes 13 protein-coding genes (PCGs), 22 transfer RNAs (tRNAs), two ribosomal RNAs (rRNAs), and one control region (CR). Most of the genes were encoded on the majority strand, except NADH dehydrogenase subunit 6 (nad6) and eight tRNAs. All PCGs start with an ATG initiation codon, except for Cytochrome oxidase subunit 1 (cox1) and NADH dehydrogenase subunit 5 (nad5), which both start with GTG codon. The study also found the typical cloverleaf secondary structures in most of the predicted tRNA structures, except for serine (trnS1) which lacks of conventional DHU arm and loop. Both Bayesian and maximum-likelihood phylogenetic inference using 13 concatenated PCGs demonstrated strong support for the monophyly of all 52 Testudines species within their respective families and revealed Batagur trivittata as the nearest neighbor of P. sylhetensis. The mitogenomic phylogeny with other amniotes is congruent with previous research, supporting the sister relationship of Testudines and Archosaurians (birds and crocodilians). Additionally, the mitochondrial Gene Order (GO) analysis indicated plesiomorphy with the typical vertebrate GO in most of the Testudines species.	[Kundu, Shantanu; Kumar, Vikas; Tyagi, Kaomud; Chandra, Kailash] Zool Survey India, Ctr DNA Taxon, Mol Systemat Div, Kolkata, India	Zoological survey of India	Kumar, V (corresponding author), Zool Survey India, Ctr DNA Taxon, Mol Systemat Div, Kolkata, India.	vikaszsi77@gmail.com	Kundu, Dr. Shantanu/AAX-1130-2020	Kundu, Dr. Shantanu/0000-0002-5488-4433; Kumar, Vikas/0000-0002-0215-0120; CHANDRA, KAILASH/0000-0001-9076-5442	Ministry of Environment, Forest and Climate Change (MoEF&CC): Zoological Survey of India (ZSI), Kolkata in-house project, 'National Faunal Genome Resources (NFGR); Council of Scientific and Industrial Research (CSIR) [9072-A]	Ministry of Environment, Forest and Climate Change (MoEF&CC): Zoological Survey of India (ZSI), Kolkata in-house project, 'National Faunal Genome Resources (NFGR); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India)	This research was funded by the Ministry of Environment, Forest and Climate Change (MoEF&CC): Zoological Survey of India (ZSI), Kolkata in-house project, `National Faunal Genome Resources (NFGR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank the Director of Zoological Survey of India (ZSI), Ministry of Environment, Forests and Climate Change (MoEF&CC), Govt. of India for allowing this research work. We are thankful to the Arunachal Pradesh Biodiversity Board for providing necessary permissions. We are also thankful to Professor Rainer Breitling, Manchester Institute of Biotechnology, The University of Manchester for his help in improving the language. The first author (S.K) acknowledges a fellowship grant received from the Council of Scientific and Industrial Research (CSIR) Senior Research Associateship (Scientists' Pool Scheme) Pool No. 9072-A.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; ANDERSON S, 1982, J MOL BIOL, V156, P683, DOI 10.1016/0022-2836(82)90137-1; [Anonymous], 1877, DIFFERENT FORMS FLOW; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Babbucci M, 2014, GENOME BIOL EVOL, V6, P3326, DOI 10.1093/gbe/evu265; Barley AJ, 2010, MOL PHYLOGENET EVOL, V55, P1189, DOI 10.1016/j.ympev.2009.11.005; Bernt M, 2008, LECT N BIOINFORMAT, V5267, P143, DOI 10.1007/978-3-540-87989-3_11; Bernt M, 2007, BIOINFORMATICS, V23, P2957, DOI 10.1093/bioinformatics/btm468; Buhlmann KA, 2009, CHELONIAN CONSERV BI, V8, P116, DOI 10.2744/CCB-0774.1; Cameron SL, 2007, J MOL EVOL, V65, P589, DOI 10.1007/s00239-007-9042-8; Cao DN, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0067-9; Chiari Y, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-65; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; Crawford NG, 2012, BIOL LETTERS, V8, P783, DOI 10.1098/rsbl.2012.0331; Das I., 1991, COLOUR GUIDE TURTLES; Dierckxsens N, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw955; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Engstrom TN, 2004, SYST BIOL, V53, P693, DOI 10.1080/10635150490503053; Feng L, 2017, CONSERV GENET RESOUR, V9, P95, DOI 10.1007/s12686-016-0629-5; Fong JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048990; Fujita MK, 2004, MOL PHYLOGENET EVOL, V31, P1031, DOI 10.1016/j.ympev.2003.09.016; Gaffney E.S., 1988, Systematics Association Special Volume Series, P157; Gower DJ, 2006, MOL BIOL EVOL, V23, P227, DOI DOI 10.1093/M0LBEV/MSJ025; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Guillon JM, 2012, CONTRIB ZOOL, V81, P147, DOI 10.1163/18759866-08103002; Hedges SB, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-64; Hedges S. Blair, 2009, P383; Hedges SB, 1999, SCIENCE, V283, P998, DOI 10.1126/science.283.5404.998; Huang YN, 2015, GENET MOL RES, V14, P3234, DOI 10.4238/2015.April.13.2; Irisarri I, 2017, NAT ECOL EVOL, V1, P1370, DOI 10.1038/s41559-017-0240-5; Janke A, 1997, MOL BIOL EVOL, V14, P1266, DOI 10.1093/oxfordjournals.molbev.a025736; Janke A, 2001, P ROY SOC B-BIOL SCI, V268, P623, DOI 10.1098/rspb.2000.1402; Kumar V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37889-6; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784, DOI 10.1093/oxfordjournals.molbev.a026163; Kundu S, 2019, ECOL EVOL, V9, P10854, DOI 10.1002/ece3.5606; Kundu S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35822-5; Kundu S, 2018, MITOCHONDRIAL DNA B, V3, P513, DOI 10.1080/23802359.2018.1467215; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Laslett D, 2008, BIOINFORMATICS, V24, P172, DOI 10.1093/bioinformatics/btm573; Le M, 2007, MOL PHYLOGENET EVOL, V45, P398, DOI 10.1016/j.ympev.2007.05.002; Le M, 2006, MOL PHYLOGENET EVOL, V40, P517, DOI 10.1016/j.ympev.2006.03.003; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li H, 2017, J EVOLUTION BIOL, V30, P1011, DOI 10.1111/jeb.13070; Li W, 2015, GENE, V555, P169, DOI 10.1016/j.gene.2014.10.060; Lourenco JM, 2012, MOL PHYLOGENET EVOL, V62, P496, DOI 10.1016/j.ympev.2011.10.022; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Luo HD, 2019, GENES-BASEL, V10, DOI 10.3390/genes10070487; Macey JR, 1997, MOL BIOL EVOL, V14, P91, DOI 10.1093/oxfordjournals.molbev.a025706; Maddison DR, 2007, ZOOTAXA, P19, DOI 10.11646/zootaxa.1668.1.4; MEYLAN P A, 1987, Bulletin of the American Museum of Natural History, V186, P1; Miller MA, 2015, EVOL BIOINFORM, V11, P43, DOI 10.4137/EBO.S21501; Mindell DP, 1999, SYST BIOL, V48, P138, DOI 10.1080/106351599260490; Mindell DP, 1998, P NATL ACAD SCI USA, V95, P10693, DOI 10.1073/pnas.95.18.10693; Parham JF, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-11; Peng QL, 2006, GENE, V380, P14, DOI 10.1016/j.gene.2006.04.001; PERNA NT, 1995, J MOL EVOL, V41, P353, DOI 10.1007/BF01215182; Perseke M, 2008, MOL PHYLOGENET EVOL, V47, P855, DOI 10.1016/j.ympev.2007.11.034; Praschag P, 2007, ZOOL SCR, V36, P429, DOI 10.1111/j.1463-6409.2007.00293.x; Rest JS, 2003, MOL PHYLOGENET EVOL, V29, P289, DOI 10.1016/S1055-7903(03)00108-8; Rhodin AGJ, 2018, CHELONIAN CONSERV BI, V17, P135, DOI 10.2744/CCB-1348.1; Rieppel O, 2000, ZOOL SCR, V29, P199, DOI 10.1046/j.1463-6409.2000.00039.x; Rieppel O, 1996, NATURE, V384, P453, DOI 10.1038/384453a0; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruokonen M, 2002, MOL PHYLOGENET EVOL, V23, P422, DOI 10.1016/S1055-7903(02)00021-0; Shaffer HB, 2017, MOL PHYLOGENET EVOL, V115, P7, DOI 10.1016/j.ympev.2017.07.006; Shaffer HB, 1997, SYST BIOL, V46, P235, DOI 10.1093/sysbio/46.2.235; Shen XX, 2011, MOL BIOL EVOL, V28, P3237, DOI 10.1093/molbev/msr148; Spinks PQ, 2004, MOL PHYLOGENET EVOL, V32, P164, DOI 10.1016/j.ympev.2003.12.015; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BIO203S00; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Turtle Taxonomy Working Group, 2017, Chelonian Research Monographs, V7, P1; Tzika AC, 2011, EVODEVO, V2, DOI 10.1186/2041-9139-2-19; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; van Dijk PP, 2000, CHELON RES MONOGR, P15; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; Wang L, 2011, ZOOLOGIA-CURITIBA, V28, P495, DOI 10.1590/S1984-46702011000400011; Wei SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012708; Zardoya R, 1998, P NATL ACAD SCI USA, V95, P14226, DOI 10.1073/pnas.95.24.14226; Zhang L, 2008, J GENET GENOMICS, V35, P33, DOI 10.1016/S1673-8527(08)60005-3; Zheng CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082854; Zhou HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144711	82	3	3	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0225233	10.1371/journal.pone.0225233	http://dx.doi.org/10.1371/journal.pone.0225233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324729	Green Published, Green Submitted, gold			2022-12-26	WOS:000536033700003
J	Lastra-Valdes, J; da Silva, JRMC; Duarte, M				Lastra-Valdes, Joel; Machado Cunha da Silva, Jose Roberto; Duarte, Marcelo			Morphology and histology of vom Rath's organ in brush-footed butterflies (Lepidoptera: Nymphalidae)	PLOS ONE			English	Article							PALP-PIT ORGAN; EXTERNAL MORPHOLOGY; CEPHALIC APPENDAGES; MOTHS LEPIDOPTERA; FINE-STRUCTURE; MANDUCA-SEXTA; LABIAL PALPS; FRUIT MOTH; SENSILLA; CO2	Vom Rath's organ, located at the distal end of the third segment of the labial palp, is one of the recognized synapomorphies of Lepidoptera (Insecta). Information about the structural and histological morphology of this organ is sparse. The structure of vom Rath's organ in four species of Nymphalidae, three frugivorous: Fountainea ryphea (Charaxinae: Anaeini), Morpho helenor achillaena (Satyrinae: Morphini) and Hamadryas epinome (Biblidinae: Ageroniini), and the nectarivorous species Aeria olena (Danainae: Ithomiini) is described by means of scanning electron microscopy and histology. The species showed significant differences in the cavity shape, setal morphology and arrangement, opening shape and location, associated with the organization of cell groups, type of axon, and degree of development. These differences do not seem to be related to feeding habit. No cell groups were found in Actinote thalia (Heliconiinae: Acraeini) and Heliconius erato phyllis (Heliconiinae: Heliconiini), and for the first time the absence of vom Rath's organ is documented in the clade Ditrysia. A terminology is proposed to improve understanding of the organ morphology, with an extensive analysis of the previous descriptions.	[Lastra-Valdes, Joel] Museo Nacl Hist Nat Cuba, Havana, Cuba; [Lastra-Valdes, Joel; Duarte, Marcelo] Univ Sao Paulo, Programa Posgrad Sistemat Taxon Anim & Biodiversi, Museu Zool, Sao Paulo, SP, Brazil; [Machado Cunha da Silva, Jose Roberto] Univ Sao Paulo, Dept Biol Celular & Desenvolvimento, Lab Histofisiol Evolut, Inst Ciencias Biomed, Sao Paulo, SP, Brazil; [Duarte, Marcelo] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Smithsonian Institution; Smithsonian National Museum of Natural History	Duarte, M (corresponding author), Univ Sao Paulo, Programa Posgrad Sistemat Taxon Anim & Biodiversi, Museu Zool, Sao Paulo, SP, Brazil.; Duarte, M (corresponding author), Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA.	mduartes@usp.br	Duarte, Marcelo/K-7633-2012	Duarte, Marcelo/0000-0002-9562-2974	Bolsa de Mestrado Demanda Social, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [2002/13898-0, 2016/50384-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [440597/2015-3]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES; CNPq; FAPESP; PROTAX II, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [312190/2018-2, 426914/2018-0]	Bolsa de Mestrado Demanda Social, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROTAX II, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	JLV, Bolsa de Mestrado Demanda Social, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), http://capes.gov.br/MD, 2002/13898-0 and 2016/50384-8, Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, http://fapesp.br/MD, 440597/2015-3, PROTAX II, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), http://capes.gov.br/MD, 312190/2018-2 and 426914/2018-0, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, http://cnpq.br All authors thank CAPES, CNPq and FAPESP for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrell L, 2005, GLOBAL CHANGE BIOL, V11, P1272, DOI 10.1111/j.1365-2486.2005.00989.x; Bizarro Jorge Manuel Saraiva, 2003, Rev. Bras. Zool., V20, P279, DOI 10.1590/S0101-81752003000200018; BOGNER F, 1990, J INSECT PHYSIOL, V36, P951, DOI 10.1016/0022-1910(90)90083-R; BOGNER F, 1986, J COMP PHYSIOL A, V158, P741, DOI 10.1007/BF01324818; Brown KS, 1992, HIST NATURAL SERRA J, P142; CHAUVIN G, 1981, INT J INSECT MORPHOL, V10, P425, DOI 10.1016/0020-7322(81)90023-4; Chen J, 2016, ACTA ZOOL-STOCKHOLM, V97, P42, DOI 10.1111/azo.12103; Davis D.S., 1975, Smithsonian Contributions to Zoology, VNo. 210, P1; Davis DR, 2003, INVERTEBR SYST, V17, P15, DOI 10.1071/IS02006; Davis DR, 1986, SMITHSON CONTR ZOOL, V434, P1; de Camargo AJA, 2005, REV BRAS ZOOL, V22, P619, DOI 10.1590/S0101-81752005000300014; Dong Jun-Feng, 2014, Acta Entomologica Sinica, V57, P681; Duarte Marcelo, 2001, Revista Brasileira de Zoologia, V18, P225, DOI 10.1590/S0101-81752001000100025; Espeland M, 2018, CURR BIOL, V28, P770, DOI 10.1016/j.cub.2018.01.061; Faucheux M.J., 1980, Bulletin de la Societe des Sciences Naturelles de l'Ouest de la France, V2, P4; Faucheux Michel J., 2005, Revista del Museo Argentino de Ciencias Naturales Nueva Serie, V7, P57; Faucheux Michel J., 2005, Bulletin de la Societe des Sciences Naturelles de l'Ouest de la France, V27, P1; Faucheux Michel J., 2008, Rev. Soc. Entomol. Argent., V67, P21; FAUCHEUX MJ, 1991, INT J INSECT MORPHOL, V20, P291, DOI 10.1016/0020-7322(91)90018-5; Freitas AVL, 2004, SYST BIOL, V53, P363, DOI 10.1080/10635150490445670; Guerenstein PG, 2004, NATURWISSENSCHAFTEN, V91, P329, DOI 10.1007/s00114-004-0532-x; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hicks JB, 1860, T LINN SOC LONDON ZO, V23, P139; KENT KS, 1986, CELL TISSUE RES, V245, P237; KRISTENSEN N P, 1984, Steenstrupia, V10, P141; KRISTENSEN N P, 1968, Entomologiske Meddelelser, V36, P137; Kristensen N.P., 2003, ARTHROPODA INSECTA T, V2, P39, DOI [10.1515/9783110893724, DOI 10.1515/9783110893724]; Kristensen NP, 2007, ZOOTAXA, P699, DOI 10.11646/zootaxa.1668.1.30; LEE JK, 1985, CELL TISSUE RES, V240, P333, DOI 10.1007/BF00222343; MCDOWELL EM, 1976, ARCH PATHOL LAB MED, V100, P405; Mielke Carlos Guilherme C., 2004, Rev. Bras. Zool., V21, P357, DOI 10.1590/S0101-81752004000200034; NATION JL, 1983, STAIN TECHNOL, V58, P347, DOI 10.3109/10520298309066811; NIELSEN E S, 1981, Steenstrupia, V7, P25; Orfila R. N., 1950, Revista del Instituto Nacional de Investigacion de las Ciencias Naturales Buenos Aires Ci zool, V1, P273; Paluch M, 2008, REV BRAS ZOOL, V25, P456, DOI 10.1590/S0101-81752008000300011; Penz CM, 2003, SYST ENTOMOL, V28, P451, DOI 10.1046/j.1365-3113.2003.00221.x; Leite LAR, 2010, BRAZ ARCH BIOL TECHN, V53, P1119, DOI 10.1590/S1516-89132010000500016; ROHLF F. J, 2001, TPSDIG THIN PLATE SP; SCHMITT J. B., 1938, SMITHSONIAN MISC COLL, V97, P1; Song YQ, 2016, B INSECTOL, V69, P59; Sourakov Alexandra, 2012, Psyche (Cambridge), V2012, P1, DOI 10.1155/2012/378050; STANGE G, 1995, OECOLOGIA, V102, P341, DOI 10.1007/BF00329801; STANGE G, 1992, J COMP PHYSIOL A, V171, P317, DOI 10.1007/BF00223962; Thom C, 2004, J CHEM ECOL, V30, P1285, DOI 10.1023/B:JOEC.0000030298.77377.7d; vom Rath O., 1887, ZOOL ANZ, V10, P645; vom Rath O., 1887, ZOOL ANZ, V10, P627; vom Rath O., 1888, Z WISS ZOOL, V46, P413; Wahlberg N, 2003, MOL PHYLOGENET EVOL, V28, P473, DOI 10.1016/S1055-7903(03)00052-6; Zhao XC, 2013, CELL TISSUE RES, V353, P399, DOI 10.1007/s00441-013-1657-z	49	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231486	10.1371/journal.pone.0231486	http://dx.doi.org/10.1371/journal.pone.0231486			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324746	gold, Green Published			2022-12-26	WOS:000536033700015
J	Migambi, P; Gasana, M; Uwizeye, CB; Kamanzi, E; Ndahindwa, V; Kalisvaart, N; Klinkenberg, E				Migambi, Patrick; Gasana, Michel; Uwizeye, Claude Bernard; Kamanzi, Eliane; Ndahindwa, Vedaste; Kalisvaart, Nico; Klinkenberg, Eveline			Prevalence of tuberculosis in Rwanda: Results of the first nationwide survey in 2012 yielded important lessons for TB control	PLOS ONE			English	Article								Background Rwanda conducted a national tuberculosis (TB) prevalence survey to determine the magnitude of TB in the country and determine to what extent the national surveillance system captures all TB cases. In addition we measured the patient diagnostic rate, comparing the measured TB burden data with the routine surveillance data to gain insight into how well key population groups are being detected. Methods A national representative nationwide cross-sectional survey was conducted in 73 clusters in 2012 whereby all enrolled participants (residents aged 15 years and above) were systematically screened for TB by symptoms and chest X-ray (CXR). Those with either clinical symptoms (cough of any duration) and/or CXR abnormalities suggestive of TB disease were requested to provide two sputum samples (one spot and one morning) for smear examination and solid culture. Results Of the 45,058 eligible participants, 43,779 were enrolled in the survey. Participation rate was high at 95.7% with 99.8% of participants undergoing both screening procedures and 99.0% of those eligible for sputum examination submitting at least one sputum sample. Forty cases of prevalent mycobacterium tuberculosis (MTB) and 16 mycobacteria other than tuberculosis (MOTT) cases were detected during the survey. Chest x-ray as screening tool had 3 and 5 times greater predictive odds for smear positive and bacteriological confirmed TB than symptom screening alone respectively. A TB prevalence of 74.1 (95% CI 48.3-99.3) per 100,000 adult population for smear positive TB and 119.3 (95% CI 78.8-159.9) per 100,000 adult population for bacteriological confirmed MTB was estimated for Rwanda. Conclusions The survey findings indicated a lower TB prevalence than previously estimated by WHO providing key lessons for national TB control, calling for more sensitive screening and diagnostic tools and a focus on key populations. Use of chest x-ray as screening tool was introduced to improve the diagnostic yield of TB.	[Migambi, Patrick; Gasana, Michel; Kamanzi, Eliane] Rwanda Minist Hlth, Rwanda Biomed Ctr, Kigali, Rwanda; [Uwizeye, Claude Bernard] Family Hlth Int, Kigali, Rwanda; [Ndahindwa, Vedaste] Univ Rwanda, Coll Med & Hlth Sci, Sch Publ Hlth, Kigali, Rwanda; [Kalisvaart, Nico; Klinkenberg, Eveline] KNCV TB Fdn, The Hague, Netherlands; [Klinkenberg, Eveline] Univ Amsterdam, Med Ctr, Dept Global Hlth, Amsterdam, Netherlands; [Klinkenberg, Eveline] Univ Amsterdam, Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Rwanda Biomedical Center; University of Rwanda; KNCV Tuberculosis Foundation; University of Amsterdam; University of Amsterdam	Migambi, P (corresponding author), Rwanda Minist Hlth, Rwanda Biomed Ctr, Kigali, Rwanda.	patrick.migambi@rbc.gov.rw		UWIZEYE, CLAUDE BERNARD/0000-0002-3858-6567	Global Fund against TB, HIV/AIDS and Malaria, under the Grant (RWA-T-MoH) Rwanda National Tuberculosis Control Strategic Plan 2009-2012; US President's Emergency Plan for AIDS Relief (PEPFAR) through the US Center for disease control and prevention (CDC)	Global Fund against TB, HIV/AIDS and Malaria, under the Grant (RWA-T-MoH) Rwanda National Tuberculosis Control Strategic Plan 2009-2012; US President's Emergency Plan for AIDS Relief (PEPFAR) through the US Center for disease control and prevention (CDC)	The bulk of the survey funding was provided by the Global Fund against TB, HIV/AIDS and Malaria, under the Grant (RWA-T-MoH) Rwanda National Tuberculosis Control Strategic Plan 2009-2012 and from the US President's Emergency Plan for AIDS Relief (PEPFAR) through the US Center for disease control and prevention (CDC). Funders did not play any role in study design, data collection and analysis, decision to publish and in preparation of the manuscript.	[Anonymous], 2000, RWAND DEM HLTH SURV; Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Dunbar R, 2011, INT J TUBERC LUNG D, V15, P1038, DOI 10.5588/ijtld.10.0695; Federal-Republic-of-Nigeria, REP 1 NAT TB PREV SU; Floyd S, 2013, EMERG THEMES EPIDEMI, V10, DOI 10.1186/1742-7622-10-10; Giefing-Kroll C, 2015, AGING CELL, V14, P309, DOI 10.1111/acel.12326; Hoa NB, B WHO, V88, P273; Hoa NB, 2010, B WORLD HEALTH ORGAN, V2010; Kapata Nathan, 2016, PLoS One, V11, pe0146392, DOI 10.1371/journal.pone.0146392; Kebede AH, 2014, INT J TUBERC LUNG D, V18, P635, DOI 10.5588/ijtld.13.0417; Law I, 2015, TROP MED INT HEALTH, V20, P1146, DOI 10.1111/tmi.12536; Mao TE, 2014, B WORLD HEALTH ORGAN, V92, P573, DOI 10.2471/BLT.13.131581; Ministry-of-Health -And-Social-Welfare, 2013, 1 NAT TUB PREV SURV; Onozaki I, 2015, TROP MED INT HEALTH, V20, P1128, DOI 10.1111/tmi.12534; Qadeer E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148293; Rwanda-Ministry-of-Health, 2017, TUB NAT STRAT PLAN 2; Rwanda-Ministry-of-Health, 2016, 1 NAT TUB PREV SURV; Thorson A, 2004, J CLIN EPIDEMIOL, V57, P398, DOI 10.1016/j.jclinepi.2002.11.001; Uwizeye CB, 2011, INT J TUBERC LUNG D, V15, P776, DOI 10.5588/ijtld.10.0454; van't Hoog AH, 2011, AM J RESP CRIT CARE, V183, P1245, DOI 10.1164/rccm.201008-1269OC; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World-Health-Organization, 2008, GLOB TUB REP 2008; 2012, GLOB TUB REP 2013, P1	23	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231372	10.1371/journal.pone.0231372	http://dx.doi.org/10.1371/journal.pone.0231372			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324750	Green Published, gold			2022-12-26	WOS:000536033700013
J	Nishi, T; Ueda, T; Mizusawa, Y; Semba, K; Shinomiya, K; Mitamura, Y; Sonoda, S; Uchino, E; Sakamoto, T; Ogata, N				Nishi, Tomo; Ueda, Tetsuo; Mizusawa, Yuutaro; Semba, Kentaro; Shinomiya, Kayo; Mitamura, Yoshinori; Sonoda, Shozo; Uchino, Eisuke; Sakamoto, Taiji; Ogata, Nahoko			Effect of optical correction on choroidal structure in children with anisohypermetropic amblyopia	PLOS ONE			English	Article							COHERENCE TOMOGRAPHY; THICKNESS; BINARIZATION; RETINA; EYE	The aim of this study was to assess the effect of wearing optical correction on the choroidal structure in eyes of children with anisohypermetropic amblyopia. This study was conducted at the Nara Medical University Hospital and at the Tokushima University Hospital. Twenty-nine anisohypermetropic amblyopic eyes and their fellow eyes of 29 amblyopic patients (mean age, 5.7 +/- 1.7 years, range 3- to 8-years) and twenty eyes of 20 age-similar control children (4.9 +/- 0.8 years, range 4- to 6-years) were studied. All patients wore optical correction and 15 patients had both optical correction and patching. The values at the baseline were compared to that at one year later. The binarization method was used to determine the total, luminal, and stromal areas of the choroid in the enhanced depth imaging optical coherence tomographic images. The best-corrected visual acuity (BCVA) of the amblyopic eyes was significantly improved after the one-year period. A large luminal area was characteristic of the amblyopic eye at the baseline, and it was significantly reduced after the optical treatment. The stromal area widened significantly in the amblyopic and fellow eyes after one year whereas there were no significant changes in the choroid of the control eyes after one year. After one-year of optical correction, the luminal/stromal ratios in the amblyopic and fellow eyes were decreased and were then not significantly different from that of the normal control eyes. There was a significant and positive correlation between the improvement of the BCVA and the stromal area at the baseline (r = 0.64, P = 0.001). Wearing corrective lenses on the amblyopic eyes improves the BCVA, and the choroidal structure of the amblyopic eye becomes closer to that of the control eyes. The narrowed luminal area is a specific response of the amblyopic eye associated with the correction of the refractive error. The larger stromal area in the amblyopic eyes at the baseline is a predictive factor for improvements of the BCVA.	[Nishi, Tomo; Ueda, Tetsuo; Mizusawa, Yuutaro; Ogata, Nahoko] Nara Med Univ, Dept Ophthalmol, Nara, Japan; [Semba, Kentaro; Shinomiya, Kayo; Mitamura, Yoshinori] Tokushima Univ, Grad Sch, Inst Biomed Sci, Dept Ophthalmol, Tokushima, Japan; [Sonoda, Shozo; Uchino, Eisuke; Sakamoto, Taiji] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Ophthalmol, Kagoshima, Japan	Nara Medical University; Tokushima University; Kagoshima University	Nishi, T (corresponding author), Nara Med Univ, Dept Ophthalmol, Nara, Japan.	tomon@naramed-u.ac.jp						[Anonymous], 2000, INVEST OPHTH VIS SCI, V41, P1259; [Anonymous], 2016, CLIN EXP OPTOM, V100, P184, DOI [10.1111/cxo.12483, DOI 10.1111/CX0.12483]; Araki S, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0894-z; Araki S, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0559-3; Bayhan SA, 2017, CURR EYE RES, V42, P1254, DOI 10.1080/02713683.2017.1315141; Chen WH, 2013, AM J OPHTHALMOL, V155, P536, DOI 10.1016/j.ajo.2012.09.028; Donahue SP, 2013, J AAPOS, V17, P4, DOI 10.1016/j.jaapos.2012.09.012; EL, VIS DEP CHANG CHOR T; Fujiwara A, 2012, JPN J OPHTHALMOL, V56, P230, DOI 10.1007/s10384-012-0128-5; Holmes JM, 2006, LANCET, V367, P1343, DOI 10.1016/S0140-6736(06)68581-4; Kur J, 2012, PROG RETIN EYE RES, V31, P377, DOI 10.1016/j.preteyeres.2012.04.004; Mori T, 2014, CURR EYE RES, p[20, 1]; Nishi T, 2016, PLOS ONE, V13; Nishi T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189735; Nishi T, 2015, BRIT J OPHTHALMOL, V99, P1060, DOI 10.1136/bjophthalmol-2014-305685; Nishi T, 2014, BRIT J OPHTHALMOL, V98, P228, DOI 10.1136/bjophthalmol-2013-303938; Oner V, DOES TREATMENT AMBLY; Park KA, 2012, INVEST OPHTH VIS SCI, V53, P7201, DOI 10.1167/iovs.12-10599; Read SA, 2013, INVEST OPHTH VIS SCI, V54, P3586, DOI 10.1167/iovs.13-11732; Ruiz-Medrano J, 2018, RETINA-J RET VIT DIS, V38, P508, DOI 10.1097/IAE.0000000000001571; Schrodl F, 2003, INVEST OPHTH VIS SCI, V44, P3705, DOI 10.1167/iovs.03-0232; Sonoda S, 2015, AM J OPHTHALMOL, V159, P1123, DOI 10.1016/j.ajo.2015.03.005; Stewart CE, 2005, INVEST OPHTH VIS SCI, V46, P3152, DOI 10.1167/iovs.05-0357; Tan CS, 2012, INVEST OPHTH VIS SCI, V53, P261, DOI 10.1167/iovs.11-8782; Toor S, 2018, BRIT J OPHTHALMOL, V102, P772, DOI 10.1136/bjophthalmol-2017-310282; Troilo D, 2000, INVEST OPHTH VIS SCI, V41, P1249; WALLMAN J, 1995, VISION RES, V35, P37, DOI 10.1016/0042-6989(94)E0049-Q; Xu JL, 2014, INVEST OPHTH VIS SCI, V55, P7361, DOI 10.1167/iovs.14-14439; Zhu XY, 2009, INVEST OPHTH VIS SCI, V50, P37, DOI 10.1167/iovs.08-2102	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231903	10.1371/journal.pone.0231903	http://dx.doi.org/10.1371/journal.pone.0231903			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324782	Green Published, gold, Green Submitted			2022-12-26	WOS:000536033700043
J	Roe, KD; Jawa, V; Zhang, XH; Chute, CG; Epstein, JA; Matelsky, J; Shpitser, I; Taylor, CO				Roe, Kenneth D.; Jawa, Vibhu; Zhang, Xiaohan; Chute, Christopher G.; Epstein, Jeremy A.; Matelsky, Jordan; Shpitser, Ilya; Taylor, Casey Overby			Feature engineering with clinical expert knowledge: A case study assessment of machine learning model complexity and performance	PLOS ONE			English	Article							ELECTRONIC HEALTH RECORDS; TEMPORAL PATTERNS; PREDICTION; REPRESENTATION; ABSTRACTION; ASTHMA	Incorporating expert knowledge at the time machine learning models are trained holds promise for producing models that are easier to interpret. The main objectives of this study were to use a feature engineering approach to incorporate clinical expert knowledge prior to applying machine learning techniques, and to assess the impact of the approach on model complexity and performance. Four machine learning models were trained to predict mortality with a severe asthma case study. Experiments to select fewer input features based on a discriminative score showed low to moderate precision for discovering clinically meaningful triplets, indicating that discriminative score alone cannot replace clinical input. When compared to baseline machine learning models, we found a decrease in model complexity with use of fewer features informed by discriminative score and filtering of laboratory features with clinical input. We also found a small difference in performance for the mortality prediction task when comparing baseline ML models to models that used filtered features. Encoding demographic and triplet information in ML models with filtered features appeared to show performance improvements from the baseline. These findings indicated that the use of filtered features may reduce model complexity, and with little impact on performance.	[Roe, Kenneth D.; Jawa, Vibhu; Chute, Christopher G.; Shpitser, Ilya; Taylor, Casey Overby] Johns Hopkins Univ, Johns Hopkins Malone Ctr Engn Healthcare, Baltimore, MD 21218 USA; [Roe, Kenneth D.; Chute, Christopher G.; Taylor, Casey Overby] Johns Hopkins Univ, Inst Clin & Translat Res, Baltimore, MD 21202 USA; [Jawa, Vibhu; Shpitser, Ilya] Johns Hopkins Univ, Dept Comp Sci, Whiting Sch Engn, Baltimore, MD 21218 USA; [Zhang, Xiaohan; Chute, Christopher G.; Taylor, Casey Overby] Johns Hopkins Univ, Sch Med, Div Hlth Sci Informat, Baltimore, MD 21205 USA; [Chute, Christopher G.; Epstein, Jeremy A.; Taylor, Casey Overby] Johns Hopkins Univ, Div Gen Internal Med, Sch Med, Baltimore, MD 21205 USA; [Matelsky, Jordan] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Taylor, Casey Overby] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; Johns Hopkins University	Taylor, CO (corresponding author), Johns Hopkins Univ, Johns Hopkins Malone Ctr Engn Healthcare, Baltimore, MD 21218 USA.; Taylor, CO (corresponding author), Johns Hopkins Univ, Inst Clin & Translat Res, Baltimore, MD 21202 USA.; Taylor, CO (corresponding author), Johns Hopkins Univ, Sch Med, Div Hlth Sci Informat, Baltimore, MD 21205 USA.; Taylor, CO (corresponding author), Johns Hopkins Univ, Div Gen Internal Med, Sch Med, Baltimore, MD 21205 USA.; Taylor, CO (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	cot@jhu.edu	Chute, Christopher/AAT-8540-2021	Roe, Kenneth/0000-0002-2619-8911; Chute, Christopher/0000-0001-5437-2545	NCATS (NIH) [1OT3TR002019, 1OT3TR002020, 1OT3TR002025, 1OT3TR002026, 1OT3TR002027, 1OT2TR002514, 1OT2TR002515, 1OT2TR002517, 1OT2TR002520, 1OT2TR002584]; Biomedical Translator Program	NCATS (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Biomedical Translator Program	This work was funded in part by the Biomedical Translator Program initiated and funded by NCATS (NIH awards 1OT3TR002019, 1OT3TR002020, 1OT3TR002025, 1OT3TR002026, 1OT3TR002027, 1OT2TR002514, 1OT2TR002515, 1OT2TR002517, 1OT2TR002520, 1OT2TR002584). Any opinions expressed in this manuscript are those of co-authors who are members of the Translator community and do not necessarily reflect the views of NCATS, individual Translator team members, or affiliated organizations and institutions.	[Anonymous], 2004, MUT INF; [Anonymous], 2014, ACM SIGKDD EXPLOR NE, DOI [DOI 10.1145/2594473.2594475, 10.1145/2594473.2594475]; Banaee H, 2015, IEEE J BIOMED HEALTH, V19, P1557, DOI 10.1109/JBHI.2015.2438645; Cespedes M, 2012, IEEE ENER CONV, P3090, DOI 10.1109/ECCE.2012.6342511; CHEN HF, 2015, 2015 IEEE INT C EL C, V22, P1; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Eisner MD, 2005, J ASTHMA, V42, P315, DOI 10.1081/JAS-200062959; Goldstein BA, 2017, J AM MED INFORM ASSN, V24, P198, DOI 10.1093/jamia/ocw042; Guidotti R, 2019, ACM COMPUT SURV, V51, DOI 10.1145/3236009; Harutyunyan H., 2017, ARXIV170307771; Hastie T, 1996, J ROY STAT SOC B MET, V58, P155; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Lin J., 2003, P 8 ACM SIGMOD WORKS, P2, DOI DOI 10.1145/882082.882086; Luo Gang, 2017, JMIR Med Inform, V5, pe32, DOI 10.2196/medinform.8076; Miotto R, 2016, SCI REP-UK, V6, DOI 10.1038/srep26094; Moskovitch R, 2017, J BIOMED INFORM, V75, P70, DOI 10.1016/j.jbi.2017.07.018; Moskovitch R, 2017, IEEE ACM T COMPUT BI, V14, P555, DOI 10.1109/TCBB.2016.2591539; Moskovitch R, 2015, KNOWL INF SYST, V45, P35, DOI 10.1007/s10115-014-0784-5; Moskovitch R, 2015, DATA MIN KNOWL DISC, V29, P871, DOI 10.1007/s10618-014-0380-z; Orphanou K, 2018, J BIOMED INFORM, V81, P74, DOI 10.1016/j.jbi.2018.03.002; Orphanou K, 2014, ARTIF INTELL MED, V60, P133, DOI 10.1016/j.artmed.2013.12.007; Puranik S, 2017, AM J RESP CRIT CARE, V195, P854, DOI 10.1164/rccm.201606-1213PP; Sacchi L, 2007, DATA MIN KNOWL DISC, V15, P217, DOI 10.1007/s10618-007-0077-7; Schulam P., 2015, NIPS; Schulam P, 2017, RELIABLE DECISION SU; Shknevsky A, 2017, J BIOMED INFORM, V75, P83, DOI 10.1016/j.jbi.2017.10.002; Singh A, 2015, J BIOMED INFORM, V53, P220, DOI 10.1016/j.jbi.2014.11.005; Soleimani H, 2017, SCALABLE JOINT MODEL; Su MY, 2011, EXPERT SYST APPL, V38, P3492, DOI 10.1016/j.eswa.2010.08.137; Vazquez L, 2013, CHOP ASTHMA; Verduijn M, 2007, ARTIF INTELL MED, V41, P1, DOI 10.1016/j.artmed.2007.06.003; Yereva NN, 2018, MIMIC 3 BENCHMARK RE	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231300	10.1371/journal.pone.0231300	http://dx.doi.org/10.1371/journal.pone.0231300			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324754	Green Published, gold, Green Submitted			2022-12-26	WOS:000536033700011
J	Pamphlett, R; Jew, SK; Doble, PA; Bishop, DP				Pamphlett, Roger; Jew, Stephen Kum; Doble, Philip A.; Bishop, David P.			Elemental imaging shows mercury in cells of the human lateral and medial geniculate nuclei	PLOS ONE			English	Article							VISUAL HALLUCINATION; LOCALIZATION; RAT; CNS; DISORDERS; BISMUTH; SCHIZOPHRENIA; NEUROMELANIN; DEPRESSION; LIPOFUSCIN	Objective Interference with the transmission of sensory signals along visual and auditory pathways has been implicated in the pathogenesis of hallucinations. The relay centres for vision (the lateral geniculate nucleus) and hearing (the medial geniculate nucleus) appear to be susceptible to the uptake of circulating mercury. We therefore investigated the distribution of mercury in cells of both these geniculate nuclei. Materials and methods Paraffin-embedded tissue sections containing the lateral geniculate nucleus were obtained from 50 adults (age range 20-104 years) who at autopsy had a variety of clinicopathological conditions, including neurological and psychiatric disorders. The medial geniculate nucleus was present in seven sections. Sections were stained for mercury using autometallography. Laser ablation-inductively coupled plasma-mass spectrometry was used to confirm the presence of mercury. Results Ten people had mercury in cells of the lateral geniculate nucleus, and in the medial geniculate nucleus of three of these. Medical diagnoses in these individuals were: none (3), Parkinson disease (3), and one each of depression, bipolar disorder, multiple sclerosis, and mercury self-injection. Mercury was distributed in different groups of geniculate capillary endothelial cells, neurons, oligodendrocytes, and astrocytes. Mass spectrometry confirmed the presence of mercury. Conclusion Mercury is present in different combinations of cell types in the lateral and medial geniculate nuclei in a proportion of people from varied backgrounds. This raises the possibility that mercury-induced impairment of the function of the geniculate nuclei could play a part in the genesis of visual and auditory hallucinations. Although these findings do not provide a direct link between mercury in geniculate cells and hallucinations, they suggest that further investigations into the possibility of toxicant-induced hallucinations are warranted.	[Pamphlett, Roger; Jew, Stephen Kum] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia; [Doble, Philip A.; Bishop, David P.] Univ Technol Sydney, Sch Math & Phys Sci, Elemental Bioimaging Facil, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Technology Sydney	Pamphlett, R (corresponding author), Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au	; Bishop, David/F-2891-2019	Pamphlett, Roger/0000-0003-3326-7273; Bishop, David/0000-0002-6533-4410	Aimee Stacy Memorial and Ignacy Burnett bequests; Australian Research Council [DP170100036, DP190102361, DE180100194]; National Institute of Health [R21AR072950]; Multiple Sclerosis Research Australia; University of Sydney; NSW Office for Health and Medical Research; Royal Prince Alfred Hospital Sydney; Trish multiple sclerosis Research Foundation; Levy Foundation; Collier Charitable Fund; Medical Advances Without Animals Trust; FIL Foundation	Aimee Stacy Memorial and Ignacy Burnett bequests; Australian Research Council(Australian Research Council); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Sclerosis Research Australia; University of Sydney(University of Sydney); NSW Office for Health and Medical Research; Royal Prince Alfred Hospital Sydney; Trish multiple sclerosis Research Foundation; Levy Foundation; Collier Charitable Fund; Medical Advances Without Animals Trust; FIL Foundation	RP is supported by the Aimee Stacy Memorial and Ignacy Burnett bequests. PAD is supported by Australian Research Council Discovery Project Grants DP170100036 and DP190102361. DPB is supported by an Australian Research Council Discovery Early Career Researcher Award DE180100194. PAD and DPB are supported by a National Institute of Health Grant R21AR072950. The Multiple Sclerosis Research Australia Brain Bank is supported by Multiple Sclerosis Research Australia, the University of Sydney, the NSW Office for Health and Medical Research, and Royal Prince Alfred Hospital Sydney, and has received funding support from the Trish multiple sclerosis Research Foundation, the Levy Foundation, the Collier Charitable Fund, the Medical Advances Without Animals Trust, and the FIL Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2018, CHEMOSPHERE, V190, P144, DOI 10.1016/j.chemosphere.2017.09.117; Alao AO, 2003, INT J PSYCHIAT MED, V33, P195, DOI 10.2190/0NUQ-Y5Q9-TA6H-RJHH; Attademo L, 2017, SCHIZOPHR RES, V181, P55, DOI 10.1016/j.schres.2016.10.003; Baethge C, 2005, BIPOLAR DISORD, V7, P136, DOI 10.1111/j.1399-5618.2004.00175.x; Benveniste H., 2018, CEREBRUM, DOI [10.1016/0041-008x(91)90092-s, DOI 10.1016/0041-008X(91)90092-S]; Bergquist BA, 2017, P NATL ACAD SCI USA, V114, P8675, DOI 10.1073/pnas.1709070114; Boksa Patricia, 2009, J Psychiatry Neurosci, V34, P260; BRAAK H, 1984, CELL TISSUE RES, V237, P509; Bridges CC, 2017, ARCH TOXICOL, V91, P63, DOI 10.1007/s00204-016-1803-y; CHANG LW, 1972, EXP NEUROL, V35, P122, DOI 10.1016/0014-4886(72)90064-7; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; Covington BP, 2020, NEUROANATOMY NUCL LA; Danscher G, 2000, J HISTOCHEM CYTOCHEM, V48, P1503, DOI 10.1177/002215540004801107; DANSCHER G, 1994, NEUROPATH APPL NEURO, V20, P454, DOI 10.1111/j.1365-2990.1994.tb00996.x; DANSCHER G, 1986, HISTOCHEM J, V18, P109, DOI 10.1007/BF01675364; Dorph-Petersen KA, 2009, ACTA NEUROPATHOL, V117, P369, DOI 10.1007/s00401-008-0410-2; Double KL, 2008, CELL MOL LIFE SCI, V65, P1669, DOI 10.1007/s00018-008-7581-9; Eversfield CL, 2019, PSYCHOL MED, V49, P2342, DOI 10.1017/S0033291718003161; FARRAR WP, 1994, J VET DIAGN INVEST, V6, P511, DOI 10.1177/104063879400600426; Finley BD, 2009, ATMOS ENVIRON, V43, P6074, DOI 10.1016/j.atmosenv.2009.08.046; Ghodrati M, 2017, PROG NEUROBIOL, V156, P214, DOI 10.1016/j.pneurobio.2017.06.002; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; JOHNSON RF, 1988, P NATL ACAD SCI USA, V85, P5301, DOI 10.1073/pnas.85.14.5301; Kalinin S, 2006, EUR J NEUROSCI, V24, P3393, DOI 10.1111/j.1460-9568.2006.05223.x; Kaskie RE, 2017, NAT SCI SLEEP, V9, P227, DOI 10.2147/NSS.S121076; Khan A, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000353; Kolbinger V, 2019, ENVIRON RES, V176, DOI 10.1016/j.envres.2019.05.043; Kristensen LJ, 2012, ENVIRON HEALTH PERSP, V120, pA56, DOI 10.1289/ehp.1104672; Kullmann JAP, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122874; Lawrence RE, 2019, NAT CELL BIOL, V21, P133, DOI 10.1038/s41556-018-0244-7; Lee JY, 2016, MOVEMENT DISORD, V31, P547, DOI 10.1002/mds.26533; Lohren H, 2015, METALLOMICS, V7, P1420, DOI 10.1039/c5mt00171d; Maliepaard M, 2001, CANCER RES, V61, P3458; MOLLERMADSEN B, 1991, FUND APPL TOXICOL, V16, P172, DOI 10.1016/0272-0590(91)90145-T; MOLLERMADSEN B, 1986, ENVIRON RES, V41, P29, DOI 10.1016/S0013-9351(86)80165-7; MOLLERMADSEN B, 1992, ARCH TOXICOL, V66, P79, DOI 10.1007/BF02342499; MOLLERMADSEN B, 1990, TOXICOL APPL PHARM, V103, P303, DOI 10.1016/0041-008X(90)90232-J; MOLLERMADSEN B, 1991, TOXICOL APPL PHARM, V108, P457, DOI 10.1016/0041-008X(91)90092-S; Newbury JB, 2019, JAMA PSYCHIAT, V76, P614, DOI 10.1001/jamapsychiatry.2019.0056; Niehoff AC, 2015, ANAL CHEM, V87, P10392, DOI 10.1021/acs.analchem.5b02500; OLSZEWSKI WA, 1974, ACTA NEUROL SCAND, V50, P581; Pamphlett R, 1998, ACTA NEUROPATHOL, V96, P515, DOI 10.1007/s004010050927; Pamphlett R, 2000, NEUROTOXICOL TERATOL, V22, P559, DOI 10.1016/S0892-0362(00)00083-0; Pamphlett R, 1996, ACTA NEUROPATHOL, V92, P525, DOI 10.1007/s004010050556; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203627; Pamphlett R, 2018, BIOMETALS, V31, P807, DOI 10.1007/s10534-018-0124-4; Pamphlett R, 2016, BIOMETALS, V29, P171, DOI 10.1007/s10534-015-9898-9; Pamphlett Roger, 2013, Acta Neuropathol Commun, V1, P13, DOI 10.1186/2051-5960-1-13; Papadopoulou A, 2019, NEUROLOGY, V92, pE2240, DOI 10.1212/WNL.0000000000007450; PARKER G, 1991, AUST NZ J PSYCHIAT, V25, P169, DOI 10.3109/00048679109077732; Rasmussen MK, 2018, LANCET NEUROL, V17, P1016, DOI 10.1016/S1474-4422(18)30318-1; Ross JF, 1996, BRAIN RES, V725, P137; SATO T, 1991, ADV MERCURY TOXICOLO, P353, DOI DOI 10.1016/0041-008X(90)90232-J; Selemon LD, 2007, PSYCHIAT RES, V151, P1, DOI 10.1016/j.psychres.2006.11.003; SHAW CM, 1975, AM J PATHOL, V80, P451; Streets DG, 2017, ENVIRON SCI TECHNOL, V51, P5969, DOI 10.1021/acs.est.7b00451; Tiffany-Castiglioni E, 2001, NEUROTOXICOLOGY, V22, P577, DOI 10.1016/S0161-813X(01)00050-X; Waters F, 2017, SCHIZOPHRENIA BULL, V43, P32, DOI 10.1093/schbul/sbw132; Waters F, 2014, SCHIZOPHRENIA BULL, V40, pS233, DOI 10.1093/schbul/sbu036; WEST CD, 1979, J COMP NEUROL, V186, P109, DOI 10.1002/cne.901860108; Weyand TG, 2016, REV NEUROSCIENCE, V27, P135, DOI 10.1515/revneuro-2015-0018; Wilhelm SM, 2001, ENVIRON SCI TECHNOL, V35, P4704, DOI 10.1021/es001804h; Zucca FA, 2014, NEUROTOX RES, V25, P13, DOI 10.1007/s12640-013-9435-y	66	4	5	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231870	10.1371/journal.pone.0231870	http://dx.doi.org/10.1371/journal.pone.0231870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9QD	32320439	gold, Green Published			2022-12-26	WOS:000536028800036
J	Stanczyk, U; Zielosko, B; Baron, G				Stanczyk, Urszula; Zielosko, Beata; Baron, Grzegorz			Discretisation of conditions in decision rules induced for continuous data	PLOS ONE			English	Article							ROUGH SET APPROACH; AUTHORSHIP; CLASSIFIERS; CLASSIFICATION; OPTIMIZATION; ATTRIBUTES; TREE	Typically discretisation procedures are implemented as a part of initial pre-processing of data, before knowledge mining is employed. It means that conclusions and observations are based on reduced data, as usually by discretisation some information is discarded. The paper presents a different approach, with taking advantage of discretisation executed after data mining. In the described study firstly decision rules were induced from real-valued features. Secondly, data sets were discretised. Using categories found for attributes, in the third step conditions included in inferred rules were translated into discrete domain. The properties and performance of rule classifiers were tested in the domain of stylometric analysis of texts, where writing styles were defined through quantitative attributes of continuous nature. The performed experiments show that the proposed processing leads to sets of rules with significantly reduced sizes while maintaining quality of predictions, and allows to test many data discretisation methods at the acceptable computational costs.	[Stanczyk, Urszula; Baron, Grzegorz] Silesian Tech Univ, Dept Graph Comp Vis & Digital Syst, Fac Automat Control Elect & Comp Sci, Gliwice, Poland; [Zielosko, Beata] Univ Silesia Katowice, Inst Comp Sci, Sosnowiec, Poland	Silesian University of Technology; University of Silesia in Katowice	Zielosko, B (corresponding author), Univ Silesia Katowice, Inst Comp Sci, Sosnowiec, Poland.	beata.zielosko@us.edu.pl	Zielosko, Beata/E-7765-2019; Stanczyk, Urszula/S-1132-2018	Zielosko, Beata/0000-0003-3788-1094; Baron, Grzegorz/0000-0001-8613-631X; Stanczyk, Urszula/0000-0002-5071-7187	Silesian University of Technology, Gliwice [RAU-6]	Silesian University of Technology, Gliwice	The research works described in the paper were performed at the University of Silesia in Katowice, Institute of Computer Science, and at the Silesian University of Technology, Gliwice, within the statutory project (RAU-6, 2020).	Ali Z, 2016, INT CONF FRONT INFO, P87, DOI [10.1109/FIT.2016.024, 10.1109/FIT.2016.22]; [Anonymous], 1998, ROUGH SETS KNOWL DIS; Argamon S, 2010, STRUCTUE OF STYLE: ALGORITHMIC APPROACHES TO UNDERSTANDING MANNER AND MEANING, P79, DOI 10.1007/978-3-642-12337-5_5; Baayen H., 1996, Literary & Linguistic Computing, V11, P121, DOI 10.1093/llc/11.3.121; Baron G, 2018, SMART INNOV SYST TEC, V73, P33, DOI 10.1007/978-3-319-59424-8_4; Baron G, 2016, SMART INNOV SYST TEC, V57, P149, DOI 10.1007/978-3-319-39627-9_14; Baron G, 2016, COMM COM INF SC, V659, P81, DOI 10.1007/978-3-319-47217-1_9; Bazan J. G., 1994, Methodologies for Intelligent Systems. 8th International Symposium, ISMIS '94 Proceedings, P346; Bazan JG, 2005, LECT NOTES COMPUT SC, V3400, P37; Blaszczynski J, 2012, ENG APPL ARTIF INTEL, V25, P284, DOI 10.1016/j.engappai.2011.09.003; Burrows J., 2004, COMPANION DIGITAL HU; CATLETT J, 1991, LECT NOTES ARTIF INT, V482, P164, DOI 10.1007/BFb0017012; Chikalov I., 2013, INTELLIGENT SYSTEMS, V41; Clark P., 1989, Machine Learning, V3, P261, DOI 10.1007/BF00116835; Craig Hugh, 2004, COMPANION DIGITAL HU; Dougherty J., 1995, Machine Learning. Proceedings of the Twelfth International Conference on Machine Learning, P194; Eder M, 2015, DIGIT SCHOLARSH HUM, V30, P167, DOI 10.1093/llc/fqt066; Farid DM, 2014, EXPERT SYST APPL, V41, P1937, DOI 10.1016/j.eswa.2013.08.089; FAYYAD UM, 1993, IJCAI-93, VOLS 1 AND 2, P1022; Forsyth R. S., 1996, Literary & Linguistic Computing, V11, P163, DOI 10.1093/llc/11.4.163; Garcia S, 2013, IEEE T KNOWL DATA EN, V25, P734, DOI 10.1109/TKDE.2012.35; Greco S., 1999, ADV MULTIPLE CRITERI; Greco S, 2007, LECT NOTES COMPUT SC, V4400, P36; Grzymala-Busse J.W., 1997, ROUGH SETS DATA MINI, P91; Grzymala-Busse JW, 2004, COG TECH, P543; Grzymala-Busse JW, 2001, INT J INTELL SYST, V16, P29, DOI 10.1002/1098-111X(200101)16:1<29::AID-INT4>3.0.CO;2-0; Han J, 2012, MOR KAUF D, P1; HOLMES DI, 1994, COMPUT HUMANITIES, V28, P87, DOI 10.1007/BF01830689; Jockers ML, 2010, LIT LINGUIST COMPUT, V25, P215, DOI 10.1093/llc/fqq001; Khmelev D. V., 2001, Literary & Linguistic Computing, V16, P299, DOI 10.1093/llc/16.3.299; Kim D, 2000, LECT NOTES ARTIF INT, V1810, P211; Kononenko I., 1995, IJCAI-95. Proceedings of the Fourteenth International Joint Conference on Artificial Intelligence, P1034; Koppel M., 2013, J LAW POLICY, V21, P317, DOI [10.2139/ssrn.2274891, DOI 10.2139/SSRN.2274891]; Koppel M, 2009, J AM SOC INF SCI TEC, V60, P9, DOI 10.1002/asi.20961; Kotsiantis S, 2006, GESTS INT T COMPUT S, V32, P47; Kurgan LA, 2004, IEEE T KNOWL DATA EN, V16, P145, DOI 10.1109/TKDE.2004.1269594; Liu H, 2002, DATA MIN KNOWL DISC, V6, P393, DOI 10.1023/A:1016304305535; Lynam T., 2001, P HUMAN LANGUAGE TEC, P1; MICHALSKI RS, 1983, ARTIF INTELL, V20, P111, DOI 10.1016/0004-3702(83)90016-4; Mizianty M, 2008, SEVENTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P823, DOI 10.1109/ICMLA.2008.29; MOSTELLER F, 1963, J AM STAT ASSOC, V58, P275, DOI 10.2307/2283270; Munro R., 2003, P 1 AUSTRALASIAN LAN, P1; Pawlak Z, 2002, INFORM SCIENCES, V147, P1, DOI 10.1016/S0020-0255(02)00197-4; Pawlak Z, 2007, INFORM SCIENCES, V177, P41, DOI 10.1016/j.ins.2006.06.007; Peng RD, 2002, AM STAT, V56, P175, DOI 10.1198/000313002100; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Quinlan JR, 1996, J ARTIF INTELL RES, V4, P77, DOI 10.1613/jair.279; Shen Q, 2008, IEEE PRESS SERIES CO; Slowinski R, 2007, LECT NOTES ARTIF INT, V4585, P5, DOI 10.1007/978-3-540-73451-2_2; Stamatatos E, 2009, J AM SOC INF SCI TEC, V60, P538, DOI 10.1002/asi.21001; Stanczyk U., 2017, LECT NOTES ARTIF INT, P333; Stanczyk U, 2018, LECT NOTES ARTIF INT, V11103, P350, DOI 10.1007/978-3-319-99368-3_27; Stanczyk U, 2018, SMART INNOV SYST TEC, V72, P159, DOI 10.1007/978-3-319-59421-7_15; Stanczyk U, 2017, LECT NOTES ARTIF INT, V10313, P329, DOI 10.1007/978-3-319-60837-2_28; Stanczyk U, 2015, J INTELL FUZZY SYST, V29, P899, DOI 10.3233/IFS-151620; Stapor K., 2017, P FEDERATED C COMPUT, VVolume 13, P37; Waugh S., 2000, Literary & Linguistic Computing, V15, P187, DOI 10.1093/llc/15.2.187; Witten IH, 2011, MOR KAUF D, P3, DOI 10.1016/B978-0-12-374856-0.00001-8; Wrobel L, 2016, FUND INFORM, V149, P419, DOI 10.3233/FI-2016-1455; Zielosko B, 2018, INTEL SYST REF LIBR, V138, P73, DOI 10.1007/978-3-319-67588-6_5; Zielosko B, 2016, FUND INFORM, V148, P87, DOI 10.3233/FI-2016-1424	61	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231788	10.1371/journal.pone.0231788	http://dx.doi.org/10.1371/journal.pone.0231788			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320407	Green Published, gold			2022-12-26	WOS:000536028800033
J	Tok, PSK; Liew, SM; Wong, LP; Razali, A; Loganathan, T; Chinna, K; Ismail, N; Kadir, NA				Tok, Peter Seah Keng; Liew, Su May; Wong, Li Ping; Razali, Asmah; Loganathan, Tharani; Chinna, Karuthan; Ismail, Nurhuda; Kadir, Naim Abdul			Determinants of unsuccessful treatment outcomes and mortality among tuberculosis patients in Malaysia: A registry-based cohort study	PLOS ONE			English	Article							RISK-FACTORS	Introduction The monitoring of tuberculosis (TB) treatment outcomes and examination of the factors affecting these outcomes are important for evaluation and feedback of the national TB control program. This study aims to assess the TB treatment outcomes among patients registered in the national TB surveillance database in Malaysia from 2014 until 2017 and identify factors associated with unsuccessful treatment outcomes and all-cause mortality. Materials and methods Using registry-based secondary data, a retrospective cohort study was conducted. TB patients' sociodemographic characteristics, clinical disease data and treatment outcomes at one-year surveillance were extracted from the database and analyzed. Logistic regression analysis was used to determine factors associated with unsuccessful treatment outcomes and all-cause mortality. Results A total of 97,505 TB cases (64.3% males) were included in this study. TB treatment success (cases categorized as cured and completed treatment) was observed in 80.7% of the patients. Among the 19.3% patients with unsuccessful treatment outcomes, 10.2% died, 5.3% were lost to follow-up, 3.6% had outcomes not evaluated while the remaining failed treatment. Unsuccessful TB treatment outcomes were found to be associated with older age, males, foreign nationality, urban dwellers, lower education levels, passive detection of TB cases, absence of bacille Calmette-Guerin (BCG) scar, underlying diabetes mellitus, smoking, extrapulmonary TB, history of previous TB treatment, advanced chest radiography findings and human immunodeficiency virus (HIV) infection. Factors found associated with all-cause mortality were similar except for nationality (higher among Malaysians) and place of residence (higher among rural dwellers), while smoking and history of previous TB treatment were not found to be associated with all-cause mortality. Conclusions This study identified various sociodemographic characteristics and TB disease-related variables which were associated with unsuccessful TB treatment outcomes and mortality; these can be used to guide measures for risk assessment and stratification of TB patients in future.	[Tok, Peter Seah Keng; Wong, Li Ping; Loganathan, Tharani] Univ Malaya, Ctr Epidemiol & Evidence Based Practice, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia; [Tok, Peter Seah Keng] Minist Hlth Malaysia, Natl Inst Hlth NIH, Inst Clin Res, Shah Alam, Selangor, Malaysia; [Liew, Su May] Univ Malaya, Dept Primary Care Med, Fac Med, Kuala Lumpur, Malaysia; [Razali, Asmah; Kadir, Naim Abdul] Fed Govt Adm Ctr, Dis Control Div, Sect TB Leprosy, Minist Hlth Malaysia, Putrajaya, Malaysia; [Chinna, Karuthan] Taylors Univ, Sch Med, Fac Hlth & Med Sci, Subang Jaya, Selangor, Malaysia; [Ismail, Nurhuda] Univ Teknol MARA, Fac Med, Dept Publ Hlth Med, Sungai Buloh, Selangor, Malaysia	Universiti Malaya; Kementerian Kesihatan Malaysia; Universiti Malaya; Kementerian Kesihatan Malaysia; Taylor's University; Universiti Teknologi MARA	Tok, PSK (corresponding author), Univ Malaya, Ctr Epidemiol & Evidence Based Practice, Fac Med, Dept Social & Prevent Med, Kuala Lumpur, Malaysia.; Tok, PSK (corresponding author), Minist Hlth Malaysia, Natl Inst Hlth NIH, Inst Clin Res, Shah Alam, Selangor, Malaysia.	petertok.crc@gmail.com	Loganathan, Tharani/L-8836-2018; WONG, LI PING/B-2782-2010; Tok, Peter Seah Keng/ABE-6489-2021; Ismail, Nurhuda/AGH-0838-2022	Loganathan, Tharani/0000-0001-6690-000X; WONG, LI PING/0000-0002-0107-0532; Tok, Peter Seah Keng/0000-0003-3663-450X; Ismail, Nurhuda/0000-0002-3423-0475				[Anonymous], 2019, THE SUN DAILY; [Anonymous], 2010, TREATM TUB GUID NAT; [Anonymous], 2018, GLOB TUB REP; [Anonymous], WHOHTMTB2007390; Atif M, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-399; Caminero JA, 2010, INT J TUBERC LUNG D, V14, P382; Chang SH, 2014, INT J TUBERC LUNG D, V18, P168, DOI 10.5588/ijtld.13.0181; Dara M, 2017, INT J TUBERC LUNG D, V21, P727, DOI 10.5588/ijtld.16.0940; Disease Control Division (TB/Leprosy Sector) Ministry of Health Malaysia, 2016, KKMBI50002018 MIN HL; Eshetie S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194675; Gebrezgabiher G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150560; Gegia M, 2015, B WORLD HEALTH ORGAN, V93, P390, DOI 10.2471/BLT.14.147439; Hannah HA, 2017, PUBLIC HEALTH REP, V132, P366, DOI 10.1177/0033354917698117; IBM Knowledge Centre, IBM SPSS STAT V24 0; Institute for Public Health Ministry of Health Malaysia, 2015, NAT HLTH MORB SURV 2; Ismail I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073250; Ismail I, 2013, PREV MED, V57, pS27, DOI 10.1016/j.ypmed.2012.12.023; Karo B, 2016, AIDS, V30, P1089, DOI 10.1097/QAD.0000000000001016; Kawatsu L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6273-0; Li Y, 2018, INT J TUBERC LUNG D, V22, P655, DOI 10.5588/ijtld.17.0726; Liew SM, 2015, INT J TUBERC LUNG D, V19, P764, DOI 10.5588/ijtld.14.0767; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Ministry of Health Malaysia, 2012, MOHPPAK25812GU MIN H; Ministry of Health Malaysia, 2002, NAT TUB INF SYST TBI; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Munro SA, 2007, PLOS MED, V4, P1230, DOI 10.1371/journal.pmed.0040238; Nik Nor Ronaidi NM, 2011, MALAYS J PUBLIC HLTH, V11, P6; Noyes J, 2007, J ADV NURS, V57, P227, DOI 10.1111/j.1365-2648.2006.04092.x; Pizzol Damiano, 2018, BMC Res Notes, V11, P99, DOI 10.1186/s13104-018-3209-9; Siddiqui AN, 2018, DIABETES METAB SYND, V12, P1101, DOI 10.1016/j.dsx.2018.05.009; Slama K, 2007, INT J TUBERC LUNG D, V11, P496; Tafess K, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00038; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Wen YF, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3019-7; WHO, 2019, GLOB TUB REP, P1; WHO, 2011, COLLABORATIVE FRAMEW; Wohlleben J, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2655-7; World Health Organization, 2013, DEFINITIONS REPORTIN; World Health Organization, 2012, WHOHTMTB20121; World Health Organization, 2018, TUB COUNTR PROF MAL; World Health Organization, 2018, END TB STRAT GLOB ST; World Health Organization, 2015, WHOHTMTB201522; Yen YF, 2012, T ROY SOC TROP MED H, V106, P303, DOI 10.1016/j.trstmh.2012.01.011	43	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231986	10.1371/journal.pone.0231986	http://dx.doi.org/10.1371/journal.pone.0231986			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320443	Green Published, gold			2022-12-26	WOS:000536028800046
J	DeMers, LC; Redekar, NR; Kachroo, A; Tolin, SA; Li, S; Maroof, MAS				DeMers, Lindsay C.; Redekar, Neelam R.; Kachroo, Aardra; Tolin, Sue A.; Li, Song; Maroof, M. A. Saghai			A transcriptional regulatory network of Rsv3-mediated extreme resistance against Soybean mosaic virus	PLOS ONE			English	Article							CONFERRING RESISTANCE; DISEASE RESISTANCE; GENE-EXPRESSION; ABSCISIC-ACID; DEFENSE; MYC2; SEQUENCE; CLASSIFICATION; IDENTIFICATION; VALIDATION	Resistance genes are an effective means for disease control in plants. They predominantly function by inducing a hypersensitive reaction, which results in localized cell death restricting pathogen spread. Some resistance genes elicit an atypical response, termed extreme resistance, where resistance is not associated with a hypersensitive reaction and its standard defense responses. Unlike hypersensitive reaction, the molecular regulatory mechanism(s) underlying extreme resistance is largely unexplored. One of the few known, naturally occurring, instances of extreme resistance is resistance derived from the soybean Rsv3 gene, which confers resistance against the most virulent Soybean mosaic virus strains. To discern the regulatory mechanism underlying Rsv3-mediated extreme resistance, we generated a gene regulatory network using transcriptomic data from time course comparisons of Soybean mosaic virus-G7-inoculated resistant (L29, Rsv3-genotype) and susceptible (Williams82, rsv3-genotype) soybean cultivars. Our results show Rsv3 begins mounting a defense by 6 hpi via a complex phytohormone network, where abscisic acid, cytokinin, jasmonic acid, and salicylic acid pathways are suppressed. We identified putative regulatory interactions between transcription factors and genes in phytohormone regulatory pathways, which is consistent with the demonstrated involvement of these pathways in Rsv3-mediated resistance. One such transcription factor identified as a putative transcriptional regulator was MYC2 encoded by Glyma.07G051500. Known as a master regulator of abscisic acid and jasmonic acid signaling, MYC2 specifically recognizes the G-box motif ("CACGTG"), which was significantly enriched in our data among differentially expressed genes implicated in abscisic acid- and jasmonic acid-related activities. This suggests an important role for Glyma.07G051500 in abscisic acid- and jasmonic acid-derived defense signaling in Rsv3. Resultantly, the findings from our network offer insights into genes and biological pathways underlying the molecular defense mechanism of Rsv3-mediated extreme resistance against Soybean mosaic virus. The computational pipeline used to reconstruct the gene regulatory network in this study is freely available at https://github.com/LiLabAtVT/rsv3-network.	[DeMers, Lindsay C.; Redekar, Neelam R.; Tolin, Sue A.; Li, Song; Maroof, M. A. Saghai] Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA; [Kachroo, Aardra] Univ Kentucky, Dept Plant Pathol, Lexington, VA USA; [Redekar, Neelam R.] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA	Virginia Polytechnic Institute & State University; Oregon State University	Maroof, MAS (corresponding author), Virginia Tech, Sch Plant & Environm Sci, Blacksburg, VA 24061 USA.	smaroof@vt.edu		Redekar, Neelam/0000-0002-4819-9034; Saghai Maroof, MA/0000-0002-1398-7110	Virginia Soybean Board; Agricultural Experiment Station Hatch Program at Virginia Tech; Open Access Subvention Fund at Virginia Tech; John Lee Pratt Fellowship Program at Virginia Tech	Virginia Soybean Board; Agricultural Experiment Station Hatch Program at Virginia Tech; Open Access Subvention Fund at Virginia Tech; John Lee Pratt Fellowship Program at Virginia Tech	This project was funded in part by the Virginia Soybean Board. Additional funding was provided by the Agricultural Experiment Station Hatch Program and Open Access Subvention Fund -both at Virginia Tech. LD was funded in part by the John Lee Pratt Fellowship Program at Virginia Tech.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Alazem M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110581; Alazem M, 2015, MOL PLANT PATHOL, V16, P529, DOI 10.1111/mpp.12204; Anderson JP, 2004, PLANT CELL, V16, P3460, DOI 10.1105/tpc.104.025833; Argueso CT, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002448; Atsumi G, 2009, MOL PLANT MICROBE IN, V22, P166, DOI 10.1094/MPMI-22-2-0166; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; BAILEY TL, 1994, P 2 INT C INT SYST M, P28; Banf M, 2017, BBA-GENE REGUL MECH, V1860, P41, DOI 10.1016/j.bbagrm.2016.09.003; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bedre R, 2019, PLANT DIRECT, V3, DOI 10.1002/pld3.191; Bendahmane A, 1999, PLANT CELL, V11, P781, DOI 10.1105/tpc.11.5.781; Biernacki C, 2000, IEEE T PATTERN ANAL, V22, P719, DOI 10.1109/34.865189; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boter M, 2004, GENE DEV, V18, P1577, DOI 10.1101/gad.297704; Buss GR, 1997, CROP SCI, V37, P1987, DOI 10.2135/cropsci1997.0011183X003700060068x; Montes RAC, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-97; CHEN P, 1991, CROP SCI, V31, P305, DOI 10.2135/cropsci1991.0011183X003100020015x; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; CHO EK, 1979, PHYTOPATHOLOGY, V69, P467, DOI 10.1094/Phyto-69-467; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dombrecht B, 2007, PLANT CELL, V19, P2225, DOI 10.1105/tpc.106.048017; Du MM, 2017, PLANT CELL, V29, P1883, DOI 10.1105/tpc.16.00953; Faith JJ, 2007, PLOS BIOL, V5, P54, DOI 10.1371/journal.pbio.0050008; Grangeon R, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00351; Grangeon R, 2012, CURR OPIN VIROL, V2, P683, DOI 10.1016/j.coviro.2012.10.003; Grant D, 2010, NUCLEIC ACIDS RES, V38, pD843, DOI 10.1093/nar/gkp798; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; Gutterson N, 2004, CURR OPIN PLANT BIOL, V7, P465, DOI 10.1016/j.pbi.2004.04.007; Hajimorad MR, 2018, MOL PLANT PATHOL, V19, P1563, DOI 10.1111/mpp.12644; Hamaguchi A, 2008, BIOSCI BIOTECH BIOCH, V72, P2687, DOI 10.1271/bbb.80348; Haque S, 2019, CURR OPIN PLANT BIOL, V47, P96, DOI 10.1016/j.pbi.2018.10.005; Haury AC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-145; Hayes AJ, 2000, CROP SCI, V40, P1434, DOI 10.2135/cropsci2000.4051434x; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Huynh-Thu VA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012776; Ikeuchi M, 2018, PLANT CELL PHYSIOL, V59, P770, DOI 10.1093/pcp/pcy013; Jeong SC, 2002, CROP SCI, V42, P265, DOI 10.2135/cropsci2002.0265; Jin JP, 2017, NUCLEIC ACIDS RES, V45, pD1040, DOI 10.1093/nar/gkw982; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kaleta C, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-116; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Kim KH, 2011, DNA RES, V18, P483, DOI 10.1093/dnares/dsr033; Klepadlo M, 2017, CROP SCI, V57, P1844, DOI 10.2135/cropsci2016.05.0290; Kuffner R, 2012, BIOINFORMATICS, V28, P1376, DOI 10.1093/bioinformatics/bts143; Lee TI, 2013, CELL, V152, P1237, DOI 10.1016/j.cell.2013.02.014; Li YP, 2015, TRENDS PLANT SCI, V20, P664, DOI 10.1016/j.tplants.2015.06.013; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu HL, 2016, EUPHYTICA, V209, P49, DOI 10.1007/s10681-016-1631-4; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma G, 2002, J HERED, V93, P179, DOI 10.1093/jhered/93.3.179; Makinen K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00110; Marbach D, 2012, NAT METHODS, V9, P796, DOI [10.1038/nmeth.2016, 10.1038/NMETH.2016]; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; Maroof MAS, 2010, PLANT GENOME-US, V3, P14, DOI 10.3835/plantgenome2009.07.0020; Meyer PE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-461; Meyer RS, 2013, NAT REV GENET, V14, P840, DOI 10.1038/nrg3605; Moffat CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035995; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; O'Malley RC, 2016, CELL, V165, P1280, DOI 10.1016/j.cell.2016.04.038; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; Tran PT, 2018, VIROLOGY, V513, P153, DOI 10.1016/j.virol.2017.10.014; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Redekar N.R., 2016, PLANT GENOME, V9, P1; Redekar N, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.02029; Robert-Seilaniantz A, 2011, ANNU REV PHYTOPATHOL, V49, P317, DOI 10.1146/annurev-phyto-073009-114447; Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062; Schafer J, 2006, R NEWS, V6, P50; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Schweizer F, 2013, PLANT CELL, V25, P3117, DOI 10.1105/tpc.113.115139; Scrucca L, 2016, R J, V8, P289; Senthil G, 2005, J GEN VIROL, V86, P2615, DOI 10.1099/vir.0.81043-0; Seo JK, 2014, SCI REP-UK, V4, DOI 10.1038/srep05905; Seo JK, 2009, MOL PLANT MICROBE IN, V22, P1151, DOI 10.1094/MPMI-22-9-1151; Shibata M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.159707; Shin R, 2007, PLANT CELL, V19, P2440, DOI 10.1105/tpc.107.050963; Singh AK, 2011, MOL PLANT MICROBE IN, V24, P506, DOI 10.1094/MPMI-09-10-0201; Singh KB, 2002, CURR OPIN PLANT BIOL, V5, P430, DOI 10.1016/S1369-5266(02)00289-3; Singh P, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.22611; Suh SJ, 2011, PLANT GENOME-US, V4, P55, DOI 10.3835/plantgenome2010.11.0024; Taylor-Teeples M, 2015, NATURE, V517, P571, DOI 10.1038/nature14099; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; TU JC, 1989, J PHYTOPATHOL, V126, P231, DOI 10.1111/j.1439-0434.1989.tb01109.x; Wang Y, 2015, PLANT DIS, V99, P1644, DOI 10.1094/PDIS-01-15-0108-PDN	86	5	5	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231658	10.1371/journal.pone.0231658	http://dx.doi.org/10.1371/journal.pone.0231658			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315334	gold, Green Published			2022-12-26	WOS:000536024800042
J	Griffiths, PR; Lolait, SJ; Bijabhai, A; O'Carroll-Lolait, A; Paton, JFR; O'Carroll, AM				Griffiths, Philip R.; Lolait, Stephen J.; Bijabhai, Aarifah; O'Carroll-Lolait, Aoife; Paton, Julian F. R.; O'Carroll, Anne-Marie			Increased apelin receptor gene expression in the subfornical organ of spontaneously hypertensive rats	PLOS ONE			English	Article							SENSORY CIRCUMVENTRICULAR ORGANS; RIBONUCLEIC-ACID EXPRESSION; APJ RECEPTOR; ORPHAN RECEPTOR; AREA POSTREMA; CARDIOVASCULAR ACTIONS; FLUID HOMEOSTASIS; ENDOGENOUS LIGAND; VASOPRESSIN; PRESSURE	The vascular organ of the lamina terminalis, subfornical organ (SFO), and area postrema comprise the sensory circumventricular organs (CVO) which are central structures that lie outside the blood brain barrier and are thought to provide an interface between peripherally circulating signals and the brain through their projections to central autonomic structures. The SFO expresses mRNA for the G protein-coupled apelin receptor (APJ, gene name aplnr) and exogenous microinjection of the neuropeptide apelin (apln) to the SFO elicits a depressor effect. Here we investigated the expression and cellular distribution of aplnr, apln and the recently described ligand apela (apela) in the CVOs and investigated whether differences in the levels of expression of apelinergic gene transcripts in these regions might underlie the chronic elevated blood pressure seen in hypertension. We carried out multiplex in situ hybridization histochemistry on CVO tissue sections from spontaneously hypertensive rats (SHR) and normotensive Wistar Kyoto (WKY) controls. Confocal immunofluorescent images indicated strong aplnr expression, with lower levels of apln and modest apela expression, in the CVOs of both WKY rats and SHRs, in both neurons and glia. The expression level of aplnr transcripts was increased in the SFO of SHRs compared to WKY rats. Our data may highlight a potential dysfunction in the communication between CVOs and downstream signalling pathways in SHRs, which may contribute to its different phenotype/s.	[Griffiths, Philip R.; Lolait, Stephen J.; Bijabhai, Aarifah; O'Carroll, Anne-Marie] Univ Bristol, Bristol Med Sch, Fac Hlth Sci, Bristol, Avon, England; [O'Carroll-Lolait, Aoife] Univ Manchester, Fac Biol Med & Hlth, Sch Med Sci, Manchester, Lancs, England; [Paton, Julian F. R.] Univ Auckland, Fac Med & Hlth Sci, Dept Physiol, Auckland, New Zealand; [Paton, Julian F. R.] Univ Bristol, Sch Physiol Pharmacol & Neurosci, Biomed Sci, Bristol, Avon, England	University of Bristol; University of Manchester; University of Auckland; University of Bristol	O'Carroll, AM (corresponding author), Univ Bristol, Bristol Med Sch, Fac Hlth Sci, Bristol, Avon, England.	a.m.ocarroll@bristol.ac.uk		O'Carroll, Anne-Marie/0000-0001-5255-8506	British Heart Foundation (BHF) [PG/15/14/31311]	British Heart Foundation (BHF)(British Heart Foundation)	A-MO'C, SJL, JFRP This work was supported by the British Heart Foundation (BHF; www.bhf.org.uk) (PG/15/14/31311). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MA, 1997, AM J PHYSIOL-REG I, V272, pR1698, DOI 10.1152/ajpregu.1997.272.6.R1698; Barnes G, 2010, HEART, V96, P1011, DOI 10.1136/hrt.2009.191122; Barnes GD, 2013, CIRC-HEART FAIL, V6, P482, DOI 10.1161/CIRCHEARTFAILURE.111.000077; Biancardi VC, 2014, HYPERTENSION, V63, P572, DOI 10.1161/HYPERTENSIONAHA.113.01743; Boucher J, 2005, ENDOCRINOLOGY, V146, P1764, DOI 10.1210/en.2004-1427; Bulbul M, 2018, AUTON NEUROSCI-BASIC, V212, P17, DOI 10.1016/j.autneu.2018.03.005; Bulbul M, 2018, AM J PHYSIOL-GASTR L, V314, pG201, DOI 10.1152/ajpgi.00223.2017; Chandra SM, 2011, ARTERIOSCL THROM VAS, V31, P814, DOI 10.1161/ATVBAHA.110.219980; Chen C, 2015, ASN NEURO, V7, DOI 10.1177/1759091415575845; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Chu HL, 2017, CEREBROVASC DIS, V44, P10, DOI 10.1159/000460261; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; Dai L, 2013, J PHYSIOL-LONDON, V591, P3421, DOI 10.1113/jphysiol.2013.254144; Deng C, 2015, J BIOL CHEM, V290, P18261, DOI 10.1074/jbc.M115.648238; Duvernoy HM, 2007, BRAIN RES REV, V56, P119, DOI 10.1016/j.brainresrev.2007.06.002; Fisher JP, 2012, J HUM HYPERTENS, V26, P463, DOI 10.1038/jhh.2011.66; Griffiths PR, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01488; Griffiths PR, 2017, J PHYSIOL-LONDON, V595, P3303, DOI 10.1113/JP274178; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Harford-Wright E, 2017, BRAIN, V140, P2939, DOI 10.1093/brain/awx253; Higuchi K, 2007, ENDOCRINOLOGY, V148, P2690, DOI 10.1210/en.2006-1270; Ho LN, 2017, SCIENCE, V357, P707, DOI 10.1126/science.aam6607; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Iwanaga Y, 2006, J MOL CELL CARDIOL, V41, P798, DOI 10.1016/j.yjmcc.2006.07.004; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Jia Yue Xia, 2007, Peptides, V28, P2023, DOI 10.1016/j.peptides.2007.07.016; JOHNSON AK, 1993, FASEB J, V7, P678, DOI 10.1096/fasebj.7.8.8500693; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Kagiyama S, 2005, REGUL PEPTIDES, V125, P55, DOI 10.1016/j.regpep.2004.07.033; Kang YJ, 2013, CIRC RES, V113, P22, DOI 10.1161/CIRCRESAHA.113.301324; Katugampola SD, 2001, BRIT J PHARMACOL, V132, P1255, DOI 10.1038/sj.bjp.0703939; Kawamata Y, 2001, BBA-MOL CELL RES, V1538, P162, DOI 10.1016/S0167-4889(00)00143-9; Kidoya H, 2012, J BIOCHEM, V152, P125, DOI 10.1093/jb/mvs071; Kleinz MJ, 2005, REGUL PEPTIDES, V126, P233, DOI 10.1016/j.regpep.2004.10.019; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; LARSEN PJ, 1995, J NEUROSCI, V15, P2609; Lathen C, 2014, CIRCULATION, V130, P1179, DOI 10.1161/CIRCULATIONAHA.113.007822; Lee DK, 2006, TRENDS PHARMACOL SCI, V27, P190, DOI 10.1016/j.tips.2006.02.006; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Li YT, 2020, CLIN EXP HYPERTENS, V42, P239, DOI 10.1080/10641963.2019.1619756; Liu QZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7020; Lv SY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00320; Maguire JJ, 2009, HYPERTENSION, V54, P598, DOI 10.1161/HYPERTENSIONAHA.109.134619; Masaki T, 2012, BRAIN RES BULL, V87, P540, DOI 10.1016/j.brainresbull.2012.02.004; McKinley MJ, 2003, ADV ANAT EMBRYOL CEL, V172, P1; Medhurst AD, 2003, J NEUROCHEM, V84, P1162, DOI 10.1046/j.1471-4159.2003.01587.x; Mitra A, 2006, PHYSIOL BEHAV, V89, P221, DOI 10.1016/j.physbeh.2006.06.006; Munji RN, 2019, NAT NEUROSCI, V22, P1892, DOI 10.1038/s41593-019-0497-x; Najafipour H, 2012, REGUL PEPTIDES, V178, P43, DOI 10.1016/j.regpep.2012.06.006; O'Carroll AM, 2003, J NEUROENDOCRINOL, V15, P661, DOI 10.1046/j.1365-2826.2003.01044.x; O'Carroll AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183094; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; Pang H, 2014, INT J MOL MED, V34, P756, DOI 10.3892/ijmm.2014.1829; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Prager-Khoutorsky M, 2015, AM J PHYSIOL-REG I, V309, pR324, DOI 10.1152/ajpregu.00134.2015; Pulman KJ, 2006, J NEUROSCI, V26, P2022, DOI 10.1523/JNEUROSCI.3218-05.2006; Read C, 2019, PHARMACOL REV, V71, P467, DOI 10.1124/pr.119.017533; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Roberts EM, 2009, J ENDOCRINOL, V202, P453, DOI 10.1677/JOE-09-0134; Santoso P, 2015, NEUROREPORT, V26, P820, DOI 10.1097/WNR.0000000000000431; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seyedabadi M, 2002, AUTON NEUROSCI-BASIC, V101, P32, DOI 10.1016/S1566-0702(02)00178-9; SHAPIRO RE, 1985, J COMP NEUROL, V234, P344, DOI 10.1002/cne.902340306; Smith PM, 2009, AM J PHYSIOL-REG I, V296, pR512, DOI 10.1152/ajpregu.90858.2008; Smith PM, 1997, NEUROENDOCRINOLOGY, V66, P130, DOI 10.1159/000127230; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep08170; Yang PR, 2017, CIRCULATION, V135, P1160, DOI 10.1161/CIRCULATIONAHA.116.023218; Zhang F, 2014, ACTA PHYSIOL, V212, P17, DOI 10.1111/apha.12342; Zhang J, 2006, LIFE SCI, V79, P1153, DOI 10.1016/j.lfs.2006.03.040; Zhang Q, 2009, CIRC RES, V104, P1421, DOI 10.1161/CIRCRESAHA.108.192302; Zhong JC, 2005, CARDIOVASC RES, V65, P743, DOI 10.1016/j.cardiores.2004.10.020	76	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231844	10.1371/journal.pone.0231844	http://dx.doi.org/10.1371/journal.pone.0231844			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315363	Green Published, gold			2022-12-26	WOS:000536024800058
J	Wu, XX; Zhang, SM; Liu, XH; Shang, J; Zhang, AD; Zhu, ZW; Zha, DS				Wu, Xuexia; Zhang, Shengmei; Liu, Xiaohui; Shang, Jing; Zhang, Aidong; Zhu, Zongwen; Zha, Dingshi			Chalcone synthase (CHS) family members analysis from eggplant (Solanum melongena L.) in the flavonoid biosynthetic pathway and expression patterns in response to heat stress	PLOS ONE			English	Article							HIGH-TEMPERATURE; GENOME SEQUENCE; ANTHOCYANIN BIOSYNTHESIS; POLYKETIDE SYNTHASES; PROVIDES INSIGHTS; GENES; TOMATO; ROLES; COLOR	Enzymes of the chalcone synthase (CHS) family participate in the synthesis of multiple secondary metabolites in plants, fungi and bacteria. CHS showed a significant correlation with the accumulation patterns of anthocyanin. The peel color, which is primarily determined by the content of anthocyanin, is an economically important trait for eggplants that is affected by heat stress. A total of 7 CHS (SmCHS1-7) putative genes were identified in a genome-wide analysis of eggplants (S. melongena L.). The SmCHS genes were distributed on 7 scaffolds and were classified into 3 clusters. Phylogenetic relationship analysis showed that 73 CHS genes from 7 Solanaceae species were classified into 10 groups. SmCHS5, SmCHS6 and SmCHS7 were continuously down-regulated under 38 degrees C and 45 degrees C treatment, while SmCHS4 was up-regulated under 38 degrees C but showed little change at 45 degrees C in peel. Expression profiles of key anthocyanin biosynthesis gene families showed that the PAL, 4CL and AN11 genes were primarily expressed in all five tissues. The CHI, F3H, F3'5'H, DFR, 3GT and bHLH1 genes were expressed in flower and peel. Under heat stress, the expression level of 52 key genes were reduced. In contrast, the expression patterns of eight key genes similar to SmCHS4 were up-regulated at a treatment of 38 degrees C for 3 hour. Comparative analysis of putative CHS protein evolutionary relationships, cis-regulatory elements, and regulatory networks indicated that SmCHS gene family has a conserved gene structure and functional diversification. SmCHS showed two or more expression patterns, these results of this study may facilitate further research to understand the regulatory mechanism governing peel color in eggplants.	[Wu, Xuexia; Zhang, Shengmei; Liu, Xiaohui; Shang, Jing; Zhang, Aidong; Zhu, Zongwen; Zha, Dingshi] Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China	Shanghai Academy of Agricultural Sciences	Zha, DS (corresponding author), Shanghai Acad Agr Sci, Inst Hort Res, Shanghai Key Lab Protected Hort Technol, Shanghai, Peoples R China.	dingshizha1966@126.com			Agricultural Committee Basic Project (Shanghai Agricultural word) [6-2-3]; National Key Technology R&D Program during the 13th Five-Year Plan Period [2017YFD0101904]; China Agriculture Research System [CARS-25]	Agricultural Committee Basic Project (Shanghai Agricultural word); National Key Technology R&D Program during the 13th Five-Year Plan Period(National Key Technology R&D Program); China Agriculture Research System	In addition, the authors have declared this work was supported by the Agricultural Committee Basic Project (Shanghai Agricultural word (2015) No 6-2-3), the National Key Technology R&D Program during the 13th FiveYear Plan Period (2017YFD0101904) and the China Agriculture Research System (Grant No. CARS25). And the funding bodies supporting this work did not play a role in the design of the study and the collection, analysis, and interpretation of data or in the composition of the manuscript.	Austin MB, 2003, NAT PROD REP, V20, P79, DOI 10.1039/b100917f; Bombarely A, 2016, NAT PLANTS, V2, DOI [10.1038/nplants.2016.74, 10.1038/NPLANTS.2016.74]; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Buer CS, 2010, J INTEGR PLANT BIOL, V52, P98, DOI 10.1111/j.1744-7909.2010.00905.x; Chen C., 2020, TBTOOLS TOOLKIT BIOL, V289660, P289660, DOI DOI 10.1101/289660; Chennupati P, 2012, J AGR FOOD CHEM, V60, P12421, DOI 10.1021/jf3036319; Correia B, 2014, J PLANT PHYSIOL, V171, P399, DOI 10.1016/j.jplph.2013.12.004; Dao TTH, 2011, PHYTOCHEM REV, V10, P397, DOI 10.1007/s11101-011-9211-7; Dela G, 2003, PLANT SCI, V164, P333, DOI 10.1016/S0168-9452(02)00417-X; Ferreyra MLF, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00222; Ferrer JL, 1999, NAT STRUCT BIOL, V6, P775, DOI 10.1038/11553; Glagoleva AY, 2019, BMC GENET, V20, DOI 10.1186/s12863-019-0727-y; Han YH, 2017, MOL BREEDING, V37, DOI 10.1007/s11032-017-0721-x; Han YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020161; Hirakawa H, 2014, DNA RES, V21, P649, DOI 10.1093/dnares/dsu027; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; JACOBS M, 1988, SCIENCE, V241, P346, DOI 10.1126/science.241.4863.346; Jiang MM, 2016, ACTA PHYSIOL PLANT, V38, DOI 10.1007/s11738-016-2172-0; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lin-Wang K, 2011, PLANT CELL ENVIRON, V34, P1176, DOI 10.1111/j.1365-3040.2011.02316.x; Liu R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44527; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lv LL, 2019, GENOME, V62, P503, DOI 10.1139/gen-2019-0021; Mori K, 2007, J EXP BOT, V58, P1935, DOI 10.1093/jxb/erm055; Movahed N, 2016, J PLANT RES, V129, P513, DOI 10.1007/s10265-016-0786-3; Nozaki K, 2006, J HORTIC SCI BIOTECH, V81, P728, DOI 10.1080/14620316.2006.11512130; Pang YZ, 2005, PLANT SCI, V168, P1525, DOI 10.1016/j.plantsci.2005.02.003; Pastore C, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00929; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schmidt MHW, 2017, PLANT CELL, V29, P2336, DOI 10.1105/tpc.17.00521; Schroder J, 1997, TRENDS PLANT SCI, V2, P373, DOI 10.1016/S1360-1385(97)01104-7; Sierro N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4833; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Subramanian B, 2019, NUCLEIC ACIDS RES, V47, pW270, DOI 10.1093/nar/gkz357; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TROPF S, 1995, J BIOL CHEM, V270, P7922, DOI 10.1074/jbc.270.14.7922; Winkel-Shirley B, 2001, PLANT PHYSIOL, V127, P1399, DOI 10.1104/pp.127.4.1399; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu XC, 2018, INTERPRETATION-J SUB, V6, pT499, DOI 10.1190/INT-2017-0129.1; Xu X, 2011, NATURE, V475, P189, DOI 10.1038/nature10158; Zhang SM, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-1960-2; Zhang YJ, 2014, J AGR FOOD CHEM, V62, P2906, DOI 10.1021/jf404574c; Zhou B, 2013, AM J BOT, V100, P2458, DOI 10.3732/ajb.1300305	46	22	24	6	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2020	15	4							e0226537	10.1371/journal.pone.0226537	http://dx.doi.org/10.1371/journal.pone.0226537			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9LH	32302307	Green Published, Green Submitted, gold			2022-12-26	WOS:000536016100004
J	Agbadi, P; Eunice, TT; Akosua, AF; Owusu, S				Agbadi, Pascal; Eunice, Tagoe Twumwaa; Akosua, Agyemang F.; Owusu, Seth			Complex samples logistic regression analysis of predictors of the current use of modern contraceptive among married or in-union women in Sierra Leone: Insight from the 2013 demographic and health survey	PLOS ONE			English	Article							REPRODUCTIVE AGE; RURAL DISTRICTS; AFRICA; DEMAND	Background Non-use of modern contraceptives among married or in-union women aged 15 to 49 years is a demographic and public health challenge. Studies on the predictors of contraceptive use among women in Sierra Leone are few, more than two decades old, and not nationally representative. This study aims to fill this gap by estimating the prevalence and the predictors of the current use of modern contraceptives among married or in-union women in Sierra Leone. Methods This is a population-based study that used the 2013 Sierra Leone Demographic and Health Survey (SDHS) dataset. We performed complex samples logistic regression with 9,111 reproductive-age women. The analysis was done using the IBM SPSS Statistics version 21, and statistical significance was pegged at p <= 0.01 and p <= 0.05. The outcome of interest is the current use of modern contraceptives among reproductive-age married or in-union women in Sierra Leone, measured as `Yes' (currently using a modern method) and `No' (using a folkloric method, traditional method, and no method). Results About 18.1% of reproductive-age women were currently using a modern contraceptive. The study found the following sociodemographic factors as positive correlates: being within the age group of 20-24 years [AOR = 1.52, CI: 1.05, 2.19], 25-29 years [AOR = 1.57, CI: 1.10, 2.19], 30-34 years [AOR = 2.31, CI: 1.59, 3.36], 35-39 years [AOR = 1.89, CI: 1.33, 2.70], 40-44 years [AOR = 1.68, CI: 1.12, 2.52], obtaining either a primary [AOR = 1.40, CI: 1.14, 1.71] or secondary level education [AOR = 1.34, CI: 1.02, 1.74], belonging to the category of women that condemned wife beating under only one condition [AOR = 1.37, CI: 1.03, 1.78], under two conditions [AOR = 1.45, CI: 1.08, 1.93], under three conditions [AOR = 1.73, CI: 1.28, 2.35], under four conditions [AOR = 1.91, CI: 1.34, 2.72], and under five conditions [AOR = 1.41, CI: 1.07, 1.85], having the ability to refuse sex [AOR = 1.46, CI: 1.23, 1.76], ever heard family planning on the radio [AOR = 1.30, CI: 1.08, 1.58], being sexually active four weeks prior to the survey [AOR = 3.90, CI: 3.14, 4.84], ever taken an HIV test [AOR = 1.67, CI: 1.39, 2.02], ever visited a health facility in the last 12 months [AOR = 1.73, CI: 1.44, 2.09], dwelling in a richer household [AOR = 1.32, CI: 1.01, 1.72], and dwelling in an urban area [AOR = 1.44, CI: 1.14, 1.81]. Exposure to family planning through print media (newspaper/magazine) was negatively associated with current use of modern contraceptive [AOR = 0.60, CI: 0.37, 0.96]. Conclusion The study provided in-depth insight into the sociodemographic predictors of the current use of modern contraceptives among married or in-union women in Sierra Leone. The study underscored the need to promote the protective factors of the current use of modern contraceptives and address the risk factors of the low prevalence of modern contraceptive use through policies, programs, and interventions in Sierra Leone.	[Agbadi, Pascal] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana; [Eunice, Tagoe Twumwaa] Ghana Christian Univ Coll, Sch Dev Management, Kumasi, Ghana; [Akosua, Agyemang F.] Univ Ghana, Dept Social Work, Accra, Ghana; [Owusu, Seth] African Inst Math Sci, Adisadel Cape Coast, Ghana	Kwame Nkrumah University Science & Technology; University of Ghana	Agbadi, P (corresponding author), Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Nursing, Kumasi, Ghana.	pascalagbadi@gmail.com	Agbadi, Pascal/AAS-6842-2020	Agbadi, Pascal/0000-0001-5297-2512; Adwubi, Eunice Twumwaa/0000-0002-2198-4980				Achana FS, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0017-8; ADB, 2021, ADBS SUPP SUST DEV G; Ajaero CK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2979-z; Amin R, 1998, J BIOSOC SCI, V30, P287, DOI 10.1017/S0021932098002879; Amin R, 1992, INT FAMILY PLANNING, P24; Andi Jimmy Ronald, 2014, Etude Popul Afr, V28, P1009; [Anonymous], AFRICAN J REPROD HLT; Apanga PA, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.10.5301; Aryeetey R, 2010, GHANA AFR J REPROD H, V14, P27; Bogale B, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-342; Cahill N, 2018, LANCET, V391, P870, DOI 10.1016/S0140-6736(17)33104-5; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Croft Trevor N., 2018, GUIDE DHS STAT; Daniels K., 2018, URBAN RURAL VARIATIO; Darroch JE, 2016, COSTS BENEFITS M CON, V1, P1; Darroch JE, 2016, ADD COSTS BEN INV SE; Flint J, 2017, PACIFIC J REPROD HLT; Ganatra B, 2016, BEST PRACT RES CL OB, V36, P145, DOI 10.1016/j.bpobgyn.2016.07.008; Kantorova V, 2017, STUD FAMILY PLANN, V48, P223, DOI 10.1111/sifp.12025; Lilungulu Athanase, 2015, Matern Health Neonatol Perinatol, V1, P1, DOI 10.1186/s40748-014-0002-1; Mekonnen W, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-37; Mignini L, 2016, BJOG-INT J OBSTET GY, V123, P730; Mosher WD, 2010, VITAL HLTH STAT, V23, P1; Muhindo R, 2015, INT J POPULATION RES, V2015, P1, DOI [10.1155/2015/617907, DOI 10.1155/2015/617907]; OlaOlorun Funmilola, 2010, Afr J Reprod Health, V14, P9; Oringanje C, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005215.pub3; Population Reference Bureau, 2019, FAM PLANN DAT SHEET; Rahman M. M., 2010, Journal of Population and Social Studies, V18, P87; Sabbah-Karkaby M, 2017, STUD FAMILY PLANN, V48, P23, DOI 10.1111/sifp.12015; Shiferaw S, 2015, GLOBAL HEALTH ACTION, V8, P35, DOI 10.3402/gha.v8.29720; Statistics Sierra Leone (SSL), 2014, SIERR LEON DEM HLTH; Stiegler N, 2016, J ASIAN AFR STUD, V51, P416, DOI 10.1177/0021909614547462; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; Wulifan JK, 2017, J HEALTH CARE POOR U, V28, P228, DOI 10.1353/hpu.2017.0019	34	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231630	10.1371/journal.pone.0231630	http://dx.doi.org/10.1371/journal.pone.0231630			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298333	Green Published, gold			2022-12-26	WOS:000536011400077
J	Cortes-Flores, J; Cornejo-Tenorio, G; Sanchez-Coronado, ME; Orozco-Segovia, A; Ibarra-Manriquez, G				Cortes-Flores, Jorge; Cornejo-Tenorio, Guadalupe; Esther Sanchez-Coronado, Maria; Orozco-Segovia, Alma; Ibarra-Manriquez, Guillermo			Disentangling the influence of ecological and historical factors on seed germination and seedling types in a Neotropical dry forest	PLOS ONE			English	Article							TROPICAL FOREST; LIFE-HISTORY; RAIN-FOREST; TRADE-OFFS; SIZE; DISPERSAL; PHYLOGENY; EVOLUTION; TIME; MASS	In tropical dry forests, although seed germination and seedling establishment are in general limited by the seasonal availability of water, high interspecific variability, nonetheless, exists in terms of seedling traits and germination dynamics. Differences among species in seed germination and seedling traits may be related to other plant life-history traits, such that assessing these relationships may increase our understanding of factors influencing plant establishment, which would affect the regeneration pathways of tropical dry forest communities. In this study, taking into consideration the effect species' phylogeny, we evaluated the relationships of seed germination metrics (percentage, lag time, and rate of germination) and seedling types (i.e. cotyledons functional morphology), with plant life-history traits (growth form, seed mass, dispersal syndrome and dispersal phenology) for 110 species in a Neotropical dry forest in Mexico. A total of 92% of the species studied disperse their seeds during the dry season, mainly at the beginning of this season (66%), a strategy mostly associated with autochorous herbs. Seed germination was more frequent in species that dispersed seeds at the end of the dry season. Germination percentage was not related to any of the traits studied. However, germination lag time and rate were negatively related to seed mass, a trait that in turn depended on growth form and dispersal syndrome. The dominant seedling type in the community was phanerocotylar epigeal with foliaceous cotyledons (56%), which was mostly associated with small seed mass and herbaceous growth form. Our results provide evidence that several plant life-history traits explain an important part of the variation in seed germination and seedling characteristics observed among species. Therefore, these plant life-history traits may be useful for grouping species in terms of their establishment strategies and roles on the regeneration of tropical dry communities.	[Cortes-Flores, Jorge; Cornejo-Tenorio, Guadalupe; Ibarra-Manriquez, Guillermo] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico; [Cortes-Flores, Jorge] Univ Nacl Autonoma Mexico, Escuela Nacl Estudios Super, Unidad Morelia, Lab Nacl Anal & Sintesis Ecol, Morelia, Michoacan, Mexico; [Esther Sanchez-Coronado, Maria; Orozco-Segovia, Alma] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Func, Ciudad De Mexico, Mexico; [Cortes-Flores, Jorge] Inst Biol, Jardin Bot, Ex Fabrica San Manuel S-N, Santa Cruz Tlaxcala, Tlaxcala, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Ibarra-Manriquez, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabilidad, Morelia, Michoacan, Mexico.	gibarra@cieco.unam.mx		Cortes-Flores, Jorge/0000-0001-9578-7827	Posgrado en Ciencias Biologicas of Universidad Nacional Autonoma de Mexico (UNAM) - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of UNAM [IN207512]	Posgrado en Ciencias Biologicas of Universidad Nacional Autonoma de Mexico (UNAM) - Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of UNAM	The first author thanks the Posgrado en Ciencias Biologicas of Universidad Nacional Autonoma de Mexico (UNAM) for its support during his PhD studies. This work was funded by the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT) of UNAM, Project IN207512 (Fenologia de especies arboreas del bosque tropical caducifolio en la Depresion del Balsas, Michoacan) (GIM as Head Researcher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Baraloto C, 2005, ECOLOGY, V86, P2461, DOI 10.1890/04-1956; Baraloto C, 2007, AM J BOT, V94, P901, DOI 10.3732/ajb.94.6.901; Baskin CC, 2014, SEEDS: ECOLOGY, BIOGEOGRAPHY, AND EVOLUTION OF DORMANCY AND GERMINATION, 2ND EDITION, P1, DOI 10.1016/B978-0-12-416677-6.00001-9; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Cervantes M, 2014, BOT SCI, V92, P281, DOI 10.17129/botsci.96; CORDAZZO C. V., 2002, Braz. J. Biol., V62, P427, DOI 10.1590/S1519-69842002000300005; Cortes-Flores J, 2018, OECOLOGIA, V189, P1, DOI [10.1007/s00442-018-4233-0, DOI 10.1007/S00442-018-4233-0]; Cortes-Flores J, 2017, AM J BOT, V104, P39, DOI 10.3732/ajb.1600305; Donohue K, 2010, ANNU REV ECOL EVOL S, V41, P293, DOI 10.1146/annurev-ecolsys-102209-144715; Eriksson O, 2008, INT J PLANT SCI, V169, P863, DOI 10.1086/589888; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Garcia E., 2004, MODIFICACIONES SISTE; GARWOOD NC, 1983, ECOL MONOGR, V53, P159, DOI 10.2307/1942493; Garwood NC., 1996, ECOLOGY TROPICAL FOR, P59; GRIME JP, 1981, J ECOL, V69, P1017, DOI 10.2307/2259651; Griz LMS, 2001, J TROP ECOL, V17, P303, DOI 10.1017/S0266467401001201; Braz MIG, 2010, BIOTROPICA, V42, P327, DOI 10.1111/j.1744-7429.2009.00602.x; Gutterman Y., 1993, SEED GERMINATION DES; Harper J. L., 1977, Population biology of plants.; Heydel F, 2017, OIKOS, V126, P738, DOI 10.1111/oik.03442; Ho LST, 2014, SYST BIOL, V63, P397, DOI 10.1093/sysbio/syu005; Ibarra-Manriquez G, 2001, AM J BOT, V88, P1801, DOI 10.2307/3558356; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Khurana E, 2001, ENVIRON CONSERV, V28, P39, DOI 10.1017/S0376892901000042; KITAJIMA K, 1994, OECOLOGIA, V98, P419, DOI 10.1007/BF00324232; Kitajima K, 2002, AM J BOT, V89, P1925, DOI 10.3732/ajb.89.12.1925; Kitajima K., 2000, Seeds: the ecology of regeneration in plant communities, P331, DOI 10.1079/9780851994321.0331; Kitajima K., 2007, HDB FUNCTIONAL PLANT; LEISHMAN MR, 1995, J ECOL, V83, P517, DOI 10.2307/2261604; LORD J, 1995, AM NAT, V146, P349, DOI 10.1086/285804; Magallon S, 2015, NEW PHYTOL, V207, P437, DOI 10.1111/nph.13264; MAZER SJ, 1990, EVOL ECOL, V4, P326, DOI 10.1007/BF02270931; Milberg P, 1997, NEW PHYTOL, V137, P665, DOI 10.1046/j.1469-8137.1997.00870.x; Moles AT, 2007, GLOBAL ECOL BIOGEOGR, V16, P109, DOI 10.1111/j.1466-8238.2006.00259.x; Moles AT, 2004, J ECOL, V92, P384, DOI 10.1111/j.0022-0477.2004.00880.x; Muscarella R, 2013, J ECOL, V101, P171, DOI 10.1111/1365-2745.12027; Norden N, 2009, FUNCT ECOL, V23, P203, DOI 10.1111/j.1365-2435.2008.01477.x; Orme CDL, 2013, CAPER COMP ANAL PHYL, DOI DOI 10.1371/journal.pone.0066213; Paradis Emmanuel, 2019, Bioinformatics, V35, P526, DOI 10.1093/bioinformatics/bty633; Pijl van der L., 1972, PRINCIPLES DISPERSAL; Poorter L, 2008, BIOTROPICA, V40, P321, DOI 10.1111/j.1744-7429.2007.00380.x; Poorter L, 2007, AM NAT, V169, P433, DOI 10.1086/512045; R Core Team, 2021, R LANGUAGE ENV STAT; Rees M, 1997, OIKOS, V78, P116, DOI 10.2307/3545807; Santos HP, 2004, ANN BOT-LONDON, V94, P819, DOI 10.1093/aob/mch209; Sautu A, 2006, FOREST ECOL MANAG, V234, P245, DOI 10.1016/j.foreco.2006.07.006; Stan K, 2019, FORESTS, V10, DOI 10.3390/f10050443; Vazquez-Yanes C, 1997, REPRODUCCION PLANTAS; VENABLE DL, 1980, OECOLOGIA, V46, P272, DOI 10.1007/BF00540137; Vieira DLM, 2006, RESTOR ECOL, V14, P11, DOI 10.1111/j.1526-100X.2006.00100.x; Wang JH, 2009, EVOL ECOL, V23, P827, DOI 10.1007/s10682-008-9273-1; Wang ZN, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01532; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098601; Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194; Zanne AE, 2005, AM J BOT, V92, P972, DOI 10.3732/ajb.92.6.972; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhang ST, 2004, FOLIA GEOBOT, V39, P129, DOI 10.1007/BF02805242	61	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231526	10.1371/journal.pone.0231526	http://dx.doi.org/10.1371/journal.pone.0231526			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298323	gold, Green Published			2022-12-26	WOS:000536011400061
J	Halpert, MM; Konduri, V; Liang, D; Vazquez-Perez, J; Hofferek, CJ; Weldon, SA; Baig, YY; Vedula, I; Levitt, JM; Decker, WK				Halpert, Matthew M.; Konduri, Vanaja; Liang, Dan; Vazquez-Perez, Jonathan; Hofferek, Colby J.; Weldon, Scott A.; Baig, Yunyu; Vedula, Indira; Levitt, Jonathan M.; Decker, William K.			MHC class I and II peptide homology regulates the cellular immune response	FASEB JOURNAL			English	Article						AIMp1; CTLA-4; dendritic cell; PAMP; PRR; T(H)1 polarization	TRANSFER-RNA SYNTHETASE; GMP-AMP SYNTHASE; DENDRITIC CELLS; CROSS-PRESENTATION; TLR LIGANDS; DNA SENSOR; RECOGNITION; INFECTION; CYTOKINE; MICE	Mammalian immune responses are initiated by "danger" signals--immutable molecular structures known as PAMPs. When detected by fixed, germline encoded receptors, pathogen-associated molecular pattern (PAMPs) subsequently inform the polarization of downstream adaptive responses depending upon identity and localization of the PAMP. Here, we report the existence of a completely novel "PAMP" that is not a molecular structure but an antigenic pattern. This pattern--the incidence of peptide epitopes with stretches of 100% sequence identity bound to both dendritic cell (DC) major histocompatibility (MHC) class I and MHC class II--strongly induces T(H)1 immune polarization and activation of the cellular immune response. Inherent in the existence of this PAMP is the concomitant existence of a molecular sensor complex with the ability to scan and compare amino acid sequence identities of bound class I and II peptides. We provide substantial evidence implicating the multienzyme aminoacyl-tRNA synthetase (mARS) complex and its AIMp1 structural component as the key constituents of this complex. The results demonstrate a wholly novel mechanism by which T-helper (T-H) polarization is governed and provide critical information for the design of vaccination strategies intended to provoke cell-mediated immunity.	[Halpert, Matthew M.; Konduri, Vanaja; Liang, Dan; Vazquez-Perez, Jonathan; Hofferek, Colby J.; Baig, Yunyu; Vedula, Indira; Levitt, Jonathan M.; Decker, William K.] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA; [Weldon, Scott A.] Baylor Coll Med, Michael E DeBakey Dept Surg, Houston, TX 77030 USA; [Levitt, Jonathan M.] Baylor Coll Med, Scott Dept Urol, Houston, TX 77030 USA; [Levitt, Jonathan M.; Decker, William K.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Decker, William K.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Decker, WK (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA.	decker@bcm.edu			HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID) [AI127387]; Cancer Prevention and Research Institute of Texas (CPRIT) [RP110545]	HHS \ NIH \ National Institute of Allergy and Infectious Diseases (NIAID); Cancer Prevention and Research Institute of Texas (CPRIT)	HHS vertical bar NIH vertical bar National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: AI127387; Cancer Prevention and Research Institute of Texas (CPRIT), Grant/Award Number: RP110545	Ablasser A, 2009, J IMMUNOL, V182, P6824, DOI 10.4049/jimmunol.0803001; Ahn SS, 2018, CLIN EXP RHEUMATOL, V36, P533; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Azouz NP, 2014, J IMMUNOL, V192, P4043, DOI 10.4049/jimmunol.1302196; Bafica A, 2005, J EXP MED, V202, P1715, DOI 10.1084/jem.20051782; Belizaire R, 2009, P NATL ACAD SCI USA, V106, P17463, DOI 10.1073/pnas.0908583106; BHARDWAJ N, 1994, J CLIN INVEST, V94, P797, DOI 10.1172/JCI117399; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Carroll EC, 2016, IMMUNITY, V44, P597, DOI 10.1016/j.immuni.2016.02.004; Dabbagh K, 2002, J IMMUNOL, V168, P4524, DOI 10.4049/jimmunol.168.9.4524; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; Decker WK, 2008, J IMMUNOTHER, V31, P157, DOI 10.1097/CJI.0b013e31815eb0df; Decker WK, 2009, BLOOD, V113, P4213, DOI 10.1182/blood-2008-10-185470; Decker WK, 2006, VACCINE, V24, P3203, DOI 10.1016/j.vaccine.2006.01.029; Dow C, 2008, J VIROL, V82, P11734, DOI 10.1128/JVI.00435-08; Embgenbroich M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01643; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Gorchakov R, 2005, J VIROL, V79, P9397, DOI 10.1128/JVI.79.15.9397-9409.2005; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Halpert MM, 2016, STEM CELLS DEV, V25, P774, DOI 10.1089/scd.2016.0009; Hausmann CD, 2008, FEMS MICROBIOL REV, V32, P705, DOI 10.1111/j.1574-6976.2008.00119.x; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Hong HJ, 2012, CLIN IMMUNOL, V143, P256, DOI 10.1016/j.clim.2012.02.004; Hong SH, 2015, BIOMATERIALS, V44, P45, DOI 10.1016/j.biomaterials.2014.12.017; JAKUBOWSKI H, 1992, MICROBIOL REV, V56, P412, DOI 10.1128/MMBR.56.3.412-429.1992; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim E, 2006, J IMMUNOL, V176, P256, DOI 10.4049/jimmunol.176.1.256; Kim E, 2008, J IMMUNOL, V180, P2894, DOI 10.4049/jimmunol.180.5.2894; Kim MS, 2015, J IMMUNOL, V194, P4729, DOI 10.4049/jimmunol.1401352; Kleijmeer MJ, 2001, TRAFFIC, V2, P124, DOI 10.1034/j.1600-0854.2001.020207.x; Klein O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15047-8; KNIGHT SC, 1993, RES VIROLOGY, V144, P75, DOI 10.1016/S0923-2516(06)80015-4; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Konduri V, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1213933; Konduri V, 2013, J INFECT DIS, V207, P1764, DOI 10.1093/infdis/jit087; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Kurts C, 1998, J EXP MED, V188, P409, DOI 10.1084/jem.188.2.409; Lamhamedi-Cherradi SE, 2008, J IMMUNOL, V180, P6000, DOI 10.4049/jimmunol.180.9.6000; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Liang D, 2015, INT REV IMMUNOL, V34, P367, DOI 10.3109/08830185.2015.1077829; Liang D, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01801; Lim HX, 2018, J IMMUNOL, V201, P2832, DOI 10.4049/jimmunol.1800386; LJUNGGREN HG, 1991, INT J CANCER, P38; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Luecke S, 2017, CYTOKINE, V98, P4, DOI 10.1016/j.cyto.2016.10.003; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Murakami D, 2007, CLIN EXP ALLERGY, V37, P339, DOI 10.1111/j.1365-2222.2006.02633.x; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Navabi H, 2009, VACCINE, V27, P107, DOI 10.1016/j.vaccine.2008.10.024; Nembrini C, 2006, J IMMUNOL, V176, P7180, DOI 10.4049/jimmunol.176.12.7180; Park SG, 2005, AM J PATHOL, V166, P387, DOI 10.1016/S0002-9440(10)62262-6; Pilon C, 2009, MOL IMMUNOL, V46, P437, DOI 10.1016/j.molimm.2008.10.014; Qian C, 2013, ANN NY ACAD SCI, V1283, P67, DOI 10.1111/j.1749-6632.2012.06786.x; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rodriguez MJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40449; Rohn TA, 2004, NAT IMMUNOL, V5, P909, DOI 10.1038/ni1108; Safdar A, 2009, VACCINE, V27, P1479, DOI 10.1016/j.vaccine.2009.01.017; Shi GP, 2013, J IMMUNOL, V191, P415, DOI 10.4049/jimmunol.1201732; Spranger S, 2010, J IMMUNOL, V185, P738, DOI 10.4049/jimmunol.1000060; Sprokholt JK, 2017, J IMMUNOL, V198, P4764, DOI 10.4049/jimmunol.1602121; Stephens R, 2002, J IMMUNOL, V169, P5468, DOI 10.4049/jimmunol.169.10.5468; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Strong BSI, 2011, J IMMUNOL, V187, P2193, DOI 10.4049/jimmunol.1100152; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Toribio R, 2010, P NATL ACAD SCI USA, V107, P9837, DOI 10.1073/pnas.1004110107; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wolkers MC, 2004, SCIENCE, V304, P1314, DOI 10.1126/science.1096268; Wu MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020923; Xagorari Angeliki, 2008, Open Microbiol J, V2, P49, DOI 10.2174/1874285800802010049	79	6	6	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8082	8101		10.1096/fj.201903002R	http://dx.doi.org/10.1096/fj.201903002R		APR 2020	20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32298026	Green Accepted			2022-12-26	WOS:000526651700001
J	Landman, R; Sharma, J; Hyman, JB; Fanucci-Kiss, A; Meisner, O; Parmar, S; Feng, GP; Desimone, R				Landman, Rogier; Sharma, Jitendra; Hyman, Julia B.; Fanucci-Kiss, Adrian; Meisner, Olivia; Parmar, Shivangi; Feng, Guoping; Desimone, Robert			Close-range vocal interaction in the common marmoset (Callithrix jacchus)	PLOS ONE			English	Article							TURN-TAKING; ACOUSTIC ANALYSIS; PYGMY MARMOSETS; SOCIAL-CONTEXT; CONTACT CALLS; VOCALIZATIONS; COMMUNICATION; ORGANIZATION; INDIVIDUALS; VARIABILITY	Vocal communication in animals often involves taking turns vocalizing. In humans, turn-taking is a fundamental rule in conversation. Among non-human primates, the common marmoset is known to engage in antiphonal calling using phee calls and trill calls. Calls of the trill type are the most common, yet difficult to study, because they are not very loud and uttered in conditions when animals are in close proximity to one another. Here we recorded trill calls in captive pair-housed marmosets using wearable microphones, while the animals were together with their partner or separated, but within trill call range. Trills were exchanged mainly with the partner and not with other animals in the room. Animals placed outside the home cage increased their trill call rate and uttered more trills in response to their partner compared to strangers. The fundamental frequency, F0, of trills increased when animals were placed outside the cage. Our results indicate that trill calls can be monitored using wearable audio equipment and that minor changes in social context affect trill call interactions and spectral properties of trill calls.	[Landman, Rogier; Sharma, Jitendra; Hyman, Julia B.; Fanucci-Kiss, Adrian; Meisner, Olivia; Parmar, Shivangi; Feng, Guoping; Desimone, Robert] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Landman, Rogier; Sharma, Jitendra; Feng, Guoping; Desimone, Robert] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Landman, Rogier; Feng, Guoping] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Sharma, Jitendra] MIT, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sharma, Jitendra] Harvard Med Sch, Dept Radiol, Martinos Ctr Biomed Imaging, Massachusetts Gen Hosp, Cambridge, MA USA; [Sharma, Jitendra] Harvard Med Sch, Dept Anesthesia Crit Care & Pain Med, Massachusetts Gen Hosp, Cambridge, MA USA; [Sharma, Jitendra] MIT, Simons Ctr Social Brain, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)	Landman, R (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Landman, R (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Landman, R (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA.	landman@mit.edu	Landman, Rogier/AAB-4757-2021		Stanley Center for Psychiatric Research; Simons Center for the Social Brain; National Institutes of Health [1R01MH111916-01A1, 2P50MH094271-06, 5R01MH111916-02]; Poitras Center for Psychiatric Disorders Research; Tan-Yang Center for Autism Research	Stanley Center for Psychiatric Research; Simons Center for the Social Brain; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Poitras Center for Psychiatric Disorders Research; Tan-Yang Center for Autism Research	This work has been supported by the Stanley Center for Psychiatric Research (https://www.broadinstitute.org/stanley), the Poitras Center for Psychiatric Disorders Research (https://mcgovern.mit.edu/center/poitras-center/), the Simons Center for the Social Brain (https://scsb.mit.edu/), the Tan-Yang Center for Autism Research (https://mcgovern.mit.edu/centers/hock-e-tan-and-k-lisa-yang-center-for-autism-research/), the National Institutes of Health, Award No. 1R01MH111916-01A1 and Award No. 2P50MH094271-06 to Guoping Feng, Award No. 5R01MH111916-02 to Robert Desimone. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agamaite JA, 2015, J ACOUST SOC AM, V138, P2906, DOI 10.1121/1.4934268; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; BAUERS K, 1990, AM J PRIMATOL, V21, P53, DOI 10.1002/ajp.1350210106; Bezerra BM, 2008, INT J PRIMATOL, V29, P671, DOI 10.1007/s10764-008-9250-0; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Candiotti A, 2012, BIOL LETTERS, V8, P382, DOI 10.1098/rsbl.2011.1182; Cheney DL, 1996, ANIM BEHAV, V52, P507, DOI 10.1006/anbe.1996.0193; Choi JY, 2015, J NEUROPHYSIOL, V114, P274, DOI 10.1152/jn.00228.2015; Chow CP, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0069; Clarke E, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0332-2; De la Torre S, 2002, ANIM BEHAV, V63, P847, DOI 10.1006/anbe.2001.1978; DIGBY LJ, 1995, PRIMATES, V36, P361, DOI 10.1007/BF02382859; Dittus W., 1988, P31; Golkar A, 2013, BEHAV NEUROSCI, V127, P59, DOI 10.1037/a0030892; Gratier M, 2015, FRONT PSYCHOL, V6, DOI [10.3389/fpsyg.2015.01167, 10.3389/fpgyg.2015.01167]; Guggenberger Mario, 2015, MultiMedia Modeling. 21st International Conference, MMM 2015, January 5-7, 2015, Proceedings: LNCS 8935, P203, DOI 10.1007/978-3-319-14445-0_18; Leentjens AFG, 1998, J NEUROL NEUROSUR PS, V64, P375, DOI 10.1136/jnnp.64.3.375; Lemasson A, 2011, J ACOUST SOC AM, V129, P3341, DOI 10.1121/1.3569704; Lemasson A, 2013, PRIMATES, V54, P283, DOI 10.1007/s10329-013-0347-5; Ma JKY, 2015, J PARKINSON DIS, V5, P291, DOI 10.3233/JPD-140451; Masataka N, 2008, BEHAVIOUR, V98, P259, DOI [10.1163/156853986x0099, DOI 10.1163/156853986X00991]; Mendoza E, 1998, J VOICE, V12, P263, DOI 10.1016/S0892-1997(98)80017-9; Miller CT, 2012, J COMP PHYSIOL A, V198, P337, DOI 10.1007/s00359-012-0712-7; Miller CT, 2006, J COMP PHYSIOL A, V192, P27, DOI 10.1007/s00359-005-0043-z; MORRIS TH, 1993, LAB ANIM, V27, P381, DOI 10.1258/002367793780745534; NEWMAN JD, 1983, FOLIA PRIMATOL, V40, P114, DOI 10.1159/000156093; NORCROSS JL, 1993, AM J PRIMATOL, V30, P37, DOI 10.1002/ajp.1350300104; Norcross JL, 1997, AM J PRIMATOL, V43, P135, DOI 10.1002/(SICI)1098-2345(1997)43:2<135::AID-AJP3>3.0.CO;2-Y; Oikarinen T, 2019, J ACOUST SOC AM, V145, P654, DOI 10.1121/1.5087827; POLA YV, 1975, ANIM BEHAV, V23, P826, DOI 10.1016/0003-3472(75)90108-6; Rapin I, 2003, BRAIN DEV-JPN, V25, P166, DOI 10.1016/S0387-7604(02)00191-2; Rendall D, 2000, J COMP PSYCHOL, V114, P36, DOI 10.1037/0735-7036.114.1.36; SACKS H, 1974, LANGUAGE, V50, P696, DOI 10.2307/412243; Sauter DA, 2010, Q J EXP PSYCHOL, V63, P2251, DOI 10.1080/17470211003721642; Scherer KR, 2003, SPEECH COMMUN, V40, P227, DOI 10.1016/S0167-6393(02)00084-5; SCHRADER L, 1993, ANIM BEHAV, V46, P1026, DOI 10.1006/anbe.1993.1288; SNOWDON CT, 1981, BEHAV ECOL SOCIOBIOL, V9, P295, DOI 10.1007/BF00299886; SNOWDON CT, 1984, AM J PRIMATOL, V7, P15, DOI 10.1002/ajp.1350070104; Stivers T, 2009, P NATL ACAD SCI USA, V106, P10587, DOI 10.1073/pnas.0903616106; SUGIURA H, 1995, CURRENT TOPICS IN PRIMATE VOCAL COMMUNICATION, P121; SUGIURA H, 1993, BEHAVIOUR, V124, P207, DOI 10.1163/156853993X00588; Tabachnick B. G, 2019, USING MULIVARIATE ST, V7th; Takahashi DY, 2015, SCIENCE, V349, P734, DOI 10.1126/science.aab1058; Takahashi DY, 2013, CURR BIOL, V23, P2162, DOI 10.1016/j.cub.2013.09.005; WILLIAMS CE, 1972, J ACOUST SOC AM, V52, P1238, DOI 10.1121/1.1913238; Yamaguchi C, 2009, AM J PRIMATOL, V71, P617, DOI 10.1002/ajp.20697	46	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0227392	10.1371/journal.pone.0227392	http://dx.doi.org/10.1371/journal.pone.0227392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298305	gold, Green Published, Green Submitted			2022-12-26	WOS:000536011400004
J	Wiacek, J; Polak, M; Filipiuk, M; Kucharczyk, M; Dawidowicz, L				Wiacek, Jaroslaw; Polak, Marcin; Filipiuk, Maciej; Kucharczyk, Marek; Dawidowicz, Lukasz			Do railway lines affect the distribution of woodland birds during autumn?	PLOS ONE			English	Article							FOREST EDGES; IMPACT; ROADS; POPULATIONS; DISPERSAL; DIVERSITY	Research results on the impact of railway noise on birds show a variety of bird responses. These behaviours are often different from those exhibited by birds occupying habitats along tarred roads. Knowledge of this subject is still incomplete. We attempted to define the influence of a heavily transited railway line on bird communities at stopover sites near the tracks during the autumn migration period. Birds were counted using the point method at 45 observation points located at three distances (30 m, 280 m, 530 m) from the tracks. At each point we determined the habitat parameters and the intensity of noise. A total of 614 individuals from 29 species were recorded on the study plot. The results of our observations indicate that the railway line does not adversely affect woodland birds during the autumn migration. The results showed that the abundance of birds and the species richness were actually the highest near the railway line. Species foraging on invertebrates preferred the neighbourhood of the tracks. The number of the most common species did not differ widely in relation to distance from the tracks. These data may be helpful in planning and managing the environment in the context of bird conservation, protection from railway noise and collisions with trains.	[Wiacek, Jaroslaw; Polak, Marcin; Filipiuk, Maciej; Kucharczyk, Marek] Marie Curie Sklodowska Univ, Inst Biol Sci, Dept Zool & Nat Conservat, Lublin, Poland; [Dawidowicz, Lukasz] Droga Meczennikow Majdanka, Lublin, Poland	Maria Curie-Sklodowska University	Wiacek, J (corresponding author), Marie Curie Sklodowska Univ, Inst Biol Sci, Dept Zool & Nat Conservat, Lublin, Poland.	wiacek@hektor.umcs.lublin.pl		Kucharczyk, Marek/0000-0002-8182-5658; Filipiuk, Maciej/0000-0002-8833-2856; Polak, Marcin/0000-0002-2118-3294	Institute of Biological Sciences UMCS	Institute of Biological Sciences UMCS	This research was supported by the Institute of Biological Sciences UMCS. Our special thanks go to Peter Senn for English language edition of this paper and anonymous reviewers for their advice and suggestions.	Alerstam T, 2003, AVIAN MIGRATION, P253; Barbaro L, 2014, DIVERS DISTRIB, V20, P149, DOI 10.1111/ddi.12132; Barbaro L, 2012, LANDSCAPE ECOL, V27, P1451, DOI 10.1007/s10980-012-9800-x; Batary P, 2014, FOREST ECOL MANAG, V319, P44, DOI 10.1016/j.foreco.2014.02.004; Bibby CJ, 1992, BIRD CENSUS TECHNIQU; Borda de Agua L., 2017, RAILWAY ECOLOGY, DOI [10.1007/978-3-319-57496-7, DOI 10.1007/978-3-319-57496-7]; Braak C., 2002, GELUID, V1, P2; Burger J, 1998, ENVIRON CONSERV, V25, P13, DOI 10.1017/S0376892998000058; Christ C, 2003, TOURISM BIODIVERSITY; Clewlow RR, 2014, TRANSPORT POLICY, V33, P136, DOI 10.1016/j.tranpol.2014.01.015; Cramp S., 1994, BIRDS W PALEARCTIC, V1-9; Delgado JD, 2007, LANDSCAPE URBAN PLAN, V81, P328, DOI 10.1016/j.landurbplan.2007.01.005; Erritzoe J, 2003, ACTA ORNITHOL, V38, P77, DOI 10.3161/068.038.0204; GLUE DE, 1971, BIRD STUDY, V18, P137, DOI 10.1080/00063657109476307; Hedenstrom A, 1997, J THEOR BIOL, V189, P227, DOI 10.1006/jtbi.1997.0505; Hutto R.L., 1985, P455; Kuitunen MT, 2003, ENVIRON MANAGE, V31, P79, DOI 10.1007/s00267-002-2694-7; Li ZQ, 2010, TRANSPORT RES D-TR E, V15, P525, DOI 10.1016/j.trd.2010.07.004; McClure CJW, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2290; Morelli F, 2014, TRANSPORT RES D-TR E, V30, P21, DOI 10.1016/j.trd.2014.05.006; Penone C, 2013, INSECT CONSERV DIVER, V6, P319, DOI 10.1111/j.1752-4598.2012.00217.x; Pfeifer M, 2017, NATURE, V551, P187, DOI 10.1038/nature24457; Polak M, 2013, EUR J FOREST RES, V132, P931, DOI 10.1007/s10342-013-0732-z; Pomeroy AC, 2006, OIKOS, V112, P629, DOI 10.1111/j.0030-1299.2006.14403.x; RATTI JT, 1988, J WILDLIFE MANAGE, V52, P484, DOI 10.2307/3801596; Reijnen R, 1997, BIODIVERS CONSERV, V6, P567, DOI 10.1023/A:1018385312751; REIJNEN R, 1995, J APPL ECOL, V32, P187, DOI 10.2307/2404428; REIJNEN R, 1994, J APPL ECOL, V31, P85, DOI 10.2307/2404601; Reijnen R, 2006, ENVIRONM POLLUT SER, V10, P255, DOI 10.1007/1-4020-4504-2_12; Rheindt FE, 2003, J ORNITHOL, V144, P295, DOI 10.1046/j.1439-0361.2003.03004.x; Santos SM, 2017, RAILWAY ECOLOGY, P11, DOI [10.1007/978-3-319-57496-7, DOI 10.1007/978-3-319-57496-7]; Sillett TS, 2002, J ANIM ECOL, V71, P296, DOI 10.1046/j.1365-2656.2002.00599.x; Silva Lucas P., 2017, RAILWAY ECOLOGY; Statsoft Statsoft Inc, 2014, STAT WIND DAT AN SYS; Summers PD, 2011, J APPL ECOL, V48, P1527, DOI 10.1111/j.1365-2664.2011.02041.x; Ter Braak C.J.F., 1998, CANOCO RELEASE 4 REF; TOMIALOJC L, 1984, Acta Ornithologica (Warsaw), V20, P241; VERMEULEN HJW, 1995, LANDSCAPE URBAN PLAN, V31, P233, DOI 10.1016/0169-2046(94)01050-I; VERMEULEN HJW, 1994, BIOL CONSERV, V69, P339, DOI 10.1016/0006-3207(94)90433-2; Wiacek J, 2019, EUR J FOREST RES, V138, P907, DOI 10.1007/s10342-019-01212-3; Wiacek J, 2015, ENVIRON MANAGE, V56, P643, DOI 10.1007/s00267-015-0528-7; Wiacek J, 2015, LANDSCAPE URBAN PLAN, V134, P76, DOI 10.1016/j.landurbplan.2014.10.016; Wight P. A., 2002, Current Issues in Tourism, V5, P222, DOI 10.1080/13683500208667920; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a	44	0	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2020	15	4							e0231301	10.1371/journal.pone.0231301	http://dx.doi.org/10.1371/journal.pone.0231301			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9GL	32294129	Green Published, gold			2022-12-26	WOS:000536003500028
J	Jeffreys, LN; Pacholarz, KJ; Johannissen, LO; Girvan, HM; Barran, PE; Voice, MW; Munro, AW				Jeffreys, Laura N.; Pacholarz, Kamila J.; Johannissen, Linus O.; Girvan, Hazel M.; Barran, Perdita E.; Voice, Michael W.; Munro, Andrew W.			Characterization of the structure and interactions of P450 BM3 using hybrid mass spectrometry approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytochrome P450; dimerization; enzyme catalysis; enzyme structure; flavoprotein; fusion protein; mass spectrometry (MS); reductase; structural biology; collision induced unfolding (CIU); cytochrome P450 BM3; domain interactions; hydrogen-deuterium exchange mass spectrometry (HDX-MS); native ion mobility mass spectrometry (IM-MS); protein dynamics; protein solvent accessibility; monooxygenase; solution structure	HYDROGEN-DEUTERIUM EXCHANGE; ELECTRON-TRANSFER; CYTOCHROME-P450 ENZYMES; LIGAND-BINDING; HEME DOMAINS; DYNAMICS; SITE; HYDROXYLATION; PURIFICATION; STABILITY	The cytochrome P450 monooxygenase P450 BM3 (BM3) is a biotechnologically important and versatile enzyme capable of producing important compounds such as the medical drugs pravastatin and artemether, and the steroid hormone testosterone. BM3 is a natural fusion enzyme comprising two major domains: a cytochrome P450 (heme-binding) catalytic domain and a NADPH-cytochrome P450 reductase (CPR) domain containing FAD and FMN cofactors in distinct domains of the CPR. A crystal structure of full-length BM3 enzyme is not available in its monomeric or catalytically active dimeric state. In this study, we provide detailed insights into the protein-protein interactions that occur between domains in the BM3 enzyme and characterize molecular interactions within the BM3 dimer by using several hybrid mass spectrometry (MS) techniques, namely native ion mobility MS (IM-MS), collision-induced unfolding (CIU), and hydrogen-deuterium exchange MS (HDX-MS). These methods enable us to probe the structure, stoichiometry, and domain interactions in the ?240 kDa BM3 dimeric complex. We obtained high-sequence coverage (88?99%) in the HDX-MS experiments for full-length BM3 and its component domains in both the ligand-free and ligand-bound states. We identified important protein interaction sites, in addition to sites corresponding to heme-CPR domain interactions at the dimeric interface. These findings bring us closer to understanding the structure and catalytic mechanism of P450 BM3.	[Jeffreys, Laura N.; Johannissen, Linus O.; Girvan, Hazel M.; Barran, Perdita E.; Munro, Andrew W.] Univ Manchester, Manchester Inst Biotechnol, Sch Nat Sci, Dept Chem, 131 Princess St, Manchester M1 7DN, Lancs, England; [Jeffreys, Laura N.; Johannissen, Linus O.; Girvan, Hazel M.; Barran, Perdita E.; Munro, Andrew W.] Univ Manchester, Manchester Synthet Biol Res Ctr Fine & Special Ch, 131 Princess St, Manchester M1 7DN, Lancs, England; [Pacholarz, Kamila J.; Barran, Perdita E.] Univ Manchester, Michael Barber Ctr Collaborat Mass Spectrometry, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England; [Voice, Michael W.] Cypex Ltd, 6 Tom McDonald Ave, Dundee DD241NH, Scotland	University of Manchester; University of Manchester; University of Manchester	Munro, AW (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Sch Nat Sci, Dept Chem, 131 Princess St, Manchester M1 7DN, Lancs, England.	andrew.munro@manchester.ac.uk	Barran, Perdita/AAY-6303-2021; Jeffreys, Laura/GVU-4604-2022	Jeffreys, Laura/0000-0002-0607-6116; Girvan, Hazel/0000-0003-2299-8644; Barran, Perdita/0000-0002-7720-586X	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L017253/1]; Cypex Ltd.; BBSRC Responsive Mode Grant [BB/K001884/1]; BBSRC [BB/R009961/1, BB/K001884/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cypex Ltd.; BBSRC Responsive Mode Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/L017253/1 for a CASE PhD Studentship with Cypex Ltd. (to L. N. J.), and by BBSRC Responsive Mode Grant BB/K001884/1) (to A. W. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Anderson KW, 2016, J BIOL CHEM, V291, P11876, DOI 10.1074/jbc.M116.723577; Behan RK, 2006, J AM CHEM SOC, V128, P11471, DOI 10.1021/ja062428p; BODDUPALLI SS, 1992, J BIOL CHEM, V267, P10375; Bui SH, 2012, J BIOL CHEM, V287, P19699, DOI 10.1074/jbc.M111.319202; Butler CF, 2013, J BIOL CHEM, V288, P25387, DOI 10.1074/jbc.M113.479717; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Daff SN, 1997, BIOCHEMISTRY-US, V36, P13816, DOI 10.1021/bi971085s; Darimont D, 2018, BIOELECTROCHEMISTRY, V119, P119, DOI 10.1016/j.bioelechem.2017.08.009; Dodhia VR, 2006, J BIOL INORG CHEM, V11, P903, DOI 10.1007/s00775-006-0144-3; Ellis J, 2009, J BIOL CHEM, V284, P36628, DOI 10.1074/jbc.M109.054304; Girvan HM, 2016, CURR OPIN CHEM BIOL, V31, P136, DOI 10.1016/j.cbpa.2016.02.018; Girvan HM, 2011, ARCH BIOCHEM BIOPHYS, V507, P75, DOI 10.1016/j.abb.2010.09.014; Govindaraj S, 1996, PROTEIN SCI, V5, P1389, DOI 10.1002/pro.5560050717; Gricman L, 2016, CHEMISTRYSELECT, V1, P1243, DOI 10.1002/slct.201600369; Gustafsson MCU, 2004, BIOCHEMISTRY-US, V43, P5474, DOI 10.1021/bi035904m; Hamuro Y, 2008, J INORG BIOCHEM, V102, P364, DOI 10.1016/j.jinorgbio.2007.10.001; Joyce MG, 2012, FEBS J, V279, P1694, DOI 10.1111/j.1742-4658.2012.08544.x; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kitazume T, 2007, BIOCHEMISTRY-US, V46, P11892, DOI 10.1021/bi701031r; Larriba C, 2013, J COMPUT PHYS, V251, P344, DOI 10.1016/j.jcp.2013.05.038; Larriba C, 2013, J PHYS CHEM A, V117, P3887, DOI 10.1021/jp312432z; LI HY, 1991, J BIOL CHEM, V266, P11909; Liao WL, 2009, BIOCHEMISTRY-US, V48, P4150, DOI 10.1021/bi900168m; Liu YL, 2018, J RAMAN SPECTROSC, V49, P287, DOI 10.1002/jrs.5278; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Meinhold P, 2005, CHEMBIOCHEM, V6, P1765, DOI 10.1002/cbic.200500261; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Migas LG, 2018, INT J MASS SPECTROM, V427, P20, DOI 10.1016/j.ijms.2017.08.014; MILES JS, 1992, BIOCHEM J, V288, P503, DOI 10.1042/bj2880503; MIURA Y, 1975, BIOCHIM BIOPHYS ACTA, V388, P305, DOI 10.1016/0005-2760(75)90089-2; Munro AW, 1996, BBA-PROTEIN STRUCT M, V1296, P127, DOI 10.1016/0167-4838(96)00061-1; Munro AW, 2002, TRENDS BIOCHEM SCI, V27, P250, DOI 10.1016/S0968-0004(02)02086-8; Neeli R, 2005, FEBS LETT, V579, P5582, DOI 10.1016/j.febslet.2005.09.023; Noble MA, 1999, BIOCHEM J, V339, P371, DOI 10.1042/0264-6021:3390371; Pacholarz KJ, 2017, STRUCTURE, V25, P730, DOI 10.1016/j.str.2017.03.005; Pacholarz KJ, 2014, ANGEW CHEM INT EDIT, V53, P7765, DOI 10.1002/anie.201402863; Rittle J, 2010, SCIENCE, V330, P933, DOI 10.1126/science.1193478; Sevrioukova IF, 1999, P NATL ACAD SCI USA, V96, P1863, DOI 10.1073/pnas.96.5.1863; Siddhanta U, 1998, J BIOL CHEM, V273, P18950, DOI 10.1074/jbc.273.30.18950; Treuheit NA, 2016, BIOCHEMISTRY-US, V55, P1058, DOI 10.1021/acs.biochem.5b01313; Verma R, 2014, BIOPOLYMERS, V101, P197, DOI 10.1002/bip.22301; Wilderman PR, 2010, J BIOL CHEM, V285, P38602, DOI 10.1074/jbc.M110.180646; Xia CW, 2018, BIOCHEMISTRY-US, V57, P945, DOI 10.1021/acs.biochem.7b01102; Zhang HM, 2018, J BIOL CHEM, V293, P7727, DOI 10.1074/jbc.RA117.000600	44	3	3	8	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2020	295	22					7595	7607		10.1074/jbc.RA119.011630	http://dx.doi.org/10.1074/jbc.RA119.011630			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	LU9AG	32303637	Green Published, hybrid			2022-12-26	WOS:000538038900004
J	Fang, YH; Liu, J; Mao, YY; He, Y; Li, M; Yang, L; Zhu, QX; Tong, Q; Zhou, WJ				Fang, Yuhang; Liu, Jun; Mao, Yanyan; He, Yang; Li, Min; Yang, Liu; Zhu, Qianxi; Tong, Qi; Zhou, Weijin			Pre-pregnancy body mass index and time to pregnancy among couples pregnant within a year: A China cohort study	PLOS ONE			English	Article							OBESITY; OVERWEIGHT; CONCEPTION; FECUNDABILITY; FERTILITY; HEALTH; IMPACT; AGE; RECEPTIVITY; PREVALENCE	Background Extreme pre-pregnancy body mass index (BMI) values have been associated with reduced fecundability and prolonged time to pregnancy in previous studies. However, the effect in fertile couples is unclear. Objectives This study aimed to evaluate the association between pre-pregnancy BMI and fecundability, measured as time to pregnancy (TTP), among couples that achieved pregnancy within 1 year. Methods This was a retrospective cohort study of 50,927 couples wishing to conceive, enrolled in the National Free Preconception Health Examination Project (NFPHEP) in Chongqing, China, during 2012-2016. Participants' weight and height were measured by NFPHEP-trained preconception guidance physicians. TTP measured in months was used to determine subfecundity (TTP > 6 months). The strength of association between BMI and TTP/subfecundity was measured with fecundability odds ratios (FOR)/odds ratios (OR) and their corresponding 95% confidence intervals (CI), calculated with Cox and logistic regression analysis. We used restricted cubic spline regression (RCS) to test the observed FOR trends. Results Compared to women with normal BMI, women with pre-pregnancy overweight/obesity had longer TTP (FOR = 0.96, 95% CI: 0.94-0.99) and increased risk of subfecundity (OR = 1.08, 95% CI: 1.00-1.17). There was no association between TTP and male BMI. RCS trends varied when data were stratified by male pre-pregnancy BMI, with the greatest change detected in pre-pregnancy underweight men. Conclusions Pre-pregnancy overweight/obesity was associated with longer TTP and subfecundity among women who became pregnant within 1 year; this effect was likely mediated by their partners' pre-pregnancy BMI. These findings indicate that BMI could affect fecundability, independently of affecting the risk of sterility. Advice on weight management and maintaining healthy weight should be included in couples' preconception guidance.	[Fang, Yuhang; Mao, Yanyan] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China; [Fang, Yuhang; Mao, Yanyan; Li, Min; Zhu, Qianxi; Zhou, Weijin] Fudan Univ, Shanghai Inst Planned Parenthood Res, NHC Key Lab Reprod Regulat, Shanghai, Peoples R China; [Liu, Jun; He, Yang; Yang, Liu; Tong, Qi] Chongqing Populat & Family Planning Sci & Technol, NHC Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China	Fudan University; Fudan University	Zhou, WJ (corresponding author), Fudan Univ, Shanghai Inst Planned Parenthood Res, NHC Key Lab Reprod Regulat, Shanghai, Peoples R China.; Tong, Q (corresponding author), Chongqing Populat & Family Planning Sci & Technol, NHC Key Lab Birth Defects & Reprod Hlth, Chongqing, Peoples R China.	gytong2003@163.com; zw0822@sina.com		Fang, Yuhang/0000-0002-8967-7434; MAO, Yanyan/0000-0001-9936-694X; Zhou, Weijin/0000-0002-0958-2866	Innovation-oriented Science and Technology Grant from NHC Key Laboratory of Reproduction Regulation [CX2017-04]; ChongQing Science And Technology Bureau [cstc2017shmsA130102, cstc2017jxjl10001]; Health Commission of Chongqing province [2017ZDXM015]; NHC Key Laboratory of Reproduction Regulation [2017KF04]	Innovation-oriented Science and Technology Grant from NHC Key Laboratory of Reproduction Regulation; ChongQing Science And Technology Bureau; Health Commission of Chongqing province; NHC Key Laboratory of Reproduction Regulation	This study was supported by Innovation-oriented Science and Technology Grant from NHC Key Laboratory of Reproduction Regulation (No. CX2017-04); grant from ChongQing Science And Technology Bureau (No. cstc2017shmsA130102, No. cstc2017jxjl10001); grant from Health Commission of Chongqing province (No. 2017ZDXM015); grant from NHC Key Laboratory of Reproduction Regulation (No. 2017KF04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batsis JA, 2016, CLIN NUTR, V35, P1472, DOI 10.1016/j.clnu.2016.03.028; Bellver J, 2013, FERTIL STERIL, V100, P1050, DOI 10.1016/j.fertnstert.2013.06.001; Bolumar F, 2000, AM J EPIDEMIOL, V151, P1072, DOI 10.1093/oxfordjournals.aje.a010150; Brewer CJ, 2010, REPRODUCTION, V140, P347, DOI 10.1530/REP-09-0568; Chambers TJG, 2015, HORM-INT J ENDOCRINO, V14, P563, DOI 10.14310/horm.2002.1621; CRAMER DW, 1994, J CLIN ENDOCR METAB, V79, P1105, DOI 10.1210/jc.79.4.1105; Di Cesare M, 2016, LANCET, V387, P1377, DOI 10.1016/S0140-6736(16)30054-X; FRISCH RE, 1987, HUM REPROD, V2, P521, DOI 10.1093/oxfordjournals.humrep.a136582; Gaskins AJ, 2015, OBSTET GYNECOL, V126, P850, DOI 10.1097/AOG.0000000000001030; Guldbrandsen K, 2014, HUM REPROD, V29, P2058, DOI 10.1093/humrep/deu153; Hassan MAM, 2004, FERTIL STERIL, V81, P384, DOI 10.1016/j.fertnstert.2003.06.027; He Y, 2016, AM J PUBLIC HEALTH, V106, P2103, DOI 10.2105/AJPH.2016.303499; Jacobsen BK, 2012, EUR J EPIDEMIOL, V27, P923, DOI 10.1007/s10654-012-9749-8; Jensen TK, 1999, EPIDEMIOLOGY, V10, P422, DOI 10.1097/00001648-199907000-00014; Lash MM, 2009, FERTIL STERIL, V91, P1712, DOI 10.1016/j.fertnstert.2008.02.141; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Liu J, 2017, LANCET GLOB HEALTH, V5, pE624, DOI 10.1016/s2214-109x(17)30142-0; Louis GMB, 2014, FERTIL STERIL, V101, P453, DOI 10.1016/j.fertnstert.2013.10.022; Louis GMB, 2011, FERTIL STERIL, V95, P2184, DOI 10.1016/j.fertnstert.2010.06.078; Loy SL, 2018, HUM REPROD, V33, P2141, DOI 10.1093/humrep/dey300; Luque EM, 2017, REPROD FERT DEVELOP, V29, P731, DOI 10.1071/RD15351; Lynch CD, 2012, FERTIL STERIL, V98, P453, DOI 10.1016/j.fertnstert.2012.05.018; McKinnon CJ, 2016, FERTIL STERIL, V106, P451, DOI 10.1016/j.fertnstert.2016.04.011; Mutsaerts MAQ, 2012, HUM REPROD, V27, P583, DOI 10.1093/humrep/der429; Nguyen RHN, 2007, HUM REPROD, V22, P2488, DOI 10.1093/humrep/dem139; Olsen J, 2014, HDB EPIDEMIOLOGY, P1705; Pasquali Renato, 2007, Curr Opin Endocrinol Diabetes Obes, V14, P482, DOI 10.1097/MED.0b013e3282f1d6cb; Ramlau-Hansen CH, 2007, HUM REPROD, V22, P1634, DOI 10.1093/humrep/dem035; Sallmen M, 2006, EPIDEMIOLOGY, V17, P520, DOI 10.1097/01.ede.0000229953.76862.e5; Schulte MMB, 2015, REPROD SCI, V22, P6, DOI 10.1177/1933719114561552; Sharma S, 2013, ENDOCRINOLOGY, V154, P2188, DOI 10.1210/en.2012-2218; Sorensen TIA, 2010, BBA-MOL CELL BIOL L, V1801, P400, DOI 10.1016/j.bbalip.2009.12.011; Sundaram R, 2017, HUM REPROD, V32, P662, DOI 10.1093/humrep/dex001; Taylor KC, 2011, ANN EPIDEMIOL, V21, P864, DOI 10.1016/j.annepidem.2011.04.011; Wang N, 2014, METABOLISM, V63, P94, DOI 10.1016/j.metabol.2013.09.001; Wilcox AJ., 2010, FERTILITY PREGNANCY; Wise LA, 2013, HUM REPROD, V28, P2856, DOI 10.1093/humrep/det333; Wise LA, 2010, HUM REPROD, V25, P253, DOI 10.1093/humrep/dep360; World Health Organization, 2018, OB OV; Xu WL, 2016, OBESITY FACTS, V9, P17, DOI 10.1159/000443003; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484; Zain MM, 2008, WOMENS HEALTH, V4, P183, DOI 10.2217/17455057.4.2.183; Zhang Q, 2017, THESIS; Zhang Shikun, 2015, Zhonghua Yi Xue Za Zhi, V95, P162; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83	45	4	4	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2020	15	4							e0231751	10.1371/journal.pone.0231751	http://dx.doi.org/10.1371/journal.pone.0231751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9SA	32324768	Green Published, gold			2022-12-26	WOS:000536033700035
J	Goitia, B; Bruno, D; Abrevaya, S; Sedeno, L; Ibanez, A; Manes, F; Sigman, M; Sinay, V; Torralva, T; Duncan, J; Roca, M				Goitia, Belen; Bruno, Diana; Abrevaya, Sofia; Sedeno, Lucas; Ibanez, Agustin; Manes, Facundo; Sigman, Mariano; Sinay, Vladimiro; Torralva, Teresa; Duncan, John; Roca, Maria			The relationship between executive functions and fluid intelligence in multiple sclerosis	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; MATTER VOLUME; FATIGUE; LESIONS; PERFORMANCE; DYSFUNCTION; REGIONS; THALAMUS; ATROPHY; SCALE	Background & objective Deficits in cognitive functions dependent upon the integrity of the prefrontal cortex have been described in Multiple Sclerosis (MS). In a series of studies we have shown that fluid intelligence (g) is a substantial contributor to frontal deficits and that, for some classical "executive" tasks, frontal deficits were entirely explained by g. However, for another group of frontal tasks deficits remained once g was introduced as a covariate. This second set of tests included multitasking and theory of mind tasks. In the present study, we aimed at determining the role of fluid intelligence in frontal deficits seen in patients with MS. Methods A group of patients with Relapsing Remitting MS (n = 36) and a group of control subjects (n = 42) were assessed with a battery of classical executive tests (which included the Wisconsin Card Sorting Test, Verbal Fluency, and Trail Making Test B), a multitasking test, a theory of mind test and a fluid intelligence test. Results MS patients showed significant deficits in the fluid intelligence task. We found differences between patients and control subjects in all tests except for the multitasking test. The differences in the classical executive tests became non-significant once fluid intelligence was introduced as a covariate, but differences in theory of mind remained. Conclusions The present results suggest that fluid intelligence can be affected in MS and that this impairment can play a role in the executive deficits described in MS.	[Goitia, Belen; Bruno, Diana; Abrevaya, Sofia; Sedeno, Lucas; Ibanez, Agustin; Manes, Facundo; Sinay, Vladimiro; Torralva, Teresa; Roca, Maria] Favaloro Univ, Inst Translat & Cognit Neurosci INCyT, INECO Fdn, Buenos Aires, DF, Argentina; [Goitia, Belen; Sigman, Mariano] Torcuato Di Tella Univ, Lab Neurosci, Buenos Aires, DF, Argentina; [Goitia, Belen; Abrevaya, Sofia; Sedeno, Lucas; Ibanez, Agustin; Manes, Facundo; Sigman, Mariano; Roca, Maria] Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina; [Ibanez, Agustin] Univ Adolfo Ibanez, Sch Psychol, Ctr Social & Cognit Neurosci CSCN, Santiago, Chile; [Ibanez, Agustin] Univ Autonoma Caribe, Barranquilla, Colombia; [Ibanez, Agustin] Australian Res Council ACR, Ctr Excellence Cognit & Its Disorders, Sydney, NSW, Australia; [Duncan, John] Med Res Council MRC, Cognit & Brain Sci Unit, Cambridge, England; [Duncan, John] Univ Oxford, Dept Expt Psychol, Oxford, England	Universidad Torcuato Di Tella; Centro Nacional Patagonico (CENPAT); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Adolfo Ibanez; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Oxford	Roca, M (corresponding author), Favaloro Univ, Inst Translat & Cognit Neurosci INCyT, INECO Fdn, Buenos Aires, DF, Argentina.; Roca, M (corresponding author), Natl Sci & Tech Res Council CONICET, Buenos Aires, DF, Argentina.	mroca@ineco.org.ar	Ibanez, Agustin/H-7976-2015	Ibanez, Agustin/0000-0001-6758-5101; Abrevaya, Sofia/0000-0003-4091-9962	Medical Research Council [MC_UU_00005/6] Funding Source: Medline; MRC [MC_UU_00005/6] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abrevaya S, 2017, J ALZHEIMERS DIS, V55, P1429, DOI 10.3233/JAD-160737; Ansell EB, 2012, BIOL PSYCHIAT, V72, P57, DOI 10.1016/j.biopsych.2011.11.022; ARNETT PA, 1994, NEUROLOGY, V44, P420, DOI 10.1212/WNL.44.3_Part_1.420; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bailey A, 2007, MULT SCLER J, V13, P73, DOI 10.1177/1352458506071162; Bang L, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0856-z; Batista S, 2018, ARCH CLIN NEUROPSYCH, V33, P541, DOI 10.1093/arclin/acx101; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Benton AL, 1994, MULTILINGUAL APHASIA; Burin DI, 2000, J CLIN EXP NEUROPSYC, V22, P677, DOI 10.1076/1380-3395(200010)22:5;1-9;FT677; Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2010, MULT SCLER J, V16, P1220, DOI 10.1177/1352458510376405; Calabrese M, 2010, ANN NEUROL, V67, P376, DOI 10.1002/ana.21906; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Couto B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00467; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Damjanovic D, 2017, AM J NEURORADIOL, V38, P18, DOI 10.3174/ajnr.A4952; Debernard L, 2015, PSYCHIAT RES-NEUROIM, V234, P352, DOI 10.1016/j.pscychresns.2015.10.004; Denney DR, 2004, J INT NEUROPSYCH SOC, V10, P948, DOI 10.1017/S1355617704107030; Duncan J, 2000, SCIENCE, V289, P457, DOI 10.1126/science.289.5478.457; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Filley CM, 2005, ANN NY ACAD SCI, V1064, P162, DOI 10.1196/annals.1340.028; Foong J, 1997, BRAIN, V120, P15, DOI 10.1093/brain/120.1.15; Garcia AM, 2017, J MED GENET, V54, P84, DOI 10.1136/jmedgenet-2016-104148; Garcia-Cordero I, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2016.0006; Garcia-Cordero I, 2015, STROKE, V46, P2673, DOI 10.1161/STROKEAHA.115.009598; Gilbert SJ, 2007, SOC COGN AFFECT NEUR, V2, P217, DOI 10.1093/scan/nsm014; Gilbert SJ, 2006, J COGNITIVE NEUROSCI, V18, P932, DOI 10.1162/jocn.2006.18.6.932; Glascher J, 2010, P NATL ACAD SCI USA, V107, P4705, DOI 10.1073/pnas.0910397107; Goitia B, 2017, PSYCHIAT RES, V257, P346, DOI 10.1016/j.psychres.2017.07.066; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; HEATON RK, 1985, J CONSULT CLIN PSYCH, V53, P103, DOI 10.1037/0022-006X.53.1.103; Heesen C, 2010, BRAIN BEHAV IMMUN, V24, P1148, DOI 10.1016/j.bbi.2010.05.006; Heinen R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165719; Hojjat S-P, 2016, MULT SCLER, P1; Houtchens MK, 2007, NEUROLOGY, V69, P1213, DOI 10.1212/01.wnl.0000276992.17011.b5; Irish M, 2014, HUM BRAIN MAPP; Kern KC, 2015, NEUROIMAGE-CLIN, V8, P440, DOI 10.1016/j.nicl.2014.12.015; Kos D, 2005, MULT SCLER, V11, P76, DOI 10.1191/1352458505ms1117oa; Krupp LB, 2000, NEUROLOGY, V55, P934, DOI 10.1212/WNL.55.7.934; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Manly T, 2002, NEUROPSYCHOLOGIA, V40, P271, DOI 10.1016/S0028-3932(01)00094-X; Matias-Guiu JA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00643; MCINTOSHMICHAELIS SA, 1991, BRIT J CLIN PSYCHOL, V30, P333, DOI 10.1111/j.2044-8260.1991.tb00954.x; Melloni M, 2016, BRAIN; Minagar A, 2013, NEUROLOGY, V80, P210, DOI 10.1212/WNL.0b013e31827b910b; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Nelson HE., 1991, REVISED NATL ADULT R; Nunnari D., 2015, BIOMED RES INT, V2015, P11; O'Callaghan C, 2016, BRAIN; Parmenter BA, 2003, MULT SCLER, V9, P111, DOI 10.1191/1352458503ms859oa; Partington JE, 1949, PSYCHOL SERVICE CTR, V1, P11; Paul RH, 1998, APPL NEUROPSYCHOL, V5, P143, DOI 10.1207/s15324826an0503_5; PEYSER JM, 1980, ARCH NEUROL-CHICAGO, V37, P577, DOI 10.1001/archneur.1980.00500580073013; Poser CM, 1983, ANN NEUROL; Rando K, 2013, ADDICT BIOL, V18, P147, DOI 10.1111/adb.12008; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Roca M, 2008, MULT SCLER, V14, P364, DOI 10.1177/1352458507084270; Roca M, 2012, PSYCHOL MED, V42, P2445, DOI 10.1017/S0033291712000451; Roca M, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00046; Roca M, 2013, NEUROPSYCHOLOGIA, V51, P725, DOI 10.1016/j.neuropsychologia.2013.01.008; Roca M, 2011, NEUROPSYCHOLOGIA, V49, P3525, DOI 10.1016/j.neuropsychologia.2011.09.003; Roca M, 2010, BRAIN, V133, P234, DOI 10.1093/brain/awp269; Rossi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044826; Schoonheim MM, 2015, NEUROLOGY, V84, P776, DOI 10.1212/WNL.0000000000001285; Sedeno L, 2016, J INT NEUROPSYCH SOC, V22, P250, DOI 10.1017/S1355617715000703; Sollberger M, 2009, NEUROPSYCHOLOGIA; Sommer M, 2007, NEUROIMAGE, V35, P1378, DOI 10.1016/j.neuroimage.2007.01.042; Spearman C, 1904, AM J PSYCHOL, V15, P201, DOI 10.2307/1412107; Stone VE, 1998, J COGNITIVE NEUROSCI, V10, P640, DOI 10.1162/089892998562942; STUSS DT, 1992, J CONSULT CLIN PSYCH, V60, P349, DOI 10.1037/0022-006X.60.3.349; SWIRSKYSACCHETTI T, 1992, NEUROLOGY, V42, P1291, DOI 10.1212/WNL.42.7.1291; Thompson AJ, 2018, LANCET; Thompson AJ, 2018, LANCET NEUROLOGY; Torralva T, 2009, BRAIN, V132, P1299, DOI 10.1093/brain/awp041; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Wechsler D, 2002, ESCALA INTELIGENCIA; Wolk DA, 2009, ANN NEUROL, V65, P557, DOI 10.1002/ana.21598; Woolgar A, 2010, P NATL ACAD SCI USA, V107, P14899, DOI 10.1073/pnas.1007928107	80	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231868	10.1371/journal.pone.0231868	http://dx.doi.org/10.1371/journal.pone.0231868			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9QD	32320404	Green Published, gold			2022-12-26	WOS:000536028800035
J	Perez-Quintanilla, M; Mendez-Martinez, R; Vazquez-Vega, S; Espinosa-Romero, R; Sotelo-Regil, R; Perez-Montiel, MD; Ramos-Alamillo, U; Cabrera-Lopez, TD; Barquet-Munoz, SA; Perez-Plascencia, C; Garcia-Carranca, A; de Leon, DC				Perez-Quintanilla, Milagros; Mendez-Martinez, Rocio; Vazquez-Vega, Salvador; Espinosa-Romero, Raquel; Sotelo-Regil, Rita; Delia Perez-Montiel, Maria; Ramos-Alamillo, Ubaldo; de Jesus Cabrera-Lopez, Teresita; Abraham Barquet-Munoz, Salim; Perez-Plascencia, Carlos; Garcia-Carranca, Alejandro; Cantu de Leon, David			High prevalence of human papillomavirus and European variants of HPV 16 infecting concomitantly to cervix and oral cavity in HIV positive women	PLOS ONE			English	Article							NATURAL-HISTORY; RISK-FACTORS; PERSISTENCE; HUMAN-PAPILLOMAVIRUS-16; EPIDEMIOLOGY; TYPE-16; LESIONS; CANCER	Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide, with a high prevalence and high transmissibility. High-risk HPV (hrHPV) infection is the primary cause of cervical cancer. The HPV variants present in the uterine cervix and oral cavity of HIV+ women have not been described. Objective Identify the prevalence of HPV infections in the uterine cervix and oral cavity and HPV16 variants in HIV+ women. Methods A total of 174 HIV+ women attended an HIV+ specialized clinic in Mexico City. Cells were obtained from the oral cavity and cervix to extract DNA. Polymerase chain reaction (PCR) was used to amplify the HPV sequence with generic primers. We detected specific HPV types using the INNO-LiPA HPV Genotyping Extra II Kit (INNOGENETICS). The identification of variants was studied by sequencing the E6 gene with a Big Dye Terminator Kit and an Applied Biosystems 3500/3500xL genetic analyzer. Results HPV infection was very high in the uterine cervix (168/174, 96.6%) and oral cavity (161/174, 92.5%). The prevalence of HPV concurrent infections in the cervix and oral cavity was 155/174 (89.1%). We found hrHPVs to be more prevalent than low-risk HPVs (lrHPVs) in the oral cavity (90.2% versus 45.4%) and that infections simultaneously affected the cervix (94.3% versus 36.2%) and oral cavity (85.1% versus 20.1%). Surprisingly, only European variants of HPV type 16 were found in the uterine cervix of women and the oral cavity of all tested samples (52 oral cavity samples and 52 uterine cervix samples). Conclusions The high prevalence of HPV, multiple infections and presence of the EP350G intravariant in both anatomical regions are strongly related to the persistence of the virus, which is fundamental for the development of cancer. Therefore, it is very important to control and monitor this high-risk population as well as implement programs for the early detection of HPV and vaccination.	[Perez-Quintanilla, Milagros] Secretaria Salud SSA, Inst Nacl Cancerol Mexico INCan, Subdirecc Invest Clin, Mexico City, DF, Mexico; [Mendez-Martinez, Rocio; Garcia-Carranca, Alejandro] Inst Nacl Cancerol, SS, Subdirecc Invest Basica, Unidad Invest Biomed Canc, Mexico City, DF, Mexico; [Mendez-Martinez, Rocio] Univ Autonoma Sinaloa, Fac Ciencias Quim Biol, Doctorado Biotecnol, Culiacan, Sinaloa, Mexico; [Mendez-Martinez, Rocio] Univ Autonoma Sinaloa, Fac Ciencias Quim Biol, Doctorado Ciencias Biomed, Culiacan, Sinaloa, Mexico; [Vazquez-Vega, Salvador] Inst Mexicano Seguro Social IMSS, Ctr Med Nacl Siglo 21, Unidad Invest Epidemiol & Serv Salud, Mexico City, DF, Mexico; [Espinosa-Romero, Raquel; Sotelo-Regil, Rita] SSA, INCan, Serv Citopatol, Mexico City, DF, Mexico; [Delia Perez-Montiel, Maria] SSA, INCan, Serv Patol Quirurg, Mexico City, DF, Mexico; [Ramos-Alamillo, Ubaldo; de Jesus Cabrera-Lopez, Teresita] SSA, Serv Salud Publ Dist Fed, Clin Especializada Condesa CEC, Serv Ginecol, Mexico City, DF, Mexico; [Abraham Barquet-Munoz, Salim] SSA, INCan, Serv Ginecol Oncolo, Mexico City, DF, Mexico; [Perez-Plascencia, Carlos] SSA, INCan, Subdirecc Invest Basicas, Unidad Genom & Canc, Mexico City, DF, Mexico; [Perez-Plascencia, Carlos] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Mexico City, DF, Mexico; [Garcia-Carranca, Alejandro] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico; [Cantu de Leon, David] SSA, INCan, Subdirecc Invest Clin, Mexico City, DF, Mexico	Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Autonoma de Sinaloa; Universidad Autonoma de Sinaloa; Instituto Mexicano del Seguro Social; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Cancerologia (INCAN); Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Cancerologia (INCAN)	Garcia-Carranca, A (corresponding author), Inst Nacl Cancerol, SS, Subdirecc Invest Basica, Unidad Invest Biomed Canc, Mexico City, DF, Mexico.; Garcia-Carranca, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City, DF, Mexico.; de Leon, DC (corresponding author), SSA, INCan, Subdirecc Invest Clin, Mexico City, DF, Mexico.	carranca@biomedicas.unam.mx; dcantude@gmail.com		Mendez Martinez, Rocio/0000-0002-8310-6796; PEREZ QUINTANILLA, MILAGROS/0000-0002-1291-4534; Vazquez-Vega, Salvador/0000-0001-7544-0906; Barquet, Salim/0000-0002-3950-157X	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, de la Direccion General de Apoyo a Personal Academico de la Universidad Nacional Autonoma de Mexico (Genomica de Virus de Papiloma Humano tipo 16 en Mexico: Nuevas implicaciones biolo [PAPIIT-IN213016]; Division de Investigacion Basica, Instituto Nacional de Cancerologia, Secretaria de Salud; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica de la Direccion General de Apoyo a Personal Academico de la Universidad Nacional Autonoma de Mexico (Genomica de Virus de Papiloma Humano tipo 16 en Mexico: Nuevas implicaciones biolog [PAPIIT-IN213016]; Colposcopy and Gynecology Oncology Service at the Instituto Nacional de Cancerologia, Secretaria de Salud	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, de la Direccion General de Apoyo a Personal Academico de la Universidad Nacional Autonoma de Mexico (Genomica de Virus de Papiloma Humano tipo 16 en Mexico: Nuevas implicaciones biolo; Division de Investigacion Basica, Instituto Nacional de Cancerologia, Secretaria de Salud; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica de la Direccion General de Apoyo a Personal Academico de la Universidad Nacional Autonoma de Mexico (Genomica de Virus de Papiloma Humano tipo 16 en Mexico: Nuevas implicaciones biolog; Colposcopy and Gynecology Oncology Service at the Instituto Nacional de Cancerologia, Secretaria de Salud	We acknowledge the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, de la Direccion General de Apoyo a Personal Academico de la Universidad Nacional Autonoma de Mexico (PAPIIT-IN213016; Genomica de Virus de Papiloma Humano tipo 16 en Mexico: Nuevas implicaciones biologicas, to AGC) and from Division de Investigacion Basica, Instituto Nacional de Cancerologia, Secretari ' a de Salud. We thank the Colposcopy and Gynecology Oncology Service at the Instituto Nacional de Cancerologia, Secretaria de Salud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica de la Direccion General de Apoyo a Personal Acade ' mico de la Universidad Nacional Auto ' noma de Mexico (PAPIIT-IN213016; Genomica de Virus de Papiloma Humano tipo 16 en Mexico: Nuevas implicaciones biologicas, to AGC) and from Division de Investigacion Basica, Instituto Nacional de Cancerologi ' a, Secretaria de Salud. We also thank MC. Patricia de la Torre for her support in the sequencing of the samples and MC Miriam Cecilia Guido Jimenez, Silvia Maldonado and Jose Rendon Maldonado for her technical support in the experiments (Institute of Biomedical Research, National Autonomous University of Mexico (UNAM). We thank the Colposcopy and Gynecology Oncology Service at the Instituto Nacional de Cancerologi ' a, Secretaria de Salud.	Asadurian Y, 2007, J MED VIROL, V79, P1751, DOI 10.1002/jmv.20978; Badial RM, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009545; BASILE C, 2003, J NATL CANC I MONOGR, P35, DOI DOI 10.1093/OXFORDJOURNALS.JNCIMONOGRAPHS.A003480; Beachler DC, 2012, CANCER EPIDEM BIOMAR, V21, P122, DOI 10.1158/1055-9965.EPI-11-0734; Chung CH, 2014, ORAL ONCOL, V50, P364, DOI 10.1016/j.oraloncology.2013.09.003; de Martel C, 2017, INT J CANCER, V141, P664, DOI 10.1002/ijc.30716; Egawa N, 2015, VIRUSES-BASEL, V7, P3863, DOI 10.3390/v7072802; Fakhry C, 2013, ORAL ONCOL, V49, P863, DOI 10.1016/j.oraloncology.2013.06.002; Fakhry C, 2006, J CLIN MICROBIOL, V44, P4479, DOI 10.1128/JCM.01321-06; Fatahzadeh M, 2013, OR SURG OR MED OR PA, V115, P505, DOI 10.1016/j.oooo.2012.11.004; Ghebre RG, 2017, GYNECOL ONCOL REP, V21, P101, DOI 10.1016/j.gore.2017.07.009; Gravitt PE, 2017, ANN INTERN MED, V167, P748, DOI 10.7326/M17-2628; HO L, 1993, J VIROL, V67, P6413, DOI 10.1128/JVI.67.11.6413-6423.1993; Juckett G, 2010, AM FAM PHYSICIAN, V82, P1209; Lima MDM, 2014, INT J GYNECOL OBSTET, V126, P33, DOI 10.1016/j.ijgo.2014.01.017; Liu G, 2018, AIDS, V32, P795, DOI [10.1097/QAD.0000000000001765, 10.1097/qad.0000000000001765]; Londesborough P, 1996, INT J CANCER, V69, P364; Mandishora RSD, 2018, PAPILLOMAVIRUS RES, V5, P180, DOI 10.1016/j.pvr.2018.04.006; Moscicki AB, 2004, J INFECT DIS, V190, P37, DOI 10.1086/421467; Palefsky J, 2009, CURR OPIN HIV AIDS, V4, P52, DOI 10.1097/COH.0b013e32831a7246; Schlecht NF, 2005, J GEN VIROL, V86, P2709, DOI 10.1099/vir.0.81060-0; Sichero L, 2012, VIROLOGY, V432, P127, DOI 10.1016/j.virol.2012.06.011; Sonawane K, 2017, ANN INTERN MED, V167, P714, DOI [10.7326/M17-1363, 10.7326/m17-1363]; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Termine N, 2011, ORAL ONCOL, V47, P244, DOI 10.1016/j.oraloncology.2011.02.011; Thorsteinsson K, 2018, J CLIN VIROL, V105, P64, DOI 10.1016/j.jcv.2018.05.010; Togtema M, 2015, VIROLOGY, V485, P274, DOI 10.1016/j.virol.2015.07.025; Tornesello ML, 2008, J GEN VIROL, V89, P1380, DOI 10.1099/vir.0.83553-0; Wallin KL, 1999, NEW ENGL J MED, V341, P1633, DOI 10.1056/NEJM199911253412201; Bosch FX, 2013, VACCINE, V31, pH1, DOI [10.1016/j.vaccine.2013.10.003, 10.1016/j.vaccine.2013.07.026]; YAMADA T, 1995, J VIROL, V69, P7743, DOI 10.1128/JVI.69.12.7743-7753.1995; Zehbe I, 1998, LANCET, V352, P1441, DOI 10.1016/S0140-6736(05)61263-9	32	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0227900	10.1371/journal.pone.0227900	http://dx.doi.org/10.1371/journal.pone.0227900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320400	gold, Green Published			2022-12-26	WOS:000536028800004
J	Zhang, M; Li, ZH; Gao, DW; Gong, WJ; Gao, Y; Zhang, CG				Zhang, Miao; Li, Zhihui; Gao, Dawen; Gong, Wenjing; Gao, Yan; Zhang, Chenggang			Hydrogen extends Caenorhabditis elegans longevity by reducing reactive oxygen species	PLOS ONE			English	Article							STRESS-RESISTANCE; OXIDATIVE STRESS; LIFE-SPAN; ANTIOXIDANT; METABOLISM; INSULIN; INHALATION; EXPRESSION; PATHWAY; INJURY	At present, a large number of studies have reported that hydrogen has antioxidant functions and prevents oxidative stress damage. However, it is not clear whether hydrogen can prolong longevity based on these effects. Therefore, we studied and explored the antiaging potential of exogenous hydrogen and its ability to extend longevity using Caenorhabditis elegans (C. elegans) as an animal model. Our results showed that the lifespans of the N2, sod-3 and sod-5 mutant strains were extended by approximately 22.7%, 9.5%, and 8.7%, respectively, after hydrogen treatment, but hydrogen had no effect on the lifespans of the daf-2 and daf-16 mutant strains. Meanwhile, the level of reactive oxygen species (ROS) in the hydrogen treatment group was significantly lower than that in the control group. At the transcript level, the expression of age-1 and let-363 was obviously decreased, while the expression of ins-18 was increased at the same time point (14 d). Compared with the control group, paraquat (PQ) could reduce the lifespan of the N2 and sod-5 mutant strains. Importantly, the longevity of these mutant strains recovered to normal levels when the animals were treated with exogenous hydrogen. According to these results, the lifespan of C. elegans is closely related to oxidative stress and can be significantly prolonged by reducing oxidative stress damage. Taken together, our data showed that hydrogen is a valuable antioxidant that can significantly reduce the body's ROS levels and extend the lifespan of C. elegans. This study also laid a foundation for the subsequent application of hydrogen in antiaging studies.	[Zhang, Miao; Li, Zhihui; Gao, Dawen; Gong, Wenjing; Gao, Yan; Zhang, Chenggang] Acad Mil Sci Mil Cognit & Mental Hlth, Res Ctr PLA, Acad Mil Med Sci, Inst Radiat Med, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Gong, WJ; Zhang, CG (corresponding author), Acad Mil Sci Mil Cognit & Mental Hlth, Res Ctr PLA, Acad Mil Med Sci, Inst Radiat Med, Beijing, Peoples R China.	l3521025015@163.com; zhangcg@bmi.ac.cn			National Basic Research Project (973 program) [2012CB518200]; Natural Science Foundation of China [81371232, 81573251]; Special Key Programs for Drug RD of China [2012ZX09102301-016, 2014ZX09J14107-05B]	National Basic Research Project (973 program)(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Key Programs for Drug RD of China	This work was supported by the National Basic Research Project (973 program, 2012CB518200); General Program (81371232, 81573251) of the Natural Science Foundation of China; Special Key Programs for Drug R&D of China (2012ZX09102301-016, 2014ZX09J14107-05B).	Berman JR, 2006, CELL, V124, P1055, DOI 10.1016/j.cell.2006.01.039; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Charao MF, 2015, INT J NANOMED, V10, P5093, DOI 10.2147/IJN.S84909; Chen J, 2016, FOOD FUNCT, V7, P943, DOI [10.1039/C5FO01241D, 10.1039/c5fo01241d]; Chen X, 2018, CELL PHYSIOL BIOCHEM, V47, P176, DOI 10.1159/000489764; Cornelissen G, 2017, GERONTOLOGY, V63, P118, DOI 10.1159/000450945; FRIEDMAN DB, 1988, GENETICS, V118, P75; Gu HX, 2014, J SURG RES, V188, P243, DOI 10.1016/j.jss.2013.12.007; Han Y, 2017, PESTIC BIOCHEM PHYS, V138, P43, DOI 10.1016/j.pestbp.2017.02.005; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hayashida K, 2008, BIOCHEM BIOPH RES CO, V373, P30, DOI 10.1016/j.bbrc.2008.05.165; Hunter T, 1997, J BIOL CHEM, V272, P28652, DOI 10.1074/jbc.272.45.28652; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Keith SA, 2014, METHODS, V68, P476, DOI 10.1016/j.ymeth.2014.04.003; Khare S, 2009, MECH AGEING DEV, V130, P670, DOI 10.1016/j.mad.2009.08.002; Kobatake E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177106; Lee SJ, 2010, CURR BIOL, V20, P2131, DOI 10.1016/j.cub.2010.10.057; Lithgow GJ, 2002, MECH AGEING DEV, V123, P765, DOI 10.1016/S0047-6374(01)00422-5; Lu T, 2008, EXP CELL RES, V314, P1918, DOI 10.1016/j.yexcr.2008.01.011; Matsunaga Y, 2012, BIOCHEM BIOPH RES CO, V423, P478, DOI 10.1016/j.bbrc.2012.05.145; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Ohta S, 2015, METHOD ENZYMOL, V555, P289, DOI 10.1016/bs.mie.2014.11.038; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Senchuk MM, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2086; Shen MH, 2020, NEUROL RES, V42, P22, DOI 10.1080/01616412.2019.1685064; Sohal RS, 1996, SCIENCE, V273, P59, DOI 10.1126/science.273.5271.59; Song SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107685; Tatar Marc, 2002, Sci Aging Knowledge Environ, V2002, ppe2, DOI 10.1126/sageke.2002.3.pe2; Teshiba E, 2016, BIOSCI BIOTECH BIOCH, V80, P1436, DOI 10.1080/09168451.2016.1158634; Xiang YX, 2017, REJUV RES, V20, P34, DOI 10.1089/rej.2016.1830; Xu J, 2017, FREE RADICAL RES, V51, P529, DOI 10.1080/10715762.2017.1331037; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Zecic A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010109; Zhang WB, 2018, BIOMED PHARMACOTHER, V106, P1126, DOI 10.1016/j.biopha.2018.07.020	36	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 22	2020	15	4							e0231972	10.1371/journal.pone.0231972	http://dx.doi.org/10.1371/journal.pone.0231972			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9QD	32320994	Green Published, gold			2022-12-26	WOS:000536028800044
J	Al-Salam, S; Sharma, C; Afandi, B; Al Dahmani, K; Al-Zahrani, AS; Al Shamsi, A; Al Kaabi, J				Al-Salam, Suhail; Sharma, Charu; Afandi, Bachar; Al Dahmani, Khaled; Al-Zahrani, Ali S.; Al Shamsi, Amal; Al Kaabi, Juma			BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; V600E MUTATION; CLINICOPATHOLOGICAL FEATURES; PATHOGENIC ROLE; CANCER; RAS; ASSOCIATION; BRAF(V600E); RET/PTC; CELLS	Background Papillary thyroid carcinoma (PTC) is the most common malignant thyroid neoplasm comprising 80-90% of all thyroid malignancies. Molecular changes in thyroid follicular cells are likely associated with the development of PTC. Mutations in serine/threonine-protein kinase (BRAF) and Rat sarcoma viral oncogene homolog (RAS) are commonly seen in PTC. Methods In total, 90 cases of PTC are randomly selected from archive paraffin blocks and 10 mu m sections were cut and processed for DNA extraction. BRAF V600E mutation and 8 types of KRAS mutations were investigated using Real Time PCR. Results BRAF V600E mutation was identified in 46% of PTC while KRAS mutations were seen in 11% of PTC. There was significant correlation between BRAF V600E mutation and PTC larger than 5cm in diameter, positive surgical margin and lymph node metastasis. BRAF V600E mutation was significantly higher in patients with less than 55-year of age than those more than 55-year of age. BRAF V600E mutation was significantly higher in patients with family history of thyroid cancer than those without. There was no significant difference in BRAFV600E mutation between males and females, PTC classic and follicular variants, unifocal and multifocal PTC. There was a significant higher percentage of BRAF V600E mutation in classic PTC than papillary microcarcinoma variant. There was no significant age, gender, histologic type, tumor size, lymph node metastasis, tumor focality, and surgical margin status differences between KRAS mutated and non-mutated PTC. Conclusion BRAF V600E and KRAS mutation are seen in a significant number of PTC in the UAE. BRAF mutation is significantly correlated with large tumor size, positive surgical margins and lymph node metastasis suggesting an association between BRAF V600E mutation and tumor growth and spread.	[Al-Salam, Suhail] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Sharma, Charu; Al Shamsi, Amal; Al Kaabi, Juma] United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Internal Med, Al Ain, U Arab Emirates; [Afandi, Bachar; Al Dahmani, Khaled] Tawam Hosp, Endocrine Div, Al Ain, U Arab Emirates; [Al-Zahrani, Ali S.] Alfaisal Univ, Mol Endocrinol Div, Dept Med, Riyadh, Saudi Arabia; [Al-Zahrani, Ali S.] King Faisal Specialist Hosp & Res Ctr, Dept Mol Oncol, Riyadh, Saudi Arabia	United Arab Emirates University; United Arab Emirates University; Alfaisal University; King Faisal Specialist Hospital & Research Center	Al Kaabi, J (corresponding author), United Arab Emirates Univ, Coll Med & Hlth Sci, Dept Internal Med, Al Ain, U Arab Emirates.	j.kaabi@uaeu.ac.ae		Alkaabi, Juma/0000-0003-2477-0408	College of Medicine & Health Sciences, UAE University [31M176]; Laboratory Medicine Department, Anatomic Pathology Division at Tawam Hospital, Al Ain City, UAE	College of Medicine & Health Sciences, UAE University; Laboratory Medicine Department, Anatomic Pathology Division at Tawam Hospital, Al Ain City, UAE	This work was supported by the College of Medicine & Health Sciences, UAE University (Research Grant 31M176) to JAK and the Laboratory Medicine Department, Anatomic Pathology Division at Tawam Hospital, Al Ain City, UAE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubaker J, 2008, J CLIN ENDOCR METAB, V93, P611, DOI 10.1210/jc.2007-1717; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Al-Zaher Nabil, 2008, Hematol Oncol Stem Cell Ther, V1, P14; [Anonymous], 2014, J CLIN ONCOL, V32, P2718, DOI [10.1200/JCO.2014.55.5094, DOI 10.1200/JCO.2014.55.5094]; [Anonymous], 2014, CANC REG REP; Chunping L, 2016, WORLD J SURG ONCOL, V14, P241, DOI DOI 10.1186/S12957-016-0979-1; Costa AM, 2008, CLIN ENDOCRINOL, V68, P618, DOI 10.1111/j.1365-2265.2007.03077.x; Davies L, 2006, JAMA-J AM MED ASSOC, V295, P2164, DOI 10.1001/jama.295.18.2164; Di Cristofaro J, 2006, HUM PATHOL, V37, P824, DOI 10.1016/j.humpath.2006.01.030; Elisei R, 2008, J CLIN ENDOCR METAB, V93, P3943, DOI 10.1210/jc.2008-0607; Frasca F, 2008, ENDOCR-RELAT CANCER, V15, P191, DOI 10.1677/ERC-07-0212; Fugazzola L, 2004, CLIN ENDOCRINOL, V61, P239, DOI 10.1111/j.1365-2265.2004.02089.x; Fukushima Toshihiko, 2005, Fukushima J Med Sci, V51, P67; Geng JQ, 2017, SCI CHINA LIFE SCI, V60, P729, DOI 10.1007/s11427-017-9083-8; George Nelson, 2018, Indian J Endocrinol Metab, V22, P505, DOI 10.4103/ijem.IJEM_441_17; Giordano TJ, 2005, ONCOGENE, V24, P6646, DOI 10.1038/sj.onc.1208822; Goutas N, 2008, ANTICANCER RES, V28, P305; Guan HX, 2009, J CLIN ENDOCR METAB, V94, P1612, DOI 10.1210/jc.2008-2390; Ito Y, 2009, ENDOCR J, V56, P89, DOI 10.1507/endocrj.K08E-208; Jin LP, 2016, ONCOTARGET, V7, P18346, DOI 10.18632/oncotarget.7811; Jung CK, 2014, J CLIN ENDOCR METAB, V99, pE276, DOI 10.1210/jc.2013-2503; Kebebew E, 2007, ANN SURG, V246, P466, DOI 10.1097/SLA.0b013e318148563d; Kim TY, 2006, CLIN ENDOCRINOL, V65, P364, DOI 10.1111/j.1365-2265.2006.02605.x; Knauf JA, 2005, CANCER RES, V65, P4238, DOI 10.1158/0008-5472.CAN-05-0047; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Li C, 2013, J CLIN ENDOCR METAB, V98, P3702, DOI 10.1210/jc.2013-1584; Li C, 2012, J CLIN ENDOCR METAB, V97, P4559, DOI 10.1210/jc.2012-2104; Lloyd RV, 2017, WHO CLASSIFICATION T, V4th; Lupi C, 2007, J CLIN ENDOCR METAB, V92, P4085, DOI 10.1210/jc.2007-1179; MacCorkle RA, 2005, CELL BIOCHEM BIOPHYS, V43, P451, DOI 10.1385/CBB:43:3:451; Marwa S, 2017, J ENDOCRINOL THYROID, V2; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Melillo RM, 2005, J CLIN INVEST, V115, P1068, DOI 10.1172/JCI22758; Mesa C, 2006, CANCER RES, V66, P6521, DOI 10.1158/0008-5472.CAN-06-0739; Mitsutake N, 2005, CANCER RES, V65, P2465, DOI 10.1158/0008-5472.CAN-04-3314; Nato H, 1998, CANCER LETT, V131, P171, DOI 10.1016/S0304-3835(98)00149-9; Pellegriti G, 2013, J CANCER EPIDEMIOL, V2013, DOI 10.1155/2013/965212; Pessoa-Pereira D, 2019, ARCH ENDOCRIN METAB, V63, P97, DOI 10.20945/2359-3997000000120; Rosenbaum E, 2005, MODERN PATHOL, V18, P898, DOI 10.1038/modpathol.3800252; Sezer A, 2017, BOSNIAN J BASIC MED, V17, P144, DOI 10.17305/bjbms.2017.1924; Shah JP, 2015, CLIN ADV HEMATOL ONC, V13, P3; Siraj AK, 2016, AM J HUM GENET, V98, P1170, DOI 10.1016/j.ajhg.2016.04.014; Song YS, 2015, ENDOCRINOL METAB, V30, P252, DOI 10.3803/EnM.2015.30.3.252; Tang KT, 2010, J CHIN MED ASSOC, V73, P113, DOI 10.1016/S1726-4901(10)70025-3; Tavares C, 2016, EUR J ENDOCRINOL, V174, pR117, DOI 10.1530/EJE-15-0605; Trovisco V, 2007, ARQ BRAS ENDOCRINOL, V51, P643, DOI 10.1590/S0004-27302007000500002; Ugolini C, 2007, THYROID, V17, P389, DOI 10.1089/thy.2006.0306; Wang YG, 2008, ENDOCR-RELAT CANCER, V15, P183, DOI 10.1677/ERC-07-0182; Xing MZ, 2007, ENDOCR REV, V28, P742, DOI 10.1210/er.2007-0007; Xing MZ, 2015, J CLIN ONCOL, V33, P42, DOI 10.1200/JCO.2014.56.8253; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Yang LB, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/642046; Zoghlami A, 2014, EUR ANN OTORHINOLARY, V131, P7, DOI 10.1016/j.anorl.2013.01.004; Zou MJ, 2014, THYROID, V24, P1256, DOI 10.1089/thy.2013.0610	54	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231341	10.1371/journal.pone.0231341	http://dx.doi.org/10.1371/journal.pone.0231341			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315324	Green Published, gold			2022-12-26	WOS:000536024800023
J	Coonan, A; Schnell, P; Smith, J; Forbes, J				Coonan, Anna; Schnell, Patrick; Smith, Joel; Forbes, John			Using the Bayesian credible subgroups method to identify populations benefiting from treatment: An application to the Look AHEAD trial	PLOS ONE			English	Article							LIFE-STYLE INTERVENTIONS; QING DIABETES PREVENTION; ALL-CAUSE MORTALITY; POST-HOC ANALYSIS; WEIGHT-LOSS; CLINICAL-TRIAL; INSTRUMENTAL VARIABLES; CARDIOVASCULAR-DISEASE; ADAPTIVE DESIGNS; HEALTH	Traditionally, subgroup analyses are used to assess whether patient characteristics moderate treatment effectiveness with general disregard for issues of multiplicity. Using data from The Action for Health in Diabetes (Look AHEAD) trial in the United States, we aim to identify a subgroup where all of its types of members experience a treatment benefit defined as reducing the likelihood of a major cardiovascular event under an intensive lifestyle and weight-loss intervention. We apply the credible subgroups method to a Bayesian logistic model with a conservative prior that is sceptical of large treatment effect heterogeneity. The covariate profiles for which there is sufficient evidence of treatment benefit are, coarsely, middle-aged women, in poor subjective general health and with moderately to poorly controlled diabetes. There is at least 80% posterior probability that the conditional average treatment effect is positive for all covariate profiles fitting this description, which account for 0.5% of trial participants. Conversely, the covariate profiles that are likely to be associated with no benefit are middle aged and older men in excellent subjective general health, with well-controlled diabetes. These profiles apply to less than 2% of trial participants. More information is required to determine treatment benefit or no benefit for the remainder of the trial population.	[Coonan, Anna; Forbes, John] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Schnell, Patrick] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA; [Smith, Joel] Univ Oxford, Nuffield Dept Populat Hlth, Oxford, England	University of Limerick; University System of Ohio; Ohio State University; University of Oxford	Coonan, A (corresponding author), Univ Limerick, Grad Entry Med Sch, Limerick, Ireland.	Anna.Coonan@gmit.ie	Forbes, John/L-2558-2013	Forbes, John/0000-0002-8255-3762	Health Research Board [HRB-RL-2013-11]; National Institute for Health Research Biomedical Research Centre at the University of Oxford [NIHR-BRC-1215-20008]	Health Research Board; National Institute for Health Research Biomedical Research Centre at the University of Oxford	This work was supported by the Health Research Board HRB-RL-2013-11 and the National Institute for Health Research Biomedical Research Centre at the University of Oxford NIHR-BRC-1215-20008. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2019, R LANG ENV STAT COMP; Athey Susan, 2015, STAT-US, V1050, P5; Basu A, 2014, J APPL ECONOMET, V29, P671, DOI 10.1002/jae.2343; Basu A, 2011, J HEALTH ECON, V30, P695, DOI 10.1016/j.jhealeco.2011.05.012; Bauer P, 2016, STAT MED, V35, P325, DOI 10.1002/sim.6472; Baum A, 2017, LANCET DIABETES ENDO, V5, P808, DOI 10.1016/S2213-8587(17)30176-6; Bhatt DL, 2016, NEW ENGL J MED, V375, P65, DOI 10.1056/NEJMra1510061; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Brancati FL, 2012, CLIN TRIALS, V9, P113, DOI 10.1177/1740774511432726; Breyer BN, 2014, J UROLOGY, V192, P144, DOI 10.1016/j.juro.2014.02.036; Cameron C., 2005, MICROECONOMETRICS US, P1056; Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), 2018, AD DES CLIN TRIALS D; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Green DP, 2012, PUBLIC OPIN QUART, V76, P491, DOI 10.1093/poq/nfs036; Gregg EW, 2017, LANCET DIABETES ENDO, V5, P763, DOI 10.1016/S2213-8587(17)30238-3; Gregg EW, 2016, LANCET DIABETES ENDO, V4, P913, DOI 10.1016/S2213-8587(16)30162-0; Harrington M, 2009, NUTR RES REV, V22, P93, DOI 10.1017/S0954422409990035; Heckman J, 1997, J HUM RESOUR, V32, P441, DOI 10.2307/146178; Imai K, 2013, ANN APPL STAT, V7, P443, DOI 10.1214/12-AOAS593; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Li GW, 2014, LANCET DIABETES ENDO, V2, P474, DOI 10.1016/S2213-8587(14)70057-9; Look AHEAD Research Group, 2007, DIABETES CARE; Nimble Development Team, 2015, NIMBLE R PACK PROGR; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Olken BA, 2015, J ECON PERSPECT, V29, P61, DOI 10.1257/jep.29.3.61; Pi-Sunyer Xavier, 2014, Curr Nutr Rep, V3, P387; Pocock SJ, 2002, STAT MED, V21, P2917, DOI 10.1002/sim.1296; POCOCK SJ, 1977, BIOMETRIKA, V64, P191, DOI 10.1093/biomet/64.2.191; Ruberg SJ, 2010, CLIN TRIALS, V7, P574, DOI 10.1177/1740774510369350; Schellenberg ES, 2013, ANN INTERN MED, V159, P543, DOI 10.7326/0003-4819-159-8-201310150-00007; Schnell P, 2017, CREDSUBS CREDIBLE SU; Schnell PM, 2016, BIOMETRICS, V72, P1026, DOI 10.1111/biom.12522; Schnell PM, 2017, CREDIBLE SUBGROUPS I; Simon N, 2013, BIOSTATISTICS, V14, P613, DOI 10.1093/biostatistics/kxt010; Simon R, 2002, STAT MED, V21, P2909, DOI 10.1002/sim.1295; Unick JL, 2011, DIABETES CARE; Uusitupa M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005656; Wadden TA, 2014, JAMA-J AM MED ASSOC, V312, P1779, DOI 10.1001/jama.2014.14173; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914	39	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231241	10.1371/journal.pone.0231241	http://dx.doi.org/10.1371/journal.pone.0231241			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315340	Green Published, gold, Green Submitted			2022-12-26	WOS:000536024800019
J	Ukita, A; Abe, M; Kishigami, H; Hatta, T				Ukita, Atsuki; Abe, Masayuki; Kishigami, Hirotoshi; Hatta, Tatsuo			Influence of back support shape in wheelchairs offering pelvic support on asymmetrical sitting posture and pressure points during reaching tasks in stroke patients	PLOS ONE			English	Article							TRUNK-IMPAIRMENT-SCALE; SIT-TO-STAND; SPINAL POSTURE; VIDEO ANALYSIS; RELIABILITY; BALANCE; GAIT; RECOVERY; POSITION; RISK	Many poststroke hemiplegic patients have an asymmetrical wheelchair-sitting posture. This study aimed to investigate the impact of different back support shapes on asymmetrical sitting posture and pressure points among poststroke hemiplegic patients during an activities of daily living-related reaching task. This study included 23 poststroke hemiplegic patients who performed tasks that involved the movement of objects using the unaffected upper limb to the affected side while sitting in a conventional wheelchair (C-WC) with a flat back support or a wheelchair providing pelvic and thoracic support (P-WC). Body alignment angles from video images and pressure distribution on supporting surfaces were measured using a two-dimensional motion analysis software (Dartfish) and a pressure mapping system (FSA). Regarding movement performance, although postural asymmetry increased in both wheelchair types, the degree of postural variation was smaller with P-WC use than C-WC use (p < 0.05), with partly reduced postural asymmetry. With P-WC, one-sided ischial asymmetrical pressure was significantly less after the movement (p < 0.05). In conclusion, P-WC's back support shape contributed to a decrease in postural asymmetry for pelvic girdle support both at rest and during movement. This highlights the importance of a wheelchair back support shape and may help to increase the quality of activities of daily living movement in poststroke hemiplegic patients in wheelchairs.	[Ukita, Atsuki; Abe, Masayuki] Social Med Corp Hokuto, Tokachi Rehabil Ctr, Obihiro, Hokkaido, Japan; [Ukita, Atsuki] Tohoku Fukushi Univ, Sendai, Miyagi, Japan; [Kishigami, Hirotoshi; Hatta, Tatsuo] Japan Hlth Care Coll, Eniwa, Japan		Hatta, T (corresponding author), Japan Hlth Care Coll, Eniwa, Japan.	thatta@nihoniryo-c.ac.jp			Social Medical Corporation Hokuto	Social Medical Corporation Hokuto	Social Medical Corporation Hokuto provided support in the form of salaries to the authors (AU and MA) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alt Murphy M, 2006, J NEUROENG REHABIL, V3, DOI 10.1186/1743-0003-3-18; Azevedo DC, 2014, J BODYW MOV THER, V18, P210, DOI 10.1016/j.jbmt.2013.05.017; Barreca SR, 2005, ARCH PHYS MED REHAB, V86, P1616, DOI 10.1016/j.apmr.2005.03.017; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bonan IV, 2013, CLIN NEUROPHYSIOL, V124, P713, DOI 10.1016/j.clinph.2012.09.019; Borel S, 2011, GAIT POSTURE, V33, P727, DOI 10.1016/j.gaitpost.2011.02.012; Boukadida A, 2015, ANN PHYS REHABIL MED, V58, P167, DOI 10.1016/j.rehab.2015.04.007; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Capon A, 2007, J ADV NURS, V58, P263, DOI 10.1111/j.1365-2648.2007.04232.x; Constand MK, 2013, BMC SPORTS SCI MED R, V5, DOI 10.1186/2052-1847-5-21; de Graaf-Peters VB, 2007, EXP BRAIN RES, V181, P647, DOI 10.1007/s00221-007-0964-6; de Haart M, 2004, ARCH PHYS MED REHAB, V85, P886, DOI 10.1016/j.apmr.2003.05.012; Defloor T, 1999, APPL NURS RES, V12, P136, DOI 10.1016/S0897-1897(99)80045-7; Dey Zita Ranajoy, 2013, Journal of Medical Engineering & Technology, V37, P213, DOI 10.3109/03091902.2013.765517; Dieterich M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00172; Engardt M, 1994, Scand J Rehabil Med Suppl, V31, P1; Genthon N, 2007, CLIN BIOMECH, V22, P1024, DOI 10.1016/j.clinbiomech.2007.07.011; Green G, 2011, EUR GERIATR MED, V2, P52, DOI 10.1016/j.eurger.2010.11.012; Jamal K, 2018, EXP BRAIN RES, V236, P2377, DOI 10.1007/s00221-018-5308-1; Kim HD, 2014, ANN REHABIL MED-ARM, V38, P317, DOI 10.5535/arm.2014.38.3.317; Kim WJ, 2013, J PHYS THER SCI, V25, P1185, DOI 10.1589/jpts.25.1185; Kuo YL, 2009, J MANIP PHYSIOL THER, V32, P210, DOI 10.1016/j.jmpt.2009.02.002; Lecours J, 2008, J REHABIL MED, V40, P200, DOI 10.2340/16501977-0155; Lee IH, 2011, J PHYS THER SCI, V23, P837, DOI 10.1589/jpts.23.837; Li CT, 2017, BIOMED ENG ONLINE, V16, DOI 10.1186/s12938-017-0398-8; Li CT, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-1358-3; Li CT, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0008-6; Li CT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113644; Linder-Ganz E, 2007, Technol Health Care, V15, P195; MILETTE D, 1987, PHYS THER, V67, P1697, DOI 10.1093/ptj/67.11.1697; Miller DM, 2014, CLIN NEUROPHYSIOL, V125, P2070, DOI 10.1016/j.clinph.2014.01.035; Mountain AD, 2010, ARCH PHYS MED REHAB, V91, P639, DOI 10.1016/j.apmr.2009.11.025; National Collaborating Centre for Mental Health, 2014, PSYCH SCHIZ AD TREAT, P14; Oliveira CB, 2011, CLINICS, V66, P2043, DOI 10.1590/S1807-59322011001200008; Parent F, 2000, J REHABIL RES DEV, V37, P325; Perennou D, 2014, NEUROPHYSIOL CLIN, V44, P25, DOI 10.1016/j.neucli.2013.10.131; Platz T, 2005, CLIN REHABIL, V19, P404, DOI 10.1191/0269215505cr832oa; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010820.pub2; Richards LG, 2008, NEUROREHAB NEURAL RE, V22, P180, DOI 10.1177/1545968307305355; Roy G, 2006, CLIN BIOMECH, V21, P585, DOI 10.1016/j.clinbiomech.2006.01.007; Sakuma T, 2010, J ORAL REHABIL, V37, P583, DOI 10.1111/j.1365-2842.2010.02084.x; Samuelsson K, 2009, DISABIL REHABIL-ASSI, V4, P329, DOI 10.1080/17483100902978426; Scheer JK, 2013, J NEUROSURG-SPINE, V19, P141, DOI 10.3171/2013.4.SPINE12838; Straker LM, 2008, AUST J PHYSIOTHER, V54, P127, DOI 10.1016/S0004-9514(08)70046-1; Takashima N, 2017, CIRC J, V81, P1636, DOI 10.1253/circj.CJ-17-0177; Tasker LH, 2014, PROSTHET ORTHOT INT, V38, P46, DOI 10.1177/0309364613486918; Teasell RW, 2005, CAN J NEUROL SCI, V32, P512, DOI 10.1017/S0317167100004534; Turin TC, 2010, STROKE, V41, P1552, DOI 10.1161/STROKEAHA.110.581363; Ukita A, 2017, BIOMED RES CLIN PRAC, P21, DOI [10.15761/BRCP.1000149, DOI 10.15761/BRCP.1000149]; Ukita A, 2015, J HEALTHC ENG, V6, P179, DOI 10.1260/2040-2295.6.2.179; Van Criekinge T, 2017, GAIT POSTURE, V54, P133, DOI 10.1016/j.gaitpost.2017.03.004; van Nes IJW, 2008, GAIT POSTURE, V28, P507, DOI 10.1016/j.gaitpost.2008.03.004; van Niekerk SM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-113; Venketasubramanian N, 2017, J STROKE, V19, P286, DOI 10.5853/jos.2017.00234; Verheyden G, 2006, CLIN REHABIL, V20, P451, DOI 10.1191/0269215505cr955oa; Verheyden G, 2005, DISABIL REHABIL, V27, P1023, DOI 10.1080/09638280500052872; Verheyden G, 2004, CLIN REHABIL, V18, P326, DOI 10.1191/0269215504cr733oa; Wee SK, 2015, PHYS THER, V95, P1163, DOI 10.2522/ptj.20140487; Wee SK, 2014, NEUROREHAB NEURAL RE, V28, P660, DOI 10.1177/1545968314521011; Winzeler-Mercay U, 2002, DISABIL REHABIL, V24, P875, DOI 10.1080/09638280210142220; Wonsetler EC, 2017, TOP STROKE REHABIL, V24, P435, DOI 10.1080/10749357.2017.1285746; Yoo WG, 2014, J PHYS THER SCI, V26, P1547, DOI 10.1589/jpts.26.1547	62	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231860	10.1371/journal.pone.0231860	http://dx.doi.org/10.1371/journal.pone.0231860			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315353	Green Published, gold			2022-12-26	WOS:000536024800059
J	Zhai, JJ; Yan, Z; Ping, F; Lei, Q; Chen, XL; Qi, YP				Zhai, Junjun; Yan, Zhang; Ping, Feng; Lei, Qu; Chen, Xuelong; Qi, Yanping			Establishment and application of isothermal amplification techniques for the detection of heat-stable I enterotoxin of enterotoxigenic Escherichia coli	PLOS ONE			English	Article							CROSS-PRIMING AMPLIFICATION; GENOTYPIC CHARACTERIZATION; SENSITIVE DETECTION; RAPID DETECTION; PCR ASSAYS; LABILE-I; GENES; DIARRHEA; VIRUS; PIGS	The aim of this study was to establish isothermal multiple self-matching initiated amplification (IMSA) and cross-priming amplification (CPA) methods to detect heat-stable I enterotoxin (STa)-producing enterotoxigenic Escherichia coli (ETEC). To avoid cross-contamination of aerosols, a closed independent isothermal amplification tube (IAT) was used to perform the assays. Optimal amplification conditions for IMSA and CPA were selected for specificity and sensitivity, respectively, and for clinical relevance. Both IMSA and CPA assays could specifically recognize all 3-STa positive strains in which they fluoresced green under UV light, but not in the 11 non-STa strains. The results of the sensitivity analysis indicated that the detection limit of the IMSA assay was 1.5 x 10(2) CFU, comparable to real-time PCR, but 10-fold more sensitive than CPA and LAMP. Further evaluation of the detection methods of swine diarrhea samples demonstrated that both could successfully identify the DNA of STa-producing ETEC in clinical specimens, consistent with LAMP and qPCR methods. The results demonstrated that the IMSA and CPA methods had high specificity and sensitivity with rapid detection of ETEC, so having great potential in clinical applications.	[Zhai, Junjun; Lei, Qu] Yulin Univ, Shaanxi Prov Engn & Technol Res Ctr Shanbei Cashm, Yulin, Shanxi, Peoples R China; [Yan, Zhang; Ping, Feng] Yulin Univ, Coll Life Sci, Yulin, Shanxi, Peoples R China; [Chen, Xuelong; Qi, Yanping] Anhui Sci & Technol Univ, Coll Anim Sci, Fengyang, Anhui, Peoples R China	Yulin University; Yulin University; Anhui Science & Technology University	Chen, XL; Qi, YP (corresponding author), Anhui Sci & Technol Univ, Coll Anim Sci, Fengyang, Anhui, Peoples R China.	cxlandqyp@163.com; qypandcxl@163.com		CHEN, Xuelong/0000-0002-9683-9200	Natural Science Foundation of Heilongjiang Province of China [C2017050]; Fund for Less Developed Regions of the National Natural Science Foundation of China [31960710]; PhD Research Startup Foundation of Yulin college [18GK09]	Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Fund for Less Developed Regions of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); PhD Research Startup Foundation of Yulin college	The current study was funded by the Natural Science Foundation of Heilongjiang Province of China (No. C2017050), and The Fund for Less Developed Regions of the National Natural Science Foundation of China (31960710), and PhD Research Startup Foundation of Yulin college (18GK09).	Bin P, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1704-9; Choi C, 2001, J VET DIAGN INVEST, V13, P26, DOI 10.1177/104063870101300106; Cui LB, 2012, J CLIN MICROBIOL, V50, P3881, DOI 10.1128/JCM.01931-12; Ding X, 2014, J CLIN MICROBIOL, V52, P1862, DOI 10.1128/JCM.03298-13; Fang RD, 2009, J CLIN MICROBIOL, V47, P845, DOI 10.1128/JCM.01528-08; Goo YK, 2016, KOREAN J PARASITOL, V54, P329, DOI 10.3347/kjp.2016.54.3.329; Jiang KY, 2012, CURR MICROBIOL, V65, P633, DOI 10.1007/s00284-012-0204-6; Kuta A, 2015, J APPL MICROBIOL, V119, P632, DOI 10.1111/jam.12859; Li YH, 2017, FOODBORNE PATHOG DIS, V14, P333, DOI 10.1089/fpd.2016.2233; Liu BG, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0310-8; Liu WX, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216272; Liu WX, 2019, J MICROBIOL METH, V161, P47, DOI 10.1016/j.mimet.2019.04.010; Liu WX, 2014, VET J, V199, P286, DOI 10.1016/j.tvjl.2013.11.019; Madoroba E, 2009, TROP ANIM HEALTH PRO, V41, P1539, DOI 10.1007/s11250-009-9345-4; Moredo FA, 2015, FOODBORNE PATHOG DIS, V12, P704, DOI 10.1089/fpd.2015.1959; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Nagy B, 2005, INT J MED MICROBIOL, V295, P443, DOI 10.1016/j.ijmm.2005.07.003; Nemoto J, 2011, J FOOD PROTECT, V74, P1462, DOI 10.4315/0362-028X.JFP-10-519; Pattabiraman V, 2016, FOODBORNE PATHOG DIS, V13, P212, DOI 10.1089/fpd.2015.2064; Qadri F, 2005, CLIN MICROBIOL REV, V18, P465, DOI 10.1128/CMR.18.3.465-483.2005; Rajkhowa S, 2009, J APPL MICROBIOL, V106, P455, DOI 10.1111/j.1365-2672.2008.04013.x; Reischl U, 2004, J CLIN MICROBIOL, V42, P4092, DOI 10.1128/JCM.42.9.4092-4100.2004; Rodas C, 2009, J CLIN MICROBIOL, V47, P1218, DOI 10.1128/JCM.00316-09; THOMPSON MR, 1984, J CLIN MICROBIOL, V20, P59, DOI 10.1128/JCM.20.1.59-64.1984; Wozniakowski G, 2015, J APPL MICROBIOL, V118, P528, DOI 10.1111/jam.12705; Xu GL, 2012, SCI REP-UK, V2, DOI [10.1038/srep00246, 10.1038/srep00986]; Yang ZG, 2018, EXP THER MED, V16, P3353, DOI 10.3892/etm.2018.6617; Yano A, 2007, J MICROBIOL METH, V68, P414, DOI 10.1016/j.mimet.2006.09.024	28	1	4	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0230881	10.1371/journal.pone.0230881	http://dx.doi.org/10.1371/journal.pone.0230881			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9OP	32315305	Green Submitted, gold, Green Published			2022-12-26	WOS:000536024800012
J	Zhou, GY; Xiao, X; Tu, MT; Liu, PX; Yang, D; Liu, XG; Zhang, RY; Li, LP; Lei, S; Wang, H; Song, Y; Wang, P				Zhou, Guanyu; Xiao, Xun; Tu, Mengtian; Liu, Peixi; Yang, Dan; Liu, Xiaogang; Zhang, Renyi; Li, Liangping; Lei, Shan; Wang, Han; Song, Yan; Wang, Pu			Computer aided detection for laterally spreading tumors and sessile serrated adenomas during colonoscopy	PLOS ONE			English	Article							ENDOSCOPIC MUCOSAL RESECTION; COLORECTAL-CANCER; INATTENTIONAL BLINDNESS; PROSPECTIVE MULTICENTER; POLYPS; RISK; VALIDATION; DIAGNOSIS; SYSTEM; RATES	Background Evidence has shown that deep learning computer aided detection (CADe) system achieved high overall detection accuracy for polyp detection during colonoscopy. Aim The detection performance of CADe system on non-polypoid laterally spreading tumors (LSTs) and sessile serrated adenomas/polyps (SSA/Ps), with higher risk for malignancy transformation and miss rate, has not been exclusively investigated. Methods A previously validated deep learning CADe system for polyp detection was tested exclusively on LSTs and SSA/Ps. 1451 LST images from 184 patients were collected between July 2015 and January 2019, 82 SSA/Ps videos from 26 patients were collected between September 2018 and January 2019. The per-frame sensitivity and per-lesion sensitivity were calculated. Results (1) For LSTs image dataset, the system achieved an overall per-image sensitivity and per-lesion sensitivity of 94.07% (1365/1451) and 98.99% (197/199) respectively. The perframe sensitivity for LST-G(H), LST-G(M), LST-NG(F), LST-NG(PD) was 93.97% (343/365), 98.72% (692/701), 85.71% (324/378) and 85.71% (6/7) respectively. The per-lesion sensitivity of each subgroup was 100.00% (71/71), 100.00% (64/64), 98.31% (58/59) and 80.00% (4/5). (2) For SSA/Ps video dataset, the system achieved an overall per-frame sensitivity and per-lesion sensitivity of 84.10% (15883/18885) and 100.00% (42/42), respectively. Conclusions This study demonstrated that a local-feature-prioritized automatic CADe system could detect LSTs and SSA/Ps with high sensitivity. The per-frame sensitivity for non-granular LSTs and small SSA/Ps should be further improved.	[Zhou, Guanyu; Xiao, Xun; Tu, Mengtian; Liu, Peixi; Liu, Xiaogang; Zhang, Renyi; Li, Liangping; Lei, Shan; Wang, Han; Song, Yan; Wang, Pu] Sichuan Acad Med Sci, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China; [Zhou, Guanyu; Xiao, Xun; Tu, Mengtian; Liu, Peixi; Liu, Xiaogang; Zhang, Renyi; Li, Liangping; Lei, Shan; Wang, Han; Song, Yan; Wang, Pu] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Yang, Dan] Southwest Med Univ, Affiliated Hosp, Dept Gastroenterol, Luzhou, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Southwest Medical University	Wang, P (corresponding author), Sichuan Acad Med Sci, Dept Gastroenterol, Chengdu, Sichuan, Peoples R China.; Wang, P (corresponding author), Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China.	wangpuhuaxi@qq.com	Tu, Mengtian/AAU-6816-2020	Wang, Pu/0000-0002-1234-309X				Alagappan M, 2018, WORLD J GASTRO ENDOS, V10, P239, DOI 10.4253/wjge.v10.i10.239; American Cancer Society, 2017, CANC FACTS FIG 2017; Aslanian HR, 2013, AM J GASTROENTEROL, V108, P166, DOI 10.1038/ajg.2012.237; Bandos AI, 2009, BIOMETRICS, V65, P247, DOI 10.1111/j.1541-0420.2008.01049.x; Burgess NG, 2016, GUT, V65, P437, DOI 10.1136/gutjnl-2014-308603; Burke Carol, 2017, Gastroenterol Hepatol (N Y), V13, P1; Cenaj O, 2018, MODERN PATHOL, V31, P633, DOI 10.1038/modpathol.2017.169; Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086; Erichsen R, 2016, GASTROENTEROLOGY, V150, P895, DOI 10.1053/j.gastro.2015.11.046; Fan Claire, 2018, Curr Treat Options Gastroenterol, V16, P182, DOI 10.1007/s11938-018-0176-0; Fang JY, 2014, GASTROINTEST TUMORS, V1, P53, DOI 10.1159/000362585; Heresbach D, 2008, ENDOSCOPY, V40, P284, DOI 10.1055/s-2007-995618; Hetzel JT, 2010, AM J GASTROENTEROL, V105, P2656, DOI 10.1038/ajg.2010.315; Hewett DG, 2012, GASTROENTEROLOGY, V143, P599, DOI 10.1053/j.gastro.2012.05.006; Hurlstone DP, 2004, GUT, V53, P1334, DOI 10.1136/gut.2003.036913; Kahi CJ, 2019, CLIN ENDOSC, V52, P235, DOI 10.5946/ce.2018.112; Kaminski MF, 2010, NEW ENGL J MED, V362, P1795, DOI 10.1056/NEJMoa0907667; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Lami M, 2018, ENDOSCOPY, V50, P701, DOI 10.1055/s-0044-101026; Limketkai BN, 2013, GASTROINTEST ENDOSC, V77, P360, DOI 10.1016/j.gie.2012.11.013; Mahmud N, 2015, GASTROENTEROL REP, V3, P179, DOI 10.1093/gastro/gov027; Memmert D, 2010, J GEN PSYCHOL, V137, P129, DOI 10.1080/00221301003645061; Rex DK, 1997, GASTROENTEROLOGY, V112, P24, DOI 10.1016/S0016-5085(97)70214-2; Rogart JN, 2008, AM J GASTROENTEROL, V103, P2841, DOI 10.1111/j.1572-0241.2008.02085.x; Rotondano G, 2011, ENDOSCOPY, V43, P856, DOI 10.1055/s-0030-1256639; Sano Y, 2016, DIGEST ENDOSC, V85, P822; Simons DJ, 1999, PERCEPTION, V28, P1059, DOI 10.1068/p2952; Simons DJ, 2005, TRENDS COGN SCI, V9, P16, DOI 10.1016/j.tics.2004.11.006; Szylberg L, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/573814; Tziatzios G, 2019, DIGEST LIVER DIS, V51, P1079, DOI 10.1016/j.dld.2019.05.012; Uraoka T, 2006, GUT, V55, P1592, DOI 10.1136/gut.2005.087452; Uraoka T, 2015, J GASTROENTEROL, V50, P555, DOI 10.1007/s00535-014-0999-y; Wang P, 2020, LANCET GASTROENTEROL, V5, P343, DOI [10.1016/S2468-1253(19)30411-X, 10.1016/S2468-1253(19)30411-x]; Wang P, 2019, GUT, V68, P1813, DOI 10.1136/gutjnl-2018-317500; Wang P, 2018, NAT BIOMED ENG, V2, P741, DOI 10.1038/s41551-018-0301-3; Wolfe JM, 2006, VIS COGN, V14, P749, DOI 10.1080/13506280500195292; Zhao XH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094552	37	14	15	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 21	2020	15	4							e0231880	10.1371/journal.pone.0231880	http://dx.doi.org/10.1371/journal.pone.0231880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9OP	32315365	Green Published, gold			2022-12-26	WOS:000536024800062
J	Malizia, A; Blundo, C; Carilla, J; Acosta, OO; Cuesta, F; Duque, A; Aguirre, N; Aguirre, Z; Ataroff, M; Baez, S; Calderon-Loor, M; Cayola, L; Cayuela, L; Ceballos, S; Cedillo, H; Rios, WF; Feeley, KJ; Fuentes, AF; Alvarez, LEG; Grau, R; Homeier, J; Jadan, O; Llambi, LD; Rivera, MIL; Macia, MJ; Malhi, Y; Malizia, L; Peralvo, M; Pinto, E; Tello, S; Silman, M; Young, KR				Malizia, Agustina; Blundo, Cecilia; Carilla, Julieta; Osinaga Acosta, Oriana; Cuesta, Francisco; Duque, Alvaro; Aguirre, Nikolay; Aguirre, Zhofre; Ataroff, Michele; Baez, Selene; Calderon-Loor, Marco; Cayola, Leslie; Cayuela, Luis; Ceballos, Sergio; Cedillo, Hugo; Farfan Rios, William; Feeley, Kenneth J.; Fernando Fuentes, Alfredo; Gamez Alvarez, Luis E.; Grau, Ricardo; Homeier, Juergen; Jadan, Oswaldo; Daniel Llambi, Luis; Loza Rivera, Maria Isabel; Macia, Manuel J.; Malhi, Yadvinder; Malizia, Lucio; Peralvo, Manuel; Pinto, Esteban; Tello, Sebastian; Silman, Miles; Young, Kenneth R.			Elevation and latitude drives structure and tree species composition in Andean forests: Results from a large-scale plot network	PLOS ONE			English	Article							LAND-USE; ALTITUDINAL GRADIENT; SUBTROPICAL FORESTS; NICHE CONSERVATISM; DIVERSITY PATTERNS; CLIMATE-CHANGE; BIODIVERSITY; BIOMASS; DYNAMICS; PRODUCTIVITY	Our knowledge about the structure and function of Andean forests at regional scales remains limited. Current initiatives to study forests over continental or global scales still have important geographical gaps, particularly in regions such as the tropical and subtropical Andes. In this study, we assessed patterns of structure and tree species diversity along similar to 4000 km of latitude and similar to 4000 m of elevation range in Andean forests. We used the Andean Forest Network (Red de Bosques Andinos, https://redbosques.condesan.org/) database which, at present, includes 491 forest plots (totaling 156.3 ha, ranging from 0.01 to 6 ha) representing a total of 86,964 identified tree stems. 10 cm diameter at breast height belonging to 2341 identified species, 584 genera and 133 botanical families. Tree stem density and basal area increases with elevation while species richness decreases. Stem density and species richness both decrease with latitude. Subtropical forests have distinct tree species composition compared to those in the tropical region. In addition, floristic similarity of subtropical plots is between 13 to 16% while similarity between tropical forest plots is between 3% to 9%. Overall, plots similar to 0.5-ha or larger may be preferred for describing patterns at regional scales in order to avoid plot size effects. We highlight the need to promote collaboration and capacity building among researchers in the Andean region (i.e., SouthSouth cooperation) in order to generate and synthesize information at regional scale.	[Malizia, Agustina; Blundo, Cecilia; Carilla, Julieta; Osinaga Acosta, Oriana; Ceballos, Sergio; Grau, Ricardo] Univ Nacl Tucuman, Consejo Nacl Invest Cient & Tecn, CONICET, Inst Ecol Reg IER, San Miguel De Tucuman, Argentina; [Cuesta, Francisco; Calderon-Loor, Marco] Univ Las Amer UDLA, Grp Invest Biodiversidad Medio Ambiente & Salud B, Quito, Ecuador; [Cuesta, Francisco; Peralvo, Manuel; Pinto, Esteban] Consorcio Desarrollo Sostenible Ecorreg Andina CO, Quito, Ecuador; [Duque, Alvaro] Univ Nacl Colombia, Fac Ciencias Agr, Dept Ciencias Forestales, Medellin, Colombia; [Aguirre, Nikolay] Univ Nacl Loja, Ctr Invest Trop Ambiente & Biodiversidad, Loja, Ecuador; [Aguirre, Zhofre] Univ Nacl Loja, Herbario Reinaldo Espinoza, Loja, Ecuador; [Ataroff, Michele] Univ Los Andes, Fac Ciencias, Inst Ciencias Ambientales & Ecol ICAE, Merida, Venezuela; [Baez, Selene; Daniel Llambi, Luis] Escuela Politec Nacl, Quito, Ecuador; [Calderon-Loor, Marco] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Geelong, Vic, Australia; [Cayola, Leslie; Fernando Fuentes, Alfredo; Loza Rivera, Maria Isabel] Herbario Nacl Bolivia LPB, La Paz, Bolivia; [Cayola, Leslie; Fernando Fuentes, Alfredo] Missouri Bot Garden, St Louis, MO USA; [Cayuela, Luis] Univ Rey Juan Carlos, Area Biodiversidad & Conservac, Madrid, Spain; [Cedillo, Hugo; Jadan, Oswaldo] Univ Cuenca, Fac Ciencias Agropecuarias, Cuenca, Ecuador; [Farfan Rios, William] Univ Nacl San Antonio Abad Cusco, Herbario Vargas CUZ, Cuzco, Peru; [Feeley, Kenneth J.] Univ Miami, Dept Biol, Coral Gables, FL 33124 USA; [Gamez Alvarez, Luis E.] Univ Los Andes, Fac Ciencias Forestales & Ambientales, Lab Dendrol, Merida, Venezuela; [Homeier, Juergen] Univ Gottingen, Plant Ecol & Ecosyst Res, Gottingen, Germany; [Homeier, Juergen] Univ Gottingen, Ctr Biodivers & Sustainable Land Use CBL, Gottingen, Germany; [Loza Rivera, Maria Isabel] Univ Missouri, Dept Biol, Columbia, MO USA; [Loza Rivera, Maria Isabel; Tello, Sebastian] Missouri Bot Garden, Ctr Conservat & Sustainable Dev, St Louis, MO USA; [Macia, Manuel J.] Univ Autonoma Madrid, Dept Biol, Area Bot, Madrid, Spain; [Macia, Manuel J.] Univ Autonoma Madrid, Ctr Invest Biodiversidad & Cambio Global CIBC UAM, Madrid, Spain; [Malhi, Yadvinder] Univ Oxford, Sch Geog & Environm, Environm Change Inst, Oxford, England; [Malizia, Lucio] Univ Nacl Jujuy, Fac Ciencias Agr, San Salvador De Jujuy, Argentina; [Silman, Miles] Ctr Energy Environm & Sustainabil, Winston Salem, NC USA; [Young, Kenneth R.] Univ Texas Austin, Dept Geog & Environm, Austin, TX 78712 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Universidad Nacional de Tucuman; Universidad de Las Americas - Ecuador; Universidad Nacional de Colombia; University of Los Andes Venezuela; Escuela Politecnica Nacional Ecuador; Deakin University; Missouri Botanical Gardens; Universidad Rey Juan Carlos; Universidad de Cuenca; Universidad Nacional de San Antonio Abad del Cusco; University of Miami; University of Los Andes Venezuela; University of Gottingen; University of Gottingen; University of Missouri System; University of Missouri Columbia; Missouri Botanical Gardens; Autonomous University of Madrid; Autonomous University of Madrid; University of Oxford; University of Texas System; University of Texas Austin	Malizia, A (corresponding author), Univ Nacl Tucuman, Consejo Nacl Invest Cient & Tecn, CONICET, Inst Ecol Reg IER, San Miguel De Tucuman, Argentina.	agustinamalizia@yahoo.com	Homeier, Jürgen/G-1662-2011; Fuentes, Alfredo F./FNZ-7942-2022; Macia, Manuel J/H-4631-2012; Farfan-Rios, William/J-9881-2015; Cayuela, Luis/K-7255-2015	Homeier, Jürgen/0000-0001-5676-3267; Macia, Manuel J/0000-0002-4676-612X; Farfan-Rios, William/0000-0002-3196-0317; Feeley, Kenneth/0000-0002-3618-1144; Cayuela, Luis/0000-0003-3562-2662; Cuesta, Francisco/0000-0002-5150-073X; Jadan, Oswaldo/0000-0002-7865-2418	Andean Forest Program; Helvetas Swiss Intercooperation; Swiss Agency for Development and Cooperation (SDC); EcoAndes Project; Global Environment Facility (GEF) [4750]; FONCYT, Argentina [PICT-O 2014-0059]; Universidad de las Americas; United Nations Environment Programme (UN Environment); NERC [NE/J023418/1] Funding Source: UKRI; Natural Environment Research Council [NE/J023418/1] Funding Source: researchfish	Andean Forest Program; Helvetas Swiss Intercooperation; Swiss Agency for Development and Cooperation (SDC); EcoAndes Project; Global Environment Facility (GEF); FONCYT, Argentina(FONCyT); Universidad de las Americas; United Nations Environment Programme (UN Environment); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	FC, MP received funding from Andean Forest Program implemented by the Consortium for the Sustainable Development of the Andean Ecoregion (CONDESAN) and Helvetas Swiss Intercooperation, and funded by the Swiss Agency for Development and Cooperation (SDC). Additional funding came from the EcoAndes Project EcoAndes Project conducted by CONDESAN and United Nations Environment Programme (UN Environment), funded by the Global Environment Facility (GEF; Cooperation Agreement No. 4750). AM, CB, LRM received funding for PICT-O 2014-0059 Project, FONCYT, Argentina. FC received funding from Universidad de las Americas for covering the publication fee and make this research open access.	Aide TM, 2004, SCIENCE, V305, P1915, DOI 10.1126/science.1103179; Armenteras D, 2011, REG ENVIRON CHANGE, V11, P693, DOI 10.1007/s10113-010-0200-y; Ashton PS, 2003, PERSPECT PLANT ECOL, V6, P87, DOI 10.1078/1433-8319-00044; Baez S, 2016, PROPUESTAS ANDINAS, V14; Baez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126594; Barwell LJ, 2015, J ANIM ECOL, V84, P1112, DOI 10.1111/1365-2656.12362; Blundo C, 2018, J TROP ECOL, V34, P93, DOI 10.1017/S026646741800010X; Brown AD., 2001, BOSQUES NUBLADOS NEO, P27, DOI DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; Cincotta RP, 2000, NATURE, V404, P990, DOI 10.1038/35010105; Clark DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122905; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Crowther TW, 2015, NATURE, V525, P201, DOI 10.1038/nature14967; Cuesta F, J BIOGEOGR; Cuesta F, 2017, ECOGRAPHY, V40, P1381, DOI 10.1111/ecog.02567; Duque A, 2015, P NATL ACAD SCI USA, V112, P10744, DOI 10.1073/pnas.1506570112; Eraso NR, 2013, J LAND USE SCI, V8, P154, DOI 10.1080/1747423X.2011.650228; Fadrique B, 2018, NATURE, V564, P207, DOI 10.1038/s41586-018-0715-9; Fahey TJ, 2016, J TROP ECOL, V32, P355, DOI 10.1017/S0266467415000176; Feeley KJ, 2010, GLOBAL CHANGE BIOL, V16, P3215, DOI 10.1111/j.1365-2486.2010.02197.x; Fehse J, 2002, FOREST ECOL MANAG, V163, P9, DOI 10.1016/S0378-1127(01)00535-7; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; Geist HJ, 2002, BIOSCIENCE, V52, P143, DOI 10.1641/0006-3568(2002)052[0143:PCAUDF]2.0.CO;2; Gentry AH, 1995, BIODIVERSITY AND CONSERVATION OF NEOTROPICAL MONTANE FORESTS, P103; Girardin CAJ, 2010, GLOBAL CHANGE BIOL, V16, P3176, DOI 10.1111/j.1365-2486.2010.02235.x; GRUBB PJ, 1966, J ECOL, V54, P303, DOI 10.2307/2257951; Giehl ELH, 2012, ECOGRAPHY, V35, P933, DOI 10.1111/j.1600-0587.2011.07430.x; Homeier J, 2010, BIOTROPICA, V42, P140, DOI 10.1111/j.1744-7429.2009.00547.x; HOOGHIEMSTRA H, 1989, PALAEOGEOGR PALAEOCL, V72, P11, DOI 10.1016/0031-0182(89)90129-6; Hoorn CFP, 2010, AMAZONIA TIME ANDEAN, V30, P927; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jarvis A, 2011, HYDROL PROCESS, V25, P327, DOI 10.1002/hyp.7847; Joppa LN, 2011, P NATL ACAD SCI USA, V108, P13171, DOI 10.1073/pnas.1109389108; Karger DN, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.122; Kattan GH, 2004, J BIOGEOGR, V31, P1829, DOI 10.1111/j.1365-2699.2004.01109.x; Kerkhoff AJ, 2014, P NATL ACAD SCI USA, V111, P8125, DOI 10.1073/pnas.1308932111; Kessler M, 2011, CLIMATE CHANGE BIODI, P204; Kromer T, 2005, J BIOGEOGR, V32, P1799, DOI 10.1111/j.1365-2699.2005.01318.x; Kruskal J.B., 1978, MULTIDIMENSIONAL SCA; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Legendre P., 2012, NUMERICAL ECOLOGY; Lieberman D, 1996, J ECOL, V84, P137, DOI 10.2307/2261350; Malizia A, 2017, J VEG SCI, V28, P1240, DOI 10.1111/jvs.12572; Malizia L., 2012, Ecosistemas, V21, P53; Malizia L, 2012, AGRARIA, V13, P106; Mathez-Stiefel SL, 2017, MT RES DEV, V37, P323, DOI 10.1659/MRD-JOURNAL-D-16-00093.1; McCune B, 2002, ANAL ECOLOGICAL COMM; Aide TM, 2019, GLOBAL CHANGE BIOL, V25, P2112, DOI 10.1111/gcb.14618; Mourguiart P, 2003, GEOLOGY, V31, P195, DOI 10.1130/0091-7613(2003)031<0195:LGMIAA>2.0.CO;2; MULLIGAN M, 2010, TROPICAL MONTANE CLO, V740, P16, DOI DOI 10.1017/CBO9780511778384.004; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Osinaga Acosta O, 2014, PROTOCOLO EXTENDIDO; Pacheco S, 2010, TROP CONSERV SCI, V3, P423, DOI 10.1177/194008291000300407; Pena MA, 2018, PLANT ECOL, V219, P1481, DOI 10.1007/s11258-018-0895-2; Pena MA, 2013, FOREST ECOL MANAG, V302, P54, DOI 10.1016/j.foreco.2013.03.025; Pinto E, 2018, RBOLES REPRESENTATIV; Pinto E, 2019, MONITOREO BIODIVERSI; Polato NR, 2018, P NATL ACAD SCI USA, V115, P12471, DOI 10.1073/pnas.1809326115; R Core Team, 2021, R LANGUAGE ENV STAT; Rahbek C, 2019, SCIENCE, V365, P1114, DOI 10.1126/science.aax0151; Ramirez-Villegas J, 2014, J NAT CONSERV, V22, P391, DOI 10.1016/j.jnc.2014.03.007; Grau HR, 2008, ECOL SOC, V13; Romdal TS, 2013, GLOBAL ECOL BIOGEOGR, V22, P344, DOI 10.1111/j.1466-8238.2012.00786.x; Salazar L, 2015, PLANT ECOL DIVERS, V8, P13, DOI 10.1080/17550874.2013.843036; Schemske DW, 2009, ANNU REV ECOL EVOL S, V40, P245, DOI 10.1146/annurev.ecolsys.39.110707.173430; Sokal R. H., 1995, BIOMETRY PRINCIPLES; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Suarez DR, 2019, GLOBAL CHANGE BIOL, V25, P3609, DOI 10.1111/gcb.14767; Tovar C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063634; Unger M, 2012, OECOLOGIA, V170, P263, DOI 10.1007/s00442-012-2295-y; Urrutia R, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011021; Vazquez JA, 1998, J ECOL, V86, P999, DOI 10.1046/j.1365-2745.1998.00325.x; Vuille M, 2000, GEOPHYS RES LETT, V27, P3885, DOI 10.1029/2000GL011871; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032; WOLF JHD, 1993, ANN MO BOT GARD, V80, P928, DOI 10.2307/2399938; Young KR, 2009, ANN MO BOT GARD, V96, P492, DOI 10.3417/2008035; Zhu Y, 2018, ECOL LETT, V21, P506, DOI 10.1111/ele.12915; Zuur Alain F., 2009, P1	79	27	27	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2020	15	4							e0231553	10.1371/journal.pone.0231553	http://dx.doi.org/10.1371/journal.pone.0231553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9MR	32311701	Green Published, gold			2022-12-26	WOS:000536019800020
J	Wang, D; Pun, CCM; Huang, ST; Tang, TCM; Ho, KKW; Rothrauff, BB; Yung, PSH; Blocki, AM; Ker, EDF; Tuan, RS				Wang, Dan; Pun, Charmaine C. M.; Huang, Shuting; Tang, Thomas C. M.; Ho, Kevin K. W.; Rothrauff, Benjamin B.; Yung, Patrick S. H.; Blocki, Anna M.; Ker, Elmer D. F.; Tuan, Rocky S.			Tendon-derived extracellular matrix induces mesenchymal stem cell tenogenesis via an integrin/transforming growth factor-beta crosstalk-mediated mechanism	FASEB JOURNAL			English	Article						cell-matrix interaction; cell signaling; tendon regeneration; tissue engineering	TGF-BETA; STEM/PROGENITOR CELLS; STROMAL CELLS; COLLAGEN; DIFFERENTIATION; INTEGRIN; LIGAMENT; PROLIFERATION; TENOMODULIN; FIBRONECTIN	Treatment of tendon injuries is challenging. To develop means to augment tendon regeneration, we have previously prepared a soluble, low immunogenic (DNA-free), tendon extracellular matrix fraction (tECM) by urea extraction of juvenile bovine tendons, which is capable of enhancing transforming growth factor-beta (TGF-beta) mediated tenogenesis in human adipose-derived stem cells (hASCs). Here, we aimed to elucidate the mechanism of tECM-driven hASC tenogenic differentiation in vitro, focusing on the integrin and TGF-beta/SMAD pathways. Our results showed that tECM promoted hASC proliferation and tenogenic differentiation in vitro based on tenogenesis-associated markers. tECM also induced higher expression of several integrin subunits and TGF-beta receptors, and nuclear translocation of p-SMAD2 in hASCs. Pharmacological inhibition of integrin-ECM binding, focal adhesion kinase (FAK) signaling, or TGF-beta signaling independently led to compromised pro-tenogenic effects of tECM and actin fiber polymerization. Additionally, integrin blockade inhibited tECM-driven TGFBR2 expression, while inhibiting TGF-beta signaling decreased tECM-mediated expression of integrin alpha 1, alpha 2, and beta 1 in hASCs. Together, these findings suggest that the strong pro-tenogenic bioactivity of tECM is regulated via integrin/TGF-beta signaling crosstalk. Understanding how integrins interact with signaling by TGF-beta and/or other growth factors (GFs) within the tendon ECM microenvironment will provide a rational basis for an ECM-based approach for tendon repair.	[Wang, Dan; Pun, Charmaine C. M.; Huang, Shuting; Tang, Thomas C. M.; Yung, Patrick S. H.; Blocki, Anna M.; Ker, Elmer D. F.; Tuan, Rocky S.] Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Hong Kong, Peoples R China; [Wang, Dan; Pun, Charmaine C. M.; Huang, Shuting; Tang, Thomas C. M.; Blocki, Anna M.; Ker, Elmer D. F.; Tuan, Rocky S.] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Peoples R China; [Ho, Kevin K. W.; Yung, Patrick S. H.] Chinese Univ Hong Kong, Fac Med, Dept Orthopaed & Traumatol, Hong Kong, Peoples R China; [Rothrauff, Benjamin B.; Tuan, Rocky S.] Univ Pittsburgh, Ctr Cellular & Mol Engn, Sch Med, Pittsburgh, PA USA; [Tuan, Rocky S.] Univ Pittsburgh, Sch Med, Dept Orthopaed Surg, Pittsburgh, PA 15261 USA; [Tuan, Rocky S.] Univ Pittsburgh, Swanson Sch Engn, Dept Bioengn, Pittsburgh, PA USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tuan, RS (corresponding author), Chinese Univ Hong Kong, Inst Tissue Engn & Regenerat Med, Shatin, Hong Kong, Peoples R China.	tuanr@cuhk.edu.hk	Ker, Dai Fei Elmer/R-5959-2018; Blocki, Anna/R-7938-2018; Ho, Kevin Ki Wai/J-7703-2018; Yung, Patrick Shu-Hang/J-9054-2018	Ker, Dai Fei Elmer/0000-0003-3434-8390; Blocki, Anna/0000-0002-9878-3781; Ho, Kevin Ki Wai/0000-0001-8647-8475; Yung, Patrick Shu-Hang/0000-0002-7214-5503; Tang, Thomas/0000-0001-5328-245X	Chinese University of Hong Kong; Chinese University of Hong Kong [2018.092]; Innovation and Technology Commission Hong Kong (Innovation and Technology Commission of Hong Kong Special Administrative Government) [ITS/333/18]	Chinese University of Hong Kong(Chinese University of Hong Kong); Chinese University of Hong Kong(Chinese University of Hong Kong); Innovation and Technology Commission Hong Kong (Innovation and Technology Commission of Hong Kong Special Administrative Government)	The Chinese University of Hong Kong, Grant/Award Number: Starup grant; The Chinese University of Hong Kong, Grant/Award Number: Direct grant 2018.092; Innovation and Technology Commission Hong Kong (Innovation and Technology Commission of Hong Kong Special Administrative Government), Grant/Award Number: ITS/333/18	Banos Charles C., 2008, Birth Defects Research, V84, P228, DOI 10.1002/bdrc.20130; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Bean A. C., 2015, BIOMED MATER, V10, P1, DOI DOI 10.1088/1748-6041/10/1/015018; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Boraschi-Diaz I, 2017, FRONT PHYS-LAUSANNE, V5, DOI 10.3389/fphy.2017.00012; Brown JP, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0043-z; Chiquet-Ehrismann R, 2004, INT J BIOCHEM CELL B, V36, P1085, DOI 10.1016/j.biocel.2004.01.007; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Dunkman AA, 2014, ANN BIOMED ENG, V42, P619, DOI 10.1007/s10439-013-0915-2; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gabler C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6432742; Goncalves AI, 2018, J TISSUE ENG REGEN M, V12, P762, DOI 10.1002/term.2495; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Handorf AM, 2015, ORGANOGENESIS, V11, P1, DOI 10.1080/15476278.2015.1019687; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hayashida T, 2007, J CELL SCI, V120, P4230, DOI 10.1242/jcs.03492; Hochwald SN, 2009, CELL CYCLE, V8, P2435, DOI 10.4161/cc.8.15.9145; Hodivala-Dilke KM, 1998, J CELL BIOL, V142, P1357, DOI 10.1083/jcb.142.5.1357; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Janson IA, 2015, J BIOMED MATER RES A, V103, P1246, DOI 10.1002/jbm.a.35254; Ker DFE, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1027-6; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; Kuo CK, 2008, TISSUE ENG PT A, V14, P1615, DOI 10.1089/ten.tea.2006.0415; Kuo CK, 2008, DEV DYNAM, V237, P1477, DOI 10.1002/dvdy.21547; Lin H, 2012, BIOMATERIALS, V33, P4480, DOI 10.1016/j.biomaterials.2012.03.012; Lin TW, 2004, J BIOMECH, V37, P865, DOI 10.1016/j.jbiomech.2003.11.005; LIU SH, 1995, CLIN ORTHOP RELAT R, P265; Longo UG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/517165; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Margadant C, 2010, EMBO REP, V11, P97, DOI 10.1038/embor.2009.276; Martin-Bermudo MD, 2000, DEVELOPMENT, V127, P2607; Marturano JE, 2016, J BIOMECH, V49, P3281, DOI 10.1016/j.jbiomech.2016.08.011; Marturano JE, 2013, P NATL ACAD SCI USA, V110, P6370, DOI 10.1073/pnas.1300135110; Mather RC, 2013, J BONE JOINT SURG AM, V95A, P1993, DOI 10.2106/JBJS.L.01495; MCDONALD JA, 1982, J CELL BIOL, V92, P485, DOI 10.1083/jcb.92.2.485; Molloy T, 2003, SPORTS MED, V33, P381, DOI 10.2165/00007256-200333050-00004; Mueller MB, 2010, CELLS TISSUES ORGANS, V192, P158, DOI 10.1159/000313399; Munger JS, 2011, COLD SPRING HARB PER, V3, P1; Nguyen PK, BIOMATERIALS SCI INT; Omae H, 2009, J ORTHOP RES, V27, P937, DOI 10.1002/jor.20823; Pan XS, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0325; Popov C, 2015, BMC MOL BIOL, V16, DOI 10.1186/s12867-015-0036-6; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Ratcliffe A, 2015, ANN BIOMED ENG, V43, P819, DOI 10.1007/s10439-015-1263-1; Riley GP, 1996, AM J PATHOL, V149, P933; Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004; Rothrauff BB, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0580-8; Schiele NR, 2013, CURR OPIN BIOTECH, V24, P834, DOI 10.1016/j.copbio.2013.07.003; SCHRECK PJ, 1995, J ORTHOP RES, V13, P174, DOI 10.1002/jor.1100130205; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Seif-Naraghi SB, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005503; Sharma RI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031504; Shen Francis H, 2006, Spine J, V6, P615, DOI 10.1016/j.spinee.2006.03.006; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Sottile J, 2007, AM J PHYSIOL-CELL PH, V293, pC1934, DOI 10.1152/ajpcell.00130.2007; Thorpe CT, 2013, INT J EXP PATHOL, V94, P248, DOI 10.1111/iep.12027; Wang DH, 1999, J BIOL CHEM, V274, P12840, DOI 10.1074/jbc.274.18.12840; WILLIAMS IF, 1984, CONNECT TISSUE RES, V12, P211, DOI 10.3109/03008208409013684; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Xue JX, 2012, BIOMATERIALS, V33, P5832, DOI 10.1016/j.biomaterials.2012.04.054; Yang G, 2017, TISSUE ENG PT A, V23, P166, DOI [10.1089/ten.tea.2015.0498, 10.1089/ten.TEA.2015.0498]; Yang G, 2013, BIOMATERIALS, V34, P9295, DOI 10.1016/j.biomaterials.2013.08.054; Yeo GC, 2019, P NATL ACAD SCI USA, V116, P2042, DOI 10.1073/pnas.1812951116; Yin Z, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600874; Zeng Q, 2007, BONE, V40, P374, DOI 10.1016/j.bone.2006.09.022; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang YY, 2009, BIOMATERIALS, V30, P4021, DOI 10.1016/j.biomaterials.2009.04.005	68	18	18	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2020	34	6					8172	8186		10.1096/fj.201902377RR	http://dx.doi.org/10.1096/fj.201902377RR		APR 2020	15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	MR4QG	32301551				2022-12-26	WOS:000526644300001
J	Castor, KJ; Shenoi, S; Edminster, SP; Tran, T; King, KS; Chui, H; Pogoda, JM; Fonteh, AN; Harrington, MG				Castor, K. J.; Shenoi, S.; Edminster, S. P.; Tran, T.; King, K. S.; Chui, H.; Pogoda, J. M.; Fonteh, A. N.; Harrington, M. G.			Urine dicarboxylic acids change in pre-symptomatic Alzheimer's disease and reflect loss of energy capacity and hippocampal volume	PLOS ONE			English	Article							CEREBROSPINAL-FLUID BIOMARKER; AMYLOID-BETA; QUANTITATIVE-ANALYSIS; LYSINE SUCCINYLATION; DIAGNOSIS; PROGRESSION; METABOLISM; NEUROPATHOLOGY; ALBUMINURIA; POPULATION	Non-invasive biomarkers will enable widespread screening and early diagnosis of Alzheimer's disease (AD). We hypothesized that the considerable loss of brain tissue in AD will result in detection of brain lipid components in urine, and that these will change in concert with CSF and brain biomarkers of AD. We examined urine dicarboxylic acids (DCA) of carbon length 3-10 to reflect products of oxidative damage and energy generation or balance that may account for changes in brain function in AD. Mean C4-C5 DCAs were lower and mean C7-C10 DCAs were higher in the urine from AD compared to cognitively healthy (CH) individuals. Moreover, mean C4-C5 DCAs were lower and mean C7-C9 were higher in urine from CH individuals with abnormal compared to normal CSF amyloid and Tau levels; i.e., the apparent urine changes in AD also appeared to be present in CH individuals that have CSF risk factors of early AD pathology. In examining the relationship between urine DCAs and AD biomarkers, we found short chain DCAs positively correlated with CSF A beta 42, while C7-C10 DCAs negatively correlated with CSF A beta 42 and positively correlated with CSF Tau levels. Furthermore, we found a negative correlation of C7-C10 DCAs with hippocampal volume (p < 0.01), which was not found in the occipital volume. Urine measures of DCAs have an 82% ability to predict cognitively healthy participants with normal CSF amyloid/Tau. These data suggest that urine measures of increased lipoxidation and dysfunctional energy balance reflect early AD pathology from brain and CSF biomarkers. Measures of urine DCAs may contribute to personalized healthcare by indicating AD pathology and may be utilized to explore population wellness or monitor the efficacy of therapies in clinical trials.	[Castor, K. J.; Shenoi, S.; Edminster, S. P.; Fonteh, A. N.; Harrington, M. G.] Huntington Med Res Inst, Neurosci, Pasadena, CA 91105 USA; [Tran, T.; King, K. S.] Huntington Med Res Inst, Clin MR Unit, Pasadena, CA USA; [Chui, H.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA USA; [Pogoda, J. M.] Cipher Biostat & Reporting, Reno, NV USA	Huntington Medical Research Institutes; Huntington Medical Research Institutes; University of Southern California	Fonteh, AN; Harrington, MG (corresponding author), Huntington Med Res Inst, Neurosci, Pasadena, CA 91105 USA.	alfred.fonteh@hmri.org; michael.harrington@hmri.org	King, Kevin S/AFZ-1275-2022	King, Kevin S/0000-0003-4449-2468; Harrington, Michael/0000-0002-7923-8032				Alleyn M, 2018, AM J PHYSIOL-CELL PH, V314, pC228, DOI 10.1152/ajpcell.00148.2017; Alvarez G, 2003, J NEUROSCI RES, V73, P260, DOI 10.1002/jnr.10648; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Alzheimer's Association, 2016, 2016 ALZH DIS FACTS; Bai F, 2018, MED HYPOTHESES, V121, P54, DOI 10.1016/j.mehy.2018.09.018; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bateman RJ, 2017, ALZHEIMERS DEMENT, V13, P8, DOI 10.1016/j.jalz.2016.07.005; Bazan NG, 2009, J LIPID RES, V50, pS400, DOI 10.1194/jlr.R800068-JLR200; Beekly DL, 2007, ALZ DIS ASSOC DIS, V21, P249, DOI 10.1097/WAD.0b013e318142774e; Blennow K, 2017, NEUROL THER, V6, pS15, DOI 10.1007/s40120-017-0073-9; Boccardi M, 2017, NEUROBIOL AGING, V52, P141, DOI 10.1016/j.neurobiolaging.2017.01.021; Caselli RJ, 2017, MAYO CLIN PROC, V92, P978, DOI 10.1016/j.mayocp.2017.02.011; Chatterjee P, 2019, J ALZHEIMERS DIS, V71, P775, DOI 10.3233/JAD-190533; Chen Y, 2016, METHODS MOL BIOL, V1410, P23, DOI 10.1007/978-1-4939-3524-6_2; Costa CG, 2000, J PHARMACEUT BIOMED, V21, P1215, DOI 10.1016/S0731-7085(99)00235-6; Deckers K, 2017, NEUROLOGY, V88, P198, DOI 10.1212/WNL.0000000000003482; Fiala M, 2017, FASEB J, V31, P3229, DOI [10.1096/fj.201700065R, 10.1096/fj.201700065r]; Filon JR, 2016, J NEUROPATH EXP NEUR, V75, P748, DOI 10.1093/jnen/nlw047; Fonteh AN, 2006, DIS MARKERS, V22, P39, DOI 10.1155/2006/202938; Fonteh AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100519; Fukushima A, 2016, AM J PHYSIOL-HEART C, V311, pH347, DOI 10.1152/ajpheart.00900.2015; Garde AH, 2004, ANN OCCUP HYG, V48, P171, DOI 10.1093/annhyg/meh019; Georgakis MK, 2017, J AM GERIATR SOC, V65, P1190, DOI 10.1111/jgs.14750; Gibson GE, 2015, J NEUROCHEM, V134, P86, DOI 10.1111/jnc.13096; GREGERSEN N, 1982, SCAND J CLIN LAB INV, V42, P15; Harrington MG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079378; Inouye M, 2000, ATHEROSCLEROSIS, V148, P197, DOI 10.1016/S0021-9150(99)00263-4; Isopi E, 2015, NEUROBIOL DIS, V81, P214, DOI 10.1016/j.nbd.2014.11.013; Jack CR, 2013, LANCET NEUROL, V12, P207, DOI 10.1016/S1474-4422(12)70291-0; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Kester MI, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0142-1; Klosinski LP, 2015, EBIOMEDICINE, V2, P1888, DOI 10.1016/j.ebiom.2015.11.002; Lipton R B, 2001, Curr Med Res Opin, V17 Suppl 1, ps4, DOI 10.1185/0300799039117005; Llano DA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182098; Lugli G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139233; Lutz MI, 2014, NEUROMOL MED, V16, P405, DOI 10.1007/s12017-014-8288-8; MANTAGOS S, 1979, J CLIN INVEST, V64, P1580, DOI 10.1172/JCI109619; Martens RJH, 2017, AM J KIDNEY DIS, V69, P179, DOI 10.1053/j.ajkd.2016.04.017; Mishra S, 2017, NEUROIMAGE, V161, P171, DOI 10.1016/j.neuroimage.2017.07.050; Montine TJ, 2005, ANTIOXID REDOX SIGN, V7, P269, DOI 10.1089/ars.2005.7.269; MORTENSEN PB, 1981, BIOCHIM BIOPHYS ACTA, V664, P335, DOI 10.1016/0005-2760(81)90056-4; Musiek ES, 2012, CURR OPIN NEUROL, V25, P715, DOI 10.1097/WCO.0b013e32835a30f4; PASSI S, 1993, BIOCHIM BIOPHYS ACTA, V1168, P190, DOI 10.1016/0005-2760(93)90124-R; Paterson RW, 2019, NAT REV NEUROL, V15, P419, DOI 10.1038/s41582-019-0222-0; Reid CN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053354; Reiman EM, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.177; Salminen A, 2015, PROG NEUROBIOL, V131, P1, DOI 10.1016/j.pneurobio.2015.05.001; Selkoe DJ, 2000, ANN NY ACAD SCI, V924, P17; Strozyk D, 2003, NEUROLOGY, V60, P652, DOI 10.1212/01.WNL.0000046581.81650.D0; Sun DK, 2019, NEUROLOGY, V92, pE1890, DOI 10.1212/WNL.0000000000007279; Sutphen CL, 2015, JAMA NEUROL, V72, P1029, DOI 10.1001/jamaneurol.2015.1285; Tapiola T, 2009, ARCH NEUROL-CHICAGO, V66, P382, DOI 10.1001/archneurol.2008.596; Tarawneh R, 2016, JAMA NEUROL, V73, P561, DOI 10.1001/jamaneurol.2016.0086; Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644; Vlassenko AG, 2016, ANN NEUROL, V80, P379, DOI 10.1002/ana.24719; Vlassenko AG, 2012, BBA-MOL BASIS DIS, V1822, P370, DOI 10.1016/j.bbadis.2011.11.005; Wang C, 2015, BIOMARKERS, V20, P84, DOI 10.3109/1354750X.2014.994036; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Wilder C, 2018, FASEB J; Yang Y, 2019, NEUROCHEM RES, V44, P2346, DOI 10.1007/s11064-019-02780-x; Yokoyama A, 2017, BIOCHEM RES INT, V2017, DOI 10.1155/2017/8529404; Youn YC, 2011, J AM MED DIR ASSOC, V12, P372, DOI 10.1016/j.jamda.2010.03.004; Zhang FS, 2018, J ALZHEIMERS DIS, V66, P613, DOI 10.3233/JAD-180412	63	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231765	10.1371/journal.pone.0231765	http://dx.doi.org/10.1371/journal.pone.0231765			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298384	gold, Green Published			2022-12-26	WOS:000536011400106
J	Elbaz, A; Yeshurun, Y				Elbaz, Asaf; Yeshurun, Yaffa			Can rhythm-induced attention improve the perceptual representation?	PLOS ONE			English	Article							TIME; SYNCHRONIZATION; EXPECTANCY; REGULARITY; ALERTNESS; DYNAMICS; SEE	Temporal attention can be entrained exogenously to rhythms. Indeed, faster and more accurate responses were previously found when the target appeared in-phase with a preceding rhythm in comparison to when it was out of phase. However, the nature of this rhythm-induced attentional effect is not well understood. To better understand the processes underlying rhythm-induced attention, we employed a continuous measure of perceived orientation and a mixture-model analysis. A trial in our study started with a sequence of auditory beeps separated by a fixed inter-beeps interval in the regular (rhythmic) condition or by variable inter-beeps intervals in the irregular condition. A visual target-a line embedded in a circle-followed the sequence. The 'critical' interval between the last beep and the target was chosen randomly from several possible Inter-Onset Intervals (IOIs), of which only one was in-phase with the rhythm. The target was followed by a probe line, and the participants were asked to rotate it to reproduce the target's orientation. The measure of performance for a given trial was the difference in degrees between the orientation of the target and that reproduced by the observer. We found that guessing rate was lower with regular than irregular rhythms. However, there was no effect of rhythm type (regular vs irregular) on the quality of representation (measured as the variability in reproducing the target). Furthermore, the rhythm effect was present only when rhythm type was fixed within a block, and it was found with all IOIs, not just the in-phase IOI. This lack of specificity suggests that these results reflect a general effect of rhythm on alertness.	[Elbaz, Asaf; Yeshurun, Yaffa] Univ Haifa, Dept Psychol, Haifa, Israel; [Elbaz, Asaf; Yeshurun, Yaffa] Univ Haifa, Inst Informat Proc & Decis Making, Haifa, Israel	University of Haifa; University of Haifa	Elbaz, A (corresponding author), Univ Haifa, Dept Psychol, Haifa, Israel.	asafelbaz@gmail.com	Yeshurun, Yaffa/AAC-9164-2021	Yeshurun, Yaffa/0000-0003-0513-9290; Elbaz, Asaf/0000-0002-4940-9785	Israel Science Foundation [1081/13]	Israel Science Foundation(Israel Science Foundation)	This study was supported by the Israel Science Foundation Grant 1081/13 to YY https://www.isf.org.il/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaoglu S, 2015, VISION RES, V115, P23, DOI 10.1016/j.visres.2015.07.003; Asplund CL, 2014, PSYCHOL SCI, V25, P824, DOI 10.1177/0956797613513810; Barnhart AS, 2018, ATTEN PERCEPT PSYCHO, V80, P1240, DOI 10.3758/s13414-018-1497-8; Bauer AKR, 2015, BRAIN RES, V1626, P198, DOI 10.1016/j.brainres.2015.04.032; Bays PM, 2009, J VISION, V9, DOI 10.1167/9.10.7; Bermeitinger C, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01847; Bolger D, 2014, J COGNITIVE NEUROSCI, V26, P593, DOI 10.1162/jocn_a_00511; Bolger D, 2013, ACTA PSYCHOL, V142, P238, DOI 10.1016/j.actpsy.2012.11.012; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Breska A, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001665; Breska A, 2016, J NEUROSCI, V36, P7154, DOI 10.1523/JNEUROSCI.4619-15.2016; Breska A, 2014, J COGNITIVE NEUROSCI, V26, P1555, DOI 10.1162/jocn_a_00564; De Freitas J, 2016, J VISION, V16, DOI 10.1167/16.3.22; de la Rosa MD, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00308; Escoffier N, 2015, NEUROIMAGE, V111, P267, DOI 10.1016/j.neuroimage.2015.02.024; Ester EF, 2014, J EXP PSYCHOL HUMAN, V40, P1022, DOI 10.1037/a0035377; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hackley SA, 2009, PSYCHOPHYSIOLOGY, V46, P163, DOI 10.1111/j.1469-8986.2008.00722.x; Haegens S, 2018, NEUROSCI BIOBEHAV R, V86, P150, DOI 10.1016/j.neubiorev.2017.12.002; Hove MJ, 2013, PSYCHOL RES-PSYCH FO, V77, P388, DOI 10.1007/s00426-012-0441-0; Jones A, 2015, FRONT INTEGR NEUROSC, V8, DOI [10.3389/fnint.2014.00096, 10.3389/tnint.2014.00096]; Jones MR, 2002, PSYCHOL SCI, V13, P313, DOI 10.1111/1467-9280.00458; JONES MR, 1976, PSYCHOL REV, V83, P323, DOI 10.1037/0033-295x.83.5.323; Jonides J., 1981, ATTENTION PERFORM, P187, DOI DOI 10.1037/0096-1523.29.5.835; Kunert R, 2017, J EXP PSYCHOL GEN, V146, P77, DOI 10.1037/xge0000246; Kusnir F, 2011, CONSCIOUS COGN, V20, P1201, DOI 10.1016/j.concog.2011.01.012; Large E.W, 1994, THESIS; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Lawrence MA, 2013, J EXP PSYCHOL GEN, V142, P560, DOI 10.1037/a0029023; Lotto Andrew J., 2008, V29, P281; Mathewson KE, 2010, COGNITION, V115, P186, DOI 10.1016/j.cognition.2009.11.010; Matthias E, 2010, J EXP PSYCHOL HUMAN, V36, P38, DOI 10.1037/a0017602; Miller JE, 2013, PSYCHOL SCI, V24, P11, DOI 10.1177/0956797612446707; Minier L, 2016, COGNITIVE SCI, V40, P1019, DOI 10.1111/cogs.12279; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Olivers CNL, 2016, J EXP PSYCHOL HUMAN, V42, P2115, DOI 10.1037/xhp0000268; Patel AD, 2005, EXP BRAIN RES, V163, P226, DOI 10.1007/s00221-004-2159-8; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Prince JB, 2019, J EXP PSYCHOL HUMAN, V45, P585, DOI 10.1037/xhp0000629; Repp BH, 2004, PSYCHOL RES-PSYCH FO, V68, P252, DOI 10.1007/s00426-003-0143-8; Rohenkohl G, 2012, J NEUROSCI, V32, P8424, DOI 10.1523/JNEUROSCI.0804-12.2012; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Sanabria D, 2011, J EXP PSYCHOL HUMAN, V37, P236, DOI 10.1037/a0019956; Skerritt-Davis B, 2019, ACTA ACUST UNITED AC, V105, P1, DOI 10.3813/AAA.919279; Suchow JW, 2013, J VISION, V13, DOI 10.1167/13.10.9; Weinbach N, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00236; Weinbach N, 2011, COGNITION, V121, P454, DOI 10.1016/j.cognition.2011.08.010; Zhang JX, 2015, NEUROIMAGE, V107, P266, DOI 10.1016/j.neuroimage.2014.12.021; Zhang WW, 2008, NATURE, V453, P233, DOI 10.1038/nature06860	49	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231200	10.1371/journal.pone.0231200	http://dx.doi.org/10.1371/journal.pone.0231200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298272	Green Published, gold			2022-12-26	WOS:000536011400031
J	Faini, D; Hanson, C; Baisley, K; Kapiga, S; Hayes, R				Faini, Diana; Hanson, Claudia; Baisley, Kathy; Kapiga, Saidi; Hayes, Richard			Sexual behaviour, changes in sexual behaviour and associated factors among women at high risk of HIV participating in feasibility studies for prevention trials in Tanzania	PLOS ONE			English	Article							FEMALE BAR WORKERS; CONDOM USE; VACCINE TRIALS; INTERVENTION; PARTNERS; ENROLLMENT; INFECTION	Introduction Risk reduction towards safer behaviour is promoted after enrolment in HIV prevention trials. We evaluated sexual behaviour, changes in sexual behaviour and factors associated with risky behaviour after one-year of follow-up among women enrolled in HIV prevention trials in Northern Tanzania. Methods Self-reported information from 1378 HIV-negative women aged 18-44 enrolled in microbicide and vaccine feasibility studies between 2008-2010,was used to assess changes in behaviour during a 12-month follow-up period. Logistic regression with random intercepts was used to estimate odds ratios for trends in each behaviour over time. A behavioural risk score was derived from coefficients of three behavioural variables in a Poisson regression model for HIV incidence and thereafter, dichotomized to risky vs less-risky behaviour. Logistic regression was then used to identify factors associated with risky behaviour at 12 months. Results At baseline, 22% reported multiple partners, 28% were involved in transactional sex and only 22% consistently used condoms with non-regular partners. The proportion of women reporting multiple partners, transactional sex and high-risk sex practices reduced at each 3-monthly visit (33%, 43% and 47% reduction in odds per visit respectively, p for linear trend < 0.001 for all), however, there was no evidence of a change in the proportion of women consistently using condoms with non-regular partners (p = 0.22). Having riskier behaviours at baseline, being younger than 16 years at sexual debut, having multiple partners, selling sex and excessive alcohol intake at baseline were strongly associated with increased odds of risky sexual behaviour after 12 months (p<0.005 for all). Conclusion An overall reduction in risky behaviours over time was observed in HIV prevention cohorts. Risk reduction counselling was associated with decreased risk behaviour but was insufficient to change behaviours of all those at highest risk. Biological HIV prevention interventions such as PrEP for individuals at highest risk, should complement risk reduction counselling so as to minimize HIV acquisition risk.	[Faini, Diana] Muhimbili Univ Hlth & Allied Sci MUHAS, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Faini, Diana; Hanson, Claudia] Karolinska Inst, Dept Global Publ Hlth Global Hlth Hlth Syst & Pol, Stockholm, Sweden; [Faini, Diana; Baisley, Kathy; Kapiga, Saidi; Hayes, Richard] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Hanson, Claudia] London Sch Hyg & Trop Med, Dept Dis Control, London, England; [Kapiga, Saidi] Mwanza Intervent Trials Unit, Mwanza, Tanzania	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Faini, D (corresponding author), Muhimbili Univ Hlth & Allied Sci MUHAS, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.; Faini, D (corresponding author), Karolinska Inst, Dept Global Publ Hlth Global Hlth Hlth Syst & Pol, Stockholm, Sweden.; Faini, D (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.	fainidiana@gmail.com	Visan, Delia/GXW-3349-2022	Hayes, Richard/0000-0002-1729-9892; Kapiga, Saidi/0000-0003-1753-4060; Faini, Diana/0000-0003-3824-8848	European and Developing Countries Clinical Trials Partnership (EDCTP) [CT_ct_05_32070_002]; EDCTP; Bill and Melinda Gates Foundation [CG_ct_06_33111]; MRC [G0901756, MR/R010161/1, MR/R00255X/1] Funding Source: UKRI	European and Developing Countries Clinical Trials Partnership (EDCTP); EDCTP; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The microbicides-preparedness study was funded by the European and Developing Countries Clinical Trials Partnership (EDCTP; project code: CT_ct_05_32070_002) and the vaccines-preparedness study was funded by EDCTP and the Bill and Melinda Gates Foundation (project code: CG_ct_06_33111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholow BN, 2005, JAIDS-J ACQ IMM DEF, V39, DOI [10.1097/01.qai, DOI 10.1097/01.QAI]; Cassell MM, 2006, BMJ-BRIT MED J, V332, P605, DOI 10.1136/bmj.332.7541.605; Chesney MA, 1997, J ACQ IMMUN DEF SYND, V16, P266, DOI 10.1097/00042560-199712010-00007; Dareng EO, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00172; de Walque D, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000747; Esparza J, 2001, AIDS, V15, pS49, DOI 10.1097/00002030-200100005-00008; Guenter D, 2000, J MED ETHICS, V26, P37, DOI 10.1136/jme.26.1.37; Gunn JKL, 2016, COMMUNITY MENT HLT J, V52, P1064, DOI 10.1007/s10597-015-9844-x; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; HIV/AIDS JUNPo World Health Organization, 2012, ETH CONS BIOM HIV PR; Kapiga SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068825; Kaul R, 2002, J ACQ IMMUN DEF SYND, V30, P69, DOI 10.1097/00042560-200205010-00009; Kurtz SP, 2013, J SUBST ABUSE TREAT, V44, P301, DOI 10.1016/j.jsat.2012.08.004; Laukamm-Josten U, 2000, AIDS CARE, V12, P27, DOI 10.1080/09540120047440; Lowndes CM, 2000, AIDS, V14, P2523, DOI 10.1097/00002030-200011100-00015; Mgalla Z, 1997, AIDS CARE, V9, P407, DOI 10.1080/713613167; Mwaluko G, 2003, AIDS, V17, P2645, DOI 10.1097/00002030-200312050-00012; Neumann MS, 2002, J ACQ IMMUN DEF SYND, V30, pS106, DOI 10.1097/01.QAI.0000018919.84759.50; Ngugi EN, 2007, JAIDS-J ACQ IMM DEF, V45, P588, DOI 10.1097/QAI.0b013e3180f616db; Reproductive & Child Health Section MoH Tanzania, 2003, SEX TRANSM INF MAN S; Riedner G, 2003, SEX TRANSM INFECT, V79, P382, DOI 10.1136/sti.79.5.382; Schroder KEE, 2003, ANN BEHAV MED, V26, P76, DOI 10.1207/S15324796ABM2602_02; Semaan S, 2002, METAANALYSIS EFFECT, V5, P6; Sheets RL, 2016, BIOLOGICALS, V44, P73, DOI 10.1016/j.biologicals.2015.10.004; Shlay JC, 2004, SEX TRANSM DIS, V31, P154, DOI 10.1097/01.OLQ.0000114338.60980.12; Tracas A, 2016, AIDS EDUC PREV, V28, P312, DOI 10.1521/aeap.2016.28.4.312; Vallely A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010661; van Loggerenberg F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030669; Watson-Jones D, 2008, NEW ENGL J MED, V358, P1560, DOI 10.1056/NEJMoa0800260; Watson-Jones D, 2007, JAIDS-J ACQ IMM DEF, V46, P631, DOI 10.1097/QAI.0b013e31815b2d9c; Weinhardt LS, 1998, ARCH SEX BEHAV, V27, P155, DOI 10.1023/A:1018682530519; Yadav G, 2005, JAIDS-J ACQ IMM DEF, V38, P329	32	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231766	10.1371/journal.pone.0231766	http://dx.doi.org/10.1371/journal.pone.0231766			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298383	Green Published, gold			2022-12-26	WOS:000536011400107
J	Kaewseekhao, B; Roytrakul, S; Yingchutrakul, Y; Salao, K; Reechaipichitkul, W; Faksri, K				Kaewseekhao, Benjawan; Roytrakul, Sittiruk; Yingchutrakul, Yodying; Salao, Kanin; Reechaipichitkul, Wipa; Faksri, Kiatichai			Proteomic analysis of infected primary human leucocytes revealed PSTK as potential treatment-monitoring marker for active and latent tuberculosis	PLOS ONE			English	Article								Markers for monitoring clearance of Mycobacterium tuberculosis (Mtb) infection during anti-TB drug treatment could facilitate management of tuberculosis (TB) treatment, but are lacking. We aimed to screen for Mtb clearance markers from in-vitro-infected leucocytes and to evaluate these markers in followed-up active TB (ATB) patients and latent TB (LTBI) cases after anti-TB drug treatment. Extracellular proteins from primary leucocytes infected with each of the Mtb lineages (East-Asian, Indo-Oceanic, Euro-American and the laboratory strain H37Rv) were screened as possible clearance markers. Leucocytes infected with Staphylococcus aureus acted as controls. The proteomic analysis was performed using GeLC-MS/MS. Several quantitative and qualitative candidate clearance markers were found. These proteins were suppressed during the infection stage of all Mtb lineages and re-expressed after bacillary clearance. PSTK, FKBP8 and MGMT were common clearance markers among the four Mtb lineages in our model. Only PSTK was a potential clearance marker based on western blot validation analysis from culture supernatants. The PSTK marker was further validated with western blot analysis using serum samples (n = 6) from ATB patients and LTBI cases during anti-TB drug treatment, and from healthy controls (n = 3). Time-dependent increase of PSTK was found both in ATB and LTBI patients during the course of anti-TB drug treatment, but not in healthy controls. We have demonstrated that PSTK is a potential treatment-monitoring marker for active and latent TB.	[Kaewseekhao, Benjawan; Salao, Kanin; Faksri, Kiatichai] Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand; [Kaewseekhao, Benjawan; Faksri, Kiatichai] Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Fac Med, Khon Kaen, Thailand; [Roytrakul, Sittiruk; Yingchutrakul, Yodying] Natl Sci & Technol Dev Agcy NSTDA, Natl Ctr Genet Engn & Biotechnol BIOTEC, Pathum Thani, Thailand; [Reechaipichitkul, Wipa] Khon Kaen Univ, Dept Med, Fac Med, Khon Kaen, Thailand	Khon Kaen University; Khon Kaen University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Khon Kaen University	Faksri, K (corresponding author), Khon Kaen Univ, Dept Microbiol, Fac Med, Khon Kaen, Thailand.; Faksri, K (corresponding author), Khon Kaen Univ, Res & Diagnost Ctr Emerging Infect Dis RCEID, Fac Med, Khon Kaen, Thailand.	kiatichai@kku.ac.th		Faksri, Kiatichai/0000-0001-5022-4182; salao, kanin/0000-0003-4731-9556; Roytrakul, Sittiruk/0000-0003-3696-8390	Thailand Research Fund, Khon Kaen University [MRG5980002]; Invitation Research 2018, Faculty of Medicine, Khon Kaen University [IN61210]; Research Fund for Supporting Lecturer to Admit High Potential Student to Study and Research on His Expert Program Year 2015, Graduate Studies, Khon Kaen University [581H223]	Thailand Research Fund, Khon Kaen University; Invitation Research 2018, Faculty of Medicine, Khon Kaen University; Research Fund for Supporting Lecturer to Admit High Potential Student to Study and Research on His Expert Program Year 2015, Graduate Studies, Khon Kaen University	This study was supported by the Thailand Research Fund (Grant number MRG5980002), Invitation Research 2018, Faculty of Medicine (IN61210) and Research Fund for Supporting Lecturer to Admit High Potential Student to Study and Research on His Expert Program Year 2015 (581H223), Graduate Studies, Khon Kaen University to KF.	[Anonymous], 2018, LATENT TUBERCULOSIS; [Anonymous], GUID TREATM TUB; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Dooley KE, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-140; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gallo-Oller G, 2018, J IMMUNOL METHODS, V457, P1, DOI 10.1016/j.jim.2018.03.004; Horne DJ, 2010, LANCET INFECT DIS, V10, P387, DOI 10.1016/S1473-3099(10)70071-2; Kaewseekhao B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134168; Lee Hyungmin, 2014, Osong Public Health Res Perspect, V5, pS8, DOI 10.1016/j.phrp.2014.11.001; Leem AY, 2018, SCI REP, V8, P1, DOI [https://doi.org/10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Mack U, LTBI LATENT TUBERCUL, DOI [https://doi.org/10.1183/09031936.00120908, DOI 10.1183/09031936.00120908]; Mirsaeidi M, 2018, INT J MYCOBACT, V7, P1, DOI 10.4103/ijmy.ijmy_164_17; Ramakrishnan K, 2012, CLIN LAB, V58, P165; Seyedrezazadeh E, 2008, RESPIROLOGY, V13, P294, DOI 10.1111/j.1440-1843.2007.01200.x; SIGAL GB, 2017, BIOMARKERS TUBERCULO, V25, P112, DOI DOI 10.1016/J.EBIOM.2017.10.018; Steinbrenner H, 2009, BBA-GEN SUBJECTS, V1790, P1478, DOI 10.1016/j.bbagen.2009.02.014; Thomas HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138982; Touat-Hamici Z, 2014, J BIOL CHEM, V289, P14750, DOI 10.1074/jbc.M114.551994; Wanchu A, 2009, Indian J Chest Dis Allied Sci, V51, P207; Waterborg JH, 2009, SPRINGER PROTOC HAND, P7, DOI 10.1007/978-1-59745-198-7_2; World Health Organization (WHO), GLOB TUB REP 2019; Yong YK, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02789; Zheng D, 2015, LIFE SCI, V123, P9, DOI 10.1016/j.lfs.2014.12.023; Zong Z, 2018, CHINA FRONT MICROBIO, V9, DOI [https://doi.org/10.3389/ fmicb.2018.01858, DOI 10.3389/FMICB.2018.01858]	24	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231834	10.1371/journal.pone.0231834	http://dx.doi.org/10.1371/journal.pone.0231834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	LR9JM	32298370	Green Published, gold			2022-12-26	WOS:000536011400117
J	Molina, M; Carmona, I; Fuentes, LJ; Plaza, V; Estevez, AF				Molina, Michael; Carmona, Isabel; Fuentes, Luis J.; Plaza, Victoria; Estevez, Angeles F.			Enhanced learning and retention of medical information in Alzheimer's disease after differential outcomes training	PLOS ONE			English	Article							STATIN THERAPY; OLDER-ADULTS; MEMORY; ADHERENCE; EXPECTANCIES; NONADHERENCE; RECOGNITION; DIAGNOSIS; CHILDREN; AMYGDALA	Background Adherence to treatment is a crucial factor for patients who have chronic illnesses or multiple morbidities and polypharmacy, which is frequently found in older adults. The non-adherence to medications has important economic and social consequences as well as impacts on the health of the patients. One of the reasons that can explain the low adherence to treatment, is the memory deficits that are characteristics of this population and that are even more evident in cases that involve neurodegenerative diseases. Methods and findings In this study, we explore whether the differential outcomes procedure (DOP), which has been shown to be useful in improving discriminative learning and memory in different populations, may facilitate learning and retention of medical recommendations in older adults who have been diagnosed with Alzheimer's disease. The results demonstrate that when this procedure was applied, the patients showed improvements in learning and long-term retention of two pill/time of day associations in a situation that simulates adherence to medical prescriptions. Conclusions These findings contribute new data about the potential benefits of the DOP in patients with neurodegenerative disorders, highlighting the important role that this procedure could play in addressing important issues related to the health and quality of life of older adults, with or without neurodegenerative diseases, such as low adherence to medical treatments.	[Molina, Michael] Univ Mayor, Fac Humanidades, Escuela Educ, Santiago, Chile; [Carmona, Isabel; Estevez, Angeles F.] Univ Almeria, Dept Psicol, Almeria, Spain; [Fuentes, Luis J.] Univ Murcia, Dept Psicol Basica & Metodol, Murcia, Spain; [Plaza, Victoria] Univ Autonoma Madrid, Dept Psicol Basica, Madrid, Spain; [Plaza, Victoria] Univ Autonoma Chile, Dept Psicol, Santiago, Chile; [Estevez, Angeles F.] Univ Almeria, CERNEP Res Ctr, Almeria, Spain	Universidad Mayor; Universidad de Almeria; University of Murcia; Autonomous University of Madrid; Universidad Autonoma de Chile; Universidad de Almeria	Estevez, AF (corresponding author), Univ Almeria, Dept Psicol, Almeria, Spain.; Plaza, V (corresponding author), Univ Autonoma Madrid, Dept Psicol Basica, Madrid, Spain.; Plaza, V (corresponding author), Univ Autonoma Chile, Dept Psicol, Santiago, Chile.; Estevez, AF (corresponding author), Univ Almeria, CERNEP Res Ctr, Almeria, Spain.	victoria.plaza@uam.es; mafernan@ual.es	Fuentes, Luis J/B-3520-2011; Estevez, Angeles F./N-5804-2014	Fuentes, Luis J/0000-0002-3203-9976; Estevez, Angeles F./0000-0003-0067-0840; CARMONA, ISABEL/0000-0002-1872-9137	ERDF (FEDER) [PSI2015-65248-P, PSI2017-84556-P, RTI2018-094554-A-I00]; Spanish Ministry of Economy and Competitiveness; Spanish Ministry of Economy, Industry and Competitiveness; Spanish Ministry of Science, Innovation and Universities; Chilean Ministry of Education [11140365]	ERDF (FEDER)(European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish Ministry of Economy, Industry and Competitiveness(Spanish Government); Spanish Ministry of Science, Innovation and Universities(Spanish Government); Chilean Ministry of Education	This study was supported by grants from the Spanish Ministry of Economy and Competitiveness, co-funded by ERDF (FEDER) funds to AFE (PSI2015-65248-P); from the Spanish Ministry of Economy, Industry and Competitiveness, co-funded by ERDF (FEDER) funds to LJF (PSI2017-84556-P); from the Spanish Ministry of Science, Innovation and Universities, co-funded by ERDF (FEDER) funds to VP (RTI2018-094554-A-I00); and from the Chilean Ministry of Education to VP (Conicyt-Fondecyt Iniciation 11140365). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adisa Rasaq, 2009, Pharmacy Pract (Granada), V7, P163, DOI 10.4321/s1886-36552009000300006; [Anonymous], 2003, ADHERENCE LONG TERM; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Blanco-Reina E, 2015, EUR J CLIN PHARMACOL, V71, P199, DOI 10.1007/s00228-014-1780-0; Bosworth HB, 2011, AM HEART J, V162, P412, DOI 10.1016/j.ahj.2011.06.007; Carmona I, 2019, COGNITION, V189, P181, DOI 10.1016/j.cognition.2019.04.007; Carmona I, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02671; Chisholm-Burns MA, 2012, J AM PHARM ASSOC, V52, P823, DOI 10.1331/JAPhA.2012.11088; Cho H, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011470; COL N, 1990, ARCH INTERN MED, V150, P841, DOI 10.1001/archinte.150.4.841; El-Saifi N, 2018, J PHARM PRACT, V31, P322, DOI 10.1177/0897190017710524; Estevez AF, 2003, AM J MENT RETARD, V108, P108, DOI 10.1352/0895-8017(2003)108<0108:DOEICA>2.0.CO;2; Estevez AF, 2001, LEARN MOTIV, V32, P48, DOI 10.1006/lmot.2000.1060; Estevez AF, 2007, Q J EXP PSYCHOL, V60, P571, DOI 10.1080/17470210600820039; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gainotti G, 1998, ALZ DIS ASSOC DIS, V12, P152, DOI 10.1097/00002093-199809000-00006; Guerci B, 2019, DIABETES THER, V10, P437, DOI 10.1007/s13300-019-0590-x; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hochhalter A. K., 2000, CLIN GERONTOLOGIST, V22, P3, DOI DOI 10.1300/J018V22N02_; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Kessels RPC, 2003, J ROY SOC MED, V96, P219, DOI 10.1258/jrsm.96.5.219; Leal Hernandez M, 2004, Aten Primaria, V33, P451, DOI 10.1157/13061580; Lopez-Crespo G, 2009, INT PSYCHOGERIATR, V21, P503, DOI 10.1017/S1041610209008576; Martinez L, 2013, LEARN BEHAV, V41, P298, DOI 10.3758/s13420-013-0105-y; Martinez L, 2009, Q J EXP PSYCHOL, V62, P1617, DOI 10.1080/17470210802557827; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Mattis S, 1988, DEMENTIA RATING SCAL; McCormack JC, 2019, J APPL BEHAV ANAL, V52, P870, DOI 10.1002/jaba.578; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Miranda AC, 2019, AM J HEALTH-SYST PH, V76, P560, DOI 10.1093/ajhp/zxz010; Mok LW, 2009, BRAIN RES, V1265, P111, DOI 10.1016/j.brainres.2008.12.072; Molina M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01780; Mravcik V, 2013, PATIENT PREFER ADHER, V7, P1067, DOI 10.2147/PPA.S49113; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; PETERSON GB, 1980, LEARN MOTIV, V11, P267, DOI 10.1016/0023-9690(80)90001-6; Plaza V, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00157; Plaza V, 2012, NEUROPSYCHOLOGY, V26, P483, DOI 10.1037/a0028485; Plaza V, 2011, ACTA PSYCHOL, V136, P129, DOI 10.1016/j.actpsy.2010.11.001; Psychology Software Tools, 2012, E PRIM COMP SOFTW; Ramirez DR, 2007, BEHAV NEUROSCI, V121, P896, DOI 10.1037/0735-7044.121.5.896; REISBERG B, 1982, AM J PSYCHIAT, V139, P1136; Savage LA, 2004, NEUROBIOL LEARN MEM, V82, P109, DOI 10.1016/j.nlm.2004.05.002; Savage LM, 2009, BEHAV BRAIN RES, V198, P1, DOI 10.1016/j.bbr.2008.10.028; Savage LM, 2001, INTEGR PHYS BEH SCI, V36, P182, DOI 10.1007/BF02734092; Savage LM, 1997, PSYCHOBIOLOGY, V25, P303; Silva Germán Enrique, 2005, Acta Med Colomb, V30, P268; Thiruchselvam T, 2012, INT J GERIATR PSYCH, V27, P1275, DOI 10.1002/gps.3778; Trapold M.A., 1972, CLASSICAL CONDITION, P427; Urcuioli PJ, 2005, LEARN BEHAV, V33, P1; Vivas AB, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00364	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2020	15	4							e0231578	10.1371/journal.pone.0231578	http://dx.doi.org/10.1371/journal.pone.0231578			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	LR9JM	32298362	Green Published, gold			2022-12-26	WOS:000536011400068
